NEUROPROTECTIVE AGENTS

/ PILLARS OF LONGEVITY, SCIENCE, SOLUTIONS / By
  1. Neuroprotection by estradiol
  2. Neuroprotection by the inhibition of apoptosis
  3. The problem of assessing effective Neuroprotection in experimental cerebral ischemia
  4. Perinatal brain injury: from pathogenesis to Neuroprotection
  5. Nerve growth factor signaling, Neuroprotection , and neural repair
  6. Neuroprotection by the metabolic antioxidant α-lipoic acid
  7. Adenosine and Neuroprotection
  8. Estrogens and Neuroprotection
  9. Erythropoietin–a novel concept for Neuroprotection
  10. Antioxidant Neuroprotection in Alzheimer’s disease as preventive and therapeutic approach
  11. Neuroprotection against oxidative stress by estrogens: structure-activity relationship
  12. Innate immunity: the missing link in Neuroprotection and neurodegeneration?
  13. Estrogen-mediated Neuroprotection after experimental stroke in male rats
  14. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of Neuroprotection
  15. Neuroprotection in relation to retinal ischemia and relevance to glaucoma
  16. Bilobalide and Neuroprotection
  17. Endocannabinoids and Neuroprotection
  18. Hibernation, a model of Neuroprotection
  19. Neuroprotection and the ischemic cascade
  20. Is Neuroprotection a viable therapy for glaucoma?
  21. Neuroprotection and traumatic brain injury: theoretical option or realistic proposition
  22. Neuroprotection : heat shock proteins
  23. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
  24. Endogenous Neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy
  25. Drug-mediated Neuroprotection and antiepileptogenesis: animal data
  26. Neuroprotection mediated by changes in the endothelial actin cytoskeleton
  27. Glycine antagonist (gavestinel) in Neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial
  28. Experimental stroke and Neuroprotection in the aging rat brain
  29. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant
  30. Erythropoietin-mediated Neuroprotection involves cross-talk between Jak2 and NF-κ B signalling cascades
  31. Neuroprotection by a caspase inhibitor in acute bacterial meningitis
  32. Testosterone‐mediated Neuroprotection through the androgen receptor in human primary neurons
  33. Glycine antagonist in Neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial
  34. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies
  35. Nonproteolytic Neuroprotection by human recombinant tissue plasminogen activator
  36. Cannabinoids and Neuroprotection in global and focal cerebral ischemia and in neuronal cultures
  37. brain cooling during transient focal ischemia provides complete Neuroprotection
  38. Current status and perspectives of Neuroprotection in ischemic stroke treatment
  39. Neuroprotection with noninvasive neurotrophin delivery to the brain
  40. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat
  41. Cytokines in CNS disorders: neurotoxicity versus Neuroprotection
  42. Caspase inhibitor affords Neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury.
  43. Assessment of the retinal nerve fiber layer in clinical trials of glaucoma Neuroprotection
  44. Glaucoma, apoptosis, and Neuroprotection .
  45. Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep
  46. Neuroprotection by (−)-deprenyl and related compounds
  47. A new concept in the pharmacology of Neuroprotection
  48. Neuroprotection by memantine against neurodegeneration induced by β-amyloid (1–40)
  49. The mitogen-activated protein kinase pathway mediates estrogen Neuroprotection after glutamate toxicity in primary cortical neurons
  50. The role of the complement cascade in ischemia/reperfusion injury: implications for Neuroprotection
  51. Current status of Neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies
  52. Neuroprotection by a bile acid in an acute stroke model in the rat
  53. Neuroprotection and traumatic brain injury: the search continues
  54. Neuroprotection by brain -derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase
  55. Neuroprotection by bromocriptine against 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurotoxicity in mice1
  56. Reaction of uric acid with peroxynitrite and implications for the mechanism of Neuroprotection by uric acid
  57. Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia
  58. NOS knockouts and Neuroprotection
  59. Glycogen synthase kinase‐3β, mood stabilizers, and Neuroprotection
  60. The potential of Neuroprotection in glaucoma treatment
  61. The pharmacological manipulation of glutamate receptors and Neuroprotection
  62. Interactions of estrogens and insulin-like growth factor-I in the brain : implications for Neuroprotection
  63. Nuclear estrogen receptor-independent Neuroprotection by estratrienes: a novel interaction with glutathione
  64. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-β
  65. Pathways of neuron-astrocyte interactions and their possible role in Neuroprotection
  66. Role of sodium channel inhibition in Neuroprotection : effect of vinpocetine
  67. Neuroprotection for acute stroke: making clinical trials work
  68. Neurotrophins, Neuroprotection and the blood-brain barrier
  69. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt
  70. The future of Neuroprotection
  71. Evaluation of memantine for Neuroprotection in dementia
  72. Neuroprotection in cerebrovascular disease
  73. Subthalamic nucleus‐mediated excitotoxicity in Parkinson’s disease: a target for Neuroprotection
  74. Erythropoietin and the brain : from neurodevelopment to Neuroprotection
  75. Central nicotinic receptors, neurotrophic factors and Neuroprotection
  76. Potential treatment modalities for glaucomatous neuropathy: Neuroprotection and neuroregeneration.
  77. Hematopoietic factor erythropoietin fosters Neuroprotection through novel signal transduction cascades
  78. Hyperalgesia, anxiety, and decreased hypoxic Neuroprotection in mice lacking the adenosine A1 receptor
  79. Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson’s disease
  80. RGC death in mice after optic nerve crush injury: oxidative stress and Neuroprotection
  81. Inhibition of p38 mitogen‐activated protein kinase provides Neuroprotection in cerebral focal ischemia
  82. Cannabinoids and Neuroprotection
  83. Impact of progestins on estrogen-induced Neuroprotection : synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate
  84. Glia-dependent neurotoxicity and Neuroprotection in mesencephalic cultures
  85. Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson’s disease
  86. Dopamine agonists and Neuroprotection in Parkinson’s disease
  87. Caspase activation and Neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation
  88. New horizons in Neuroprotection
  89. Magnesium for Neuroprotection in ischaemic stroke
  90. GABA and Neuroprotection
  91. Vitamin D hormone confers Neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons
  92. Neuroprotection : is it already applicable to glaucoma therapy?
  93. Minocycline provides Neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia
  94. Neuroprotection by the α2-Adrenoreceptor Agonist Dexmedetomidine in a Focal Model of Cerebral Ischemia
  95. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors
  96. Neuroprotection is unlikely to be effective in humans using current trial designs
  97. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients
  98. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers Neuroprotection during chemical ischemia
  99. Action of Glucocorticoids on Survival of Nerve Cells: Promoting Neurodegeneration or Neuroprotection ?1
  100. Detailed characterization of Neuroprotection by a rescue factor humanin against various Alzheimer’s disease-relevant insults
  101. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension
  102. Epilepsy and Neuroprotection : an illustrated review
  103. … system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and Neuroprotection
  104. Monosialogangliosides, Neuroprotection , and neuronal repair processes.
  105. Nuclear factor κB is a critical determinant in N‐methyl‐d‐aspartate receptor‐mediated Neuroprotection
  106. Melatoninergic Neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge
  107. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia.
  108. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for Neuroprotection
  109. Neuroprotection and dopamine agonists
  110. Vaccination for Neuroprotection in the mouse optic nerve: implications for optic neuropathies
  111. Vitamin E and other antioxidants in Neuroprotection
  112. Mechanisms of Neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein
  113. A putative role for platelet-derived growth factor in angiogenesis and Neuroprotection after ischemic stroke in humans
  114. Caspases and Neuroprotection .
  115. Preconditioning-induced Neuroprotection is mediated by reactive oxygen species
  116. Modeling of acute spinal cord injury in the rat: Neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673
  117. The therapeutic potential of the cannabinoids in Neuroprotection
  118. The protease thrombin is an endogenous mediator of hippocampal Neuroprotection against ischemia at low concentrations but causes degeneration at high …
  119. Apoptosis, Neuroprotection , and retinal ganglion cell death: an overview
  120. Endogenous mechanisms of Neuroprotection : role of zinc, copper, and carnosine
  121. The novel β-blocker, carvedilol, provides Neuroprotection in transient focal stroke
  122. Propofol Neuroprotection in a rat model of ischaemia reperfusion injury
  123. Neuroprotection by propargylamines in Parkinson’s disease: suppression of apoptosis and induction of prosurvival genes
  124. Glial cell survival is enhanced during melatonin‐induced Neuroprotection against cerebral ischemia
  125. Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack
  126. Neuroprotection by dehydroepiandrosteronesulfate: role of an NFκB-like factor
  127. REVIEW■: Neuroprotection in brain Ischemia: An Update (Part I
  128. Differential mechanisms of Neuroprotection by 17 β-estradiol in apoptotic versus necrotic neurodegeneration
  129. On the mechanisms of Neuroprotection by creatine and phosphocreatine
  130. Current understanding of Neuroprotection in glaucoma
  131. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson’s disease
  132. Neuroprotection by S‐nitrosoglutathione of brain dopamine neurons from oxidative stress
  133. Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and Neuroprotection
  134. Cellular and molecular mechanisms of estrogen regulation of memory function and Neuroprotection against Alzheimer’s disease: recent insights and remaining …
  135. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons
  136. Estrogen provides Neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats
  137. Partial Neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats
  138. Molecular Pathology of Cerebral Ischemia: Delayed Gene Expression and Strategies for Neuroprotection a
  139. Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal
  140. Marked age‐dependent Neuroprotection by brain ‐derived neurotrophic factor against neonatal hypoxic—ischemic brain injury
  141. Modest hypothermia provides partial Neuroprotection for ischemic neonatal brain
  142. Stimulation of β-adrenoceptors activates astrocytes and provides Neuroprotection
  143. Indefatigable CA1 sector Neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats
  144. Differential Neuroprotection from human heat shock protein 70 overexpression in in vitro and in vivo models of ischemia and ischemia-like conditions
  145. Dopamine agonists and Neuroprotection in Parkinson’s disease
  146. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos
  147. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for Neuroprotection in stroke and trauma
  148. Inducible nitric oxide synthase expression after traumatic brain injury and Neuroprotection with aminoguanidine treatment in rats
  149. Dopaminergic Neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive …
  150. Medical treatment and Neuroprotection in traumatic brain injury
  151. Autoimmune maintenance and Neuroprotection of the central nervous system
  152. Cellular basis for progesterone Neuroprotection in the injured spinal cord
  153. Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats
  154. Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism
  155. Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia
  156. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells
  157. Alpha-lipoic acid provides Neuroprotection from ischemia-reperfusion injury of peripheral nerve
  158. CDP‐choline: Neuroprotection in transient forebrain ischemia of gerbils
  159. Lithium induces brain -derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for Neuroprotection against glutamate excitotoxicity
  160. Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795
  161. Ca2+ channel antagonists and Neuroprotection from cerebral ischemia
  162. Recombinant human erythropoietin for Neuroprotection : what is the evidence?
  163. Association of serum estrogen level and ischemic Neuroprotection in female rats
  164. Antioxidant property of pramipexole independent of dopamine receptor activation in Neuroprotection
  165. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization
  166. Role of metallothionein and other antioxidants in scavenging superoxide radicals and their possible role in Neuroprotection
  167. Amphiphilic, tri‐block copolymers provide potent, membrane‐targeted Neuroprotection
  168. Neuroprotection by the α2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia
  169. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to Neuroprotection in Parkinson’s disease
  170. Does Neuroprotection improve stroke outcome?
  171. Preconditioning‐induced Neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor‐κB
  172. Neuroprotection of glial cell line‐derived neurotrophic factor in damaged spinal cords following contusive injury
  173. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia
  174. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity
  175. Death and Neuroprotection of retinal ganglion cells after different types of injury
  176. Neuroprotection for ischaemic stroke
  177. Neuroprotection of acute ischemic stroke: where are we?
  178. Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and Neuroprotection
  179. Adenosine A2A Receptors and Neuroprotection
  180. Glaucomatous neurodegeneration and the concept of Neuroprotection .
  181. Neuroprotection of S (+) ketamine isomer in global forebrain ischemia
  182. Neuroprotection by melatonin from kainate‐induced excitotoxicity in rats
  183. Neuroprotection by T-cells depends on their subtype and activation state
  184. Neuroprotection at Drosophila synapses conferred by prior heat shock
  185. Prophylactic Neuroprotection for cerebral ischemia.
  186. Relationship between the increased cell surface α7 nicotinic receptor expression and Neuroprotection induced by several nicotinic receptor agonists
  187. brain -derived neurotrophic factor-mediated Neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3′-kinase …
  188. Neuroprotection after several days of mild, drug-induced hypothermia
  189. Estrogen‐mediated Neuroprotection against β‐amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway
  190. Progesterone Neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease
  191. Neuroprotection by Δ9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity
  192. Cerebrolysin® reduces microglial activation in vivo and in vitro: a potential mechanism of Neuroprotection
  193. Lipid alterations in transient forebrain ischemia: Possible new mechanisms of CDP‐choline Neuroprotection
  194. σ Receptor-mediated Neuroprotection against glutamate toxicity in primary rat neuronal cultures
  195. Hyperbaric oxygen preconditioning induces Neuroprotection against ischemia in transient not permanent middle cerebral artery occlusion rat model.
  196. Dendritic spines for Neuroprotection : a hypothesis
  197. Ginkgo biloba Neuroprotection : Therapeutic implications in Alzheimer’s disease
  198. Discovery of endocannabinoids and some random thoughts on their possible roles in Neuroprotection and aggression
  199. brain damage due to episodic alcohol exposure in vivo and in vitro: furosemide Neuroprotection implicates edema‐based mechanism
  200. Neuroprotection
  201. Conjugation of brain -derived neurotrophic factor to a blood–brain barrier drug targeting system enables Neuroprotection in regional brain ischemia following …
  202. Physiological approaches to Neuroprotection : boosting of protective autoimmunity
  203. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein …
  204. Modest hypothermia provides partial Neuroprotection when used for immediate resuscitation after brain ischemia
  205. Differential damage to auditory neurons and hair cells by ototoxins and Neuroprotection by specific neurotrophins in rat cochlear organotypic cultures
  206. Persistent Neuroprotection with prolonged postischemic hypothermia in adult rats subjected to transient middle cerebral artery occlusion
  207. Drug-induced Neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats
  208. Erythropoietin exerts Neuroprotection in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production
  209. Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector
  210. Differential Neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability …
  211. Combination of intraischemic and postischemic hypothermia provides potent and persistent Neuroprotection against temporary focal ischemia in rats
  212. Accelerated functional recovery and Neuroprotection by agmatine after spinal cord ischemia in rats
  213. Valproate and Neuroprotection
  214. Neuroprotection in acute ischemic stroke
  215. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington’s disease
  216. Is pharmacological Neuroprotection dependent on reduced glutamate release?
  217. Neuroprotection against CA1 injury with metalloporphyrins.
  218. Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats
  219. Symposium overview: the role of glutathione in Neuroprotection and neurotoxicity.
  220. Survival signaling and selective Neuroprotection through glutamatergic transmission
  221. Future of Neuroprotection in Parkinson’s disease
  222. Caffeine’s Neuroprotection against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice
  223. Microglial reaction induced by noncytotoxic methylmercury treatment leads to Neuroprotection via interactions with astrocytes and IL‐6 release
  224. Selective mGluR5 receptor antagonist or agonist provides Neuroprotection in a rat model of focal cerebral ischemia
  225. Neuroprotection in ischemia–reperfusion injury: an antiinflammatory approach using a novel broad-spectrum chemokine inhibitor
  226. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia
  227. Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia
  228. Hypoxic-ischemic brain injury in the newborn: cellular mechanisms and potential strategies for Neuroprotection
  229. Oxidative changes in brain pyridine nucleotides and Neuroprotection using nicotinamide
  230. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral …
  231. Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex—a possible mechanism of Neuroprotection in major depression?
  232. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: Neuroprotection and local regeneration
  233. Neuroimmunophilin ligands exert neuroregeneration and Neuroprotection in midbrain dopaminergic neurons
  234. Quantitative assessment of Neuroprotection against NMDA-induced brain injury
  235. Retrograde cerebral perfusion as a method of Neuroprotection during thoracic aortic surgery
  236. Neuroprotection by pigment epithelial‐derived factor against glutamate toxicity in developing primary hippocampal neurons
  237. Group I and group III metabotropic glutamate receptor subtypes provide enhanced Neuroprotection
  238. Nimodipine Neuroprotection in cardiac valve replacement: report of an early terminated trial
  239. Electroencephalographic burst suppression is not required to elicit maximal Neuroprotection from pentobarbital in a rat model of focal cerebral ischemia
  240. Oxidative stress in the pathogenesis of Alzheimer’s disease and antioxidant Neuroprotection
  241. Treatment of acute ischemic stroke: Part II: Neuroprotection and medical management
  242. NMDA recepter-mediated Neuroprotection by essential oils from the rhizomes of Acorus gramineus
  243. Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-κB and Neuroprotection by antioxidants
  244. Nitric oxide is involved in anoxic preconditioning Neuroprotection in rat hippocampal slices
  245. The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo
  246. Mechanism of Action and Persistence of Neuroprotection by Cell-Permeant Ca2+ Chelators
  247. Neuroprotection in Alzheimer’s disease—new strategies for treatment
  248. KATP channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal Neuroprotection
  249. Neuroprotection by propofol in acute mechanical injury: role of GABAergic inhibition
  250. Neuroprotection by ketamine at the cellular level
  251. Preconditioning‐mediated Neuroprotection : role of nitric oxide, cGMP, and new protein expression
  252. A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides Neuroprotection against NMDA-and hypoxia/hypoglycemia-induced cell death
  253. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression: a prominent role in Neuroprotection against excitotoxicity
  254. Estrogen and Neuroprotection : from clinical observations to molecular mechanisms
  255. Pharmacologic Neuroprotection in experimental spinal cord ischemia: a systematic review
  256. Isoflurane Neuroprotection : a passing fantasy, again?
  257. Neuroprotection by pramipexole against dopamine-and levodopa-induced cytotoxicity
  258. Estrogen-astrocyte interactions: implications for Neuroprotection
  259. Rapid preconditioning Neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C
  260. The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers Neuroprotection
  261. Preconditioning-mediated Neuroprotection through erythropoietin?
  262. Nitric oxide in acute ischaemic stroke: a target for Neuroprotection
  263. Transient ischemia of the retina results in altered retrograde axoplasmic transport: Neuroprotection with brimonidine
  264. Delayed sclerosis, Neuroprotection , and limbic epileptogenesis after status epilepticus in the rat
  265. Animal and culture models of glaucoma for studying Neuroprotection
  266. Neuroprotection in acute ischaemic stroke
  267. Characterization of postischemic behavioral deficits in gerbils with and without hypothermic Neuroprotection
  268. Neuroprotection due to irrigation during bipolar cautery
  269. Corticotropin-releasing hormone-mediated Neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid β …
  270. Is there a rationale for Neuroprotection against dopamine toxicity in Parkinson’s disease?
  271. Dose‐ and time‐dependence of l‐NAME Neuroprotection in transient focal cerebral ischaemia in rats
  272. Nicotine blocks TNF‐α‐mediated Neuroprotection to NMDA by an α‐bungarotoxin‐sensitive pathway
  273. Retracted: Neuroprotection mediated by glial group‐II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol‐3 …
  274. Neuroprotection : a new treatment modality for glaucoma?
  275. Potential signalling pathways underlying corticotrophin‐releasing hormone‐mediated Neuroprotection from excitotoxicity in rat hippocampus
  276. New conceptual approaches for pharmacological Neuroprotection in glaucomatous neuronal degeneration
  277. Hypothermic Neuroprotection : a global ischemia study using 18-to 20-month-old gerbils
  278. Glucose deprivation and chemical hypoxia: Neuroprotection by P2 receptor antagonists
  279. Ischemic preconditioning acts upstream of GluR2 down-regulation to afford Neuroprotection in the hippocampal CA1
  280. N-methyl-D-aspartate receptor-mediated Neuroprotection in cerebellar granule cells requires new RNA and protein synthesis
  281. An improved survival model of hypoxia/ischaemia in the piglet suitable for Neuroprotection studies
  282. Intravenous agents and intraoperative Neuroprotection : beyond barbiturates
  283. p75-mediated Neuroprotection by NGF against glutamate cytotoxicity in cortical cultures
  284. Statins and Neuroprotection
  285. Group I metabotropic glutamate receptors in spinal cord injury: roles in Neuroprotection and the development of chronic central pain
  286. Neuroprotection after focal cerebral ischaemia in hyperglycaemic and diabetic rats
  287. Janus kinase 2, an early target of α7 nicotinic acetylcholine receptor-mediated Neuroprotection against Aβ-(1–42) amyloid
  288. Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco
  289. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis
  290. Anti-oxidative Neuroprotection by estrogens in mouse cortical cultures.
  291. Morphological aspects of spinal cord autoimmune Neuroprotection : colocalization of T cells with B7‐2 (CD86) and prevention of cyst formation
  292. Hypoxia and hypoxia-inducible factor modulated gene expression in brain : involvement in Neuroprotection and cell death
  293. Enoxaparin in experimental stroke: Neuroprotection and therapeutic window of opportunity
  294. Investigations of neurotoxicity and Neuroprotection within the nucleus basalis of the rat
  295. Insulin-like growth factor-1-mediated Neuroprotection against oxidative stress is associated with activation of nuclear factor κB
  296. Neuroprotection is associated with β-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients
  297. Neuroprotection . Models and basic principles
  298. Modulation of neuronal and glial cell function by adenosine and Neuroprotection in vascular demential
  299. Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-κB activation
  300. Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B
  301. Where do we stand on Neuroprotection ? Where do we go from here?
  302. Neuroprotection from glutamate toxicity with ultra-low dose glutamate
  303. Estrogen attenuates tumor necrosis factor-α expression to provide ischemic Neuroprotection in female rats
  304. Cellular delivery of trophic factors for the treatment of Huntington’s disease: is Neuroprotection possible?
  305. Brief electrical stimulation of cerebellar fastigial nucleus conditions long-lasting salvage from focal cerebral ischemia: conditioned central neurogenic Neuroprotection
  306. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers Neuroprotection that exceeds the transduced population
  307. Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart Neuroprotection to an excitotoxin through distinct pathways
  308. Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil
  309. Hypoglycaemia-induced cell death: features of Neuroprotection by the P2 receptor antagonist basilen blue
  310. The Pivotal Role of Iron in NF‐κB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson’s Disease with Iron …
  311. Age‐and concentration‐dependent Neuroprotection and toxicity by TNF in cortical neurons from β‐amyloid
  312. Head trauma and Neuroprotection
  313. Neuroprotection by estrogen via extracellular signal‐regulated kinase against quinolinic acid‐induced cell death in the rat hippocampus
  314. Neuroprotection and aging of the cholinergic system: a role for the ergoline derivative nicergoline (Sermion®)
  315. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons
  316. Corticostriatopallidal Neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration
  317. Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-β
  318. The dopamine agonist cabergoline provides Neuroprotection by activation of the glutathione system and scavenging free radicals
  319. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides Neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
  320. Improved Neuroprotection with hypothermia delayed by 6 hours following cerebral hypoxia-ischemia in the 14-day-old rat
  321. T cell immunity to copolymer 1 confers Neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies
  322. The estrogen receptor is not essential for all estrogen Neuroprotection : new evidence from a new analog
  323. Evidence that brain ‐derived neurotrophic factor Neuroprotection is linked to its ability to reverse the NMDA‐induced inactivation of protein kinase C in cortical neurons
  324. Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide
  325. Attempts to obtain Neuroprotection in Parkinson’s disease
  326. Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor
  327. Stress‐inducible protein 1 is a cell surface ligand for cellular prion that triggers Neuroprotection
  328. Combined argatroban and edaravone caused additive Neuroprotection against 15 min of forebrain ischemia in gerbils
  329. Hypoxia, excitotoxicity, and Neuroprotection in the hippocampal slice preparation
  330. Advances in Neuroprotection trials
  331. Stimulus-dependent activation of NF-κB specifies apoptosis or Neuroprotection in cerebellar granule cells
  332. Traumatic Neuroprotection with inhibitors of nitric oxide and ADP-ribosylation
  333. … : an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in Neuroprotection
  334. Acute administration of Ginkgo biloba extract (EGb 761) affords Neuroprotection against permanent and transient focal cerebral ischemia in Sprague‐Dawley rats
  335. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members
  336. Estrogen Neuroprotection : the involvement of the Bcl-2 binding protein BNIP2
  337. Unexpected Neuroprotection observed with the adenosine A2A receptor agonist CGS 21680
  338. Inhibition of the cyclooxygenase isoenzymes COX‐1 and COX‐2 provide Neuroprotection in the MPTP‐mouse model of Parkinson’s disease
  339. Phosphatidylinositol 3‐kinase mediates Neuroprotection by estrogen in cultured cortical neurons
  340. Long-term Neuroprotection by benzodiazepine: full versus partial agonists after transient cerebral ischemia in the gerbil
  341. Role of calcium in sigma-mediated Neuroprotection in rat primary cortical neurons
  342. Dose-dependent Neuroprotection with tiagabine in a focal cerebral ischemia model in rat
  343. Pharmacology of AMPA antagonists and their role in Neuroprotection
  344. Nitric-oxide synthase and neurodegeneration/Neuroprotection
  345. Comparative optic nerve physiology: implications for glaucoma, Neuroprotection , and neuroregeneration.
  346. Design and application of HSV vectors for Neuroprotection
  347. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA‐074: a novel strategy for Neuroprotection based on ‘calpain–cathepsin …
  348. Monitoring for Neuroprotection : new technologies for the new millennium
  349. Assessment of cannabinoid induced gene changes: tolerance and Neuroprotection
  350. Neuroprotection by ATP-dependent potassium channels in rat neocortical brain slices during hypoxia
  351. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
  352. Opportunities for Neuroprotection in traumatic brain injury
  353. Strategies for Neuroprotection
  354. Prolonged induction of neuronal NOS expression and activity following cortical spreading depression (SD): implications for SD-and NO-mediated Neuroprotection
  355. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting Neuroprotection in cerebral ischemia through apoptosis reduction …
  356. Neuroprotection by the pyridoindole stobadine: a minireview
  357. Expectations in the treatment of retinal diseases: Neuroprotection
  358. Immortalized dopamine neurons: A model to study neurotoxicity and Neuroprotection
  359. Neuroprotection : the role of neuroglia.
  360. Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for Neuroprotection
  361. Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation.
  362. Strategies for Neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies.
  363. Neuroprotection in brain Ischemia: An Update (Part II
  364. Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity
  365. Felbamate Neuroprotection against CA1 traumatic neuronal injury
  366. BDNF and NGF afford in vitro Neuroprotection against ethanol combined with acute ischemia and chronic hypoglycemia
  367. Neuroprotection by scatter factor/hepatocyte growth factor and FGF‐1 in cerebellar granule neurons is phosphatidylinositol 3‐kinase/akt‐dependent and MAPK/CREB …
  368. A dose-response study of Neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
  369. Clinical trial update: Neuroprotection against acute ischaemic stroke
  370. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation
  371. Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view
  372. Harnessing the immune system for Neuroprotection : therapeutic vaccines for acute and chronic neurodegenerative disorders
  373. Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX)
  374. Monitoring Neuroprotection and restorative therapies in Parkinson’s disease with PET
  375. Dose‐related Neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of Neuroprotection in α4 nicotinic receptor subunit knockout mice
  376. Neuroprotection by corticotropin releasing factor during hypoxia in rat brain .
  377. Evaluation of Neuroprotection by lithium and valproic acid against ouabain‐induced cell damage
  378. Do statins afford Neuroprotection in patients with cerebral ischaemia and stroke?
  379. … audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of Neuroprotection …
  380. Multiple pathways of Neuroprotection against oxidative stress and excitotoxic injury in immature primary hippocampal neurons
  381. Optic nerve degeneration and potential Neuroprotection : implications for glaucoma
  382. Gene therapeutic strategies for Neuroprotection : implications for Parkinson’s disease
  383. Toxicity of CSF in motor neurone disease: a potential route to Neuroprotection
  384. Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat
  385. AP-1 proteins in the adult brain : facts and fiction about effectors of Neuroprotection and neurodegeneration
  386. Intrinsic neurons of fastigial nucleus mediate neurogenic Neuroprotection against excitotoxic and ischemic neuronal injury in rat
  387. Lidocaine for Neuroprotection : more evidence of efficacy
  388. -Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl)-Piperidine Affords Neuroprotection From Focal Ischemia With Prolonged Reperfusion
  389. Neurotoxicity of polyamines and pharmacological Neuroprotection in cultures of rat cerebellar granule cells
  390. Feasibility and efficacy of balloon-based Neuroprotection during carotid artery stenting in a single-center setting
  391. Oestrogen and nerve growth factor–Neuroprotection and repair in Alzheimer’s disease
  392. brain antioxidant regulation in mammals and anoxia-tolerant reptiles: balanced for Neuroprotection and neuromodulation
  393. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and Neuroprotection in the central nervous system
  394. Interactions between Hypothermia and the Latency to Ischemic Depolarization Implications for Neuroprotection
  395. Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced Neuroprotection in stroke rats
  396. Neuroprotection with anaesthetic agents
  397. Enhanced Neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate
  398. Cellular basis of steroid Neuroprotection in the wobbler mouse, a genetic model of motoneuron disease
  399. Neuroprotection for Parkinson’s disease
  400. Diazepam-induced Neuroprotection : dissociating the effects of hypothermia following global ischemia
  401. Cyclic guanosine 3′, 5′-monophosphate-mediated Neuroprotection by nitric oxide in dissociated cultures of rat dorsal root ganglion neurones
  402. Neuroprotection for Parkinson’s disease: a new approach for a new millennium
  403. Hypothermic Neuroprotection of peripheral nerve of rats from ischaemia–reperfusion injury
  404. Conus peptides and Neuroprotection .
  405. Activation of σ1 receptor subtype leads to Neuroprotection in the rat primary neuronal cultures
  406. Review of clinical trials of Neuroprotection in acute spinal cord injury
  407. Postischemic hypothermia and IL-10 treatment provide long-lasting Neuroprotection of CA1 hippocampus following transient global ischemia in rats
  408. Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemia
  409. Spectrin proteolysis in the hippocampus: a biochemical marker for neuronal injury and Neuroprotection
  410. Neuroprotection in acute ischaemic stroke
  411. Neuroprotection by 2-h postischemia administration of two free radical scavengers, α-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN …
  412. Neonatal ischemic Neuroprotection by modest hypothermia is associated with attenuated brain acidosis
  413. Neuroprotection by recombinant thrombomodulin
  414. Iron and neurodegeneration: prospects for Neuroprotection
  415. Neurodegeneration and Neuroprotection in Parkinson’s disease
  416. Neuroprotection in Parkinson’s disease: love story or mission impossible?
  417. Nitric oxide synthase expression in the transient ischemic rat retina: Neuroprotection of betaxolol
  418. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives
  419. Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+ antagonist nimodipine, influence of aging and developmental drug treatment
  420. Injury mechanisms in the ischaemic penumbra–approaches to Neuroprotection in acute ischaemic stroke
  421. Calcium antagonists: their role in Neuroprotection
  422. Discovery of molecular mechanisms of Neuroprotection using cell-based bioassays and oligonucleotide arrays
  423. Neuroprotection by peptide growth factors against anoxia and nitric oxide toxicity requires modulation of protein kinase C
  424. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat
  425. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.
  426. Role of alpha-2 adrenergic receptors in Neuroprotection and glaucoma
  427. Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides Neuroprotection
  428. Studies of damaged processes in the nervous system and possibilities of Neuroprotection
  429. NMDA antagonists: their role in Neuroprotection
  430. cDNA microarray to study gene expression of dopaminergic neurodegeneration and Neuroprotection in MPTP and 6-hydroxydopamine models: implications for …
  431. The rapid effects of estrogen are implicated in estrogen-mediated Neuroprotection
  432. Metallothionein induction in human CNS in vitro: Neuroprotection from ionizing radiation
  433. Neuroprotection and intracellular Ca2+ modulation with fructose-1, 6-bisphosphate during in vitro hypoxia–ischemia involves phospholipase C-dependent signaling
  434. Cerebral Neuroprotection and ketamine
  435. Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia
  436. … 4-aryl-3-aminoquinolin-2-ones: a new class of calcium-Dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke Neuroprotection
  437. Beneficial autoimmune T cells and posttraumatic Neuroprotection
  438. Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model
  439. Neuronal cell death and strategies for Neuroprotection
  440. Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3β pathway: Implications for Neuroprotection
  441. Neurogenesis and Neuroprotection in the Adult brain : A Putative Role for 5‐Lipoxygenase?
  442. … (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in Neuroprotection
  443. … precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: Neuroprotection by Ca2+ antagonist …
  444. Neuroprotection with felbamate: a 7-and 28-day study in transient forebrain ischemia in gerbils
  445. Neuroprotection and antiepileptogenesis: overview, definitions, and context
  446. Neuroprotection in neuroanesthesia: current practices in Germany
  447. Selegiline: current perspectives on issues related to Neuroprotection and mortality
  448. Early and late molecular events in neurodegeneration and Neuroprotection in Parkinson’s disease MPTP model as assessed by cDNA microarray; the role of iron
  449. Usefulness of postischemic thrombolysis with or without Neuroprotection in a focal embolic model of cerebral ischemia
  450. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile
  451. Role of potassium channels in the central neurogenic Neuroprotection elicited by cerebellar stimulation in rat
  452. Sodium and potassium channel modulators: their role in Neuroprotection
  453. Liposome-mediated transfer of the bcl-2 gene results in Neuroprotection after in vivo transient focal cerebral ischemia in an animal model
  454. Neuroprotection disappointment yet aGAIN
  455. Les leucomalacies périventriculaires. IL Diagnostic, séquelles et Neuroprotection
  456. Excitotoxicity and Neuroprotection
  457. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N …
  458. Inhibition of glutamate release: a possible mechanism of hypothermic Neuroprotection
  459. Glutamate-induced excitotoxicity in retina: Neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers
  460. Neuroprotection by melatonin from glutamate‐induced excitotoxicity during development of the cerebellum in the chick embryo
  461. HU-211, a nonpsychotropic cannabinoid, produces short-and long-term Neuroprotection after optic nerve axotomy
  462. Neuroprotection —rationale for pharmacological modulation of Na+-channels
  463. The effect of oedema and tissue swelling on the measurement of Neuroprotection ; a study using chlormethiazole and permanent middle cerebral artery occlusion in …
  464. Neuroprotection : establishing proof of concept in human stroke
  465. Strategies for Neuroprotection against L‐trans‐2,4‐pyrrolidine dicarboxylate‐induced neuronal damage during energy impairment in vitro
  466. Is there Neuroprotection in Parkinson syndrome?
  467. Amyloid protein precursor stimulates excitatory amino acid transport: implications for roles in Neuroprotection and pathogenesis
  468. Neuroprotection failure in stroke
  469. Hypothermia and metabolic stress: narrowing the cellular site of early Neuroprotection .
  470. Neuroprotection with Bcl-220–34 peptide against trauma
  471. In glaucoma, should enthusiasm about Neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
  472. Therapeutic coma or Neuroprotection by anaesthetics
  473. Cellular and molecular basis of estrogen’s Neuroprotection
  474. VIP Neuroprotection against excitotoxic lesions of the developing mouse brain
  475. Combined Neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia.
  476. No additional Neuroprotection provided by barbiturate-induced burst suppression under mild hypothermic conditions in rats subjected to reversible focal ischemia
  477. … as a stressor in mice:: Against the dopaminergic neurotoxicity of d-mdma, low body weight mitigates restraint-induced hypothermia and consequent Neuroprotection
  478. Modeling pediatric head trauma: mechanisms of degeneration and potential strategies for Neuroprotection
  479. Characterization of Neuroprotection from excitotoxicity by moderate and profound hypothermia in cultured cortical neurons unmasks a temperature-insensitive …
  480. Imaging technologies for assessing Neuroprotection in glaucomatous optic neuropathy
  481. ATP-dependent potassium channel mediates Neuroprotection by chemical preconditioning with 3-nitropropionic acid in gerbil hippocampus
  482. Neuroprotection by intrathecal application of liposome-entrapped fasudil in a rat model of ischemia
  483. Neurotoxic action of veratridine in rat brain neuronal cultures: mechanism of Neuroprotection by Ca++ antagonists nonselective for slow Ca++ channels.
  484. Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R, S)‐4‐phosphonophenylglycine
  485. A global hypoxia preconditioning model: Neuroprotection against seizure-induced specific gravity changes (edema) and brain damage in rats
  486. Do dopamine agonists provide Neuroprotection ?
  487. T cell-mediated Neuroprotection involves antithrombin activity
  488. Selective blockade of type-1 metabotropic glutamate receptors induces Neuroprotection by enhancing gabaergic transmission
  489. Transgenic glutathione peroxidase mouse models for Neuroprotection studies.
  490. Metallothionein, neurotrophins and selegiline in providing Neuroprotection in Parkinson’s disease
  491. Neuroprotection against N-methyl-D-aspartate-induced excitotoxicity in rat magnocellular nucleus basalis by the 5-HT1A receptor agonist 8-OH-DPAT
  492. Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats
  493. Retinal neuronal cell death: molecular mechanism and Neuroprotection
  494. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for Neuroprotection studies
  495. Neuroprotection during cardiac surgery: strategies to reduce cognitive decline
  496. Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in Neuroprotection
  497. Vasoprotection as Neuroprotection for the optic nerve
  498. Practical importance of Neuroprotection in Parkinson’s disease
  499. Structure/function in Neuroprotection and apoptosis
  500. Neuroprotection by a novel compound, NS521
  501. A model of ‘epileptic tolerance’for investigating Neuroprotection , epileptic susceptibility and gene expression-related plastic changes
  502. Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl (R) salsolinol, and Neuroprotection by propargylamines
  503. Ketamine racemate and S-(+)-ketamine. Cerebrovascular effects and Neuroprotection following focal ischemia
  504. Neuroprotection for Parkinson’s disease using viral vector-mediated delivery of GDNF
  505. Neuroprotection induced by stimulating A1 or blocking A2A adenosine receptors: an apparent paradox
  506. In vitro Neuroprotection against glutamate-induced toxicity by pGlu-Glu-Pro-NH2 (EEP)
  507. Ketamine and Neuroprotection . Clinical outlook
  508. Intravenous Magnesium for Neuroprotection in Acute Stroke: Clinical Hope Versus Basic
  509. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
  510. Neuroprotection : past successes and future challenges
  511. T cell mediated Neuroprotection is a physiological response to central nervous system insults
  512. Neuroprotection in acute ischaemic stroke. II: Clinical potential
  513. Extradural compression of sensorimotor cortex: a useful model for studies on ischemic brain damage and Neuroprotection
  514. Neuroprotection and antiepileptogenesis: Where are we now?
  515. ACTH/MSH-derived peptides and peripheral nerve plasticity: neuropathies, Neuroprotection and repair
  516. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke
  517. Neuroprotection by the N‐Methyl‐d‐Aspartate Receptor Antagonist CGP 40116: In Vivo and In Vitro Studies
  518. MCI-186: further histochemical and biochemical evidence of Neuroprotection
  519. Neuroprotection in aortic surgery
  520. Cocaine dependence. A clinical syndrome requiring Neuroprotection .
  521. The effect of reperfusion on Neuroprotection using an inhibitor of poly (ADP-ribose) polymerase
  522. Preclinical studies with modafinil. Evidence for vigilance enhancement and Neuroprotection .
  523. Deleterious effects of IL-9–activated mast cells and Neuroprotection by antihistamine drugs in the developing mouse brain
  524. Neuroprotection against ischemic brain injury conferred by a novel nitrate ester
  525. Hypothermic Neuroprotection of peripheral nerve of rats from ischemia–reperfusion injury: intraischemic vs. reperfusion hypothermia
  526. Neuroprotection by novel antagonists at the NMDA receptor channel and glycineB sites
  527. Chemokines released from astroglia by vasoactive intestinal peptide. Mechanism of Neuroprotection from HIV envelope protein toxicity.
  528. Neuroprotection in HIV-positive drug users: implications for antioxidant therapy
  529. Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: in vivo model for drug-induced Neuroprotection ?
  530. Possible role of microglial prostanoids and free radicals in Neuroprotection and neurodegeneration
  531. Glutamate-mediated Neuroprotection against N-methyl-D-aspartate toxicity: a role for metabotropic glutamate receptors
  532. Neuroprotection by caspase inhibitors
  533. Opioids: Epilepsy and Neuroprotection
  534. Assessment of neurotoxicity and “Neuroprotection ”
  535. Evaluation of Neuroprotection and behavioral recovery by the kappa-opioid, PD117302 following transient forebrain ischemia
  536. Neuroprotection by selegiline and other MAO inhibitors
  537. Calcium channel blockers and Neuroprotection
  538. Transcriptional pharmacology of neurodegenerative disorders: novel venue towards Neuroprotection against excitotoxicity?
  539. NO-Related species: Neuroprotection verses neurodestruction
  540. Hydroxyl radicals and nitric oxide in neurotoxicity and Neuroprotection
  541. Neuroprotection in stroke: is it time to consider large-molecule drugs?
  542. Gene transfer for Neuroprotection in animal models of Parkinson’s disease and amyotrophic lateral sclerosis
  543. Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail
  544. Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, Neuroprotection , and adrenomedullary secretion
  545. Clinical trials of Neuroprotection in Parkinson’s disease: long-term selegiline and alpha-tocopherol treatment.
  546. Neuroprotection by memantine as increased by hypothermia and nimodipine
  547. Immunosuppressant Analogs in Neuroprotection
  548. Prophylactic pharmacologic Neuroprotection against focal cerebral ischemia.
  549. The pursuit of effective Neuroprotection during infant cardiac surgery
  550. Correlates of delayed neuronal damage and Neuroprotection in a rat model of cardiac-arrest-induced cerebral ischemia
  551. In vitro Neuroprotection against glutamate toxicity provided by novel non‐competitive N‐methyl‐d‐aspartate antagonists
  552. Neuroprotection in idiopathic Parkinson’s disease
  553. Human retina contains polyamine sensitive [3H]-ifenprodil binding sites: implications for Neuroprotection ?
  554. Neuroprotection by dextromethorphan in acute experimental subdural hematoma in the rat
  555. Neuroprotection by anti-oxidant strategies in Parkinson’s disease
  556. Neuroprotection with herpes simplex vectors expressing virally derived anti-apoptotic agents
  557. Emerging strategies in Neuroprotection
  558. Neuroprotection in stroke: Analysis of failure, and alternative strategies
  559. Neuroprotection in ischemia of the retina in an animal model
  560. Neuroprotection by MK-801 in temperature maintained gerbils
  561. … class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and Neuroprotection
  562. Neuroprotection by A2A receptor antagonists
  563. Neuroprotection by R (−)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus …
  564. Neuroprotection for the new millennium: matchmaking pharmacology and technology
  565. Corticosteroid hormones in Neuroprotection and brain damage
  566. Neuroprotection to the retina: relevance in glaucoma
  567. Quantitative and dynamic MRI of Neuroprotection in experimental stroke
  568. Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative …
  569. Azulenyl nitrones: Colorimetric detection of oxyradical end products and Neuroprotection in the gerbil transient forebrain ischemia/reperfusion model
  570. Delayed multidose treatment with nicotinamide extends the degree and duration of Neuroprotection by reducing infarction and improving behavioral scores up to two …
  571. Cell Death in Spinal Cord Injury (SCI) Requires de Novo Protein Synthesis: Calpain Inhibitor E‐64‐d Provides Neuroprotection in SCI Lesion and Penumbra
  572. Neuroprotection and stroke
  573. Basic neurobiochemical mechanisms of brain Neuroprotection
  574. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides Neuroprotection in the aged parkinsonian rat.
  575. Neuroprotection : fact or fantasy?
  576. Synthesis, brain antihypoxic activity and cell Neuroprotection of 1-substituted-3, 7-dimethylxanthines
  577. Neuroprotection of mild hypothermia: differential effects
  578. Mild hypothermia: an alternative to deep hypothermia for achieving Neuroprotection
  579. Temporal dependent Neuroprotection with propentofylline (HWA 285) in a temporary focal ischemia model
  580. Oxidation of N-methyl (R) salsolinol: involvement to neurotoxicity and Neuroprotection by endogenous catechol isoquinolines
  581. Stereoselective effects of 2, 3-benzodiazepines in vivo: electrophysiology and Neuroprotection studies
  582. The Role of the Metabolism of (−)-Deprenyl in Neuroprotection
  583. Grand prematurity, risk of neuropsychic handicaps and Neuroprotection
  584. Glycosaminoglycans boost insulin-like growth factor-I-promoted Neuroprotection : blockade of motor neuron death in the wobbler mouse
  585. Cell culture models of neuronal degeneration and Neuroprotection
  586. Neuroprotection role of adenosine under hypothermia in the rat global ischemia involves inhibition of not dopamine release but delayed postischemic hypoperfusion
  587. Neuroprotection during hypoxic insults: role of adenosine
  588. Neuroprotection in Parkinson’s disease; a commentary
  589. Neuroprotection (including hypothermia)
  590. Inflammation in stroke—a potential target for Neuroprotection ?
  591. Neuroprotection from focal ischemia by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is dependent on treatment duration in rats
  592. Alcohol Blocks TNFα but Not Other Cytokine‐Mediated Neuroprotection to NMDA
  593. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats
  594. Unilateral Hypoxic-Ischemic Injury in the Neonatal Rat brain Evaluated by In Vivo MRI: Correlation with Histopathology and Neuroprotection by MK-801
  595. Cellular delivery of trophic factors for the treatment of Huntington’s disease: is Neuroprotection possible?
  596. The environmental estrogenic compound bisphenol A exerts estrogenic effects on mouse hippocampal (HT-22) cells: Neuroprotection against glutamate and amyloid …
  597. Neuroprotection in stroke. A critical overview
  598. Prophylactic Neuroprotection to improve stroke outcome
  599. Learning may provide Neuroprotection against dementia.
  600. Excitotoxicity and Neuroprotection
  601. … motor system: Analyses of motoneuron cell death, motility, and target trophic factor activity and in vitro analyses of neurotoxicity and trophic factor Neuroprotection
  602. Positive modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors elicits Neuroprotection after trimethyltin exposure in …
  603. Dopamine receptor agonists mediate Neuroprotection in malonate-induced striatal lesion in the rat
  604. Participation of manganese-superoxide dismutase in the Neuroprotection exerted by copper sulfate against 1-methyl 4-phenylpyridinium neurotoxicity
  605. Neuroprotection against excitotoxicity by N-alkylglycines in rat hippocampal neurons
  606. European Stroke Prevention Study-2 results: serendipitous demonstration of Neuroprotection induced by endogenous adenosine accumulation?
  607. Clinical aspects of Neuroprotection in Parkinson’s disease.
  608. Mechanisms of 1S, 3R-ACPD-induced Neuroprotection in rat hippocampal slices subjected to oxygen and glucose deprivation
  609. Dual effect of cerebrolysin in children with attention deficit syndrome with hyperactivity: Neuroprotection and immunomodulation.
  610. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing
  611. Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in Neuroprotection
  612. The case for Neuroprotection with dopamine agonists
  613. Neuroprotection and perinatal brain care: the field of the future, currently going nowhere!?
  614. Introduction to the special issue on Neuroprotection by steroids: new perspectives
  615. Neurotrophin-mediated Neuroprotection by solid fetal telencephalic graft in middle cerebral artery occlusion: a preventive approach
  616. Hypothermic Neuroprotection in cerebral ischemia
  617. SOD‐1 Transgenic Mice as a Model for Studies of Neuroprotection in Stroke and brain Traumaa
  618. Neuroprotection as initial therapy in acute stroke
  619. Neuroprotection , neuroregeneration, and interaction with insulin‐like growth factor‐I: novel non‐anticoagulant action of glycosaminoglycans
  620. Neuroprotection against ischemia by metabolic inhibition revisited: A comparison of hypothermia, a pharmacologic cocktail and magnesium plus mexiletine
  621. Metallothionein provides ubiquinone-mediated Neuroprotection in Parkinson’s disease
  622. Correlation of CGS 19755 Neuroprotection against in vitro excitotoxicity and focal cerebral ischemia
  623. Immunohistochemical evidence of Neuroprotection by R(−)‐deprenyl and N‐(2‐hexyl)‐N‐methylpropargylamine on DSP‐4‐induced degeneration of rat brain …
  624. Neuroprotection after cardiac arrest
  625. Neuroprotection of completely lacerated spinal cord of adult rats by homotopic and heterotopic transplantation
  626. Acidic fibroblast growth factor delays in vitro ischemia-induced intracellular calcium elevation in gerbil hippocampal slices: a sign of Neuroprotection
  627. Noise, Calpain, Calpain Inhibitors, and Neuroprotection : A Preliminary Report of Tinnitus Control.
  628. Current situation of Neuroprotection in stroke
  629. Peptidic endothelin-1 receptor antagonist, BQ-123, and Neuroprotection
  630. Neuroprotection by caffeine and pentoxifylline during experimental cerebral ischaemia.
  631. Neuroprotection against oxidative stress by serum from heat acclimated rats
  632. Central neurogenic Neuroprotection : Protection of brain from focal ischemia by cerebellar stimulation
  633. Stereoselective Neuroprotection by novel 2, 3-benzodiazepine non-competitive AMPA antagonists against non-NMDA receptor-mediated excitotoxicity in primary rat …
  634. Characterization of mianserin Neuroprotection in experimental spinal trauma: dose/route response and late treatment.
  635. Workshop II:“Neuroprotection ”–the Lugano consensus
  636. Neurotrophins and Neuroprotection improve axonal regeneration into Schwann cell transplants placed in transected adult rat spinal cord
  637. Neuroprotection afforded by some hindered phenols and α-tocopherol in guinea-pig detrusor strips subjected to anoxia-glucopenia and reperfusion-like conditions
  638. Increase of ATP levels by glutamate antagonists is unrelated to Neuroprotection .
  639. RS-100642-198, a novel sodium channel blocker, provides differential Neuroprotection against hypoxia/hypoglycemia, veratridine or glutamate-mediated neurotoxicity …
  640. Neuroprotection by aspirin in cerebrovascular pathology
  641. Failure of Neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy)
  642. Intraoperative Neuroprotection
  643. Motor, cytoarchitectural and biochemical assessment of pharmacological Neuroprotection against CNS damage induced by neonatal exposure to ionizing radiation
  644. Prospects for improved Neuroprotection trials in stroke
  645. In vitro Neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
  646. Neuroprotection in Acute Stroke: Is there Still Hope?
  647. Heme oxygenase 1 transgenic mice as a model to study Neuroprotection .
  648. Neuroprotection in selective focal ischemia in rats by nitrates, an alternative redox manipulation on nitric oxide: experimental model
  649. Is MK-801 Neuroprotection mediated by systemic hypothermia in the immature rat?
  650. Pharmacological strategies for Neuroprotection and rehabilitation
  651. Blockade of voltage-sensitive Na+ channels by the 5-HT1A receptor agonist 8-OH-DPAT: possible significance for Neuroprotection
  652. Neuroprotection after spinal cord injury: state of the science.
  653. For ischemic brain damage, is preclinical evidence of Neuroprotection by presynaptic blockade of glutamate release enough?
  654. Mechanisms of the Neuroprotection of astrocyte during cerebral ischemic disease
  655. Nitric oxide-mediated mitochondrial impairment in neural cells: a role for glucose metabolism in Neuroprotection
  656. Neuroprotection in acute stroke
  657. Neuroprotection afforded by MK-801 against L-2-chloropropionic acid-induced cerebellar granule cell necrosis in the rat
  658. Neuroprotection , anaesthesia, and the brain
  659. Transforming Growth Factor-β Signaling and Neuroprotection
  660. Neuroprotection in vitro and in vivo by cell membrane-permeant Ca2+ chelators.
  661. Parkinson therapy yesterday, today, tomorrow. Neuroprotection gains in importance
  662. Acid–base management–is it relevant for the study design of hypothermic Neuroprotection ?
  663. Neuroprotection and selective vulnerability of neurons within the nucleus basalis magnocellularis
  664. Physiologic roles for the heme oxygenase products carbon monoxide, bilirubin and iron: links to Neuroprotection in stroke and Alzheimer’s disease
  665. Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment
  666. IGF-I in neuronal differentiation and Neuroprotection
  667. Periventricular leukomalacia and brain protection. II. Diagnosis, sequelae and Neuroprotection
  668. Primary dissociated cultures of human brain stem cells: a useful tool for their characterization and Neuroprotection study
  669. Excitatory amino acids and Neuroprotection
  670. The glycine binding site of the NMDA receptor: involvement in neurodegeneration and new approach for Neuroprotection .
  671. Membrane-derived lipid second messengers as targets for Neuroprotection : Platelet-activating factor
  672. Strategies and Techniques for Neuroprotection in Coronary Artery Surgery
  673. Neuroprotection for acute ischemic stroke: an overview
  674. Induced mild hypothermia: the spearhead strategy for effective neonatal Neuroprotection ?
  675. Neuroprotection by NMDA and non-NMDA glutamate antagonists
  676. β2‐Adrenoceptor Agonist Clenbuterol Causes NGF Expression and Neuroprotection
  677. ARL-15896, a NovelN-Methyl-D-aspartate Receptor Ion Channel Antagonist: Neuroprotection against Mitochondrial Metabolic Toxicity and Regional Pharmacology
  678. Isoflurane preconditioning induces Neuroprotection against middle cerebral artery occlusion damage in rat
  679. Cannabinoids and Neuroprotection in stroke
  680. Lipid peroxidation blockade: Neuroprotection from cell membranes to humans
  681. Studies on the interaction between 1, 2, 3, 4-tetrahydro-β-carboline and cigarette smoke: a potential mechanism of Neuroprotection for Parkinson’s disease
  682. Neuroprotection reduces the risk of peri-procedural major strokes and death in octogenarians
  683. Neuroprotection of mild hypothermia beginning at different time intervals on cerebral ischemia/reperfusion injury
  684. Pharmacological Characterization of [3H]-Ifenprodil Binding to Polyamine Binding Sites on Rabbit and Rat Retinal Homogenates: Role in Neuroprotection ?
  685. “Low-Tech” Neuroprotection for brain Injury
  686. Neurotrophic factors, Neuroprotection and hypothalamic function
  687. Excitatory and inhibitory pathways for anoxic preconditioning Neuroprotection in hippocampal slices
  688. CNS Neuroprotection
  689. Biomarkers of 3‐nitropropionic acid (3‐NPA)‐induced mitochondrial dysfunction as indicators of Neuroprotection
  690. … -Ischemic (HI) Hypothermia (Ht) Reduces Necrosis and Apoptosis Correspondingly in the Newborn Rat However Restraint Stress Ameliorates Neuroprotection
  691. Neuroprotection in neuro-ophthalmic disease
  692. Excitotoxic cascade and Neuroprotection in various stages of cerebral development
  693. Perioperative Neuroprotection
  694. Molecular mechanisms of Neuroprotection from neuronal death by trophic factor deprivation
  695. Neuroprotection by High Dose Magnesium in CABG Patients: Preliminary Data
  696. Neuroprotection as Initial Therapy in Acute Stroke: Third Report of an Ad Hoc Consensus Group Meeting
  697. Estrogens and other antioxidants in Neuroprotection : implications for Alzheimer’s disease
  698. Neuroprotection for ischemic stroke
  699. Theoretical aspects of Neuroprotection in acute ischaemic stroke. I: basic mechanisms
  700. Neuroprotection EFFECT OF TAURINE IN YOUNG RATS AND THE MECHANISM INVOLVED
  701. Neuroprotection by free radical scavengers and other antioxidants
  702. Neuroprotection during carotid endarterectomy
  703. Hydroxyl radical generation and post-ischemic reperfusion brain damage implications for Neuroprotection
  704. Mild hypothermia as a clinical strategy for Neuroprotection
  705. Neuroprotection by 21-aminosteroids: insights from latencies of anoxic terminal negativity in hippocampus slices of guinea pig
  706. Mitochondrial approaches to Neuroprotection
  707. Antiepileptics and Neuroprotection
  708. Neuroprotection and antiepileptogenesis
  709. Vaccination for T cell‐mediated Neuroprotection : Dream or reality?
  710. Sights set on Neuroprotection for glaucoma
  711. Future perspectives of gender hormones in Neuroprotection
  712. Hyperbaric oxygen preconditioning induces Neuroprotection against ischemia in transient not permanent middle cerebral artery occlusion rat model
  713. Results of two controlled studies on estrogen: avenue to Neuroprotection in schizophrenia
  714. Neuroprotection by neurotrophic factors in apoptosis
  715. Regulation of cyclic AMP synthesis in microglial cells and possible role of cyclic AMP in Neuroprotection
  716. Mild hypothermia provides Neuroprotection in an in vitro model of fetal cerebral ischemia.
  717. Current situation of experimental studies of glaucomatous optic Neuroprotection therapy [J]
  718. Mitochondria: Aspects for Neuroprotection
  719. No Naip: naff Neuroprotection
  720. gp120-Neuroprotection by mernantine
  721. Selective estrogen receptor modulator LY353381. HCl-mediated Neuroprotection and Bcl-2 expression after experimental stroke
  722. Monoamine oxidase inhibition and Neuroprotection by N1‐propargylphenelzine
  723. Plasma and CSF levels of dizocilplne (MK-801) required for Neuroprotection in the quinolinate-injected rat striatum
  724. Neuroprotection in glaucoma. Where is the clinical evidence?
  725. Modeling neurodegeneration and Neuroprotection in hippocampal slices
  726. Treatment of laser-induced retinal injuries by Neuroprotection
  727. Deleterious consequences of corticosteroid exposure: possible therapeutic Neuroprotection
  728. Neuroprotection in cerebral ischemia
  729. Pharmacological treatment of laser eye injuries by Neuroprotection
  730. HIGH PROSTAGLANDIN (PG) LEVELS IN THE PERINATAL PERIOD CONFER Neuroprotection .† 1218
  731. Free radical scavengers in Neuroprotection
  732. Rationale for the use of soy phytoestrogens for Neuroprotection
  733. Neuroprotection of cultured foetal rat hippocampal cells against glucose deprivation: are GABAergic neurons less vulnerable or more sensitive to TCP protection?
  734. Excitotoxicity, cerebral ischemia, and Neuroprotection by competitive NMDA receptor antagonists
  735. Neuroprotection IN ICU
  736. Effect of fractalkine on Neuroprotection
  737. Neuronal death mode switch and neurogenesis as in vivo Neuroprotection
  738. LONG-TERM Neuroprotection BY MATERNALLY-ADMINISTERED MAGNESIUM SULFATE (MgSO 4) IN PRETERM INFANTS IS RELATED TO INITIAL POST …
  739. Experimental and Clinical Neuroprotection : An Update
  740. KN-62 provides Neuroprotection against glutamate-induced excitotoxicity in neurons.
  741. Intraoperative Neuroprotection
  742. … inhibitors in Alzheimer’s disease: An experimental study on mechanisms of interatcion with muscarinic and nicotinic receptors and Neuroprotection
  743. A model of neonatal cerebral ischemia in rats (“levine”) to study Neuroprotection and neuroregeneration,”
  744. Beyond Neuroprotection : the protection of axons and oligodendrocytes in cerebral ischemia
  745. The approach of Neuroprotection for the new millennium
  746. Caroverine Depressesthe Activity of Cochlear Glutamate Receptors (in vivo Model for Drug-Induced Neuroprotection )
  747. Mitochondrial dysfunction in neurodegeneration: prospects for Neuroprotection
  748. Mild and moderate hypothermia for Neuroprotection
  749. Immune-mediated cell death and Neuroprotection in neurodegenerative diseases
  750. Molecular mechanism underlying Neuroprotection by rasagiline
  751. of Neuroprotection in the CNS
  752. Trophic factors, Neuroprotection and spinal cord repair
  753. The Pathophysiology of Stroke: Neuroprotection Following Stroke and Head Injury
  754. Neuroprotection in rabbit retina with N-acetyl-aspartylglutamate and 2-phosphonyl-methyl pentanedioic acid
  755. The role of estrogen receptor subtypes alpha and beta in developmental Neuroprotection and neurotrophism.
  756. Neuroprotection in Neuro-Ophthalmology-Introduction
  757. EARLY CEREBRAL Neuroprotection BY MATERNALLY-ADMINISTERED MAGNESIUM SULFATE (MgSO 4) IN PRETERM INFANTS IS RELATED TO INITIAL …
  758. Central neurogenic regulation of regional cerebral blood flow (rCBF) and relationship to Neuroprotection
  759. Neuroprotection of selective brain hyprothermia to neonates with the hypoxic-ischemic brain damage
  760. Neuroprotection with tetracyclines in brain ischemia models
  761. Lack of Neuroprotection by glutamate antagonist lubeluzole after transient global cerebral ischemia in fetal sheep
  762. Head Cooling and Neuroprotection
  763. Preservation Of Ganglion Cells In Adult Retinal Tissue Cultures-An In Vitro-Model For Neuroprotection
  764. prophylactic Neuroprotection • Design of clinical trials for prophylactic Neuroprotection • Conclusion
  765. Neuroprotection During CPB: From Mechanisms to Interventions
  766. Quantitative DWI analysis of Neuroprotection against soman-induced neuropathology
  767. The Endocannabinoid Anandamide: Metabolism & Neuroprotection
  768. 2 Understanding cerebral energy metabolism: a key to successful Neuroprotection
  769. An inhibitor of injury-induced COX-2 transcriptional activation elicits Neuroprotection in a brain damage model
  770. Substrate and mechanism of central neurogenic Neuroprotection .
  771. Neuroprotection in Parkinson’s Disease
  772. Neuroprotection as a possible therapy in glaucoma
  773. Neuroprotection in cerebral ischemia
  774. Poster Sessions CP11: Neurotoxicity and Neuroprotection
  775. Lubeluzole pretreatment does not provide Neuroprotection against transient global cerebral ischemia in fetal sheep near term
  776. Head Injuries: A Target for Neuroprotection
  777. Neuroprotection and Stroke: Neuroprotectants as initial therapy
  778. New evidence for Neuroprotection by estrogen
  779. Nitric oxide-induced neurotoxicity versus Neuroprotection ; relationship with selective motor neuronal death
  780. Neuroprotection of Excitotoxic brain Lesions in the Newborn Mouse by Glycine Antagonist and Inhibitor of No°. 159
  781. Sex hormones, Neuroprotection and cognition
  782. Neuregulins, Neuroprotection and Parkinson’s Disease
  783. Cerebral ischemia and Neuroprotection from the viewpoint of the neurosurgeon
  784. Hypothermia for Neuroprotection
  785. Probing into signaling transduction mechanisms of ischemic preconditioning based on generality of cardioprotection and Neuroprotection
  786. PPARγ: a new avenue to Neuroprotection
  787. Global cerebral ischemia and Neuroprotection .
  788. Early detection of paracentral defects: Implications for Neuroprotection in primary open-angle glaucoma
  789. Mechanisms of reversible injury and Neuroprotection
  790. Reactive oxygen species mediate Neuroprotection induced by mitochondrial ATP-sensitive potassium channel opener in rat hippocampal slices during hypoxia
  791. Neuroprotection and neurotransplantation strategies in models of Parkinson’s disease
  792. Electrocortical concomitants of Neuroprotection and ischemic damage following cerebral circulatory arrest.
  793. Is Neuroprotection the Next Wave In Glaucoma Management?
  794. NEURODEGENRATION AND Neuroprotection IN SEVERE RETINAL DYSFUNCTION
  795. Possible Mechanisms of Neuroprotection in Response to Diverse Insults
  796. Deep brain Stimulation and Neuroprotection
  797. Neuroprotection in optic neuropathy: assessment of effect
  798. Medical management of head injury and Neuroprotection
  799. Cerebral Ischemia: Pathophysiology and Neuroprotection
  800. An experimental study on the Neuroprotection of magnesium sulfate.
  801. Serum from patients with diabetic neuropathy impairs laminin Neuroprotection by altering laminin receptor integrin expression
  802. Correlation between 5‐HT Content and Uptake Site Density following (S)‐MDMA and Dexfenfluramine‐induced Depletion, and with Neuroprotection by the Glycine …
  803. Neuroprotection : the next step in glaucoma therapy
  804. Neuroprotection in schizophrenia-What does it mean?-What means do we have?
  805. Neuroprotection : Rescuing the brain from endogenous assassins
  806. Physical and Pharmacological Neuroprotection in Cardiac Surgery
  807. Dual-action drug gives good Neuroprotection
  808. Neuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson’s Disease
  809. Milestones in Neurotoxicity and Neuroprotection : A Tribute to Professor Toshiharu Nagatsu
  810. Neuroprotection : ion flux and receptor mechanisms
  811. Effects of oxidative stress and Neuroprotection in apoptosis in neuronal cell models
  812. Minocycline Provides Neuroprotection
  813. Limiting Apoptosis as a Strategy for CNS Neuroprotection
  814. Neuroprotection : The Next Breakthrough in Glaucoma?
  815. Neuroprotection for acute ischemic stroke: Who is most to blame for current failure?
  816. Angiotensin II receptors: New targets for Neuroprotection
  817. Neuroprotection in an animal model of retinal ischemia
  818. Carotid artery stenting with Neuroprotection : a single center experience
  819. Pay attention to the study and clinical application of Neuroprotection for retinal diseases
  820. Combined Neuroprotection /Thrombolysis in Acute Stroke
  821. Partial Neuroprotection to oxidative stress by selective antioxidants in culture
  822. Insulin, Hypoglycemia, and Ischemic Neuroprotection
  823. Neuroprotection From Op-Induced Seizures and Neuropathology.
  824. Neuroprotection effect of taurine in young rats and the mechanism involved
  825. Blood perfusion-independent Neuroprotection induced by antiplatelet agents and its gender-difference
  826. Expression and Neuroprotection of Vascular Endothelial Growth Factor in an in vitro Ischemia
  827. Neuroprotection by Drug-Induced Neurotrophic Factors
  828. The study of Neuroprotection of bcl-2 gene by transfecting it into PC12 cell line
  829. Novel mediators of ischemic preconditioning induced Neuroprotection
  830. c‐DNA Microarray to determine molecular events in neurodegeneration and Neuroprotection
  831. Combining Neuroprotection with thrombolysis: how to translate laboratory success to our clinical trials
  832. Neuroprotection and Stroke: Stroke and the role of the emergency physician
  833. Transcriptional mechanisms of Neuroprotection by iron chelators
  834. Neuroprotection IN CNS DISEASES. 1997. Edited by PR Bar and M. Flint Beal. Published by Marcel Dekker Publishers. 585 pages. $ C241. 00
  835. Neuroprotection With NPS1506, A Novel NMDA Receptor Antagonist: 605
  836. Novel players in Neuroprotection and tissue reorganisation after hippocampal lesion
  837. Neuroprotection for Nerve Agent-Induced brain Damage
  838. Putative mechanisms of cortical spreading depression-induced Neuroprotection .
  839. Neurochemical Changes Following Stroke: Role in Neuroprotection and Cardiac Susceptibility
  840. Blood perfusion-independent Neuroprotection induced by antiplatelet agents and its gender-difference
  841. Neuroprotection and Functional Alterations in Mice Over-Expressing Heat Shock Protein 70i
  842. An investigation into the mechanism responsible for clomethiazole-induced Neuroprotection in a rat model of severe global ischemia.
  843. Neuroprotection : A Society of Cardiovascular Anesthesiologists Monograph
  844. Molecules for Neuroprotection and Regeneration in Animal Models of Parkinson’s Disease
  845. Neuroprotection from brain Injury by Novel Estrogens
  846. Neuroprotection of retinal ganglion cells in experimental models of glaucoma. A review
  847. Results of two controlled studies on estrogen: avenue to Neuroprotection in schizophrenia
  848. Neuroprotection by Progesterone Through Simulation of Mitochondrial Gene Expression
  849. Postmortem interval and anesthetic Neuroprotection in regenerating cortical neuron cultures used as a model for TNF Neuroprotection from beta-amyloid toxicity.
  850. Assessment of ischemic damage and Neuroprotection in an experimental model of forebrain ischemia
  851. Diltiazem-Induced Neuroprotection in an In Vitro Model of Photoreceptor Degeneration
  852. Neuroprotection from delayed post-ischemic administration of a metalloporphyrin catalytic antioxidant in the rat
  853. Neuroprotection Profile of the High Affinity NMDA Receptor Antagonist Conantokin-G
  854. Neuroprotection by heat shock protein 27 in sensory and motor neurons
  855. The Neuroprotection effects of basic fibroblast growth factor on focal cerebral ischemia in rats and the expression of bax
  856. Neuroprotection of Propofol during an In Vitro Cerebral Ischemia: Glutamate Transporters Are a Major Target
  857. Interactions Between Hypothermia and the Latency to Ischemic Depolarization: Implications for Neuroprotection
  858. Prenatal Choline Supplementation Modifies brain Development: Improved cognition and Neuroprotection
  859. East of England Neonatal Neuroprotection Guideline Diagnosis & Management of Neonatal Seizures in the Term Infant
  860. Delayed post ischemic hypothermia: A six month survival study using behavioral and histological assessments of Neuroprotection
  861. Neuroprotection of Hypothermia in Full Term Neonates After Asphyxia: a Safety Study
  862. The Neuroprotection effects of basic fibroblast growth factor on focal cerebral ischemia in rats and the expression of bax
  863. Neuroprotection with the N-methyl-D-aspartate antagonist dizocilpine (MK-801) in a model of focal ischaemia
  864. Estrogen provides Neuroprotection in focal cerebral ischemia modulation and bcl-2 protein expression
  865. Role of intracellular calcium in neuronal death following cerebral ischemica: Neuroprotection by dantrolene and BCL-2.
  866. Neuroprotection by Selective Nitric Oxide Synthase Inhibition at 24 Hours After Perinatal Hypoxia-Ischemia
  867. Electrophysiologic Evidence of Functional Neuroprotection of Photoreceptors by X-Linked Inhibitor of Apoptosis (XIAP) in a Chemotoxic Model of Retinal …
  868. Hippocampal Expression of a Human GRINL1A Complex Transcription Unit (CTU) Splice Variant Suggests a Role in Neuroprotection
  869. Apoptotic degeneration induction in retinal cells by acute ocular hypertension and Neuroprotection by troxolol
  870. The Neuroprotection effect of acute infective brain edema induced by pertussis bacilli in rat
  871. MODULATION OF CEREBRAL BLOOD FLOW IS NOT THE MECHANISM OF Neuroprotection IN TRANSGENIC MICE OVER EXPRESSING HUMAN …
  872. Tumor necrosis factor appear the Neuroprotection through the enhancement of transient outward potassium currents in cultured rat cortical neurons
  873. … family is the largest and fastest-growing family of ion channels. Evidence is accumulating that modulation of potassium channels is a new approach to Neuroprotection …
  874. Neuroprotection for Parkinson’s disease using viral vector-mediated delivery of GDNF
  875. Nimodipine Neuroprotection does not decrease thromboxane release following global cerebral ischemia
  876. ESTROGEN PROVIDES PERFUSION-INDEPENDENT Neuroprotection IN RAT TRANSIENT FOREbrain ISCHEMIA
  877. Mechanisms of dopamine D2-induced Neuroprotection against glutamate neurotoxicity in rat mesencephalon
  878. Neuroprotection of 1400W, a Selective Inhibitor of Inducible Nitric Oxide Synthetase in Rat after Traumatic brain Injury
  879. Chromosome Mapping of the Human Homologue of a New Glutamate Receptor Gene Suggests Roles in Neuroprotection and Autism
  880. Investigation of sigma and dextromethorphan-like Neuroprotection using glutamate-induced LDH release, cellular morphology and dynamic calcium signaling.
  881. 11 Beyond NMDA antagonists: looking to the future of Neuroprotection
  882. Neuroprotection of Progesterone on the Hippocampal Neurons of Gerbil Following Transient Forebrain Ischemia
  883. Delayed neurodegeneration induced by extracellular lactacidity and Neuroprotection by basic fibroblast growth factor in rat hippocampal neurons
  884. Neuroprotection effects of exogenous adrenomedullin against hypoxic-ischemia reperfusion brain damage in neonatal rats
  885. Outcome From Temporary brain Artery Clipping Using Etomidate or Desflurane for Neuroprotection
  886. Mechanisms of cerebral injury and strategies for Neuroprotection following deep hypothermic circulatory arrest in the neonatal piglet
  887. Poster Sessions CP11: Neurotoxicity and Neuroprotection . Secretory phospholipase A2 signalling partly overlaps glutamate‐mediated events
  888. Roles of hypoxia regulated genes/protein in Neuroprotection against hypoxia injury in differentiated SH-SY5Y cells preconditioned with CoCl_2
  889. Nitric oxide synthase is required for nerve growth factor-mediated Neuroprotection in cerebellar granule cell cultures [J]
  890. Neuroprotection in the hibernating brain : tissue trauma and glutamate studied by microdialysis
  891. DEXAMETHASONE Neuroprotection IS ASSOCIATED WITH PRESERVED EXPRESSION OF BCL-2 AND SUPPRESSION OF GLIAL FIBRILLARY ACID …
  892. Development of novel treatment against glaucoma; Intraocular pressure-lowering by cytoskeletal drugs and Neuroprotection by neurotrophic factors.
  893. … of mild hypothermia-assisted stereotactic hematoma puncture and catheter drainage on postoperative intracranial pressure and Neuroprotection in elderly patients …
  894. Alzheimer’s Disease–Neuroprotection
  895. Blockade of the N-methyl-D-aspartate-type glutamate receptor in the animal: Target for Neuroprotection in head trauma and brain ischemia
  896. Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris-serendipitous demonstration of Neuroprotection induced by endogenous …
  897. Serotonin (5-HT)1A Receptor Agonists and Neuroprotection
  898. Acidosis and Neuroprotection in two types of acidosis model rats under isoflurane anesthesia: evaluation of blood flow, pH and amino acid levels in the cortex
  899. GABA and Neuroprotection : Do GABAergic circuitries play a critical role in the regulation of seizure-induced neuronal damage and synaptic reorganization in the rat …
  900. Enhancement of entorhinal-dentate evoked potentials following repeated electroconvulsive shock seizures in the rat, Neuroprotection studies
  901. Akerud P, Canals JM, Snyder EY, et al. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of …
  902. α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid‐mediated Neuroprotection requires TRKB receptor activation
  903. … Resource Utilization in the Three Months after Acute Stroke: A Report on 1604 Patients from the Glycine Antagonist in Neuroprotection (GAIN) Americas Trial
  904. Erratum: Sheardown MJ, Knutsen LJS (1996): Unexpected Neuroprotection observed with the adenosine A2A receptor agonist CGS 21680. Drug Dev Res 39:108 …
  905. Posthypoxic hypothermia for 24 hrs in unsedated newborn pigs gives no Neuroprotection
  906. 5 Selective modulation of voltage-gated sodium channels: a rational approach for Neuroprotection
  907. Identification of a novel synergistic interaction between 17 B-estradiol and glutathione in Neuroprotection .
  908. Neurotoxicity and clonal mouse hippocampal cell line (HT-22): Neuroprotection by tamoxifen, bisphenol-A and pregnenalone.
  909. … ICAM-1 MONOCLONAL ANTIBODY DECREASES LEUKOCYTE RECRUITMENT AND INFILTRATION AND OFFERS Neuroprotection AFTER SPINAL CORD …
  910. 398. Non-Viral Gene Delivery to the Primate CNS: A Model for Pre-Operative Neuroprotection
  911. 21 Neuroprotection IN HEAD INJURY
  912. … of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for Neuroprotection
  913. 907 Potent O1-Receptor Ligand, PPBP [4-Phenyl-1-(4-Phenylbutyl) piperidine] Affords Neuroprotection From Focal Ischemia and Prolonged Reperfusion
  914. Neuroprotection by flavonoids
  915. Ischemic tolerance and endogenous Neuroprotection
  916. Neuroprotection and neurodegenerative disease
  917. Neurosphere-derived multipotent precursors promote Neuroprotection by an immunomodulatory mechanism
  918. Neuroprotection for ischemic stroke: two decades of success and failure
  919. Neuroprotection in cerebral ischaemia: facts and fancies–the need for new approaches
  920. Estrogen and ischemic Neuroprotection : an integrated view
  921. Neuroprotection in glaucoma.
  922. Astrocyte apoptosis: implications for Neuroprotection
  923. Mechanisms of radiation injury to the central nervous system: implications for Neuroprotection
  924. Neuroprotection in experimental stroke with targeted neurotrophins
  925. Multifunctional activities of green tea catechins in Neuroprotection
  926. Heat shock proteins and Neuroprotection
  927. VEGF: once regarded as a specific angiogenic factor, now implicated in Neuroprotection
  928. Neuroprotection and acute spinal cord injury: a reappraisal
  929. Neuroprotection by tetracyclines
  930. Molecular and cellular mechanisms of Neuroprotection by vascular endothelial growth factor
  931. β-Lactam antibiotics offer Neuroprotection by increasing glutamate transporter expression
  932. Optic nerve and Neuroprotection strategies
  933. Neurodegeneration and Neuroprotection in Parkinson disease
  934. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions
  935. Bioenergetic approaches for Neuroprotection in Parkinson’s disease
  936. Lithium Neuroprotection : molecular mechanisms and clinical implications
  937. Critical appraisal of Neuroprotection trials in head injury: what have we learned?
  938. A focus on the synapse for Neuroprotection in Alzheimer disease and other dementias
  939. From clinical evidence to molecular mechanisms underlying Neuroprotection afforded by estrogens
  940. Microglia and Neuroprotection : implications for Alzheimer’s disease
  941. Neuroprotection by KATP channels
  942. Fibroblast growth factors and Neuroprotection
  943. Hypothermia for Neuroprotection after cardiac arrest: systematic review and individual patient data meta-analysis
  944. (−)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and Neuroprotection
  945. Cannabinoid receptors and their role in Neuroprotection
  946. Effect of magnesium sulfate given for Neuroprotection before preterm birth: a randomized controlled trial
  947. Quinol-based cyclic antioxidant mechanism in estrogen Neuroprotection
  948. VEGF-induced Neuroprotection , neurogenesis, and angiogenesis after focal cerebral ischemia
  949. Mechanisms of hyperbaric oxygen and Neuroprotection in stroke
  950. Neuroprotection by osteopontin in stroke
  951. The TREK K2P channels and their role in general anaesthesia and Neuroprotection
  952. Neuroprotection in Parkinson’s disease: clinical trials
  953. Neuroprotection from the collateral perspective.
  954. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels
  955. Neuroprotection by crocetin in a hemi-parkinsonian rat model
  956. Lost in translation: taking Neuroprotection from animal models to clinical trials
  957. Mitochondria in cell death: novel targets for Neuroprotection and cardioprotection
  958. Neuroprotection by adenosine in the brain : From A1 receptor activation to A2A receptor blockade
  959. Lipid signaling in neural plasticity, brain repair, and Neuroprotection
  960. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice
  961. Neuroprotection associated with running: is it a result of increased endogenous neurotrophic factors?
  962. Catechin polyphenols: neurodegeneration and Neuroprotection in neurodegenerative diseases
  963. Pharmacological inhibition of AMP-activated protein kinase provides Neuroprotection in stroke
  964. Erythropoietin: a candidate compound for Neuroprotection in schizophrenia
  965. Neuroprotection by bioactive components in medicinal and food plant extracts
  966. Lipid signaling: sleep, synaptic plasticity, and Neuroprotection
  967. Activation of complement in the central nervous system: roles in neurodegeneration and Neuroprotection
  968. Molecular mechanisms of light-induced photoreceptor apoptosis and Neuroprotection for retinal degeneration
  969. Control of nerve agent-induced seizures is critical for Neuroprotection and survival
  970. Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, Neuroprotection : the 2002 Thomas Willis Lecture
  971. Mechanisms of ischemic Neuroprotection by acetyl-L-carnitine
  972. A role for hypoxia-inducible factor-1α in desferoxamine Neuroprotection
  973. The mechanism of Neuroprotection by topiramate in an animal model of epilepsy
  974. Xenon and hypothermia combine to provide Neuroprotection from neonatal asphyxia
  975. Inhibition of GSK3β is a common event in Neuroprotection by different survival factors
  976. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for Neuroprotection in stroke
  977. Antiepileptic drugs and Neuroprotection : current status and future roles
  978. Neurogenic Neuroprotection
  979. Antioxidant properties of minocycline: Neuroprotection in an oxidative stress assay and direct radical‐scavenging activity
  980. Immunomodulation in multiple sclerosis: from immunosuppression to Neuroprotection
  981. Dual effects of nicotine on oxidative stress and Neuroprotection in PC12 cells
  982. Akt contributes to Neuroprotection by hypothermia against cerebral ischemia in rats
  983. Neuroprotection by estrogen in animal models of global and focal ischemia
  984. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage
  985. Prion protein accumulation and Neuroprotection in hypoxic brain damage
  986. Anaesthesia induced Neuroprotection
  987. Prevention of Alzheimer’s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation
  988. Nanotechnology approaches for the regeneration and Neuroprotection of the central nervous system
  989. The potential of minocycline for Neuroprotection in human neurologic disease
  990. Mechanism of estrogen-mediated Neuroprotection : regulation of mitochondrial calcium and Bcl-2 expression
  991. Organotypic hippocampal slice cultures for studies of brain damage, Neuroprotection and neurorepair
  992. Participation of adenosine receptors in Neuroprotection .
  993. Erythropoietin: novel approaches to Neuroprotection in human brain disease
  994. Neuroprotection in ophthalmology: a review
  995. Mechanisms of hyperbaric oxygen-induced Neuroprotection in a rat model of subarachnoid hemorrhage
  996. Antiepileptic drugs in Neuroprotection
  997. Regulation of body temperature and Neuroprotection by endogenous interleukin-6 in cerebral ischemia
  998. Cell cycle inhibition provides Neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury
  999. The role of α‐synuclein in both Neuroprotection and neurodegeneration
  1000. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport
  1001. Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members
  1002. brain edema induced by in vitro ischemia: causal factors and Neuroprotection
  1003. Effect of two different Neuroprotection systems on microembolization during carotid artery stenting
  1004. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats
  1005. Estrogen activates classical and alternative mechanisms to orchestrate Neuroprotection
  1006. Neuroprotection by a selective estrogen receptor β agonist in a mouse model of global ischemia
  1007. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways
  1008. Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicity
  1009. Protective autoimmunity and Neuroprotection in inflammatory and noninflammatory neurodegenerative diseases
  1010. Interactions between the cells of the immune and nervous system: neurotrophins as Neuroprotection mediators in CNS injury
  1011. Carotid artery stenting with Neuroprotection : assessing the learning curve and treatment outcome
  1012. Purines and Neuroprotection
  1013. Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia
  1014. Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis
  1015. α2-Adrenoceptor agonists: shedding light on Neuroprotection ?
  1016. Optimal delivery of minocycline to the brain : implication for human studies of acute Neuroprotection
  1017. Physiological roles of hydrogen sulfide: synaptic modulation, Neuroprotection , and smooth muscle relaxation
  1018. Prophylactic creatine administration mediates Neuroprotection in cerebral ischemia in mice
  1019. Neurogenesis and Neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis
  1020. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in Neuroprotection
  1021. Forebrain -specific neuronal inhibition of nuclear factor-κB activity leads to loss of Neuroprotection
  1022. Signal transduction pathways implicated in neural recognition molecule L1 triggered Neuroprotection and neuritogenesis
  1023. Incipient neurovulnerability and Neuroprotection in early psychosis
  1024. Rasagiline: neurodegeneration, Neuroprotection , and mitochondrial permeability transition
  1025. Neuroprotection in Huntington’s disease: a 2-year study on minocycline
  1026. Role of mitochondria in neuronal cell death induced by oxidative stress; Neuroprotection by Coenzyme Q10
  1027. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons
  1028. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke
  1029. Targeting mitochondrial ATP-sensitive potassium channels—a novel approach to Neuroprotection
  1030. Choroid plexus megalin is involved in Neuroprotection by serum insulin-like growth factor I
  1031. A preclinical view of cholinesterase inhibitors in Neuroprotection : do they provide more than symptomatic benefits in Alzheimer’s disease?
  1032. Transforming Growth Factor-β1-Mediated Neuroprotection against Excitotoxic Injury in Vivo
  1033. Indicators of Neuroprotection with galantamine
  1034. Erythropoietin exerts Neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings
  1035. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for Neuroprotection
  1036. CB1 cannabinoid receptors are involved in Neuroprotection via NF-κB inhibition
  1037. Calpain in the pathophysiology of spinal cord injury: Neuroprotection with calpain inhibitors
  1038. Peroxisome proliferator-activated receptor-α activation as a mechanism of preventive Neuroprotection induced by chronic fenofibrate treatment
  1039. Neuroprotection and pharmacotherapy for motor symptoms in Parkinson’s disease
  1040. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin
  1041. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic Neuroprotection
  1042. Methodological quality of animal studies on Neuroprotection in focal cerebral ischaemia
  1043. Astrocyte mitochondrial mechanisms of ischemic brain injury and Neuroprotection
  1044. Paraquat induces oxidative stress and neuronal cell death; Neuroprotection by water-soluble Coenzyme Q10
  1045. Estrogen activates protein kinase C in neurons: role in Neuroprotection
  1046. Pharmacologic Neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma
  1047. Blockade of gap junctions in vivo provides Neuroprotection after perinatal global ischemia
  1048. Clinical perspectives: Neuroprotection lessons from hypoxia-tolerant organisms
  1049. Isoflurane preconditioning induces Neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases
  1050. Signal transduction pathways involved in melatonin‐induced Neuroprotection after focal cerebral ischemia in mice
  1051. Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI
  1052. Creatine therapy provides Neuroprotection after onset of clinical symptoms in Huntington’s disease transgenic mice
  1053. Antiepileptogenesis, Neuroprotection , and disease modification in the treatment of epilepsy: focus on levetiracetam
  1054. Effect of Antioxidant Flavanone, Naringenin, from Citrus junos on Neuroprotection
  1055. Is white matter involved in patients entered into typical trials of Neuroprotection ?
  1056. Some current ideas on the pathogenesis and the role of Neuroprotection in glaucomatous optic neuropathy
  1057. A novel mechanism of FK506‐mediated Neuroprotection : downregulation of cytokine expression in glial cells
  1058. Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for Neuroprotection /neurodegeneration …
  1059. Magnesium Neuroprotection is limited in humans with acute brain injury
  1060. Isoflurane preconditioning induces Neuroprotection that is inducible nitric oxide synthase–dependent in neonatal rats
  1061. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for Neuroprotection in Alzheimer’s disease.
  1062. Activin: an important regulator of wound repair, fibrosis, and Neuroprotection
  1063. Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia
  1064. Endogenous Neuroprotection in the retina
  1065. Involvement of tyrosine kinases and STAT3 in Humanin-mediated Neuroprotection
  1066. Neuroprotection by Brazilian green propolis against in vitro and in vivo ischemic neuronal damage
  1067. Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and Neuroprotection
  1068. Neuroprotection and neurorescue against Aβ toxicity and PKC‐dependent release of non‐amyloidogenic soluble precursor protein by green tea polyphenol (‐) …
  1069. Effects of estrogen on brain development and Neuroprotection —implications for negative symptoms in schizophrenia
  1070. Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for Neuroprotection in Alzheimer’s, Parkinson’s, and other neurodegenerative …
  1071. Neuroprotection in hypothermia linked to redistribution of oxygen in brain
  1072. Melatonin‐induced Neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late‐phase activation of NF‐κB and AP‐1
  1073. CD4-positive T cell-mediated Neuroprotection requires dual compartment antigen presentation
  1074. Neuroprotection in brain and spinal cord trauma
  1075. TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: Neuroprotection by NFκB inhibition
  1076. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia
  1077. brain nitric oxide and its dual role in neurodegeneration/Neuroprotection : understanding molecular mechanisms to devise drug approaches
  1078. Nicotinic acetylcholine receptor-mediated Neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons
  1079. Thioredoxin as a neurotrophic cofactor and an important regulator of Neuroprotection
  1080. Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: Potential strategies for Neuroprotection 1
  1081. Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: Neuroprotection of dopaminergic neurons
  1082. Topiramate extends the therapeutic window for hypothermia-mediated Neuroprotection after stroke in neonatal rats
  1083. Neurodegeneration and Neuroprotection in glaucoma: development of a therapeutic Neuroprotective vaccine: the Friedenwald lecture
  1084. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious Neuroprotection in the postischemic brain
  1085. Rise and fall of minocycline in Neuroprotection : need to promote publication of negative results
  1086. Free radical trapping as a therapeutic approach to Neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers
  1087. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway
  1088. Pharmacology update/Neuroprotection for ischemic stroke
  1089. Differential effects of ethanol antagonism and Neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity
  1090. Neuroprotection against transient cerebral ischemia by exercise pre-conditioning in rats
  1091. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson’s disease
  1092. … hippocampal slice cultures: a model system to study basic cellular and molecular mechanisms of neuronal cell death, Neuroprotection , and synaptic plasticity
  1093. BDNF-induced white matter Neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge
  1094. Neuroprotection of photoreceptors by minocycline in light-induced retinal degeneration
  1095. Stroke units, tissue plasminogen activator, aspirin and Neuroprotection : which stroke intervention could provide the greatest community benefit?
  1096. α-Tocotrienol provides the most potent Neuroprotection among vitamin E analogs on cultured striatal neurons
  1097. Melatonin provides Neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion
  1098. Estrogen-like compounds for ischemic Neuroprotection
  1099. Different levels of Neuroprotection by two insulin-like growth factor-I splice variants
  1100. Preconditioning with isoflurane produces dose-dependent Neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral …
  1101. Metallothionein-mediated Neuroprotection in genetically engineered mouse models of Parkinson’s disease
  1102. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B
  1103. Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFκB
  1104. Simultaneous Neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis
  1105. Intracerebral transplantation of porcine choroid plexus provides structural and functional Neuroprotection in a rodent model of stroke
  1106. Neuroprotection in glaucoma: a model for Neuroprotection in optic neuropathies
  1107. Glutathione monoethyl ester provides Neuroprotection in a rat model of stroke
  1108. Enhancement of glutamate uptake mediates the Neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes
  1109. Activity-dependent Neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB …
  1110. Significant Neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with …
  1111. IGF‐I Neuroprotection in the immature brain after hypoxia‐ischemia, involvement of Akt and GSK3β?
  1112. Glycogen synthase kinase 3β links Neuroprotection by 17β-estradiol to key Alzheimer processes
  1113. Neuroprotection by NGF in the PC12 In Vitro OGD Model: Involvement of Mitogen‐Activated Protein Kinases and Gene Expression
  1114. The Neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation
  1115. Estrogen receptor-mediated Neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway
  1116. Tumor necrosis factor (TNF)-mediated Neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation …
  1117. Propofol Neuroprotection in cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks
  1118. Progesterone Neuroprotection in spinal cord trauma involves up-regulation of brain -derived neurotrophic factor in motoneurons
  1119. A potent antioxidant, lycopene, affords Neuroprotection against microglia activation and focal cerebral ischemia in rats
  1120. Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression
  1121. Coactivation of GABAA and GABAB Receptor Results in Neuroprotection During In Vitro Ischemia
  1122. Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia
  1123. Mechanisms of progesterone‐induced Neuroprotection
  1124. Reconstituted high-density lipoprotein exhibits Neuroprotection in two rat models of stroke
  1125. Uric acid administration for Neuroprotection in patients with acute brain ischemia
  1126. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases
  1127. Neuronal growth‐promoting and inhibitory cues in Neuroprotection and neuroregeneration
  1128. β-Synuclein Regulates Akt Activity in Neuronal Cells: A POSSIBLE MECHANISM FOR Neuroprotection IN PARKINSON′ S DISEASE
  1129. Immunosuppressants: Neuroprotection and promoting neurological recovery following peripheral nerve and spinal cord lesions
  1130. Sensory Neuroprotection , mitochondrial preservation, and therapeutic potential of N-acetyl-cysteine after nerve injury
  1131. Pharmacological Neuroprotection
  1132. Cannabinoids produce Neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores
  1133. Role of PPAR-γ ligands in Neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells
  1134. Valproic acid-mediated Hsp70 induction and anti-apoptotic Neuroprotection in SH-SY5Y cells
  1135. Local saline infusion into ischemic territory induces regional brain cooling and Neuroprotection in rats with transient middle cerebral artery occlusion
  1136. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to Neuroprotection in Parkinson’s disease and other …
  1137. … low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides Neuroprotection and induces behavioral …
  1138. Neuroprotection and regeneration in glaucoma.
  1139. Insulin Neuroprotection against oxidative stress in cortical neurons—involvement of uric acid and glutathione antioxidant defenses
  1140. Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation
  1141. Neuroprotection by transforming growth factor-β1 involves activation of nuclear factor-κB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein …
  1142. A responsive outcome for Parkinson’s disease Neuroprotection futility studies
  1143. Neuroprotection from complement‐mediated inflammatory damage
  1144. Unequal Neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic …
  1145. Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation
  1146. Microglial NADPH oxidase is a novel target for femtomolar Neuroprotection against oxidative stress
  1147. Neuroprotection after Transient Global Cerebral Ischemia in Wlds Mutant Mice
  1148. Blood-brain barrier drug targeting enables Neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins
  1149. Wide therapeutic time window for nimesulide Neuroprotection in a model of transient focal cerebral ischemia in the rat
  1150. T-cell-based vaccination for morphological and functional Neuroprotection in a rat model of chronically elevated intraocular pressure
  1151. Prospects for Neuroprotection in multiple sclerosis.
  1152. Novel role for gabapentin in Neuroprotection of central nervous system in streptozotocine-induced diabetic rats
  1153. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration
  1154. The mitochondrial permeability transition as a target for Neuroprotection
  1155. Tenascin-R plays a role in Neuroprotection via its distinct domains that coordinate to modulate the microglia function
  1156. Erythropoietin and Neuroprotection : a therapeutic perspective
  1157. Preclinical evidence for Neuroprotection with monoamine oxidase-B inhibitors in Parkinson’s disease
  1158. Neuroprotection by human neural progenitor cells after experimental contusion in rats
  1159. Behavioral and histological Neuroprotection by tamoxifen after reversible focal cerebral ischemia
  1160. Effect of estrogen receptor agonists treatment in MPTP mice: evidence of Neuroprotection by an ERα agonist
  1161. Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration
  1162. Local brain hypothermia for Neuroprotection in stroke treatment and aneurysm repair
  1163. Neuroprotection by α-lipoic acid in streptozotocin-induced diabetes
  1164. Neuroprotection of catalpol in transient global ischemia in gerbils
  1165. The c‐Raf inhibitor GW5074 provides Neuroprotection in vitro and in an animal model of neurodegeneration through a MEK‐ERK and Akt‐independent mechanism
  1166. … brain -derived neurotrophic factor gene: a portal to transform mesenchymal stem cells into advantageous engineering cells for neuroregeneration and Neuroprotection
  1167. Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for Neuroprotection
  1168. Clinical trials of Neuroprotection for Parkinson’s disease
  1169. Neuroprotection with angiotensin receptor antagonists
  1170. L-DOPA treatment from the viewpoint of Neuroprotection
  1171. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen
  1172. Cannabinoids and Neuroprotection in CNS inflammatory disease
  1173. The kinder side of killer proteases: caspase activation contributes to Neuroprotection and CNS remodeling
  1174. Retinal Neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor
  1175. Gene activation and protein expression following ischaemic stroke: strategies towards Neuroprotection
  1176. Voluntary running provides Neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle
  1177. Transplantation of vascular endothelial growth factor-transfected neural stem cells into the rat brain provides Neuroprotection after transient focal cerebral ischemia
  1178. Central nervous system–targeted complement inhibition mediates Neuroprotection after closed head injury in transgenic mice
  1179. Neuroprotection and regeneration strategies for spinal cord repair
  1180. Hypothesis for a common basis for Neuroprotection in glaucoma and Alzheimer’s disease: anti-apoptosis by alpha-2-adrenergic receptor activation
  1181. Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson’s disease?
  1182. The intracerebral application of the PPARγ‐ligand pioglitazone confers Neuroprotection against focal ischaemia in the rat brain
  1183. Neuroprotection trek—the next generation: neuromodulation I. Techniques—deep brain stimulation, vagus nerve stimulation, and transcranial magnetic stimulation
  1184. Structural and functional Neuroprotection in a rat model of Huntington’s disease by viral gene transfer of GDNF
  1185. Functional aspects of estrogen Neuroprotection
  1186. Neuroprotection with carotenoids in glaucoma
  1187. Optical coherence tomography: measuring in-vivo axonal survival and Neuroprotection in multiple sclerosis and optic neuritis
  1188. … colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated Neuroprotection against Alzheimer’s disease …
  1189. Vascular aspects of Neuroprotection
  1190. Isoflurane Neuroprotection in Hypoxic Hippocampal Slice Cultures Involves Increases in Intracellular Ca2+and Mitogen-activated Protein Kinases
  1191. Insulin exerts Neuroprotection by counteracting the decrease in cell‐surface GABAA receptors following oxygen–glucose deprivation in cultured cortical neurons
  1192. Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromatase
  1193. Adenosine, neurodegeneration and Neuroprotection
  1194. Neuroprotection and neurodegenerative diseases: from biology to clinical practice
  1195. Provoking Neuroprotection by peroxynitrite
  1196. Zinc-induced apoptosis in substantia nigra of rat brain : Neuroprotection by vitamin D3
  1197. Neuroprotection of naloxone against ischemic injury in rats: role of mu receptor antagonism
  1198. Rubia cordifolia, Fagonia cretica linn and Tinospora cordifolia exert Neuroprotection by modulating the antioxidant system in rat hippocampal slices subjected …
  1199. Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes
  1200. Neuroprotection following fluid percussion brain trauma: a pilot study using quercetin
  1201. Role of insulin-like growth factors in neuronal plasticity and Neuroprotection
  1202. Timing of neutrophil depletion influences long-term Neuroprotection in neonatal rat hypoxic-ischemic brain injury
  1203. NF-E2-related factor-2 mediates Neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary …
  1204. Neuroprotection in acute ischemic stroke
  1205. Empirical evidence of Neuroprotection by dual cholinesterase inhibition in Alzheimer’s disease
  1206. Clomethiazole: mechanisms underlying lasting Neuroprotection after hypoxia‐ischemia
  1207. Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced Neuroprotection in transgenic R6/2 mouse model of Huntington’s …
  1208. In vitro Gender Differences in Neuronal Survival on Hypoxia and in 17β-Estradiol-Mediated Neuroprotection
  1209. Estrogen provides Neuroprotection against activated microglia‐induced dopaminergic neuronal injury through both estrogen receptor‐α and estrogen receptor‐β in …
  1210. What can adenosine neuromodulation do for Neuroprotection ?
  1211. Novel Diketopiperazine Enhances Motor and cognitive Recovery after Traumatic brain Injury in Rats and Shows Neuroprotection In Vitro and In Vivo
  1212. Neuroprotection as a treatment for glaucoma: pharmacological and immunological approaches
  1213. Depth of delayed cooling alters Neuroprotection pattern after hypoxia‐ischemia
  1214. Long-term Neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats
  1215. Neuroprotection and enhancement of learning and memory by BF-7
  1216. Neuroprotection of edaravone on hypoxic-ischemic brain injury in neonatal rats
  1217. Inhibition of mitochondrial respiration by nitric oxide: its role in glucose metabolism and Neuroprotection
  1218. Neuroprotection trek—the next generation: neuromodulation II. Applications—epilepsy, nerve regeneration, neurotrophins
  1219. NF-κB factor c-Rel mediates Neuroprotection elicited by mGlu5 receptor agonists against amyloid β-peptide toxicity
  1220. Dual role of DENN/MADD (Rab3GEP) in neurotransmission and Neuroprotection
  1221. The role of the estrogen in Neuroprotection : implications for neurodegenerative diseases.
  1222. Circulatory arrest as a model for studies of global ischemic injury and Neuroprotection
  1223. Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome C to cytoplasm
  1224. Perioperative Neuroprotection : are we asking the right questions?
  1225. Estrogen and Neuroprotection : higher constitutive expression of glutaredoxin in female mice offers protection against MPTP‐mediated neurodegeneration
  1226. Challenges of Neuroprotection and neurorestoration in ischemic stroke treatment
  1227. Imaging end points for monitoring Neuroprotection in Parkinson’s disease
  1228. Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke
  1229. Protease-activated receptors in neuronal development, neurodegeneration, and Neuroprotection : thrombin as signaling molecule in the brain
  1230. Neuroprotection and enhanced recovery with edaravone after acute spinal cord injury in rats
  1231. Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term Neuroprotection with brimonidine
  1232. A3 receptors in cortical neurons: Pharmacological aspects and Neuroprotection during hypoxia
  1233. Neurotrophin-based strategies for Neuroprotection
  1234. Estrogen Neuroprotection against the neurotoxic effects of ethanol withdrawal: potential mechanisms
  1235. Cannabinoids in neurodegeneration and Neuroprotection
  1236. Possible sources of Neuroprotection following subretinal silicon chip implantation in RCS rats
  1237. Asymptomatic ischemic cerebrovascular disorders and Neuroprotection with vinpocetine.
  1238. Mitochondria are involved in the neurogenic Neuroprotection conferred by stimulation of cerebellar fastigial nucleus
  1239. γ-Aminobutyric acid-A receptors contribute to isoflurane Neuroprotection in organotypic hippocampal cultures
  1240. Heat acclimation increases hypoxia-inducible factor 1α and erythropoietin receptor expression: implication for Neuroprotection after closed head injury in mice
  1241. Glucagon-like peptide-1 receptor is involved in learning and Neuroprotection
  1242. Dose-dependent Neuroprotection by 17β-estradiol after cardiac arrest and cardiopulmonary resuscitation
  1243. TREK‐1, a K+ channel involved in Neuroprotection and general anesthesia
  1244. Cellular strategies of estrogen-mediated Neuroprotection during brain development
  1245. Advances in stroke Neuroprotection : hyperoxia and beyond
  1246. Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington’s disease
  1247. Models of epilepsy in the developing and adult brain : implications for Neuroprotection
  1248. Glial‐mediated Neuroprotection : Evidence for the protective role of the NO‐cGMP pathway via neuron–glial communication in the peripheral nervous system
  1249. Neuroprotection and peptide toxins
  1250. Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase‐2 inhibitor APHS can be reversed by a prostanoid
  1251. Plasma membrane oestrogen receptor mediates Neuroprotection against β‐amyloid toxicity through activation of Raf‐1/MEK/ERK cascade in septal‐derived …
  1252. Multiple calcium channels and kinases mediate α7 nicotinic receptor Neuroprotection in PC12 cells
  1253. Neuroprotection against Aβ and glutamate toxicity by melatonin: Are GABA receptors involved?
  1254. Induction of thioredoxin and mitochondrial survival proteins mediates preconditioning‐induced cardioprotection and Neuroprotection
  1255. l‐Carnitine and Neuroprotection in the Animal Model of Mitochondrial Dysfunction
  1256. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides Neuroprotection in a rat model of Parkinson’s disease
  1257. NO stimulation of ATP-sensitive potassium channels: involvement of Ras/mitogen-activated protein kinase pathway and contribution to Neuroprotection
  1258. Synaptophysin enhances the Neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells
  1259. A “cure” for Parkinson’s disease: can Neuroprotection be proven with current trial designs?
  1260. Role of protein phosphatases in estrogen-mediated Neuroprotection
  1261. Galantamine and memantine produce different degrees of Neuroprotection in rat hippocampal slices subjected to oxygen–glucose deprivation
  1262. Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo …
  1263. Neuroprotection in ischemic stroke—combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia
  1264. Combining insulin-like growth factor derivatives plus caffeinol produces robust Neuroprotection after stroke in rats
  1265. Neuroprotection of immortalized hippocampal neurones by brain ‐derived neurotrophic factor and Raf‐1 protein kinase: role of extracellular signal‐regulated protein …
  1266. Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient Neuroprotection against ischemic stroke
  1267. Corticotropin-releasing factor (CRF) and related peptides confer Neuroprotection via type 1 CRF receptors
  1268. Aging blunts ischemic-preconditioning-induced Neuroprotection following transient global ischemia in rats
  1269. Immune-mediated neurodegeneration and Neuroprotection in MS.
  1270. Expression of apoptosis inhibitor protein Mcl1 linked to Neuroprotection in CNS neurons
  1271. Neuroprotection in PD—a role for dopamine agonists?
  1272. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and Neuroprotection by distinct signaling pathways
  1273. Dexamethasone downregulates chemokine receptor CXCR4 and exerts Neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats
  1274. Caspase 3 activation is essential for Neuroprotection in preconditioning
  1275. Prolonged opportunity for ischemic Neuroprotection with selective κ-opioid receptor agonist in rats
  1276. Neuroprotection by fructose-1, 6-bisphosphate involves ROS alterations via p38 MAPK/ERK
  1277. Neuroprotection in Parkinson disease
  1278. Partial characterization of retina-derived cone Neuroprotection in two culture models of photoreceptor degeneration
  1279. Neuroprotection by Na+ channel blockade
  1280. Ionotropic glutamate receptors: still a target for Neuroprotection in brain ischemia? Insights from in vitro studies
  1281. Role of nonfeminizing estrogen analogues in Neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity
  1282. Neuroprotection by D-securinine against neurotoxicity induced by beta-amyloid (25–35)
  1283. Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts Neuroprotection in autoimmune encephalomyelitis
  1284. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition: a target for Neuroprotection in the central nervous system
  1285. … element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced Neuroprotection
  1286. Kappa-opioid receptor selectivity for ischemic Neuroprotection with BRL 52537 in rats
  1287. Signaling cascades involved in Neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38
  1288. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury
  1289. Mitochondrial ATP-sensitive potassium channel: a novel site for Neuroprotection
  1290. Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels
  1291. Neuroprotection in the rat lateral fluid percussion model of traumatic brain injury by SNX-185, an N-type voltage-gated calcium channel blocker
  1292. Role of alpha-2 agonists in Neuroprotection
  1293. Consensus review. Pharmacological Neuroprotection in cerebral ischemia: is it still a therapeutic option?
  1294. Mechanisms of neuronal death and Neuroprotection
  1295. Neuroprotection by rasagiline: a new therapeutic approach to Parkinson’s disease?
  1296. FGF-2 promotes neurogenesis and Neuroprotection and prolongs survival in a transgenic mouse model of Huntington’s disease
  1297. Lack of Neuroprotection by heat shock protein 70 overexpression in a mouse model of global cerebral ischemia
  1298. Reduction of calcium release from the endoplasmic reticulum could only provide partial Neuroprotection against beta‐amyloid peptide toxicity
  1299. Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to Neuroprotection
  1300. Lithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in Neuroprotection against N-methyl-D-aspartate receptor-mediated …
  1301. Nicotine‐induced Neuroprotection against N‐methyl‐d‐aspartic acid or β‐amyloid peptide occur through independent mechanisms distinguished by pro …
  1302. Mechanisms involved in prostaglandin E2-mediated Neuroprotection against TNF-α: possible involvement of multiple signal transduction and β-catenin/T-cell factor
  1303. Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents
  1304. Molecular mechanisms of cytokine-induced Neuroprotection : NFκB and neuroplasticity
  1305. Peroxynitrite protects neurons against nitric oxide-mediated apoptosis: a key role for glucose-6-phosphate dehydrogenase activity in Neuroprotection
  1306. Single-dose ebselen does not afford sustained Neuroprotection to rats subjected to severe focal cerebral ischemia
  1307. Phosphatidylinositol 3‐kinase and Akt effectors mediate insulin‐like growth factor‐I Neuroprotection in dorsal root ganglia neurons
  1308. Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia
  1309. Retinal detachment neuropathology and potential strategies for Neuroprotection
  1310. SOD1 overexpression and female sex exhibit region-specific Neuroprotection after global cerebral ischemia due to cardiac arrest
  1311. First clinical experiences with an endovascular clamping system for Neuroprotection during carotid stenting
  1312. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector
  1313. Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17β-estradiol-mediated Neuroprotection
  1314. Neuroprotection in cardiac surgery.
  1315. Neurotoxicity of lidocaine: implications for spinal anesthesia and Neuroprotection
  1316. Neuroprotection in brain ischemia–doubts and hopes
  1317. Neuroprotection from soman-induced seizures in the rodent: evaluation with diffusion-and T2-weighted magnetic resonance imaging
  1318. Mitochondrial medicine: Neuroprotection and life extension by the new amphiphilic nitrone LPBNAH1 acting as a highly potent antioxidant agent
  1319. … derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: Neuroimmunophilin ligand‐mediated Neuroprotection in a model of …
  1320. Neuroprotection strategies: effect of vinpocetine in vitro oxidative stress models.
  1321. Regulation of c‐Jun N‐terminal kinase, p38 kinase and AP‐1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium Neuroprotection
  1322. Levodopa therapy from the Neuroprotection viewpoint
  1323. Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: a mechanistic target-site approach to Neuroprotection
  1324. Severe hypotension is not essential for isoflurane Neuroprotection against forebrain ischemia in mice
  1325. The Neuroprotection of resveratrol in the experimental cerebral ischemia
  1326. Neuroprotection in progressive brain disorders
  1327. Inhibition of release of taurine and excitatory amino acids in ischemia and Neuroprotection
  1328. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma
  1329. Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: a combined magnetic resonance imaging, histopathologic and functional study
  1330. Designing Neuroprotection trials in Parkinson’s disease
  1331. Neuroprotection in Parkinson’s disease: an elusive goal
  1332. Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following Neuroprotection by FK506 in the ischemic rat brain
  1333. Mediation of BMP7 Neuroprotection by MAPK and PKC IN rat primary cortical cultures
  1334. Microglial NADPH oxidase mediates leucine enkephalin dopaminergic Neuroprotection
  1335. Prenatal hypoxia-induced adaptation and Neuroprotection that is inducible nitric oxide synthase-dependent
  1336. Polycyclic phenols, estrogens and Neuroprotection : a proposed mitochondrial mechanism
  1337. Electroacupuncture provides a new approach to Neuroprotection in rats with induced glaucoma
  1338. Female-specific Neuroprotection against transient brain ischemia observed in mice devoid of prion protein is abolished by ectopic expression of prion protein-like …
  1339. Gonadotropins and Alzheimer’s disease: the link between estrogen replacement therapy and Neuroprotection
  1340. An in vitro model of inflammatory neurodegeneration and its Neuroprotection
  1341. Neuroprotection and epilepsy
  1342. Time for a cool head—Neuroprotection becomes a reality
  1343. Targeting Neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy
  1344. Long-term Neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system
  1345. Signaling pathways involved with serotonin1A agonist-mediated Neuroprotection against ethanol-induced apoptosis of fetal rhombencephalic neurons
  1346. Retinal ganglion cell death and Neuroprotection : involvement of the CaMKIIα gene
  1347. Opportunities for Neuroprotection in ALS using cell death mechanism rationales
  1348. Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist
  1349. … brain after transient forebrain ischemia accompanied by an increased expression of galectin-1, and the implication of ΔFosB and galectin-1 in Neuroprotection …
  1350. Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides Neuroprotection , and reduces inflammation in a rat model of traumatic brain injury
  1351. A novel mechanism for pergolide-induced Neuroprotection : inhibition of NF-κB nuclear translocation
  1352. Atrial natriuretic peptide expression is increased in rat cerebral cortex following spreading depression: possible contribution to sd-induced Neuroprotection
  1353. Neuroprotection against hypoxia-ischemia by insulin-like growth factor-I (IGF-I).
  1354. Modulation of calcium/calmodulin kinase‐II provides partial Neuroprotection against beta‐amyloid peptide toxicity
  1355. Glutathione peroxidase-1 contributes to the Neuroprotection seen in the superoxide dismutase-1 transgenic mouse in response to ischemia/reperfusion injury
  1356. A comparison of carotid artery stenting with Neuroprotection versus carotid endarterectomy under local anesthesia
  1357. Challenge of conducting trials of Neuroprotection in the asphyxiated term infant
  1358. VPAC2 receptors mediate vasoactive intestinal peptide-induced Neuroprotection against neonatal excitotoxic brain lesions in mice
  1359. Stilbazulenyl nitrone, a second-generation azulenyl nitrone antioxidant, confers enduring Neuroprotection in experimental focal cerebral ischemia in the rat …
  1360. Monoamine oxidase B inhibition and Neuroprotection : studies on selective adenosine A2A receptor antagonists
  1361. Neuroprotection for Parkinson’s disease: a call for clinically riven experimental design
  1362. Involvement of γ protein kinase C in estrogen‐induced Neuroprotection against focal brain ischemia through G protein‐coupled estrogen receptor
  1363. 681. Non-Viral DNA and mRNA Gene Delivery to the CNS Pre-Operatively for Neuroprotection and Following Neurotrauma
  1364. Mechanism of electrical stimulation-induced Neuroprotection : effects of verapamil on protection of primary auditory afferents
  1365. Failure of ischemic Neuroprotection by potentiators of gamma-aminobutyric acid
  1366. Neuroprotection induced by the adenosine A 2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways
  1367. The dual role of prostaglandin E2 in excitotoxicity and preconditioning-induced Neuroprotection
  1368. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4. 1) motoneurons exposed to glutamate: calpain inhibition provides functional Neuroprotection
  1369. Long-term Neuroprotection induced by regional brain cooling with saline infusion into ischemic territory in rats: a behavioral analysis
  1370. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring Neuroprotection
  1371. Oxidative injury to the locus coeruleus of rat brain : Neuroprotection by melatonin
  1372. What is the learning curve for carotid artery stenting with Neuroprotection ? Analysis of 200 consecutive cases at an academic institution
  1373. Cerebral ischemia-hypoxia and biophysical mechanisms of neurodegeneration and Neuroprotection effects
  1374. Lack of Neuroprotection by an ACTH (4–9) analogue. A randomized trial in patients treated with vincristine for Hodgkin’s or non-Hodgkin’s lymphoma
  1375. Synthesis and evaluation of peptidic metal chelators for Neuroprotection in neurodegenerative diseases
  1376. 17β‐Estradiol activates ICI 182,780‐sensitive estrogen receptors and cyclic GMP‐dependent thioredoxin expression for Neuroprotection
  1377. An alternative Ca2+‐dependent mechanism of Neuroprotection by the metalloporphyrin class of superoxide dismutase mimetics
  1378. Anesthetic mediated Neuroprotection : established fact or passing fancy?
  1379. Combination of early perinatal factors to identify near-term and term neonates for Neuroprotection
  1380. Biological and molecular mechanisms of hypothermic Neuroprotection
  1381. In vitro Neuroprotection by novel antioxidants in guinea-pig urinary bladder subjected to anoxia-glucopenia/reperfusion damage
  1382. nNOS is involved in estrogen mediated Neuroprotection in neuroblastoma cells
  1383. Neuroprotection and nerve grafts in the treatment of neurogenic erectile dysfunction
  1384. Diltiazem-induced Neuroprotection in glutamate excitotoxicity and ischemic insult of retinal neurons
  1385. Humanin antagonists: mutants that interfere with dimerization inhibit Neuroprotection by Humanin
  1386. Antisense oligonucleotide against GTPase Rab5b inhibits metabotropic agonist DHPG-induced Neuroprotection
  1387. The use of hypothermia as a method of Neuroprotection during neurosurgical procedures and after traumatic brain injury: a survey of clinical practice in Great Britain …
  1388. The Ras Inhibitor S-Trans, Trans-Farnesylthiosalicylic Acid Exerts Long-Lasting Neuroprotection in a Mouse Closed Head Injury Model
  1389. Dopamine transporter as a marker of Neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol
  1390. STN stimulation and Neuroprotection in Parkinson’s disease—when beautiful theories meet ugly facts
  1391. Mechanisms of Neuroprotection by polyphenols
  1392. Neuroprotection in the PNS: erythropoietin and immunophilin ligands
  1393. Postischemic Neuroprotection in the ischemia-tolerant state gerbil hippocampus is associated with increased ligand binding to inhibitory GABA A receptors
  1394. Reactive oxygen species mediate the Neuroprotection conferred by a mitochondrial ATP-sensitive potassium channel opener during ischemia in the rat hippocampal …
  1395. Single intravenous injection of naked plasmid DNA encoding erythropoietin provides Neuroprotection in hypoxia–ischemia rats
  1396. Ischemic Neuroprotection with selective κ-opioid receptor agonist is gender specific
  1397. Human ganglion cells express the alpha-2 adrenergic receptor: relevance to Neuroprotection
  1398. Neuroprotection with delayed initiation of prolonged hypothermia after in vitro transient global brain ischemia
  1399. Neuroprotection against hypoxia-ischemia in neonatal rat brain by novel superoxide dismutase mimetics
  1400. Caffeinol confers cortical but not subcortical Neuroprotection after transient focal cerebral ischemia in rats
  1401. Estrogen receptor alpha mediates neuronal differentiation and Neuroprotection in PC12 cells: critical role of the A/B domain of the receptor
  1402. In vitro model of neurotoxicity of Aβ 1–42 and Neuroprotection by a pentapeptide: irreversible events during the first hour
  1403. Neurochemical correlates of differential Neuroprotection by long-term dietary creatine supplementation
  1404. Adenosine A2A Receptor Antagonism and Neuroprotection : Mechanisms, Lights, and Shadows
  1405. Morphinan Neuroprotection : new insight into the therapy of neurodegeneration
  1406. Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration
  1407. Detailed in vitro pharmacological analysis of FK506-induced Neuroprotection
  1408. Hypothermia for 24 hours after asphyxic cardiac arrest in piglets provides striatal Neuroprotection that is sustained 10 days after rewarming
  1409. Neuroprotection and protein damage prevention by estradiol replacement in rat hippocampal slices exposed to oxygen-glucose deprivation
  1410. Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: Neuroprotection with brimonidine
  1411. Neuroprotection in cardiac surgery
  1412. Inhibition of neuronal nitric oxide synthase-mediated activation of poly (ADP-ribose) polymerase in traumatic brain injury: Neuroprotection by 3-aminobenzamide
  1413. Transactivation in astrocytes as a novel mechanism of Neuroprotection
  1414. Poly (ADP‐Ribose) polymerase‐1 in acute neuronal death and inflammation: a strategy for Neuroprotection
  1415. Effects of neonatal and prepubertal hormonal manipulations upon estrogen Neuroprotection of the nigrostriatal dopaminergic system within female and male mice
  1416. Mechanisms of Neuroprotection against glaucoma
  1417. Neuroprotection by pergolide against levodopa-induced cytotoxicity of neural stem cells
  1418. Health care resource use after acute stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas trial
  1419. The therapeutic window of hypothermic Neuroprotection in experimental ischemic neuropathy: protection in ischemic phase and potential deterioration in later …
  1420. Potent ς1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Provides Ischemic Neuroprotection Without Altering Dopamine Accumulation In Vivo in Rats
  1421. Neuroprotection
  1422. … deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38α and p38β activation and confers Neuroprotection in the pheochromocytoma …
  1423. Nicotinic receptor modulation for Neuroprotection and enhancement of functional recovery following brain injury or disease
  1424. The lipid‐activated two‐pore domain K+ channel TREK‐1 is resistant to hypoxia: implication for ischaemic Neuroprotection
  1425. Uncoupling protein 2: a novel player in Neuroprotection
  1426. Cannabinoid‐mediated Neuroprotection following interferon‐gamma treatment in a three‐dimensional mouse brain aggregate cell culture
  1427. Angiotensin II blocks nicotine-mediated Neuroprotection against β-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1
  1428. Neuroprotection and regeneration after traumatic lesion of the optic nerve
  1429. Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration
  1430. Clinical trials in Neuroprotection
  1431. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson’s disease and Neuroprotection ; are there links?
  1432. Neuroprotection assessment by topographic electroencephalographic analysis: effects of a sodium channel blocker to reduce polymorphic delta activity following …
  1433. In vitro Neuroprotection against oxidative stress by pre-treatment with a combination of dihydrolipoic acid and phenyl-butyl nitrones
  1434. Transplantation of fetal kidney cells: Neuroprotection and neuroregeneration
  1435. Neuroprotection by the caspase-1 inhibitor Ac-YVAD-(acyloxy) mk in experimental neuroAIDS is independent from IL-1 β generation
  1436. No magic bullets: the ephemeral nature of anesthetic-mediated Neuroprotection
  1437. How to keep injured CNS neurons viable—strategies for Neuroprotection and gene transfer to retinal ganglion cells
  1438. Strategies for Neuroprotection in the newborn
  1439. The immunophilin‐ligands FK506 and V‐10,367 mediate Neuroprotection by the heat shock response
  1440. The prospects for Neuroprotection in MS.
  1441. Neuroprotection of adult rat dorsal root ganglion neurons by combined hypothermia and alkalinization against prolonged ischemia
  1442. Post-ischemic diazepam does not reduce hippocampal CA1 injury and does not improve hypothermic Neuroprotection after forebrain ischemia in gerbils
  1443. Neuroprotection : Where Are We Going?
  1444. Neuroprotection of Parkin against apoptosis is independent of inclusion body formation
  1445. Does Neuroprotection prevent epileptogenesis?
  1446. Neuroprotection in traumatic brain injury
  1447. The inhibition of glycogen synthase kinase 3β by a metabotropic glutamate receptor 5 mediated pathway confers Neuroprotection to Aβ peptides
  1448. Neuroprotection mediated by subtoxic dose of NMDA in SH-SY5Y neuroblastoma cultures: activity-dependent regulation of PSA-NCAM expression
  1449. Molecular targets for Neuroprotection
  1450. Rapid Report: Acute hypoxia occludes hTREK‐1 modulation: re‐evaluation of the potential role of tandem P domain K+ channels in central Neuroprotection
  1451. Neuroprotection in Glaucoma
  1452. Dietary supplementation with 3-deaza adenosine, N-acetyl cysteine, and S-adenosyl methionine provide Neuroprotection against multiple consequences of vitamin …
  1453. Lens epithelium-derived growth factor: Neuroprotection on rat retinal damage induced by N-methyl-D-aspartate
  1454. Possible involvement of astrocytes in Neuroprotection by the cognitive enhancer T-588
  1455. VEGF–mediated Neuroprotection in ischemic retina
  1456. Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosis
  1457. Calcineurin and cyclophilin D are differential targets of Neuroprotection by immunosuppressants CsA and FK506 in ischemic brain damage
  1458. Angiotensin receptor gene expression in candesartan mediated Neuroprotection
  1459. Neuroprotection possibilities in epileptic children
  1460. Angiotensin type 2 receptor Neuroprotection against chemical hypoxia is dependent on the delayed rectifier K+ channel, Na+/Ca2+ exchanger and Na+/K+ ATPase in …
  1461. Clinical trials in Neuroprotection . 23-25 January 2003, Key Biscayne, FL, USA.
  1462. Inhibition of nitric oxide production and protein tyrosine nitration contribute to Neuroprotection by a novel calmodulin antagonist, DY-9760e, in the rat microsphere …
  1463. Endogenously expressed estrogen receptors mediate Neuroprotection in hippocampal cells (HT22)
  1464. Astrocytic cytochromes p450: an enzyme subfamily critical for brain metabolism and Neuroprotection
  1465. Small molecule activators of the heat shock response and Neuroprotection from stroke
  1466. Clinical pharmacology and Neuroprotection in Parkinson’s disease
  1467. Retinal ganglion cell Neuroprotection in culture
  1468. Remyelination as Neuroprotection
  1469. Strategies of Neuroprotection for intracranial aneurysms
  1470. Suppression of protein kinase Cε mediates 17β‐estradiol‐induced Neuroprotection in an immortalized hippocampal cell line
  1471. In the rostral ventrolateral medulla, the 70-kDa heat shock protein (HSP70), but not HSP90, confers Neuroprotection against fatal endotoxemia via augmentation of …
  1472. P2 receptor antagonist PPADS confers Neuroprotection against glutamate/NMDA toxicity
  1473. C5b‐9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and Neuroprotection
  1474. Neuroprotection of vestibular sensory cells from gentamicin ototoxicity obtained using nitric oxide synthase inhibitors, reactive oxygen species scavengers, brain …
  1475. Introduction: A2A receptors in Neuroprotection of dopaminergic neurons
  1476. Con: Retrograde cerebral perfusion is not an optimal method of Neuroprotection in thoracic aortic surgery
  1477. Perioperative cerebral ischemia and the possibility of Neuroprotection by inhalational anesthetics
  1478. Neuronal injury and Neuroprotection
  1479. Role of peroxynitrite in methamphetamine-induced dopaminergic neurodegeneration and Neuroprotection by antioxidants and selective NOS inhibitors
  1480. Assessment and explorations on the mechanism of Neuroprotection of patients in ischemic stroke by traditional Chinese medicine
  1481. Perinatal brain damage–from Neuroprotection to neuroregeneration using cord blood stem cells
  1482. Gene therapy and Neuroprotection for cerebral infarction
  1483. Neuroprotection by the stable nitroxide 3-carbamoyl-proxyl during reperfusion in a rat model of transient focal ischemia
  1484. Neuroprotection in epilepsy: the Holy Grail of antiepileptogenic therapy.
  1485. Secondary Neuroprotection
  1486. New directions in Neuroprotection : Basic mechanisms, molecular targets and treatment strategies
  1487. Neuroprotection Becomes Reality
  1488. Delayed transient ischemic attacks kill some CA1 neurons previously salvaged with postischemic hypothermia: Neuroprotection undone
  1489. … effects of hypothermia ranging from 34 degrees C to 31 degrees C on brain ischemia in gerbils and determination of the mechanism of Neuroprotection .
  1490. Neuroprotection and dopamine agonists
  1491. Neuroprotection
  1492. Poly (ADP-ribosyl) ation enzyme-1 as a target for Neuroprotection in acute central nervous system injury
  1493. Monoamine oxidase inhibitors, their structural analogues, and Neuroprotection
  1494. Neuroprotection : A realistic goal for aged brain ?
  1495. Current status of Neuroprotection in cerebrovascular disease
  1496. Erythropoiesis and Neuroprotection : two sides of the same coin?
  1497. … expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent Neuroprotection
  1498. Ocular Neuroprotection
  1499. Neuroprotection against glaucoma remains a concept
  1500. Synthesis of water-soluble prodrugs of BMS-191011: a maxi-K channel opener targeted for post-stroke Neuroprotection
  1501. Neuro-overprotection? A functional evaluation of clomethiazole-induced Neuroprotection following hypoxic-ischemic injury
  1502. Cell-permeant calcium buffer induced Neuroprotection after cortical devascularization
  1503. Gap junction-mediated intercellular communication in astrocytes and Neuroprotection
  1504. Low molecular weight compounds with affinity to melanocortin receptors exert Neuroprotection in spinal cord injury—an experimental study in the rat
  1505. Neuroprotection or Neurotoxicity
  1506. Limiting iron availability confers Neuroprotection from chronic mild carbon monoxide exposure in the developing auditory system of the rat
  1507. CAI is a potent inhibitor of neovascularization and imparts Neuroprotection in a mouse model of ischemic retinopathy
  1508. Neuroprotection by estrogen in animal models of ischemia and Parkinson’s disease
  1509. Time Window of Fibroblast Growth Factor-18—Mediated Neuroprotection after Occlusion of the Middle Cerebral Artery in Rats
  1510. Involvement of phosphatidylinositol 3-kinase and insulin-like growth factor-I in YXLST-mediated Neuroprotection
  1511. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of Neuroprotection in preterm labor
  1512. The role of BF-7 on Neuroprotection and enhancement of cognitive function
  1513. The synthetic estrogen 4-estren-3α, 17β-diol (estren) induces estrogen-like Neuroprotection
  1514. COMT inhibition in the treatment of Parkinson’s disease: Neuroprotection and future perspectives
  1515. Pontine cholinergic neurons depend on three Neuroprotection systems to resist nitrosative stress
  1516. Fenfluramine‐induced serotonergic neurotoxicity in mice: lack of Neuroprotection by inhibition/ablation of nNOS
  1517. Neuroprotection in Ischemic/Hypoxic Disorders
  1518. Magnesium sulfate for preterm Neuroprotection
  1519. Postischemic nitrous oxide alone versus intraischemic nitrous oxide in the presence of isoflurane: What it may change for Neuroprotection against cerebral stroke in …
  1520. Neuroprotection trek—the next generation: the measurement is the message
  1521. Vasopressin mediates Neuroprotection in mice by stimulation of V1 vasopressin receptors: Influence of PI-3 kinase and gap junction inhibitors
  1522. Neuroprotection against focal ischemia in the hyperbilirubinemic rat model
  1523. Microwave‐assisted synthesis and chiral HPLC separation of 18F‐labeled MaxiPost™. An agent for post‐stroke Neuroprotection
  1524. Advances in neuroregulation and Neuroprotection
  1525. Effect of magnesium sulfate given for Neuroprotection before preterm birth
  1526. Multi-organ protection and the kidney. From nephroprotection, cardioprotection, Neuroprotection to multi-organ protection
  1527. Magnesium sulfate and Neuroprotection
  1528. Monounsaturated fatty acids and Neuroprotection . The results of a study of cognitive decline in old age. Is there a case for this treatment in multiple sclerosis?
  1529. Transfert cérébral et Neuroprotection
  1530. N-methyl-D-aspartate attenuates CXCR2-mediated Neuroprotection through enhancing the receptor phosphorylation and blocking the receptor recycling
  1531. Role of erythropoietin in brain homeostasis, neurodevelopment and Neuroprotection
  1532. Characteristic features of optic nerve ganglion cells and approaches for Neuroprotection . From intracellular to capillary processes and therapeutic considerations
  1533. Neuroprotection in Hungtington’s disease
  1534. Neuroprotection in the peripheral nervous system
  1535. Neuroprotection of nerve growth factor in experiment retinal detachment
  1536. Neuroprotection against Apoptosis
  1537. Ca2+-ATPase isoforms are expressed in Neuroprotection in rat, but not human, neurons
  1538. Oxidative Toxicity in BV‐2 Microglia Cells: Sesamolin Neuroprotection of H2O2 Injury Involving Activation of p38 Mitogen‐Activated Protein Kinase
  1539. Nanoceria particles confer Neuroprotection in retinal cells in vitro
  1540. The Gtx homeodomain transcription factor exerts Neuroprotection using its homeodomain
  1541. Neuroprotection of photoreceptor cells in rod-cone dystrophies: from cell therapy to cell signalling
  1542. Progestins and antiprogestins: mechanisms of action, Neuroprotection and myelination
  1543. Inhibition of brain phospholipase A2 by antimalarial drugs: Implications for Neuroprotection in neurological disorders
  1544. Green tea catechins Neuroprotection mediated by nAChR
  1545. Erythropoietic agents in the management of cancer patients. Part 2: studies on their role in Neuroprotection and neurotherapy.
  1546. Neuroprotection by cAMP
  1547. Neurotoxicity and Neuroprotection , two aspects of microglial activation in human immunodeficiency virus (HIV) infection
  1548. Perinatal Neuroprotection by muscle relaxants against hypoxic-ischemic lesions: Is it a possible hypothesis?
  1549. A viable Neuroprotection strategy following soman-induced status epilepticus
  1550. Advances in studies on Neuroprotection of natural medicines
  1551. Neuronal nicotinic receptors and Neuroprotection : newer ligands may help us understand their role in neurodegeneration
  1552. Neuroprotection with Aminoguanidine treatment after brain injury in rats
  1553. Possible role of cerebellar fastigial nucleus in preconditioned Neuroprotection
  1554. International Journal of Neuroprotection and Neuroregeneration: IJNN
  1555. … 14C labeled (S)‐3‐(5‐chloro‐2‐methoxyphenyl)‐1, 3‐dihydro‐3‐fluoro‐6‐(trifluoromethyl)‐2H‐indol‐2‐one, maxipost™. An agent for post‐stroke Neuroprotection
  1556. Advances in Neuroprotection research for neurodegenerative diseases
  1557. Magnesium Sulfate for Preterm Neuroprotection —Reply
  1558. Neuroprotection by resveratrol against cytotoxicity of oxidized low density lipoprotein in PC12 cells
  1559. Seizure-Induced Neuroprotection
  1560. Neuroprotection by ketamine
  1561. Experimental Neuroprotection : translation to human stroke trials
  1562. brain atrophy as a measure of neurodegeneration and Neuroprotection
  1563. Primary Neuroprotection
  1564. Polycyclic aminoguanidines: novel entities for Neuroprotection
  1565. Neuroprotection and neurodegenerative parkinsonian syndromes
  1566. Evolution of the Neuroprotection concept
  1567. An improved quantitative method for evaluation of ischemic injury and Neuroprotection in mouse brain slices
  1568. Effect of magnesium sulfate given for Neuroprotection before preterm birth: a randomized, controlled trial
  1569. Proceedings of the Perioperative Neuroprotection Symposium
  1570. Neuroprotection of lithium and the antagonism of lithium to toxic effects of lead on primary culturing cerebrocortical neurons in vitro
  1571. Cholecystokinin and Neuroprotection
  1572. Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions
  1573. White matter Neuroprotection in preterm infants
  1574. Neuroprotection induced by Estrogen Against Focal Cerebral Ischemic-reperfusion Injury in Ovariectomized Rats
  1575. Neutrophil elastase: a target of Neuroprotection
  1576. Molecular mechanisms of neurodegeneration and Neuroprotection -experimental approaches and the diseased brain .
  1577. Soyisoflavones provide Neuroprotection in focal cerebral ischemia of ovariectmized female rats
  1578. Xenon Exhibits Its Neuroprotection Through an Anti-Apoptotic Mechanism
  1579. Clinical Trials Promote treatment and Neuroprotection in Parkinson Disease
  1580. Neuroprotection in Hungtington’s Disease: RESPONSE FROM THE AUTHORS
  1581. Estratriene Neuroprotection through Antioxidant, Non-Estrogen Receptor Mediated Mechanisms
  1582. Mechanisms of Neuroprotection in hippocampal organotypic culture
  1583. Incipient neurovulnerability and Neuroprotection in early psychosis: A proton spectroscopy study of the anterior hippocampus at 3Tesla
  1584. Carbon dioxide provides Neuroprotection in fluid percussion injured rats
  1585. Neuroprotection for Ischemic Injury in the immature brain
  1586. Neuroprotection in Stroke
  1587. Session IV: Role of Carnitines and Other agents in Neuroprotection
  1588. Perioperative Neuroprotection Symposium
  1589. Role of Akt1 in estrogen-mediated Neuroprotection
  1590. Neuroprotection of Hypothermia Combined with Salvia Miltiorrhiza Bunge on brain Damage in the Immature Rat
  1591. Neuroprotection of Veratrum nigrum var. ussurience alkaloids on focal cerebral ischemia-reperfusion injury in rats
  1592. Apoptosis and glaucoma: new insight from basic research to the development of novel strategies for Neuroprotection
  1593. … of N-type Ca2+ currents. An increase in the isoflurane blocking potency of N-type Ca2+ currents may contribute to the known Neuroprotection action of isoflurane …
  1594. Blocking the axonal injury cascade: Neuroprotection in multiple sclerosis and its models
  1595. Effects of aging on hypothermic Neuroprotection in acute stroke
  1596. Neuroprotection by the α2-adrenoceptor agonist, dexmedetomidine, in experimental stroke models
  1597. Mechanism of isoflurane preconditioning’s Neuroprotection against global cerebral ischemia in rat [J]
  1598. Endogenous mechanisms of Neuroprotection and neuroregeneration
  1599. Nicotinic acetylcholine receptor-mediated mechanisms of Neuroprotection in AD
  1600. Lithium and Neuroprotection
  1601. Effect of two different Neuroprotection systems on microembolization during carotid artery stenting
  1602. … CHRONIC OCULAR HYPERTENSION RESULTS IN DEGENERATION OF RETINO–TECTAL AFFERENTS: Neuroprotection WITH TOPICAL BRIMONIDINE.
  1603. Neuroprotection in Parkinson’s Disease
  1604. Neuroprotection Therapeutics: Part 2-Companies & Drugs in Development
  1605. Neuroprotection and the anesthesiologist
  1606. The functional change in the 5-HT1A receptor induced by stress and the role of the 5-HT1A receptor in Neuroprotection
  1607. ELECTRIC MAGNETIC NEUROSTIMULA-TIONS ARE REALLY Neuroprotection
  1608. Intravenous Magnesium for Neuroprotection in Acute Stroke: Neuropharmacology Supports Clinical Hope: Response
  1609. Persistent Neuroprotection Against Focal Cerebral Ischemia Induced By Cortical Spreading Depression In Mice
  1610. Preventive Neuroprotection : from experimental data to therapeutic
  1611. The role of neuregulins in Neuroprotection following acute stroke
  1612. Cerebral transfer and Neuroprotection
  1613. Long-lasting Neuroprotection induced in mouse retina by repeated hypoxic preconditioning
  1614. Glycosaminoglycans and Neuroprotection : effect on cholinergic neurodegeneration
  1615. Anesthesia for neurosurgery Neuroprotection 2005
  1616. 17 The Essentiality of Iron Chelation in Neuroprotection : A Potential Role of Green Tea Catechins
  1617. Development of sleep therapeutic instrument based on the mechanism of Neuroprotection
  1618. Updating the Dual Role of brain Nitric Oxide in Neurodegeneration/Neuroprotection : Understanding Molecular Mechanisms to Devise Drug Approaches
  1619. Regulation of immune-dependent Neuroprotection for arresting neuronal degeneration in optic neuropathies
  1620. Preconditioning Neuroprotection afforded by xenon requires new protein synthesis in an vitro nodel of neuronal injury
  1621. Society for Neuroscience–34th Annual Meeting. Neuroprotection and Anxiety. 23-27 October 2004, San Diego, CA, USA
  1622. Neuroprotection in Parkinson’s Disease
  1623. Quality of preclinical evidence for Neuroprotection in stroke
  1624. Ketamine and Neuroprotection : hemodynamic and metabolic effects in severe traumatic brain injury
  1625. Molecular Mechanisms of Dopaime Receptor Mediated Neuroprotection
  1626. Neuroprotection by Brimonidine Treatment in a Rat Model of Anterior Ischemic Optic Neuropathy
  1627. Neuroprotection in Progressive brain Disorders
  1628. The Neuroprotection of polysaccharidesulfate in the experimental cerebral ischemia
  1629. Neuroprotection Therapeutics: Part 1-New Scientific Strategies & Broader Clinical Applications
  1630. Lamotrigine Neuroprotection in the rabbit retina after pars plana vitrectomy with silicone oil tamponade
  1631. Modulators of endogenous Neuroprotection : Estrogen, corticotropin-releasing hormone and endocannabinoids
  1632. Approaches to Neuroprotection and Recovery Enhancement After Acute Stroke
  1633. Endovanilloid and endocannabinoid mechanism in Neuroprotection
  1634. Neuroprotection in Huntington; s Disease
  1635. Apoptosis and Neuroprotection an exciting and rapidly expanding field of research in ophthalmology
  1636. From a cage to a model, from the heart to the brain : novel concepts in Neuroprotection
  1637. Adenosine-induced Neuroprotection
  1638. Mechanisms underlying in vivo Neuroprotection by the endocannabinoid anandamide and the cannabinoid/vanilloid receptor agonist, arvanil
  1639. … ) on Retinal Ganglion Cells (RGCs) Survival After Optic Nerve Crush, and the Role of brain Derived Neurotrophic Factor (BDNF) in Immune Mediated Neuroprotection
  1640. Anti-apoptotic mechanism of androgen Neuroprotection
  1641. Neuroprotection by drug-induced growth factors
  1642. The müller glia: role in Neuroprotection
  1643. Adaptation of different Neuroprotection devices during carotid stenting procedures
  1644. Mechanisms of Neuroprotection by acetyl-L-carnitine
  1645. Neuroprotection and ageing in sensory neurons.
  1646. Immuno-pharmacological properties of panaxadiol and panaxatriol and their potential effects in Neuroprotection in vitro
  1647. Assessment of functional Neuroprotection in a rat model of neonatal stroke
  1648. Preface [Hot Topic: Current Status of Neuroprotection in Traumatic brain Injury (Executive Editors: Maria Mataro and Juan Sahuquillo)]
  1649. Neuroprotection against ischemic stroke by early or delayed treatment with MC4 receptor-stimulating melanocortins
  1650. Erythropoietin: A Beneficial Approach to Neuroprotection in Stroke
  1651. Acid–base management during hypothermic Neuroprotection
  1652. A-type potassium currents and Neuroprotection after ischemia
  1653. Correlation between Mitochondrial Membrane Potential and Topiramate′ s Neuroprotection
  1654. Low stroke rates during carotid artery stenting with Neuroprotection
  1655. Neuroprotection Effect of Ascorbic Acid in Model of Ischemic Retinal Injury
  1656. Neuroprotection in multiple sclerosis report from the MS Forum 16th Modern Management Workshop, March 2004, Cernobbio, Italy.
  1657. Postischemic Hypothermia Provides Long-Term Neuroprotection in Rodents
  1658. Modern Therapeutic Approaches to Acute Focal brain Ischemia. Basic Strategies for Neuroprotection
  1659. Neuroprotection During Acute Oxidative Stress: Role of the PKG
  1660. Neuroprotection in Acute Ischemic Stroke: Lessons for Early Treatment in Multiple Sclerosis
  1661. Cell Death and Neuroprotection of Retinal Ganglion (RGC–5) Cells
  1662. In vivo Neuroprotection of melatonin against focal cerebral
  1663. Parkinson’s Disease: Possible Mechanisms of Neurodegeneration and Strategies for Neuroprotection
  1664. Perspectives on Neuroprotection . Could acid-sensing ion channels be a target of new treatments?
  1665. Albumin therapy for Neuroprotection in ischemic stroke: Alias I trial
  1666. WHAT CAUSES RETINAL GANGLION CELLS TO DIE? NEUROTOXICITY AND Neuroprotection
  1667. Neuroprotection in acute cerebral ischemia by acetylsalicylic acid
  1668. Metallothionein is Implicated in Zn” Neuroprotection of
  1669. Combined Neuroprotection by Xenon and Dexmedetomidine in vitro
  1670. Mechanism of isoflurane preconditioning’s Neuroprotection against global cerebral ischemia in rat
  1671. Neurodegeneration and Neuroprotection in transient cerebral ischemic stroke
  1672. Tenascin-R plays a role in Neuroprotection via its distinct
  1673. Neurodegeneration and Neuroprotection : epilepsy and Parkinsonism
  1674. Molecular Basis of Neuroprotection in a Mouse Model of Focal Cerebral Ischaemia
  1675. Developmental effects of gonadal steriod hormones upon Neuroprotection of the nigrostriatal dopaminergic system
  1676. Estrogen Regulate Neuroprotection and PDI Gene Expression in Ischemic Rat brain
  1677. Estrogen Regulate Neuroprotection and PDI Gene Expression in Ischemic Rat brain
  1678. Therapeutic T-cell-based vaccination versus pharmacological intervention for Neuroprotection : restoring lost homeostasis
  1679. Mechanisms of HBO-induced Neuroprotection in a Neonatal Hypoxia-ischemia Model
  1680. Neuroprotection BY TEMPOL IN A MODEL OF IRON INDUCED
  1681. Neuroprotection of zinc against apoptotic cell death in model of anoxia in vitro
  1682. The role of activin in Neuroprotection and long-term potentiation
  1683. Neuroprotection of ginsenoside Rg3 and signal evidences in neuroblastom a cell line (SK-N-MC)
  1684. Evaluation of Early and Prolonged Effects of Acute Neurotoxicity and Neuroprotection Using Novel Functional Imaging Techniques
  1685. Gene expression and spinal cord injury: Using microarrays to find genes associated with Neuroprotection and regeneration.
  1686. In vitro modelling of neurodegeneration and Neuroprotection specific for Alzheimer’s disease in cell cultures
  1687. Sigma Agonists Afford Neuroprotection via a Post-Synaptic Mechanism
  1688. Neuroprotection by 3-CP During Reperfusion in a Rat Model of Transient Focal Ischemia
  1689. Ischemic preconditioning promotes Neuroprotection via cyclooxygenase-2 induction in vitro
  1690. Organ Cultures of Adult Porcine Retina: A Model for Studing Neuroprotection in the Retina
  1691. The role of glia cells in purine receptor-induced Neuroprotection
  1692. CAI Appears to Provide Neuroprotection in Mouse Model of Ischemia Induced Retinal Neovascularization
  1693. Is tumor necrosis factor-α-converting enzyme (TACE) a therapeutic target for Neuroprotection ?
  1694. Neuroprotection of sini decoction after focal cerebral ischemia in rat and mechanism
  1695. Mechanisms of dantrolene‐induced Neuroprotection against excitotoxic injury
  1696. Neuroprotection of Fructose-1, 6-bisphosphate Modifying ROS through p38 MAPK/ERK
  1697. Survivin expression after traumatic brain injury: Potential roles in Neuroprotection
  1698. Progress in study on Neuroprotection of erythropoietin against hypoxic-ischemic brain damage
  1699. Neuroprotection following acute spinal cord injury through inhibition of the Fas apoptotic pathway.
  1700. Adenosine-induced Neuroprotection : involvement of glia cells and cytokines
  1701. Ischemic preconditioning and erythropoietin Neuroprotection share common downstream pathways
  1702. The multiple effects of mood stabilizers and antidepressants on Neuroprotection : translating basic findings into clinical practice
  1703. Mechanisms of Neuroprotection by estrogen and selective estrogen receptor modulators
  1704. Neuroprotection induced by delta-9-THC in a model of transient global cerebral ischemia
  1705. Uptake of Tavocept™ in dorsal root ganglia (DRG) cells: Evidence for pharmacological effects of Neuroprotection
  1706. Neuroprotection Following Acute Spinal Cord Injury Through Inhibition of the Fas Apoptotic
  1707. Transgenic VEGF induces post-ischemic Neuroprotection , but facilitates hemodynamic steal phenomena
  1708. Cannabinoids and Neuroprotection in mouse models of demyelination.
  1709. Glia-regulated, apolipoprotein E specific mechanisms of Neuroprotection and neurodegeneration
  1710. Pathological study on the Neuroprotection effect of mikvetch and memantine against hypoxic-ischemic reperfusion damage in neonatal rats
  1711. Sexual dimorphism and Neuroprotection by sex steroids in an animal model of Parkinson
  1712. A quantitative measurement of formazan for evaluating ischemic injury and Neuroprotection in mouse brain slices
  1713. Sigma-Receptor Mediated Neuroprotection Occurs by a Post-Synaptic Mechanism in Neuronal Cell Culture
  1714. Prolonged Therapeutic Window for Ischemic Neuroprotection with Selective Kappa-Opioid Receptor Agonist, BRL 52537 in Rat
  1715. Neuroprotection of estrogen against injury induced by?-amyloid protein (25-35) in rat cortical neurons
  1716. Isoflurane Neuroprotection is dependent on post-ischemic hypothermia in rats subjected to severe global forebrain ischemia, Alex
  1717. Neuroprotection of retinal ganglion cells in BDNF over–expression mice with induced elevated intraocular pressure
  1718. Peroxisome proliferator-activated receptor-γ activation as a mechanism of preventive Neuroprotection induced by pioglitazone treatment
  1719. Neuroprotection in Ischemic Stroke Mediated by Intracerebral Transplantation of Human Umbilical Cord Cells
  1720. Role of microtubule-associated kinases and phosphatases in Neuroprotection against amyloid-beta toxicity.
  1721. Distribution, Expression, and Inflammatory Response after Non-Viral Gene Delivery to the Primate CNS: A Model for Operative Neuroprotection
  1722. Neuroprotection of MK-801 and magnesium sulfate in 7-day rats with hypoxic ischemic encephalathy (HIE)
  1723. Sigma receptors mediate potent Neuroprotection in vivo and inhibit neuronal depolarisation and swelling in rat brain slices
  1724. Neuroprotection action of Aspirin on cerebral ischemia-reperfusion rats with different treatment time-window and its effect on ATP levels
  1725. Estrogen mediates Neuroprotection via estrogen receptor α, not β, in a neuronal in vitro model
  1726. Caffeine, adenosine A2A receptors, and Neuroprotection in PD Schwarzschiid MA Massacusetts General Hospital, Boston, USA
  1727. Analogous Neuroprotection induced by resveratrol and ischemic preconditioning in CA1 region of hippocampus after ischemia
  1728. Strategies for Neuroprotection Using Passive (Neurotrophin-Deprivation) and Active (Virotoxin Exposure) Models of Neuronal Cell Death
  1729. SPONTANEOUS HYPOTHERMIA PROVIDES ENDOGENOUS Neuroprotection FROM CARDIAC ARREST AND CARDIOPULMONARY RESUSCITATION (CPR …
  1730. Neuroprotection From Calcineurin–Mediated Retinal Ganglion Cell Apoptosis by FK506 in Experimental Glaucoma
  1731. Neuroprotection by LAU–0901 in light–induced retinal damage: rod and cone photoreceptor sparing
  1732. ACh Receptor Activation Links Two Separate Signaling Proteins to Neuroprotection Against Glutamate–Induced Excitotoxicity in Isolated Pig Retinal Ganglion Cells
  1733. Neuroprotection by Native Wild Vegetable Extract against Oxidative Damage in the Mouse brain Induced by Kainic Acid
  1734. Stroke units, tissue plasminogen activator, aspirin and Neuroprotection : which stroke intervention could provide the greatest community benefit?
  1735. Ketamine Neuroprotection in the Rabbit Retina after Pars Plana Vitrectomy with Silicone Oil Tamponade
  1736. Understanding apoptosis: the key to Neuroprotection in glaucoma; As researchers unlock the secrets of programmed cell death, they shed new light on optic …
  1737. Secreted Proteins from Retinal Mueller Glia Enhance Photoreceptor Survival: An Approach to Detection of New Candidates for Neuroprotection
  1738. … Protein Co-Localizes with an NMDA Receptor Subunit in Transfected Cells and Is Detectable in brain Extracts: Prerequisites for a Possible Role in Neuroprotection
  1739. Isoflurane Neuroprotection in Hypoxic Hippocampal Slice Cultures Involves Increases in Intracellular Ca2+ and MAP Kinases
  1740. Pretreament with repeated electroacupuncture induced Neuroprotection against spinal cord ischemia-reperfusion injury in rabbits
  1741. Metabotropic glutamate receptors in spinal cord injury: Roles in Neuroprotection , chronic central pain, and locomotor recovery.
  1742. Aggravation of ischemic brain injury by prion protein deficiency, but lack of Neuroprotection by elevated prion protein levels: Role of tyrosine kinases
  1743. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against In Vivo excitoxicity in the rat: Role of vanilloid receptors and lipoxygenases
  1744. Transient Ischemia of the Retina Results in Altered Retrograde Axonal Transport by Retinal Ganglion Cells: Neuroprotection With Brimonidine
  1745. Correlative Electrophysiological and Anatomical Studies on the Effects of Retinal Ischemia on the ERG and Orthograde Axonal Transport: Neuroprotection with …
  1746. Mechanism of Apoptosis in Rat Retinal Ganglion Cell Line RGC–5 Involves Calpain–Mediated Proteolysis: Calpain Inhibition Provides Functional Neuroprotection
  1747. … AND ANATOM-ICAL STUDIES ON THE EFFECTS OF RETINAL ISCHEMIA ON THE ERG AND ORTHOGRADE AXONAL TRANSPORT: Neuroprotection WITH …
  1748. NF-B factor c-Rel mediates Neuroprotection elicited by mGlu5 receptor agonists against amyloid-peptide toxicity
  1749. Neuroprotection against ischemic CA1 neurodegeneration by pituitary adenylate cyclase activating polypeptide via cAMP-response-element-binding protein-mediated …
  1750. Neuroprotection in hippocampal slices from the hibernating species Arctic ground squirrel, Spermophilus parryii
  1751. Hypothermia Prolongs the Viability of Ischemic brain Tissue Due to Neuroprotection Linked to Redistribution of Oxygen in brain : Positron Emission Tomography Study …
  1752. … in the brain after transient forebrain ischemia accompanied by an increased expression of galectin-1, and the implication of ΔFosB and galectin-1 in Neuroprotection …
  1753. 4 Cellular brain Ischemia and Stroke: Neuroprotection , Metabolism, and New Strategies for brain
  1754. … Three Months Later in Altered Erg, Degeneration of Inner Retinal Layers, and Deafferentation of the Contralateral Superior Colliculus: Long–Term Neuroprotection …
  1755. Copolymer-1 vaccination regimens for Neuroprotection in laser-induced retinal injuries
  1756. Uncoupling Proteins: Regulation by IGF-1 and Neuroprotection during Hyperglycemia in Vitro
  1757. 155 Combined Inhibition of Neuronal and Inducible Nos Provides Neuroprotection After Hypoxia-Ischaemia in P3 and P7 Rat Pups
  1758. … Meeting of the American Society for Experimental Neurotherapeutics, Washington, DC, March 13-15, 2003—Editor’s Note: Neuroprotection : Translation of Mechanism …
  1759. The role of cyclooxygenase-2 in neurotoxicity and preconditioning-induced Neuroprotection .
  1760. 234 Magnesium Sulphate Given for Neuroprotection Before Preterm Birth
  1761. Optimization of Copolymer–1 Vaccination regimen for Neuroprotection in Laser–Induced Retinal Injuries
  1762. LINGO–1 Exerts Neuroprotection in a Rat Glaucoma Model
  1763. 17 valerate regulates Protein Disulfide Isomerase, c-fos and Nrf2 gene expressions to provide ischemic Neuroprotection in ovariectomized rat
  1764. … BETWEEN THE NEURONAL TRANSCRIPTION FACTOR NOct-3 AND THE HIV-1 TAR AND RRE RNAS: ARationale FOR Neuroprotection ?
  1765. Metallothionein is implicated in zinc (2+) Neuroprotection of cultured rat dopaminergic neurons.
  1766. Age-associated biochemical changes, Alzheimer’s disease and Neuroprotection
  1767. Oxidative Toxicity in BV-2 Microglia Cells: Sesamolin Neuroprotection of H2O2 Injury Involving Activation of p38 Mitogen-Activated Protein Kinase
  1768. PB-007 Memantine Provides Neuroprotection in Animal Models at Therapeutically Relevant Doses
  1769. Neuroprotection : challenges and opportunities
  1770. Pathologically activated therapeutics for Neuroprotection
  1771. Hypothermic Neuroprotection
  1772. Future of Neuroprotection for acute stroke: in the aftermath of the SAINT trials
  1773. Glaucoma Neuroprotection : What is it? Why is it needed?
  1774. Mechanisms of Neuroprotection by estrogen
  1775. Nitric oxide in the central nervous system: Neuroprotection versus neurotoxicity
  1776. Neuroprotection and stroke: time for a compromise
  1777. Microglia provide Neuroprotection after ischemia
  1778. Pharmacological Neuroprotection for glaucoma
  1779. Minocycline for short‐term Neuroprotection
  1780. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and Neuroprotection
  1781. Cell survival matters: docosahexaenoic acid signaling, Neuroprotection and photoreceptors
  1782. Kynurenine pathway in major depression: evidence of impaired Neuroprotection
  1783. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature
  1784. PPAR: a new pharmacological target for Neuroprotection in stroke and neurodegenerative diseases
  1785. Paradigm shift in Neuroprotection by NMDA receptor blockade: memantine and beyond
  1786. Neuroprotection targets after traumatic brain injury
  1787. Neuroprotection by ovarian hormones in animal models of neurological disease
  1788. Neuroprotection and neuroplasticity–a holistic approach and future perspectives
  1789. Magnesium sulfate for Neuroprotection after traumatic brain injury: a randomised controlled trial
  1790. Novel mechanisms for estrogen-induced Neuroprotection
  1791. Estrogen action in Neuroprotection and brain inflammation
  1792. brain aromatase: roles in reproduction and Neuroprotection
  1793. The role of T helper cells in Neuroprotection and regeneration
  1794. Autophagy, bafilomycin and cell death: the “aB-cs” of plecomacrolide-induced Neuroprotection
  1795. Neuroprotection by resveratrol against traumatic brain injury in rats
  1796. Role of astrocytes in reproduction and Neuroprotection
  1797. Molecular and cellular immune mediators of Neuroprotection
  1798. Prolonged activation of ASIC1a and the time window for Neuroprotection in cerebral ischaemia
  1799. Progesterone: therapeutic opportunities for Neuroprotection and myelin repair
  1800. Neuroprotection by pharmacologic blockade of the GAPDH death cascade
  1801. Auto-catalytic ceria nanoparticles offer Neuroprotection to adult rat spinal cord neurons
  1802. Lymphocytes: potential mediators of postischemic injury and Neuroprotection
  1803. brain Neuroprotection by scavenging blood glutamate
  1804. Preconditioning doses of NMDA promote Neuroprotection by enhancing neuronal excitability
  1805. Neuroprotection by histone deacetylase-related protein
  1806. Aspects of growth hormone and insulin-like growth factor-I related to Neuroprotection , regeneration, and functional plasticity in the adult brain
  1807. Activation of the Keap1/Nrf2 pathway for Neuroprotection by electrophillic phase II inducers
  1808. PPARs: a new target for Neuroprotection
  1809. Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia
  1810. Role of astrocytes in estrogen-mediated Neuroprotection
  1811. On the hypes and falls in Neuroprotection : targeting the NMDA receptor
  1812. Cell biology and clinical promise of G‐CSF: immunomodulation and Neuroprotection
  1813. A systematic review of cooling for Neuroprotection in neonates with hypoxic ischemic encephalopathy–are we there yet?
  1814. Role of δ‐opioid receptor function in neurogenesis and Neuroprotection
  1815. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia
  1816. Dopamine in neurotoxicity and Neuroprotection : what do D2 receptors have to do with it?
  1817. Neuroprotection by erythropoietin administration after experimental traumatic brain injury
  1818. Nicotine Neuroprotection against nigrostriatal damage: importance of the animal model
  1819. A select combination of neurotrophins enhances Neuroprotection and functional recovery following spinal cord injury
  1820. Neurorepair versus Neuroprotection in stroke
  1821. Progesterone-induced Neuroprotection
  1822. Inhibition of mitochondrial function in astrocytes: implications for Neuroprotection
  1823. Dual effects of antioxidants in neurodegeneration: direct Neuroprotection against oxidative stress and indirect protection via suppression of gliamediated inflammation
  1824. Inflammation, demyelination, neurodegeneration and Neuroprotection in the pathogenesis of multiple sclerosis
  1825. Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats
  1826. The ischemic penumbra: a new opportunity for Neuroprotection
  1827. Cystine/glutamate exchange modulates glutathione supply for Neuroprotection from oxidative stress and cell proliferation
  1828. Neuroprotection in emerging psychotic disorders
  1829. Peptide Neuroprotection through specific interaction with brain tubulin
  1830. Transplantation of human neural stem cells exerts Neuroprotection in a rat model of Parkinson’s disease
  1831. Chinese herbs and herbal extracts for Neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson’s disease
  1832. Erythropoietin enhances long-term Neuroprotection and neurogenesis in neonatal stroke
  1833. Xenon provides short-term Neuroprotection in neonatal rats when administered after hypoxia-ischemia
  1834. Improved reperfusion and Neuroprotection by creatine in a mouse model of stroke
  1835. Cannabinoids and Neuroprotection in basal ganglia disorders
  1836. SIRT1 activation confers Neuroprotection in experimental optic neuritis
  1837. Human neural stem cells over-expressing VEGF provide Neuroprotection , angiogenesis and functional recovery in mouse stroke model
  1838. Neuro (active) steroids actions at the neuromodulatory sigma1 (σ1) receptor: biochemical and physiological evidences, consequences in Neuroprotection
  1839. Pleiotropic functions of PACAP in the CNS: Neuroprotection and neurodevelopment
  1840. Eicosapentaenoic acid confers Neuroprotection in the amyloid-β challenged aged hippocampus
  1841. Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats
  1842. Dissecting the signaling pathway of nicotine‐mediated Neuroprotection in a mouse Alzheimer disease model
  1843. Adenosine A2A receptors and brain injury: broad spectrum of Neuroprotection , multifaceted actions and “fine tuning” modulation
  1844. Modulation of interleukin-1β mediated inflammatory response in human astrocytes by flavonoids: implications in Neuroprotection
  1845. Suppression of mitochondrial oxidative stress provides long-term Neuroprotection in experimental optic neuritis
  1846. Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with Neuroprotection
  1847. Protease-activated receptors in the brain : receptor expression, activation, and functions in neurodegeneration and Neuroprotection
  1848. Parkin mediates Neuroprotection through activation of IκB kinase/nuclear factor-κB signaling
  1849. Mitochondrial mechanism of Neuroprotection by CART
  1850. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated Neuroprotection
  1851. Structure–nongenomic Neuroprotection relationship of estrogens and estrogen-derived compounds
  1852. Neuroprotection by endogenous and exogenous PACAP following stroke
  1853. Hypothermia for Neuroprotection after cardiac arrest: mechanisms, clinical trials and patient care
  1854. Calcium: a role for Neuroprotection and sustained adaptation
  1855. Life after cerovive: a personal perspective on ischemic Neuroprotection in the post–NXY-059 era
  1856. Valproic acid-mediated Neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation
  1857. Neuroprotection and free radical scavenging effects of Osmanthus fragrans
  1858. Estrogen, neuroinflammation and Neuroprotection in Parkinson’s disease: glia dictates resistance versus vulnerability to neurodegeneration
  1859. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/Neuroprotection
  1860. Novel Neuroprotection by caffeine and adenosine A2A receptor antagonists in animal models of Parkinson’s disease
  1861. A novel role for Sema3A in Neuroprotection from injury mediated by activated microglia
  1862. Pathologically-activated therapeutics for Neuroprotection : mechanism of NMDA receptor block by memantine and S-nitrosylation
  1863. Gender-Specific Neuroprotection by 2-Iminobiotin after Hypoxia—Ischemia in the Neonatal Rat via a Nitric Oxide Independent Pathway
  1864. The seek of Neuroprotection : introducing cannabinoids
  1865. The dynamics of statins: from event prevention to Neuroprotection
  1866. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARγ target gene involved in Neuroprotection
  1867. Estrogen receptor α and β differentially regulate intracellular Ca2+ dynamics leading to ERK phosphorylation and estrogen Neuroprotection in hippocampal neurons
  1868. T lymphocyte trafficking: a novel target for Neuroprotection in traumatic brain injury
  1869. Neuroprotection at the nanolevel—Part I: Introduction to nanoneurosurgery
  1870. The role of erythropoietin in Neuroprotection : therapeutic perspectives.
  1871. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing Neuroprotection
  1872. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator‐activated receptor‐γ agonist rosiglitazone
  1873. Fractalkine: moving from chemotaxis to Neuroprotection
  1874. New insights into the roles of metalloproteinases in neurodegeneration and Neuroprotection
  1875. Cross-talk between IGF-I and estradiol in the brain : focus on Neuroprotection
  1876. Role of cocaine-and amphetamine-regulated transcript in estradiol-mediated Neuroprotection
  1877. Antenatal magnesium sulphate Neuroprotection in the preterm infant
  1878. Serotonin and Neuroprotection in functional bowel disorders
  1879. Mechanisms of cell death and Neuroprotection by poloxamer 188 after mechanical trauma
  1880. Neuroprotection in the peripheral nervous system: rationale for more effective therapies
  1881. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and Neuroprotection by PSD-95 inhibitors
  1882. Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal Neuroprotection in vivo and in vitro
  1883. … in epigenetic modulators superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron Neuroprotection studies
  1884. Peroxisome proliferator‐activated receptor‐γ agonists induce Neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as …
  1885. Induction of multiple heat shock proteins and Neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis
  1886. Extensive Neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys
  1887. Distinct mechanisms underlie distinct polyphenol-induced Neuroprotection
  1888. Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence
  1889. Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 Neuroprotection
  1890. Tumor necrosis factor α but not interleukin 1β mediates Neuroprotection in response to acute nitric oxide excitotoxicity
  1891. Neuroprotection against neurodegenerative diseases
  1892. Neuroprotection against surgically induced brain injury
  1893. Transient Neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or …
  1894. Deterioration in acute ischemic stroke as the target for Neuroprotection
  1895. Therapeutic time window of post-ischemic mild hypothermia and the gene expression associated with the Neuroprotection in rat focal cerebral ischemia
  1896. Physiological Neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson’s disease
  1897. Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis
  1898. Neurodegeneration and Neuroprotection in multiple sclerosis and other neurodegenerative diseases
  1899. Cardiac glycosides provide Neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform
  1900. Neurotoxicity of reactive aldehydes: the concept of “aldehyde load” as demonstrated by Neuroprotection with hydroxylamines
  1901. Neuroprotection : a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
  1902. Activation of cerebral peroxisome proliferator‐activated receptors gamma promotes Neuroprotection by attenuation of neuronal cyclooxygenase‐2 overexpression …
  1903. G-CSF and Neuroprotection : a therapeutic perspective in cerebral ischaemia
  1904. Estrogen prevents Neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson’s disease
  1905. Endogenous α-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in Neuroprotection against glutamate-induced …
  1906. Can imaging techniques measure Neuroprotection and remyelination in multiple sclerosis?
  1907. The function of microglia, either Neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro
  1908. Intrinsic and extrinsic erythropoietin enhances Neuroprotection against ischemia and reperfusion injury in vitro
  1909. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington’s disease
  1910. Neuroprotection in multiple sclerosis
  1911. Preclinical evidence of Neuroprotection by cholinesterase inhibitors
  1912. Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia
  1913. Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in α7 nicotinic receptor knockout mice
  1914. Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in Neuroprotection
  1915. Neuroprotection of nicotiflorin in permanent focal cerebral ischemia and in neuronal cultures
  1916. Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke
  1917. Axonal loss and Neuroprotection in optic neuropathies
  1918. Mechanisms of Neuroprotection during ischemic preconditioning: lessons from anoxic tolerance
  1919. Pregnane X receptor (PXR) activation: a mechanism for Neuroprotection in a mouse model of Niemann–Pick C disease
  1920. Post‐trauma Lipitor treatment prevents endothelial dysfunction, facilitates Neuroprotection , and promotes locomotor recovery following spinal cord injury
  1921. Neuroprotection in cerebral infarction: the opportunity of new studies
  1922. Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and Neuroprotection
  1923. Cell signaling pathways in the mechanisms of Neuroprotection afforded by bergamot essential oil against NMDA‐induced cell death in vitro
  1924. Sigma receptor agonists provide Neuroprotection in vitro by preserving bcl-2
  1925. Vanilloid VR1 receptor is involved in rimonabant‐induced Neuroprotection
  1926. Role of the Fas-signaling pathway in photoreceptor Neuroprotection
  1927. Mild hypothermia diminishes oxidative DNA damage and pro-death signaling events after cerebral ischemia: a mechanism for Neuroprotection
  1928. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres
  1929. Neuroprotection by selective inhibition of inducible nitric oxide synthase after experimental brain contusion
  1930. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat
  1931. Neuroprotection in epilepsy
  1932. Neuroprotection in Parkinson models varies with toxin administration protocol
  1933. Methamphetamine‐induced alterations in monoamine transport: implications for neurotoxicity, Neuroprotection and treatment
  1934. Issues in Neuroprotection clinical trials in Parkinson’s disease
  1935. Gene transfer of insulin-like growth factor–I providing Neuroprotection after spinal cord injury in rats
  1936. Opioid preconditioning induces opioid receptor-dependent delayed Neuroprotection against ischemia in rats
  1937. Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor κB (NF-κB), inflammatory gene expression, and …
  1938. Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity
  1939. Aldehyde load in ischemia–reperfusion brain injury: Neuroprotection by neutralization of reactive aldehydes with phenelzine
  1940. Neuroprotection from secondary injury by polyethylene glycol requires its internalization
  1941. Calpeptin provides functional Neuroprotection to rat retinal ganglion cells following Ca2+ influx
  1942. Nonredundant role of Akt2 for Neuroprotection of rod photoreceptor cells from light-induced cell death
  1943. Wide therapeutic time window for fasudil Neuroprotection against ischemia-induced delayed neuronal death in gerbils
  1944. Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or Neuroprotection
  1945. Mechanism of progesterone Neuroprotection of rat cerebellar Purkinje cells following oxygen–glucose deprivation
  1946. Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins
  1947. A novel immune-based therapy for stroke induces Neuroprotection and supports neurogenesis
  1948. Low molecular proanthocyanidin dietary biofactor Oligonol: Its modulation of oxidative stress, bioefficacy, Neuroprotection , food application and chemoprevention …
  1949. Gender-dependent pathways of hypoxia-ischemia-induced cell death and Neuroprotection in the immature P3 rat
  1950. Role of Nrf2-dependent ARE-driven antioxidant pathway in Neuroprotection
  1951. Immune control by endocannabinoids—new mechanisms of Neuroprotection ?
  1952. Erythropoietin: a new paradigm for Neuroprotection
  1953. Reduction in oxidative stress and cell death explains hypothyroidism induced Neuroprotection subsequent to ischemia/reperfusion insult
  1954. Neuroprotection during chemotherapy: a systematic review
  1955. Prevention of inflammation is a mechanism of preconditioning-induced Neuroprotection against focal cerebral ischemia
  1956. Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion
  1957. Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson’s disease
  1958. Tryptophan, adenosine, neurodegeneration and Neuroprotection
  1959. Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways
  1960. Zinc attenuates malathion-induced depressant-like behavior and confers Neuroprotection in the rat brain
  1961. Preventing clinical deterioration in the course of schizophrenia: the potential for Neuroprotection .
  1962. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent Neuroprotection
  1963. Enhancement of Neuroprotection of mulberry leaves (Morus alba L.) prepared by the anaerobic treatment against ischemic damage
  1964. The role of nitric oxide in the Neuroprotection of limb ischemic preconditioning in rats
  1965. Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice
  1966. Clinical trials for Neuroprotection in Parkinson’s disease: overcoming angst and futility?
  1967. Broad spectrum Neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation
  1968. Dose-dependent Neuroprotection of delta opioid peptide [D-Ala2, D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats
  1969. An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF Neuroprotection
  1970. Neuroprotection and neurosupplementation in ischaemic brain
  1971. Polyphenol amentoflavone affords Neuroprotection against neonatal hypoxic‐ischemic brain damage via multiple mechanisms
  1972. Neuroprotection by cAMP
  1973. Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic Neuroprotection conferred by the slow …
  1974. Melanocortins defend their territory: multifaceted Neuroprotection in cerebral ischemia
  1975. Age-related changes in Neuroprotection
  1976. Cannabinoids and Neuroprotection in motor-related disorders
  1977. Neuroprotection by GDNF-secreting stem cells in a Huntington’s disease model: optical neuroimage tracking of brain -grafted cells
  1978. Overexpression of APP provides Neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats
  1979. Ischaemic brain damage after stroke: new insights into efficient therapeutic strategies: International Symposium on Neurodegeneration and Neuroprotection
  1980. Dexmedetomidine and Neuroprotection
  1981. Immune-mediated Neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells
  1982. Experimental models of Neuroprotection relevant to multiple sclerosis
  1983. XIAP-mediated Neuroprotection in retinal ischemia
  1984. NO‐induced Neuroprotection in ischemic preconditioning stimulates mitochondrial Mn‐SOD activity and expression via RAS/ERK1/2 pathway
  1985. Edaravone Neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats
  1986. The role of extracellular signal-regulated kinases in the Neuroprotection of limb ischemic preconditioning
  1987. The Neuroprotection conferred by activating the mitochondrial ATP-sensitive K+ channel is mediated by inhibiting the mitochondrial permeability transition pore
  1988. Slit modulates cerebrovascular inflammation and mediates Neuroprotection against global cerebral ischemia
  1989. Neuroprotection : a therapeutic strategy to prevent deterioration associated with schizophrenia.
  1990. Galantamine postischemia provides Neuroprotection and memory recovery against transient global cerebral ischemia in gerbils
  1991. Neuroprotection during cardiac surgery
  1992. Neuroprotection in ischemic mouse brain induced by stem cell-derived brain implants
  1993. Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-κB and JNK activation and suppression of …
  1994. Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growth
  1995. Transplants of encapsulated rat choroid plexus cells exert Neuroprotection in a rodent model of Huntington’s disease
  1996. Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in Neuroprotection afforded by 17β‐estradiol
  1997. Evolving paradigms for Neuroprotection : molecular identification of ischemic penumbra
  1998. Why hasn’t Neuroprotection worked in Parkinson’s disease?
  1999. Neuroprotection by estradiol: a role of aromatase against spine synapse loss after blockade of GABAA receptors
  2000. Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked Neuroprotection against stroke injury
  2001. Omega-3 fatty acids, pro-inflammatory signaling and Neuroprotection
  2002. Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window
  2003. The application of proteomics and genomics to the study of age-related neurodegeneration and Neuroprotection
  2004. Stroke: the dashed hopes of Neuroprotection .
  2005. Neuroprotection of G-CSF in cerebral ischemia.
  2006. Neuroprotection of Tat-GluR6-9c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear pathways
  2007. Neuroprotection by sodium ferulate against glutamate‐induced apoptosis is mediated by ERK and PI3 kinase pathways1
  2008. Neuroprotection conferred by astrocytes is insufficient to protect animals from succumbing to Japanese encephalitis
  2009. Role of estrogen receptors in Neuroprotection by estradiol against MPTP toxicity
  2010. Geranylgeranylacetone, a noninvasive heat shock protein inducer, induces protein kinase C and leads to Neuroprotection against cerebral infarction in rats
  2011. Impact of Neuroprotection on incidence of Alzheimer’s disease
  2012. New insights into purinergic receptor signaling in neuronal differentiation, Neuroprotection , and brain disorders
  2013. Neuroprotection of selenite against ischemic brain injury through negatively regulating early activation of ASK1/JNK cascade via activation of PI3K/AKT pathway1
  2014. Behavioral and histologic Neuroprotection of aqueous garlic extract after reversible focal cerebral ischemia
  2015. Peripheral inflammation and Neuroprotection : systemic pretreatment with complete Freund’s adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of …
  2016. Neurogenesis and Neuroprotection in the CNS—fundamental elements in the effect of glatiramer acetate on treatment of autoimmune neurological disorders
  2017. Neuroprotection in the juvenile rat model of light-induced retinopathy: evidence suggesting a role for FGF-2 and CNTF
  2018. Purinergic receptor-stimulated IP3-mediated Ca2+ release enhances Neuroprotection by increasing astrocyte mitochondrial metabolism during aging
  2019. Neuroprotection for Parkinson’s disease
  2020. Group I metabotropic receptor Neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and β-catenin during oxidative stress
  2021. Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased Neuroprotection after chronic cerebral hypoperfusion in …
  2022. Neuronal death and Neuroprotection : a review
  2023. Currently evaluated calpain and caspase inhibitors for Neuroprotection in experimental brain ischemia
  2024. Deprenyl: from chemical synthesis to Neuroprotection
  2025. Synergistic Neuroprotection by bis (7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase
  2026. Selective cerebral hypothermia for post-hypoxic Neuroprotection in neonates using a solid ice cap
  2027. NMDA Neuroprotection against a phosphatidylinositol‐3 kinase inhibitor, LY294002 by NR2B‐mediated suppression of glycogen synthase kinase‐3β‐induced …
  2028. Delivery of neurturin by AAV2 (CERE‐120)‐mediated gene transfer provides structural and functional Neuroprotection and neurorestoration in MPTP‐treated monkeys
  2029. Evidence for Neuroprotection and remyelination using imaging techniques
  2030. In vitro and in vivo Neuroprotection by γ-glutamylcysteine ethyl ester against MPTP: Relevance to the role of glutathione in Parkinson’s disease
  2031. Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design
  2032. Neuroprotection by extract of Petasites japonicus leaves, a traditional vegetable, against oxidative stress in brain of mice challenged with kainic acid
  2033. Evidence of GLP-1-mediated Neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
  2034. Thrombolysis and Neuroprotection in cerebral ischemia
  2035. Enhancement of Neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia
  2036. Testosterone induces Neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse …
  2037. Endogenous α2-adrenergic receptor-mediated Neuroprotection after severe hypoxia in preterm fetal sheep
  2038. Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERα in primary cultures of mouse mesencephalon
  2039. The role of CaMKII in BDNF-mediated Neuroprotection of retinal ganglion cells (RGC-5)
  2040. ERK 1/2 signaling pathway is involved in nicotine‐mediated Neuroprotection in spinal cord neurons
  2041. Non-pharmacological Neuroprotection : role of emergency stroke management
  2042. Neuroprotection in Parkinson’s disease: an elusive goal
  2043. Multimodal assessment of Neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia
  2044. What constitutes clinical evidence for Neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors?
  2045. Neuroprotection by propargylamines in Parkinson’s disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers
  2046. Akt phosphorylation is required for heat acclimation‐induced Neuroprotection
  2047. Neuroprotection via inhibition of nitric oxide synthase by bis (7)-tacrine
  2048. Molecular mechanisms of Neuroprotection in the eye
  2049. Neuroprotection for ischemic stroke using hypothermia
  2050. … -traumatic application of brain -derived neurotrophic factor and glia-derived neurotrophic factor on the rat spinal cord enhances Neuroprotection and improves motor …
  2051. Neuroprotection and stroke rehabilitation: modulation and enhancement of recovery
  2052. Prophylactic Neuroprotection
  2053. Complement activation in autoimmune demyelination: dual role in neuroinflammation and Neuroprotection
  2054. Neuroprotection by taurine and taurine analogues
  2055. A critical appraisal of the NXY-059 Neuroprotection studies for acute stroke: a need for more rigorous testing of Neuroprotective agents in animal models of stroke
  2056. Dopaminergic Neuroprotection by neurturin-expressing c17. 2 neural stem cells in a rat model of Parkinson’s disease
  2057. Exogenous erythropoietin provides Neuroprotection of grafted dopamine neurons in a rodent model of Parkinson’s disease
  2058. Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation
  2059. Neuroprotection : A new strategy in the treatment of schizophrenia
  2060. Sex, Neuroprotection , and neonatal ischemia’/’Johnston and Hagberg reply’
  2061. Estimation of the hypothermic component in Neuroprotection provided by cannabinoids following cerebral ischemia
  2062. Neuroprotection and enhanced recovery with hypericum perforatum extract after experimental spinal cord injury in mice
  2063. Gene expression in cerebral ischemia: a new approach for Neuroprotection
  2064. Evidence to implicate early modulation of interleukin‐1β expression in the Neuroprotection afforded by 17β‐Estradiol in male rats undergone transient middle cerebral …
  2065. Neuroprotection of adenoviral-vector-mediated GDNF expression against kainic-acid-induced excitotoxicity in the rat hippocampus
  2066. Conventional protein kinase C isoforms mediate Neuroprotection induced by phorbol ester and estrogen
  2067. VIP provides cellular protection through a specific splice variant of the PACAP receptor: a new Neuroprotection target
  2068. Neuroprotection of insulin against oxidative stress‐induced apoptosis in cultured retinal neurons: involvement of phosphoinositide 3‐kinase/Akt signal pathway
  2069. Neuroprotection of retinal ganglion cell function and their central nervous system targets
  2070. Neuroprotection by small molecule activators of the nerve growth factor receptor
  2071. Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate Neuroprotection in a rat model of permanent focal ischemia
  2072. Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated Neuroprotection through increased levels of glutathione …
  2073. Substance P provides Neuroprotection in cerebellar granule cells through Akt and MAPK/Erk activation: evidence for the involvement of the delayed rectifier potassium …
  2074. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces Neuroprotection in cerebral ischemia
  2075. Neuroprotection of the nigrostriatal dopaminergic neurons by melatonin in hemiparkinsonium rat
  2076. … oxidative stress mediated by 2, 2-azobis (2-amidino-propane) dihydrochloride (AAPH) or Fe2+/H2O2: Insight into mechanisms of Neuroprotection and relevance to …
  2077. Rab‐mediated endocytosis: linking neurodegeneration, Neuroprotection , and synaptic plasticity?
  2078. Neuroprotection in vascular dementia
  2079. Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain : Neuroprotection versus neurotoxicity
  2080. Acetylcholine Neuroprotection against glutamate-induced excitotoxicity in adult pig retinal ganglion cells is partially mediated through α4 nAChRs
  2081. Sustained Neuroprotection and facilitation of behavioral recovery by the Ginkgo biloba extract, EGb 761, after transient forebrain ischemia in rats
  2082. Recent advances in Neuroprotection for treating traumatic brain injury
  2083. Perfusing the cold brain : optimal Neuroprotection for aortic surgery
  2084. Direct evidence for calpain involvement in apoptotic death of neurons in spinal cord injury in rats and Neuroprotection with calpain inhibitor
  2085. Pharmacologic Neuroprotection : the search continues
  2086. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms
  2087. Selective γ-aminobutyric acid type A receptor antagonism reverses isoflurane ischemic Neuroprotection
  2088. Neuroprotection by early and delayed treatment of acute stroke with high dose aspirin
  2089. Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated Neuroprotection against hippocampal neuronal death after transient global …
  2090. Neuroprotection of rat hippocampal slices exposed to oxygen–glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of …
  2091. The mechanism of 1, 2, 3, 4‐tetrahydroisoquinolines Neuroprotection : the importance of free radicals scavenging properties and inhibition of glutamate‐induced …
  2092. Neuroprotection : models, mechanisms and therapies
  2093. nPKCε and NMDA receptors participate in Neuroprotection induced by morphine pretreatment
  2094. Glioblastoma in a boy with fragile X: an unusual case of Neuroprotection
  2095. Role of signal transducer and activator of transcription-3 in estradiol-mediated Neuroprotection
  2096. Clinical trials aimed at detecting Neuroprotection in Parkinson’s disease
  2097. Isoflurane Neuroprotection in Rat Hippocampal Slices Decreases with Aging: Changes in Intracellular Ca2+ Regulation and N-methyl-d-aspartate Receptor–mediated …
  2098. Neuroprotection : lessons from a spectrum of neurological disorders
  2099. Bcl-2 upregulation and Neuroprotection in guinea pig brain following chronic simvastatin treatment
  2100. Intracarotid injection of granulocyte–macrophage colony-stimulating factor induces Neuroprotection in a rat transient middle cerebral artery occlusion model
  2101. The limits of viability and the uncertainty of Neuroprotection : challenges in optimizing outcomes in extreme prematurity
  2102. Amine oxidases and their inhibitors: what can they tell us about Neuroprotection and the development of drugs for neuropsychiatric disorders?
  2103. Neuroprotection afforded by diazepam against oxygen/glucose deprivation-induced injury in rat cortical brain slices
  2104. Coenzyme Q 10 provides Neuroprotection in iron-induced apoptosis in dopaminergic neurons
  2105. Gender, sex steroids, and Neuroprotection following traumatic brain injury
  2106. … Heat Stress–Induced cognitive Dysfunction and brain Pathology: An Experimental Study in the Rat, Using Growth Hormone Therapy for Possible Neuroprotection
  2107. … tea polyphenol (–)‐epigallocatechin‐3‐gallate promotes the rapid protein kinase C‐and proteasome‐mediated degradation of Bad: implications for Neuroprotection
  2108. … of new 4H-pyrano [2, 3-b] quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause Neuroprotection against calcium overload and free …
  2109. Estrogen-mediated Neuroprotection in the cortex may require NMDA receptor activation
  2110. Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector
  2111. Dual effect of adenovirus‐mediated transfer of BMP7 in mixed neuron‐glial cultures: Neuroprotection and cellular differentiation
  2112. Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21Waf1/Cip1 as a novel mechanism of Neuroprotection by glucocorticoids
  2113. Erythropoietin depletes iron stores: antioxidant Neuroprotection for ischemic stroke?
  2114. Hippocampal vulnerability following traumatic brain injury: A potential role for neurotrophin‐4/5 in pyramidal cell Neuroprotection
  2115. Transient expression of Nxf, a bHLH–PAS transactivator induced by neuronal preconditioning, confers Neuroprotection in cultured cells
  2116. Neuroprotection in schizophrenia
  2117. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis
  2118. Farnesyl transferase inhibitors induce Neuroprotection by inhibiting Ha‐Ras signalling pathway
  2119. Global hypothermia for Neuroprotection after cardiac arrest
  2120. Cannabinoids in microglia: a new trick for immune surveillance and Neuroprotection
  2121. Bench to bedside strategies for optimizing Neuroprotection following perinatal hypoxia–ischaemia in high and low resource settings
  2122. Neuroprotection –STAIR-way to the future?
  2123. Macrophage-mediated Neuroprotection and neurogenesis in the olfactory epithelium
  2124. Traumatic brain injury induced Neuroprotection of retinal ganglion cells to optic nerve crush
  2125. Nerve growth factor Neuroprotection of ethanol-induced neuronal death in rat cerebral cortex is age dependent
  2126. T cell independent mechanism for copolymer‐1‐induced Neuroprotection
  2127. Valproic acid prevents brain injury in a canine model of hypothermic circulatory arrest: a promising new approach to Neuroprotection during cardiac surgery
  2128. Delta opioid receptors stimulation with [D-Ala2, D-Leu5] enkephalin does not provide Neuroprotection in the hippocampus in rats subjected to forebrain ischemia
  2129. Trypanosome trans-sialidase mediates Neuroprotection against oxidative stress, serum/glucose deprivation, and hypoxia-induced neurite retraction in Trk-expressing …
  2130. Induced hypothermia for Neuroprotection : understanding the underlying mechanisms
  2131. Glycogen synthase kinase-3 in neurodegeneration and Neuroprotection : lessons from lithium
  2132. Neuroprotection in primary brain tumors: sense or nonsense?
  2133. … the base-excision repair pathway after focal ischemic brain injury: a protein phosphorylation-dependent mechanism reversed by hypothermic Neuroprotection
  2134. I can’t get no satisfaction: still no Neuroprotection for Parkinson disease
  2135. Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for Neuroprotection ?
  2136. Role of CDK5 in Neuroprotection from serum deprivation by μ-opioid receptor agonist
  2137. Neurotrophin-mediated Neuroprotection of hippocampal neurons following traumatic brain injury is not associated with acute recovery of hippocampal function
  2138. Neuroprotection of α-phenyl-n-tert-butyl-nitrone on the neonatal white matter is associated with anti-inflammation
  2139. Exercise-induced Neuroprotection in SMA model mice: a means for determining new therapeutic strategies
  2140. Neuroprotection by a central nervous system–type prostacyclin receptor ligand demonstrated in monkeys subjected to middle cerebral artery occlusion and …
  2141. Translational vehicles for Neuroprotection
  2142. Adenosine in the central nervous system: effects on neurotransmission and Neuroprotection
  2143. … during adolescence changes brain -derived neurotrophic factor and TrkB levels in the rat visual system but does not offer Neuroprotection to retinal ganglion cells …
  2144. Neuroprotection for acute ischaemic stroke: hope reignited.
  2145. Time course of changes in pyridoxal 5′-phosphate (vitamin B6 active form) and its Neuroprotection in experimental ischemic damage
  2146. Oestrogen receptor subtype‐specific repression of calpain expression and calpain enzymatic activity in neuronal cells – implications for Neuroprotection against Ca2+ …
  2147. A call for clinically driven experimental design in assessing Neuroprotection in experimental Parkinsonism
  2148. Effect of cyclosporin a on immediate early gene in rat global ischemia and its Neuroprotection
  2149. New approaches to clinical trials in Neuroprotection : introduction
  2150. Can clinical outcomes be used to detect Neuroprotection in multiple sclerosis?
  2151. Lost in translation: again, another failed Neuroprotection trial
  2152. How to improve Neuroprotection in Parkinson’s disease?
  2153. Model of acute injury to study Neuroprotection
  2154. Mechanisms of VIP‐induced Neuroprotection against neonatal excitotoxicity
  2155. Plasticity of the central nervous system (CNS) following perinatal asphyxia: does nicotinamide provide Neuroprotection ?
  2156. Blockade of PARP activity attenuates poly (ADP‐ribosyl) ation but offers only partial Neuroprotection against NMDA‐induced cell death in the rat retina
  2157. Neuronal cell culture from human embryonic stem cells as in vitro model for Neuroprotection
  2158. Oxidative Stress and Neuroprotection
  2159. Evidence for a role of Hsp70 in the Neuroprotection induced by heat shock pre‐treatment against 3, 4‐methylenedioxymethamphetamine toxicity in rat brain
  2160. Progestins and Neuroprotection : are all progestins created equal?
  2161. Cannabinoid CB 1 receptor stimulation affords Neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro
  2162. Pharmacological Neuroprotection during cardiac surgery
  2163. Marker for a preclinical diagnosis of Parkinson’s disease as a basis for Neuroprotection
  2164. Therapeutic time window of Neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats
  2165. Neuroprotection at the nanolevel—Part II: Nanodevices for neuromodulation—Deep brain stimulation and spinal cord injury
  2166. Effects of long-term adrenalectomy on apoptosis and Neuroprotection in the rat hippocampus
  2167. Neuroprotection with or without erythropoiesis; sometimes less is more
  2168. Neuroprotection in Parkinson’s disease: clinical trials
  2169. Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its Neuroprotection for the PC12 cells damaged by …
  2170. Acute implantation of an avulsed lumbosacral ventral root into the rat conus medullaris promotes Neuroprotection and graft reinnervation by autonomic and motor …
  2171. Perturbed synaptosomal calcium homeostasis and behavioral deficits following carbofuran exposure: Neuroprotection by N-acetylcysteine
  2172. Glutamate-related excitotoxicity Neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer’s disease and vascular …
  2173. Activations of nPKCε and ERK1/2 were involved in oxygen-glucose deprivation-induced Neuroprotection via NMDA receptors in hippocampal slices of mice
  2174. Lead and Neuroprotection by iron in ADHD
  2175. Molecular mechanism of ischemic brain injuries and perspectives of drug therapies for Neuroprotection
  2176. Polysialylation of NCAM is upregulated by hyperthermia and participates in heat shock preconditioning-induced Neuroprotection
  2177. Simultaneous bilateral carotid stenting under the circumstance of Neuroprotection device: a retrospective analysis
  2178. … pressure augmentation during retrograde cerebral perfusion under moderate hypothermia provides adequate Neuroprotection : An experimental study
  2179. Quantitative EEG assessment of brain injury and hypothermic Neuroprotection after cardiac arrest
  2180. Potentiation of in vivo Neuroprotection by BclX L and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons
  2181. Effects of Pravastatin on Neuroprotection and neurogenesis after cerebral ischemia in rats.
  2182. Assessing Neuroprotection in Parkinson’s disease: from the animal models to molecular neuroimaging in vivo
  2183. 1, 1′-Xylyl bis-1, 4, 8, 11-tetraaza cyclotetradecane: a new potential copper chelator agent for Neuroprotection in Alzheimer’s disease. Its comparative effects with …
  2184. Transcervical carotid stenting with flow reversal for Neuroprotection : technique, results, advantages, and limitations
  2185. Neuroprotection in glaucoma
  2186. Vitamin E in the Neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity
  2187. Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in Neuroprotection (GAIN) Americas trial
  2188. Back to basics—ephrins, axonal guidance, Neuroprotection and glaucoma
  2189. Neuroprotection : present and future
  2190. Neuroprotection associated with alternative splicing of NMDA receptors in rat cortical neurons
  2191. Increases in expression of 14‐3‐3 eta and 14‐3‐3 zeta transcripts during Neuroprotection induced by Δ9‐tetrahydrocannabinol in AF5 cells
  2192. Carotid artery stenting with distal protection using the carotid wallstent and filterwire Neuroprotection : single-center experience of 380 cases with midterm outcomes
  2193. … immunodeficiency virus–induced neurodegeneration using isolated populations of human neurons, astrocytes, and microglia and Neuroprotection mediated by insulin …
  2194. Nefopam is more potent than carbamazepine for Neuroprotection against veratridine in vitro and has anticonvulsant properties against both electrical and chemical …
  2195. Neuroprotection by 7-nitroindazole against iron-induced hippocampal neurotoxicity
  2196. Inhibition of MLK3‐MKK4/7‐JNK1/2 pathway by Akt1 in exogenous estrogen‐induced Neuroprotection against transient global cerebral ischemia by a non‐genomic …
  2197. Neuroprotection in perinatal hypoxic-ischemic encephalopathy. Effective treatment and future perspectives
  2198. Bacterial DNA confers Neuroprotection after optic nerve injury by suppressing CD4+ CD25+ regulatory T-cell activity
  2199. Optimising clinical trial design for proof of Neuroprotection in acute ischaemic stroke: the SAINT clinical trial programme
  2200. Neuroprotection of photoreceptors in the RCS rat after implantation of a subretinal implant in the superior or inferior retina
  2201. Development of non-erythropoietic erythropoietin variants for Neuroprotection
  2202. 4th Global College of Neuroprotection and Neuroregeneration meeting
  2203. Retrograde cerebral perfusion with intermittent pressure augmentation provides adequate Neuroprotection : diffusion-and perfusion-weighted magnetic …
  2204. Neuroanesthesia and Neuroprotection : where are we now?
  2205. Identification of Fasting‐induced Genes in the Rat Hypothalamus: Relationship with Neuroprotection
  2206. Neuroprotection induced by mucosal tolerance is epitope-dependent: conflicting effects in different strains
  2207. The combination of isoflurane and caspase 8 inhibition results in sustained Neuroprotection in rats subject to focal cerebral ischemia
  2208. Neuroprotection in malignant mca infarction
  2209. Injections of vehicle, but not cyclosporin A or tacrolimus (FK506) afford Neuroprotection following injury in the developing rat brain
  2210. Competing approaches to excitotoxic Neuroprotection by inert and catalytic antioxidant porphyrins
  2211. Lithium-mediated Neuroprotection during cranial irradiation: a phase I trial
  2212. Adenylyl cyclase isoforms as novel therapeutic targets: an exciting example of excitotoxicity Neuroprotection
  2213. The direct and indirect effects of serofendic acid on Neuroprotection
  2214. Preconditioning with estradiol abolishes its Neuroprotection in cerebellar neurons
  2215. Up-regulation of Bcl-2 in APP transgenic mice is associated with Neuroprotection
  2216. Perinatal Neuroprotection
  2217. Neuroprotection and enhancement of neurite outgrowth with small molecular weight compounds from screens of chemical libraries
  2218. PAN-811 provides Neuroprotection against glutamate toxicity by suppressing activation of JNK and p38 MAPK
  2219. Heat shock proteins and Neuroprotection
  2220. Neuroprotection : where to now?
  2221. Neuroprotection : new pharmacological targets
  2222. Unconventional Neuroprotection against Ca2+‐dependent insults by metalloporphyrin catalytic antioxidants
  2223. Insulin-like growth factor-I and Neuroprotection
  2224. Neuroprotection by diazoxide in animal models for cerebrovascular disorders
  2225. Neuroprotection and neurogenesis: modulation of cornus ammonis 1 neuronal survival after transient forebrain ischemia by prior fimbria-fornix deafferentation
  2226. Neuroprotection of adult human neurons against ischemia by hypothermia and alkalinization
  2227. A clinical trial studying Neuroprotection in low-pressure glaucoma
  2228. Short-and long-term outcome after carotid artery stenting with Neuroprotection : single-center experience within a prospective registry
  2229. EndothelinA receptor antagonist BSF-208075 causes immune modulation and Neuroprotection after stroke in gerbils
  2230. Inhibition of caspase-9 activation and apoptosis is involved in ischemic preconditioning-induced Neuroprotection in rat brain
  2231. Prospects for Neuroprotection in Parkinson’s disease
  2232. Involvement of purα gene in Neuroprotection effects of estrogen in rat ischemic brain model
  2233. How to judge animal models of Parkinson’s disease in terms of Neuroprotection
  2234. Hypertension, vascular cognitive disorders and Neuroprotection
  2235. Breathing, Feeding, and Neuroprotection
  2236. Heparan sulfate mediates Neuroprotection from degeneration in experimental glutaric aciduria
  2237. Motoneurons and CD4+ effector T cell subsets: Neuroprotection and repair
  2238. 15 Lipidomic Approaches to Neuroprotection Signaling in the Retinal Pigment Epithelium
  2239. Rasagiline preclinical studies: Implications for Neuroprotection
  2240. The role of vasoactive intestinal peptide in Neuroprotection : Professor Illana Gozes is interviewed by Emma Quigley.
  2241. Estrogen, neuroinflammation and Neuroprotection in Parkinson’s disease: key role of neuron-glia crosstalk
  2242. Mitochondrial Nutrition as a Strategy for Neuroprotection in Parkinson’s Disease—Research Focus in the Department of Alternative Medicine and Experimental …
  2243. Assessment of the optic disc to measure Neuroprotection
  2244. Neuroprotection by dexmedetomidine
  2245. Study on Chemical and Optic Neuroprotection Components of Erigeron breviscapus
  2246. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and Neuroprotection
  2247. Cleft-type cyclophanes confer Neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors
  2248. Neuroprotection during carotid angioplasty and stenting: Comparison of no protection, occlusion, or filters
  2249. Neuroprotection and repair by using adult-derived neural stem cell grafting for neurological disorders
  2250. Neuroprotection of Baicalin on brain Damage Following Experimental Intracerebral Hemorrhage in Rats
  2251. Effects of selective head mild hypothermia on endogenous Neuroprotection in brain following global cerebral ischemia/reperfusion injury: experiment with dogs
  2252. Neuroprotection and drugs used to treat psychiatric disorders
  2253. Anesthetic Neuroprotection : some things do last
  2254. Are cinnamic acids responsible for in vitro Neuroprotection exerted by Bryothamnion triquetrum (SG Gmelin) Howe aqueous extract?
  2255. Neuroprotection : A valuable goal in glaucoma management?
  2256. THE Neuroprotection OF DIETHYLSTILBESTROL ON MESENCEPHALIC NEURONS IN VITRO [J]
  2257. Glutamate transport modulation: a possible role in retinal Neuroprotection
  2258. NXY-059 for acute ischemic stroke: the promise of Neuroprotection is finally realized?
  2259. Mild hypothermia for Neuroprotection after cardiac arrest
  2260. Neuroprotection AND NEUROPLASTICITY IN CRANIOCEREBRAL TRAUMA.
  2261. Shc proteins and brain functions: Possible implications for Neuroprotection
  2262. Detecting the effects of Neuroprotection in living cells
  2263. Neuroprotection with methylaminochroman and lazaroid of embryonic ventral mesencephalic tegmental dopaminergic neurons in cold storage
  2264. Neuroprotection methods and protocols
  2265. Neurodegeneration, Neuroprotection , glial cells, and myelin in multiple sclerosis
  2266. Understanding optic nerve degeneration: key to Neuroprotection in glaucoma
  2267. Superoxide dismutase participates in p38 MAPK-mediated Neuroprotection of limb ischemic preconditioning in global brain ischemic rats
  2268. What have we learned about Neuroprotection in the lab?
  2269. The study on the Neuroprotection of cerebrospinal fluid containing LDP components [J]
  2270. Neuroprotection : Promise and Pitfalls
  2271. Approaches to Neuroprotection and Recovery
  2272. Pharmacologic Neuroprotection in patients with spinal cord injury and the efficacy of early decompressive surgery
  2273. The role of the estrogen in Neuroprotection : Implications for neurodegenerative diseases
  2274. Preface–Special Issue: Molecular mechanisms of CNS injury and Neuroprotection : new roles of amino acids, heme oxygenase system, stress proteins and …
  2275. In vivo tomographic imaging studies of neurodegeneration and Neuroprotection : a review
  2276. Neuroprotection in traumatic brain injury: practical implications for Papua New Guinea and some research developments
  2277. Erythropoietin and Neuroprotection in the central nervous system: intracellular signaling pathways
  2278. Genetical character of CNS injury and autoimmune Neuroprotection [J]
  2279. TRANSCRIPTIONS AND Neuroprotection
  2280. Role of Exercise and GDNF in an Animal Model of Parkinson’s Disease: Implications for Neuroprotection
  2281. Neuroprotection of chloride channel blockers against NMDA-induced apoptosis of cultured rat hippocampal neurons
  2282. Effects of acupuncture at the LU8· KI7 on Anti-apoptotic cell death and Neuroprotection in Rat hippocampus following focal brain ischemic injury induced by …
  2283. ECT and Neuroprotection : a review and proposed study
  2284. Neuronal plasticity as an evolutionary strategy: Implications for Neuroprotection in response to hypoxic challenge
  2285. MHP-133, a drug with multiple CNS targets: potential for Neuroprotection and enhanced cognition
  2286. Global hypothermia for Neuroprotection after cardiac arrest
  2287. Neuroprotection , the role of iron in photoreceptor toxicity induced by subretinal hemorrhage
  2288. Polycyclic indole derivatives as novel structures for Neuroprotection
  2289. Erythropoietin and Neuroprotection in the Peripheral Nervous System: In Vivo Studies
  2290. Novel Endocannabinoids Confer Neuroprotection in NMDA Rat Model
  2291. Pharmacological Neuroprotection against experimental acute cerebral ischemia of neurons of sensomotor area of frontal cortex and hippocampus in rats
  2292. ACUTE STROKE Neuroprotection MODEL
  2293. Selective β1-adrenoreceptor antagonists provide Neuroprotection after focal ischemia in rats
  2294. Neuroprotection in Glaucoma: Is It Possible?
  2295. Neuroprotection strategies from the research lab (’cause there aren’t any ready for prime time yet)
  2296. Recent progress in Neuroprotection of humanin against Alzheimer’s disease-relevant neurotoxicity
  2297. Nitric oxide and histamine in hibernation and Neuroprotection
  2298. Possible sources of Neuroprotection following subretinal silicon chip implantation in RCS rats
  2299. Pharmacological Neuroprotection for glaucoma
  2300. Neuronal restoration of memory disturbances and Neuroprotection for fall in vegetation after cardiac arrest
  2301. Neuroprotection after stroke
  2302. Neuregulins, Neuroprotection and Parkinson’s Disease
  2303. Behavioural aspects of neurodegeneration and Neuroprotection
  2304. Interaction of prion protein with divalent metals: possible role in Neuroprotection and neurodegeneration in prion disease model
  2305. Thyroid hormone regulation of neural and oligodendrocyte precursors in the mature brain : a possibility for remyelination and Neuroprotection
  2306. Phytocannabinoids and Neuroprotection : mechanisms of action and in vitro models
  2307. NT2N cell transplantation and GDNF treatment in stroke: Linking neurotrophic factor therapy and Neuroprotection
  2308. Timecourse of haloperidol-induced midbrain tyrosine hydroxylase downregulation and interventions for Neuroprotection
  2309. Insulin Confers Neuroprotection Against Hyperglycemic Stress-Induced Apoptosis Through PI3K/Akt/mTOR/Nrf2/GCL/Redox Signaling.
  2310. Neuroprotection IN brain HYPOXIA
  2311. Visual Cycle Controls Neuroprotection Switch in the Eye
  2312. Mechanisms of Neuroprotection by Erythropoietin
  2313. A New Dawn for Neuroprotection : NXY-059 for Acute Ischemic Stroke
  2314. Regulation of Calcium Influx in Retinal Ganglion Cells by Sigma-1 Receptor Ligands and Neuroprotection Relevance
  2315. The proteomic study of Ras-induced Neuroprotection
  2316. Cellular and molecular studies of ciliary neurotrophic factor receptor alpha expression and ciliary neurotrophic factor mediated Neuroprotection in the canine retina
  2317. Role of MAPK in Neuroprotection by cart in ischemic stroke
  2318. Neurogeneration and Neuroprotection by Copolymer 1 and Therapeutic Vaccines
  2319. Reduced Neuroprotection by aged astrocytes
  2320. Receptor abuse-dependent antagonism for Neuroprotection
  2321. The role of vasoactive intestinal peptide in Neuroprotection : interview with Professor Illana Gozes
  2322. Does Neuroprotection with NXY-059 improve patient outcome after acute ischemic stroke?
  2323. Erythropoietin signaling and Neuroprotection
  2324. CATHEPSIN B, ANTIAMYLOIDOGENESIS, AND Neuroprotection
  2325. Ginkgo biloba extract and Alzheimer’s disease: Is the Neuroprotection explained merely by antioxidant action
  2326. GROWTH FACTORS AND Neuroprotection OF THE PERINATAL brain
  2327. Neurotoxicity in oncology: Is Neuroprotection (NP) attainable? A critical review
  2328. Neuroprotection by N-methyl-D-aspartate antagonists
  2329. Initiation mechanism of estrogen Neuroprotection pathway
  2330. Exercise induced Neuroprotection in spontaneuosly running rats
  2331. Neurodegenerazione, neuroprotezione e sclerosi multipla [Neurodegeneration, Neuroprotection and multiple sclerosis]
  2332. Cellular and Molecular Mechanisms that Distinguish the Effects of Progestorone and Medroxyprogesterone Acetate on Neuroprotection
  2333. Mechanisms underlying Neuroprotection by PARP inhibitors
  2334. Introduction-Neuroprotection : A Therapeutic Strategy to Prevent Deterioration Associated with Schizophrenia
  2335. Erythropoietin Neuroprotection in the Retina
  2336. In vitro models to investigate the role of PI-TPα in Neuroprotection and neurodegeneration
  2337. Role of Serine/Threon protein Phosphateases in Estrogen Mediated Neuroprotection
  2338. Neuroprotection in aortic arch surgery: A risk factor analysis
  2339. Molecular Mechanisms of Neuroprotection in the Anoxia Tolerant
  2340. Molecular mechanisms of Homer protein in ischemic Neuroprotection
  2341. James C. Grotta: Best Stroke Advances in Prevention, Treatment, and Neuroprotection
  2342. Cysteamine metabolism: Relevance to Neuroprotection .
  2343. Perioperative Neuroprotection : is it possible to prevent brain injury in high risk patients?
  2344. 17β-Estradiol Fails To Provide Neuroprotection during Cardiac Surgery
  2345. VIP-and PACAP-Related Neuroprotection
  2346. HOPE FOR BETTER TREATMENTS FOR PARKINSON DISEASE THROUGH ADVANCES IN GENETICS, EPIDEMIOLOGY, AND Neuroprotection
  2347. Genetical character of CNS injury and autoimmune Neuroprotection
  2348. Promising Early Candidates for Neuroprotection Against HIV-Dementia
  2349. Assessing Neuroprotection in Parkinson’s disease: from the animal models to molecular neuroimaging in vivo
  2350. Study of Neuroprotection of 17 beta-estradiol after spinal cord injury in rats
  2351. Neuroprotection of Ischemic Injury in Pig Retina, Part III–Functional Assessment
  2352. Developing New Neuroprotection and Neural Regeneration Strategies Using Mouse Models of Neurological Diseases
  2353. Targeting Cell Cycle in a Coordinated Strategy for Anticancer Treatment and Neuroprotection
  2354. Sex Hormone Modulation of Mitochondrial Function: A Possible Mechanism for Neuroprotection
  2355. Neuroprotection of Ischemic Injury in Pig Retina, Part I: The Injury Model
  2356. Macrophage-mediated Neuroprotection and neurogenesis
  2357. Dynamics of neural stem cell-mediated Neuroprotection in the presence of oxidative stress: studies in vitro and in vivo
  2358. Neuroprotection and sudden infant death. A robust Brussels–Paris collaboration and future perspectives
  2359. Two Signaling Proteins Linked to ACh–Induced Neuroprotection in Isolated Pig Retinal Ganglion Cells
  2360. The activation of ERK1/2 participates in Neuroprotection induced by sevoflurane preconditioning on oxygen-glucose deprivation injury in rat hippocampal slices
  2361. MECHANISMS OF NEURODEGENERATION IN MULTIPLE SCLEROSIS: PREMISE FOR Neuroprotection ?
  2362. Radiated-induced brain injury: advance of molecular mechanisms and Neuroprotection strategies
  2363. S9 CANNABINOID RECEPTORS AND THEIR ROLE IN Neuroprotection
  2364. Duplicate Anesthetic Preconditioning Improves Neuroprotection In Vitro
  2365. The Neuroprotection effect of edaravone on spinal cord injury in rats
  2366. Double Isoflurane Preoconditioning Improves Neuroprotection Againt OGD Injury in Rat brain
  2367. Transferrin in Müller Cells and Neuroprotection in the Retina
  2368. Isoflurane Provides Sustained Neuroprotection in Rats Subjected to Focal Ischemia
  2369. A New Transgenic Mouse Model of Neuroprotection in Ischemic Optic Neuropathy
  2370. Estrogen Neuroprotection in Anterior Ischemic Optic Neuropathy (AION)
  2371. Signaling events in activity dependent Neuroprotection , neurodegeneration, and synaptic plasticity
  2372. A role for uncoupling proteins in Neuroprotection following recurrent hypoglycemia?
  2373. Soluble epoxide hydrolase: Sex differences and role in estrogen-mediated Neuroprotection
  2374. Systematic Pharmacotherapy for Sensory Neuroprotection After Peripheral Nerve Injury
  2375. Erythropoietin Neuroprotection in the Term and Preterm Infant: Safety and Efficacy
  2376. The role of excitatory amino acid transporters in Neuroprotection and neuropathology
  2377. VEGF‐based therapeutic angiogenesis for ischemic stroke is associated with damage of nervous tissue and loss of Neuroprotection
  2378. Does Neuroprotection Still Have a Role in Injured brain Following Aneurysmal Subarachnoid Haemorrhage?
  2379. Preconditioning Triggers Neuroprotection Against Excitotoxicity in Pig Retinal Ganglion Cells
  2380. Neuroprotection by delayed high dose Aspirin treatment in cerebral ischemia
  2381. Molecular Mechanisms of Dietary Restriction on the Neuroprotection and Hippocampal Neurogenesis
  2382. The Neuroprotection of Mild hypothermia in the Acute Phase of Subarachnoid Hemorrhage
  2383. Comparative Neuroprotection of Multi-Dose Lidocaine in a Rabbit Model of Subarachnoid Hemorrhage
  2384. Opioid Preconditioning Induces an Opioid Receptor-Dependent Delayed Neuroprotection
  2385. Estrogen-induced Neuroprotection is Mediated by an Increase in Caspase-12-associated Apoptosis Following MCAO.
  2386. Creatine mediates Neuroprotection towards excitoxicity in an in vitro model of neurodegeneration
  2387. Neuroprotection of AG490 in Oxidative Stress-induced Neuronal Death
  2388. Human Neural Stem Cells Over-Expressing VEGF Provide Neuroprotection
  2389. Neuroprotection in Non-Arteritic Anterior Ischemic Optic Neuropathy
  2390. Overactivation of NMDA receptors in ammonia neurotoxicity: a target for Neuroprotection ?
  2391. Cell cycle regulation provides Neuroprotection after focal cerebral ischemia brain damage
  2392. P20 NEURODEGENERATION AND Neuroprotection ON MODEL OF PHOTOCHEMICALLY INDUCED ISCHEMIA OF RAT brain CORTEX
  2393. Exercise-induced Neuroprotection against kainic acid-induced seizures in the rat
  2394. 599. Neuron Loss Mediated by HIV-1 gp120 In Vivo: Neuroprotection Using SV40 Gene Transfer of Antioxidant Enzymes
  2395. CELL CYCLE INHIBITOR PROVIDES Neuroprotection IN RATS AFTER FOCAL CEREBRAL ISCHEMIA
  2396. Neuroprotection of Ischemic Injury in Pig Retina, Part II: Ganglion Cell Rescue
  2397. Role of cocaine and amphetamine regulated transcript in estradiol-mediated Neuroprotection .
  2398. Long lasting Neuroprotection by JNK activity blockade in severe cerebral ischemia
  2399. Metabolism of Primary Astrocytes Studied by NMR Metabolic Trafficking and Neuroprotection
  2400. Metabolism of primary astrocytes studied by NMR: metabolic trafficking and Neuroprotection
  2401. CHAPTER III. Neuroprotection FROM OXIDATIVE STRESS IN THE STEM CELL NICHE: CELLULAR NETWORKS AND REGULATION OF ANTIOXIDANT …
  2402. Neuroprotection of spinal cord by application of an extract from Paeonin Lactiflora, animal studies
  2403. Role of LIFR-gp130 Activation in Endogenous Neuroprotection of Retinal Photoreceptors
  2404. Studies into The Mechanisms of Neurodegeneration and Neuroprotection in Rd1 Mouse Retina.
  2405. Neuroprotection by granulocyte colony-stimulating factor (G-CSF) after focal cerebral ischemia
  2406. Anxiety Reactions as a Neuroprotection Strategy: Acetylcholinesterase modulations under stress and neurodegenerative diseases as a case study
  2407. Neuroprotection by 20 (S) Protopanaxadiol in Focal Cerebral Ischemia Mouse Model
  2408. Prophylaxis against nerve agent toxicity: Physiological, behavioral, and Neuroprotection of current and novel treatments
  2409. Neuroprotection by Nicotine in Hippocampal Slices Subjected to Oxygen-Glucose Deprivation: Involvement of the α7…
  2410. Carotid Artery Stenting with Neuroprotection : the first percutaneous revascularization technique shown to be clinically superior to surgery in a randomized trial
  2411. A pilot study of Neuroprotection with umbilical cord blood cell transplantation for preterm very low birth weight infants
  2412. Bacterial DNA Confers Neuroprotection Following Optic Nerve Injury by Suppressing CD4+ CD25+ Regulatory T Cell Activity
  2413. HPLC-based activity profiling of Erigeron breviscapus for optic Neuroprotection
  2414. Neuroprotection in Parkinson’s disease: modafinil and Δ9-tetrahydrocannabinol
  2415. Autoimmune Uveitis Induces Loss of Retinal Ganglion Cells: Immune Modulation Rather Than Suppression for Neuroprotection
  2416. Erythropoietin exerts Neuroprotection during Deep Hypothermic Circulatory Arrest
  2417. Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in α7 nicotinic receptor knockout mice
  2418. Neuroprotection of progesterone on retinal ganglion cells in chronic ocular hypertension model rats
  2419. Neuroprotection following repeated hypoxia preconditioning (RHP): pivotal role of brain -derived erythropoietin
  2420. A Perfusion Culture System for Whole Retina From Adult Rat: An in–vitro Model for Neuroprotection on Retinal Ganglion Cells
  2421. Conditional Knock Out of HIF-La and the Consequences for Hypoxia Induced Retinal Neuroprotection in a Model of Light Induced Retinal Degeneration
  2422. PUFA-induced Neuroprotection against cerebral or spinal cord ischemia via the TREK-1 channel
  2423. Assessment of Longterm Neuroprotection by CNTF Gene Transfer in a Mouse Inherited Retinal Degeneration
  2424. Correlation between the repair of oxidative DNA damage and the Neuroprotection in mice after forebrain ischemia
  2425. Pharmacokinetic properties of selective and non-selective AMPA-receptor antagonists and their role in Neuroprotection
  2426. Neuroprotection by 1, 25 (OH) 2-Vitamin D3 Against Kainic Acid-Induced Excitotoxicity in the Rat Hippocampus
  2427. THE Neuroprotection OF OLPRINONE, A PHOSPHODIESTERASE 3 INHIBITOR, ON GLOBAL CEREBRAL ISCHEMIA IN RATS.: 149
  2428. Molecular mechanisms of Neuroprotection by extract from Rosmarinus officinalis (Rosemary) in dopaminergic cell line, SH-SY5Y
  2429. Neuroprotection of Green Tea Derived EGCG: Implications for HIV associated dementia
  2430. Noscapine is synergistic with vincristine and provides Neuroprotection of myelin in cell culture.
  2431. The Insulin Sensitizer Rosiglitazone Decreases Inflammatory Pattern and Improves Vascular Neuroprotection in Insulin-Resistant Type 2 Diabetic Subjects with …
  2432. Neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: targets for Neuroprotection
  2433. Glycogen synthase kinase 3: role in neurodegeneration and Neuroprotection
  2434. Neuroprotection by pharmacological preconditioning, the role of the mitochondrial ATP-sensitive K+ channel
  2435. Leukocyte Anti-adhesion Therapy Provides Neuroprotection after Transient Global Cerebral Ischemia in the Mouse
  2436. GLP-1 secreting encapsulated human mesenchymal stem cells for Neuroprotection
  2437. Riluzole confers Neuroprotection by increasing the amount of HSF1 for a more robust heat shock response
  2438. Erythropoietin Exerts Endogenous Neuroprotection After Ocular Hypertension Induced Glaucoma and Optic Nerve Transection Injuries
  2439. Neuroprotection by sodium ferulate against glutamate-induced apoptosis is mediated by ERK and PI3 kinase pathways1
  2440. Modulation of the endocannabinoid system is implicated in the Neuroprotection afforded by 17Beta-estradiol (E2) against brain damage caused by transient middle …
  2441. … ultrastructural damage in the neurons of hippocampal CA_3 subarea during kainic acid induced status epilepticus and the Neuroprotection of topiramate in rats
  2442. Testosterone-mediated Neuroprotection in NO Induced Cell Death of Motor Neuron Cells Expressing Wild Type or Mutant Cu/Zn Superoxide Dismutase
  2443. The Neuropeptide NAP Provides Neuroprotection of Retinal Ganglion Cells After Optic Nerve Crush and Retinal Ischemia in vivo
  2444. Reversal of Cerebral Vasospasm and Neuroprotection by Injecting Magnesium Sulfate into Cisterna Magna in Rabbit with Subarachnoid Hemorrhage
  2445. … Colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of Colivelin-mediated Neuroprotection against Alzheimer’s disease …
  2446. S07H5 Fuctional analysis of tripartite synapses using membrane potential imaging: memory enhancement and Neuroprotection by neurosteroids (Leading Edge in …
  2447. The Beneficial Role of Extracellular Signal-regulated Kinases 1 and 2 in Exercise-induced Neuroprotection after Stroke
  2448. Concurrent Treatment with Lovastatin and 5‐Aminoimidazole‐4‐Carboxamide‐1‐Beta‐D‐Ribofuranoside provides Neuroprotection and alleviate Neurodegeneration …
  2449. Decrease in Rate of NMDA-induced Ca^ 2^+ Entry May Explain Neuroprotection by Anti-GRINL1A Antibodies
  2450. AM 404 leads to Neuroprotection against ischemia-induced neuronal injury
  2451. Anaesthesia for thoracic and thoraco-abdominal aortic disease—Part 2: Anaesthetic management and Neuroprotection
  2452. Metabotropic glutamate receptor 3 Neuroprotection
  2453. 354 MECHANISMS OF ENDOGENOUS SEX HORMONE MEDIATED Neuroprotection IN THE AGING brain : A SYSTEMATIC REVIEW.
  2454. S20 DIFFERENTIAL ROLES OF 1, 2, 3, 4-TETRAHYDROISOQUINOLINES IN NEURODEGENERATION AND Neuroprotection
  2455. EVIDENCE TO IMPLICATE EARLY MODULATION OF INTERLEUKIN-1 EXPRESSION IN THE Neuroprotection AFFORDED BY 17-ESTRADIOLIN MALE RATS …
  2456. Journal of Neuroal Transmission Suppplement 71: Oxidative Stress and Neuroprotection
  2457. Cytotoxicity of Levodopa on c17. 2 neural stem cell and Neuroprotection of Pergolide
  2458. 8 Erythropoietin Signaling Pathways in Neuroprotection
  2459. 2 Diagnosis and Neuroprotection in Parkinson’s Disease
  2460. Metabotropic glutamate receptor 3 Neuroprotection A. Berent-Spillson and JW Russell Received June 12, 2006; revised manuscript received October 3, 2006; …
  2461. Neurotox-98 Neuroprotection by Progesterones Through Stimulation of Mitochondrial Gene Expression
  2462. Neurone and astrocyte response to Aβ25-35: Role in glutathione in Neuroprotection
  2463. n-3 poly-unsaturated fatty Acid (n-3PUFA) and Neuroprotection : Is docosahexaenoic acid (DHA) involved in glutamate uptake by astrocytes?
  2464. A~ 2-adrenergic system: From neurotransmitans to Neuroprotection
  2465. The role of astroglia in Neuroprotection
  2466. Neuroprotection for ischemic stroke: past, present and future
  2467. Mitochondrial approaches for Neuroprotection
  2468. Statins: mechanisms of Neuroprotection
  2469. Neuroinflammation in Parkinson’s disease: a target for Neuroprotection ?
  2470. Targets for Neuroprotection in Parkinson’s disease
  2471. Metabolic downregulation: a key to successful Neuroprotection ?
  2472. Neuroprotection does not work!
  2473. Current status of Neuroprotection for cerebral ischemia: synoptic overview
  2474. Imaging outcomes for Neuroprotection and repair in multiple sclerosis trials
  2475. Why have we failed to achieve Neuroprotection in Parkinson’s disease?
  2476. The role of kynurenines in disorders of the central nervous system: possibilities for Neuroprotection
  2477. Progress in Neuroprotection in Parkinson’s disease
  2478. The specificity of Neuroprotection by antioxidants
  2479. Magnesium sulphate for women at risk of preterm birth for Neuroprotection of the fetus
  2480. Neuroprotection (and lack of Neuroprotection ) afforded by a series of noble gases in an in vitro model of neuronal injury
  2481. Steroids and Neuroprotection : new advances
  2482. Wnt signaling in Neuroprotection and stem cell differentiation
  2483. Neuroprotection in glaucoma: drug-based approaches
  2484. AMPK in the brain : its roles in energy balance and Neuroprotection
  2485. Antioxidants and Neuroprotection in the adult and developing central nervous system
  2486. Molecular mechanisms of Neuroprotection by two natural antioxidant polyphenols
  2487. Toll-like receptor signaling in endogenous Neuroprotection and stroke
  2488. Mitochondrial mechanisms of estrogen Neuroprotection
  2489. Autophagy and the ubiquitin-proteasome system: collaborators in Neuroprotection
  2490. The multiple faces of quercetin in Neuroprotection
  2491. Assessment of Neuroprotection in the retina with DARC
  2492. Inflammation and its role in Neuroprotection , axonal regeneration and functional recovery after spinal cord injury
  2493. Toll-like receptors: roles in Neuroprotection ?
  2494. Biochemical, molecular and epigenetic mechanisms of valproic acid Neuroprotection
  2495. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease
  2496. Neuroprotection by the NR3A subunit of the NMDA receptor
  2497. Citicoline: update on a promising and widely available agent for Neuroprotection and neurorepair
  2498. Autophagy in Neuroprotection and neurodegeneration: a question of balance
  2499. Estrogen therapy: is time of initiation critical for Neuroprotection ?
  2500. Fluoxetine affords robust Neuroprotection in the postischemic brain via its anti‐inflammatory effect
  2501. Neuroprotection : extrapolating from neurologic diseases to the eye
  2502. History of Neuroprotection and rationale as a therapy for glaucoma
  2503. Alcohol in moderation, cardioprotection, and Neuroprotection : epidemiological considerations and mechanistic studies
  2504. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, Neuroprotection possibly
  2505. Can we achieve Neuroprotection with currently available anti-parkinsonian interventions?
  2506. Recent trends in erythropoietin-mediated Neuroprotection
  2507. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and Neuroprotection
  2508. Neuroprotection in the newborn infant
  2509. Leptin Neuroprotection in the CNS: mechanisms and therapeutic potentials
  2510. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis
  2511. Therapeutic targets and limits of minocycline Neuroprotection in experimental ischemic stroke
  2512. More than a decade of estrogen Neuroprotection
  2513. Forced, not voluntary, exercise effectively induces Neuroprotection in stroke
  2514. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons
  2515. Estrogen and SERM Neuroprotection in animal models of Parkinson’s disease
  2516. Vitagenes, dietary antioxidants and Neuroprotection in neurodegenerative diseases (498 views visite)
  2517. Delayed post-ischaemic Neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
  2518. Mechanisms of disease: sodium channels and Neuroprotection in multiple sclerosis—current status
  2519. Adenosine receptors and neurological disease: Neuroprotection and neurodegeneration
  2520. Neuroprotection trials in Parkinson’s disease: systematic review
  2521. Endogenous Neuroprotection : mitochondria as gateways to cerebral preconditioning?
  2522. All-you-can-eat: autophagy in neurodegeneration and Neuroprotection
  2523. The role of Wnt signaling in Neuroprotection
  2524. CD4+ T cells support glial Neuroprotection , slow disease progression, and modify glial morphology in an animal model of inherited ALS
  2525. Experimental and clinical evidence of Neuroprotection by nerve growth factor eye drops: Implications for glaucoma
  2526. Targeting post-mitochondrial effectors of apoptosis for Neuroprotection
  2527. Neuroprotection in stroke by complement inhibition and immunoglobulin therapy
  2528. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement
  2529. Two different molecular mechanisms underlying progesterone Neuroprotection against ischemic brain damage
  2530. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and Neuroprotection
  2531. Recent clinical findings with memantine should not mean that the idea of Neuroprotection in glaucoma is abandoned
  2532. Progesterone Neuroprotection in traumatic CNS injury and motoneuron degeneration
  2533. Neuroinflammation in spinal cord injury: therapeutic targets for Neuroprotection and regeneration
  2534. Effects of antenatal exposure to magnesium sulfate on Neuroprotection and mortality in preterm infants: a meta-analysis
  2535. Cellular stress response: a novel target for chemoprevention and nutritional Neuroprotection in aging, neurodegenerative disorders and longevity
  2536. Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of Neuroprotection
  2537. Nicotinic acetylcholine receptor signalling: roles in Alzheimer’s disease and amyloid Neuroprotection
  2538. Taurine increases mitochondrial buffering of calcium: role in Neuroprotection
  2539. Endocannabinoids in the retina: from marijuana to Neuroprotection
  2540. Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury
  2541. Mitochondrial mechanisms of cell death and Neuroprotection in pediatric ischemic and traumatic brain injury
  2542. Immunomodulation and Neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other …
  2543. A review of published reports on Neuroprotection in spinal cord injury
  2544. An approach to using recombinant erythropoietin for Neuroprotection in very preterm infants
  2545. Robust docosahexaenoic acid–mediated Neuroprotection in a rat model of transient, focal cerebral ischemia
  2546. Nrf2-mediated Neuroprotection in the MPTP mouse model of Parkinson’s disease: Critical role for the astrocyte
  2547. Adaptive immune Neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice
  2548. Metallothionein‐I+ II in Neuroprotection
  2549. PPAR‐gamma‐mediated Neuroprotection in a chronic mouse model of Parkinson’s disease
  2550. Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired Neuroprotection induced by synaptic activity
  2551. Neuroprotection in diet-induced ketotic rat brain after focal ischemia
  2552. Randomized, double-blinded, placebo controlled study of Neuroprotection with lidocaine in cardiac surgery
  2553. Nicotinic receptor-mediated Neuroprotection in neurodegenerative disease models
  2554. Neuroprotection by radical avoidance: search for suitable agents
  2555. Glucocorticoid receptors modulate mitochondrial function: A novel mechanism for Neuroprotection
  2556. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for Neuroprotection and tissue repair
  2557. Sex differences in minocycline-induced Neuroprotection after experimental stroke
  2558. Targeting oxidative stress for Neuroprotection
  2559. Molecular and cell-based approaches for Neuroprotection in glaucoma
  2560. Neuronal death after peripheral nerve injury and experimental strategies for Neuroprotection
  2561. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards Neuroprotection
  2562. A core review of temperature regimens and Neuroprotection during cardiopulmonary bypass: does rewarming rate matter?
  2563. Transcribe to survive: transcriptional control of antioxidant defense programs for Neuroprotection in Parkinson’s disease
  2564. Mesenchymal stem cells therapy exerts Neuroprotection in a progressive animal model of Parkinson’s disease
  2565. Encapsulated cell biodelivery of GDNF: a novel clinical strategy for Neuroprotection and neuroregeneration in Parkinson’s disease?
  2566. Nano-drug delivery and Neuroprotection in spinal cord injury
  2567. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced Neuroprotection
  2568. Dantrolene: mechanisms of Neuroprotection and possible clinical applications in the neurointensive care unit
  2569. Regulation of Mn-superoxide dismutase activity and Neuroprotection by STAT3 in mice after cerebral ischemia
  2570. Angiotensin AT2 receptor stimulation causes Neuroprotection in a conscious rat model of stroke
  2571. A Nurr1 pathway for Neuroprotection
  2572. Cooling Combined with Immediate or Delayed Xenon Inhalation Provides Equivalent Long-Term Neuroprotection after Neonatal Hypoxia—Ischemia
  2573. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate
  2574. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated Neuroprotection is independent of its deacetylase activity
  2575. Study of Neuroprotection of donepezil, a therapy for Alzheimer’s disease
  2576. Propofol: Neuroprotection in an in vitro model of traumatic brain injury
  2577. Uric acid administration in patients with acute stroke: a novel approach to Neuroprotection
  2578. Disease progression and the need for Neuroprotection in glaucoma management
  2579. Matrix metalloproteinases inhibition provides Neuroprotection against hypoxia‐ischemia in the developing brain
  2580. Insulin Neuroprotection against oxidative stress is mediated by Akt and GSK-3β signaling pathways and changes in protein expression
  2581. Xenon and hypothermia combine additively, offering long-term functional and histopathologic Neuroprotection after neonatal hypoxia/ischemia
  2582. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in Neuroprotection
  2583. Neuroprotection by pravastatin in acute ischemic stroke in rats
  2584. Erythropoietin modulation of astrocyte water permeability as a component of Neuroprotection
  2585. Cannabinoid-mediated Neuroprotection , not immunosuppression, may be more relevant to multiple sclerosis
  2586. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of Neuroprotection
  2587. Optimal Neuroprotection by erythropoietin requires elevated expression of its receptor in neurons
  2588. Neuroprotection in cerebral ischemia: emphasis on the SAINT trial
  2589. Is it time to definitely abandon Neuroprotection in acute ischemic stroke?
  2590. Novel anti-Alzheimer’s dimer bis (7)-cognitin: cellular and molecular mechanisms of Neuroprotection through multiple targets
  2591. Neuroprotection by estrogen in the brain : the mitochondrial compartment as presumed therapeutic target
  2592. Research into Neuroprotection must continue… But with a different approach
  2593. Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway
  2594. Neuroprotection for diabetic retinopathy
  2595. Physical activity and Neuroprotection in amyotrophic lateral sclerosis
  2596. Secretoneurin promotes Neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke
  2597. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis
  2598. Pathogenesis of ganglion “cell death” in glaucoma and Neuroprotection : focus on ganglion cell axonal mitochondria
  2599. Strong Neuroprotection by inhibition of NF-κB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines
  2600. The impact of neuroimmune dysregulation on Neuroprotection and neurotoxicity in psychiatric disorders-relation to drug treatment
  2601. Methylene blue provides behavioral and metabolic Neuroprotection against optic neuropathy
  2602. Endocannabinoids mediate Neuroprotection after transient focal cerebral ischemia
  2603. Cellular NAD replenishment confers marked Neuroprotection against ischemic cell death: role of enhanced DNA repair
  2604. Intranasal delivery of erythropoietin plus insulin-like growth factor–I for acute Neuroprotection in stroke
  2605. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors
  2606. Progesterone and progestins: Neuroprotection and myelin repair
  2607. Ferulic acid provides Neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in …
  2608. TNF receptor I sensitizes neurons to erythropoietin-and VEGF-mediated Neuroprotection after ischemic and excitotoxic injury
  2609. Neuroprotection and repair
  2610. Neuroprotection for Huntington’s disease: ready, set, slow
  2611. Should amplitude-integrated electroencephalography be used to identify infants suitable for hypothermic Neuroprotection ?
  2612. Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the …
  2613. Striatal Neuroprotection with methylene blue
  2614. NAP and D-SAL: Neuroprotection against the β amyloid peptide (1–42)
  2615. Neural stem/progenitor cells initiate the formation of cellular networks that provide Neuroprotection by growth factor‐modulated antioxidant expression
  2616. Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro
  2617. Progesterone reverses 17β‐estradiol‐mediated Neuroprotection and BDNF induction in cultured hippocampal slices
  2618. Phylogeny of proteolipid proteins: divergence, constraints, and the evolution of novel functions in myelination and Neuroprotection
  2619. Bioenergetic‐based Neuroprotection and glaucoma
  2620. P2Y1 receptor signaling enhances Neuroprotection by astrocytes against oxidative stress via IL‐6 release in hippocampal cultures
  2621. New targets of Neuroprotection in ischemic stroke
  2622. Nasal administration of osteopontin peptide mimetics confers Neuroprotection in stroke
  2623. The past and future of Neuroprotection in cerebral ischaemic stroke
  2624. Neuroprotection by nitrous oxide: Facts and evidence.
  2625. Aggravation of infarct formation by brain swelling in a large territorial stroke: a target for Neuroprotection ?
  2626. Neuroprotection in a 6‐hydroxydopamine‐lesioned Parkinson model using lactoferrin‐modified nanoparticles
  2627. Carotid Artery Stenting with Patient-and Lesion-Ta ilo r ed Selection of the Neuroprotection System and Stent Type: Early and 5-Year Results from a Prospective …
  2628. New insight into the molecular pathways of metallothionein‐mediated Neuroprotection and regeneration
  2629. Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13
  2630. Stromal cell-derived factor-1α promotes Neuroprotection , angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats
  2631. Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and Neuroprotection
  2632. Uracil nucleotides: from metabolic intermediates to Neuroprotection and neuroinflammation
  2633. Effects of optic nerve injury, glaucoma, and Neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina
  2634. Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1
  2635. … complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21waf1/cip1 in cell cycle-independent Neuroprotection
  2636. Stem cells for Neuroprotection in glaucoma
  2637. Leptin is induced in the ischemic cerebral cortex and exerts Neuroprotection through NF-κB/c-Rel–dependent transcription
  2638. TGF-β in dopamine neuron development, maintenance and Neuroprotection
  2639. In search of clinical Neuroprotection after brain ischemia: the case for mild hypothermia (35 C) and magnesium
  2640. Human neural stem cells genetically modified to overexpress Akt1 provide Neuroprotection and functional improvement in mouse stroke model
  2641. Potential roles of (endo) cannabinoids in the treatment of glaucoma: from intraocular pressure control to Neuroprotection
  2642. The yellow fluorescent protein (YFP-H) mouse reveals Neuroprotection as a novel mechanism underlying chondroitinase ABC-mediated repair after spinal cord injury
  2643. CNTF induces photoreceptor Neuroprotection and Müller glial cell proliferation through two different signaling pathways in the adult zebrafish retina
  2644. Marked calpastatin (CAST) depletion in Alzheimer’s disease accelerates cytoskeleton disruption and neurodegeneration: Neuroprotection by CAST overexpression
  2645. Molecular and clinical pathways to Neuroprotection of dopaminergic drugs in Parkinson disease
  2646. Dimethyl sulfoxide provides Neuroprotection in a traumatic brain injury model
  2647. Neuroprotection by Spirulina platensis protean extract and phycocyanin against iron-induced toxicity in SH-SY5Y neuroblastoma cells
  2648. Progesterone with vitamin D affords better Neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone
  2649. Neuroprotection in mice by NGP1-01 after transient focal brain ischemia
  2650. Lovastatin induces Neuroprotection through tumor necrosis factor receptor 2 signaling pathways
  2651. Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic Neuroprotection in a model of Parkinson’s disease
  2652. Long-term Neuroprotection from a potent redox-modulating metalloporphyrin in the rat
  2653. Current controversies in hypothermic Neuroprotection
  2654. Acute Neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome
  2655. TNF‐α‐mediates Neuroprotection against glutamate‐induced excitotoxicity via NF‐κB‐dependent up‐regulation of KCa2.2 channels
  2656. Progesterone attenuates oestrogen Neuroprotection via downregulation of oestrogen receptor expression in cultured neurones
  2657. Modeling axonal degeneration within the anterior visual system: implications for demonstrating Neuroprotection in multiple sclerosis
  2658. P2X7 receptors in oligodendrocytes: a novel target for Neuroprotection
  2659. Neuroprotection during cardiac surgery
  2660. Acetyl-L-carnitine provides effective in vivo Neuroprotection over 3, 4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain
  2661. The seed extract of Cassia obtusifolia offers Neuroprotection to mouse hippocampal cultures
  2662. DHEA-Neuroprotection and-neurotoxicity after transient cerebral ischemia in rats
  2663. TAT-Hsp70-mediated Neuroprotection and increased survival of neuronal precursor cells after focal cerebral ischemia in mice
  2664. Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for Neuroprotection
  2665. Nrf2 activators provide Neuroprotection against 6‐hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures
  2666. Involvement of TRPC channels in CCL2-mediated Neuroprotection against tat toxicity
  2667. Multifunction of myricetin on Aβ: Neuroprotection via a conformational change of Aβ and reduction of Aβ via the interference of secretases
  2668. Retinal ganglion cell Neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments
  2669. Possible involvement of P2X7 receptor activation in microglial Neuroprotection against focal cerebral ischemia in rats
  2670. Functional mechanism of Neuroprotection by inhibitors of type B monoamine oxidase in Parkinson’s disease
  2671. Neuroprotection of aucubin in primary diabetic encephalopathy
  2672. A closed-circuit neonatal xenon delivery system: a technical and practical Neuroprotection feasibility study in newborn pigs
  2673. Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for Neuroprotection
  2674. Neuroprotection by cord blood stem cells against glutamate-induced apoptosis is mediated by Akt pathway
  2675. New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit Neuroprotection properties
  2676. Neuroprotection of ginsenoside Re in cerebral ischemia–reperfusion injury in rats
  2677. Tamoxifen Neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide …
  2678. Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and …
  2679. Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by …
  2680. Post-ischemic helium provides Neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia
  2681. A critique of SAINT II: wishful thinking, dashed hopes, and the future of Neuroprotection for acute stroke
  2682. The role of the somatotrophic axis in Neuroprotection and neuroregeneration of the addictive brain
  2683. Activation of cerebral peroxisome proliferator-activated receptors gamma exerts Neuroprotection by inhibiting oxidative stress following pilocarpine-induced status …
  2684. Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression
  2685. P2X 7 nucleotide receptor is coupled to GSK-3 inhibition and Neuroprotection in cerebellar granule neurons
  2686. Involvement of ERK1/2 signaling pathway in DJ-1-induced Neuroprotection against oxidative stress
  2687. Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of Neuroprotection in neonatal rat
  2688. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced Neuroprotection and nicotinic receptor up-regulation
  2689. Neuroprotection and neuroregeneration in multiple sclerosis
  2690. Are delayed‐start design trials to show Neuroprotection in Parkinson’s disease fundamentally flawed?
  2691. Docosahexaenoic acid pretreatment confers Neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia
  2692. The APCs of Neuroprotection
  2693. The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic Neuroprotection
  2694. Hypoxic-ischemic injury in neonatal brain : involvement of a novel neuronal molecule in neuronal cell death and potential target for Neuroprotection
  2695. Long-term administration of estrogen or tamoxifen to ovariectomized rats affords Neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and …
  2696. Molecular mechanisms leading to Neuroprotection /ischemic tolerance: effect of preconditioning on the stress reaction of endoplasmic reticulum
  2697. Blood–central nervous system barriers: the gateway to neurodegeneration, Neuroprotection and neuroregeneration
  2698. Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K–Akt signaling pathway: A novel …
  2699. Heat shock proteins and the brain : implications for neurodegenerative diseases and Neuroprotection
  2700. Cyclosporine A for Neuroprotection : establishing dosing guidelines for safe and effective use
  2701. Chronic treatment with red wine polyphenol compounds mediates Neuroprotection in a rat model of ischemic cerebral stroke
  2702. Long-term pharmacologic Neuroprotection after birth asphyxia: where do we stand?
  2703. Evidence for Neuroprotection by the fenamate NSAID, mefenamic acid
  2704. Hyperphosphorylation of microtubule-associated tau protein plays dual role in neurodegeneration and Neuroprotection
  2705. Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK
  2706. Pharmacological strategies for Neuroprotection in traumatic brain injury.
  2707. Mechanism of guanosine-induced Neuroprotection in rat hippocampal slices submitted to oxygen–glucose deprivation
  2708. Neuroprotection by melatonin on astrocytoma cell death
  2709. Effects of Vinpocetine on mitochondrial function and Neuroprotection in primary cortical neurons
  2710. Uric acid and Neuroprotection
  2711. Diazepam Neuroprotection in excitotoxic and oxidative stress involves a mitochondrial mechanism additional to the GABAAR and hypothermic effects
  2712. Pharmacologic Neuroprotection —Is xenon the light at the end of the tunnel?
  2713. Essential role for zinc-triggered p75NTR activation in preconditioning Neuroprotection
  2714. Rho kinase inhibitor Fasudil induces Neuroprotection and neurogenesis partially through astrocyte-derived G-CSF
  2715. Gabapentin Neuroprotection and seizure suppression in immature mouse brain ischemia
  2716. TRPC channel-mediated Neuroprotection by PDGF involves Pyk2/ERK/CREB pathway
  2717. VEGF as a target for Neuroprotection
  2718. Combination therapy of lovastatin and rolipram provides Neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis
  2719. A novel insight into Neuroprotection against hypoxic/ischemic stress
  2720. HIV protease inhibitors provide Neuroprotection through inhibition of mitochondrial apoptosis in mice
  2721. Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse
  2722. Nicotinamide treatment provides acute Neuroprotection and GFAP regulation following fluid percussion injury
  2723. Differential Neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity
  2724. High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation Neuroprotection with statin therapy for acute recovery trial (NeuSTART)
  2725. Small molecule activators of the Trk receptors for Neuroprotection
  2726. Transplantation of human amniotic cells exerts Neuroprotection in MPTP-induced Parkinson disease mice
  2727. Oleoylethanolamide exerts partial and dose-dependent Neuroprotection of substantia nigra dopamine neurons
  2728. Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, Neuroprotection , and neurotoxicity
  2729. PI3 kinase/Akt activation mediates estrogen and IGF‐1 nigral DA neuronal Neuroprotection against a unilateral rat model of Parkinson’s disease
  2730. Retinal Neuroprotection against ischemia-reperfusion damage induced by postconditioning
  2731. Neuroprotection of ebselen against ischemia/reperfusion injury involves GABA shunt enzymes
  2732. The neuropeptide NAP provides Neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush
  2733. Desflurane, isoflurane, and sevoflurane provide limited Neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm
  2734. Antioxidant Neuroprotection against ethanol-induced apoptosis in HN2-5 cells
  2735. A global view of Parkinson’s disease pathogenesis: Implications for natural history and Neuroprotection
  2736. Oxidative stress in stroke pathophysiology: Validation of hydrogen peroxide metabolism as a pharmacological target to afford Neuroprotection
  2737. Additive Neuroprotection of GABA A and GABA B receptor agonists in cerebral ischemic injury via PI-3K/Akt pathway inhibiting the ASK1-JNK cascade
  2738. Neuroprotection of brain -derived neurotrophic factor against hypoxic injury in vitro requires activation of extracellular signal-regulated kinase and phosphatidylinositol …
  2739. Lactation is a natural model of hippocampus Neuroprotection against excitotoxicity
  2740. The novel Cholinesterase–Monoamine Oxidase inhibitor and Antioxidant, Ladostigil, confers Neuroprotection in neuroblastoma cells and aged rats
  2741. Neuroprotection of γ‐aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric …
  2742. Melatonin provides Neuroprotection by reducing oxidative stress and HSP70 expression during chronic cerebral hypoperfusion in ovariectomized rats
  2743. GABA synapses mediate Neuroprotection after ischemic and εPKC preconditioning in rat hippocampal slice cultures
  2744. Intranasal bFGF-induced progenitor cell proliferation and Neuroprotection after transient focal cerebral ischemia
  2745. Novel regimen through combination of memantine and tea polyphenol for Neuroprotection against brain excitotoxicity
  2746. Prolonged opportunity for Neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity
  2747. Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Aβ25–35 model of Alzheimer’s disease
  2748. Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia
  2749. Diphenyl diselenide confers Neuroprotection against hydrogen peroxide toxicity in hippocampal slices
  2750. Neuroprotection and imaging studies in Parkinson’s disease
  2751. The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute …
  2752. Neuroprotection : VEGF, IL-6, and clusterin: the dark side of the moon
  2753. Neuroprotection against Spinal Cord Ischemia–Reperfusion Injury Induced by Different Ischemic Postconditioning Methods: Roles of Phosphatidylinositol 3-Kinase …
  2754. Neuroprotection of microglial conditioned medium on 6‐hydroxydopamine‐induced neuronal death: role of transforming growth factor beta‐2
  2755. Neuroprotection and functional recovery conferred by administration of kappa-and delta1-opioid agonists in a rat model of global ischemia
  2756. Photoreceptor Neuroprotection in RCS rats via low-dose intravitreal sustained-delivery of fluocinolone acetonide
  2757. Apolipoprotein E may be a critical factor in hormone therapy Neuroprotection
  2758. Neuronal nicotinic receptors as novel targets for inflammation and Neuroprotection : mechanistic considerations and clinical relevance
  2759. IGF-IR in Neuroprotection and brain tumors
  2760. … receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK‐3beta: connecting neurotransmission with Neuroprotection
  2761. Targeting Neuroprotection as an alternative approach to preventing and treating neuropathic pain
  2762. Synergistic effect of galantamine on nicotine-induced Neuroprotection in hemiparkinsonian rat model
  2763. 17β-estradiol-mediated Neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and β-arrestin-1
  2764. Preconditioning Neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk
  2765. Clinical trials in Neuroprotection
  2766. Limited minocycline Neuroprotection after balloon-compression spinal cord injury in the rat
  2767. PACAP-mediated Neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration
  2768. L-kynurenine: metabolism and mechanism of Neuroprotection
  2769. Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates Neuroprotection against normoxic oxidative death via HIF-and CREB-independent …
  2770. Mechanisms of platelet‐derived growth factor‐mediated Neuroprotection –implications in HIV dementia
  2771. NMDA-induced Neuroprotection in hippocampal neurons is mediated through the protein kinase A and CREB (cAMP-response element-binding protein) pathway
  2772. DJ-1 knock-down in astrocytes impairs astrocyte-mediated Neuroprotection against rotenone
  2773. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords Neuroprotection in experimental stroke
  2774. Interaction between neuropeptide Y (NPY) and brain ‐derived neurotrophic factor in NPY‐mediated Neuroprotection against excitotoxicity: a role for microglia
  2775. Small-molecule mediated Neuroprotection in an in situ model of tauopathy
  2776. Therapeutic hypothermia for Neuroprotection
  2777. Sonic hedgehog mediates BDNF-induced Neuroprotection against mitochondrial inhibitor 3-nitropropionic acid
  2778. Mitochondrial localization of DJ‐1 leads to enhanced Neuroprotection
  2779. Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway
  2780. Ischemic preconditioning-induced Neuroprotection is associated with differential expression of IL-1β and IL-1 receptor antagonist in the ischemic cortex
  2781. Propofol exerts greater Neuroprotection with disodium edetate than without it
  2782. 5-HT4 receptor-mediated Neuroprotection and neurogenesis in the enteric nervous system of adult mice
  2783. Potential Neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole
  2784. Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncation
  2785. Progesterone blocks estrogen Neuroprotection from kainate in middle-aged female rats
  2786. Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate
  2787. Neuroprotection by oxygen in acute transient focal cerebral ischemia is dose dependent and shows superiority of hyperbaric oxygenation
  2788. Mitochondrial Ca 2+ overload underlies Aβ oligomers neurotoxicity providing an unexpected mechanism of Neuroprotection by NSAIDs
  2789. A nanomedicine transports a peptide caspase-3 inhibitor across the blood–brain barrier and provides Neuroprotection
  2790. Neuroprotection of GluR5-containing kainate receptor activation against ischemic brain injury through decreasing tyrosine phosphorylation of N-methyl-D …
  2791. Functional characterization of basic helix-loop-helix-PAS type transcription factor NXF in vivo: putative involvement in an “on demand” Neuroprotection system
  2792. Extraluminal cooling of bilateral common carotid arteries as a method to achieve selective brain cooling for Neuroprotection
  2793. Proteomic analysis of differential proteins related to the neuropathic pain and Neuroprotection in the dorsal root ganglion following its chronic compression in rats
  2794. Delta2‐Specific Opioid Receptor Agonist and Hibernating Woodchuck Plasma Fraction Provide Ischemic Neuroprotection
  2795. Role of Dickkopf-1, an antagonist of the Wnt/β-catenin signaling pathway, in estrogen-induced Neuroprotection and attenuation of tau phosphorylation
  2796. Toll‐like receptor 4 is involved in Neuroprotection afforded by ischemic preconditioning
  2797. Allele-specific RNA silencing of mutant ataxin-3 mediates Neuroprotection in a rat model of Machado-Joseph disease
  2798. Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences
  2799. Atorvastatin enhances hypothermia-induced Neuroprotection after stroke
  2800. Non-conventional MRI techniques for measuring Neuroprotection , repair and plasticity in multiple sclerosis
  2801. Repeated preconditioning with hyperbaric oxygen induces Neuroprotection against forebrain ischemia via suppression of p38 mitogen activated protein kinase
  2802. Selective sigma receptor agonist 2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate (PRE084) promotes Neuroprotection and neurite elongation through protein …
  2803. Progesterone, BDNF and Neuroprotection in the injured CNS
  2804. Role of melatonin receptors in the effects of melatonin on BDNF and Neuroprotection in mouse cerebellar neurons
  2805. Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons
  2806. CT-guided radiofrequency ablation of spinal osteoid osteomas with concomitant perineural and epidural irrigation for Neuroprotection
  2807. In vivo Neuroprotection by a creatine-derived compound: Phosphocreatine–Mg-complex acetate
  2808. Pharmacological inhibition of mitochondrial membrane permeabilization for Neuroprotection
  2809. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of Neuroprotection
  2810. Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy
  2811. Stereo-selective Neuroprotection against stroke with vitamin A derivatives
  2812. Neuroprotection in Parkinson’s disease: myth or reality?
  2813. Oxidative insults induce DJ-1 upregulation and redistribution: implications for Neuroprotection
  2814. Ischemic insult to cerebellar Purkinje cells causes diminished GABAA receptor function and allopregnanolone Neuroprotection is associated with GABAA receptor …
  2815. Growth hormone‐induced Neuroprotection in the neural retina during chick embryogenesis
  2816. Mechanism of Neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil
  2817. Parameters of optic nerve electrical stimulation affecting Neuroprotection of axotomized retinal ganglion cells in adult rats
  2818. Essential involvement of the NMDA receptor in ethanol preconditioning‐dependent Neuroprotection from amyloid‐βin vitro
  2819. Retinal Neuroprotection by hypoxic preconditioning is independent of hypoxia‐inducible factor‐1α expression in photoreceptors
  2820. Species‐dependent Neuroprotection by activated protein C mutants with reduced anticoagulant activity
  2821. The 2007 Feinberg lecture: a new road map for Neuroprotection
  2822. Unconventional neurotransmitters, neurodegeneration and Neuroprotection
  2823. DNA damage response and Neuroprotection
  2824. Partial Neuroprotection with low-dose infusion of the α2-adrenergic receptor agonist clonidine after severe hypoxia in preterm fetal sheep
  2825. Estrogen receptor-mediated Neuroprotection : The role of the Alzheimer’s disease-related gene seladin-1
  2826. Can overexpression of parkin provide a novel strategy for Neuroprotection in Parkinson’s disease?
  2827. Cannabinoids, multiple sclerosis and Neuroprotection
  2828. Activity of adenosine receptors type 1 is required for CX3CL1-mediated Neuroprotection and neuromodulation in hippocampal neurons
  2829. Estrogen receptor-independent Neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation
  2830. Neuroplasticity and Neuroprotection in enteric neurons: role of epithelial cells
  2831. How to study Neuroprotection ?
  2832. A pivotal role for interleukin-4 in atorvastatin-associated Neuroprotection in rat brain
  2833. Induced Neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin
  2834. Oxygen-conserving implications of the trigemino-cardiac reflex in the brain : the molecular basis of Neuroprotection ?
  2835. Multiple molecular pathways are involved in the Neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo
  2836. Neuroprotection of soyabean isoflavone co-administration with folic acid against β-amyloid 1-40-induced neurotoxicity in rats
  2837. Neuroprotection by rasagiline in thiamine deficient rats
  2838. Withdrawal of fenofibrate treatment partially abrogates preventive Neuroprotection in stroke via loss of vascular protection
  2839. Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion
  2840. Neuroprotection : still achievable in humans
  2841. Microglial inhibition of Neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
  2842. Neuroprotection and enhancement of spatial memory by herbal mixture HT008-1 in rat global brain ischemia model
  2843. New avenue of research: antiepileptic drug and estradiol Neuroprotection in epilepsy
  2844. Morphine: axon regeneration, Neuroprotection , neurotoxicity, tolerance, and neuropathic pain
  2845. Inhibition of PKCgamma membrane translocation mediated morphine preconditioning-induced Neuroprotection against oxygen–glucose deprivation in the …
  2846. The Neuroprotection of prodromal transient ischaemic attack on cerebral infarction
  2847. Mechanisms of DJ‐1 Neuroprotection in a cellular model of Parkinson’s disease
  2848. … oxygen-glucose deprivation: the role of adenosine triphosphate dependent potassium channels and reactive oxygen species in sevoflurane-induced Neuroprotection
  2849. Sodium channel blockers and Neuroprotection in multiple sclerosis using lamotrigine
  2850. Clearing the brain ‘s cobwebs: the role of autophagy in Neuroprotection
  2851. Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and Neuroprotection
  2852. Therapeutic potential of statins in multiple sclerosis: immune modulation, Neuroprotection and neurorepair
  2853. Sirtuin 1 overexpression mice show a reference memory deficit, but not Neuroprotection
  2854. Strategies for Neuroprotection following spinal cord injury.
  2855. Microglial involvement in Neuroprotection following experimental traumatic brain injury in heat-acclimated mice
  2856. Prevention of glutamate accumulation and upregulation of phospho‐akt may account for Neuroprotection afforded by bergamot essential oil against brain injury …
  2857. Neuroprotection and enhancement of remyelination by estradiol and dexamethasone in cocultures of rat DRG neurons and Schwann cells
  2858. Antenatal magnesium sulfate for Neuroprotection before preterm birth?
  2859. PRO: Temperature regimens and Neuroprotection during cardiopulmonary bypass: does rewarming rate matter?
  2860. Linkage between immunomodulation, Neuroprotection and neurogenesis
  2861. Neuroprotection of hypothermia against neuronal death in rat hippocampus through inhibiting the increased assembly of GluR6‐PSD95‐MLK3 signaling module …
  2862. High-dose propofol triggers short-term Neuroprotection and long-term neurodegeneration in primary neuronal cultures from rat embryos
  2863. Inhaled nitric oxide and Neuroprotection in preterm infants
  2864. Interleukin-6 upregulates neuronal adenosine A 1 receptors: implications for neuromodulation and Neuroprotection
  2865. PHYTOMEDICINES FOR Neuroprotection
  2866. Patents related to therapeutic activation of KATP and K2P potassium channels for Neuroprotection : ischemic/hypoxic/anoxic injury and general anesthetics
  2867. Neuroprotection in Parkinson’s disease and other neurodegenerative disorders: preclinical and clinical findings
  2868. Study of red wine Neuroprotection on astrocytes
  2869. Neuroprotection by c-Jun NH2-terminal kinase inhibitor SP600125 against potassium deprivation–induced apoptosis involves the Akt pathway and inhibition of cell …
  2870. Neuroprotection after status epilepticus by targeting protein interactions with postsynaptic density protein 95
  2871. Pharmacology of Neuroprotection in acute ischemic stroke
  2872. The endocannabinoid anandamide: from immunomodulation to Neuroprotection . Implications for multiple sclerosis
  2873. Patterned Neuroprotection in the Inpp4awbl mutant mouse cerebellum correlates with the expression of Eaat4
  2874. Neuroprotection in diabetic encephalopathy
  2875. Repeated exposure to MDMA provides Neuroprotection against subsequent MDMA-induced serotonin depletion in brain
  2876. Effects of simvastatin on Neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington’s disease
  2877. Xenon/hypothermia Neuroprotection regimes in spontaneously breathing neonatal rats after hypoxic-ischemic insult: the respiratory and sedative effects
  2878. Lack of Neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions
  2879. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced Neuroprotection in the mouse model of surgical brain injury
  2880. The continued promise of Neuroprotection for acute stroke treatment
  2881. CON: Temperature regimens and Neuroprotection during cardiopulmonary bypass: does rewarming rate matter?
  2882. Glaucoma: an open-window to neurodegeneration and Neuroprotection
  2883. Redox activated MAP kinase death signaling cascade initiated by ASK1 is not activated in female mice following MPTP: novel mechanism of Neuroprotection
  2884. Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances Neuroprotection from moderate but not severe hypoxia–ischemia
  2885. Hypoxia‐induced deactivation of NGF‐mediated ERK1/2 signaling in hippocampal cells: Neuroprotection by acetyl‐L‐carnitine
  2886. Estrogens and Neuroprotection in retinal diseases
  2887. Acute Neuroprotection to pilocarpine-induced seizures is not sustained after traumatic brain injury in the developing rat
  2888. Neuron‐microglia crosstalk up‐regulates neuronal FGF‐2 expression which mediates Neuroprotection against excitotoxicity via JNK1/2
  2889. Neuroprotection of preconditioning against ischemic brain injury in rat hippocampus through inhibition of the assembly of GluR6—PSD95—mixed lineage kinase 3 …
  2890. … advanced glycation end products‐inductor glyoxal and hydrogen peroxide as oxidative stress factors on rat retinal organ cultures and Neuroprotection by UK‐14,304
  2891. Estrogen receptors increased expression during hippocampal Neuroprotection in lactating rats
  2892. Nicotine attenuates iNOS expression and contributes to Neuroprotection in a compressive model of spinal cord injury
  2893. Additive Neuroprotection by metabotropic glutamate receptor subtype-selective ligands in a rat Parkinson’s model
  2894. Role of prions in Neuroprotection and neurodegeneration: a mechanism involving glutamate receptors?
  2895. Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the Neuroprotection after embolic stroke
  2896. New possibilities of Neuroprotection in the treatment of ischemic stroke
  2897. … -ekki-to combined with interferon-gamma moderately enhances daily activity of chronic fatigue syndrome mice by increasing NK cell activity, but not Neuroprotection
  2898. Neuroprotection Against Transient Focal Cerebral Ischemia and Oxygen–Glucose Deprivation by Interference with GluR6-PSD95 Protein Interaction
  2899. Hypothermia-induced increase in galanin concentrations and ischemic Neuroprotection in the rat brain
  2900. Neuroprotection in infant heart surgery
  2901. Effect of endoplasmic reticulum stress in VEGF-induced Neuroprotection
  2902. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced Neuroprotection of the injured nigrostriatal system in the murine …
  2903. Glaucoma as a neuropathy amenable to Neuroprotection and immune manipulation
  2904. Fibroblast growth factor 9 prevents MPP+‐induced death of dopaminergic neurons and is involved in melatonin Neuroprotection in vivo and in vitro
  2905. Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen Neuroprotection in HIV dementia
  2906. Optimal dose of aprotinin for Neuroprotection and renal function in a piglet survival model
  2907. Huperzine A provides Neuroprotection against several cell death inducers using in vitro model systems of motor neuron cell death
  2908. Prolyl 4-hydroxylase activity-responsive transcription factors: from hydroxylation to gene expression and Neuroprotection
  2909. Granulocyte-colony stimulating factor is involved in low-dose LPS-induced Neuroprotection
  2910. … mouse striatum and its modulation in 1-methyl 4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson’s disease phenotype and nicotine-mediated Neuroprotection
  2911. Neuroprotection with delayed calpain inhibition after transient forebrain ischemia
  2912. Activation of NF-κB p65/c-Rel dimer is associated with Neuroprotection elicited by mGlu5 receptor agonists against MPP+ toxicity in SK-N-SH cells
  2913. Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for …
  2914. Neuroprotection of ethanol against cerebral ischemia/reperfusion induced brain injury through GABA receptor activation
  2915. Cyclic adenosine monophosphate response element-binding protein phosphorylation and Neuroprotection by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP)
  2916. Use of induced hypothermia for Neuroprotection : indications and application
  2917. Neuroprotection by herbal formula FBD and its active compounds
  2918. Neuroprotection and neurotrophism effects of liquiritin on primary cultured hippocampal cells
  2919. Basal ganglia Neuroprotection with anticonvulsants after energy stress: a comparative study
  2920. Regulation of interleukin-1β by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: endogenous Neuroprotection
  2921. It’s all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke Neuroprotection
  2922. Magnesium sulfate for Neuroprotection : what do we do now?
  2923. Bis (7)-tacrine, a promising anti-Alzheimer’s dimer, affords dose-and time-dependent Neuroprotection against transient focal cerebral ischemia
  2924. Quantitative evaluation of chaperone activity and Neuroprotection by different preparations of a cell-penetrating Hsp70
  2925. Combinatorial-approached Neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is …
  2926. Potential of choroid plexus epithelial cell grafts for Neuroprotection in Huntington’s disease: what remains before considering clinical trials
  2927. Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated Neuroprotection
  2928. Use of endovascular clamping as Neuroprotection during carotid stenting in the presence of a critical ipsilateral stenosis of the external carotid artery.
  2929. Neuroprotection and enhanced neurogenesis by extract from the tropical plant Knema laurina after inflammatory damage in living brain tissue
  2930. Aprotinin confers Neuroprotection by reducing excitotoxic cell death
  2931. Sirt1’s complex roles in Neuroprotection
  2932. Differential cannabinoid receptor expression during reactive gliosis: a possible implication for a nonpsychotropic Neuroprotection
  2933. NMDA preconditioning and Neuroprotection in vivo: delayed onset of kainic acid-induced neurodegeneration and c-Fos attenuation in CA3a neurons
  2934. … a novel anilidoquinoline derivative, 2-(2-methyl-quinoline-4ylamino)-N-(2-chlorophenyl)-acetamide, in Japanese encephalitis: correlation with in vitro Neuroprotection
  2935. Activation of the extracellular signal‐regulated kinases 1 and 2 by glial cell line‐derived neurotrophic factor and its relation to Neuroprotection in a mouse model of …
  2936. Co-application of ischemic preconditioning and postconditioning provides additive Neuroprotection against spinal cord ischemia in rabbits
  2937. Neonatal hypertonia: II. Differential diagnosis and proposed Neuroprotection
  2938. Sulfhydryl oxidation: A potential strategy to achieve Neuroprotection during severe hypoxia?
  2939. PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] confers MAO-B independent Neuroprotection in ER stress-induced cell death
  2940. Neuroprotection by neurotrophic factors and membrane depolarization is regulated by calmodulin kinase IV
  2941. Implication of pituitary adenylate cyclase-activating polypeptide (PACAP) for Neuroprotection of nicotinic acetylcholine receptor signaling in PC12 cells
  2942. Neurolological disorders and Neuroprotection after heart surgery
  2943. Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses
  2944. Ischemic postconditioning induces Neuroprotection via up-regulation of endogenous antioxidant enzyme activities: experiment with rabbits
  2945. Moderate alcohol consumption, apolipoprotein E, and Neuroprotection
  2946. Acetaminophen confers Neuroprotection during early cerebral ischemia-reperfusion
  2947. A secretory phospholipase A 2-mediated Neuroprotection and anti-apoptosis
  2948. Sevoflurane preconditioning induced delayed Neuroprotection against focal cerebral ischemia in rats
  2949. Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not Neuroprotection
  2950. Delayed administration of a potent cyclin dependent kinase and glycogen synthase kinase 3 β inhibitor produces long-term Neuroprotection in a hypoxia-ischemia …
  2951. … inducer of cellular glutathione and NAD (P) H: quinone oxidoreductase 1 in PC12 neuronal cells: a potential adaptive mechanism for dopaminergic Neuroprotection
  2952. Melatonin and its therapeutic potential in Neuroprotection
  2953. Flow reversal for proximal Neuroprotection during endovascular management of critical symptomatic carotid artery stenosis coexisting with ipsilateral external carotid …
  2954. HIF‐1 alpha is an essential effector for purine nucleoside‐mediated Neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons
  2955. … strychnine-sensitive glycine receptors modulate N-methyl-d-aspartate–evoked acetylcholine release from rat spinal motoneurons: A possible role in Neuroprotection
  2956. Targeting β2-adrenoceptors for Neuroprotection after cerebral ischemia: is inhibition or stimulation best?
  2957. 5th Annual Global College of Neuroprotection and Neuroregeneration
  2958. Neuroprotection against staurosporine by metalloporphyrins independent of antioxidant capability
  2959. … of some urea and thiourea derivatives of naphtha [1, 2-d] thiazol-2-amine as anti-Parkinsonian agents that cause Neuroprotection against haloperidol-induced …
  2960. Anesthetic drugs and sustained Neuroprotection in acute cerebral ischemia: can we alter clinical outcomes?
  2961. Neuroprotection of microglia conditioned media from apoptotic death induced by staurosporine and glutamate in cultures of rat cerebellar granule cells
  2962. Erythropoiesis-stimulating protein delivery in providing erythropoiesis and Neuroprotection
  2963. The impact of astrocyte mitochondrial metabolism on Neuroprotection during aging
  2964. Hsp70 and Neuroprotection [J]
  2965. Does postmenopausal estrogen use confer Neuroprotection ?
  2966. Research progress of protein kinase C in Neuroprotection
  2967. Nitrous oxide: From neurotoxicity to Neuroprotection ?
  2968. p42/44 MAPK is an essential effector for purine nucleoside-mediated Neuroprotection of hypoxic PC12 cells and primary cerebellar granule neurons
  2969. Effective delivery of Pep-1-cargo protein into ischemic neurons and long-term Neuroprotection of Pep-1-SOD1 against ischemic injury in the gerbil hippocampus
  2970. Neuroprotection in stroke.
  2971. Neuroprotection in Parkinson’s disease: analysis though group of experts’ methodology
  2972. Current trends in glaucoma: what about Neuroprotection ?
  2973. Anesthetic-induced Neuroprotection : a review
  2974. LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring Neuroprotection in experimental focal cerebral ischemia in the rat
  2975. Modulation of innate immunity by copolymer‐1 leads to Neuroprotection in murine HIV‐1 encephalitis
  2976. Neuroprotection for Parkinson’s disease: clinically driven experimental design in non-human primates
  2977. 6th Global College of Neuroprotection and Neuroregeneration, annual meeting
  2978. Management of acute stroke: Neuroprotection
  2979. Advancement of therapies for Neuroprotection in multiple sclerosis
  2980. Neuroprotection from diazinon-induced toxicity in differentiating murine N2a neuroblastoma cells
  2981. Multiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pleiotropic effects in reno-, cardio-and Neuroprotection
  2982. Exploratory analysis about Neuroprotection after ischemic stroke.
  2983. La Neuroprotection est-elle à portée de main?
  2984. Neuroprotection : is it close to us?
  2985. Surgical strategies for Neuroprotection during ascending aortic and arch surgery
  2986. Sustained delivery of NT‐3 from lens fiber cells in transgenic mice reveals specificity of Neuroprotection in retinal degenerations
  2987. Perioperative strategy of Neuroprotection
  2988. Glaucoma Neuroprotection –how far is it from a dream to reality
  2989. Preconditioning with+ Gz acceleration (head-to-foot inertial load) produces Neuroprotection against transient focal cerebral ischemia in rats
  2990. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors
  2991. Antioxidant therapy and Neuroprotection in the newborn
  2992. Neuroprotection of antipsychotic olanzapine [J]
  2993. Perinatal brain damage: from pathogenesis to Neuroprotection
  2994. Neuroprotection of venlafaxine and fluoxetine [J]
  2995. Cannabinoids and Neuroprotection
  2996. Selective over expression of EAAT2 in astrocytes enhances Neuroprotection from moderate but not severe hypoxia-ischemia
  2997. Neuroprotection against ischemic brain injury by knockdown of hematopietic progenitor kinase 1 expression
  2998. The Neuroprotection of kappa opioid receptor agonist BRL52537 is partly through enhancing endogenous GABA function
  2999. Neuroprotection in Glaucoma
  3000. Endogenous Neuroprotection
  3001. Targeting immunophilins for Neuroprotection
  3002. brain damage from soman-induced seizures is greatly exacerbated by dimethyl sulfoxide (DMSO): Modest Neuroprotection by 2-aminoethyl diphenylborinate (2-APB) …
  3003. Neuroprotection in epilepsy: the role of antiepileptic drugs
  3004. The role of Neuroprotection in schizophrenia
  3005. Potential mechanisms of Neuroprotection induced by low dose total-body γ-irradiation in C57 mice administered with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine …
  3006. Neuroprotection with hypothermia for hypoxic ischemic encephalopathy in term newborn: review of the learning
  3007. Kynurenines and Neuroprotection
  3008. Neuroprotection , Neuronal Remodelling, and Anxiety-Like Behavior: The Role of the Teneurin and Teneurin C-Terminal Associated Peptide (TCAP) System in the …
  3009. Neuroprotection using hypothermia after perinatal asphyxia in full-term neonates
  3010. Antioxidants: promising Neuroprotection against cardiotoxin-4b-induced cell death which triggers oxidative stress with early calpain activation
  3011. 11 Adenosine Neuromodulation and Neuroprotection
  3012. Neurodegeneration and Neuroprotection in the epileptic brain
  3013. The future of Neuroprotection in glaucoma therapeutics
  3014. Effect of VEGF-B on Neuroprotection in mouse retinal ganglion cells
  3015. Neuronal and astrocytic mitochondrial dynamics as vulnerability factors and targets for Neuroprotection
  3016. Neuroprotection of sevoflurane against the ischemia injury in hippocampal slices of rat
  3017. Neuroprotection : Pharmacological Approaches
  3018. Neuroprotection of phenolic alkaloids from Menispermum dauricum versus melatonin against oxygen-glucose-serum-deprivation-mediated injury*☆
  3019. Ocular delivery of TUDCA provides Neuroprotection in a mouse model of retinal degeneration
  3020. Neuroprotection against surgically induced brain injury
  3021. Neuroprotection of GST, an extract of traditional Chinese herb, against ischemic brain injury induced by transient brain ischemia and reperfusion in rat hippocampus
  3022. Neuroprotection of recombinant human erythropoietin via modulation of N-methyl-D-aspartate receptors in neonatal rats with hypoxic-ischemic brain injury
  3023. Diagnosis and treatment strategy for Neuroprotection with combined tcm and western medicine in the early stage of Parkinson’s disease
  3024. Lewy body formation in Parkinson’s disease: neurodegeneration or Neuroprotection ?
  3025. Neuroprotection Against Neurodegenerative Diseases: Development of a Novel Hybrid Neuroprotective Peptide Colivelin
  3026. Neurodegeneration and Neuroprotection in multiple sclerosis
  3027. α-Synuclein, CSPα, SNAREs and Neuroprotection in vivo
  3028. Experimental studies on hypoxic preconditioning-induced Neuroprotection against focal ischemic injury of mice and its p38 MAPK mechanism
  3029. Neuroprotection by angiotensin receptor blockers?
  3030. Neuroprotection –DO AEDS PROTECT THE brain ?(NO)
  3031. Intraoperative neuromonitoring, Neuroprotection and preventive carotid endarterectomy in patients with increased risk for development of cerebral ischemia indicated …
  3032. D. Neuroprotection in the PICU
  3033. Preclinical versus clinical Neuroprotection
  3034. Antenatal Magnesium Sulfate for Neuroprotection Before Preterm Birth?
  3035. Deprenyl and its metabolites in Neuroprotection
  3036. Akt activation mediates estrogen-induced Neuroprotection against beta amyloid
  3037. Valproic acid-mediated Neuroprotection and neuroregeneration in optic nerve injury is associated with CREB-induction and activation of pERK1/2
  3038. IGF-I and Neuroprotection
  3039. Advantages of MRI study of normobaric hyperoxia therapy in stroke Neuroprotection
  3040. The Underlying Mechanism (s) of Fasting Induced Neuroprotection After Moderate Traumatic brain Injury
  3041. The time‐dependency of post‐conditioning for Neuroprotection against global cerebral ischemia and reperfusion injury in C57BL/6 mice
  3042. Application of induced hypothermia for Neuroprotection after cardiac arrest: a systematic review
  3043. Neuroprotection of Extraction of Gastrodia Elata for Status Epilepticus Induced by Li-Pilocarpin
  3044. Neuroprotection and Glaucoma.
  3045. Experimental Study of Different Perfusion Methods and Neuroprotection during Deep Hypothermic Circulatory Arrest [J]
  3046. The PERG as a Useful Tool in Demonstrating Functional Neuroprotection in the Mouse
  3047. Neuroprotection in spinal cord injury
  3048. Molecular mechanisms of Neuroprotection in the anoxia tolerant freshwater turtle
  3049. A Model of Sporadic Parkinson’s Disease: Herbicide Induced Parkinson’s Disease in Rat and Neuroprotection by Water Soluble CoQ10
  3050. Non-Amyloid Approaches to Neuroprotection
  3051. CRMP-2 were involved in hypoxic preconditioning-induced Neuroprotection against cerebral ischemic injuries of mice
  3052. Neuroprotection Effect of Aspirin on Neuron Apoptosis Following Chronic Spinal Cord Compressive Injury in Rats [J]
  3053. Neuroprotection against hyperhomocysteinemia-induced selective oxidative stress in brain regions of rats with folic acid or Dioscorea alata supplementation.
  3054. Abstract P28: Early Antioxidant Treatment Does Not Provide Additive Neuroprotection with Delayed Hypothermia after Asphyxic Cardiac Arrest in Newborn Pigs
  3055. … MOLECULAR CHAPERONE HSP90 IN THE HIPPOCAMPAL CA1 NEURONS―A POSSIBLE MECHANISM OF Neuroprotection BY ANGIOTENSIN RECEPTOR …
  3056. Neuroprotection Effect of Fufang Shexiang Injection in Neonates with Hypoxic Ischemic Encephalopathy
  3057. Neuroprotection of Lidocaine by Injecting into Cisterna Magna in a Rabbit Model of Subarachnoid Hemorrhage [J]
  3058. Strategies for ischemic Neuroprotection : learning from mice
  3059. Neuroprotection by DJNKI1 following seizure activity.
  3060. Clinical Neuroprotection and secondary neuronal injury mechanisms
  3061. Downstream signaling of reactive oxygen species, protein kinase C epsilon translocation and delayed Neuroprotection in sevoflurane preconditioned rats following …
  3062. Neuroprotection via activation of glutamate dehydrogenase against cerebral ischemia and reperfusion
  3063. Neuroprotection Against Ischemia-Reperfusion Injury in the Rat Retina by Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Type 1 Receptor Blocker
  3064. Identification of protein markers of Neuroprotection from radiation
  3065. Statins linked with Neuroprotection
  3066. Induced Hypothermia for Neuroprotection Following
  3067. Functional and molecular partitioning of the brain provides Neuroprotection to cardiorespiratory nuclei in ground squirrels during hibernation
  3068. Neuroprotection During Cerebral Aneurysm Surgery
  3069. Protein Kinase C Subytpes and Mechanisms of Endogenous Neuroprotection
  3070. Docosahexaenoic acid Confers Neuroprotection in a Rat Model of Perinatal Hypoxia-ischemia potentiated by E. coli lipopolysaccharide-induced systemic …
  3071. Neuroprotection of Optic Nerve in Glaucoma
  3072. Neuroprotection of adenovirus expressing glutamic acid receptor c-terminal peptide in rat hippocampal CA1 region during brain ischemia and reperfusion
  3073. Redox-Based Therapies for Neuroprotection
  3074. Pharmacological Neuroprotection for spinal cord injury
  3075. Erratum: Neuroprotection and Enhancement of Learning and memory by BF-7 [J. Health Sci. 51 (3): 317-324 (2005)]
  3076. Granolocyte-macrophage clony-stimulating factor and Neuroprotection
  3077. A computational investigation of FTY720P-mediated Neuroprotection in multiple sclerosis
  3078. Neuroprotection of PROG in rat acute ocular hypertention model
  3079. Traumatic Optic Neuropathy: Recommendations and Neuroprotection
  3080. Angiotensin Ⅱ Receptor Blockers and Neuroprotection
  3081. The brain innate immune response in Neuroprotection and repair
  3082. Wnt signaling in Neuroprotection and stem cell differentiation
  3083. EXCITOXIC brain DAMAGE IN CHILDREN WITH EPILEPSY AND POTENTIAL OF Neuroprotection
  3084. Hypothesis-based Screening of Candidate miRNAs in Dopaminergic Neuroprotection
  3085. Mechanisms of Estrogen Receptor Neuroprotection in Dopamine Neurons
  3086. Hypothermia therapy, Neuroprotection and meaningful brain recovery
  3087. Contribution of GDNF to the Estrogen-mediated Neuroprotection
  3088. Apolipoprotein E, hormone therapy, and Neuroprotection
  3089. CD4 T cell‐mediated Neuroprotection : Relevence to ALS and Motoneuron Injury
  3090. 10 Free Radicals and Neuroprotection in Traumatic brain and Spinal Cord Injury
  3091. Molecular mechanisms of Neuroprotection by the herpes simplex virus type 2 gene ICP10PK
  3092. STUDY ON THE Neuroprotection EFFECT OF MAGNESIUM SULFATE ON GLOBAL ISCHEMIA IN RABBITS [J]
  3093. Neuroprotection induced by the adenosine A1-receptor and IL-6: Do they use the same mechanisms?
  3094. Neuroinffammation in spinal cord injury: therapeutic targets for Neuroprotection and regeneration
  3095. Pharmacological Neuroprotection of Photoreceptors in Vigabatrin-Treated Animals
  3096. The role of standardized Mangifera Indica L. leaf extracts in antioxidation and Neuroprotection
  3097. Neuroprotection by hypoxic preconditioning: the role of HIF-1α
  3098. Neuroprotection of Vegf-b by Inhibition of Apoptosis
  3099. Neuroprotection as a treatmeNt for Nerve ageNt survivors
  3100. Study on the Neuroprotection effect of magnesium sulfate on global ischemia in rabbits.
  3101. Evoluation on Neuroprotection of Memantine in acute elevated IOP
  3102. Role of phosphorylation events in Neuroprotection due to ethanol preconditioning
  3103. The Neuroprotection of fusion protein TAT-Flip in MCAO mice models
  3104. The Neuroprotection of Monosialoganglioside on the Middle Cerebral Artery Occlusion Reperfusion in Rats [J]
  3105. Emphasizes the research of diabetic retinal neurons lesions and retinal Neuroprotection
  3106. Neuroprotection by erythropoetin and Darbopoetin-alfa following experimental intracerebral haemorrhage: P 038
  3107. Erythropoietin for Neuroprotection in preterm infants: feasiblity and safety study
  3108. The study of Neuroprotection about erythropoietin on traumatic brain injury in rats
  3109. Pathological study on the Neuroprotection of memantine against cerebral ischemia in SD rats
  3110. Study on the Neuroprotection of HSP72 during brain injury induced by ischemia
  3111. Angiotensin AT2 Receptor-Mediated Neuroprotection and Nitric Oxide–Bioavailability in Stroke
  3112. Survival Pathways Downstream Cyclic Bright Light-Induced Endogenous Neuroprotection
  3113. FGF2, Müller Glia and Neuroprotection in the Chicken Retina
  3114. Neuroprotection by delayed high dose Aspirin treatment in cerebral ischemia
  3115. Toll like receptors in the central nervous system regulators of inflammation, Neuroprotection , development and repair
  3116. Regulation of microvascular endothelial barrier function: a new mechanism for Neuroprotection of statins
  3117. Estrogen, progesterone and BDNF interactions: Roles in Neuroprotection
  3118. Neuroprotection of Laser-Injured Retina by Intravitreal Saline Injection
  3119. Neuroprotection by Leukemia Inhibitory Factor Does Not Require Reduced Phototransduction
  3120. Neuroprotection of Copolymer 1 in glaucoma rats with elevated intraocular pressure
  3121. Effect of Maleate on Blood Scavenging Activity and Neuroprotection in Closed Head Injury in Rats
  3122. Ultrasound-Controlled Therapeutic Gas Delivery Provides Enhanced Neuroprotection Following Hypoxic-Ischemia
  3123. Comparative Neuroprotection of different-dose Lidocaine by injecting into in a rabbit model of subarachnoid hemorrhage
  3124. Neuroprotection of mild brain hypothermia against cerebral ischemic injury
  3125. Uncovering the molecular mechanisms of ischemic tolerance—the role of ATP in depolarization-induced Neuroprotection
  3126. Targeting Cytokine Systems to Achieve Neuroprotection : Experimental Models of Seizures and Neurodegeneration
  3127. No Neuroprotection Afforded by the Noble Gases Neon, Argon and Krypton In Vitro.
  3128. FK506 Binding Protein 51 (FKBP51) mediated Neuroprotection against glutamate excitotoxicity in RGC-5 cells
  3129. Neuroprotection for Acute Spinal Cord Injury-Comparison of Simvastatin and Atorvastatin
  3130. Strategies of Neuroprotection in an in vivo model of retinal degeneration induced by mitochondrial dysfunction
  3131. Flavonoids and Neuroprotection : biochemical and population-based analyses of potential Neuroprotective factors related to dementia.
  3132. Fluocinolone Acetonide-Mediated Neuroprotection in S334-ter-4 Rat Retinal Degeneration
  3133. Cellular Mechanisms for Motor Stimulation and Neuroprotection by A2A Antagonists in PD Model
  3134. Full retraction of Kumar DM, Simpkins JW, Agarwal N. Estrogens and Neuroprotection in retinal diseases. Mol Vis. 2008; 14: 1480-6. Review.
  3135. T cell-mediated Neuroprotection in the injured central nervous system: Gaining insight with the facial nerve axotomy model
  3136. Endogenous Neuroprotection Induced by STAT3 Activation Is Independent of Akt or FGF2
  3137. Androgen-Androgen Receptor Signaling Provides Dose-Dependent Neuroprotection In the Male brain
  3138. Estradiol regulation of cerebral metabolism: Implications for Neuroprotection and mitochondrial bioenergetics
  3139. Excitotoxicity, oxidative stress and Neuroprotection in cerebellar granule neurones
  3140. Strategies for Conferring Neuroprotection and Countering the High Threshold for Induction of the Stress Response in Motor Neurons
  3141. Mitochondrial ATP-sensitive potassium-channel: A novel target of Neuroprotection in cerebral hypoperfusion
  3142. Parameters of optic nerve electrical stimulation affecting Neuroprotection of axotomized retinal ganglion cells in adult rats
  3143. Molecular Analysis of Neuroprotection of Photoreceptor Neurons by RanBP2 Haploinsufficiency Upon Light-Induced Damage
  3144. Müller Cell/Microglia Interactions in CNTF-Mediated Photoreceptor Neuroprotection
  3145. … , ZK238519 and ZK166350: comparison of different potent antagonists of AMPA-type glutamate receptor channels and their potential role for Neuroprotection
  3146. Neuroprotection of dexamethasone prophylaxis on brain damage in neonatal rat with hypoxia-ischemia [J]
  3147. Lovastatin-mediated in vivo Neuroprotection against excitotoxicity is PKB/Akt dependent
  3148. Alpha 7 nicotinic acetylcholine receptors: Molecular pharmacology and role in Neuroprotection
  3149. Neuroprotection from inflammation: Experimental allergic encephalomyelitis facilitates traumatic spinal cord injury recovery
  3150. Human umbilical cord blood collagen-adherent, nestin-positive neurological progenitors mediate Neuroprotection in an oxidative stress-induced ischaemic model
  3151. Molecular mechanisms underlying the Neuroprotection of novel anti-Alzheimer dimers targeting pathologically activated NMDA receptors
  3152. Investigation of neurodevelopment, degeneration and polyphenol induced Neuroprotection in Nothobranchius furzeri.
  3153. Physiological and Biochemical Neuroprotection in Cetaceans: Are Some Marine Mammal Species Safeguarded From Emboli Formation and Barotrauma
  3154. Gene silencing as a promising strategy for Neuroprotection : on the development of a lipid-based system for the delivery of siRNAs to he central nervous system
  3155. Formulation and Characterization of N-Acetyl Cysteine Loaded PLGA Nanoparticles for Neuroprotection to Retinal Ganglion Cells in an in vitro Model of …
  3156. Minocycline reveals Neuroprotection in an accelerated rhesus macaque model of neuroAIDS by 1H MR Spectroscopy
  3157. Strong Neuroprotection by Inhibition of NF-B After Neonatal Hypoxia-Ischemia Involves Apoptotic Mechanisms but Is Independent of Cytokines
  3158. 1H-magnetic resonance spectroscopy of vascular endothelial growth factor-induced Neuroprotection following acute cerebral ischemia and reperfusion***☆
  3159. SB220025 a p38 inhibitor mediates Neuroprotection by inhibiting transcriptional activation and apoptosis in focal cerebral ischemia
  3160. US Army Battlefield Exercise and Combat Related Spinal Cord Injury Research: Neuroprotection and Repair After Spinal Cord Injury. Addendum
  3161. Neuroprotection and neuroplasticity–A short consensus of the concepts: Clinical utility of neurotrophic factor therapy (cerebrolysin) in VaD–Data from a new pilot …
  3162. Neuroprotection effect of Ginsenoside Rb1 and geniposide in rat cultured hippocampal neurons
  3163. Prolonged Neuroprotection of Degenerating Photoreceptors in the S334ter4 rat Retina via Single Intravitreal Injection of Mouse Embryonic Stem Cells Expressing a …
  3164. Interactions of neurons, astrocytes and microglia with HUCB cell populations in stroke models: Migration, Neuroprotection and inflammation
  3165. The Retinal Toxicity of the Antiepileptic Drug, Vigabatrin: In vivo Examination of Retinal Lesions and Pharmacological Neuroprotection
  3166. … PURE OXYGEN VS ROOM-AIR DOWN-REGULATES VEGFR2 AND HIF-1ALPHA IN NEWBORN PIGLETS RETINA AND MAY INDICATE LESS Neuroprotection
  3167. CD4+ T cell responses and the role of IL-10 in T cell-mediated Neuroprotection after facial nerve axotomy
  3168. P3. 065 Nimesulide, a preferential cyclooxygenase-2 inhibitor exhibits Neuroprotection against MPTP-induced striatal lesions in rats: behavioral, biochemical, cellular …
  3169. Preconditioning and postconditioning exert stroke Neuroprotection modulating NCX and ASIC1a expression
  3170. … Neurotrophic Factors, Their Receptors, and Signalling Pathways with Small Molecule Mimetics and Modulators to Achieve Neuroprotection and Regeneration Guest …
  3171. Nicotine Attenuates Both iNOS and nNOS Involved Antioxidative Effects and Contributes to Neuroprotection in Spinal Cord Injury
  3172. Lithium Radioprotection of Hippocampal Neurons: Promotion of NHEJ DNA Repair and Reversal of Neuroprotection with DNA-PK Inhibition
  3173. Lowered set‐point for hypothalamic temperature regulation alters hippocampal activity and may enhance Neuroprotection in hibernating hamsters
  3174. Age-Dependent Neuroprotection of Retinal Ganglion Cells by Tempol C8-acyl Ester in a Rat NMDA Toxicity Model
  3175. Neuroprotection BY 3-(METHYLTHIO)–5, 6–DI-(4–METHOXYPHENYL)–1, 2, 4-TRIAZINE AGAINST OXIDATIVE-INDUCED CELL DEATH: INVOLVEMENT OF …
  3176. Effects of Age-Inductor Glyoxal and H2O2 As Oxidative Stress Factors on Rat Retinal Organ Cultures and Neuroprotection by Brimonidine
  3177. … relevant proteins in neuronal cells through coupled microarray and siRNA screening: Role of a novel selenoprotein in calcium regulation and Neuroprotection
  3178. Reversal of Cerebral Vasospasm and Neuroprotection by Injecting Magnesium Sulfate into Cisterna Magna in Rabbit with Subarachnoid Hemorrhage
  3179. Neuroprotection Induced by Preconditioning with Prolonged and Intermittent Normobaric Hyperoxia Upregulate TNF-α Converting Enzyme and Increase NF-kB …
  3180. Glutathione depletion in neurodegenerative disorders: Cell death mechanisms and Neuroprotection , exacerbation of manganese neurotoxicity, and the role in …
  3181. Neuroprotection of adenovirus expressing glutamic acid receptor c-terminal peptide in brain ischemic injury in rat involved in MLK3
  3182. Neuroprotection of a cocktail therapy involving anti-intercellular adhesion molecule 1 antibody and insulin-like growth factor 1 in treatment of cerebral ischemia …
  3183. Pretreatment is not mandatory for Neuroprotection with 1alpha, 25-dihydroxyvitamin D3 in perinatal hypoxic-ischemic rat brain damage in vivo and in excitotoxic injury …
  3184. 3-Hydroxymorphinan, the Parent Molecule of GCC1290, Provides Neuroprotection against Glutamateinduced Toxicity
  3185. P1-127 LOVASTATIN MEDIATES IN VIVO Neuroprotection AGAINST NMDA-INDUCED EXCITOTOXICITY
  3186. 3-Hydroxymorphinan-Mediated Neuroprotection Against Methamphetamine-lnduced Neuropsychotoxicity: Possible Modulation of Neurotrophic-and …
  3187. 100. Magnesium in a Polyethylene Glycol Formulation Provides Neuroprotection after Acute Spinal Cord Injury
  3188. 116. A novel moderate-affinity metal binding ligand confers Neuroprotection against 6-hydroxydopamine mediated chronic cell death and improves rotational …
  3189. 2 Adrenergic Modulation of NMDA Receptor Function: A Novel Mechanism of Neuroprotection in Experimental Glaucoma
  3190. The Anti-NgR Blocking Protein, NgR (310) ecto-Fc, Has a Potential Role for Neuroprotection in an EVC Rat Model of Glaucoma
  3191. Hypoxia-Inducible-Factor 1 Ablation in a Model of Retinal Neuroprotection by Hypoxic Preconditioning
  3192. Nimodipine Enhances 2 Adrenergic Modulation of NMDA Receptor: A Novel Mechanism of RGC Neuroprotection
  3193. Glucocorticoids, 11 [beta] HSDs and Neuroprotection
  3194. 17-β-estradiol-induced Neuroprotection through ERK activation by G protein-and β-arrestin-dependent mechanisms
  3195. RGC-5 Cells Express Opioid Receptors: Role in Neuroprotection
  3196. Abstract No. 64: Carotid Artery Stenting Without Neuroprotection . Influence of the Learning Curve on Clinical Results
  3197. Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in
  3198. 12 Tocotrienol Neuroprotection
  3199. 5-HT1A receptors are present in the retina and are involved in the outer retina Neuroprotection by 5-HT1A agonists through the activation of MAP kinase …
  3200. Inhibitory effect of lithium tungstate on the secretion of amyloid beta-protein 1-42, and its Neuroprotection
  3201. MRI/MRS of ischemic evolution in mouse brain at 14.1 T and Neuroprotection with lactate
  3202. The handbook of Neuroprotection
  3203. Treatment advances in neonatal Neuroprotection and neurointensive care
  3204. Anaesthetic-related Neuroprotection
  3205. From neuroprogression to Neuroprotection : implications for clinical care
  3206. Neuroprotection in glaucoma–is there a future role?
  3207. Prospects for minocycline Neuroprotection
  3208. Neuroprotection in glaucoma: recent and future directions
  3209. Neuroprotection of sex steroids
  3210. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies
  3211. Neuroprotection in glaucoma
  3212. Mechanisms of hypothermic Neuroprotection
  3213. Neuroprotection in acute ischemic stroke–current status
  3214. Astrocytes: targets for Neuroprotection in stroke
  3215. Education, the brain and dementia: Neuroprotection or compensation? EClipSE Collaborative Members
  3216. Microglia and Neuroprotection : from in vitro studies to therapeutic applications
  3217. Investigational therapies for ischemic stroke: Neuroprotection and neurorecovery
  3218. Neuroprotection by ketamine: a review of the experimental and clinical evidence
  3219. Mitochondrial mechanisms of estrogen Neuroprotection
  3220. Alternative mitochondrial electron transfer as a novel strategy for Neuroprotection
  3221. Autophagy for tissue homeostasis and Neuroprotection
  3222. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for Neuroprotection
  3223. The biological basis of injury and Neuroprotection in the fetal and neonatal brain
  3224. Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
  3225. Cell-mediated Neuroprotection in a mouse model of human tauopathy
  3226. Statins and Neuroprotection : a prescription to move the field forward
  3227. Ethanol and cognition : indirect effects, neurotoxicity and Neuroprotection : a review
  3228. Vision in multiple sclerosis (MS): the story, structure-function correlations, and models for Neuroprotection
  3229. Actions of estrogens on glial cells: implications for Neuroprotection
  3230. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal Neuroprotection .
  3231. Neurodegenerative diseases and Neuroprotection : current views and prospects
  3232. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for Neuroprotection
  3233. Current perspectives on potential role of albumin in Neuroprotection
  3234. Central nervous system agents for ischemic stroke: Neuroprotection mechanisms
  3235. Clinical prediction of Parkinson’s disease: planning for the age of Neuroprotection
  3236. Riluzole, Neuroprotection and amyotrophic lateral sclerosis
  3237. Neuroprotection by spice-derived nutraceuticals: you are what you eat!
  3238. Neuroprotection in subarachnoid hemorrhage
  3239. Perioperative Neuroprotection
  3240. Érythropoïétine et Neuroprotection
  3241. SIRT2 inhibition achieves Neuroprotection by decreasing sterol biosynthesis
  3242. Psychopharmacological Neuroprotection in neurodegenerative disease: assessing the preclinical data
  3243. Clinical trials for Neuroprotection in ALS
  3244. Therapeutic targets for Neuroprotection in acute ischemic stroke: lost in translation?
  3245. Neuroprotection by a mitochondria-targeted drug in a Parkinson’s disease model
  3246. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for Neuroprotection
  3247. Xenon enhances hypothermic Neuroprotection in asphyxiated newborn pigs
  3248. Astrocytic-neuronal crosstalk: implications for Neuroprotection from brain injury
  3249. Vitamin E Neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial
  3250. Neuroprotection mediated through estrogen receptor-α in astrocytes
  3251. Neuroprotection and recovery: recent data at the bench on citicoline
  3252. Effects of caffeine in Parkinson’s disease: from Neuroprotection to the management of motor and non-motor symptoms
  3253. NAP (davunetide) provides functional and structural Neuroprotection
  3254. Curcumin provides Neuroprotection after spinal cord injury
  3255. Clinical evidence for Neuroprotection in glaucoma
  3256. Ocular Neuroprotection by siRNA targeting caspase-2
  3257. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats
  3258. Autophagy activation is associated with Neuroprotection in a rat model of focal cerebral ischemic preconditioning
  3259. Role of ghrelin system in Neuroprotection and cognitive functions: implications in Alzheimer’s disease
  3260. TGF‐β1 Pathway as a New Target for Neuroprotection in Alzheimer’s Disease
  3261. Bone marrow mesenchymal stem cells: agents of immunomodulation and Neuroprotection
  3262. MicroRNAs as effectors of brain function with roles in ischemia and injury, Neuroprotection , and neurodegeneration
  3263. Valproate administered after traumatic brain injury provides Neuroprotection and improves cognitive function in rats
  3264. Toll-like receptor tolerance as a mechanism for Neuroprotection
  3265. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade
  3266. Dexmedetomidine provides cortical Neuroprotection : impact on anaesthetic‐induced neuroapoptosis in the rat developing brain
  3267. Medical management of Parkinson’s disease: focus on Neuroprotection
  3268. Targeting microvasculature for Neuroprotection after SCI
  3269. Ion channels on microglia: therapeutic targets for Neuroprotection
  3270. Mitochondrial dysfunction in Parkinson’s disease: pathogenesis and Neuroprotection
  3271. In vitro antioxidant activities and an investigation of Neuroprotection by six Salvia species from Iran: a comparative study
  3272. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30‐day outcomes in the EMPiRE Clinical Study
  3273. Oxytocin mediates social Neuroprotection after cerebral ischemia
  3274. Phenobarbital augments hypothermic Neuroprotection
  3275. Niaspan treatment induces Neuroprotection after stroke
  3276. Iron chelation and Neuroprotection in neurodegenerative diseases
  3277. NF-κB inhibitory action of resveratrol: a probable mechanism of Neuroprotection in experimental diabetic neuropathy
  3278. Lamotrigine for Neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
  3279. Pharmacological Neuroprotection after perinatal hypoxic-ischemic brain injury
  3280. Role of the glyoxalase system in astrocyte-mediated Neuroprotection
  3281. Evidence for neuroinflammation and Neuroprotection in HCV infection-associated encephalopathy
  3282. Complement in Neuroprotection and neurodegeneration
  3283. Serum uri acid: Neuroprotection in thrombolysis. The Bergen NORSTROKE study
  3284. Safety and feasibility of a novel transcervical access Neuroprotection system for carotid artery stenting in the PROOF Study
  3285. Clinical Neuroprotection in Parkinson’s disease—still waiting for the breakthrough
  3286. Remyelination—an effective means of Neuroprotection
  3287. Inhibition of c-Jun kinase provides Neuroprotection in a model of Alzheimer’s disease
  3288. miRNA Expression profile after status epilepticus and hippocampal Neuroprotection by targeting miR-132
  3289. Valproic acid–mediated Neuroprotection and regeneration in injured retinal ganglion cells
  3290. Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and Neuroprotection
  3291. Excitotoxic Neuroprotection and vulnerability with CaMKII inhibition
  3292. Magnesium for Neuroprotection in birth asphyxia
  3293. Exercise Neuroprotection in a rat model of binge alcohol consumption
  3294. Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?
  3295. Neuroprotection for optic nerve disorders
  3296. Therapeutic challenges to retinitis pigmentosa: from Neuroprotection to gene therapy
  3297. Antioxidant activity of 7, 8-dihydroxyflavone provides Neuroprotection against glutamate-induced toxicity
  3298. Menstrual blood cells display stem cell–like phenotypic markers and exert Neuroprotection following transplantation in experimental stroke
  3299. A serial study of retinal changes following optic neuritis with sample size estimates for acute Neuroprotection trials
  3300. Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation
  3301. Mechanisms of Neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of α4 and α7 receptors in Neuroprotection
  3302. Magnesium for fetal Neuroprotection
  3303. Cerebral blood flow alteration in Neuroprotection following cerebral ischaemia
  3304. Decreased cerebrovascular brain -derived neurotrophic factor–mediated Neuroprotection in the diabetic brain
  3305. Chitosan produces potent Neuroprotection and physiological recovery following traumatic spinal cord injury
  3306. Endogenous Neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
  3307. The PPAR-γ agonist pioglitazone modulates inflammation and induces Neuroprotection in parkinsonian monkeys
  3308. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages
  3309. Human microglia transplanted in rat focal ischemia brain induce Neuroprotection and behavioral improvement
  3310. Magnesium sulphate for fetal Neuroprotection
  3311. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study
  3312. Polyphenols and Neuroprotection against ischemia and neurodegeneration
  3313. Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease
  3314. Can molecular and cellular Neuroprotection be translated into therapies for patients? Yes, but not the way we tried it before
  3315. Complement protein C1q-mediated Neuroprotection is correlated with regulation of neuronal gene and microRNA expression
  3316. Adaptive Müller cell responses to microglial activation mediate Neuroprotection and coordinate inflammation in the retina
  3317. The RNA-binding protein RBM3 is involved in hypothermia induced Neuroprotection
  3318. Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain
  3319. Phenothiazine-mediated rescue of cognition in tau transgenic mice requires Neuroprotection and reduced soluble tau burden
  3320. GDNF fails to exert Neuroprotection in a rat α-synuclein model of Parkinson’s disease
  3321. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke
  3322. Target brain : Neuroprotection and neurorestoration in ischemic stroke.
  3323. Autophagy activation is involved in Neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats
  3324. Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite
  3325. Sex differences in Neuroprotection provided by inhibition of TRPM2 channels following experimental stroke
  3326. Sevoflurane preconditioning confers Neuroprotection via anti-inflammatory effects
  3327. The connexin43 C-terminal region mediates Neuroprotection during stroke
  3328. Prolyl hydroxylase domain inhibitors: a route to HIF activation and Neuroprotection
  3329. Human cord blood transplantation in a neonatal rat model of hypoxic–ischemic brain damage: functional outcome related to Neuroprotection in the striatum
  3330. Neuroprotection , regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis
  3331. Polycomb group proteins as epigenetic mediators of Neuroprotection in ischemic tolerance
  3332. Caffeine and uric acid mediate glutathione synthesis for Neuroprotection
  3333. Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson’s disease
  3334. NR4A orphan nuclear receptors as mediators of CREB-dependent Neuroprotection
  3335. Pharmacological therapy in Parkinson’s disease: focus on Neuroprotection
  3336. Leptin induces proliferation of neuronal progenitors and Neuroprotection in a mouse model of Alzheimer’s disease
  3337. Clinically available iron chelators induce Neuroprotection in the 6-OHDA model of Parkinson’s disease after peripheral administration
  3338. Effective post-insult Neuroprotection by a novel Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor
  3339. Transplantation of BDNF-secreting mesenchymal stem cells provides Neuroprotection in chronically hypertensive rat eyes
  3340. Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway
  3341. Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and Neuroprotection
  3342. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and Neuroprotection
  3343. Neuroprotection of midbrain dopaminergic cells in MPTP‐treated mice after near‐infrared light treatment
  3344. Newly synthesized radical-containing nanoparticles enhance Neuroprotection after cerebral ischemia-reperfusion injury
  3345. Free-radical scavenger edaravone treatment confers Neuroprotection against traumatic brain injury in rats
  3346. Sevoflurane preconditioning induces Neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats
  3347. Rasagiline, Parkinson Neuroprotection , and delayed-start trials: still no satisfaction?
  3348. Microglia-mediated IGF-I Neuroprotection in the rd10 mouse model of retinitis pigmentosa
  3349. Mechanism of Neuroprotection of melatonin against beta-amyloid neurotoxicity
  3350. Recent advances in pharmacologic Neuroprotection
  3351. Docosahexaenoic acid: brain accretion and roles in Neuroprotection after brain hypoxia and ischemia
  3352. Neuroprotection for the warrior: dietary supplementation with omega-3 fatty acids
  3353. A combination immunomodulatory treatment promotes Neuroprotection and locomotor recovery after contusion SCI
  3354. Competitive Inhibition at the Glycine Site of the N -Methyl-d-Aspartate Receptor Mediates Xenon Neuroprotection against Hypoxia–Ischemia
  3355. Human neural stem cells genetically modified to overexpress brain ‐derived neurotrophic factor promote functional recovery and Neuroprotection in a mouse stroke …
  3356. Improving outcomes of Neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice
  3357. Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor
  3358. Hypoxic preconditioning induced Neuroprotection against cerebral ischemic injuries and its cPKCγ-mediated molecular mechanism
  3359. In vivo therapeutic gas delivery for Neuroprotection with echogenic liposomes
  3360. ERK activation by the polyphenols fisetin and resveratrol provides Neuroprotection in multiple models of Huntington’s disease
  3361. Insulin, synaptic function, and opportunities for Neuroprotection
  3362. Recombinant Fv-Hsp70 protein mediates Neuroprotection after focal cerebral ischemia in rats
  3363. Propentofylline: glial modulation, Neuroprotection , and alleviation of chronic pain
  3364. Decaffeinated coffee and nicotine-free tobacco provide Neuroprotection in Drosophila models of Parkinson’s disease through an NRF2-dependent mechanism
  3365. Low dose methamphetamine mediates Neuroprotection through a PI3K-AKT pathway
  3366. Proteomic analysis of cPKCβII‐interacting proteins involved in HPC‐induced Neuroprotection against cerebral ischemia of mice
  3367. … decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on Neuroprotection in a progressive …
  3368. CSF transthyretin Neuroprotection in a mouse model of brain ischemia
  3369. Nanomolar vitamin E α‐tocotrienol inhibits glutamate‐induced activation of phospholipase A2 and causes Neuroprotection
  3370. Neuroprotection with a brain -penetrating biologic tumor necrosis factor inhibitor
  3371. Oral pelargonidin exerts dose-dependent Neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism
  3372. αB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides Neuroprotection to adjacent cells
  3373. … terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-α and the critical period hypothesis of estrogen Neuroprotection
  3374. Neuronal estrogen receptor-α mediates Neuroprotection by 17β-estradiol
  3375. Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+
  3376. Beta-lactam antibiotic offers Neuroprotection in a spinal muscular atrophy model by multiple mechanisms
  3377. Neuroprotection with intraventricular brain -derived neurotrophic factor in rat venous occlusion model
  3378. Neuroprotection : the emerging concept of restorative neural stem cell biology for the treatment of neurodegenerative diseases
  3379. Propofol post‐conditioning induced long‐term Neuroprotection and reduced internalization of AMPAR GluR2 subunit in a rat model of focal cerebral ischemia …
  3380. Benzothiophene selective estrogen receptor modulators provide Neuroprotection by a novel GPR30-dependent mechanism
  3381. Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism
  3382. Mitochondria and calcium flux as targets of Neuroprotection caused by minocycline in cerebellar granule cells
  3383. Role of sirtuins and calorie restriction in Neuroprotection : implications in Alzheimer’s and Parkinson’s diseases
  3384. Lithium-mediated long-term Neuroprotection in neonatal rat hypoxia–ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of …
  3385. Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2)
  3386. Delayed treatment with systemic (S)-roscovitine provides Neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models
  3387. Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia
  3388. Potential of edaravone for Neuroprotection in neurologic diseases that do not involve cerebral infarction
  3389. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced Neuroprotection via an NFκB-mediated increase in interleukin-6 production
  3390. ERK-and Akt-dependent Neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD
  3391. Sex-specific therapeutic strategies based on neuroactive steroids: in search for innovative tools for Neuroprotection
  3392. Pharmacological Neuroprotection after perinatal asphyxia
  3393. Neuroprotection against superoxide anion radical by metallocorroles in cellular and murine models of optic neuropathy
  3394. Neuroprotection from retinal ischemia/reperfusion injury by NOX2 NADPH oxidase deletion
  3395. Blockade of acute microglial activation by minocycline promotes Neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week …
  3396. Psychopharmacological Neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research
  3397. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain
  3398. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor
  3399. Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells
  3400. Neuroprotection in pediatric cardiac surgery: what is on the horizon?
  3401. New approaches to Neuroprotection in infant heart surgery
  3402. Mechanisms mediating brain and cognitive reserve: experience-dependent Neuroprotection and functional compensation in animal models of neurodegenerative …
  3403. Mitochondria: the missing link between preconditioning and Neuroprotection
  3404. Chitooligosaccharide-mediated Neuroprotection is associated with modulation of Hsps expression and reduction of MAPK phosphorylation
  3405. Neuroprotection by natural polyphenols: molecular mechanisms
  3406. Chitosan nanoparticle-based neuronal membrane sealing and Neuroprotection following acrolein-induced cell injury
  3407. Lymphocytes in Neuroprotection , cognition and emotion: is intolerance really the answer?
  3408. BCG vaccine-induced Neuroprotection in a mouse model of Parkinson’s disease
  3409. Structural and functional Neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors
  3410. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson’s disease: a contribution to sex-specific Neuroprotection by estrogens
  3411. Sex-independent Neuroprotection with minocycline after experimental thromboembolic stroke
  3412. 17β-Estradiol–a new modulator of neuroglobin levels in neurons: role in Neuroprotection against H2O2-induced toxicity
  3413. ERK/MAPK is essential for endogenous Neuroprotection in SCN2. 2 cells
  3414. Targeting the brain : Neuroprotection and neurorestoration in ischemic stroke
  3415. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated Neuroprotection following cerebral ischemia/reperfusion injury
  3416. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression …
  3417. … profiling of the injured sciatic nerve of mice carrying the Wld (S) mutant gene: identification of genes involved in Neuroprotection , neuroinflammation, and nerve …
  3418. Argon Neuroprotection
  3419. Intracellular mechanisms of N-acylethanolamine-mediated Neuroprotection in a rat model of stroke
  3420. Cardiac and Neuroprotection regulated by α1-adrenergic receptor subtypes
  3421. Endocannabinoid signaling in neurotoxicity and Neuroprotection
  3422. Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of α7 nicotinic receptors and internalization of NMDA receptors
  3423. … breakdown, edema formation and brain pathology: a light and electron microscopic study on a new model for neurodegeneration and Neuroprotection in porcine brain
  3424. Neuroprotection signaling pathway of nerve growth factor and brain -derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19 …
  3425. … are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance Neuroprotection
  3426. Effects of propofol on proliferation and anti-apoptosis of neuroblastoma SH-SY5Y cell line: New insights into Neuroprotection
  3427. Xenon preconditioning confers Neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion
  3428. Neuroprotection through stimulation of mitochondrial antioxidant protein expression
  3429. Mechanistic insight into DNA damage and repair in ischemic stroke: exploiting the base excision repair pathway as a model of Neuroprotection
  3430. Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson’s disease
  3431. Neuroprotection by taurine in ethanol-induced apoptosis in the developing cerebellum
  3432. Apurinic/apyrimidinic endonuclease APE1 is required for PACAP-induced Neuroprotection against global cerebral ischemia
  3433. Hepatoprotection and Neuroprotection induced by low doses of IGF-II in aging rats
  3434. Molecular mechanisms underlying hypothermia-induced Neuroprotection
  3435. VIP-induced Neuroprotection of the developing brain
  3436. Optic neuropathy in methylmalonic acidemia: the role of Neuroprotection
  3437. Antenatal exposure to magnesium sulfate and Neuroprotection in preterm infants
  3438. Acute hepatocyte growth factor treatment induces long-term Neuroprotection and stroke recovery via mechanisms involving neural precursor cell proliferation and …
  3439. Neuroprotection by leptin in a rat model of permanent cerebral ischemia: effects on STAT3 phosphorylation in discrete cells of the brain
  3440. Recent findings on Neuroprotection against excitotoxicity in the hippocampus of female rats
  3441. Isoflurane preconditioning Neuroprotection in experimental focal stroke is androgen-dependent in male mice
  3442. Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice
  3443. Neuroprotection in Parkinson’s disease
  3444. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides Neuroprotection in mice transient focal cerebral ischemia
  3445. Role of PPARgamma, a nuclear hormone receptor in Neuroprotection
  3446. Protein changes in CSF of HIV-infected patients: evidence for loss of Neuroprotection
  3447. Leptin induces Neuroprotection neurogenesis and angiogenesis after stroke
  3448. PI3K/Akt signaling pathway is required for Neuroprotection of thalidomide on hypoxic–ischemic cortical neurons in vitro
  3449. Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to Neuroprotection
  3450. Progesterone inhibits estrogen‐mediated Neuroprotection against excitotoxicity by down‐regulating estrogen receptor‐β
  3451. The role of ASIC1a in Neuroprotection elicited by quercetin in focal cerebral ischemia
  3452. Lipoic acid decreases inflammation and confers Neuroprotection in experimental autoimmune optic neuritis
  3453. Hypoxic-preconditioning induces Neuroprotection against hypoxia–ischemia in newborn piglet brain
  3454. The Neuroprotection of oxymatrine in cerebral ischemia/reperfusion is related to nuclear factor erythroid 2-related factor 2 (nrf2)-mediated antioxidant response: role of …
  3455. Isoflurane postconditioning induces Neuroprotection via Akt activation and attenuation of increased mitochondrial membrane permeability
  3456. … modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV Neuroprotection
  3457. Chemical Neuroprotection in the cochlea: the modulation of dopamine release from lateral olivocochlear efferents
  3458. Calcium preconditioning triggers Neuroprotection in retinal ganglion cells
  3459. … Neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged Neuroprotection independent of HIF-1 function
  3460. Wnt1 Neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways
  3461. Neuroprotection induced in vitro by ischemic preconditioning and postconditioning: modulation of apoptosis and PI3K–Akt pathways
  3462. Post-stroke hypothermia provides Neuroprotection through inhibition of AMP-activated protein kinase
  3463. Evaluation of cell damage in organotypic hippocampal slice culture from adult mouse: a potential model system to study Neuroprotection
  3464. Roles of estrogen receptors alpha and beta in sexually dimorphic Neuroprotection against glutamate toxicity
  3465. Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS mice
  3466. Moderate ethanol preconditioning of rat brain cultures engenders Neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling …
  3467. The NCX3 Isoform of the Na+/Ca2+ Exchanger Contributes to Neuroprotection Elicited by Ischemic Postconditioning
  3468. Meloxicam exerts Neuroprotection on spinal cord trauma in rats
  3469. Neuroprotection against cobalt chloride-induced cell apoptosis of primary cultured cortical neurons by salidroside
  3470. Activation of Akt/FoxO signaling pathway contributes to induction of Neuroprotection against transient global cerebral ischemia by hypoxic pre‐conditioning in adult …
  3471. Neuroprotection in the preterm infant: further understanding of the short-and long-term implications for brain development
  3472. Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia
  3473. Sinomenine inhibits microglial activation by Aβ and confers Neuroprotection
  3474. The Akt/GSK-3β pathway mediates flurbiprofen-induced Neuroprotection against focal cerebral ischemia/reperfusion injury in rats
  3475. Astroglial reaction to delta opioid peptide [D-Ala2, D-Leu5] enkephalin confers Neuroprotection against global ischemia in the adult rat hippocampus
  3476. Neuroprotection by local intra-arterial infusion of erythropoietin after focal cerebral ischemia in rats
  3477. Long‐term Neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson’s disease
  3478. p120 catenin/αN‐catenin are molecular targets in the Neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia
  3479. Enhanced delivery of erythropoietin across the blood–brain barrier for Neuroprotection against ischemic neuronal injury
  3480. Hydrogen saline offers Neuroprotection by reducing oxidative stress in a focal cerebral ischemia-reperfusion rat model
  3481. Neuroprotection with hypothermia in the newborn with hypoxic-ischaemic encephalopathy. Standard guidelines for its clinical application
  3482. Selected combination of neurotrophins potentiate Neuroprotection and functional recovery following spinal cord injury in the rat
  3483. Aging alters the expression of genes for Neuroprotection and synaptic function following acute estradiol treatment
  3484. Lack of Neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson’s disease
  3485. Intrastriatal transplantation of GDNF-engineered BMSCs and its Neuroprotection in lactacystin-induced Parkinsonian rat model
  3486. Synthesis and preliminary evaluation of Neuroprotection of celastrol analogues in PC12 cells
  3487. Neuroprotection by ulinastatin in experimental autoimmune encephalomyelitis
  3488. Insulin and glucagon share the same mechanism of Neuroprotection in diabetic rats: role of glutamate
  3489. Neuroprotection against retinal ischemia–reperfusion injury by blocking the angiotensin II type 1 receptor
  3490. Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent Neuroprotection in aged rats after embolic focal ischemia
  3491. Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for Neuroprotection
  3492. Characterization of neurotoxic effects of NMDA and the novel Neuroprotection by phytopolyphenols in mice.
  3493. GSK-3 as a target for lithium-induced Neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke
  3494. An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional Neuroprotection in a rat model of …
  3495. Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signal-transduction mechanisms
  3496. Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition
  3497. Neuroprotection caused by hyperoxia preconditioning in animal stroke models
  3498. Liposomal-glutathione provides maintenance of intracellular glutathione and Neuroprotection in mesencephalic neuronal cells
  3499. Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain
  3500. Regulation of posttranscriptional modification as a possible therapeutic approach for retinal Neuroprotection
  3501. Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers Neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of …
  3502. Administration of thiazolidinediones for Neuroprotection in ischemic stroke: a pre‐clinical systematic review
  3503. Role of purinergic receptors in CNS function and Neuroprotection
  3504. Omega-3 polyunsaturated fatty acid supplementation confers long-term Neuroprotection against neonatal hypoxic–ischemic brain injury through anti-inflammatory …
  3505. … agonist 2-(4-morpholinethyl) 1 phenylcyclohexanecarboxylate (Pre084) increases GDNF and BiP expression and promotes Neuroprotection after root avulsion injury
  3506. Involvement of brain ‐derived neurotrophic factor and neurogenesis in oestradiol Neuroprotection of the hippocampus of hypertensive rats
  3507. Cell signaling in NMDA preconditioning and Neuroprotection in convulsions induced by quinolinic acid
  3508. Proton magnetic resonance spectroscopy reveals Neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS
  3509. Neuroprotection by melatonin on mercury induced toxicity in the rat brain
  3510. Urban air pollution targets the dorsal vagal complex and dark chocolate offers Neuroprotection
  3511. White Tea (Camellia sinensis Kuntze) Exerts Neuroprotection against Hydrogen Peroxide-Induced Toxicity in PC12 Cells
  3512. Hypoxic preconditioning provides Neuroprotection and increases vascular endothelial growth factor A, preserves the phosphorylation of Akt-Ser-473 and diminishes …
  3513. Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats
  3514. Zonisamide: aspects in Neuroprotection
  3515. Neuroprotection in acute ischemic stroke.
  3516. Neuroprotection by valproic acid in mouse models of permanent and transient focal cerebral ischemia
  3517. Insulin-like growth factor-I mediates Neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells
  3518. Levetiracetam in brain ischemia: clinical implications in Neuroprotection and prevention of post-stroke epilepsy
  3519. New insights into the mechanisms of mitochondrial preconditioning-triggered Neuroprotection
  3520. The assessment of non-feminizing estrogens for use in Neuroprotection
  3521. Toxicity of neurons treated with herbicides and Neuroprotection by mitochondria-targeted antioxidant SS31
  3522. ACh receptors link two signaling pathways to Neuroprotection against glutamate‐induced excitotoxicity in isolated RGCs
  3523. Isoflurane preconditioning induces Neuroprotection by attenuating ubiquitin-conjugated protein aggregation in a mouse model of transient global cerebral ischemia
  3524. Inhibition of extracellular signal‐regulated kinases 1/2 provides Neuroprotection in spinal cord ischemia/reperfusion injury in rats: relationship with the nuclear factor …
  3525. Combination treatment with ethyl pyruvate and aspirin enhances Neuroprotection in the postischemic brain
  3526. Neuroprotection induced by vitamin E against oxidative stress in hippocampal neurons: involvement of TRPV1 channels
  3527. Modulation of morphological changes of microglia and Neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma
  3528. Neuroprotection by melatonin after germinal matrix hemorrhage in neonatal rats
  3529. Magnesium in a polyethylene glycol formulation provides Neuroprotection after unilateral cervical spinal cord injury
  3530. The use of Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, in robust Neuroprotection in the postischemic brain
  3531. Pituitary adenylate cyclase‐activating peptide induces long‐lasting Neuroprotection through the induction of activity‐dependent signaling via the cyclic AMP response …
  3532. ASIC1a contributes to Neuroprotection elicited by ischemic preconditioning and postconditioning
  3533. Neuroprotection by glucagon: role of gluconeogenesis
  3534. Contrasting patterns of Bim induction and Neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus
  3535. Transplantation of TAT-Bcl-xL-transduced neural precursor cells: long-term Neuroprotection after stroke
  3536. Cochrane corner: hypothermia for Neuroprotection in adults after cardiopulmonary resuscitation.
  3537. Evaluation of Samjunghwan, a traditional medicine, for Neuroprotection against damage by amyloid-beta in rat cortical neurons
  3538. Combined prostaglandin E1 and lithium exert potent Neuroprotection in a rat model of cerebral ischemia
  3539. Role of the c‐Jun N‐terminal kinase pathway in retinal excitotoxicity, and Neuroprotection by its inhibition
  3540. Boosting endogenous Neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon β in relapsing-remitting Multiple Sclerosis (ASIIMS) trial
  3541. Delayed Neuroprotection by riluzole against excitotoxic damage evoked by kainate on rat organotypic spinal cord cultures
  3542. Synergistic effect of selenium and melatonin on Neuroprotection in cerebral ischemia in rats
  3543. Caffeine and CSC, adenosine A2A antagonists, offer Neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells
  3544. Progenitor cells as remote” bioreactors”: Neuroprotection via modulation of the systemic inflammatory response
  3545. … ‐induced blood‐brain barrier breakdown, reduction in cerebral blood flow, edema formation, and brain pathology: Possible Neuroprotection with growth hormone
  3546. Targeting heme oxygenase-1 for Neuroprotection and neuroinflammation in neurodegenerative diseases
  3547. Neuroprotection against hypoxic-ischemic brain injury by inhibiting the apoptotic protease activating factor-1 pathway
  3548. Mitochondrial Na+/Ca2+ exchanger, a new target for Neuroprotection in rat hippocampal slices
  3549. Neuroinflammation and Neuroprotection : an update on (future) neurotrophin-related strategies in multiple sclerosis treatment
  3550. Nicotine-and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in Neuroprotection mechanism
  3551. Pathologically activated Neuroprotection via uncompetitive blockade of N-methyl-D-aspartate receptors with fast off-rate by novel multifunctional dimer bis …
  3552. Profile of minocycline Neuroprotection in bilirubin-induced auditory system dysfunction
  3553. Sex-specific role of thioredoxin in Neuroprotection against iron-induced brain injury conferred by estradiol
  3554. Signal transducers and activators of transcription: STATs-mediated mitochondrial Neuroprotection
  3555. Lack of Neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice
  3556. Differential Neuroprotection by A1 receptor activation and A2A receptor inhibition following pilocarpine-induced status epilepticus
  3557. Erythropoietin-induced Neuroprotection requires cystine glutamate exchanger activity
  3558. Neuroprotection and regeneration by extracellular metallothionein via lipoprotein-receptor-related proteins
  3559. Neuroglobin, estrogens, and Neuroprotection
  3560. … regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and Neuroprotection
  3561. Neuroprotection of locomotor networks after experimental injury to the neonatal rat spinal cord in vitro
  3562. Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) Neuroprotection
  3563. Neuroprotection by human umbilical cord blood-derived progenitors in ischemic brain injuries
  3564. Neuroprotection of erythropoietin and methylprednisolone against spinal cord ischemia-reperfusion injury
  3565. Esmolol and landiolol, selective β1-adrenoreceptor antagonists, provide Neuroprotection against spinal cord ischemia and reperfusion in rats
  3566. Male/female differences in Neuroprotection and neuromodulation of brain dopamine
  3567. Neuroprotection via strychnine-sensitive glycine receptors during post-ischemic recovery of excitatory synaptic transmission in the hippocampus
  3568. Hypothermia and Neuroprotection by sulfide after cardiac arrest and cardiopulmonary resuscitation
  3569. Cold pre‐conditioning Neuroprotection depends on TNF‐α and is enhanced by blockade of interleukin‐11
  3570. Psychopharmacological Neuroprotection in neurodegenerative disease: heuristic clinical applications
  3571. Neuroprotection by the traditional Chinese medicine, Tao-Hong-Si-Wu-Tang, against middle cerebral artery occlusion-induced cerebral ischemia in rats
  3572. Dietary supplementation with tBHQ, an Nrf2 stabilizer molecule, confers Neuroprotection against apoptosis in amyloid β-injected rat
  3573. Enhancing the GLP‐1 receptor signaling pathway leads to proliferation and Neuroprotection in human neuroblastoma cells
  3574. Neuroprotection in stroke in the mouse with intravenous erythropoietin–Trojan horse fusion protein
  3575. Glucagon‐like peptide 1 receptor stimulation as a means of Neuroprotection
  3576. Ethyl pyruvate inhibits peroxynitrite-induced DNA damage and hydroxyl radical generation: implications for Neuroprotection
  3577. Neuroprotection of taurine against bilirubin-induced elevation of apoptosis and intracellular free calcium ion in vivo
  3578. 2-(-2-benzofuranyl)-2-imidazoline induces Bcl-2 expression and provides Neuroprotection against transient cerebral ischemia in rats
  3579. Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson’s disease mice
  3580. Cell non-autonomous functions of homeoproteins in Neuroprotection in the brain
  3581. Engineered superparamagnetic Mn0. 5Zn0. 5Fe2O4 nanoparticles as a heat shock protein induction agent for ocular Neuroprotection in glaucoma
  3582. Pigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: Neuroprotection against loss of function in two animal models
  3583. The Impact of Subthalamic Deep brain Stimulation on Nigral Neuroprotection —Myth or Reality?
  3584. Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and Neuroprotection
  3585. Neuroprotection and functional recovery associated with decreased microglial activation following selective activation of mGluR2/3 receptors in a rodent …
  3586. Corticotropin releasing factor—distribution in rat intestine and role in Neuroprotection
  3587. Field-induced therapeutic hypothermia for Neuroprotection after out-of hospital cardiac arrest: a systematic review of the literature
  3588. Sex difference in sensitivity to allopregnanolone Neuroprotection in mice correlates with effect on spontaneous inhibitory post synaptic currents
  3589. Duplicate preconditioning with sevoflurane in vitro improves Neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase
  3590. Short-term exposure to nickel alters the adult rat brain antioxidant status and the activities of crucial membrane-bound enzymes: Neuroprotection by L-cysteine
  3591. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson’s disease mutations A30P, A53T and …
  3592. The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in Neuroprotection and memory function in mouse brain
  3593. Incrementally applied multifaceted therapeutic bundles in Neuroprotection clinical trials… time for change
  3594. Astrocytic glutamate transporter-dependent Neuroprotection against glutamate toxicity: an in vitro study of maslinic acid
  3595. IL-10 within the CNS is necessary for CD4+ T cells to mediate Neuroprotection
  3596. α2-Adrenoceptors do not Mediate Neuroprotection in Acute Ischemic Stroke in Mice
  3597. Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat—possible involvement of kynurenic acid
  3598. Neuroprotection in Parkinson’s disease: a realistic goal?
  3599. Olfactory Ensheathing Cell Transplantation Into Spinal Cord Prolongs the Survival of Mutant SOD1G93A ALS Rats Through Neuroprotection and Remyelination
  3600. The hippocampal fimbria of cuprizone-treated animals as a structure for studying Neuroprotection in multiple sclerosis
  3601. Striatal Neuroprotection from neonatal hypoxia-ischemia in piglets by antioxidant treatment with EUK-134 or edaravone
  3602. Role of cystatin C in Neuroprotection and its therapeutic implications
  3603. A role for neuronal NF-κB in suppressing neuroinflammation and promoting Neuroprotection in the CNS
  3604. DJ‐1 modulates the expression of Cu/Zn‐superoxide dismutase‐1 through the Erk1/2–Elk1 pathway in Neuroprotection
  3605. Neuroprotection offered by Majun Khadar, a traditional unani medicine, during cerebral ischemic damage in rats
  3606. Rosuvastatin preconditioning provides Neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions
  3607. Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and Neuroprotection
  3608. … increases resveratrol‐induced heme oxygenase‐1 expression through the inhibition of ubiquitin‐dependent proteasome pathway: a possible role in Neuroprotection
  3609. Omega-3 polyunsaturated fatty acids in the brain : metabolism and Neuroprotection
  3610. Preconditioning and postconditioning for Neuroprotection : the most recent evidence
  3611. NCAM-mediated locomotor recovery from spinal cord contusion injury involves Neuroprotection , axon regeneration, and synaptogenesis
  3612. Gene therapy approaches for Neuroprotection and axonal regeneration after spinal cord and spinal root injury
  3613. Neuroprotection of ethanol against ischemia/reperfusion-induced brain injury through decreasing c-Jun N-terminal kinase 3 (JNK3) activation by enhancing GABA …
  3614. Electrophysiological actions of zonisamide on striatal neurons: selective Neuroprotection against complex I mitochondrial dysfunction
  3615. Ceftriaxone preconditioning confers Neuroprotection in neonatal rats through glutamate transporter 1 upregulation
  3616. Lentivirus-mediated transfer of MMP-9 shRNA provides Neuroprotection following focal ischemic brain injury in rats
  3617. Advanced neuroimaging techniques: their role in the development of future fetal and neonatal Neuroprotection
  3618. Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and Neuroprotection
  3619. … in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of Neuroprotection for striatal neurons
  3620. Strategies for study of Neuroprotection from cold-preconditioning
  3621. Minocycline Neuroprotection in a rat model of asphyxial cardiac arrest is limited
  3622. … -α (TNF-α) regulates shedding of TNF-α receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in Neuroprotection
  3623. Mitochondrial ERK plays a key role in delta-opioid receptor Neuroprotection against acute mitochondrial dysfunction
  3624. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for Neuroprotection
  3625. … Mechanism of Mitochondrial Ferritin on 6-Hydroxydopamine–Induced Dopaminergic Cell Damage: Implication for Neuroprotection in Parkinson’s Disease
  3626. Inhibition of gp91phox contributes towards normobaric hyperoxia afforded Neuroprotection in focal cerebral ischemia
  3627. Mechanisms of Neuroprotection by protein disulphide isomerase in amyotrophic lateral sclerosis
  3628. Treatment with Ginsenoside Rb1, A Component of Panax Ginseng, Provides Neuroprotection in Rats Subjected to Subarachnoid Hemorrhage-Induced brain Injury
  3629. The role of neural stem cells for in vitro models of schizophrenia: Neuroprotection via Akt/ERK signal regulation
  3630. … interacting mediator of cell death (Bim) E3 ligase, tripartite motif-containing protein 2 (TRIM2), and its role in rapid ischemic tolerance-induced Neuroprotection
  3631. Excitotoxicity‐induced endocytosis mediates Neuroprotection by TAT‐peptide‐linked JNK inhibitor
  3632. Traumatic brain injury: Current endeavours and trends for Neuroprotection and related recovery
  3633. MRI measures of Neuroprotection and repair in multiple sclerosis
  3634. Chronic hypertension aggravates heat stress-induced brain damage: possible Neuroprotection by cerebrolysin
  3635. Neuroprotection in experimental stroke in the rat with an IgG–erythropoietin fusion protein
  3636. Rosuvastatin-induced Neuroprotection in cortical neurons exposed to OGD/reoxygenation is due to nitric oxide inhibition and ERK1/2 pathway activation
  3637. Bioenergetic homeostasis decides Neuroprotection or neurotoxicity induced by volatile anesthetics: a uniform mechanism of dual effects
  3638. Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways …
  3639. Involvement of glutamate transporter-1 in Neuroprotection against global brain ischemia-reperfusion injury induced by postconditioning in rats
  3640. Success of immunomodulators in MS shifts discovery focus to Neuroprotection
  3641. Post-treatment with selective beta1 adrenoceptor antagonists provides Neuroprotection against transient focal ischemia in rats
  3642. Role of salt-induced kinase 1 in androgen Neuroprotection against cerebral ischemia
  3643. “Won’t you be my neighbor?” Deciphering the mechanisms of Neuroprotection induced by social interaction
  3644. … oxygen species assessed by electron spin resonance spectroscopy in the initial stage of ischemia–reperfusion are not associated with hypothermic Neuroprotection
  3645. Cinnamophilin offers prolonged Neuroprotection against gray and white matter damage and improves functional and electrophysiological outcomes after transient …
  3646. Ibuprofen for Neuroprotection after cerebral ischemia
  3647. … necrosis factor‐α and neuronal nitric oxide synthase antibodies applied topically over the traumatized spinal cord enhances Neuroprotection and functional recovery …
  3648. Astrocytic Neuroprotection through induction of cytoprotective molecules; a proteomic analysis of mutant P301S tau-transgenic mouse
  3649. HspB1 (Hsp 27) expression and Neuroprotection in the retina
  3650. C‐terminal mechano‐growth factor induces heme oxygenase‐1‐mediated Neuroprotection of SH‐SY5Y cells via the protein kinase Cϵ/Nrf2 pathway
  3651. Cystine glutamate exchanger upregulation by retinoic acid induces Neuroprotection in neural stem cells
  3652. Neuroprotection of spinal neurons against blunt trauma and ischemia
  3653. Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for Neuroprotection : results from a prospective randomized study
  3654. Citicoline and postconditioning provides Neuroprotection in a rat model of ischemic spinal cord injury
  3655. Assessment of Parkinson disease: what do we need to show Neuroprotection ?
  3656. Targeting individual calpain isoforms for Neuroprotection
  3657. Achyranthes bidentata polypeptides confer Neuroprotection through inhibition of reactive oxygen species production, Bax expression, and mitochondrial dysfunction …
  3658. Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide 25-35, N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death
  3659. FK506 Neuroprotection after cavernous nerve injury is mediated by thioredoxin and glutathione redox systems
  3660. Studies of locomotor network Neuroprotection by the selective poly(ADP‐ribose) polymerase‐1 inhibitor PJ‐34 against excitotoxic injury to the rat spinal cord in vitro
  3661. Optimizing neurodevelopmental outcomes after prematurity: lessons in Neuroprotection and early intervention.
  3662. Inactivation of GABAA receptor reduces ginsenoside Rb3 Neuroprotection in mouse hippocampal slices after oxygen–glucose deprivation
  3663. In silico theoretical molecular modeling for Alzheimer’s disease: the nicotine-curcumin paradigm in Neuroprotection and neurotherapy
  3664. Distribution of radiolabeled l-glutamate and d-aspartate from blood into peripheral tissues in naive rats: significance for brain Neuroprotection
  3665. Hippocampal damage after intra-amygdala kainic acid-induced status epilepticus and seizure preconditioning-mediated Neuroprotection in SJL mice
  3666. Multi‐targeted Neuroprotection by the HSV‐2 gene ICP10PK includes robust bystander activity through PI3‐K/Akt and/or MEK/ERK‐dependent neuronal release of …
  3667. Mitogen-and stress-activated protein kinase 1-induced Neuroprotection in Huntington’s disease: role on chromatin remodeling at the PGC-1-alpha promoter
  3668. Neuroprotection against excitotoxic and ischemic insults by bis (12)-hupyridone, a novel anti-acetylcholinesterase dimer, possibly via acting on multiple targets
  3669. Estrogen and P2 purinergic receptor systems in microglia: therapeutic targets for Neuroprotection
  3670. Peroxisome proliferator-activated receptor γ promotes Neuroprotection by modulating cyclic D1 expression after focal cerebral ischemia
  3671. Overcoming cell death and tau phosphorylation mediated by PI3KInhibition: a cell assay to measure Neuroprotection
  3672. Cortistatin is induced in brain tissue and exerts Neuroprotection in a rat model of bacterial meningoencephalitis
  3673. Isoflurane preconditioning affords functional Neuroprotection in a murine model of intracerebral hemorrhage
  3674. Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter‐1#
  3675. Neuroprotection of glycyrrhizin against ischemic vascular dementia in vivo and glutamate-induced damage in vitro.
  3676. The critical limiting temperature and selective brain cooling: Neuroprotection during exercise?
  3677. Effects of valsartan on Neuroprotection and neurogenesis after ischemia
  3678. Therapeutic targets for Neuroprotection and/or enhancement of functional recovery following traumatic brain injury
  3679. Donepezil-induced Neuroprotection of acetylcholinergic neurons in olfactory bulbectomized mice
  3680. Acute Neuroprotection by the synaptic blocker botulinum neurotoxin E in a rat model of focal cerebral ischaemia
  3681. Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional Neuroprotection in global ischemia
  3682. Differential Neuroprotection of selective estrogen receptor agonists against autonomic dysfunction and ischemic cell death in permanent versus reperfusion …
  3683. Stem cell plasticity, Neuroprotection and regeneration in human eye diseases
  3684. Hypoxic preconditioning induces Neuroprotection against transient global ischemia in adult rats via preserving the activity of Na+/K+-ATPase
  3685. Future strategies for Neuroprotection in Parkinson’s disease
  3686. Broad-spectrum Neuroprotection against traumatic brain injury by agonism of peroxisome proliferator-activated receptors
  3687. The phosphatidylinositol-3 kinase/Akt pathway mediates geranylgeranylacetone-induced Neuroprotection against cerebral infarction in rats
  3688. During glaucoma, α2-macroglobulin accumulates in aqueous humor and binds to nerve growth factor, neutralizing Neuroprotection
  3689. Elevation of heme oxygenase‐1 by proteasome inhibition affords dopaminergic Neuroprotection
  3690. Neuroprotection of Alpinia katsumadai seed extract against neuronal damage in the ischemic gerbil hippocampus is linked to altered brain -derived neurotrophic …
  3691. Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced Neuroprotection in hypoxia ischemia
  3692. Docosahexaenoic acid confers Neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic …
  3693. Past, present and future of Neuroprotection
  3694. Potential role of IL-13 in Neuroprotection and cortical excitability regulation in multiple sclerosis
  3695. The multimodal prospects for Neuroprotection and disease modification in epilepsy: relationship to its challenging neurobiology
  3696. Iptakalim, an ATP-sensitive potassium channel opener, confers Neuroprotection against cerebral ischemia/reperfusion injury in rats by protecting neurovascular unit …
  3697. Magnetic resonance spectroscopy of the brain under mild hypothermia indicates changes in Neuroprotection -related metabolites
  3698. Human embryonic stem cell-derived neurons as a tool for studying Neuroprotection and neurodegeneration
  3699. Trypanosoma cruzi-derived neurotrophic factor: role in neural repair and Neuroprotection
  3700. Inhibition of hexokinase leads to Neuroprotection against excitotoxicity in organotypic hippocampal slice culture
  3701. Involvement of ERK1/2 pathway in Neuroprotection by salidroside against hydrogen peroxide-induced apoptotic cell death
  3702. A subchronic application period of glucocorticoids leads to rat cognitive dysfunction whereas physostigmine induces a mild Neuroprotection
  3703. Potent Neuroprotection induced by remote preconditioning in a rat model of neonatal cerebral hypoxic–ischemic injury
  3704. Hypothermia for Neuroprotection in adults after cardiopulmonary resuscitation
  3705. Adhesion molecules as potential targets for Neuroprotection in a rodent model of Parkinson’s disease
  3706. Stem cells and Neuroprotection : understanding the players
  3707. Expression of heat shock protein (HSP 72 kDa) during acute methamphetamine intoxication depends on brain hyperthermia: neurotoxicity or Neuroprotection ?
  3708. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides Neuroprotection after embolic stroke in rats
  3709. Primary Neuroprotection : the Holy Grail of multiple sclerosis therapy
  3710. Magnesium sulfate for Neuroprotection in patients at risk for early preterm delivery: not yet
  3711. Blood–CNS barrier, neurodegeneration and Neuroprotection : recent therapeutic advancements and nano-drug delivery
  3712. LPS-induced iNOS expression in Bv-2 cells is suppressed by an oxidative mechanism acting on the JNK pathway—a potential role for Neuroprotection
  3713. α-Synuclein Promotes Neuroprotection Through NF-κB–Mediated Transcriptional Regulation of Protein Kinase Cδ
  3714. Davunetide (NAP) pharmacology: Neuroprotection and tau
  3715. Magnesium sulfate for fetal Neuroprotection .
  3716. Partial Neuroprotection by 17-β-estradiol in neonatal gamma-irradiated rat cerebellum
  3717. Interleukin‐6‐type cytokines in Neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor …
  3718. Neuroprotection by estradiol: some important considerations
  3719. The use of antenatal magnesium sulfate for Neuroprotection for infants born prematurely
  3720. Small temperature variations alter edaravone-induced Neuroprotection of cortical cultures exposed to prolonged hypoxic episodes
  3721. … PDZ1 domain of PSD-95 decreases Src phosphorylation and increases nNOS (Ser847) phosphorylation contributing to Neuroprotection after cerebral ischemia
  3722. The c‐Jun N‐terminal kinase (JNK) inhibitor XG‐102 enhances the Neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats
  3723. Epileptic tolerance is associated with enduring Neuroprotection and uncoupling of the relationship between CA3 damage, neuropeptide Y rearrangement and …
  3724. Y-P30 confers Neuroprotection after optic nerve crush in adult rats
  3725. Neuroprotection by S-PBN in hyperglycemic ischemic brain injury in rats
  3726. Pharmacological Neuroprotection against brain damage in ischemiai/reperfusion experiment
  3727. Strongylophorine-8, a pro-electrophilic compound from the marine sponge Petrosia (Strongylophora) corticata, provides Neuroprotection through Nrf2/ARE pathway
  3728. Passive immunization with LINGO-1 polyclonal antiserum afforded Neuroprotection and promoted functional recovery in a rat model of spinal cord injury
  3729. Editorial [Hot topic: VIP and PACAP: Novel Approaches to brain Functions and Neuroprotection (Executive Guest Editors: Seiji Shioda and Illana Gozes)]
  3730. Aroclor1254 interferes with estrogen receptor-mediated Neuroprotection against beta-amyloid toxicity in cholinergic SN56 cells
  3731. Granulocyte colony-stimulating factor treatment provides Neuroprotection in surgically induced brain injured mice
  3732. Vasodilation and Neuroprotection : the magnesium saga in subarachnoid hemorrhage
  3733. … , intrinsic propensity/pathological processes–causes of self recovery limits and also, subtle related targets for Neuroprotection /pleiotropicity/multimodal actions …
  3734. Neuroprotection and brain cholesterol biosynthesis in Huntington’s disease
  3735. Unilateral brain hypothermia as a method to examine efficacy and mechanisms of Neuroprotection against global ischemia
  3736. The activation of β2-adrenergic receptors in naïve rats causes a reduction of blood glutamate levels: Relevance to stress and Neuroprotection
  3737. Phytoceramide shows Neuroprotection and ameliorates scopolamine-induced memory impairment
  3738. Neuroprotection in glaucoma: a review
  3739. Lack of Neuroprotection of inhibitory peptides targeting Jun/JNK after transient focal cerebral ischemia in spontaneously hypertensive rats
  3740. Glial cell-line derived neurotrophic factor is essential for electroconvulsive shock-induced Neuroprotection in an animal model of Parkinson’s disease
  3741. Neuroprotection of selective brain cooling after penetrating ballistic-like brain injury in rats
  3742. Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis
  3743. Acetylcholinesterase variants in Alzheimer’s disease: from Neuroprotection to programmed cell death
  3744. Neuroprotection of retinal ganglion cells with GDNF-Loaded biodegradable microspheres in experimental glaucoma
  3745. New perspectives on molecular and cellular mechanisms of Neuroprotection and neuroregeneration: part I
  3746. Ironing out neurodegeneration: iron chelation for Neuroprotection
  3747. Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity
  3748. Posttreatment but not pretreatment with selective β-adrenoreceptor 1 antagonists provides Neuroprotection in the hippocampus in rats subjected to transient forebrain …
  3749. Magnesium sulphate for fetal Neuroprotection
  3750. Joongpoongtang 05 (JP05) confers Neuroprotection via anti-apoptotic activities in Neuro-2a cells during oxygen–glucose deprivation and reperfusion
  3751. Endogenous Neuroprotection in multiple sclerosis.
  3752. Sevoflurane‐induced post‐conditioning has no beneficial effects on Neuroprotection after incomplete cerebral ischemia in rats
  3753. “Therapeutic Hypercapnia” after Ischemic brain Injury: Is There a Potential for Neuroprotection ?
  3754. Therapeutic time window of YGY-E Neuroprotection of cerebral ischemic injury in rats
  3755. Clinical Neuroprotection and secondary neuronal injury mechanisms
  3756. Neuroprotection of paclitaxel against cerebral ischemia/reperfusion-induced brain injury through JNK3 signaling pathway
  3757. Overestimating Neuroprotection in congenital heart disease: problems with Bayley III outcomes
  3758. Refining Neuroprotection strategies in the era of therapeutic hypothermia.
  3759. Hormones in neurodegeneration, Neuroprotection , and neurogenesis
  3760. Molecular Aspects of Neurodegeneration and Neuroprotection
  3761. … -activated protein kinase and peroxisome proliferator-activated receptor gamma coactivator 1α signaling provides Neuroprotection in status epilepticus in rats
  3762. … R-Pia reduces the imbalance between cerebral glucose metabolism and blood flow during status epilepticus: could this mechanism be involved with Neuroprotection ?
  3763. Further assessment of neuropathology in retinal explants and Neuroprotection by human neural progenitor cells
  3764. Expression of pancreatitis-associated protein after traumatic brain injury: a mechanism potentially contributing to Neuroprotection in human brain
  3765. Indirect measures of Neuroprotection are parameters to avoid: examples from research on neonatal rat hypoxia-ischemia
  3766. Prostaglandin E2 EP1 Receptor Inhibition Fails to Provide Neuroprotection in Surgically Induced brain -Injured Mice
  3767. Mesenchymal Stem Cell Transplantation Confers Neuroprotection in Experimental Glaucoma
  3768. Study on the Neuroprotection components of ethnomedicine Erigeron breviscapus [J]
  3769. Involvement of histamine 1 receptor in seizure susceptibility and Neuroprotection in immature mice
  3770. Neuroprotection , SCHIZOPHRÉNIE ET ANTIPSYCHOTIQUES: REVUE SYSTÉMATIQUE DE LA LITTÉRATURE.
  3771. Hypothermia for Neuroprotection in adults after cardiopulmonary resuscitation
  3772. Magnesium for Neuroprotection
  3773. Neuroprotection by hypothermia plus alkalinization of dorsal root ganglia neurons through ischemia
  3774. Translati onal challenges of Neuroprotection strategy in ischemic stroke
  3775. Aprotinin confers Neuroprotection by reducing apoptotic cell death
  3776. Neonatal hypothermia: a method to provide Neuroprotection after hypoxic ischemic encephalopathy
  3777. Effects of hominis placenta pharmacopuncture and electroacupuncture Neuroprotection in contused spinal cord of rats
  3778. Neuroprotection of a neotype transactivating-brain -derived neurotrophic factor fusion protein with penetrating activity of blood-brain barrier
  3779. Discovering Neuroprotection in Parkinson’s disease, or getting to haphazard
  3780. Combinatorial techniques for enhancing Neuroprotection : hypothermia and alkalinization
  3781. Neuroprotection by IL-6 is mediated by STAT3 and antioxidative signaling in ischemic stroke
  3782. Neuroprotection in neonatal hypoxic ischemic encephalopathy: Therapeutic hypothermia and beyond
  3783. Pharmacological preconditioning with GYKI 52466: a prophylactic approach to Neuroprotection
  3784. Neuroprotection in bipolar depression
  3785. Complement protein 6 deficiency in PVG/c rats does not lead to Neuroprotection against seizure induced cell death
  3786. Beyond Neuroprotection to brain repair: exploring the next frontier in clinical neuroscience to expand the therapeutic window for stroke
  3787. Low-molecular-mass peptides from the venom of the Amazonian viper Bothrops atrox protect against brain mitochondrial swelling in rat: potential for Neuroprotection
  3788. The role of MSUT-2 in tau neurotoxicity: a target for Neuroprotection in tauopathy?
  3789. Dual isoflurane-induced preconditioning improves Neuroprotection in rat brain in vitro and the role of extracellular signal-regulated protein kinase
  3790. Hypertonic mannitol in mice poisoned by a convulsive dose of soman: Antilethal activity without Neuroprotection
  3791. Calcium transport mechanisms in Neuroprotection and neurotoxicity
  3792. Towards a new paradigm in Neuroprotection and neuroplasticity
  3793. Autophagy and its Neuroprotection in neurodegenerative diseases
  3794. New possibilities of Neuroprotection in ischemic stroke
  3795. Forsythiae fructus and its active component, arctigenin, provide Neuroprotection by inhibiting neuroinflammation
  3796. Effects of minocycline on the expression of NGF and HSP70 and its Neuroprotection role following intracerebral hemorrhage in rats
  3797. Past, present and future of hypothermic Neuroprotection for neonatal encephalopathy in Japan: time to say good-by to the old remedies.
  3798. New perspectives on molecular and cellular mechanisms of Neuroprotection and neuroregeneration: part II
  3799. The delayed-start study in Parkinson disease: Can’t satisfy everyone: Rasagiline, Parkinson Neuroprotection , and delayed-start trials: Still no satisfaction?
  3800. … regulation of FGF-2 in neurons and reactive astrocytes of axotomized rat hypoglossal nucleus. A possible therapeutic target for Neuroprotection in peripheral nerve …
  3801. Oestrogen and Neuroprotection
  3802. Retinal Neuroprotection
  3803. Neuroprotection of Maslinic Acid, a novel glycogen phosphorylase inhibitor, in type 2 diabetic rats
  3804. Marine toxins, neurodegeneration and Neuroprotection
  3805. Prospects for Neuroprotection in glaucoma
  3806. Dopaminergic Neuroprotection of Poacynum hendersonni in MPTP mouse
  3807. Improved Neuroprotection with melatonin-augmented hypothermia vs hypothermia alone in a perinatal asphyxia model: a randomized study
  3808. What’s new in Neuroprotection
  3809. How effective is hypothermia for Neuroprotection in adults after cardiopulmonary resuscitation?
  3810. Copper and Prion Protein Function: A Brief Review of Emerging Theories of Neuroprotection
  3811. Uncoupling Neuroprotection from immunosuppression: The discovery of ILS-920
  3812. Mechanism of NMDA receptor-dependent neuronal survival and Neuroprotection
  3813. Neuroprotection of the newborn brain : therapeutic targets & behavioral outcome
  3814. The impact of Neuroprotection on brain metabolism during carotid endarterectomy
  3815. Developments in Neuroprotection
  3816. News and views of Neuroprotection in complete traumatic spinal cord injuries
  3817. Comparing Different Erigerontis Preparations on the Neuroprotection Activity and Chemical Constituents
  3818. Hypothermia for Neuroprotection in the newborn
  3819. The conundrum of Neuroprotection in Parkinson’s disease.
  3820. Mechanisms of social Neuroprotection after cerebral ischemia
  3821. Neuroprotection in Glaucoma
  3822. Progenitor cell therapies as a novel treatment for traumatic brain injury: A pathway towards Neuroprotection
  3823. Neuroprotection of retinal degenerative disease by ciliary neurotrophic factor
  3824. Neuroprotection in Parkinson’s disease: a multi-directional genetic strategy for maximum protection of dopaminergic neurons against Parkinsonian toxicity
  3825. Recombinant human erythropoietin: novel approach to Neuroprotection and neuroregeneration in schizophrenia
  3826. Development of intravenous topiramate for Neuroprotection and seizure control in neonates.
  3827. Synthesis of Indolylquinones as a Potential Therapy for Diabetes and as Candidates for Neuroprotection
  3828. Magnesium sulfate Neuroprotection : time to start?
  3829. Fetal Cardiac Arrest Due to Asphyxia in Late Preterm Lambs: Propofol Mediates Neuroprotection for the Fetus When Administered During Emergency Caesarean …
  3830. From bone marrow to brain : stem cells in Neuroprotection , plasticity, and neuroregeneration
  3831. Does anesthetic provide similar Neuroprotection to therapeutic hypothermia after cardiac arrest?
  3832. Clinical analysis on Neuroprotection of transient ischemic attacks
  3833. Citicoline: a promising agent for Neuroprotection and neurorepair
  3834. Dimethyl-carbamic acid 2, 3-Bis-Dimethylcarbamoyloxy-6-(4-Ethyl-Piperazine-1-Carbonyl)-phenyl ester: A novel multi-target therapeutic approach to Neuroprotection
  3835. Medical Treatment: Neuroprotection
  3836. Sustained Neuroprotection after a single intravitreal injection of PGJ2 in a rodent model of NAION
  3837. Impact of belief in Neuroprotection on therapeutic intervention in Parkinson’s disease
  3838. Strategies to Promote Neuroprotection and Repair in Multiple Sclerosis
  3839. How right is the righting reflex? The risk of false positives in Neuroprotection studies using behavioral measures to certify forebrain ischemia
  3840. Enhance effort for study of Neuroprotection of degenerative fundus disease
  3841. Expression of liquoral Neuroprotection markers in children with acute lymphoblastic leukemia
  3842. The fabulous Neuroprotection of selegiline: memoir and prospectus
  3843. Reply to Valenza and Cattaneo: SIRT2-mediated Neuroprotection and cholesterol dyshomeostasis in Huntington’s disease
  3844. Neuroprotection and neuroregeneration: what to expect from a stem cell-based therapy of acute brain injury
  3845. Somatostatin and Neuroprotection in Retina
  3846. Effect of sivelestat on neutrophil elastase and Neuroprotection in rats with craniocerebral injury at simulated high altitude
  3847. Erythropoietic Neuroprotection : Holy Grail or potential to fail?
  3848. Transpupillary thermotherapy: New observations on Neuroprotection of retinal ganglion cells
  3849. Frontiers in Perinatal Neuroprotection
  3850. Role of CX3CL1 in synaptic activity and Neuroprotection
  3851. Moxibustion therapy on diabetic peripheral neuropathy in rats for the peripheral Neuroprotection
  3852. Structure–Nongenomic Neuroprotection Relationship of Estrogens and Estrogen‐Derived Compounds
  3853. The Influence of G-CSF on the Expression of VEGF and Neuroprotection in Rats’ brain s After Ischemia/reperfusion Injury [J]
  3854. Relationship between oestrogen and cholesterol in Neuroprotection
  3855. Pharmacological Neuroprotection : that long, long road from idea to practice
  3856. Neuroprotection and cognitive Enhancing Training Strategies: Environmental Enrichment and Motor Skills Training
  3857. A10 SIRT2 inhibition achieves Neuroprotection by decreasing sterol biosynthesis
  3858. Neuroprotection and axonal regeneration after peripheral nerve injury
  3859. Neuroprotection against excitotoxicity and oxidative stress by hypothermia and alkalinization
  3860. Neuroprotection in multiple sclerosis
  3861. Reply to Bell et al.: Nrf2-dependent and-independent mechanisms of astrocytic Neuroprotection
  3862. Secreted amyloid precursor protein-α mediates Neuroprotection and gene expression
  3863. Role of calcium binding proteins in the Neuroprotection of hippocampal CA1 neurons
  3864. Hippocampus Neuroprotection during lactation: a model to study neuroendocrine-immune interactions
  3865. Xenon Neuroprotection against hypoxia–ischaemia is mediated by the N-methyl-D-aspartate receptor glycine site.
  3866. Neuroapoptosis and Neuroprotection by NMDA-receptors antagonists
  3867. Neuroprotection in glaucoma
  3868. Protein transduction technique and its application in Neuroprotection
  3869. The role of oxygen radicals-scavenger in Neuroprotection -induced by normobaric hyperoxia on infarct volume in the rat brain
  3870. Membrane-initiated signaling of estrogen related to Neuroprotection .“Social networks” are required
  3871. Foetal hypoxia is an important determinant of birth asphyxia and subsequent adverse outcome: antenatal Neuroprotection at term
  3872. Efficacy of topiramate against soman intoxication: attenuation of seizures without Neuroprotection
  3873. Neuroprotection in Parkinson’s
  3874. Alpha1A-Adrenergic Receptors in Neuroprotection
  3875. Effects of lithium chloride on behavior and Neuroprotection of dopaminergic neurons in a mice model of MPTP-induced Parkinsons disease
  3876. The Neuroprotection of edaravone and GM1 on the rat model of parkinson disease
  3877. Neuroprotection in Parkinson’s Disease
  3878. Mechanism of Neuroprotection of Estrogen [J]
  3879. Neuroprotection in the Newborn Infant
  3880. CHALLENGES TO OBTAINING Neuroprotection IN PARKINSON’S DISEASE
  3881. Magnetic resonance biomarkers of hypothermic rescue Neuroprotection following neonatal encephalopathy in a south indian neonatal unit
  3882. Effects of ischemic postconditioning on hippocampal Neuroprotection in different cerebral ischemia models at the same” time window” in tree shrews
  3883. Autologous Mononuclear Progenitor Cell Injection for Traumatic brain Injury (TBI): The Effect of Injury Cavity Volume on Potential Neuroprotection
  3884. Neuroprotection in Parkinson’s Disease
  3885. DNA damage and repair in the brain : implications for seizure-induced neuronal injury, endangerment, and Neuroprotection
  3886. Purine nucleoside mediated Neuroprotection in the 6-hydroxydopamine rodent model of Parkinson’s disease
  3887. Neuroprotection in the treatment of multiple sclerosis
  3888. Neurovascular unit and poststroke Neuroprotection
  3889. STUDIES ON Neuroprotection IN TRAUMA AND STROKE MODELS
  3890. The Neuroprotection role of heat shock protein 70 (HSP70) against microwave radiation induced DNA damage in male Wistar rat brain
  3891. Liposome-mediated transfer of the HGF gene results in Neuroprotection in adult rat brain after cerebral ischemia [J]
  3892. Direct VEGF-A Mediated Neuroprotection : Mechanistic Studies in RGCs
  3893. Neuroprotection in the therapy of the brain injury: 7AP5–4
  3894. Experimental studies on ischemic Neuroprotection : criteria for translational significance.
  3895. The Design and Methodology of Clinical Studies of Neuroprotection in Cardiac Surgery
  3896. Neuroprotection of Retinal Ganglion Cells
  3897. Uncovering Novel Therapeutic Targets Promoting Neuroprotection Against Oxidative Stress
  3898. Smoking and Mental Disorders: Focus on Neuroprotection
  3899. Leptin Neuroprotection in the Central Nervous System
  3900. Neuroprotection during pediatric cardiac anesthesia
  3901. Mechanisms of estrogen Neuroprotection in stroke
  3902. Autophagy and its Neuroprotection in neurodegenerative diseases
  3903. Oxidative damage in brain genome and Neuroprotection
  3904. Antenatal brain injury and prospects for Neuroprotection
  3905. A Mechanistic Investigation of STAT3 Regulated Neuroprotection
  3906. Future Perspective: Directions for Future Development on Various Aspects of Neurodegeneration and Neuroprotection in Neurological Disorders
  3907. Dopaminergic Neuroprotection and reconstruction of neural network tiara
  3908. Anti-inflammatory and anti-oxidant Neuroprotection in the prevention of Alzheimer’s disease
  3909. Effects of Sanguisorbae Radix on Neuroprotection in an In Vitro Parkinson’s Disease Model
  3910. Editorial [Hot topic: Neuroprotection in ALS: From Pathology to Treatment (Guest Editors: Gabriele Siciliano and Luigi Murri)]
  3911. Role of Serpinin in Granule Biogenesis and Neuroprotection
  3912. Neuroprotection and Antioxidative Constituents in Sesame (Sesamum indicum L.)
  3913. Investigating the Role of the Prion Protein Polybasic Domain in PrPSc Formation and Neuroprotection
  3914. Local rock-inhibition as a novel therapeutic approach for Neuroprotection of retinal ganglion cells (FRO)
  3915. Mechanism of estrogen-mediated Neuroprotection : regulation of mitochondrial function
  3916. The Corticotropin‐Releasing Hormone in Neuroprotection
  3917. Neuroprotection of Mouse Retina Ganglion Cells by N-Acylethanolamines
  3918. MS pipeline flowing, but niche remains for Neuroprotection
  3919. Neuroprotection with Anesthetics in Two Models of Cerebral Ischemia
  3920. Bench to bedside, tertiary centres to developing world–” tailoring” best available Neuroprotection in high and low resource settings
  3921. Pharmacological Neuroprotection in cervical spinal cord injury
  3922. THE RATIONALE FOR Neuroprotection IN EPILEPSY: STEPS FORWARD FOR NEW THERAPEUTIC AND PREVENTIVE STRATEGIES
  3923. Neuroprotection by estrogen under hypoglycemic condition with special emphasis on AKT_GSK pathway
  3924. by Crystallography on Three Enzymes-Implication on Anesthesia and Neuroprotection Mechanisms
  3925. The effect of estrogen receptor alpha36 involved in Neuroprotection of estrogen
  3926. Tailoring the heterogeneous macrophage response to spinal cord injury towards Neuroprotection
  3927. Neuroprotection by S-PBN in hyperglycemic ischemic brain injury
  3928. Neuroprotection and cell-based therapy in retinal degeneration
  3929. MSK-1 and CREB were involved in HPC-induced Neuroprotection against cerebral ischemic injuries of mice
  3930. Role of α7 nicotinic acetylcholine receptor subtype in Neuroprotection : An overview
  3931. Elucidating Mechanisms of Retinal Ganglion Cell Neuroprotection by Mesenchymal Stem Cell Transplantation
  3932. LEPTIN INDUCES NEUROGENESIS AND Neuroprotection IN A MOUSE MODEL OF ALZHEIMERS DISEASE
  3933. The Neuroprotection of nicotine to the cerebral ischemia/reperfusion injury of rats
  3934. Mechanisms of Erythropoietin-induced Neuroprotection in: in-vivo and in-vitro Models of hypoxia Ischema
  3935. Genetic Ablation or Pharmacological Inhibition of Cell Cycle Pathways Provides Neuroprotection in Experimental TBI
  3936. Cellular mechanisms of neurodegeneration and Neuroprotection in the mammalian cortex
  3937. Neuroprotection and Behavior Regulation by Adrenomedullin and PAMP as Shown by Conditional Knockout Models
  3938. Dhea-Analogue Neuroprotection In An Experimental Model Of Retinal Detachment
  3939. Magnesium sulphate in women at risk of preterm birth for Neuroprotection of the fetus
  3940. Therapeutic Hypothermia for Neuroprotection in Adults after Cardiopulmonary Resuscitation
  3941. Modulation of Crystallin Network by Lipin1 is Associated With Neuroprotection in the Mouse Retina
  3942. Amyloid Precursor Protein-mediated Neuroprotection In The Aged Retina
  3943. Study of telmisartan on the c-fos expression and Neuroprotection on MCAO rats
  3944. Progestins and Neuroprotection : Why the Choice of Progestin Matters
  3945. The Neuroprotection role of hypervolemic hemodilution on rat brain suffered from cerebral ischemia-reperfusion insults
  3946. Antiepileptic Drug and Estradiol Neuroprotection in Epilepsy
  3947. Neuroprotection in Sepsis by Complement Inhibition and Immunoglobulin Therapy
  3948. Neuroprotection BY GDNF AND A PHYSICAL EXERCISE THERAPY IN THE 3XTGAD MOUSE MODEL
  3949. Real-time monitoring of potential effects of Neuroprotection by acupuncture in global ischemic model of hyperglycemic rats
  3950. brain CYP2D6 and its role in Neuroprotection against Parkinson’s Disease
  3951. Siglec-F receptor and Neuroprotection in mouse central nervous system
  3952. Palmitoyl-proteins: regulators of neuronal functions and potential targets for Neuroprotection
  3953. Neuroprotection and mechanism of 17β-estradiol in ovariectomized female rats with cerebral ischemia
  3954. Intracellular Accumulation of A2E in Retinal Microglia Influences Neuroprotection and Cellular Migration
  3955. Investigation of neurodegeneration and Neuroprotection in secondary progressive multiple sclerosis using volumetric MRI measures
  3956. Neuroprotection ‐A role played by Acorus calamus in experimental temporal lobe epilepsy
  3957. Neuroprotection of Retinal Ganglion Cells in P23H Rats: A Way to Improve Resolution in Retinal Prosthesis or Optogenic Approach
  3958. Neuroprotection effect of FLOS ROSAE RUGOSAE extracts on PC12 cells against Aβ25-35-induced cytotoxity.
  3959. A Possible Role of Microglia in Igf-Mediated Neuroprotection of Rd10 Mouse Retina
  3960. Nrf2 Mediated Neuroprotection in In Vitro Models of Parkinson’s Disease
  3961. Common Gene Expression Profiles Of Induced Neuroprotection By Preconditioning And By Injection Of Leukemia Inhibitory Factor
  3962. Mechanisms of Ipsapirone-Mediated Neuroprotection of Ethanol-Treated Fetal Rhombencephalic Neurons: Role of Endogenous Antioxidants
  3963. Chemically-induced anoxia in retinal cell cultures: mechanisms of injury and Neuroprotection
  3964. Effects of recombine human granuloctye cololny-stimulating factor on Neuroprotection and influence on expression of Fas protein of brain tissue in cerebral infarction …
  3965. Mechanisms of Bone-Marrow Stem Cell-Mediated Delayed Ischemic Neuroprotection in Rat Retina
  3966. Role of-Opioid-Receptor Activation in Retina Neuroprotection Against Ischemic Retinal Injury
  3967. Neuroprotection and Neurorestoration in the MPTP Model for Parkinson’s Disease
  3968. The Mechanisms of Neuroprotection by Melatonin in Cerebral Ischaemia Reperfusion
  3969. S44–Rapid development and implementation of guidelines for infant Neuroprotection with antenatal magnesium sulfate (MgSO4)
  3970. Therapeutic hypothermia for Neuroprotection after off-hospital cardiac arrest: Too cool for school?
  3971. Neuroprotection against ischemic injury induced by morphine preconditioning in different time in mice
  3972. Neuroprotection by estrogen on hypoglycemic injury on hypothalamic cells at the cellular and molecular level
  3973. Adenosine A2A antagonists: Neuroprotection and autophagy induction by a new compound
  3974. Effect of Acacetin on Neuroprotection in MPTPinduced Parkinson’s Disease Model via Anti-inflammatory Actions
  3975. Neuroprotection of minocycline on chronic ocular hypertension rat retina
  3976. The human NT2 cell line as in vitro test system for Neuroprotection and developmental neurotoxicity
  3977. Sevoflurane postconditioning provides Neuroprotection up to 7 days after ischemia/reperfusion via mitoKATP: BAPCAP2–5
  3978. Neuroprotection of Exenatide in rats with diabetic peripheral nerve injury
  3979. Neuroprotection of erythropoietin on rabbit retinal ganglion cells in chronic ocular hypertension
  3980. MOLECULAR MECHANISMS OF NCX1 AND NCX3-INDUCED Neuroprotection IN ANOXIC brain PRECONDITIONOING
  3981. The Regulatory Role of Visfatin in Neuronal Differentiation and Neuroprotection through Activation of Vigin Signaling Pathway
  3982. Signaling in retinal degeneration and Neuroprotection -the role of JAK/STAT and HIF
  3983. … BASICS OF ACUTE brain ISCHEMIA MODERN PHARMACOTHERAPY. NOOTROPICS AND ANTIOXIDANTS’ROLE IN Neuroprotection
  3984. Involvement of the NMDA Receptor in Moderate Ethanol Preconditioning-Dependent Neuroprotection From Amyloid-Beta in Vitro
  3985. Neurology: vitamin E Neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial
  3986. Engineered superparamagnetic Mn₀. ₅Zn₀. ₅Fe₂O₄ nanoparticles as a heat shock protein induction agent for ocular Neuroprotection in glaucoma
  3987. Erratum to: T-cell-based vaccination for morphological and functional Neuroprotection in a rat model of chronically elevated intraocular pressure
  3988. In vivo Neuroprotection through M-type K+ Channels after Cerebrovascular Stroke
  3989. Neuroprotection mediated by P2 receptors of NMDA-dependent toxicity in hippocampal slices
  3990. NQO2: A Novel Target to Mediate Neuroprotection Against Retinal Degeneration
  3991. Influence of therapeutic hypothermia on Neuroprotection and post-ischemic plasticity in a rat model of global ischemia
  3992. Mechanisms of Neuroprotection of silent information regulation 2 homolog 3 against hypoxic injury in hypoxic preconditioning
  3993. Mechanisms of action of Methylthioadenosine: pathways implicated in Neuroprotection in models of Multiple Sclerosis and other neurological diseases
  3994. Cold enhances Neuroprotection in hippocampal slices from hibernating Syrian hamsters
  3995. Beta-lactam antibiotic offers Neuroprotection in a spinal muscular atrophy model by multiple mechanisms
  3996. Review on the Endogenous Neuroprotection Mechanisms of the Cerebellar Fastigial Nucleus Stimulation in Rats with Ischemic [J]
  3997. Mitochondrial potassium sequestration and Neuroprotection is mediated by connexin43
  3998. APPL1 mediates synaptic NMDA receptor-dependent Neuroprotection
  3999. Neuroprotection EFFECT OF FEMALE SEX STEROIDS AFTER TRAUMATIC brain INJURY IN RATS: THE ROLE OF INFLAMMATORY CYTOKINES
  4000. Evaluation of NMDA receptor-mediated Neuroprotection in the endothelin-1 model of upper extremity impairment in stroke
  4001. Neuroprotection against nerve agent using a blood glutamate scavenging system in rats
  4002. Mechanisms of Observed Neuroprotection of Dopaminergic Neurons in Wallerian Degeneration Slow (WldS) Mice
  4003. … Spectral Domain Optical Coherence Tomography Evaluation During Retinal Neurodegeneration Has Quantitative Predictive Value for Studies of Neuroprotection in …
  4004. HIF-1α-Mediated Neuroprotection on MPP+-Induced Apoptosis in SH-SY5Y Cells
  4005. GSK-3b-Nrf2 Signaling Pathway for Neuroprotection in Alzheimer’s Disease
  4006. Identification of the Receptor Tyrosine Kinase Inibitor Sunitinib, and Related Analogues, as Candidate Molecules for Glaucoma Neuroprotection
  4007. The Neuroprotection of Psoralen on βamyloid-induced Cholinergic System Injury in Hippocampal Neuron Cultures
  4008. … in Optic Nerve Axotomy, Manipulation of the p75 Neurotrophin Receptor Signals Activate Neuro-Gial Mechanisms Causing RGC Neuroprotection or Increased RGC …
  4009. The Neuroprotection and cognition -amelioration after G-CSF treatment in chronic cerebral ischemic aged rats
  4010. Fast nongenomic Neuroprotection mediated by GPR30-dependent depression of NR2B-containing NMDA receptors
  4011. OECs transplantation in spinal cord prolongs the survival of mutant SOD1 (G93A) ALS rats through Neuroprotection
  4012. Roles of nuclear receptors LXRs and ERs in the Neuroprotection of dopaminergic neurons in the midbrain
  4013. Newly synthesized radical-containing nanoparticles (RNP) enhance Neuroprotection after cerebral ischemia-reperfusion injury
  4014. Light Reduction, Neuroprotection , And Subretinal Gene Therapy In A Mouse Model Of Bardet Biedl Syndrome
  4015. Retinoic acid receptor‐mediated Neuroprotection and its implications for amyotrophic lateral sclerosis
  4016. The role of Peroxisome Proliferator Activated Receptors in Amyotrophic Lateral Sclerosis: potential mechanisms for Neuroprotection
  4017. The Neuroprotection of SIRT1 on NMDA-induce excitotoxicity in cultured cortical cell
  4018. Neuroprotection with Melatonin and the Caspase-2 Inhibitor TRP601: Novel Aspects by Analysis of the Metabolome in Excitotoxic brain Injury
  4019. NEUROSCIENCES AND NEUROANAESTHESIA-Small temperature variations alter edaravone-induced Neuroprotection of cortical cultures exposed to …
  4020. Boosting endogenous Neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon b in relapsing–remitting Multiple Sclerosis (ASIIMS) trial
  4021. Pregnancy-associated Effects on Immune Modulation and Neuroprotection in Experimental Autoimmune Encephalomyelitis: Role of T Cells and Serum Exosomes
  4022. Exosomes: Mediators of Pregnancy-associated Immune Modulation and Neuroprotection in a Model of Multiple Sclerosis
  4023. The Effects of Paraquat Exposure on Serial Reaction Time Performance in Rats (Rattus norvegicus) and Neuroprotection by Water-Soluble COQ10
  4024. Hippocampal Alterations in Rats Submitted to Streptozotocin-Induced Dementia Model: Neuroprotection with Aminoguanidine
  4025. Improved Neuroprotection with melatonin-augmented hypothermia versus hypothermia alone in a perinatal asphyxia model
  4026. First clinical use of a novel neurovascular access and Neuroprotection system demonstrates complete absence of emboli by transcranial Doppler during carotid artery …
  4027. Calpain Inhibition Confers Histological and Functional Neuroprotection to Retinal Ganglion Cells in Experimental Optic Neuritis
  4028. Neuroprotection of adenoassociated vira-mediated brain -derived neurotrophic factor on retinal ganglion cells in DBA/2J mice with glaucoma
  4029. … of blood glutamate into peripheral tissues is increased by stress response and adrenaline administration, providing Neuroprotection following traumatic brain injury …
  4030. Neuroprotection of Retinal Ganglion Cells and Their Axons With Gdnf & Vit E Loaded Biodegradable Microparticles in Rat Experimental Glaucoma Model
  4031. Docosahexaenoic Acid Pretreatment Confers Neuroprotection in a Rat Model of Perinatal Cerebral Hypoxia-Ischemia
  4032. Hydrogen is Neuroprotective and preserves cerebrovascular reactivity in asphyxiated newborn pigs Running title: Neuroprotection by hydrogen
  4033. 3.2. 2. Retinal Neuroprotection by hypoxic preconditioning is independent of hypoxia-inducible factor-1α expression in photoreceptors
  4034. Intracellular calcium concentration alteration during H202 induced primary cultured retinal neurons injury and 17β-Estradiol Neuroprotection
  4035. In Experimental Glaucoma Using Agonists or Antagonists of TrkA, TrkB, or TrkC Reveal Neuro-Glial Mechanisms of Action and Novel Approaches to Neuroprotection
  4036. Stress, adrenaline and CRH provide Neuroprotection in traumatic brain injury by enhancing the brain -to-blood glutamate driving force: 7AP5–7
  4037. The mechanism of Neuroprotection mediated by nicotinamide mononucleotide adenylyl transferase (NMNAT)
  4038. NR4A orphan nuclear receptors in immediate early regulation of retinoid signaling and Neuroprotection
  4039. Broccoli sprout supplementation during placental insufficiency confers structural and functional Neuroprotection to the fetal rat
  4040. Sulforaphane inhibits redox-regulated permeability transition and provides Neuroprotection following cardiac arrest
  4041. Neurodegeneration and Neuroprotection in glaucoma retinopathy-probing the role of endothelin-1, RAGE, A {221} and lycium barbarum
  4042. Neuroprotection of ischemic postconditioning on spinal cord ischemia reperfusion injury might be related to PI3K/AKT pathway in rabbit
  4043. Transient Lack of Glucose but Not Oxygen is Involved in Ischemic Postconditioning-Induced Neuroprotection in Mouse Corticostriatal Slices by Regulating Glutamate …
  4044. The changes of acid-sensing ion channel 1a in focal cerebral ischemic diabetes rats and Neuroprotection of fasudil
  4045. Gene expression profiles of sevoflurane and isoflurane in a rat model of focal cerebral ischemia: Preconditioning provide Neuroprotection by inhibition of apoptosis …
  4046. … of Poly (triethylene glycol methyl acrylate-co-α-tocopheryl acrylate): a Water Soluble Antioxidant Polymer Derivative to Enable Localized Neuroprotection
  4047. Olfactory ensheathing cells (OECs) transplantation in spinal cord prolongs the survival of mutant SOD1 (G93A) ALS rats through Neuroprotection and remyelination
  4048. Effects Of The Advanced Glycation End Products-Inductor Glyoxal On Mouse Retinal Explants And Neuroprotection By Memantine And Erythropoietin
  4049. Agrin C20 peptide provides Neuroprotection by activating a Na, K‐ATPase/Inositol 1, 4, 5‐Trisphosphate receptor signaling pathway
  4050. 193 The Rna-Binding Protein Rbm3 is Involved in Hypothermia Induced Neuroprotection
  4051. COX-2/PGI2 pathway is involved in Neuroprotection induced by N1-methylnicotinamide in hypoxia/ischemia of newborn rats
  4052. 8-OH DPAT-Mediated Neuroprotection in a mouse model of atrophic age-related macular degeneration
  4053. Morphological insight into new opportunities using Bcl-2 and P53 in studies of neurotrophicity, Neuroprotection and neuroplasticity in brain ischemia
  4054. Abstract# 2: Diffusion Tensor Imaging As a Neuroprotection Outcome Metric in Multiple Sclerosis: Clinical Trial Sample Size Estimates
  4055. Aroclor 1254 Disturbs Estrogen Receptor-mediated Neuroprotection Against Beta-amyloid Toxicity in Cholinergic SN56 Cells
  4056. Status of the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis in relation to growth failure, body weight and Neuroprotection in children with Ataxia …
  4057. FK506 Binding Protein 51 (FKBP51) Mediated Neuroprotection Against Glutamate Excitotoxicity in 661w and HT22 Cell Culture
  4058. Roles of reactive oxygen species and phosphatidyl-inositol 3-kinase-Akt in Neuroprotection against spinal cord ischemia-reperfusion injury by ischemic …
  4059. 194: MEMANTINE PROVIDES SUPERIOR MOLECULAR Neuroprotection COMPARED TO MK801 AFTER TRAUMATIC brain INJURY IN IMMATURE RATS
  4060. Sphingosine-1-Phosphate Has A Key Role In Müller Glia Proliferation, Migration And Neuroprotection
  4061. HIF-1 Neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors
  4062. Carcinine Has Antioxidant and 4-Hydroxynonenal Scavenging Properties Offering Strong Neuroprotection From Oxidative Damage in Mouse Retina
  4063. Interleukin-6-type cytokines in Neuroprotection and neuromodulation Moidunny, Shamsudheen; Dias, Raquel Baptista; Wesseling, Evelyn; Sekino, Yuko; …
  4064. Effects of chronic, systemic treatment with metabotropic glutamate receptor 5 antagonist on behavioral activity and Neuroprotection in a preclinical rat model of …
  4065. The Anti-NgR Blocking Protein, NgR (310) ecto-Fc, Has a Potential Role for Neuroprotection in an EVC Rat Model of Glaucoma
  4066. Hypoxic preconditioning by HIF‐1 accumulation not angiogenesis provides Neuroprotection in rats following MCAO
  4067. The roles of postsynaptic density-95 protein (PSD-95) and its interactor, cypin, in the regulation of microtubule organization, dendrite morphology, and Neuroprotection
  4068. Role of PPAR< img src=’/image/spc_char/gamma2. gif’border= 0>, a Nuclear Hormone Receptor in Neuroprotection
  4069. 18 Neuroprotection in Parkinson’s
  4070. 113 The Apoptotic Effect of Propofol in Immature Rat brain and Possible Neuroprotection by Erythropoietin
  4071. 247 Neuroprotection with Rhepo in Cyantoic Neonatal Mice
  4072. From the bench to the bedside: Emerging science in Parkinson’s disease, cholesterol metabolism, and Neuroprotection
  4073. Roles of angiotensin type 1 receptor signaling in Neuroprotection
  4074. 717. Broad Spectrum Activity of the HSV-2 Vector∆ RR Enhances Neuroprotection and Includes Crosstalk between Neurons and Glial Cells
  4075. Adenosine A^ sub 2^ A antagonists: Neuroprotection and autophagy induction by a new compound
  4076. Neuroprotection : lessons from hibernators
  4077. Neuroprotection for stroke: current status and future perspectives
  4078. Neuroprotection and repair in multiple sclerosis
  4079. Ischemic stroke and Neuroprotection
  4080. Novel mitochondrial targets for Neuroprotection
  4081. Neuroprotection for ischaemic stroke: translation from the bench to the bedside
  4082. An antagomir to microRNA Let7f promotes Neuroprotection in an ischemic stroke model
  4083. Neurometabolic mechanisms for memory enhancement and Neuroprotection of methylene blue
  4084. Neuroprotection in diabetic retinopathy
  4085. Effects of dimethyl fumarate on Neuroprotection and immunomodulation
  4086. Neuroprotection and estrogen receptors
  4087. Inhibition of Drp1 provides Neuroprotection in vitro and in vivo
  4088. Wine polyphenols: potential agents in Neuroprotection
  4089. Estrogen Neuroprotection and the critical period hypothesis
  4090. A review of Neuroprotection pharmacology and therapies in patients with acute traumatic brain injury
  4091. Microvascular protection is essential for successful Neuroprotection in stroke
  4092. Progesterone receptors: a key for Neuroprotection in experimental stroke
  4093. Hypoxic-ischemic encephalopathy and novel strategies for Neuroprotection
  4094. Nonhuman primate models of stroke for translational Neuroprotection research
  4095. Maximizing Neuroprotection : where do we stand?
  4096. Clinical trials for glaucoma Neuroprotection are not impossible
  4097. Neuroprotection from stroke in the absence of MHCI or PirB
  4098. Neuroprotection of apelin and its signaling pathway
  4099. Kynurenine pathway inhibition as a therapeutic strategy for Neuroprotection
  4100. Neuroprotection and its molecular mechanism following spinal cord injury
  4101. Translational Neuroprotection research in glaucoma: a review of definitions and principles
  4102. Erythropoietin for Neuroprotection in neonatal encephalopathy: safety and pharmacokinetics
  4103. Induction of autophagy contributes to the Neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia
  4104. Neural stem cell transplantation in central nervous system disorders: from cell replacement to Neuroprotection
  4105. Neuroprotection by GDNF in the ischemic brain
  4106. Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease
  4107. Lipopolysaccharide-induced microglial activation and Neuroprotection against experimental brain injury is independent of hematogenous TLR4
  4108. Enteric glia and Neuroprotection : basic and clinical aspects
  4109. Resveratrol Neuroprotection in a chronic mouse model of multiple sclerosis
  4110. Blood glutamate scavenging: insight into Neuroprotection
  4111. Expression patterns of histone deacetylases in experimental stroke and potential targets for Neuroprotection
  4112. Phytochemical characteristics, free radical scavenging activities, and Neuroprotection of five medicinal plant extracts
  4113. Transplantation of human central nervous system stem cells–Neuroprotection in retinal degeneration
  4114. Oestrogen signalling and Neuroprotection in cerebral ischaemia
  4115. Neuroprotection in vascular dementia: a future path
  4116. Neuroprotection in metabolism-based therapy
  4117. Gene therapy for retinal ganglion cell Neuroprotection in glaucoma
  4118. Multifaces of neuropeptide Y in the brain –Neuroprotection , neurogenesis and neuroinflammation
  4119. Minocycline-preconditioned neural stem cells enhance Neuroprotection after ischemic stroke in rats
  4120. Nanowired drug delivery to enhance Neuroprotection in spinal cord injury
  4121. Sirt1 mediates Neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway
  4122. Roles of amyloid precursor protein family members in Neuroprotection , stress signaling and aging
  4123. Cytochrome c Oxidase and Its Role in Neurodegeneration and Neuroprotection
  4124. Role of mTOR in Neuroprotection and axon regeneration after inflammatory stimulation
  4125. Silencing of miR20a is crucial for Ngn1-mediated Neuroprotection in injured spinal cord
  4126. Erythropoietin: still on the Neuroprotection road
  4127. Translational potential of preclinical trials of Neuroprotection through pharmacotherapy for spinal cord injury
  4128. Sex differences in mechanisms and outcome of neonatal hypoxia-ischemia in rodent models: implications for sex-specific Neuroprotection in clinical neonatal …
  4129. Inhibition of autophagy contributes to ischemic postconditioning-induced Neuroprotection against focal cerebral ischemia in rats
  4130. Glycyrrhizic acid affords robust Neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion
  4131. Different magnesium sulphate regimens for Neuroprotection of the fetus for women at risk of preterm birth
  4132. Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson’s disease
  4133. Monoamine oxidase inhibitors and Neuroprotection : a review
  4134. Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke
  4135. Ex vivo and in vivo Neuroprotection induced by argon when given after an excitotoxic or ischemic insult
  4136. The soluble isoform of CX3CL1 is necessary for Neuroprotection in a mouse model of Parkinson’s disease
  4137. Carvacrol, a food-additive, provides Neuroprotection on focal cerebral ischemia/reperfusion injury in mice
  4138. Seizure suppression and Neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice
  4139. Metabotropic glutamate receptors in neurodegeneration/Neuroprotection : still a hot topic?
  4140. Neuroglobin, a novel target for endogenous Neuroprotection against stroke and neurodegenerative disorders
  4141. Autophagy activation is associated with Neuroprotection against apoptosis via a mitochondrial pathway in a rat model of subarachnoid hemorrhage
  4142. Neuroprotection against iron-induced cell death by perineuronal nets-an in vivo analysis of oxidative stress
  4143. New strategies in Neuroprotection and neurorepair
  4144. Taurine provides Neuroprotection against retinal ganglion cell degeneration
  4145. Overexpression of CXCR4 in mesenchymal stem cells promotes migration, Neuroprotection and angiogenesis in a rat model of stroke
  4146. N-Acetylserotonin: Neuroprotection , Neurogenesis, and the Sleepy brain
  4147. Antenatal magnesium sulfate and Neuroprotection
  4148. Neuroprotection by urate on 6‐OHDA‐lesioned rat model of Parkinson’s disease: linking to Akt/GSK 3β signaling pathway
  4149. The metastasis-promoting S100A4 protein confers Neuroprotection in brain injury
  4150. Functional analysis of VPS41-mediated Neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson’s disease
  4151. Targeting mitochondria for Neuroprotection in Parkinson’s disease
  4152. Human neuroglobin functions as an oxidative stress-responsive sensor for Neuroprotection
  4153. Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust Neuroprotection in the postischemic brain
  4154. An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes Neuroprotection and glial engulfment of Aβ
  4155. Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons
  4156. Xenon Neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage
  4157. Immunopathogenesis of neurodegenerative diseases: current therapeutic models of Neuroprotection with special reference to natural products.
  4158. A natural coumarin derivative esculetin offers Neuroprotection on cerebral ischemia/reperfusion injury in mice
  4159. Manipulating kynurenic acid levels in the brain –on the edge between Neuroprotection and cognitive dysfunction
  4160. ATP-dependent potassium channel blockade strengthens microglial Neuroprotection after hypoxia–ischemia in rats
  4161. Human embryonic stem cell derived astrocytes mediate non-cell-autonomous Neuroprotection through endogenous and drug-induced mechanisms
  4162. A Spirulina-Enhanced diet provides Neuroprotection in an α-synuclein model of Parkinson’s disease
  4163. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson’s disease
  4164. Strong Neuroprotection with a novel platinum nanoparticle against ischemic stroke-and tissue plasminogen activator-related brain damages in mice
  4165. New agents promote Neuroprotection in Parkinson’s disease models
  4166. Therapeutic effect of mesenchymal stem cells in rats with intracerebral hemorrhage: reduced apoptosis and enhanced Neuroprotection
  4167. Non-analgesic effects of opioids: Neuroprotection in the retina
  4168. Phosphorylation of HSP27 by protein kinase D is essential for mediating Neuroprotection against ischemic neuronal injury
  4169. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury
  4170. brain ‐derived neurotrophic factor‐mediated effects on mitochondrial respiratory coupling and Neuroprotection share the same molecular signalling pathways
  4171. Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats
  4172. α7 nicotinic acetylcholine receptor-mediated Neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation
  4173. Neuroprotection provided by dietary restriction in rats is further enhanced by reducing glucocortocoids
  4174. Nanowired drug delivery for Neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and …
  4175. … abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer’s disease: implications for Neuroprotection and lifespan extension
  4176. Mitochondrial biogenesis contributes to ischemic Neuroprotection afforded by LPS pre‐conditioning
  4177. Treatment of alloxan-induced diabetic rats with metformin or glitazones is associated with amelioration of hyperglycaemia and Neuroprotection
  4178. … expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted Neuroprotection against hippocampal neurone cell …
  4179. Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB …
  4180. Cerebrolysin, a mixture of neurotrophic factors induces marked Neuroprotection in spinal cord injury following intoxication of engineered nanoparticles from metals
  4181. Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson’s disease
  4182. α7 nicotinic acetylcholine receptor mediated Neuroprotection in Parkinson’s disease
  4183. Acetyl‐L‐carnitine‐mediated Neuroprotection during hypoxia is attributed to ERK1/2‐Nrf2‐regulated mitochondrial biosynthesis
  4184. Multimodal Neuroprotection induced by PACAP38 in oxygen–glucose deprivation and middle cerebral artery occlusion stroke models
  4185. Curcumin-mediated Neuroprotection against amyloid-β-induced mitochondrial dysfunction involves the inhibition of GSK-3β
  4186. New evidence of Neuroprotection by lactate after transient focal cerebral ischaemia: extended benefit after intracerebroventricular injection and efficacy of intravenous …
  4187. Interrelation between inflammation, thrombosis, and Neuroprotection in cerebral ischemia
  4188. Neurotrophin production in brain pericytes during hypoxia: a role of pericytes for Neuroprotection
  4189. Sevoflurane and isoflurane preconditioning provides Neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia
  4190. B‐vitamins for Neuroprotection : Narrowing the evidence gap
  4191. Ischemic Neuroprotection by TRPV1 receptor-induced hypothermia
  4192. Quercetin in hypoxia-induced oxidative stress: novel target for Neuroprotection
  4193. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for Neuroprotection
  4194. α7 nicotinic acetylcholine receptor agonism confers Neuroprotection through GSK-3β inhibition in a mouse model of intracerebral hemorrhage
  4195. Role of secondary mediators in caffeine-mediated Neuroprotection in maneb-and paraquat-induced Parkinson’s disease phenotype in the mouse
  4196. Ginkgo extract EGb761 confers Neuroprotection by reduction of glutamate release in ischemic brain
  4197. CR8, a selective and potent CDK inhibitor, provides Neuroprotection in experimental traumatic brain injury
  4198. Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria-dependent apoptosis pathways and reactive oxygen induced-NF-κB activation in a …
  4199. Neuroprotection by Manganese Superoxide Dismutase (M n SOD) Mimics: Antioxidant Effect and Oxidative Stress Regulation in Acute Experimental Stroke
  4200. Estrogen, Neuroprotection and neurogenesis after ischemic stroke
  4201. Neuroprotection and hypothermia in infants and children
  4202. Preconditioning induces sustained Neuroprotection by downregulation of adenosine 5′-monophosphate-activated protein kinase
  4203. Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive Neuroprotection in experimental traumatic brain injury
  4204. Valproic acid-mediated Neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation
  4205. Allosteric modulation of the group III mGlu4 receptor provides functional Neuroprotection in the 6‐hydroxydopamine rat model of Parkinson’s disease
  4206. Neuroprotection by urokinase plasminogen activator in the hippocampus
  4207. AKT/GSK 3β‐Dependent Autophagy Contributes to the Neuroprotection of Limb Remote Ischemic Postconditioning in the Transient Cerebral Ischemic Rat Model
  4208. AIF depletion provides Neuroprotection through a preconditioning effect
  4209. Complement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory Neuroprotection following reperfused stroke
  4210. Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated Neuroprotection
  4211. Increased neuronal glutathione and Neuroprotection in GTRAP3-18-deficient mice
  4212. The Neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive …
  4213. Curcumin has Neuroprotection effect on homocysteine rat model of Parkinson
  4214. The mitochondrial calcium regulator cyclophilin D is an essential component of oestrogen-mediated Neuroprotection in amyotrophic lateral sclerosis
  4215. Challenging the Role of Adaptive Immunity in Neurotrauma: Rag1−/− Mice Lacking Mature B and T Cells Do Not Show Neuroprotection after Closed Head Injury
  4216. Functional and molecular evidence of myelin‐and Neuroprotection by thyroid hormone administration in experimental allergic encephalomyelitis
  4217. Modulation of microglial activation enhances Neuroprotection and functional recovery derived from bone marrow mononuclear cell transplantation after cortical …
  4218. Riluzole Neuroprotection in a Parkinson’s disease model involves suppression of reactive astrocytosis but not GLT-1 regulation
  4219. Health benefits of wine and alcohol from Neuroprotection to heart health.
  4220. Neuroprotection of VEGF-expression neural stem cells in neonatal cerebral palsy rats
  4221. Role of magnesium sulfate in Neuroprotection in acute ischemic stroke
  4222. Mechanisms of neuronal damage and Neuroprotection underlying ischemia/reperfusion injury after physical exercise
  4223. The Neuroprotection effect of pretreatment with olive leaf extract on brain lipidomics in rat stroke model
  4224. Dopaminergic Neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system
  4225. Coordination between proteasome impairment and caspase activation leading to TAU pathology: Neuroprotection by cAMP
  4226. Cyclin D1 gene ablation confers Neuroprotection in traumatic brain injury
  4227. Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: potential Neuroprotection and limitations
  4228. A priming role of local estrogen on exogenous estrogen-mediated synaptic plasticity and Neuroprotection
  4229. Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood–brain barrier …
  4230. A derivative of the CRMP2 binding compound lanthionine ketimine provides Neuroprotection in a mouse model of cerebral ischemia
  4231. Direct protection of neurons and astrocytes by matrine via inhibition of the NF-κB signaling pathway contributes to Neuroprotection against focal cerebral ischemia
  4232. Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson’s model: A promising candidate for the treatment of Parkinson’s …
  4233. Specific inhibition of the JNK pathway promotes locomotor recovery and Neuroprotection after mouse spinal cord injury
  4234. Feasibility of implementing magnesium sulphate for Neuroprotection in a tertiary obstetric unit
  4235. Muscone exerts Neuroprotection in an experimental model of stroke via inhibition of the fas pathway
  4236. TMP prevents retinal neovascularization and imparts Neuroprotection in an oxygen-induced retinopathy model
  4237. Interrupted intracarotid artery cold saline infusion as an alternative method for Neuroprotection after ischemic stroke
  4238. Galantamine elicits Neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation
  4239. Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock
  4240. Overexpression of CB2 cannabinoid receptors results in Neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of …
  4241. Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers Neuroprotection after spinal cord injury in vivo
  4242. Neuroprotection of the leaf and stem of Vitis amurensis and their active compounds against ischemic brain damage in rats and excitotoxicity in cultured neurons
  4243. Neuronal growth-promoting and inhibitory cues in Neuroprotection and neuroregeneration
  4244. Neuroprotection from tissue inhibitor of metalloproteinase-1 and its nanoparticles
  4245. Neuroprotection of lipoic acid treatment promotes angiogenesis and reduces the glial scar formation after brain injury
  4246. Pizotifen activates ERK and provides Neuroprotection in vitro and in vivo in models of Huntington’s disease
  4247. Blocking of connexin-mediated communication promotes Neuroprotection during acute degeneration induced by mechanical trauma
  4248. Prospective, multicenter European study of the GORE flow reversal system for providing Neuroprotection during carotid artery stenting
  4249. Activation of Akt/FoxO and inactivation of MEK/ERK pathways contribute to induction of Neuroprotection against transient global cerebral ischemia by delayed hypoxic …
  4250. Evaluation of sirtuin role in Neuroprotection of retinal ganglion cells in hypoxia
  4251. Therapeutic hypothermia after cardiac arrest in adults: mechanism of Neuroprotection , phases of hypothermia, and methods of cooling
  4252. … utilization of lactate satisfy increased energy demands upon neuronal activation in hippocampal slices and provide Neuroprotection against oxidative stress
  4253. Intranasal delivery of HMGB1-binding heptamer peptide confers a robust Neuroprotection in the postischemic brain
  4254. Combination treatment of hypothermia and mesenchymal stromal cells amplifies Neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like …
  4255. Long‐lasting Neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly (ADP‐ribose) polymerase
  4256. Dietary therapy to promote Neuroprotection in chronic spinal cord injury
  4257. Neurogenic Neuroprotection : clinical perspectives
  4258. Striatal pleiotrophin overexpression provides functional and morphological Neuroprotection in the 6-hydroxydopamine model
  4259. Combined treatment with capsaicin and resveratrol enhances Neuroprotection against glutamate-induced toxicity in mouse cerebral cortical neurons
  4260. Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy
  4261. Glaucoma 2.0: Neuroprotection , neuroregeneration, neuroenhancement
  4262. Gene expression analysis to identify molecular correlates of pre-and post-conditioning derived Neuroprotection
  4263. Neuroprotection and neurodegeneration in Alzheimer’s disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention …
  4264. Toll-like receptor 7 preconditioning induces robust Neuroprotection against stroke by a novel type I interferon-mediated mechanism
  4265. Pegylated granulocyte colony-stimulating factor conveys long-term Neuroprotection and improves functional outcome in a model of Parkinson’s disease
  4266. Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke
  4267. Sevoflurane-induced delayed Neuroprotection involves mitoKATP channel opening and PKC ε activation
  4268. Delayed Neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation
  4269. Neuroprotection or increased brain damage mediated by temperature in stroke is time dependent
  4270. The omega‐6 fatty acid derivative 15‐deoxy‐Δ12,14‐prostaglandin J2 is involved in Neuroprotection by enteric glial cells against oxidative stress
  4271. Swim training attenuates oxidative damage and promotes Neuroprotection in cerebral cortical slices submitted to oxygen glucose deprivation
  4272. Vascular Neuroprotection via TrkB‐and Akt‐dependent cell survival signaling
  4273. Edaravone offers Neuroprotection in a diabetic stroke model via inhibition of endoplasmic reticulum stress
  4274. Alzheimer’s disease, Neuroprotection , and CNS immunosenescence
  4275. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to Neuroprotection
  4276. Inhibition of neuron-specific CREB dephosphorylation is involved in propofol and ketamine-induced Neuroprotection against cerebral ischemic injuries of mice
  4277. 6-Shogaol, a ginger product, modulates neuroinflammation: a new approach to Neuroprotection
  4278. Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin‐releasing factor (CRF) in glutamate injured cortical neurons
  4279. Neuroprotection of neurotrophin-3 against focal cerebral ischemia/reperfusion injury is regulated by hypoxia-responsive element in rats
  4280. Neuroprotection by hypoxic preconditioning involves upregulation of hypoxia‐inducible factor‐1 in a prenatal model of acute hypoxia
  4281. Neuroprotection by lowering cholesterol: a decrease in membrane cholesterol content reduces transporter-mediated glutamate release from brain nerve …
  4282. Upregulation of heme oxygenase-1 by acteoside through ERK and PI3 K/Akt pathway confer Neuroprotection against beta-amyloid-induced neurotoxicity
  4283. Potential role of glucagon-like peptide-1 (GLP-1) in Neuroprotection
  4284. Co-administration of apocynin with lipoic acid enhances Neuroprotection in a rat model of ischemia/reperfusion
  4285. Controlled release of rasagiline mesylate promotes Neuroprotection in a rotenone-induced advanced model of Parkinson’s disease
  4286. … ) mouse model of Parkinson’s disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for Neuroprotection …
  4287. Neuroprotection in glaucoma
  4288. Glutathione-mediated Neuroprotection against methylmercury neurotoxicity in cortical culture is dependent on MRP1
  4289. Estrogen receptors in lipid raft signalling complexes for Neuroprotection
  4290. The complexity of sporadic Alzheimer’s disease pathogenesis: the role of RAGE as therapeutic target to promote Neuroprotection by inhibiting neurovascular …
  4291. The role of the DNA damage response kinase ataxia telangiectasia mutated in Neuroprotection
  4292. The effects of hemodialysis on blood glutamate levels in chronic renal failure: implementation for Neuroprotection
  4293. Pro-cellular survival and Neuroprotection of citrus flavonoid: the actions of hesperetin in PC12 cells
  4294. Neuroprotection of co-activation of GABA receptors by preventing caspase-3 denitrosylation in KA-induced seizures
  4295. Neuroprotection in Parkinson’s disease: a systematic review of the preclinical data
  4296. Specific conditions for resveratrol Neuroprotection against ethanol-induced toxicity
  4297. Mitochondrial inhibition in rat retinal cell cultures as a model of metabolic compromise: mechanisms of injury and Neuroprotection
  4298. Preconditioning with Ginkgo biloba (EGb 761®) provides Neuroprotection through HO1 and CRMP2
  4299. Methylene blue administration fails to confer Neuroprotection in two amyotrophic lateral sclerosis mouse models
  4300. Neuroprotection of Ilex latifolia and caffeoylquinic acid derivatives against excitotoxic and hypoxic damage of cultured rat cortical neurons
  4301. Caffeic acid ester fraction from Erigeron breviscapus inhibits microglial activation and provides Neuroprotection
  4302. Platelet-derived growth factor CC-mediated Neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta
  4303. Rapid conditioning with oxygen oscillation: Neuroprotection by intermittent normobaric hyperoxia after transient focal cerebral ischemia in rats
  4304. Anti-amnesic effect of neurosteroid PREGS in Aβ25–35-injected mice through σ1 receptor-and α7nAChR-mediated Neuroprotection
  4305. Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for Neuroprotection
  4306. Nanowired drug delivery of antioxidant compound H-290/51 enhances Neuroprotection in hyperthermia-induced neurotoxicity
  4307. Role of the pituitary–adrenal axis in granulocyte-colony stimulating factor-induced Neuroprotection against hypoxia–ischemia in neonatal rats
  4308. Kinin-B2 receptor mediated Neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonists
  4309. Association of Neuroprotection and Oxidative Stress Gene Polymorphism With Neurodevelopmental Outcomes After Preterm Birth
  4310. Nonadditive Neuroprotection with early glutamate receptor blockade and delayed hypothermia after asphyxia in preterm fetal sheep
  4311. State of the art in Neuroprotection during acute type A aortic dissection repair
  4312. Neuroprotection by nicotine against colchicine-induced apoptosis is mediated by PI3-kinase–Akt pathways
  4313. Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice
  4314. G-protein coupled estrogen receptor 1 mediated estrogenic Neuroprotection against spinal cord injury
  4315. SHPS‐1 deficiency induces robust Neuroprotection against experimental stroke by attenuating oxidative stress
  4316. TLR9 bone marrow chimeric mice define a role for cerebral TNF in Neuroprotection induced by CpG preconditioning
  4317. Rodent spinal cord injury model and application of neurotrophic factors for Neuroprotection
  4318. Glycosaminoglycans and Neuroprotection
  4319. Resveratrol potentiates cytochrome P450 2 d22-mediated Neuroprotection in maneb-and paraquat-induced parkinsonism in the mouse
  4320. Oroxylin A induces BDNF expression on cortical neurons through adenosine A2A receptor stimulation: a possible role in Neuroprotection
  4321. Neurodegeneration and Neuroprotection in multiple sclerosis
  4322. Role of electrical activity of neurons for Neuroprotection
  4323. … -activated protein kinase–induced nuclear factor kappa-light-chain-enhancer of activated B cell activity is required for Neuroprotection in retinal ischemia …
  4324. Cerebral aneurysm as an exacerbating factor in stroke pathology and a therapeutic target for Neuroprotection
  4325. HDAC 6 at the Intersection of Neuroprotection and Neurodegeneration
  4326. The multimodal strategy for the Neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL
  4327. Molecular and Cellular Biology of Neuroprotection in the CNS
  4328. Mechanisms of Neuroprotection underlying physical exercise in ischemia-reperfusion injury
  4329. Neuroglobin upregulation offers Neuroprotection in traumatic brain injury
  4330. Neuroprotection and sex steroid hormones: evidence of estradiol-mediated protection in hypertensive encephalopathy
  4331. Endogenous neural precursors influence grafted neural stem cells and contribute to Neuroprotection in the parkinsonian rat
  4332. Negative modulation of NMDA receptor channel function by DREAM/calsenilin/KChIP3 provides Neuroprotection ?
  4333. Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated Neuroprotection against 1-methyl-4-phenyl pyridinium-induced …
  4334. The C-terminal domain of the heavy chain of tetanus toxin given by intramuscular injection causes Neuroprotection and improves the motor behavior in rats treated …
  4335. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and Neuroprotection by gene delivery of antioxidant enzymes
  4336. Time course of Neuroprotection induced by normobaric hyperoxia in focal cerebral ischemia
  4337. Valproic acid Neuroprotection in 6-OHDA lesioned rat, a model for parkinson’s disease
  4338. Plate reader-based assays for measuring cell viability, Neuroprotection and calcium in primary neuronal cultures
  4339. A ketogenic diet may offer Neuroprotection in glaucoma and mitochondrial diseases of the optic nerve
  4340. Neuroprotection by NMDA preconditioning against glutamate cytotoxicity is mediated through activation of ERK 1/2, inactivation of JNK, and by prevention of …
  4341. Nanoerythropoietin is 10-times more effective than regular erythropoietin in Neuroprotection in a neonatal rat model of hypoxia and ischemia
  4342. Piperphentonamine (PPTA) attenuated cerebral ischemia-induced memory deficits via Neuroprotection associated with anti-apoptotic activity
  4343. Angiotensin II type 2 receptor stimulation initiated after stroke causes Neuroprotection in conscious rats
  4344. Time dependent Neuroprotection of mycophenolate mofetil: effects on temporal dynamics in glial proliferation, apoptosis, and scar formation
  4345. Lymphocyte cell kinase activation mediates Neuroprotection during ischemic preconditioning
  4346. NAD+-converting enzymes in neuronal and glial cells: CD38 as a novel target for Neuroprotection
  4347. Co-regulation of survival of motor neuron and Bcl-xL expression: implications for Neuroprotection in spinal muscular atrophy
  4348. Renin inhibitor aliskiren exerts Neuroprotection against amyloid beta-peptide toxicity in rat cortical neurons
  4349. CD4+ T cell-mediated Neuroprotection is independent of T cell-derived BDNF in a mouse facial nerve axotomy model
  4350. Cyclin‐Dependent Kinase Inhibition With Roscovitine: Neuroprotection in Acute Ischemic Stroke
  4351. Contribution of microRNA-203 to the isoflurane preconditioning-induced Neuroprotection
  4352. Long-term behavioral and biochemical effects of an ultra-low dose of Δ 9-tetrahydrocannabinol (THC): Neuroprotection and ERK signaling
  4353. Neuroprotection of green tea catechins on surgical menopause-induced overactive bladder in a rat model
  4354. Endothelin B receptor agonist, IRL-1620, provides long-term Neuroprotection in cerebral ischemia in rats
  4355. Pre, intra and post-ischemic hypothermic Neuroprotection in temporary focal cerebral ischemia in rats: morphometric analysis
  4356. Neuroprotection for premature infants?: another perspective on caffeine
  4357. Sigma-1 receptor agonists provide Neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures
  4358. Transcriptional regulation of specific protein 1 (SP1) by hypoxia-inducible factor 1 alpha (HIF-1α) leads to PRNP expression and Neuroprotection from toxic prion …
  4359. An in-silico strategy to explore Neuroprotection by quercetin in cerebral ischemia: a novel hypothesis based on inhibition of matrix metalloproteinase (MMPs) and acid …
  4360. New perspectives of central nervous system injury and Neuroprotection
  4361. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting Neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia
  4362. Is cerebrospinal fluid drainage of benefit to Neuroprotection in patients undergoing surgery on the descending thoracic aorta or thoracoabdominal aorta?
  4363. C5a receptor (CD88) inhibition improves hypothermia-induced Neuroprotection in an in vitro ischemic model
  4364. Neuroprotection of desferrioxamine in lipopolysaccharide-induced nigrostriatal dopamine neuron degeneration
  4365. Chiral mercaptoacetamides display enantioselective inhibition of histone deacetylase 6 and exhibit Neuroprotection in cortical neuron models of oxidative stress
  4366. Benzothiazepine CGP37157 and its isosteric 2′-methyl analogue provide Neuroprotection and block cell calcium entry
  4367. Post‐ischemic vascular adhesion protein‐1 inhibition provides Neuroprotection in a rat temporary middle cerebral artery occlusion model
  4368. Tau and caspase 3 as targets for Neuroprotection
  4369. Comprehensive strategy for retinal Neuroprotection . Challenging the clinical application
  4370. Neuropeptides in Neuroprotection and neuroregeneration
  4371. Cerebroside-A provides potent Neuroprotection after cerebral ischaemia through reducing glutamate release and Ca2+ influx of NMDA receptors
  4372. Novel route to Neuroprotection
  4373. Changes in the hemostasis system and free-radical lipid oxidation in the acute stage of ischemic stroke in patients on Neuroprotection treatment
  4374. Pharmacological enhancement of ex vivo gene therapy Neuroprotection in a rodent model of retinal degeneration
  4375. Neuroprotection in epilepsy
  4376. Supra-additive Neuroprotection by renexin, a mixed compound of ginkgo biloba extract and cilostazol, against apoptotic white matter changes in rat after chronic …
  4377. Early antioxidant treatment and delayed hypothermia after hypoxia-ischemia have no additive Neuroprotection in newborn pigs
  4378. Selective cerebral perfusion using moderate flow in complex cardiac surgery provides sufficient Neuroprotection . Are children young adults?
  4379. Toll-like receptor 4 signaling is involved in PACAP-induced Neuroprotection in BV2 microglial cells under OGD/reoxygenation
  4380. Neuroprotection by mefenamic acid against d-serine: Involvement of oxidative stress, inflammation and apoptosis
  4381. Neuroprotection supports signal processing in the hippocampus of Syrian hamsters, a facultative hibernator
  4382. A novel mechanism for sevoflurane preconditioning-induced Neuroprotection
  4383. Selective regulation of NR2B by protein phosphatase-1 for the control of the NMDA receptor in Neuroprotection
  4384. UPEI-100, a conjugate of lipoic acid and apocynin, mediates Neuroprotection in a rat model of ischemia/reperfusion
  4385. Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived …
  4386. Mesenchymal stromal cell Neuroprotection of hydrogen peroxide-challenged pheochromocytoma cells through reducing apoptosis and releasing cytokines
  4387. Flurbiprofen axetil promotes Neuroprotection by activation of cerebral peroxisome proliferator-activated receptor gamma after focal cerebral ischemia in rats
  4388. Hypoxic preconditioning induces an AT2-R/VEGFR-2 (Flk-1) interaction in the neonatal brain microvasculature for Neuroprotection
  4389. Small molecule anticonvulsant agents with potent in vitro Neuroprotection
  4390. Recent approaches towards selected lamiaceae plants for their prospective use in Neuroprotection
  4391. Modes of action of taurine and granulocyte colony-stimulating factor in Neuroprotection
  4392. Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to Neuroprotection in the peri …
  4393. Myelin repair and Neuroprotection in multiple sclerosis
  4394. A new alternative NF-ΚB Pathway mediated the Neuroprotection of GDNF on 6-OHDA-induced DA neurons neurotoxicity
  4395. Editorial Comment: Re: Selective cerebral perfusion using moderate flow in complex cardiac surgery provides sufficient Neuroprotection . Are children young adults?
  4396. Relationship between glutamate, GOT and GPT levels in maternal and fetal blood: a potential mechanism for fetal Neuroprotection
  4397. SNP-mediated Neuroprotection under glucose deprivation is enhanced by hypericum perforatum
  4398. The critical role of adrenomedullin and its binding protein, AMBP-1, in Neuroprotection
  4399. In vitro neurotoxic Fe (III) and Fe (III)-chelator activities in rat hippocampal cultures. From neurotoxicity to Neuroprotection prospects
  4400. Neuroprotection in animal models of global cerebral ischemia
  4401. Neurogenic Neuroprotection : Future perspectives
  4402. Window of Opportunity for Neuroprotection with an Antioxidant, A llene O xide S ynthase, after Hypoxia–Ischemia in Adult Male Rats
  4403. Galectin-1 for Neuroprotection ?
  4404. Urinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for Neuroprotection in preterm neonates
  4405. Neuroprotection on multiple sclerosis: A BDNF perspective
  4406. Involvement of molecular chaperones and the transcription factor Nrf2 in Neuroprotection mediated by para-substituted-4, 5-diaryl-3-thiomethyl-1, 2, 4-triazines
  4407. Effect of 710-nm visible light irradiation on Neuroprotection and immune function after stroke
  4408. Neuroprotection of n-Butanol Extract from Roots of Potentilla anserina on Hypoxic Injury in Primary Hippocampal Neurons
  4409. Neuroprotection and pain management
  4410. Intraoperative hypoxic preconditioning as a method of Neuroprotection in operations on internal carotid arteries
  4411. Time-window of progesterone Neuroprotection after stroke and its underlying molecular mechanisms
  4412. Selenium and selenoproteins in Neuroprotection and neuronal cell death
  4413. Neuroprotection and neurodegeneration in submucosal VIP-IR neurons in the jejunum of ascorbic acid supplemented aging Wistar rats
  4414. Neuroprotection in steroid therapy: a rodent model
  4415. Pharmacological Neuroprotection in blinding eye diseases
  4416. Involvement of K ATP/PI 3 K/AKT/Bcl-2 pathway in hydrogen sulfide-induced Neuroprotection against the toxicity of 1-methy-4-phenylpyridinium ion
  4417. The six gaps in the search of Neuroprotection for Parkinson’s disease
  4418. Neuroprotection of GluK1 kainate receptor agonist ATPA against ischemic neuronal injury through inhibiting GluK2 kainate receptor–JNK3 pathway via GABAA …
  4419. Different Neuroprotection and therapeutic time windows by two specific diazepam regimens on retinal ganglion cells after optic nerve transection in adult rats
  4420. Neuroprotection for patients with stroke moves one step closer to the clinic
  4421. Neuroprotection and Neuroregeneration in Alzheimer’s Disease
  4422. Molecular and cellular preconditiong-powerful strategies for Neuroprotection
  4423. Reviving Neuroprotection using a new approach: targeting postsynaptic density-95 to arrest glutamate excitotoxicity
  4424. Early indicators early treatments Neuroprotection in multiple sclerosis
  4425. Conference Report (8th Annual Meeting of the Society for the Study of Neuroprotection and Neuroplasticity)
  4426. High-dose albumin for Neuroprotection in acute ischemic stroke: from basic investigations to multicenter clinical trial
  4427. β-Carbolines and Neuroprotection : Inhibition of Monoamine Oxidase
  4428. Magnesium and Neuroprotection in subarachnoid haemorrhage
  4429. Neuroprotection by dietary restriction and the PPAR transcription complex
  4430. Neurabin: a key factor in the specific Neuroprotection mediated by Adenosine
  4431. The use of hypothermia to provide Neuroprotection for neonatal hypoxic-ischemic brain injury
  4432. … of human neuroblastoma cells with Alzheimer’s disease brain hallmarks as a promising strategy to investigate the role of Neurosteroidogenesis in Neuroprotection
  4433. Multitarget drugs for stabilization of calcium cycling and Neuroprotection in neurodegenerative diseases and stroke
  4434. Neuroprotection Against Oxidative Injury by a Nucleic Acid–Based Health Product (Squina DNA) Through Enhancing Mitochondrial Antioxidant Status and Functional …
  4435. Magnesium and Neuroprotection in stroke
  4436. Neuroprotection induced by paeoniflorin against cerebral ischemia through mediating muscarinic receptor signaling pathway
  4437. Estrogen-mediated Neuroprotection : hope to combat neuronal degeneration and synaptic plasticity post-menopause
  4438. The role of davunetide in Neuroprotection and microtubule stabilization
  4439. Wine polyphenols: potential agents in Neuroprotection
  4440. Neuroprotection and functional restoration in an animal model of multiple sclerosis
  4441. Exercise-induced Neuroprotection in a hemiparkinsonian 6-hydroxydopamine rat model
  4442. Neuroglobin: a novel target for endogenous Neuroprotection
  4443. Retinal Ischemia in Relation to Glaucoma and Neuroprotection
  4444. Antioxidants and Neuroprotection
  4445. Mechanisms of Neuroprotection in SCN2. 2 Cells
  4446. Editorial [Hot Topic: New Mechanisms of Neuronal Injury and Neuroprotection (Guest Editor: Weihai Ying)]
  4447. Neuroprotection provided by dietary restriction in rats is further enhanced by reducing glucocortocoids
  4448. Neuroprotection in Stroke
  4449. Immune cell-mediated Neuroprotection is independent of estrogen action through estrogen receptor-alpha
  4450. Neuroprotection of sulfuretin is mediated by inhibition of microglial inflammatory activation in BV‐2 cells
  4451. Gene therapy approaches to evaluate Neuroprotection from oxidation stress in experimental models of amyotrophic lateral sclerosis
  4452. Cone photoreceptor Neuroprotection in inherited retinal degenerations
  4453. Ceftriaxone-induced Neuroprotection in glutamate excitotoxicity: one more reason to treat bacterial meningitis with it?
  4454. Granulocyte-stimulating colony factor Neuroprotection for thoracic myelopathy
  4455. Neuroprotection of extract of Ginkgo biloba on the focal cerebral ischemia-reperfusion injury of rats
  4456. A study of neurodegeneration and Neuroprotection in Nothobranchius guentheri
  4457. Enteric Neuroprotection
  4458. Mechanism of Neuroprotection in stroke-related models
  4459. Microglia-conditioned medium promotes locomotor recovery and Neuroprotection after rat spinal cord injury
  4460. Neuroprotection in Parkinson’s
  4461. Neuroprotection and Neuroregeneration in Alzheimer’s Disease
  4462. Effects of ulinastatin on delayed cerebral vasospasm following subarachnoid hemorrahage in rats and its Neuroprotection [J]
  4463. Cellular basis of neurodegeneration-The possible role of ryanodine receptor and potassium channel in neuronal death and Neuroprotection
  4464. Neuroprotection in ischaemic stroke
  4465. Neonatal Neuroprotection : cooling outside trial criteria
  4466. Provides Long-Term Neuroprotection in Rodents
  4467. High dose intravenous melatonin for augmentation of hypothermic Neuroprotection leads to hypotension
  4468. The role of Neuroprotection in complex rehabilitation of patients with ischemic stroke
  4469. Neuroprotection by Erythropoietin
  4470. Vascular Protection Mediates Neuroprotection : Role of VEGF-A and B
  4471. Temperature Management and Hypothermic Neuroprotection
  4472. Searhing for phytochemicals involved in ageing intervention and Neuroprotection
  4473. Ex Vivo and In Vivo Neuroprotection Induced by Argon When Given after an
  4474. Resveratrol+ ethanol preconditioning and Neuroprotection
  4475. Pharmacological Neuroprotection in Severe Traumatic brain Injury
  4476. MECANISMES D’ACTION IMPLIQUANT LES RÉCEPTEURS OESTROGÉNIQUES DANS LA Neuroprotection CHEZ LA SOURIS MPTP
  4477. Neuroprotection In Chronic brain Ischemia: Clinical And Immunological Features
  4478. Exercise and Neuroprotection in an animal model of multiple sclerosis
  4479. Neuroprotection and autoimmunity in glaucoma
  4480. Routine application of Neuroprotection in surgery of intracranial aneurysms
  4481. Frontiers in Clinical Neuroscience: Neurodegeneration and Neuroprotection A Symposium in Abel Lajtha’s Honour
  4482. CSSI workshop in Brazil highlights “Stress Responses in the Nervous System” in relation to neurodegenerative diseases and Neuroprotection
  4483. Recent progress in kalirin of a new Neuroprotection factor [J]
  4484. Autophagy: a new way to retinal Neuroprotection
  4485. Nicotine, neurodegeneration, and Neuroprotection in neuropsychiatric disorders
  4486. Traumatic spinal cord injuries: Neuroprotection and recent outcomes
  4487. Neuroprotection effect of IL-17 in an autoimmune disease mediated neuroinflammation
  4488. brain Aromatase and Neuroprotection in Mammals
  4489. Effects of exercise on Neuroprotection in experimental autoimmune encephalomyelitis
  4490. Using Pimonidazole Delineated Penumbra To Improve Translational Research on Acute Stroke Neuroprotection (P01. 013)
  4491. Multifunctional small molecular weight compounds from Peltiphyllum Peltatum: From antioxicant to Neuroprotection and antidiabetic effects
  4492. Antenatal magnesium sulfate for fetal Neuroprotection
  4493. Soluble IL-6R and Neuroprotection of Retinal Ganglion Cells in Glaucoma
  4494. Enhancement of-Opioidergic-Receptor Activity Provides Retina Neuroprotection Against Glaucomatous Injury
  4495. Clinical Neuroprotection Against Tissue Hypoxia During brain Injuries; The Challenges and the Targets
  4496. Resveratrol Neuroprotection in cerebral ischemia
  4497. Molecular determinants of hypoxic-ischemic injury in developing brain and potential strategies for Neuroprotection
  4498. The Investigation on the Mechanism of Neuroprotection by Adenosine in 1, 3-Dinitrobenzene Toxicity.
  4499. Immunological mechanism of Neuroprotection function of Copolymer 1 in elevated intraocular pressure in rats
  4500. Silencing of miR20a is Crucial for Ngn1-mediating Neuroprotection in Injured Spinal Cord
  4501. Neuroprotection of estrogen on hypoglycemic attack is through AKT/GSK3b pathway
  4502. Nicotine-Induced Neuroprotection in Drosophila Models of Parkinson’s Disease
  4503. Retinal Ganglion Cell Neuroprotection By Mesenchymal Stem Cell-derived Factors
  4504. Direct Neuroprotection by Exogenous and Endogenous VEGF-A in Rodent Models of Glaucoma
  4505. LOCAL ANAESTHETICS: REAPPRAISAL OF THEIR ROLE IN REGIONAL ANAESTHESIA AND PAIN MANAGEMENT–Neuroprotection
  4506. Studies on astrocyte function: potential roles in brain water homeostasis and Neuroprotection
  4507. In vivo imaging of Neuroprotection in stroke: In search of the penumbra
  4508. The Role of Complement Factors in Neurodegeneration, Neuroinflammation and Neuroprotection : Friend or Foe?
  4509. Neuroprotection Effects of Ischemic Postconditioning after Cerebral Ischemia-reperfusion in Rats [J]
  4510. Volatile meets versatile: Does isoflurane strike a new path to Neuroprotection ?
  4511. Calcium-permeable ion channels in cerebral ischemia and Neuroprotection
  4512. P07 Astrocytes affect Neuroprotection : glatiramer acetate in Huntington’s disease therapy
  4513. Role of the Cerebral Vascular Toll-Like Receptor Signaling Pathway in Neuroprotection Induced by Combination Therapy of VELCADE and TPA
  4514. Mechanisms of Bone-Marrow Stem Cell-Mediated Delayed Ischemic Neuroprotection in Rat Retina<!–field:–
  4515. Ischemic Lesion Evolution and Hemorrhagic Transformation After Thrombolysis with Neuroprotection in FAST-MAG
  4516. Hypothermia-induced Neuroprotection in rats: evidence of a blood glutamate scavenging mechanism: 7AP2-1
  4517. Agmatine Produces Neuroprotection and cognitive Improvement in Rat Treated with Streptozotocin
  4518. Proteomic analysis of npkc epsilon-interactingproteins involved in hpc-induced Neuroprotection against cerebral ischemia of mice
  4519. Somatostatin receptors on neuronal cilia: Evidence for Neuroprotection
  4520. TMP Prevents Retinal Neovascularization and Imparts Neuroprotection in an Oxygen-Induced Retinopathy Model
  4521. Functional role of HIF-1α in hypoxic preconditioning-induced Neuroprotection against focal cerebral ischemia
  4522. Investigation of Normobaric Oxygen Neuroprotection in Acute Schemia-Reperfusion Rat Using MR Diffusion Weighted Imaging
  4523. Erythropoietin and C-erythropoietin Neuroprotection in mouse models of middle cerebral artery occlusion
  4524. Neuroprotection of progesterone against cerebral ischemia-reperfusion injury on rats and the effect on IP3 content
  4525. Role of the prolyl isomerase Pin1 in the pathogenesis of Parkinson’s disease and Neuroprotection by novel targeted compounds in pre-clinical animal models of the …
  4526. Effects of maternal milk lactoferrin supplementation on neurodevelopment and Neuroprotection
  4527. FTOX037 Cisplatin-induced DNA damage and neurotoxicity: Neuroprotection by coenzyme Q10
  4528. Tropisetron as a Neuroprotective Agent Against Glutamate-Induced Excitotoxicity: Potential Mechanisms of Neuroprotection
  4529. Neuroprotection of high concentration normobaric oxygen in stroke rat model observed with MR diffusion-weighted imaging
  4530. The Neuroprotection of SIRT1 on NMDA-induced excitotoxicity in cultured cortical cell
  4531. Neuroprotection and Inhibition of Blood-Retinal Barrier Breakdown In a Transgenic Model of Conditional Müller Cell Ablation
  4532. Adoptive Transfer Of Regulatory T Cells Confers Long Term Neuroprotection Against Cerebral Ischemic Stroke
  4533. Stressed-Induced Neuroprotection through the LIF/GP130/STAT3 Pathway is Mediated by TLR2 Signaling
  4534. brain -Derived Neurotrophic Factor and Exercise-Induced Neuroprotection in the spastic Han-Wistar rat, a model of ataxia
  4535. Behavioral Effects of Calcium Channel Blockers: Acute Exposures and Neuroprotection Against Methylmercury Neurotoxicity
  4536. A study of excitotoxicity as pathological process responsible for spinal cord injury: insight from an in vitro rat spinal cord model with a focus on Neuroprotection
  4537. A study of excitotoxicity as pathological process responsible for spinal cord injury: insight from an in vitro rat spinal cord model with a focus on Neuroprotection
  4538. Neuroprotection And Neurotoxicity Of The Sustained Intraocular Delivery Of Gdnf In Retinal Degeneration
  4539. Role of AMP-activated protein kinase in the Neuroprotection against hypoxia injury in hypoxic preconditioning
  4540. Differential expression of genes involved in Neuroprotection conferred by blackberry polyphenols after simulated gastrointestinal digestion
  4541. Bystander effect of adipose-derived stem cell extracts on neurogenesis, Neuroprotection and β-amyloid claearing
  4542. Inhibition of GSK-3β by valproic acid confers Neuroprotection to key Alzheimer processes and cognitive impairment
  4543. Neuroprotection of Sodium Valproate against Rotenone induced Mitochondrial Dysfunction in SH-SY5Y Cells
  4544. The Combination Therapy of Chemical Chaperone and n-NOS inhibitor Affords Enhanced Neuroprotection in a Rodent model of Ischemic Stroke associated with …
  4545. Granulocyte‐Colony Stimulating Factor Exerts Neuroprotection in the Neonatal Hypoxia‐Ischemia Rat Model via the Hypothalamic‐Pituitary‐Adrenal Axis
  4546. Histamine enhances excitability and may augment Neuroprotection in the Syrian hamster hippocampus
  4547. Kinin-B2 Receptor Mediated Neuroprotection after NMDA Excitotoxicity Is
  4548. The Akt/NFκB Pathway in Postconditioning Induced Neuroprotection through TLR5 in Cerebral Ischemia
  4549. An in vitro model for assessment of excitotoxicity induced by glutamate and Neuroprotection using digitized fluorescent imaging of mitochondrial potentials
  4550. Neuroprotection for Stroke Using Glial Cell Line-Derived Neurotrophic Factor/Neural Stem Cells Grafting
  4551. Neuroprotection by peptides designed to block interactions between glutamate receptors and neuronal activity regulated pentraxin
  4552. ATP-dependent potassium channel blockade strengthens microglial Neuroprotection after hypoxia-ischemia in rats.
  4553. Purinergic control of neuroinflammation and Neuroprotection by the blockade of P2 receptors under excitotoxic conditions in the hippocampus
  4554. Neuroprotection of the leaf and stem of vids amurensis and their active compounds against ischemic brain damage in rats and excitotoxicity in cultured neurons
  4555. Local Induction of Heat Shock Proteins using Magnetic Fluid hyperthermia for Ocular-Neuroprotection in Glaucoma
  4556. Expression of brain -derived neurotrophic factor in reactive astrocytes provides Neuroprotection to SH-SY5Y cells against six-hydroxydopamine toxicity invitro
  4557. 190: IRL-1620, ETB RECEPTOR AGONIST, PROVIDES Neuroprotection AND PROMOTES ANGIOGENESIS FOLLOWING CEREBRAL ISCHEMIA IN RATS
  4558. … of inflammation signaling by DNA “Decoy” treatment improves sensory and motor recovery after spinal cord injury in rats by Neuroprotection and microglial inhibition
  4559. Neuroprotection of Active Principles from the Leaves of Laurus nobilis and Mori Cortex Radicis in Neuronal Cell Culture and Rodent Models of Parkinson’s Disease …
  4560. 338 Nutrient for Neuroprotection : MRI Assessment of Lactoferrin Supplementation after HI Injury in the P3 Rat brain
  4561. 191: ESTROGEN-MEDIATED Neuroprotection DEMONSTRATES GENDER SPECIFICITY IN JUVENILE MICE AFTER CARDIAC ARREST …
  4562. 56 Safety of High-Dose Erythopoietin for Neuroprotection in Preterm Infants
  4563. 1111 Pilot Case Series on the Use of Magnesium Sulphate as Neuroprotection in HIE Babies in the Cooling Era
  4564. LOXblock-1 Provides Efficient, Specific, And Long-lasting Neuroprotection Against Transient Focal Ischemia In Mice By Inhibiting 12/15-Lipoxygenase
  4565. 189: ACETYL-L-CARNITINE (ALCAR) PROVIDES LONG-TERM Neuroprotection AFTER TRAUMATIC brain INJURY IN IMMATURE RATS
  4566. Transfection of IGF-1 and IGFBPL-1 in Neuronal Progenitor Cells from Human Persistent Fetal Vascular for Neuroprotection
  4567. AS06-03-Lithium: neuroimaging evidence of Neuroprotection and its implication for bipolar disorder
  4568. 10 Angiotensin II Receptors and Neuroprotection
  4569. 799 ANGIOTENSIN AT2 RECEPTOR STIMULATION INITIATED AFTER STROKE CAUSES Neuroprotection IN CONSCIOUS RATS
  4570. Interaction between estrogen receptor and metabotropic glutamate receptor 1 mediates the dual effect of estrogen in Neuroprotection and neurodegeneration
  4571. Estrogen receptor-alpha-36, not ER-α66, contribute to Neuroprotection of low concentration of E2 against OGD in PC12 cells
  4572. 193: PROGESTERONE FOR Neuroprotection IN PEDIATRIC TRAUMATIC brain INJURY IN IMMATURE RATS
  4573. Progesterone’s role in Neuroprotection , a review of the evidence
  4574. Neuroprotection in stroke: past, present, and future
  4575. Progesterone and Neuroprotection
  4576. Traumatic brain injury: oxidative stress and Neuroprotection
  4577. Excitotoxicity and stroke: identifying novel targets for Neuroprotection
  4578. Emerging roles of Nrf2 and phase II antioxidant enzymes in Neuroprotection
  4579. Animal models of Parkinson’s disease: limits and relevance to Neuroprotection studies
  4580. Parkinson’s disease, insulin resistance and novel agents of Neuroprotection
  4581. Mechanisms of hypothermic Neuroprotection
  4582. Therapeutic hypothermia for Neuroprotection : history, mechanisms, risks, and clinical applications
  4583. Carboxyfullerene Neuroprotection postinjury in Parkinsonian nonhuman primates
  4584. APOE2 enhances Neuroprotection against Alzheimer’s disease through multiple molecular mechanisms
  4585. Pharmacological perioperative brain Neuroprotection : a qualitative review of randomized clinical trials
  4586. Preconditioning provides Neuroprotection in models of CNS disease: paradigms and clinical significance
  4587. Exosomes: mediators of neurodegeneration, Neuroprotection and therapeutics
  4588. Novel approaches to Neuroprotection trials in acute ischemic stroke
  4589. Neurodegeneration and Neuroprotection in diabetic retinopathy
  4590. VEGF-A is necessary and sufficient for retinal Neuroprotection in models of experimental glaucoma
  4591. The role of citicoline in Neuroprotection and neurorepair in ischemic stroke
  4592. Neuroprotection of microRNA in neurological disorders
  4593. The failure of animal models of Neuroprotection in acute ischemic stroke to translate to clinical efficacy
  4594. Erythropoietin Neuroprotection with traumatic brain injury
  4595. The science of cerebral ischemia and the quest for Neuroprotection : navigating past failure to future success: A review
  4596. Aerobic exercise effects on Neuroprotection and brain repair following stroke: a systematic review and perspective
  4597. Heme oxygenase in Neuroprotection : from mechanisms to therapeutic implications
  4598. Resveratrol: new avenues for a natural compound in Neuroprotection
  4599. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to Neuroprotection
  4600. Neuroprotection in glaucoma: present and future
  4601. Food, nutrigenomics, and neurodegeneration—Neuroprotection by what you eat!
  4602. Lithium and Neuroprotection : translational evidence and implications for the treatment of neuropsychiatric disorders
  4603. Immune regulation toward immunomodulation for Neuroprotection in glaucoma
  4604. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival
  4605. Antioxidant drug therapy approaches for Neuroprotection in chronic diseases of the retina
  4606. Perspectives of drug-based Neuroprotection targeting mitochondria
  4607. Mitochondrial respiration as a target for Neuroprotection and cognitive enhancement
  4608. Estrogen receptors and ischemic Neuroprotection : who, what, where, and when?
  4609. Clinical application of preconditioning and postconditioning to achieve Neuroprotection
  4610. Microglial displacement of inhibitory synapses provides Neuroprotection in the adult brain
  4611. Magnesium sulphate for women at term for Neuroprotection of the fetus
  4612. Lipid rafts in neurodegeneration and Neuroprotection
  4613. Melatonin augments hypothermic Neuroprotection in a perinatal asphyxia model
  4614. Retinal cell death and current strategies in retinal Neuroprotection
  4615. Progesterone–estrogen interactions in synaptic plasticity and Neuroprotection
  4616. Erythropoietin: emerging role of erythropoietin in neonatal Neuroprotection
  4617. Can we switch microglia’s phenotype to foster Neuroprotection ? Focus on multiple sclerosis
  4618. Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for Neuroprotection
  4619. Perinatal Neuroprotection
  4620. GPR30 mediates estrogen rapid signaling and Neuroprotection
  4621. Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress
  4622. Statins and Neuroprotection : basic pharmacology needed
  4623. Tsc1 (hamartin) confers Neuroprotection against ischemia by inducing autophagy
  4624. Stem cell transplantation for Neuroprotection in stroke
  4625. Olive oil phenols and Neuroprotection
  4626. Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and Neuroprotection
  4627. Small-molecule activator of glutamate transporter EAAT2 translation provides Neuroprotection
  4628. Stroke Neuroprotection : targeting mitochondria
  4629. Progesterone, brain -derived neurotrophic factor and Neuroprotection
  4630. Neonatal encephalopathy: pre-clinical studies in Neuroprotection
  4631. Neuroprotection and lifespan extension in Ppt1−/− mice by NtBuHA: therapeutic implications for INCL
  4632. Neuroprotection signaling of nuclear akt in neuronal cells
  4633. Exercise-induced Neuroprotection of hippocampus in APP/PS1 transgenic mice via upregulation of mitochondrial 8-oxoguanine DNA glycosylase
  4634. Targeting ASIC1 in primary progressive multiple sclerosis: evidence of Neuroprotection with amiloride
  4635. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to Neuroprotection , neurogenesis, and angiogenesis
  4636. Magnesium treatment for Neuroprotection in ischemic diseases of the brain
  4637. Bcl-xL in Neuroprotection and plasticity
  4638. Luteolin provides Neuroprotection in models of traumatic brain injury via the Nrf2–ARE pathway
  4639. Neuroprotection by astrocytes in brain ischemia: importance of microRNAs
  4640. Hypothermia and erythropoietin for Neuroprotection after neonatal brain damage
  4641. Implication of GPER1 in Neuroprotection in a mouse model of Parkinson’s disease
  4642. Calcium‐sensing receptor (CaSR) as a novel target for ischemic Neuroprotection
  4643. XENON in medical area: emphasis on Neuroprotection in hypoxia and anesthesia
  4644. Dual effects of ketamine: neurotoxicity versus Neuroprotection in anesthesia for the developing brain
  4645. Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for Neuroprotection
  4646. Immunomodulation Neuroprotection and remyelination–The fundamental therapeutic effects of glatiramer acetate: A critical review
  4647. Squalenoyl adenosine nanoparticles provide Neuroprotection after stroke and spinal cord injury
  4648. BDNF–TrkB signaling and Neuroprotection in schizophrenia
  4649. Saffron and retina: Neuroprotection and pharmacokinetics
  4650. Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway
  4651. FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct Neuroprotection
  4652. Docosahexaenoic acid confers enduring Neuroprotection in experimental stroke
  4653. Differential mechanisms underlying Neuroprotection of hydrogen sulfide donors against oxidative stress
  4654. Fingolimod may support Neuroprotection via blockade of astrocyte nitric oxide
  4655. Identification of retinal ganglion cell Neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome
  4656. Neuroprotection in a novel mouse model of multiple sclerosis
  4657. Estrogen mediates Neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or …
  4658. Sex steroids and Neuroprotection in spinal cord injury: a review of preclinical investigations
  4659. Greatly improved survival and Neuroprotection in aquaporin‐4‐knockout mice following global cerebral ischemia
  4660. School-age outcomes following a randomized controlled trial of magnesium sulfate for Neuroprotection of preterm infants
  4661. Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events
  4662. Calcium-dependent N-cadherin up-regulation mediates reactive astrogliosis and Neuroprotection after brain injury
  4663. Modulation of mitochondrial function and autophagy mediates carnosine Neuroprotection against ischemic brain damage
  4664. Multinutrient diets improve cerebral perfusion and Neuroprotection in a murine model of Alzheimer’s disease
  4665. Simvastatin Induces Neuroprotection in 6‐OHDA‐Lesioned PC 12 via the PI 3K/AKT/Caspase 3 Pathway and Anti‐Inflammatory Responses
  4666. Neuroprotection after cerebral ischemia
  4667. Cell transplantation approaches to retinal ganglion cell Neuroprotection in glaucoma
  4668. Neuroprotection of medical IOP-lowering therapy
  4669. Doxycycline restrains glia and confers Neuroprotection in a 6‐OHDA Parkinson model
  4670. Ursolic acid promotes the Neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice
  4671. N-acetylcysteine amide confers Neuroprotection , improves bioenergetics and behavioral outcome following TBI
  4672. Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia
  4673. Mechanisms of cannabidiol Neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors
  4674. Role of growth hormone (GH) in the treatment on neural diseases: from Neuroprotection to neural repair
  4675. Calcitriol imparts Neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression
  4676. Paracrine-mediated Neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone …
  4677. Astaxanthin offers Neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage
  4678. Acute metformin preconditioning confers Neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagy
  4679. PreImplantation factor promotes Neuroprotection by targeting microRNA let-7
  4680. Sigma receptors as potential therapeutic targets for Neuroprotection
  4681. Antioxidant activity, genotoxicity and cytotoxicity evaluation of lemon balm (Melissa officinalis L.) ethanolic extract: Its potential role in Neuroprotection
  4682. NeuroAiD: properties for Neuroprotection and neurorepair
  4683. Intravitreally transplanted dental pulp stem cells promote Neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury
  4684. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1α
  4685. Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for Neuroprotection and …
  4686. Klotho upregulation contributes to the Neuroprotection of ligustilide in an Alzheimer’s disease mouse model
  4687. Microglia trigger astrocyte-mediated Neuroprotection via purinergic gliotransmission
  4688. Guanosine controls inflammatory pathways to afford Neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions
  4689. Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated Neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration
  4690. Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms
  4691. Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and Neuroprotection
  4692. Hydrogen sulfide offers Neuroprotection on traumatic brain injury in parallel with reduced apoptosis and autophagy in mice
  4693. Research advances on the usage of traditional Chinese medicine for Neuroprotection in glaucoma
  4694. Autophagy activation contributes to the Neuroprotection of remote ischemic perconditioning against focal cerebral ischemia in rats
  4695. Hypothermia-induced Neuroprotection is associated with reduced mitochondrial membrane permeability in a swine model of cardiac arrest
  4696. Dexmedetomidine provides Neuroprotection : impact on ketamine‐induced neuroapoptosis in the developing rat brain
  4697. Neuroprotection with glatiramer acetate: evidence from the PreCISe trial
  4698. Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson’s disease
  4699. Isoflurane provides Neuroprotection in neonatal hypoxic ischemic brain injury
  4700. Dock GEFs and their therapeutic potential: Neuroprotection and axon regeneration
  4701. … formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for Neuroprotection
  4702. Role of crystallins in ocular Neuroprotection and axonal regeneration
  4703. Progesterone-induced Neuroprotection : factors that may predict therapeutic efficacy
  4704. Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and Neuroprotection share a PPAR-alpha-mediated mechanism
  4705. EPO-dependent activation of PI3K/Akt/FoxO3a signalling mediates Neuroprotection in in vitro and in vivo models of Parkinson’s disease
  4706. Can medical herbs stimulate regeneration or Neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?
  4707. Neuroprotection by acetyl-11-keto-β-boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathway
  4708. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and natural history in …
  4709. N-acetyl-serotonin offers Neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury
  4710. Neuroprotection against Traumatic brain Injury by Xenon, but Not Argon, Is Mediated by Inhibition at the N-Methyl-d-Aspartate Receptor Glycine Site
  4711. Stroke Neuroprotection : oestrogen and insulin‐like growth factor‐1 interactions and the role of microglia
  4712. Feasibility and safety of erythropoietin for Neuroprotection after perinatal arterial ischemic stroke
  4713. Multifaceted effects of rapamycin on functional recovery after spinal cord injury in rats through autophagy promotion, anti-inflammation, and Neuroprotection
  4714. mGlu3 receptor and astrocytes: partners in Neuroprotection
  4715. Melatonin-based therapeutics for Neuroprotection in stroke
  4716. Resveratrol induced Neuroprotection is mediated via both estrogen receptor subtypes, ERα and ERβ
  4717. Curcumin inhibits microglia inflammation and confers Neuroprotection in intracerebral hemorrhage
  4718. Amyloid-beta Neuroprotection mediated by a targeted antioxidant
  4719. Targeting Wnt signaling at the neuroimmune interface for dopaminergic Neuroprotection /repair in Parkinson’s disease
  4720. Survivin is a transcriptional target of STAT3 critical to estradiol Neuroprotection in global ischemia
  4721. Neuroprotection against Aβ25–35-induced apoptosis by Salvia miltiorrhiza extract in SH-SY5Y cells
  4722. NADPH oxidase as a therapeutic target for Neuroprotection against ischaemic stroke: future perspectives
  4723. New synaptic and molecular targets for Neuroprotection in Parkinson’s disease
  4724. Creatine for women in pregnancy for Neuroprotection of the fetus
  4725. Activation of the phase II enzymes for Neuroprotection by ginger active constituent 6-dehydrogingerdione in PC12 cells
  4726. Inhibition of autophagy contributes to melatonin-mediated Neuroprotection against transient focal cerebral ischemia in rats
  4727. Neuroprotection of antioxidant enzymes against transient global cerebral ischemia in gerbils
  4728. Sex hormones and biomarkers of Neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder
  4729. Ligand-gated ion channel interacting proteins and their role in Neuroprotection
  4730. Indirect application of near infrared light induces Neuroprotection in a mouse model of parkinsonism–an abscopal Neuroprotective effect
  4731. Dual effects of Neuroprotection and neurotoxicity by general anesthetics: role of intracellular calcium homeostasis
  4732. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation
  4733. … actors in astrocyte–neuron crosstalk in P arkinson’s disease: the W nt/β‐catenin signaling cascade as the common final pathway for Neuroprotection and self‐repair
  4734. The Microglial α7-Acetylcholine Nicotinic Receptor Is a Key Element in Promoting Neuroprotection by Inducing Heme Oxygenase-1 via Nuclear Factor Erythroid-2 …
  4735. Unraveling the mechanism of Neuroprotection of curcumin in arsenic induced cholinergic dysfunctions in rats
  4736. Isoflurane postconditioning reduces ischemia-induced nuclear factor-κB activation and interleukin 1β production to provide Neuroprotection in rats and mice
  4737. Developmental changes in the transcriptome of the rat choroid plexus in relation to Neuroprotection
  4738. Formononetin mediates Neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling …
  4739. Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
  4740. The endoplasmic reticulum stress inhibitor salubrinal inhibits the activation of autophagy and Neuroprotection induced by brain ischemic preconditioning
  4741. Autophagy activation and Neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis
  4742. Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress
  4743. Mitochondrial-targeted human catalase affords Neuroprotection from proton irradiation
  4744. Anti-inflammatory effect of tanshinone I in Neuroprotection against cerebral ischemia–reperfusion injury in the gerbil hippocampus
  4745. Sildenafil mediates blood-flow redistribution and Neuroprotection after neonatal hypoxia-ischemia
  4746. Neuroprotection Induced by N-acetylcysteine and Selenium Against Traumatic brain Injury-Induced Apoptosis and Calcium Entry in Hippocampus of Rat
  4747. Mitochondrial Neuroprotection in traumatic brain injury: rationale and therapeutic strategies
  4748. Citicoline (CDP‐choline) increases S irtuin1 expression concomitant to Neuroprotection in experimental stroke
  4749. Early Neuroprotection after cardiac arrest
  4750. Hypoxia-inducible factor 1α mediates Neuroprotection of hypoxic postconditioning against global cerebral ischemia
  4751. Lesional-targeting of Neuroprotection to the inflammatory penumbra in experimental multiple sclerosis
  4752. Molecular targets underlying SUMO‐mediated Neuroprotection in brain ischemia
  4753. Saffron pre-treatment offers Neuroprotection to Nigral and retinal dopaminergic cells of MPTP-Treated mice
  4754. Downregulation of miR‐181b in mouse brain following ischemic stroke induces Neuroprotection against ischemic injury through targeting heat shock protein A5 and …
  4755. Astrocyte-derived growth factors and estrogen Neuroprotection : role of transforming growth factor-α in estrogen-induced upregulation of glutamate transporters in …
  4756. Mechanisms of Neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states
  4757. Exogenous T3 administration provides Neuroprotection in a murine model of traumatic brain injury
  4758. Hypoxia-inducible factor prolyl hydroxylases as targets for Neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke
  4759. Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and Neuroprotection by progesterone
  4760. Ginsenoside Rg1 provides Neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through …
  4761. Membrane-mediated Neuroprotection by curcumin from amyloid-β-peptide-induced toxicity
  4762. nNOS and p-ERK involvement in the Neuroprotection exerted by remote postconditioning in rats subjected to transient middle cerebral artery occlusion
  4763. Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors
  4764. Temporal activation of Nrf2 in the penumbra and Nrf2 activator-mediated Neuroprotection in ischemia–reperfusion injury
  4765. The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and Neuroprotection in cerebral ischemia
  4766. Neuroprotection conferred by post‐ischemia ethanol therapy in experimental stroke: an inhibitory effect on hyperglycolysis and NADPH oxidase activation
  4767. Improved Neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann–Pick disease type C1 mice
  4768. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson’s disease
  4769. Reprint of” GPR30 mediates estrogen rapid signaling and Neuroprotection ”
  4770. Phosphorylation of p38 MAPK mediates hypoxic preconditioning-induced Neuroprotection against cerebral ischemic injury via mitochondria translocation of Bcl-xL in …
  4771. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson’s disease
  4772. Activation of K2P channel–TREK1 mediates the Neuroprotection induced by sevoflurane preconditioning
  4773. Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions
  4774. Effect of HDAC inhibitors on Neuroprotection and neurite outgrowth in primary rat cortical neurons following ischemic insult
  4775. brain -targeting delivery for RNAi Neuroprotection against cerebral ischemia reperfusion injury
  4776. Notoginsenoside R1-mediated Neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: a novel mechanism of Nrf2/ARE …
  4777. Anesthetic Neuroprotection : antecedents and an appraisal of preclinical and clinical data quality
  4778. Transplants of adult mesenchymal and neural stem cells provide Neuroprotection and behavioral sparing in a transgenic rat model of Huntington’s disease
  4779. Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for Neuroprotection in stroke
  4780. Activation of STAT3 is involved in Neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats
  4781. Magnesium sulfate provides Neuroprotection in lipopolysaccharide-activated primary microglia by inhibiting NF-κB pathway
  4782. NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in Neuroprotection ?
  4783. Prophylactic Neuroprotection by blueberry-enriched diet in a rat model of light-induced retinopathy
  4784. Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation
  4785. Possible roles of astrocytes in estrogen Neuroprotection during cerebral ischemia
  4786. Delta opioid receptor and its peptide: a receptor-ligand Neuroprotection
  4787. Gap junction-mediated death of retinal neurons is connexin and insult specific: a potential target for Neuroprotection
  4788. Activations of GABAergic signaling, HSP70 and MAPK cascades are involved in baicalin’s Neuroprotection against gerbil global ischemia/reperfusion injury
  4789. Bone marrow mononuclear cells exert long-term Neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis
  4790. Ceruloplasmin and β-amyloid precursor protein confer Neuroprotection in traumatic brain injury and lower neuronal iron
  4791. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous Neuroprotection –design and MRI measurements
  4792. SIRT1 silencing confers Neuroprotection through IGF‐1 pathway activation
  4793. Melatonin renders Neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia
  4794. Harmine mediated Neuroprotection via evaluation of glutamate transporter 1 in a rat model of global cerebral ischemia
  4795. Granulocyte-colony stimulating factor in combination with stem cell factor confers greater Neuroprotection after hypoxic–ischemic brain damage in the neonatal rats …
  4796. A dietary polyphenol resveratrol acts to provide Neuroprotection in recurrent stroke models by regulating AMPK and SIRT 1 signaling, thereby reducing energy …
  4797. TLR4 inhibitor resatorvid provides Neuroprotection in experimental traumatic brain injury: implication in the treatment of human brain injury
  4798. Inhibition of the NLRP3 inflammasome provides Neuroprotection in rats following amygdala kindling-induced status epilepticus
  4799. Docosahexaenoic acid complexed to albumin provides Neuroprotection after experimental stroke in aged rats
  4800. Dual role of astrocytes in perinatal asphyxia injury and Neuroprotection
  4801. Enhanced Neuroprotection by local intra-arterial infusion of human albumin solution and local hypothermia
  4802. Neuroprotection following mild hypothermia after spinal cord ischemia in rats
  4803. The role of ghrelin in Neuroprotection after ischemic brain injury
  4804. Phenelzine mitochondrial functional preservation and Neuroprotection after traumatic brain injury related to scavenging of the lipid peroxidation-derived aldehyde 4 …
  4805. Role of histidine/histamine in carnosine-induced Neuroprotection during ischemic brain damage
  4806. Pharmacologically induced hypothermia via TRPV1 channel agonism provides Neuroprotection following ischemic stroke when initiated 90 min after reperfusion
  4807. Mesenchymal stem cells transplantation for Neuroprotection in preterm infants with severe intraventricular hemorrhage
  4808. The Neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and …
  4809. Altered selenium status in Huntington’s disease: Neuroprotection by selenite in the N171-82Q mouse model
  4810. Magnesium sulphate for fetal Neuroprotection : a cost-effectiveness analysis
  4811. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways
  4812. Neuroprotection elicited by P2Y13 receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery
  4813. Ghrelin is Neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic Neuroprotection
  4814. Dexamethasone-induced Neuroprotection in hypoxic-ischemic brain injury in newborn rats is partly mediated via Akt activation
  4815. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of Neuroprotection by sodium salicylate in a chronic rotenone model of …
  4816. The proton permeability of self-assembled polymersomes and their Neuroprotection by enhancing a Neuroprotective peptide across the blood–brain barrier after …
  4817. [Gly14]-Humanin offers Neuroprotection through glycogen synthase kinase-3β inhibition in a mouse model of intracerebral hemorrhage
  4818. Probucol affords Neuroprotection in a 6-OHDA mouse model of Parkinson’s disease
  4819. Neuroprotection induced by N-acetylcysteine against cytosolic glutathione depletion-induced Ca2+ influx in dorsal root ganglion neurons of mice: role of TRPV1 …
  4820. 5‐Hydroxytryptamine type 7 receptor Neuroprotection against NMDA‐induced excitotoxicity is PDGFβ receptor dependent
  4821. Erythropoietin Neuroprotection in neonatal cardiac surgery: a phase I/II safety and efficacy trial
  4822. Hippocampal neuronal metal ion imbalance related oxidative stress in a rat model of chronic aluminum exposure and Neuroprotection of meloxicam
  4823. A novel in vivo model of focal light emitting diode-induced cone-photoreceptor phototoxicity: Neuroprotection afforded by brimonidine, BDNF, PEDF or bFGF
  4824. Normobaric hyperoxia combined with minocycline provides greater Neuroprotection than either alone in transient focal cerebral ischemia
  4825. Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for Neuroprotection
  4826. … refilling and mitochondrial calcium extrusion promoted in neurons by NCX1 and NCX3 in ischemic preconditioning are determinant for Neuroprotection
  4827. Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling
  4828. Enhanced neurotrophic distribution, cell signaling and Neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120)
  4829. BDNF mediates Neuroprotection against oxygen-glucose deprivation by the cardiac glycoside oleandrin
  4830. Zinc in traumatic brain injury: from Neuroprotection to neurotoxicity
  4831. Synergistical Neuroprotection of rofecoxib and statins against malonic acid induced Huntington’s disease like symptoms and related cognitive dysfunction in rats
  4832. Functional Neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson’s disease
  4833. Biomarkers for trials of Neuroprotection in Parkinson’s disease
  4834. Calmodulin Kinase IV–dependent CREB activation is required for Neuroprotection via NMDA receptor‐PSD 95 disruption
  4835. Dose dependent Neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by KATP—Channel opening
  4836. Carboxypeptidase E (NF-α1): a new trophic factor in Neuroprotection
  4837. Mechanisms of Neuroprotection from hypoxia-ischemia (HI) brain injury by up-regulation of cytoglobin (CYGB) in a neonatal rat model
  4838. Potential benefits of therapeutic use of β2-adrenergic receptor agonists in Neuroprotection and Parkinson’s disease
  4839. Neuroprotection by inhaled nitric oxide in a murine stroke model is concentration and duration dependent
  4840. Urate and Neuroprotection trials
  4841. Light activation of the insulin receptor regulates mitochondrial hexokinase. A possible mechanism of retinal Neuroprotection
  4842. Neurotrophin strategies for Neuroprotection : are they sufficient?
  4843. NCX as a key player in the Neuroprotection exerted by ischemic preconditioning and postconditioning
  4844. Hyperbaric oxygen therapy provides Neuroprotection following spinal cord injury in a rat model
  4845. A peroxisome proliferator-activated receptor-δ agonist provides Neuroprotection in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson’s …
  4846. Decreased extracellular adenosine levels lead to loss of hypoxia-induced Neuroprotection after repeated episodes of exposure to hypoxia
  4847. Mechanisms of ocular Neuroprotection by antioxidant molecules in animal models.
  4848. N-Acetylserotonin: Circadian Activation of the BDNF Receptor and Neuroprotection in the Retina and brain
  4849. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated Neuroprotection in an MPTP-induced model of Parkinson’s disease
  4850. Serum exosomes in pregnancy-associated immune modulation and Neuroprotection during CNS autoimmunity
  4851. L‐theanine administration results in Neuroprotection and prevents glutamate receptor agonist‐mediated injury in the rat model of cerebral ischemia‐reperfusion
  4852. Synergetic Neuroprotection of normobaric oxygenation and ethanol in ischemic stroke through improved oxidative mechanism
  4853. Overview of immunotherapy in Alzheimer’s disease (AD) and mechanisms of IVIG Neuroprotection in preclinical models of AD
  4854. Endoplasmic reticulum stress is associated with Neuroprotection against apoptosis via autophagy activation in a rat model of subarachnoid hemorrhage
  4855. Neuroprotection in multiple sclerosis: a therapeutic approach
  4856. The anti-tumor histone deacetylase inhibitor SAHA and the natural flavonoid curcumin exhibit synergistic Neuroprotection against amyloid-beta toxicity
  4857. Reactive oxygen species scavenging activities in a chemiluminescence model and Neuroprotection in rat pheochromocytoma cells by astaxanthin, beta …
  4858. Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent Neuroprotection following traumatic brain injury in mice
  4859. Neuroprotection effect of interleukin (IL)‐17 secreted by reactive astrocytes is emerged from a high‐level IL‐17‐containing environment during acute …
  4860. Trichilia catigua (Catuaba) bark extract exerts Neuroprotection against oxidative stress induced by different neurotoxic agents in rat hippocampal slices
  4861. Valproic acid potentiates curcumin-mediated Neuroprotection in lipopolysaccharide induced rats
  4862. Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats
  4863. Bacillus Calmette‐Guerin vaccine‐mediated Neuroprotection is associated with regulatory T‐cell induction in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine …
  4864. … pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: possible mechanisms of Neuroprotection
  4865. The systemic administration of oleoylethanolamide exerts Neuroprotection of the nigrostriatal system in experimental Parkinsonism
  4866. Mediator lipidomics in ophthalmology: targets for modulation in inflammation, Neuroprotection and nerve regeneration
  4867. Simulated microgravity facilitates cell migration and Neuroprotection after bone marrow stromal cell transplantation in spinal cord injury
  4868. Both Creatine and Its Product Phosphocreatine Reduce Oxidative Stress and Afford Neuroprotection in an In Vitro Parkinson’s Model
  4869. Hinokitiol, a natural tropolone derivative, offers Neuroprotection from thromboembolic stroke in vivo
  4870. Early transplantation of bone marrow mononuclear cells promotes Neuroprotection and modulation of inflammation after status epilepticus in mice by paracrine …
  4871. Neuroprotection mediated by the EP4 receptor avoids the detrimental side effects of COX-2 inhibitors following ischaemic injury
  4872. PI3K/Akt and NF-κB activation following intravitreal administration of 17β-estradiol: Neuroprotection of the rat retina from light-induced apoptosis
  4873. Mitochondria: prospective targets for Neuroprotection in Parkinson’s disease
  4874. Hypothermia for Neuroprotection in children after cardiopulmonary arrest
  4875. Neuroprotection by steroids after neurotrauma in organotypic spinal cord cultures: A key role for progesterone receptors and steroidal modulators of GABAA receptors
  4876. Effective Neuroprotection by ischemic postconditioning is associated with a decreased expression of RGMa and inflammation mediators in ischemic rats
  4877. A case for Neuroprotection in ophthalmology: developments in translational research
  4878. Preconditioning to mild oxidative stress mediates astroglial Neuroprotection in an IL-10-dependent manner
  4879. TAT-Hsp70 induces Neuroprotection against stroke via anti-inflammatory actions providing appropriate cellular microenvironment for transplantation of neural …
  4880. In search of new targets for retinal Neuroprotection : is there a role for autophagy?
  4881. Catalpol induces Neuroprotection and prevents memory dysfunction through the cholinergic system and BDNF
  4882. Intra-carotid cold magnesium sulfate infusion induces selective cerebral hypothermia and Neuroprotection in rats with transient middle cerebral artery occlusion
  4883. Caffeoylquinic acid-rich purple sweet potato extract, with or without anthocyanin, imparts Neuroprotection and contributes to the improvement of spatial learning and …
  4884. … role of peroxisome proliferator-activated receptor and effects of its agonist, pioglitazone, on a rat model of optic nerve crush: PPARγ in retinal Neuroprotection
  4885. Neuroprotection for retinal detachment
  4886. Antenatal pharmacokinetics and placental transfer of N-acetylcysteine in chorioamnionitis for fetal Neuroprotection
  4887. Norepinephrine provides short-term Neuroprotection against Aβ1–42 by reducing oxidative stress independent of Nrf2 activation
  4888. Co-administration of resveratrol and lipoic acid, or their synthetic combination, enhances Neuroprotection in a rat model of ischemia/reperfusion
  4889. Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to Neuroprotection against cerebral ischemia via blocking the tBid‐mitochondrial apoptotic …
  4890. Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early Neuroprotection against MPP+
  4891. Endogenous ghrelin’s role in hippocampal Neuroprotection after global cerebral ischemia: does endogenous ghrelin protect against global stroke?
  4892. Novel protective properties of auranofin: inhibition of human astrocyte cytotoxic secretions and direct Neuroprotection
  4893. The effects of peritoneal dialysis on blood glutamate levels: implementation for Neuroprotection
  4894. WISP1 Neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1
  4895. Neuroprotection by argon ventilation after perinatal asphyxia: a safety study in newborn piglets
  4896. Sevoflurane postconditioning provides Neuroprotection against brain hypoxia–ischemia in neonatal rats
  4897. Electrical stimulation of cerebellar fastigial nucleus: mechanism of Neuroprotection and prospects for clinical application against cerebral ischemia
  4898. Hemopexin induces Neuroprotection in the rat subjected to focal cerebral ischemia
  4899. Globular adiponectin elicits Neuroprotection by inhibiting NADPH oxidase-mediated oxidative damage in ischemic stroke
  4900. Neuroprotection by rAAV-mediated gene transfer of bone morphogenic protein 7
  4901. Neuroprotection or neurotoxicity? New insights into the effects of Acanthopanax senticosus harms on nervous system through cerebral metabolomics analysis
  4902. New perspective on the dual functions of indirubins in cancer therapy and Neuroprotection
  4903. Microglial ion channels as potential targets for Neuroprotection in Parkinson’s disease
  4904. Preconditioning with the traditional Chinese medicine Huang-Lian-Jie-Du-Tang initiates HIF-1α-dependent Neuroprotection against cerebral ischemia in rats
  4905. Transient Neuroprotection by SRY upregulation in dopamine cells following injury in males
  4906. Neuroprotection by genipin against reactive oxygen and reactive nitrogen species-mediated injury in organotypic hippocampal slice cultures
  4907. Neuroprotection against degeneration of SK-N-MC cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin
  4908. Alterations in energy metabolism, Neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeys
  4909. The roles of p38 MAPK/MSK1 signaling pathway in the Neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in adult rats
  4910. Neamine induces Neuroprotection after acute ischemic stroke in type one diabetic rats
  4911. Challenges in the development of glaucoma Neuroprotection therapy
  4912. MyD88 is a critical regulator of hematopoietic cell-mediated Neuroprotection seen after stroke
  4913. Neuroprotection and axonal regeneration after lumbar ventral root avulsion by re-implantation and mesenchymal stem cells transplant combined therapy
  4914. Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides Neuroprotection in two rat models of temporal lobe epilepsy
  4915. Neuroprotection of dietary virgin olive oil on brain lipidomics during stroke
  4916. … acid, but not arachidonic acid, activates glutathione and thioredoxin antioxidant systems in murine hippocampal HT22 cells: potential implications in Neuroprotection
  4917. p-ERK involvement in the Neuroprotection exerted by ischemic preconditioning in rat hippocampus subjected to four vessel occlusion
  4918. Neonatal serum magnesium concentrations are determined by total maternal dose of magnesium sulfate administered for Neuroprotection
  4919. Chronic ibuprofen administration reduces neuropathic pain but does not exert Neuroprotection after spinal cord injury in adult rats
  4920. Translational strategies for Neuroprotection in ischemic stroke—focusing on acid-sensing ion channel 1a
  4921. Fast Neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now
  4922. Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated Neuroprotection after oxygen and glucose deprivation: role of vascular …
  4923. The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell Neuroprotection in a rat model of optic nerve axotomy
  4924. The extent of neurodegeneration and Neuroprotection in two chemical in vitro models related to Parkinson’s disease is critically dependent on cell culture conditions
  4925. Decreased brain K ATP Channel Contributes to Exacerbating Ischemic brain Injury and the Failure of Neuroprotection by Sevoflurane Post-Conditioning in …
  4926. Combined antiapoptotic and antioxidant approach to acute Neuroprotection for stroke in hypertensive rats
  4927. ERKs and mitochondria-related pathways are essential for glycyrrhizic acid-mediated Neuroprotection against glutamate-induced toxicity in differentiated …
  4928. Marine-derived bioactive materials for Neuroprotection
  4929. Prevention of JNK phosphorylation as a mechanism for rosiglitazone in Neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase
  4930. Chlorpromazine confers Neuroprotection against brain ischemia by activating BKCa channel
  4931. Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to Neuroprotection
  4932. Neuroprotection with erythropoietin in preterm and/or low birth weight infants
  4933. p38 MAPK signaling acts upstream of LIF-dependent Neuroprotection during photoreceptor degeneration
  4934. … role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for Neuroprotection with Cerebrolysin therapy
  4935. Involvement of p-CREB and phase II detoxifying enzyme system in Neuroprotection mediated by the flavonoid calycopterin isolated from Dracocephalum kotschyi
  4936. Targeted delivery of erythropoietin by transcranial focused ultrasound for Neuroprotection against ischemia/reperfusion-induced neuronal injury: a long-term …
  4937. Phosphorylation enhances recombinant HSP27 Neuroprotection against focal cerebral ischemia in mice
  4938. Induction of ischemic stroke in awake freely moving mice reveals that isoflurane anesthesia can mask the benefits of a Neuroprotection therapy
  4939. Aquaporin-4 inhibition mediates piroxicam-induced Neuroprotection against focal cerebral ischemia/reperfusion injury in rodents
  4940. Knocking out DJ-1 attenuates astrocytes Neuroprotection against 6-hydroxydopamine toxicity
  4941. Docosahexaenoic acid augments hypothermic Neuroprotection in a neonatal rat asphyxia model
  4942. Daphnetin, a natural coumarin derivative, provides the Neuroprotection against glutamate-induced toxicity in HT22 cells and ischemic brain injury
  4943. Engineered N-cadherin and L1 biomimetic substrates concertedly promote neuronal differentiation, neurite extension and Neuroprotection of human neural stem cells
  4944. Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate Neuroprotection independent of HDAC inhibition
  4945. Neural repair and Neuroprotection with stem cells in ischemic stroke
  4946. Glycyrrhizic acid confers Neuroprotection after subarachnoid hemorrhage via inhibition of high mobility group box-1 protein: a hypothesis for novel therapy of …
  4947. Neuroprotection in glaucoma
  4948. ARRB1/β-arrestin-1 mediates Neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia
  4949. Crosstalk between delta opioid receptor and nerve growth factor signaling modulates Neuroprotection and differentiation in rodent cell models
  4950. Regulated expression of lentivirus-mediated GDNF in human bone marrow-derived mesenchymal stem cells and its Neuroprotection on dopaminergic cells in …
  4951. Neuroprotection of atractylenolide III from Atractylodis macrocephalae against glutamate-induced neuronal apoptosis via inhibiting caspase signaling pathway
  4952. Structure and function of Parkin, PINK1, and DJ-1, the three musketeers of Neuroprotection
  4953. Neuroprotection by the kappa-opioid receptor agonist, BRL52537, is mediated via up-regulating phosphorylated signal transducer and activator of transcription-3 in …
  4954. Estimated cerebral oxyhemoglobin as a useful indicator of Neuroprotection in patients with post-cardiac arrest syndrome: a prospective, multicenter …
  4955. GluN2B N‐methyl‐D‐aspartic acid receptor subunit mediates atorvastatin‐Induced Neuroprotection after focal cerebral ischemia
  4956. Spatiotemporal resolution of BDNF Neuroprotection against glutamate excitotoxicity in cultured hippocampal neurons
  4957. Neuroprotection by docosahexaenoic acid in brain injury
  4958. Ischemic preconditioning-induced Neuroprotection against transient cerebral ischemic damage via attenuating ubiquitin aggregation
  4959. Mechanisms of Neuroprotection by glucose in rat retinal cell cultures subjected to respiratory inhibition
  4960. Hemin‑mediated neuroglobin induction exerts Neuroprotection following ischemic brain injury through PI3K/Akt signaling
  4961. Neuroprotection by 6-(methylsulfinyl) hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳ s disease
  4962. Effects of tetrahydrohyperforin in mouse hippocampal slices: Neuroprotection , long-term potentiation and TRPC channels
  4963. Partial Neuroprotection by nNOS inhibition during profound asphyxia in preterm fetal sheep
  4964. Sildenafil promotes Neuroprotection of the pelvic ganglia neurones after bilateral cavernosal nerve resection in the rat
  4965. The role of neuroglobin in the Neuroprotection of limb ischemic preconditioning in rats
  4966. Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer Neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis
  4967. Neuroprotection of S-nitrosoglutathione against ischemic injury by down-regulating Fas S-nitrosylation and downstream signaling
  4968. The divergence–convergence model of acquired Neuroprotection
  4969. Inhibition of brain ischemia-caused notch activation in microglia may contribute to isoflurane postconditioning-induced Neuroprotection in male rats
  4970. Treatment with lutein provides Neuroprotection in mice subjected to transient cerebral ischemia
  4971. Anti-seizure medications and estradiol for Neuroprotection in epilepsy: the 2013 update
  4972. The potential Neuroprotection mechanism of GDNF in the 6-OHDA-induced cellular models of Parkinson’s disease
  4973. Flavocoxid, dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, exhibits Neuroprotection in rat model of ischaemic stroke
  4974. Omega-3 fatty acids and traumatic neurological injury: from Neuroprotection to neuroplasticity?
  4975. Neuroprotection by platelet-activating factor acetylhydrolase in a mouse model of transient cerebral ischemia
  4976. Cell penetrating peptide (CPP)-conjugated desferrioxamine for enhanced Neuroprotection : Synthesis and in vitro evaluation
  4977. Cudarflavone B provides Neuroprotection against glutamate-induced mouse hippocampal HT22 cell damage through the Nrf2 and PI3K/Akt signaling pathways
  4978. Interleukin-10 mediates the Neuroprotection of hyperbaric oxygen therapy against traumatic brain injury in mice
  4979. Intravenous administration of Honokiol provides Neuroprotection and improves functional recovery after traumatic brain injury through cell cycle inhibition
  4980. … treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in Neuroprotection
  4981. Coumestrol treatment prevents Na+, K+-ATPase inhibition and affords histological Neuroprotection to male rats receiving cerebral global ischemia
  4982. The G Protein‐Coupled Receptor 55 Ligand l‐α‐Lysophosphatidylinositol Exerts Microglia‐Dependent Neuroprotection After Excitotoxic Lesion
  4983. When human immunodeficiency virus meets chemokines and microglia: Neuroprotection or neurodegeneration?
  4984. Targeting mitochondria for Neuroprotection in Parkinson disease
  4985. TrkB receptor agonist 7, 8 dihydroxyflavone triggers profound gender-dependent Neuroprotection in mice after perinatal hypoxia and ischemia
  4986. Sustained Neuroprotection from a single intravitreal injection of PGJ2 in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy
  4987. Studies of (±)-3, 4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to Neuroprotection and neurotoxicity profile
  4988. Neuroprotection of posttreatment with risperidone, an atypical antipsychotic drug, in rat and gerbil models of ischemic stroke and the maintenance of antioxidants in a …
  4989. Drug-induced hypothermia by 5HT1A agonists provide Neuroprotection in experimental stroke: new perspectives for acute patient treatment
  4990. GPR30 activation is neither necessary nor sufficient for acute Neuroprotection by 17β-estradiol after an ischemic injury in organotypic hippocampal slice cultures
  4991. The Neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by …
  4992. The early stage formation of PI3K-AMPAR GluR2 subunit complex facilitates the long term Neuroprotection induced by propofol post-conditioning in rats
  4993. Neuroprotection against permanent focal cerebral ischemia by ginkgolides A and B is associated with obstruction of the mitochondrial apoptotic pathway via inhibition …
  4994. Astrocyte‐like cells derived from human oral mucosa stem cells provide Neuroprotection in vitro and in vivo
  4995. Neuroprotection by bilobalide in ischemia: improvement of mitochondrial function
  4996. Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes Neuroprotection in conscious hypertensive rats
  4997. Neuroprotection of a novel cyclopeptide C* HSDGIC* from the cyclization of PACAP (1–5) in cellular and rodent models of retinal ganglion cell apoptosis
  4998. RTCB-1 mediates Neuroprotection via XBP-1 mRNA splicing in the unfolded protein response pathway
  4999. Differential effects of synthetic progestagens on neuron survival and estrogen Neuroprotection in cultured neurons
  5000. Intermittent hypobaric hypoxia induces Neuroprotection in kainate-induced oxidative stress in rats
  5001. Effect of heparin on Neuroprotection against spinal cord ischemia and reperfusion in rats
  5002. Electroacupuncture preconditioning-induced Neuroprotection may be mediated by glutamate transporter type 2
  5003. Differential pattern of Neuroprotection in lumbar, cervical and thoracic spinal cord segments in an organotypic rat model of glutamate-induced excitotoxicity
  5004. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated Neuroprotection in stroke for middle-aged female rats
  5005. Albumin induces Neuroprotection against ischemic stroke by altering Toll-like receptor 4 and regulatory T cells in mice
  5006. FGF-2 released from degenerating neurons exerts microglial-induced Neuroprotection via FGFR3-ERK signaling pathway
  5007. Influence of delivery method on Neuroprotection by bone marrow mononuclear cell therapy following ventral root reimplantation with fibrin sealant
  5008. Current advances in neurotrauma research: diagnosis, Neuroprotection , and neurorepair
  5009. Copper-zinc superoxide dismutase (SOD1) is released by microglial cells and confers Neuroprotection against 6-OHDA neurotoxicity
  5010. The Neuroprotection of Rattin against amyloid β peptide in spatial memory and synaptic plasticity of rats
  5011. A military-centered approach to Neuroprotection for traumatic brain injury
  5012. Neuroprotection of ischemic postconditioning by downregulating the postsynaptic signaling mediated by kainate receptors
  5013. Bone marrow-derived mononuclear cells do not exert acute Neuroprotection after stroke in spontaneously hypertensive rats
  5014. The essential role of endothelial nitric oxide synthase activation in insulin-mediated Neuroprotection against ischemic stroke in diabetes
  5015. Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides Neuroprotection after brain hypoxia–ischemia in neonatal rats
  5016. Hypothermia plus erythropoietin for neonatal Neuroprotection ? Commentary on Fan et al. and Fang et al.
  5017. Prophylactic Neuroprotection with A91 improves the outcome of spinal cord injured rats
  5018. RNAi screening identifies GSK3β as a regulator of DRP1 and the Neuroprotection of lithium chloride against elevated pressure involved in downregulation of DRP1
  5019. Hypoxia-inducible factor 1 is essential for spontaneous recovery from traumatic brain injury and is a key mediator of heat acclimation induced Neuroprotection
  5020. PACAP signaling exerts opposing effects on Neuroprotection and neuroinflammation during disease progression in the SOD1 (G93A) mouse model of amyotrophic …
  5021. 2‐Methoxyestradiol confers Neuroprotection and inhibits a maladaptive HIF‐1α response after traumatic brain injury in mice
  5022. P2X7 receptor inhibition increases CNTF in the subventricular zone, but not neurogenesis or Neuroprotection after stroke in adult mice
  5023. Neuroprotection with non-feminizing estrogen analogues: An overlooked possible therapeutic strategy
  5024. Neuroprotection & mechanism of ethanol in stroke and traumatic brain injury therapy: new prospects for an ancient drug
  5025. Neuroprotection and neuroregeneration for retinal diseases
  5026. Antioxidant agents in Neuroprotection treatment of glaucoma
  5027. … sensitivity of acid-sensitive outwardly rectifying (ASOR) anion channels in cortical neurons is involved in hypothermic Neuroprotection against acidotoxic necrosis
  5028. Statin-induced T-lymphocyte modulation and Neuroprotection following experimental subarachnoid hemorrhage
  5029. Paraoxonase-2 (PON2) in brain and its potential role in Neuroprotection
  5030. The role of fatty acids in the regulation of cerebral vascular function and Neuroprotection in ischemia
  5031. Sustained Neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy
  5032. … normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for Neuroprotection
  5033. Dose-dependent Neuroprotection of VEGF165 in Huntington’s disease striatum
  5034. Electroacupuncture-induced Neuroprotection against cerebral ischemia in rats: role of the dopamine D2 receptor
  5035. Lymphocyte-mediated Neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways
  5036. Neuroprotection by monocarbonyl dimethoxycurcumin C: ameliorating the toxicity of mutant TDP-43 via HO-1
  5037. Spinal cord injury Neuroprotection and the promise of flexible adaptive clinical trials
  5038. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia
  5039. Involvement of TREK-1 activity in astrocyte function and Neuroprotection under simulated ischemia conditions
  5040. Emulsion-core and polyelectrolyte-shell nanocapsules: biocompatibility and Neuroprotection against SH-SY5Y cells
  5041. Histone deacetylase inhibition leads to Neuroprotection through regulation on glial function
  5042. Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood–brain Barrier
  5043. Mitochondrial mechanisms of neuroglobin’s Neuroprotection
  5044. Modulation of neuronal nicotinic receptor by quinolizidine alkaloids causes Neuroprotection on a cellular Alzheimer model
  5045. The future of ischemic stroke: flow from prehospital Neuroprotection to definitive reperfusion
  5046. Hemin offers Neuroprotection through inducing exogenous neuroglobin in focal cerebral hypoxic-ischemia in rats
  5047. Minocycline mechanism of Neuroprotection involves the Bcl-2 gene family in optic nerve transection
  5048. Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent Neuroprotection in rats after stroke
  5049. Fatty acid methyl esters and Solutol HS 15 confer Neuroprotection after focal and global cerebral ischemia
  5050. Are there cognitive and neurobehavioural correlates of hormonal Neuroprotection for women after TBI?
  5051. Neuroprotection and repair of 3′-blocking DNA ends by glaikit (gkt) encoding Drosophila tyrosyl-DNA phosphodiesterase 1 (TDP1)
  5052. Magnesium sulphate at 30 to 34 weeks’ gestational age: Neuroprotection trial (MAGENTA)-study protocol
  5053. Canadian journal of ophthalmology lecture: translational research advances in glaucoma Neuroprotection
  5054. Neuroprotection of a novel synthetic caffeic acid-syringic acid hybrid compound against experimentally induced transient cerebral ischemic damage
  5055. Neuroprotection for acute optic neuritis—Can it work?
  5056. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal Neuroprotection : the IRIS randomised trial
  5057. Prophylactic angiotensin type 1 receptor antagonism confers Neuroprotection in an aged rat model of postoperative cognitive dysfunction
  5058. Rosiglitazone attenuates cerebral vasospasm and provides Neuroprotection in an experimental rat model of subarachnoid hemorrhage
  5059. A Chinese medicine preparation induces Neuroprotection by regulating paracrine signaling of brain microvascular endothelial cells
  5060. Inhibition of N-myc Downstream–regulated Gene-2 Is Involved in an Astrocyte-specific Neuroprotection Induced by Sevoflurane Preconditioning
  5061. PPAR-γ activator induces Neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: In vivo and in vitro inhibition of …
  5062. Is cholesterol and amyloid-β stress induced CD147 expression a protective response? Evidence that extracellular cyclophilin a mediated Neuroprotection is reliant on …
  5063. Inhibition of transforming growth factor beta-activated kinase 1 confers Neuroprotection after traumatic brain injury in rats
  5064. IL-6, A1 and A2aR: A crosstalk that modulates BDNF and induces Neuroprotection
  5065. Nicotine-induced Neuroprotection against ischemic injury involves activation of endocannabinoid system in rats
  5066. An active component of Achyranthes bidentata polypeptides provides Neuroprotection through inhibition of mitochondrial-dependent apoptotic pathway in …
  5067. Vehicles for lipophilic drugs: implications for experimental design, Neuroprotection , and drug discovery
  5068. Lack of resveratrol Neuroprotection in developing rats treated with kainic acid
  5069. Sesamin suppresses activation of microglia and p44/42 MAPK pathway, which confers Neuroprotection in rat intracerebral hemorrhage
  5070. Substantial Neuroprotection Against K+ Deprivation‐Induced Apoptosis in Primary Cerebellar Granule Neurons by Novel Dimer Bis(propyl)‐Cognitin Via the …
  5071. Glutamate/glutamine metabolism coupling between astrocytes and glioma cells: Neuroprotection and inhibition of glioma growth
  5072. Intermittent hypoxia stimulates formation of binuclear neurons in brain cortex—A role of cell fusion in Neuroprotection ?
  5073. In vitro antiophidian mechanisms of Hypericum brasiliense choisy standardized extract: quercetin-dependent Neuroprotection
  5074. Angiotensin receptor type 2 activation induces Neuroprotection and neurogenesis after traumatic brain injury
  5075. Involvement of heme oxygenase-1 expression in Neuroprotection by piceatannol, a natural analog and a metabolite of resveratrol, against glutamate-mediated …
  5076. Soyasaponin I improved Neuroprotection and regeneration in memory deficient model rats
  5077. Restoring Neuroprotection through a new preclinical paradigm: translational success for NA-1 in stroke therapy
  5078. Transgenic overproduction of omega-3 polyunsaturated fatty acids provides Neuroprotection and enhances endogenous neurogenesis after stroke
  5079. Upregulation of Hsp72 mediates anoxia/reoxygenation Neuroprotection in the freshwater turtle via modulation of ROS
  5080. Neuroprotection by the synthetic neurosteroid enantiomers ent-PREGS and ent-DHEAS against Aβ 25–35 peptide-induced toxicity in vitro and in vivo in mice
  5081. Neuroprotection against neuroblastoma cell death induced by depletion of mitochondrial glutathione
  5082. SCO-spondin derived peptide NX210 induces Neuroprotection in vitro and promotes fiber regrowth and functional recovery after spinal cord injury
  5083. … pretreatment affecting antioxidant defense system and inflammatory, but not Nrf-2 signaling pathways resulted in female Neuroprotection and male neurotoxicity in the …
  5084. Kinin-B2 receptor exerted Neuroprotection after diisopropylfluorophosphate-induced neuronal damage
  5085. Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers Neuroprotection
  5086. Clinical implications of bilirubin-associated Neuroprotection and neurotoxicity
  5087. Melatonin: Therapeutic value and Neuroprotection
  5088. Stem cell-like dog placenta cells afford Neuroprotection against ischemic stroke model via heat shock protein upregulation
  5089. Probenecid: an emerging tool for Neuroprotection
  5090. Possible involvement of cathepsin B/D and caspase‐3 in deferoxamine‐related Neuroprotection of early brain injury after subarachnoid haemorrhage in rats
  5091. Cyclophilin-D inhibition in Neuroprotection : dawn of a new era of mitochondrial medicine
  5092. Total arch replacement using selective antegrade cerebral perfusion as the Neuroprotection strategy
  5093. Clinical efficacy and pharmacoeconomic characteristics of the Neuroprotection with low doses of cortexin in the treatment of acute ischemic stroke
  5094. No evidence of Neuroprotection ? Perhaps not… perhaps so
  5095. The role of mitochondrial calcium uniporter in Neuroprotection in traumatic brain injury
  5096. Phosphatase-Mediated Intracellular Signaling Contributes to Neuroprotection by Flavonoids of Iris tenuifolia
  5097. 2-(4-Methoxyphenyl) ethyl-2-acetamido-2-deoxy-β-d-pyranoside confers Neuroprotection in cell and animal models of ischemic stroke through calpain1/PKA/CREB …
  5098. The role and dynamics of β-catenin in precondition induced Neuroprotection after traumatic brain injury
  5099. Transient Lack of Glucose but not O2 is Involved in Ischemic Postconditioning‐Induced Neuroprotection
  5100. SOD1G93A transgenic mouse CD4+ T cells mediate Neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment
  5101. Modulation of paraoxonase 2 (PON2) in mouse brain by the polyphenol quercetin: a mechanism of Neuroprotection ?
  5102. Dopaminergic Neuroprotection via Nrf2-ARE pathway activation: identification of an activator from green perilla leaves
  5103. Mind your rhythms: an important role for circadian genes in Neuroprotection
  5104. Dock3 overexpression and p38 MAPK inhibition synergistically stimulate Neuroprotection and axon regeneration after optic nerve injury
  5105. 4-Hydroxybenzyl alcohol confers Neuroprotection through up-regulation of antioxidant protein expression
  5106. Baicalin’s therapeutic time window of Neuroprotection during transient focal cerebral ischemia and its antioxidative effects in vitro and in vivo
  5107. Lithium’s gene expression profile, relevance to Neuroprotection A cDNA microarray study
  5108. Neuroprotection and physical preconditioning: Exercise, Hypothermia, and hyperthermia
  5109. Transferred inter-cell ischemic preconditioning-induced Neuroprotection may be mediated by adenosine A1 receptors
  5110. Novel multitarget ligand ITH33/IQM9. 21 provides Neuroprotection in in vitro and in vivo models related to brain ischemia
  5111. Adamantane amine derivatives as dual acting NMDA receptor and voltage-gated calcium channel inhibitors for Neuroprotection
  5112. Extended normobaric hyperoxia therapy yields greater Neuroprotection for focal transient ischemia-reperfusion in rats
  5113. Neuroprotection of total steroid saponins from Dioscorea zingiberensis against transient focal cerebral ischemia-reperfusion injury in rats via anti-inflammatory and …
  5114. Metabolic adaptation and Neuroprotection differ in the retina and choroid in a piglet model of acute postnatal hypoxia
  5115. Critical role of large-conductance calcium-and voltage-activated potassium channels in leptin-induced Neuroprotection of N-methyl-d-aspartate-exposed cortical …
  5116. Launching Hsp70 Neuroprotection : two drugs better than one
  5117. Enhanced Neuroprotection and improved motor function in traumatized rat spinal cords by rAAV2-mediated glial-derived neurotrophic factor combined with early …
  5118. The nucleolus fine-tunes the orchestration of an early Neuroprotection response in neurodegeneration
  5119. A pilot study of darbepoetin alfa for prophylactic Neuroprotection in aortic surgery
  5120. Triggering receptor expressed on myeloid cells-2 correlates to hypothermic Neuroprotection in ischemic stroke
  5121. D-512 and D-440 as novel multifunctional dopamine agonists: characterization of Neuroprotection properties and evaluation of in vivo efficacy in a Parkinson’s disease …
  5122. Neuroprotection of up-regulated carbon monoxide by electrical acupuncture on perinatal hypoxic–ischemic brain damage in rats
  5123. High-mobility group box-1 induces decreased brain -derived neurotrophic factor-mediated Neuroprotection in the diabetic retina
  5124. AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific Neuroprotection in a Parkinson’s disease rat model
  5125. Sildenafil provides sustained Neuroprotection in the absence of learning recovery following the 4-vessel occlusion/internal carotid artery model of chronic …
  5126. Engraftment of mouse embryonic stem cells differentiated by default leads to Neuroprotection , behaviour revival and astrogliosis in parkinsonian rats
  5127. Neuroprotection of granulocyte colony-stimulating factor during the acute phase of transient forebrain ischemia in gerbils
  5128. Intracerebral administration of ultrasound-induced dissolution of lipid-coated GDNF microbubbles provides Neuroprotection in a rat model of Parkinson’s disease
  5129. Neuroprotection in glaucoma: current and emerging approaches
  5130. Normoxia and hyperoxia in Neuroprotection
  5131. Small-molecule anticonvulsant agents with potent in vitro Neuroprotection and favorable drug-like properties
  5132. Vinpocetine: hype, hope and hurdles towards Neuroprotection
  5133. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson’s rats: Neuroprotection by Serotonin, GABA and Bone …
  5134. High‐fat diet reduces Neuroprotection of isoflurane post‐treatment: Role of carboxyl‐terminal modulator protein‐Akt signaling
  5135. Neuroprotection in ischemic stroke: AhR we making progress?
  5136. DPP-4 inhibition and Neuroprotection : do mechanisms matter?
  5137. Benzothiazole aniline tetra (ethylene glycol) and 3-amino-1, 2, 4-triazole inhibit Neuroprotection against amyloid peptides by catalase overexpression in vitro
  5138. cognitive enhancement and Neuroprotection by catechin‐rich oil palm leaf extract supplement
  5139. Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing Neuroprotection (RIPCAGE): study protocol for a …
  5140. Sensory stimulation for lowering intraocular pressure, improving blood flow to the optic nerve and Neuroprotection in primary open-angle glaucoma
  5141. Autocrine and paracrine interactions and Neuroprotection in glaucoma
  5142. Technique and clinical evidence of Neuroprotection in carotid artery stenting
  5143. Water-soluble antioxidant derivative poly (triethylene glycol methyl acrylate-co-α-tocopheryl acrylate) as a potential prodrug to enable localized Neuroprotection
  5144. Chemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2. 1 channel confers acute Neuroprotection to HIV-1 glycoprotein gp120 exposure
  5145. miR-7-1 potentiated estrogen receptor agonists for functional Neuroprotection in VSC4. 1 motoneurons
  5146. Time course of Neuroprotection induced by normobaric hyperoxia and NCX1 expression
  5147. Creatine amides: perspectives for Neuroprotection
  5148. Neuroglobin: Neuroprotection and neurogenesis
  5149. SFRR-E Young Investigator AwardeeNOXing out stroke: Identification of NOX4 and 5 as targets in blood-brain -barrier stabilisation and Neuroprotection
  5150. Biological basis of Neuroprotection and neurotherapeutic effects of Whole Body Periodic Acceleration (pGz)
  5151. Neuroprotection and regeneration of the spinal cord
  5152. Involvement of heme oxygenase-1 in Neuroprotection by sanguinarine against glutamate-triggered apoptosis in HT22 neuronal cells
  5153. Extract of Antrodia camphorata exerts Neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence
  5154. Monocyte locomotion inhibitory factor produced by E. histolytica improves motor recovery and develops Neuroprotection after traumatic injury to the spinal …
  5155. Current concepts of perinatal ischemic injury in the brain neurovascular unit: molecular targets for Neuroprotection
  5156. Neurotoxicity and Neuroprotection in spinal cord injury
  5157. 17α‐Oestradiol‐Induced Neuroprotection in the brain of Spontaneously Hypertensive Rats
  5158. Neuroprotection by diarylpropionitrile in mice with spinal cord injury
  5159. Clinical Neuroprotection and secondary neuronal injury mechanisms
  5160. Blockade of Ser16-Hsp20 phosphorylation attenuates Neuroprotection dependent upon Bcl-2 and Bax
  5161. CNS Neuroprotection
  5162. Normothermia for Neuroprotection : It’s Hot to Be Cool
  5163. A modified chronic ocular hypertension rat model for retinal ganglion cell Neuroprotection
  5164. Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces Neuroprotection and neuroregeneration in a ubiquitin …
  5165. Grapevine stilbenoids: Bioavailability and Neuroprotection
  5166. Magnesium sulfate during anticipated preterm birth for infant Neuroprotection
  5167. Implementation of a clinical practice guideline for antenatal magnesium sulphate for Neuroprotection in A ustralia and N ew Z ealand
  5168. Erythropoietin Neuroprotection is enhanced by direct cortical application following subdural blood evacuation in a rat model of acute subdural hematoma
  5169. UPEI-300, a conjugate of lipoic acid and edaravone, mediates Neuroprotection in ischemia/reperfusion
  5170. Cone photoreceptor Neuroprotection conferred by CNTF in a novel in vivo model of battlefield retinal laser injury
  5171. … : mixed population of differentiated mouse embryonic stem cells, rather than magnetically sorted and enriched dopaminergic cells provide Neuroprotection
  5172. Neuroprotection Benedetto Falsini, Ronald A. Bush, Paul A. Sieving
  5173. Neuroprotection by exendin-4 is GLP-1 receptor specific but DA D3 receptor dependent, causing altered BrdU incorporation in subventricular zone and …
  5174. Pharmacological perioperative brain Neuroprotection : nimodipine?
  5175. Small synthetic hyaluronan disaccharides afford Neuroprotection in brain ischemia-related models
  5176. Chinese herbal medicines for Neuroprotection in ischemic stroke: promise and reality
  5177. Age-dependent Neuroprotection of retinal ganglion cells by tempol-C8 acyl ester in a rat NMDA toxicity model
  5178. Acute and sustained isoflurane Neuroprotection : the effect of culture age and duration of oxygen and glucose deprivation
  5179. Multifunctional Enzyme Inhibition for Neuroprotection -A Focus on MAO, NOS, and AChE Inhibitors
  5180. Biotechnology for Neuroprotection
  5181. Genetic Susceptibility Model of Parkinson’s Disease Resulting from Exposure of DJ-1 Deficient Mice to MPTP: Evaluation of Neuroprotection by Ubisol-Q 10
  5182. Small interfering RNA specific for N-methyl-D-aspartate receptor 2B offers Neuroprotection to dopamine neurons through activation of MAP kinase
  5183. Aprotinin, but not ε-aminocaproic acid and tranexamic acid, exerts Neuroprotection against excitotoxic injury in an in vitro neuronal cell culture model
  5184. Strategies for Neuroprotection in Glaucoma
  5185. Platelet-derived growth factor-BB is involved in mesenchymal stem cell secretome-induced Neuroprotection of retinal ganglion cells
  5186. Biotherapies in multiple sclerosis: A step toward remyelination and Neuroprotection ?
  5187. Neuroprotection versus neurotoxicity
  5188. The effect of an NgR1 antagonist on the Neuroprotection of cortical axons after cortical infarction in rats
  5189. Stroke following transcatheter aortic valve implantation. Is Neuroprotection justified?
  5190. … of transcutaneous electrical acupoint stimulation combined with general anesthesia or controlled hypotension on postoperative hippocampal Neuroprotection
  5191. Neuroprotection by μ-calpain and matrix metalloproteinases inhibition by Piroxicam in cerebral ischemia: an in silico study
  5192. Targeting the endocannabinoid system for Neuroprotection : a 19F-NMR study of a selective FAAH inhibitor binding with an anandamide carrier protein, HSA
  5193. Synthesis, Crystal Structure and Neuroprotection of Methyl 2-((4-(2-(2-Methylphenoxy) acetyl)-piperazin-1-yl)-methyl) benzoate
  5194. Intrinsic Neuroprotection in traumatic brain injury
  5195. Psychomotor seizure test, neurotoxicity and in vitro Neuroprotection assay of some semicarbazone analogues
  5196. Glutamate transporter type 3 mediates isoflurane preconditioning-induced acute phase of Neuroprotection in mice
  5197. “Tripping out” with the TRP superfamily and TRPV1 for novel Neuroprotection
  5198. Research and application of the recombinant human erythropoietin about Neuroprotection of patients with craniocerebral injury
  5199. Therapeutic hypothermia: effects beyond Neuroprotection
  5200. … -β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients-implication of novel neurotensin/NTSR1 pathway in Neuroprotection
  5201. Endogenous Neuroprotection : Hamartin modulates an austere approach to staying alive in a recession
  5202. Pigs as animal model for low-birth-weight babies. Developing cognitive tests and examining Neuroprotection
  5203. The modern aspects of Neuroprotection
  5204. Neuroprotection from induced glutamate excitotoxicity by
  5205. Effect on zebrafish neurodevelopment and Neuroprotection of a polyphenolic extract olive seeds
  5206. Lipopolysaccharide preconditioning induces Neuroprotection against early brain injury after experimental subarachnoid hemorrhage
  5207. Estrogen Effects on Traumatic brain Injury: Mechanisms of Neuroprotection and Repair
  5208. Preconditioning induces sustained Neuroprotection by down regulation of AMPK
  5209. Simultaneous inhibition of COX-2 and activation of PPAR-γ resulted in the same level and pattern of Neuroprotection as they were targeted separately
  5210. Neuroactive alkaloids that modulate the neuronal nicotinic receptor and provide Neuroprotection in an Alzheimer′ s disease model: the case of Teline …
  5211. Prehospital versus in‐hospital initiation of mild therapeutic hypothermia for survival and Neuroprotection after out‐of‐hospital cardiac arrest
  5212. Electrical stimulation and tinnitus: neuroplasticity, neuromodulation, Neuroprotection .
  5213. The Neuroprotection of brain -derived neurotrophic factor in experimental retinal detachment reattached
  5214. Neuroprotection of Persea major extract against oxygen and glucose deprivation in hippocampal slices involves increased glutamate uptake and modulation of A1 …
  5215. Protecting the brain during cardiac surgery: Does understanding the molecular mechanisms of cerebral injury provide insight into Neuroprotection strategies?
  5216. Flavones from the root of Scutellaria baicalensis Georgi—drug of the future in neurodegeneration and Neuroprotection
  5217. The effects of lornoxicam on Neuroprotection following diffuse traumatic brain injury in rats.
  5218. Neuroprotection for Photoreceptors
  5219. Low-dose GYKI-52466: Prophylactic preconditioning confers long-term Neuroprotection and functional recovery following hypoxic–ischaemic brain injury
  5220. Xenon delivery into subarachnoid hemorrhage via echogenic liposomes provides long-term Neuroprotection
  5221. cognitive reserve as Neuroprotection for cognitive functions in individuals with clinical hypertension
  5222. Plasma topiramate concentrations resulting from doses associated with Neuroprotection against white matter injury and stroke in two strains of rat pups
  5223. Mechanism Underlying Increased eNOS Expression and Neuroprotection in Mice With Targeted Deletion of ROCK2
  5224. Lycopersicon esculentum Miller: from by-products towards Neuroprotection
  5225. What KYNA Neuroprotection Do You Need?
  5226. Neuroprotection in perinatal hypoxic-ischemic encephalopathy–pharmacologic combination therapy
  5227. Real-time impedance-based cell analyzer as a tool to delineate molecular pathways involved in neurotoxicity and Neuroprotection in a neuronal cell line
  5228. Prevention of cerebral embolization by placing a Neuroprotection filter before recoarctation stent dilation
  5229. Pharmacological Neuroprotection of the brain during carotid artery surgery
  5230. Combination treatment with AcSDKP and tissue plasminogen activator provides potent Neuroprotection in rats after stroke
  5231. Recent advances in the study on Neuroprotection effects of resveratrol
  5232. NAMPT Neuroprotection
  5233. Neuroprotection by sex steroid hormones in Parkinson’s disease (P3. 068)
  5234. Procedures for fetal Neuroprotection : use of magnesium sulfate
  5235. Normobaric hyperoxia (HO) preconditioning induces durable and effective Neuroprotection against cerebral ischemia and mGluRII expression
  5236. Neuroprotection in the real world
  5237. Clinical Neuroprotection in relation to ophthalmology
  5238. Response to “No evidence of Neuroprotection ? Perhaps not… perhaps so”
  5239. Research Progress of Bioactive Polysaccharides in Neuroprotection and in the Prevention and Treatment of Alzheimer’s Disease
  5240. Possible future strategies in Neuroprotection
  5241. Current and emerging concepts in Neuroprotection
  5242. Neuroprotection in Glaucoma: the Odyssey against Degeneration
  5243. Combining hypothermia with other. therapies for neonatal Neuroprotection
  5244. Will the next breakthrough for Neuroprotection after cardiac arrest come out of thin air?
  5245. Retinal Neuroprotection using small molecule GDNF mimetics
  5246. Creatine for women in pregnancy for Neuroprotection of the fetus
  5247. Hypothermia for Neuroprotection in severe traumatic brain injury
  5248. Role of PSD-95 inhibitors in stroke and Neuroprotection : A systematic review on NA-1 (Tat-NR2B9c)
  5249. Neuroprotection In PICU
  5250. Retinal Neuroprotection in dry age-related macular degeneration
  5251. Mesenchymal stem cells and Neuroprotection after nerve root injury
  5252. Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF
  5253. … state induced by adenosine, lidocaine and magnesium administration after prolonged circulatory arrest improves cardioprotection and Neuroprotection in a rat model …
  5254. Neuroprotection in the NICU
  5255. The Nrf2-are pathway as a therapeutic target in traumatic brain injury: genetic and pharmacological approaches for Neuroprotection
  5256. BMP2 shows neurotrophic effects including Neuroprotection against neurodegeneration
  5257. Neuroprotection of overexpression of neuroglobin gene on injury of SH-SY5Y cells and relevant mechanism
  5258. HMGB1 suppression confers Neuroprotection against stroke in diabetic rats
  5259. Palmitoylethanolamide: a useful adjunct in chemotherapy providing analgesia and Neuroprotection
  5260. Neuroprotection in Glaucoma
  5261. Exogenous cell myelin repair and Neuroprotection in multiple sclerosis
  5262. Restoring Vision to the Blind: Neuroprotection
  5263. Identification and characterization of neural crest stem cells in rat olfactory mucosa as a use for cell-mediated Neuroprotection as treatment of glaucoma
  5264. New Approaches to Neuroprotection in Parkinson’s Disease
  5265. New Approaches to Neuroprotection in Parkinson’s
  5266. Ganglion cell Neuroprotection by angiotensin II blockers identified by drug screening in retinal explants
  5267. Neuroprotection in Glaucoma
  5268. Characterisation of lupin-derived lupeol with a metabolomics study of the impact and potential Neuroprotection of luepol
  5269. Hypothermia-induced Neuroprotection is associated with reduced mitochondrial membrane permeability in a swine model of cardiac arrest
  5270. Neuroprotection in Glaucoma: Is it a Myth or Reality?
  5271. Pharmacological strategies related to ocular Neuroprotection
  5272. Reply: Platelet-derived growth factor-BB may be involved in mesenchymal stem cell secretome-induced Neuroprotection of retinal ganglion cells
  5273. Sirtuin mediated Neuroprotection and its association with autophagy and apoptosis: Studies employing transgenic C. elegans model
  5274. Predicting natural Neuroprotection in marine mammals: Environmental and biological factors affecting the vulnerability to acoustically mediated tissue trauma in …
  5275. Pharmacological preconditioning with GYKI-52466: a prophylactic approach to Neuroprotection against ischaemic stroke in the rat
  5276. Transcranial low-level light therapy produces Neuroprotection , neurogenesis and BDNF after TBI in mice
  5277. Neuroprotection for Retinal Detachment
  5278. Phoenix dactylifera conferred Neuroprotection against lead acetate induced neuronal damage on the occipital cortex of Wistar rats
  5279. Cone Neuroprotection afforded by Brimonidine and BDNF in a new model of focal Light-Emitting-Diode (LED)-induced phototoxicity
  5280. Perfusion of a cerebral protective solution enhances Neuroprotection in a rabbit model of occlusion-reperfusion: prolonged cerebral dormancy time
  5281. Mécanismes de Neuroprotection de stéroïdes neuroactifs de la toxicité du MPTP
  5282. Intranasal delivery of pGDNF nanoparticles provides Neuroprotection in the rat 6‐hydroxydopamine model of Parkinson’s disease
  5283. In vitro assay systems in the development of therapeutic interventions strategies for Neuroprotection and repair
  5284. Procedures for fetal Neuroprotection : use of magnesium sulfate
  5285. Neuroprotection by Lowering Cholesterol
  5286. Possible reasons for a miss match between animal Neuroprotection studies and clinical findings
  5287. MgSO4 for Neuroprotection
  5288. Neuroprotection by erythropoietin-a review.
  5289. Estrogen Signaling through Estrogen Receptor Alpha in Astrocytes Mediates Neuroprotection during Experimental Autoimmune Encephalomyelitis and Decreases …
  5290. The neuroscience of glaucoma in relation to the possibility for Neuroprotection
  5291. Computational Therapeutic Hypothermia Model for Neuroprotection Treatment
  5292. The possible role of peritoneal dialysis in Neuroprotection : 7AP4-5
  5293. Neuroprotection of Pabing Formula I for Rats with Parkinson’s Disease
  5294. Hypercapnia and Neuroprotection : Goldilocks Returns
  5295. Mesenchymal stem cells nanovesicles: An innovative therapeutic approach for Neuroprotection and neuroregeneration
  5296. mGluR3 and astrocytes: partners in Neuroprotection
  5297. Neuroprotection from excitotoxic RGC death: is there a role for MMPs?
  5298. Roles of the Retinal Pigment Epithelium in Neuroprotection
  5299. Neuroprotection in hypertensive patients: Minimization of poor prognosis
  5300. Molecular mechanisms of ischemic preconditioning mediated Neuroprotection
  5301. Role of Nrf2 in Neuroprotection and its mechanisms
  5302. CD4+ T cells and Neuroprotection : Relevance to motoneuron injury and ALS
  5303. The Role of Neuroprotection in the Treatment of Hypertensive Encephalopathy
  5304. Antioxidative Treatment for Neuroprotection in Glaucoma
  5305. Targeting the Cell Cycle for Cancer Treatment and Neuroprotection
  5306. Autoimmunity and Neuroprotection in glaucoma
  5307. Inhibition of Sirtuin 2 exerts Neuroprotection in aging rats with increased neonatal iron intake
  5308. Neuroprotection in Demyelinating Diseases: The Therapeutic Potential of the Neurotrophins
  5309. Modeling Neurodegeneration and Neuroprotection in Hippocampal
  5310. brain Sciences Special Issue: Neuroprotection against Ischemic brain Injury
  5311. Pharmacological Neuroprotection for Acute Spinal Cord Injury
  5312. Urate and Neuroprotection trials–Authors’ reply
  5313. Modulation of Retinal Ganglion Cell Function and Implications for Neuroprotection
  5314. ERYTHROPOIETIN Neuroprotection IS ENHANCED BY DIRECT
  5315. RGC Neuroprotection by Manipulating ER Stress Signaling Molecules
  5316. Neuronal Death and Neuroprotection after Stroke and brain Trauma
  5317. Editorial (Hot Topic: Neuroprotection and Neuroregeneration in Ischemic Stroke: Emerging Treatment Strategies and Potential Molecular Targets)
  5318. A Phase II Trial Of Neuroprotection With Riluzole In Early Relapsing-Remitting MS: Lessons For Future Neuroprotection Trials (I7-1.006)
  5319. Pharmacological perioperative brain Neuroprotection : A qualitative review of randomized clinical trials
  5320. A Phase II Trial Of Neuroprotection With Riluzole In Early Relapsing-Remitting MS: Lessons For Future Neuroprotection Trials (P5. 017)
  5321. Role of glial activation in Neuroprotection of the retina
  5322. O1. 4REHABILITATION AND Neuroprotection : USE OF EXERCISE AND ENVIRONMENT IN FAS (MODEL)
  5323. Preconditioning and Neuroprotection in the Immature brain
  5324. PI3K/Akt signaling pathway and Neuroprotection
  5325. Advances in optic nerve regeneration and Neuroprotection strategies
  5326. The Interplay Between White Matter, Mitochondria, and Neuroprotection
  5327. Hemofiltration-induced Neuroprotection following ischemic stroke
  5328. Retina-specific T cells provide Neuroprotection in a model of glaucoma
  5329. Cytochrome P450 2C9 Is a Target for Photoreceptor Neuroprotection
  5330. Neuroprotection of cone photoreceptors in retinitis pigmentosa
  5331. Neuroprotection after perinatal asphyxia: mitochondrial and inflammatory targets
  5332. Cyclophilin-D Inhibition in Neuroprotection : Dawn of a New Era
  5333. Molecular Mechanisms of Neuroprotection by an Alternative Drug Scutellaria lateriflora
  5334. THE ROLE OF EPENDYMOSECRETION AND SUBEPENDYMAL GLIA IN Neuroprotection
  5335. The Neuroprotection of Angiotensin-(1-7) in Tg (RHO P347S) and rd10 mice
  5336. Neuroprotection by Chitosan and Chitosan Nanoparticles
  5337. Modulation of pro-inflammatory response of retina by adenosinergic systems: neuroinflammation/Neuroprotection
  5338. Neuroprotection gene therapy in retinal degeneration
  5339. Evidence Based Medicine Review: Benefit of Neuroprotection in acute ischaemic stroke, shall we dare to hope?
  5340. Mechanisms of Mitochondrial Regulation and Ischemic Neuroprotection by the PKC? Pathway
  5341. Remote ischemia: effects on retinal function and Neuroprotection in a light damage model
  5342. Bone marrow stromal cell: mediated Neuroprotection for spinal cord repair
  5343. Neuroprotection in Parkinson’s Disease: Controlling Mitochondria-dependent Apoptosis
  5344. Dexmedetomidine causes Neuroprotection via astrocytic α
  5345. The effects of peritoneal dialysis on blood glutamate levels: Implementation for Neuroprotection
  5346. Mechanism of noble gas Neuroprotection in an in vitro model of traumatic brain injury
  5347. Research progress on effects of indirubin and its structurally similar compounds on anticancer and Neuroprotection
  5348. Cochrane in context: Hypothermia for Neuroprotection in children after cardiopulmonary arrest
  5349. Acetyl-L-Carnitine Neuroprotection in Mitochondrial Dysfunction
  5350. Neuroprotection of Melatonin in Lipopolysaccaride-induced Alzheimer’s Disease in rats
  5351. Neuroprotection Against Ischemic brain Injury with Methylene Blue (P1. 104)
  5352. Hypoxic–ischemic brain injury and Neuroprotection in the newborn infant
  5353. Neuroprotection of estrogen of hypothalamic cell line due to hypoglycemic injury
  5354. Characterization and Therapeutic Potential of Human Amniotic Fluid Cells in Mediating Neuroprotection
  5355. Amyloid precursor protein-mediated Neuroprotection and processing in the aged retina
  5356. Investigation on Neuroprotection of Pioglitazone and its mechanisms in rats with cerebral ischemia reperfusion injury
  5357. Neuroprotection by Endothelial Progenitor Cells for Retinal Degeneration
  5358. Cell death Neuroprotection and repair mechanisms in a model of rat spinal cord injury in vitro
  5359. Targeted temperature management for Neuroprotection in adults after cardiac arrest: an integrative review
  5360. Mechanisms of Neuroprotection by Latanoprost for Retinal Ganglion Cells under Hypoxia
  5361. Neurodegeneration after cardiac arrest: Cell death mechanisms and methods of Neuroprotection
  5362. Exogenous T3 administration provides Neuroprotection in a murine model of traumatic brain injury
  5363. Neuroprotection of Dopaminergic Neurons and their Subcellular Structures from Parkinson’s Disease-like Treatment
  5364. Neurotoxicity induced by bortezomib. Study of toxicity and evaluation of Neuroprotection in a mouse model
  5365. Mechanisms of Neuroprotection Against Retinal Ganglion Cell Loss Using an In Vivo Glaucoma Model
  5366. The mechanism of miR-181c induced Neuroprotection by hypoxia preconditioning in rats
  5367. Abstract WMP70: HIF-1alpha Sumoylation Provides Neuroprotection in Ischemic Stroke
  5368. Lovastatin in combination with metformin provides Neuroprotection in experimental animal model of multiple sclerosis (P5195)
  5369. Delineation of the molecular and genetic role of teneurin C-terminal associated peptide-1 (TCAP-1) in cytoskeletal development and Neuroprotection against stress
  5370. Editorial (Thematic Issue: Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD)
  5371. SECONDARY MEMBRANE DAMAGE AND THE POTEN-TIAL FOR MEMBRANE-TARGETED Neuroprotection
  5372. Effects of Antenatal Exposure to Magnesium Sulfate on Neuroprotection in Preterm Infants
  5373. Janus-faced Taurine: Neuroprotection and Toxicity
  5374. Engineered smart tools for neurodegenerative disorders: chondroitin sulphate delivery in Neuroprotection
  5375. Distal Neuroprotection system as option for right subclavian artery ostial recanalization
  5376. Genetic engineering of a TNFR2 agonist to promote immunomodulation and Neuroprotection
  5377. Abstract T P223: Role of GSK-3ß and Transforming Growth Factor-ß-activated Kinase in Ischemic Neuroprotection
  5378. The Experiment Research of Neuroprotection of Hypoperfusion Postconditioning on Cerebral Ischemia
  5379. Corrigendum to “Neuroprotection by IL-10 producing MOG CD4+ T-cells following ischemic stroke”[J Neurol Sci 233 (2005) 125–132]
  5380. Serotonin Receptor Modulation and Neuroprotection in Models of Light Damage and Retinal Degeneration
  5381. How Do Subcellular Organelles Participate in Preconditioning-Conferred Neuroprotection ?
  5382. Advances in research on early brain injury and therapeutic options for Neuroprotection following subarachnoid hemorrhage.
  5383. Investigation of the endoplsmic reticulum calcium stores for their potential roles in Neuroprotection using the NG115-401L neuronal cell line model
  5384. Novel tricycloundecane derivatives as potential N-methyl-Daspartate receptor and calcium channel inhibitors for Neuroprotection
  5385. Pharmacological hypothermia by Trpv1 agonism provides Neuroprotection following ischemic stroke (877.13)
  5386. Molecular Mechanisms of Neuroprotection and cognitive Enhancement by an Alternative drug Centella asiatica
  5387. MRI characterization of mild traumatic brain injury in rats and evaluation of Neuroprotection by methylene blue
  5388. Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
  5389. Calcitriol imparts Neuroprotection to midbrain dopaminergic neurons through up-regulation of GDNF
  5390. CereboostTM, an American Ginseng Extract, Improves cognitive Function via Up-regulation of ChAT Expression and Neuroprotection
  5391. SIRT1 silencing confers Neuroprotection through IGF-1 pathway activation
  5392. Connexin expression in CNS: Pathological significance and Lithium-mediated Neuroprotection
  5393. EXCITATORY AND INHIBITORY PATHWAYS FOR ANOXIC PRECONDITIONING Neuroprotection IN HIPPOCAMPAL
  5394. Hypothermic Total Liquid Ventilation Offers Neuroprotection After Non-Shockable Cardiac Arrest
  5395. The Neuroprotection of cinepazide maleate on acute cerebral ischemic brain in rats: a proton magnetic spectroscopy study
  5396. Abstract WMP31: Neamine, A Angiogenin Inhibitor, Induces Neuroprotection After Acute Ischemic Stroke In Type One Diabetic Rats
  5397. Testosterone Mediated Neuroprotection from FasL Induced Apoptosis within Purkinje Cells
  5398. ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride (S31. 002)
  5399. Abstract T P204: Thioredoxin Interacting Protein: A Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice
  5400. Abstract WMP32: Immunomodulation and Neuroprotection by Progesterone in Infections following Ischemic brain Injury in Middle-Aged Rats
  5401. Modulation of Mitochondrial Function and Autophagy during Ischemic Neuroprotection by Carnosine
  5402. The signal pathway of SIRT1 underlying the Neuroprotection in NMDA-induced excitotoxicity
  5403. Alterations in energy metabolism, Neuroprotection and visual signal transduction in the retina of parkinsonian, MPTP-treated monkeys
  5404. Gene therapy mediated Neuroprotection of the neuromuscular junction in the spinal muscular atrophy
  5405. Erythromycin induced Neuroprotection during prolonged deep hypothermic circulatory arrest in an acute porcine model
  5406. Cannabidiol for Neuroprotection in newborn hypoxic-ischemic encephalopathy: pharmacological aspects and mechanisms of action
  5407. Study of phenotypιc changes in cortical neuron cultures induced by mesenchymal stem cells CM during Neuroprotection against glutamate-induced cell death
  5408. Cdp-Choline Neuroprotection and Vascular Remodelling Via Irs-1 Mechanisms in Vascular Dementia
  5409. Abstract WP62: Enhanced Neuroprotection of Normobaric Oxygenation with Ethanol Conferred by Apoptosis Reduction in Acute Ischemic Stroke
  5410. Mesenchymal stem cell based ex vivo gene therapy provides enhanced Neuroprotection in X-linked retinoschisis mouse model
  5411. BDNF-overexpression augments bone marrow stromal cell-mediated Neuroprotection in the contused rat spinal cord
  5412. Effects of hyperbaric oxygen preconditioning on expression of P2X7 receptor and its Neuroprotection for cerebral ischemia in mice [J]
  5413. Neuroprotection from the huntingtin-repressed transcriptional coactivator PGC-1α
  5414. Neural Progenitor Cell Transplantation and Proneurogenic Compound Administration Improve Outcomes After Trauma: Neuroprotection and Neurogenesis for the …
  5415. Repeated Doses of Dodecafluoropentane Emulsion Provide Neuroprotection Up to 24 Hours Following Cerebral Artery Occlusion in Rabbits
  5416. Anti-inflamatory Effect of Tanshinone I in Neuroprotection Against Cerebral Ischemia-reperfusion Injury in the Gerbil Hippocampus
  5417. Neuroprotection during anoxic stress in Drosophila melanogaster: The role of PKG pathway on protection of function and survival
  5418. Neuroprotection by Antiinflammatory and Antioxidative Flavone, Eupatilin, in Mice with Cerebral Focal Ischemia Reperfusion Injury
  5419. Abstract WP124: Targeting Prodeath Signaling Upstream Of Mitochondria Damage-cathepsins In Astrocytes Contributes To Neuroprotection Against Cerebral Ischmia
  5420. Ursolic acid promotes the Neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice
  5421. Annexin-A1 Bioactive Peptide Provides Neuroprotection by Attenuating Microglial Activation Following Cardiac Surgery in Rats
  5422. In vivo therapeutic modulation of stress response signaling by Pitanga (Eugenia uniflora) extracts in C. elegans for Neuroprotection (829.24)
  5423. CDP-Choline Neuroprotection and Vascular Remodeling via IRS-1 mechanisms in Vascular Dementia-Growing Neurons ATOP Microelectronic chips as a new model …
  5424. Flying before diving: induction of Neuroprotection against CNS‐oxygen toxicity (CNS‐OT) seizures while breathing 100% oxygen at 5 atmospheres absolute (ATA)
  5425. Role of Akt-GSK3β signaling pathway in long-term Neuroprotection induced by propofol postconditioning in a rat model of focal cerebral ischemia/reperfusion injury
  5426. Targeting prodeath signaling upstream of mitochondria damage-cathepsins in astrocytes contributes to Neuroprotection against cerebral ischmia
  5427. Elucidating the role of microglial group III metabotropic glutamate receptors in microglial inflammation: focus on Parkinson’s disease and Neuroprotection
  5428. Eye drops containing pigment epithelium-derived factor promotes retinal ganglion cell Neuroprotection and axon regeneration
  5429. MAP Kinase Signaling Differences between Neural Stem Cells and Glioma Cells Provide a Mechanism for Selective Neuroprotection During Cranial Irradiation
  5430. Minor project: Investigating Neuroprotection and working mechanism of human TNFR1 antagonist (ATROSAB) and human TNFR2 agonist (TNC-scTNF) in hTNFR …
  5431. Abstract T P326: Additive Neuroprotection of a 20-hete Inhibitor with Delayed Therapeutic Hypothermia after Asphyxic Cardiac Arrest in Neonatal Piglets
  5432. Predegenerated Schwann cells promote Neuroprotection and regeneration of retinal ganglion cells in ex vivo rat retinal explants
  5433. Short-term exposure to nickel alters the adult rat brain antioxidant status and the activities of crucial membrane-bound enzymes: Neuroprotection by L-cysteine.
  5434. Ceftriaxone provides Neuroprotection against global brain ischemia via modulating glial glutamate transporter-1
  5435. PROGESTERONE INHIBITS ESTROGEN-MEDIATED Neuroprotection AGAINST EXCITOTOXICITY BY DOWN-REGULATING ESTROGEN RECEPTOR-β
  5436. Carbenoxolone Exerts Neuroprotection in an Animal Model of Parkinson’s Disease Induced by Proteasome Inhibitor MG-132.
  5437. Therapeutic hypothermia achieves Neuroprotection via a decrease in acetylcholine with a concurrent increase in carnitine in the neonatal hypoxia‐ischemia (877.2)
  5438. Defining premotor Parkinson’s disease: a window of opportunity for Neuroprotection ?
  5439. Mitochondrial dysfunction in Parkinson’s disease: a possible target for Neuroprotection
  5440. 5-HT7 Receptor Neuroprotection against Excitotoxicity in the Hippocampus
  5441. Roles of Nitric Oxide in Delta Opioid-Receptor Agonist (SNC 121) Mediated Retina Neuroprotection in Chronic Glaucoma Rat Model
  5442. IL-6, A1 and A2aR: A crosstalk that modulates BDNF and induces Neuroprotection
  5443. Maternal n‐3 Fatty Acid Supplementation Before and During Pregnancy Provides Neuroprotection after Neonatal Hypoxic‐ischemic brain Injury
  5444. High-mobility group box-1 induces decreased brain -derived neurotrophic factor-mediated Neuroprotection in the diabetic retina
  5445. Omega-3 fatty acids and Neuroprotection in pregnancy
  5446. Research on Dihuang Yinzi Decoction’s Neuroprotection effects on MCAO rats from the HPA axis reaction and apoptosis aspects
  5447. KALLIKREIN-1 AS A POTENTIAL BIOMARKER OF GLOBAL CEREBRAL ISCHEMIA AND Neuroprotection IN JUVENILE MICE
  5448. Caspase-8 inhibition for immunomodulation and Neuroprotection in glaucoma
  5449. 2 Paraoxonase-2 (PON2) in brain and its potential role in 3 Neuroprotection
  5450. O-013 Lactoferrin In Inflammatory Neonatal Rat brain Injury: A Nutrient For Neuroprotection ?
  5451. Commentary-1 (Research Highlights: USP30 Regulates the Mitophagy-Mediated Neuroprotection in Parkinson’s Disease)
  5452. Abstract W P201: Angiopoietin-1 Mimetic Peptide Treatment of Stroke Regulates MicroRNA Expression and Promotes Neuroprotection in Type One Diabetic Rats
  5453. Abstract T P83: The CYP Epoxygenase Metabolite of Arachidonic Acid 14, 15-Epoxyeicosatrienoic Acid: a Novel Therapeutic Target in Neuroprotection
  5454. Interrelation between Interleukin-6 and Ceruloplasmin in the Neuroprotection in Response to Kainic Acid-induced Excitotoxicity
  5455. 96. Anti-depressants and kynurenine pathway inhibition: A therapeutic strategy for Neuroprotection in vitro?
  5456. TIMP-1 loaded nanoparticles: A therapeutic strategy for Neuroprotection
  5457. The Dual Role of Hypoxia-Inducible Factor-1 in Ischemic Stroke: Neuroprotection and Blood-brain Barrier Disruption
  5458. Neuroprotection and antioxidants
  5459. Inflammation and Neuroprotection in traumatic brain injury
  5460. Microglia and Neuroprotection
  5461. Neuroprotection for ischaemic stroke: current status and challenges
  5462. Hypothermia for Neuroprotection in adults after cardiopulmonary resuscitation
  5463. Neuroprotection in glaucoma
  5464. Current perspective of Neuroprotection and glaucoma
  5465. Inflammatory Neuroprotection following traumatic brain injury
  5466. Anti-inflammatory role of microglial alpha7 nAChRs and its role in Neuroprotection
  5467. Physical exercise, reactive oxygen species and Neuroprotection
  5468. Nucleotides in neuroregeneration and Neuroprotection
  5469. Mechanisms of Neuroprotection by quercetin: counteracting oxidative stress and more
  5470. Astrocytes, therapeutic targets for Neuroprotection and neurorestoration in ischemic stroke
  5471. Neuroprotection in acute brain injury: an up-to-date review
  5472. New horizons for newborn brain protection: enhancing endogenous Neuroprotection
  5473. Neuroprotection for traumatic brain injury
  5474. Preterm birth and the role of Neuroprotection
  5475. Erythropoietin and neonatal Neuroprotection
  5476. Update on anesthetic Neuroprotection
  5477. Prehospital use of magnesium sulfate as Neuroprotection in acute stroke
  5478. Cannabidiol, Neuroprotection and neuropsychiatric disorders
  5479. Rational modulation of the innate immune system for Neuroprotection in ischemic stroke
  5480. Neuroprotection by saponins
  5481. Neuroprotection as a therapeutic target for diabetic retinopathy
  5482. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation
  5483. Neuroprotection in preterm infants
  5484. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview
  5485. Hypothermia for Neuroprotection in convulsive status epilepticus
  5486. Neuroprotection trials in traumatic brain injury
  5487. Progesterone Neuroprotection : the background of clinical trial failure
  5488. Sex differences in mitochondrial (dys) function: Implications for Neuroprotection
  5489. Neuronal changes in the diabetic cornea: perspectives for Neuroprotection
  5490. Translating mechanisms of Neuroprotection , regeneration, and repair to treatment of spinal cord injury
  5491. An introduction to the roles of purinergic signalling in neurodegeneration, Neuroprotection and neuroregeneration
  5492. Melatonin use for Neuroprotection in perinatal asphyxia: a randomized controlled pilot study
  5493. Current trends in cannulation and Neuroprotection during surgery of the aortic arch in Europe
  5494. A novel mechanism of Neuroprotection : blood glutamate grabber
  5495. Neuroprotection by selective neuronal deletion of Atg7 in neonatal brain injury
  5496. Progesterone and allopregnanolone in the central nervous system: response to injury and implication for Neuroprotection
  5497. Endocannabinoids in synaptic plasticity and Neuroprotection
  5498. Creatine for Neuroprotection in neurodegenerative disease: end of story?
  5499. New strategies for Neuroprotection in glaucoma, a disease that affects the central nervous system
  5500. Non-coding RNAs in stroke and Neuroprotection
  5501. Effects and safety of magnesium sulfate on Neuroprotection : a meta-analysis based on PRISMA guidelines
  5502. Phenytoin for Neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
  5503. Purine nucleosides in neuroregeneration and Neuroprotection
  5504. Glaucoma: focus on mitochondria in relation to pathogenesis and Neuroprotection
  5505. Exercise after spinal cord injury as an agent for Neuroprotection , regeneration and rehabilitation
  5506. Resveratrol Neuroprotection in stroke and traumatic CNS injury
  5507. Pharmacologic Neuroprotection for functional outcomes after traumatic brain injury: a systematic review of the clinical literature
  5508. Cardiorespiratory fitness and cognitive function in midlife: Neuroprotection or neuroselection?
  5509. Neuroprotection of coenzyme Q10 in neurodegenerative diseases
  5510. Neuroprotection by estrogen and progesterone in traumatic brain injury and spinal cord injury
  5511. Potential for brain accessibility and analysis of stability of selected flavonoids in relation to Neuroprotection in vitro
  5512. Design of acute Neuroprotection studies
  5513. Melatonin as an antioxidant for stroke Neuroprotection
  5514. Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to Neuroprotection and neurogenesis
  5515. Vitamin D in clinically isolated syndrome: evidence for possible Neuroprotection
  5516. Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond Neuroprotection
  5517. Oxidative stress is a central target for physical exercise Neuroprotection against pathological brain aging
  5518. A probable dual mode of action for both L-and D-lactate Neuroprotection in cerebral ischemia
  5519. Signaling pathways leading to ischemic mitochondrial Neuroprotection
  5520. Focus: the aging brain : neurodegeneration and Neuroprotection in glaucoma
  5521. Natural compounds and Neuroprotection : mechanisms of action and novel delivery systems
  5522. Neurodegeneration as a primary change and role of Neuroprotection in diabetic retinopathy
  5523. Neuroprotection , growth factors and BDNF-TrkB signalling in retinal degeneration
  5524. Glutamate-mediated blood–brain barrier opening: implications for Neuroprotection and drug delivery
  5525. The Neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K/AKT and MAPK pathways
  5526. PINK1-induced mitophagy promotes Neuroprotection in Huntington’s disease
  5527. Neuroprotection for perinatal hypoxic ischemic encephalopathy in low-and middle-income countries
  5528. NF-κB in innate Neuroprotection and age-related neurodegenerative diseases
  5529. Expanding the concept of Neuroprotection for acute ischemic stroke: the pivotal roles of reperfusion and the collateral circulation
  5530. Thioredoxin-interacting protein: a novel target for Neuroprotection in experimental thromboembolic stroke in mice
  5531. Idebenone and Neuroprotection : antioxidant, pro-oxidant, or electron carrier?
  5532. p53 isoforms regulate astrocyte-mediated Neuroprotection and neurodegeneration
  5533. Melatonin for women in pregnancy for Neuroprotection of the fetus
  5534. An open‐label evaluator‐blinded clinical study of minocycline Neuroprotection in ischemic stroke: gender‐dependent effect
  5535. Safety of early high-dose recombinant erythropoietin for Neuroprotection in very preterm infants
  5536. Edaravone’s free radical scavenging mechanisms of Neuroprotection against cerebral ischemia: review of the literature
  5537. Remote ischemic preconditioning‐mediated Neuroprotection against stroke is associated with significant alterations in peripheral immune responses
  5538. Systemically administered brain -targeted nanoparticles transport peptides across the blood—brain barrier and provide Neuroprotection
  5539. Mechanism of microglia Neuroprotection : involvement of P2X 7, TNF α, and valproic acid
  5540. Major pathogenic mechanisms in vascular dementia: roles of cellular stress response and hormesis in Neuroprotection
  5541. Insulin Neuroprotection and the mechanisms
  5542. TREM2 modifies microglial phenotype and provides Neuroprotection in P301S tau transgenic mice
  5543. The molecular pathway of argon-mediated Neuroprotection
  5544. Neuroprotection in ischemic stroke: what does the future hold?
  5545. Progesterone for Neuroprotection in pediatric traumatic brain injury
  5546. Oligodendrocyte regeneration: Its significance in myelin replacement and Neuroprotection in multiple sclerosis
  5547. Targeting brain microvascular endothelial cells: a therapeutic approach to Neuroprotection against stroke
  5548. Mesenchymal stromal cell–mediated Neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
  5549. Evidence to support mitochondrial Neuroprotection , in severe traumatic brain injury
  5550. Astrocytes from old Alzheimer’s disease mice are impaired in Aβ uptake and in Neuroprotection
  5551. Compound K derived from ginseng: Neuroprotection and cognitive improvement
  5552. Oxytocin modulates GABA AR subunits to confer Neuroprotection in stroke in vitro
  5553. Chronic exercise confers Neuroprotection in experimental autoimmune encephalomyelitis
  5554. Taming glutamate excitotoxicity: strategic pathway modulation for Neuroprotection
  5555. Selecting patients for intra-arterial therapy in the context of a clinical trial for Neuroprotection
  5556. Neuroprotection requires the functions of the RNA-binding protein HuR
  5557. Tetrahydrocurcumin provides Neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism
  5558. Xuefu Zhuyu decoction, a traditional Chinese medicine, provides Neuroprotection in a rat model of traumatic brain injury via an anti-inflammatory pathway
  5559. Ischemic preconditioning provides Neuroprotection by induction of AMP-activated protein kinase-dependent autophagy in a rat model of ischemic stroke
  5560. Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in Neuroprotection against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced …
  5561. CNTF gene therapy confers lifelong Neuroprotection in a mouse model of human retinitis pigmentosa
  5562. Metformin preconditioning provide Neuroprotection through enhancement of autophagy and suppression of inflammation and apoptosis after spinal cord injury
  5563. Acute carbon monoxide poisoning and delayed neurological sequelae: a potential Neuroprotection bundle therapy
  5564. Neuroprotection of osthole against cerebral ischemia/reperfusion injury through an anti-apoptotic pathway in rats
  5565. Synergistic Neuroprotection by epicatechin and quercetin: activation of convergent mitochondrial signaling pathways
  5566. Cerebrovascular safety of sulfonylureas: the role of KATP channels in Neuroprotection and the risk of stroke in patients with type 2 diabetes
  5567. The role of AMPK pathway in Neuroprotection
  5568. Polyphenon E, non-futile at Neuroprotection in multiple sclerosis but unpredictably hepatotoxic: phase I single group and phase II randomized placebo …
  5569. Gaps between aims and achievements in therapeutic modification of neuronal damage (“Neuroprotection ”)
  5570. Resveratrol provides Neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats
  5571. Pre‐hospital versus in‐hospital initiation of cooling for survival and Neuroprotection after out‐of‐hospital cardiac arrest
  5572. Gene Therapy: A Promising approach for Neuroprotection in Parkinson’s disease?
  5573. Astrocytes as a target for Neuroprotection : modulation by progesterone and dehydroepiandrosterone
  5574. Lithium-induced Neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory …
  5575. Towards axonal regeneration and Neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
  5576. Neuronal networks provide rapid Neuroprotection against spreading toxicity
  5577. Molecular mechanisms of estrogen for Neuroprotection in spinal cord injury and traumatic brain injury
  5578. Ethoxyquin provides Neuroprotection against cisplatin-induced neurotoxicity
  5579. Activated protein C promotes Neuroprotection : mechanisms and translation to the clinic
  5580. Dexmedetomidine–induced Neuroprotection : is it translational?
  5581. Drugs for Neuroprotection after birth asphyxia: pharmacologic adjuncts to hypothermia
  5582. Pathophysiology and Neuroprotection of global and focal perinatal brain injury: lessons from animal models
  5583. Targeting repulsive guidance molecule A to promote regeneration and Neuroprotection in multiple sclerosis
  5584. Estrogen-IGF-1 interactions in Neuroprotection : ischemic stroke as a case study
  5585. Gliptin‐mediated Neuroprotection against stroke requires chronic pretreatment and is independent of glucagon‐like peptide‐1 receptor
  5586. brain train to combat brain drain; focus on exercise strategies that optimize Neuroprotection
  5587. The Neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling
  5588. Animal studies of neonatal hypothermic Neuroprotection have translated well in to practice
  5589. Astrocytes in Neuroprotection and neurodegeneration: the role of connexin43 and pannexin1
  5590. Retinoic acid-loaded polymeric nanoparticles induce Neuroprotection in a mouse model for Parkinson’s disease
  5591. Perinatal Neuroprotection for extremely preterm infants
  5592. Neuroactive gonadal drugs for Neuroprotection in male and female models of Parkinson’s disease
  5593. Dexmedetomidine post-treatment induces Neuroprotection via activation of extracellular signal-regulated kinase in rats with subarachnoid haemorrhage
  5594. Isoflurane preconditioning provides Neuroprotection against stroke by regulating the expression of the TLR4 signalling pathway to alleviate microglial …
  5595. Neuroprotection comparison of chlorogenic acid and its metabolites against mechanistically distinct cell death-inducing agents in cultured cerebellar granule neurons
  5596. Mitophagy and the therapeutic clearance of damaged mitochondria for Neuroprotection
  5597. Neuroprotection in experimental autoimmune encephalomyelitis and progressive multiple sclerosis by cannabis-based cannabinoids
  5598. EGCG-mediated autophagy flux has a Neuroprotection effect via a class III histone deacetylase in primary neuron cells
  5599. Intraocular pressure reduction and Neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma
  5600. Increased BDNF protein expression after ischemic or PKC epsilon preconditioning promotes electrophysiologic changes that lead to Neuroprotection
  5601. Neuroprotection by caffeine in the MPTP model of parkinson’s disease and its dependence on adenosine A2A receptors
  5602. Long‐term exercise‐specific Neuroprotection in spinal muscular atrophy‐like mice
  5603. Fetal and neonatal effects of N-acetylcysteine when used for Neuroprotection in maternal chorioamnionitis
  5604. Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil
  5605. The P2X4 receptor is required for Neuroprotection via ischemic preconditioning
  5606. Ischemia reperfusion injury as a modifiable therapeutic target for cardioprotection or Neuroprotection in patients undergoing cardiopulmonary resuscitation
  5607. GDNF-secreting mesenchymal stem cells provide localized Neuroprotection in an inflammation-driven rat model of Parkinson’s disease
  5608. Selective VIP receptor agonists facilitate immune transformation for dopaminergic Neuroprotection in MPTP-intoxicated mice
  5609. Mechanistic characterization of nitrite‐mediated Neuroprotection after experimental cardiac arrest
  5610. … symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing Neuroprotection and myelin repair
  5611. Transcriptome analysis in calorie-restricted rats implicates epigenetic and post-translational mechanisms in Neuroprotection and aging
  5612. PcTx1 affords Neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a
  5613. PreImplantation Factor bolsters Neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling
  5614. Neuroprotection of taurine against reactive oxygen species is associated with inhibiting NADPH oxidases
  5615. Prophylactic edaravone prevents transient hypoxic-ischemic brain injury: implications for perioperative Neuroprotection
  5616. Activation of RXR/PPARγ underlies Neuroprotection by bexarotene in ischemic stroke
  5617. c-Abl inhibitors enable insights into the pathophysiology and Neuroprotection in Parkinson’s disease
  5618. Fisetin imparts Neuroprotection in experimental diabetic neuropathy by modulating Nrf2 and NF-κB pathways
  5619. Chaperone-mediated autophagy: roles in Neuroprotection
  5620. … inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible Neuroprotection
  5621. Valproic acid-mediated Neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential
  5622. … promotes adipose-derived mesenchymal stem cells based repair of diabetic erectile dysfunction via augmenting angiogenesis and Neuroprotection
  5623. Granzyme B-inhibitor serpina3n induces Neuroprotection in vitro and in vivo
  5624. Targeting the SUMO pathway for Neuroprotection in brain ischaemia
  5625. Argon mediates anti-apoptotic signaling and Neuroprotection via inhibition of toll-like receptor 2 and 4
  5626. Blockage of GSK3β-mediated Drp1 phosphorylation provides Neuroprotection in neuronal and mouse models of Alzheimer’s disease
  5627. Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1
  5628. Intranasal delivery of bFGF with nanoliposomes enhances in vivo Neuroprotection and neural injury recovery in a rodent stroke model
  5629. Transplantation of human neural stem cells in a parkinsonian model exerts Neuroprotection via regulation of the host microenvironment
  5630. Oleuropein, a natural extract from plants, offers Neuroprotection in focal cerebral ischemia/reperfusion injury in mice
  5631. The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal Neuroprotection
  5632. Neuroprotection mediated by P2Y13 nucleotide receptors in neurons
  5633. Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion
  5634. Neural progenitor cell transplantation promotes Neuroprotection , enhances hippocampal neurogenesis, and improves cognitive outcomes after traumatic brain injury
  5635. Aescin reduces oxidative stress and provides Neuroprotection in experimental traumatic spinal cord injury
  5636. GPER1-mediated immunomodulation and Neuroprotection in the myenteric plexus of a mouse model of Parkinson’s disease
  5637. Stepchild or prodigy? Neuroprotection in multiple sclerosis (MS) research
  5638. Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain : evidence of the mechanism of Neuroprotection by ApoE2 and …
  5639. Chronic metformin preconditioning provides Neuroprotection via suppression of NF-κB-mediated inflammatory pathway in rats with permanent cerebral ischemia
  5640. Micro RNA‐29c Correlates with Neuroprotection Induced by FNS by Targeting Both Birc2 and Bak1 in Rat brain after Stroke
  5641. Assessment of C-phycocyanin effect on astrocytes-mediated Neuroprotection against oxidative brain injury using 2D and 3D astrocyte tissue model
  5642. Panax notoginseng saponins provide Neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo
  5643. Investigation of the mechanisms of Neuroprotection mediated by Ro5-4864 in brain injury
  5644. Perinatal Neuroprotection update
  5645. Prolactin mediates Neuroprotection against excitotoxicity in primary cell cultures of hippocampal neurons via its receptor
  5646. Progesterone receptor signalling in retinal photoreceptor Neuroprotection
  5647. Quercetin glycosides induced Neuroprotection by changes in the gene expression in a cellular model of Parkinson’s disease
  5648. Stroke Neuroprotection revisited: intra-arterial verapamil is profoundly Neuroprotective in experimental acute ischemic stroke
  5649. Neuroprotection by safinamide in the 6‐hydroxydopamine model of P arkinson’s disease
  5650. Resveratrol supplementation confers Neuroprotection in cortical brain tissue of nonhuman primates fed a high-fat/sucrose diet
  5651. Histidine provides long-term Neuroprotection after cerebral ischemia through promoting astrocyte migration
  5652. Artemisinin conferred ERK mediated Neuroprotection to PC12 cells and cortical neurons exposed to sodium nitroprusside-induced oxidative insult
  5653. Long-term Neuroprotection of retinal ganglion cells by inhibiting caspase-2
  5654. Withanolide A offers Neuroprotection , ameliorates stress resistance and prolongs the life expectancy of Caenorhabditis elegans
  5655. Sevoflurane Preconditioning Confers Neuroprotection via Anti-apoptosis Effects
  5656. Monomethyl fumarate promotes Nrf2-dependent Neuroprotection in retinal ischemia-reperfusion
  5657. L-lactate-mediated Neuroprotection against glutamate-induced excitotoxicity requires ARALAR/AGC1
  5658. Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct Neuroprotection
  5659. From chemotherapy-induced emesis to Neuroprotection : therapeutic opportunities for 5-HT 3 receptor antagonists
  5660. A mouse retinal explant model for use in studying Neuroprotection in glaucoma
  5661. The Neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins …
  5662. Vitamin E Neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo‐controlled trial
  5663. Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations
  5664. Prucalopride exerts Neuroprotection in human enteric neurons
  5665. Estrogen replacement therapy-induced Neuroprotection against brain ischemia-reperfusion injury involves the activation of astrocytes via estrogen receptor β
  5666. Autocrine production of IGF‐I increases stem cell‐mediated Neuroprotection
  5667. Neurogenesis and Neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin
  5668. The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) confers acute Neuroprotection after intracerebral hemorrhage in mice
  5669. Hydrogen-rich saline mediates Neuroprotection through the regulation of endoplasmic reticulum stress and autophagy under hypoxia-ischemia neonatal brain injury in …
  5670. Paradigms and mechanisms of inhalational anesthetics mediated Neuroprotection against cerebral ischemic stroke
  5671. Potential Neuroprotection of protodioscin against cerebral ischemia-reperfusion injury in rats through intervening inflammation and apoptosis
  5672. Neuroprotection of sevoflurane against ischemia/reperfusion-induced brain injury through inhibiting JNK3/caspase-3 by enhancing Akt signaling pathway
  5673. Dimethyl fumarate confers Neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage
  5674. Effects of voluntary physical exercise, citicoline, and combined treatment on object recognition memory , neurogenesis, and Neuroprotection after traumatic brain injury …
  5675. Neuroprotection elicited by nerve growth factor and brain -derived neurotrophic factor released from astrocytes in response to methylmercury
  5676. A Nurr1 agonist causes Neuroprotection in a Parkinson’s disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly (I: C)
  5677. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
  5678. Neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: new evidence on Neuroprotection in a rat model of global cerebral …
  5679. … enrichment modified epigenetic mechanisms in SAMP8 mouse hippocampus by reducing oxidative stress and inflammaging and achieving Neuroprotection
  5680. Sinomenine provides Neuroprotection in model of traumatic brain injury via the Nrf2–ARE pathway
  5681. Identifying specific RGC types may shed light on their idiosyncratic responses to Neuroprotection
  5682. Chloroquine exerts Neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death
  5683. Role of quetiapine beyond its clinical efficacy in bipolar disorder: From Neuroprotection to the treatment of psychiatric disorders
  5684. Salidroside-mediated Neuroprotection is associated with induction of early growth response genes (Egrs) across a wide therapeutic window
  5685. HIF1α is necessary for exercise-induced Neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta
  5686. Addition of low-dose valproic acid to saline resuscitation provides Neuroprotection and improves long-term outcomes in a large animal model of combined traumatic …
  5687. Perspectives on mitochondrial uncoupling proteins-mediated Neuroprotection
  5688. Pyrroloquinoline quinone-conferred Neuroprotection in rotenone models of Parkinson’s disease
  5689. Vitamin C Neuroprotection against dose-dependent glutamate-induced neurodegeneration in the postnatal brain
  5690. Angiogenesis contributes to the Neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats
  5691. Delivery of dual drug loaded lipid based nanoparticles across the blood–brain barrier impart enhanced Neuroprotection in a rotenone induced mouse model of …
  5692. Alternative splicing of Drosophila Nmnat functions as a switch to enhance Neuroprotection under stress
  5693. Memantine mediates Neuroprotection via regulating neurovascular unit in a mouse model of focal cerebral ischemia
  5694. Neuroprotection induced by post-conditioning following ischemia/reperfusion in mice is associated with altered microRNA expression
  5695. Cereboost™, an American ginseng extract, improves cognitive function via up-regulation of choline acetyltransferase expression and Neuroprotection
  5696. Oncostatin M confers Neuroprotection against ischemic stroke
  5697. Estrogen provides Neuroprotection against brain edema and blood brain barrier disruption through both estrogen receptors α and β following traumatic brain …
  5698. Hydrogen sulfide induces Neuroprotection against experimental stroke in rats by down-regulation of AQP4 via activating PKC
  5699. Susceptibility to excitotoxicity in aged hippocampal cultures and Neuroprotection by non‐steroidal anti‐inflammatory drugs: role of mitochondrial calcium
  5700. Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than Neuroprotection after focal cerebral ischemia
  5701. cognitive improvement induced by environment enrichment in chronic cerebral hypoperfusion rats: a result of upregulated endogenous Neuroprotection ?
  5702. Multitarget intervention of Fasudil in the Neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson’s disease
  5703. Involvement of GluR2 up-regulation in Neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice
  5704. Getting to NO Alzheimer’s disease: Neuroprotection versus neurotoxicity mediated by nitric oxide
  5705. CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic brain Injury in Mice
  5706. Neuroprotection by Kukoamine A against oxidative stress may involve N-methyl-D-aspartate receptors
  5707. Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264. 7 macrophages and …
  5708. Attenuation of mitochondrial and nuclear p38α signaling: a novel mechanism of estrogen Neuroprotection in cerebral ischemia
  5709. Sevoflurane preconditioning-induced Neuroprotection is associated with Akt activation via carboxy-terminal modulator protein inhibition
  5710. Targeting the body to protect the brain : inducing Neuroprotection with remotely-applied near infrared light
  5711. Novel cellular mechanisms for Neuroprotection in ischemic preconditioning: A view from inside organelles
  5712. Baclofen mediates Neuroprotection on hippocampal CA1 pyramidal cells through the regulation of autophagy under chronic cerebral hypoperfusion
  5713. Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and Neuroprotection during experimental autoimmune encephalomyelitis
  5714. Intravitreal injection of forskolin, homotaurine, and L-carnosine affords Neuroprotection to retinal ganglion cells following retinal ischemic injury
  5715. GPER1 mediates estrogen-induced Neuroprotection against oxygen-glucose deprivation in the primary hippocampal neurons
  5716. The Neuroprotection of lysosomotropic agents in experimental subarachnoid hemorrhage probably involving the apoptosis pathway triggering by cathepsins via …
  5717. Acute blockage of notch signaling by DAPT induces Neuroprotection and neurogenesis in the neonatal rat brain after stroke
  5718. Noninvasive tracking of gene transcript and Neuroprotection after gene therapy
  5719. Neuroprotection by combined administration with maslinic acid, a natural product from Olea europaea, and MK-801 in the cerebral ischemia model
  5720. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides Neuroprotection
  5721. A human neural stem cell line provides Neuroprotection and improves neurological performance by early intervention of neuroinflammatory system
  5722. Valproic acid Neuroprotection in the 6-OHDA model of Parkinson’s disease is possibly related to its anti-inflammatory and HDAC inhibitory properties
  5723. Enhanced Neuroprotection of acetyl-11-keto-β-boswellic acid (AKBA)-loaded O-carboxymethyl chitosan nanoparticles through antioxidant and anti-inflammatory …
  5724. Antidepressants for Neuroprotection in Huntington’s disease: A review
  5725. Long-term caloric restriction in ApoE-deficient mice results in Neuroprotection via Fgf21-induced AMPK/mTOR pathway
  5726. Sumoylation of LYS590 of NCX3 f-Loop by SUMO1 participates in brain Neuroprotection induced by ischemic preconditioning
  5727. A multicenter, randomized trial on Neuroprotection with remote ischemic per-conditioning during acute ischemic stroke: the REmote iSchemic Conditioning in acUtE …
  5728. MicroRNA-146a down-regulation correlates with Neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro
  5729. Crmp4 deletion promotes recovery from spinal cord injury by Neuroprotection and limited scar formation
  5730. Silencing miR-181a produces Neuroprotection against hippocampus neuron cell apoptosis post-status epilepticus in a rat model and in children with temporal …
  5731. BDNF-TrkB pathway mediates Neuroprotection of hydrogen sulfide against formaldehyde-induced toxicity to PC12 cells
  5732. Transthyretin provides trophic support via megalin by promoting neurite outgrowth and Neuroprotection in cerebral ischemia
  5733. The Neuroprotection of repetitive transcranial magnetic stimulation pre-treatment in vascular dementia rats
  5734. Novel analogs of allopregnanolone show improved efficiency and specificity in Neuroprotection and stimulation of proliferation
  5735. Exosomes in neurological disease, Neuroprotection , repair and therapeutics: problems and perspectives
  5736. Peptide TFP5/TP5 derived from Cdk5 activator P35 provides Neuroprotection in the MPTP model of Parkinson’s disease
  5737. CDK5 knockdown in astrocytes provide Neuroprotection as a trophic source via Rac1
  5738. … remote ischemic perconditioning and cerebral ischemic postconditioning inhibits autophagy to attenuate plasma HMGB1 and induce Neuroprotection against stroke in …
  5739. Neuroprotection by progesterone after transient cerebral ischemia in stroke-prone spontaneously hypertensive rats
  5740. Role of adaptor protein MyD88 in TLR-mediated preconditioning and Neuroprotection after acute excitotoxicity
  5741. Induction of NQO1 and Neuroprotection by a novel compound KMS04014 in Parkinson’s disease models
  5742. Protocatechuic acid: Inhibition of fibril formation, destabilization of preformed fibrils of amyloid-β and α-synuclein, and Neuroprotection
  5743. A randomized trial of the effects of the noble gases helium and argon on Neuroprotection in a rodent cardiac arrest model
  5744. Targeting the nNOS/peroxynitrite/calpain system to confer Neuroprotection and aid functional recovery in a mouse model of TBI
  5745. Neuroprotection by JM-20 against oxygen-glucose deprivation in rat hippocampal slices: Involvement of the Akt/GSK-3β pathway
  5746. Neuroprotection , learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain …
  5747. Neuroprotection promoted by guanosine depends on glutamine synthetase and glutamate transporters activity in hippocampal slices subjected to oxygen/glucose …
  5748. Inhibition of neuronal p38α, but not p38β MAPK, provides Neuroprotection against three different neurotoxic insults
  5749. The Neuroprotection of hypoxic preconditioning on rat brain against traumatic brain injury by up-regulated transcription factor Nrf2 and HO-1 expression
  5750. Anle138b partly ameliorates motor deficits despite failure of Neuroprotection in a model of advanced multiple system atrophy
  5751. p35 and Rac1 underlie the Neuroprotection and cognitive improvement induced by CDK5 silencing
  5752. Carbamylated erythropoietin: a prospective drug candidate for Neuroprotection
  5753. Intravitreal injection of lipoamino acid-modified connexin43 mimetic peptide enhances Neuroprotection after retinal ischemia
  5754. Interaction of paroxetine with mitochondrial proteins mediates Neuroprotection
  5755. Barriers and enablers to implementing antenatal magnesium sulphate for fetal Neuroprotection guidelines: a study using the theoretical domains framework
  5756. Additive Neuroprotection of a 20-HETE inhibitor with delayed therapeutic hypothermia after hypoxia-ischemia in neonatal piglets
  5757. Hesperidin inhibits glutamate release and exerts Neuroprotection against excitotoxicity induced by kainic acid in the hippocampus of rats
  5758. Recent advances in autophagy-based Neuroprotection
  5759. Mitochondrial division inhibitor 1 (Mdivi-1) offers Neuroprotection through diminishing cell death and improving functional outcome in a mouse model of traumatic brain …
  5760. NRSF is an essential mediator for the Neuroprotection of trichostatin A in the MPTP mouse model of Parkinson’s disease
  5761. Peptidic exenatide and herbal catalpol mediate Neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway
  5762. Global SUMO ylation facilitates the multimodal Neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration …
  5763. Hyperbaric oxygen preconditioning: a reliable option for Neuroprotection
  5764. Osthole confers Neuroprotection against cortical stab wound injury and attenuates secondary brain injury
  5765. Neuroprotection by vitamin C against ethanol-induced neuroinflammation associated neurodegeneration in developing rat brain
  5766. Neuroprotection induced by sevoflurane-delayed post-conditioning is attributable to increased phosphorylation of mitochondrial GSK-3β through the PI3K/Akt survival …
  5767. Neuroprotection in critical care neurology
  5768. Retinal ganglion cell Neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
  5769. Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and Neuroprotection by AK-7
  5770. Xenon-mediated Neuroprotection in response to sustained, low-level excitotoxic stress
  5771. Neuroprotection in the treatment of glaucoma–a focus on connexin43 gap junction channel blockers
  5772. Tyrphostin AG126 exerts Neuroprotection in CNS inflammation by a dual mechanism
  5773. Tetramethylpyrazine nitrone improves neurobehavioral functions and confers Neuroprotection on rats with traumatic brain injury
  5774. … calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for Neuroprotection
  5775. Natural compounds and retinal ganglion cell Neuroprotection
  5776. Growth factor therapy sequesters inflammation in affording Neuroprotection in cerebrovascular diseases
  5777. Ischemic preconditioning mediates Neuroprotection against ischemia in mouse hippocampal CA1 neurons by inducing autophagy
  5778. Ferulic acid–carbazole hybrid compounds: combination of cholinesterase inhibition, antioxidant and Neuroprotection as multifunctional anti-Alzheimer agents
  5779. Neuroprotection mediated by inhibition of calpain during acute viral encephalitis
  5780. Combined Oral Supplementation of Fish Oil and Quercetin Enhances Neuroprotection in a Chronic Rotenone Rat Model: Relevance to Parkinson’s Disease.
  5781. Inhibition of Histone Methyltransferases SUV39H1 and G9a Leads to Neuroprotection in an in vitro Model of Cerebral Ischemia
  5782. Neuroprotection by polynitrogen manganese complexes: regulation of reactive oxygen species-related pathways
  5783. New melatonin–cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and Neuroprotection
  5784. Rutin inhibits neuroinflammation and provides Neuroprotection in an experimental rat model of subarachnoid hemorrhage, possibly through suppressing the RAGE …
  5785. Patrolling monocytes play a critical role in CX3CR1-mediated Neuroprotection during excitotoxicity
  5786. … derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and Neuroprotection properties against Alzheimer’s …
  5787. Neuroprotection after major cardiovascular surgery
  5788. Neuroprotection via reduction in stress: altered menstrual patterns as a marker for stress and implications for long-term neurologic health in women
  5789. PACAP signaling in Neuroprotection
  5790. Implementation of an antenatal magnesium sulfate protocol for fetal Neuroprotection in preterm infants
  5791. Critical period for dopaminergic Neuroprotection by hormonal replacement in menopausal rats
  5792. Optic neuritis as a phase 2 paradigm for Neuroprotection therapies of multiple sclerosis: update on current trials and perspectives
  5793. Zonarol, a sesquiterpene from the brown algae Dictyopteris undulata, provides Neuroprotection by activating the Nrf2/ARE pathway
  5794. Rosiglitazone‐activated PPAR γ induces neurotrophic factor‐α1 transcription contributing to Neuroprotection
  5795. Central IGF‐I receptors in the brain are instrumental to Neuroprotection by systemically injected IGF‐I in a rat model for ischemic stroke
  5796. Novel hexapeptide interacts with tubulin and microtubules, inhibits Aβ fibrillation, and shows significant Neuroprotection
  5797. Innominate and axillary cannulation in aortic arch surgery provide similar Neuroprotection
  5798. The role of vitamin D3 in the development and Neuroprotection of midbrain dopamine neurons
  5799. Inhibition of BDNF-AS provides Neuroprotection for retinal ganglion cells against ischemic injury
  5800. Neuroprotection by epigenetic modulation in a transgenic model of multiple system atrophy
  5801. Delayed Neuroprotection against cerebral ischemia reperfusion injury: putative role of BDNF and GSK-3β
  5802. Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with Neuroprotection after focal cerebral ischemia
  5803. Arctigenin confers Neuroprotection against mechanical trauma injury in human neuroblastoma SH-SY5Y cells by regulating miRNA-16 and miRNA-199a expression to …
  5804. A diphenyl diselenide-supplemented diet and swimming exercise promote Neuroprotection , reduced cell apoptosis and glial cell activation in the hypothalamus of old …
  5805. The 5-lipoxygenase inhibitor zileuton confers Neuroprotection against glutamate oxidative damage by inhibiting ferroptosis
  5806. Treadmill exercise promotes Neuroprotection against cerebral ischemia–reperfusion injury via downregulation of pro-inflammatory mediators
  5807. Reduction of inflammatory responses by l-serine treatment leads to Neuroprotection in mice after traumatic brain injury
  5808. Failure of Neuroprotection despite microglial suppression by delayed-start myeloperoxidase inhibition in a model of advanced multiple system atrophy: clinical …
  5809. The CB 1 cannabinoid receptor signals striatal Neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
  5810. Epigenetics and therapeutic targets mediating Neuroprotection
  5811. Effects of a higher dose of near-infrared light on clinical signs and Neuroprotection in a monkey model of Parkinson’s disease
  5812. Neuroprotection and mechanisms of atractylenolide III in preventing learning and memory impairment induced by chronic high-dose homocysteine administration in …
  5813. Anemoside A3 enhances cognition through the regulation of synaptic function and Neuroprotection
  5814. Pathophysiology of blood-brain barrier in brain injury in cold and hot environments: novel drug targets for Neuroprotection
  5815. Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
  5816. Glycine triggers a non-ionotropic activity of GluN2A-containing NMDA receptors to confer Neuroprotection
  5817. MRI heralds secondary nigral lesion after brain ischemia in mice: a secondary time window for Neuroprotection
  5818. A study of methylprednisolone Neuroprotection against acute injury to the rat spinal cord in vitro
  5819. Heme oxygenase-1 mediates Neuroprotection conferred by argon in combination with hypothermia in neonatal hypoxia–ischemia brain injury
  5820. Neuroprotection mediated through GluN2C-containing N-methyl-D-aspartate (NMDA) receptors following ischemia
  5821. Lithium posttreatment confers Neuroprotection through glycogen synthase kinase-3β inhibition in intracerebral hemorrhage rats
  5822. Retinal ganglion cell Neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors
  5823. Neuroprotection against 6-OHDA-induced oxidative stress and apoptosis in SH-SY5Y cells by 5, 7-Dihydroxychromone: Activation of the Nrf2/ARE pathway
  5824. Signals mediating Klotho-induced Neuroprotection in hippocampal neuronal cells
  5825. Edaravone offers Neuroprotection for acute diabetic stroke patients
  5826. Neuroprotection of Chrysanthemum indicum Linne against cerebral ischemia/reperfusion injury by anti-inflammatory effect in gerbils
  5827. MCP-induced protein 1 mediates the minocycline-induced Neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo
  5828. Adenosine transporters and receptors: key elements for retinal function and Neuroprotection
  5829. CD4+ T cells and Neuroprotection : relevance to motoneuron injury and disease
  5830. Therapeutic strategies in multiple sclerosis: a focus on Neuroprotection and repair and relevance to schizophrenia
  5831. Transarterial regional hypothermia provides robust Neuroprotection in a rat model of permanent middle cerebral artery occlusion with transient collateral …
  5832. Ginsenoside Rd and ginsenoside Re offer Neuroprotection in a novel model of Parkinson’s disease
  5833. PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit Neuroprotection in cell-based models of brain ischemia
  5834. Neuroprotection against glutamate-induced excitotoxicity and induction of neurite outgrowth by T-006, a novel multifunctional derivative of tetramethylpyrazine in …
  5835. Neuroprotection
  5836. Neuroprotection and reduced gliosis by atomoxetine pretreatment in a gerbil model of transient cerebral ischemia
  5837. Synergic effect of borneol and ligustrazine on the Neuroprotection in global cerebral ischemia/reperfusion injury: a region-specificity study
  5838. Neuroprotection of early locomotor exercise poststroke: evidence from animal studies
  5839. Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and Neuroprotection
  5840. The Contributing Role of Lipid Peroxidation and Protein Oxidation in the Course of CNS Injury Neurodegeneration and Neuroprotection
  5841. Combined oral supplementation of fish oil and quercetin enhances Neuroprotection in a chronic rotenone rat model: relevance to Parkinson’s disease
  5842. Cystamine improves functional recovery via axon remodeling and Neuroprotection after stroke in mice
  5843. Delayed Neuroprotection in the era of hypothermia: What can we add?
  5844. … models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of Neuroprotection for lithium and …
  5845. Chrysophanol affords Neuroprotection against microglial activation and free radical-mediated oxidative damage in BV2 murine microglia
  5846. Neuroprotection by GH against excitotoxic-induced cell death in retinal ganglion cells
  5847. Multifunction of chrysin in Parkinson’s model: anti-neuronal apoptosis, Neuroprotection via activation of MEF2D, and inhibition of monoamine oxidase-B
  5848. Pharmacological blockade of the calcium plateau provides Neuroprotection following organophosphate paraoxon induced status epilepticus in rats
  5849. Sub-toxic ethanol exposure modulates gene expression and enzyme activity of antioxidant systems to provide Neuroprotection in hippocampal HT22 cells
  5850. p53 signalling mediates acupuncture-induced Neuroprotection in Parkinson’s disease
  5851. Neuroprotection by cocktails of dietary antioxidants under conditions of nerve growth factor deprivation
  5852. Treatment with an activator of hypoxia-inducible factor 1, DMOG provides Neuroprotection after traumatic brain injury
  5853. Neuroprotection of Gueichih-Fuling-Wan on cerebral ischemia/reperfusion injury in streptozotocin-induced hyperglycemic rats via the inhibition of the cellular …
  5854. Therapeutic Hypothermia Achieves Neuroprotection via a Decrease in Acetylcholine with a Concurrent Increase in Carnitine in the Neonatal Hypoxia-Ischemia
  5855. PPARβ/δ agonist provides Neuroprotection by suppression of IRE1α–Caspase-12-mediated endoplasmic reticulum stress pathway in the rotenone rat model of …
  5856. Human placental eXpanded (PLX) mesenchymal-like adherent stromal cells confer Neuroprotection to nerve growth factor (NGF)-differentiated PC12 cells …
  5857. Opposing needling promotes behavior recovery and exerts Neuroprotection via the cAMP/PKA/CREB signal transduction pathway in transient MCAO rats
  5858. Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: focus on antiepileptic drugs
  5859. MiRNA-124 induces Neuroprotection and functional improvement after focal cerebral ischemia
  5860. The Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrid ITH91/IQM157 Affords Neuroprotection in an in Vitro Alzheimer’s Model via Hemo-oxygenase-1 Induction
  5861. Novel treatments in Neuroprotection for aneurysmal subarachnoid hemorrhage
  5862. Identification of sleep-modulated pathways involved in Neuroprotection from stroke
  5863. Do the genes of the innate immune response contribute to Neuroprotection in Drosophila?
  5864. HspB8 mediates Neuroprotection against OGD/R in N2A cells through the phosphoinositide 3-kinase/Akt pathway
  5865. The effect of magnesium sulfate administration for Neuroprotection on latency in women with preterm premature rupture of membranes
  5866. Estrogen receptor variant ER-α36 is involved in estrogen Neuroprotection against oxidative toxicity
  5867. Effects of neonatal hypoxic-ischemic injury and hypothermic Neuroprotection on neural progenitor cells in the mouse hippocampus
  5868. Neuroprotection against diisopropylfluorophosphate in acute hippocampal slices
  5869. Neuroprotection of Cilostazol against ischemia/reperfusion-induced cognitive deficits through inhibiting JNK3/caspase-3 by enhancing Akt1
  5870. Inhibition of microRNA-210 provides Neuroprotection in hypoxic–ischemic brain injury in neonatal rats
  5871. Neuroprotection of luteolin against methylmercury-induced toxicity in lobster cockroach Nauphoeta cinerea
  5872. Isoflurane postconditioning induces concentration-and timing-dependent Neuroprotection partly mediated by the GluR2 AMPA receptor in neonatal rats after brain …
  5873. Neuroprotection after traumatic brain injury
  5874. Galectin-1-secreting neural stem cells elicit long-term Neuroprotection against ischemic brain injury
  5875. Advanced Neuroprotection for brain ischemia: an alternative approach to minimize stroke damage
  5876. … -Melanopsin–Containing Retinal Ganglion Cells Response to Acute Ocular Hypertension With or Without brain -Derived Neurotrophic Factor Neuroprotection
  5877. Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to Neuroprotection
  5878. Osteopontin mediates hyperbaric oxygen preconditioning-induced Neuroprotection against ischemic stroke
  5879. ERα Signaling Is Required for TrkB-Mediated Hippocampal Neuroprotection in Female Neonatal Mice after Hypoxic Ischemic Encephalopathy
  5880. Nrf2-mediated Neuroprotection against recurrent hypoglycemia is insufficient to prevent cognitive impairment in a rodent model of type 1 diabetes
  5881. Neuroprotection against vascular dementia after acupuncture combined with donepezil hydrochloride: P300 event related potential
  5882. Neuroprotection by combination of resveratrol and enriched environment against ischemic brain injury in rats
  5883. In search for novel strategies towards Neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
  5884. TrkB signaling in retinal glia stimulates Neuroprotection after optic nerve injury
  5885. Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of Neuroprotection and neurodegeneration
  5886. Novel multifunctional dopamine D2/D3 receptors agonists with potential Neuroprotection and anti-alpha synuclein protein aggregation properties
  5887. Atypical 1, 4-dihydropyridine derivatives, an approach to Neuroprotection and memory enhancement
  5888. Intranasal delivery of RGD motif-containing osteopontin icosamer confers Neuroprotection in the postischemic brain via α v β 3 integrin binding
  5889. Neuroprotection during aortic surgery
  5890. Egg white hydrolysate promotes Neuroprotection for neuropathic disorders induced by chronic exposure to low concentrations of mercury
  5891. Neuroprotection by triptolide against cerebral ischemia/reperfusion injury through the inhibition of NF-κB/PUMA signal in rats
  5892. Sleep is critical for remote preconditioning-induced Neuroprotection
  5893. From the 90׳ s to now: A brief historical perspective on more than two decades of estrogen Neuroprotection
  5894. Carbamylated erythropoietin mediates retinal Neuroprotection in streptozotocin-induced early-stage diabetic rats
  5895. Anti-high mobility group box 1 antibody exerts Neuroprotection in a rat model of Parkinson’s disease
  5896. Non-steroidal anti-inflammatory drugs (NSAIDs) and Neuroprotection in the elderly: a view from the mitochondria
  5897. CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with Neuroprotection against ischemic injury
  5898. Sirtuin 3 mediates Neuroprotection of ketones against ischemic stroke
  5899. Nuclear factor erythroid 2-related factor 2 (Nrf2) mediates Neuroprotection in traumatic brain injury at least in part by inactivating microglia
  5900. Propofol, but not ketamine or midazolam, exerts Neuroprotection after ischaemic injury by inhibition of Toll-like receptor 4 and nuclear factor kappa-light-chain …
  5901. Fastigial nucleus stimulation regulates Neuroprotection via induction of a novel micro RNA, rno‐miR‐676‐1, in middle cerebral artery occlusion rats
  5902. Efficacy of some non-conventional herbal medications (sulforaphane, tanshinone IIA, and tetramethylpyrazine) in inducing Neuroprotection in comparison with …
  5903. The indirect NMDAR antagonist acamprosate induces postischemic neurologic recovery associated with sustained Neuroprotection and neuroregeneration
  5904. Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: Implications for Neuroprotection
  5905. Carbon monoxide offers Neuroprotection from hippocampal cell damage induced by recurrent febrile seizures through the PERK-activated ER stress pathway
  5906. Melatoninergic system in Parkinson’s disease: from Neuroprotection to the management of motor and nonmotor symptoms
  5907. Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and α-synuclein aggregation in 6-OHDA induced parkinson׳ s …
  5908. Neuroprotection of ischemic preconditioning is mediated by anti-inflammatory, not pro-inflammatory, cytokines in the gerbil hippocampus induced by a subsequent …
  5909. Systemic proteasome inhibition induces sustained post-stroke neurological recovery and Neuroprotection via mechanisms involving reversal of peripheral …
  5910. Early resuscitation with lyophilized plasma provides equal Neuroprotection compared with fresh frozen plasma in a large animal survival model of traumatic brain …
  5911. 20-Hydroxyeicosatetraenoic acid inhibition by HET0016 offers Neuroprotection , decreases edema, and increases cortical cerebral blood flow in a pediatric asphyxial …
  5912. Selective inhibition of ASIC1a confers functional and morphological Neuroprotection following traumatic spinal cord injury
  5913. Neuroprotection by epigallo catechin gallate against bupivacaine anesthesia induced toxicity involves modulation of PI3/Akt/PTEN signalling in N2a and SH …
  5914. Acute stress enhances the expression of Neuroprotection -and neurogenesis-associated genes in the hippocampus of a mouse restraint model
  5915. Stem cell approaches to glaucoma: from aqueous outflow modulation to retinal Neuroprotection
  5916. Uncoupling protein 2 in the glial response to stress: implications for Neuroprotection
  5917. Neuroprotection by noble gases: new developments and insights
  5918. Glycine confers Neuroprotection through microRNA-301a/PTEN signaling
  5919. l‐Lactate mediates Neuroprotection against ischaemia by increasing TREK1 channel expression in rat hippocampal astrocytes in vitro
  5920. Heme oxygenase-1-mediated Neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine
  5921. Non-amyloidogenic effects of α 2 adrenergic agonists: implications for brimonidine-mediated Neuroprotection
  5922. Erythropoietin-mediated Neuroprotection in a pediatric mouse model of chronic hypoxia
  5923. Neuroprotection by peripheral nerve electrical stimulation and remote postconditioning against acute experimental ischaemic stroke
  5924. The indirect NMDAR inhibitor flupirtine induces sustained post-ischemic recovery, Neuroprotection and angioneurogenesis
  5925. Considerations for Neuroprotection in the traumatic brain injury population.
  5926. Neuregulin 1 confers Neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons
  5927. Nonreceipt of antenatal magnesium sulphate for fetal Neuroprotection at the Women’s and Children’s Hospital, Adelaide 2010–2013
  5928. Paracrine effect of carbon monoxide–astrocytes promote Neuroprotection through purinergic signaling in mice
  5929. Role of microRNAs in innate Neuroprotection mechanisms due to preconditioning of the brain
  5930. CX3CL1/CX3CR1 in Alzheimer’s disease: a target for Neuroprotection
  5931. Neuroprotective core measures 1–7: Neuroprotection of skin-to-skin contact (SSC)
  5932. Neuroprotection by endoplasmic reticulum stress-induced HRD1 and chaperones: possible therapeutic targets for Alzheimer’s and Parkinson’s disease
  5933. Sex-and isoform-specific mechanism of Neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium
  5934. 810 nm near-infrared light offers Neuroprotection and improves locomotor activity in MPTP-treated mice
  5935. TFP5/TP5 peptide provides Neuroprotection in the MPTP model of Parkinson’s disease
  5936. Proline-, glutamic acid-, and leucine-rich protein 1 mediates estrogen rapid signaling and Neuroprotection in the brain
  5937. Intranasal insulin Neuroprotection in ischemic stroke
  5938. Fresh frozen plasma resuscitation provides Neuroprotection compared to normal saline in a large animal model of traumatic brain injury and polytrauma
  5939. Neuroprotection of resveratrol against neurotoxicity induced by methamphetamine in mouse mesencephalic dopaminergic neurons
  5940. Autoregulation of inducible nitric oxide synthase expression by RNA interference provides Neuroprotection in neonatal rats
  5941. Enhanced Neuroprotection of minimally invasive surgery joint local cooling lavage against ICH-induced inflammation injury and apoptosis in rats
  5942. Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their Neuroprotection …
  5943. The key target of Neuroprotection after the onset of ischemic stroke: secretory pathway Ca2+-ATPase 1
  5944. Mesenchymal stem cell therapy for retinal ganglion cell Neuroprotection and axon regeneration
  5945. Translational pharmacology in glaucoma Neuroprotection
  5946. Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and Neuroprotection ?
  5947. Ischemic preconditioning, retinal Neuroprotection and histone deacetylase activities
  5948. Neuroprotection and recovery from early-life adversity: considerations for environmental enrichment
  5949. The role of SUMO-conjugating enzyme Ubc9 in the Neuroprotection of isoflurane preconditioning against ischemic neuronal injury
  5950. Neuroprotection of grape seed extract and pyridoxine against triton-induced neurotoxicity
  5951. Inhibition of myeloid differentiation factor 88 (MyD88) by ST2825 provides Neuroprotection after experimental traumatic brain injury in mice
  5952. Lovastatin induces Neuroprotection by inhibiting inflammatory cytokines in 6-hydroxydopamine treated microglia cells
  5953. Neuroprotection , plasticity manipulation, and regenerative strategies to improve cardiovascular function following spinal cord injury
  5954. The neuronal nitric oxide synthase (nNOS) gene and Neuroprotection against alcohol toxicity
  5955. Inhibition of myeloperoxidase-mediated oxidative damage by nitrite in SH-SY5Y cells: Relevance to Neuroprotection in neurodegenerative diseases
  5956. Acteoside binds to caspase-3 and exerts Neuroprotection in the rotenone rat model of Parkinson’s disease
  5957. Effective PI3K modulators for improved therapy against malignant tumors and for Neuroprotection of brain damage after tumor therapy
  5958. Progranulin levels in status epilepticus as a marker of neuronal recovery and Neuroprotection
  5959. Increases of catalase and glutathione peroxidase expressions by lacosamide pretreatment contributes to Neuroprotection against experimentally induced transient …
  5960. HIF‑1 signaling pathway involving iNOS, COX‑2 and caspase‑9 mediates the Neuroprotection provided by erythropoietin in the retina of chronic ocular …
  5961. Neuroprotection and retinal diseases
  5962. Melatonin receptor signaling contributes to Neuroprotection upon arousal from torpor in thirteen-lined ground squirrels
  5963. Chloride transporter KCC2-dependent Neuroprotection depends on the N-terminal protein domain
  5964. Pterostilbene mediates Neuroprotection against oxidative toxicity via oestrogen receptor α signalling pathways
  5965. Estrogen/Huntingtin: a novel pathway involved in Neuroprotection
  5966. Neuroprotection of nalmefene for postoperative patients with spontaneous intracerebral hemorrhage
  5967. Poly (ADP-ribose) polymerase inhibition reveals a potential mechanism to promote Neuroprotection and treat neuropathic pain
  5968. Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell Neuroprotection and axon regeneration
  5969. Comprehensive evaluation of Neuroprotection achieved by extended selective brain cooling therapy in a rat model of penetrating ballistic-like brain injury
  5970. … high-throughput screen identifies drugs that both activate SUMO conjugation via the inhibition of microRNAs 182 and 183 and facilitate Neuroprotection in a model of …
  5971. Resveratrol promotes myenteric Neuroprotection in the ileum of rats after ischemia-reperfusion injury
  5972. Bivalent compound 17MN exerts Neuroprotection through interaction at multiple sites in a cellular model of Alzheimer’s disease
  5973. Blueberry polyphenols and Neuroprotection
  5974. Hippocampal Neuroprotection by Minocycline and Epigallo‐Catechin‐3‐Gallate Against Cardiopulmonary Bypass‐Associated Injury
  5975. Neuroprotection by Carbenoxolone Against Ischemia Injury Involves PI3K/Akt Pathway.
  5976. Dextromethorphan provides Neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury
  5977. Targeting the 18-kDa translocator protein: recent perspectives for Neuroprotection
  5978. Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 1. Acute stroke
  5979. TRPV1 may increase the effectiveness of estrogen therapy on Neuroprotection and neuroregeneration
  5980. Neuroprotection of brain -targeted bioactive dietary artoindonesianin O (AIO) from mulberry on rat neurons as a novel intervention for Alzheimer’s disease
  5981. Melatonin–sulforaphane hybrid ITH 12674 induces Neuroprotection in oxidative stress conditions by a ‘drug–prodrug’mechanism of action
  5982. Magnesium sulphate for eclampsia and fetal Neuroprotection : a comparative analysis of protocols across Canadian tertiary perinatal centres
  5983. Neuroinflammation and demyelination from the point of nitrosative stress as a new target for Neuroprotection
  5984. Impact of glatiramer acetate on paraclinical markers of Neuroprotection in multiple sclerosis: a prospective observational clinical trial
  5985. General anesthetics as a factor of the effective Neuroprotection in ischemic stroke models
  5986. Antrodia camphorata potentiates Neuroprotection against cerebral ischemia in rats via downregulation of iNOS/HO-1/Bax and activated caspase-3 and …
  5987. Prolonged hypothermia exposure diminishes Neuroprotection for severe ischemic-hypoxic primary neurons
  5988. Intravenous treatment with a long-chain Omega-3 lipid emulsion provides Neuroprotection in a murine model of ischemic stroke–A pilot study
  5989. Dual kinase inhibition affords extended in vitro Neuroprotection in amyloid-β toxicity
  5990. Hsp70 inducer, 17-allylamino-demethoxygeldanamycin, provides Neuroprotection via anti-inflammatory effects in a rat model of traumatic brain injury
  5991. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone‐Induced Central …
  5992. Sodium channel blockers for Neuroprotection in multiple sclerosis
  5993. Liver X receptors: from cholesterol regulation to Neuroprotection —a new barrier against neurodegeneration in amyotrophic lateral sclerosis?
  5994. Mitochondria as a target for Neuroprotection
  5995. The cytoskeleton as a drug target for Neuroprotection : the case of the autism-mutated ADNP
  5996. IGF-1 signaling via the PI3K/Akt pathway confers Neuroprotection in human retinal pigment epithelial cells exposed to sodium nitroprusside insult
  5997. Prosurvival NMDA 2 A receptor signaling mediates postconditioning Neuroprotection in the hippocampus
  5998. Neuroprotection and anti-seizure effects of levetiracetam in a rat model of penetrating ballistic-like brain injury
  5999. Presenilin 1 is necessary for neuronal, but not glial, EGFR expression and Neuroprotection via γ‐secretase‐independent transcriptional mechanisms
  6000. Tuscan black kale sprout extract bioactivated with myrosinase: a novel natural product for Neuroprotection by inflammatory and oxidative response during …
  6001. brain -derived neurotrophic factor mediates Neuroprotection against A β-induced toxicity through a mechanism independent on adenosine 2A receptor activation
  6002. Chocolate, air pollution and children’s Neuroprotection : what cognition tools should be at hand to evaluate interventions?
  6003. Purine receptors are required for DHA-mediated Neuroprotection against oxygen and glucose deprivation in hippocampal slices
  6004. Neuroprotection and spatial memory enhancement of four herbal mixture extract in HT22 hippocampal cells and a mouse model of focal cerebral ischemia
  6005. Treatment with a herbal formula B401 enhances Neuroprotection and angiogenesis in the R6/2 mouse model of Huntington’s disease
  6006. What is the use of hypothermia for Neuroprotection after out-of-hospital cardiac arrest?
  6007. Computational analysis of AMPK-mediated Neuroprotection suggests acute excitotoxic bioenergetics and glucose dynamics are regulated by a minimal set of …
  6008. Nutraceuticals in CNS diseases: potential mechanisms of Neuroprotection
  6009. Aging enables Ca 2+ overload and apoptosis induced by amyloid-β oligomers in rat hippocampal neurons: Neuroprotection by non-steroidal anti-inflammatory drugs …
  6010. Neuroprotection of Sanhua decoction against focal cerebral ischemia/reperfusion injury in rats through a mechanism targeting aquaporin 4
  6011. Novel RIPK3 inhibitors discovered through a structure-based approach exert post-ischemic Neuroprotection
  6012. Neuroprotection by JM-1232 (−) against oxygen–glucose deprivation-induced injury in rat hippocampal slice culture
  6013. Post-hypoxic and ischemic Neuroprotection of BMP-7 in the cerebral cortex and caudate–putamen tissue of rat
  6014. Early alterations of mitochondrial morphology in dopaminergic neurons from Parkinson’s disease-like pathology and time-dependent Neuroprotection with D2 receptor …
  6015. Hypothermic Neuroprotection is associated with recovery of spectral edge frequency after asphyxia in preterm fetal sheep
  6016. Poly (ADP-ribose) polymerase is not involved in the Neuroprotection exerted by azithromycin against ischemic stroke in mice
  6017. Neuroprotection of hyperbaric oxygen therapy in sub-acute traumatic brain injury: not by immediately improving cerebral oxygen saturation and oxygen partial …
  6018. Targeting α7 nicotinic acetylcholine receptors: a future potential for Neuroprotection from traumatic brain injury
  6019. Neuroprotection by methylene blue in cerebral global ischemic injury induced blood-brain barrier disruption and brain pathology: a review
  6020. Exercise-induced Neuroprotection in the spastic Han Wistar rat: the possible role of brain -derived neurotrophic factor
  6021. Evaluation of Neuroprotection by melatonin against adverse effects of prenatal exposure to a nonsteroidal anti-inflammatory drug during peripheral nerve development
  6022. Dual activities of the anti-cancer drug candidate PBI-05204 provide Neuroprotection in brain slice models for neurodegenerative diseases and stroke
  6023. Neuroprotection of donepezil against morphine-induced apoptosis is mediated through Toll-like receptors
  6024. Neuroprotection of medial septal cholinergic neurons by memantine after intralateral septal injection of Aβ1–40
  6025. Failure and rescue of preconditioning-induced Neuroprotection in severe stroke-like insults
  6026. Molecular programs induced by heat acclimation confer Neuroprotection against TBI and hypoxic insults via cross-tolerance mechanisms
  6027. A prospective audit of the adherence to a new magnesium sulphate guideline for the Neuroprotection of infants born less than 30 weeks’ gestation
  6028. Conditioned medium of dental pulp cells stimulated by Chinese propolis show Neuroprotection and neurite extension in vitro
  6029. Astroglial heterogeneity: merely a neurobiological question? Or an opportunity for Neuroprotection and regeneration after brain injury?
  6030. Synthesis and biological evaluation of palmyrolide A macrocycles as sodium channel blockers towards Neuroprotection
  6031. Piroxicam confer Neuroprotection in cerebral ischemia by inhibiting cyclooxygenases, acid-sensing Ion Channel-1a and aquaporin-4: an in silico comparison …
  6032. Dose-dependent Neuroprotection and neurotoxicity of simvastatin through reduction of farnesyl pyrophosphate in mice treated with intracerebroventricular injection of …
  6033. High-frequency stimulation of the rat entopeduncular nucleus does not provide functional or morphological Neuroprotection from 6-hydroxydopamine
  6034. Neuroprotection in Alzheimer’s Disease
  6035. Predegenerated Schwann cells–a novel prospect for cell therapy for glaucoma: Neuroprotection , neuroregeneration and neuroplasticity
  6036. Neuroprotection of (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate against hydrogen peroxide and lipopolysaccharide induced injury via modulating arachidonic …
  6037. Antioxidant activity of some medicinal plant extracts: implications for Neuroprotection
  6038. Corticosteroid responses following hypoxic preconditioning provide Neuroprotection against subsequent hypoxic-ischemic brain injury in the newborn rats
  6039. A decade after the CATIE study, the focus has shifted from effectiveness to Neuroprotection
  6040. S-nitrosoglutathione reduces tau hyper-phosphorylation and provides Neuroprotection in rat model of chronic cerebral hypoperfusion
  6041. … treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes Neuroprotection
  6042. Peroxisome proliferator‐activated receptor‐γ coactivator‐1α mediates Neuroprotection against excitotoxic brain injury in transgenic mice: role of mitochondria and X …
  6043. Anti-inflammatory signaling: the point of convergence for medical gases in Neuroprotection against ischemic stroke
  6044. Trans‐sodium crocetinate provides Neuroprotection against cerebral ischemia and reperfusion in obese mice
  6045. Another failed attempt of Neuroprotection : progesterone for moderate and severe traumatic brain injury.
  6046. Vitamins C and E (ascorbate/α-tocopherol) provide synergistic Neuroprotection in the jejunum in experimental diabetes
  6047. p120‐catenin is necessary for Neuroprotection induced by CDK 5 silencing in models of Alzheimer’s disease
  6048. Molecular and physiological factors of Neuroprotection in hypoxia-tolerant models: pharmacological clues for the treatment of stroke
  6049. Dose-dependent Neuroprotection of delta-opioid peptide [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into …
  6050. Matrix metalloproteinase-13 participates in Neuroprotection and neurorepair after cerebral ischemia in mice
  6051. A bout analysis reveals age-related methylmercury neurotoxicity and nimodipine Neuroprotection
  6052. Adipose-brain crosstalk: do adipokines have a role in Neuroprotection ?
  6053. Neuroprotection effect of Y-27632 against H 2 O 2-induced cell apoptosis of primary cultured cortical neurons
  6054. All roads go to Salubrinal: endoplasmic reticulum stress, Neuroprotection and glial scar formation
  6055. Inhibition of the AMPK/nNOS pathway for Neuroprotection in stroke
  6056. The plant-derived chalcone 2, 2′, 5′-trihydroxychalcone provides Neuroprotection against toll-like receptor 4 triggered inflammation in microglia
  6057. Combining hypobaric hypoxia or hyperbaric oxygen postconditioning with memantine reduces Neuroprotection in 7-day-old rat hypoxia-ischemia
  6058. Neuroprotection by α2-adrenergic receptor stimulation after excitotoxic retinal injury: a study of the total population of retinal ganglion cells and their …
  6059. A novel compound ITC-3 activates the Nrf2 signaling and provides Neuroprotection in Parkinson’s disease models
  6060. Prehospital stroke care: telemedicine, thrombolysis and Neuroprotection
  6061. Isoflurane preconditioning induces Neuroprotection by up-regulation of TREK1 in a rat model of spinal cord ischemic injury
  6062. Presenilin 1 promotes trypsin-induced Neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations
  6063. Probiotics and Neuroprotection
  6064. Proof-of concept that an acute trophic factors intervention after spinal cord injury provides an adequate niche for Neuroprotection , recruitment of nestin-expressing …
  6065. Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for Neuroprotection
  6066. … derivatives with monoamine oxidase inhibition, anti-β-amyloid aggregation, metal chelation, antioxidant and Neuroprotection properties against Alzheimer’s disease
  6067. PEGylated rhFGF-2 conveys long-term Neuroprotection and improves neuronal function in a rat model of Parkinson’s disease
  6068. Blocking transient receptor potential vanilloid 2 channel in astrocytes enhances astrocyte‐mediated Neuroprotection after oxygen–glucose deprivation and …
  6069. GlyT1 inhibitor NFPS exerts Neuroprotection via GlyR alpha1 subunit in the rat model of transient focal cerebral ischaemia and reperfusion
  6070. Targeting the cholinergic system for Neuroprotection and/or enhancement of functional recovery following neurotrauma
  6071. Gonadal hormone modulation of intracellular calcium as a mechanism of Neuroprotection
  6072. Comparative analysis of gonadal steroid-mediated Neuroprotection after transient focal ischemia in rats: route of application and substrate composition
  6073. Polarizing the immune system towards Neuroprotection in brain ischemia
  6074. Effects of rice bran extracts fermented with Lactobacillus plantarum on Neuroprotection and cognitive improvement in a rat model of ischemic brain Injury
  6075. Energy restriction combined with dipeptidyl peptidase-4 inhibitor exerts Neuroprotection in obese male rats
  6076. The underestimated effect of normobaric hyperoxia on cerebral blood flow and its relationship to Neuroprotection
  6077. Photoreceptor Neuroprotection : regulation of Akt activation through serine/threonine phosphatases, PHLPP and PHLPPL
  6078. Creatine monohydrate supplementation for 10 weeks mediates Neuroprotection and improves learning/memory following neonatal hypoxia ischemia encephalopathy …
  6079. Behavioral and neurochemical deficits in aging rats with increased neonatal iron intake: silibinin’s Neuroprotection by maintaining redox balance
  6080. Neuroprotection and mechanisms of dexmedetomidine
  6081. N-acetylcysteine in combination with IGF-1 enhances Neuroprotection against proteasome dysfunction-induced neurotoxicity in SH-SY5Y cells
  6082. Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for Neuroprotection
  6083. 5-HT4-mediated Neuroprotection : a new therapeutic modality on the way?
  6084. Neuroprotection of the rat’s retinal ganglion cells against glutamate-induced toxicity
  6085. PHARMACOLOGICAL Neuroprotection IN CARDIOSURGERY (Part 1): DRUGS FOR GENERAL ANESTHESIA
  6086. Orchestrated activation of mGluR5 and CB 1 promotes Neuroprotection
  6087. Combination of sitagliptin and insulin against type 2 diabetes mellitus with neuropathy in rats: Neuroprotection and role of oxidative and inflammation stress
  6088. A new face of orexins action-Neuroprotection
  6089. The use of therapeutic magnesium for Neuroprotection during global cerebral ischemia associated with cardiac arrest and cardiac bypass surgery in adults: a …
  6090. Cytosolic receptor melanoma differentiation–associated protein 5 mediates preconditioning-induced Neuroprotection against cerebral ischemic injury
  6091. Neuroprotection of Stilbenes from Leaves of Cajanus cajan against Oxidative Damage Induced by Corticosterone and Glutamate in Differentiated PC12 Cells
  6092. Translocator protein 18 kDa (TSPO): old dogma, new mice, new structure, and new questions for Neuroprotection
  6093. Reply: The underestimated effect of normobaric hyperoxia on cerebral blood flow and its relationship to Neuroprotection
  6094. Neuroprotection by salubrinal treatment in global cerebral ischemia
  6095. Erratum: Squalenoyl adenosine nanoparticles provide Neuroprotection after stroke and spinal cord injury
  6096. Can we protect the brain via preconditioning? Role of microRNAs in Neuroprotection
  6097. Magnesium sulphate for fetal Neuroprotection : benefits and challenges of a systematic knowledge translation project in Canada
  6098. Improved Neuroprotection provided by drug combination in neurons exposed to cell-derived soluble amyloid-β peptide
  6099. Electroacupuncture exerts Neuroprotection through caveolin-1 mediated molecular pathway in intracerebral hemorrhage of rats
  6100. Neuroprotection boosts neurotrophic mechanisms preventing damage of neurons and neuroglia in case of cerebral hypoxia
  6101. Neural transmission pathways are involved in the Neuroprotection induced by post-but not perischemic limb remote conditioning
  6102. Ghrelin is the metabolic link connecting calorie restriction to Neuroprotection
  6103. Neuroprotection following acute ischemic stroke: efficacy of preconditioning and antioxidants
  6104. Pretreatment of caffeine leads to partial Neuroprotection in MPTP model of Parkinson’s disease
  6105. Neuroprotection of dopaminergic neurons by Hominis Placenta herbal acupuncture in in vitro and in vivo models of Parkinson’s disease induced by MPP+/MPTP …
  6106. The inhibition of transforming growth factor beta-activated kinase 1 contributed to Neuroprotection via inflammatory reaction in pilocarpine-induced rats with epilepsy
  6107. Neuroprotection by intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats in a model of ischemic stroke
  6108. Magnesium sulfate for Neuroprotection
  6109. Bacillus calmette-guerin confers Neuroprotection in a murine model of Japanese encephalitis
  6110. The inactivation of extracellular signal-regulated kinase by glucagon-like peptide-1 contributes to Neuroprotection against oxidative stress
  6111. Acid-sensing ion channels as a target for Neuroprotection : acidotoxicity revisited
  6112. A single intravitreal injection of ranibizumab provides no Neuroprotection in a nonhuman primate model of moderate-to-severe nonarteritic anterior ischemic …
  6113. Discovery of benzofuran derivatives that collaborate with insulin-like growth factor 1 (IGF-1) to promote Neuroprotection
  6114. Percutaneous balloon mitral valvuloplasty under Neuroprotection : Too Early for Knighthood
  6115. Rin GTPase deficiency promotes Neuroprotection following traumatic brain injury
  6116. Remote ischemic preconditioning provides Neuroprotection : impact on ketamine-induced neuroapoptosis in the developing rat brain
  6117. Pichiapastoris Production of Tat-NGB and Its Neuroprotection on Rat Pheochromocytoma Cells
  6118. How to stabilize both the proteins and the membranes: Diverse effects of sHsps in Neuroprotection
  6119. Percutaneous thrombin embolisation of an iatrogenic pseudoaneurysm of the subclavian artery with Neuroprotection in a critically ill patient
  6120. Hypothermic preconditioning in human cortical neurons: coupling Neuroprotection to ontogenic reversal of tau
  6121. Maternal dietary supplementation with omega-3 polyunsaturated fatty acids confers Neuroprotection to the newborn against hypoxia-induced dopamine …
  6122. Phenytoin for Neuroprotection
  6123. GLP-1 analogues for Neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial
  6124. Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular Neuroprotection
  6125. 4‐hydroxy‐3‐methoxy‐acetophenone‐mediated long‐lasting memory recovery, hippocampal Neuroprotection , and reduction of glial cell activation after transient …
  6126. Medical Treatment: Neuroprotection
  6127. Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the Aβ-injected rat
  6128. Sigma-1 receptor and Neuroprotection : current outlook and potential therapeutic effects
  6129. Commentary: histaminergic drugs could be novel targets for Neuroprotection in CNS disorders
  6130. Time interval after ischaemic preconditioning affects Neuroprotection and gliosis in the gerbil hippocampal CA1 region induced by transient cerebral ischaemia
  6131. Neuroprotection and antioxidative effects of Sijunzi Tang Decoction in the nematode Caenorhabditis elegans
  6132. Intravenous anesthetics and Neuroprotection
  6133. Neuroprotection therapy of multiple sclerosis with high doses of ethylmethylhydroxypyridine succinate
  6134. Exercise Preconditioning and Neuroprotection : A Review of Mechanisms
  6135. Ischemic Preconditioning: The Long-Awaited Savior of Neuroprotection . Has It Arrived?
  6136. Volatile anesthetics and Neuroprotection
  6137. Phenytoin for Neuroprotection
  6138. Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases
  6139. Neuroprotection in Parkinson’s disease: a difficult challenge.
  6140. Nanocapsules with polyelectrolyte shell as a platform for 1, 25-dihydroxyvitamin D3 Neuroprotection : study in organotypic hippocampal slices
  6141. Mechanism of Neuroprotection by Capsaicin in a Model of Parkinson’s Disease
  6142. Neuroprotection : fact and fantasy
  6143. Failure in Neuroprotection of remote limb ischemic postconditioning in the hippocampus of a gerbil model of transient cerebral ischemia
  6144. Mitochondria-targeted antioxidant SS-31 is a potential novel ophthalmic medication for Neuroprotection in glaucoma
  6145. Decreased DNA disruption in the porcine neocortex with erythromycin preconditioning during prolonged hypothermic circulatory arrest: evidence for Neuroprotection
  6146. Carnosine-induced Neuroprotection
  6147. Neuroprotection of genistein in Alzheimer’s disease
  6148. Neuroprotection and cardioprotection after cardiac arrest: how cool is cool enough?
  6149. Mechanisms of innate Neuroprotection
  6150. Involvement of Bcl-2-associated athanogene (BAG)-family proteins in the Neuroprotection by rasagiline
  6151. Neuroprotection by Dietary Isoflavones and Their Role in Cerebral Ischemia
  6152. Neuroprotection as a therapeutic target in diabetic retinopathy: a basic approach
  6153. Neuroprotection
  6154. Caffeine and Neuroprotection in Parkinson’s disease
  6155. Fractalkine: multiple strategies to counteract glutamate receptors activation leading to Neuroprotection
  6156. 58. Repetitive transcranial magnetic stimulation induces Neuroprotection via activating CaMKIIα-CREB-Bcl-2 pathway in rat brain
  6157. Intracellular disulfide reduction by phosphine-borane complexes: Mechanism of action for Neuroprotection
  6158. Neuroprotective core measure 4: Safeguarding sleep—Its value in Neuroprotection of the newborn
  6159. Retinal ganglion cell Neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors
  6160. Carotid artery stenting: current role of proximal Neuroprotection and technical advancements in stroke prevention
  6161. Magnesium sulphate for Neuroprotection
  6162. Neuroprotection induced by NMDA preconditioning as a strategy to understand brain tolerance mechanism
  6163. Neuroprotection of the preterm infant
  6164. Novel use of epidural catheter: Air injection for Neuroprotection during radiofrequency ablation of spinal osteoid osteoma
  6165. Melatonin and Melatonin Receptors in Neuroprotection
  6166. FDA Clears Transcarotid Neuroprotection System
  6167. The Cytomegalovirus protein pUL37× 1 targets mitochondria to mediate Neuroprotection
  6168. Epigallocatechin-3-gallate treatment to promote Neuroprotection and functional recovery after nervous system injury
  6169. Neurochemical changes in different brain regions induced by PACAP-relations to Neuroprotection
  6170. Enhanced Neuroprotection of Ischemic Stroke Based on Liposomal Drug Delivery System Loading a Novel Uncoupler of Ischemia-Induced nNOSPSD-95
  6171. Need to explore nanodelivery of stem cells with multimodal drug like cerebrolysin for effective strategies for enhanced Neuroprotection and neurorecovery in …
  6172. POSSIBILITIES OF PHARMACOLOGICAL Neuroprotection IN CARDIAC PATIENTS DRUGS NOT INTENDED FOR GENERAL ANESTHESIA
  6173. Neuroprotection by exogenous estrogenic compounds following traumatic brain injury
  6174. Epsilon aminocaproic acid pretreatment provides Neuroprotection following surgically induced brain injury in a rat model
  6175. Neuroprotection in the adjunctive treatment of early POAG stages
  6176. Neuroprotection of herbs promoting EPO on cerebral ischemia
  6177. Peroxisome proliferator activated receptor gamma coactivator 1 alpha: an emerging target for Neuroprotection in Parkinson’s disease
  6178. Proposed methods for Neuroprotection during human head transplantation: A critical review of HEAVEN.
  6179. Immune System Involvement in the Degeneration, Neuroprotection , and Restoration after Stroke
  6180. … the Cellular and Plasma Antioxidative Capacity Between Transient and Defined Focal brain Ischemia: Does it Suggest Supporting Time-Dependent Neuroprotection …
  6181. Exploring molecular and cellular strategies for Neuroprotection and neuroregeneration in multiple sclerosis
  6182. Sport-Related Neurotrauma and Neuroprotection : Are Return-to-Play Protocols Justified by Paternalism?
  6183. Neuroprotection and anti-epileptogenesis with mitochondria-targeted antioxidant
  6184. Hydrogen sulfide: A promising therapy in Neuroprotection following cardiac arrest?
  6185. Neuroprotection in Neurodegenerative Disorders A Minireview on an Unmet Medical Need
  6186. Purines in Parkinson’s: Adenosine A2A Receptors and Urate as Targets for Neuroprotection
  6187. Postoperative cognitive Dysfunction After Cardiac Surgery and Neuroprotection
  6188. Transplantation of Neural Stem Cells Cotreated with Thyroid Hormone and GDNF Gene Induces Neuroprotection in Rats of Chronic Experimental Allergic …
  6189. How does zebrafish support new strategies for Neuroprotection and neuroregeneration in hypoxia-related diseases?
  6190. Differential Expression of IL-6/gp130 Cytokines, Jak-STAT Signaling and Neuroprotection After Müller Cell Ablation in a Transgenic Mouse Model
  6191. brain cholesterol and the role of statins in Neuroprotection
  6192. Function, regeneration and Neuroprotection of dopaminergic neurons in the zebrafish
  6193. Targeting mitochondria via methylene blue: implications in memory enhancement and Neuroprotection
  6194. Postoperative cognitive Dysfunction After Noncardiac Surgery and Neuroprotection
  6195. A dietary polyphenol resveratrol acts to provide Neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy …
  6196. In silico approaches to identify the potential inhibitors of glutamate carboxypeptidase II (GCPII) for Neuroprotection
  6197. Exenatide for Neuroprotection after out-of-hospital cardiac arrest, a double-blind randomized controlled trial
  6198. Neuroprotection by mast cell stabilizers and histamine H1 receptor blockade in rotenone-induced oxidative stress and nigrostriatal damage
  6199. Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and Neuroprotection
  6200. Postoperative cognitive Dysfunction as a Complication of General Anesthesia. The Importance of Early Pharmacological Neuroprotection
  6201. Molecular Effects of Cinnamon Bioactive Compounds for Neuroprotection in D. Melanogaster
  6202. POLYPHENOLS FROM NATURAL HERBS IN Neuroprotection
  6203. Propofol pretreatment fails to provide Neuroprotection following a surgically induced brain injury rat model
  6204. Neuroprotection after ischemic stroke by activation of angiotensin receptor type 2: why clinical data do not fit the paradigm?
  6205. Lipoic Acid for Neuroprotection in Secondary Progressive Multiple Sclerosis (P1. 373)
  6206. Neurointervention and Neuroprotection in Stroke
  6207. Assessment of oxidative stress status and Neuroprotection by vitamin E in chronic cerebral hypoperfusion-induced neurodegeneration in rats
  6208. Correction: Neuroprotection by Argon Ventilation after Perinatal Asphyxia: A Safety Study in Newborn Piglets
  6209. NATURAL HERBS, HUMAN brain AND Neuroprotection
  6210. Current Research on the δ-Opioid Receptor: From Neuroprotection Against Hypoxia/Ischemia to Broad Neural Functions
  6211. 7, 8-Dihydroxy-4-methylcoumarin provides Neuroprotection by increasing hippocalcin expression
  6212. Phenytoin for Neuroprotection –Authors’ reply
  6213. cognitive impairment in patients poluchennym ischemic stroke in the acute and early recovery periods in the process of Neuroprotection low-dose drug cortexin
  6214. Functional Neuroprotection for the ischemic neonatal brain with lps preconditioning
  6215. Advisability of Neuroprotection in Hypertension
  6216. Adenosine Al receptor mediated Neuroprotection of Shenmai injection on rat cerebral ischemia/reperfusion injury: An experimental study
  6217. Application of genetic models for experimental study of cognitive functions and Neuroprotection
  6218. Perinatal Neuroprotection update
  6219. Drug Trials in Neuroprotection
  6220. Neuroprotection and Immunity in the Medicinal Leech Hirudo medicinalis: What About Microglia?
  6221. Neuroprotection and neuroregeneration triggered through the FUS-induced opening of the blood-brain barrier in a Parkinson’s mouse model
  6222. Gelatin nanoparticles for improved Neuroprotection of intranasally delivered osteopontin in ischemic stroke
  6223. Intraoperative Neuroprotection –influence of the anaesthesiological management
  6224. Neuroprotection : Basic mechanisms and translational potential
  6225. Neuroprotection in Glaucoma: A Review
  6226. Synthesis and Neuroprotection of 5α-androst-3β, 5, 6β-triol derivatives
  6227. Development of Neuroprotection Assay and Analysis of Endogenous Production for Eicosanoyl-5-Hydroxytryptamide
  6228. Effect of Beta Asarone–The Active Principle of Acorus Calamus in Neuroprotection and Nerve Cell Regeneration on the Pyramidal Region of Hippocampus in …
  6229. Features of Combined Neuroprotection in Ischemic Stroke
  6230. Neurovascular protection instead of only Neuroprotection
  6231. CONGRESS OF THE SOCIETY FOR THE STUDY OF Neuroprotection AND NEUROPLASTICITY
  6232. Neuroprotection of ischemic preconditioning is mediated by thioredoxin 2 in the hippocampal CA1 region following a subsequent transient cerebral ischemia
  6233. … suggests a prominent role for sGC in stroke: Validation by mechanism-based activation of apo-sGC in non-steal dosing coveys Neuroprotection and increased survival
  6234. … Effectively Prevents Central Nervous System Invasion by Influenza A (H5N1) Virus Through the Olfactory Pathway: A Proposed Mechanism of Neuroprotection
  6235. Neuroprotection and Other Clinical Indications of Lithium
  6236. Neuroprotection and Recovery in Multiple Sclerosis
  6237. Neuroprotection in Parkinson’s disease.
  6238. Mechanism of neurodegeneration and Neuroprotection
  6239. Perinatal Neuroprotection update [version 1; referees: 2
  6240. Reparixin attenuates neuronal injury in experimental Klebsiella pneumoniae meningoencephalitis through dual effects on Neuroprotection and neuroinflammation
  6241. Phosphorylation enhances recombinant HSP27 Neuroprotection against focal cerebral
  6242. Glucagon-Like Peptide 1, Neuroprotection and Neurodegenerative Disorders
  6243. A new look at platelet inhibition and Neuroprotection
  6244. MIMOSA PUDICA EXERTS Neuroprotection AGAINST MPP
  6245. Neuroprotection Therapy for Traumatic brain Injury
  6246. NOVEL THERAPEUTIC INTERVENTIONS FOR Neuroprotection IN CENTRAL AND PERIPHERAL NEUROLOGICAL DISORDERS
  6247. In vitro Neuroprotection by medicinal plant extracts
  6248. PHARMACOLOGICAL Neuroprotection OF TYPE 1 DIABETES MELLITUS
  6249. Neuroprotection in the Aftermath of a First Episode of Mania.
  6250. Features of Neuroprotection in the Comprehensive Treatment of Traumatic brain Injury
  6251. Neurodegenerative diseases: molecular mechanisms and new strategies for Neuroprotection
  6252. Supplementing mechanical thrombectomy with Neuroprotection
  6253. Abstract PR167: The Neuroprotection Therapy of the Traumatic brain Injury
  6254. Hypoxic ischemic encephalopathy: new insights in Neuroprotection
  6255. Neuroprotection : Do Onions have the Answer
  6256. Neuroprotection : divalproex sodium-NMR studies-s
  6257. Microglial Acivation as a Possible Mechanism for Neuroprotection by CoQ10
  6258. The Study on the Korean and Western Medical Literatures for Neuroprotection Therapy of Glaucoma
  6259. ITH33/IQM9. 21 provides Neuroprotection in a novel ALS model based on TDP-43 and Na+/Ca2+ overload induced by VTD
  6260. Essay: Therapeutic hypothermia: mechanisms of Neuroprotection
  6261. Study of the Neuroprotection mechanisms in a model of spinal cord injury in vitro
  6262. Mechanisms underlying the endogenous Neuroprotection of hamartin in ischaemic stroke
  6263. Systemic Inflammation Negates Hypothermic Neuroprotection in a Neonatal HIE-model
  6264. Biotech approach for enhanced Neuroprotection based on adipose-MSCs and drugs properties
  6265. Diabetic retinopathy: Neuroprotection as a therapeutic target
  6266. Delta Opioids Provide RGC Neuroprotection Via Adenylyl Cyclase (AC) Superactivation
  6267. Retinal Gene Transcriptional Regulation and Neuroprotection of Photoreceptors
  6268. Neuroprotection : A New Therapeutic Approach of Relapsing Remitting Multiple Sclerosis
  6269. Novel Targets of Delta Opioid-Receptor for RGC Neuroprotection
  6270. Choline in neuronal development and Neuroprotection
  6271. Efffcts of retino-collicular coculture system on the Neuroprotection of retinal ganglion cells
  6272. Modulation of Retinal Ganglion Cell Function and Implications for Neuroprotection
  6273. Use of an Atg16l1 mouse model to study the role played by autophagy in Neuroprotection
  6274. Estetrols’ Potential for Neuroprotection Following the injury to the Developing brain : Preclinical Studies
  6275. Use of Therapeutic Hypothermia after Stroke: Beyond Neuroprotection
  6276. Neuroprotection and acidosis induced by cortical spreading depression
  6277. The best basic science paper in multiple sclerosis in 2014: Citicoline, remyelination and Neuroprotection : Commentary
  6278. Cannabidiol, Neuroprotection and neuropsychiatric
  6279. A possible role of transthyretin in the biological mechanism of regulatory peptide Neuroprotection
  6280. Neuroprotection by noble gases and other drugs in models of trauma
  6281. Electrophysiological Assessment of Neuroprotection and Rehabilitation Interventions in ischemic Stroke
  6282. Voluntary Exercise for Neuroprotection in Glaucoma
  6283. brain energy metabolism-neurotoxicity, Neuroprotection
  6284. Precursors of coenzyme A-panthenol and pantethine-in the mechanisms of Neuroprotection
  6285. Looking to the future of stroke treatment: Combining recanalization and Neuroprotection in acute ischemic stroke
  6286. CREATINE SALTS PROVIDE Neuroprotection EVEN AFTER
  6287. Retinal Neurodegeneration in the Course of Diabetes: Neuroprotection as a Potential Treatment Target
  6288. Drugs for Neuroprotection after birth asphyxia: Pharmacologic adjuncts to hypothermia
  6289. Sirt1 activators induced Neuroprotection of photoreceptors in rd10 mice
  6290. Author Response: Phenytoin for Neuroprotection in acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
  6291. The Molecular Mechanisms of Magnesium Neuroprotection in Patients with Eclampsia: A Short Review
  6292. Computational Analysis of Coffee Constituents and Their Potential Neuroprotection Action in Alzheimer’s Disease
  6293. Mechanisms mediating Neuroprotection and recovery with AT2 receptor stimulation after stroke
  6294. Winter‐Like Conditions Do Not Enhance Neuroprotection from OGD in Syrian Hamsters
  6295. Pay attention to the secondary optic neuropathy and the safe appropriate applications of optic Neuroprotection
  6296. Neuroprotection by Near-infrared Light in a Rat Stroke Model
  6297. Inhibiting the Prostaglandin Pathway for Neonatal Neuroprotection
  6298. Birth Asphyxia: Prevalence, Causes, Clinical Progression and Neuroprotection
  6299. Neuroprotection of Plant Polyphenols in Cerebral Ischemia
  6300. Erythropoietin-mediated Neuroprotection in insects
  6301. Neuroprotection and acidosis induced by cortical spreading depression
  6302. Design and Synthesis of Neurologically Active Glycopeptides for Neuroprotection and Antinociception
  6303. Role of Astrocytes in Ischemic Preconditioning-Induced Neuroprotection
  6304. Neuroprotection with Estradiol in Experimental Perinatal Asphyxia: A New Approach
  6305. Potential role of dietary sulforaphane in Neuroprotection
  6306. The Neuroprotection effect of vascular endothelial growth factor on epileptic seizure
  6307. New Spinal cord models: Characterization of Excitotoxicity and Neuroprotection
  6308. Neuroprotection Following Stroke in the Gyrencephalic Non-Human Primate brain
  6309. Erratum to: Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection
  6310. Neuroprotection by estrogenic compounds following inflammatory insult in the brain
  6311. Neuroprotection of Luteolin Against Aβ_ (25-35) Induced Neural Damage
  6312. CHAPTER THREE ISOFLURANE PROVIDES Neuroprotection IN NEONATAL HYPOXIC ISCHEMIC brain INJURY
  6313. Using MR Techniques to Detect Neuroprotection of Pinocembrin on TBI in Rats
  6314. Neuroprotection Comparison of Different Nutraceutical Compounds Against Mechanistically Distinct Cell Death Inducing agents .
  6315. Crystal Structure and Neuroprotection of a Novel Isoflavone Sulfonamide Compound
  6316. Neuroprotection of melatonin against intracerebral hemorrhage
  6317. Pathological Mechanisms of Retinal Ischemia/Reperfusion Injury and Potential Targets of Neuroprotection
  6318. Retina-specific T cells provide Neuroprotection in a mouse model of glaucoma (BA6P. 140)
  6319. Hypothermic modulation of human cortical neurons to explore a role for tau protein in Neuroprotection
  6320. Deciphering the mechanisms underlying the loss of BDNF Neuroprotection in an Alzheimer’s disease model
  6321. Docosahexaenoic Acid Promotes Recovery of Motor Function by Neuroprotection and Neuroplasticity Mechanisms
  6322. Natural Products, Neuroprotection and cosmeceuticals: a translational approach
  6323. Molecular Basis of Angiogenesis and Neuroprotection by Angiogenin
  6324. Is selective nasopharyngeal brain cooling detrimental to Neuroprotection ?
  6325. Correction to “Molecular and Physiological Factors of Neuroprotection in Hypoxia-tolerant Models: Pharmacological Clues for the Treatment of Stroke”
  6326. Steroid induced Neuroprotection of damaged photoreceptor cells
  6327. Neuronal Gap Junctions form Novel Therapeutic Targets for Neuroprotection in Glaucoma
  6328. Nanogold Mediated the Neuroprotection in Mutant Huntingtin Expressing Neuronal cells
  6329. Transcription Factor Brn3b Mediated Neuroprotection in an Ocular Hypertension Rat Model of Glaucoma
  6330. Lactate Neuroprotection in cerebral ischemia: a probable dual mechanism of action
  6331. Two Opposite Effects of NMDA-Receptors in Terms of Increased Range of Pharmacological Neuroprotection in Acute Cerebral Ischemia
  6332. Abstract WP250: Prehospital Initiation of Neuroprotection Followed by Endovascular Therapy for Acute Ischemic Stroke
  6333. Filter Neuroprotection of a single patent internal carotid artery during transapical aortic valve implantation
  6334. MT1 receptor mediated Neuroprotection in R6/2 mouse model of Huntington’s disease
  6335. The role of Npas4 in Neuroprotection and neurogenesis
  6336. Switching from astrocytic Neuroprotection to neurodegeneration by cytokine stimulation
  6337. Sensory Stimulation-Induced Neuroprotection in Hyperacute Phase of Ischemic Stroke-A Multimodal Imaging Study
  6338. Chocolate, air pollution and children’s Neuroprotection : What cognition tools should be at hand to evaluate interventions?
  6339. Correction to:“Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection ”
  6340. Naïve retina-specific T cells provide Neuroprotection to retinal ganglion cells in mouse models of glaucoma
  6341. Profound hypothermia provides Neuroprotection following hypothermic circulatory arrest: Ultrastructural observations
  6342. Nanoparticle-mediated Neuroprotection in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION)
  6343. Abstract TP97: Experimental Stroke During Aging: Docosahexaenoic Acid Therapy Provides Robust Neuroprotection
  6344. Study of mechanism on NF-κB mediates injection coryadlis decumbens pers par-ticipated in Neuroprotection after ischemia reperfusion of rats
  6345. Abstract TP270: Ischemic Preconditioning-afforded Neuroprotection Against Ischemic Stroke is Associated With Altered Peripheral Immune Responses
  6346. A role for nicotine in Neuroprotection against disorders associated with monoaminergic and cognitive dysfunction
  6347. Letter by Hartung and Cottrell Regarding Article,“What Is the Use of Hypothermia for Neuroprotection After Out-of-Hospital Cardiac Arrest?”
  6348. Neuroprotection by MKK7 inhibition in excitotoxicity
  6349. Role of estrogen-induced neuroglobin expression in neurodegeneration and Neuroprotection
  6350. Neuroprotection in a rotenone model of Parkinson’s disease
  6351. Human cord blood derived CD14 cell therapy provides Neuroprotection in aquired brain injury
  6352. Patent application title: METHODS OF Neuroprotection INVOLVING MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR AGONISTS …
  6353. Neuropeptide Y gene transfer for Neuroprotection in Machado-Joseph Disease
  6354. Investigation of Neuroprotection using a Novel Antioxidant Therapy to Reduce Cellular Stress in Rat Cortical Astrocytes
  6355. Understanding the mecahanisms of acetyl-l-carnitine through Neuroprotection after methamphetamine administration
  6356. Synthesis, Crystal Structure and Neuroprotection of a Novel Isoflavone Sulfonamide Compound
  6357. Xenon Confers Neuroprotection in Organotypic Hippocampal Slice Cultures
  6358. Nanotechnological approaches using curcumin and Withania somnifera: Neuroprotection and antimicrobial activities
  6359. Neuroprotection and cardioprotection after cardiac arrest: how cool is cool enough? Response to Polderman
  6360. Molecular mechanism of Abeta recognition and Neuroprotection by the glycoconjugate beta-sheet-breaker peptide Ac-LPFFD-Th
  6361. ERK is Invovled in Neuroprotection of Win55, 212-2 Pharmacological Hypothermia After CPR in a Rat Cardiac Arrest Model
  6362. Mechanisms of Neuroprotection against ischemic insult by stress-inducible phosphoprotein-1
  6363. Therapeutic potential of non‐viral MRNA delivery to Müller cells for Neuroprotection
  6364. Neuroprotection and neurorestoration through the opened blood-brain barrier using focused ultrasound and microbubbles
  6365. Neuroprotection after infection-sensitized neonatal hypoxic-ischemic brain injury
  6366. TFP5/TP5 peptide provides Neuroprotection in the MPTP model of Parkinson’s disease
  6367. Retinal Ganglion Cell Neuroprotection Induced by Neuropharmacological agents in an In-vivo Model of Glaucoma
  6368. Neuroprotection of human retinal ganglion cells by human mesenchymal stem cells and platelet derived growth factor
  6369. Pharmacological modulation of HSP70-dependent mechanisms of endogenous Neuroprotection in conditions of prenatal chronic alcoholism by Cerebrocurin and …
  6370. Fetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis
  6371. Neuroprotection , HMGR inhibition, vitamin E quantification and antimicrobial properties of palm puree
  6372. P7: Valproic Acid Mediated Neuroprotection and Neurogenesis after Acute Spinal Cord Injury
  6373. Current intensity-dependent Neuroprotection in eyes with traumatic optic neuropathy by transcorneal electrical stimulation
  6374. Neuroinflammation in Ischaemic Stroke: Utilizing the Biphasic Niche of Neuroprotection and Neurotoxicity for Clinic
  6375. Abstract T P77: Long-term Neuroprotection with Pharmacological Hypothermia by TRPV1 Agonism in Ischemic Stroke
  6376. The Neuroprotection of hydrogen sulfide against hypoxia-induced injury in neonatal mice
  6377. Anemoside A3 Enhances cognition Through the Regulation of Synaptic Function and Neuroprotection OPEN
  6378. … EFFECT OF CIRCULATING BONE MARROW PROGENITORS AS A POSSIBLE MECHANISM OF Neuroprotection IN TRAUMATIC brain INJURY
  6379. Molecular Mechanisms Underlying Environmental Enrichment-Induced Neuroprotection in Vulnerability to Nicotine Addiction
  6380. Blockade of Retinal Gap Junctions Offers Significant Neuroprotection in an Experimental Mouse Model of Glaucoma
  6381. Acute stress enhances the expression of Neuroprotection -and neurogenesis-associated genes in the hippocampus of a mouse restraint model
  6382. Knockout Mice With Gene Ablation of the Acid-Extruding Membrane Protein Nbcn1 Develop Neuroprotection
  6383. Abstract WP112: Trans-arterial Regional Hypothermia Provides Robust Neuroprotection in Rat Permanent Middle Cerebral Artery Occlusion Model
  6384. Sphingolipid biology, lipid rafts and their roles in neurodegeneration and Neuroprotection
  6385. THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS: A MULTI-ARM, MULTI-CENTRE TRIAL OF Neuroprotection
  6386. Intravitreal delivery of chemically modified mRNA for Neuroprotection through Müller cell transfection
  6387. Human neuroblastoma SH-SY5Y cells-in vitro model to study neurodegeneration and Neuroprotection in relation to Parkinson’s disease
  6388. Organic Cation Transporters as Modulators of Neurodegeneration and Neuroprotection in the brain
  6389. Presynaptic and Postsynaptic Compartments Regulate Neuronal Cell Excitability and Neuroprotection
  6390. Fingolimod-Induced Neuroprotection from Experimental Hemorrhagic Stroke in Adults and Neonates
  6391. AMP‐Activated Protein Kinase (AMPK) as a Cellular Energy Sensor and Therapeutic Target for Neuroprotection
  6392. INVESTIGATION OF OXIDATIVE STRESS STATUS AND Neuroprotection BY VITAMIN E IN CHRONIC CEREBRAL HYPOPERFUSION-INDUCED …
  6393. Failure in Neuroprotection of remote limb ischemic postconditioning in the hippocampus of a gerbil model of transient cerebral ischemia
  6394. A bout analysis reveals age-dependent methylmercury neurotoxicity and nimodipine Neuroprotection : Implications for the role of calcium homeostasis in aging
  6395. Albumin confers Neuroprotection against bilirubin toxicity in experimental intracerebral hemorrhage in mice
  6396. Neuroprotection of rifampicin in global cerebral ischemia via inhibiting microglial activation
  6397. A phase II, double blind, randomised, placebo-controlled trial of Neuroprotection with phenytoin in acute optic neuritis
  6398. Abstract WP258: Effective Neuroprotection After Clinically Relevant Delay Using Intra-arterial Recanalization Plus Perivascular Hypothermia: Novel Approach to an …
  6399. Flibanserin, a FDA approved dual serotonin receptor agonist-antagonist, provides retinal Neuroprotection from light induced damage
  6400. Neuroprotection by Nerve Growth Factor (NGF) involves modulation of neuronal autophagy
  6401. Cytosolic receptor MDA5 mediates Poly-ICLC preconditioning induced Neuroprotection against cerebral ischemic injury
  6402. Red/Near-infrared irradiation therapy (R/NIR IT) LASER pretreatment promotes Neuroprotection of retinal neurons in a model of retinal metabolic dysfunction in vitro.
  6403. Neuroprotection of neuroserpin in oxygen-glucose deprivation-and reoxygenation-treated rat neurons and microglias in vitro
  6404. Role of autophagy in GM1-mediated Neuroprotection in Huntington’s Disease
  6405. Mechanism of Neuroprotection by magnesium acetyltaurate on experimental glutamate-induced excitotoxicity in rat retinal ganglion cells/Associate Professor Dr Igor …
  6406. Pharmacological inhibition of GSK3β enables RGC Neuroprotection and promotes neurite growth in cultured retinal cells
  6407. TrkB signaling in Müller glia stimulates Neuroprotection after optic nerve injury
  6408. Abstract TP280: Resveratrol Preconditioning Alters MicroRNA Expression Profiles to Induce Neuroprotection Against Ischemic Stroke
  6409. Neuroprotection against traumatic brain injury by xenon but not argon, is mediated by inhibition at the NMDA receptor glycine site
  6410. Abstract WP270: Myeloid P2X4 Receptor Deletion Confers Neuroprotection in Females but not in Males After Experimental Stroke
  6411. Neuroprotection by caloric restriction is associated with a distinct state of hippocampal energy metabolism linked to PGC-1alpha and GSK3beta
  6412. Resuscitation with Lyophillized Plasma Is Safe and Provides Neuroprotection in a Long-Term Survival Model of Swine Subjected to Traumatic brain Injury …
  6413. Neuroprotection in an ALS mouse model following peripheral delivery of motor neuron targeted aCAR-IGF-1 Lentiviral vector
  6414. Whole transcriptome sequencing in rd10 revealed new factors and pathways involved in stem cells biology and Neuroprotection in the inner retina and ciliary body.
  6415. Neuroprotection exerted by ischemic preconditioning in rat hippocampus involves extracellular signal receptor changes
  6416. Neuroprotection of selective antegrade cerebral perfusion on pig model exposed to deep hypothermia circulatory arrest
  6417. CereboostTM, an American ginseng extract, improves cognitive function via up-regulation of choline acetyltransferase expression and Neuroprotection .
  6418. Antenatal magnesium sulfate for both short-term tocolysis and fetal Neuroprotection in premature rupture of the membranes remote from term
  6419. Failurein Neuroprotection of remote limb ischemic postconditioning (RIPoC) in the hippocampus of a gerbil model of transient cerebral ischemia
  6420. The effect of coenzyme Q10 supplementation on mitochondrial chanes and Neuroprotection in chronic celebral hypoperfusion-induced neurodegeneration in rats
  6421. The Angiotensin Type 2-receptor Agonist, Compound 21, Provides Neuroprotection After Ischemia Reperfusion Injury Through Interleukin 10 Upregulation
  6422. ATP-Sensitive K+ Channel in Nigra Dopamine Neurons is a Novel Target for Tetrahydroprotoberberines’ Neuroprotection
  6423. Effects of voluntary physical exercise, citicoline, and combined treatment on object recognition memory , neurogenesis and Neuroprotection after traumatic brain …
  6424. Time interval after ischemic preconditioning affects Neuroprotection and gliosis in the gerbil hippocampal CA1 region induced by transient cerebral ischemia
  6425. Pharmacologic Inhibition of Intermediate Filament Accumulation in Astrocytes and Müller Glia Mediates Retinal Neuroprotection
  6426. Neuroprotection in the Injured Spinal Cord: Novel Strategies using Immunomodulation, Stem cell Transplantation and Hyaluronic acid Hydrogel carriers
  6427. Neuroprotection of ligustrazine hydrochloride combined with bone marrow mesenchymal stem cell transplantation in rats with spinal cord injury
  6428. Hippocampal Neuroprotection by Minocycline or Epigallocatechin-3-Gallate against Cardiopulmonary Bypass-Associated Injury
  6429. Ischemic preconditioning induces Neuroprotection cause by a transient global ischemia via maintaining the expression of p63
  6430. Neuroprotection of Retinal Ganglion Cells in Glaucoma by Blocking LINGO-1 Function or Using a Nogo-66 Receptor Antagonist
  6431. Neural Resilience to Traumatic brain Injury: Identification of Bioactive Metabolites of Docosahexaenoic Acids Involved in Neuroprotection and Recovery
  6432. Neuropathy Associated HSPB1 Mutations Result in Loss of Neuroprotection in an In Vitro Model of Astrocyte Toxicity to Motor Neurons (P5. 021)
  6433. A Multicenter Phase II Randomized Trial of a HIF-Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic Aortic Repair (S7. 008)
  6434. Neuroprotection by α2-Adrenergic Receptor Stimulation after Excitotoxic Injury of Chicken Retinal Ganglion Cells: A Population Study
  6435. Neurosurgery (Neuro Vascular): Albumin confers Neuroprotection against bilirubin toxicity in experimental intracerebral hemorrhage in mice
  6436. Effect of rasagiline on Neuroprotection and behavior improvement in MPTP-induced acute mouse model of Parkinson’s disease
  6437. Liposomal Astaxanthin provides Neuroprotection against methamphetamine-induced dopaminergic toxicity
  6438. Relationship between ischemic preconditioninginduced Neuroprotection and antioxidants enzymes expressions in the gerbil hippocampal CA1 region following a …
  6439. Onion Beverages Improve Amyloid β Peptide-Induced cognitive Defects via Up-Regulation of Cholinergic Activity and Neuroprotection
  6440. Neuroprotection in the treatment of acute ischemic stroke
  6441. Neuroprotection for treatment of glaucoma in adults
  6442. Reconsidering Neuroprotection in the reperfusion era
  6443. Neuroprotection in stroke: the importance of collaboration and reproducibility
  6444. The emerging field of epigenetics in neurodegeneration and Neuroprotection
  6445. Neuroprotection and neurorestoration as experimental therapeutics for Parkinson’s disease
  6446. GRP78 at the centre of the stage in cancer and Neuroprotection
  6447. Astroglia as a cellular target for Neuroprotection and treatment of neuro‐psychiatric disorders
  6448. Disease modification and Neuroprotection in neurodegenerative disorders
  6449. Metabolic syndrome and Neuroprotection
  6450. Rethinking Neuroprotection in severe traumatic brain injury: toward bedside Neuroprotection
  6451. Experimental Neuroprotection in ischemic stroke: a concise review
  6452. Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid Neuroprotection and stent system
  6453. A working model for hypothermic Neuroprotection
  6454. Neuroprotection and secondary damage following spinal cord injury: concepts and methods
  6455. Targeting NMDA receptors in stroke: new hope in Neuroprotection
  6456. Effects of anesthesia on cerebral blood flow, metabolism, and Neuroprotection
  6457. Targets of Neuroprotection in glaucoma
  6458. Preconditioning in Neuroprotection : from hypoxia to ischemia
  6459. Help-me signaling: non-cell autonomous mechanisms of Neuroprotection and neurorecovery
  6460. Bioactivity of olive oil phenols in Neuroprotection
  6461. Mechanism of Neuroprotection by trehalose: controversy surrounding autophagy induction
  6462. From mitochondrial function to Neuroprotection —an emerging role for methylene blue
  6463. The emerging role of retromer in Neuroprotection
  6464. The role of astrocytes in Neuroprotection after brain stroke: potential in cell therapy
  6465. Inhibition of the NLRP3-inflammasome as a potential approach for Neuroprotection after stroke
  6466. Refocusing Neuroprotection in cerebral reperfusion era: New challenges and strategies
  6467. Combining Neuroprotection with endovascular treatment of acute stroke: is there hope?
  6468. New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and Neuroprotection
  6469. Cerium oxide nanoparticles in Neuroprotection and considerations for efficacy and safety
  6470. Neuroprotection in glaucoma: animal models and clinical trials
  6471. Phosphodiesterase inhibitors as a therapeutic approach to Neuroprotection and repair
  6472. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway
  6473. brain SIRT1 mediates metabolic homeostasis and Neuroprotection
  6474. Sex differences in neuroinflammation and Neuroprotection in ischemic stroke
  6475. Achieving Neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
  6476. Role of estrogen and other sex hormones in brain aging. Neuroprotection and DNA repair
  6477. Neuroprotection for glaucoma: Requirements for clinical translation
  6478. L-Carnitine and acetyl-L-carnitine roles and Neuroprotection in developing brain
  6479. Modulating inflammation and Neuroprotection in multiple sclerosis
  6480. Exercise-induced Neuroprotection of the nigrostriatal dopamine system in Parkinson’s disease
  6481. Prophylactic early erythropoietin for Neuroprotection in preterm infants: a meta-analysis
  6482. Paradigm shift to neuroimmunomodulation for translational Neuroprotection in stroke
  6483. Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to Neuroprotection
  6484. Fine‐tuning PERK signaling for Neuroprotection
  6485. Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
  6486. On the role of endogenous neurotoxins and Neuroprotection in Parkinson’s disease
  6487. Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and Neuroprotection
  6488. PGC-1α sparks the fire of Neuroprotection against neurodegenerative disorders
  6489. In vogue: ketamine for Neuroprotection in acute neurologic injury
  6490. Synergistic Neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB
  6491. Anti-oxidant and anti-inflammatory activity of ketogenic diet: new perspectives for Neuroprotection in Alzheimer’s disease
  6492. Heat shock proteins and autophagy pathways in Neuroprotection : from molecular bases to pharmacological interventions
  6493. Fetal Neuroprotection by magnesium sulfate: from translational research to clinical application
  6494. Neuroprotection in schizophrenia and its therapeutic implications
  6495. Hydrogen gas inhalation treatment in acute cerebral infarction: a randomized controlled clinical study on safety and Neuroprotection
  6496. Metabotropic glutamate receptors in glial cells: a new potential target for Neuroprotection ?
  6497. Neuroprotection via AT2 receptor agonists in ischemic stroke
  6498. Novel tactics for Neuroprotection in Parkinson’s disease: role of antibiotics, polyphenols and neuropeptides
  6499. Neuroprotection in glaucoma: Old and new promising treatments
  6500. Steroid transport, local synthesis, and signaling within the brain : roles in neurogenesis, Neuroprotection , and sexual behaviors
  6501. DHCR24 exerts Neuroprotection upon inflammation-induced neuronal death
  6502. LncRNA-N1LR enhances Neuroprotection against ischemic stroke probably by inhibiting p53 phosphorylation
  6503. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related Neuroprotection
  6504. Anesthetic Neuroprotection in experimental stroke in rodents: a systematic review and meta-analysis
  6505. Non-coding RNAs and Neuroprotection after acute CNS injuries
  6506. Nrf2 weaves an elaborate network of Neuroprotection against stroke
  6507. MicroRNA changes in preconditioning-induced Neuroprotection
  6508. A review of traumatic brain injury and the gut microbiome: insights into novel mechanisms of secondary brain injury and promising targets for Neuroprotection
  6509. Amyloid beta modulators and Neuroprotection in Alzheimer’s disease: a critical appraisal
  6510. Neuroprotection and neurotoxicity in the developing brain : an update on the effects of dexmedetomidine and xenon
  6511. The effect of polyphenols on protein degradation pathways: implications for Neuroprotection
  6512. Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation
  6513. Could conservative iron chelation lead to Neuroprotection in amyotrophic lateral sclerosis?
  6514. Inhibition of phosphodiesterases as a strategy to achieve Neuroprotection in Huntington’s disease
  6515. Hypoxia-inducible factor-1α target genes contribute to retinal Neuroprotection
  6516. Mechanism of salvianolic acid B Neuroprotection against ischemia/reperfusion induced cerebral injury
  6517. PARP inhibition in platinum-based chemotherapy: Chemopotentiation and Neuroprotection
  6518. Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and Neuroprotection
  6519. Magnesium sulfate and fetal Neuroprotection : overview of clinical evidence
  6520. Carvacrol promotes Neuroprotection in the mouse hemiparkinsonian model
  6521. Mechanisms involved in the Neuroprotection of electroacupuncture therapy for ischemic stroke
  6522. Glaucoma and the brain : trans-synaptic degeneration, structural change, and implications for Neuroprotection
  6523. Neuroprotection strategies in aortic surgery
  6524. Salidroside provides Neuroprotection by modulating microglial polarization after cerebral ischemia
  6525. Centella asiatica: Phytochemistry and mechanisms of Neuroprotection and cognitive enhancement
  6526. Dexmedetomidine-mediated Neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats
  6527. Neuroprotection of brain -permeable iron chelator VK-28 against intracerebral hemorrhage in mice
  6528. Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and Neuroprotection in glaucoma
  6529. ΔN-Bcl-xL, a therapeutic target for Neuroprotection
  6530. Environmental enrichment cognitive Neuroprotection in an experimental model of cerebral ischemia: biochemical and molecular aspects
  6531. Predictive value of amplitude-integrated EEG (aEEG) after rescue hypothermic Neuroprotection for hypoxic ischemic encephalopathy: a meta-analysis
  6532. Neuroprotection by caffeine in hyperoxia-induced neonatal brain injury
  6533. Neuroprotection of agomelatine against cerebral ischemia/reperfusion injury through an antiapoptotic pathway in rat
  6534. Neuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation
  6535. Transthyretin Neuroprotection in Alzheimer’s disease is dependent on proteolysis
  6536. DNP, mitochondrial uncoupling, and Neuroprotection : A little dab’ll do ya
  6537. Postconditioning-induced Neuroprotection , mechanisms and applications in cerebral ischemia
  6538. How long is sufficient for optimal Neuroprotection with cerebral cooling after ischemia in fetal sheep?
  6539. Splenic responses play an important role in remote ischemic preconditioning-mediated Neuroprotection against stroke
  6540. Maternal inflammation, fetal brain implications and suggested Neuroprotection : a summary of 10 years of research in animal models
  6541. HIF-1α/Beclin1-mediated autophagy is involved in Neuroprotection induced by hypoxic preconditioning
  6542. L-lactate regulates the expression of synaptic plasticity and Neuroprotection genes in cortical neurons: a transcriptome analysis
  6543. Microglia-mediated Neuroprotection , TREM2, and Alzheimer’s disease: evidence from optical imaging
  6544. The application of nanoparticles for Neuroprotection in acute ischemic stroke
  6545. Reperfusion changes after stroke and practical approaches for Neuroprotection
  6546. Fucoxanthin provides Neuroprotection in models of traumatic brain injury via the Nrf2-ARE and Nrf2-autophagy pathways
  6547. Curcumin provides Neuroprotection in model of traumatic brain injury via the Nrf2-ARE signaling pathway
  6548. Mitochondria as a target for Neuroprotection : implications for Alzheimer s disease
  6549. Topical Coenzyme Q10 demonstrates mitochondrial-mediated Neuroprotection in a rodent model of ocular hypertension
  6550. Curcumin-loaded polymeric nanoparticles for Neuroprotection in neonatal rats with hypoxic-ischemic encephalopathy
  6551. Neuroprotection provided by isoflurane pre-conditioning and post-conditioning
  6552. Food, polyphenols and Neuroprotection
  6553. Modulation of Nrf2 by olive oil and wine polyphenols and Neuroprotection
  6554. Ghrelin mediated Neuroprotection -A possible therapy for Parkinson’s disease?
  6555. Effects of fluoxetine on hippocampal neurogenesis and Neuroprotection in the model of global cerebral ischemia in rats
  6556. Curcumin affords Neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson’s disease model
  6557. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson’s disease
  6558. Almond, hazelnut and walnut, three nuts for Neuroprotection in Alzheimer’s disease: A neuropharmacological review of their bioactive constituents
  6559. Estrogen interactions with lipid rafts related to Neuroprotection . Impact of brain ageing and menopause
  6560. Neuroprotection and immunomodulation following intraspinal axotomy of motoneurons by treatment with adult mesenchymal stem cells
  6561. Progesterone induces Neuroprotection following reperfusion-promoted mitochondrial dysfunction after focal cerebral ischemia in rats
  6562. Positive social interactions in a lifespan perspective with a focus on opioidergic and oxytocinergic systems: Implications for Neuroprotection
  6563. Potent Neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a
  6564. Mitochondrial-targeted antioxidant MitoQ provides Neuroprotection and reduces neuronal apoptosis in experimental traumatic brain injury possibly via the …
  6565. Switching from astrocytic Neuroprotection to neurodegeneration by cytokine stimulation
  6566. Using functional and molecular MRI techniques to detect neuroinflammation and Neuroprotection after traumatic brain injury
  6567. Neuroprotection by post‐stroke administration of an oral formulation of angiotensin‐(1–7) in ischaemic stroke
  6568. Resveratrol provides Neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats
  6569. Selenoprotein T is a key player in ER proteostasis, endocrine homeostasis and Neuroprotection
  6570. Mesenchymal stem cell–derived small extracellular vesicles promote Neuroprotection in rodent models of glaucoma
  6571. Maternal protein malnutrition: Current and future perspectives of spirulina supplementation in Neuroprotection
  6572. Activation of Nrf2-driven antioxidant enzymes by cardamonin confers Neuroprotection of PC12 cells against oxidative damage
  6573. Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for Neuroprotection
  6574. Melatonin prevents mitochondrial dysfunction and promotes Neuroprotection by inducing autophagy during oxaliplatin‐evoked peripheral neuropathy
  6575. A small-molecule inhibitor of Bax and Bak oligomerization prevents genotoxic cell death and promotes Neuroprotection
  6576. Neuroprotection by eIF2 α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss
  6577. Neuroprotection by (endo) cannabinoids in glaucoma and retinal neurodegenerative diseases
  6578. NF-κB p65 directs sex-specific Neuroprotection in human neurons
  6579. MAGnesium sulphate for fetal Neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
  6580. Thiamet G mediates Neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling
  6581. Erythropoietin and Nrf2: key factors in the Neuroprotection provided by apo-lactoferrin
  6582. Neuroprotection in optic neuropathy
  6583. Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer Neuroprotection in models of Huntington’s disease
  6584. In the era of therapeutic hypothermia, how well do studies of perinatal Neuroprotection control temperature?
  6585. Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white …
  6586. Retinal Neuroprotection from optic nerve trauma by deletion of arginase 2
  6587. Neuroprotection with hypothermia and allopurinol in an animal model of hypoxic-ischemic injury: Is it a gender question?
  6588. Modulating the oxytocin system during the perinatal period: a new strategy for Neuroprotection of the immature brain ?
  6589. Neurosteroid metabolites of gonadal steroid hormones in Neuroprotection : implications for sex differences in neurodegenerative disease
  6590. Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara
  6591. N-acetylcysteine amide provides Neuroprotection via Nrf2-ARE pathway in a mouse model of traumatic brain injury
  6592. TGF-β1 Neuroprotection via inhibition of microglial activation in a rat model of Parkinson’s disease
  6593. Neuroprotection of dexmedetomidine against cerebral ischemia-reperfusion injury in rats: Involved in inhibition of NF-κB and inflammation response
  6594. Marine compound xyloketal B as a potential drug development target for Neuroprotection
  6595. Subthalamic nucleus deep brain stimulation employs trkB signaling for Neuroprotection and functional restoration
  6596. Activation of the Nrf2 signaling pathway and Neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220
  6597. Combination of NAD+ and NADPH offers greater Neuroprotection in ischemic stroke models by relieving metabolic stress
  6598. Treadmill exercise exerts Neuroprotection and regulates microglial polarization and oxidative stress in a streptozotocin-induced rat model of sporadic Alzheimer’s …
  6599. Neuroprotection of rhGLP‐1 in diabetic rats with cerebral ischemia/reperfusion injury via regulation of oxidative stress, EAAT2, and apoptosis
  6600. A dual role for hyperbaric oxygen in stroke Neuroprotection : Preconditioning of the brain and stem cells
  6601. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain -derived neurotrophic factor …
  6602. miR-196a enhances neuronal morphology through suppressing RANBP10 to provide Neuroprotection in Huntington’s disease
  6603. Autophagosome maturation mediated by Rab7 contributes to Neuroprotection of hypoxic preconditioning against global cerebral ischemia in rats
  6604. PPARδ activation by bexarotene promotes Neuroprotection by restoring bioenergetic and quality control homeostasis
  6605. Betaine in the brain : characterization of betaine uptake, its influence on other osmolytes and its potential role in Neuroprotection from osmotic stress
  6606. Autophagy-mediated Neuroprotection induced by octreotide in an ex vivo model of early diabetic retinopathy
  6607. GSK-3β inhibition induced Neuroprotection , regeneration, and functional recovery after intracerebral hemorrhagic stroke
  6608. Low-dose minocycline mediated Neuroprotection on retinal ischemia-reperfusion injury of mice
  6609. Multi-faceted role of melatonin in Neuroprotection and amelioration of Tau aggregates in Alzheimer’s disease
  6610. Neuroprotection by human dental pulp mesenchymal stem cells: from billions to nano
  6611. Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson’s Disease
  6612. New evidences for a role of mGluR7 in astrocyte survival: possible implications for Neuroprotection
  6613. Morin exerts Neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy
  6614. Sonic hedgehog signalling mediates astrocyte crosstalk with neurons to confer Neuroprotection
  6615. Inhibition of HMGB1 mediates Neuroprotection of traumatic brain injury by modulating the microglia/macrophage polarization
  6616. … exercise and glaucoma: a review on the roles of physical exercise on intraocular pressure control, ocular blood flow regulation, Neuroprotection and glaucoma‐related …
  6617. Neuroprotection with the endozepine octadecaneuropeptide, ODN
  6618. Peptide-based acetylcholinesterase inhibitor crosses the blood-brain barrier and promotes Neuroprotection
  6619. Inhibition of the SOCS1-JAK2-STAT3 signaling pathway confers Neuroprotection in rats with ischemic stroke
  6620. Epigenetic regulation of HDAC1 SUMOylation as an endogenous Neuroprotection against A β toxicity in a mouse model of Alzheimer’s disease
  6621. Memantine ameliorates depressive-like behaviors by regulating hippocampal cell proliferation and Neuroprotection in olfactory bulbectomized mice
  6622. Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: involvement of cytokine modulation and Neuroprotection
  6623. Neuroprotection from organophosphate-induced damage by novel phenoxyalkyl pyridinium oximes in rat brain
  6624. Triglyceride form of docosahexaenoic acid mediates Neuroprotection in experimental parkinsonism
  6625. Baicalin provides Neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway
  6626. Dexmedetomidine reduces oxidative stress and provides Neuroprotection in a model of traumatic brain injury via the PGC-1α signaling pathway
  6627. The role of TRPC6 in the Neuroprotection of calycosin against cerebral ischemic injury
  6628. Current evidence for AMPK activation involvement on resveratrol-induced Neuroprotection in cerebral ischemia
  6629. Activation of nrf2 pathway contributes to Neuroprotection by the dietary flavonoid tiliroside
  6630. Herbal compounds play a role in Neuroprotection through the inhibition of microglial activation
  6631. Dual effects of human placenta-derived neural cells on Neuroprotection and the inhibition of neuroinflammation in a rodent model of Parkinson’s disease
  6632. Rosmarinic acid elicits Neuroprotection in ischemic stroke via Nrf2 and heme oxygenase 1 signaling
  6633. Neuroprotection through rapamycin-induced activation of autophagy and PI3K/Akt1/mTOR/CREB signaling against amyloid-β-induced oxidative stress, synaptic …
  6634. Anthocyanin-loaded PEG-gold nanoparticles enhanced the Neuroprotection of anthocyanins in an Aβ 1–42 mouse model of Alzheimer’s disease
  6635. Glial cell line-derived neurotrophic factor gene delivery in Parkinson’s disease: a delicate balance between Neuroprotection , trophic effects, and unwanted …
  6636. Anesthetic Neuroprotection ? It’s complicated
  6637. Apolipoprotein E as a novel therapeutic Neuroprotection target after traumatic spinal cord injury
  6638. Dexmedetomidine confers Neuroprotection against transient global cerebral ischemia/reperfusion injury in rats by inhibiting inflammation through inactivation of the …
  6639. Endurance exercise mediates Neuroprotection against MPTP-mediated Parkinson’s disease via enhanced neurogenesis, antioxidant capacity, and autophagy
  6640. Targeting neuronal gap junctions in mouse retina offers Neuroprotection in glaucoma
  6641. Sesamin imparts Neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress
  6642. Resveratrol promotes Neuroprotection and attenuates oxidative and nitrosative stress in the small intestine in diabetic rats
  6643. Berberine confers Neuroprotection in coping with focal cerebral ischemia by targeting inflammatory cytokines
  6644. Enhanced Neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ1-42-induced neuroinflammation and neurodegeneration via the NF-KB/JNK …
  6645. Retinal Neuroprotection : overcoming the translational roadblocks
  6646. Neuroprotection by chitosan nanoparticles in oxidative stress-mediated injury
  6647. Neuroprotection afforded by circadian regulation of intracellular glutathione levels: A key role for miRNAs
  6648. A novel CXCR4 antagonist CX549 induces Neuroprotection in stroke brain
  6649. Neuroprotection of ischemic preconditioning is mediated by thioredoxin 2 in the hippocampal CA1 region following a subsequent transient cerebral ischemia
  6650. Pramipexole and Fingolimod exert Neuroprotection in a mouse model of Parkinson’s disease by activation of sphingosine kinase 1 and Akt kinase
  6651. Antenatal magnesium sulphate administration for fetal Neuroprotection : a French national survey
  6652. Prolactin-induced Neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-κB activation
  6653. Dihydropyridines allosterically modulate Hsp90 providing a novel mechanism for heat shock protein co-induction and Neuroprotection
  6654. Estriol‐mediated Neuroprotection in multiple sclerosis localized by voxel‐based morphometry
  6655. Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces Neuroprotection
  6656. Equol, a dietary daidzein gut metabolite attenuates microglial activation and potentiates Neuroprotection in vitro
  6657. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7-and lactoferrin-grafted liposomes carrying quercetin
  6658. α-Synuclein structural features inhibit harmful polyunsaturated fatty acid oxidation, suggesting roles in Neuroprotection
  6659. Mesenchymal stem cell–derived small extracellular vesicles promote Neuroprotection in a genetic DBA/2J mouse model of glaucoma
  6660. Modulation of mitochondrial phenotypes by endurance exercise contributes to Neuroprotection against a MPTP-induced animal model of PD
  6661. SIRT2 inhibition confers Neuroprotection by downregulation of FOXO3a and MAPK signaling pathways in ischemic stroke
  6662. The striatal kinase DCLK3 produces Neuroprotection against mutant huntingtin
  6663. Müller cell-derived PEDF mediates Neuroprotection via STAT3 activation
  6664. Nrf2-mediated Neuroprotection by MANF against 6-OHDA-induced cell damage via PI3K/AKT/GSK3β pathway
  6665. Pioglitazone confers Neuroprotection against ischemia-induced pyroptosis due to its inhibitory effects on HMGB-1/RAGE and Rac1/ROS pathway by activating PPAR …
  6666. Infant-guided, co-regulated feeding in the neonatal intensive care unit. part I: theoretical underpinnings for Neuroprotection and safety
  6667. Ginsenoside Rb1 confers Neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson’s disease
  6668. Docosahexaenoic acid (DHA) provides Neuroprotection in traumatic brain injury models via activating Nrf2-ARE signaling
  6669. Targeting CDK5 post-stroke provides long-term Neuroprotection and rescues synaptic plasticity
  6670. Improving microcirculatory reperfusion reduces parenchymal oxygen radical formation and provides Neuroprotection
  6671. Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic Neuroprotection
  6672. Exercise training attenuates experimental autoimmune encephalomyelitis by peripheral immunomodulation rather than direct Neuroprotection
  6673. Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes Neuroprotection and functional recovery after spinal cord injury
  6674. Curcumin confers Neuroprotection against alcohol-induced hippocampal neurodegeneration via CREB-BDNF pathway in rats
  6675. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated Neuroprotection of dopaminergic neurons in a mouse Parkinson’s disease model
  6676. Neuroprotection in traumatic brain injury: mesenchymal stromal cells can potentially overcome some limitations of previous clinical trials
  6677. Cordycepin confers Neuroprotection in mice models of intracerebral hemorrhage via suppressing NLRP3 inflammasome activation
  6678. Inhibition of complement drives increase in early growth response proteins and Neuroprotection mediated by salidroside after cerebral ischemia
  6679. Novel hemoglobin-based oxygen carrier bound with albumin shows Neuroprotection with possible antioxidant effects
  6680. Neuroprotection comparison of rosmarinic acid and carnosic acid in primary cultures of cerebellar granule neurons
  6681. Chondroitin sulfate glycosaminoglycan matrices promote neural stem cell maintenance and Neuroprotection post-traumatic brain injury
  6682. Lower affinity of isradipine for L-type Ca2+ channels during substantia nigra dopamine neuron-like activity: implications for Neuroprotection in Parkinson’s disease
  6683. Neuroprotection by quercetin via mitochondrial function adaptation in traumatic brain injury: PGC‐1α pathway as a potential mechanism
  6684. Neuroprotection of Ro25-6981 against ischemia/reperfusion-induced brain injury via inhibition of autophagy
  6685. Neurotrophic function of phytochemicals for Neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signaling and gene expression
  6686. Regulation of excitatory amino acid transmission in the retina: studies on Neuroprotection
  6687. Autonomous CaMKII activity as a drug target for histological and functional Neuroprotection after resuscitation from cardiac arrest
  6688. Metabolomic profiling reveals that reprogramming of cerebral glucose metabolism is involved in ischemic preconditioning-induced Neuroprotection in a rodent model …
  6689. Quinolinyl nitrone RP19 induces Neuroprotection after transient brain ischemia
  6690. Hormetic effect of panaxatriol saponins confers Neuroprotection in PC12 cells and zebrafish through PI3K/AKT/mTOR and AMPK/SIRT1/FOXO3 pathways
  6691. Hibernation-like Neuroprotection in stroke by attenuating brain metabolic dysfunction
  6692. Dual action of L-Lactate on the activity of NR2B-containing NMDA receptors: from potentiation to Neuroprotection
  6693. Traditional Food Items in Ogimi, Okinawa: l-Serine Content and the Potential for Neuroprotection
  6694. Differences in statin associated Neuroprotection corresponds with either decreased production of IL-1β or TNF-α in an in vitro model of neuroinflammation-induced …
  6695. Distinct functional roles of Vps41-mediated Neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration
  6696. The Neuroprotection of low-dose morphine in cellular and animal models of Parkinson’s disease through ameliorating endoplasmic reticulum (ER) stress and …
  6697. Conditioned medium derived from neural progenitor cells induces long-term post-ischemic Neuroprotection , sustained neurological recovery, neurogenesis, and …
  6698. The future is now: Neuroprotection during cardiopulmonary resuscitation
  6699. Melatonin signaling in mitochondria extends beyond neurons and Neuroprotection : Implications for angiogenesis and cardio/gastroprotection
  6700. A non-ionotropic activity of NMDA receptors contributes to glycine-induced Neuroprotection in cerebral ischemia-reperfusion injury
  6701. In vitro effects of serotonin, melatonin, and other related indole compounds on amyloid‐β kinetics and Neuroprotection
  6702. Fractalkine-CX3CR1 signaling is critical for progesterone-mediated Neuroprotection in the retina
  6703. Time dependent Neuroprotection of dexamethasone in experimental focal cerebral ischemia: The involvement of NF-κB pathways
  6704. Activation of Nrf2 and hypoxic adaptive response contribute to Neuroprotection elicited by phenylhydroxamic acid selective HDAC6 inhibitors
  6705. Phenytoin: Neuroprotection or neurotoxicity?
  6706. Ethyl acetate extract components of bushen-yizhi formula provides Neuroprotection against scopolamine-induced cognitive impairment
  6707. Sestrin2, as a negative feedback regulator of mTOR, provides Neuroprotection by activation AMPK phosphorylation in neonatal hypoxic-ischemic encephalopathy in …
  6708. Temperature control in rodent Neuroprotection studies: methods and challenges
  6709. Rapamycin confers Neuroprotection against colistin-induced oxidative stress, mitochondria dysfunction, and apoptosis through the activation of autophagy and mTOR …
  6710. Neuroprotection of catalpol for experimental acute focal ischemic stroke: preclinical evidence and possible mechanisms of antioxidation, anti-inflammation …
  6711. Troxerutin exerts Neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson’s disease: Possible involvement of PI3K/ERβ signaling
  6712. Neuroprotection of transplanting human umbilical cord mesenchymal stem cells in a microbead induced ocular hypertension rat model
  6713. The Neuroprotection Effect of Oxygen Therapy: A Systematic Review and Meta‑analysis
  6714. Learning and memory improvement and Neuroprotection of Gardenia jasminoides (Fructus gardenia) extract on ischemic brain injury rats
  6715. Astrocyte truncated tropomyosin receptor kinase B mediates brain ‐derived neurotrophic factor anti‐apoptotic effect leading to Neuroprotection
  6716. Combined use of emodin and ginsenoside Rb1 exerts synergistic Neuroprotection in cerebral ischemia/reperfusion rats
  6717. A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct Neuroprotection
  6718. The alternative receptor for complement component 5a, C5aR2, conveys Neuroprotection in traumatic spinal cord injury
  6719. Nrf2-ARE signaling provides Neuroprotection in traumatic brain injury via modulation of the ubiquitin proteasome system
  6720. Why and how does light therapy offer Neuroprotection in Parkinson’s disease?
  6721. DL-3-n-butylphthalide induced Neuroprotection , regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice
  6722. Astrocyte-derived lipoxins A4 and B4 promote Neuroprotection from acute and chronic injury
  6723. East Indian sandalwood (Santalum album L.) oil confers Neuroprotection and geroprotection in Caenorhabditis elegans via activating SKN-1/Nrf2 signaling …
  6724. IGF-II promotes Neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids
  6725. Nobiletin improves propofol-induced Neuroprotection via regulating Akt/mTOR and TLR 4/NF-κB signaling in ischemic brain injury in rats
  6726. Neuroprotection of edaravone on the hippocampus of kainate-induced epilepsy rats through Nrf2/HO-1 pathway
  6727. PI3K/Akt Pathway: A Role in δ-Opioid Receptor–Mediated RGC Neuroprotection
  6728. Sulfonylurea and Neuroprotection : The bright side of the moon
  6729. Neuroprotection of bradykinin/bradykinin B2 receptor system in cerebral ischemia
  6730. Neuroprotection by chlorpromazine and promethazine in severe transient and permanent ischemic stroke
  6731. Humanin exerts Neuroprotection during cardiac ischemia-reperfusion injury
  6732. Neuroprotection against hypoxic/ischemic injury: δ-opioid receptors and BDNF-TrkB pathway
  6733. Formulated Chinese medicine Shaoyao Gancao Tang reduces tau aggregation and exerts Neuroprotection through anti-oxidation and anti-inflammation
  6734. Acute complement inhibition potentiates neurorehabilitation and enhances tPA-mediated Neuroprotection
  6735. Using the anterior visual system to assess Neuroprotection and remyelination in multiple sclerosis trials
  6736. Magnesium sulfate for Neuroprotection in the setting of chorioamnionitis
  6737. Dopaminergic Neuroprotection with Atremorine in Parkinson´ s Disease
  6738. The role of axon transport in Neuroprotection and regeneration
  6739. Boosting phagocytosis and anti‐inflammatory phenotype in microglia mediates Neuroprotection by PPARγ agonist MDG548 in Parkinson’s disease models
  6740. Pro‐survival redox signalling in progesterone‐mediated retinal Neuroprotection
  6741. Fluoro-substituted cyanine for reliable in vivo labelling of amyloid-β oligomers and Neuroprotection against amyloid-β induced toxicity
  6742. Posttraumatic administration of a sub-anesthetic dose of ketamine exerts Neuroprotection via attenuating inflammation and autophagy
  6743. Adiponectin confers Neuroprotection against cerebral ischemia-reperfusion injury through activating the cAMP/PKA-CREB-BDNF signaling
  6744. L-PGDS mediates vagus nerve stimulation-induced Neuroprotection in a rat model of ischemic stroke by suppressing the apoptotic response
  6745. Diosgenin glucoside provides Neuroprotection by regulating microglial M1 polarization
  6746. Systematic review seeking erythropoietin role for Neuroprotection in neonates with hypoxic ischemic encephalopathy: presently where do we stand
  6747. Neuroprotection of the inner retina: Müller cells and lactate
  6748. Effect of hyperbaric oxygen on BDNF-release and Neuroprotection : Investigations with human mesenchymal stem cells and genetically modified NIH3T3 …
  6749. Upregulation of klotho and erythropoietin contributes to the Neuroprotection induced by curcumin-loaded nanoparticles in experimental model of chronic epilepsy
  6750. Dihydrocapsaicin (DHC) enhances the hypothermia-induced Neuroprotection following ischemic stroke via PI3K/Akt regulation in rat
  6751. … kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for Neuroprotection in Parkinson’s disease
  6752. Cortical spreading depression preconditioning mediates Neuroprotection against ischemic stroke by inducing AMP‐activated protein kinase‐dependent autophagy in …
  6753. Intra-vitreal αB crystallin fused to elastin-like polypeptide provides Neuroprotection in a mouse model of age-related macular degeneration
  6754. Folic acid exerts post-ischemic Neuroprotection in vitro through HIF-1α stabilization
  6755. Adjudin-preconditioned neural stem cells enhance Neuroprotection after ischemia reperfusion in mice
  6756. Synergistically induced hypothermia and enhanced Neuroprotection by pharmacological and physical approaches in stroke
  6757. Dimethyl fumarate treatment after traumatic brain injury prevents depletion of antioxidative brain glutathione and confers Neuroprotection
  6758. Anti-oxidative stress activity is essential for Amanita caesarea mediated Neuroprotection on glutamate-induced apoptotic HT22 cells and an Alzheimer’s disease …
  6759. Biodegradable neuro-compatible peptide hydrogel promotes neurite outgrowth, shows significant Neuroprotection , and delivers anti-alzheimer drug
  6760. Neuroprotection in traumatic brain injury.
  6761. L-Serine-mediated Neuroprotection includes the upregulation of the ER stress chaperone protein disulfide isomerase (PDI)
  6762. Music in the NICU: The role of nurses in Neuroprotection
  6763. Dopamine D2 receptor-mediated Neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
  6764. Lithium-induced Neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein …
  6765. Neuroprotection of the hypoxic-ischemic mouse brain by human CD117+ CD90+ CD105+ amniotic fluid stem cells
  6766. … daytime sleepiness and REM sleep behavior disorders in parkinson’s disease: a narrative review on early intervention with implications to Neuroprotection
  6767. Novel synthetic chalcone‐coumarin hybrid for Aβ aggregation reduction, antioxidation, and Neuroprotection
  6768. Magnesium sulfate provides Neuroprotection in eclampsia-like seizure model by ameliorating neuroinflammation and brain edema
  6769. microRNA-21a-5p/PDCD4 axis regulates mesenchymal stem cell-induced Neuroprotection in acute glaucoma
  6770. Pituitary adenylate cyclase activating polypeptide elicits Neuroprotection against acute ischemic neuronal cell death associated with NMDA receptors
  6771. Preventive treatment of astaxanthin provides Neuroprotection through suppression of reactive oxygen species and activation of antioxidant defense pathway after …
  6772. Comparative transcriptome of neurons after oxygen–glucose deprivation: Potential differences in Neuroprotection versus reperfusion
  6773. … glial inflammatory response and alters BDNF/TrkB/pCREB signaling in a rat model of global cerebral ischemia: implications for Neuroprotection and cognitive recovery
  6774. Pregnancy swimming causes short-and long-term Neuroprotection against hypoxia–ischemia in very immature rats
  6775. Neuroprotection by plumbagin involves BDNF‐TrkB‐PI 3K/Akt and ERK 1/2/JNK pathways in isoflurane‐induced neonatal rats
  6776. Glycine confers Neuroprotection through PTEN/AKT signal pathway in experimental intracerebral hemorrhage
  6777. Maternal side effects & fetal Neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial
  6778. Neurochemical and behavior deficits in rats with iron and rotenone co-treatment: role of redox imbalance and Neuroprotection by biochanin A
  6779. Rollercoaster ride of kynurenines: Steering the wheel towards Neuroprotection in Alzheimer’s disease
  6780. Curcumin exerted Neuroprotection against ozone-induced oxidative damage and decreased NF-κB activation in rat hippocampus and serum levels of …
  6781. Intrapartum magnesium sulfate is associated with Neuroprotection in growth-restricted fetuses
  6782. Activation of the PI3K-Akt pathway promotes Neuroprotection of the δ-opioid receptor agonist against cerebral ischemia-reperfusion injury in rat models
  6783. Umbilical cord-derived mesenchymal stromal cells contribute to Neuroprotection in neonatal cortical neurons damaged by oxygen-glucose deprivation
  6784. Mangiferin potentiates Neuroprotection by isoflurane in neonatal hypoxic brain injury by reducing oxidative stress and activation of phosphatidylinositol-3 …
  6785. Amyloid-β42 clearance and Neuroprotection mediated by X-box binding protein 1 signaling decline with aging in the Drosophila brain
  6786. Ischemic post-conditioning induces post-stroke Neuroprotection via Hsp70-mediated proteasome inhibition and facilitates neural progenitor cell transplantation
  6787. Transgenic human embryonic stem cells overexpressing FGF2 stimulate Neuroprotection following spinal cord ventral root avulsion
  6788. Exogenous β-hydroxybutyrate treatment and Neuroprotection in a suckling rat model of hypoxic-ischemic encephalopathy
  6789. Network-based approach to identify potential targets and drugs that promote Neuroprotection and neurorepair in acute ischemic stroke
  6790. Pro-nociceptive migraine mediator CGRP provides Neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling
  6791. Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition
  6792. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo …
  6793. ADNP, a microtubule interacting protein, provides Neuroprotection through end binding proteins and tau: an amplifier effect
  6794. The duration of hypothermia affects short-term Neuroprotection in a mouse model of neonatal hypoxic ischaemic injury
  6795. Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer’s disease like pathology via maintaining oxidative balance through SIRT1 pathway
  6796. Activation of mitochondrial KATP channels mediates Neuroprotection induced by chronic morphine preconditioning in hippocampal CA-1 neurons following cerebral …
  6797. A novel mechanism of non-feminizing estrogens in Neuroprotection
  6798. Mechanisms of L-serine Neuroprotection in vitro include ER proteostasis regulation
  6799. Klotho upregulation contributes to the Neuroprotection of ligustilide against cerebral ischemic injury in mice
  6800. Acute toxicity profiling of the ethyl acetate fraction of Swietenia macrophylla seeds and in-vitro Neuroprotection studies
  6801. The PTEN inhibitor bpV (pic) promotes Neuroprotection against amyloid β-peptide (25-35)-induced oxidative stress and neurotoxicity
  6802. Phenothiazines enhance mild hypothermia-induced Neuroprotection via PI3K/Akt regulation in experimental stroke
  6803. B355252, a novel small molecule, confers Neuroprotection against cobalt chloride toxicity in mouse hippocampal cells through altering mitochondrial …
  6804. Neuroprotection and reduced gliosis by pre-and post-treatments of hydroquinone in a gerbil model of transient cerebral ischemia
  6805. … Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative …
  6806. Neurodegeneration, neuroregeneration, and Neuroprotection in psychiatric disorders
  6807. Experimental and clinical evidence of differential effects of magnesium sulfate on Neuroprotection and angiogenesis in the fetal brain
  6808. Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
  6809. Antioxidant-mediated Neuroprotection by Allium schoenoprasum L. leaf extract against ischemia reperfusion-induced cerebral injury in mice
  6810. Faim2 contributes to Neuroprotection by erythropoietin in transient brain ischemia
  6811. Neuroglobin mediates Neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in rats through preserving the activity of Na+/K+ …
  6812. Roles of p62 in BDNF‐dependent autophagy suppression and Neuroprotection against mitochondrial dysfunction in rat cortical neurons
  6813. Neuroprotection mediated by upregulation of endothelial nitric oxide synthase in Rho-associated, coiled-coil-containing kinase 2 deficient mice
  6814. Statins for Neuroprotection after acute ischemic stroke: ASSORTed results but more trials needed
  6815. Neuroprotection of granulocyte colony-stimulating factor for early stage Parkinson’s disease
  6816. Topiramate confers Neuroprotection against methylphenidate-induced neurodegeneration in dentate gyrus and CA1 regions of Hippocampus via CREB/BDNF …
  6817. Reflections on Neuroprotection research and the path toward clinical success
  6818. Moving to human trials for argon Neuroprotection in neurological injury: a narrative review
  6819. Nrf2‐mediated Neuroprotection against oxygen‐glucose deprivation/reperfusion injury by emodin via AMPK‐dependent inhibition of GSK‐3β
  6820. Neuroprotection Against MPP+-Induced Cytotoxicity Through the Activation of PI3-K/Akt/GSK3β/MEF2D Signaling Pathway by Rhynchophylline, the Major …
  6821. Neuroprotection and endocytosis: erythropoietin receptors in insect nervous systems
  6822. Hazelnut and Neuroprotection : Improved memory and hindered anxiety in response to intra-hippocampal Aβ injection
  6823. Neuroprotection induced by transplanted CDK5 knockdown astrocytes in global cerebral ischemic rats
  6824. Resveratrol and pinostilbene confer Neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism
  6825. Neuroprotection of hypoxic postconditioning against global cerebral ischemia through influencing posttranslational regulations of heat shock protein 27 in adult rats
  6826. Nicotinic acetylcholine receptor alpha7 subunit mediates vagus nerve stimulation-induced Neuroprotection in acute permanent cerebral ischemia by a7nAchR …
  6827. Administration of Momordica charantia enhances the Neuroprotection and reduces the side effects of LiCl in the treatment of Alzheimer’s disease
  6828. Age-dependent effects of ALK5 inhibition and mechanism of Neuroprotection in neonatal hypoxic-ischemic brain injury
  6829. Lingonberry extract provides Neuroprotection by regulating the purinergic system and reducing oxidative stress in diabetic rats
  6830. Neuroprotection in neurodegenerative disease: from basic science to clinical applications
  6831. Nicotinic acetylcholine receptor signaling: Roles in Neuroprotection
  6832. Drugging SUMOylation for Neuroprotection and oncotherapy
  6833. Gastrodin exerts robust Neuroprotection in the postischemic brain via its protective effect against Zn2+-toxicity and its anti-oxidative effects in astrocytes
  6834. A co‐drug conjugate of naringenin and lipoic acid mediates Neuroprotection in a rat model of oxidative stress
  6835. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection
  6836. Role of dopamine D2/D3 receptors in development, plasticity, and Neuroprotection in human iPSC-derived midbrain dopaminergic neurons
  6837. Integrated treatment modality of cathodal-transcranial direct current stimulation with peripheral sensory stimulation affords Neuroprotection in a rat stroke model
  6838. Involvement of angiotensin-(1–7) in the Neuroprotection of captopril against focal cerebral ischemia
  6839. Dual delivery of bFGF-and NGF-binding coacervate confers Neuroprotection by promoting neuronal proliferation
  6840. Genetic and pharmacological inhibition of Cdk1 provides Neuroprotection towards ischemic neuronal death
  6841. Intra-cerebral cannabidiol infusion-induced Neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia
  6842. The degradation of mixed lineage kinase domain-like protein promotes Neuroprotection after ischemic brain injury
  6843. Optimization of maternal magnesium sulfate administration for fetal Neuroprotection : application of a prospectively constructed pharmacokinetic model to the BEAM …
  6844. The membrane mesenchymal stem cell derived conditioned medium exerts Neuroprotection against focal cerebral ischemia by targeting apoptosis
  6845. Neuroprotection and CD131/GDNF/AKT pathway of carbamylated erythropoietin in hypoxic neurons
  6846. microRNA-21 confers Neuroprotection against cerebral ischemia-reperfusion injury and alleviates blood-brain barrier disruption in rats via the MAPK signaling …
  6847. Does inhibition of angiotensin function cause Neuroprotection in diffuse traumatic brain injury?
  6848. … prevent neurodegeneration failed?-A cellular investigation of novel phenothiazine-type antioxidants reveals competing objectives for pharmaceutical Neuroprotection
  6849. ITH14001, a CGP37157-nimodipine hybrid designed to regulate calcium homeostasis and oxidative stress, exerts Neuroprotection in cerebral ischemia
  6850. Longistyline C acts antidepressant in vivo and Neuroprotection in vitro against glutamate-induced cytotoxicity by regulating NMDAR/NR2B-ERK pathway in …
  6851. Estrogen receptor activation contributes to RNF146 expression and Neuroprotection in Parkinson’s disease models
  6852. … hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the Neuroprotection of physical exercise in …
  6853. Piper sarmentosum Roxb. confers Neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in …
  6854. Free radical scavenger edaravone produces robust Neuroprotection in a rat model of spinal cord injury
  6855. Nicotine-induced Neuroprotection against cognitive dysfunction after partial hepatectomy involves activation of BDNF/TrkB signaling pathway and inhibition of NF-κB …
  6856. Neuroprotection of cytisine against cerebral ischemia–reperfusion injury in mice by regulating NR2B-ERK/CREB signal pathway
  6857. RACK1 upregulation induces Neuroprotection by activating the IRE1-XBP1 signaling pathway following traumatic brain injury in rats
  6858. Multifarious biologic loaded liposomes that stimulate the mammalian target of rapamycin signaling pathway show retina Neuroprotection after retina damage
  6859. A novel shk-like toxic peptide from the transcriptome of the cnidarian palythoa caribaeorum displays Neuroprotection and cardioprotection in zebrafish
  6860. Effects of cafeteria diet on memory and hippocampal oxidative stress in a rat model of Alzheimer-like disease: Neuroprotection of green tea supplementation
  6861. Pharmacological targeting of GSK-3 and NRF2 provides Neuroprotection in a preclinical model of tauopathy
  6862. Riluzole–Triazole Hybrids as Novel Chemical Probes for Neuroprotection in Amyotrophic Lateral Sclerosis
  6863. Enhanced Neuroprotection with decellularized brain extracellular matrix containing bFGF after intracerebral transplantation in Parkinson’s disease rat model
  6864. Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and Neuroprotection
  6865. Inhibition of cathepsins B induces Neuroprotection against secondary degeneration in ipsilateral substantia nigra after focal cortical infarction in adult male …
  6866. Nicotine‐mediated Neuroprotection of rat spinal networks against excitotoxicity
  6867. Neuronal Rho GTPase Rac1 elimination confers Neuroprotection in a mouse model of permanent ischemic stroke
  6868. Mechanisms of Neuroprotection against ischemic insult by stress‐inducible phosphoprotein‐1/prion protein complex
  6869. Association of exercise-induced autophagy upregulation and apoptosis suppression with Neuroprotection against pharmacologically induced Parkinson’s …
  6870. Activated protein C, protease activated receptor 1, and Neuroprotection
  6871. Striatal vulnerability in Huntington’s disease: Neuroprotection versus neurotoxicity
  6872. Maresin 1 promotes inflammatory resolution, Neuroprotection , and functional neurological recovery after spinal cord injury
  6873. Neuroprotection by heat shock factor-1 (HSF1) and trimerization-deficient mutant identifies novel alterations in gene expression
  6874. New perspectives on study designs for evaluating Neuroprotection in Parkinson’s disease
  6875. Thermosensitive heparin‐poloxamer hydrogels enhance the effects of GDNF on neuronal circuit remodeling and Neuroprotection after spinal cord injury
  6876. Synthesis and evaluation of new pyridyl/pyrazinyl thiourea derivatives: Neuroprotection against amyloid-β-induced toxicity
  6877. Inhibition of gelatinases (MMP-2 and MMP-9) by Withania somnifera phytochemicals confers Neuroprotection in stroke: an in silico analysis
  6878. Roles of HIF-1α, VEGF, and NF-κB in ischemic preconditioning-mediated Neuroprotection of hippocampal CA1 pyramidal neurons against a subsequent transient …
  6879. Mesenchymal stem cells overexpressing interleukin-10 promote Neuroprotection in experimental acute ischemic stroke
  6880. Cytokine therapy‐mediated Neuroprotection in a Friedreich’s ataxia mouse model
  6881. Use of magnesium sulfate in preterm deliveries for Neuroprotection of the neonate
  6882. Sigma-1 receptors and neurodegenerative diseases: towards a hypothesis of sigma-1 receptors as amplifiers of neurodegeneration and Neuroprotection
  6883. Intraparenchymal treatment with bone marrow mesenchymal stem cell-conditioned medium exerts Neuroprotection following intracerebral hemorrhage
  6884. Nicotinamide reverses behavioral impairments and provides Neuroprotection in 3˗ nitropropionic acid induced animal model ofHuntington’s disease: implication of …
  6885. Antenatal magnesium sulfate for both tocolysis and fetal Neuroprotection in premature rupture of the membranes before 32 weeks’ gestation
  6886. Estrogen-like Neuroprotection of isopsoralen against spinal cord injury through estrogen receptor ERα
  6887. MicroRNA-132 provides Neuroprotection for tauopathies via multiple signaling pathways
  6888. Meta-analysis of Creatine for Neuroprotection against Parkinson’s disease
  6889. Morus alba leaf extract mediates Neuroprotection against glyphosate-induced toxicity and biochemical alterations in the brain
  6890. Cannabinoid receptors and TRPA1 on Neuroprotection in a model of retinal ischemia
  6891. Post-ischemic administration of 5-methoxyindole-2-carboxylic acid at the onset of reperfusion affords Neuroprotection against stroke injury by preserving mitochondrial …
  6892. Interruption of perivascular sympathetic nerves of cerebral arteries offers Neuroprotection against ischemia
  6893. Amyloid-beta degradation and Neuroprotection of dauricine mediated by unfolded protein response in a Caenorhabditis elegans model of Alzheimer’s disease
  6894. Pitavastatin treatment induces Neuroprotection through the BDNF-TrkB signalling pathway in cultured cerebral neurons after oxygen-glucose deprivation
  6895. Tetrahydrocurcumin provides Neuroprotection in experimental traumatic brain injury and the Nrf2 signaling pathway as a potential mechanism
  6896. … -induced anti-inflammation via inhibition of the toll-like receptor-4/nuclear factor kappa B pathway contributes to Neuroprotection against transient global cerebral …
  6897. MicroRNA-410 inhibition of the TIMP2-dependent MAPK pathway confers Neuroprotection against oxidative stress-induced apoptosis after ischemic stroke in mice
  6898. Early detection of hypothermic Neuroprotection using T2-weighted magnetic resonance imaging in a mouse model of hypoxic ischemic encephalopathy
  6899. TFP5 peptide, derived from CDK5-activating cofactor p35, provides Neuroprotection in early-stage of adult ischemic stroke
  6900. DJ-1 regulating PI3K-Nrf2 signaling plays a significant role in bibenzyl compound 20C-mediated Neuroprotection against rotenone-induced oxidative insult
  6901. New thrombolytic strategy providing Neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator
  6902. Endoplasmic reticulum stress and NF-κ B pathway in salidroside mediated Neuroprotection : Potential of salidroside in neurodegenerative diseases
  6903. Angiopoietin-1 mimetic peptide promotes Neuroprotection after stroke in type 1 diabetic rats
  6904. Ischemic optic neuropathy as a model of neurodegenerative disorder: A review of pathogenic mechanism of axonal degeneration and the role of Neuroprotection
  6905. Sustained (S)-roscovitine delivery promotes Neuroprotection associated with functional recovery and decrease in brain edema in a randomized blind focal cerebral …
  6906. Targeting mitoNEET with pioglitazone for therapeutic Neuroprotection after spinal cord injury
  6907. Astrocyte Neuroprotection and dehydroepiandrosterone
  6908. Medicinal plants as novel promising therapeutics for Neuroprotection and neuroregeneration
  6909. Neuroglobin overexpression plays a pivotal role in Neuroprotection through mitochondrial raft-like microdomains in neuroblastoma SK-N-BE2 cells
  6910. Reduction of nitrosative stress by methane: Neuroprotection through xanthine oxidoreductase inhibition in a rat model of mesenteric ischemia-reperfusion
  6911. Neuroprotection of N-benzylcinnamide on scopolamine-induced cholinergic dysfunction in human SH-SY5Y neuroblastoma cells
  6912. Neuroprotection and cognitive enhancement by treatment with γ-oryzanol in sporadic Alzheimer’s disease
  6913. Neuroprotection against CCl4 induced brain damage with crocin in Wistar rats
  6914. Prophylactic Neuroprotection of total glucosides of Paeoniae Radix Alba against semen strychni-induced neurotoxicity in rats: suppressing oxidative stress and …
  6915. The role of trophic factors and inflammatory processes in physical activity-induced Neuroprotection in Parkinson’s disease.
  6916. Role of Myo/Nog cells in Neuroprotection : evidence from the light damaged retina
  6917. Photoacoustic microscopy reveals the hemodynamic basis of sphingosine 1-phosphate-induced Neuroprotection against ischemic stroke
  6918. Protective effect of naringin on pentylenetetrazole (PTZ)-induced kindling; possible mechanisms of antikindling, memory improvement, and Neuroprotection
  6919. Ferulic Acid: A Natural Antioxidant with Application Towards Neuroprotection Against Alzheimer’s Disease
  6920. Enhanced oxidative stress response and Neuroprotection of combined limb remote ischemic conditioning and atorvastatin after transient ischemic stroke in …
  6921. SS-31 provides Neuroprotection by reversing mitochondrial dysfunction after traumatic brain injury
  6922. Long-term consumption of fermented rooibos herbal tea offers Neuroprotection against ischemic brain injury in rats
  6923. Neuroprotection by paeoniflorin against nuclear factor kappa B-induced neuroinflammation on spinal cord injury
  6924. Molecular mechanism of estrogen-mediated Neuroprotection in the relief of brain ischemic injury
  6925. Infant-guided, co-regulated feeding in the neonatal intensive care unit. Part II: interventions to promote Neuroprotection and safety
  6926. Neuroprotection by aripiprazole against β-amyloid-induced toxicity by P-CK2α activation via inhibition of GSK-3β
  6927. P450 eicosanoids and reactive oxygen species interplay in brain injury and Neuroprotection
  6928. Synaptic dysfunction in Alzheimer’s disease and glaucoma: from common degenerative mechanisms toward Neuroprotection
  6929. Fibroblast growth factor type 1 (FGF1)-overexpressed adipose-derived mesenchaymal stem cells (AD-MSC FGF1) induce Neuroprotection and functional recovery in a …
  6930. Puerarin provides a Neuroprotection against transient cerebral ischemia by attenuating autophagy at the ischemic penumbra in neurons but not in astrocytes
  6931. RGC Neuroprotection following optic nerve trauma mediated by intranasal delivery of amnion cell secretome
  6932. Neuroprotection in glaucoma
  6933. Swimming improves cognitive reserve in ovariectomized rats and enhances Neuroprotection after global cerebral ischemia
  6934. Bisperoxovandium (pyridin‐2‐squaramide) targets both PTEN and ERK1/2 to confer Neuroprotection
  6935. Tetrahydroxystilbene glucoside produces Neuroprotection against 6-OHDA-induced dopamine neurotoxicity
  6936. Tryptophan-2, 3-Dioxygenase (TDO) deficiency is associated with subclinical Neuroprotection in a mouse model of multiple sclerosis
  6937. Sigma-1 receptor: a new player in Neuroprotection against chemotherapy-induced peripheral neuropathy
  6938. IL-33/ST2L signaling provides Neuroprotection through inhibiting autophagy, endoplasmic reticulum stress, and apoptosis in a mouse model of traumatic brain …
  6939. Buyang huanwu decoction ameliorates poststroke depression via promoting neurotrophic pathway mediated Neuroprotection and neurogenesis
  6940. TAVI and the brain : update on definitions, evidence of Neuroprotection and adjunctive pharmacotherapy.
  6941. Neuroprotection and neuroregeneration of retinal ganglion cells after intravitreal carbon monoxide release
  6942. Increased autophagic degradation contributes to the Neuroprotection of hydrogen sulfide against cerebral ischemia/reperfusion injury
  6943. Recombinant human erythropoietin offers Neuroprotection through inducing endogenous erythropoietin receptor and neuroglobin in a neonatal rat model of …
  6944. Sesquiterpenes from stigma maydis (Zea mays) as a crop by-product and their potential Neuroprotection and inhibitory activities of Aβ aggregation
  6945. The GluN1/GluN2B NMDA receptor and metabotropic glutamate receptor 1 negative allosteric modulator has enhanced Neuroprotection in a rat subarachnoid …
  6946. … in vitro and in vivo following traumatic brain injury by scavenging the reactive carbonyls 4-hydroxynonenal and acrolein leading to cortical histological Neuroprotection
  6947. Drug and Gene Delivery to the Central Nervous System for Neuroprotection : Nanotechnological Advances
  6948. P7C3-A20 Neuroprotection is independent of Wallerian degeneration in primary neuronal culture
  6949. 2-(4-methoxyphenyl) ethyl-2-acetamido-2-deoxy-β-d-pyranoside (a salidroside analog) confers Neuroprotection with a wide therapeutic window by regulating local …
  6950. Erythropoietin’s beta common receptor mediates Neuroprotection in spinal cord neurons
  6951. Analysis of FK506‑mediated functional recovery and Neuroprotection in a rat model of spinal cord injury indicates that EGF is modulated in astrocytes
  6952. Activation of glucagon-like peptide-1 receptor promotes Neuroprotection in experimental autoimmune encephalomyelitis by reducing neuroinflammatory responses
  6953. Neuroprotection against hydrogen peroxide-induced toxicity by Dictyophora echinovolvata polysaccharide via inhibiting the mitochondria-dependent apoptotic …
  6954. Targeting cellular stress mechanisms and metabolic homeostasis by Chinese herbal drugs for Neuroprotection
  6955. Triggering receptor expressed on myeloid cells 2, a novel regulator of immunocyte phenotypes, confers Neuroprotection by relieving neuroinflammation
  6956. Apurinic/apyrimidinic endonuclease 1 (APE1) contributes to resveratrol‑induced Neuroprotection against oxygen‑glucose deprivation and re‑oxygenation …
  6957. Tau at the Crossroads between Neurotoxicity and Neuroprotection
  6958. Neuroprotection by new ligustrazine-cinnamon acid derivatives on CoCl2-induced apoptosis in differentiated PC12 cells
  6959. Combined oral supplementation of chromium picolinate, docosahexaenoic acid, and boron enhances Neuroprotection in rats fed a high-fat diet
  6960. Co-administration of tissue plasminogen activator and hyperbaric oxygen in ischemic stroke: a continued promise for Neuroprotection
  6961. PR‐957 mediates Neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke
  6962. A novel indication of platonin, a therapeutic immunomodulating medicine, on Neuroprotection against ischemic stroke in mice
  6963. dl-3-n-Butylphthalide (NBP) Provides Neuroprotection in the Mice Models After Traumatic brain Injury via Nrf2-ARE Signaling Pathway
  6964. Inhibition of mitochondrial permeability transition pore opening contributes to cannabinoid type 1 receptor agonist ACEA-induced Neuroprotection
  6965. Neuroprotection and visual function after optic neuritis
  6966. Limb remote ischaemic postconditioning‐induced elevation of fibulin‐5 confers Neuroprotection to rats with cerebral ischaemia/reperfusion injury: Activation of the AKT …
  6967. New insights into the potential roles of 3-iodothyronamine (T1AM) and newly developed thyronamine-like TAAR1 agonists in Neuroprotection
  6968. Upregulation of miR-215 exerts Neuroprotection effects against ischemic injury via negative regulation of Act1/IL-17RA signaling
  6969. … trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated Neuroprotection for acute spinal cord …
  6970. Effects of Leontice leontopetalum and Bongardia chrysogonum on oxidative stress and Neuroprotection in PTZ kindling epilepsy in rats
  6971. IL-33 provides Neuroprotection through suppressing apoptotic, autophagic and NF-κB-mediated inflammatory pathways in a rat model of recurrent neonatal …
  6972. Five rare dimeric sesquiterpenes exhibiting potential Neuroprotection activity from Vladimiria souliei
  6973. Neonatal Neuroprotection : Bringing best practice to the bedside in the NICU
  6974. Analysis of Neuroprotection by taurine and taurine combinations in primary neuronal cultures and in neuronal cell lines exposed to glutamate excitotoxicity and to …
  6975. Post-stroke angiotensin II type 2 receptor activation provides long-term Neuroprotection in aged rats
  6976. Molecular Neuroprotection Induced by Zinc-Dependent Expression of Hepatitis C–Derived Protein NS5A Targeting Kv2. 1 Potassium Channels
  6977. Organotypic hippocampal slice cultures as a model to study Neuroprotection and invasiveness of tumor cells
  6978. Regulation by nicotinic acetylcholine receptors of microglial glutamate transporters: role of microglia in Neuroprotection
  6979. Enriched brain omega-3 polyunsaturated fatty acids confer Neuroprotection against microinfarction
  6980. … treatment strategies using TiO2-nanowired delivery of histaminergic drugs and antibodies to tau with cerebrolysin for superior Neuroprotection in the pathophysiology …
  6981. Withania somnifera phytochemicals confer Neuroprotection by inhibition of the catalytic domain of human matrix metalloproteinase-9
  6982. … improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain -derived neurotrophic factor-mediated Neuroprotection …
  6983. Neuroprotection of brain cells by lipoic acid treatment after cellular stress
  6984. Integrating insulin-like growth factor 1 and sex hormones into Neuroprotection : implications for diabetes
  6985. Deleting IGF-1 receptor from forebrain neurons confers Neuroprotection during stroke and upregulates endocrine somatotropin
  6986. Neuroprotection by propofol post-conditioning: focus on PKMζ/KCC2 pathway activity
  6987. Do cannabinoids confer Neuroprotection against epilepsy? An overview
  6988. Pre-treatment with amitriptyline causes epigenetic up-regulation of Neuroprotection -associated genes and has anti-apoptotic effects in mouse neuronal cells
  6989. In vitro Neuroprotection of rat hippocampal neurons by manninotriose and astragaloside IV against corticosterone-induced toxicity
  6990. Induced neural stem cell-derived astrocytes modulate complement activation and mediate Neuroprotection following closed head injury
  6991. Lanthionine ketimine-5-ethyl ester provides Neuroprotection in a zebrafish model of okadaic acid-induced Alzheimer’s disease
  6992. Current opinion on a role of the astrocytes in Neuroprotection
  6993. Neuroprotection by anaesthetics in rodent models of traumatic brain injury: a systematic review and network meta-analysis
  6994. Combinatorial preconditioning of rat brain cultures with subprotective ethanol and resveratrol concentrations promotes synergistic Neuroprotection
  6995. Neuroprotection by misoprostol against rotenone-induced neurotoxicity in rat brain
  6996. Neuroprotection exerted by Netrin-1 and kinesin motor KIF1A in secondary brain injury following experimental intracerebral hemorrhage in rats
  6997. … modulate spinal cord injury-induced neuronal nitric oxide synthase upregulation and cord pathology: new roles of nanowired drug delivery for Neuroprotection
  6998. Prolonged DADLE exposure epigenetically promotes Bcl-2 expression and elicits Neuroprotection in primary rat cortical neurons via the PI3K/Akt/NF-κB pathway
  6999. Neurotrophin-3 provides Neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model
  7000. Systemic interleukin-4 administration after spinal cord injury modulates inflammation and promotes Neuroprotection
  7001. Pharmacological Neuroprotection in stroke in clinical practice: new perspectives
  7002. NGF, TrkA-P and Neuroprotection after a hypoxic event in the developing central nervous system
  7003. RNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in Neuroprotection
  7004. Markers of Neuroprotection of combined EPA and DHA provided by fish oil are higher than those of EPA (Nannochloropsis) and DHA (Schizochytrium) from …
  7005. A cystine-rich whey supplement (Immunocal®) provides Neuroprotection from diverse oxidative stress-inducing agents in vitro by preserving cellular …
  7006. miRNA profile of Neuroprotection mechanism of echinomycin in Parkinson’s disease
  7007. Melatonin promotes Neuroprotection of induced pluripotent stem cells-derived neural stem cells subjected to H2O2-induced injury in vitro
  7008. Nanoformulation: a useful therapeutic strategy for improving Neuroprotection and the neurorestorative potential in experimental models of Parkinson’s disease
  7009. Retinal ganglion cell Neuroprotection by growth factors and exosomes: lessons from mesenchymal stem cells
  7010. Neurotoxicity versus Neuroprotection of Anesthetics: Young Children on the Ropes?
  7011. Intravenous hydrogen sulfide does not induce Neuroprotection after aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury in a human-like …
  7012. Downregulation of G‑protein‑coupled receptor 30 in the hippocampus attenuates the Neuroprotection of estrogen in the critical period hypothesis
  7013. Minocycline prevents cerebral malaria, confers Neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection
  7014. Retinal astrocytes and GABAergic wide-field amacrine cells express PDGFRα: connection to retinal ganglion cell Neuroprotection by PDGF-AA
  7015. Oxidative stress status and Neuroprotection of tocotrienols in chronic cerebral hypoperfusion-induced neurodegeneration rat animal model
  7016. α2δ-1 signaling drives cell death, synaptogenesis, circuit reorganization, and gabapentin-mediated Neuroprotection in a model of insult-induced cortical …
  7017. Chinese Herbal Medicine Glycyrrhiza inflata Reduces Aβ Aggregation and Exerts Neuroprotection through Anti-Oxidation and Anti-Inflammation
  7018. Small interfering RNA targeting Dickkopf-1 contributes to Neuroprotection after intracerebral hemorrhage in rats
  7019. Anticonvulsant activity and Neuroprotection assay of 3-substituted-N-aryl-6, 7-dimethoxy-3a, 4-dihydro-3H-indeno [1, 2-c] pyrazole-2-carboxamide analogues
  7020. … of a novel multifunctional carbazole–aminoquinoline dimer for Alzheimer’s disease: copper selective chelation, anti-amyloid aggregation, and Neuroprotection
  7021. Inhibition of myeloid differentiation primary response protein 88 provides Neuroprotection in early brain injury following experimental subarachnoid …
  7022. LPA1 is a key mediator of intracellular signalling and Neuroprotection triggered by tetracyclic antidepressants in hippocampal neurons
  7023. Fingolimod confers Neuroprotection through activation of Rac1 after experimental germinal matrix hemorrhage in rat pups
  7024. Withania somnifera phytochemicals confer Neuroprotection by selective inhibition of nNos: An in silico study to search potent and selective inhibitors for human …
  7025. Neuroprotection of ulinastatin on transient cerebral ischemia via antioxidative mechanisms.
  7026. Anesthetic preconditioning as endogenous Neuroprotection in glaucoma
  7027. Pharmacological Neuroprotection in cardiac surgery: effectiveness of pharmacologic-preconditioning with erythromycin
  7028. The ATM kinase inhibitor KU-55933 provides Neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent …
  7029. Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human …
  7030. Progranulin and its related microRNAs after status epilepticus: possible mechanisms of Neuroprotection
  7031. Hypoxia, hibernation and Neuroprotection : An Experimental Study in Mice
  7032. Neuroprotection is technology, not science
  7033. Cooperation between NMDA-Type glutamate and P2 receptors for Neuroprotection during stroke: Combining astrocyte and neuronal protection
  7034. Cannabidiol and Neuroprotection : Evidence from Preclinical Studies
  7035. Opioid receptor activation is involved in Neuroprotection induced by TRPV1 channel activation against excitotoxicity in the rat retina
  7036. The search continues: Neuroprotection for all neonates with hypoxic-ischemic encephalopathy
  7037. Neuroprotection via RNA-binding protein RBM3 expression is regulated by hypothermia but not by hypoxia in human SK-N-SH neurons
  7038. Traditional Chinese medicine in Neuroprotection after brain insults with special reference to radioprotection
  7039. … regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for Neuroprotection by selegiline and …
  7040. Neuroprotection with the P53-inhibitor pifithrin-μ after cardiac arrest in a rodent model
  7041. Neuroprotection of botch in experimental intracerebral hemorrhage in rats
  7042. β-Estradiol-3-benzoate confers Neuroprotection in Parkinson MPP+ rat model through inhibition of lipid peroxidation
  7043. Effects of therapeutic hypothermia for Neuroprotection from the viewpoint of redox regulation
  7044. Spontaneous running wheel improves Neuroprotection efficacy of ischemic postconditioning in mice following ischemia/reperfusion injury
  7045. 2-(2-Benzofuranyl)-2-imidazoline mediates Neuroprotection by regulating the neurovascular unit integrity in a rat model of focal cerebral ischemia
  7046. The use of therapeutic magnesium for Neuroprotection during global cerebral ischemia associated with cardiac arrest and cardiac surgery in adults: a systematic …
  7047. Soluble amyloid precursor protein alpha interacts with alpha3-Na, K-ATPAse to induce axonal outgrowth but not Neuroprotection : evidence for distinct mechanisms …
  7048. Neuroprotection in hypoxic-ischemic brain injury targeting glial cells
  7049. New insights about the peculiar role of the 28–38 C-terminal segment and some selected residues in PACAP for signaling and Neuroprotection
  7050. Evaluation of neuregulin-1’s Neuroprotection against ischemic injury in rats using diffusion tensor imaging
  7051. Targeting microglia: a new avenue for anesthesia Neuroprotection after brain injury?
  7052. GPR30 Activation Contributes to the Puerarin-Mediated Neuroprotection in MPP+-Induced SH-SY5Y Cell Death
  7053. UPEI-400, a conjugate of lipoic acid and scopoletin, mediates Neuroprotection in a rat model of ischemia/reperfusion
  7054. Intracerebral injections of DNA nanoparticles encoding for a therapeutic gene provide partial Neuroprotection in an animal model of neurodegeneration
  7055. Parkin mediates Neuroprotection through activation of Notch1 signaling
  7056. SAK3-induced Neuroprotection is mediated by nicotinic acetylcholine receptors
  7057. In silico analysis of the association relationship between Neuroprotection and flavors of traditional chinese medicine based on the mGluRs
  7058. Amyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BB-induced Neuroprotection
  7059. Erythropoietin-mediated Neuroprotection in insects suggests a prevertebrate evolution of erythropoietin-like signaling
  7060. Inhibition of transient receptor potential vanilloid‐1 confers Neuroprotection , reduces tumor necrosis factor‐alpha, and increases IL‐10 in a rat stroke model
  7061. 3′-Daidzein sulfonate sodium provides Neuroprotection by promoting the expression of the α7 nicotinic acetylcholine receptor and suppressing inflammatory …
  7062. Diazoxide induces endoplasmic reticulum stress-related Neuroprotection mediated by p38 MAPK against Aβ
  7063. Neuronal expression of the mitochondrial protein prohibitin confers profound Neuroprotection in a mouse model of focal cerebral ischemia
  7064. Creatine salts provide Neuroprotection even after partial impairment of the creatine transporter
  7065. Neuritin provides Neuroprotection against experimental traumatic brain injury in rats
  7066. Role of Cranial Temperature in Neuroprotection by Sodium Hydrogen Sulfide After Cardiac Arrest in Mice
  7067. Expression of glial CBP in steroid mediated Neuroprotection in male and female zebra finches
  7068. Astrocytic expression of GSTA4 is associated to dopaminergic Neuroprotection in a rat 6-OHDA model of Parkinson’s disease
  7069. … impacts on lipopolysaccharide-induced glucocorticoid-mediated inflammatory response. A molecular link to nociception, Neuroprotection , and anti-inflammatory …
  7070. Neuroprotection of Heat Shock Proteins (HSPs) in brain Ischemia
  7071. Reduction of the foreign body response and Neuroprotection by apyrase and minocycline in chronic cannula implantation in the rat brain
  7072. Neuroprotection of Strongylocentrotus nudus gangliosides against Alzheimer’s disease via regulation of neurite loss and mitochondrial apoptosis
  7073. Modulation of GSK-3 provides cellular and functional Neuroprotection in the rd10 mouse model of retinitis pigmentosa
  7074. Natural steroids and androgen antagonists used as Neuroprotection in common neurological disorders
  7075. Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells–a possible sign of endogenous Neuroprotection failure
  7076. Acylated and unacylated ghrelin confer Neuroprotection to mesencephalic neurons
  7077. Mechanisms of retinal Neuroprotection of calcium dobesilate: therapeutic implications
  7078. Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic Neuroprotection after traumatic brain injury
  7079. Identification, characterization and in vitro Neuroprotection of N6-(4-hydroxybenzyl) adenine riboside and its metabolites
  7080. Electroacupuncture-induced Neuroprotection against focal cerebral ischemia in the rat is mediated by adenosine A1 receptors
  7081. Neuroprotection and timely troubleshooting of electric drive equipment
  7082. … -chondroitin sulfate proteoglycan strategies in spinal cord injury: temporal and spatial considerations explain the balance between neuroplasticity and Neuroprotection
  7083. Design and synthesis of multipotent 3-aminomethylindoles and 7-azaindoles with enhanced protein phosphatase 2A-activating profile and Neuroprotection
  7084. Neuroprotection by taurine on HBCD-induced apoptosis in PC12 cells
  7085. Nesting environment provides sex-specific Neuroprotection in a rat model of neonatal hypoxic-ischemic injury
  7086. Interleukin-1 receptor antagonist-mediated Neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke …
  7087. Neuroprotection and Blood–brain Barrier Restoration by Salubrinal After a Cortical Stab Injury
  7088. Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxyphenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal …
  7089. MicroRNA expression profiles in chronic epilepsy rats and Neuroprotection from seizures by targeting miR-344a
  7090. Anacardium microcarpum promotes Neuroprotection dependently of AKT and ERK phosphorylation but does not prevent mitochondrial damage by 6-OHDA
  7091. Antenatal magnesium sulfate use for fetal Neuroprotection : experience from a tertiary care hospital in Turkey
  7092. Extraction and isolation of polyhydroxy triterpenoids from Rosa laevigata Michx. fruit with anti-acetylcholinesterase and Neuroprotection properties
  7093. Nanocarriers as cns drug delivery systems for enhanced Neuroprotection
  7094. Snx27 deletion promotes recovery from spinal cord injury by Neuroprotection and reduces macrophage/microglia proliferation
  7095. Application of a neuroscience research model to study Neuroprotection in children with congenital heart disease
  7096. Toll-like receptor 2 confers partial Neuroprotection during prion disease
  7097. Neuroprotection in Perimenopausal Women
  7098. Antenatal magnesium sulphate (MgSO4) for fetal Neuroprotection prior to preterm labor: Mini-review
  7099. Abstract TP72: transcranial Direct Current Stimulation (tDCS) for Neuroprotection in acute cerebral ischemia: meta-analysis of preclinical studies and implications for …
  7100. Neuroprotection by minocycline in murine traumatic spinal cord injury: analyses of matrix metalloproteinases
  7101. The synergistic combination of everolimus and paroxetine exerts post-ischemic Neuroprotection in vitro
  7102. Hippocampal insulin signaling and Neuroprotection mediated by physical exercise in Alzheimer´ s Disease
  7103. Cellular hormetic response to 27-hydroxycholesterol promotes Neuroprotection through AICD induction of MAST4 abundance and kinase activity
  7104. Anesthetic neurotoxicity: an emerging role for glia in Neuroprotection
  7105. Altered Micro-RNA Regulation and Neuroprotection Activity of Eremostachys labiosiformis in Alzheimer’s Disease Model
  7106. 2-(4-Methoxyphenyl) ethyl-2-acetamido-2-deoxy-β-D-pyranoside, an analog of salidroside, contributes to Neuroprotection in cerebral ischemic injury in vitro and in …
  7107. A meta-analysis of pharmacological Neuroprotection in noncardiac surgery: focus on statins, lidocaine, ketamine, and magnesium sulfate
  7108. Neuroprotection in TBI
  7109. Neuroprotection Strategies for the Newborn
  7110. A Combination of Ulinastatin and Xuebijing Amplifies Neuroprotection after Transient Cerebral Ischemia via Attenuating Apoptosis Signal Pathways in Hippocampus
  7111. Trkb-IP3 pathway mediating Neuroprotection in rat hippocampal neuronal cell culture following induction of kainic acid
  7112. Redox-dependent mechanisms of brain Neuroprotection of rats with experimental diabetes mellitus
  7113. Author Correction: The emerging field of epigenetics in neurodegeneration and Neuroprotection
  7114. … up-regulates BDNF expression through NF-κB as an adaptive response against ROS, which may improve neuronal bioenergetics and enhance Neuroprotection (P3 …
  7115. Magnesium for Fetal Neuroprotection : Should it be Started When Delivery is Not Imminent in PPROM?[12D]
  7116. Sphingosine 1-phosphate receptor 1 modulates CNTF-induced axonal growth and Neuroprotection in the mouse visual system
  7117. Perspective in current Neuroprotection strategies
  7118. Allopurinol for women in pregnancy for Neuroprotection of the fetus
  7119. Publisher Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer Neuroprotection in models of Huntington’s disease
  7120. Monoacylglycerol lipase inhibitor, JZL-184, confers Neuroprotection in the mice middle cerebral artery occlusion model of stroke
  7121. Neurosonographical characteristics of dysmature infants depending on conducted Neuroprotection
  7122. Anticonvulsant activity, organotypic hippocampal Neuroprotection assay and in-silico sodium channel blocking potential of 2-amino-6-nitrobenzothiazole derived …
  7123. Experimental models to study the Neuroprotection of acidic Postconditioning against cerebral ischemia
  7124. Neuroprotection Effects of Celastrus paniculatus seed oil against monosodium glutamate in human IMR-32 cells
  7125. The Quest for Neuroprotection for Injuries in the Developing brain
  7126. The role of ERK1/2 activation in sarpogrelate-mediated Neuroprotection
  7127. Albumin-Induced Neuroprotection in Focal Cerebral Ischemia in the ALIAS Trial: Does Severity, Mechanism, and Time of Infusion Matter?
  7128. Neuroprotection by cannabinoids in neurodegenerative diseases
  7129. Amikacin inhibits miR-497 maturation and exerts post-ischemic Neuroprotection
  7130. Neuroprotection Mechanisms and their Potential Applications
  7131. CCBs and Neuroprotection : A Genuine Benefit
  7132. The delta opioid peptide D‐Alanine 2, Leucine 5 Enkephaline (DADLE)‐induces Neuroprotection through cross‐talk between the UPR and pro‐survival MAPK‐NGF …
  7133. International perspectives: hypothermic Neuroprotection for neonatal encephalopathy in low-and middle-income countries: a new approach to an old problem
  7134. Neuroprotection and cognition in multiple sclerosis: Effects of cognitive and brain reserve.
  7135. Neuron-glia metabolic coupling: Role in plasticity and Neuroprotection
  7136. Racial/ethnic disparities in magnesium sulfate Neuroprotection : a subgroup analysis of a multicenter randomized controlled trial
  7137. cPKCγ membrane translocation is involved in herkinorin‑induced Neuroprotection against cerebral ischemia/reperfusion injury in mice
  7138. Evaluation of the safety of laser-delivered Photobiomodulation and its Neuroprotection efficacy in a mouse model of Retinitis Pigmentosa
  7139. Erythropoietin and Its Derivatives: Mechanisms of Neuroprotection and Challenges in Clinical Translation
  7140. Intracellular compartmentation of cAMP promotes Neuroprotection and regeneration of CNS neurons
  7141. Curcumin and an antioxidant Formulation protect C57BL/6J mice from MPTP-induced Parkinson’s disease like changes: Potential Neuroprotection for …
  7142. TIR-domain-containing adapter-inducing interferon-β (TRIF) is essential for MPTP-induced dopaminergic Neuroprotection via microglial cell M1/M2 …
  7143. Recombinant human Tat-Hsp70-2: A tool for Neuroprotection
  7144. Transthyretin—a key gene involved in regulating learning and memory in brain , and providing Neuroprotection in Alzheimer Disease via neuronal synthesis of …
  7145. BDNF-producing human mesenchymal stem cells in an alginate-matrix: Neuroprotection and cochlear implant coating stability in vitro
  7146. Neuroprotection in Neuroanesthesia and
  7147. The role of pentoxifylline on Neuroprotection in neonatal rat model of hypoxic ischemic brain injury.
  7148. High-throughput sequencing analysis of differentially expressed miRNAs and target genes in ischemia/reperfusion injury and apelin-13 Neuroprotection
  7149. Inhibition of notch signaling pathways contribute to Neuroprotection effect by the combination of astragalus membranaceus and ligustrazine in rat model after …
  7150. Anticonvulsant activity, organotypic hippocampal Neuroprotection assay and in-silico sodium channel blocking potential of 2-amino-6-nitrobenzothiazole derived …
  7151. Mechanisms of Neuroprotection by capsaicin, a red pepper extract
  7152. Chemical constituents from Pterocephalus hookeri and their Neuroprotection activities
  7153. Nouveaux concepts de Neuroprotection pour le développement de traitements en repositionnement, en screening et en biothérapie
  7154. Running on Trk to Neuroprotection in diabetic retinopathy
  7155. Neuroprotection by freshwater clam extract against the neurotoxin MPTP in C57BL/6 mice
  7156. Naringenin protects motor neuron against methylglyoxal-induced neurotoxicity through activatinG IGF-1R-related Neuroprotection
  7157. Time course of Neuroprotection induced by in vivo normobaric hyperoxia preconditioning and angiogenesis factors
  7158. Commentary: gene therapy: a promising approach for Neuroprotection in Parkinson’s Disease?
  7159. GW28-e0097 Application of genome-wide microarray analysis technology to explore the Neuroprotection mechanism of hypothermia after cardiopulmonary …
  7160. Neuroprotection by chotosan, a Kampo formula, against glutamate excitotoxicity involves the inhibition of GluN2B-, but not GluN2A-containing NMDA receptor …
  7161. An innovative nanocarrier for Neuroprotection
  7162. Single Intranasal Administration of 17ß-Estradiol Loaded Gelatin Nanoparticles Confers Neuroprotection in the Post-Ischemic Mouse brain
  7163. Expression of HSP70 in the brain of rats during experimental cerebral ischemia modeling and on the background of Neuroprotection
  7164. An innovative nanocarrier for Neuroprotection
  7165. Retraction: The Early Stage Formation of PI3K-AMPAR GluR2 Subunit Complex Facilitates the Long Term Neuroprotection Induced by Propofol Post-Conditioning in …
  7166. Using of Magnesium Sulphate for Fetal Neuroprotection in Patients Presenting by Intrapartum Fetal Distress at Term: A Randomized Controlled Trial
  7167. The p38-MAPK Pathway Is Involved in Neuroprotection of Artemisinin against H2O2-induced Apoptosis in PC12 Cells
  7168. Therapeutic management of neonatal arterial cerebral infarction and Neuroprotection perspectives
  7169. Study of exosomal microRNAs from microglia involved in Neuroprotection in Hirudo medicinalis
  7170. NEUROPHYSIOLOGY/Neuroprotection
  7171. Medico-legal implications of hypothermic Neuroprotection in the newborn
  7172. The Role of Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection
  7173. clinical Status of Neuroprotection in cerebral Ischemia
  7174. Validation of an in-vitro Parkinson’s disease model for the study of Neuroprotection
  7175. Blood–brain Barrier Transporters and Neuroinflammation: Partners in Neuroprotection and in Pathology
  7176. Penumbral freeze: travel distance and delays provide an opportunity to study prerecanalization therapy Neuroprotection
  7177. Medical Radiation Countermeasures for Neuroprotection : Herbal Solutions, Evidences, and Challenges Therein
  7178. In Response to” Hypothermia for Neuroprotection in Convulsive Status Epilepticus”.
  7179. A novel Neuroprotection target with distinct regulation in stroke and Alzheimer’s disease
  7180. mGluR5, CB1 and Neuroprotection
  7181. Effects of ginkgolide K on platelet aggregation activity and Neuroprotection
  7182. Psychomotor Seizure Screening and in vitro Neuroprotection Assay of Hydrazones Derived from 2-Acetyl Thiophene
  7183. Correspondence (letter to the editor): Importance in Neuroprotection
  7184. brain Injury-Neuroprotection
  7185. Ethyl pyruvate does not require microglia for mediating Neuroprotection after excitotoxic injury
  7186. Human placenta-derived mesenchymal stem cell transplantation provides Neuroprotection against cerebral infarction in rats
  7187. New Insights for Hormone Therapy in Perimenopausal Women Neuroprotection
  7188. Supplémentation nutritionnelle maternelle en resvératrol: Neuroprotection dans l’hypoxie-ischémie du rat nouveau-né
  7189. History of Neuroprotection : Trials and Tribulations
  7190. Targeting Transition Metals for Neuroprotection in Alzheimer’s Disease
  7191. Mechanisms of RGC Neuroprotection Mediated by ST266
  7192. Mechanisms of Neuroprotection against oxidative stress in the anoxia tolerant turtle Trachemys scripta
  7193. ABCP-An Antiapoptotic Peptide for Neuroprotection in Glaucoma.
  7194. Neuroprotection of quercetin on central neurons against chronic high glucose through enhancement of Nrf2/Glo-1 mediated by phosphorylation regulation
  7195. Updating Neuroprotection with EPO
  7196. Neuroprotection in Neuroanesthesia and Neurocritical Care
  7197. Efficacy of complex Neuroprotection in glaucomatous optic neuropathy
  7198. Pentoxifylline use for Neuroprotection in neonates with hypoxic ischemic encephalopathy
  7199. Neuroprotection In Acute Stroke
  7200. Myelin water imaging provides evidence of long-term remyelination and Neuroprotection in Alemtuzumab treated multiple sclerosis patients (P5. 335)
  7201. Cellular and molecular basis of progesterone-induced Neuroprotection
  7202. Mechanisms Supporting Astrocyte-Mediated Neuroprotection
  7203. Neuroprotection after traumatic brain injury: Is there any hope?
  7204. Neuroprotection in glaucoma: an optogenetic approach
  7205. Potential Neuroprotection Against Detrimental Effects of Diabetes and Hyperglycemia in Ischemic Stroke
  7206. Research advance on central suppression and Neuroprotection of reduced matrine-type alkaloids.
  7207. Neuroprotection IN ACUTE STROKE
  7208. Strategies of Neuroprotection after Successful Resuscitation
  7209. Isoprenol-Induced Neuroprotection in Experimental Multiple Sclerosis
  7210. How to Define Neuroprotection : The Case of Phenytoin
  7211. Amyloid-β breaks brain ‘s Neuroprotection
  7212. Design, preparation and activity evaluation of two novel proteins with thrombolysis or/and Neuroprotection
  7213. Effects of Different Treatment Regimens in ST266-Mediated RGC Neuroprotection
  7214. Estrogen Receptor β Ligand Acts on Two Pathways Within the CNS to Mediate Neuroprotection in the MS Model (P2. 404)
  7215. Neuroprotection mechanism of lidocaine in rabbits with early brain injury resulted from subarachnoid hemorrhage
  7216. HIE and Neuroprotection
  7217. Neuroprotection in Critical Care and Perioperative Medicine
  7218. Authors’ reply [Use of magnesium sulfate in preterm deliveries for Neuroprotection of the neonate]
  7219. The Role of Neuroprotection in Subarachnoid Haemorrhage
  7220. Addition to “ITH14001, a CGP37157-nimodipine hybrid designed to regulate calcium homeostasis and oxidative stress, exerts Neuroprotection in cerebral ischemia”
  7221. Cellular Neuroprotection as a modern treatment approach for optic neuropathy
  7222. Adherence to uptake of magnesium sulphate for Neuroprotection in preterm births< 30 weeks at Christchurch Hospital
  7223. Neurotoxicity versus Neuroprotection of Anesthetics: Young Children on the Ropes?
  7224. Post-Stroke Neuroprotection and Repair of Astrocytes
  7225. Clinical Neuroprotection and secondary neuronal injury mechanisms
  7226. An alkaloid extract obtained from Phlegmariurus Saururus induces Neuroprotection after status epilepticus
  7227. Risk stratification and targeted Neuroprotection in Parkinson disease utilising the glucocerebrosidase pathway
  7228. A Mnemonic Device to Optimize Post ROSC Care for Neuroprotection
  7229. Role of PACAP/PAC1 Signaling in Neuromodulation of the Immune System and Neuroprotection
  7230. Prospects for Neuroprotection in Glaucoma
  7231. Hypothermic Neuroprotection in Neonatal Inflammatory-Sensitised Hypoxic-Ischaemic brain Injury
  7232. Amyloid-beta Induction of PIAS1 Ser-503 Phosphorylation and Elk-1 SUMOylation Mediate Endogenous Neuroprotection against Amyloid-beta Toxicity (P2. 188)
  7233. Neuroprotection of hyperbaric oxygen treatment for traumatic brain injury involving autophagy pathway in rats
  7234. Neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by …
  7235. GW28-e0656 c-fos participates the Neuroprotection of Win55, 212-2 pharmacological hypothermia after CPR
  7236. Isoprenol‐Induced Neuroprotection in Experimental Multiple Sclerosis
  7237. Clinical Efficacy and Therapeutic Mechanisms of Traditional Chinese Medicine for Neuroprotection and Neurogenesis in Stroke Treatment
  7238. Accepted Manuscript Pre-treatment with amitriptyline causes epigenetic up-regulation of Neuroprotection -associated genes and has anti-apoptotic effects in …
  7239. Neuroprotection AND ITS PLACE IN GLAUCOMA TREATMENT
  7240. Perspectives of Neuroprotection in patients with severe traumatic brain injury (analytical review)
  7241. Clinical Guideline: IMAGING THE ENCEPHALOPATHIC INFANT, Neuroprotection GUIDELINES FOR THE EAST OF ENGLAND
  7242. Argon treatment provides short and long-term Neuroprotection in a mouse model of traumatic brain injury (S23. 001)
  7243. In vitro detection of oxygen and glucose deprivation-induced neurodegeneration and pharmacological Neuroprotection based on hippocampal stratum pyramidale …
  7244. USING NON-INVASIVE SENSORY STIMULI TO ELICIT Neuroprotection IN ALZHEIMER’S DISEASE MOUSE MODELS
  7245. Beyond Anti-inflammation: Steroid-induced Neuroprotection in the Retina
  7246. Angiogenesis and Neuroprotection according to the administration methods of erythropoietin and Mechanical Barrier Disruption on ischemic rat model
  7247. The precise personal management is expected to glaucoma Neuroprotection
  7248. Evaluation of brain Permeability and Neuroprotection of Novel 3-hydroxy-4-pyridinone Bidentate Iron Chelators for the Treatment of Parkinson’s Disease
  7249. Treatment with relaxin reduces disease symptoms and enhances Neuroprotection and remyelination in murine experimental autoimmune encephalomyelitis
  7250. Neuroprotection of brain permeable Forskolin ameliorates behavioral, biochemical and histopathological alterations in rat model of intracerebral hemorrhage
  7251. Neuroprotection in Neurodegenerative Disease: From Basic Science to Clinical Applications
  7252. Mechanisms of Neuroprotection and Remyelination in Demyelinating Disease Models of Multiple Sclerosis: A Lesson From Estrogen Receptor Specific …
  7253. 1 5 Neuroprotection for Spinal Cord Injury
  7254. C3 Transferase Gene Therapy for Neuroprotection and Optic Nerve Regeneration
  7255. Neuroprotection of photoreceptors bearing the P23H mutation in Rhodopsin
  7256. MONOSIALOGANGLIOSIDE GM1: STRUCTURE, ANTI-APOPTOTIC PROPERTIES AND Neuroprotection
  7257. Improving Microcirculatory Reperfusion Reduces Parenchymal Oxygen Radical Formation And Provides Neuroprotection
  7258. Albumin Neuroprotection in focal cerebral ischemia in humans: Another look at ALIAS trial subgroup (P4. 058)
  7259. Understanding Molecular Pathology along Injured Spinal Cord Axis: Moving Frontiers toward Effective Neuroprotection and Regeneration
  7260. The mechanism of Neuroprotection by positive modulation of Ca 2+-activated K+ channels of cerebellar neurons in primary culture
  7261. Neuroprotection during Acute Hyperthermic Stress: Role of the PKG Pathway in Neurons and Glia in the Protection of Neural Function in Drosophila …
  7262. Effects of physiological ischemic training on post-stroke Neuroprotection and angiogenesis in adult rats
  7263. Neuroprotection in diabetic patients with acute stroke
  7264. Autocatalytic synthesis of 3-ethyl-3-hydroxy-indole-2-ones and their Neuroprotection and antitumor activities’ evaluation
  7265. Neuroprotection by overexpression of transcription factor Max in experimental glaucoma.
  7266. An Antiapoptotic Peptide for Neuroprotection in Glaucoma
  7267. DOES MEDITERRANEAN DIET CONFER Neuroprotection AGAINST NEUROINFLAMMATION AND RELATED DISEASES? AN OVERVIEW
  7268. Avenues for Acute Neuroprotection in Traumatic Optic Neuropathy
  7269. Neuroprotection : Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate‐Induced Excitotoxicity (Adv. Mater. 14/2018)
  7270. Novel sulfoglycolipid IG20 causes Neuroprotection by activating the phase II antioxidant response in rat hippocampal slices
  7271. Implementation of antenatal magnesium sulfate for fetal Neuroprotection in the third-level teaching university hospital: The retrospective analysis in period 2012-2016
  7272. Mitochondrial Transplantation After Spinal Cord Injury: Effects on Tissue Bioenergetics and Functional Neuroprotection
  7273. 8 Genomic effects of food bioactives in Neuroprotection
  7274. Delayed Neuroprotection In the Era of Hypothermia: What Can We Add?
  7275. The Role of the Amyloid Precursor Protein (APP) in Protein Homeostasis and Neuroprotection
  7276. 1 8 Neuroprotection for Carotid Endarterectomy and Carotid Artery Stenting
  7277. Corrigendum to” Amyloid beta modulators and Neuroprotection in Alzheimer’s disease: a critical appraisal”[Drug Discov. Today 22 (February (2))(2017) 223-233].
  7278. Human in vitro models of ischaemic stroke: new strategies for Neuroprotection
  7279. B05 Environment-driven influences and Neuroprotection in the BACHD RAT model for huntington disease
  7280. Inhaled Nitric Oxide as Neuroprotection After Deep Hypothermic Circulatory Arrest
  7281. P39: The Neuroprotection Effect of Erythropoietin in Cerebral Ischemia
  7282. Neuroprotection with antepartum magnesium sulfate in preterm birth between 32 and 34 weeks’ gestation: multicentre randomized clinical trial
  7283. The role of PKD1 in brain injury: ROS detoxification and Neuroprotection
  7284. Human Amniotic Epithelial Cell Therapy for Neuroprotection and Neuro-repair after Perinatal Asphyxial brain Injury
  7285. Plant-Derived Antiinflammatory Steroid Analogs for Neuroprotection : A Recent Update
  7286. Dual Effects of Neuroprotection and Neurotoxicity By General Anesthetics On Neural Stem Cells: Role of Autophagy
  7287. Reprogramming The Retina: Next Generation Strategies Of Retinal Neuroprotection And Gene Therapy Vector Potency Assessment
  7288. Neuroprotection As a Therapeutic Approach for Spinal Muscular Atrophy
  7289. Protein acetylation in δ-opioid receptor mediated RGC Neuroprotection
  7290. Effects of fluoxetine on hippocampal neurogenesis and Neuroprotection in the model of global cerebral ischemia in rats
  7291. Neuroprotection in Huntington’s Disease via Transcriptional Modification
  7292. Addendum: Shinozuka, K. et al. Stem Cell Transplantation for Neuroprotection in Stroke. brain Sci. 2013, 3, 239–261
  7293. Impairment of ER-mitochondrial coupling provides Neuroprotection in a model of oxytosis
  7294. Microglial modulation for gray matter Neuroprotection : mixed-lineage kinase 3 inhibitor URMC-099 protects hippocamapal synapses in EAE (P1. 396)
  7295. Combined inhibition of apoptosis and necrosis promotes transient Neuroprotection of retinal ganglion cells and partial-axon regeneration after optic nerve damage
  7296. Potential and pitfalls of intravitreal injected mRNA as ocular Neuroprotection strategy
  7297. Role of Lactate and TREK1 Channels in Neuroprotection during Cerebral Ischemia–in Vitro Study in Rat Hippocampus
  7298. Neuroprotection of ceruloplasmin on experimental stroke model
  7299. Metabolic Mechanisms of Injury and Neuroprotection with Riluzole against Hypoxic Damage in Mild Distraction Spinal Cord Injury
  7300. Do Histone Acetyltransferase Inhibitors Confer Neuroprotection against Neurodegenerative Disorders? An Overview
  7301. Neuroprotection by noble gases in models of brain injury
  7302. Characterisation of angiogenin mediated paracrine Neuroprotection in in vitro models
  7303. Global Neuroprotection of huntingtin in culture and alterations of cortico-striatal connections in Huntington’s disease culture and mouse models
  7304. Randomized controlled trial of antenatal magnesium sulfate for short-term Neuroprotection in premature neonates
  7305. Patent: Neuroprotection and myelin repair using Nestorone. RTM
  7306. Methanolic Extract of Mucuna pruriens Seed Acts for Neuroprotection and Antioxidant Defense in A Fish Model
  7307. Neuroprotection activity of marine fungi metabolites in toxin-induced model of Parkinson’s disease
  7308. Effects of Leontice leontopetalum and Bongardia chrysogonum on oxidative stress and Neuroprotection in PTZ kindling epilepsy in rats
  7309. Black Tea: A Possible Multitherapeutic Combinatorics Aiding Neuroprotection in Alzheimer’s Disease
  7310. Comparison of Two Methods of Lidocaine Administrating for Neuroprotection in Rabbit Model of Subarachnoid Hemorrhage
  7311. Pharmacological Neuroprotection for intracerebral hemorrhages in patients with polyvascular disease
  7312. Gene and cell therapy: combining two approaches to promote Neuroprotection and neuroregeneration in a model of optic nerve injury
  7313. How Does DHA Reach the brain to Provide Neuroprotection after Hypoxic‐Ischemic Injury?
  7314. Role of MicroRNAs in Preconditioning-mediated Ischemic Tolerance and Neuroprotection After Stroke
  7315. The effectiveness of magnesium for Neuroprotection during global cerebral ischemia associated with cardiac arrest or cardiac surgery
  7316. The hemodialysis induced blood glutamate reduction in chronic renal failure: potential implementation for Neuroprotection
  7317. Mechanisms of Müller glia-mediated Neuroprotection in diabetic retinopathy and hypoxic retinal diseases
  7318. Propofol Infusion in the Early Post-Cardiac Arrest Phase Improves Cerebral Perfusion and Confers Anti-Apoptotic Neuroprotection via Akt-eNOS-NO Signaling
  7319. … WP261: Dcr1 and Dcr2 Protect Neuron Against Ischemia and Hypoxia Damage via Differential Mechanisms on Ischemia Preconditioning-Induced Neuroprotection
  7320. … HEMODIALYSIS INDUCED BLOOD GLUTAMATE REDUCTION IN CHRONIC RENAL FAILURE: POTENTIAL IMPLEMENTATION FOR Neuroprotection
  7321. Assessment of the effects of systemically administered levetiracetam in an ocular model for Neuroprotection .
  7322. Abstract WP99: Fingolimod Promotes Functional Recovery via Neuroprotection , Angiogenesis and Neurogenesis in Diabetic Stroke Mice
  7323. Development and Evaluation of Quercetin Nanoparticles and Hot Melt Cast Films for Retinal Neuroprotection
  7324. The P2X4 receptor is required for Neuroprotection via ischemic preconditioning
  7325. The silver lining of cerebrosterol in Alzheimer’s disease: the involvement of sirtuin 1 in Neuroprotection
  7326. Pharmacological Neuroprotection of rat spinal locomotor networks against experimental spinal cord injury in vitro
  7327. Neuroprotection via LRP‐1 Signaling in the Retina of Diabetic Mice
  7328. Consequences of mTOR inhibition on epileptogenesis and Neuroprotection in lithium-pilocarpine model of epilepsy in rats
  7329. Delayed blockade of retinal gap junctions still promotes Neuroprotection in a mouse model of glaucoma
  7330. Erratum to: Traditional Food Items in Ogimi, Okinawa: l-Serine Content and the Potential for Neuroprotection
  7331. Endothelin receptors are targets for Neuroprotection in a rat model of glaucoma
  7332. The role of brain -derived neurotrophic factor in the regulation of dendritic arbor morphology, neuronal network activity, and Neuroprotection
  7333. Identification of a molecular mechanism underlying estrogen‐mediated Neuroprotection in neuronal cells against oxidative stress
  7334. Study on Neuroprotection of α-phenyl-N-tert-butyl nitrone for anti-Parkinson’s disease in vitro and in vivo
  7335. Biochemical Mechanisms Associated With Exercise-Induced Neuroprotection in Aging brain s and Related Neurological Diseases
  7336. Enhanced Neuroprotection by Synergistically Induced Hypothermia with Pharmacological and Physical Approach in Experimental Stroke
  7337. Improving Spinal Cord Protection During the Frozen Elephant Trunk Technique: Effect of a Dedicated Neuroprotection Protocol
  7338. Fluoro-substituted cyanine for reliable in vivo labelling of amyloid-b oligomers and Neuroprotection against amyloid-b induced toxicity
  7339. Balancing Neuroprotection with Functional Recovery: The Role of the Perineuronal Net in Preventing Excitotoxicity after Spinal Cord Injury
  7340. The Transdifferentiation of brain derived neurotrophic factor secreting mesenchymal stem cells for Neuroprotection
  7341. Effect of a glutamatergic antagonist on epileptogenesis and Neuroprotection in the rat lithium pilocarpine epileptogenesis model: Study in microTEP FDG
  7342. The Transdifferentiation of brain derived neurotrophic factor secreting mesenchymal stem cells for Neuroprotection
  7343. Multifunctional Effects of Human Serum Albumin Toward Neuroprotection in Alzheimer Disease
  7344. The P2x4 Receptor is Required for Neuroprotection via Ischemic Preconditioning
  7345. Triggering receptor expressed on Myeloid Cells-2 (TREM-2) correlates to hypothermic Neuroprotection in ischemic stroke
  7346. A possible emerging role of Stachys siedlbodii MIQ extract in Neuroprotection : in vitro and in vivo
  7347. αB crystallin peptide fused to elastin-like polypeptide provides long-term Neuroprotection in a mouse model of AMD
  7348. Abstract WP118: Docosahexaenoic Acid Provides Neuroprotection by Increasing Neurogenesis After Experimental Stroke
  7349. Retinal Neuroprotection : The Role of Hydrogen Sulfide and Cannabinoids
  7350. Rho-GTPase and p38 mediated Neuroprotection in spiral ganglion cells
  7351. Abstract WP262: Neuroglobin Mediates Neuroprotection of Hypoxic Postconditioning Against Transient Global Cerebral Ischemia in Rats via Preserving the Activity of …
  7352. Abstract TP104: Thyroid Hormone Neuroprotection After Stroke and Fatty Acid Oxidation
  7353. Transgene expression, processing and activity following intravitreal Injection of QTA020V, a novel rAAV2 vector for retinal ganglion cell Neuroprotection
  7354. Specific induction of the internalization and degradation of inflammatory Wnt5a in damaged RPE cells by Neuroprotection D1 (NPD1).
  7355. Olfactomedin1 provides retinal ganglion cell Neuroprotection and stimulates axon regeneration after optic nerve crush in rodents
  7356. Lung-brain Immunological Coupling Mediates Neutrophil De-Priming and Neuroprotection following Cerebral Ischemia-Reperfusion
  7357. Abstract TP268: Induction Profile of Mesencephalic Astrocyte-derived Neurotrophic Factor by Cerebral Ischemia and its Implication for Neuroprotection
  7358. Neuroprotection and reduced gliosis by pre-and post-treatments of hydroquinone in a gerbil model of transient cerebral ischemia
  7359. Preconditioning Across Generations: Intermittent Hypoxia in F0 Mice Promotes Neuroprotection from Retinal Ischemia in F1 Offspring
  7360. Alcohol-Induced Neuroinflammation in an Animal Model of FASD and Neuroprotection by Anti-Inflammatory agents
  7361. Neuroprotection of retinal ganglion cells via NMDA-dependent mechanism in the mouse non-arteritic anterior ischemic optic neuropathy (NAION) model
  7362. Neuroprotection of lurasidone by antagonist activities of histamine in a cranial nerve involvement mouse model
  7363. Activation of LPA1 signaling mediates antidepressant-induced Neuroprotection from apoptosis triggered by pro-inflammatory cytokines
  7364. Novel Functions of C-terminus of HSC70-Interacting Protein (CHIP) in Mitophagy and Neuroprotection
  7365. Neuroprotection by VNUT-mediated microglial ATP exocytosis in the ischemic brain
  7366. Nampt-mediated Neuroprotection and neurogenesis in ischemic stroke
  7367. Nanowired Delivery of Cerebrolysin and Mesenchymal Stem Cells Potentiate Neuroprotection Following Concussive Head Injury
  7368. Alcohol-Induced Neuroimmune Activity in the Developing brain and Neuroprotection by Anti-Inflammatory agents
  7369. Effects of TRPM2 Inhibition in Neuroprotection following Neonatal Hypoxic-Ischemic brain Injury
  7370. Targeting drugs to specific cell layers of the posterior eye segment: implementation of “smart” strategies of ocular Neuroprotection in zebrafish model
  7371. Jujuboside A attenuates LPS-induced microglial activation and provides Neuroprotection
  7372. Shining a light on glaucoma: optogenetic brain stimulation confers retinal Neuroprotection
  7373. Glutamine supplementation provides Neuroprotection by inhibiting endoplasmic reticulum stress response after traumatic brain injury in rats
  7374. OB03: Routine use or non-use of antenatal magnesium sulfate exposure for Neuroprotection and risk of necrotizing enterocolitis in preterm neonates
  7375. Mechanism of JAK2-STAT3 signaling pathway in ischemic postconditio-ning Neuroprotection after cerebral ischemia in tree shrews
  7376. Inside Front Cover-Neuroprotection : Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate‐Induced Excitotoxicity (Adv. Mater …
  7377. Developing peptidomimetics of secreted amyloid precursor protein-alpha (sAPPα) that confer Neuroprotection and stimulate novel protein synthesis
  7378. Neuroprotection effects of Cudraisoflavones and extracts from the fruit of Maclura tricuspidata against in vitro and in vivo brain ischemic injury models via induction of …
  7379. Activation of LPA1 signaling mediates antidepressant-induced Neuroprotection from apoptosis triggered by pro-inflammatory cytokines
  7380. Pre-implantation factor promotes Neuroprotection by modulating long non-coding RNA H19 of the neuronal stem cells
  7381. A novel ShK-like toxic peptide fromthe transcriptome of the cnidarian Palythoa caribaeorum displays Neuroprotection and cardioprotection in zebrafish
  7382. The mechanism of Neuroprotection mediated by bibenzyl compound 20C against rotenone-induced oxidative insulting
  7383. … nuclear export of C9ORF72 repeat transcripts: targeting toxic gain-of-functions induced by protein sequestration as a selective therapeutic strategy for Neuroprotection
  7384. Abstract TP266: Phenothiazines Enhance Mild Hypothermia-induced Neuroprotection via PI3K/Akt Regulation in Experimental Ischemia/Reperfusion Injury
  7385. The ability of retrograde axonal migration and Neuroprotection of tetanus toxin fragments and Bcl2 fusion proteins
  7386. Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates Neuroprotection by PPARγ agonist MDG548 in Parkinson’s disease
  7387. Curcumin-Loaded Polymeric Nanoparticles for Neuroprotection in Neonatal Rats with Hypoxic-Ischemic Encephalopathy (HIE)
  7388. Role for Nitro-Conjugated Linoleic Acid and cGMP in Nitrite-Mediated Neuroprotection in Out-of-Hospital Cardiac Arrest
  7389. Dexmedetomidine confers Neuroprotection against transient global cerebral ischemia/reperfusion injury in rats: Anti-inflammatory effect through inactivation of the TLR …
  7390. Regulation of Cannabinoid‐mediated Neuroprotection by Hydrogen Sulfide in Bovine Isolated Retina
  7391. Thyroid Hormone Neuroprotection from Ischemic Stroke by Stimulation of Astrocyte Fatty Acid Oxidation
  7392. PE11) Nrf2-mediated Neuroprotection against Oxygen-Glucose Deprivation/Reperfusion Injury by Novel Compound from Polygonum multiflorum
  7393. … and molecular analysis of anti-tumour bioactivities of Urgines maritima (L.) baker aqueous extract on human malignant neuroblastoma with its Neuroprotection ability
  7394. Prophylactic Administration of CN-105 Confers Neuroprotection Against Acute brain Injury
  7395. The synthesis of polyhydroxy sterone 2β, 3α, 5-trihydroxy-5α-androst-6-one and its Neuroprotection
  7396. Comparison of pharmacological Neuroprotection provided by propofol versus desflurane for long term postoperative cognitive dysfunction in patients undergoing …
  7397. Abstract TP267: Protein Kinase C Epsilon-activation Mediates Ischemic Neuroprotection by Activating an Activity-regulated Cytoskeleton-associated Protein …
  7398. PRL-1 is required for Neuroprotection against olfactory CO2 stimulation in Drosophila
  7399. Evaluation of Neuroprotection and Antioxidant Activities via Drosophila Model System in the Active Principle Derived from Sida Glutinosa Comm. Ex Cav.-An …
  7400. MicroRNA-21a-5p/PDCD4 axis Regulates Mesenchymal-Stem-Cell-Induced Neuroprotection in Acute Glaucoma
  7401. Neuroprotection of NCX4016 via converging on phosphorylation and s-nitrosylation of Bcl-2 in rat hippocampal neurons after cerebral ischemia/reperfusion
  7402. Nrf2-mediated Neuroprotection against Oxygen-Glucose Deprivation/Reperfusion Injury by Novel Compound from Polygonum multiflorum
  7403. Synergistic effect among BDNF, GDNF, or VEGF on protecting Müller cells in hypoxia: implication in Neuroprotection in age-related macular degeneration and diabetic …
  7404. A novel selective cell-permeable peptide disrupts presynaptic JNK2-STX1a interaction, providing Neuroprotection and preventing glutamate-mediated …
  7405. … II randomised controlled trial of amiloride as a Neuroprotective treatment in optic neuritis: studying in vivo neurodegeneration, Neuroprotection and cortical plasticity …
  7406. Neuroprotection of 17β-Estradiol Against D-Glucose Exposure Effect on Tyrosine Hydroxylase Expression and Apoptotic Cells in Zebrafish (Danio rerio) brain During …
  7407. Neuroprotection in traumatic brain injury
  7408. Antioxidant therapies for Neuroprotection —a review
  7409. Retinal Neuroprotection : Current strategies and future directions
  7410. Neuroprotection by therapeutic hypothermia
  7411. Ketone bodies in neurological diseases: focus on Neuroprotection and underlying mechanisms
  7412. Curcumin, gut microbiota, and Neuroprotection
  7413. Natural products and Neuroprotection
  7414. GLP-1’s role in Neuroprotection : a systematic review
  7415. Gamma entrainment binds higher-order brain regions and offers Neuroprotection
  7416. Neuroprotection in Parkinson’s disease: facts and hopes
  7417. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, Neuroprotection , and autophagy
  7418. Neuroprotection in glaucoma: recent advances and clinical translation
  7419. Taurine treatment provides Neuroprotection in a mouse model of manganism
  7420. Newer pharmacological approaches for antioxidant Neuroprotection in traumatic brain injury
  7421. Small vessels are a big problem in neurodegeneration and Neuroprotection
  7422. Deep brain stimulation: potential for Neuroprotection
  7423. Rapamycin improves the Neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI
  7424. P2 receptor interaction and signalling cascades in Neuroprotection
  7425. Imaging outcome measures of Neuroprotection and repair in MS: a consensus statement from NAIMS
  7426. Reactive microglia and IL1β/IL-1R1-signaling mediate Neuroprotection in excitotoxin-damaged mouse retina
  7427. Mitochondria in Neuroprotection by phytochemicals: Bioactive polyphenols modulate mitochondrial apoptosis system, function and structure
  7428. … associated with a transcarotid artery revascularization-centered protocol in high-risk carotid revascularizations using the ENROUTE Neuroprotection system
  7429. Current evidence on cognitive improvement and Neuroprotection promoted by anthocyanins
  7430. Combined treatment with three natural antioxidants enhances Neuroprotection in a SH-SY5Y 3D culture model
  7431. Autophagy activator drugs: a new opportunity in Neuroprotection from misfolded protein toxicity
  7432. Lasting effects of general anesthetics on the brain in the young and elderly:“mixed picture” of neurotoxicity, Neuroprotection and cognitive impairment
  7433. Neuroprotection from acute brain injury in preterm infants
  7434. Hollow prussian blue nanozymes drive Neuroprotection against ischemic stroke via attenuating oxidative stress, counteracting inflammation, and suppressing cell …
  7435. Neuroprotection in glaucoma: old concepts, new ideas
  7436. Neuroprotection strategies in preterm encephalopathy
  7437. Repurposing azithromycin for neonatal Neuroprotection
  7438. Inflammatory cytokines are involved in dihydrocapsaicin (DHC) and regional cooling infusion (RCI)-induced Neuroprotection in ischemic rat
  7439. Stem cell‐based cell therapy for Neuroprotection in stroke: A review
  7440. Exercise-induced Neuroprotection and recovery of motor function in animal models of Parkinson’s disease
  7441. Sex-specific Neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson’s disease
  7442. Exosomes from LPS-stimulated macrophages induce Neuroprotection and functional improvement after ischemic stroke by modulating microglial polarization
  7443. Curcumin and heme oxygenase: Neuroprotection and beyond
  7444. Targeting MAPK phosphorylation of Connexin43 provides Neuroprotection in stroke
  7445. Neuroprotection of the preterm brain
  7446. Neuroprotection : pro-survival and anti-neurotoxic mechanisms as therapeutic strategies in neurodegeneration
  7447. Bilirubin links heme metabolism to Neuroprotection by scavenging superoxide
  7448. NEAT1 is overexpressed in Parkinson’s disease substantia nigra and confers drug‐inducible Neuroprotection from oxidative stress
  7449. Tandem pore TWIK-related potassium channels and Neuroprotection
  7450. Hesperetin confers Neuroprotection by regulating Nrf2/TLR4/NF-κB signaling in an Aβ mouse model
  7451. Magnesium sulfate use for fetal Neuroprotection
  7452. Use of a combination strategy to improve Neuroprotection and neuroregeneration in a rat model of acute spinal cord injury
  7453. Magnesium sulfate and novel therapies to promote Neuroprotection
  7454. Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson’s disease mice via gut microbiota and metabolites
  7455. Novel Oxindole–Curcumin Hybrid Compound for Antioxidative Stress and Neuroprotection
  7456. Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and Neuroprotection
  7457. Inflammatory process in Parkinson disease: Neuroprotection by neuropeptide Y
  7458. Remote photobiomodulation: an emerging strategy for Neuroprotection
  7459. Mesenchymal stem cell-derived exosomes provide Neuroprotection and improve long-term neurologic outcomes in a swine model of traumatic brain injury and …
  7460. Prevention of excitotoxicity‐induced processing of BDNF receptor TrkB‐FL leads to stroke Neuroprotection
  7461. Neuroprotection by glucose‐6‐phosphate dehydrogenase and the pentose phosphate pathway
  7462. TRIM9-mediated resolution of neuroinflammation confers Neuroprotection upon ischemic stroke in mice
  7463. Intensive care in traumatic brain injury including multi-modal monitoring and Neuroprotection
  7464. Antioxidant and anti-inflammatory mechanisms of Neuroprotection by ursolic acid: addressing brain injury, cerebral ischemia, cognition deficit, anxiety, and …
  7465. Anaesthetic Neuroprotection in children: does it exist or is it all just bad?
  7466. Vastly extended drug release from poly (pro-17β-estradiol) materials facilitates in vitro neurotrophism and Neuroprotection
  7467. CSF1R stimulation promotes increased Neuroprotection by CD11c+ microglia in EAE
  7468. Microscopic viscosity of neuronal plasma membranes measured using fluorescent molecular rotors: Effects of oxidative stress and Neuroprotection
  7469. Neuroprotection after hemorrhagic stroke depends on cerebral heme oxygenase-1
  7470. Naringenin produces Neuroprotection against LPS-induced dopamine neurotoxicity via the inhibition of microglial NLRP3 inflammasome activation
  7471. Pigment epithelium-derived factor mediates retinal ganglion cell Neuroprotection by suppression of caspase-2
  7472. Neuroprotection
  7473. Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer’s disease by positive modulation of σ1 receptors
  7474. Metformin mediates Neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis
  7475. Neuroprotection of resveratrol against focal cerebral ischemia/reperfusion injury in mice through a mechanism targeting gut-brain axis
  7476. Extracellular prolyl oligopeptidase derived from activated microglia is a potential Neuroprotection target
  7477. Mechanism of Neuroprotection against experimental spinal cord injury by riluzole or methylprednisolone
  7478. Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinsonʼs Disease
  7479. Сlass II histone deacetylases in the post‐stroke recovery period—expression, cellular, and subcellular localization—promising targets for Neuroprotection
  7480. Neuroprotection of mangiferin against oxidative damage via arousing Nrf2 signaling pathway in PC12 cells
  7481. Inhibition of the glutamine transporter SNAT1 confers Neuroprotection in mice by modulating the mTOR-autophagy system
  7482. Neuroprotection of quercetin on central neurons against chronic high glucose through enhancement of Nrf2/ARE/glyoxalase-1 pathway mediated by …
  7483. Adrenergic receptor antagonism induces Neuroprotection and facilitates recovery from acute ischemic stroke
  7484. Synthesis of andrographolide analogues and their Neuroprotection and neurite outgrowth-promoting activities
  7485. Biochanin A provides Neuroprotection against cerebral ischemia/reperfusion injury by Nrf2-mediated inhibition of oxidative stress and inflammation signaling …
  7486. Differential modulation of NF-κB in neurons and astrocytes underlies Neuroprotection and antigliosis activity of natural antioxidant molecules
  7487. Changes in the levels of 12/15-lipoxygenase, apoptosis-related proteins and inflammatory factors in the cortex of diabetic rats and the Neuroprotection of baicalein
  7488. Altered metabolism for Neuroprotection provided by mesenchymal stem cells
  7489. Properdin: a novel target for Neuroprotection in neonatal hypoxic-ischemic brain injury
  7490. Effects of Varying Intranasal Treatment Regimens in ST266-Mediated RGC Neuroprotection
  7491. Neural stem cells transfected with leukemia inhibitory factor promote Neuroprotection in a rat model of cerebral ischemia
  7492. Ischemic injury-induced CaMKIIδ and CaMKIIγ confer Neuroprotection through the NF-κB signaling pathway
  7493. Retinal long term Neuroprotection by Cerium Oxide nanoparticles after an acute damage induced by high intensity light exposure
  7494. M1 muscarinic receptor is a key target of Neuroprotection , neuroregeneration and memory recovery by i-Extract from Withania somnifera
  7495. Therapeutic hypothermia and Neuroprotection in acute neurological disease
  7496. Neuroprotection with natural antioxidants and nutraceuticals in the context of brain cell degeneration: the epigenetic connection
  7497. Iron is neurotoxic in retinal detachment and transferrin confers Neuroprotection
  7498. Salubrinal offers Neuroprotection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model
  7499. Intranasal delivery of pGDNF DNA nanoparticles provides Neuroprotection in the rat 6-hydroxydopamine model of Parkinson’s disease
  7500. Antenatal magnesium sulfate for fetal Neuroprotection : a critical appraisal and systematic review of clinical practice guidelines
  7501. Role of exosomes induced by remote ischemic preconditioning in Neuroprotection against cerebral ischemia
  7502. Mesenchymal stem cell derived EVs mediate Neuroprotection after spinal cord injury in rats via the microRNA-21-5p/FasL gene axis
  7503. Pretreatment with Korean red ginseng or dimethyl fumarate attenuates reactive gliosis and confers sustained Neuroprotection against cerebral hypoxic-ischemic …
  7504. Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad Neuroprotection via its actions on microglia cells
  7505. brain hypoxia and ischemia: new insights into neurodegeneration and Neuroprotection
  7506. Starting ketamine for Neuroprotection earlier than its current use as an anesthetic/antiepileptic drug late in refractory status epilepticus
  7507. Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide
  7508. Neuroprotection by luteolin and gallic acid against cobalt chloride-induced behavioural, morphological and neurochemical alterations in Wistar rats
  7509. Mechanisms underlying Neuroprotection by the NSAID mefenamic acid in an experimental model of stroke
  7510. Design, synthesis and biological evaluation of cinnamic acid derivatives with synergetic Neuroprotection and angiogenesis effect
  7511. Vitamin B 12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers Neuroprotection
  7512. The role of magnesium sulfate (MgSO4) in fetal Neuroprotection
  7513. Neuroprotection , recovery of function and endogenous neurogenesis in traumatic spinal cord injury following transplantation of activated adipose tissue
  7514. Herbal compatibility of ginseng and rhubarb exerts synergistic Neuroprotection in cerebral ischemia/reperfusion injury of rats
  7515. Mitochondria and Neuroprotection in stroke: cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted Neuroprotective therapeutics
  7516. HDAC Inhibition by valproic acid induces Neuroprotection and improvement of PD-like behaviors in LRRK2 R1441G transgenic mice
  7517. ORAI1/STIM1 interaction intervenes in stroke and in Neuroprotection induced by ischemic preconditioning through store-operated calcium entry
  7518. Rapamycin confers Neuroprotection against aging-induced oxidative stress, mitochondrial dysfunction, and neurodegeneration in old rats through activation of …
  7519. Neuroenhancement and Neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized …
  7520. iTRAQ-based quantitative proteomics reveals the Neuroprotection of rhubarb in experimental intracerebral hemorrhage
  7521. Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial …
  7522. Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor
  7523. Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage
  7524. Ouabain activates transcription factor EB and exerts Neuroprotection in models of Alzheimer’s disease
  7525. The autism/Neuroprotection -linked ADNP/NAP regulate the excitatory glutamatergic synapse
  7526. The Neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis
  7527. Central nervous system electrical stimulation for Neuroprotection in acute cerebral ischemia: meta-analysis of preclinical studies
  7528. Cell autonomous Neuroprotection by the mitochondrial uncoupling protein 2 in a mouse model of glaucoma
  7529. The effect of preventive exercise on the Neuroprotection in 6-hydroxydopamine-lesioned rat brain
  7530. Norgestrel, a progesterone analogue, promotes significant long-term Neuroprotection of cone photoreceptors in a mouse model of retinal disease
  7531. Mesencephalic astrocyte‐derived neurotrophic factor affords Neuroprotection to early brain injury induced by subarachnoid hemorrhage via activating Akt‐dependent …
  7532. Neuroprotection mediated by remote preconditioning is associated with a decrease in systemic oxidative stress and changes in brain and blood glutamate …
  7533. Pretreated fucoidan confers Neuroprotection against transient global cerebral ischemic injury in the gerbil hippocampal CA1 area via reducing of glial cell …
  7534. Neuroprotection of multifunctional phytochemicals as novel therapeutic strategy for neurodegenerative disorders: Antiapoptotic and antiamyloidogenic activities by …
  7535. The Neuroprotection of progesterone against Aβ-induced NLRP3-Caspase-1 inflammasome activation via enhancing autophagy in astrocytes
  7536. MicroRNA-200a-3p mediates Neuroprotection in Alzheimer-related deficits and attenuates amyloid-beta overproduction and tau hyperphosphorylation via …
  7537. Lupeol inhibits LPS-induced neuroinflammation in cerebellar cultures and induces Neuroprotection associated to the modulation of astrocyte response and expression …
  7538. Dexras1 deletion and iron chelation promote Neuroprotection in experimental optic neuritis
  7539. Loss of Shp2 rescues BDNF/TrkB signaling and contributes to improved retinal ganglion cell Neuroprotection
  7540. Neuroprotection by mesenchymal stem cell (MSC) administration is enhanced by local cooling infusion (LCI) in ischemia
  7541. Neuroprotection of andrographolide against microglia-mediated inflammatory injury and oxidative damage in PC12 neurons
  7542. Comparative effects of progesterone and the synthetic progestin norethindrone on Neuroprotection in a model of spontaneous motoneuron degeneration
  7543. Exogenous adenosine facilitates Neuroprotection and functional recovery following cerebral ischemia in rats
  7544. Exogenous hydrogen sulfide offers Neuroprotection on intracerebral hemorrhage injury through modulating endogenous H2S metabolism in mice
  7545. Artemether activation of AMPK/GSK3β (ser9)/Nrf2 signaling confers Neuroprotection towards β-amyloid-induced neurotoxicity in 3xTg Alzheimer’s mouse …
  7546. Disease mechanisms and Neuroprotection by tauroursodeoxycholic acid in Rpgr knockout mice
  7547. Neuroprotection in idiopathic REM sleep behavior disorder: a role for exercise?
  7548. Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers Neuroprotection in SH-SY5Y cells and neurons exposed to MPP+-induced oxidative …
  7549. Electroacupuncture pretreatment elicits Neuroprotection against cerebral ischemia-reperfusion injury in rats associated with transient receptor potential vanilloid 1 …
  7550. Targeting the mitochondrial pyruvate carrier for Neuroprotection
  7551. Statins for Neuroprotection in spontaneous intracerebral hemorrhage
  7552. Activation of GPR55 induces Neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation
  7553. Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior Neuroprotection in Alzheimer’s disease
  7554. Network-centric medicine for peripheral nerve injury: Treating the whole to boost endogenous mechanisms of Neuroprotection and regeneration
  7555. Pregabalin affords retinal Neuroprotection in diabetic rats: suppression of retinal glutamate, microglia cell expression and apoptotic cell death
  7556. Electrostimulation in an autonomous culture lab-on-chip provides Neuroprotection of a retinal explant from a retinitis pigmentosa mouse-model
  7557. Tilianin mediates Neuroprotection against ischemic injury by attenuating CaMKII-dependent mitochondrion-mediated apoptosis and MAPK/NF-κB signaling
  7558. BpV (pic) confers Neuroprotection by inhibiting M1 microglial polarization and MCP-1 expression in rat traumatic brain injury
  7559. The changes of systemic immune responses during the Neuroprotection induced by remote ischemic postconditioning against focal cerebral ischemia in mice
  7560. Dynamin and reverse-mode sodium calcium exchanger blockade confers Neuroprotection from diffuse axonal injury
  7561. Methylene blue offers Neuroprotection after intracerebral hemorrhage in rats through the PI3K/Akt/GSK3β signaling pathway
  7562. Tribulusterine containing Tribulus terrestris extract exhibited Neuroprotection through attenuating stress kinases mediated inflammatory mechanism: in vitro and in vivo …
  7563. Effects of phytochemicals on blood pressure and Neuroprotection mediated via brain renin-angiotensin system
  7564. Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer’s Disease
  7565. ApoE-associated modulation of Neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans
  7566. Trigonelline therapy confers Neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke
  7567. Rationale for Neuroprotection in glaucoma
  7568. Intraperitoneal delivery of acetate-encapsulated liposomal nanoparticles for Neuroprotection of the penumbra in a rat model of ischemic stroke
  7569. Wogonin improves functional Neuroprotection for acute cerebral ischemia in rats by promoting angiogenesis via TGF-β1
  7570. α7 nicotinic ACh receptors are necessary for memory recovery and Neuroprotection promoted by attention training in amyloid‐β‐infused mice
  7571. Troxerutin exerts Neuroprotection against lipopolysaccharide (LPS) induced oxidative stress and neuroinflammation through targeting SIRT1/SIRT3 signaling pathway
  7572. Biliverdin administration regulates the microRNA-mRNA expressional network associated with Neuroprotection in cerebral ischemia reperfusion injury in rats
  7573. Azithromycin affords Neuroprotection in rat undergone transient focal cerebral ischemia
  7574. Cold‐inducible protein RBM3 mediates hypothermic Neuroprotection against neurotoxin rotenone via inhibition on MAPK signalling
  7575. Hypoxia‐inducible factor 1 alpha and nuclear‐related receptor 1 as targets for Neuroprotection by albendazole in a rat rotenone model of Parkinson’s disease
  7576. Noble gas Neuroprotection : xenon and argon protect against hypoxic–ischaemic injury in rat hippocampus in vitro via distinct mechanisms
  7577. Neuroprotection strategies for term encephalopathy
  7578. Molecular chaperones in the brain endothelial barrier: neurotoxicity or Neuroprotection ?
  7579. Neural stem cells of the subventricular zone contribute to Neuroprotection of the corpus callosum after cuprizone-induced demyelination
  7580. Nicotine-induced Neuroprotection in rotenone in vivo and in vitro models of Parkinson’s disease: Evidences for the involvement of the labile iron pool level as the …
  7581. Potentiation of spinal cord conduction and Neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord …
  7582. Investigations into bioenergetic Neuroprotection of cone photoreceptors: relevance to retinitis pigmentosa
  7583. Neuroprotection of cordycepin in NMDA-induced excitotoxicity by modulating adenosine A1 receptors
  7584. Autophagy activation is associated with Neuroprotection in diabetes-associated cognitive decline
  7585. Conditioned medium from Endothelial Progenitor Cells promotes number of dopaminergic neurons and exerts Neuroprotection in cultured ventral mesencephalic …
  7586. Optogenetic stimulation of the superior colliculus confers retinal Neuroprotection in a mouse glaucoma model
  7587. Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing Neuroprotection
  7588. Unique properties of PTEN-L contribute to Neuroprotection in response to ischemic-like stress
  7589. The ‘Yin’and the ‘Yang’of the kynurenine pathway: excitotoxicity and Neuroprotection imbalance in stress-induced disorders
  7590. Role of reactive oxygen species at reperfusion stage in isoflurane preconditioning-induced Neuroprotection
  7591. … blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal Neuroprotection in early-onset …
  7592. The Neuroprotection of KIBRA in promoting neuron survival and against amyloid β-induced apoptosis
  7593. Nrf2 plays an essential role in long-term brain damage and Neuroprotection of Korean red ginseng in a permanent cerebral ischemia model
  7594. Isolation of microglia-derived extracellular vesicles: towards miRNA signatures and Neuroprotection
  7595. Cannulation strategies, circulation management and Neuroprotection for type A intramural hematoma: tips and tricks
  7596. Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts Neuroprotection in spinocerebellar ataxia type 17 …
  7597. Comparing the effects of progressive and mild intensity treadmill running protocols on Neuroprotection of parkinsonian rats
  7598. Therapeutic approaches to Alzheimer’s type of dementia: A focus on FGF21 mediated Neuroprotection
  7599. Intra-arterial stem cell therapy modulates neuronal calcineurin and confers Neuroprotection after ischemic stroke
  7600. Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) derivatives: from neurotoxicity to Neuroprotection
  7601. Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt …
  7602. The 5α-reductase inhibitor finasteride exerts Neuroprotection against ischemic brain injury in aged male rats
  7603. BET protein inhibition regulates cytokine production and promotes Neuroprotection after spinal cord injury
  7604. Activated protein C in Neuroprotection and malaria
  7605. Endothelial progenitor cells conditioned medium supports number of GABAergic neurons and exerts Neuroprotection in cultured striatal neuronal progenitor cells
  7606. Neuroprotection for ischemic stroke in the endovascular era: A brief report on the future of intra-arterial therapy
  7607. The flavonoid, 2′-methoxy-6-methylflavone, affords Neuroprotection following focal cerebral ischaemia
  7608. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and Neuroprotection
  7609. A novel, highly-water-soluble apigenin derivative provides Neuroprotection following ischemia in male rats by regulating the ERK/Nrf2/HO-1 pathway
  7610. Long-term depression induced by endogenous cannabinoids produces Neuroprotection via astroglial CB1R after stroke in rodents
  7611. Systemic taurine treatment provides Neuroprotection against retinal photoreceptor degeneration and visual function impairments
  7612. Circulating messenger for Neuroprotection induced by molecular hydrogen
  7613. Retinoid X receptor-mediated Neuroprotection via CYP19 upregulation and subsequent increases in estradiol synthesis
  7614. Realgar and cinnabar are essential components contributing to Neuroprotection of Angong Niuhuang Wan with no hepatorenal toxicity in transient ischemic brain …
  7615. The Nrf2/HO-1 axis as targets for flavanones: Neuroprotection by pinocembrin, naringenin, and eriodictyol
  7616. Neuroprotection in autism, schizophrenia and Alzheimer’s disease
  7617. 2-BFI provides Neuroprotection against inflammation and necroptosis in a rat model of traumatic brain injury
  7618. Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer Neuroprotection to astrocytes following …
  7619. Peripheral administration of IL-13 induces anti-inflammatory microglial/macrophage responses and provides Neuroprotection in ischemic stroke
  7620. Dual-acting cholinesterase–human cannabinoid receptor 2 ligands show pronounced Neuroprotection in vitro and overadditive and disease-modifying …
  7621. δ-Opioid receptor activation attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel mechanism of Neuroprotection against Parkinsonian injury
  7622. Neuroprotection mediated by the Wnt/Frizzled signaling pathway in early brain injury induced by subarachnoid hemorrhage
  7623. PINK1/parkin-mediated mitophagy pathway is related to Neuroprotection by carnosic acid in SH-SY5Y cells
  7624. CPCGI confers Neuroprotection by enhancing blood circulation and neurological function in cerebral ischemia/reperfusion rats
  7625. Icariin attenuates neuroinflammation and exerts dopamine Neuroprotection via an Nrf2-dependent manner
  7626. Neuroprotection mediated by cystatin C-loaded extracellular vesicles
  7627. Neuroprotection of indole-derivative compound NC001-8 by the regulation of the NRF2 pathway in Parkinson’s disease cell models
  7628. Ethyl acetate fraction from trichilia catigua confers partial Neuroprotection in components of the enteric innervation of the jejunum in diabetic rats
  7629. … , nitric oxide synthase upregulation and brain pathology after heat stroke in diabetic and hypertensive rats. Potential Neuroprotection with cerebrolysin treatment
  7630. Neuroprotection by nicotinamide mononucleotide adenylyltransferase 1 with involvement of autophagy in an aged rat model of transient cerebral ischemia and …
  7631. Piper sarmentosum roxb. Root extracts confer Neuroprotection by attenuating beta amyloid-induced pro-inflammatory cytokines released from microglial cells
  7632. β-carotene provides Neuroprotection after experimental traumatic brain injury via the Nrf2-ARE pathway
  7633. Novel application of amino-acid buffered solution for Neuroprotection against ischemia/reperfusion injury
  7634. Indole compound NC009-1 augments APOE and TRKA in Alzheimer’s disease cell and mouse models for Neuroprotection and cognitive improvement
  7635. Pharmacological evidence for lithium-induced Neuroprotection against methamphetamine-induced neurodegeneration via Akt-1/GSK3 and CREB-BDNF …
  7636. Neuroprotection by exogenous and endogenous neuregulin-1 in mouse models of focal ischemic stroke
  7637. Upregulation of GLT-1 via PI3K/Akt pathway contributes to Neuroprotection induced by dexmedetomidine
  7638. Transplantation of mesenchymal stem cells overexpressing interleukin‐10 induces autophagy response and promotes Neuroprotection in a rat model of TBI
  7639. Induction of Autophagy and Activation of SIRT‐1 Deacetylation Mechanisms Mediate Neuroprotection by the Pomegranate Metabolite Urolithin A in BV2 Microglia and …
  7640. HSF1/HSP pathway in the hippocampus is involved in SIRT1-mediated caloric restriction-induced Neuroprotection after surgery in aged mice
  7641. Morin post-treatment confers Neuroprotection in a novel rat model of mild repetitive traumatic brain injury by targeting dementia markers, APOE, autophagy and Wnt/β …
  7642. The role of long non-coding RNA SNHG12 in Neuroprotection following cerebral ischemic injury
  7643. Neuroprotection induced by Navβ2‑knockdown in APP/PS1 transgenic neurons is associated with NEP regulation
  7644. Exosomes from miR-21-5p-increased neurons play a role in Neuroprotection by suppressing Rab11a-mediated neuronal autophagy in vitro after traumatic …
  7645. Neuroprotection of miR-214 against isoflurane-induced neurotoxicity involves the PTEN/PI3K/Akt pathway in human neuroblastoma cell line SH-SY5Y
  7646. Growth hormone Neuroprotection against kainate excitotoxicity in the retina is mediated by Notch/PTEN/Akt signaling
  7647. No. 376-magnesium sulphate for fetal Neuroprotection
  7648. Caffeine Neuroprotection decreases A2A adenosine receptor content in aged mice
  7649. Neuroprotection and improvement of the histopathological and behavioral impairments in a murine Alzheimer’s model treated with Zephyranthes carinata …
  7650. Docosahexaenoic acid reduces microglia phagocytic activity via miR-124 and induces Neuroprotection in rodent models of spinal cord contusion injury
  7651. SCING—Spinal Cord Injury Neuroprotection with Glyburide: a pilot, open-label, multicentre, prospective evaluation of oral glyburide in patients with acute …
  7652. Effect of DJ-1 on the Neuroprotection of astrocytes subjected to cerebral ischemia/reperfusion injury
  7653. 4-Imidazo [2, 1-b] thiazole-1, 4-DHPs and Neuroprotection : preliminary study in hits searching
  7654. Age-Dependent Levels of Protein Kinase Cs in brain : Reduction of Endogenous Mechanisms of Neuroprotection
  7655. Caspase-1 inhibition mediates Neuroprotection in experimental stroke by polarizing M2 microglia/macrophage and suppressing NF-κB activation
  7656. Dl-3-n-butylphthalide exerts dopaminergic Neuroprotection through inhibition of neuroinflammation
  7657. The Neuroprotection of hypoxic adipose tissue-derived mesenchymal stem cells in experimental traumatic brain injury
  7658. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert Neuroprotection through inhibiting oxidative stress and cell death after traumatic brain …
  7659. Effects of fentanyl for pain control and Neuroprotection in very preterm newborns on mechanical ventilation
  7660. Critical Role of Trophic Factors in Protecting Müller Glia: Implications to Neuroprotection in Age-Related Macular Degeneration, Diabetic Retinopathy, and Anti-VEGF …
  7661. A novel mechanism of sigma 1 receptor Neuroprotection : modulation of miR-214-3p
  7662. … endothelial progenitor cells: Endothelial progenitor cell-derived conditioned medium promotes proliferation and exerts Neuroprotection in cultured neuronal …
  7663. Nanowired delivery of DL-3-n-butylphthalide induces superior Neuroprotection in concussive head injury
  7664. Why do we say ‘Neuroprotection ‘in stroke when we mean ‘brain protection or cerebroprotection’?
  7665. Plasma brain -derived neurotrophic factor (BDNF) and sphingosine-1-phosphat (S1P) are NOT the main mediators of Neuroprotection induced by resistance training in …
  7666. Non‐canonical activation of CREB mediates Neuroprotection in a Caenorhabditis elegans model of excitotoxic necrosis
  7667. Prolonged peripheral hypoperfusion promotes Neuroprotection in ischemic stroke
  7668. MicroRNA-26b/PTEN signaling pathway mediates glycine-induced Neuroprotection in SAH injury
  7669. N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced Neuroprotection against kainic acid toxicity
  7670. Evaluation of taurine Neuroprotection in aged rats with traumatic brain injury
  7671. HucMSCs-derived miR-206-knockdown exosomes contribute to Neuroprotection in subarachnoid hemorrhage induced early brain injury by targeting BDNF
  7672. Zhile Capsule Exerts Antidepressant-Like Effects through Upregulation of the BDNF Signaling Pathway and Neuroprotection
  7673. Preconditioning in the Rhesus Macaque Induces a Proteomic Signature Following Cerebral Ischemia that Is Associated with Neuroprotection
  7674. Design, synthesis and biological evaluation of diosgenin-amino acid derivatives with dual functions of Neuroprotection and angiogenesis
  7675. miR-499-5p suppresses C-reactive protein and provides Neuroprotection in hypoxic-ischemic encephalopathy in neonatal rat
  7676. Neuroprotection of two C21 steroidal glycosides from Cynanchum auriculatum against H2O2-induced damage on PC12 cells
  7677. Introductory Chapter: Concept of Neuroprotection -A New Perspective
  7678. Early post-stroke activation of vascular endothelial growth factor receptor 2 hinders the receptor 1-dependent Neuroprotection afforded by the endogenous …
  7679. VB1 promoted green synthesis of chalcones and its Neuroprotection potency evaluation
  7680. Mitochondria-targeted antioxidant peptide SS-31 mediates Neuroprotection in a rat experimental glaucoma model
  7681. Recent advances in perinatal Neuroprotection
  7682. Autophagy inhibition exerts Neuroprotection on white matter ischemic damage after chronic cerebral hypoperfusion in mice
  7683. AKT3 gene transfer promotes anabolic reprogramming and photoreceptor Neuroprotection in a pre-clinical model of retinitis pigmentosa
  7684. Neuroprotection against stroke and encephalopathy after cardiac surgery
  7685. Successful Management of Massive Air Embolism During Cardiopulmonary Bypass Using Multimodal Neuroprotection Strategies
  7686. Glaucoma Neuroprotection trials are practical using visual field outcomes
  7687. Catalytic-independent Neuroprotection by SIRT1 is mediated through interaction with HDAC1
  7688. Neuroprotection and vasculoprotection using genetically targeted protease-ligands
  7689. Electro-acupuncture-induced Neuroprotection is associated with activation of the IGF-1/PI3K/Akt pathway following adjacent dorsal root ganglionectomies in …
  7690. Oxidative Stress-Induced brain Damage Triggered by Voluntary Ethanol Consumption during Adolescence: A Potential Target for Neuroprotection ?
  7691. Study on the material basis of Neuroprotection of Myrica rubra bark
  7692. Neuroprotection of Glibenclamide against brain Injury after Cardiac Arrest via Modulation of NLRP3 Inflammasome
  7693. Neuroprotection of reduced thyroid hormone with increased estrogen and progestogen in postpartum depression
  7694. The post-cardiac arrest syndrome: A case for lung–brain coupling and opportunities for Neuroprotection
  7695. Postnatal N‑acetylcysteine does not provide Neuroprotection in extremely low birth weight infants: A follow-up of a randomized controlled trial
  7696. Immune cell derived BDNF does not mediate Neuroprotection of the murine anti-CD52 antibody in a chronic autoimmune mouse model
  7697. Pharmaceutical biotechnology in herbal Neuroprotection
  7698. Multitarget-directed cotreatment with cilostazol and aripiprazole for augmented Neuroprotection against oxidative stress-induced toxicity in HT22 mouse hippocampal …
  7699. Repurposing azithromycin for Neuroprotection in neonates
  7700. Omics and Epigenetics of Polyphenol-Mediated Neuroprotection : The Curcumin Perspective
  7701. Inhibition of MicroRNA-204 conducts Neuroprotection against spinal cord ischemia
  7702. Tetramethylpyrazine‑2′ O‑sodium ferulate provides Neuroprotection against neuroinflammation and brain injury in MCAO/R rats by suppressing TLR-4/NF-κB …
  7703. Ubiquitin and endogenous antioxidant enzymes participate in Neuroprotection of the rabbit spinal cord after ischemia and bradykinin postconditioning
  7704. Neuroprotection by 2, 3, 5, 4ʹ-tetrahydroxystilbene-2-O-β-D-glucoside extracts from Polygonum multiflorum against cerebral ischemia/reperfusion injury …
  7705. Risperidone treatment after transient ischemia induces hypothermia and provides Neuroprotection in the gerbil hippocampus by decreasing oxidative stress
  7706. Hypothermic properties of dexmedetomidine provide Neuroprotection in rats following cerebral ischemia‑reperfusion injury
  7707. Hinokitiol offers Neuroprotection against 6-OHDA-induced toxicity in SH-SY5Y neuroblastoma cells by downregulating mRNA expression of MAO/α-Synuclein/LRRK2 …
  7708. Aqueous Coriandrum sativum L. extract promotes Neuroprotection against motor changes and oxidative damage in rat progeny after maternal exposure to …
  7709. Argon inhalation for 24 hours after onset of permanent focal cerebral ischemia in rats provides Neuroprotection and improves neurologic outcome
  7710. Neuroprotection , Photoperiod, and Sleep
  7711. Neuroprotection During Neospora caninum Infection Is Related To the Release of Neurotrophic Factors BDNF and NGF
  7712. Caveolin-1 in stroke neuropathology and Neuroprotection : a novel molecular therapeutic target for ischemic-related injury
  7713. Does estrogen provide “Neuroprotection ” for postmenopausal women?
  7714. 17 β-Estradiol oxidative stress attenuation and autophagy-induced dopaminergic Neuroprotection
  7715. Update on erythropoiesis-stimulating agents administered to neonates for Neuroprotection
  7716. … of Autophagy by Ubisol-Q10 in Presenilin-1 Mutated Fibroblasts and Transgenic AD Mice: Implications for Inhibition of Senescence and Neuroprotection
  7717. Therapeutic hypothermia after cardiac arrest: Involvement of the risk pathway in mitochondrial PTP-mediated Neuroprotection
  7718. Neuroprotection in spinal cord injury
  7719. Advances in dammarane-type triterpenoid saponins from Bacopa monnieri: Structure, bioactivity, biotechnology and Neuroprotection
  7720. Efficacy and safety of Neuroprotection in patients with primary open-angle glaucoma
  7721. Single dose of 17β-estradiol provides transient Neuroprotection in female juvenile mice after cardiac-arrest and cardiopulmonary resuscitation
  7722. Axonal and myelin Neuroprotection by the peptoid bn201 in brain inflammation
  7723. … aurones with monoamine oxidase and amyloid-beta inhibitory activities: Structure-activity relationship and translating multi-potency to Neuroprotection
  7724. 19. Modern retinal laser for Neuroprotection in open-angle glaucoma
  7725. Hypothermic Neuroprotection during reperfusion following exposure to aglycemia in central white matter is mediated by acidification
  7726. Recent advances in perinatal Neuroprotection
  7727. Principles of Neuroprotection
  7728. Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for Neuroprotection in glaucoma
  7729. The differential Neuroprotection of HSP70-hom gene single nucleotide polymorphisms: In vitro (neuronal hypoxic injury model) and in vivo (rat MCAO model) studies
  7730. Intracarotid cold saline infusion contributes to Neuroprotection in MCAO‑induced ischemic stroke in rats via serum and glucocorticoid‑regulated kinase 1
  7731. Combined Neuroprotection in the treatment of post-stroke aphasia
  7732. Understanding Neurodegeneration and Neuroprotection Through Genetic Screens in Drosophila
  7733. Nanomedicine for Neuroprotection
  7734. Alterations of Calcium Channels in a Mouse Model of Huntington’s Disease and Neuroprotection by Blockage of CaV1 Channels
  7735. Recent advances in perinatal Neuroprotection [version 1; peer
  7736. Polyphenols and Neuroprotection : The Role of Adenosine Receptors
  7737. Encapsulated Neuroprotection to the Rescue—or How to Safely Protect a brain From Seizing
  7738. Role of Heat Shock Proteins (HSP) in Neuroprotection for Ischemic Stroke
  7739. Investigation on seco-prezizaane sesquiterpenes from fruits of Illicium lanceolatum and their Neuroprotection activity
  7740. Time-Dependent Bidirectional Neuroprotection by Adenosine 2A Receptor in Experimental Traumatic brain Injury
  7741. Novel Therapeutic Targets for Glaucoma: Disease Modification Treatment, Neuroprotection , and Neuroregeneration
  7742. A11, a novel diaryl acylhydrazone derivative, exerts Neuroprotection against ischemic injury in vitro and in vivo
  7743. Homeoprotein Neuroprotection of embryonic neuronal cells
  7744. The efficacy of combined Neuroprotection in motor and cognitive recovery following the acute phase of ischemic stroke
  7745. Neuroprotection in neurodegenerative disorders
  7746. Palmitic acid methyl ester directly induces hippocampal Neuroprotection against oxygen and glucose deprivation
  7747. Redispersible Spray-Dried Powder Containing Nanoencapsulated Curcumin: the Drying Process Does Not Affect Neuroprotection In vitro
  7748. Ginger provides Neuroprotection in experimental model of traumatic brain injury
  7749. Estrogen Neuroprotection and Anti-Inflammation
  7750. Hemofiltration for Neuroprotection in acute ischemic stroke: A prospective, pilot study
  7751. Lifestyle Factors, Mitochondrial Dynamics, and Neuroprotection
  7752. Neuroprotection : yes, ear CAN!
  7753. 17 Oxo Sparteine and Lupanine, Obtained from Cytisus scoparius, Exert a Neuroprotection against Soluble Oligomers of Amyloid-β Toxicity by Nicotinic Acetylcholine …
  7754. Endogenous Neuroprotection after perinatal hypoxia-ischaemia: the resilient developing brain
  7755. Current Therapeutic Approaches from Imidazoline and Opioid Receptors Modulators in Neuroprotection
  7756. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection
  7757. Neuroprotection Effect of Quercetin on TNF-α Levels and Gene Expression of Caspase 3 in MPTP-Induced Male NMRI Mice
  7758. Neuroprotection in Parkinson Disease
  7759. Neuroprotection in Cerebrovascular Disease
  7760. Neuroprotection in Amyotrophic Lateral Sclerosis
  7761. Neuroprotection in multiple system atrophy: unresolved issues
  7762. Methods for Promoting Retinal Ganglion Cell Neuroprotection and Axon Regeneration
  7763. Neuroprotection of the preterm infant
  7764. Neural stem cells Neuroprotection by simvastatin via autophagy induction and apoptosis inhibition.
  7765. Estrogenic Regulation of Neuroprotection and Inflammation in Ischemic Stroke and Aging
  7766. G193 Implementation of a national Neuroprotection care pathway: a national audit of practice
  7767. Dopaminergic Neuroprotection with ginkgolide in 6-hydroxydopamine rat parkinson’s disease model
  7768. Intra-arterial mesenchymal stem cell therapy modulates inflammasome to confer Neuroprotection in animal model of ischemic stroke (P2. 3-026)
  7769. Curcumin Plays Neuroprotection Activity by Modulation of Neurotrophic Factor BDNF, GAP-43 and GFAP in Mice with Traumatic brain Injury (P06-043-19)
  7770. Investigation of the role and modulation of autophagy for Neuroprotection and nerve regeneration using models of peripheral nerve injury
  7771. Delayed Rewarming for Neuroprotection in Infants Following Cardiopulmonary Bypass Surgery: A Pilot Study
  7772. Ndrg2: a novel target for estrogen Neuroprotection against cerebral ischaemia
  7773. Neuroprotection in neurocritical care
  7774. Transnasal Induction of Therapeutic Hypothermia for Neuroprotection
  7775. Neuroprotection by Non Steroidal Anti-Inflammatory Drugs Against an In Vivo & In Vitro Ischemic Stroke via Downregulating Intrinsic Apoptosis Pathways.(P2. 3-028)
  7776. Non-pharmacological methods of Neuroprotection and neurorehabilitation
  7777. Neuroprotection by γ-Tocopherol in Lean and Obese Murine Models of Ischemic Stroke
  7778. Response to letter ‘Why do we say “Neuroprotection ” in stroke when we mean “brain Protection or Cerebroprotection”?’
  7779. Neuroprotection under Anesthesia
  7780. Abstract TMP8: High flow normobaric oxygen (NBO) therapy provides effective Neuroprotection after endovascular recanalization in acute ischemic stroke
  7781. MATERNAL AND NEONATAL MAGNESEMIA AFTER Neuroprotection
  7782. Multifactorial Neuroprotection : Does the brain have an answer
  7783. Hydrogen Sulfide as a Factor of Neuroprotection during the Constitutive and Reparative Neurogenesis in Fish brain
  7784. Neuroprotection of progesterone on neonatal rats after sevoflurane inhalation anesthesia
  7785. Novel computational deep learning strategy for Neuroprotection identification reveals unique set of nicotine analogs as potential therapeutic compounds against …
  7786. Molecular basis for amyloid precursor protein mediated Neuroprotection in traumatic brain injury
  7787. Neuroprotection TO COUNTERACT GLAUCOMATOUS DEGENERATION OF RETINA; THE USE OF CITICOLINE
  7788. Neuroprotection by Regulating the mBDNF/proBDNF Ratio after Cerebral Intracerebral Hemorrhage Is Affected by ATP Administration Through P2X4 r/P38-MAPK/Ca …
  7789. Silicone Oil-Induced Ocular Hypertension in Mouse Models Glaucomatous Neurodegeneration and Neuroprotection
  7790. Ellagic acid produces Neuroprotection against LPS-induced dopamine neurotoxicity via the inhibition of microglial NLRP3 inflammasome activation
  7791. Neuroprotection of retinal ganglion cells by Müller Glia in vitro in health and disease
  7792. Regulation of Antioxidant Defenses, DNA Damage Repair, the Immune Response, and Neuroprotection During Hibernation in the Thirteen-Lined Ground Squirrel
  7793. Secondary Neuroprotection in Glaucoma by Reduction of Intraocular Pressure
  7794. Neuroprotection in Miscellaneous Neurological Disorders
  7795. Neuroprotection by 2,3,5,4ʹ-tetrahydroxystilbene-2-O-β-D-glucoside extracts from Polygonum multiflorum against cerebral ischemia/reperfusion injury through the 5 …
  7796. Remote ischemic preconditioning induces Neuroprotection assessed by cerebral magnetic resonance imaging: Essential role of blood pressure and hemoglobin …
  7797. Coupling Deoxy Sugars to Polyphenols: Neuroprotection and Bioavailability
  7798. MECHANISMS OF Neuroprotection BY MTOR INHIBITORS
  7799. Neuroprotection During Anesthesia and Surgery
  7800. OPTIC NERVE SESSION III: Neuroprotection AND NEURODEGENERATION
  7801. Neuroprotection in glaucoma
  7802. Cell Autonomous Neuroprotection by the Mitochondrial Uncoupling Protein 2 in a Mouse Model of Glaucoma
  7803. Molecular and cellular mechanisms of microglia-mediated Neuroprotection
  7804. Light and Shadow of Hyperuricemia-Neuroprotection , Comorbidities and Therapeutic Strategies
  7805. Mechanisms of Neurodegeneration and Neuroprotection in Parkinson’s and Alzheimer’s Disease
  7806. Neuroprotection in brain Hypoxia
  7807. Neuroprotection of HP-beta-CD in the adult transgenic mice of Alzheimer disease (P1. 1-003)
  7808. Neuroprotection from acute brain injury in preterm infants-CPS podcast
  7809. Peptide Conjugates For Neuroprotection And Amyloid Detection
  7810. Synthesis and investigation of radical scavenging activity, neurotoxicity and Neuroprotection of new theophilline hydrazones
  7811. Neuroprotection in Alzheimer Disease
  7812. Corrigendum to” Postnatal N-acetylcysteine Does Not Provide Neuroprotection in Extremely Low Birth Weight Infants: A Follow-Up of a Randomized Controlled Trial” …
  7813. Neuroprotection with Novel Anti-Oxidant and Cannabinoid-Based Small Molecules
  7814. Synthesis and biological evaluation of 2, 2-dimethylbenzopyran derivatives as potent Neuroprotection agents
  7815. The Neuroprotection project: a community-based initiative towards fostering safer playing fields, and reducing sport-related concussions
  7816. Nicotine Neuroprotection of brain Neurons: The Other Side of Nicotine Addiction
  7817. ATP-dependent Neuroprotection in NMDA-treated OHSCs depends on functional P2X7 expression in microglia
  7818. Targeting glial β2-adrenoceptors for immunomodulation & Neuroprotection in a rat model of Parkinson’s disease
  7819. The role of the cold shock protein, RBM3, in cooling, synaptic structural plasticity and Neuroprotection
  7820. Neuroprotection in Huntington Disease
  7821. Characterization and evaluation of hemp protein hydrolysates on Neuroprotection
  7822. Macrophage Migration Inhibitor (MIF) Therapeutics for Neuroprotection and Prevention of Scar in Traumatic Retinal Detachment
  7823. Investigating sex specific mechanisms of Neuroprotection using mouse organotypic hippocampal slice cultures
  7824. Application of a nonhuman primate model of retinal detachment to evaluate Neuroprotection efficacy
  7825. Correction: Neuroenhancement and Neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A …
  7826. Human placenta-derived mesenchymal stromal cell exosome-mimicking nanovesicles for Neuroprotection
  7827. THE AMPK-PGC-1a AXIS IN Neuroprotection : IMPLICATIONS FOR ENERGY DEFICITS IN PARKINSON’S DISEASE
  7828. What’s the Future of Glaucoma Diagnosis and Neuroprotection
  7829. FCPR16 induces AMPK-dependent autophagy and provides Neuroprotection in SH-SY5Y cells and neurons exposed to MPP~+-induced oxidative damage
  7830. Inhibition of matirx‐metalloproteinases mediates carnosine‐Neuroprotection during ischemia
  7831. Minor compounds from virgin olive oil promote M2 microglia polarization and Neuroprotection
  7832. Role of the cholesterol hydroxylase enzyme CYP46A1 in cholesterol metabolism and Neuroprotection in Huntington’s disease
  7833. Implication of vitamin A in Neuroprotection of dopaminergic neurons in a rat model of Parkinson’s disease
  7834. Preclinical Neonatal Neuroprotection : Neuroprotective Effect of Remote Ischemic Postconditioning and Dexmedetomidine in a Piglet Model of Perinatal Asphyxia
  7835. Abstract WP111: Who Needs Neuroprotection With Endovascular Stroke Therapy? Findings From the Trevo Retriever Registry
  7836. Role of cannabinoid receptor (CB2 receptor) agonist in Neuroprotection after hypoxic ischemic injury in rat pups
  7837. Neuroprotection from optic nerve trauma by deletion of arginase 2
  7838. Balancing Neuroprotection with Functional Recovery: The Potential Role of the PNN in Preventing Excitotoxicity after SCI
  7839. Brorin, a Chordin-related protein, facilitates Neuroprotection of injured retinal ganglion cells
  7840. Risperidone treatment after transient ischemia induces hypothermia via 5-HT2aAntagonism and provides Neuroprotection in the gerbil hippocampus by decreasing …
  7841. Progesterone Induces Neuroprotection in a Model of Neonatal Hypoxic‐Ischemic brain Injury
  7842. Role of Nicotine Mediated Neuroprotection in MPTP‐induced Parkinson’s disease
  7843. Abstract TP129: The Combination of Tissue Plasminogen Activatorand Vepoloxamer Results in Sustained Neuroprotection in Aged Rats After Embolic Stroke
  7844. Vagus Nerve Stimulation Activates the Critical brain Nuclei Involved in Ischemic Neuroprotection
  7845. Promising New Gene Therapy for Optic Nerve Regeneration and Neuroprotection
  7846. Abstract WP146: DHC Enhances the Hypothermia-induced Neuroprotection Following Ischemic Stroke in Rat Over a Long-term Period
  7847. Interactome Analysis Identifies Novel Targets of Phosphoinositide 3-kinase (PI3K) that Mediate Astrocyte Neuroprotection
  7848. A novel PI3k interaction with RNA binding protein ZC3H14 coordinates astrocyte-mediated Neuroprotection
  7849. Targeting Kv2. 1/Syntaxin Interaction for Neuroprotection
  7850. The Endothelin Receptor Antagonist Macitentan Ameliorates Endothelin-Mediated Vasoconstriction and Promotes Neuroprotection of Retinal Ganglion Cells in Rats.
  7851. Galantamine confers Neuroprotection in a model of indirect traumatic optic neuropathy
  7852. Abstract TP559: Sulforaphane Confers Neuroprotection Against Neuronal Loss, White Matter Injury and BBB Damage Following Experimental Vascular cognitive …
  7853. Adenosine 2A Receptor Inhibition Promotes Neuroprotection Following Toxic Insult to Phrenic Motor Neurons
  7854. IL-1β conveys Neuroprotection via astrocytic IL1R1 signaling following excitotoxic retinal injury
  7855. Noninvasive Mitochondrial Modulation: Neuroprotection in a Translational Model of Cardiac Arrest and Resuscitation
  7856. Dose Optimization of Early High-Dose Valproic Acid for Neuroprotection After Cardiac Arrest
  7857. Save the brain !; studies on GLP-1-mediated Neuroprotection
  7858. Acyl‐CoA Synthetase 6 Mediates brain Docosahexaenoic Acid (DHA) Enrichment and Neuroprotection
  7859. Neuroprotection of Retinal Ganglion Cells by AAV2-gamma-Synuclein Promoter-Mediated CRISPR/Cas9 Gene Editing
  7860. Abstract WP141: Neuroprotection by Mesenchymal Stem Cells (MSC) Administration Was Enhanced by Local Cooling Infusion (LCI) in Ischemic Rats
  7861. FK506 treatment promotes Neuroprotection in organ transplanted glaucoma patients: a retrospective chart review.
  7862. Neuroprotection Provided by Transnasal Airflow-Induced brain Cooling in a Model of Pediatric Cardiac Arrest
  7863. Mechanism of BDNF-mediated Neuroprotection : critical role of Müller glia in diabetic retinopathy and age-related macular degeneration
  7864. (−)‐α‐Bisabolol Promotes Neuroprotection on Neuronal Damage, Motor and memory Deficits Induced by Focal Cerebral Ischemia in Mice
  7865. The Effect of BDNF on the Neuroprotection of Win55, 212-2 Pharmacological Hypothermia After CPR in a Rat Cardiac Arrest Model
  7866. brain Selective Hypothermia With Intra-arterial Cold Infusions Plus Early Normobaric Hyperoxygenation for Neuroprotection in Experimental Acute Ischemic Stroke
  7867. Ischemic preconditioning does not display Neuroprotection in high-fat diet-induced obese gerbils but rather elicits neuronal death through increase of abnormal mTOR …
  7868. Polyamine mediated Neuroprotection in a-synuclein expressing cell and animal models.
  7869. Abstract WP132: Korean Red Ginseng Attenuates Reactive Gliosis and Confers Sustained Neuroprotection against Cerebral Hypoxic-Ischemic Damage in an Nrf2 …
  7870. Ocular Hypertension Model Induced by Episcleral Vein Cauterization for Screening Retinal Ganglion Cells Neuroprotection Therapies in Brown Norway Rats
  7871. Neuroprotection with Polynitroxylated PEGylated Hemoglobin as a Macromolecular Superoxide Dismutase/Catalase Mimetic Drug for Resuscitation after Traumatic …
  7872. Ultra-Fast Cooling Induced by Total Liquid Ventilation Provides Neuroprotection Through a Delay in the Acute Systemic Inflammatory Response After Cardiac Arrest in …
  7873. The Role of Interleukin-10 in CD4+ T Cell-Mediated Neuroprotection after Facial Nerve Injury
  7874. Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, provides photoreceptor Neuroprotection
  7875. A Multimodal Neuroprotection Strategy Using Ketamine, Melatonin, and Limited Initial Reoxygenation Following Cardiac Arrest Does Not Improve MRI Cytotoxic Injury …
  7876. 36-LB: Mechanism of Neurotrophin-Mediated Neuroprotection in Diabetic and Hypoxic Conditions
  7877. 468: Magnesium Neuroprotection may be mediated by modulation of NMDA-R subtypes
  7878. Alzheimer’s disease and the genetics of Neuroprotection
  7879. The Phosphodiesterase-4 Inhibitor Roflumilast Reverses cognition Deficits and Depression-Like Effects via cAMP Signaling-Mediated Neuroprotection in APP/PS1 …
  7880. n-3 Long-Chain PUFA-Containing Phospholipids and Neuroprotection
  7881. Potential cancer therapy for activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, provides photoreceptor Neuroprotection
  7882. Gene regulation dynamics induced by the protein kinase inhibitor, SBJ-051 associated with Neuroprotection in light-induced photoreceptor cell death
  7883. Peptain-1 for Neuroprotection in Glaucoma
  7884. Marine biocompounds for Neuroprotection —A review
  7885. Mitophagy and Neuroprotection
  7886. Polyphenols from food and natural products: Neuroprotection and safety
  7887. A randomized trial of erythropoietin for Neuroprotection in preterm infants
  7888. Potential circadian effects on translational failure for Neuroprotection
  7889. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation
  7890. The future of Neuroprotection in stroke
  7891. Seven Solutions for Neuroprotection in Parkinson’s Disease
  7892. Neurodegeneration by oxidative stress: A review on prospective use of small molecules for Neuroprotection
  7893. Neuroprotection : A versatile approach to combat glaucoma
  7894. A critical review on grape polyphenols for Neuroprotection : Strategies to enhance bioefficacy
  7895. CAPE and Neuroprotection : A Review
  7896. Hypothermic Neuroprotection against acute ischemic stroke: The 2019 update
  7897. Histone deacetylases inhibitors in neurodegenerative diseases, Neuroprotection and neuronal differentiation
  7898. VIPergic Neuroprotection in epileptogenesis: challenges and opportunities
  7899. Characterization and Neuroprotection Potential of Seleno-Polymannuronate
  7900. Neuroprotection by curcumin: A review on brain delivery strategies
  7901. Presynaptic homeostasis opposes disease progression in mouse models of ALS-like degeneration: evidence for homeostatic Neuroprotection
  7902. Strategies for Neuroprotection in multiple sclerosis and the role of calcium
  7903. Retromer stabilization results in Neuroprotection in a model of Amyotrophic Lateral Sclerosis
  7904. Resilience to Injury: A New Approach to Neuroprotection ?
  7905. Mitochondria as a target for Neuroprotection : role of methylene blue and photobiomodulation
  7906. Intrastriatal administration of coenzyme Q10 enhances Neuroprotection in a Parkinson’s disease rat model
  7907. A Systematic Review of Magnesium Sulfate for Perinatal Neuroprotection : What Have We Learnt From the Past Decade?
  7908. The role of non-coding RNAs in Neuroprotection and angiogenesis following ischemic stroke
  7909. The main targets involved in Neuroprotection for the treatment of Alzheimer’s disease and Parkinson disease
  7910. Ketogenic diet, Neuroprotection , and antiepileptogenesis
  7911. RIPC provides Neuroprotection against ischemic stroke by suppressing apoptosis via the mitochondrial pathway
  7912. Novel Neuroprotection using antioxidant nanoparticles in a mouse model of head trauma
  7913. Potential of Müller glia for retina Neuroprotection
  7914. Bio-tactics for Neuroprotection of retinal ganglion cells in the treatment of glaucoma
  7915. Inhaled gases for Neuroprotection of neonates: a review
  7916. Neuroprotection care bundle implementation to decrease acute brain injury in preterm infants
  7917. Translational intracerebral hemorrhage research: has current Neuroprotection research ARRIVEd at a standard for experimental design and reporting?
  7918. Mesenchymal Stromal Cell–Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils
  7919. Perspective: the potential role of circulating lysophosphatidylcholine in Neuroprotection against Alzheimer Disease
  7920. Minutes of PPAR-γ Agonism and Neuroprotection
  7921. Synaptic restoration by cAMP/PKA drives activity-dependent Neuroprotection to motoneurons in ALS
  7922. Neuropharmacology in traumatic brain injury: from preclinical to clinical Neuroprotection ?
  7923. Extracellular vesicles mediate Neuroprotection and functional recovery after traumatic brain injury
  7924. Nicotinamide pathway-dependent Sirt1 activation restores calcium homeostasis to achieve Neuroprotection in spinocerebellar ataxia type 7
  7925. The critical period for Neuroprotection by estrogen replacement therapy and the potential underlying mechanisms
  7926. Natural products: evidence for Neuroprotection to be exploited in glaucoma
  7927. Natural medicine in Neuroprotection for ischemic stroke: Challenges and prospective
  7928. New targets and therapeutics for Neuroprotection , remyelination and repair in multiple sclerosis
  7929. Neuroprotection against oxidative stress: Phytochemicals targeting TrkB signaling and the Nrf2-ARE antioxidant system
  7930. Magnesium sulphate for fetal Neuroprotection at imminent risk for preterm delivery: a systematic review with meta‐analysis and trial sequential analysis
  7931. Molecular mechanism of olesoxime-mediated Neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC
  7932. Simultaneous targeting of mitochondria and monocytes enhances Neuroprotection against ischemia–reperfusion injury
  7933. Synthesis, antioxidant properties and Neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models
  7934. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers Neuroprotection
  7935. Galectins in the brain : advances in neuroinflammation, Neuroprotection and therapeutic opportunities
  7936. Erinacine A and related cyathane diterpenoids: Molecular diversity and mechanisms underlying their Neuroprotection and anticancer activities
  7937. Neuron-derived estrogen is critical for astrocyte activation and Neuroprotection of the ischemic brain
  7938. Melatonin/polydopamine nanostructures for collective Neuroprotection -based Parkinson’s disease therapy
  7939. Substituted α-Phenyl and α-Naphthlyl-N-tert-butyl Nitrones: Synthesis, Spin-Trapping, and Neuroprotection Evaluation
  7940. Endogenous Mechanisms of Neuroprotection : To Boost or Not to Boost
  7941. Hemiterpene compound, 3, 3-dimethylallyl alcohol promotes longevity and Neuroprotection in Caenorhabditis elegans
  7942. Chlorogenic acid confers robust Neuroprotection against arsenite toxicity in mice by reversing oxidative stress, inflammation, and apoptosis
  7943. Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson’s disease using 6-hydroxydopamine …
  7944. Remote ischemic preconditioning-induced Neuroprotection in cerebral ischemia-reperfusion injury: Preclinical evidence and mechanisms
  7945. iNOS‐inhibitor driven Neuroprotection in a porcine retina organ culture model
  7946. Nerve growth factor confers Neuroprotection against colistin-induced peripheral neurotoxicity
  7947. Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer’s Disease
  7948. Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient Neuroprotection through M1/M2 microglial polarization in an Alzheimer’s disease model
  7949. Neuroprotection by insulin-like growth factor-1 in rats with ischemic stroke is associated with microglial changes and a reduction in neuroinflammation
  7950. Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
  7951. Neuroprotection induced by dexpramipexole delays disease progression in a mouse model of progressive multiple sclerosis
  7952. Hydrogels for Neuroprotection and functional rewiring: a new era for brain engineering
  7953. Ischemic preconditioning provides long-lasting Neuroprotection against ischemic stroke: The role of Nrf2
  7954. The new role of F1Fo ATP synthase in mitochondria-mediated neurodegeneration and Neuroprotection
  7955. Inhibition of TLR4 induces M2 Microglial polarization and provides Neuroprotection via the NLRP3 inflammasome in Alzheimer’s disease
  7956. Roflupram exerts Neuroprotection via activation of CREB/PGC‐1α signalling in experimental models of Parkinson’s disease
  7957. Induced Neuroprotection by remote ischemic perconditioning as a new paradigm in ischemic stroke at the acute phase, a systematic review
  7958. … inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting Neuroprotection through multiple mechanisms in ALS …
  7959. Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species
  7960. Focal and dose-dependent Neuroprotection in ALS mice following AAV2-neurturin delivery
  7961. Synucleinphagy: a microglial “community cleanup program” for Neuroprotection
  7962. Small molecule induces mitochondrial fusion for Neuroprotection via targeting CK2 without affecting its conventional kinase activity
  7963. Enhanced axonal response of mitochondria to demyelination offers Neuroprotection : implications for multiple sclerosis
  7964. Defining a time window for Neuroprotection and glia modulation by caffeine after neonatal hypoxia-ischaemia
  7965. A novel partial MHC Class II construct, DRmQ, inhibits central and peripheral inflammatory responses to promote Neuroprotection in experimental stroke
  7966. Neuroprotection of rotenone-induced Parkinsonism by ursolic acid in PD mouse model
  7967. Luteolin exerts Neuroprotection via modulation of the p62/Keap1/Nrf2 pathway in intracerebral hemorrhage
  7968. Early single-dose treatment with exosomes provides Neuroprotection and improves blood-brain barrier integrity in swine model of traumatic brain injury and …
  7969. The effect of exosomes derived from bone marrow stem cells in combination with rosuvastatin on functional recovery and Neuroprotection in rats after ischemic stroke
  7970. Bioenergetic restoration and Neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury
  7971. Resolvin D3 Promotes Inflammatory Resolution, Neuroprotection , and Functional Recovery After Spinal Cord Injury
  7972. Neuroprotection mediated by natural products and their chemical derivatives
  7973. Mitochondrial SIRT3 confers Neuroprotection in Huntington’s disease by regulation of oxidative challenges and mitochondrial dynamics
  7974. Neuroprotection by walnut-derived peptides through autophagy promotion via Akt/mTOR signaling pathway against oxidative stress in PC12 cells
  7975. Differential glucose and beta-hydroxybutyrate metabolism confers an intrinsic Neuroprotection to the immature brain in a rat model of neonatal hypoxia ischemia
  7976. Hydroxysafflor yellow A confers Neuroprotection from focal cerebral ischemia by modulating the crosstalk between JAK2/STAT3 and SOCS3 signaling pathways
  7977. Effect of fluoxetine on HIF-1α-Netrin/VEGF cascade, angiogenesis and Neuroprotection in a rat model of transient middle cerebral artery occlusion
  7978. Neuroprotection in glaucoma: towards clinical trials and precision medicine
  7979. Metformin preferentially provides Neuroprotection following cardiac ischemia/reperfusion in non-diabetic rats
  7980. Uric acid Neuroprotection associated to IL-6/STAT3 signaling pathway activation in rat ischemic stroke
  7981. Laminarin pretreatment provides Neuroprotection against forebrain ischemia/reperfusion injury by reducing oxidative stress and Neuroinflammation in aged gerbils
  7982. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside Neuroprotection against Parkinson’s disease
  7983. Pharmacological Neuroprotection of the Preterm brain : Current Evidence and Perspectives
  7984. Neuroprotection of radiosensitive juvenile mice by ultra-high dose rate flash irradiation
  7985. Naringin exhibits Neuroprotection against rotenone-induced neurotoxicity in experimental rodents
  7986. Single intranasal administration of 17β-estradiol loaded gelatin nanoparticles confers Neuroprotection in the post-ischemic brain
  7987. Trehalose-conjugated, catechin-loaded polylactide nanoparticles for improved Neuroprotection against intracellular polyglutamine aggregates
  7988. Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
  7989. Blood-related toxicity after traumatic brain injury: potential targets for Neuroprotection
  7990. Chlorzoxazone exhibits Neuroprotection against Alzheimer’s disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo
  7991. Mechanisms of l-serine-mediated Neuroprotection include selective activation of lysosomal cathepsins B and L
  7992. Combination treatments with therapeutic hypothermia for hypoxic‐ischemic Neuroprotection
  7993. Prolactin attenuates global cerebral ischemic injury in rat model by conferring Neuroprotection
  7994. Minocycline treatment prevents depression and anxiety-like behaviors and promotes Neuroprotection after experimental ischemic stroke
  7995. Glycine, the smallest amino acid, confers Neuroprotection against D-galactose-induced neurodegeneration and memory impairment by regulating c-Jun N …
  7996. Hydrogen exerts Neuroprotection by activation of the miR‐21/PI3K/AKT/GSK‐3β pathway in an in vitro model of traumatic brain injury
  7997. White Matter and Neuroprotection in Alzheimer’s Dementia
  7998. Efficacy of human HC016 cell transplants on Neuroprotection and functional recovery in a rat model of acute spinal cord injury
  7999. A new cell subtype that confers Neuroprotection
  8000. Ligusticum chuanxiong exerts Neuroprotection by promoting adult neurogenesis and inhibiting inflammation in the hippocampus of ME cerebral ischemia rats
  8001. Dose-dependent microglial and astrocytic responses associated with post-ischemic Neuroprotection after lipopolysaccharide-induced sepsis-like state in mice
  8002. brain ‐derived neurotropic factor mediates Neuroprotection of mesenchymal stem cell‐derived extracellular vesicles against severe intraventricular hemorrhage in …
  8003. Disturbed glucose and pyruvate metabolism in glaucoma with Neuroprotection by pyruvate or rapamycin
  8004. Stearic acid methyl ester affords Neuroprotection and improves functional outcomes after cardiac arrest
  8005. Piperine mitigates behavioral impairments and provides Neuroprotection against 3-nitropropinoic acid-induced Huntington disease-like symptoms
  8006. Endothelial progenitor cell-derived factors exert Neuroprotection in cultured cortical neuronal progenitor cells
  8007. Melatonin Provides Neuroprotection Following Traumatic brain Injury-Promoted Mitochondrial Perturbation in Wistar Rat
  8008. Conflicting actions of inhalational anesthetics, neurotoxicity and Neuroprotection , mediated by the unfolded protein response
  8009. Nanogold Neuroprotection in Human Neural Stem Cells Against Amyloid-beta-induced Mitochondrial Dysfunction
  8010. Chemical inhibition of FBXO7 reduces inflammation and confers Neuroprotection by stabilizing the mitochondrial kinase PINK1
  8011. Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies
  8012. Progesterone and fetal-neonatal Neuroprotection
  8013. Rapid eye movement sleep behavior disorder: A proof‐of‐concept Neuroprotection study for prodromal synucleinopathies
  8014. Is it the time of autophagy fine-tuners for Neuroprotection ?
  8015. Central Neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates
  8016. A Critical Role for ISGylation, Ubiquitination and, SUMOylation in brain Damage: Implications for Neuroprotection
  8017. Refocusing the brain : new approaches in Neuroprotection against ischemic injury
  8018. Molecular and pharmacological modulation of CALHM1 promote Neuroprotection against oxygen and glucose deprivation in a model of hippocampal slices
  8019. Maternal alcoholism and neonatal hypoxia-ischemia: Neuroprotection by stilbenoid polyphenols
  8020. Intravitreal ketamine promotes Neuroprotection in rat eyes after experimental ischemia
  8021. Neuroprotection induced by energy and protein-energy undernutrition is phase-dependent after focal cerebral ischemia in mice
  8022. Bidirectional regulation of glial potassium buffering–glioprotection versus Neuroprotection
  8023. pS421 huntingtin modulates mitochondrial phenotypes and confers Neuroprotection in an HD hiPSC model
  8024. Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson’s Disease
  8025. Neuroprotection by phytoestrogens in the model of deprivation and resupply of oxygen and glucose in vitro: the contribution of autophagy and related signaling …
  8026. PERK (protein kinase RNA-like ER kinase) branch of the unfolded protein response confers Neuroprotection in ischemic stroke by suppressing protein synthesis
  8027. PPARα serves as a new receptor of aspirin for Neuroprotection
  8028. Neuroprotection by dimethyl fumarate following ventral root crush in C57BL/6J mice
  8029. HSF1 physically neutralizes amyloid oligomers to empower overgrowth and bestow Neuroprotection
  8030. Ligustilide provides Neuroprotection by promoting angiogenesis after cerebral ischemia
  8031. Neuroprotection : targeting multiple pathways by naturally occurring phytochemicals
  8032. Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia/Reperfusion Injury
  8033. Edaravone administration confers Neuroprotection after experimental intracerebral hemorrhage in rats via NLRP3 suppression
  8034. Multiphase adjuvant Neuroprotection : A novel paradigm for improving acute ischemic stroke outcomes
  8035. Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts Neuroprotection
  8036. α7nAchR mediates transcutaneous auricular vagus nerve stimulation-induced Neuroprotection in a rat model of ischemic stroke by enhancing axonal plasticity
  8037. Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study
  8038. Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
  8039. Galuteolin inhibited autophagy for Neuroprotection against transient focal cerebral ischemia in rats
  8040. Olive Leaf Polyphenols Attenuate the Clinical Course of Experimental Autoimmune Encephalomyelitis and Provide Neuroprotection by Reducing Oxidative …
  8041. Withanolide a penetrates brain via intra-nasal administration and exerts Neuroprotection in cerebral ischemia reperfusion injury in mice
  8042. MicroRNA-181c provides Neuroprotection in an intracerebral hemorrhage model
  8043. Cuprizone Affects Hypothermia-Induced Neuroprotection and Enhanced Neuroblast Differentiation in the Gerbil Hippocampus after Ischemia
  8044. Neuroprotection of intermedin against cerebral ischemia/reperfusion injury through cerebral microcirculation Improvement and apoptosis inhibition
  8045. Oxiracetam Offers Neuroprotection by Reducing Amyloid β-Induced Microglial Activation and Inflammation in Alzheimer’s Disease
  8046. Sodium/calcium exchanger as main effector of endogenous Neuroprotection elicited by ischemic tolerance
  8047. Promoting sound development of preterm infants in the name of developmental neuroscience: Beyond advanced life support and Neuroprotection
  8048. Midazolam contributes to Neuroprotection against hypoxia/reoxygenation-induced brain injury in neonatal rats via regulation of EAAT2
  8049. The green tea polyphenolic catechin epigallocatechin gallate and Neuroprotection
  8050. Vitamin D exerts Neuroprotection via SIRT1/nrf-2/NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice
  8051. Pinosylvin provides Neuroprotection against cerebral ischemia and reperfusion injury through enhancing PINK1/Parkin mediated mitophagy and Nrf2 pathway
  8052. Treatment with liraglutide exerts Neuroprotection after hypoxic–ischemic brain injury in neonatal rats via the PI3K/AKT/GSK3β pathway
  8053. An arylthiazyne derivative is a potent inhibitor of lipid peroxidation and ferroptosis providing Neuroprotection in vitro and in vivo
  8054. Oxyphylla A Promotes Degradation of α-Synuclein for Neuroprotection via Activation of Immunoproteasome
  8055. Resilience in the LPS-induced acute depressive-like behaviors: Increase of CRMP2 Neuroprotection and microtubule dynamics in hippocampus
  8056. Pharmacological Characterizations of anti-Dementia Memantine Nitrate via Neuroprotection and Vasodilation in Vitro and in Vivo
  8057. Methanolic extracts of a selected Egyptian Vicia faba cultivar mitigate the oxidative/inflammatory burden and afford Neuroprotection in a mouse model of Parkinson’s …
  8058. Huntington’s Disease: Genome-wide Neuroprotection Screening Goes Viral
  8059. Multi-enzymatic activities of ultrasmall ruthenium oxide for anti-inflammation and Neuroprotection
  8060. SIRT1 is required for the Neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice
  8061. Resveratrol and Neuroprotection : Impact and its Therapeutic Potential in Alzheimer’s disease
  8062. Early Exercise after Intracerebral Hemorrhage Inhibits Inflammation and Promotes Neuroprotection in the Sensorimotor Cortex in Rats
  8063. 3, 3′-Diindolylmethane promotes BDNF and antioxidant enzyme formation via TrkB/Akt pathway activation for Neuroprotection against oxidative stress-induced …
  8064. Increased plasma melatonin in presymptomatic Huntington disease sheep (Ovis aries): Compensatory Neuroprotection in a neurodegenerative disease?
  8065. Candesartan Neuroprotection in rat primary neurons negatively correlates with aging and senescence: a transcriptomic analysis
  8066. Sodium aescinate provides Neuroprotection in experimental traumatic brain injury via the Nrf2-ARE pathway
  8067. … like Behaviors in the Offspring through Activation of Immune-Inflammatory, Oxidative and Apoptotic Pathways, and Lowered Antioxidant Defenses and Neuroprotection
  8068. Prospects of molecular hydrogen in perioperative Neuroprotection from basic research to clinical application
  8069. Enriched environment provides Neuroprotection against experimental glaucoma
  8070. BMAA, Neurodegeneration, and Neuroprotection
  8071. Studies on the Neuroprotection of osthole on glutamate-induced apoptotic cells and an alzheimer’s disease mouse model via modulation oxidative stress
  8072. Targeted disruption of Kv2. 1-VAPA association provides Neuroprotection against ischemic stroke in mice by declustering Kv2. 1 channels
  8073. Neuroprotection and immunomodulation by dimethyl fumarate and a heterologous fibrin biopolymer after ventral root avulsion and reimplantation
  8074. Xuesaitong exerts long-term Neuroprotection for stroke recovery by inhibiting the ROCKII pathway, in vitro and in vivo
  8075. The delicate balance between neurotoxicity and Neuroprotection in the context of HIV‐1 infection
  8076. brain to blood efflux as a mechanism underlying the Neuroprotection mediated by rapid remote preconditioning in brain ischemia
  8077. Regulatory T cell is critical for interleukin-33-mediated Neuroprotection against stroke
  8078. Extended preclinical investigation of lactate for Neuroprotection after ischemic stroke
  8079. Post-treatment with oxcarbazepine confers potent Neuroprotection against transient global cerebral ischemic injury by activating Nrf2 defense pathway
  8080. Electrochemical Sensing of Ascorbate as an Index of Neuroprotection from Seizure Activity by Physical Exercise in Freely Moving Rats
  8081. CELSR1 promotes Neuroprotection in cerebral ischemic injury mainly through the Wnt/PKC signaling pathway
  8082. Polydopamine nanoparticles as an organic and biodegradable multitasking tool for Neuroprotection and remote neuronal stimulation
  8083. Neuroprotection of Tropical Fruit Juice Mixture via the Reduction of iNOS Expression and CRH Level in β-Amyloid-Induced Rats Model of Alzheimer’s Disease
  8084. The role of peptidase neurolysin in Neuroprotection and neural repair after stroke
  8085. Simvastatin preconditioning confers Neuroprotection against hypoxia-ischemia induced brain damage in neonatal rats via autophagy and silent information regulator 1 …
  8086. Gateways for Glutamate Neuroprotection in Parkinson’s Disease (PD): Essential Role of EAAT3 and NCX1 Revealed in an In Vitro Model of PD
  8087. Neuroprotection through G-CSF: recent advances and future viewpoints
  8088. Melatonin Promotes Neuroprotection of H2O2-induced Neural Stem Cells via lncRNA MEG3/miRNA-27a-3p/MAP2K4 axis
  8089. Neuroprotection Effect of Astragaloside IV from 2-DG-Induced Endoplasmic Reticulum Stress
  8090. Melatonin receptor as a drug target for Neuroprotection
  8091. Axon degeneration is rescued with human umbilical cord perivascular cells: a potential candidate for Neuroprotection after traumatic brain injury
  8092. Dermatan sulfate obtained from the Phallusia nigra marine organism is responsible for antioxidant activity and Neuroprotection in the neuroblastoma-2A cell lineage
  8093. Molecular changes in glaucomatous trabecular meshwork. Correlations with retinal ganglion cell death and novel strategies for Neuroprotection .
  8094. Enolase inhibition alters metabolic hormones and inflammatory factors to promote Neuroprotection in spinal cord injury
  8095. Acetylcholinesterase inhibitory activity and Neuroprotection in vitro, molecular docking, and improved learning and memory functions of demethylcurcumin in …
  8096. Ropinirole induces Neuroprotection following reperfusion-promoted mitochondrial dysfunction after focal cerebral ischemia in Wistar rats
  8097. Demonstrated Hormetic Putatively Mechanisms Subserve Riluzole-induced Effects in Neuroprotection Against Amyotrophic Lateral Sclerosis (ALS): Implications for …
  8098. Agomelatine confers Neuroprotection against cisplatin-induced hippocampal neurotoxicity
  8099. PI3K/Akt and ERK1/2 signalling are involved in quercetin-mediated Neuroprotection against copper-induced injury
  8100. Marine Natural Products: Promising Candidates in the Modulation of Gut-brain Axis towards Neuroprotection
  8101. Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´ s Disease
  8102. Blockade of HCN2 Channels Provides Neuroprotection Against Ischemic Injury via Accelerating Autophagic Degradation in Hippocampal Neurons
  8103. Neuroprotection by trans-resveratrol against collagenase-induced neurological and neurobehavioural deficits in rats involves adenosine A1 receptors
  8104. Sulfated polysaccharides of some seaweeds exhibit Neuroprotection via mitigation of oxidative stress, cholinergic dysfunction and inhibition of Zn–induced …
  8105. Neurodegeneration, Neuroprotection and Regeneration in the Zebrafish Retina
  8106. Naringin provides Neuroprotection in CCL2-induced cognition impairment by attenuating neuronal apoptosis in the hippocampus
  8107. Role of Baclofen in Modulating Spasticity and Neuroprotection in Spinal Cord Injury
  8108. GardeninA confers Neuroprotection against environmental toxin in a Drosophila model of Parkinson’s disease
  8109. Irisin Contributes to Neuroprotection by Promoting Mitochondrial Biogenesis After Experimental Subarachnoid Hemorrhage
  8110. Carvacryl acetate, a semisynthetic monoterpenic ester obtained from essential oils, provides Neuroprotection against cerebral ischemia reperfusion-induced oxidative …
  8111. Neuroprotection of netrin-1 on neurological recovery via Wnt/β-catenin signaling pathway after spinal cord injury
  8112. Aqueous extract of Dendrobium officinale confers Neuroprotection against hypoxic‐ischemic brain damage in neonatal rats
  8113. Resveratrol confers Neuroprotection against high-fat diet in a mouse model of Alzheimer’s disease via modulation of proteolytic mechanisms
  8114. An endogenous PI3K interactome promoting astrocyte-mediated Neuroprotection identifies a novel association with RNA-binding protein ZC3H14
  8115. Molecular Targets from Traditional Medicines for Neuroprotection in Human Neurodegenerative Diseases
  8116. Variability and sex-dependence of hypothermic Neuroprotection in a rat model of neonatal hypoxic–ischaemic brain injury: a single laboratory meta-analysis
  8117. Sanhua Decoction, a Classic Herbal Prescription, Exerts Neuroprotection Through Regulating Phosphorylated Tau Level and Promoting Adult Endogenous …
  8118. Mirtazapine exerts astrocyte-mediated dopaminergic Neuroprotection
  8119. Reactive gliosis contributes to Nrf2-dependent Neuroprotection by pretreatment with dimethyl fumarate or Korean red ginseng against hypoxic-ischemia: Focus on …
  8120. Growth Hormone and Neuronal Hemoglobin in the brain —Roles in Neuroprotection and Neurodegenerative Diseases
  8121. Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease
  8122. Neuroprotection by Remote Ischemic Conditioning in Rodent Models of Focal Ischemia: a Systematic Review and Meta-Analysis
  8123. Immuno-Modulation and Neuroprotection mediate the therapeutic effect of exosomes in mice model of autism
  8124. Potential Neuroprotection of wheat alkylresorcinols in hippocampal neurons via Nrf2/ARE pathway
  8125. Vitamin D supplementation compared to placebo in people with First Episode psychosis-Neuroprotection Design (DFEND): a protocol for a randomised …
  8126. Perampanel Add-on to Standard Radiochemotherapy in vivo Promotes Neuroprotection in a Rodent F98 Glioma Model
  8127. Neuronal Metabolism and Neuroprotection : Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage
  8128. Ceftriaxone pretreatment confers Neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
  8129. Fmoc-amino acid-based hydrogel vehicle for delivery of amygdalin to perform Neuroprotection
  8130. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords Neuroprotection after spinal cord injury
  8131. Neuroprotection with rasagiline in patients with macula-off retinal detachment: A randomized controlled pilot study
  8132. Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinson’s disease model
  8133. Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy
  8134. Neuroprotection Following Concussion: The Potential Role for Cannabidiol
  8135. Edaravone-Loaded Macrophage-Derived Exosomes Enhance Neuroprotection in the Rat Permanent Middle Cerebral Artery Occlusion Model of Stroke
  8136. Exercise-Induced Neuroprotection in the 6-Hydroxydopamine Parkinson’s Disease Model
  8137. The antibiotic doxycycline mimics the NGF signaling in PC12 cells: a relevant mechanism for Neuroprotection
  8138. Inhibition of LPA5 Activity Provides Long-Term Neuroprotection in Mice with brain Ischemic Stroke
  8139. Spleen participation in partial MHC class II construct Neuroprotection in stroke
  8140. Innovative IOP-Independent Neuroprotection and Neuroregeneration Strategies in the Pipeline for Glaucoma
  8141. topical ripasudil stimulates Neuroprotection and axon regeneration in adult mice following optic nerve injury
  8142. Microglial Cell Morphology and Phagocytic Activity Are Critically Regulated by the Neurosteroid Allopregnanolone: A Possible Role in Neuroprotection
  8143. Glycyrrhizic acid renders robust Neuroprotection in rodent model of vascular dementia by controlling oxidative stress and curtailing cytochrome-c release
  8144. Downregulation of candidate gene expression and Neuroprotection by Piperine in Streptozotocin-induced Hyperglycemia and memory Impairment in Rat
  8145. Resection of internal carotid artery aneurysm under Neuroprotection with flow reversal technique
  8146. Neuroprotection by selective endovascular brain cooling-the TwinFlo™ Catheter.
  8147. memory -Enhancing Effects of Mangosteen Pericarp Water Extract through Antioxidative Neuroprotection and Anti-Apoptotic Action
  8148. Circadian effects on stroke outcome–Did we not wake up in time for Neuroprotection ?
  8149. Effect of acute and subchronic administration of (R)-WIN55, 212-2 induced Neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor …
  8150. Ephrin–Eph Signaling as a Novel Neuroprotection Path in Ischemic Stroke
  8151. Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells
  8152. miR-7b-3p exerts a dual role after spinal cord injury, by supporting plasticity and Neuroprotection at cortical level
  8153. Induced neural stem cell grafts exert Neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury
  8154. Neuroprotection against cerebral ischemia/reperfusion by dietary phytochemical extracts from Tibetan turnip (Brassica rapa L.)
  8155. Oxytocin mediates Neuroprotection against hypoxic-ischemic injury in hippocampal CA1 neuron of neonatal rats
  8156. Neuroprotection of hypoxic/ischemic preconditioning in neonatal brain with hypoxic-ischemic injury
  8157. Can Natural Products Exert Neuroprotection without Crossing the Blood–brain Barrier?
  8158. CypD deficiency confers Neuroprotection against mitochondrial abnormality caused by lead in SH-SY5Y cell
  8159. Voltage-Gated Ca2+ Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson’s Disease?
  8160. Small molecule induces mitochondrial fusion for Neuroprotection via targeting CK2 without affecting its conventional kinase activity
  8161. Natural Molecules and Neuroprotection : Kynurenic Acid, Pantethine and α-Lipoic Acid
  8162. Is there hope that transpinal direct current stimulation corrects motoneuron excitability and provides Neuroprotection in amyotrophic lateral sclerosis?
  8163. Effects of repetitive hyperbaric oxygen therapy on Neuroprotection in middle cerebral artery occlusion rats
  8164. Neuroprotection with Bacopa monnieri–A review of experimental evidence
  8165. Molecular Basis of Sex Difference in Neuroprotection induced by Hypoxia preconditioning in zebrafish
  8166. Neuroprotection Against Parkinson’s Disease Through the Activation of Akt/GSK3β Signaling Pathway by Tovophyllin A
  8167. Neuroprotection elicited by resveratrol in a rat model of hypothyroidism: Possible involvement of cholinergic signaling and redox status
  8168. Edible dairy formula fortified with coconut oil for Neuroprotection against aluminium chloride-induced Alzheimer’s disease in rats
  8169. Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases
  8170. Neuroprotection of dihydrotestosterone via suppression of the toll-like receptor 4/nuclear factor-kappa B signaling pathway in high glucose-induced BV-2 microglia …
  8171. Composite nanofibers incorporating alpha lipoic acid and atorvastatin provide Neuroprotection after peripheral nerve injury in rats
  8172. Icaritin Provides Neuroprotection in Parkinson’s Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency
  8173. TGF-β1 Provides Neuroprotection via Inhibition of Microglial Activation in 3-Acetylpyridine-Induced Cerebellar Ataxia Model Rats
  8174. Role of connexins 30, 36, and 43 in brain tumors, neurodegenerative diseases, and Neuroprotection
  8175. Specific occupational profiles as proxies of cognitive reserve induce Neuroprotection in dementia with Lewy bodies
  8176. Magnesium and Hydrogen in Subarachnoid Hemorrhage: Is Neuroprotection Finally a Reality?
  8177. Predicting a potential link to antidepressant effect: Neuroprotection of zhi-zi-chi decoction on glutamate-induced cytotoxicity in PC12 cells
  8178. Isoliquiritigenin Confers Neuroprotection and Alleviates Amyloid-β42-Induced Neuroinflammation in Microglia by Regulating the Nrf2/NF-κB Signaling
  8179. Pregnancy swimming prevents early brain mitochondrial dysfunction and causes sex-related long-term Neuroprotection following neonatal hypoxia-ischemia in rats
  8180. ALDH 2 conferred Neuroprotection on cerebral ischemic injury by alleviating mitochondria-related apoptosis through JNK/caspase-3 signing pathway
  8181. Commentary: Therapeutic Potential of Targeting the Auto-Inhibition of ASIC1a for Neuroprotection Against Ischemic brain Injury
  8182. HCN Channel Activity Balances Quiescence and Proliferation in Neural Stem Cells and Is a Selective Target for Neuroprotection During Cancer Treatment
  8183. Growth differentiation factor 5 exerts Neuroprotection in an α-synuclein rat model of Parkinson’s disease
  8184. The impact of cannabinoid type 2 receptors (CB2Rs) in Neuroprotection against neurological disorders
  8185. Organizational Update: NINDS Stroke Research Strategies for Large Vessel Occlusion and Neuroprotection
  8186. Enhancement of Neuroprotection , antioxidant capacity, and water-solubility of crocins by transglucosylation using dextransucrase under high hydrostatic pressure
  8187. Enhanced neurogenesis is involved in Neuroprotection provided by rottlerin against trimethyltin-induced delayed apoptotic neuronal damage
  8188. Delta opioid peptide [d-Ala2, d-Leu5] enkephalin confers Neuroprotection by activating delta opioid receptor-AMPK-autophagy axis against global ischemia
  8189. Transient receptor potential vanilloid 1 antagonism in neuroinflammation, Neuroprotection and epigenetic regulation: Potential therapeutic implications for severe …
  8190. Selective-cerebral-hypothermia-induced Neuroprotection against-focal cerebral ischemia/reperfusion injury is associated with an increase in SUMO2/3 conjugation
  8191. Neu-horizons: Neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial
  8192. Neuroprotection or neurotoxicity of illicit drugs on Parkinson’s disease
  8193. S100 calcium-binding protein A9 knockout contributes to Neuroprotection and functional improvement after traumatic brain injury
  8194. Photobiomodulation Mediates Neuroprotection against Blue Light Induced Retinal Photoreceptor Degeneration
  8195. Physiological Metals Can Induce Conformational Changes in Transthyretin Structure: Neuroprotection or Misfolding Induction?
  8196. Calcium export from neurons and multi-kinase signaling cascades contribute to ouabain Neuroprotection in hyperhomocysteinemia
  8197. Study of Neuroprotection by a Combination of the Biological Antioxidant (Eucalyptus Extract) and the Antihypertensive Drug Candesartan against Chronic Cerebral …
  8198. Targeting the mitochondrial permeability transition pore for Neuroprotection in a piglet model of neonatal hypoxic‐ischemic encephalopathy
  8199. 7-O-Esters of taxifolin with pronounced and overadditive effects in Neuroprotection , anti-neuroinflammation, and amelioration of short-term memory …
  8200. L-Cysteine Provides Neuroprotection of Hypoxia-Ischemia Injury in Neonatal Mice via a PI3K/Akt-Dependent Mechanism
  8201. Hydrogen-Induced Neuroprotection in Neonatal Hypoxic-Ischemic Encephalopathy
  8202. Design and synthesis of novel 3, 4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the Neuroprotection against Parkinson’s disease
  8203. Mesenchymal stem cells provide Neuroprotection by regulating heat stroke-induced brain inflammation
  8204. Rod Photoreceptor Neuroprotection in Dark-Reared Pde6brd10 Mice
  8205. Hypocaloric Diet Initiated Post-Ischemia Provides Long-Term Neuroprotection and Promotes Peri-Infarct brain Remodeling by Regulating Metabolic and …
  8206. Clinical Neuroprotection and secondary neuronal injury mechanisms
  8207. Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
  8208. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson’s disease
  8209. Synthesis, Neuroprotection , and Antioxidant Activity of 1, 1′-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models
  8210. Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat
  8211. Anakinra Reduces Epileptogenesis, Provides Neuroprotection , and Attenuates Behavioral Impairments in Rats in the Lithium–Pilocarpine Model of Epilepsy
  8212. l-lysine confers Neuroprotection by suppressing inflammatory response via microRNA-575/PTEN signaling after mouse intracerebral hemorrhage injury
  8213. Homo-Tris-Nitrones Derived from α-Phenyl-N-tert-butylnitrone: Synthesis, Neuroprotection and Antioxidant Properties
  8214. Intravenous Administration of Heat Shock-Treated MSCs Can Improve Neuroprotection and Neuroregeneration in Canine Spinal Cord Injury Model
  8215. brain -derived CCR5 Contributes to Neuroprotection and brain Repair after Experimental Stroke
  8216. SOX9 Knockdown-Mediated FOXO3 Downregulation Confers Neuroprotection Against Ischemic brain Injury
  8217. Casein micelles from bovine Milk exerts Neuroprotection by stalling metabolic complications linked to oxidative brain injury
  8218. Melatonin for Neuroprotection in neonatal encephalopathy: A systematic review & meta-analysis of clinical trials
  8219. Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or Neuroprotection in the cuprizone model
  8220. Neuroprotection of Chikusetsu saponin V on transient focal cerebral ischemia/reperfusion and the underlying mechanism
  8221. Hypoxia-inducible factor-1α in acute ischemic stroke: Neuroprotection for better clinical outcome
  8222. An Overview on the Mechanisms of Neuroprotection and Neurotoxicity of Isoflurane and Sevoflurane in Experimental Studies
  8223. … treatment with exosomes following traumatic brain injury and hemorrhagic shock in a swine model promotes transcriptional changes associated with Neuroprotection
  8224. New perspectives of immunomodulation and Neuroprotection in glaucoma
  8225. Induction of p73, Δ133p53, Δ160p53, pAKT lead to Neuroprotection via DNA repair by 5-LOX inhibition
  8226. Aza‐CGP37157‐lipoic hybrids designed as novel Nrf2‐inducers and antioxidants exert Neuroprotection against oxidative stress and show neuroinflammation …
  8227. Promotion of mitochondrial biogenesis via the regulation of PARIS and PGC-1α by parkin as a mechanism of Neuroprotection by carnosic acid
  8228. Guanosine Neuroprotection of Presynaptic Mitochondrial Calcium Homeostasis in a Mouse Study with Amyloid-β Oligomers
  8229. HDAC9 silencing exerts Neuroprotection against ischemic brain injury via miR-20a-dependent downregulation of NeuroD1
  8230. Differential expression of the metabotropic P2Y receptor family in the cortex following status epilepticus and Neuroprotection via P2Y1 antagonism in mice
  8231. Exogenous recombinant Hsp70 mediates Neuroprotection after photothrombotic stroke
  8232. Neuroprotection from excitotoxic injury by local administration of lipid emulsion into the brain of rats
  8233. GPETAFLR, a peptide from Lupinus angustifolius L. prevents inflammation in microglial cells and confers Neuroprotection in brain
  8234. Chronic Treatment of Ascorbic Acid Leads to Age-Dependent Neuroprotection against Oxidative Injury in Hippocampal Slice Cultures
  8235. NMDA Receptor Antagonism for Neuroprotection in a Canine Model of Hypothermic Circulatory Arrest
  8236. Modulation of autophagy for Neuroprotection and functional recovery in traumatic spinal cord injury
  8237. … -2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, Neuroprotection and cognition enhancing …
  8238. Neuroprotection against Amyloid-β-Induced DNA Double-Strand Breaks Is Mediated by Multiple Retinoic Acid-Dependent Pathways
  8239. Deep brain stimulation of the pedunculopontine tegmental nucleus renders Neuroprotection through the suppression of hippocampal apoptosis: An …
  8240. Celecoxib-Dependent Neuroprotection in a Rat Model of Transient Middle Cerebral Artery Occlusion (tMCAO) Involves Modifications in Unfolded Protein Response …
  8241. Neuroprotection in glaucoma‑electrophysiology
  8242. Neuroprotection of benzoinum in cerebral ischemia model rats via the ACE-AngI-VEGF pathway
  8243. … Multiple Sclerosis Treatment, Reduces brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection
  8244. Oral melatonin as a new tool for Neuroprotection in preterm newborns: study protocol for a randomized controlled trial
  8245. Virgin Coconut Oil-Induced Neuroprotection in Lipopolysaccharide-Challenged Rats is Mediated, in Part, Through Cholinergic, Anti-Oxidative and Anti-Inflammatory …
  8246. The Effects of Crinum asiaticum var. japonicum Baker Seeds on Neuroprotection and Antineuroinflammation in Neuronal Cell Lines
  8247. Supplementation of Taurine Insulates Against Oxidative Stress, Confers Neuroprotection and Attenuates memory Impairment in Noise Stress Exposed Male Wistar …
  8248. Neuroprotection by Neurotropin through crosstalk of neurotrophic and innate immune receptors in PC12 cells
  8249. Generation of potent Nrf2 activators via tuning the electrophilicity and steric hindrance of vinyl sulfones for Neuroprotection
  8250. Pretreatment with bisoprolol and vitamin E alone or in combination provides Neuroprotection against cerebral ischemia/reperfusion injury in rats
  8251. Dual benefit of combined Neuroprotection : Cholesterol depletion restores membrane microviscosity but not lipid order and enhances Neuroprotective action of …
  8252. Novel humanin analogs confer Neuroprotection and myoprotection to neuronal and myoblast cell cultures exposed to ischemia-like and doxorubicin-induced cell …
  8253. Naringin Exhibits Mas Receptor–Mediated Neuroprotection Against Amyloid Beta–Induced cognitive Deficits and Mitochondrial Toxicity in Rat brain
  8254. Different ischemic duration and frequency of ischemic postconditioning affect Neuroprotection in focal ischemic stroke
  8255. TrkB signaling regulates the cold-shock protein RBM3-mediated Neuroprotection
  8256. The Potential of Liquid Biopsy of the brain Using Blood Extracellular Vesicles: The First Step Toward Effective Neuroprotection Against Neurodegenerative Diseases
  8257. Lithium modulates miR‐1906 levels of mesenchymal stem cell‐derived extracellular vesicles contributing to poststroke Neuroprotection by toll‐like receptor 4 …
  8258. … Acupoints Ameliorates Poststroke cognitive Impairment in Rats with Middle Cerebral Artery Occlusion: Involvement of Neuroprotection and Synaptic Plasticity
  8259. Oxyresveratrol exerts ATF4-and Grp78-mediated Neuroprotection against endoplasmic reticulum stress in experimental Parkinson’s disease
  8260. Downregulation of circular RNA HECTD1 induces Neuroprotection against ischemic stroke through the microRNA-133b/TRAF3 pathway
  8261. Zinc provides Neuroprotection by regulating NLRP3 inflammasome through autophagy and ubiquitination in a spinal contusion injury model
  8262. Systemic administration of sunflower oil exerts Neuroprotection in a mouse model of transient focal cerebral ischaemia
  8263. GPR18 drives FAAH inhibition-induced Neuroprotection against HIV-1 Tat-induced neurodegeneration
  8264. Acetyl-L-carnitine confers Neuroprotection against lipopolysaccharide (LPS)-induced neuroinflammation by targeting TLR4/NFκB, autophagy, inflammation and …
  8265. Réussir les essais de Neuroprotection
  8266. Effect of humic acid on oxidative stress and Neuroprotection in hypoxic-ischemic brain injury: part 1
  8267. Apolipoprotein E genotype-dependent nutrigenetic effects to prebiotic inulin for modulating systemic metabolism and Neuroprotection in mice via gut-brain axis
  8268. Neuroprotection of the Developing brain by Dexmedetomidine Is Mediated by Attenuating Single Propofol-induced Hippocampal Apoptosis and Synaptic …
  8269. Protein Quality Control in Neurodegeneration and Neuroprotection
  8270. Neurofilament results for the phase II Neuroprotection study of phenytoin in optic neuritis
  8271. Neuroprotection of Ketosis in Acute Injury of the Mammalian Central Nervous System: a Meta‐Analysis
  8272. Neuroprotection of SAK3 on scopolamine-induced cholinergic dysfunction in human neuroblastoma SH-SY5Y cells
  8273. Pharmacological Neuroprotection
  8274. Spermidine, a caloric restriction mimetic, provides Neuroprotection against normal and D-galactose-induced oxidative stress and apoptosis through activation of …
  8275. Shrm4 contributes to autophagy inhibition and Neuroprotection following ischemic stroke by mediating GABAB receptor activation
  8276. BMS-986020, a Specific LPA1 Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice
  8277. The TOTEM RRMS (Testosterone Treatment on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a …
  8278. Controversies on Neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy
  8279. 6-O-angeloylplenolin exerts Neuroprotection against lipopolysaccharide-induced neuroinflammation in vitro and in vivo
  8280. Treatment with AAV1-Rheb (S16H) provides Neuroprotection in a mouse model of photothrombosis-induced ischemic stroke
  8281. Presenilin1 familial Alzheimer disease mutants inactivate EFNB1- and BDNF-dependent Neuroprotection against excitotoxicity by affecting Neuroprotective complexes of N …
  8282. Dimethyl fumarate exerts Neuroprotection by modulating calcineurin/NFAT1 and NFκB dependent BACE1 activity in Aβ1-42 treated neuroblastoma SH-SY5Y cells
  8283. (-)-Epigallocatechin-3-gallate provides Neuroprotection via AMPK activation against traumatic brain injury in a mouse model
  8284. Expression regulation of cold-inducible protein RBM3 by FAK/Src signaling for Neuroprotection against rotenone under mild hypothermia
  8285. … Hippocampal CA1 Field Following Transient Forebrain Ischemia and Postischemic Treatment with Risperidone Displays Neuroprotection without CD200 Change
  8286. Two Rationally Identified Novel Glitazones Reversed the Behavioral Dysfunctions and Exhibited Neuroprotection Through Ameliorating brain Cytokines and …
  8287. Selective brain hypothermia-induced Neuroprotection against focal cerebral ischemia/reperfusion injury is associated with Fis1 inhibition
  8288. Reduced perforin release from T cells as a mechanism underlying hypothermia‐mediated Neuroprotection
  8289. Role of Regular Physical Activity in Neuroprotection against Acute Ischemia
  8290. Melatonin as fetal Neuroprotection : links and risks
  8291. MicroRNA‐144 promotes remote limb ischemic preconditioning-mediated Neuroprotection against ischemic stroke via PTEN/Akt pathway
  8292. Can Neuroprotection effectively manage primary open-angle glaucoma? a protocol of systematic review and meta-analysis
  8293. α7 Nicotinic Acetylcholine Receptor Mediates the Neuroprotection of Remote Ischemic Postconditioning in a Rat Model of Asphyxial Cardiac Arrest
  8294. Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection after brain Injury
  8295. Exploring genetic contributors to Neuroprotection from AD pathologies: A genome‐wide association study: Genetics/genetic factors of Alzheimer’s disease
  8296. Intravenous edaravone plus therapeutic hypothermia offers limited Neuroprotection in the hypoxic-ischaemic newborn piglet
  8297. Artesunate Provides Neuroprotection against Cerebral Ischemia–Reperfusion Injury via the TLR-4/NF-κB Pathway in Rats
  8298. Neuroprotection by cattle encephalon glycoside and ignotin beyond the time window of thrombolysis in ischemic stroke
  8299. Papaverine provides Neuroprotection by suppressing neuroinflammation and apoptosis in the traumatic brain injury via RAGE-NF-< kappa> B pathway
  8300. The Silver Lining in a Time of Crisis: The Foundation of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN) Conference Proceedings Go …
  8301. Xanthine Derivatives as agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease
  8302. Neuroprotection of melatonin on spinal cord injury by activating autophagy and inhibiting apoptosis via SIRT1/AMPK signaling pathway
  8303. Oxidative modifications of parkin underlie its selective Neuroprotection in adult human brain
  8304. Author reply to letter to editor” melatonin as fetal Neuroprotection : Links and risks”
  8305. Translating antenatal magnesium sulphate Neuroprotection for infants born< 28 weeks’ gestation into practice: A geographical cohort study
  8306. Eugenol-Encapsulated Nanocarriers for Microglial Polarisation: a Promising Therapeutic Application for Neuroprotection
  8307. Nutraceuticals in central nervous system diseases: potential mechanisms of Neuroprotection
  8308. Clinical trial design for Neuroprotection in RHO autosomal dominant retinitis pigmentosa; outcome measure considerations
  8309. Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal Neuroprotection via the M1 mAChR: a promising agent for the treatment of …
  8310. Neuroprotection of Cyperus esculentus L. orientin against cerebral ischemia/reperfusion induced brain injury
  8311. Long-term Exercise Confers Equivalent Neuroprotection in Females Despite Lower Cardiorespiratory Fitness
  8312. Survey on use of antenatal magnesium sulphate for fetal Neuroprotection prior to preterm birth in Australia and New Zealand–Ongoing barriers and enablers
  8313. Common carotid artery endovascular clamping for Neuroprotection during carotid stenting: Flow‐gate system as an innovative treatment approach
  8314. Preservation of spatial memory and Neuroprotection by the fatty acid amide hydrolase inhibitor URB597 in a rat model of vascular dementia
  8315. Activation of Glutamate Transporter-1 (GLT-1) Confers Sex-Dependent Neuroprotection in brain Ischemia
  8316. Quantitative Analysis of 7 Compounds in Diospyros lotus Leaf Extract and Its Biological Effects on Neuroprotection and Antineuroinflammation
  8317. Neuroprotection in the Acute Stage Enables Functional Recovery Following Repair of Chronic Cervical Root Transection After a 3-Week Delay
  8318. TrkB agonist antibody delivery to the brain using a TfR1 specific BBB shuttle provides Neuroprotection in a mouse model of Parkinson’s Disease
  8319. VEGF/VEGFR-2 system exerts Neuroprotection against Phoneutria nigriventer spider envenomation through PI3K-AKT-dependent pathway
  8320. Neurotensin receptor 1 agonist provides Neuroprotection in pre-diabetic rats
  8321. Stem cell secretome derived from human amniotic fluid affords Neuroprotection in an ischemic model
  8322. … combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents : monoamine oxidase-B inhibition, Neuroprotection and oxidative stress …
  8323. Carbon Monoxide Exerts Functional Neuroprotection After Cardiac Arrest Using Extracorporeal Resuscitation in Pigs
  8324. A failure of forward translation? The case of Neuroprotection
  8325. Neuroprotection in brain Injury
  8326. Neuroprotection of round scad (Decapterus maruadsi) hydrolysate in glutamate-damaged PC12 cells: Possible involved signaling pathways and potential …
  8327. Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants
  8328. Intermittent Hypoxia Promotes Functional Neuroprotection from Retinal Ischemia in Untreated First-Generation Offspring: Proteomic Mechanistic Insights
  8329. Using the Quantum Cell Expansion System to Generate Mesenchymal Stromal Cells for Neuroprotection After Cardiopulmonary Bypass
  8330. … Attenuates Apoptosis Mechanism by Inhibiting NF-κB and Caspase-3 Activity: TLR4 Pre-activation in the Signaling Pathway of LPS-Induced Neuroprotection
  8331. The 5-HT1A receptor as a serotonergic target for Neuroprotection in cerebral ischemia
  8332. Insulin-Producing Cells Differentiated from Adipose Mesenchymal Stem Cells Neuroprotection Strategy in Diabetic Rats
  8333. Reply: Growth differentiation factor 5 exerts Neuroprotection in an α-synuclein rat model of Parkinson’s disease and BMP5/7 protect dopaminergic neurons in an α …
  8334. Hardy-Weinberg Equilibrium in different mitochondrial haplogroups of four genes associated with Neuroprotection and neurodegeneration
  8335. Neuroprotection in paediatric traumatic brain injury
  8336. CAPE and Neuroprotection : A Review. Biomolecules 2021, 11, 176
  8337. Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with Neuroprotection as potential therapeutic agent for Alzheimer’s disease
  8338. … gold nano-flowers toward immunosensing of 2-AG in human plasma samples: A novel immuno-platform for the screening of immunomodulation and Neuroprotection …
  8339. State and perspectives on flavonoid Neuroprotection against aminochrome-induced neurotoxicity
  8340. Acute treatment with TrkB agonist LM22A-4 confers Neuroprotection and preserves myelin integrity in a mouse model of pediatric traumatic brain injury
  8341. Secondary Neuroprotection in glaucoma through the concepts of complementary drug therapy
  8342. Magnesium Sulfate for Fetal Neuroprotection : Pros and Cons
  8343. A pilot protocol and review of triple Neuroprotection with targeted hypothermia, controlled induced hypertension, and barbiturate infusion during emergency …
  8344. Quantitative analysis by reversed-phase high-performance liquid chromatography and retinal Neuroprotection after topical administration of moxonidine
  8345. An increase in AMPK/e-NOS signaling and attenuation of MMP-9 may contribute to remote ischemic perconditioning associated Neuroprotection in rat model of focal …
  8346. Mahanimbine-induced Neuroprotection via cholinergic system and attenuated amyloidogenesis as well as neuroinflammation in lipopolysaccharides-induced …
  8347. … of PDE1-B by Vinpocetine Regulates Microglial Exosomes and Polarization Through Enhancing Autophagic Flux for Neuroprotection Against Ischemic Stroke
  8348. Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo
  8349. Neonatal encephalopathy therapy optimization for better Neuroprotection with inhalation of CO 2: The HENRIC feasibility and safety trial
  8350. Safety of Triple Neuroprotection with Targeted Hypothermia, Controlled Induced Hypertension, and Barbiturate Infusion during Emergency Carotid Endarterectomy for …
  8351. A new oleanane type pentacyclic triterpenoid saponin from the husks of xanthoceras sorbifolium bunge and its Neuroprotection on PC12 cells injury induced by Aβ25 …
  8352. Trophic factors are essential for the survival of grafted oligodendrocyte progenitors and for Neuroprotection after perinatal excitotoxicity
  8353. Decoding signaling pathways involved in prolactin-induced Neuroprotection : a review
  8354. Destabilization of β‐amyloid aggregates by thrombin derived peptide: plausible role of thrombin in Neuroprotection
  8355. Continuous theta burst stimulation provides Neuroprotection by accelerating local cerebral blood flow and inhibiting inflammation in a mouse model of acute ischemic …
  8356. Epigallocatechin-3-Gallate-Loaded Liposomes Favor Anti-Inflammation of Microglia Cells and Promote Neuroprotection
  8357. Celecoxib in a Preclinical Model of Repetitive Mild Traumatic brain Injury: Hippocampal Learning Deficits Persist with Inflammatory and Excitotoxic Neuroprotection
  8358. Anesthetic Management in Aortic Arch Surgery and Neuroprotection
  8359. Neostigmine treatment induces Neuroprotection against oxidative stress in cerebral cortex of asthmatic mice
  8360. Adenosine and NMDA Receptors Modulate Neuroprotection -Induced NMDA Preconditioning in Mice
  8361. Lessons from Recent Advances in Ischemic Stroke Management and Targeting Kv2. 1 for Neuroprotection
  8362. Human neural stem cell transplant location–dependent Neuroprotection and motor deficit amelioration in rats with penetrating traumatic brain injury
  8363. Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer’s, Parkinson’s, and Huntington’s Diseases
  8364. Naringenin induces Neuroprotection against homocysteine-induced PC12 cells via the upregulation of superoxide dismutase 1 expression by decreasing miR-224-3p …
  8365. Failed Neuroprotection of Combined Inhibition of L-Type and ASIC1a Calcium Channels with Nimodipine and Amiloride
  8366. The Role of Heat Shock Proteins in Neuroprotection
  8367. Retraction: Aquaporin-4 Inhibition Mediates Piroxicam-Induced Neuroprotection against Focal Cerebral Ischemia/Reperfusion Injury in Rodents
  8368. Epigallocatechin-3-gallate preconditioned Adipose-derived Stem Cells confer Neuroprotection in aging rat brain
  8369. Stomatin-like protein-2 confers Neuroprotection effect in oxygen-glucose deprivation/reoxygenation-injured neurons by regulating AMPK/Nrf2 signalling
  8370. Mitosis Inhibitors and Medicinal Plants: Neurotoxicity and Neuroprotection
  8371. Trojan Horse Delivery of 4, 4′‐Dimethoxychalcone for Parkinsonian Neuroprotection
  8372. Excitotoxicity-induced endocytosis as a potential target for stroke Neuroprotection
  8373. Mechanical Thrombectomy of Symptomatic Acute Carotid Stent Thrombosis Using Transcarotid Artery Revascularization Neuroprotection Flow Reversal Technique
  8374. Can glucagon-like peptide-1 (GLP-1) analogues make Neuroprotection a reality?
  8375. Resuscitation with macromolecular superoxide dismutase/catalase mimetic polynitroxylated PEGylated hemoglobin offers Neuroprotection in guinea pigs after …
  8376. Liraglutide provides Neuroprotection by regulating autophagy through the AMPK-FOXO3 signaling pathway in a spinal contusion injury rat model
  8377. Dose optimization of early high-dose valproic acid for Neuroprotection in a swine cardiac arrest model
  8378. Neuroprotection -New Approaches and Prospects
  8379. Neuroprotection and the Aorta: One System, One Artery, One Expectation, One Team
  8380. Saponins of Panax japonicus Confer Neuroprotection against brain Aging through Mitochondrial Related Oxidative Stress and Autophagy in Rats
  8381. Monoamine Oxidase Inhibitor (MAO-I)-Mediated Neuroprotection for Treating Parkinson’s Disease
  8382. Phytochemical Profiling of Hemidesmus indicus (L.) R. Br. ex Schult and its Antioxidant, Anti-Inflammatory and Neuroprotection Linked Enzyme Inhibitory Properties
  8383. Magnesium Sulphate for Fetal Neuroprotection at Imminent Risk for Preterm Delivery: A Systematic Review With Meta-analysis and Trial Sequential Analysis
  8384. Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
  8385. Neuroprotection in Glaucoma–Is Erythropoietin the Solution?
  8386. Impact of Minority Races on Clinical Trials on Magnesium for Neuroprotection [13C]
  8387. Neuroprotection for Retinal Ganglion Cells
  8388. Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in …
  8389. An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic brain Injury
  8390. Successful Use of Adjunctive Orbital Atherectomy for Extensively Calcified Carotid Artery Lesions Using Flow Reversal Neuroprotection Technique
  8391. Effective Neuroprotection and organ protection: activation of the endogenous mechanisms of sanogenesis
  8392. Novel Regulators of Neuroinflammation and Neuroprotection
  8393. GOLGA2/GM130 is a novel target of Neuroprotection therapy in intracerebral hemorrhage
  8394. Emerging Trends in the Use of Therapeutic Hypothermia as a Method for Neuroprotection in brain Damage
  8395. … growth factor β1 differently modulates wild‐type and TgF344‐AD astrocyte cultures’ function: Molecular and cell biology/neurodegeneration and Neuroprotection
  8396. Emerging Trends in the Use of Therapeutic Hypothermia as a Method for Neuroprotection in brain Damage
  8397. Glucagon‐like peptide‐1 analog improves neuronal and behavioral impairment and promotes Neuroprotection in a rat model of aluminum‐induced dementia
  8398. Senescence marker protein 30 confers Neuroprotection in oxygen-glucose deprivation/reoxygenation-injured neurons through modulation of Keap1/Nrf2 signaling …
  8399. Closing Research Gaps for Cerebral Palsy Prevention and Magnesium Sulphate Neuroprotection
  8400. Author Correction: Potential circadian effects on translational failure for Neuroprotection
  8401. An Alternate View of Neuroprotection with Peptides in Alzheimer’s Disease
  8402. Neuroprotection in the injured spinal cord
  8403. KIF 2 mediates the Neuroprotection in cerebral ischaemia injury by affecting NF‐κB pathway
  8404. … brain neurotensin receptors were associated with brain pathology in obese, insulin‐resistant rats: Molecular and cell biology/neurodegeneration and Neuroprotection
  8405. Molecular Aspects of Neurodegeneration, Neuroprotection , and Regeneration in Neurological Disorders
  8406. TREM2-independent Neuroprotection is mediated by monocyte-derived macrophages in a mouse model of Alzheimer’s disease
  8407. Neuroprotection for Acute brain Ischaemia
  8408. Curcumin: A review on Neuroprotection
  8409. Effect of dihydroferulic acid obtained from fermented rice bran extract on Neuroprotection and behavioral recovery in an ischemic rat model
  8410. … disturbance, neuropathology, and cognitive decline in high‐fat diet–induced obese rats: Molecular and cell biology: Neurodegeneration versus Neuroprotection
  8411. Traditional Chinese Medicine in Neuroprotection after brain Insults with Special Reference to Radioprotection
  8412. Deep brain Stimulation of the Pedunculopontine Tegmental Nucleus Renders Neuroprotection through the Suppression of Hippocampal Apoptosis: An Experimental …
  8413. Herbal decoction of Gastrodia, Uncaria, and Curcuma confers Neuroprotection against cerebral ischemia in vitro and in vivo
  8414. Author Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer Neuroprotection in models of Huntington’s disease
  8415. Induced Neuroprotection by remote ischemic perconditioning as a new paradigm in ischemic stroke at the acute phase, a systematic review
  8416. Neuroinflammation and Neuroprotection in schizophrenia and autism spectrum disorder
  8417. Magnesium Sulphate Neuroprotection in Neonatal Encephalopathy
  8418. Nicotinamide provides Neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
  8419. GHB confers Neuroprotection by stabilizing the CaMKIIα hub domain
  8420. Hyperbaric Oxygen Preconditioning-Induced Neuroprotection
  8421. Neurodegeneration, Neuroprotection and Regeneration in the Zebrafish Retina. Cells 2021, 10, 633
  8422. Neuroprotection : The Way of Anti-Inflammatory agents
  8423. Identification of candidate genes and pathways in dexmedetomidine-induced Neuroprotection in rats using RNA sequencing and bioinformatics analysis.
  8424. Demonstrated hormetic mechanisms putatively subserve riluzole-induced effects in Neuroprotection against amyotrophic lateral sclerosis (ALS): Implications for …
  8425. Strategies for Neuroprotection and Intraocular Pressure Modulation in Experimental Models of Glaucoma
  8426. Dietary Choline, Inflammation, and Neuroprotection Across the Lifespan
  8427. Concussive head injury exacerbates neuropathology of sleep deprivation: Superior Neuroprotection by co-administration of TiO2-nanowired cerebrolysin, alpha …
  8428. Insights on the modulatory role of Ayurveda-based herbal preparations on gut microbiome and Neuroprotection
  8429. Neuroprotection of Extracellular Vesicles From Human Adipose Stem Cells Intranasally Administered 24 Hours After Stroke In Rats
  8430. Cordycepin Confers long-term Neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury
  8431. Neuroprotection from Stem Cell-Derived Human Adipose Extracellular Vesicles Intranasally Administered 24 Hours After Stroke in Rats.
  8432. Oral administration of a dual ETA/ETB receptor antagonist promotes Neuroprotection in a rodent model of glaucoma
  8433. SUN-260 Dual Role of Carboxypeptidase E in Prohormone Processing and a Novel Neurotrophic Factor Mediating Neuroprotection and cognitive Functions in …
  8434. Neuroprotection by hypercapnia in brain ischemic injury followed by persistent hypoxia: an in vivo and in vitro experimental study
  8435. PHYSICAL ACTIVITY–INDUCED Neuroprotection IN PARKINSON’S DISEASE IS MEDIATED BY NEUROTROPHIC FACTORS
  8436. Efficacy of Neuroprotection from Curcumin through Heat Shock Protein 70 Induction in Traumatic brain Injury–Rat Model
  8437. EDARAVONE BASED ANTIOXIDANTS FOR CARDIOPROTECTION AND Neuroprotection
  8438. Role of N-Nitro-L-Arginine-Methylester in Neuroprotection of Cerebral Ischemic Preconditioning in Rats
  8439. Midkine in chick and mouse retinas: Neuroprotection , glial reactivity and the formation of Müller glia-derived progenitor cells
  8440. Activation of Glutamate Transporter-1 (GLT-1) Confers Sex-Dependent Neuroprotection in brain Ischemia. brain Sci. 2021, 11, 76
  8441. The mechanistic role of thymoquinone in Parkinson’s disease: focus on Neuroprotection in pre-clinical studies.
  8442. Retained Neuroprotection filter after stenting of the internal carotid artery
  8443. Total Saponins of Panax Notoginseng Exhibit Neuroprotection by The Activation of Akt/mTOR Pathway in Vitro and in Vivo
  8444. Astrocytes express DMT1 and transferrin receptors, which transport iron thus activating Ca2+ signalling: possible role in Neuroprotection against iron overload?
  8445. Current State of Primary Neuroprotection in Glaucoma
  8446. Glitazones, PPAR-γ and Neuroprotection .
  8447. Poly-arginine-18 (R18) confers Neuroprotection through glutamate receptor modulation, intracellular calcium reduction, and preservation of mitochondrial function
  8448. Investigation of the Mechanisms of Neuroprotection Mediated by Lobelia Species via Computational Network Pharmacology and Molecular Modeling
  8449. A novel synthetic peptide provides Neuroprotection and rescues rat cortical neurons from anesthetic-induced cell death and modulation of growth and synaptic …
  8450. Salidroside-pretreated mesenchymal stem cells contribute to Neuroprotection in cerebral ischemic injury in vitro and in vivo
  8451. … and Neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: Critical role of arginine guanidinium head groups for Neuroprotection
  8452. Author Correction: A novel indication of platonin, a therapeutic immunomodulating medicine, on Neuroprotection against ischemic stroke in mice
  8453. Novel Peptain for Neuroprotection in Glaucoma
  8454. MicroRNA-19a mediates Neuroprotection through the PTEN/AKT pathway in SK-N-SH cells after oxygen-glucose deprivation/reoxygenation injury.
  8455. Investigating the Role of Mitochondrial Trifunctional Protein Subunits in Neuroprotection After Stroke
  8456. An injectable refrigerated hydrogel for Inducing local hypothermia and Neuroprotection against traumatic brain injury
  8457. The Neuroprotection of hyperbaric oxygen therapy against traumatic brain injury via NF-κB/MAPKs-CXCL1 signaling pathway
  8458. Tetramethylpyrazine nitrone exerts Neuroprotection via PGC-1α/Nrf2 activation and α-synuclein clearance in Parkinson’s disease models
  8459. Combined Neuroprotection in chronic brain ischemia: goals, problems, instruments
  8460. Alzheimer’s Disease Neuroprotection : Associated Receptors
  8461. Recent Research Efforts to Achieve Neuroprotection , Progression and Treatment of Glaucoma
  8462. … of Autophagy by Ubisol-[Q. sub. 10] in Presenilin-1 Mutated Fibroblasts and Transgenic AD Mice: Implications for Inhibition of Senescence and Neuroprotection .
  8463. In Vivo Expression of Reprogramming Factor OCT4 Ameliorates Myelination Deficits and Induces Striatal Neuroprotection in Huntington’s Disease
  8464. Mechanistic insights into the curcumin-mediated Neuroprotection in Alzheimer’s disease: an integrated System Pharmacology and Molecular Simulation Study
  8465. PS1 familial Alzheimer disease mutants inactivate EFNB1-and BDNF-dependent Neuroprotection against excitotoxicity by affecting Neuroprotective complexes of …
  8466. Cerebral ischemia: options for perioperative Neuroprotection
  8467. Abstract WP310: PRIMED Preclinical Evidence Scoring Tool to Assess Readiness for Translation of Neuroprotection Therapies
  8468. Secondary Neuroprotection in Glaucoma from Change in Lifestyle
  8469. TREM2 interacts with TDP-43 and mediates microglial Neuroprotection against TDP-43-related neurodegeneration
  8470. Role of Adiponectin in Neuroinflammation & Neuroprotection
  8471. Efficacy of RAA7 treatment in TG4510 mouse model of Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8472. Neuroprotection by optical delivery of therapeutic gene into retina
  8473. Alfaxalone activates Human Pregnane-X Receptors with greater efficacy than Allopregnanolone: an in-vitro study with implications for Neuroprotection during …
  8474. Neuronal Metabolism and Neuroprotection : Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage. Cells 2021, 10, 34
  8475. Prenatal Stroke: Dectection and Neuroprotection
  8476. Neuroprotection in animal models of Parkinson’s disease: exploring exercise, sound, and light
  8477. Favorable Outcomes After Transcarotid Stenting With Reverse Flow Neuroprotection and Carotid Endarterectomy in High-Risk Patients in a High-Volume …
  8478. EVOO polyphenols can relieve autophagy dysregulation in Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8479. Anti-oxidants in astrocytes as target of Neuroprotection for Parkinson’s disease
  8480. The Endothelin Receptor Antagonist Macitentan Ameliorates Endothelin-Mediated Vasoconstriction and Promotes Neuroprotection of Retinal Ganglion Cells in Rats
  8481. THE EFFECTS Neuroprotection OF TELMISARTAN ON STROKE WITH HYPERTENSION
  8482. The Role of Glutamate Transporters in Neuroprotection After in vitro Stroke and Cocaine Seeking Behavior in vivo
  8483. Abstract P752: Neuroprotection by Remote Ischemic Conditioning in the Setting of Acute Ischemic Stroke: A Preclinical Two-Centre International Study
  8484. Abstract WP139: Intranasal Administration of Mesenchymal Stem Cell (MSC)-Derived Exosomes Confers Acute Neuroprotection After Neonatal Stroke
  8485. Melatonin as fetal Neuroprotection : Links and risks.
  8486. Effects of Magnetic Nanoparticle Drug Delivery Systems on Thrombosis and Neuroprotection in brain Stroke Model
  8487. Role of Antenatal Magnesium Sulphate as a Fetal Neuroprotection in Preterm Babies
  8488. Characterizing chromogranin and secretogranin proteoforms in dementia pathophysiology: Molecular and cell biology/neurodegeneration and Neuroprotection
  8489. Molecules capable to induce Neuroprotection via lysophagy activation
  8490. Bioenergetic Neuroprotection in experimental glaucoma
  8491. Rapid eye movement sleep behavior disorder: A proof-of-concept Neuroprotection study for prodromal synucleinopathies
  8492. MECHANISMS OF EXCITOTOXICITY AND Neuroprotection : A STUDY USING VITAL FLUORESCENCE TECHNIQUES
  8493. Correction to: Molecular mechanism of olesoxime-mediated Neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC
  8494. Induced Neuroprotection by remote ischemic perconditioning as a new paradigm in ischemic stroke at the acute phase
  8495. The Viability of Engineering a Clostridium to Produce DBHB and Enhance Neuroprotection
  8496. Study on the Mechanism of Gastrodia Rhizoma” FEATURE Identification based Quality Assessmen” based on Neuroprotection
  8497. Magnesium Sulfate for Fetal Neuroprotection
  8498. … and temporal cortex to intranasal insulin in rat model of sporadic Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8499. COMBINED Neuroprotection IN RECOVERY TREATMENT AFTER ISCHEMIC STROKE
  8500. … via restoring autophagy, apoptosis, microglia activation and synaptic plasticity in hippocampus: Molecular and cell biology/neurodegeneration and Neuroprotection
  8501. … ‐associated circular RNA circHOMER1 regulates synaptic gene expression and cognition : Molecular and cell biology: Neurodegeneration versus Neuroprotection
  8502. AC-YVAD-CMK Inhibits Caspase-1-mediated Imflammatory Response to Improve Bone Marrow Stromal Cells on Neuroprotection After Sci in Rats
  8503. Morinda citrifolia Linn.(Noni) fruit, antioxidant effects, and Neuroprotection
  8504. Chronic cerebrovascular diseases and Neuroprotection : the clinical efficacy of meldonium (Mildronat)
  8505. Abstract WP389: Anatomical Trajectory for Focused Ultrasound Stimulation of Fastigial Nucleus for Neuroprotection in Human Cerebral Ischemia
  8506. Molecular Markers of Endogenous Neuroprotection in the brain of Rats With Experimental Parkinson’s Disease and on the Background of Using New …
  8507. Cannabinoid Modulation of Development and Neuroprotection in African Naked Mole-Rats
  8508. Influence of amyloid‐beta isoforms in different in vitro models: Molecular and cell biology/neurodegeneration and Neuroprotection
  8509. STIFFENING THE POSTERIOR RAT SCLERA TO PROVIDE Neuroprotection IN GLAUCOMA
  8510. Circadian effects on stroke outcome–did we not wake up in time for Neuroprotection ?
  8511. … and memory impairment in diet‐induced insulin‐resistant mice are reversed by diet normalization: Molecular and cell biology/neurodegeneration and Neuroprotection
  8512. N-Nitro-L-Arginine-Methylester exerts Neuroprotection by inhibiting inflammation in Cerebral Injury Induced by Transient Ischemia/Reperfusion in rats.(2021)
  8513. Reduced Hemorrhagic Transformation and Neurological Worsening with Neuroprotection (3K3A-APC) During Thrombolysis and Thrombectomy
  8514. Co-administration of TiO2-nanowired dl-3-n-butylphthalide (dl-NBP) and mesenchymal stem cells enhanced Neuroprotection in Parkinson’s disease exacerbated by …
  8515. Metformin mediates Neuroprotection by regulating miR-141 and dampening the NF-ĸB-mediated inflammasome pathway in a diabetic mouse model
  8516. Modulation of HSP70-dependent mechanisms of endogenous Neuroprotection with selenium derivatives under conditions of ischemic-type acute cerebrovascular …
  8517. … in iron‐induced neurodegeneration: Implications in the pathogenesis of Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8518. Translating antenatal magnesium sulphate Neuroprotection for infants born
  8519. Abstract TP115: Nrf2 Plays an Essential Role in Long-Term Neuroprotection of Ginseng in Permanent Cerebral Ischemia
  8520. Tracking the ancestral functions of erythropoietin: Neuroprotection & mitochondria
  8521. Author Correction: Ethyl Acetate Extract Components of Bushen-Yizhi Formula Provides Neuroprotection against Scopolamine-induced cognitive Impairment
  8522. Investigating the potential of enhanced Neuroprotection through unfolded protein response inhibition and autophagy induction in neurodegeneration
  8523. InflaMab: A novel NLRP3 Inflammasome inhibitor provides Neuroprotection in a mouse model of glaucoma
  8524. … in the retinal ganglion cells is attenuated upon silencing of SHP2 phosphatase: Molecular and cell biology: Neurodegeneration versus Neuroprotection
  8525. … gene expression changes in young AD transgenic (APPswe/PS1ΔE9) mice through RNA‐seq: Molecular and cell biology/neurodegeneration and Neuroprotection
  8526. Using of Mg Sulphate for Fetal Neuroprotection in women Presenting by Fetal Distress during labour at Term: A Randomized Controlled Trial.
  8527. … ‐protein diet and decelerated by selected essential amino acids in a murine model of tauopathies: Molecular and cell biology/neurodegeneration and Neuroprotection
  8528. … editing of CLU to examine clusterin’s contribution to neurodegeneration and Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8529. TGF344‐AD rats exhibit cognitive reserve despite continual Aβ and tau accumulation: Molecular and cell biology: Neurodegeneration versus Neuroprotection
  8530. Neuroprotection of retinal ganglion cells suppresses microglia activation in a mouse model of glaucoma
  8531. Composite Nanofibers Incorporating Alpha Lipoic Acid and Atorvastatin Provide Neuroprotection after Peripheral Nerve Injury in Rats
  8532. Neuroprotection of experimental anterior ischemic optic neuropathy using adenovirus-mediated enhancement of cAMP signaling in the perinuclear compartment
  8533. Ischemic Preconditioning for Neuroprotection of Infants Undergoing Cardiopulmonary Bypass for Correction of Congenital Heart Disease
  8534. Thermostabilized chondroitinase ABC Promotes Neuroprotection after Contusion Spinal Cord Injury
  8535. … /NF‐κB pathway in D‐galactose and aluminum‐induced rat model with cognitive impairments: Molecular and cell biology/neurodegeneration and Neuroprotection
  8536. Neuroprotection against Alzheimer’s and lifespan extension induced by dietary restriction are associated with metabolomic changes and depend on oxidative …
  8537. Nicotinamide, neural cells, and Parkinson’s disease: exploring nicotinamide’s effects on proliferation, neuronal differentiation, and Neuroprotection within in vitro …
  8538. Rasagiline, Parkinson Neuroprotection , and delayed-start trials: Still no satisfaction?
  8539. HSP70-mediated Neuroprotection by combined treatment of valproic acid with hypothermia in a rat asphyxial cardiac arrest model
  8540. Progranulin improves memory in normal aging and Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8541. MicroRNA‐200a‐3p mediates Neuroprotection in Alzheimer‐related deficits and attenuates amyloid‐beta overproduction and tau hyperphosphorylation via co …
  8542. Pretreated Korean red pine bark extract provides potent Neuroprotection against transient global cerebral ischemic injury in the gerbil hippocampus through its …
  8543. The antidiabetic drug glibenclamide exerts direct retinal Neuroprotection
  8544. Post-treatment with oxcarbazepine confers potent Neuroprotection against transient global cerebral ischemic injury by activating Nrf2 defense pathway
  8545. … /SUR, increased vulnerability to neurodegeneration in drosophila models of Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8546. … of focal subclinical ischemia to pathogenesis in a mouse model of Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8547. THE PHOSPHODIESTERASE TYPE 4 INHIBITOR ROFLUMILAST CONFERS Neuroprotection AGAINST CEREBRAL ISCHEMIA BY TARGETING …
  8548. 466: Magnesium for Neuroprotection at the borderline of viability
  8549. DJ-1 in astrocytic Neuroprotection to oxidative stress
  8550. … of age‐and sex‐associated risk of mild cognitive impairment and subsequent Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8551. Protective low expression of PU. 1 reduces microglial inflammatory and phagocytic response: Molecular and cell biology: Neurodegeneration versus Neuroprotection
  8552. Melanocortin 1 receptor: Parkinson’s disease, melanoma risk, and Neuroprotection
  8553. … and activity dependent protein translation in ovariectomized Alzheimer’s disease mouse model: Molecular and cell biology/neurodegeneration and Neuroprotection
  8554. Preventive strategy against PM2. 5‐induced neuronal cell death: Molecular and cell biology/neurodegeneration and Neuroprotection
  8555. … of memory and affective behavior in common transgenic mouse models of Alzheimer’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8556. Chemical Inhibition of PTEN‐Induced Kinase 1 (PINK1) Degradation Confers Neuroprotection in Culture Models of Parkinson’s Disease
  8557. Development of novel pyruvate kinase muscle isoform 2 (PKM2) activators for photoreceptor Neuroprotection
  8558. … synthase kinase 3 beta protects against tau phosphorylation and stabilises microtubule assembly: Molecular and cell biology/neurodegeneration and Neuroprotection
  8559. Effectiveness of 6-shogaol in potentiating sevoflurane mediated Neuroprotection against ischemia/reperfusion-induced brain injury via regulating apoptotic proteins …
  8560. … ‐Rab4 vesicle causes synaptic defects and behavioral deficits seen in Huntington’s disease: Molecular and cell biology/neurodegeneration and Neuroprotection
  8561. Resumption of Autophagy by Ubisol-Q10 in Presenilin-1 Mutated Fibroblasts and Transgenic AD Mice: Implications for Inhibition of Senescence and Neuroprotection
  8562. LDN‐212320 improves Neuroprotection and synaptic plasticity in the hippocampus in an inflammatory pain model
  8563. 1462: Neuroprotection OF INTRANASAL HNSCS AND GLIBENCLAMIDE AGAINST brain INJURY AFTER CARDIAC ARREST
  8564. Risperidone treatment after transient ischemia induces hypothermia via 5-HT2a antagonism and provides Neuroprotection in the gerbil hippocampus by decreasing …
  8565. Neuroprotective therapy
  8566. DATATOP: a decade of Neuroprotective inquiry
  8567. The Neuroprotective pharmacology of methylprednisolone
  8568. Neuroprotective properties of nitric oxide
  8569. Recommendations for standards regarding preclinical Neuroprotective and restorative drug development
  8570. A femtomolar-acting Neuroprotective peptide.
  8571. Vascular endothelial growth factor: direct Neuroprotective effect in in vitro ischemia
  8572. Neuroprotective effects of estrogens: potential mechanisms of action
  8573. Ascorbate regulation and its Neuroprotective role in the brain
  8574. Prospects for new restorative and Neuroprotective treatments in Parkinson’s disease
  8575. A redox-based mechanism for the Neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
  8576. Do transient ischemic attacks have a Neuroprotective effect?
  8577. Adenosine: does it have a Neuroprotective role after all?
  8578. The Neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis
  8579. Clinical trials with Neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
  8580. Na+ channels as targets for Neuroprotective drugs
  8581. Production of neurotrophins by activated T cells: implications for Neuroprotective autoimmunity
  8582. Neuroprotective antioxidants from marijuana
  8583. Complete sequence of a novel protein containing a femtomolar‐activity‐dependent Neuroprotective peptide
  8584. Neuroprotective properties of statins in cerebral ischemia and stroke
  8585. Neuroprotective role of adenosine in cerebral ischaemia
  8586. The Neuroprotective potential of heat shock protein 70 (HSP70)
  8587. Neuroprotective signaling and the aging brain : take away my food and let me run
  8588. Immunophilins mediate the Neuroprotective effects of FK506 in focal cerebral ischaemia
  8589. Cannabidiol and (−) Δ9-tetrahydrocannabinol are Neuroprotective antioxidants
  8590. Neuroprotective role of IL-4 against activated microglia.
  8591. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
  8592. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington’s disease
  8593. Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system
  8594. Phenolic A ring requirement for the Neuroprotective effects of steroids
  8595. Potential Neuroprotective therapy for glaucomatous optic neuropathy
  8596. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts Neuroprotective effects
  8597. Estradiol exerts Neuroprotective effects when administered after ischemic insult
  8598. The antioxidant Neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties
  8599. Neuroprotective signal transduction: relevance to stroke
  8600. Gender differences in acute CNS trauma and stroke: Neuroprotective effects of estrogen and progesterone
  8601. Neuroprotective effects of creatine in a transgenic mouse model of Huntington’s disease
  8602. Serum growth factors and Neuroprotective surveillance
  8603. Platinum neurotoxicity: clinical profiles, experimental models and Neuroprotective approaches
  8604. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
  8605. … human T cells, B cells, and monocytes produce brain -derived neurotrophic factor in vitro and in inflammatory brain lesions: a Neuroprotective role of inflammation?
  8606. Progesterone is Neuroprotective after transient middle cerebral artery occlusion in male rats
  8607. Neuroprotective role of dopamine against hippocampal cell death
  8608. Neuroprotective strategies in a model of chronic glutamate‐mediated motor neuron toxicity
  8609. Neuroprotective role of curcumin from Curcuma longa on ethanol‐induced brain damage
  8610. In vivo and in vitro experiments show that betaxolol is a retinal Neuroprotective agent
  8611. The Neuroprotective agent riluzole activates the two P domain K+ channels TREK-1 and TRAAK
  8612. Repetitive transcranial magnetic stimulation in rats: evidence for a Neuroprotective effect in vitro and in vivo
  8613. Activity-dependent release of brain -derived neurotrophic factor underlies the Neuroprotective effect of N-methyl-D-aspartate
  8614. Neuroprotective and neurorestorative properties of GDNF
  8615. Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin‐like growth factor‐I signalling
  8616. Comparative Neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia
  8617. Duration of Neuroprotective treatment for ischemic stroke
  8618. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage
  8619. Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury
  8620. Excitotoxicity, oxidative stress, and the Neuroprotective potential of melatonin
  8621. Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat
  8622. Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity
  8623. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide
  8624. Animal models of acute ischaemic stroke: can they predict clinically successful Neuroprotective drugs?
  8625. Dopamine D2 receptor-mediated antioxidant and Neuroprotective effects of ropinirole, a dopamine agonist
  8626. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat
  8627. Memantine is Neuroprotective in a rat model of pressure-induced retinal ischemia.
  8628. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons
  8629. A novel Neuroprotective mechanism of riluzole: direct inhibition of protein kinase C
  8630. Long-lasting Neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic …
  8631. Genistein is Neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke
  8632. Neuroprotective effects of glycine for therapy of acute ischaemic stroke
  8633. Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury
  8634. A convenient extension of the Wessely–Moser rearrangement for the synthesis of substituted alkylaminoflavones as Neuroprotective agents in vitro
  8635. brain endothelial cell production of a Neuroprotective cytokine, interleukin-6, in response to noxious stimuli
  8636. Increased activity‐regulating and Neuroprotective efficacy of α‐secretase‐derived secreted amyloid precursor protein conferred by a C‐terminal heparin‐binding …
  8637. Evidence for Neuroprotective effects of endogenous brain -derived neurotrophic factor after global forebrain ischemia in rats
  8638. Neuroprotective activity of acetyl‐L‐carnitine: Studies in vitro
  8639. Induction of activin A is essential for the Neuroprotective action of basic fibroblast growth factor in vivo
  8640. The Neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1
  8641. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases
  8642. Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia
  8643. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial.
  8644. Possible Neuroprotective role of clusterin in Alzheimer’s disease: a quantitative immunocytochemical study
  8645. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus
  8646. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia
  8647. Neutrophil inhibitory factor is Neuroprotective after focal ischemia in rats
  8648. Potent Neuroprotective properties against the Alzheimer β-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid
  8649. The neurosteroid 3α, 5α-THP has antiseizure and possible Neuroprotective effects in an animal model of epilepsy
  8650. Diffusion-weighted magnetic resonance imaging confirms marked Neuroprotective efficacy of albumin therapy in focal cerebral ischemia
  8651. A transforming growth factor-β antagonist unmasks the Neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury
  8652. Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis
  8653. Dehydroepiandrosterone sulfate is Neuroprotective in a reversible spinal cord ischemia model
  8654. Induction of Neuroprotective κB-dependent transcription by secreted forms of the Alzheimer’s β-amyloid precursor
  8655. Neuroprotective versus neurodestructive effects of NO‐related species
  8656. Towards a Neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in …
  8657. The unique histopathological responses of the injured spinal cord: implications for Neuroprotective therapy
  8658. Ischemia-induced interleukin-6 as a potential endogenous Neuroprotective cytokine against NMDA receptor-mediated excitoxicity in the brain
  8659. Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures
  8660. Block of the rat brain IIA sodium channel alpha subunit by the Neuroprotective drug riluzole.
  8661. Neuroprotective properties of propofol and midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABAA receptors
  8662. Sarcophytolide: A new Neuroprotective compound from the soft coral Sarcophyton glaucum
  8663. TV3326, a novel Neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer’s disease
  8664. Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat
  8665. Neuroprotective efficacy of ebselen, an anti‐oxidant with anti‐inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion
  8666. Neurotrophic and Neuroprotective Effects of hAPP in Transgenic Mice a
  8667. Pharmacology and Neuroprotective properties of rasagiline
  8668. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic …
  8669. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo
  8670. Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor
  8671. Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia
  8672. Neuroprotective effects of TGF-beta 1.
  8673. Up‐regulation of a serine protease inhibitor in astrocytes mediates the Neuroprotective activity of transforming growth factor β1
  8674. The Neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat
  8675. Neuroprotective effects of group III mGluR in traumatic neuronal injury
  8676. The Neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats
  8677. Neurotrophic and Neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain
  8678. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons
  8679. Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse
  8680. The Neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia
  8681. Neuroprotective activity of chemokines against N-methyl-D-aspartate or β-amyloid-induced toxicity in culture
  8682. Neuroprotective phenylpropanoid esters of rhamnose isolated from roots of Scrophularia buergeriana
  8683. Neuroprotective Strategies in Parkinson’s Disease Using the Models of 6‐Hydroxydopamine and MPTPa
  8684. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: Neuroprotective strategies
  8685. Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats
  8686. Pathogenesis and Neuroprotective treatment in Purtscher’s retinopathy
  8687. The causes of Parkinson’s disease are being unraveled and rational Neuroprotective therapy is close to reality
  8688. Neuroprotective effects of brain -derived neurotrophic factor in seizures during development
  8689. Neurotoxicity of advanced glycation endproducts during focal stroke and Neuroprotective effects of aminoguanidine.
  8690. Neuroprotective approaches in experimental models of β-amyloid neurotoxicity: relevance to Alzheimer’s disease
  8691. Emerging Neuroprotective strategies for Alzheimer’s disease: dietary restriction, telomerase activation, and stem cell therapy
  8692. A mouse model of focal cerebral ischemia for screening Neuroprotective drug effects
  8693. The Neuroprotective and neuronal rescue effects of (—)-deprenyl
  8694. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
  8695. Neuroprotective Effects of L-Kynurenine on Hypoxia—Ischemia and NMDA Lesions in Neonatal Rats
  8696. Evaluation of designs for clinical trials of Neuroprotective agents in head injury
  8697. Characterization of the Neuroprotective and toxic effects of α7 nicotinic receptor activation in PC12 cells
  8698. The Neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial–neuronal signaling
  8699. Neuroprotective effects of citicoline on brain edema and blood—brain barrier breakdown after traumatic brain injury
  8700. Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia
  8701. Neuroprotective effects of PACAP38 in a rat model of transient focal ischemia under various experimental conditions
  8702. Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen‐glucose deprivation or excitatory amino acids
  8703. In vivo evidence that erythropoietin has a Neuroprotective effect during subarachnoid hemorrhage
  8704. A mechanism for the Neuroprotective effect of apolipoprotein E: isoform‐specific modification by the lipid peroxidation product 4‐hydroxynonenal
  8705. Mechanisms involved in the Neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia
  8706. Can calcium antagonists provide a Neuroprotective effect in Parkinson’s disease?
  8707. Neurotoxic and Neuroprotective actions of catecholamines in cortical neurons
  8708. N-Substituted Adenosines as Novel Neuroprotective A1 Agonists with Diminished Hypotensive Effects
  8709. Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist
  8710. Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways
  8711. Neuroprotective effects of α-lipoic acid and its positively charged amide analogue
  8712. Neuroprotective effects of α-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia
  8713. In vitro Neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418
  8714. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation
  8715. Glucocorticoids reduce interleukin‐1β concentration and result in Neuroprotective effects in rat heatstroke
  8716. Neuroprotective effect of 5-HT1A receptor agonist, Bay× 3702, demonstrated in vitro and in vivo
  8717. Adenosine–an endogenous Neuroprotective metabolite and neuromodulator.
  8718. Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells
  8719. The Neuroprotective agent MS-153 stimulates glutamate uptake
  8720. Neuroprotective actions of GR89696, a highly potent and selective κ‐opioid receptor agonist
  8721. Neuroprotective properties of calcium-channel blockers.
  8722. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia
  8723. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis
  8724. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury
  8725. Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.
  8726. The Neuroprotective actions of 2, 3-dihydroxy-6-nitro-7-sulfamoyl-benzo (F) quinoxaline (NBQX) in a rat focal ischaemia model
  8727. The putative essential nutrient pyrroloquinoline quinone is Neuroprotective in a rodent model of hypoxic/ischemic brain injury
  8728. Progesterone in conjunction with estradiol has Neuroprotective effects in an animal model of neurodegeneration
  8729. Dexanabinol; a novel Neuroprotective drug in experimental focal cerebral ischemia
  8730. Effects of the Neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons
  8731. Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for Neuroprotective strategies
  8732. Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy
  8733. Neuroprotective role for the p50 subunit of NF-κB in an experimental model of Huntington’s disease
  8734. Modulation of the kynurenine pathway in search for new Neuroprotective agents . Synthesis and preliminary evaluation of (m-nitrobenzoyl) alanine, a potent inhibitor of …
  8735. Neuroprotective effects of riluzole on a model of Parkinson’s disease in the rat
  8736. Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse Neuroprotective agents , exhibits Δ8-Δ7 sterol isomerase activity in …
  8737. Neuroprotective effects of melatonin
  8738. Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not Neuroprotective
  8739. Neuroprotective effects of NG-nitro-L-arginine in focal stroke in the 7-day old rat
  8740. Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons
  8741. Preclinical testing of Neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration
  8742. HSP70 is essential to the Neuroprotective effect of heat-shock
  8743. Propentofylline: a nucleoside transport inhibitor with Neuroprotective effects in cerebral ischemia
  8744. Kynurenate is Neuroprotective following experimental brain injury in the rat
  8745. memory restoring and Neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model.
  8746. Cerebral interleukin-6 is Neuroprotective during permanent focal cerebral ischemia in the rat
  8747. Neuroprotective effects of inhibiting poly (ADP-ribose) synthetase on focal cerebral ischemia in rats
  8748. The Neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine …
  8749. Techniques for assessing Neuroprotective drugs in vitro
  8750. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and Neuroprotective effects in manic depressive illness
  8751. The Neuroprotective action of dizocilpine (MK‐801) in the rat middle cerebral artery occlusion model of focal ischaemia
  8752. Neuroprotective efficacy of microvascularly-localized versus brain -penetrating antioxidants
  8753. Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its Neuroprotective activity
  8754. Efficacy of a new Neuroprotective agent, gacyclidine, in a model of rat spinal cord injury
  8755. Estradiol is a Neuroprotective factor in in vivo and in vitro models of brain injury
  8756. A novel signaling molecule for neuropeptide action: activity‐dependent Neuroprotective protein
  8757. Lithium at 50: have the Neuroprotective effects of this unique cation been overlooked?
  8758. Neuroprotective effect of hypothermia on neuronal injury in diffuse traumatic brain injury coupled with hypoxia and hypotension
  8759. Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation
  8760. Neuroprotective effects of riluzole in ALS CSF toxicity.
  8761. Nitrone-based free radical traps as Neuroprotective agents in cerebral ischaemia and other pathologies
  8762. Synthesis, structure, and Neuroprotective properties of novel imidazolyl nitrones
  8763. Neuroprotective mechanism of glial cell line‐derived neurotrophic factor in mesencephalic neurons
  8764. Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro
  8765. Neuroprotective effect of high-dose albumin therapy against global ischemic brain injury in rats
  8766. Neuroprotective and memory -Related Actions of NovelAlpha-7 Nicotinic agents with Different Mixed Agonist/Antagonist Properties
  8767. Neuroprotective Effects of Ginkgo biloba Extract
  8768. Neuroprotective Effects of MgSO4 and MgCl2 in Closed Head Injury: A Comparative Phosphorus NMR Study
  8769. Resazurin detection of energy metabolism changes in serum-starved PC12 cells and of Neuroprotective agent effect
  8770. Neurotrophic and Neuroprotective effects of pituitary adenylate cyclase‐activating polypeptide (PACAP) on mesencephalic dopaminergic neurons
  8771. Neuroprotective effects of brain -derived neurotrophic factor in eyes with NMDA-induced neuronal death
  8772. An investigation into the potential mechanisms underlying the Neuroprotective effect of clonidine in the retina
  8773. Involvement of monoamine oxidase inhibition in Neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal …
  8774. AMPA, but not NMDA, receptor antagonism is Neuroprotective in gerbil global ischaemia, even when delayed 24 h
  8775. Flupirtine: A review of its Neuroprotective and behavioral properties
  8776. Neuroprotective effects of acetyl-L-carnitine after stroke in rats
  8777. Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury
  8778. Neuroprotective effect of the free radical scavenger MCI-186 in patients with cerebral infarction: clinical evaluation using magnetic resonance imaging and …
  8779. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist,(+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison …
  8780. The Neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain
  8781. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is Neuroprotective whereas E4 increases fatalities
  8782. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with Neuroprotective effects in global cerebral ischaemia
  8783. Dopamine D2‐type agonists protect mesencephalic neurons from glutamate neurotoxicity: Mechanisms of Neuroprotective treatment against oxidative stress
  8784. Considerations in the design of clinical trials of Neuroprotective therapy in acute stroke
  8785. Pyrrolopyrimidines: novel brain -penetrating antioxidants with Neuroprotective activity in brain injury and ischemia models
  8786. Nerve agent poisoning in primates: antilethal, anti-epileptic and Neuroprotective effects of GK-11
  8787. Mechanisms of the Neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices
  8788. Endothelin inhibition improves cerebral blood flow and is Neuroprotective in pneumococcal meningitis
  8789. Neurotoxic/Neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024
  8790. TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential Neuroprotective …
  8791. Astrocyte metallothioneins (MTs) and their Neuroprotective role.
  8792. Neuroprotective strategies in Parkinson’s disease: protection against progressive nigral damage induced by free radicals
  8793. Neuroprotective effects of 2, 4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats
  8794. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors
  8795. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential Neuroprotective effects of β-blockers
  8796. A novel VIP responsive gene: activity dependent Neuroprotective protein
  8797. A review of earlier clinical studies on Neuroprotective agents and current approaches
  8798. NGF mediates the Neuroprotective effect of the β2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study
  8799. Asymmetric synthesis of a Neuroprotective and orally active N-methyl-D-aspartate receptor ion-channel blocker, CNS 5788
  8800. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia
  8801. The Neuroprotective actions of a calcium channel antagonist, flunarizine, in the infant rat
  8802. Vulnerability of Midbrain Dopaminergic Neurons in Calbindin‐D28k‐deficient Mice: Lack of Evidence for a Neuroprotective Role of Endogenous Calbindin in …
  8803. Neuroprotective therapies
  8804. Neuroprotective effects of phenolic A ring oestrogens
  8805. Overexpression of heme oxygenase‐1 is Neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice
  8806. ACTH-related peptides: receptors and signal transduction systems involved in their neurotrophic and Neuroprotective actions
  8807. Vinpocetine increases the Neuroprotective effect of adenosine in vitro
  8808. Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro
  8809. Neuroprotective effect of melatonin on cortical impact injury in the rat
  8810. Antiparkinsonian and Neuroprotective effects of modafinil in the mptp-treated common marmoset
  8811. Insulin-like growth factor-1 (IGF-1): a Neuroprotective trophic factor acting via the Akt kinase pathway
  8812. NMDA and kainate‐evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a Neuroprotective role
  8813. Neuroprotective actions of dipyridamole on cultured CNS neurons
  8814. Neuroprotective therapy for Parkinson’s disease
  8815. 45Ca accumulation in rat brain after closed head injury; attenuation by the novel Neuroprotective agent HU-211
  8816. Activation of group III metabotropic glutamate receptors is Neuroprotective in cortical cultures
  8817. Caspase inhibitors are functionally Neuroprotective against oxygen glucose deprivation induced CA1 death in rat organotypic hippocampal slices
  8818. The Neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat
  8819. Neuroprotective activity of tiagabine in a focal embolic model of cerebral ischemia
  8820. Neuroprotective effects of creatine administration against NMDA and malonate toxicity
  8821. Neuroprotective effects of riluzole and ketamine during transient spinal cord ischemia in the rabbit
  8822. Postischemic diazepam is Neuroprotective in the gerbil hippocampus
  8823. Antidepressants upregulate messenger RNA levels of the Neuroprotective enzyme superoxide dismutase (SOD1).
  8824. Neuroprotective and neurodestructive effects of nitric oxide and redox congeners
  8825. Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with Neuroprotective properties
  8826. Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system
  8827. … in ionized and total blood magnesium after experimental traumatic brain injury: relationship to neurobehavioral outcome and Neuroprotective efficacy of magnesium …
  8828. Neuroprotective Drug Therapy: A Medical and Pharmacological Treatment for Tinnitus Control.
  8829. Blockade of adenosine A2A receptors by SCH 58261 results in Neuroprotective effects in cerebral ischaemia in rats
  8830. VIP neurotrophism in the central nervous system: Multiple effectors and identification of a femtomolar‐acting Neuroprotective peptide
  8831. Neuroprotective properties of a protein kinase inhibitor against ischaemia‐induced neuronal damage in rats and gerbils
  8832. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia.
  8833. Regional Neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage
  8834. Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat
  8835. Neuroprotective potency of kynurenic acid against excitotoxicity
  8836. Growth factors and gangliosides as Neuroprotective agents in excitotoxicity and ischemia
  8837. Neuroprotective strategies in nature—novel clues for the treatment of stroke and trauma
  8838. Neuroprotective nitric oxide synthase inhibitor reduces intracellular calcium accumulation following transient global ischemia in the gerbil
  8839. Development of a novel Neuroprotective drug (TV3326) for the treatment of Alzheimer’s disease, with cholinesterase and monoamine oxidase inhibitory activities
  8840. Properties of Neuroprotective cell-permeant Ca2+ chelators: effects on [Ca2+] i and glutamate neurotoxicity in vitro
  8841. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo …
  8842. Glutamate receptor requirement for neuronal death from anoxia–reoxygenation: an in vitro model for assessment of the Neuroprotective effects of estrogens
  8843. Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: Neuroprotective effects when used alone or in combination with urokinase
  8844. Riluzole, a novel Neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat
  8845. Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil
  8846. Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its Neuroprotective effects
  8847. Neuroprotective electrical stimulation of cerebellar fastigial nucleus attenuates expression of periinfarction depolarizing waves (PIDs) and inhibits cortical spreading …
  8848. Neuroprotective therapies in stroke
  8849. Imidazoline-induced Neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures
  8850. Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study
  8851. Selective Neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep
  8852. LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is Neuroprotective in gerbil global, but not focal, cerebral ischaemia
  8853. Antagonism of non-NMDA receptors augments the Neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen …
  8854. Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia
  8855. Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase
  8856. Heme oxygenase-2 is Neuroprotective in cerebral ischemia
  8857. Activation of metabotropic receptors has a Neuroprotective effect in a rodent model of focal ischaemia
  8858. Analysis of the Neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture
  8859. The Neuroprotective drug vinpocetine prevents veratridine-induced [Na+] i and [Ca2+] i rise in synaptosomes
  8860. Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration
  8861. Recruitment of several Neuroprotective pathways after permanent focal ischemia in mice
  8862. The Neuroprotective actions of chlormethiazole
  8863. Both the antioxidant and D3 agonist actions of pramipexole mediate its Neuroprotective actions in mesencephalic cultures
  8864. Neuroprotective therapy for argon-laser induced retinal injury
  8865. MK-801, memantine and amantadine show Neuroprotective activity in the nucleus basalis magnocellularis
  8866. Clinical potential for the use of Neuroprotective agents . A brief overview.
  8867. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an ω3 site ligand
  8868. Androgens are Neuroprotective in the dentate gyrus of adrenalectomized female rats
  8869. Neuroprotective properties of 5-HT1A receptor agonists En rodent models of focal and global cerebral ischemia
  8870. Neuroprotective effects of riluzole on N-methyl-D-aspartate-or veratridine-induced neurotoxicity in rat hippocampal slices
  8871. Neuroprotective effects of nicergoline in immortalized neurons
  8872. Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: dose-window and time-window effects
  8873. Distinct Neuroprotective profiles for σ ligands against N-methyl-d-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies
  8874. Techniques for examining Neuroprotective drugs in vivo
  8875. Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions
  8876. Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: Neuroprotective drug design
  8877. Neuroprotective actions of peripherally administered insulin‐like growth factor I in the injured olivo‐cerebellar pathway
  8878. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia
  8879. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the Neuroprotective drugs, chlormethiazole and dizocilpine
  8880. Evidence for Neuroprotective effects of acidic fibroblast growth factor in Alzheimer disease
  8881. LY377770, a novel iGlu5 kainate receptor antagonist with Neuroprotective effects in global and focal cerebral ischaemia
  8882. EEG Spectral Analysis of the Neuroprotective KappaOpioids Enadoline and PD117302
  8883. Intracerebroventricular propofol is Neuroprotective against transient global ischemia in rats: extracellular glutamate level is not a major determinant
  8884. A rationale for monoamine oxidase inhibition as Neuroprotective therapy for Parkinson’s disease
  8885. Neuroprotective effect of high glucose against NMDA, free radical, and oxygen–glucose deprivation through enhanced mitochondrial potentials
  8886. Neuroprotective Effect of the χ‐Agonist Enadoline (CI‐977) in Rat Models of Focal Cerebral Ischaemia
  8887. Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology
  8888. N-acetylated-α-linked-acidic dipeptidase inhibitor has a Neuroprotective effect on mouse retinal ganglion cells after pressure-induced ischemia
  8889. Neuregulins as potential Neuroprotective agents .
  8890. Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones
  8891. Postischemic treatment (2–4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are Neuroprotective after transient (2 h) focal cerebral ischemia in the rat
  8892. Anticonvulsive and Neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat
  8893. BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising Neuroprotective strategy
  8894. Recently developed Neuroprotective therapies for acute stroke
  8895. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia
  8896. Neuroprotective effect of AIP on N-methyl-D-aspartate-induced cell death in retinal neurons
  8897. … of astrocytes to hypoxia/reoxygenation enhances expression of glucose‐regulated protein 78 facilitating astrocyte release of the Neuroprotective cytokine interleukin 6
  8898. Selective N-type calcium channel antagonist omega conotoxin MVIIA is Neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures …
  8899. Neuroprotective effects of 619C89, a use-dependent sodium channel blocker, in rat traumatic brain injury
  8900. Neuroprotective effect of γ-hydroxybutyrate in transient global cerebral ischemia in the rat
  8901. An investigation into the Neuroprotective properties of ibuprofen
  8902. A femtomolar-acting Neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential Neuroprotective mechanism
  8903. High dose baclofen is Neuroprotective but also causes intracerebral hemorrhage: a quantal bioassay study using the intraluminal suture occlusion method
  8904. The Neuroprotective effect of cerebral poly (ADP-ribose) polymerase inhibition in a rat model of global ischemia
  8905. Spermine is Neuroprotective against anoxia and N-methyl-D-aspartate in hippocampal slices
  8906. Ion channel modulation as the basis for Neuroprotective action of MS‐153
  8907. The endogenous cofactors, thioctic acid and dihydrolipoic acid, are Neuroprotective against NMDA and malonic acid lesions of striatum
  8908. Novel polyamine derivatives as Neuroprotective agents
  8909. NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: Neuroprotective properties of amantadine and memantine
  8910. Delayed treatment with AM-36, a novel Neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in …
  8911. A stereological study on the Neuroprotective actions of acute modafinil treatment on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced nigral lesions of the male …
  8912. Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones
  8913. Selection of neonates for Neuroprotective therapies: one set of criteria applied to a population
  8914. Altered Na+-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other Neuroprotective drugs
  8915. GABA agonist” muscimol” is Neuroprotective in repetitive transient forebrain ischemia in gerbils
  8916. Zonisamide as a Neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study
  8917. Overexpression of Bcl‐2 is Neuroprotective after experimental brain injury in transgenic mice
  8918. Treatment with antiepileptic drugs: possible Neuroprotective effects
  8919. Astressin, a novel and potent CRF antagonist, is Neuroprotective in the hippocampus when administered after a seizure
  8920. Electrophysiology of the Neuroprotective agent riluzole on striatal spiny neurons
  8921. Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia
  8922. Neuroprotective effect of insulin-like growth factor I in immortalized hypothalamic cells
  8923. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is Neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington’s disease
  8924. Hypoxia triggers Neuroprotective alterations in hippocampal gene expression via a heme-containing sensor
  8925. Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons
  8926. Neuroprotective efficacy of YM872, an α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in …
  8927. Ultrastructural changes in nitric oxide synthase immunoreactivity in the brain of rats subjected to perinatal asphyxia: Neuroprotective effects of cold treatment
  8928. Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion
  8929. Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats
  8930. Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits in an experimental Alzheimer’s disease in rats
  8931. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia
  8932. Enzyme-catalyzed production of the Neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo
  8933. Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat
  8934. Aortic arch surgery: retrospective analysis of outcome and Neuroprotective strategies
  8935. Neuroprotective effects of riluzole in neurotrauma models: a review
  8936. Selective blockade of metabotropic glutamate receptor subtype 5 is Neuroprotective
  8937. Posthypoxic treatment with felbamate is Neuroprotective in a rat model of hypoxia‐ischemia
  8938. Neuroprotective and neurodestructive functions of nitric oxide after spinal cord hemisection
  8939. MK-801 is Neuroprotective in gerbils when administered during the post-ischaemic period
  8940. The Neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia
  8941. Neuroprotective efficacy of Nω-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase
  8942. Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain …
  8943. Opportunities for Neuroprotective drugs in clinical management of head injury.
  8944. Neuroprotective effects of hypothermia and U‐78517F in cerebral ischemia are due to reducing oxygen‐based free radicals: an electron paramagnetic resonance …
  8945. The Neuroprotective effect of a new serotonin receptor agonist, BAY X3702, upon focal ischemic brain damage caused by acute subdural hematoma in the rat
  8946. From the lab to the clinic: activation of an alpha-2 agonist pathway is Neuroprotective in models of retinal and optic nerve injury
  8947. Neuroprotective effect of chronic infusion of basic fibroblast growth factor on seizure-associated hippocampal damage
  8948. Evaluating Neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary …
  8949. (R, S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and Neuroprotective in vivo
  8950. Cigarette smoking and Parkinson disease: the illusion of a Neuroprotective effect.
  8951. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82, 0715 on hippocampal cells in culture.
  8952. brain concentrations of kynurenic acid after a systemic Neuroprotective dose in the gerbil model of global ischemia
  8953. Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible Neuroprotective mechanism in dopaminergic neurotoxicity
  8954. Neuroprotective effect of somatostatin on nonapoptotic NMDA‐induced neuronal death: role of cyclic GMP
  8955. Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson’s disease
  8956. Neuroprotective effects of early vs. late administration of dantrolene in experimental status epilepticus
  8957. Neuroblastoma cells for testing Neuroprotective drug effects
  8958. Ironing-out mechanisms of neuronal injury under hypoxic–ischemic conditions and potential role of iron chelators as Neuroprotective agents
  8959. Neuroprotective utility and neurotrophic action of neurturin in postnatal motor neurons: comparison with GDNF and persephin
  8960. The Neuroprotective effect of high-dose methylprednisolone in rat spinal cord hemisection
  8961. Neuroprotective sigma ligands interfere with the glutamate‐activated NOS pathway in hippocampal cell culture
  8962. A novel evidence of different mechanisms of lithium and valproate Neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency
  8963. N‐Methyl‐d‐Aspartate Receptor Desensitisation Is Neuroprotective by Inhibiting Glutamate‐Induced Apoptotic‐Like Death
  8964. Leads for the development of Neuroprotective treatment in Parkinson’s disease and brain imaging methods for estimating treatment efficacy
  8965. Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the rat
  8966. Endogenous interleukin-1 receptor antagonist is Neuroprotective
  8967. Pentamidine is an N-methyl-D-aspartate receptor antagonist and is Neuroprotective in vitro
  8968. Neuroprotective effects of preischemia subcutaneous magnesium sulfate in transient cerebral ischemia
  8969. Potential of Neuroprotective therapy in Parkinson’s disease
  8970. Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a Neuroprotective drug
  8971. The Neuroprotective effects of gamma-vinyl GABA in transient global ischemia: a morphological study with early and delayed evaluations
  8972. The Neuroprotective effects of the recombinant interleukin–1 receptor antagonist rhIL–1ra after excitotoxic stimulation with kainic acid and its relationship to the …
  8973. In vivo evidence against clomethiazole being Neuroprotective against MDMA (‘ecstasy’)-induced degeneration of rat brain 5-HT nerve terminals by a free radical …
  8974. Additive Neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia
  8975. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil
  8976. Mechanisms of tissue injury in multiple sclerosis: opportunities for Neuroprotective therapy
  8977. … effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to Neuroprotective
  8978. Ascorbic acid is Neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data
  8979. Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia
  8980. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton …
  8981. Determination of serum and brain concentrations of Neuroprotective and non-Neuroprotective doses of MK-801
  8982. Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model
  8983. Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils
  8984. Neuroprotective therapeutic strategies comparison of experimental and clinical results
  8985. Acute reorganization of the forepaw representation in the rat SI cortex after focal cortical injury: Neuroprotective effects of piracetam treatment
  8986. Neuroprotective effects of the α2-adrenoceptor antagonists,(+)-efaroxan and (±)-idazoxan, against quinolinic acid-induced lesions of the rat striatum
  8987. Neuroprotective effect of selenium on iminodipropionitrile-induced toxicity.
  8988. Relative Neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat
  8989. Neuroprotective efficacy of lifarizine (RS‐87476) in a simplified rat survival model of 2 vessel occlusion
  8990. Potent Neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity
  8991. Basic fibroblast growth factor is highly Neuroprotective against seizure-induced long-term behavioural deficits
  8992. Neuroprotective potential of aromatic alcohols against oxidative cell death
  8993. The Neuroprotective efficacy of MK-801 in focal cerebral ischemia varies with rat strain and vendor
  8994. Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model
  8995. An international network for evaluating Neuroprotective therapy after severe birth asphyxia
  8996. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats
  8997. Moclobemide reduces intracellular pH and neuronal activity of CA3 neurones in guinea-pig hippocampal slices—implication for its Neuroprotective properties
  8998. Neuroprotective effect of felbamate after kainic acid‐induced status epilepticus
  8999. Overexpression of the cell death suppressor Bcl-w in ischemic brain : implications for a Neuroprotective role via the mitochondrial pathway
  9000. In vitro antioxidant Neuroprotective activity of BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation
  9001. Postischemic seizures and necrotizing ischemic brain damage: Neuroprotective effect of postischemic diazepam and insulin
  9002. The Neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia.
  9003. The women’s health initiative estrogen replacement therapy is neurotrophic and Neuroprotective
  9004. Mediation of the Neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.
  9005. Neuroprotective effect of low dose riluzole in gerbil model of transient global ischemia
  9006. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons
  9007. SNX-111, a novel, presynaptic N-type calcium channel antagonist, is Neuroprotective against focal cerebral ischemia in rabbits
  9008. Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia.
  9009. … Different Acidic Function in the 3-Position:  6,7-Dichloro-2(1H)-oxoquinoline-3-phosphonic Acid, a New Potent and Selective AMPA/Kainate Antagonist with Neuroprotective …
  9010. Neuroprotective profile of lifarizine (RS‐87476) in rat cerebrocortical neurones in culture
  9011. NMDA receptor antagonists and their potential as Neuroprotective agents
  9012. Neuroprotective Agent Chlomethiazole Attenuates c-fos, c-jun, and AP-1 Activation through Inhibition of p38 MAP Kinase
  9013. Inhibitory effect of the Neuroprotective agent idebenone on arachidonic acid metabolism in astrocytes
  9014. Polyamine amides are Neuroprotective in cerebellar granule cell cultures challenged with excitatory amino acids
  9015. Neuroprotective effects of PKC inhibition against chemical hypoxia
  9016. Selegiline is Neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium
  9017. Neuroprotective effect of N-methyl-D-aspartate receptor antagonists in an experimental glaucoma model in the rat
  9018. The Neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia
  9019. Herpes simplex viral vectors expressing Bcl-2 are Neuroprotective when delivered after a stroke
  9020. The Neuroprotective Effect of the Glycine Site Antagonist 3R-(+)-cis-4-Methyl-HA966 (L-687,414) in a Rat Model of Focal Ischaemia
  9021. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen–glucose deprivation-induced neuronal death
  9022. Neuroprotective effect of α-phenyl-N-tert-butylnitrone in gerbil hippocampus is mediated by the mitogen-activated protein kinase pathway and heat shock proteins
  9023. Synergistic Neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia
  9024. Neuroprotective effects of the novel brain ‐penetrating pyrrolopyrimidine antioxidants U‐101033E and U‐104067F against post‐ischemic degeneration of nigrostriatal …
  9025. The Neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats
  9026. Synthesis of novel 2, 4-diaminopyrrolo [2, 3-d] pyrimidines with antioxidant, Neuroprotective , and antiasthma activity
  9027. Studies on the Neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration
  9028. Neuroprotective effect of 8-OH-DPAT in global cerebral ischemia assessed by stereological cell counting
  9029. Role of Neuroprotective Drugs inAcute Ischemic Stroke
  9030. A Neuroprotective compound, aurin tricarboxylic acid, stimulates the tyrosine phosphorylation cascade in PC12 cells
  9031. Pharmacologic studies of the Neuroprotective actions of a glutamate antagonist in ischemia
  9032. Flunarizine, a calcium channel antagonist, is partially prophylactically Neuroprotective in hypoxic-ischemic encephalopathy in the fetal sheep
  9033. The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by Neuroprotective agents
  9034. Neuroprotective and neuronal rescue effects of selegiline
  9035. Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: a possible Neuroprotective mechanism of peptide growth factors
  9036. Neuroprotective effect of thyrotropin-releasing hormone against excitatory amino acid-induced cell death in hippocampal slices
  9037. Neuroprotective strategies involving the neurotrophins and their signaling pathways
  9038. Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia
  9039. Effect of cortical spreading depression on the levels of mRNA coding for putative Neuroprotective proteins in rat brain
  9040. Neuroprotective signal transduction
  9041. Recent advances in developing Neuroprotective strategies for perinatal asphyxia.
  9042. Limitations in the Neuroprotective potential of gene therapy with Bcl-2
  9043. Effect of the Neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex
  9044. Synthesis and in vitro evaluation of new 8-amino-1, 4-benzoxazine derivatives as Neuroprotective antioxidants
  9045. Neuroprotective effect of acteoside against rotenone-induced damage of SH-SY5Y cells and its possible mechanism
  9046. Peripheral type benzodiazepine binding sites following transient forebrain ischemia in the rat: effect of Neuroprotective drugs
  9047. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress
  9048. Neuroprotective effects of some monoamine oxidase‐B inhibitors against DSP‐4‐induced noradrenaline depletion in the mouse hippocampus
  9049. Functional human heme oxygenase has a Neuroprotective effect on adult rat ganglion cells after pressure-induced ischemia
  9050. Protection of focal ischemic infarction by rilmenidine in the animal: evidence that interactions with central imidazoline receptors may be Neuroprotective
  9051. ARL 17477, a selective nitric oxide synthase inhibitor, with Neuroprotective effects in animal models of global and focal cerebral ischaemia
  9052. Postinjury magnesium sulfate treatment is not markedly Neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat
  9053. Neurotoxic and Neuroprotective roles of nitric oxide in cerebral ischaemia
  9054. Neuroprotective effects of HU‐211 on brain damage resulting from soman‐induced seizures
  9055. Comparison of the Neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord …
  9056. Blockade of NAALADase: a novel Neuroprotective strategy based on limiting glutamate and elevating NAAG
  9057. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model
  9058. NMDA antagonists: antiepileptic-Neuroprotective drugs with diversified neuropharmacological profiles
  9059. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia
  9060. Superior Neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia
  9061. Neuroprotective clinical strategies for Parkinson’s disease
  9062. Neuroprotective effect of dapsone against quinolinate-and kainate-induced striatal neurotoxicities in rats.
  9063. Neuroprotective doses of N-methyl-D-aspartate receptor antagonists profoundly reduce the minimum alveolar anesthetic concentration (MAC) for isoflurane in rats.
  9064. Roles of p53, c-Myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible Neuroprotective mechanism of basic fibroblast growth factor
  9065. Effect of Neuroprotective N-Methyl-D-Aspartate Antagonists on Increased Intracranial Pressure: Studies in the Rat Acute Subdural Hematoma Model
  9066. Determination of intracellular Ca2+ concentration can be a useful tool to predict neuronal damage and Neuroprotective properties of drugs
  9067. Nilvadipine as a Neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride
  9068. The Neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies
  9069. Neuroprotective role of ornithine decarboxylase activation in transient focal cerebral ischaemia: a study using ornithine decarboxylase‐overexpressing transgenic rats
  9070. Neuroprotective effect of acteoside against MPTP-induced mouse model of Parkinsons disease
  9071. Neuroprotective effects of poly (ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats.
  9072. Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia
  9073. Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor
  9074. Application of a Neuroprotective ACTH (4–9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs
  9075. The GABAergic system of the dentate gyrus after withdrawal from chronic alcohol consumption: effects of intracerebral grafting and putative Neuroprotective agents
  9076. Neuroprotective therapy.
  9077. The Neuroprotective and neuronal rescue effect of (-)-deprenyl
  9078. MPTP-induced deficits in motor activity: Neuroprotective effects of the spintrapping agent, α-phenyl-tert-butyl-nitrone (PBN)
  9079. Extracellular ions during veratridine-induced neurotoxicity in hippocampal slices: Neuroprotective effects of flunarizine and tetrodotoxin
  9080. The Neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson’s disease, the bilaterally MPTP-treated rhesus monkey
  9081. Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat
  9082. On the inhibition of voltage activated calcium currents in rat cortical neurones by the Neuroprotective agent 619C89
  9083. Neuroprotective effect of sodium channel blockers in ischemia: the pathomechanism of early ischemic dysfunction
  9084. Neuroprotective and neurorestorative strategies for neuronal injury
  9085. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy) pyridine]: I. A potent and selective cholinergic channel modulator with Neuroprotective properties
  9086. Challenges in translating the efficacy of Neuroprotective agents in experimental models into knowledge of clinical benefits in head injured patients
  9087. Comparative Neuroprotective properties of the benzodiazepine receptor full agonist diazepam and the partial agonist PNU-101017 in the gerbil forebrain ischemia …
  9088. Neuroprotective Effect of the Iron Chelator Desferrioxamine Against MPP+ Toxicity on Striatal Dopaminergic Terminals
  9089. Cell death and associated c-jun induction in perinatal hypoxia–ischemia. Effect of the Neuroprotective drug dexamethasone
  9090. Sipatrigine (BW 619C89) is a Neuroprotective agent and a sodium channel and calcium channel inhibitor
  9091. Neuroprotective effects of omega-Aga-IVA against in vitro ischaemia in the rat hippocampal slice.
  9092. Regional Neuroprotective effects of pentobarbital on ischemia-induced brain damage
  9093. Gangliosides and Neurotrophic Growth Factors in the Retina: Molecular Interactions and Applications as Neuroprotective agents a
  9094. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with Neuroprotective activity
  9095. brain temperature and the Neuroprotective action of enadoline and dizocilpine in the gerbil model of global ischaemia
  9096. The Neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat
  9097. Therapy of Alzheimer disease: symptomatic or Neuroprotective ?
  9098. Calpain inhibitors as Neuroprotective agents in neurodegenerative disorders.
  9099. Neurotoxic versus Neuroprotective actions of endogenous opioid peptides: implications for treatment of CNS injury
  9100. Neuroprotective strategies based on targeting of postreceptor signaling events
  9101. Neuroprotective effects of a new glutathione peroxidase mimetic on neurons of the chick embryo’s retina
  9102. Neuroprotective effects of lamotrigine enhanced by flunarizine in gerbil global ischemia
  9103. Neuroprotective effects of an antioxidant in cortical cerebral ischemia: prevention of early reduction of the apurinic/apyrimidinic endonuclease DNA repair enzyme
  9104. Dexanabinol (HU‐211): A nonpsychotropic cannabinoid with Neuroprotective properties
  9105. Voltage-gated Na+ channels as targets for anticonvulsant, analgesic and Neuroprotective drugs
  9106. Ultrastructural and biochemical studies on the Neuroprotective effects of excitatory amino acid antagonists in the ischemic rat retina
  9107. Neuroprotective effects of the pyrrolopyrimidine U-104067F in 3-acetylpyridine-treated rats
  9108. Is selegiline Neuroprotective in Parkinson’s disease?
  9109. Regulation of Neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen‐activated protein kinase …
  9110. Neuroprotective effect of mild hypothermia cannot be explained in terms of a reduction of glutamate release during ischemia
  9111. Morphological investigation of the Neuroprotective effects of graded hypothermia after diverse periods of global cerebral ischemia in gerbils
  9112. Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and Neuroprotective effects of MK801
  9113. Human serotonin transporter: regulation by the Neuroprotective agent aurintricarboxylic acid and by epidermal growth factor
  9114. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats
  9115. Neuroprotective activity of alpha-dihydroergocryptine in animal models.
  9116. Neuroprotective effect of 5-HT3 receptor antagonist on ischemia-induced decrease in CA1 field potential in rat hippocampal slices
  9117. Neuroprotective effects of riluzole: an electrophysiological and histological analysis in an in vitro model of ischemia
  9118. Activation of the metabotropic glutamate receptor is Neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats
  9119. The Neuroprotective Effect of the Forebrain -S elective NMD A Antagonist CP101, 606 upon Focal Ischemic brain Damage Caused by Acute Subdural Hematoma in …
  9120. In vivo assessment of kynurenate Neuroprotective potency and quinolinate excitotoxicity
  9121. Inhibition of recombinant low-voltage-activated Ca2+ channels by the Neuroprotective agent BW619C89 (Sipatrigine)
  9122. Nitric oxide does not mediate acute glutamate neurotoxicity, nor is it Neuroprotective , in rat brain slices
  9123. MK-801 has Neuroprotective and antiproliferative effects in retinal laser injury.
  9124. Lack of Neuroprotective effect of some σ ligands in a model of focal cerebral ischemia in the mouse
  9125. The Neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia
  9126. Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat
  9127. Neuroprotective effect of cyclic GMP against radical‐induced toxicity in cultured spinal motor neurons
  9128. The Neuroprotective effect of DL-tetrahydropalmatine in rat heatstroke
  9129. Nitric oxide-mediated death of cultured neonatal retinal ganglion cells: Neuroprotective properties of glutamate and chondroitin sulfate proteoglycan
  9130. Do transient ischemic attacks have a Neuroprotective effect?
  9131. Neuroprotective role of c-fos antisense oligonucleotide: in vitro and in vivo studies
  9132. Characterization of the Neuroprotective effects of estrogens onhydrogen peroxide-induced cell death in hippocampal HT22 cells: time and dose-dependency
  9133. Neuroprotective effect of eliprodil: attenuation of a conditioned freezing deficit induced by traumatic injury of the right parietal cortex in the rat
  9134. Risk assessment strategies for Neuroprotective agents .
  9135. Anti-inflammatory and Neuroprotective effects of magnolol in chemical hypoxia in rat cultured cortical cells in hypoglycemic media.
  9136. Neuroprotective Use‐Dependent Blockers of Na+ and Ca2+ Channels Controlling Presynaptic Release of Glutamatea
  9137. The Neuroprotective effect of tacrine on trimethyltin induced memory and muscarinic receptor dysfunction in the rat
  9138. Neuroprotective potential of a viral vector system induced by a neurological insult
  9139. Neuroprotective effects of anesthetics
  9140. Clomethiazole is Neuroprotective in models of global and focal cerebral ischemia when infused at doses producing clinically relevant plasma concentrations
  9141. Inhibitory effects of a new Neuroprotective diltiazem analogue, T-477, on cloned brain Ca2+ channels expressed in Xenopus oocytes
  9142. Reducing conditions significantly attenuate the Neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro
  9143. Identification and pharmacological characterization of GV150526, a novel glycine antagonist as a potent Neuroprotective agent
  9144. Lack of a Neuroprotective effect from N-acetylcysteine after cardiac arrest and resuscitation in a canine model
  9145. Neuroprotective properties of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia
  9146. Additivity and independence of Neuroprotective effects of GABA A and GABA B receptor agonists in complete global cerebral ischemia
  9147. Interaction of Neuroprotective substances with human brain superoxide dismutase. An in vitro study.
  9148. Regulation by Neuroprotective factors of NMDA receptor mediated nitric oxide synthesis in the brain and retina
  9149. Aspirin: a Neuroprotective agent at high doses?
  9150. Evidence for a Neuroprotective Effect of Pyrid‐3‐yl‐sulphonylurea in Photochemically Induced Focal Ischaemia in Rats: Magnetic Resonance Imaging Evaluation
  9151. Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischemia-induced neurone death
  9152. Mechanisms of Neuroprotective cytokines
  9153. 31P NMR spectroscopy of perinatal hypoxic‐ischemic brain damage: A model to evaluate Neuroprotective drugs in immature rats
  9154. Volume‐sensitive chloride channels blocked by Neuroprotective drugs in human glial cells (U‐138MG)
  9155. Neuroprotective effect of acidic fibroblast growth factor on seizure-associated brain damage
  9156. Neuroprotective effects of carvedilol in diabetic rats: prevention of defective peripheral nerve perfusion and conduction velocity
  9157. Neuroprotective agents
  9158. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats
  9159. Modulation of rat striatal glutamatergic response in search for new Neuroprotective agents : evaluation of melatonin and some kynurenine derivatives
  9160. Protection of Neurological Function in Stroke Models and Neuroprotective Properties of Lubeluzole (Part 1 of 2)
  9161. Polypeptide ω‐conotoxin GVIA as a basis for new analgesic and Neuroprotective agents
  9162. Neuroprotective effect of retro-inverso Prosaptide D5 on focal cerebral ischemia in rat
  9163. Further evidences for Neuroprotective effects of melatonin
  9164. Neuroprotective agents in acute ischemic stroke
  9165. Deprenyl in Parkinson’s disease: mechanisms, Neuroprotective effect, indications and adverse effects
  9166. Long term changes in NADPH-diaphorase reactivity in striatal and cortical neurons following experimental perinatal asphyxia: Neuroprotective effects of hypothermia
  9167. Neurochemical and Neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine‐like monoamine oxidase B inhibitors
  9168. T-588, a novel Neuroprotective agent, delays progression of neuromuscular dysfunction in wobbler mouse motoneuron disease
  9169. Neuroprotective effects of pterin-6-aldehyde in gerbil global brain ischemia: comparison with those of α-phenyl-N-tert-butyl nitrone
  9170. Nitric oxide synthase, immunophilins and poly (ADP-ribose) synthetase: novel targets for the development of Neuroprotective drugs
  9171. Comparative Neuroprotective effects of pentobarbital, vinpocetine, flunarizine and ifenprodil on ischemic neuronal damage in the gerbil hippocampus
  9172. The travails of Neuroprotective drug development for acute ischemic stroke
  9173. Glycosaminoglycans co-administration enhance insulin-like growth factor-I Neuroprotective and neuroregenerative activity in traumatic and genetic models of motor …
  9174. Symptomatic and Neuroprotective properties of the aliphatic propargylamines
  9175. The Neuroprotective and hypothermic effect of GYKI-52466, a non-competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and …
  9176. Modulation of glutamate receptor pathways in the search for new Neuroprotective agents
  9177. Possible Neuroprotective therapy for Parkinson’s disease.
  9178. A comparative analysis of the Neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the …
  9179. The Neuroprotective glycine receptor antagonist GV150526 does not produce neuronal vacuolization or cognitive deficits in rats
  9180. Development of a novel arylalkylpiperazine compound (AM‐36) as a hybrid Neuroprotective drug
  9181. Antagonism by Ng-nitro-l-arginine ofl-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons. Prolonged application enhances Neuroprotective …
  9182. Neuroprotective strategies for HIV-1-associated neurologic disease
  9183. Hypoxic-ischemic damage and the Neuroprotective effects of GM1 ganglioside.
  9184. Measles virus-induced hippocampal neurodegeneration in the mouse: a novel, subacute model for testing Neuroprotective agents
  9185. GK 11: promising additional Neuroprotective therapy for organophosphate poisoning.
  9186. State-dependent inhibition of Na+ currents by the Neuroprotective agent 619C89 in rat hippocampal neurons and in a mammalian cell line expressing rat brain type IIA …
  9187. Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): A partial agonist at strychnine-insensitive glycine sites
  9188. Is chlormethiazole Neuroprotective in experimental global cerebral ischemia? A microdialysis and behavioral study
  9189. Estrogens: Neuroprotective or neurotoxic?
  9190. Neuroprotective and thrombolytic agents : advances in stroke treatment
  9191. Neuroprotective effect of basic fibroblast growth factor on wobbler mouse motor neuron disease
  9192. A Neuroprotective effect of adenosine A1-receptor agonists on ischemia-induced decrease in 2-deoxyglucose uptake in rat hippocampal slices
  9193. Programmed cell life: Neuroprotective signal transduction and ischemic brain injury
  9194. Neuroprotective effects of NMDA receptor glycine recognition site antagonism: Dependence on glycine concentration
  9195. The Neuroprotective effects of non-NMDA antagonists in the cerebellum of the spastic Han Wistar mutant
  9196. The Neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e
  9197. Neuroprotective properties of calretinin against the HIV‐1 gp120 toxicity
  9198. Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist (R)-HA-966 in an experimental model of Parkinson’s disease
  9199. GV150526: a Neuroprotective agent
  9200. Synthesis of novel orthoalkylaminophenol derivatives as potent Neuroprotective agents in vitro
  9201. Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion
  9202. Neuroprotective effects of a dihydropyridine derivative, 1, 4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3, 5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) …
  9203. Parkinson’s disease: an epidemiologic method for distinguishing between symptomatic and Neuroprotective treatments.
  9204. Neurotoxins and Monoamine Oxidase B Inhibitors: Possible Mechanisms for the Neuroprotective Effect of (—)-Deprenyl
  9205. Human Pharmacokinetics of the Neuroprotective Agent NBQX.
  9206. Neuroprotective drug development in stroke: blood pressure and its impact.
  9207. Neuroprotective effect of Gastrodiae rhizoma on global ischemia induced by 4-vessel occlusion in rats
  9208. The effect of age on cerebral oedema, cerebral infarction and Neuroprotective potential in experimental occlusive stroke
  9209. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled
  9210. Neuroprotective effects of the novel brain -penetrating antioxidant U-101033E and the spin-trapping agent α-phenyl-N-tert-butyl nitrone (PBN)
  9211. 8 General anaesthetics as Neuroprotective agents
  9212. Pharmacokinetics of the Neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo (f) quinoxaline-2, 3-dione) in mice, rats, and dogs. Interactions with …
  9213. Neuroprotective , anesthetic, and cardiovascular effects of the NMDA antagonist, CNS 5161A, in isoflurane-anesthetized lambs
  9214. Neuroprotective interactions in rats between paclitaxel and cisplatin
  9215. Inhibition of ischemia‐induced fodrin breakdown by a novel phenylpyrimidine derivative NS‐7: an implication for its Neuroprotective action in rats with middle cerebral …
  9216. Neuroprotective agents
  9217. Antioxidant drugs as Neuroprotective agents
  9218. Neuroprotective effects of the neuronal Ca2+ channel blockers, LY042826 and LY393615 in vivo
  9219. Effects of the antihypoxic and Neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording
  9220. Ifenprodil and eliprodil: Neuroprotective NMDA receptor antagonists and calcium channel blockers
  9221. Neuroprotective effect of free radical scavengers on β-N-oxalylamino-l-alanine (BOAA)-induced neuronal damage in rat hippocampus
  9222. Neuroprotective properties of the benzodiazepine receptor, partial agonist PNU-101017 in the gerbil forebrain ischemia model
  9223. Experimental neuronal protection in cerebral ischaemia Part II: Potential Neuroprotective drugs
  9224. Neuroprotective role of S12024 against neurodegeneration in the rat dentate gyrus
  9225. Roles of p53, c-Myc, Bcl-2, Bax and caspases in serum deprivation-induced neuronal apoptosis: a possible Neuroprotective mechanism of basic fibroblast growth …
  9226. The Neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood–brain barrier disruption: implications for …
  9227. Neuroprotective mechanism of (+) SKF 10,047 in vitro and in gerbil global brain ischemia.
  9228. Nizofenone, a Neuroprotective drug, suppresses glutamate release and lactate accumulation
  9229. Halothane anesthesia is Neuroprotective in experimental spinal cord injury: early hemodynamic mechanisms of action.
  9230. Primary cultures of neurons for testing Neuroprotective drug effects
  9231. Antimyoclonic and Neuroprotective effects of lamotrigine in an animal model of cardiac arrest
  9232. Evaluation of U-50,488 H analogs for Neuroprotective activity in the gerbil
  9233. Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor
  9234. Bilateral sequential common carotid artery sectioning in mice as a new model for testing Neuroprotective drugs
  9235. Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists—ifenprodil and eliprodil
  9236. Time course of the Neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum
  9237. The desglycinyl metabolite of remacemide hydrochloride is Neuroprotective in cultured rat cortical neurons
  9238. In vitro Neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese …
  9239. Actions of the novel Neuroprotective agent, lifarizine (RS‐87476), on voltage‐dependent sodium currents in the neuroblastoma cell line, N1E‐115
  9240. Neuroprotective effects of α-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1, 3, 3, 6 …
  9241. Development of the NMDA ion-channel blocker, aptiganel hydrochloride, as a Neuroprotective agent for acute CNS injury
  9242. Neuroprotective strategies: voltage-gated Na+-channel down-modulation versus presynaptic glutamate release inhibition.
  9243. Gabapentin-lactam (8-aza-spiro [5, 4] decan-9-on; GBP-L) inhibits oxygen glucose deprivation-induced [3 H] glutamate release and is a Neuroprotective agent in a …
  9244. Neuronal nitric oxide synthase inhibitor has a Neuroprotective effect in a rat model of brain injury
  9245. Divergent Neuroprotective effects of nimodipine in PDD and MID provide indirect evidence of disturbances in Ca2+ homeostasis in dementia.
  9246. Calpain as proposed target for Neuroprotective treatment of brain ischemia.
  9247. Neuroprotective effect of nimodipine is not mediated by increased cerebral blood flow after transient forebrain ischemia in rats.
  9248. Neurochemical Mechanisms Underlying Neuroprotective Actions of Bromocriptine, Salicylate, d- and L-Deprenyl in Neurodegeneration caused by MPTP
  9249. … (ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible Neuroprotective …
  9250. The Neuroprotective effects of MK-801 on the induction of microgyria by freezing injury to the newborn rat neocortex
  9251. Neuroprotective effect of kapakh, representative of new nootropic class non-anticholinesterase organophosphoric compounds
  9252. … -4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: potent inhibitors of kynurenine-3-hydroxylase as potential Neuroprotective …
  9253. Neuroprotective fibroblast growth factor type-2 down-regulates the c-Jun transcription factor in axotomized sympathetic preganglionic neurons of adult rat
  9254. AIT-082 as a potential Neuroprotective and regenerative agent in stroke and central nervous system injury
  9255. Cyclophosphamide is Neuroprotective in a gerbil model of transient severe focal cerebral ischemia: correlation with effects of tirilazad mesylate (U-74006F)
  9256. Neuroprotective strategies in neural grafting
  9257. Current status of Neuroprotective drugs in stroke
  9258. Neuroprotective effects of estrogens
  9259. Neuroprotective synergism of 2-amino-3-phosphonoproprionate (D, L-AP3) and MK-801 against ibotenate induced brain injury
  9260. Neurochemical, Neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties
  9261. A cell culture model of cerebral ischemia as a convenient system to screen for Neuroprotective drugs
  9262. The Neuroprotective effects of dextromethorphan on guinea pig-derived hippocampal slices during hypoxia
  9263. Gangliosides: New generation of Neuroprotective agents
  9264. The objective of acute stroke therapy and Neuroprotective therapeutic approaches
  9265. Focal cerebral ischaemia induced by middle cerebral artery occlusion and the Neuroprotective effect of ketoprofen in rats
  9266. Neuroprotective effect of Batroxobin in ischemic/reperfusion injury of rats (Decrease of cerebral NO concentration)[J]
  9267. Quantitative histological evaluation of Neuroprotective compounds.
  9268. Secondary brain injury and the role of Neuroprotective agents .
  9269. Intraneuronal ion distribution during experimental oxygen/glucose deprivation: Routes of ion flux as targets of Neuroprotective strategies
  9270. The Neuroprotective properties of ginkgo extracts
  9271. Blockade by NS‐7, a Neuroprotective Compound, of Both L‐Type and P/Q‐Type Ca2+ Channels Involving Depolarization‐Stimulated Nitric Oxide Synthase Activity in …
  9272. Flunarizine, a calcium channel antagonist, is not Neuroprotective when given after hypoxia-ischemia in the infant rat
  9273. Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro
  9274. The inhibition of peroxide formation as a possible substrate for the Neuroprotective action of dihydroergocryptine.
  9275. Neuroprotective effects of currently used antidotes in soman-poisoned rats
  9276. The electrochemical oxidation of Riluzole, a Neuroprotective drug: comparison with the reaction with oxygen derived radicals
  9277. Neuron damage induced by some potent kainoids and Neuroprotective action of new agonists for metabotropic glutamate receptors
  9278. CGS-19755 is Neuroprotective during repetitive ischemia: this effect is significantly enhanced when combined with hypothermia
  9279. Neuroprotective Properties of Aptiganel HCL (Cerestat©) following Controlled Cortical Impact Injury
  9280. Neuroprotective effects of NPS 846, a novel N-methyl-D-aspartate receptor antagonist, after closed head trauma in rats
  9281. Inhibition of human N-type voltage-gated Ca2+ channels by the Neuroprotective agent BW619C89
  9282. Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting Neuroprotective effects
  9283. Neuroprotective effect of L-lysine monohydrochloride on acute iterative anoxia in rats with quantitative analysis of electrocorticogram
  9284. Neuroprotective effects of colchicine in the gerbil model of cerebral ischaemia
  9285. Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)
  9286. An investigation of the possible interaction of clomethiazole with glutamate and ion channel sites as an explanation of its Neuroprotective activity
  9287. Neuroprotective effects of a novel broad‐spectrum cation channel blocker, LOE 908 MS, on experimental focal ischemia: A multispectral study
  9288. The influence of repeated doses, route and time of administration on the Neuroprotective effects of BIII 277 CL in a rat model of focal cerebral ischemia
  9289. Neuroprotective effect of phenytoin against in utero hypoxic brain injury in fetal guinea pigs
  9290. Neuroprotective efficacy and mechanisms of the lazaroids
  9291. Long‐term Neuroprotective effects of glycosaminoglycans–IGF‐I cotreatment in the motor neuron degeneration (mnd) mutant mouse
  9292. Blockade of voltage-sensitive sodium channels by NS-7, a novel Neuroprotective compound, in the rat brain
  9293. Neuroprotective strategies in the treatment of Parkinson’s disease: clinical evidence
  9294. The polyamine synthesis inhibitor α-difluoromethylornithine is Neuroprotective against N-methyl-D-aspartate-induced brain damage in vivo
  9295. Neuroprotective effects of scutellariae radix on the brain ischemia induced by four-vessel occlusion in rats
  9296. Neuroprotective actions of 2-amino-N-(1, 2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.
  9297. Neuroprotective effects of graded reoxygenation following chronic hypoxia in neuronal cell cultures
  9298. Evaluation of the Neuroprotective action of WEB 1881 FU on hypoglycemia/hypoxia-induced neuronal damage using rat striatal slices
  9299. Postischemic Glial Responses and Amyloid Accumulation are Modified by Propentofylline: Neuroprotective Pharmacon for Alzheimer’s Disease?
  9300. Effects of the novel Neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies …
  9301. The effect of X-radiation on cerebellar granule cells grown in culture. Ganglioside GM1 Neuroprotective activity
  9302. Glutamate neurotoxicity and Neuroprotective factors
  9303. Novel glycineB antagonists show Neuroprotective activityin vivo
  9304. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
  9305. Neuroprotective Effect of Gastrodiae Rhizoma on Dopaminergic Neuronal Cell Death in Parkinson’s disease
  9306. Investigational Neuroprotective drugs in traumatic brain injury
  9307. Halothane anaesthesia reverses the Neuroprotective effect of ketamine against ibotenic acid toxicity in the rat hippocampus
  9308. The Neuroprotective kappa-opioid CI-977 alters glutamate-induced calcium signaling in vitro.
  9309. Neuroprotective effect of protein kinase C inhibitors on oxygen/glucose free-induced decreases in 2-deoxyglucose uptake and CA1 field potentials in rat hippocampal …
  9310. Possible Neuroprotective properties of flunarizine infused after asphyxia in fetal lambs are not explained by effects on cerebral blood flow or systemic blood pressure
  9311. Do microglial cells have a Neuroprotective function?
  9312. Receptor agonists as perspective Neuroprotective agents
  9313. Safety and pharmacokinetics of the Neuroprotective drug lubeluzole in patients with ischemic stroke
  9314. Oxidative neuropathology and putative chemical entities for Alzheimer’s disease: Neuroprotective effects of salen-manganese catalytic anti-oxidants
  9315. Can we differentiate symptomatic and Neuroprotective effects in parkinsonism? The dopamine agonist lisuride delays the need for levodopa therapy to a similar extent …
  9316. A review of the neurotrophic and Neuroprotective properties of ONO-1603: comparison with those of tetrahydroaminoacridine, an antidementia drug
  9317. Neuroprotective effect of phenylsuccinate, an inhibitor of cytosolic glutamate formation from glutamine, under anoxic conditions but not during exposure to exogenous …
  9318. Neuroprotective effect of TTC-909, an isocarbacyclin methyl ester incorporated in lipid microspheres, on hippocampal delayed neuronal death of stroke-prone …
  9319. ONO-1603, a potential antidementia drug, shows Neuroprotective effects and increases m3-muscarinic receptor mRNA levels in differentiating rat cerebellar granule …
  9320. Dextromethorphan analogs are Neuroprotective in vitro and block glutamate-induced excitotoxic calcium signals in neurons
  9321. Comparison of the Neuroprotective effects of APV and bcl-2 in glutamate-induced cell death
  9322. Neuroprotective effect of sumatriptan, a 5-HT1D receptor agonist, in focal cerebral ischemia of rat brain
  9323. Neuroprotective “agents ” in Surgery: Secret “Agent” Man, or Common “Agent” Machine?
  9324. Neuroprotective activity of fructose-1, 6-bisphosphate following transient forebrain ischemia in the Mongolian gerbil
  9325. The metabolism of clomethiazole in gerbils and the Neuroprotective and sedative activity of the metabolites
  9326. Neuroprotective strategies in epilepsy
  9327. Lack of Neuroprotective effect of σ receptor ligands in the neurotoxicity of p-chloroamphetamine in rat brain
  9328. Neuroprotective effects of NBQX on hypoxia-induced neuronal damage in rat hippocampus.
  9329. … -methylphenyl)-1-piperazinyl] ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel Neuroprotective agent, in vitro …
  9330. Na+ and high-voltage-activated Ca2+ channel blocking actions of NS-7, a novel Neuroprotective agent, in NG108-15 cells
  9331. New horizons in molecular mechanisms underlying Parkinson’s disease and in our understanding of the Neuroprotective effects of selegiline
  9332. IS MAGNESIUM Neuroprotective TO THE FETUS?† 1324
  9333. Reduced facilitation and vesicular uptake in crustacean and mammalian neuromuscular junction by T-588, a Neuroprotective compound
  9334. Neuroprotective Effect of WEB 1881 FU (Nebracetam) on an Ischemia-Induced Deficit of Glucose Uptake in Rat Hippocampal and Cerebral Cortical Slices and CAl …
  9335. The Non‐peptide Neuroprotective Agent SR 57746A Interacts with Neurotrophin‐3 to Induce Differentiation in the PC12 Cell‐line
  9336. … antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and Neuroprotective …
  9337. Effects of Neuroprotective dose of fructose-1, 6-bisphosphate on hypoxia-induced expression of c-fos and hsp70 mRNA in neonatal rat cerebrocortical slices
  9338. Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion
  9339. Neuroprotective effects of Acori graminei rhizoma on the brain ischemia induced by four-vessel occlusion in rats
  9340. Rasagiline, a novel monoamine oxidase‐B inhibitor with Neuroprotective effects under ischemic conditions in PC12 cells
  9341. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
  9342. Neuroprotective effects of the GABAA receptor partial agonist U-101017 in 3-acetylpyridine-treated rats
  9343. Neuroprotective (+) 3S, 4S cannabinoids with modified 5′-side chain
  9344. The potential of 21-aminosteroids (lazaroids) as Neuroprotective therapies in CNS injury
  9345. Neuroprotective effects of a novel AMPA receptor antagonist, YM872
  9346. The Neuroprotective effect of GABA-ergic substances in cerebral ischemia
  9347. NPC 16377, a potent and selective sigma-ligand. II. Behavioral and Neuroprotective profile.
  9348. Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with Neuroprotective properties
  9349. Neuroprotective effects of glycine in the acute period of ischemic stroke
  9350. The Neuroprotective effects of (−) deprenyl in the gerbil hippocampus following transient global ischemia
  9351. Neuroprotective effect ofN-methyl-d-aspartate non-competitive antagonists (arylcyclohexylamine derivatives) on human cultured spinal cord cells
  9352. Neuroprotective effects of glutathione on rainbow trout olfactory receptor neurons during exposure to copper sulfate
  9353. Neuroprotective effect of YM-39558, orotic acid ethylester, in gerbil forebrain ischemia
  9354. CPI-1189 inhibits interleukin 1β-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its Neuroprotective properties?
  9355. Neuroprotective Role of Na+/myo‐Inositol Cotransporter Against Veratridine Cytotoxicity
  9356. Dose‐dependent pharmacokinetics of a new Neuroprotective agent for ischemia‐reperfusion damage, KR‐31378, in rats
  9357. Neuroprotective effects of phencyclidine on acute cerebral ischemia and reperfusion injury of rabbits.
  9358. SB 201823-A, a neuronal Ca2+ antagonist is Neuroprotective in two models of cerebral ischaemia
  9359. Neuroprotective effects of thiamine-megadoses after long-term ethanol application in the rat brain . A structural investigation of hippocampal CA1 pyramidal and …
  9360. Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats
  9361. Comparative analysis of Neuroprotective activity of new chemical agent Vp and piracetam
  9362. Neuroprotective effect of Toki‐Shakuyaku‐San (TJ‐23) on hypoglycaemia/hypoxia‐induced neuronal damage in rat striatal slices
  9363. In vitro models for the study of nerve lesions and potential Neuroprotective drugs
  9364. A Neuroprotective effect of histamine H1 receptor antagonist on ischemia-induced decrease in 2-deoxyglucose uptake in rat hippocampal slices
  9365. CGS 19755 (Selfotel): a novel Neuroprotective agent against CNS injury
  9366. Short‐and long‐term differential effects of Neuroprotective drug NS‐7 on voltage‐dependent sodium channels in adrenal chromaffin cells
  9367. 1-Amino-APDC, a partial agonist of group II metabotropic glutamate receptors with Neuroprotective properties
  9368. Permeability of a Neuroprotective compound NS-7 into brain : comparison between normal and middle cerebral artery-occluded rats
  9369. A Radioimmunoassay for the Anticonvulsant and Neuroprotective Agent, MK-801%
  9370. Reversal of neurotoxin-induced ornithine decarboxylase activity in rat cerebral cortex by nimodipine. A potential Neuroprotective mechanism.
  9371. Neuroprotective Effects of Daeseungkitang on the brain Ischemia induced by Four-Vessel Occlusion in Rats
  9372. Neuroprotective action of a novel compound–M50463–in primary cultured neurons
  9373. Neuroprotective strategies in a model of selective neuronal necrosis from hypothermic circulatory arrest
  9374. Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for Neuroprotective and anticonvulsant actions in vivo
  9375. Neuroprotective effect of graded postischemic reoxygenation in spinal cord ischemia in the rabbit
  9376. Neuroprotective effect of nicotine against beta amyloid cytotoxicity
  9377. The Neuroprotective properties of ES-242s, novel NMDA receptor antagonists, in neuronal cell culture toxicity studies
  9378. In vivo brain microdialysis as a tool in studies of Neuroprotective effects of cyclosporin A in acute excitotoxicity.
  9379. The σ receptor ligand JO 1784 (igmesine hydrochloride) is Neuroprotective in the gerbil model of global cerebral ischaemia
  9380. Neuroprotective strategies based on interleukin signaling
  9381. Neuroprotective
  9382. Synthesis and Neuroprotective Properties of Isosteric Analogs of Nicotine
  9383. Histological Evidence for Neuroprotective Action of Nebracetam on Ischemic Neuronal Injury in the Hippocampus of Stroke-Prone Spontaneously Hypertensive
  9384. L‐687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be Neuroprotective
  9385. Neuroprotective activity of dimer of 16, 16′-dimethyl-15-dehydroprostaglandin B1 (di-Calciphor) in cerebral ischemia
  9386. Determination of the Neuroprotective agent 6-nitro-7-sulphamoylbenzo [f] quinoxaline-2, 3-dione in plasma using high-performance liquid chromatography
  9387. Experiments on the Neuroprotective action of vitamin E.
  9388. MK-801 is Neuroprotective but does not improve survival in severe forebrain ischemia
  9389. Neuroprotective effects of felbamate on global ischaemia in Mongolian gerbils
  9390. Inhibition by Neuroprotective drug NS-7 of nicotine-induced 22Na+ influx, 45Ca2+ influx and catecholamine secretion in adrenal chromaffin cells
  9391. Neuroprotective effect of cholecystokininB receptor antagonist on ischemia-induced decrease in CA1 presynaptic fiber spikes in rat hippocampal slices
  9392. Contributions of the physical properties of Neuroprotective agents to their efficacy as inhibitors of lipid peroxidation
  9393. Neuroprotective effects of dextromethorphan against transient cerebral ischemia/reperfusion injury in gerbils.
  9394. Neuroprotective effects of Toki‐shakuyaku‐san (TJ‐23) on glutamate induced neuronal death in cultured cerebellar granule cells
  9395. Issues in accelerating the pace of development for Neuroprotective agents .
  9396. Comparison of Neuroprotective efficacy of competitive and non-competitive AMPA antagonists in vitro
  9397. Synthesis of deuterated dexanabinol, a nonpsychotropic cannabinoid with Neuroprotective properties
  9398. Low-energy laser irradiation: a possible Neuroprotective modality
  9399. Neuropharmacological effects of sigma receptor ligands: anxiolytic, anti-amnesic and Neuroprotective effects
  9400. Guanidinoethane sulfate is Neuroprotective towards delayed CA1 neuronal death in gerbils
  9401. Neuroprotective actions of taurine
  9402. Nicotine: A new Neuroprotective agent?
  9403. Cannabis on the brain : Is it neurotoxic or Neuroprotective ?
  9404. Effects of the novel Neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies …
  9405. Primary cultures for testing Neuroprotective drugs
  9406. Neuroprotective strategies for treatment of acute ischemic stroke
  9407. Molecular characterization of the Neuroprotective activity of salicylates
  9408. Neuroprotective effect of GYKI 52466 on AMPA-induced neurotoxicity in rat striatum.
  9409. The putative Neuroprotective role of dopamine agonists in Parkinson’s disease
  9410. Neuroprotective agents and cerebral ischaemia
  9411. Erythropoietin as a Neuroprotective agent
  9412. Behavioral and neuroanatomical consequences of a unilateral intraventricular infusion of AF64A and limitations on the Neuroprotective effects of nimodipine
  9413. Experimental Neuroprotective agents : nursing challenge.
  9414. Novel glycine antagonists as potent Neuroprotective agents
  9415. Neuroprotective effects of pre-treatment with systemic steroids in a neonatal piglet model of cardiopulmonary bypass with deep hypothermic circulatory arrest
  9416. Neuroprotective effects of neurosteroids against hypoxic-neurotoxicity in naive and benzodiazepine inverse agonist FG 7142-treated mice
  9417. The Neuroprotective and neuronal rescue effect of selegiline
  9418. Cannabinoid is Neuroprotective in head trauma
  9419. Ethics in clinical trials: ethical standards in phase 1 trials of Neuroprotective agents for stroke therapy
  9420. Neuroprotective effect of 4′-(4-methylphenyl)-2, 2′: 6′, 2-terpyridine trihydrochloride, a novel inducer of nerve growth factor
  9421. Adenosine is a Neuroprotective agent in retinal ischaemia.
  9422. Neuroprotective EFFECT OF BATROXOBIN ON ISCHEMIC REPERFUSION INJURY── NEUROPHATHOLOGICAL EVIDENCE [J]
  9423. Neuroprotective effects and mechanism of phycocyanin in cerebral ischemia reperfusion injury in rats
  9424. Neuroprotective autoimmunity—a double-edged sword?
  9425. Neuroprotective effect of taurine on focal cerebral ischemia in rats
  9426. Neuroprotective effect of vinconate against postischemic alterations in binding of [3H] SCH 23390 in the gerbil brain .
  9427. Lubeluzole shows Neuroprotective effects in an “in-vitro”-model for neuronal lesions in the chicken retina
  9428. Stroke models for preclinical trials of Neuroprotective agents
  9429. The role of anaesthetic agents as Neuroprotective drugs
  9430. Neuroprotective Strategies
  9431. Neuroprotective action of dextromethorphan in rat photochemically-induced focal cerebral ischemia.
  9432. Neuroprotective effects of an extract of Gingko biloba (EGB-761) in heat stress induced brain damage in the rat
  9433. Neuroprotective actions of excitatory amino acid receptor antagonists
  9434. Ginkgolides and Neuroprotective Effects 146
  9435. Neuroprotective compounds inhibit depolarisation‐evoked calcium transients in granule cells
  9436. Establishment and characterization of a CHO cell line producing a secreted form of human ciliary neurotrophic factor: Neuroprotective effects of the recombinant …
  9437. Reducing conditions produce a loss of Neuroprotective efficacy of competitive but not non-competitive antagonists in a model of NMDA-mediated excitotoxicity in …
  9438. Pharmacomodulation of torasemide led to original diuretic, Neuroprotective , anticonvulsant and antithrombotic drugs.
  9439. Neuroprotective EFFECTS OF ANIRACETAM
  9440. An experimental study on the Neuroprotective effects of Chinese angelica (Angelica sinensis) on cerebral ischemia injury in rat
  9441. Neuroprotective activity of angiotensin-converting enzyme inhibitors in cerebral ischemia
  9442. Amyotrophic lateral sclerosis: Transgenic model and novel Neuroprotective agent
  9443. Is there an effective Neuroprotective treatment of Parkinson’s disease?(therapeutic possibilities against the background of etiopathogenetic concepts
  9444. Neuroprotective Effects of Lamotrigine in Transient Global Ischemia
  9445. Neuroprotective effect of alpha-dihydroergocryptine depends on activation of nuclear factor kappa B
  9446. The Neuroprotective effect of the heat shock proteins
  9447. Neuroprotective effects of antidotes in soman-poisoned rats
  9448. Synthesis of 6, 6-dicarboxy-3, 4-methano-L-proline, a new constrained glutamate analog endowed with Neuroprotective properties.
  9449. Neuroprotective effects of the Rhei Rhizoma on the Rats’ transient forebrain ischemia caused by 4-vessel-occlusion
  9450. Neuroprotective Effects of Hypothermia Historical Considerations and Contemporary Basic Knowledge
  9451. … SAR of (.+-.)-2-Amino-N-methyl-. alpha.-(3-methyl-2-thienyl) benzeneethanamine and Related Analogs as Noncompetitive NMDA Antagonists with Neuroprotective …
  9452. An Investigation Into the Neuroprotective Properties of Melatonin
  9453. Neuroprotective effect of ba-troxobin on ischemic reperfusion injury-neurophathological evidence
  9454. Neuroprotective and neurorestorative therapy in Parkinson’s disease
  9455. Microsurgical, Neuroprotective plaque isolation in plastic penile induration
  9456. Intrastriatal injections of quinolinic acid as a model for developing Neuroprotective strategies in Huntington’s disease
  9457. Mechanisms underlying the Neuroprotective activity of group-II metabotropic glutamate receptors IIN culture
  9458. Eliprodil: a novel Neuroprotective agent acting at a modulatory site of the NMDA receptor
  9459. NPS 1506: a novel NMDA receptor antagonist: Neuroprotective effects in a model of closed head trauma in rats
  9460. Neuroprotective effects of MAO-B inhibition: clinical studies in Parkinson’s disease
  9461. THE Neuroprotective EFFECT OF CITALOPRAM ON ISCHEMIA AND NMDAINDUCED DAMAGE
  9462. Cortical focal stroke model to evaluate Neuroprotective action of drugs
  9463. Neuroprotective therapy for argon-laser-induced retinal injury
  9464. The MPTP Model of Parkinson’s Disease in the Mouse. Modafinil—a New Potential Neuroprotective Agent
  9465. Glutamate neurotoxicity during spinal cord ischemia—The Neuroprotective effects of adenosine—
  9466. Neurotoxic Effect of Streptozotocin and Neuroprotective Effect of Insulin Growth Factor-II to the Cultured Mouse Schwann Cells.
  9467. Nicotine Has Neuroprotective Effects Against Excitatory Amino Acid-Induced Neurotoxicity in Neocortical Cultures
  9468. Pharmacological Augmentation of Endogenous Neuroprotective Responses after Traumatic brain Injury
  9469. Preclinical anticonvulsant and Neuroprotective profile of 8319, a non-competitive NMDA antagonist.
  9470. Gingko Biloba: An ancient Chinese tree with Neuroprotective properties.
  9471. Neuroprotective therapies for acute stroke
  9472. Expression of neuroglobin after focal cerebral ischemia and its Neuroprotective effect
  9473. Analysis of The Neuroprotective and Neurodestructive Effects of Nitric Oxide Donor Compounds in Murine Mixed Cortical Cell Cultures.• 1767
  9474. Neuroprotective Effects of Uncariae Ramulus et Uncus on the brain Ischemia induced by Four-Vessel Occlusion in Rats
  9475. A REVIEW OF EARLIER CLINICAL STUDIES ON Neuroprotective agents AND CURRENT
  9476. Neuroprotective Effect of Focal Ischemic Preconditioning in Transient Focal Ischemia Animal Model
  9477. Neuroprotective Approaches in Vivo Against Ca2+-Induced Neurodegeneration in Rat Nucleus Basalis
  9478. Neuroprotective effect of perinatal hypoxia against 3-nitropropionic acid neurotoxicity
  9479. Inhibitory function following experimental brain injury: An immunohistochemical and behavioral analysis of the Neuroprotective effects of diazepam.
  9480. Neuroprotective agents in Acute Ischemic Stroke
  9481. … -6-nitro-7-sulphamoyl-benzo (f) quinoxaline, a selective non-N-methyl-D-aspartate excitatory amino acid receptor antagonist, has Neuroprotective properties in a …
  9482. The Neuroprotective activity of group-II mGlu receptor agonist is sensitive to protein synthesis inhibitors and involves the interaction between neurons and astrocytes
  9483. Neuroprotective effects of electro-acupuncture in a gerbil model of transient cerebral ischemia and reperfusion
  9484. Neuroprotective Effects of Intraischemic (1 hour) Moderate Hypothermia in Gerbil brain Global Ischemic Model
  9485. Neuroprotective agents and Cerebral Ischaemia
  9486. The Neuroprotective Effect and Inflammatory Gene Expression of Hypothermia and Lamotrigine in Transient Spinal Ischemia in the Rat.
  9487. Potential Neuroprotective Therapy for Glaucoma
  9488. Neuroprotective Signal Transduction Pathways of sAPP and TNF
  9489. Neuroprotective Effect of Hepatocyte Growth Factor
  9490. Novel glycineB antagonists show Neuroprotective activityin vivo
  9491. ABT-089: an orally effective cholinergic channel modulator (ChCM) with cognitive enhancement and Neuroprotective action
  9492. The Effect of Brief Post-Ischemic Hypothermia in Combination with Neuroprotective agents on Hypoxic-Ischemic (HI) brain Damage in the Immature Rat• 1910
  9493. Neuroprotective effects of Erigreon breviscapus flavonoids on transient cerebral ischemia-reperfusion injury in gerbils
  9494. Neuroprotective effects of mGlu receptor agonists
  9495. Neuroprotective Efficacy of Recombinant Platelet-Activating Factor Acetylhydrolase in Neonatal Cerebral Hypoxia-Ischemia
  9496. Protection of Neurological Function in Stroke Models and Neuroprotective Properties of Lubeluzole (Part 2 of 2)
  9497. Neuroprotective Effects of Magnesium Sulfate and Dextromethorphan on Cerebral Ischemia after Middle Cerebral Artery Occlusion in Rats.
  9498. Prospects for Neuroprotective Gene Therapy for Neurodegenerative Diseases
  9499. Neuroprotective Effects of BAPTA-AM: A Dose-response Study and Estimation of Therapeutic Window.
  9500. Have Randomized Controlled Trials of Neuroprotective Drugs Been Underpowered?: An Illustration of Three Statistical Principles
  9501. Neuroprotective Strategies Against Cellular Hypoxia
  9502. Neuroprotective Actions and Possible Underlying Molecular Mechanisms of Valproate
  9503. Metabotropic glutamate receptors as targets for Neuroprotective drugs
  9504. The mechanisms behind the Neuroprotective effect of N-acetylcysteine.
  9505. New method for evaluating the effects of Neuroprotective therapy in the hemodynamic penumbra
  9506. IS EXERCISE Neuroprotective FOR TRAUMATIC brain INJURY?
  9507. Investigation of the Neuroprotective effect of phenelzine.
  9508. The Feasibility of Neuroprotective Agent Administration by Pre-hospital Personnel in an Urban Setting
  9509. 68. Neuroprotective actions of olanzapine in rat: mechanism
  9510. Neuroprotective Effects of Interleukin-6 in PC12 Cells
  9511. Neuroprotective effects of arcaine on focal cerebral ischemia in rats
  9512. The Neuroprotective effects of GDNF against 6-OHDA in vivo.
  9513. Neuroprotective effects of Topirmate on rats brain with ischemia-reperfusion damage
  9514. Neuroprotective Function of Erythropoietin in the Central Nervous System
  9515. NMR imaging of the Neuroprotective effects of estrogen
  9516. Neuroprotective effects of nicardipine in a rat model of ischemia and reperfusion
  9517. Neuroprotective Effect of 2-Methylaminochroman Compound in Human Hippocampal Neuron Cultures
  9518. Effects of Neuroprotective drugs in a model of perinatal hypoxic/ischemic encephalopathy.
  9519. The Neuroprotective efficacy of NXY-059 in permanent MCAo in the rat: Dose response and therapeutic window
  9520. Recent advances in possible Neuroprotective and neurorestorative therapies for Parkinson’s disease
  9521. Neuroprotective effects of exogenous brain -derived…
  9522. Oestrogen as a Neuroprotective hormone
  9523. Asialoerythropoietin is a nonerythropoietic cytokine with broad Neuroprotective activity in vivo
  9524. Neuroprotective strategies in Parkinson’s disease
  9525. The “French Paradox” and beyond: Neuroprotective effects of polyphenols
  9526. Cerebral ischemia and trauma—different etiologies yet similar mechanisms: Neuroprotective opportunities
  9527. Toward wisdom from failure: lessons from Neuroprotective stroke trials and new therapeutic directions
  9528. Cellular prion protein transduces Neuroprotective signals
  9529. Neuroprotective effects of Ginkgo biloba extract
  9530. Mitochondria as a target for neurotoxins and Neuroprotective agents
  9531. brain aromatase is Neuroprotective
  9532. Microglia as Neuroprotective , immunocompetent cells of the CNS
  9533. Design of NAALADase inhibitors a novel Neuroprotective strategy
  9534. C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and Neuroprotective effects
  9535. Neuroprotective agents for the treatment of acute ischemic stroke
  9536. Neuroprotective agents for clinical trials in Parkinson’s disease: a systematic assessment
  9537. Animal models of stroke: do they have value for discovering Neuroprotective agents ?
  9538. Aromatase: a Neuroprotective enzyme
  9539. Cloning and characterization of the human activity-dependent Neuroprotective protein
  9540. Neuroprotective effect of granulocyte colony–stimulating factor after focal cerebral Ischemia
  9541. Cell culture protection and in vivo Neuroprotective capacity of flavonoids
  9542. Neuroprotective effects of lithium in cultured cells and animal models of diseases
  9543. Production and Neuroprotective functions of fractalkine in the central nervous system
  9544. Neuroprotective role of adenosine in the CNS
  9545. Metabotropic glutamate receptor subtypes as targets for Neuroprotective drugs
  9546. Minireview: Neuroprotective effects of estrogen—new insights into mechanisms of action
  9547. Implications for Neuroprotective treatments
  9548. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy
  9549. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice
  9550. Neuroprotective effects of estradiol in middle-aged female rats
  9551. Aromatase expression by reactive astroglia is Neuroprotective
  9552. Citicoline: Neuroprotective mechanisms in cerebral ischemia
  9553. Neurotrophic and Neuroprotective actions of estrogens and their therapeutic implications
  9554. Neuroprotective effects of the green tea components theanine and catechins
  9555. Neuroprotective and neurorestorative strategies for Parkinson’s disease
  9556. Pharmacological and clinical profile of the free radical scavenger edaravone as a Neuroprotective agent
  9557. Activity-dependent Neuroprotective protein: a novel gene essential for brain formation
  9558. Blockade of microglial activation is Neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease
  9559. Neuroprotective and neurotoxic properties of the ‘inert’gas, xenon
  9560. Potential role of Neuroprotective agents in the treatment of patients with acute ischemic stroke
  9561. Potential Neuroprotective effects of acamprosate
  9562. BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells?
  9563. Neuroimmunophilins: novel Neuroprotective and neuroregenerative targets
  9564. Huntingtin’s Neuroprotective activity occurs via inhibition of procaspase-9 processing
  9565. Neuroprotective effects of leptin in vivo and in vitro
  9566. Neuroprotective actions of selegiline
  9567. Human albumin therapy of acute ischemic stroke: marked Neuroprotective efficacy at moderate doses and with a broad therapeutic window
  9568. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is Neuroprotective
  9569. Mitochondrial mechanisms of neural cell death and Neuroprotective interventions in Parkinson’s disease
  9570. Perinatal brain damage: underlying mechanisms and Neuroprotective strategies
  9571. Neuroprotective role of δ-opioid receptors in cortical neurons
  9572. The biology of erythropoietin in the central nervous system and its neurotrophic and Neuroprotective potential
  9573. Antiepileptic drugs as a possible Neuroprotective strategy in brain ischemia
  9574. Neuroprotective role of melatonin in oxidative stress vulnerable brain
  9575. Neuroprotective Constituents from Hedyotis diffusa
  9576. Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury
  9577. Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson’s disease
  9578. Neuroprotective effect of memantine in different retinal injury models in rats
  9579. The NMDA receptor antagonist memantine as a symptomatological and Neuroprotective treatment for Alzheimer’s disease: preclinical evidence
  9580. Future of Neuroprotective drugs in doubt
  9581. Oxidative nerve cell death in Alzheimers disease and stroke: antioxidants as Neuroprotective compounds
  9582. Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to γ-irradiation
  9583. Neuroprotective agents in traumatic brain injury
  9584. Neuroprotective effects of prior limb use in 6‐hydroxydopamine‐treated rats: possible role of GDNF
  9585. Neuroprotective effects of antiepileptic drugs
  9586. Excessive hexosamines block the Neuroprotective effect of insulin and induce apoptosis in retinal neurons
  9587. The Neuroprotective effects of estrogen on the aging brain
  9588. Heterogeneity of stroke pathophysiology and Neuroprotective clinical trial design
  9589. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats
  9590. Current evidence for Neuroprotective effects of nicotine and caffeine against Parkinson’s disease
  9591. Minocycline, a tetracycline derivative, is Neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
  9592. Terminally differentiated SH-SY5Y cells provide a model system for studying Neuroprotective effects of dopamine agonists
  9593. Neuroprotective effects of propofol following global cerebral ischemia in rats
  9594. The Neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice
  9595. Flavonoid wogonin from medicinal herb is Neuroprotective by inhibiting inflammatory activation of microglia
  9596. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1
  9597. Novel cognitive improving and Neuroprotective activities of Polygala tenuifolia Willdenow extract, BT‐11
  9598. Synthesis and Neuroprotective activity of bergenin derivatives with antioxidant activity
  9599. Neuroprotective effects of non‐steroidal anti‐inflammatory drugs by direct scavenging of nitric oxide radicals
  9600. AGES in brain ageing: AGE-inhibitors as Neuroprotective and anti-dementia drugs?
  9601. Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and Neuroprotective activity
  9602. Additive Neuroprotective effects of minocycline with creatine in a mouse model of ALS
  9603. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons
  9604. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of Neuroprotective mechanisms against hypoxic insult
  9605. Neurodegenerative and Neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2
  9606. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and Neuroprotective properties of interest in the treatment of Alzheimer’s disease
  9607. Neuroserpin, a Neuroprotective factor in focal ischemic stroke
  9608. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to Neuroprotective strategies in hibernation and hypoxia-tolerant states
  9609. Neuroprotective autoimmunity: naturally occurring CD4+ CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system
  9610. Anti-inflammatory, antithrombotic, and Neuroprotective effects of activated protein C in a murine model of focal ischemic stroke
  9611. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation
  9612. Tauroursodeoxycholic acid, a bile acid, is Neuroprotective in a transgenic animal model of Huntington’s disease
  9613. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo …
  9614. Synthesis and biological activity of novel Neuroprotective diketopiperazines
  9615. Role of taurine in regulation of intracellular calcium level and Neuroprotective function in cultured neurons
  9616. Estrogen and progesterone as Neuroprotective agents in the treatment of acute brain injuries
  9617. Vitamin E suppression of microglial activation is Neuroprotective
  9618. Neuroprotective Effects of Withania somnifera Dunn. in Hippocampal Sub‐regions of Female Albino Rat
  9619. Parkin: a multipurpose Neuroprotective agent?
  9620. Head cooling with mild systemic hypothermia in anesthetized piglets is Neuroprotective
  9621. Putative Neuroprotective actions of N-acyl-ethanolamines
  9622. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats
  9623. Tissue distribution and Neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson’s disease
  9624. Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery with cardiopulmonary bypass: a randomized trial
  9625. Why do Neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective
  9626. Neuroprotective peptide drug delivery and development: potential new therapeutics
  9627. Neuroprotective actions of pyridoxine
  9628. Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not Neuroprotective
  9629. Nitrones as Neuroprotective agents in cerebral ischemia, with particular reference to NXY-059
  9630. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia–reperfusion injury in rats
  9631. A peptide derived from activity-dependent Neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice
  9632. Delayed Neuroprotective effect of insulin-like growth factor-I after experimental transient focal cerebral ischemia monitored with MRI
  9633. Neuroprotective effects of antioxidative flavonoids, quercetin,(+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten
  9634. Evaluation of the Neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole
  9635. Dose-related effects of chronic antidepressants on Neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus
  9636. Neuroimmunophilin ligands: the development of novel neuroregenerative/Neuroprotective compounds
  9637. Effects of neurotoxic and Neuroprotective agents on peripheral nerve regeneration assayed by time-lapse imaging in vivo
  9638. Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases
  9639. Pigment epithelium derived factor as a Neuroprotective agent against ischemic retinal injury
  9640. Molecular Basis of Neuroprotective Activities of Rasagiline and the Anti-Alzheimer Drug TV3326 [lpar; N-Propargyl-(3 R) Aminoindan-5-YL)-Ethyl Methyl Carbamate]
  9641. Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-expression is Neuroprotective after intracerebral hemorrhage
  9642. The effect of the Neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study
  9643. Estrogen as a Neuroprotective agent in the treatment of spinal cord injury
  9644. Neuroprotective effects of bcl‐2 overexpression in hippocampal cultures: interactions with pathways of oxidative damage
  9645. The Neuroprotective effects of phytoestrogens on amyloid β protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat …
  9646. Neuroprotective activity of metabotropic glutamate receptor ligands
  9647. Screening of novel pentacyclo-undecylamines for Neuroprotective activity
  9648. Implications of the Neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders
  9649. Neuroprotective effect of garlic compounds in amyloid-β peptide-induced apoptosis in vitro
  9650. The Neuroprotective agent memantine induces brain -derived neurotrophic factor and trkB receptor expression in rat brain
  9651. Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice
  9652. Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro
  9653. Evidence for in vivo production of Humanin peptide, a Neuroprotective factor against Alzheimer’s disease-related insults
  9654. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous Neuroprotective pathway
  9655. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia
  9656. The original novel nootropic and Neuroprotective agent noopept
  9657. A Neuroprotective role for gap junctions
  9658. Identification of the Neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons
  9659. Identification of essential amino acids in Humanin, a Neuroprotective factor against Alzheimer’s disease-relevant insults
  9660. Effect of ischemic preconditioning on the expression of putative Neuroprotective genes in the rat brain
  9661. Neuroprotective effect of estradiol and phytoestrogens on MPP+‐induced cytotoxicity in neuronal PC12 cells
  9662. Modulation of recombinant and native neuronal SK channels by the Neuroprotective drug riluzole
  9663. Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior
  9664. Neurodegeneration and Neuroprotection in glaucoma: development of a therapeutic Neuroprotective vaccine: the Friedenwald lecture
  9665. Are dopamine receptor agonists Neuroprotective in Parkinson’s disease?
  9666. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson’s disease by blocking microglial activation
  9667. Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia
  9668. A comparative assessment of the efficacy and side-effect liability of Neuroprotective compounds in experimental stroke
  9669. Neuroprotective activity of tamoxifen in permanent focal ischemia
  9670. Neuroprotective effect of low-dose lidocaine in a rat model of transient focal cerebral ischemia
  9671. Neuroprotective effect of (−) Δ9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite
  9672. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral …
  9673. Neuroprotective effect of delayed moderate hypothermia after focal cerebral ischemia: an MRI study
  9674. Serial analysis of gene expression identifies metallothionein-II as major Neuroprotective gene in mouse focal cerebral ischemia
  9675. NFκB activation is required for the Neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons
  9676. Dose‐related Neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of Neuroprotection in α4 nicotinic receptor subunit knockout mice
  9677. Enhanced Neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector
  9678. Neuroprotective properties of epoetin alfa
  9679. Neuroprotective and neurotoxic effects of estrogens
  9680. Neuroprotective properties of valproate
  9681. Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy
  9682. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: role of glutamate and its transporters
  9683. Neuroprotective dibenzylbutyrolactone lignans of Torreya nucifera
  9684. Neuroprotective effect of Alpinia oxyphylla Miq. fruits against glutamate-induced apoptosis in cortical neurons
  9685. Astroglia play a key role in the Neuroprotective actions of estrogen
  9686. Neuroprotective role of astrocytic gap junctions in ischemic stroke
  9687. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia
  9688. Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons
  9689. The Neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death
  9690. Neuroprotective and behavioral efficacy of nerve growth factor—Transfected hippocampal progenitor cell transplants after experimental traumatic brain injury
  9691. The Neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide
  9692. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats
  9693. Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats
  9694. Synaptic, intracellular, and Neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
  9695. Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus
  9696. … receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to Neuroprotective interventions in neurodegenerative …
  9697. Pharmacologic inhibition of poly (ADP-ribose) polymerase is Neuroprotective following traumatic brain injury in rats
  9698. A tripartite motif protein TRIM11 binds and destabilizes Humanin, a Neuroprotective peptide against Alzheimer’s disease‐relevant insults
  9699. Novel p53 inactivators with Neuroprotective action: syntheses and pharmacological evaluation of 2-imino-2, 3, 4, 5, 6, 7-hexahydrobenzothiazole and 2-imino-2, 3, 4, 5 …
  9700. Four New Neuroprotective Iridoid Glycosides from Scrophularia buergeriana Roots
  9701. From vasoactive intestinal peptide (VIP) through activity-dependent Neuroprotective protein (ADNP) to NAP
  9702. Dictyoquinazols A, B, and C, New Neuroprotective Compounds from the Mushroom Dictyophora indusiata
  9703. brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and Neuroprotective drug monitoring
  9704. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington’s disease
  9705. Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity
  9706. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats
  9707. K252a and CEP1347 are Neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK
  9708. Key Neuroprotective Role for Endogenous Adenosine A1 Receptor Activation During Asphyxia in the Fetal Sheep
  9709. Neuroprotective effects of aspirin in patients with acute cerebral infarction
  9710. Methamphetamine‐induced dopaminergic neurotoxicity: role of peroxynitrite and Neuroprotective role of antioxidants and peroxynitrite decomposition catalysts
  9711. Neuroprotective effects of α-tocopherol on oxidative stress in rat striatal cultures
  9712. Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity
  9713. Neuroprotective effects of estrogen and tamoxifen in vitro
  9714. Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage
  9715. BDNF mediates the Neuroprotective effect of PACAP-38 on rat cortical neurons
  9716. Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures
  9717. An endogenous cannabinoid (2-AG) is Neuroprotective after brain injury
  9718. cognition enhancing or Neuroprotective compounds for the treatment of cognitive disorders: why? when? which?
  9719. Total syntheses of Neuroprotective mastigophorenes A and B
  9720. Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia
  9721. Erythropoietin exerts Neuroprotective effect in neonatal rat model of hypoxic–ischemic brain injury
  9722. Neuroprotective effect of vitamin E on the early model of Parkinson’s disease in rat: behavioral and histochemical evidence
  9723. New imaging strategies for patient selection for thrombolytic and Neuroprotective therapies
  9724. Recombinant murine-activated protein C is Neuroprotective in a murine ischemic stroke model
  9725. Purification of a Neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake
  9726. brain region-specific Neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons
  9727. Neuroprotective effect and intraocular penetration of nipradilol, a β-blocker with nitric oxide donative action
  9728. Neuroprotective and neurotrophic effects of quinic acids from Aster scaber in PC12 cells
  9729. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (−)-epigallocatechin 3-gallate Neuroprotective action
  9730. Intrinsic activation of PI3K/Akt signaling pathway and its Neuroprotective effect against retinal injury
  9731. Gacyclidine: a new Neuroprotective agent acting at the N‐methyl‐D‐aspartate receptor
  9732. Posttraumatic hypothermia is Neuroprotective in a model of traumatic brain injury complicated by a secondary hypoxic insult
  9733. The Neuroprotective antioxidant α-lipoic acid induces detoxication enzymes in cultured astroglial cells
  9734. Neuroprotective roles of microglia in the central nervous system
  9735. Synthesis of N-propargylphenelzine and analogues as Neuroprotective agents
  9736. A new Neuroprotective pinusolide derivative from the leaves of Biota orientalis
  9737. Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis
  9738. Increased survival and Neuroprotective effects of BN82451 in a transgenic mouse model of Huntington’s disease
  9739. The Neuroprotective effects of Cerebrolysin™ in a transgenic model of Alzheimer’s disease are associated with improved behavioral performance
  9740. Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti‐Alzheimer drugs
  9741. Neuroprotective effects of L‐carnitine in induced mitochondrial dysfunction
  9742. Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells
  9743. Activation of neuropeptide Y receptors is Neuroprotective against excitotoxicity in organotypic hippocampal slice cultures
  9744. Immunophilin ligand FK506 is Neuroprotective for penile innervation
  9745. FK506 is Neuroprotective in a model of antiretroviral toxic neuropathy
  9746. Soman‐induced seizures: limbic activity, oxidative stress and Neuroprotective proteins
  9747. Estrogen is Neuroprotective via an apolipoprotein E—dependent mechanism in a mouse model of global ischemia
  9748. Early c-Fos induction after cerebral ischemia: a possible Neuroprotective role
  9749. Expression and Neuroprotective effect of hepatocyte growth factor in retinal ischemia–reperfusion injury
  9750. Neurotrophic and Neuroprotective effects of milk thistle (Silybum marianum) on neurons in culture
  9751. Preclinical development of neurosteroids as Neuroprotective agents for the treatment of neurodegenerative diseases
  9752. Neuroprotective effect of riluzole in MPTP-treated mice
  9753. The Neuroprotective activities of melatonin against the Alzheimer β‐protein are not mediated by melatonin membrane receptors
  9754. Neuroprotective effects of D3 dopamine receptor agonists
  9755. Using cDNA microarray to assess Parkinson’s disease models and the effects of Neuroprotective drugs
  9756. Phosphodiesterase inhibitors are Neuroprotective to cultured spinal motor neurons
  9757. Differences in dopaminergic Neuroprotective effects of estrogen during estrous cycle
  9758. Neuroprotective agent riluzole potentiates postsynaptic GABAA receptor function
  9759. Endogenous estrogen formation is Neuroprotective in model of cerebellar ataxia
  9760. Current status of Neuroprotective agents in the treatment of acute ischemic stroke
  9761. Inhibition of glutamate release via recovery of ATP levels accounts for a Neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation
  9762. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu1 receptor antagonist BAY 36-7620
  9763. Retinal ganglion cell death induced by retinal ischemia: Neuroprotective effects of two alpha-2 agonists
  9764. Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain
  9765. The potential role of cotinine in the cognitive and Neuroprotective actions of nicotine
  9766. Neuroprotective Effects of a Novel Non–Receptor-Binding Estrogen Analogue: In Vitro and In Vivo Analysis
  9767. Neuroprotective and cognition ‐Enhancing Properties of MK‐801 Flexible Analogs: Structure‐Activity Relationships
  9768. Editorial comment—elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not Neuroprotective
  9769. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic–ischemic injury
  9770. IAPs are essential for GDNF-mediated Neuroprotective effects in injured motor neurons in vivo
  9771. Neuroprotective Effects of L-Carnitine on Methamphetamine-Evoked Neurotoxicity
  9772. Neuroprotective effects of antidepressant and mood stabilizing drugs
  9773. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against …
  9774. Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and Neuroprotective actions of cannabinoids in neurons and glia
  9775. Ebselen, a seleno-organic antioxidant, is Neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator
  9776. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats.
  9777. A prodrug of a selective inhibitor of inducible nitric oxide synthase is Neuroprotective in the rat model of glaucoma
  9778. 17β-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: a new Neuroprotective pathway
  9779. Neuroprotective effects of (±)-huprine Y on in vitro and in vivo models of excitoxicity damage
  9780. Neuroprotective effects of the antifungal drug clotrimazole
  9781. Neuroprotective effects of Buyang Huanwu Decoction on neuronal injury in hippocampus after transient forebrain ischemia in rats
  9782. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated Neuroprotective response: comparison with …
  9783. Inhibition of glutamate release by delaying ATP fall accounts for Neuroprotective effects of antioxidants in experimental stroke
  9784. The Neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK
  9785. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF‐producing cells in a rat model of Parkinson’s disease
  9786. Neuroprotective Profile of Enoxaparin, a Low Molecular Weight Heparin, in In Vivo Models of Cerebral Ischemia or Traumatic brain Injury in Rats: a Review
  9787. Antiparkinsonian drugs and their Neuroprotective effects
  9788. Neuroprotective effects of PPARγ agonists against oxidative insults in HT-22 cells
  9789. Neurotrophic and Neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons
  9790. Stilbazulenyl nitrone, a novel antioxidant, is highly Neuroprotective in focal ischemia
  9791. Neuroprotective Effect of σ1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Linked to Reduced Neuronal Nitric Oxide Production
  9792. Additive Neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) …
  9793. The IGF-1/Akt pathway is Neuroprotective in Huntington’s disease and involves Huntingtin phosphorylation by Akt
  9794. Latanoprost exerts Neuroprotective activity in vitro and in vivo
  9795. The mechanisms involved in the long‐lasting Neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain
  9796. Neurotoxic and Neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like …
  9797. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies
  9798. Tamoxifen abolishes estrogen’s Neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system
  9799. Neuroprotective effects of bone marrow stromal cells on rat organotypic hippocampal slice culture model of cerebral ischemia
  9800. Inhibition of evoked glutamate release by the Neuroprotective 5-HT1A receptor agonist BAY x 3702 in vitro and in vivo
  9801. Presence of mitogen-activated protein kinase in retinal Müller cells and its Neuroprotective effect ischemia–reperfusion injury
  9802. Neuroprotective Effects of Insulin-Like Growth Factor-Binding Protein Ligand Inhibitors in Vitro and in Vivo
  9803. Neuroprotective role of monocarboxylate transport during glucose deprivation in slice cultures of rat hippocampus
  9804. Neuroprotective effects of early antiretrovirals in vertical HIV infection
  9805. Neuroprotective effects of α2-selective adrenergic agonists against ischemia-induced retinal ganglion cell death
  9806. Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study
  9807. Neuroprotective effect of riluzole in a primate model of Parkinson’s disease: behavioral and histological evidence
  9808. Neuroprotective mechanisms of antiparkinsonian dopamine D 2-receptor subfamily agonists
  9809. The regulation of glucose metabolism by HIF-1 mediates a Neuroprotective response to amyloid beta peptide
  9810. Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke
  9811. Neuroprotective effect of α2 agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure
  9812. Neuroprotective effect of intermittent hypoxia on iron-induced oxidative injury in rat brain
  9813. Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and …
  9814. Manganese-based complexes of radical scavengers as Neuroprotective agents
  9815. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia
  9816. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation
  9817. Neuroprotective gene therapy against acute neurological insults
  9818. Rasagiline: an anti-Parkinson drug with Neuroprotective activity
  9819. Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia
  9820. Positive allosteric modulators of AMPA receptors are Neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain
  9821. … -clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the Neuroprotective drug vinpocetine: a …
  9822. Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells
  9823. Plant-derived, synthetic and endogenous cannabinoids as Neuroprotective agents : Non-psychoactive cannabinoids,’entourage’compounds and inhibitors of N-acyl …
  9824. Neuroprotective effects of constituents of the oriental crude drugs, Rhodiola sacra, R. sachalinensis and Tokaku-joki-to, against beta-amyloid toxicity, oxidative stress …
  9825. An investigation of the Neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation
  9826. Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson’s disease
  9827. Neuroprotective Effect of N-Acetylcysteine and Hypothermia on the Spinal Cord Ischemia—Reperfusion Injury
  9828. Apoptotic PC12 cells exposing phosphatidylserine promote the production of anti-inflammatory and Neuroprotective molecules by microglial cells
  9829. Comparison of anticonvulsive and acute Neuroprotective activity of three 2, 3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655
  9830. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats
  9831. Ionotropic and metabotropic glutamate receptor mediation of glucocorticoid-induced apoptosis in hippocampal cells and the Neuroprotective role of synaptic N-methyl …
  9832. Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic …
  9833. The Neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site
  9834. The Neuroprotective effects of electroacupuncture on focal cerebral ischemia in monkey
  9835. Induction of antioxidative and antiapoptotic thioredoxin supports Neuroprotective hypothesis of estrogen
  9836. Five Novel Neuroprotective Triterpene Esters of Ulmus davidiana var. japonica
  9837. Neuroprotective action of melatonin on neonatal rat motoneurons after sciatic nerve transection
  9838. Regulatory mechanisms in focal cerebral ischemia. New possibilities in Neuroprotective therapy
  9839. In vivo Neuroprotective role of NMDA receptors against kainate‐induced excitotoxicity in murine hippocampal pyramidal neurons
  9840. Have randomized controlled trials of Neuroprotective drugs been underpowered? An illustration of three statistical principles
  9841. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats
  9842. HSV amplicon delivery of glial cell line-derived neurotrophic factor is Neuroprotective against ischemic injury
  9843. Isolation of a diterpenoid substance with potent Neuroprotective activity from fetal calf serum
  9844. Talampanel, a novel noncompetitive AMPA antagonist, is Neuroprotective after traumatic brain injury in rats
  9845. Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia.
  9846. Acetyl-L-carnitine shows Neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons
  9847. Neuroprotective therapy for HIV dementia
  9848. Dose-dependent Neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of …
  9849. Neuroprotective properties of tianeptine: interactions with cytokines
  9850. Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells
  9851. Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat
  9852. Neuroprotective effect of postischemic administration of sodium orthovanadate in rats with transient middle cerebral artery occlusion
  9853. Neuroprotective potential of ionotropic glutamate receptor antagonists
  9854. Neuroprotective effect of sodium orthovanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus
  9855. … structure− activity relationships of 3-aryloxindoles: A new class of calcium-dependent, large conductance potassium (Maxi-K) channel openers with Neuroprotective …
  9856. A critical assessment of the neurodestructive and Neuroprotective effects of nitric oxide
  9857. Neuroprotective effects of estradiol-17β: implications for psychiatric disorders.
  9858. Neuroprotective actions of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion (MPP+)-induced apoptosis in SK-N-SH neurons
  9859. Neuroprotective effects of insulin-like growth factor-I (IGF-I) following a penetrating brain injury in rats
  9860. Comparison of the Neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina
  9861. A novel rat gene encoding a Humanin‐like peptide endowed with broad Neuroprotective activity
  9862. Brimonidine’s Neuroprotective effects against transient ischaemia-induced retinal ganglion cell death
  9863. Presence of DNA fragmentation and lack of Neuroprotective effect in DFF45 knockout mice subjected to traumatic brain injury
  9864. Comparison of the Neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures
  9865. The adenosine A1 receptor agonist adenosine amine congener exerts a Neuroprotective effect against the development of striatal lesions and motor impairments in …
  9866. Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy
  9867. Relevance of the site of injury of glaucoma to Neuroprotective strategies
  9868. Subthalamic nucleus lesions are Neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions
  9869. Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271
  9870. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of Neuroprotective effects of IL-18—Binding protein after experimental closed …
  9871. The Neuroprotective effect of a free radical scavenger and mild hypothermia following transient focal ischemia in rats
  9872. Comparative study of the Neuroprotective effect of dehydroepiandrosterone and 17β-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum
  9873. Evaluation of topiramate Neuroprotective effect in severe TBI using microdialysis
  9874. Activation of the Neuroprotective ERK signaling pathway by fructose-1, 6-bisphosphate during hypoxia involves intracellular Ca2+ and phospholipase C
  9875. Adenosine A 2A receptor antagonists: potential therapeutic and Neuroprotective effects in Parkinson’s disease
  9876. Electroencephalogram Analysis and Neuroprotective Profile of theN-Acetylated-α-Linked Acidic Dipeptidase Inhibitor, GPI5232, in Normal and brain -Injured Rats
  9877. Two Neuroprotective compounds from mushroom Daldinia concentrica
  9878. Selective, reversible caspase-3 inhibitor is Neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury
  9879. Mild hypothermia enhances efficacy of Neuroprotective agents in cerebral ischemia in rats
  9880. Neuroprotective Effects ofl-Arginine Administration after Cortical Impact Injury in Rats: Dose Response and Time Window
  9881. Neuroprotective role of learning in dementia: a biological explanation
  9882. Beyond intraocular pressure: Neuroprotective strategies for future glaucoma therapy
  9883. Feasibility of Neuroprotective agent administration by prehospital personnel in an urban setting
  9884. The Neuroprotective properties of gabapentin-lactam
  9885. Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice
  9886. Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92
  9887. Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats
  9888. Studies on the Neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage
  9889. Minocycline and other tetracycline derivatives: a Neuroprotective strategy in Parkinson’s disease and Huntington’s disease
  9890. Regulated expression of sodium‐dependent glutamate transporters and synthetase: a Neuroprotective role for activated microglia and macrophages in HIV infection?
  9891. Acamprosate is Neuroprotective against glutamate‐induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain
  9892. brain ‐derived neurotrophic factor superinduction parallels anti‐epileptic− Neuroprotective treatment in the pilocarpine epilepsy model
  9893. Neuroprotective effects of pramipexole in young and aged MPTP-treated mice
  9894. In vitro blood–brain barrier permeability and cerebral endothelial cell uptake of the Neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic …
  9895. … release by spinal cord injury mediates production of hydroxyl radical, malondialdehyde and cell death: a site of the Neuroprotective action of methylprednisolone
  9896. Neuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: clinical benefits in the treatment of glaucoma.
  9897. Long-term Neuroprotective effect of inhibiting poly (ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment
  9898. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rats: Therapeutic time window for FK506 in transient focal ischemia
  9899. The novel Neuroprotective action of sulfasalazine through blockade of NMDA receptors
  9900. What have we learned from clinical Neuroprotective trials?
  9901. Drug distribution in man: a positron emission tomography study after oral administration of the labelled Neuroprotective drug vinpocetine
  9902. The role of kynurenines in the production of neuronal death, and the Neuroprotective effect of purines
  9903. Estradiol exerts Neuroprotective actions against ischemic brain injury
  9904. Role of N-methyl-D-aspartate receptors in the Neuroprotective activation of extracellular signal-regulated kinase 1/2 by cisplatin
  9905. Current state on development of Neuroprotective agents for cerebral ischemia
  9906. Neuroprotective κ-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats
  9907. Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice
  9908. The Neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and …
  9909. The Neuroprotective activity of 8-alkylamino-1, 4-benzoxazine antioxidants
  9910. Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damage
  9911. The mechanisms of cell death in focal cerebral ischemia highlight Neuroprotective perspectives by anti-caspase therapy
  9912. FGF-2, NGF and IGF-1, but not BDNF, utilize a nitric oxide pathway to signal neurotrophic and Neuroprotective effects against alcohol toxicity in cerebellar granule cell …
  9913. Neuroprotective effects of nitrone radical scavenger S-PBN on reperfusion nerve injury in rats
  9914. Glycine and Neuroprotective effect of hypothermia in hypoxic–ischemic brain damage
  9915. LY503430, a novel α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, Neuroprotective and neurotrophic effects in rodent …
  9916. Neuroprotective effects of IGF-I against TNFα-induced neuronal damage in HIV-associated dementia
  9917. Interaction of the Neuroprotective drug riluzole with GABAA and glycine receptor channels
  9918. Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia
  9919. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells
  9920. Neuroprotective effects of magnesium on metabolic disturbance in fetal hippocampal slices after oxygen-glucose deprivation: mediation by nitric oxide system
  9921. Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis
  9922. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the Neuroprotective potential of A2A antagonists
  9923. Neuroprotective , anti-apoptotic effects of apomorphine
  9924. Neuroprotective agent riluzole dramatically slows inactivation of Kv1. 4 potassium channels by a voltage-dependent oxidative mechanism
  9925. Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates Neuroprotective activity of transforming growth factor-β1 against NMDA …
  9926. … of neuronal nitric oxide synthase results in neurodegenerative changes in the axotomised dorsal root ganglion neurons: evidence for a Neuroprotective role of nitric …
  9927. … and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). New glutamate and aspartate analogues as potential Neuroprotective …
  9928. Neuroprotective effects of MK 801 and hypothermia used alone and in combination in hypoxic-ischemic brain injury in neonatal rats
  9929. Novel Neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline
  9930. Neuroprotective effects of currently used antidotes in tabun‐poisoned rats
  9931. Neuroprotective Activity of p-Terphenyl Leucomentins from the Mushroom Paxillus panuoides
  9932. Metabolic effects of hypothermia and its Neuroprotective effects on the recovery of metabolic and electrophysiological function in the ischemic retina in vitro
  9933. Neuroprotective effect of ebselen on rat hippocampal slices submitted to oxygen–glucose deprivation: correlation with immunocontent of inducible nitric oxide …
  9934. The use-dependent sodium channel blocker mexiletine is Neuroprotective against global ischemic injury
  9935. Neuroprotective effect of apolipoprotein E against ischemia
  9936. Neuroprotective agents in acute ischemic stroke.
  9937. Modulation of the kynurine pathway of tryptophan metabolism in search for Neuroprotective agents . Focus on kynurenine-3-hydroxylase
  9938. Neuroprotective effect of interleukin‐6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington’s syndrome
  9939. Neuroprotective effects of YM872 coadministered with t-PA in a rat embolic stroke model
  9940. Tacrolimus, a potential Neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primates
  9941. Neuroprotective actions of lithium
  9942. Comparative Neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats
  9943. Neuroprotective effects in gerbils of spiramine T from Spiraea japonica var. acuta
  9944. The neuronal nitric oxide synthase inhibitor, TRIM, as a Neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance …
  9945. … (−)-(R)-3-(2-hydroxymethylindanyl-4-oxy) phenyl-4, 4, 4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with Neuroprotective properties
  9946. The Neuroprotective effect of ONO-1714 on NMDA-mediated cytotoxicity in vitro
  9947. Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells
  9948. Neuroprotective effects of NV-31, a bilobalide-derived compound: evidence for an antioxidative mechanism
  9949. Triflusal posttreatment inhibits glial nuclear factor-κB, downregulates the glial response, and is Neuroprotective in an excitotoxic injury model in postnatal brain
  9950. Neuroprotective effect of adenine on purkinje cell survival in rat cerebellar primary cultures
  9951. An N-methyl-D-aspartate receptor channel blocker with Neuroprotective activity
  9952. Role of heme oxygenase‐1 protein in the Neuroprotective effects of cyclopentenone prostaglandin derivatives under oxidative stress
  9953. Decrease of proinflammatory molecules correlates with Neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage
  9954. Neuroprotective activity of a nanoparticulate formulation of the glycineB site antagonist MRZ 2/576 in transient focal ischaemia in rats
  9955. Towards new Neuroprotective agents : design and synthesis of 4H-thieno [2, 3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitors
  9956. Activation of the mitogen-activated protein kinase (ERK1/2) signaling pathway by cyclic AMP potentiates the Neuroprotective effect of the neurotransmitter …
  9957. Neuroprotective effect of tiagabine in transient forebrain global ischemia: an in vivo microdialysis, behavioral, and histological study
  9958. Amyloid processing and signal transduction properties of antiparkinson‐antialzheimer Neuroprotective drugs rasagiline and TV3326
  9959. Neuroprotective effect of treatment with calcium antagonists on hypertensive retina
  9960. The essentiality of Bcl-2, PKC and proteasome–ubiquitin complex activations in the Neuroprotective -antiapoptotic action of the anti-Parkinson drug, rasagiline
  9961. Neuroprotective and neurorescuing effects of isoform‐specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta‐amyloid toxicity
  9962. Fibroblast growth factor-2 requires glial-cell-line-derived neurotrophic factor for exerting its Neuroprotective actions on glutamate-lesioned hippocampal neurons
  9963. Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine …
  9964. Neuroprotective or neurotoxic activity of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline and related compounds
  9965. The dawn of Neuroprotective therapy for glaucomatous optic neuropathy
  9966. Neuroprotective and nootropic actions of a novel cyclized dipeptide after controlled cortical impact injury in mice
  9967. Evidence that inhibition of cathepsin-B contributes to the Neuroprotective properties of caspase inhibitor Tyr-Val-Ala-Asp-chloromethyl ketone
  9968. Neuroprotective effect of flupirtine in prion disease.
  9969. GSK-3 inhibition by adenoviral FRAT1 overexpression is Neuroprotective and induces Tau dephosphorylation and β-catenin stabilisation without elevation of …
  9970. Novel isoquinolinone-derived inhibitors of poly (ADP-ribose) polymerase-1: pharmacological characterization and Neuroprotective effects in an in vitro model of …
  9971. … with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased Neuroprotective efficacy and extended …
  9972. Magnetic resonance imaging of the Neuroprotective effect of xaliproden in rats
  9973. Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells
  9974. Neuroprotective role of neurophysiological monitoring during endovascular procedures in the spinal cord
  9975. Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischaemia
  9976. Early Neuroprotective effect of nitric oxide in developing rat brain irradiated in utero
  9977. Alpha-2 adrenergic receptor agonists are Neuroprotective in experimental models of glaucoma
  9978. EGb 761 is a Neuroprotective agent against beta-amyloid toxicity.
  9979. Neuroprotective effects of (±)‐kavain in the MPTP mouse model of Parkinson’s disease
  9980. Neuroprotective signal transduction in model motor neurons exposed to thrombin: G‐protein modulation effects on neurite outgrowth, Ca2+ mobilization, and …
  9981. Possible antioxidant and Neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia
  9982. Signaling pathways mediate the Neuroprotective effects of GDNF
  9983. Changes in hippocampal gene expression after Neuroprotective activation of group I metabotropic glutamate receptors
  9984. Amyloid precursor protein family-induced neuronal death is mediated by impairment of the Neuroprotective calcium/calmodulin protein kinase IV-dependent …
  9985. Thrombin attenuation is Neuroprotective in the injured rat optic nerve
  9986. Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington’s disease
  9987. Quantitative evaluation of the Neuroprotective effects of hypothermia ranging from 34 degrees C to 31 degrees C on brain ischemia in gerbils and determination of the …
  9988. Endogenous parathyroid hormone-related protein functions as a Neuroprotective agent
  9989. Dexanabinol: a novel cannabinoid with Neuroprotective properties.
  9990. The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has Neuroprotective properties in the rat
  9991. Neuroprotective effects of coenzyme Q10 at rostral ventrolateral medulla against fatality during experimental endotoxemia in the rat
  9992. 17β-Estradiol extends ischemic thresholds and exerts Neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats
  9993. Effects of Neuroprotective cocktails on hippocampal neuron death in an in vitro model of cerebral ischemia
  9994. Paradoxical increase in neuronal DNA fragmentation after Neuroprotective free radical scavenger treatment in experimental traumatic brain injury
  9995. Cyclosporine A as a potential Neuroprotective agent: a study of prolonged hypothermic circulatory arrest in a chronic porcine model
  9996. Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats
  9997. The GABAA receptor agonist THIP is Neuroprotective in organotypic hippocampal slice cultures
  9998. Is Neuroprotective efficacy of nNOS inhibitor 7-NI dependent on ischemic intracellular pH?
  9999. Paracrine Neuroprotective effect of nitric oxide in the developing retina
  10000. The role of activity-dependent Neuroprotective protein in a mouse model of fetal alcohol syndrome
  10001. Neuroprotective effects of pyridoxal phosphate and pyridoxal against ischemia in monkeys
  10002. Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6 …
  10003. Neuroprotective effect of estrogen upon retinal neurons in vitro
  10004. Neuroprotective gene therapy for Parkinson’s disease
  10005. Neuroprotective efficacy of intra-arterial and intravenous magnesium sulfate in a rat model of transient focal cerebral ischemia
  10006. Neuroprotective effect of hypothermia at defined intraischemic time courses in cortical cultures
  10007. Parathyroid hormone-related protein induction in focal stroke: a Neuroprotective vascular peptide
  10008. Aliphatic propargylamines as symptomatic and Neuroprotective treatments for neurodegenerative diseases
  10009. Bradykinin B2, but Not B1, Receptor Antagonism Has a Neuroprotective Effect after brain Injury
  10010. In vivo Neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke
  10011. Baclofen is Neuroprotective and prevents loss of calcium/calmodulin‐dependent protein kinase II immunoreactivity in the ischemic gerbil hippocampus
  10012. Neuroprotective effects of lipoxygenase inhibitors against ischemic injury in rat hippocampal slice cultures
  10013. Neuroprotective effects of a new synthetic peptide, CMX-9236, in in vitro and in vivo models of cerebral ischemia
  10014. Mood stabilizers in Alzheimer’s disease: symptomatic and Neuroprotective rationales
  10015. Hypothermia and thiopentone sodium: individual and combined Neuroprotective effects on cortical cultures exposed to prolonged hypoxic episodes
  10016. Neuroprotective effect of nitric oxide against NMDA-induced neurotoxicity in the rat retina is associated with tyrosine hydroxylase expression
  10017. Arylpropanolamines incorporating an antioxidant function as Neuroprotective agents
  10018. Evaluation of Neuroprotective qualities of brimonidine during LASIK
  10019. The Neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging
  10020. Neuroprotective effect of regional carnitine on spinal cord ischemia—reperfusion injury
  10021. Potential Neuroprotective benefits of erythropoietin during experimental hypothermic circulatory arrest
  10022. Differential Neuroprotective Effects of Equine Estrogens Against Oxidized Low Density Lipoprotein—Induced Neuronal Cell Death
  10023. Pharmacological and physiological properties of serofendic acid, a novel Neuroprotective substance isolated from fetal calf serum
  10024. Continuous delivery of neurotrophin 3 by gene therapy has a Neuroprotective effect in experimental models of diabetic and acrylamide neuropathies
  10025. The cycloxygenase-2 inhibitor SC58236 is Neuroprotective in an in vivo model of focal ischemia in the rat
  10026. Neuroprotective effects of hyperthermic preconditioning on infarcted volume after middle cerebral artery occlusion in rats: role of adenosine receptors.
  10027. Introduction: Immunosuppressants as Neuroprotective agents
  10028. Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina
  10029. Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A Neuroprotective role for activated microglia?
  10030. Neuroprotective effects of an adenoviral vector expressing the glucose transporter: a detailed description of the mediating cellular events
  10031. Estrogen—Mystery Drug for the brain ?: The Neuroprotective Activities of the Female Sex Hormone
  10032. Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its Neuroprotective properties in the MPTP mouse model of …
  10033. The Neuroprotective and antiapoptotic effects of melatonin in cerebellar neurons involve glucocorticoid receptor and p130 signal pathways
  10034. Investigation Of AM‐36: A Novel Neuroprotective Agent
  10035. Long-term Neuroprotective effects of hypothermia on neonatal hypoxic-ischemic brain injury in rats, assessed by auditory brain stem response
  10036. The Neuroprotective effect of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl] ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole …
  10037. Neurotoxic and Neuroprotective effects of glutamate are enhanced by introduction of amyloid precursor protein cDNA
  10038. Neuroprotective Effect of (2S, 3S, 4R)-N”-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine (KR …
  10039. Neuroprotective strategies in Alzheimer’s disease
  10040. Neuroprotective effects of Tripterygium Wilforddi Hook F monomer T10 on glutamate induced PC12 cell line damage and its mechanism
  10041. Neurotoxicological and Neuroprotective elements in Parkinson’s disease
  10042. Neuroprotective mechanisms of adenosine action on CNS neurons
  10043. Oestrogen has Neuroprotective effects and may reduce the risk of Alzheimer’s disease
  10044. 3, 4-dihydroxyphenylacetaldehyde: a potential target for Neuroprotective therapy in Parkinson’s disease
  10045. Injections of the Neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults
  10046. The Neuroprotective effect of creatine in rats with cerebral ischemia
  10047. The Neuroprotective agents chlomethiazole and SB203580 inhibit IL‐1β signalling but not its biosynthesis in rat cortical glial cells
  10048. Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel Neuroprotective agent, as assessed in old rhesus monkeys …
  10049. Neuroprotective Effects of the CRF1 Antagonist R121920 after Permanent Focal Ischemia in the Rat
  10050. AMPA receptor antagonists with additional mechanisms of action: new opportunities for Neuroprotective drugs?
  10051. Neuroprotective Effect of Naloxone in Inflammation-Mediated Dopaminergic Neurodegeneration
  10052. Neuroprotective effects of GYKI 52466 on experimental spinal cord injury in rats
  10053. Selegiline’s Neuroprotective capacity revisited
  10054. L‐Arginyl‐3,4‐Spermidine is Neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission
  10055. Deferoxamine, allopurinol and oxypurinol are not Neuroprotective after oxygen/glucose deprivation in an organotypic hippocampal model, lacking functional …
  10056. Neuroprotective and cerebrovascular effects of GABA mimetics
  10057. Neuroprotective effect of NPY on kainate neurotoxicity in the hippocampus
  10058. The N-methyl-D-aspartate antagonist memantine has no Neuroprotective effect during hypothermic circulatory arrest: a study in the chronic porcine model
  10059. Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist
  10060. LY393615, a novel neuronal Ca2+ and Na+ channel blocker with Neuroprotective effects in models of in vitro and in vivo cerebral ischemia
  10061. Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and …
  10062. Neuroprotective effects of estrone on NMDA-induced toxicity in primary cultures of rat cortical neurons are independent of estrogen receptors
  10063. Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer’s disease—a target for Neuroprotective treatment strategies?
  10064. Ischemic brain injury caused by interrupted versus uninterrupted occlusion in hypotensive rats with subarachnoid hemorrhage: Neuroprotective effects of citicoline
  10065. Neuroprotective therapy for Huntington’s disease: new prospects and challenges
  10066. 2-OH-estradiol, an endogenous hormone with Neuroprotective functions
  10067. A serum-and antioxidant-free primary culture model of mouse cortical neurons for pharmacological screen and studies of neurotrophic and Neuroprotective agents
  10068. Neuroprotective and antiepileptic activities of ketamine in nerve agent poisoning
  10069. Neuroprotective possibilities for Huntington’s disease
  10070. Neuroimmunophilin ligand V-10,367 is Neuroprotective after 24-hour delayed administration in a mouse model of diffuse traumatic brain injury
  10071. Huntington’s disease: prospects for Neuroprotective therapy 10 years after the discovery of the causative genetic mutation
  10072. Synthesis, molecular modeling and biological evaluation of aza-proline and aza-pipecolic derivatives as FKBP12 ligands and their in vivo Neuroprotective effects
  10073. 9-Carboxymethyl-5H, 10H-imidazo [1, 2-a] indeno [1, 2-e] pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and Neuroprotective AMPA …
  10074. AM-36, a novel Neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin …
  10075. Na+Channels and Ca2+ Channels of the Cell Membrane as Targets of Neuroprotective Substances
  10076. S-methyl-N, N-diethylthiocarbamate sulfoxide elicits Neuroprotective effect against N-methyl-D-aspartate receptor-mediated neurotoxicity
  10077. Differential expression of embryonic and maternal activity-dependent Neuroprotective protein during mouse development
  10078. Neuroprotective effects on somatotopic maps resulting from piracetam treatment and environmental enrichment after focal cortical injury
  10079. In vivo exploration of cerebral ischemia: use of Neuroprotective agents in animal studies
  10080. Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: a combined study of microdialysis and a Neuroprotective agent
  10081. An experimental study of effect on brain damage and Neuroprotective effect of angelicae gigantis radix extract against cerebral ischemia in rats
  10082. Inhibition of human LDL oxidation by the Neuroprotective drug l-deprenyl
  10083. Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and …
  10084. Possible involvement of induction of brain -derived neurotrophic factor in the Neuroprotective effect of a 5-phenylpyrimidine derivative
  10085. Neuroprotective effect of deprenyl in sensory neurons of axotomized dorsal root ganglion
  10086. Glutamate infusion coupled with hypoxia has a Neuroprotective effect in the rat
  10087. Neuroprotective MK801 is associated with nitric oxide synthase during hypoxia/reoxygenation in rat cortical cell cultures
  10088. Early and delayed Neuroprotective effects of FK506 on experimental focal ischemia quantitatively assessed by diffusion-weighted MRI
  10089. Neuroprotective activity of antazoline against neuronal damage induced by limbic status epilepticus
  10090. Targeting Expression of hsp70i to Discrete Neuronal Populations Using the Lmo-1 Promoter: Assessment of the Neuroprotective Effects of hsp70i In vivo and In vitro
  10091. Neuroprotective effects mediated by dopamine receptor agonists against malonate-induced lesion in the rat striatum
  10092. Cerebral hemorrhage due to heparin limits its Neuroprotective effects: studies in a rabbit model of photothrombotic middle cerebral artery occlusion
  10093. Studies on the Neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA (” ecstasy”)-induced …
  10094. Lamotrigine plus leukocyte filtration as a Neuroprotective strategy in experimental hypothermic circulatory arrest
  10095. Tamoxifen eliminates estrogen’s Neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system
  10096. The Neuroprotective effects of virally-derived caspase inhibitors p35 and crmA following a necrotic insult
  10097. Green tea extract may have Neuroprotective effects in Parkinson’s disease
  10098. Saturation of Neuroprotective effects of adenosine in cortical culture
  10099. Oxidative Mediated Neurodegeneration in Alzheimer’s Disease: Melatonin and Related Indoles as Neuroprotective agents
  10100. Genotyping methods to detect a unique Neuroprotective factor (Wlds) for axons
  10101. Role of the α 2A-Adrenoceptor Subtype in the Neuroprotective Effect of Dexmedetomidine
  10102. Contrast sensitivity improvements in brimonidine-treated primary open-angle glaucoma patients suggest a Neuroprotective mechanism
  10103. Neuroprotective effect of hypoxic preconditioning: phenomenon and mechanisms
  10104. Amino acids in neurobiology: Neuroprotective and neurotoxic aspects of amino acids involved in neurotransmission and neuromodulation–General Introduction
  10105. Neuroprotective effect of NS-7, a novel Na+ and Ca2+ channel blocker, in a focal ischemic model in the rat
  10106. HSV-1 vector-delivered FGF2 to the retina is Neuroprotective but does not preserve functional responses
  10107. New aspects of Neuroprotective effects of nonsteroidal anti-inflammatory drugs
  10108. Neuroprotective therapy for the treatment of acute ischemic stroke
  10109. Neuroprotective Effects of Increased Extracellular Ca2+ During Aglycemia in White Matter
  10110. Additive Neuroprotective effect of ketanserin and ipsapirone on the hippocampal damage after transient forebrain ischemia in the Mongolian gerbil
  10111. Studies on neuronal apoptoisis in primary forebrain cultures: Neuroprotective /anti-apoptotic action of NR2B NMDA antagonists
  10112. Intrathecal CGX-1007 is Neuroprotective in a rat model of focal cerebral ischemia
  10113. Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering
  10114. Neuroprotective actions of FK506 and cyclosporin A on motor neuron survival following neonatal axotomy
  10115. CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not Neuroprotective in vivo
  10116. Hypoxic tolerance induction in rat brain slices following hypoxic preconditioning due to expression of Neuroprotective proteins as revealed by dynamic changes in …
  10117. Neuroprotective effect of Angelica gigas extracts on the brain ischemia induced by four-vessel occlusion in rats
  10118. Letters to the Editor: Reasons Why Stroke Trials Underestimate the Neuroprotective Effects of Drugs
  10119. Oral administration of a Neuroprotective compound T‐588 prevents motoneuron degeneration after facial nerve avulsion in adult rats
  10120. Neuroprotective effect of Alpinia oxyphylla extract against glutamate‐induced apoptosis in cultured mouse cortical neurons
  10121. Early head cooling in newborn piglets is Neuroprotective even in the absence of profound systemic hypothermia
  10122. Neuroprotective effects of nimodipine and MK-801 on acute infectious brain edema induced by injection of pertussis bacilli to neocortex of rats.
  10123. A comparison of the Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats
  10124. Neuroprotective effect from ischemia and direct free radical scavenging activity of Choto-san (kampo medicine)
  10125. Immunophilins: Neuroprotective agents and promoters of neural regeneration
  10126. PTHrP regulates cerebral blood flow and is Neuroprotective
  10127. The Neuroprotective effect of erigeron breviscapus (vant) hand-mazz on retinal ganglion cells after optic nerve crush injury
  10128. Relationship between the Neuroprotective effect of Na+/H+ exchanger inhibitor SM-20220 and the timing of its administration in a transient middle cerebral artery …
  10129. Role of spin trapping and P2Y receptor antagonism in the Neuroprotective effects of 2, 2′-pyridylisatogen tosylate and related compounds
  10130. Multiple effects of adenosine in the arterially perfused mammalian eye. Possible mechanisms for the Neuroprotective function of adenosine in the retina
  10131. Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic …
  10132. Might deep brain stimulation of the subthalamic nucleus be Neuroprotective in patients with Parkinson’s disease?
  10133. Neuroprotective effect of nicardipine on cadmium‐induced Purkinje cell death in rat cerebellum
  10134. Effect of the Neuroprotective agent riluzole on intracellular Ca2+ levels in IMR32 neuroblastoma cells
  10135. AIT-082 is Neuroprotective against kainate-induced neuronal injury in rats
  10136. Neuroprotective effects of estrogens in the central nervous system: mechanisms of action
  10137. Trialkylglycines: A New Family of Compounds with in Vivo Neuroprotective Activity
  10138. Influence of glutathione on the oxidation chemistry of 5-S-cysteinyldopamine: potentially Neuroprotective reactions of relevance to Parkinson’s disease
  10139. Microglial proteases: strategic targets for Neuroprotective agents
  10140. Structural requirements for the Neuroprotective effects of aspirin analogues against N‐methyl‐D‐aspartate and zinc ion neurotoxicity
  10141. Neuroprotective effects of extracellular glutamate are absent in hippocampal organotypic cultures treated with the amyloid peptide Aβ25–35
  10142. Neuroprotective treatment for Parkinson’s disease
  10143. Neuroprotective effects of (S)-N-[4-[4-[(3, 4-Dihydro-6-hydroxy-2, 5, 7, 8-tetramethyl-2H-1-benzopyran-2-yl) carbonyl]-1-piperazinyl] phenyl]-2-thiophenecarboximid …
  10144. Morphometric evaluation of the Neuroprotective effect of deprenyl on postaxotomic motor neuron losses
  10145. The highly selective cyclooxygenase-2 inhibitor DFU is Neuroprotective when given several hours after transient cerebral ischemia in gerbils
  10146. Mechanisms of action of pramipexole: putative Neuroprotective effects
  10147. Neuroprotective treatment paradigms in neurovascular surgery—efficacy in a rat model of focal cerebral ischemia
  10148. Neuroprotective effects of Astragulus membranaceus on hypoxia-ischemia brain damage in neonatal rat hippocampus
  10149. Neuroprotective Synergy of N-Methyl-D-Aspartate Receptor Antagonist (MK801) and Protein Synthesis Inhibitor (Cycloheximide) on Spinal Cord Ischemia …
  10150. Neuroprotective therapy
  10151. Characterisation of a novel class of polyamine-based Neuroprotective compounds
  10152. Does transforming growth factor-beta (TGF-beta) act as a Neuroprotective agent in cerebral ischemia?
  10153. Induction of astrocytic cytoplasmic phospholipase A2 and neuronal death after intracerebroventricular carrageenan injection, and Neuroprotective effects of quinacrine
  10154. The Neuroprotective effects of ebselen in experimental spinal cord injury
  10155. Neuroprotective effect of rough aster butanol fraction against oxidative stress in the brain of mice challenged with kainic acid
  10156. Neuroprotective effects of N-methyl-D-aspartate receptor antagonist on aspartate induced neurotoxicity in the spinal cord in vivo
  10157. Caspase inhibitors as Neuroprotective agents
  10158. The Neuroprotective effect of Acori graminei rhizoma extract against cerebral ischemia in rats
  10159. Neuroprotective effects of lithium
  10160. BTS 72664–a novel CNS drug with potential anticonvulsant, Neuroprotective , and antimigraine properties
  10161. An Investigation Into the Neuroprotective Properties of Curcumin
  10162. Neuroprotective effects of low‐doses of aspirin
  10163. Experimental approaches to prophylactic Neuroprotective treatment for retinal and optic nerve disorders
  10164. Outstanding Neuroprotective efficacy of dexrazoxane in mice subjected to sequential common carotid artery sectioning
  10165. Annexins as Neuroprotective agents in the central nervous system
  10166. An ICI 182,780-sensitive, membrane-related estrogen receptor contributes to estrogenic Neuroprotective actions against amyloid-beta toxicity.
  10167. Dose-independent pharmacokinetics of a new Neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats …
  10168. Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system
  10169. Assessment of Neuroprotective ability of a spin trap, α-phenyl-N-tert-butylnitrone, against malonate-induced ischemic injury of rat brain by apparent water diffusion …
  10170. Neuroprotective stroke trials: a ten year dry season
  10171. An Investigation Into the Physico-chemical and Neuroprotective Properties of Melatonin and 6-hydroxymelatonin
  10172. Neuroprotective properties of topiramate in organotypic hippocampal cultures: implications for treatment of vascular and other dementias
  10173. Mild postischemic hypothermia is Neuroprotective in the immature rat neocortex slice
  10174. The mechanism of Neuroprotective effect of heme oxygenase on retinal ischemia-reperfusion injury in rats
  10175. The Neuroprotective effects of Uncaria hirsute Haviland on amyloid β protein-induced toxicity in rat cortical neurons
  10176. Thrombolytics and Neuroprotective agents in the treatment of the patient with an acute cerebrovascular ischemic accident
  10177. Mechanisms of development of neurodegenerative processes in multiple sclerosis: Neuroprotective influence of beta-interferons today and neurotrophic factors …
  10178. Congenital and acquired brain injury. 4. New frontiers: neuroimaging, Neuroprotective agents , cognitive -enhancing agents , new technology, and complementary …
  10179. Neuroprotective Strategies in Parkinson’s Disease
  10180. Neuroprotective effects of ganglioside GM1 on early traumatic brain injury [J]
  10181. The Neuroprotective mechanism of radix salviae miltiorrhizae in brain ischemic injury
  10182. Why Neuroprotective drugs fail: questions about cell death present new challenges
  10183. Early Prediction of Hypoxic-Ischemic brain Damage in Newbon Rats Using Proton Magnetic Resonance Spectroscopy and Neuroprotective Effect of EGb 761.
  10184. Neuroprotective effect and mechanisms of hypothermia in neonatal rat cerebral hypoxic-ischemic damages
  10185. Mild hypothermia enhances the Neuroprotective effects of a selective thrombin inhibitor following transient focal ischemia in rats
  10186. Neuroprotective effects of NS-7, voltage-gated Na+/Ca 2+ channel blocker in a rodent model of transient focal ischemia
  10187. Neuroprotective mechanisms as treatment strategy in Alzheimer’s disease
  10188. Advances in the study of Neuroprotective mechanisms of ganglioside GM1
  10189. Zinc ionophores as Neuroprotective agents
  10190. Experimental study of pharmacological hypothermia: enhanced Neuroprotective effect of a novel 5-HT 1 A agonist SUN N4057 by the pharmacological hypothermia
  10191. Is glutathione an important Neuroprotective effector molecule against amyloid beta toxicity?
  10192. Neuroprotective effects of MK‐801 on l‐2‐chloropropionic acid‐induced neurotoxicity
  10193. Neuroprotective Effects of Lithium-Pointing out Protein Phosphatases as Drug Targets?
  10194. Neuroprotective Effect of Estrogen on Motor Neuron Cells Expressing Wild Type or Mutant Cu/Zn Superoxide Dismutase
  10195. Erratum: Asialoerythropoietin is a nonerythropoietic cytokine with broad Neuroprotective activity in vivo (Proceedings of the National Academy of Sciences of the …
  10196. Neuroprotective role of PSS following cerebral ischemic reperfusion in rats
  10197. Comparative characteristics of A1-receptor agonists as Neuroprotective agents
  10198. Electrophysiological and Neurochemical Evidence for Voltage‐Dependent Ca2+ Channel Blockade by a Novel Neuroprotective Agent NS‐7
  10199. The Neuroprotective characteristics of ursodeoxycholic acid and its conjugates
  10200. Strategies and prospects for development of Neuroprotective therapy for brain ischemia
  10201. Neuroprotective Effect of Citri Pericarpium On Transient Global Ischemia in Gerbils
  10202. Neuroprotective effects of Astragalus root on experimentally spinal cord injury in rats
  10203. High-performance liquid chromatographic analysis of a new Neuroprotective agent for ischemia-reperfusion damage, KR-31378.
  10204. Erythropoietin acts as an endogenous Neuroprotective agent in retinal ischemia
  10205. Theanine provides Neuroprotective Effects of Retinal Ganglion Cells in a Rat Model of Chronic Glaucoma
  10206. Neuroprotective effect of cytoflavin in closed craniocerebral trauma
  10207. Neuroprotective effects of Growth/Differentiation Factor-5 in a rat model of Parkinson’s disease
  10208. An Investigation Into the Neuroprotective Effects of Melatonin in a Model of Rotenone-induced Neurodegeneration
  10209. Neuroprotective Effects of Propofol, Ketamine and Propofol-ketamine after Transient Forebrain Ischemia in the Rat.
  10210. Metabolism of a new Neuroprotective agent for ischemia-rep-erfusion damage, KR-31543 in the rats using liquid chroma-tography/electrospray mass spectrometry
  10211. A prodrug of a selective inhibitor of inducible nitric oxide synthase is Neuroprotective in the rat model of glaucoma
  10212. Reversal by NS-7, a Neuroprotective compound, of the decrease in transcription factor CREB mRNA expression in rat brain after permanent middle cerebral artery …
  10213. Effects of a new Neuroprotective agent KR-31378 on liver cytochrome P450s in male Sprague Dawley rats
  10214. Reproductive experience and aging: possible Neuroprotective effects of motherhood
  10215. Treatment with 7-nitroindazole enhances kainic acid induced cholinergic neurotoxicity in the rat striatum: a Neuroprotective role for neuronal nitric oxide
  10216. Neurite outgrowth-promoting prostaglandins that act as Neuroprotective agents against brain ischemia and may enhance recovery of higher neuronal functions
  10217. Cardiac electrophysiological modulation by NS-7, a novel Neuroprotective drug, of guinea pig ventricular muscles
  10218. In vitro and in vivo approaches to the study of the Neuroprotective actions of estradiol
  10219. Neuroprotective effects of acetylcholine-mediated EDHF in primarily cultured hippocamal neurons insulted by hypoxia-reoxygenation
  10220. Neuroprotective Effects of R (−)-1-(benzo [b] thiophen-5-yl)-2-[2-(N, N-diethylamino) ethoxy] Ethanol Hydrochloride (T-588) Against Retinal Ganglion Cell Death …
  10221. Neuroprotective Agent Brimonidine: A Toxicity Study
  10222. Neuroprotective & antioxidant effects of diets high in n-6 and n-3 fatty acids in rat focal brain ischemia model
  10223. Neuroprotective effects of calpain inhibitor MDL 28170 in a model of intravitreal excitotoxicity
  10224. Neuroprotective Effect of Different Formulations of Topically applied Brimonidine after Calibrated Optic Nerve Injury
  10225. Neuroprotective effect of woganin in a rodent model of permanent focal cerebral ischemia
  10226. Taurine depletion reduces the Neuroprotective effects of electroacupuncture against brain ischemia
  10227. Effects of Garlic and Nimodipine on cerebral blood flow and their Neuroprotective effects after brain ischemia in rabbit
  10228. The Neuroprotective Effect of Growth Hormone on Neuronal Injury of brain in Pilocarpine induced Status Epilepticus.
  10229. The cloning and expression of an anti-Alzheimer’s disease Neuroprotective peptide gene humanin
  10230. Application of potassium chloride to the surface of the rat visual cortex differentially affects the expression of presumptive Neuroprotective molecules
  10231. Neuroprotective Effects of Medicinal Herbs in the Transient Focal Ischemia in Rats
  10232. Characterization of a culture system for rat retinal ganglion cells: Towards a screen for potential Neuroprotective compounds
  10233. Neuroprotective actions of green tea polyphenol,(-)-epigallocatechin-3-gallate in models of Parkinson’s disease: gene targets
  10234. Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone
  10235. Neuroprotective effect of Betoptic S-considerations after 18 months of treatment
  10236. Estrogen as a Neuroprotective agent in rat spinal cord injury
  10237. Multicomponent antithrombotic effect of the Neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine
  10238. The Neuroprotective Effects of Uncariae Ramulus et Uncus on focal cerebral ischemia in rats brain s
  10239. Intracellular pathways mediating the Neuroprotective effects of GDNF and Neurturin in axotomized retinal ganglion cells
  10240. Neuroprotective effect of adenosine on calibrated optic nerve injury in rats
  10241. Neuroprotective effects of intravitreal tetanus neurotoxin (TeNT) injection in the lateral geniculate nucleus (LGN) of monocularly deprived (MD) new-born rats
  10242. Neuroprotective role of erythropoietin in central nervous system hypoxia/ischemia
  10243. Neuroprotective Peptides
  10244. Neuroprotective effect of 8-OH-DPAT on long-term sequelae from prenatal ischemia in rats
  10245. Neuroprotective vaccination with copolymer-1 decreases laser-induced retinal damage
  10246. Neuroprotective Effects of Minocycline in Rat brain Cortical Cell Culture Induced by Hypoxia
  10247. Neuroprotective effect of topical administration of Alphagan-P in rats with laser-induced chronic ocular hypertension
  10248. Strategic Challenges in Neuroprotective Drug Development
  10249. The putative Neuroprotective role of brain -derived neurotrophic factor on stress-induced hippocampal dysfunction.
  10250. Neuroprotective Effect of Growth Hormone in Neonatal Rat with Hypoxic Ischemic brain Injury.
  10251. The construction of the chiral quaternary carbon in the drug discovery directed towards the novel Neuroprotective agent E2050
  10252. Study of RSM′ s Neuroprotective effect and the expression of ICE and Bcl-2 after ischemia and reperfusion
  10253. Acute Neuroprotective effects of cortico steriods mediated by nontranscriptional activation of endothelial nitric oxide synthase
  10254. Estrogen-Mystery Drug for the brain ? The Neuroprotective Activities of the Female Sex Hormone
  10255. Hypothermia and thiopentone sodium: individual and combined Neuroprotective effects at defined intraischemic time courses in cortical cultures
  10256. Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92
  10257. Dose-dependent Neuroprotective effects of Brimonidine against ischemia-induced retinal ganglion cell death
  10258. The Neuroprotective Effect of Intravitreal Melatonin Injection in Pressure-induced Retinal Ischemia
  10259. Neuroprotective Effects of Modafinil on MPTP Mouse Model of Parkinson’s Disease
  10260. Neuroprotective Effect of (-) &Delta_upper; 9-Tetrahydrocannabinol in NMDA-Induced Apoptosis in Rat Retina
  10261. The Neuroprotective effect of ginexin (Ginko biloba extract) on rat retinal ganglion cell in optic nerve crush injury model
  10262. The Neuroprotective effects of Brimonidine on retinal ganglion cells in rats optic nerve crush mode [J]
  10263. Influence of topiramate on amino acids neurotransmitter of cerebral cortex in rats with cerebral ischemia reperfusion injury and Neuroprotective effect
  10264. Radiolabeling and biodistribution of methyl 2-(methoxycarbonyl)-2-(methylamino) bicyclo [2.1. 1]-hexane-5-carboxylate, a potential Neuroprotective drug
  10265. Mechanisms of the Neuroprotective Effects of Estrogen
  10266. Neuroprotective effect of lens epithelium-derived growth factor (LEDGF) on N-methyl-D-aspartate-induced cell death in rat retina
  10267. Simultaneous determination of the novel Neuroprotective agent KR-31378 and its metabolite KR-31612 using high performance liquid chromatography with tandem …
  10268. Neuroprotective Effects of Antioxidatives of Constituents Isolated from Plants
  10269. Duration-Dependent Neuroprotective Effect of Post-Ischemic Mild Hypothermia in the Gerbil Global Ischemic-Reperfusion Model
  10270. Neuroprotective EFFECT OF c-fos ANTISENSE OLIGODEOXYNUCLEOTIDE UPON APOPTOSIS INDUCED BY SODIUM SELENITE IN CULTURED CORTICAL …
  10271. METIPRANOLOL IS Neuroprotective IN RETINAL ISCHAEMIA
  10272. Neuroprotective effect of a neurotoxin, 3-nitropropionic acid, against hypoxic damage to the gerbil hippocampus: Neuroprotection after the onset of hypoxic …
  10273. A comparison of the Neuroprotective efficacy of pharmacological pretreatment
  10274. An Investigation Into the Possible Neuroprotective Role of Antidepressant Drugs
  10275. Neuroprotective Ganglioside Derivatives
  10276. On the Neuroprotective actions of FK506
  10277. … the MDDAS (magnesium deficiency-dependent audiogenic seizure) test: application to the detection of neurotoxic molecules or Neuroprotective (anti-inflammatory and …
  10278. Neuroprotective EFFECT OF MEMAN-TINE IN DIFFERENT GANGLION CELL INJURY MODELS
  10279. Designing Vaccination for Glaucoma: A new approach to Neuroprotective therapy
  10280. Induction of Ischemic Tolerance in the brain : A Novel Neuroprotective Strategy?
  10281. Neuroprotective Effect of Aloesin in a Rat Model of Focal Cerebral Ischemia
  10282. The Neuroprotective effects of estrogen on SK-N-SH cells and the cellular mechanisms involved.
  10283. Neuroprotective Effects of Estrogen in Nigral Dopaminergic Neurons
  10284. THE NEWS IS NOT ALL BAD FOR HRT–ESTROGEN STILL DEMONSTRATES Neuroprotective EFFECTS
  10285. The Neuroprotective Effects of Estrogen in Female Sprague-Dawley with Alchemic Stroke
  10286. Design and Combonatorial Synthesis of Selenoflavonoids and Indole Compounds for Neuroprotective Drug
  10287. Neuroprotective effector mechanisms of estrogens
  10288. Neuroprotective Mechanisms of Aloesin against Focal Ischemic brain Injury
  10289. Oxygen sensor is Neuroprotective in Alzheimer’s disease
  10290. Neuroprotective effects of AM-36 on traumatic brain injury induced by fluid percussion in rats
  10291. Neuroprotective Action of Nipradilol in a Rat Model of Optic Nerve Degeneration
  10292. Neuroprotective Effects of Medicinal Herbs in the Transient Focal Ischemia
  10293. Neuroprotective and Neurotoxic Properties of the “Inert” Gas, Xenon
  10294. An investigation into the possible Neuroprotective role of melatonin in copper-loading
  10295. LEVODOPA: IS IT NEUROTOXIC, Neuroprotective –OR NONE OF THE ABOVE?
  10296. Neuroprotective Effects of Electrical Stimulation on the Axotomized Retinal Ganglion Cells in Vivo
  10297. Are Dopamine Agonists Neuroprotective in Parkinson’s disease?
  10298. Neuroprotective effect of extract of Bombycis corpus
  10299. Neuroprotective Effects of Estrogen on Focal Cerebral Ischemia Rats [J]
  10300. Estrogen is Neuroprotective in a Model of Anterior Ischemic Optic Neuropathy (AION)
  10301. Study of the Neuroprotective mechanisms by the spin trap α-phenyl-N-tert-butylnitrone
  10302. Neuroprotective Effect of Copolymer-1 Vaccination in Laser-Induced Retinal Damage
  10303. Neuroprotective Effect of the Subretinal Artificial Silicon Retina
  10304. Glycogen synthase kinase-3Beta as a target for Neuroprotective signaling pathways
  10305. Neuroprotective effect of a TOPS-ester on retinal ischemia-reperfusion injury
  10306. Neuroprotective Mechanisms of Atoesin against Focal Ischemic brain Injury
  10307. An In Vitro Examination of Minocycline as a Retinal Neuroprotective Agent
  10308. Expression of Neuroprotective Factors by Cultured Cells of the Human Optic Nerve Head Following In Vitro Ischemia
  10309. Neuroprotective effect of aloesin in a rat model of permanent focal cerebral ischemia
  10310. Neuroprotective functions of cycloheximide following traumatic brain injury in rats
  10311. SOCS Proteins Have Neuroprotective Role in the Mammalian Retina
  10312. Chemical Structures and Biological Activities of Neuroprotective Substances from Microbial Metabolites
  10313. Neuroprotective and Detoxifying Mechanisms at the Blood-brain Interfaces
  10314. Neuroprotective efficacy of magnesium sulphate in experimental traumatic brain injury
  10315. Why Have Recent Trials of Neuroprotective agents in Head Injury Failed to Show Convincing Efficacy? A Pragmatic Analysis and Theoretical Considerations: In Reply
  10316. Neuroprotective Properties of GPI1046, A Non-Immunosuppressive Immunophilin Ligand
  10317. The Neuroprotective effects of remacemide hydrochloride in patients undergoing elective coronary artery bypass surgery
  10318. Minocycline is Neuroprotective in a Rat Model of Optic Nerve Transection
  10319. Characterization of neuronal cell injury and Neuroprotective effect of Poloxamer
  10320. Neuroprotective Effects of Treatment with Aloesin in Rat Model of Permanent Focal Cerebral Ischemia
  10321. Neuroprotective effects of lidocaine on hypoxic ischemic encephalopathy of newborn.
  10322. The Neuroprotective Properties of Mood Stabilizers: from Gene Regulation to Ultrastructural Characterization
  10323. Neuroprotective Effect of Polygae Radix on the brain Ischemia Induced by Four-Vessel Occlusionin Rats
  10324. Neuroprotective effect of carnosine in ischemia-reperfusion injury of rat
  10325. HPLC analysis of a new Neuroprotective agent for ischemia-reperfusion damage, a benzopyran derivative, in plasma and urine
  10326. Peroxynitrite as a novel Neuroprotective intercellular signal
  10327. Neuroprotective Efficacy of Different Drug Classes on a Rodent Model of Ischemic Optic Neuropathy
  10328. Chemical Structures and Biological Activities of Neuroprotective Compounds from Korean Medicinal Mushroom
  10329. Neuroprotective effect of KR-31378 in cortical cell culture and in brain ischemia-reperfusion model
  10330. Neuroprotective Effect of N-acetylcysteine in an Asphyxial Cardiac Arrest Model of Rats
  10331. Thrombin attenuation is Neuroprotective in the injured optic nerve
  10332. Neuroprotective Effect of Rho-Associated Protein Kinase Inhibitor, Y-27632, in the Eye
  10333. Neuroprotective effects of cabergoline on ischemia-induced cell death: in vitro studies
  10334. Neuroprotective Effects of Kadsurenone on Transient Focal Ischemia in Rat brain Observed by In Vivo MRI/MRS
  10335. Retinal Gene Expression Changes Associated With Treatment of the rd1 Mouse With Neuroprotective agents
  10336. Neuroprotective and Neurotriopic effect of a isolated Phospholipids from Bombycis corpus
  10337. The Neuroprotective activities of the Panax ginseng in the transient ischemic model in rats
  10338. Oral Presentations OP01: Neurodegenerative Diseases. BCL‐W Plays a key Neuroprotective role in Alzheimer’s disease
  10339. Neuroprotective Effect of Polygae Radix on the brain Ischemia Induced by Four-Vessel Occlusion in Rats
  10340. Neuroprotective effects of honokiol on mouse model with Parkinson’s disease
  10341. Cyclosporin A exerts Neuroprotective effects after diffuse axonal injury in the rat
  10342. The Neuroprotective activities of the Panax ginseng in the transient ischemic model in rats
  10343. Recent Evidence on the Neuroprotective Effects of Pituitary Adenylate Cydase-Activating Polypeptide
  10344. The Neuroprotective Activities of the Sam-Hwang-Sa-Shim-Tang in the Transient Ischemic Model in Rats.
  10345. Preclinical Evaluation of Neuroprotective agents in Transgenic Models of Amyotrophic Lateral Sclerosis
  10346. Neuroprotective Effects of Xenon Attenuate Reperfusion Damage after Cerebral Ischemia
  10347. Neuroprotective and Neurotriopic effect of a isolated Phospholipids from Bombycis corpus
  10348. Propofol attenuates the Neuroprotective effects of magnesium in experimental traumatic brain injury
  10349. ERYTHROPOIETIN IS Neuroprotective IN AN IN VITRO MODEL OF MECHANICAL HIPPOCAMPAL TRAUMA: 47
  10350. Neuroprotective effects of antioxidant constituents isolated from Opuntia ficus-indica var. saboten Makino
  10351. Neuroprotective effect of crocin on forebrain ischemia in rats.
  10352. Blood partition and protein binding of a new Neuroprotective agent for ischemia-reperfusion damage, KR-31378.
  10353. Neuroprotective Effects of Green Tea on the brain Ischemia induced by Four-Vessel Occlusion in Rats
  10354. Neuroprotective Effects of Resveratrol derivative, Compound SY014 Against Ischemic Damage in Rat
  10355. Neuroprotective Effect Of NS-398, A Cyclooxygenase 2 (COX-2) Inhibitor, On Retinal Ischemia-Reperfusion Injury In Rats
  10356. The Neuroprotective Agent Dexmedetomidine Activates the MAP Kinase ERK 1 and 2 in the Rat Hippocampus
  10357. Neuroprotective Effect of Genistein Against beta Amyloid-Induced Neurotoxicity
  10358. The Neuroprotective Effect of Ginkgo Biloba Extract on Retinal Ganglion Cells in a Rat Glaucoma Model
  10359. Neuroprotective and Neurotrophic Effect of a Novel Quinic Acids derivative Isolated from Aster Scaber
  10360. Aging attenuates the Neuroprotective effect by preconditioning with 3-nitropropionic acid
  10361. Neuroprotective effect of deferoxamine on hypoxic-ischemic brain injury in neonatal rat
  10362. Determining an Ideal Dosage of N-methyl-N-nitrosourea to Quickly Screen for Neuroprotective Compounds that can Prevent Retinal Degeneration
  10363. An Investigation of the Neuroprotective Effects of Estrogen in a Model of Quinolinic Acid-induced Neurodegeneration
  10364. Neuroprotective effects after resuscitation by hypothermia closed chest cardiopulmonary bypass in dogs
  10365. Neuroprotective effects of gossypin on beta-amyloid-and oxidative stress-induced toxicity in primary cultured rat cortical cells
  10366. Microarray Analysis of Retinas from Mice Raised in Dim-and Bright-Cyclic Light: Identification of Differentially Expressed Genes in a Mouse Adaptive Neuroprotective …
  10367. Neuroprotective effect of inosine-loaded nanoparticles on axotomized retinal ganglion cells in adult rats
  10368. Neuroprotective Effects of Lipoxygenase and Cytochrome P450 Inhibitors Against AA-induced Cell Death
  10369. The Neuroprotective Agent Dexmedetomidine Increases FAK 125 Tyrosine Kinase Phosphorylation in the Rat Hippocampus
  10370. Neuroprotective effect of wogonin in a rodent model of permanent focal cerebral ischemia
  10371. Studies of the sulfonation and Neuroprotective actions of the neurosteroids DHEA and estradiol in rat brain .
  10372. Neuroprotective Role of c-fos Antisense Oligonucleotide on Glutamate induced Hippocampal Neurons
  10373. Neuroprotective effects of peroxisome proliferator-activated receptor-gamma (PPAR-y) ligands against oxidative stress
  10374. Neuroprotective Effects of Nimodipine Combined with Mannitol in the Treatment of Focal Cerebral Ischemia/Reperfusionn in Rats
  10375. Neuroprotective effects of mild hyperthermia prior to focal ischemia in conscious rats
  10376. The Efficacy and Neuroprotective Effects of Galantamine in Alzheimer’s Disease are Associated with the Nicotinic Receptor Modulation
  10377. Neuroprotective Compounds against Glutamate-induced Toxicity in Primary Cultures of Rat Cortical Cells from Herbal Medicines
  10378. The Neuroprotective effects of mild hypothermia plus Astragalus in a model of cerebral artery occlusion in rat
  10379. Neuroprotective effect of heme oxygenase-1 induced by hemin in the brain of rats suffered from ischemia-reperfusion injury
  10380. The Neuroprotective Activity Of Lignans Isolated From Machilus thunbergii
  10381. Neuroprotective Effect of-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Linked to Reduced Neuronal Nitric Oxide Production
  10382. Purification of a Neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake
  10383. Overexpression of Homer1a Is Neuroprotective and Ameliorates Functional Recovery after Global Cerebral Ischemia in Mice
  10384. PPAR-gamma Ligands Are Neuroprotective Against Glutamate Induced Cytotoxicity in Retinal Ganglion Cells
  10385. Assessment of Neuroprotective properties of the synthetic caspase inhibitor z-devd-fmk after global cerebral ischaemia due to cardiac arrest in rats
  10386. The Neuroprotective Effect of Intravitreally Injected CNTF on Rat Retinal Ganglion Cell in Optic Nerve Crush Injury Model
  10387. The Neuroprotective Effects of Aspirin and MK-801 Against Un-Caged Caged-Glutamate for Use in a Visual Prosthetic Device
  10388. Estradiol Valerate Exerts Neuroprotective Effects in Ischemic Rat brain when Administered after Middle Cerebral Artery Occlusion
  10389. Neuroprotective properties of copper binding fragments of amyloid precursor protein and prion
  10390. A Pathological Survey of the Neuroprotective Effect of Preconditioning with Lithium on the Gerbil Forebrain Ischemia
  10391. Neuroregenerative and Neuroprotective effects of glial cell line-derived neurotrophic factor (GDNF) in repair of spinal cord injury.
  10392. High-Performance Liquid Chromatographic Analysis, Blood Partition and Protein′ binding of a New Neuroprotective Agent for Ischemia-reperfusion Damage, KR …
  10393. The Neuroprotective Effect of alpha-phenyl-N-tert-butyl-nitrone (PBN) in the Argon Laser Induced Retinal Ischemia
  10394. Cyclic AMP Response Element Binding Protein Phosphorylation May Be Closely Associated with Neuroprotective Mechanisms After Focal Ischemia in Rat brain
  10395. Prosaposin, a Polyfunctional Conserved Glycoprotein with Neuroprotective Properties, Is Down Regulated in a Model of Anterior Ischemic Optic Neuropathy (AION)
  10396. Neuroprotective potential of mGluR agonist ABHxD-I and calcium stabiliser dantrolene in the model of perinatal asphyxia in rats
  10397. Randomized Double Blind, Placebo Controlled Trial of Neuroprotective Effects of Epoetin Alfa (Procrit (Trademark)) in Patients Receiving Adjuvant Chemotherapy for …
  10398. Expression of HSP70, c-fos following focal cerebral ischemic reperfusion in rats and Neuroprotective effect of Cudrania tricuspidata
  10399. Toxicity of levodopa and dopamine on PC12 Cells and Neuroprotective effect of several anti-Parkinson drugs on the toxicity
  10400. Neuroprotective effects of baicalein. baicalin. and wogonin in primary cultured rat cortical cells
  10401. Moderate Hypothermia Enhances Xenon’s Neuroprotective Properties after NMDA Induced Neuronal Injury in a Mouse Neuronal-Glial Cell Coculture Model
  10402. Neuroprotective effect of 17-beta-estradiol in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation
  10403. Neuroprotective effect of extract of Angelicae tenuissimae on ischemic damage after oxygen and glucose deprivation (OGD) in rat organotypic hippocampal slice
  10404. Neuroprotective effects of baicalein, baicalin, and wogonin in primary cuItured rat cortical cells
  10405. Neuroprotective effect of extract of Angelica tenuissimae on ischemic damage after oxygen and glucose deprivation (OGD) in rat organotypic hippocampal …
  10406. Neuroprotective effect of Hexane fraction of A0054 on Delayed Neuronal Death after Transient global Ischemia in Gerbil Hippocampus
  10407. Molecular Mechanisms Involved in the Neuroprotective Effect of Mild Hypothermia in the Gerbil Hippocampus Following Transient Forebrain Ischemia
  10408. Neuroprotective effects of Hexane fraction of M61 on Delayed Neuronal Death after Transient global Ischemia in Gerbil Hippocampus
  10409. 4. New frontiers: Neuroimaging, Neuroprotective agents , cognitive -enhancing agents , new technology, and complementary medicine
  10410. … of a short irradiation (50 sec) by different wavelengths on audiogenic seizures in magnesium‐deficient mice: Evidence for a preventive Neuroprotective effect of yellow
  10411. Restorative and Neuroprotective treatment strategies for Parkinson’s disease: tudies on fetal dopamine cell transplants and GDNF delivery by intracerebral …
  10412. HPLC Analysis, Stability, B1ood Partition, Protein Binding, and Dose-independent Pharmacokinetics of KR-31543, a New Neuroprotective Agent for Ischemia …
  10413. An ICI 182,780‐Sensitive, Membrane‐Related Estrogen Receptor Contributes to Estrogenic Neuroprotective Actions against Amyloid‐Beta Toxicity
  10414. Annual Scientific Meeting of ASCEPT 2000: New Investigator Symposium INVESTIGATION OF AM-36: A NOVEL Neuroprotective AGENT
  10415. NEUREGULIN-1 SHOWS Neuroprotective EFFECTS IN IN VITRO ALZHEIMER’S DISEASE MODELS
  10416. 278. Neuroprotective , Neuroregenerative and Therapeutic Effects in Neurological Disorders of Defective Herpes Simplex V Defective Herpes Simplex Vectors …
  10417. 731 Role of the mGluR1 Receptor in Diffuse Axonal Injury after brain and Spinal Cord Trauma: Potential for a Novel, Clinically Relevant Neuroprotective Strategy
  10418. … , 2, 3, 4-TETRAHYDROISOQUINOLINE DERIVATIVES AS ENDOGENOUS REGULATORS OF DOPAMINERGIC ACTIVITY IN CNS WITH Neuroprotective …
  10419. Neuroprotective effects of anesthetic agents
  10420. Molecular mechanisms of Neuroprotective action of immunosuppressants‐facts and hypotheses
  10421. Minocycline as a Neuroprotective agent
  10422. Neuroprotective and abstinence-promoting effects of acamprosate
  10423. Mechanisms of Neuroprotective action of vitamin D 3
  10424. Evaluation of animal models of Parkinson’s disease for Neuroprotective strategies
  10425. Neuroprotective role of testosterone in the nervous system
  10426. Neuroprotective effects of the antiparkinson drug Mucuna pruriens
  10427. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential
  10428. Neuroprotective functions of prion protein
  10429. The Neuroprotective function of vascular endothelial growth factor (VEGF).
  10430. Immunomodulatory and Neuroprotective effects of inosine
  10431. The Neuroprotective role of inflammation in nervous system injuries
  10432. Neuroprotective effects of huperzine A
  10433. Neuroprotective strategies in Alzheimer’s disease
  10434. The search for Neuroprotective strategies in stroke
  10435. Mechanisms of neural cell death: implications for development of Neuroprotective treatment strategies
  10436. A review of Neuroprotective agents
  10437. Neuroprotective properties of statins
  10438. Neuroprotective properties of the natural vitamin E α-tocotrienol
  10439. Neuroprotective herbs for stroke therapy in traditional eastern medicine
  10440. Dexmedetomidine produces its Neuroprotective effect via the α2A-adrenoceptor subtype
  10441. Antihypertensive and Neuroprotective effects of astaxanthin in experimental animals
  10442. Neuroprotective effect of 20 (S)-ginsenoside Rg3 on cerebral ischemia in rats
  10443. Alzheimer’s disease-associated neurotoxic mechanisms and Neuroprotective strategies
  10444. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial
  10445. Microglia: Neuroprotective and neurotrophic cells in the central nervous system
  10446. Ketone body synthesis in the brain : possible Neuroprotective effects
  10447. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia
  10448. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington’s disease
  10449. Prophylactic activation of Neuroprotective stress response pathways by dietary and behavioral manipulations
  10450. memory enhancing and Neuroprotective effects of selected ginsenosides
  10451. Anti-apoptotic and Neuroprotective effects of edaravone following transient focal ischemia in rats
  10452. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats
  10453. Erythropoietin: a novel Neuroprotective cytokine
  10454. Neuroprotective effects of naturally occurring biflavonoids
  10455. Neuroprotective and anti–human immunodeficiency virus activity of minocycline
  10456. The pharmacology of chlormethiazole: a potential Neuroprotective agent?
  10457. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning
  10458. Mechanism of Neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives
  10459. Glia-neuron crosstalk in the Neuroprotective mechanisms of sex steroid hormones
  10460. Prehospital Neuroprotective therapy for acute stroke: results of the field administration of stroke therapy–magnesium (FAST–MAG) pilot trial
  10461. Dual Neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN
  10462. Cell signaling pathways in the Neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases
  10463. Galanin acts as a Neuroprotective factor to the hippocampus
  10464. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI
  10465. Pituitary adenylate cyclase activating polypeptide: a potential Neuroprotective peptide
  10466. brain response to injury and neurodegeneration: endogenous Neuroprotective signaling
  10467. Four New Neuroprotective Dihydropyranocoumarins from Angelica gigas
  10468. Production and release of Neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia
  10469. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson’s disease
  10470. Minocycline: Neuroprotective mechanisms in Parkinson’s disease
  10471. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential
  10472. Neuroprotective effect of γ-glutamylethylamide (theanine) on cerebral infarction in mice
  10473. Cellular prion protein Neuroprotective function: implications in prion diseases
  10474. Neuroprotective effects of 3, 5‐dicaffeoylquinic acid on hydrogen peroxide‐induced cell death in SH‐SY5Y cells
  10475. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
  10476. Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against β-amyloid peptide neurotoxicity
  10477. Neuroprotective mechanisms of curcumin against cerebral ischemia‐induced neuronal apoptosis and behavioral deficits
  10478. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo
  10479. Neuroprotective effect of rasagiline in a rodent model of Parkinson’s disease
  10480. Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson’s disease
  10481. Neuroprotective effects of novel small peptides in vitro and after brain injury
  10482. Neuroprotective properties of afobazol in vitro
  10483. Low dose intravenous minocycline is Neuroprotective after middle cerebral artery occlusion-reperfusion in rats
  10484. Neuroprotective role of aminoguanidine in behavioral changes after blast injury
  10485. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential Neuroprotective treatment
  10486. Humanin, a newly identified Neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor
  10487. Neuroprotective effects of (−)‐epigallocatechin gallate after hypoxia‐ischemia‐induced brain damage: novel mechanisms of action
  10488. Potentially Neuroprotective and therapeutic properties of nitrous oxide and xenon
  10489. Neuroprotective properties of Valeriana officinalis extracts
  10490. Contrasting Neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
  10491. Maternal dietary supplementation with pomegranate juice is Neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury
  10492. Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity
  10493. Neuroprotective effect of cannabidiol, a non‐psychoactive component from Cannabis sativa, on β‐amyloid‐induced toxicity in PC12 cells
  10494. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia
  10495. Axonal metabolic recovery and potential Neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis
  10496. Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: support for a Neuroprotective role of iNOS
  10497. Evaluation of antioxidant and Neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion
  10498. NAP: Research and development of a peptide derived from activity‐dependent Neuroprotective protein (ADNP)
  10499. Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity
  10500. Possible involvement of group I mGluRs in Neuroprotective effect of theanine
  10501. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease
  10502. Neuroprotective role of microglia expressing interleukin‐4
  10503. Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases
  10504. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective Neuroprotective agents
  10505. Neuroprotective effects of topiramate after hypoxia–ischemia in newborn piglets
  10506. Stress reduces the Neuroprotective effect of exercise in a rat model for Parkinson’s disease
  10507. Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its Neuroprotective properties
  10508. Post-ischemic administration of progesterone in rats exerts Neuroprotective effects on the hippocampus
  10509. Anti-adhesion molecule strategies as potential Neuroprotective agents in cerebral ischemia: a critical review of the literature
  10510. Neuroprotective effect of subretinal implants in the RCS rat
  10511. Diffusion-weighted magnetic resonance imaging and neurobiochemical markers after aortic valve replacement: implications for future Neuroprotective trials?
  10512. Interdependence of oestrogen and insulin-like growth factor-I in the brain : potential for analysing Neuroprotective mechanisms
  10513. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy
  10514. A Neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury
  10515. Additive Neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis
  10516. Evaluation of the Neuroprotective effects of S (+)-ketamine during open-heart surgery
  10517. Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury
  10518. Some aspects of the in vivo Neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship
  10519. Neutralization of transthyretin reverses the Neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and …
  10520. Subcellular localization and secretion of activity-dependent Neuroprotective protein in astrocytes
  10521. Combination therapy in ischemic stroke: synergistic Neuroprotective effects of memantine and clenbuterol
  10522. Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury: an experimental study in the rat using pharmacological and morphological …
  10523. Neuroprotective effects of ebselen on experimental spinal cord injury in rats
  10524. Moderate increases in intracellular calcium activate Neuroprotective signals in hippocampal neurons
  10525. Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide‐induced dysfunction in rat hippocampus
  10526. Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous Neuroprotective mechanism in temporal lobe epilepsy?
  10527. Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists
  10528. Glutamine as a Neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study
  10529. Cellular Neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function
  10530. AAV-mediated gene delivery of BDNF or GDNF is Neuroprotective in a model of Huntington disease
  10531. Neuroprotective effects of 2, 5-diaryl-3, 4-dimethyltetrahydrofuran neolignans
  10532. Novel multifunctional Neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity …
  10533. The powerful Neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q
  10534. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats#
  10535. Neuroprotective strategies for Parkinson’s disease: conceptual limits of animal models and clinical trials
  10536. Astrocyte-derived transforming growth factor-β mediates the Neuroprotective effects of 17β-estradiol: involvement of nonclassical genomic signaling pathways
  10537. Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia
  10538. P2Y2 receptors activate Neuroprotective mechanisms in astrocytic cells
  10539. Recombinant erythropoietin as a Neuroprotective treatment: in vitro and in vivo models.
  10540. Investigating the receptor-independent Neuroprotective mechanisms of nicotine in mitochondria
  10541. Possible Neuroprotective mechanism of human neuroglobin
  10542. Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture
  10543. Glutamate inhibition in MS: the Neuroprotective properties of riluzole
  10544. Neuroprotective effects of thiopental, propofol, and etomidate
  10545. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion
  10546. The Neuroprotective effects of z-DEVD. fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats
  10547. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor
  10548. The Neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear …
  10549. Hyperthermia masks the Neuroprotective effects of tissue plaminogen activator
  10550. Oxyresveratrol (trans-2, 3′, 4, 5′-tetrahydroxystilbene) is Neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia
  10551. Glia mediates the Neuroprotective action of estradiol on β-amyloid-induced neuronal death
  10552. Novel multifunctional Neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase …
  10553. Neuroprotective and antioxidant effects of the ethyl acetate fraction prepared from Tussilago farfara L.
  10554. A Review of the Neuroprotective Properties of the 5‐HT1A Receptor Agonist Repinotan HC1 (BAY × 3702) in Ischemic Stroke
  10555. The Neuroprotective factor Wld s does not attenuate mutant SOD1-mediated motor neuron disease
  10556. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice
  10557. Superoxide dismutase/catalase mimetics are Neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra …
  10558. Estrogen exerts Neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation
  10559. Neuroprotective effects of HSP70 overexpression after cerebral ischaemia—an MRI study
  10560. Novel Neuroprotective K+ channel inhibitor identified by high-throughput screening in yeast
  10561. Involvement of RhoA and possible Neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina
  10562. Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog
  10563. Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury‐induced pathophysiology and motor functions: an experimental study in the rat
  10564. Development of 17α‐Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study
  10565. Protein phosphatases and their potential implications in Neuroprotective processes
  10566. Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially Neuroprotective and pro‐apoptotic transcriptional responses: a microarray …
  10567. Neuroprotective therapy in Parkinson’s disease and motor complications: A search for a pathogenesis‐targeted, disease‐modifying strategy
  10568. Neuroprotective effect of H. perforatum extracts on β-amyloid-induced neurotoxicity
  10569. Neuroprotective effect of D-psicose on 6-hydroxydopamine-induced apoptosis in rat pheochromocytoma (PC12) cells
  10570. Novel Neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl‐2 family members with PKC pathway
  10571. D‐β‐hydroxybutyrate is Neuroprotective against hypoxia in serum‐free hippocampal primary cultures
  10572. Astrocytes as targets for Neuroprotective drugs.
  10573. Neuroprotective effects of the aqueous extract of the Chinese medicine Danggui-Shaoyao-san on aged mice
  10574. Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts Neuroprotective effects in traumatic brain injury
  10575. Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling
  10576. Partial Neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage
  10577. Neurophysiological study of peripheral neuropathy after high-dose paclitaxel: lack of Neuroprotective effect of amifostine
  10578. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells
  10579. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells
  10580. Differential regulation of activity-dependent Neuroprotective protein in rat astrocytes by VIP and PACAP
  10581. C1q-deficiency is Neuroprotective against hypoxic-ischemic brain injury in neonatal mice
  10582. Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage
  10583. Neuropharmacological, Neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline
  10584. Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats
  10585. Neuroprotective properties of nitric oxide and S-nitrosoglutathione
  10586. The Neuroprotective actions of corticotropin releasing hormone
  10587. Capsaicin exhibits Neuroprotective effects in a model of transient global cerebral ischemia in Mongolian gerbils
  10588. The Parkinson’s disease protein DJ-1 is Neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
  10589. Dose-dependent Neuroprotective effects of melatonin on experimental spinal cord injury in rats
  10590. Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation: Neuroprotective effect of C5a against apoptotic cell death
  10591. Mild hypothermia, but not propofol, is Neuroprotective in organotypic hippocampal cultures
  10592. Estrogen and Selective Estrogen Receptor Modulators Exert Neuroprotective Effects and Stimulate the Expression of Selective Alzheimer’s Disease Indicator-1, a …
  10593. Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model
  10594. Neuroprotective effects of metabotropic glutamate receptor ligands in a 6‐hydroxydopamine rodent model of Parkinson’s disease
  10595. The amyloid paradox: Amyloid‐β‐metal complexes can be neurotoxic and Neuroprotective
  10596. Nanoscale Aggregation Properties of Neuroprotective Carboxyfullerene (C3) in Aqueous Solution
  10597. Encapsulated vascular endothelial growth factor—secreting cell grafts have Neuroprotective and angiogenic effects on focal cerebral ischemia
  10598. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase
  10599. The Neuroprotective effect of progesterone after traumatic brain injury in male mice is independent of both the inflammatory response and growth factor expression
  10600. Zinc supplementation: Neuroprotective or neurotoxic?
  10601. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons
  10602. AMPA receptor regulation mechanisms: future target for safer Neuroprotective drugs
  10603. Neuroprotective effect of citicoline against KA-induced neurotoxicity in the rat retina
  10604. In vivo Neuroprotective adaptation of the glutamate/glutamine cycle to neuronal death
  10605. BMP4 and CNTF are Neuroprotective and suppress damage-induced proliferation of Müller glia in the retina
  10606. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors
  10607. Intranasal administration of NAP, a Neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze
  10608. Modulation of AMPA receptors in spinal motor neurons by the Neuroprotective agent riluzole
  10609. An investigation of the Neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death
  10610. Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis
  10611. Caffeic acid phenethyl ester exerts a Neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice
  10612. Neuroprotective effect of a heat shock protein inducer, geranylgeranylacetone in permanent focal cerebral ischemia
  10613. Low dose pramipexole is Neuroprotective in the MPTP mouse model of Parkinson’s disease, and downregulates the dopamine transporter via the D 3 receptor
  10614. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington’s disease phenotype
  10615. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson’s disease
  10616. Synthesis, acetylcholinesterase inhibition and Neuroprotective activity of new tacrine analogues
  10617. Regulation of Neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival
  10618. Microglia overexpressing the macrophage colony-stimulating factor receptor are Neuroprotective in a microglial-hippocampal organotypic coculture system
  10619. Heat shock protein 70 participates in the Neuroprotective response to intracellularly expressed β-amyloid in neurons
  10620. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis
  10621. Neuroprotective effects of preconditioning ischemia on ischemic brain injury through down-regulating activation of JNK1/2 via N-methyl-D-aspartate receptor …
  10622. The Neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling
  10623. Neuroprotective effects of spermine following hypoxia‐ischemia‐induced brain damage: A mechanistic study
  10624. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington’s disease in rats
  10625. Interventions with Neuroprotective agents : novel targets and opportunities
  10626. Neuroprotective properties of Bcl‐w in Alzheimer disease
  10627. Neuroprotective and Antioxidant Activity of Compounds from the Aerial Parts of Dioscorea opposita
  10628. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons
  10629. … dysregulation in striatal projection-and interneurons in a mouse model of Huntington’s disease: neuronal selectivity and potential Neuroprotective role of HAP1
  10630. Neuroprotective potential of dietary restriction against kainate-induced excitotoxicity in adult male Wistar rats
  10631. Neuroprotective effects of (24R)-1, 24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line
  10632. Erythropoietin is Neuroprotective in models of HIV sensory neuropathy
  10633. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic–ischemic …
  10634. Neuroprotective effects of phenylethanoid glycosides from Cistanches salsa against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic …
  10635. Optimisation of high performance liquid chromatography separation of Neuroprotective peptides: fractional experimental designs combined with artificial neural …
  10636. Mood-stabilizing drugs: are their Neuroprotective aspects clinically relevant?
  10637. Neuroprotective effects of M826, a reversible caspase‐3 inhibitor, in the rat malonate model of Huntington’s disease
  10638. Protective effects of zinc chelation in traumatic brain injury correlate with upregulation of Neuroprotective genes in rat brain
  10639. Identification of Neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke?
  10640. Neuroprotective effects of grape seed extract on neuronal injury by inhibiting DNA damage in the gerbil hippocampus after transient forebrain ischemia
  10641. Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson’s disease
  10642. Neuroprotective effect of Azadirachta indica on cerebral post-ischemic reperfusion and hypoperfusion in rats
  10643. Neuroprotective effects of estratriene analogs: structure‐activity relationships and molecular optimization
  10644. Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not Neuroprotective in Huntington’s disease transgenic mice
  10645. The Neuroprotective effects of estrogen in SK-N-SH neuroblastoma cell cultures
  10646. Possible Neuroprotective effects of lecithin and α‐tocopherol alone or in combination against ischemia/reperfusion insult in rat brain
  10647. A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine-mediated signaling and shows Neuroprotective activity in vitro and in animal …
  10648. Peroxynitrite in the pathogenesis of Parkinson’s disease and the Neuroprotective role of metallothioneins
  10649. Are angiotensin receptor blockers Neuroprotective ?
  10650. Glutamate-induced cell death of immortalized murine hippocampal neurons: Neuroprotective activity of heme oxygenase-1, heat shock protein 70, and sodium selenite
  10651. Novel small peptides with Neuroprotective and nootropic properties
  10652. Are cannabinoid drugs neurotoxic or Neuroprotective ?
  10653. Role of stem cells in adaptation to hypoxia and mechanisms of Neuroprotective effect of granulocytic colony-stimulating factor
  10654. Understanding regulation of nerve cell death by mGluRs as a method for development of successful Neuroprotective strategies
  10655. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a Neuroprotective hypothesis
  10656. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia
  10657. Antioxidant activity and Neuroprotective effects of zolpidem and several synthesis intermediates
  10658. Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine.
  10659. The Neuroprotective efficacy of α-crystallin against acute inflammation in mice
  10660. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is Neuroprotective after transient middle cerebral artery occlusion in …
  10661. Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats
  10662. Apoptotic characteristics of cell death and the Neuroprotective effect of homocarnosine on pheochromocytoma PC12 cells exposed to ischemia
  10663. Neuroprotective effect of ginseng total saponins in experimental traumatic brain injury
  10664. Neuroprotective action of halogenated derivatives of L-phenylalanine
  10665. Neuroprotective effects of female sex steroids in humans: current controversies and future directions.
  10666. Neuroprotective effect of wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation
  10667. Novel Neuroprotective tripeptides and dipeptides
  10668. brain ‐derived neurotrophic factor is Neuroprotective against human immunodeficiency virus‐1 envelope proteins
  10669. Poly (ADP-ribose) glycohydrolase as a target for Neuroprotective intervention: assessment of currently available pharmacological tools
  10670. Neuroprotective actions of coenzyme Q10 in Parkinson’s disease
  10671. Cannabinoids as Neuroprotective agents in traumatic brain injury
  10672. Neuroregenerative and Neuroprotective actions of neuroimmunophilin compounds in traumatic and inflammatory neuropathies
  10673. Early transplantation of an encapsulated glial cell line—derived neurotrophic factor—producing cell demonstrating strong Neuroprotective effects in a rat model of …
  10674. Neuroprotective Effects of Hypericum perforatum on Trauma Induced by Hydrogen Peroxide in PC12 Cells
  10675. Neuroprotective Efficacy of Repinotan HCl, a 5-HT1A Receptor Agonist, in Animal Models of Stroke and Traumatic brain Injury
  10676. Characterization of polysaccharides from the flowers of Nerium indicum and their Neuroprotective effects
  10677. Mild hypothermia enhances the Neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats
  10678. The Neuroprotective action of JNK3 inhibitors based on the 6, 7-dihydro-5H-pyrrolo [1, 2-a] imidazole scaffold
  10679. High-dose aspirin is Neuroprotective in a rat focal ischemia model
  10680. Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats
  10681. Neuroprotective Properties of Different Anesthetics on Axotomized Rat Retinal Ganglion Cells In Vivo
  10682. Estrogen as a multi-active Neuroprotective agent in traumatic injuries
  10683. Novel potential Neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons
  10684. Estrogen: a Neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models
  10685. Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats
  10686. Neuroprotective effects of a novel poly (ADP-ribose) polymerase-1 inhibitor, 2-{3-[4-(4-chlorophenyl)-1-piperazinyl] propyl}-4 (3H)-quinazolinone (FR255595), in an in …
  10687. Neuroprotective effect of exogenous vascular endothelial growth factor on rat spinal cord neurons in vitro hypoxia.
  10688. Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine
  10689. Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease …
  10690. Conjugation of catechins with cysteine generates antioxidant compounds with enhanced Neuroprotective activity
  10691. Adeno-associated viruses containing bFGF or BDNF are Neuroprotective against excitotoxicity
  10692. Synthesis, binding affinity at glutamic acid receptors, Neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids
  10693. A Neuroprotective derivative of erythropoietin that is not erythropoietic
  10694. A systematic review of currently available pharmacological Neuroprotective agents as a sole intervention before anticipated or induced cardiac arrest
  10695. Evaluation of topiramate as an anti‐hyperalgesic and Neuroprotective agent in the peripheral nervous system
  10696. A Neuroprotective role of extracellular signal-regulated kinase in N-acetyl-O-methyldopamine-treated hippocampal neurons after exposure to in vitro and in vivo …
  10697. Valproate is Neuroprotective against malonate toxicity in rat striatum: an association with augmentation of high-affinity glutamate uptake
  10698. Neuroprotective effects of estradiol in newborn female rat hippocampus
  10699. Neurotrophic and Neuroprotective effects of the neuregulin glial growth factor‐2 on dopaminergic neurons in rat primary midbrain cultures
  10700. Profile of anticonvulsant activity and Neuroprotective effects of novel and potential antiepileptic drugs–an update
  10701. Effect of a Neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk
  10702. Intravenous administration of magnesium is only Neuroprotective following transient global ischemia when present with post-ischemic mild hypothermia
  10703. Does GDNF exert its Neuroprotective effects on photoreceptors in the rd1 retina through the glial glutamate transporter GLAST?
  10704. Involvement of dopamine D2/D3 receptors and BDNF in the Neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally …
  10705. Nitrone derivatives of trolox as Neuroprotective agents
  10706. The Neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region
  10707. Hyperacute treatment initiation in Neuroprotective agent stroke trials
  10708. Neuregulin-1 is Neuroprotective and attenuates inflammatory responses induced by ischemic stroke
  10709. Post‐conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential Neuroprotective treatment
  10710. Sexual dimorphism of activity-dependent Neuroprotective protein in the mouse arcuate nucleus
  10711. Invited Review: Neuroprotective Properties of Certain β-Adrenoceptor Antagonists Used for the Treatment of Glaucoma
  10712. … ) polymerase inhibitor, DR2313 [2-methyl-3, 5, 7, 8-tetrahydrothiopyrano [4, 3-d]-pyrimidine-4-one]: pharmacological profiles, Neuroprotective effects, and therapeutic …
  10713. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson’s disease
  10714. The Neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo [3.2. 2] nonane (TC-1698), a novel α7 ligand, is prevented through angiotensin II activation of a tyrosine …
  10715. Protecting the brain : the search for a clinically effective Neuroprotective drug for stroke
  10716. Views on neurodegeneration as a basis for Neuroprotective strategies
  10717. brain -derived neurotrophic factor as a prototype Neuroprotective factor against HIV-1-associated neuronal degeneration
  10718. Neuroprotective properties of catalpol in transient global cerebral ischemia in gerbils: dose–response, therapeutic time-window and long-term efficacy
  10719. Novel antitumor and Neuroprotective substances discovered by characteristic screenings based on specific molecular targets
  10720. 3‐Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also Neuroprotective against LPS‐induced neurotoxicity
  10721. Neuroprotective strategies in MS: lessons from C57BL/WldS mice
  10722. Clindamycin is Neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone
  10723. Hypothermia as a Neuroprotective strategy in subarachnoid hemorrhage: a pathophysiological review focusing on the acute phase
  10724. Novel 2-alkylamino-1, 4-benzoxazine derivatives as potent Neuroprotective agents : structure− activity relationship studies
  10725. Differential Neuroprotective effects for three GABA-potentiating compounds in a model of hypoxia–ischemia
  10726. Neuroprotective effect of citicoline on retinal cell damage induced by kainic acid in rats
  10727. Neuroprotective effects of FK-506, l-carnitine and azathioprine on spinal cord ischemia-reperfusion injury
  10728. The Neuroprotective effect of glial cell line-derived neurotrophic factor in fibrin glue against chronic focal cerebral ischemia in conscious rats
  10729. Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson’s disease
  10730. Neuroprotective effect of maltol against oxidative stress in brain of mice challenged with kainic acid
  10731. Copper chaperone for Cu, Zn-SOD supplement potentiates the Cu, Zn-SOD function of Neuroprotective effects against ischemic neuronal damage in the gerbil …
  10732. The Ginkgo biloba extract (EGb 761) provides a Neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma
  10733. Synthesis and evaluation of Neuroprotective α, β-unsaturated aldehyde scavenger histidyl-containing analogues of carnosine
  10734. Activation of Neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?
  10735. Calorie restriction may be Neuroprotective in AD and PD
  10736. Combined effects of mechanical and ischemic injury to cortical cells: secondary ischemia increases damage and decreases effects of Neuroprotective agents
  10737. Analogues of the Neuroprotective tripeptide Gly-Pro-Glu (GPE): synthesis and structure–activity relationships
  10738. Neuroprotective strategies for HIV-1 associated dementia
  10739. Neuroprotective effects of Ptychopetalum olacoides Bentham (Olacaceae) on oxygen and glucose deprivation induced damage in rat hippocampal slices
  10740. The expression of activity-dependent Neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP …
  10741. TC‐1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, Neuroprotective and long‐lasting cognitive effects
  10742. Neuroprotective effect of hepatocyte growth factor against photoreceptor degeneration in rats
  10743. AS601245 (1, 3-Benzothiazol-2-yl (2-{[2-(3-pyridinyl) ethyl] amino}-4 pyrimidinyl) Acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with Neuroprotective …
  10744. Synthetic fibronectin peptide exerts Neuroprotective effects on transient focal brain ischemia in rats
  10745. … neuronal apoptosis by the cyclin‐dependent kinase inhibitor GW8510: Identification of 3′ substituted indolones as a scaffold for the development of Neuroprotective …
  10746. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of …
  10747. Synthesis and Neuroprotective activity of analogues of glycyl-l-prolyl-l-glutamic acid (GPE) modified at the α-carboxylic acid
  10748. Indolalkylamines derivatives as antioxidant and Neuroprotective agents in an experimental model of Parkinson’s disease
  10749. Remyelinating and Neuroprotective treatments in multiple sclerosis
  10750. NGP1-01, a lipophilic polycyclic cage amine, is Neuroprotective in focal ischemia
  10751. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential Neuroprotective role of SOCS proteins
  10752. Traumatic brain injury and hemorrhagic hypotension suppress Neuroprotective gene expression in injured hippocampal neurons
  10753. Cellular levels of TrkB and MAPK in the Neuroprotective role of BDNF for embryonic rat cortical neurons against hypoxia in vitro
  10754. Synthesis of proline-modified analogues of the Neuroprotective agent glycyl-l-prolyl-glutamic acid (GPE)
  10755. Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells
  10756. Neuroprotective effect of inosine on axotomized retinal ganglion cells in adult rats
  10757. Neuroprotective effect of gacyclidine. A multicenter double-blind pilot trial in patients with acute traumatic brain injury
  10758. Antioxidant and Neuroprotective activity of the extract from the seaweed, Halimeda incrassata (Ellis) Lamouroux, against in vitro and in vivo toxicity induced by methyl …
  10759. Neuroprotective effect of riluzole in acute noise-induced hearing loss
  10760. Neuroprotective effect of 4-amino-1, 8-napthalimide, a poly (ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in …
  10761. Neuroprotective effects of GluR6 antisense oligodeoxynucleotides on transient brain ischemia/reperfusion‐induced neuronal death in rat hippocampal CA1 region
  10762. Neuroprotective effects of preconditioning ischaemia on ischaemic brain injury through inhibition of mixed‐lineage kinase 3 via NMDA receptor‐mediated Akt1 …
  10763. Neuroprotective effects of afobazol in experimental cerebral hemorrhage
  10764. Tenoxicam exerts a Neuroprotective action after cerebral ischemia in rats
  10765. A Neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth
  10766. Structural insights into the Neuroprotective -acting carbonyl reductase Sniffer of Drosophila melanogaster
  10767. Neuroprotective effects of a dual L/N-type Ca2+ channel blocker cilnidipine in the rat focal brain ischemia model
  10768. Neuroprotective effect of L-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats
  10769. Protection by Petaslignolide A, a Major Neuroprotective Compound in the Butanol Extract of Petasites japonicus Leaves, against Oxidative Damage in the brain s of …
  10770. Synthesis and pharmacological evaluation of glycine-modified analogues of the Neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE)
  10771. Neuroprotective effect of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins
  10772. Multiple modes of action of tacrolimus (FK506) for Neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats
  10773. Potential Neuroprotective effect of t‐butylhydroquinone against neurotoxicity—Induced by 1‐methyl‐4‐(2′‐methylphenyl)‐1,2,3,6‐tetrahydropyridine (2′‐methyl …
  10774. Neuroprotective effects of nicotinamide after experimental spinal cord injury
  10775. Neuroprotective agents for clinical trials in Parkinson’s disease: a systematic assessment
  10776. Neuroprotective strategies in radical prostatectomy
  10777. Gabaergic mechanism of cerebrovascular and Neuroprotective effects of afobazole and picamilon
  10778. Morphine modulation of the ubiquitin-proteasome complex is Neuroprotective
  10779. Neuroprotective and neurotoxic effects of cyclosporine A on transient focal ischemia in mdr1a knockout mice
  10780. Neuroprotective effect of activity‐dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis‐linked mutant SOD1 in vitro and in vivo
  10781. The histaminergic signaling system exerts a Neuroprotective role against neurodegenerative-induced processes in the hamster
  10782. Neuronal expression of the transcription factor Gli1 using the Tα1 α-tubulin promoter is Neuroprotective in an experimental model of Parkinson’s disease
  10783. The nonthiazolidinedione PPARγ agonist L-796,449 is Neuroprotective in experimental stroke
  10784. Research progress of Neuroprotective mechanisms of Gastrodia elata and its preparation
  10785. Lack of evidence of direct mitochondrial involvement in the Neuroprotective effect of minocycline
  10786. Anticonvulsant and Neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats
  10787. brain injury-dependent expression of activity-dependent Neuroprotective protein
  10788. Neuroprotective mechanisms of lidocaine against in vitro ischemic insult of the rat hippocampal CA1 pyramidal neurons
  10789. Neuroprotective effects of indomethacin and aminoguanidine in the newborn rats with hypoxic-ischemic cerebral injury
  10790. The AMPA-antagonist talampanel is Neuroprotective in rodent models of focal cerebral ischemia
  10791. The Neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells
  10792. Neuroprotective action of hypothalamic peptide PRP-1 at various time survivals following spinal cord hemisection
  10793. Neuroprotective gene expression profiles in ischemic cortical cultures preconditioned with IGF-1 or bFGF
  10794. Neurodegeneration and Neuroprotective strategies after traumatic brain injury
  10795. Mapping the locations of estradiol and potent Neuroprotective analogues in phospholipid bilayers by REDOR
  10796. Melatonin Is Neuroprotective in Experimental Streptococcus pneumoniae Meningitis
  10797. Knock‐down of POSH expression is Neuroprotective through down‐regulating activation of the MLK3–MKK4–JNK pathway following cerebral ischaemia in the rat …
  10798. β-synuclein-derived peptides with Neuroprotective activity
  10799. Hypothermia as a Neuroprotective agent
  10800. The Neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system
  10801. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson’s disease
  10802. DNA damage and nonhomologous end joining in excitotoxicity: Neuroprotective role of DNA‐PKcs in kainic acid‐induced seizures
  10803. Characterization of the Neuroprotective activity of rasagiline in cerebellar granule cells
  10804. Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain
  10805. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons
  10806. Neuroprotective effects of prostaglandin A1 in animal models of focal ischemia
  10807. … through cyclic AMP-responsive element binding protein and nuclear factor kappa B activation in rat cultured cerebellar granule cells: Implication for its Neuroprotective …
  10808. Dipyridamole is Neuroprotective for cultured rat embryonic cortical neurons
  10809. Neuroprotective effect of N‐acetyl‐aspartyl‐glutamate in combination with mild hypothermia in the endothelin‐1 rat model of focal cerebral ischaemia
  10810. Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid‐induced striatal toxicity: involvement of pre‐and post‐synaptic mechanisms and lack …
  10811. The Neuroprotective effects of N1-dansyl-spermine in the gerbil model of cerebral ischaemia
  10812. Neuroprotective effects of β-secretase inhibitors against rat retinal ganglion cell death
  10813. The TAT protein transduction domain enhances the Neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection
  10814. Neuroprotective effects of recombinant thrombomodulin in controlled contusion spinal cord injury implicates thrombin signaling
  10815. The tyrosine phosphatase inhibitor orthovanadate mimics NGF-induced Neuroprotective signaling in rat hippocampal neurons
  10816. The candidate Neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunction
  10817. Neuroprotective adeno‐associated virus Bcl‐xL gene transfer in models of motor neuron disease
  10818. Implication of cyclin-dependent kinase 5 in the Neuroprotective properties of lithium
  10819. Memantine as a Neuroprotective treatment in schizophrenia
  10820. Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model
  10821. Neuroprotective effect of cytoflavin during compression injury of the spinal cord
  10822. Investigating the Neuroprotective mechanism of action of a CDK5 inhibitor by phosphoproteome analysis
  10823. Neuroprotective peptides as drug candidates against Alzheimer’s disease
  10824. Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for Neuroprotective treatment
  10825. Neuroprotective effect of peroxynitrite decomposition catalyst and poly (adenosine diphosphate—ribose) polymerase inhibitor alone and in combination in rats with …
  10826. Amine oxidase inhibitors and development of Neuroprotective drugs
  10827. Genotoxic, neurotoxic and Neuroprotective activities of apomorphine and its oxidized derivative 8-oxo-apomorphine
  10828. Neuroprotective effects of melatonin against anoxia/aglycemia stress, as assessed by synaptic potentials and superoxide production in rat hippocampal slices
  10829. The role of Ca2+ channel modulation in the Neuroprotective actions of estrogen in β-amyloid protein and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) …
  10830. The pre-ischaemic Neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice
  10831. Effect of Neuroprotective drugs on gene expression in G93A/SOD1 mice
  10832. Response: Neuroprotective Effects of MK-801 and Catecholamine Release in the Central Nervous System
  10833. Synthesis and pharmacological evaluation of side chain modified glutamic acid analogues of the Neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE)
  10834. Neuroprotective effect of epidural electrical stimulation against ischemic spinal cord injury in rats: electrical preconditioning
  10835. Neuroprotective effects of topiramate
  10836. Small molecule tgf-beta mimetics as potential Neuroprotective factors
  10837. Reductions in mRNA of the Neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats
  10838. Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity
  10839. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats
  10840. Neuroprotective effect of lysophosphatidic acid on AbetaP31-35-induced apoptosis in cultured cortical neurons
  10841. Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat
  10842. Neuroprotective effects of KCL-440, a new poly (ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model
  10843. Neuroprotective function of R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane,[R-(−)-BPAP], against apoptosis induced by N-methyl (R) salsolinol, an endogenous …
  10844. Neuroprotective effect of sodium ferulate on transient focal cerebral ischemia by weakening activation of postsynaptic density-95 in rats.
  10845. On the horizon: possible Neuroprotective role for glatiramer acetate
  10846. Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage
  10847. Neuroprotective effects of inhibiting N-methyl-D-aspartate receptors, P2X receptors and the mitogen-activated protein kinase cascade: a quantitative analysis in …
  10848. Neuroprotective effects of brain -derived neurotrophic factor (BDNF) on hearing in experimental pneumococcal meningitis
  10849. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington’s disease are dependent on the proximity of the implant to the lesioned …
  10850. An antioxidant tetrapeptide UPF1 in rats has a Neuroprotective effect in transient global brain ischemia
  10851. The Neuroprotective effects of BNG-1: a new formulation of traditional Chinese medicines for stroke
  10852. Ginkgo Biloba (GB) extract as a Neuroprotective agent in oxaliplatin (Ox)-induced neuropathy
  10853. Neuroprotective effects of inhibitors of dipeptidyl peptidase-iV in vitro and in vivo
  10854. Activation of extracellular signal‐regulated kinase 5 may play a Neuroprotective role in hippocampal CA3/DG region after cerebral ischemia
  10855. Combining Neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient
  10856. Delineating and understanding cerebellar Neuroprotective pathways: potential implication for protecting the cortex
  10857. Neuroprotective effect of geranylgeranylacetone, a noninvasive heat shock protein inducer, on cerebral infarction in rats
  10858. Contrasting the Neuroprotective and gliotoxic effects of PPARγ agonists
  10859. Novel analogs of choline as potential Neuroprotective agents
  10860. Purkinje cell long-term depression is prevented by T-588, a Neuroprotective compound that reduces cytosolic calcium release from intracellular stores
  10861. Neuroprotective role of neurotrophins: relationship between nerve growth factor and apoptotic cell survival pathway after cerebral ischemia
  10862. The pre-ischaemic Neuroprotective effects of N1-dansyl-spermine in a transient focal cerebral ischaemia model in mice
  10863. Neuroprotective effects of Bak Foong Pill in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahyrdropyridine (MPTP)-induced Parkinson’s disease model mice
  10864. Neuroprotective effects of estrogen
  10865. Comparison of Neuroprotective effects induced by α-phenyl-N-tert-butyl nitrone (PBN) and N-tert-butyl-α-(2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status …
  10866. Identification of novel Neuroprotective agents using pharmacophore modeling
  10867. NXY‐059: a Neuroprotective agent in acute stroke
  10868. Neuroprotective activity of proproten in rats with experimental local photothrombosis of the prefrontal cortex
  10869. The Neuroprotective KDI domain of γ1‐laminin is a universal and potent inhibitor of ionotropic glutamate receptors
  10870. Don’t give up on erythropoietin as a Neuroprotective agent
  10871. Neuroprotective effects of butterbur and rough aster against kainic Acid-induced oxidative stress in mice
  10872. Neuroprotective effects of an immunosuppressant agent on diffusion/perfusion mismatch in transient focal ischemia
  10873. Production of Neuroprotective NGF in astrocyte–T helper cell cocultures is upregulated following antigen recognition
  10874. Urea enhances the nerve growth factor-induced Neuroprotective effect on cholinergic neurons in organotypic rat brain slices
  10875. Neuroprotective role of coenzyme Q10 against dysfunction of mitochondrial respiratory chain at rostral ventrolateral medulla during fatal mevinphos intoxication in the …
  10876. Modulation of ATP levels alters the mode of hydrogen peroxide-induced cell death in primary cortical cultures: effects of putative Neuroprotective agents
  10877. Novel Neuroprotective effects with O-benzyl derivative of pralidoxime in soman-intoxicated rodents
  10878. Neuroprotective role of PACAP, VIP, and PHI in the central nervous system
  10879. A major role for astrocytes in the Neuroprotective effect of estrogen
  10880. Pharmacokinetic animal PET study of FK506 as a potent Neuroprotective agent
  10881. Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice
  10882. Improvement of learning behavior of mice by an antiacetylcholinesterase and Neuroprotective agent NX42, a Laminariales-alga extract
  10883. Clinical trials of Neuroprotective agents in glaucoma
  10884. Neuroprotective therapy for acute ischaemic stroke: down, but not out
  10885. Neuroprotective Effect of the Novel Na+/Ca2+ Channel Blocker NS-7 on Rat Retinal Ganglion Cells
  10886. (±)-huprine Y,(-)-huperzine A and tacrine do not show Neuroprotective properties in an apoptotic model of neuronal cytoskeletal alteration
  10887. Endogenous anticonvulsant and Neuroprotective agents
  10888. Neurotrophic and Neuroprotective effects of panaxynol on PC12 cells
  10889. The use of GAP-43 mRNA quantification in high throughput screening of putative Neuroprotective agents in dorsal root ganglion cultures
  10890. In vivo Neuroprotective Activity of Epopeptide AB Against Ischemic Damage
  10891. PET study of the Neuroprotective effect of TRA-418, an antiplatelet agent, in a monkey model of stroke
  10892. Therapeutic time window for the Neuroprotective action of MK-801 after decapitation ischemia: hippocampal slice data
  10893. Neuroprotective efficacy of selective brain hypothermia induced by a novel external cooling device on permanent cerebral ischemia in rats
  10894. Neuroprotective agents in Parkinson’s disease: clinical evidence and caveats
  10895. Neuroprotective effect of erigeron breviscapus (vant) hand-mazz on NMDA-induced retinal neuron injury in the rats
  10896. Neuroprotective role of heat shock protein 70 in the rostral ventrolateral medulla during acute mevinphos intoxication in the rat
  10897. Synthesis of Optically Active Methyl 7β-Hydroxykaurenoate with Potent Neuroprotective Activity
  10898. Differential Neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in …
  10899. Neuroprotective and cardioprotective actions of an association of pyruvate, vitamin E and fatty acids
  10900. Mapk Activation Via 5-Hydroxytryptamine 1A Receptor is Involved in the Neuroprotective Effects of Xaliproden
  10901. Neuroprotective activity of antiepileptic drugs
  10902. Neuroprotective effect of D-fructose-1, 6-bisphosphate against beta-amyloid induced neurotoxicity in rat hippocampal organotypic slice culture: involvement of …
  10903. … -6, 7, 8, 9-tetrahydro-2-methyl-4-phenylbenzol [1, 8] naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with “calcium promotor” and Neuroprotective …
  10904. Neuroprotective Therapy in Parkinson’s Disease: Current Status and New Directions from Experimental and Genetic Clues
  10905. Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice
  10906. Advantages and limitations in the assessment of Neuroprotective treatment of Parkinson’s disease by functional imaging
  10907. The Neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not …
  10908. Neuroprotective effect of Chuk-Me-Sun-Dan on NMDA-and AMPA-evoked nitric oxide synthase activity in mouse brain
  10909. Is oestrogen a ‘biological Neuroprotective ‘?
  10910. Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats.
  10911. Neuroprotective strategies for Parkinson’s disease
  10912. Commentary of “Copper Chaperone for Cu, Zn-SOD supplement potentiates the Cu, Zn-SOD function of Neuroprotective effects against ischemic neuronal …
  10913. An investigation into the Neuroprotective effects of Estrogen and Progesterone in a model of Homocysteine–induced neurodegeneration [Thesis of Master in …
  10914. Neuroprotective effect of VEGF on middle cerebr alartery occlusion rat
  10915. Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; Neuroprotective action of oral uridine prodrug PN401 requires …
  10916. The Neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis
  10917. The Neuroprotective properties of sex steroids and neurosteroids
  10918. Neuroprotective effect of edaravone on focal cerebral ischemia in rats
  10919. Induced hypothermia: a novel Neuroprotective treatment of neonatal encephalopathy after intrapartum hypoxia-ischemia
  10920. Neuroprotective effect of KR-31378 via KATP channel opening against ischemic insult
  10921. Neuroprotective effect of mivazerol, an α2‐agonist, after transient forebrain ischemia in rats*
  10922. Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: A Neuroprotective substitution effect?
  10923. Neuroprotective effects of magnesium on cerebral ischemia and cerebral contusion
  10924. KP544 amplifies the effects of nerve growth factor on cell differentiation and is Neuroprotective
  10925. Neuroprotective effects of iv tea polyphenol on cerebral ischemia reperfusion injury in animal models [J]
  10926. In vivo Neuroprotective effects of the novel imidazolyl nitrone free-radical scavenger (Z)-α-[2-thiazol-2-yl) imidazol-4-yl]-N-tert-butylnitrone (S34176
  10927. Neuroprotective effect of magnolol in the hippocampus of senescence-accelerated mice (SAMP1)
  10928. Neuroprotective effect of L-arginine in a newborn rat model of acute severe asphyxia
  10929. Relationship between body temperature and prognosis, and Neuroprotective effect of hypothermia in acute stroke patients
  10930. Inclusion bodies may be Neuroprotective in Huntington’s disease
  10931. Simultaneously electrogenerated diene and dienophile: A unique access to novel polyfunctionalized 1, 4-benzoxazine derivatives as Neuroprotective agents
  10932. Neuroprotective effect of combined ultrasound and microbubbles in a rat model of middle cerebral artery infarction
  10933. Effects of Neuroprotective and anti-inflammatory drugs on oxygen-glucose deprivation/reperfusion-induced injury in mouse brain slices
  10934. Anti-Oxidative and Neuroprotective Effects of Rhei Rhizoma on BV-2 microglia cells and hippocampal neurons
  10935. Neuroprotective Effect of Hydroxysafflor Yellow A on Cerebral Ischemia Injuries in Rats [J]
  10936. Neuroprotective effect of 1-aminocyclopropanecarboxylic acid in a rabbit spinal ischemia model
  10937. Neuroprotective peptides as drug candidates against Alzheimer’s diasease
  10938. Neuroprotective effect of Fitomix-40 in experimental parkinsonian syndrome
  10939. A rapid, sensitive electron-capture gas chromatographic procedure for analysis of metabolites of N-methyl, N-propargylphenylethylamine, a potential Neuroprotective …
  10940. Asialoerythropoietin (aEPO) is Neuroprotective in MCAO Injury
  10941. Experimental study of evaluation on Neuroprotective effect for tetramethylpyrazine against focal cerebral ischemic injury with diffusion-weighted magnetic resonance …
  10942. Magnesium as a Neuroprotective Agent in Cerebral Ischemia
  10943. In vitro metabolism of a new Neuroprotective agent, KR-31543 in the human liver microsomes: identification of human cytochrome P450
  10944. Experimental study of Neuroprotective effects of tetramethypyrazine on acute spinal cord injury in dog [J]
  10945. Repair and Neuroprotective Strategies in Multiple Sclerosis
  10946. Neuroprotective effect of high-dose methylprednisolone in prophylaxis in rat acute spinal cord injury [J]
  10947. Comparison of the AMPA antagonist action of new 2, 3-benzodiazepines in vitro and their Neuroprotective effects in vivo
  10948. Immunophilin ligands: from immunosuppressants to Neuroprotective drugs
  10949. LONG–TERM Neuroprotective EFFECT OF THE SUBRETINAL IMPLANT IN THE RCS RAT
  10950. An experimental study of the Neuroprotective effect of FK506 on acute spinal cord injury in dogs
  10951. Potential Neuroprotective properties of atracurium and cisatracurium in neurosurgical anaesthesia
  10952. Identification, design, synthesis, and pharmacological activity of (4-ethyl-piperazin-1-yl)-phenylmethanone derivatives with Neuroprotective properties against β …
  10953. POSSIBLE Neuroprotective EFFECTS OF ZONIPORIDE DURING RESUSCITATION FROM CARDIAC ARREST: 215
  10954. The Neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential
  10955. Neuroprotective effect of KR-31378, a novel potassium channel activator, on spinal cord ischemic injury in rabbits
  10956. The Neuroprotective and antiepileptogenic effects of the ketogenic diet
  10957. Neuroprotective Effect of Ginseng radix on ICH-induced Rats
  10958. Neuroprotective effect of N-acylethanolamines in chronic morphine dependence. III. Influence on the content of neurotransmitters in the rat brain
  10959. Neuroprotective effects of Naoxintong against neuronal injury in hippocampal CA1 region following transient forebrain ischemia in rats
  10960. Neuroprotective effects of Erigeron Breviscapus (vant) Hand− Mazz on NMDA− induced retinal neuron injury in the rats
  10961. Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic agents ?
  10962. Neuroprotective Effects of Phytoestrogen and Estrogen against Neuronal Injury in Focal Cerebral Ischemia of Female Rats [J]
  10963. Neuroprotective effect of FuUerene
  10964. C-terminal Pro-Gly-Pro tripeptide in contrast to full-length neuropeptide semax exhibits no Neuroprotective effect in experimental cerebral ischemia
  10965. Neuroprotective effect of Rhodiola sachalinensis extracts on transient focal cerebral ischemia in rats
  10966. Neuroprotective effect of N-acylethanolamines in chronic morphine dependence. I. Rat brain phospholipids as a target of their action
  10967. Possible Neuroprotective role of exogenous growth hormone on hypoxic-ischemic brain injury in neonatal rats
  10968. Neuroprotective effect of Acanthopanax sessiliflorus against toxicity induced by N-methyl-D-aspartate in rat organotypic hippocampal slice culture
  10969. The Neuroprotective effects and its mechanisms of qingkailing injection on bacterial meningitis induced by E. coli in rabbits
  10970. Neuroprotective effects of medicinal herbs in organotypic hippocampal slice cultures
  10971. Tauroursodeoxycholic acid, a bile acid with in vivo antiapoptotic and Neuroprotective properties
  10972. The Neuroprotective effect of Caspase-3 inhibitor on focal cerebral ischemia in rats [J]
  10973. Selegiline (l-deprenyl) as a unique Neuroprotective agent for chronic neurodegenerative disorders-A lesson from MAO inhibition
  10974. Molecular taxonomy of a soil actinomycete isolate, KCCM10454 showing Neuroprotective activity by 16S rRNA and rpoB gene analysis
  10975. Dose‐dependent pharmacokinetics of KR‐31378, a new Neuroprotective agent for ischaemia‐reperfusion damage in dogs
  10976. Determination of a Neuroprotective agent (S)-(+)-BMS-204352 in human, rat and dog plasma by enantioselective liquid chromatography-tandem mass spectrometry
  10977. Glutamate, calcium and neurodegenerative disease: impact of cytosolic calcium buffers and their potential role for Neuroprotective strategies
  10978. Neuroprotective effects of α2 adrenoceptors may be mediated via APLP1: A-367
  10979. Neuroprotective Effects of Multi-vitamin Therapy in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
  10980. Redefining Neuroprotective gene therapeutic strategies: Lessons learned from caloric restriction and NAD+ metabolism
  10981. Antioxidant and Neuroprotective properties of Scutellaria lateriflora
  10982. Neuroprotective and Anti-Oxidative Effect of Puerariae Radix on Hippocampal Neurons and BV-2 Microglia Cells
  10983. Possible Neuroprotective Strategies for Huntington’s Disease
  10984. Neuroprotective effects of dehydroascorbic acid
  10985. Neuroprotective effect of magnesium sulfate on neuron cell
  10986. Neuroprotective effect of 3-NPA repetitive preconditioning on dopaminergic neurons by depressing N-myc expression
  10987. Neuroprotective and memory Enhancing Effects of Pinelliae Rhizoma Extract
  10988. Neuroprotective effects of astragulus membraneaceus against hypoxia-ischemia brain damage in cerebral hippocampus of neonatal rats [J]
  10989. Neuroprotective effect of Batroxobin on rats with perinatal hypoxic-ischemic brain damage
  10990. Ocular distribution after topical instillation and potential Neuroprotective effect after intravitreal injection of the calcium channel blocker iganipidine
  10991. Dexmedetomidine Is Neuroprotective Against Wortmannin and Staurosporine-Induced Apoptosis In Vitro
  10992. Antiepileptic drugs in the treatment of headache: Neuroprotective effect or something else?
  10993. Neuroprotective pathways in the retina: Analysis of GDNF-mediated signalling in retinal Mueller glial cells (RMG) and screening for RMG-derived neurotrophic …
  10994. Neuroprotective effect of cuscuta chinensis Lam extract on the neuronal differentiated PC12 cells damage induced by reactive oxygen species
  10995. Ab initio multi-dimensional conformational analysis of R-(−)-desmethyldeprenyl: A potent Neuroprotective metabolite of R-(−)-deprenyl
  10996. Neuroprotective effects of xenon and dexmedetomidine in an oxygen and glucose deprivation model of neuronal injury
  10997. brain Neuroprotective effects of chronic exercise after middle cerebral artery occlusion in rats
  10998. Neuroprotective effect of heme oxygenase-2 gene knockout on intracerebral hemorrhage in mouse
  10999. Latanoprost has Neuroprotective ability in an intraocular pressure–independent way in vitro and in vivo.
  11000. Neuroprotective effects of estrogen on nigral dopaminergic neurons in the midbrain s of rats with Parkinson disease
  11001. Neuroprotective Action of Isoflurane Using Electrophysiological Recodings at Striatal Neurons of Mouse
  11002. Neuroprotective activity of neuroserpin against NMDA receptor-mediated excitotoxicity
  11003. The effect of bcl-xL gene transfection in vivo on the expression of Caspase-3 and Neuroprotective function following spinal cord injury
  11004. Neuroprotective Role of the Reaper-Related
  11005. Determination of the Neuroprotective Index for Neuroprotective Treatments Based on a Mouse Model of Retinitis Pigmentosa
  11006. Influence of Hypothermia on Neuroprotective Effect of Inhibiting Neurotransmitters and Agonists of Their Receptors
  11007. Neuroprotective Effects of Bax–inhibiting Peptides on Hypoxic Damages in Purified Cultured Retinal Ganglion Cells
  11008. Effect of systemic Neuroprotective agents on photoreceptor apoptosis in a rat model of retinal detachment
  11009. Neuroprotective effect of naloxone in brain damage caused by repeated febrile seizure
  11010. The Importance of Chronic Outcome Measures in Assessing Neuroprotective Strategies
  11011. Neuroprotective effect of monoamine oxidase monoclonal antibody against vasogenic brain edema in rats
  11012. An Investigation Into the Possible Neuroprotective Or Neurotoxic Properties of Metrifonate
  11013. Neuroprotective pathways in the retina
  11014. Neuroprotective (Antineurodegenerative) Properties of PRP-1
  11015. Mechanism of gentamicin induced ototoxicity and the Neuroprotective effect mediated by baicalin
  11016. Subarachnoid hemorrhage in rats – Neuroprotective efficacy of bradykinin B2 receptor blockade
  11017. Antioxidant Properties and Neuroprotective Effects of Shaengshik Extracts
  11018. Neuroprotective Effect of GDNF-transfected Cells Transplanted into Lateral Cerebral Ventricle on Focal Cerebral Ischemia in Rats
  11019. Glial cells as mediators of the Neuroprotective effects of oestrogen in the central nervous system
  11020. Neuroprotective Effects of α 2-Adrenergic Receptors May Be Mediated Via APLP1
  11021. Antihistamines as Neuroprotective agents
  11022. Neuroprotective effects of sAPPα administration following diffuse traumatic brain injury
  11023. Neuroprotective effect of calcitriol in systemic inflammation induced by lipopolysaccharide
  11024. Neuroprotective effect of dopamine receptor agonists
  11025. An Experimental Study of Neuroprotective Effect of Betaxolol on Retinal Ischemia-reperfusion Injury
  11026. Neuroprotective action of dextromethorphan analogs with negligible psychotomimetic Effects
  11027. Neuroprotective Ganglioside Derivatives
  11028. Neuroprotective Effects of Interferon-β in Multiple Sclerosis
  11029. Neuroprotective effect of STAZN in focal cerebral ischemia: A therapeutic-window study
  11030. Neuroprotective Effects of Dexmedetomidine Against Apoptosis in Vitro
  11031. Humanin, a Newly Identified Neuroprotective
  11032. Asialoerythropoietin (aEPO) Administered Via an Osmotic Mini-Pump Is Neuroprotective in MCAO
  11033. A neuroprotectant, PAN-811, representing a novel Neuroprotective approach to treat neurodegenerative diseases
  11034. An investigation into the Neuroprotective properties of acetylsalicylic acid and acetaminophen
  11035. Minocycline is Neuroprotective in glaucomatous and post optic nerve–transected rat eyes
  11036. Discovery of potential anticancer and Neuroprotective agents from North Queensland plants
  11037. Tetramethylpyraze is Neuroprotective after acute experimental spinal cord trauma in rats [J]
  11038. Experimental investigation of Neuroprotective drugs in models of retinal cell death.
  11039. Neuroprotective Effects of Guh-Poong-Chung-Sim-Hwan on Focal Cerebral Ischemia in Rats
  11040. Neuroprotective effects of propofol in an in vitro model of cerebral ischemia: A-368
  11041. A54 Neuroprotective EFFECT OF NOOGLUTYL IN RATS WITH EXPERIMENTALLY PRODUCED HEMORRHAGIC STROKE
  11042. Neuroprotective Effects of MK-801 and Catecholamine Release in the Central Nervous
  11043. Neuroprotective action of magneto-lasertherapy during the acute period of ischemic insult
  11044. Neuroprotective and antioxidant effects of Tussilago farfara
  11045. α2-Adrenergic Receptors May Mediate Their Neuroprotective Effects Via APLP1
  11046. COMMON Neuroprotective MECHANISM 1 RECEPTOR AGONIST AND INOS INHIBITOR: 357
  11047. anticancer and Neuroprotective agents from North Queensland plants. PhD thesis, James Cook University.
  11048. Neuroprotective effect of BNP7787 in animal models of paclitaxel-induced neuropathy
  11049. Carnosine is Neuroprotective in a mouse model of stroke
  11050. Neuroprotective properties of memantine in different models of excitotoxicity
  11051. STATINS’Neuroprotective QUALITIES TRACED TO BLOOD PRESSURE LOWERING
  11052. Evaluation of the Neuroprotective Effects of S (+)-Ketamine During Open-heart Surgery
  11053. Evidence for Neuroprotective Effects of BDR-29 Chines Herb against Neuronal Cell Death in Vitro and in Vivo
  11054. Neuroprotective effects of magnesium sulfate on spinal cord injury in rats
  11055. The Neuroprotective KDI Domain of γ1 Laminin is a Universal and Potent Inhibitor
  11056. Antioxidant and Neuroprotective effects of Hovenia dulcis fruits
  11057. Neuroprotective effects in hippocampal neurons vary with estrogen concentrations
  11058. Neuroprotective use of mild hypothermia for aneurysm surgery: A-1
  11059. Corticotropin releasing hormone (CRH) is a Neuroprotective peptide
  11060. Neuroprotective Effect of Tropisetron in Pig RGCs: Role of the AKT Signaling Cascade
  11061. TRAAK, a Neuroprotective K+ Channel, in Experimental Glaucoma and Axotomy in Rat Retinas: An Immunohistochemical Study
  11062. Neuroprotective effects of neuregulin on dopaminergic neurons in vitro and in vivo
  11063. Neuroprotective effects of heat stress on axonal injury
  11064. Neuroprotective effects of creatine in a mouse model of stroke: An experimental MRI study
  11065. The Neuroprotective effect of hyperbaric oxygen treatment on laser–induced retinal damage inrats.
  11066. Neuroprotective Effect of Baicalein on H_2O_2-induced PC12 Injury
  11067. Neuroprotective effects of galanin in the rat cholinergic basal forebrain .
  11068. Neuroprotective Effects of 17ß–estradiol on the Rat Retina Exposed to NMDA Administration
  11069. Possible Neuroprotective Effect of Erythropoietin in Acute Inflammation Induced by Exhaustive Exercise.
  11070. Minocycline as a Neuroprotective agent following spinal cord injury
  11071. Short and Long Term Effects of Chronic Ocular Hypertension on the Retinotectal Projection: Neuroprotective Effects of Two Hypotensive Drugs
  11072. UNRAVELING THE RECEPTOR-INDEPENDENT Neuroprotective MECHANISMS OF NICOTINE IN MITOCHONDRIA
  11073. Using cDNA microarray to assess Parkinson’s disease models and the effects of Neuroprotective drugs.
  11074. Estrogen-Mystery drug for the brain ? The Neuroprotective activities of the female sex hormone
  11075. Xenon is Neuroprotective when commenced after a hypoxic ischaemic insult in the newborn rat
  11076. Novel Neuroprotective docosanoids in human retinal pigment epithelium (RPE): endogenous survival signaling.
  11077. Interferon-Y Is Partly Involved in the Neuroprotective Mechanisms of Dietary Restriction.
  11078. Concentration-Dependent Gene and Protein Expressions of Neuroprotective and Neurotoxic Activities of Antioxidants, Including Nutrients
  11079. Neuroprotective Interactions Between σ 1 Receptor Agonist and iNOS in Postischemic brain Injury in Mice
  11080. Neuroprotective effects of dexmedetomidine-hypothermia after asphyxial cardiac arrest in rats
  11081. Neuroprotective effect of lateral ventricle infusion of low-temperature fluid following focal cerebral ischemia-reperfusion in rabbits
  11082. Neuroprotective Mechanisms of the Non–Feminizing Estrogen Analogue ZYC–3 Against Glutamate Induced Cytotoxicity in RGC–5 Cells
  11083. Experimental study of the Neuroprotective effect of methylprednisolone in prophylaxis to acute spinal cord injury
  11084. WHOLE-BODY HYPOTHERMIA FOR HYPOXIC NEWBORNS MAY PROVE Neuroprotective
  11085. Neuroprotective effects and mechanisms of Bis (12)-hupyridone on the glutamate-induced apoptosis in cerebellar granule neurons
  11086. Relationship between Neuroprotective effect of 17# beta#–estradiol and activity of phosphatidylinositol–3–kinase
  11087. M olecular Mechanisms Underlying the Neuroprotective Effects of Escule tin on Oxidative Stress-induced Apoptosis in SH-SY5Y Cells
  11088. Illuminating the photoreceptor: The search for novel synaptic proteins and Neuroprotective regimes
  11089. C60 human bone marrow mesenchimal cell-derived astrocytes: a Neuroprotective approach to ALS
  11090. Neuroprotective effect of nimesulide on brain after chronic cerebral hypoperfusion in rats
  11091. Neuroprotective effects of diazoxide against ischemia-reperfusion brain injury
  11092. The comparison of the Neuroprotective effects of isoflurane and sevoflurane on cerebral ischemia
  11093. The Neuroprotective effect of hyperbaric oxygen treatment on laser-induced retinal damage in rats
  11094. Neuroprotective Effects of Selective brain Hypothermia (SBH) on Permanent Focal Cerebral Ischemia in Rats
  11095. Neuroprotective Effect of Human Mesenchymal Stem Cell on Dopaminergic Neurons by Anti-inflammatory Action
  11096. Neuroprotective and anti-apoptotic effects of FK506 following transient focal ischemia in rats
  11097. Human Recombinant Factor VIIa is Neuroprotective in a Model of Traumatic brain Injury and Secondary Hypoxemia
  11098. Neuroprotective effects of diketopiperazines, potential clinical application of small cyclic form of neuropeptide following ischemic brain injury
  11099. Synthesis and Characterization of a Novel Class of Thiol Reducing agents Which Are Highly Neuroprotective for Retinal Ganglion Cells
  11100. Anti-epileptic and Neuroprotective mechanisms by Topiramate and Levetiracetam evaluated in primary cultures
  11101. Biocompatibility and Neuroprotective Property of a Taurine–containing Irrigation Solution for Vitrectomy in Rabbits
  11102. Neuroprotective effect of repetitive magnetic stimulation on primarily cultured hippocampus neurons in rats
  11103. Neuroprotective Effects of Opioid-Like Hibernation Factors in Cerebral Ischemia
  11104. A CELLULAR MECHANISM OF ADENOSINE-INDUCED Neuroprotective ACTIONS IN SPINAL VENTRAL HORN NEURONS
  11105. Neuroprotective effect of N-acylethanolamines in chronic morphine dependence. II. Effect on the rat brain fatty acid composition
  11106. Neuroprotective effect of lithium on retinal detachment–associated photoreceptor cell degeneration
  11107. Neuroprotective Effect of–2 Adrenoreceptor Agonist Against ER–stress Induced Apoptosis in Rat Retinal Ganglion Cell Line
  11108. Neuroprotective Effect Of Tris (2–carboxyethyl) phosphine (TCEP) In An Optic Nerve Crush Model In The Rat
  11109. 141 Neuroprotective effect of erythropoietin in oxygen-induced cell death in the immature brain
  11110. Preventing dopaminergic cell death: An investigation of the Neuroprotective effects of a substituted tetrahydronaphthalene in vivo and in vitro.
  11111. Neuroprotective and Blood–Retinal Barrier–Preserving Effects of Cannabidiol in Experimental Diabetes
  11112. Neuroprotective effect of exogenous vascular endothelial growth factor on anoxic rat spinal cord astrocyte and the underlying mechanism
  11113. Neuroprotective effect of a mixture of conjugated linoleic acid isomers on neuronal cell death
  11114. Neuroprotective Effect of Beta–adrenergic blockers on Hypoxic Damage in Purified Retinal Ganglion Cells
  11115. Neuroprotective effect of antisense oligodeoxynucleotides in experimental intracerebral hemorrhage in rats
  11116. Topical Nipradilol Exerts a Neuroprotective Ability in Experimental Rat Retina Through Nitric Oxide Donation
  11117. fMeTIQ an endogenous Neuroprotective compound prevents morphine addiction: comparison with neurotoxie analog, 1BnTIQ
  11118. The Neuroprotective Effect of TC-1698, A Novel Alpha7 Ligand, Is Prevented Through Angiotensin II Activation of a Tyrosine Phosphatase
  11119. Molecular mechanisms underlying the multiple Neuroprotective activities of a novel anti-Alzheimer’s dimer bis (7)-tacrine
  11120. The Neuroprotective effects of roscovitine in Niemann-Pick Disease Type C mice
  11121. Neuroprotective Effects of Pitavastatin, a Statin With High Affinity to Vascular Endothelium, Against Transient Retinal Ischemia
  11122. Study of Neuroprotective effects of anti–glaucoma drops on NMDA–induced retinal degeneration
  11123. The Neuroprotective Effect of BDNF on Retinal Ganglion Cells Damaged by Experimental Acute Hyper-intraocular Pressure
  11124. The Neuroprotective effect of NBQX on oligodendrocyte precursor cells in rat cerebral cortex after whole brain irradiation
  11125. The Neuroprotective effects of ginkgo biloba extraction on retinal ganglion cells in optic nerve crush model in rats
  11126. 59. rAAV-Mediated Nigral Parkin Over-Expression Is Neuroprotective in the 6-OHDA Rat Model of Parkinson’s Disease
  11127. The localization of protein disulfide isomerase and further evidence towards its role as a Neuroprotective protein in SH-SY5Y cells.
  11128. Molecular Basis for the Neuroprotective Properties of FKBP-Binding Immunophilin Ligands
  11129. Neuroprotective role of Fc gamma receptor in ischemia-reperfusion injury using Fc gamma receptor knockout mice
  11130. AEG33783, a potent JNK pathway inhibitor with Neuroprotective properties, selectively induces apoptosis in tumor cell lines
  11131. Neuroprotective Treatment in Primary Progressive Multiple Sclerosis: a Phase I/II Study with Riluzole
  11132. Improvement of Learning behavior of Mice by an Antiacetylcholinesterase and Neuroprotective agent NX42, a Laminariales-Alga Extract
  11133. Combination Therapy in Ischemic Stroke: Synergistic Neuroprotective Effects of Memantine and Clenbuterol
  11134. P12 Neuroprotective Effects of Testosterone on 3-Nitrotyrosine-Exposed Mouse Neuroblastoma Cells
  11135. … and spinal cord injury: Investigating a mechanism of action and developing and instituting a pre-clinical trial protocol to assess FK506 as a Neuroprotective …
  11136. Potential Neuroprotective characteristics of cannabinoids on excitotoxic neurodegeneration in the spastic Han-Wistar rat
  11137. Understanding the Neurotoxic Mechanism of Polychlorinated biphenyls (PCBs), Endocrine Disrupters and Neuroprotective effect of Vitamin E in …
  11138. Neuroprotective effects of etomidate on H2O2 induced injury in neuronal PC12 cells: A-352
  11139. Quantitative evaluation of the Neuroprotective effects of thiopental sodium, propofol and halothane on brain ischemia in gerbils: Use of a logistic regression …
  11140. The roles of metabotropic and N-methyl-D-aspartate receptors for glutamate in the Neuroprotective actions of N-acetyl-homotaurine (acamprosate).
  11141. Neuroprotective effects of peroxisome proliferator-activated receptor-gamma (PPAR-γ) ligands against oxidative stress
  11142. Normobaric hyperoxia therapy exerts its Neuroprotective effect through an increase in tissue pO2 and a decrease in free radical generation, caspases and MMP …
  11143. Neuroprotective Effect of l-Deprenyl Against 6-OHDA-Induced Dopamine Depletion in Rat Striatum and 6-OHDA-Induced Oxidative Stress in SH-SY5Y Cells
  11144. Neuroprotective effect of geniposide in hippocampal slice culture exposed to oxygen and glucose deprivation
  11145. Neuroprotective effect of wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation
  11146. Influence of anaesthesia on the Neuroprotective effect elicited by 3-aminobenzamide, a poly (ADP-ribose) polymerase inhibitor, in a mouse model of transient focal …
  11147. Randomized, Double Blind, Placebo Controlled Trial of Neuroprotective Effects of Epoetin alfa in Patients Receiving Adjuvant Chemotherapy for Breast Cancer
  11148. A Novel Neuroprotective Cholinesterase and brain ‐Selective MAO Inhibitor with APP Processing Activity for the Treatment of Dementia Co‐morbid with Depression …
  11149. PAF Receptor Mediating the Microenvironment Alteration in Ischemic Penumbra and the Neuroprotective Effect of Gingklide B After Cerebral Ischemia in Tree Shrews
  11150. Neuroprotective effects of dopamine agonists in terminally differentiated SH-SY5Y neuroblastoma cells
  11151. Neuroprotective effects of Erigeron Breviscapus (vant) Hand-Mazz on NMDA-induced retinal neuron injury in the rats
  11152. Neuroprotective effect of M0126E-K5 in SH-SY5Y cells with oxidative stress and transient global ischemia model in gerbils
  11153. Neuroprotective action of petaslignolide A, an antioxidant from Petasites japonicus extract, against kainic acid neurotoxicity in mice brain
  11154. Neuroprotective activity of glucocorticoids against NMDA toxicity in mouse cortical neuron-astrocyte cultures: Potential role of the tPA-PAI-1 axis
  11155. Evidence for a Neuroprotective role of the CRH-like peptide, urocortin, in the 6-hydroxydopamine treated rat
  11156. Xenon Is Neuroprotective Against Isoflurane-Induced Apoptotic Neurodegeneration in the Neonatal Rat Hippocampus
  11157. Involvement of RhoA and Neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA–induced neurotoxicity in the rat retina
  11158. Neuroprotective Effects of Sodium γ-hydroxybutyrate Against Cortical Neuron Injury Induced by hypoxia-reoxygenation
  11159. Neuroprotective effect of meso-dihydroguaiaretic acid on staurosporine induced neurotoxicity in primary rat cortical cells
  11160. … to Hypoxic Preconditioning and Hypoxic-ischemic Insult in the N eonatal Rat brain : Identification of Potential Neuroprotective Candidates for Ischemic Stroke
  11161. Transient ischemia of the retina results in loss of retinal ganglion cells and a correlated degeneration of the retinotectal innervation. Neuroprotective effects of topical …
  11162. A Neuroprotective effect of edaravone, a novel free radical scavenger, on acute phase of retinal ganglion cell degeneration following retinal ischemia/reperfusion …
  11163. Neuronal expression of the transcription factor Gli1 using the Ta1a-tubulin promoter is Neuroprotective in an experimental model of Parkinson’s disease.
  11164. Copper chaperone for Cu, Zn-SOD supplement potentates the Cu, Zn-SOD functions of Neuroprotective effects against ischemic neuronal damage in the gerbil …
  11165. Neuroprotective Effect of N-nitro-L-arginine Methylester Pretreatment on the Early Stage of Kainic Acid Induced Neuronal Degeneration in the Rat brain
  11166. BMP4 and CNTF are Neuroprotective and suppress damage–induced proliferation of Müller glia in the chicken retina
  11167. A Selective Thrombin Inhibitor Prevents Thrombin-Induced Neuronal Cell Death and Mild Hypothermia Enhances its Neuroprotective Effects Following Transient Focal …
  11168. Neuroprotective Action of Volatile Anesthetics Using Electrophysiological Recordings at Striatal Neurons of Mouse (2)—A Look into the GABA Signaling Enrollment
  11169. Neuroprotective effect of betaine against N-methyl-D-aspartate excitotoxicity in hippocampal slice culture
  11170. Neurobiology of Disease Neuroprotective Role of a Proline-Rich Akt Substrate in Apoptotic Neuronal Cell Death after Stroke: Relationships with Nerve Growth Factor
  11171. The Neuroprotective effects of a newly synthesized poly (ADP-ribose) polymerase (PARP) inhibitor (KCL-440) on neuronal cell death following transient focal ischemia …
  11172. Neuroprotective effect of Angelica gigas nakai extracts on Delayed Neuronal Death after transient global ischemia in Gerbil hippocampus
  11173. Neuroprotective Eeffects of Amentoflavone in Neonatal Hypoxic-ischemic brain Injury are M ediated by Direct Blockade of Apoptosis and Necrosis and by …
  11174. … environment during adolescence modulates brain -derived neurotrophic factor and TrkB levels in the rat visual system but is not Neuroprotective following optic nerve …
  11175. Selective PARP inhibition via benzamide is Neuroprotective from AMPA-induced excitotaxic cell death of rat cerebellar Purkinje neurons
  11176. Neuroprotective effect of Acanthopanax sessiliflorm Stems and Roots against N-methyl-D-aspartate excitotoxicity in rat organotypic hippocampal slice culture
  11177. Neuroprotective Role of Ubiquitin Carboxyl-Terminal Hydrolase L1 and Heat Shock Protein 70 at the Rostral Ventrolateral Medulla During Mevinphos Intoxication in …
  11178. 118 Delayed Hypoyhermia is Neuroprotective in Moderate, but not Severe, Perinatal Hypoxic-Ischaemic brain Injury
  11179. Synthesis and Evaluation of Alpha 7 Nicotinic Agonists as Neuroprotective agents
  11180. Neuroprotective efficacy of minocycline after intracerebral hemorrhage and possible Kv1. 3, Kv1. 5, HERG and [alpha] 7 nAChR channels as targets for …
  11181. Effect of Cyclosporin A, Topiramate, or 100% Oxygen as Proposed “Neuroprotective ” Therapies on the Microdialysis Parameters of Patients with Severe Traumatic …
  11182. Toxicity of levodopa on C17. 2 neural stem cell and Neuroprotective action of selegiline against it
  11183. R-(+)-ABP a novel derivative of 3-n-butyl-phthalide possesses anti-convulsant and Neuroprotective properties in rodents
  11184. 26 Neuroprotective Effects of Resveratrol
  11185. Simultaneous Retinal Gene Transfer of PEDF and FGF–2 by SIVagm–based Lentiviral Vector Shows Synergistic Neuroprotective Effect in an Animal Model of Retinitis …
  11186. 186 Erythropoietin is Neuroprotective in 10 Day Old Mice Subjected to Hypoxia Ischemia (USA)
  11187. PI-3/AKT kinase pathway contributes to Neuroprotective effect of hypothermia against cerebral ischemia in rats
  11188. The Herpes simplex virus type 2 (HSV-2) gene ICP10PK has a wide Neuroprotective spectrum through activation of survival signaling pathways
  11189. 189 Neuroprotective Effect of Selenium on Iminodipropionitrile-Induced Toxicity
  11190. CHRONIC ADMINISTRATION OF 17-BETA ESTRADIOL IS Neuroprotective IN A MODEL OF CARDIAC ARREST AND CARDIOPULMONARY RESUSCITATION …
  11191. 3 The Neuroprotective Effect of Inflammation: Implications for the Therapy of Multiple Sclerosis R. Hohlfeld, M. Kerschensteiner, C. Stadelmann, H. Lassmann, H …
  11192. Neuroprotective effects of curcumin
  11193. The brain as a target for inflammatory processes and Neuroprotective strategies
  11194. Neuroprotective agents for clinical trials in ALS: a systematic assessment
  11195. Toward a multimodal Neuroprotective treatment of stroke
  11196. Therapeutic hypothermia: Neuroprotective mechanisms
  11197. Neuroprotective and disease-modifying effects of the ketogenic diet
  11198. The Neuroprotective effects of caffeine: a prospective population study (the Three City Study)
  11199. Cerium and yttrium oxide nanoparticles are Neuroprotective
  11200. Neurotrophic and Neuroprotective actions of estrogen: basic mechanisms and clinical implications
  11201. Rapamycin is a Neuroprotective treatment for traumatic brain injury
  11202. New multipotent tetracyclic tacrines with Neuroprotective activity
  11203. Apoptosis: future targets for Neuroprotective strategies
  11204. Neuroprotective role of the innate immune system by microglia
  11205. A novel approach to screening for new Neuroprotective compounds for the treatment of stroke
  11206. Antiamyloidogenic and Neuroprotective functions of cathepsin B: implications for Alzheimer’s disease
  11207. Differential Neuroprotective and antiinflammatory effects of estrogen receptor (ER) α and ERβ ligand treatment
  11208. Neuroprotective effects of ginsenosides
  11209. Structure–activity relationship analysis of antioxidant ability and Neuroprotective effect of gallic acid derivatives
  11210. Neuroprotective effects of cognitive enrichment
  11211. Astrocytes aged in vitro show a decreased Neuroprotective capacity
  11212. Mitochondria-targeted peptide antioxidants: novel Neuroprotective agents
  11213. Advances in ischemic stroke treatment: Neuroprotective and combination therapies
  11214. Mitochondria: a target for Neuroprotective interventions in cerebral ischemia-reperfusion
  11215. Neuroprotective potential of ceftriaxone in in vitro models of stroke
  11216. From structural biochemistry to expression profiling: Neuroprotective activities of estrogen
  11217. The role of the octarepeat region in Neuroprotective function of the cellular prion protein
  11218. Endogenous Neuroprotective factors: neurosteroids
  11219. Neuroprotective effect of granulocyte-colony stimulating factor
  11220. Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions
  11221. Evolution of a Neuroprotective function of central nervous system myelin
  11222. Humanin is a novel Neuroprotective agent against stroke
  11223. TCH346 as a Neuroprotective drug in Parkinson’s disease: a double-blind, randomised, controlled trial
  11224. Cannabinoid activation of PPARα; a novel Neuroprotective mechanism
  11225. Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards …
  11226. Anticancer, Neuroprotective activities and computational studies of 2-amino-1, 3, 4-thiadiazole based compound
  11227. The Neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis
  11228. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease
  11229. Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera
  11230. Neuroprotective effects of cystamine in aged parkinsonian mice
  11231. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus Neuroprotective mechanisms
  11232. Up-regulation of BDNF in astrocytes by TNF-α: a case for the Neuroprotective role of cytokine
  11233. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury
  11234. Histone deacetylase inhibitors exhibit anti-inflammatory and Neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action
  11235. The Neuropharmacology of L-Theanine(N-Ethyl-L-Glutamine) A Possible Neuroprotective and cognitive Enhancing Agent
  11236. Neuroprotective activities of CD4+ CD25+ regulatory T cells in an animal model of Parkinson’s disease
  11237. Neuroprotective effects of propofol in acute cerebral injury
  11238. Timing of estrogen therapy after ovariectomy dictates the efficacy of its Neuroprotective and antiinflammatory actions
  11239. A multifunctional, Neuroprotective drug, ladostigil (TV3326), regulates holo‐APP translation and processing
  11240. Neuroprotective effect of exogenous microglia in global brain ischemia
  11241. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies
  11242. Progesterone and its derivatives are Neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis
  11243. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes
  11244. Mechanisms behind the Neuroprotective actions of cholinesterase inhibitors in Alzheimer disease
  11245. Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action
  11246. Neurosphere-derived cells exert a Neuroprotective action by changing the ischemic microenvironment
  11247. Antioxidant and Neuroprotective effects of hesperidin and its aglycone hesperetin
  11248. Antioxidative and Neuroprotective activities of extracts from the fruit hull of mangosteen (Garcinia mangostana Linn.)
  11249. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity
  11250. Characterization of the potent Neuroprotective properties of the natural vitamin E α‐tocotrienol
  11251. Neuroprotective effects of Nigella sativa on experimental spinal cord injury in rats
  11252. Treatment with an estrogen receptor α ligand is Neuroprotective in experimental autoimmune encephalomyelitis
  11253. Assessment of Neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo
  11254. Neuroprotective actions of a histidine analogue in models of ischemic stroke
  11255. Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus
  11256. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood–brain barrier damage
  11257. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert Neuroprotective effects via antioxidant actions
  11258. Neuronal cell death in Alzheimer’s disease and a Neuroprotective factor, humanin
  11259. Stabilization of hyperdynamic microtubules is Neuroprotective in amyotrophic lateral sclerosis
  11260. Resveratrol Neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats
  11261. Dextromethorphan as a potential Neuroprotective agent with unique mechanisms of action
  11262. Activity-dependent Neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model
  11263. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis
  11264. Novel Neuroprotective effects of the aqueous extracts from Verbena officinalis Linn
  11265. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia
  11266. Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert Neuroprotective properties in vitro
  11267. Neuroprotective effect of tyrosol on transient focal cerebral ischemia in rats
  11268. Evaluation of the Neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent …
  11269. Levetiracetam is Neuroprotective in murine models of closed head injury and subarachnoid hemorrhage
  11270. Nicotinic receptor agonists as Neuroprotective /neurotrophic drugs. Progress in molecular mechanisms
  11271. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma
  11272. Neuroprotective therapy in Parkinson disease
  11273. Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice
  11274. A study of the Neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro
  11275. Neuroprotective effect of protein kinase Cδ inhibitor rottlerin in cell culture and animal models of Parkinson’s disease
  11276. The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid Neuroprotective signaling
  11277. Multiple pathways transmit Neuroprotective effects of gonadal steroids
  11278. Neuroprotective efficacy of the peroxisome proliferator-activated receptor δ-selective agonists in vitro and in vivo
  11279. Production of Acid (GABA) by Lactobacillus buchneri Isolated from Kimchi and its Neuroprotective Effect on Neuronal Cells
  11280. The anti‐amnesic and Neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor
  11281. Comparative Neuroprotective effect of sodium channel blockers after experimental spinal cord injury
  11282. Neuroprotective effect of individual ginsenosides on astrocytes primary culture
  11283. Multiple Neuroprotective mechanisms of minocycline in autoimmune CNS inflammation
  11284. Isoflurane exerts Neuroprotective actions at or near the time of severe traumatic brain injury
  11285. TDP1 facilitates chromosomal single‐strand break repair in neurons and is Neuroprotective in vivo
  11286. Neuroprotective effects of N-acetylcysteine on experimental closed head trauma in rats
  11287. Toll‐like receptor 3 on adult human astrocytes triggers production of Neuroprotective mediators
  11288. N-acetylcysteine has Neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data
  11289. Canine cognitive dysfunction syndrome: prevalence, clinical signs and treatment with a Neuroprotective nutraceutical
  11290. Neuroprotective actions of endogenous interleukin‐1 receptor antagonist (IL‐1ra) are mediated by glia
  11291. Repeated treatment with cannabidiol but not Δ9-tetrahydrocannabinol has a Neuroprotective effect without the development of tolerance
  11292. Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats
  11293. Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer’s disease are associated with reduced …
  11294. Is magnesium Neuroprotective following global and focal cerebral ischaemia? A review of published studies
  11295. Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats
  11296. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain
  11297. Activity-dependent Neuroprotective protein: from gene to drug candidate
  11298. Estrogen has a Neuroprotective effect on axotomized RGCs through ERK signal transduction pathway
  11299. Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus
  11300. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and Neuroprotective through inhibition of microglial NADPH oxidase
  11301. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson’s disease
  11302. Activity-dependent Neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex
  11303. CNTF+ BDNF treatment and Neuroprotective pathways in the rd1 mouse retina
  11304. Additive Neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis
  11305. Sodium valproate exerts Neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral …
  11306. … hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential Neuroprotective candidates for stroke
  11307. Intravitreal injections of GDNF-loaded biodegradable microspheres are Neuroprotective in a rat model of glaucoma.
  11308. Hypothermia: a Neuroprotective therapy for neonatal hypoxic-ischemic encephalopathy
  11309. Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia …
  11310. Dual roles of NF‐κB in cell survival and implications of NF‐κB inhibitors in Neuroprotective therapy1
  11311. Characterizing the Neuroprotective effects of alkaline extract of Lycium barbarum on β-amyloid peptide neurotoxicity
  11312. Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is Neuroprotective
  11313. Quantitative structure− activity relationship (QSAR) for Neuroprotective activity of terpenoids
  11314. Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a Neuroprotective role
  11315. Neuroprotective evaluation of standardized extract of Centella asciatica in monosodium glutamate treated rats
  11316. Neuroprotective effect of Z-ligustilide against permanent focal ischemic damage in rats
  11317. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer’s disease
  11318. Neuroprotective Diterpenes from the Fruiting Body of Antrodia camphorata
  11319. Possible Neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.
  11320. Dose and temporal pattern of estrogen exposure determines Neuroprotective outcome in hippocampal neurons: therapeutic implications
  11321. Involvement of GABAA receptors in the Neuroprotective effect of theanine on focal cerebral ischemia in mice
  11322. Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity
  11323. Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats
  11324. The Neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: An analysis of behavioral and biochemical varibles
  11325. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage
  11326. Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion–induced ischaemia in rat
  11327. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
  11328. GDNF family ligands trigger indirect Neuroprotective signaling in retinal glial cells
  11329. Neuroprotective coumarins from the root of Angelica gigas: Structure-activity relationships
  11330. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential Neuroprotective mechanism of recombinant human …
  11331. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation
  11332. Neuroprotective role of bradykinin because of the attenuation of pro‐inflammatory cytokine release from activated microglia
  11333. Rationale for considering that propargylamines might be Neuroprotective in Parkinson’s disease
  11334. Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta
  11335. Hypoxic preconditioning induces Neuroprotective stanniocalcin-1 in brain via IL-6 signaling
  11336. Iron dysregulation in Alzheimer’s disease: multimodal brain permeable iron chelating drugs, possessing Neuroprotective -neurorescue and amyloid precursor protein …
  11337. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for Neuroprotective epilepsy therapy
  11338. Flavonoids possess Neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in …
  11339. Enhancing glutamate transport: mechanism of action of Parawixin1, a Neuroprotective compound from Parawixia bistriata spider venom
  11340. Mefenamic acid shows Neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer’s disease models
  11341. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats
  11342. Interferon-β is Neuroprotective against the toxicity induced by activated microglia
  11343. Neuroprotective effect of transcorneal electrical stimulation on the acute phase of optic nerve injury
  11344. Neuroprotective effects of synaptic modulation in Huntington’s disease R6/2 mice
  11345. Neuroprotective effects of sesamin and sesamolin on gerbil brain in cerebral ischemia
  11346. Mild hypothermia via selective head cooling as Neuroprotective therapy in term neonates with perinatal asphyxia: an experience from a single neonatal …
  11347. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models
  11348. Erythropoietin and carbamylated erythropoietin are Neuroprotective following spinal cord hemisection in the rat
  11349. Neuroprotective effects of resident microglia following acute brain injury
  11350. Ischemic preconditioning: a novel target for Neuroprotective therapy
  11351. Neuroprotective effects of safflor yellow B on brain ischemic injury
  11352. Muscle-derived but not centrally derived transgene GDNF is Neuroprotective in G93A-SOD1 mouse model of ALS
  11353. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress
  11354. Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration
  11355. Plasma fibronectin is Neuroprotective following traumatic brain injury
  11356. Neuroprotective role for carbonyl reductase?
  11357. Intrathecal upregulation of granulocyte colony stimulating factor and its Neuroprotective actions on motor neurons in amyotrophic lateral sclerosis
  11358. Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus
  11359. Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: Neuroprotective effect of interleukin 10
  11360. Ulva conglobata, a marine algae, has Neuroprotective and anti-inflammatory effects in murine hippocampal and microglial cells
  11361. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-β for its Neuroprotective action
  11362. Neuropeptide Y as an endogenous antiepileptic, Neuroprotective and pro-neurogenic peptide
  11363. Postresuscitative intensive care: Neuroprotective strategies after cardiac arrest
  11364. Neuroprotective therapies for Alzheimer’s disease
  11365. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload
  11366. Testosterone derivatives are Neuroprotective agents in experimental diabetic neuropathy
  11367. The PI3K/Akt pathway mediates the Neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat
  11368. Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional Neuroprotective -neurorescue drugs; ladostigil
  11369. Development of the new group of indole-derived Neuroprotective drugs affecting oxidative stress
  11370. Inhibition of multidrug resistance transporter-1 facilitates Neuroprotective therapies after focal cerebral ischemia
  11371. Neuroprotective effect of taurine against focal cerebral ischemia in rats possibly mediated by activation of both GABAA and glycine receptors
  11372. Role of GABAergic antagonism in the Neuroprotective effects of bilobalide
  11373. Neuroprotective effects of resveratrol against traumatic brain injury in immature rats
  11374. Differential Neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia
  11375. Neuroprotective effect of a ginseng (Panax ginseng) root extract on astrocytes primary culture
  11376. Clinical evaluation of the Neuroprotective effect of α-tocopherol against glaucomatous damage
  11377. Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery with cardiopulmonary bypass: five-year follow-up of a randomized …
  11378. Retigabine and flupirtine exert Neuroprotective actions in organotypic hippocampal cultures
  11379. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, Neuroprotective intracerebral gene expression, and neurological …
  11380. Long‐term morphological and functional evaluation of the Neuroprotective effects of post‐ischemic treatment with melatonin in rats
  11381. Neuroprotective effects of estradiol in hippocampal neurons and glia of middle age mice
  11382. Neuroprotective effects of 17β-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells
  11383. Neuroprotective effects of L-carnitine and vitamin E alone or in combination against ischemia-reperfusion injury in rats
  11384. Why should we use multifunctional Neuroprotective and neurorestorative drugs for Parkinson’s disease?
  11385. Targeted antioxidative and Neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+) 2-amino-4, 5, 6, 7 …
  11386. Soluble Neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice
  11387. TAT-mediated delivery of Bcl-xL protein is Neuroprotective against neonatal hypoxic–ischemic brain injury via inhibition of caspases and AIF
  11388. Erythropoietin: a candidate Neuroprotective agent in the treatment of glaucoma
  11389. Fibronectin and Neuroprotective effect of granulocyte colony-stimulating factor in focal cerebral ischemia
  11390. Erythropoietin is Neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice
  11391. Neuroserpin binds Aβ and is a Neuroprotective component of amyloid plaques in Alzheimer disease
  11392. Neuroprotective effects of d-allose against retinal ischemia–reperfusion injury
  11393. α-Melanocyte-stimulating hormone is Neuroprotective in rat global cerebral ischemia
  11394. Inhibition of nuclear factor κB is associated with Neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons
  11395. Evaluation of Neuroprotective and anti-fatigue effects of sildenafil
  11396. Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
  11397. Drug delivery to the spinal cord tagged with nanowire enhances Neuroprotective efficacy and functional recovery following trauma to the rat spinal cord
  11398. Clinical trials of Neuroprotective therapies
  11399. The path from anti Parkinson drug selegiline and rasagiline to multifunctional Neuroprotective anti Alzheimer drugs ladostigil and m30
  11400. Identification of Neuroprotective compounds of Caenorhabditis elegans dopaminergic neurons against 6-OHDA
  11401. Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia‐induced injury in rats
  11402. The specific FKBP38 inhibitor N-(N′, N′-dimethylcarboxamidomethyl) cycloheximide has potent Neuroprotective and neurotrophic properties in brain …
  11403. Novel Neuroprotective , neuritogenic and anti‐amyloidogenic properties of 2, 4‐dinitrophenol: The gentle face of Janus
  11404. Pyrroloquinoline quinone is a potent Neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity
  11405. A critical appraisal of the NXY-059 Neuroprotection studies for acute stroke: a need for more rigorous testing of Neuroprotective agents in animal models of stroke
  11406. Standardization and stability studies of Neuroprotective lipid soluble fraction obtained from Curcuma longa
  11407. Ketamine and thiopental sodium: individual and combined Neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide
  11408. Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical …
  11409. Proteasomal inhibition in intracerebral hemorrhage: Neuroprotective and anti-inflammatory effects of bortezomib
  11410. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: Neuroprotective effects of a new antioxidant compound H-290/51
  11411. The Neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways
  11412. Enhanced Neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice
  11413. Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia
  11414. Structure− activity relationship of Neuroprotective and reactive oxygen species scavenging activities for Allium organosulfur compounds
  11415. G protein‐associated, specific membrane binding sites mediate the Neuroprotective effect of dehydroepiandrosterone
  11416. Anticonvulsant and Neuroprotective effects of ginsenosides in rats
  11417. Progestins inhibit the Neuroprotective effects of estrogen in rat hippocampus
  11418. The Neuroprotective effect of Activin A and B: implication for neurodegenerative diseases
  11419. Neuroprotective strategies to avert seizure‐induced neurodegeneration in epilepsy
  11420. Zinc (II) binds to the Neuroprotective peptide humanin
  11421. The Neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential
  11422. Neuroprotective and intraocular pressure-lowering effects of (–) Δ9-tetrahydrocannabinol in a rat model of glaucoma
  11423. Pharmacological induction of heat shock protein exerts Neuroprotective effects in experimental intracerebral hemorrhage
  11424. Preferential Neuroprotective effect of tacrolimus (FK506) on unmyelinated axons following traumatic brain injury
  11425. Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats
  11426. Combined Neuroprotective effects of celecoxib and memantine in experimental intracerebral hemorrhage
  11427. Neuroprotective effects of short peptides derived from the Insulin-like growth factor 1
  11428. NADPH oxidase inhibitor DPI is Neuroprotective at femtomolar concentrations through inhibition of microglia over-activation
  11429. Dose dependence and therapeutic window for the Neuroprotective effects of 17β-estradiol when administered after cerebral ischemia
  11430. Heme oxygenase 2 is Neuroprotective against intracerebral hemorrhage
  11431. Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils
  11432. The nootropic and Neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer’s disease …
  11433. Neuroprotective effect of palmul-chongmyeong-tang on ischemia-induced learning and memory deficits in the rat
  11434. Comparison of Neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen–glucose deprivation (OGD) and …
  11435. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible Neuroprotective mechanisms
  11436. Magnesium lithospermate B possesses inhibitory activity on Na+,K+‐ATPase and Neuroprotective effects against ischemic stroke1
  11437. Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a Neuroprotective potential following ischaemia
  11438. Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and-2 in ischemic brain injury
  11439. Genomic and proteomic microglial profiling: pathways for Neuroprotective inflammatory responses following nerve fragment clearance and activation
  11440. Neuroprotective Effect of Oxyresveratrol from Smilacis Chinae Rhizome on Amyloid β Protein (25—35)-Induced Neurotoxicity in Cultured Rat Cortical Neurons
  11441. Neuroprotective role of neurophysiological monitoring during endovascular procedures in the brain and spinal cord
  11442. Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson’s disease
  11443. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible Neuroprotective role for noradrenaline
  11444. Geldanamycin derivatives and Neuroprotective effect on cultured P19-derived neurons
  11445. Inhibition of PTEN by peroxynitrite activates the phosphoinositide‐3‐kinase/Akt Neuroprotective signaling pathway
  11446. Hypoxia-induced retinal ganglion cell death and the Neuroprotective effects of beta-adrenergic antagonists
  11447. Re-evaluation of mitochondrial permeability transition as a primary Neuroprotective target of minocycline
  11448. Neuroprotective effect of propofol on necrosis and apoptosis following oxygen–glucose deprivation—relationship between mitochondrial membrane potential and …
  11449. Neuroprotective effects of roasted licorice, not raw form, on neuronal injury in gerbil hippocampus after transient forebrain ischemia1
  11450. Neuroprotective effect of latanoprost on rat retinal ganglion cells
  11451. NAP, a peptide derived from the activity‐dependent Neuroprotective protein, modulates macrophage function
  11452. Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA …
  11453. The Blockade of K+‐ATP Channels has Neuroprotective Effects in an In Vitro Model of brain Ischemia
  11454. Multifunctional Neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for …
  11455. Neuroprotective Activity of 3‐Aminopyridine‐2‐Carboxaldehyde Thiosemicarbazone (PAN‐811), a Cancer Therapeutic Agent
  11456. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy
  11457. Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent Neuroprotective agent from safflower, in rats and dogs
  11458. Neuroprotective effects of purslane herb aquenous extracts against D-galactose induced neurotoxicity
  11459. Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease
  11460. Oncostatin M is a Neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo
  11461. Neuroprotective effect of etomidate on functional recovery in experimental spinal cord injury
  11462. Involvement of the mitochondrial ATP-sensitive potassium channel in the Neuroprotective effect of hyperbaric oxygenation after cerebral ischemia
  11463. Neuroprotective agents in schizophrenia and affective disorders
  11464. Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects
  11465. Other Neuroprotective therapies on trial in acute stroke
  11466. Neuroprotective potential of erythropoietin and darbepoetin alfa in an experimental model of sciatic nerve injury
  11467. Lentiviral‐mediated gene transfer of brain ‐derived neurotrophic factor is Neuroprotective in a mouse model of neonatal excitotoxic challenge
  11468. Novel Neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity
  11469. Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide
  11470. Triflusal: an antiplatelet drug with a Neuroprotective effect?
  11471. Neuroprotective effects of the stable nitroxide compound Tempol on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in the Nerve Growth Factor-differentiated …
  11472. Oxyhomologation of the amide bond potentiates Neuroprotective effects of the endolipid N-palmitoylethanolamine
  11473. Neuroprotective effect of A20 on TNF-induced postischemic apoptosis
  11474. Neuroprotective effect of some plant extracts in cultured CT105-induced PC12 cells
  11475. Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin
  11476. Perspectives on Neuroprotective stroke therapy
  11477. The Neuroprotective effect of picroside II from hu-huang-lian against oxidative stress
  11478. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation
  11479. Inhibition of cyclin-dependent kinases is Neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons
  11480. Neuroprotective effects of zinc on antioxidant defense system in lithium treated rat brain
  11481. Neuroprotective Effects of Thymosin β4 in Experimental Models of Excitotoxicity
  11482. Synthesis and characterization of a novel class of reducing agents that are highly Neuroprotective for retinal ganglion cells
  11483. The Neuroprotective agent, valproic acid, regulates the mitogen-activated protein kinase pathway through modulation of protein kinase A signalling in Dictyostelium …
  11484. Reduced oxidative stress promotes NF-κB-mediated Neuroprotective gene expression after transient focal cerebral ischemia: lymphocytotrophic cytokines and …
  11485. 99m Tc-HYNIC-annexin V SPECT imaging of acute stroke and its response to Neuroprotective therapy with anti-Fas ligand antibody
  11486. Dexmedetomidine during coronary artery bypass grafting surgery: is it Neuroprotective ?–A preliminary study
  11487. Potential of Neuroprotective antioxidant-based therapeutics from Peltophorum africanum sond.(fabaceae)
  11488. Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo
  11489. Sigma 1 receptor agonists act as Neuroprotective drugs through inhibition of inducible nitric oxide synthase
  11490. Neurotrophic effects of the peptide NAP: a novel Neuroprotective drug candidate
  11491. Lipid-lowering drugs in the MPTP mouse model of Parkinson’s disease: fenofibrate has a Neuroprotective effect, whereas bezafibrate and HMG-CoA reductase …
  11492. Recombinant activity-dependent Neuroprotective protein protects cells against oxidative stress
  11493. Neuroprotective effect of long-term MgSO4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage
  11494. Lovastatin modulates increased cholesterol and oxysterol levels and has a Neuroprotective effect on rat hippocampal neurons after kainate injury
  11495. Possible anti-oxidant and Neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia—a biochemical and …
  11496. A new Neuroprotective compound of Ligustrum japonicum leaves
  11497. Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity
  11498. Pharmacological properties of BN82451: a novel multitargeting Neuroprotective agent
  11499. Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4–6 are Neuroprotective through inhibition of NADPH oxidase: potent regulators of …
  11500. Neuroprotective effect of ganglioside GM1 on the cytotoxic action of hydrogen peroxide and amyloid β-peptide in PC12 cells
  11501. Neuroprotective Effect of PACAP against Kainic Acid‐Induced Neurotoxicity in Rat Retina
  11502. The Neuroprotective effects of a locally acting IGF-1 isoform
  11503. Neuroprotective Bibenzyl Glycosides of Stemona tuberosa Roots
  11504. Dopamine activates Nrf2‐regulated Neuroprotective pathways in astrocytes and meningeal cells
  11505. Methylphenidate exerts no neurotoxic, but Neuroprotective effects in vitro
  11506. Prion protein with an octapeptide insertion has impaired Neuroprotective activity in transgenic mice
  11507. Antioxidant and Neuroprotective properties of N-docosahexaenoyl dopamine
  11508. Molecular evidence of the Neuroprotective effect of Ginkgo biloba (EGb761) using bax/bcl-2 ratio after brain ischemia in senescence-accelerated mice, strain prone-8
  11509. The combination of topiramate and diazepam is partially Neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal …
  11510. Involvement of multiple survival signal transduction pathways in the Neuroprotective , neurorescue and APP processing activity of rasagiline and its propargyl moiety
  11511. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and-2, in permanent focal cerebral ischemia
  11512. Neuroprotective activity of triterpenoid saponins from Platycodi radix against glutamate-induced toxicity in primary cultured rat cortical cells
  11513. A novel Neuroprotective agent with antioxidant and nitric oxide synthase inhibitory action
  11514. Antioxidant activity and Neuroprotective effect of Psoralea corylifolia Linne extracts
  11515. Morphological and functional changes in experimental ocular hypertension and role of Neuroprotective drugs
  11516. Long-term study of dendritic spines from hippocampal CA1 pyramidal cells, after Neuroprotective melatonin treatment following global cerebral ischemia in rats
  11517. Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study
  11518. Neuroprotective effect of hyperbaric oxygen in a rat model of subarachnoid hemorrhage
  11519. Regional differences in the Neuroprotective effect of minocycline in a mouse model of global forebrain ischemia
  11520. Antiamnesic and Neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas
  11521. Ginkgo biloba Leaf Extract (EGb761) Combined with Neuroprotective agents Reduces the Infarct Volumes of Gerbil Ischemic brain
  11522. Neuroprotective effects of receptor imidazoline 2 and its endogenous ligand agmatine.
  11523. Neuroprotective effect of mifepristone involves neuron depolarization
  11524. Aging reduces the Neuroprotective capacity, VEGF secretion, and metabolic activity of rat choroid plexus epithelial cells
  11525. Neuroprotective gene therapy for the treatment of inherited retinal degeneration
  11526. Neuroprotective effect of TNFα against the β-amyloid neurotoxicity mediated by CDK5 kinase
  11527. Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex
  11528. Neuroprotective Effect of Nitroglycerin in a Rodent Model of Ischemic Stroke: Evaluation of Bcl‐2 Expression
  11529. Neuroprotective effect on brain injury by neurotoxins from the spider Phoneutria nigriventer
  11530. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic–ischemic brain injury in neonatal rats
  11531. … receptor by RNA interference and of stimulating its activity with an α7 agonist in SH-SY5Y cells indicate that this receptor plays a Neuroprotective role in connection …
  11532. M30, a novel multifunctional Neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson’s disease
  11533. Lamotrigine is Neuroprotective in the energy deficiency model of MPTP intoxicated mice
  11534. The Neuroprotective effect of heme oxygenase (HO) on oxidative stress in HO-1 siRNA-transfected HT22 cells
  11535. Neuroprotective effects of trolox in global cerebral ischemia in gerbils
  11536. Neuroprotective effects of a standardized extract of Diospyros kaki leaves on MCAO transient focal cerebral ischemic rats and cultured neurons injured by glutamate or …
  11537. Antioxidant pyrrolidine dithiocarbamate activates Akt–GSK signaling and is Neuroprotective in neonatal hypoxia–ischemia
  11538. Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats
  11539. Anti‐inflammatory and Neuroprotective effect of a phytoestrogen compound on rat microglia
  11540. Evaluation of the Neuroprotective effects of citicoline after experimental spinal cord injury: improved behavioral and neuroanatomical recovery
  11541. Synthesis of Neuroprotective cyclopentenone prostaglandin analogs: Suppression of manganese-induced apoptosis of PC12 cells
  11542. Neurochemical characterization of a Neuroprotective compound from Parawixia bistriata spider venom that inhibits synaptosomal uptake of GABA and glycine
  11543. The Neuroprotective and Neurotrophic Effects of Tremella fuciformis in PC12h Cells
  11544. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the Neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1, 2, 3 …
  11545. Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models
  11546. Activation of protease‐activated receptors in astrocytes evokes a novel Neuroprotective pathway through release of chemokines of the growth‐regulated oncogene …
  11547. Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra
  11548. Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons
  11549. Lithium-induced activation of Akt and CaM kinase II contributes to its Neuroprotective action in a rat microsphere embolism model
  11550. Neuroprotective effect of Buddleja officinalis extract on transient middle cerebral artery occlusion in rats
  11551. Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats
  11552. cognition -enhancing and Neuroprotective effects of hederacolchiside-E from Pulsatilla koreana
  11553. The Neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity
  11554. Search for the optimal monosodium glutamate treatment schedule to study the Neuroprotective effects of PACAP in the retina
  11555. D1 and functionally selective dopamine agonists as Neuroprotective agents in Parkinson’s disease
  11556. Neuroprotective potential of group I metabotropic glutamate receptor antagonists in two ischemic models
  11557. Neuroprotective effects of pituitary adenylate cyclase–activating polypeptide (PACAP) in MPP+‐induced alteration of translational control in Neuro‐2a neuroblastoma …
  11558. The COX-2 inhibitor parecoxib produces Neuroprotective effects in MPTP-lesioned rats
  11559. Neuroprotective effect of carnosine on necrotic cell death in PC12 cells
  11560. Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury
  11561. Dehydroepiandrosterone sulfate is Neuroprotective when administered either before or after injury in a focal cortical cold lesion model
  11562. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia
  11563. Neuroprotective effect of atrial natriuretic peptide against NMDA-induced neurotoxicity in the rat retina
  11564. Design and study of some novel ibuprofen derivatives with potential nootropic and Neuroprotective properties
  11565. Neuroprotective effects of PMC, a potent α-tocopherol derivative, in brain ischemia-reperfusion: reduced neutrophil activation and anti-oxidant actions
  11566. Neuroprotective role of transgenic PAF-acetylhydrolase II in mouse models of focal cerebral ischemia
  11567. Vasoactive intestinal peptide (VIP) regulates activity-dependent Neuroprotective protein (ADNP) expression in vivo
  11568. Neuroprotective effects of FeTMPyP: a peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils
  11569. Neuroprotective role of a novel combination of certain antioxidants on lindane (g-HCH) induced toxicity in cerebrum of mice
  11570. … with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent Neuroprotective protein
  11571. Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and Neuroprotective moieties
  11572. Investigation of the dose-dependent Neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo–control trial
  11573. Transgenic mice with neuron-specific overexpression of HtrA2/Omi suggest a Neuroprotective role for HtrA2/Omi
  11574. Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin‐1‐induced optic nerve ischaemia model
  11575. Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein
  11576. Minocycline, a possible Neuroprotective agent in Leber’s hereditary optic neuropathy (LHON): studies of cybrid cells bearing 11778 mutation
  11577. Triggering endogenous Neuroprotective mechanisms in Parkinson’s disease: studies with a cellular model
  11578. Therapeutic time window and dose dependence of Neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats
  11579. High content screen microscopy analysis of Aβ1–42-induced neurite outgrowth reduction in rat primary cortical neurons: Neuroprotective effects of α7 neuronal …
  11580. Neuroprotective effects of caffeine against complex I inhibition–induced apoptosis are mediated by inhibition of the Atm/p53/E2F‐1 path in cerebellar granule neurons
  11581. Novel Neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases
  11582. Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of Neuroprotective drugs: partial agonism with deprenyl
  11583. Neuroprotective effect of mexiletine in the central nervous system of diabetic rats
  11584. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic …
  11585. Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is Neuroprotective in newborn mice
  11586. Glatiramer acetate could be a potential antidepressant through its Neuroprotective and anti-inflammatory effects
  11587. Activation of phosphatidylinositol 3-kinase/protein kinase B pathway by a vanadyl compound mediates its Neuroprotective effect in mouse brain ischemia
  11588. Intensive care for brain injury after cardiac arrest: therapeutic hypothermia and related Neuroprotective strategies
  11589. Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis
  11590. Ameliorative effects of a Neuroprotective agent, T‐817MA, on place learning deficits induced by continuous infusion of amyloid‐β peptide (1–40) in rats
  11591. Oral uridine pro-drug PN401 is Neuroprotective in the R6/2 and N171-82Q mouse models of Huntington’s disease
  11592. Modest hypothermia as a Neuroprotective strategy in high-risk term infants
  11593. Poly (ADP-ribose) polymerase inhibitor is Neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling
  11594. Neuroprotective effects of stearic acid against toxicity of oxygen/glucose deprivation or glutamate on rat cortical or hippocampal slices
  11595. Neuroprotective effect of quercetin during experimental brain ischemia
  11596. Comparison of Neuroprotective Effects of Flavonoids, Terpenoids, and Their Combinations from Ginkgo biloba. on Ischemia-Reperfusion–Injured Mice
  11597. Synthesis, SAR studies, and evaluation of 1, 4-benzoxazepine derivatives as selective 5-HT1A receptor agonists with Neuroprotective effect: Discovery of Piclozotan
  11598. The antioxidant tempamine: in vitro antitumor and Neuroprotective effects and optimization of liposomal encapsulation and release
  11599. Intranasal administration of recombinant human erythropoietin exerts Neuroprotective effects on post-ischemic brain injury in Mongolian gerbils
  11600. Anti-inflammatory treatment in oxygen–glucose-deprived hippocampal slice cultures is Neuroprotective and associated with reduced cell proliferation and intact …
  11601. Signs and symptoms of sleep apnea and acute stroke severity: is sleep apnea Neuroprotective ?
  11602. Neuroprotective effects of interleukin-10 and tumor necrosis factor-α against hypoxia-induced hyperexcitability in hippocampal slice neurons
  11603. Preclinical evaluation of the Neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke
  11604. Neuroprotective effect of the stearic acid against oxidative stress via phosphatidylinositol 3-kinase pathway
  11605. Poly (ADP-ribose) polymerase inhibition by cilostazol is implicated in the Neuroprotective effect against focal cerebral ischemic infarct in rat
  11606. Aging is Neuroprotective during global ischemia but leads to increased caspase-3 and apoptotic activity in hippocampal neurons
  11607. Neuroprotective effect of 17β‐estradiol against N‐methyl‐D‐aspartate‐induced retinal neurotoxicity via p‐ERK induction
  11608. Neuroprotective effects of MTEP, a selective mGluR5 antagonist and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures
  11609. The Neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells
  11610. The effects of concurrent cannabis use among ecstasy users: Neuroprotective or neurotoxic?
  11611. The prion protein is Neuroprotective against retinal degeneration in vivo
  11612. Neuroprotective effects of olanzapine in a rat model of neurodevelopmental injury
  11613. Design and synthesis of 1, 2-dithiolane derivatives and evaluation of their Neuroprotective activity
  11614. Neuroprotective effects of hibernation-regulating substances against low-temperature-induced cell death in cultured hamster hippocampal neurons
  11615. Neuroprotective effect of dauricine in cortical neuron culture exposed to hypoxia and hypoglycemia: involvement of correcting perturbed calcium homeostasis
  11616. Rasagiline is Neuroprotective in an experimental model of brain ischemia in the rat
  11617. Neuroprotective agents : is effective on toxicity in glial cells?
  11618. Mechanisms of Neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer’s disease
  11619. Quantitative evaluation of the Neuroprotective effects of thiopental sodium, propofol, and halothane on brain ischemia in the gerbil: effects of the anesthetics on …
  11620. Neuroprotective function of thymosin-β and its derivative peptides on the programmed cell death of chick and rat neurons
  11621. Parecoxib is Neuroprotective in spontaneously hypertensive rats after transient middle cerebral artery occlusion: a divided treatment response?
  11622. Increased cerebral lactate during hypoxia may be Neuroprotective in newborn piglets with intrauterine growth restriction
  11623. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils
  11624. Levodopa—toxic or Neuroprotective ?
  11625. Neuroprotective effect of nipradilol, an NO donor, on hypoxic–ischemic brain injury of neonatal rats
  11626. Neuroprotective role of neurokinin B (NKB) on β-amyloid (25–35) induced toxicity in aging rat brain synaptosomes: involvement in oxidative stress and excitotoxicity
  11627. Neuroprotective effects of dauricine against apoptosis induced by transient focal cerebral ischaemia in rats via a mitochondrial pathway
  11628. Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa
  11629. Neuroprotective effects of 6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acid (Trolox), an antioxidant in middle cerebral artery occlusion induced focal cerebral …
  11630. Ispronicline: a novel alpha4beta2 nicotinic acetylcholine receptor-selective agonist with cognition -enhancing and Neuroprotective properties.
  11631. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson’s disease and the Neuroprotective role of coenzyme Q10
  11632. Interest in predictive testing for Parkinson’s disease: impact of Neuroprotective therapy
  11633. Synthesis and Neuroprotective effects of serofendic acid analogues
  11634. Do sodium channel blockers have Neuroprotective effect after onset of ischemic insult?
  11635. Neuroprotective effect of a chuk-me-sun-dan on neurons from ischemic damage and neuronal cell toxicity
  11636. Synthesis of macrocyclic analogues of the Neuroprotective agent glycyl-l-prolyl-l-glutamic acid (GPE)
  11637. New molecular insights into cellular survival and stress responses: Neuroprotective role of cellular prion protein (PrP c)
  11638. Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrosative stress, and mitochondrial damage in SH-SY5Y neuroblastoma cells
  11639. Multifunctional Neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer’s and Parkinson’s diseases
  11640. Neuroprotective and anticonvulsant effects of EGIS‐8332, a non‐competitive AMPA receptor antagonist, in a range of animal models
  11641. FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/Neuroprotective properties of substituted 5, 5-dimethyl-2-(4-thiazolidine) …
  11642. Neuroprotective effect of oestrogen on the central nervous system
  11643. Hypothermia: a Neuroprotective therapy for neonatal hypoxic-ischemic encephalopathy
  11644. Semisynthetic sphingoglycolipid LIGA20 is Neuroprotective against human immunodeficiency virus‐gp120‐mediated apoptosis
  11645. Neuroprotective effects of behavioural training and nicotine on age-related deficits in spatial learning
  11646. Evaluation of Neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance …
  11647. Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity …
  11648. Neuroprotective effects of activated protein C through induction of insulin-like growth factor-1 (IGF-1), IGF-1 receptor, and its downstream signal phosphorylated serine …
  11649. Role of protein kinase C in Neuroprotective effect of geranylgeranylacetone, a noninvasive inducing agent of heat shock protein, on delayed neuronal death caused by …
  11650. Structural properties of the NMDA receptor and the design of Neuroprotective therapies.
  11651. The lipophilic metal chelators DP‐109 and DP‐460 are Neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis
  11652. Neuroprotective effects of TJ-23 (Tokishakuyakusan) on adult rat motoneurons following peripheral facial nerve axotomy
  11653. Evidence for Neuroprotective effects of antipsychotic drugs: implications for the pathophysiology and treatment of schizophrenia
  11654. Estrogen is not Neuroprotective in a rodent model of optic nerve stroke
  11655. Serofendic acid, a Neuroprotective substance derived from fetal calf serum, inhibits mitochondrial membrane depolarization and caspase-3 activation
  11656. A novel compound, maltolyl p‐coumarate, attenuates cognitive deficits and shows Neuroprotective effects in vitro and in vivo dementia models
  11657. brain ‐derived neurotrophic factor stimulates the transcriptional and Neuroprotective activity of myocyte‐enhancer factor 2C through an ERK1/2‐RSK2 signaling …
  11658. p38α MAP kinase mediates hypoxia-induced motor neuron cell death: a potential target of minocycline’s Neuroprotective action
  11659. Selective inhibition of nuclear factor-κB activation after hypoxia/ischemia in neonatal rats is not Neuroprotective
  11660. Comparison of the Neuroprotective effects of the newly developed oximes (K027, K048) with trimedoxime in tabun-poisoned rats
  11661. Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose–response and therapeutic window
  11662. Neuroprotective effect of melatonin on retinal ganglion cells in rats
  11663. Changes in immunoreactivity of HSP60 and its Neuroprotective effects in the gerbil hippocampal CA1 region induced by transient ischemia
  11664. Neuroprotective effects of growth hormone against hypoxic-ischemic brain injury in neonatal rats: 1H magnetic resonance spectroscopic study
  11665. Neuroprotective effects of steroid analogues on P19-N neurons
  11666. Neuroprotective effects of melanocortins in CNS injury
  11667. Using Caenorhabditis elegans models of neurodegenerative disease to identify Neuroprotective strategies
  11668. In search of Neuroprotective therapies based on the mechanisms of estrogens
  11669. Neuroprotective Effect of Gagamchongmyung-tang on the Deficits of Learning and memory by MCAO in the Rat
  11670. NXY-059: review of Neuroprotective potential for acute stroke
  11671. Antiinflammatory but no Neuroprotective effects of melatonin under clinical treatment conditions in rabbit models of bacterial meningitis
  11672. Copolymer-1 induces adaptive immune anti-inflammatory glial and Neuroprotective responses in a murine model of HIV-1 encephalitis
  11673. The Neuroprotective effects of the Wlds gene are correlated with proteasome expression rather than apoptosis
  11674. Neuroprotective effects of melatonin upon the offspring cerebellar cortex in the rat model of BCNU-induced cortical dysplasia
  11675. Neuroprotective effects of phenylenediamine derivatives independent of an antioxidant pathway in neuronal HT22 cells
  11676. Neuroprotective effect of pentosan polysulphate on ischemia-related neuronal death of the hippocampus
  11677. … )-1-piperazinyl] ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is Neuroprotective in rat microsphere embolism …
  11678. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.
  11679. A convenient approach for evaluating the toxicity profiles of in vitro Neuroprotective alkylaminophenol derivatives
  11680. An analog of thyrotropin-releasing hormone (TRH) is Neuroprotective against glutamate-induced toxicity in fetal rat hippocampal neurons in vitro
  11681. Neuroprotective effect of N‐acetylcysteine on neuronal apoptosis induced by a synthetic gingerdione compound: Involvement of ERK and p38 phosphorylation
  11682. Neuroprotective effect of cilostazol against retinal ischemic damage via inhibition of leukocyte–endothelial cell interactions
  11683. Lig‐8, a Highly Bioactive Lignophenol Derivative from Bamboo Lignin, Exhibits Multifaceted Neuroprotective Activity
  11684. Molecular mechanisms underlying Neuroprotective effects of albumin after ischemic stroke
  11685. Molecular mechanisms of the Neuroprotective effect of (-)-deprenyl
  11686. Total synthesis of Neuroprotective dictyoquinazol A, B, and C
  11687. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine) neurotoxicity
  11688. Assessing Neuroprotective P-glycoprotein activity at the blood-brain barrier in killifish (Fundulus heteroclitus) using behavioural profiles
  11689. Neuroprotective effect of ultra-low doses of antibodies against S100 protein in neuroblastoma culture during oxygen and glucose deprivation
  11690. Long-term Neuroprotective effects of carbon dioxide on neonatal rat hypoxic-ischemic brain injury: an experimental study of skilled motor tasks
  11691. Involvement of PI3-K in Neuroprotective effects of the 1, 25-dihydroxyvitamin D3 analogue–PRI-2191.
  11692. An inhibitor of serine proteases, neuroserpin, acts as a Neuroprotective agent in a mouse model of neurodegenerative disease
  11693. Neuroprotective effects of neuroactive steroids in the spinal cord and peripheral nerves
  11694. Viral caspase inhibitor p35, but not crmA, is Neuroprotective in the ischemic penumbra following experimental stroke
  11695. Neuroprotective effects of some newer and potential antiepileptic drugs
  11696. Functional Neuroprotective effect of CGS 26303, a dual ECE inhibitor, on ischemic-reperfusion spinal cord injury in rats
  11697. No Neuroprotective effect of erythropoietin under clinical treatment conditions in a rabbit model of Escherichia coli meningitis
  11698. Neuroprotective Mechanisms of Taurine in Vivo
  11699. Neuroprotective effects of the β-carboline abecarnil studied in cultured cortical neurons and organotypic retinal cultures
  11700. Neuroprotective actions and possible underlying molecular mechanisms of valproate
  11701. Erythropoietin is Neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures
  11702. Decreased nerve growth factor levels in hyperthyroid Graves’ ophthalmopathy highlighting the role of Neuroprotective factor in autoimmune thyroid diseases
  11703. L1 cell adhesion molecule is Neuroprotective of alcohol induced cell death
  11704. Topical CoQ10 is Neuroprotective in experimental glaucoma
  11705. PEDF: an endogenous factor displaying potent Neuroprotective , neurotrophic, and antiangiogenic activity
  11706. Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the Neuroprotective Wallerian degeneration slow (Wld s) gene
  11707. APP-based Neuroprotective strategies
  11708. Neuroprotective effect of dipeptide AVP (4-5)-NH 2 is associated with nerve growth factor and heat shock protein HSP70
  11709. Novel Neuroprotective compound SCH-20148 rescues thymocytes and SH-SY5Y cells from thapsigargin-induced mitochondrial membrane potential reduction and …
  11710. Growth factors as Neuroprotective treatment in Parkinson disease?
  11711. Use of lidocaine and fentanyl premedication for Neuroprotective rapid sequence intubation in the emergency department
  11712. Neuroprotective effects of exogenous basic fibroblast growth factor on the hypoxic-ischemic brain damage of neonatal rats
  11713. Hydrogen peroxide attenuates insulin-like growth factor-1 Neuroprotective effect, prevented by minocycline
  11714. A novel Neuroprotective compound FR901459 with dual inhibition of calcineurin and cyclophilins
  11715. Superoxide dismutase/catalase mimetics but not MAP kinase inhibitors are Neuroprotective against oxygen/glucose deprivation‐induced neuronal death in …
  11716. Neuroprotective effects of hydroxyethylpuerarin against focal cerebral ischemia-reperfusion in rats
  11717. Neuroprotective Effect of a New Taurinamide Derivative—Taurepar
  11718. Changes in the number of Neuroprotective transmitter containing mucosal nerve fibres in children with ulcerative colitis
  11719. The Neuroprotective adenosine-activated signal transduction pathway involves activation of phospholipase C
  11720. Neuroprotective effects of alpha2-adrenergic receptor agonists.
  11721. Neuroprotective potential of the Bahadori leanness program: A “mini-fast with exercise” strategy
  11722. Propofol, an anesthetic possessing Neuroprotective action against oxidative stress, promotes the process of cell death induced by H2O2 in rat thymocytes
  11723. Neuroprotective Activities of Chrysantheum Indicum L.
  11724. The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different Neuroprotective profiles in reversing behavioral …
  11725. Therapeutic and Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on …
  11726. brain senescence and Neuroprotective dietary components
  11727. Neuroprotective mechanisms of vascular endothelial growth factor
  11728. In vitro physiological evidence of enhanced antioxidant and Neuroprotective action of 2, 3-dihydromelatonin, a melatonin analogue
  11729. The Neuroprotective effects of caffeic acid phenethyl ester (CAPE) in the hippocampal formation of cigarette smoke exposed rabbits
  11730. Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards …
  11731. Neuroprotective and Antioxidant Effects of the Butanol Fraction Prepared from Opuntia ficus-indica var. saboten
  11732. A review of agents patented for their Neuroprotective properties
  11733. Basic fibroblast growth factor: lysine 134 is essential for its Neuroprotective activity
  11734. Ocular hypotensive and Neuroprotective effects of K-115, a novel Rho-kinase inhibitor
  11735. Changes in the focus of experimental ischemic stroke under the influence of Neuroprotective drugs
  11736. Neuroprotective effect of geranylgeranylacetone against ischemia-induced retinal injury
  11737. The pre-ischaemic Neuroprotective effects of the polyamine analogues BU43b and BU36b in permanent and transient focal cerebral ischaemia models in mice
  11738. X-ray crystallographic structures of Neuroprotective pyrimidine derivatives:(I) the mesylate salt of BW1003C87 and (II) sipatrigine base
  11739. Preservation of the blood brain barrier integrity may underlie Neuroprotective effects of statins in Alzheimer’s disease
  11740. Neuroprotective effects of the novel polyethylene glycol-hemoglobin conjugate SB1 on experimental cerebral thromboembolism in rats
  11741. Cardiac sympathetic Neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy
  11742. Neuroprotective effect of cycloheximide on hypoxic-ischemic brain injury in neonatal rats
  11743. Pressure-related increase of asymmetric dimethylarginine caused by hyperbaric oxygen in the rat brain : a possible Neuroprotective mechanism
  11744. Neuroprotective treatment of patients with normal tension glaucoma
  11745. Neuroprotective Effects of the Ras Inhibitor S-Trans-Trans-Farnesylthiosalicylic Acid, Measured by Diffusion-Weighted Imaging after Traumatic brain Injury in Rats
  11746. Comparative evaluation of the Neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia
  11747. Neuroprotective effects of acetyl-L-carnithine in experimental chronic compression neuropathy. A prospective, randomized and placebo-control trials.
  11748. Potential Neuroprotective effect of low dose whole-body γ-irradiation against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in …
  11749. Neuroprotective effect of the hexapeptide HLDF-6 on rat hippocampal neurons on the in vivo and in vitro models of alzheimer’s disease
  11750. Neuroprotective effect of electroacupuncture therapy on damaged cholinergic neurons in rats with Alzheimer’s disease
  11751. The Neuroprotective and neurotrophic effects of Korean gardenia (Gardenia jasminoides Ellis) in PC12h cells
  11752. Neuroprotective peptides prevent some alcohol-induced alteration in γ-aminobutyric acid A-β3, which plays a role in cleft lip and palate and learning in fetal alcohol …
  11753. 3-normeridamycin: a potent non-immunosuppressive immunophilin ligand is Neuroprotective in dopaminergic neurons
  11754. Structural preferences of Neuroprotective S14G-humanin peptide analyzed by molecular modeling and circular dichroism
  11755. Is this Neuroprotective drug good for my glaucoma patients? Some key factors in clinical decision-making
  11756. Neurobiological studies of dementia–biological markers and Neuroprotective strategies for Alzheimer disease.
  11757. Neuroprotective effects of intramuscular ketamine in rabbit retinas after pars plana vitrectomy and silicone oil injection
  11758. Mechanism of Neuroprotective effect induced by QingKaiLing as an adjuvant drug in rabbits with E. coli bacterial meningitis
  11759. Tokishakuyakusan: Pharmacological evidence for neuroactive and Neuroprotective actions
  11760. Prevention of glutamate excitotoxicity in motor neurons by 5, 6-dihydrocyclopenta-1, 2-dithiole-3-thione: implication to the development of Neuroprotective drugs
  11761. The evaluation of the Neuroprotective effects of bispyridinium oximes in tabun-poisoned rats
  11762. Neuroprotective effect of dexamethasone on the morphology of the irradiated post natal developing cerebellum of wistar rat (Rattus norvegicus)
  11763. Neuroprotective actions of 2, 4-dinitrophenol: Friend or foe?
  11764. Is xenon really Neuroprotective after cardiac arrest?
  11765. Neuroprotective effect of dopamine agonists
  11766. Neuroprotective mechanisms of nevirapine and efavirenz in a model of neurodegeneration
  11767. Neuroprotective effect of choline succinate in rats with experimental chronic cerebral ischemia evaluated by cognitive ability tests
  11768. Neuroprotective effect of scopoletin from Angelica dahurica on oxygen and glucose deprivation-exposed rat organotypic hippocampal slice culture
  11769. Neuroprotective effect of Sunghyangjungki-san on focal cerebral ischemia induced by MCAO in rats
  11770. Neuroprotective effects of diltiazem in rabbits with occluded aorta
  11771. Asymmetric Synthesis of 3‐Oxa‐15‐deoxy‐16‐(m‐tolyl)‐17,18,19,20‐tetranorisocarbacyclin and Its Neuroprotective Analogue 15‐Deoxy‐16‐(m‐tolyl)‐17,18,19,20 …
  11772. Neuroprotective effect of mild hypothermia in the temporary brain ischemia in cats
  11773. Neuroprotective effect of Hyulbuchookau-tang on focal cerebral ischemia of the rats
  11774. Axonal involvement in the Wlds Neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre‐symptomatic …
  11775. A new methodology that improves the Neuroprotective properties of the traditional Chinese medicine prescription, NaoDeSheng
  11776. What clinicians need to know about Neuroprotective issues in bipolar disorder.
  11777. The Neuroprotective effects of Woohwangcheongsim-won on cerebral ischemia following the middle cerebral artery occlusion in rats
  11778. Neuroprotective activity of the proline-containing dipeptide noopept on the model of brain ischemia induced by the middle cerebral artery occlusion
  11779. New targets for putative Neuroprotective agents .
  11780. Glatiramer acetate could be a potential therapeutic agent for Parkinson’s disease through its Neuroprotective and anti-inflammatory effects
  11781. Neuroprotective and antiretroviral effects of the immunophilin ligand GPI 1046
  11782. Neuroprotective effect of pyridoxine hydrochloride in models of mononeuropathy in rats
  11783. brain on a chip: a method to detect novel Neuroprotective candidate targets
  11784. Neuroprotective effects of polygona-polysaccharose in treatment of ischemic reperfusion injury in rats
  11785. Humanin: a potential peptide for Neuroprotective therapy against Alzheimer’s disease
  11786. Neuroprotective Effect of Yanggyuksanhwa-tang on Cerebral Infarction Induced by MCAO in Hyperlipidemic Rats
  11787. Antivasoconstrictor effect of the Neuroprotective agent dexrazoxane in rat aorta
  11788. Neuroprotective effect of Korean Mistletoe extract against damage induced by hydrogen peroxide in cultured rat cortical neurons
  11789. C60-based ebselen derivative: synthesis by bingel cyclopropanation and enhanced antioxidative and Neuroprotective activity
  11790. Long term lithium therapy: a Neuroprotective or neurotoxic factor? A systematic review of existing data
  11791. Neuroprotective effects of vitamin E in cold induced cerebral injury in guinea pigs
  11792. Neuroprotective effects of vasoactive intestinal peptide against rat cerebral ischemia
  11793. Neuroprotective Effects of Hydroxysafflor Yellow A on Focal Cerebral Ischemia-Reperfusion Injury in Rats
  11794. Neuroprotective effect of taurine against acute cortical neuron injury induced by oxygen-glucose deprivation
  11795. Neuroprotective effects of methanol extracts of Jeju native plants on hydrogen peroxide-induced cytotoxicity in SH-SY5Y human neuroblastoma Cells
  11796. Multifunctional Neuroprotective –neurorescue drugs for Parkinson’s disease
  11797. Investigation of Neuroprotective effect of dexamethasone by using nitric oxide and leukocyte levels in experimental head trauma
  11798. Gene expression profiling of SH-SY5Y cells in Neuroprotective effect of total ginsenosides on H202 induced neurotoxicity
  11799. Co-regulation of dopamine D1 receptor and uncoupling protein-2 expression in 3-nitropropionic acid-induced neurotoxicity: Neuroprotective role of L-carnitine
  11800. Prednisolone Neuroprotective therapy in age-related macular degeneration
  11801. The Neuroprotective effect of pre and perinatal nutritional factors on neurodevelopment
  11802. Anti-apoptotic and Neuroprotective effects of acupuncture techniques of tonification or sedation at LR3 on focal brain ischemic injury induced by intraluminal filament …
  11803. Neuroprotective effect of estrogen after chronic spinal cord injury in ovariectomized rats
  11804. Evidence for the Neuroprotective properties of afobazole in experimental model of focal brain ischemia
  11805. Neuroprotective effect of BDNF on hypoxia for embryonic rat cortical neurons in vitro
  11806. Neuroprotective effect of calcitriol in systemic inflammation induced by lipopolysaccharide [J]
  11807. Comparative evaluation of the Neuroprotective activity of phenibut and piracetam under experimental cerebral ischemia conditions in rats
  11808. The Neuroprotective effect of erythropoietin in prevention of neuropsychiatric manifestation of SLE
  11809. The mechanism of Neuroprotective effect of PACAP27 on rotenone-induced apoptosis in PC12 cells
  11810. Neurochemical and Neuroprotective properties of phenylethylidenehydrazine analogues.
  11811. Neuroprotective properties of erythropoietin in cerebral ischemia
  11812. Neuroprotective effect of ginsenoside Rg1 on dopaminergic neurons and blocking effect of ICI182, 780
  11813. The SNK-SPAR PATHWAY IN Neuroprotective EFFECT OF GINKGO BILOBA EXTRACT [J]
  11814. Comparison of Neuroprotective properties of nootropes, calcium channel blockers, and panangin
  11815. Imidaprilat, an angiotensin-converting enzyme inhibitor exerts Neuroprotective effect via decreasing dopamine efflux and hydroxyl radical generation induced by …
  11816. Psychotropic drug tenoten activates mitogen-activated MAP/ERK kinase regulatory cascade controlling the Neuroprotective effects
  11817. Neuroprotective effects of edaravone against anoxia-reoxygenation injury in cultured hipp-ocampal cells [J]
  11818. Neuroprotective agents for clinical trials in ALS: A systematic assessment
  11819. Influence of Valproate Sodium on Neuroprotective Effects of Topiramate
  11820. Neuroprotective activity of Phytoceramides
  11821. Neuroprotective effect of Batroxobin in rabbits with global ischemia-reperfusion
  11822. Neuroprotective Effect of Exogenous Growth Hormone in brain Injury-Rat Model.
  11823. Identification of the proteins interacting with Neuroprotective peptide humanin in a yeast two-hybrid system
  11824. In Vitro Neuroprotective Effect of Thrombopoietin [J]
  11825. Neurocognitive dysfunction post-cardiac surgery and the Neuroprotective effects of erythropoietin.
  11826. Neuroprotective effects of tanakan under conditions of hypokinesia
  11827. Aging and cognitive decline: Neuroprotective strategies
  11828. The Potential Neuroprotective Mechanisms of 17β-estradiol on Aβ_ (25~ 35)-induced Cytotoxicity in PC12 Cells [J]
  11829. A Review of Neuroprotective agents
  11830. The effect of the synthetic Neuroprotective dipeptide noopept on glutamate release from rat brain cortex slices
  11831. Neuroprotective effect of hypothermia on hypoxic-ischemic brain injury in mice
  11832. Identification of the proteins interacting with Neuroprotective peptide humanin in a yeast two-hybrid system
  11833. Neuroprotective effects of Rasagiline on PC12 cell death and apoptosis induced by Aβ_ (25-35)[J]
  11834. An Investigation into the Neuroprotective Properties of Acyclovir
  11835. Neuroprotective effects of citicoline on apoptosis of neurons induced by 6-hydroxydopamine
  11836. Neuroprotective effects of nerve growth factor on injured basal ganglia neurons in vitro [J]
  11837. Neuroprotective Effect of HyulBuChookAu-Tang on Focal Cerebral Ischemia of the Rats
  11838. Delivery of GDNF for Parkinson’s disease: transition of a Neuroprotective treatment strategy from basic sciences to clinical application
  11839. Neuroprotective effect of Saponins of panax ginseng on focal cerebral ischemia reperfusion in rats [J]
  11840. Study of apoptosis pattern of dopaminergic neurons and Neuroprotective effect of nicotine in MPTP mouse model
  11841. Neuroprotective factors and retinal degenerations
  11842. Practice Parameter: Neuroprotective strategies and alternative
  11843. Evaluation of Polyethylene Glycol as a Neuroprotective Strategy for Acute Spinal Cord Injury
  11844. The Study of Neuroprotective Effect of Huwenatoxin-I after Cerebral Ischemia-reperfusion of Rats [J]
  11845. Intracellular Signaling Pathway of Neuroprotective Function of BDNF on Hypoxic-cultured Embryonic Neurons in Vitro [J]
  11846. Neuroprotective effects of ginseng saponins against L-type channel-mediated cell death in rat cortical neurons
  11847. Neuroprotective effect ofshenfuinjection after intra-arterial thrombolysis
  11848. Timing and dosage: Neuroprotective effect of high-dose methylprednisolone preventively in rat acute spinal cord injury [J]
  11849. The Development of Voltage Controlled Current Source for Neuroprotective Treatment Instrument [J]
  11850. The evaluation of Neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI‐6) in cyclosarin‐poisoned rats
  11851. Dexmedetomidine during coronary artery bypass grafting surgery: is it Neuroprotective ? A pilot study: O-28
  11852. Neuroprotective effect of asialoerythropoietin in rats
  11853. Neuroprotective effect of edaravone on cerebral trauma rats [J]
  11854. Neuroprotective action of 9‐hydroxypinoresinol from Butterbur, a traditional vegetable
  11855. Alcohol Appears to Be Neuroprotective in TBI
  11856. A reversible FAAH inhibitor exhibits efficient bioavailability while enhancing Neuroprotective endocannabinoid responses
  11857. Experimental Study of the Neuroprotective Effect of Insulin to Acute Spinal Cord Injury in Rats
  11858. Neuroprotective agents for the treatment of ischemic and hemorrhagic stroke
  11859. THE ROLE OF CREB IN Neuroprotective MECHANISMS IN THE SPASTIC HAN WISTAR RAT
  11860. Is chronic rapeseed oil diet more Neuroprotective than chronic corn/sunflower diet?-Evaluation by audiogenic seizure test in magnesium-deficient mice (MDDAS)
  11861. Neuroprotective effect of cyclosporin A on spinal cord ischemic injury in rabbits
  11862. Neuroprotective Effects of Ginkgo biloba extract, GBB, in the Transient Ischemic Rat Model
  11863. Neuroprotective potential of N -acetylcysteine in carbofuran neurotoxicity: A biochemical and histopathological study
  11864. Neuroprotective Treatment With NAP Reduces Laser–Induced Retinal Damage in Rats
  11865. Neuroprotective Effect of 670 nm Light Following Retinal Laser
  11866. Stroke: Neuroprotective strategies remain elusive
  11867. Decrease in the glutamate release may contribute to the Neuroprotective action of the novel neuroleptic drug dilept
  11868. Caffeine and Fish Oil Found Neuroprotective for Alzheimer Disease
  11869. Neuroprotective effects of erythropoietin on cultured retinal neurocytes by glutamate [J]
  11870. Neuroprotective effect of heyneanol A, derived from the roots of Vitis amurensis Rup
  11871. Neuroprotective Effects of Procyanidins on Focal Cerebral Ischemia in Rats
  11872. Neuroprotective effect of early treatment with pioglitasone and vitamin E acetate in alloxan induced diabetes in rats
  11873. Study Progress of Neuroprotective Effect of Melatonin on brain Injury of Epilepsy
  11874. Neuroprotective effect of Puerarin following traumatic brain injury in adult rat
  11875. The Neuroprotective effects of intravascular low level laser irradiation on cerebral ischemia rats
  11876. Neuroprotective effects of delta-9-tetrahydrocannabinol in a marmoset Parkinson model
  11877. Neuroprotective effects of rehmanniae radix on pc12 cells and hippocampal neural cells
  11878. Protein Kinase C-mediated Neuroprotective Action of (-)-epigallocatechin-3-gallate against -induced Apoptotic Cell Death in SH-SY5Y Neuroblastoma Cells
  11879. Neuroprotective EFFECT OF Bak Foong Pill EXTRACTS ON MPTP-INDUCED PARKINSON’S DISEASE MOUSE MODEL [J]
  11880. Axonal involvement in Wlds Neuroprotective effect
  11881. Neuroprotective Effects of Angiotensin II Type 1 (AT1R) Receptor Blocker Telmisartan on Early Diabetic Retina
  11882. Neuroprotective properties of fluocinolone acetonide chronically delivered into the vitreous of albino RCS rats
  11883. Anti-apoptotic and Neuroprotective Effects of the Antioxidant Edaravone in Rats Subjected to Cerebral Ischemia-Reperfusion Injury [J]
  11884. Neuroprotective effects of batroxobin combined with edaravone in treatment of cerebral ischemic reperfusion injury in gerbils [J]
  11885. Preconditioning Neuroprotective effect of xenon is gender-insensitive in an adult mice stroke model
  11886. Neuroprotective Effects of Edaravone on Neonatal Mice with Hypoxia-Ischemia brain Damage
  11887. Neuroprotective Effect and Anticoagulation Effect of Total Saponins of Radix Liriopes on Focal Cerebral Ischemia
  11888. Neuroprotective effects of celecoxib against degeneration of dopaminergic neurons induced by lipopolysaccharide [J]
  11889. Common Neuroprotective effects of endothelin receptor a blockade and erythropoietin during hypoxia-associated cell injury. Perspectives of combined treatment
  11890. THE EXPERIMENTAL STUDY OF ATORVASTATIN WITH Neuroprotective EFFECTS BY UPREGULATING ENDOTHELIAL NITRIC OXIDE SYNTHASE …
  11891. Neuroprotective effects of citicoline against oxygen-glucose deprivation and reperfusion injury in cultured hippocampal cells
  11892. Molecular Mechanism Underlying a Neuroprotective Effect of Low Dose-irradiation
  11893. Search for Neuroprotective Substances from Natural Resources
  11894. Neuroprotective and neurotoxic effects of L-DOPA in rat midbrain dopaminergic neurons in culture
  11895. Neuroprotective effect by Dammishimgyu-herbal acupuncture against H2O2-induced apoptosis in human neuroblastoma, SH-SY5Y cells
  11896. Experimental study on Neuroprotective effects of preconditioning with 3NP on prognosis of dopaminergic neurons in substantia nigra of 6-OHDA-lesioned PD rats [J]
  11897. The erythropoietin Neuroprotective effect: assessment in coronary artery bypass graft surgery (TENPEAKS)–a randomized, double-blind, placebo-controlled, proof-of …
  11898. P11 Neuroprotective EFFECTS OF CYSTAMINE IN AGED PARKINSONIAN MICE
  11899. Neuroprotective effects of vitamin E: AA Argyuriou, E. Chroni, et al. Neurology 2005;64:26–31
  11900. Neuroprotective AGENT EFFECTIVE IN ISCHEMIC STROKE IN CLINICAL TRIALS
  11901. Preclinical quantitative MicroPET imaging in evaluation of Neuroprotective drug candidates
  11902. Neuroprotective Effect of Cirsium japonicum and Silibinin on Lipopolysaccharide-induced Inflammation in BV2 Microglial Cells
  11903. Ketamine Plus Diazepam Reported to Be Neuroprotective Against Status Epilepticus After Nerve Agent Exposure
  11904. Cellular and molecular properties of the Neuroprotective Wldˢ gene
  11905. Progress in Research on Neuroprotective Effects of Statins
  11906. Study on the Expression of brain -Derived Neurotrophic Factor and Semaphorin 3A After Focal Cerebral Ischemia in Rats and the Neuroprotective Effects of Puerarin
  11907. Neuroprotective mechanisms of heme oxygenase
  11908. Involvement of the Nogo-A/NgR pathway in Neuroprotective effect of ischemic preconditioning on focal ischemia in rats
  11909. Extended hypoestrogenicity negates the Neuroprotective effect of estrogen therapy
  11910. Neuroprotective effect of high-dose hyperbaric oxygenation on rats with acute cerebral infarction in super-early stage☆: Curative comparison between 9-hour and 18 …
  11911. Neuroprotective effects of sodium meta silicate on motoneurons of spinal cord ventral horn in rats underwent to compressived injury of sciatic nerve
  11912. Alpha-tocotrienolA potent Neuroprotective natural vitamin E
  11913. Neuroprotective actions and underlying molecular mechanisms of lithium
  11914. A novel Neuroprotective role for the Fas molecule
  11915. An investigation into the Neuroprotective effects of dehydroepiandrosterone
  11916. Neuroprotective role of Batroxobin in cardiopulmonary resuscitation rabbits
  11917. An investigation of the Neuroprotective properties of fenamate NSAIDs, against experimental models of ischemic stroke
  11918. Neuroprotective actions of estrogens in the central nervous system
  11919. Neuroprotective effects of ganglioside GM1 and mild hypothermia on hypoxic-ischemic brain damage in neonatal rats
  11920. Perspective author’s response: Uncompetitive/Fast Off-rate (UFO) mechanism of pathologically-activated Neuroprotective drugs
  11921. Parkinson’s disease: molecular aspects and prospective Neuroprotective and restorative therapies
  11922. P-198 DESIGN AND SYNTHESIS OF Neuroprotective PROSTAGLANDIN ANALOGS
  11923. Anticonvulsant and Neuroprotective actions of endogenous dynorphin
  11924. Neuroprotective ACTION OF CYCLOPENTYLADENOSINE AT THE CONVULSIVE STATE INDUCED BY INCREASE OF INTRACRANIAL PRESSURE
  11925. Neuroprotective agents : Is Effective on Toxicity in Glial Cells?
  11926. An investigation of the Neuroprotective properties of fenamate NSAIDs, against experimental model of ischemic stroke
  11927. Neuroprotective Effect of Natural Products with Cell Culture System
  11928. Neuroprotective effects of dietary vitamin E and Ginkgo biloba
  11929. The Neuroprotective effects of Z-bisdehydrodoisynolic acid following traumatic brain injury
  11930. A Neuroprotective effect of the herbal drug neurofit in alcoholic intoxication
  11931. Multifunctional Neuroprotective Drugs for the Treatment of Alzheimer’s Disease
  11932. Neuroprotective Mechanism of Neuroglobin
  11933. Neuroprotective effects of magnesium in preterm infants – results of the ACTOMgSO4 Study.
  11934. The Neuroprotective effects of transient ischemic attacts on acute cerebral infarction
  11935. Excitotoxicity in ALS: Investigations of underlying molecular mechanisms and evaluation of Neuroprotective strategies
  11936. Neuroprotective EFFECTS OF 17‐β‐ESTRADIOL IN THE SPASTIC HAN WISTAR RATS
  11937. Neuroprotective effects of L-carnitine and vitamin E alone or in
  11938. Neuromodulatory and Neuroprotective roles of synaptic P2 receptors
  11939. Neuroprotective Effects of Rhetsinine against H₂0₂-induced Oxidative Apoptosis in CLN29/2 cells
  11940. Application of Noninvasive Method for Assessing the Neuroprotective Effect of Magnolol
  11941. Stem cells as Neuroprotective vectors for retinal disease
  11942. Neuroprotective Effect of $ NeuBo153^{circledR} $ on Transient Focal Cerebral Ischemia in Rats
  11943. The in vivo Neuroprotective Role of the Normal Cellular Prion Prote in
  11944. Corticotropin Releasing Hormone (CRH) targets various Neuroprotective mechanisms
  11945. New aspects of retinal degeneration: mechanisms and potential Neuroprotective strategies
  11946. Antioxidative and Neuroprotective Constituents Isolated from Opuntia ficus-indica var. saboten
  11947. Pre-Conditioning Stimulus Reported to Be Neuroprotective for Stroke in Mice
  11948. Neuroprotective Effects of Daebowonjeon on PC12 Cells Exposed to Ischemia
  11949. Reactive Microglia Are Neuroprotective Following ET–1 Mediated Injury
  11950. Neuroprotective Approaches in Experimental Model of Cerebral Venous Infarct
  11951. Neuroprotective potential of methamphetamine: behavioral and histological analysi
  11952. Assessment of Neuroprotective properties of Centella asiatica employing in vitro and in vivo models
  11953. The Neuroprotective Effect of Erythropoietin on Cerebral Ischemic Injury
  11954. Neuroprotective Effects of Ginko biloba in Global Cerebral Ischemia
  11955. Influence of Valproate Sodium on Neuroprotective Effects of Topiramate
  11956. Neuroprotective effect of Sanguisorbae radix against oxidative stress-induced brain damage
  11957. Neuroprotective potential of ceftriaxone on motor neuron suvival of rat
  11958. Hemodynamic effects of clonidine outweigh potential Neuroprotective effects in experimental stroke
  11959. Neuroprotective Effect of Heyneanol A from the roots of vitis amurensis Rup
  11960. Corticotropin releasing hormone (CRH) is a Neuroprotective peptide
  11961. The brain ‘s Neuroprotective and proapoptotic effects of Aspirin-A Review
  11962. The Neuroprotective Effect of Pyruvate is Related to Blood Scavenging Activity
  11963. An Experimental Study of the Neuroprotective Effect of Uric Acid after Spinal Cord Injury in Rats
  11964. Identification of Protein Markers of Lithium Radio-and Neuroprotective Effect
  11965. Neuroprotective Effect of Extact of Ginko Biloba on the Retinal Ganglion Cells
  11966. Neuroprotective Effect of Extact of Ginko Biloba on the Retinal Ganglion Cells
  11967. Neuroprotective effect of phytic acid in Parkinson’s disease
  11968. Appendix C: Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidenced-based review): Report of the Quality …
  11969. Neuroprotective Potential of Phase II Enzyme Inducer D3T on Motor Neuron Survival in Vitro
  11970. Neuroprotective potential of methylnicotinamide versus liicotinamide in vivo and in vitro
  11971. Neuroprotective Effects of a Delta2‐Specific Opioid in Cerebral Ischemia
  11972. Neuroprotective effects of dipfluzine on dementia-mimetic rats and aged rats
  11973. The development of a method to deliver Neuroprotective peptides specifically into stroke-affected neurons
  11974. Neuroprotective Effects Of Cyclooxygenase Inhibitors On Apoptotic Retinal Ganglion Cells
  11975. Cannabinoids as Neuroprotective agents : a mechanistic study
  11976. Developing a Neuroprotective therapy for Parkinson’s and Huntington’s diseases
  11977. Development and Characterization of an in vitro Model of Retinal Ganglion Cell Ischemia for the Identification of Neuroprotective Molecules
  11978. Neuroprotective effect of antipsychotic drugs (neuroleptics) in global brain ischemia
  11979. Neuroprotective Effects of EGCG against Amyloid-beta (1-42)-Induced Apoptosis
  11980. Assessing Neuroprotective P-glycoprotein activity at the blood-brain barrier
  11981. Neuroprotective Vaccination With PN–277 Reduces Laser–Induced Retinal Damage in Rats
  11982. Usefulness of Quantitative Evaluation of Neuroprotective Effects Afforded by Anesthetics on brain Ischemia with Use of Probit Curves
  11983. The Neuroprotective effect of Tianmagouteng Yin on rats following cerebral hypoperfusion
  11984. Neuroprotective Effects of different doses of BPI-1095 in Focal Cerebral Ischemia Rats
  11985. Neuroprotective Constituents from the Stem of Lindera obtusiloba
  11986. Mechanisms of Neuroprotective effect of estrogens associated with vascular endothelial growth factor expression
  11987. Anti-apoptotic and Neuroprotective Effects of Bambusae Caulis in Liquamen Manufactured by Different Production Process
  11988. High hopes for memantine: can this Neuroprotective agent stop glaucoma damage?
  11989. Characterization of Soluble Fas Receptor as a Neuroprotective Agent following Acute Spinal Cord Injury
  11990. Chemical Genomics and Drug Discovery; Neuroprotective effect of BM-MSC using Co-culture system
  11991. The Neuroprotective Effect of Oxaloacetate is Related to Blood Scavenging Activity
  11992. In vitro and in vivo effects of the combination of SR57746A (Xaliproden), a Neuroprotective agent, with oxaliplatin (ELOXATIN®) in colon tumors
  11993. A COMPARISON OF Neuroprotective EFFECTS OF NEWLY DEVELOPED OXIMES WITH TRIMEDOXIME IN TABUN-POISONED RATS
  11994. Neural stem cells exert a Neuroprotective action by changing the ischemic microenvironment
  11995. Neuroprotective effects of heat shock proteins in experimental ischaemia: an MRI study.
  11996. Neuroprotective ROLE OF STATINS: MECHANISTIC INSIGHTS AND CLINICAL RELEVANCE IN CEREBROVASCULAR DISEASE
  11997. Neuroprotective Mechanism study of Rutaecarpine against H₂O₂and glutam ateinduced Apoptosis in CLN29/2 cells
  11998. Testosterone as a Neuroprotective /neurotherapeutic agent following partial neuronal depletion
  11999. Neuroprotective effect of the roots polygonum cuspidatum on transient focal cerebral ischemia in rats
  12000. Syntheses of Neuroprotective Bridged Diterpenes
  12001. VEGF-A Plays a Major Retinal Neuroprotective Role in the Adaptive Response to Ischemic Injury
  12002. Neuroprotective effect of transcorneal electrical stimulation on optic nerve injury
  12003. Neuroprotective Effects of Nitrite Against Cerebral Ischemia-Reperfusion Injury in Rat
  12004. Neuroprotective Coumarins from the Root of Angelica gigas: Structure-Activity Relationships
  12005. Combination of Neuroprotective agents inhibited neuron apoptosis in focal ischemic area of rat with MCAO
  12006. Neuroprotective effect of Mexidol and Nooglutyl in rats with experimentally produced hemorrhagic and ischemic stroke
  12007. Neuroprotective Effects of the Biologically Active Components From Traditional Korean Medicine on the brain Ischemia in Rats
  12008. Neuroprotective effects of isolated compounds from Gardeniae Fructus
  12009. Evaluation of the Neuroprotective Effect Exerted by Epigallocatechin Gallate on Retinal Cell Cultures
  12010. GM-CSF Has a Neuroprotective Effect by Stimulating Anti-apoptotic Signal Pathways in Neural Cells
  12011. Neuroprotective effect of Gangliosides on cerebral ischemia reperfusion injury in rats
  12012. Multiple Neuroprotective Effect of L-Theanine in memory Improvement in In Vitro and In Vivo Mice Model
  12013. The experimental study of peculiarities and mechanism of Neuroprotective action of mexidol in hemorrhagic stroke
  12014. Block of the permeability transition pore may explain the Neuroprotective effect of erythropoietin
  12015. Neuroprotective EFFECTS AND MECHANISM OF CITICOLINE ON PRIMARY CULTURED DOPAMINERGIC NEURONS OF MESENCEPHALON
  12016. Potential Neuroprotective role of anthocyanins and anthocyanidins mediated by proteasome inhibition
  12017. Neuroprotective effect of panax notoginseng saponins on RGCL of rats with chronic ocular hypertension
  12018. Neuroprotective of S-allyl-L-cysteine against ischemic damage in in vitro and in vivo models
  12019. Neuroprotective Effects of Dipyridamole against Microglial Activation
  12020. Neuroprotective effect of minocycline & estrogen after Spinal Cord Injury
  12021. Neuroprotective Effect of 17ß-Estradiol Against TNF-Induced Axonal Degeneration and p-ERK Expression
  12022. Neuroprotective effects of learning on glutamate-induced neuronal damage in rat hippocampus
  12023. Neuroprotective role of kinin via glial cells in the central nervous system
  12024. Potential Neuroprotective effects of transient ischaemic attacks in acute ischaemic stroke
  12025. New Neuroprotective approaches for stroke: use of decoy peptides targeting specific molecular events
  12026. Neuroprotective Properties of an Anti-VEGF Antibody Delivered by Gene Transfer in the Mouse Retina
  12027. Neuroprotective effect of aspirin preconditioning on cerebral ischemia reperfusion injury in Sprague-Dawley rats
  12028. Neuroprotective effects of modified Bo-Yang-Hwan-Oh-Tang in N2a neuroblastoma cells
  12029. The Neuroprotective Effect of Post-Treatment with β1-Antagonists after Focal Ischemia in Rats
  12030. Possible Neuroprotective Effect of Erythropoietin in Acute Inflammation Induced by Exhaustive Exercise
  12031. Neuroprotective Action of Volatile Anesthetics at Striatal Neurons of Mouse
  12032. Neuroprotective and vasoprotective effects of a novel calmodulin inhibitor, DY-9760e in the brain embolism
  12033. Neuroprotective AND CARDIOPROTECTIVE EFFECTS OF ERYTHROPOIETIN IN ACUTE STROKE AND ACUTE MYOCARDIAL INFARCTION
  12034. HIV-induced neurotoxicity: Determinants of developmental and regional neuronal susceptibility and potential Neuroprotective strategies
  12035. The correlation between pTiO2 and apoptosis in a rat model of a reversible cerebral ischemia-the Neuroprotective role or hypertension
  12036. Molecular Signature of Neuroprotective Effects of Metyrapone and Carbenoxolone
  12037. Neuroprotective effect of Ligustrazine on focal cerebral ischemia injury in rats
  12038. A Neuroprotective autoimmunization model induced by COP-1 in a rat with chronically elevated intraocular pressure
  12039. Neuroprotective Effect of Cannabidiol in Endotoxin-Induced Retinal Inflammation
  12040. Neuroprotective effects of erythropoietin on cultured retinal neurocytes by glutamate
  12041. Neuroprotective mechanism of aspirin preconditioning in cerebral ischemia reperfusion injury on Sprague-Dawley rats
  12042. Experimental Neuroprotective therapeutics in animal models of Huntington’s disease and Parkinson’s disease
  12043. Neuroprotective effect of limb ischemic post‐conditioning on focal brain ischemia/reperfusion injury in rats
  12044. Identification and characterisation of potential Neuroprotective proteins induced by erythropoietin (EPO) preconditioning of cortical neuronal cultures
  12045. Experimental study of the Neuroprotective properties of the melanin in embryos irradiated during antenatal development
  12046. Neuroprotective effects and mechanisms of fentanyl preconditioning against brain ischemia
  12047. Magnesium lithospermate B possesses inhibitory activity on Na+, K+-ATPase and Neuroprotective effects against ischemic stroke1
  12048. Neuroprotective EFFECT OF MAGNOLOL ON ORGANOTYPIC HIPPOCAMPAL SLICE CULTURES
  12049. Neuroprotective effect of bacopa monniera against neurodegeneration mediated by beta-amyloid
  12050. Neuroprotective effect of Glycyrrhizae Radix against A (25-35)-induced neuronal cell death in cultured rat cortical neurons.
  12051. Neuroprotective Effect of Bone Marrow-Derived Mononuclear Cells Promoting Functional Recovery from Spinal Cord Injury
  12052. Research Proposal: Neuroprotective Effects of R-Type Voltage Sensitive Calcium Chan-nel Antagonists in Traumatic brain Injury
  12053. Adenosine-induced Neuroprotective actions in ventral horn neurons of the rat spinal cord.
  12054. Neuroprotective effect of GST-22 on rat hippocampal CA1 neurons against cerebral ischemia
  12055. 17ß–Estradiol Exerts a Neuroprotective Effect Through Phosphorylation of ERK in NMDA–Induced Retinal Damage
  12056. Neuroprotective Properties of Minocycline in Paraquat Model of Parkinson’s Disease
  12057. Delivery of Neuroprotective peptides from encapsulated cells in a mouse model for neurodegenerative disease JK Utvik1, I. Youssef3, B. Kriem3, T. Oster3, AJA …
  12058. Neuroprotective effects of Ganoderma lucidum in human neuroblastoma SH-SY5Y cells.
  12059. Benefits of expressing your RAGE: New evidence for Neuroprotective effects of RAGE-ligand binding
  12060. Polycyclic cage compounds as carrier molecules for Neuroprotective non-steroidal anti-inflammatory drugs
  12061. Neuroprotective Effects of Prostaglandin E1 on Outcome from Severe Forebrain Ischemia in the Rat
  12062. Brimonidine Neuroprotective Effect in a Mouse Model of Ischemic Optic Neuropathy
  12063. A New Neuroprotective 2-(2-Phenylethyl) chromone of Imperata cylindrica
  12064. THE Neuroprotective EFFECT OF BRADYKININ RECEPTOR ANTAGONISTS IN CEREBRAL ISCHEMIA/REPERFUSION RATS
  12065. Rapid and Stable Knockdown of the Endogenous Neuroprotective Factor bFGF in the Retina in vivo Using Viral Vectors
  12066. Neuroprotective effects of modafinil in a non-human primate Parkinson model
  12067. Neuroprotective effects of mild hypothermia plus lamotrigine on hypoxicischemic brain damage in neonatal rats.
  12068. The Neuroprotective Effect of Rhizoma Arisaematis on 3-NP-induced Oxidative Injury of C6 Glial Cells
  12069. The Neuroprotective Effect of Magnesium Sulfate When Given Prior to Spinal Cord Ischemia in Rabbits
  12070. Neurotransmitter release and histological changes following perinatal asphyxia in rats and the Neuroprotective action of lamotrigine
  12071. Neuroprotective Effects of Detoxified and Non-detoxified Rhus verniciflua Stokes: Regulation of Catecholamine Biosynthesis and Neurotrophic Factors
  12072. The Damage Mechanisms of Iron Ion in Intracerebral Hemorrhage and the Neuroprotective Effects of Iron Chelator
  12073. Neuroprotective Effects of the Active Principles from Selected Chinese Medicinal Herbs On? amyloid-induced Toxicity in PC12 Cells
  12074. Neuroprotective effects of hypothermia and Caspase inhibitor on hypoxic-ischemic brain damage in neonatal rats
  12075. Inhibition of cyclin-dependent kinases is Neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons
  12076. Neuroprotective Mechanism of Rutaecarpine against H202-induced Oxidative Apoptosis in SH-SY5Y cells
  12077. Neuroprotective effects of Tripterygium regelii extract in human neuroblastoma SH-SY5Y cells
  12078. Neuroprotective activity of Fractions from Leaves of Zelkova serrata on Global Cerebral Ischemia
  12079. MPTP model of Parkinson’s disease: Mechanisms of neurodegeneration and potential Neuroprotective compounds
  12080. Neuroprotective Effects of Lithium on NMDA-induced Excitotoxicity in Mouse Cerebrum
  12081. The protective effect of lentiviral vector secreting NAP, a Neuroprotective short peptide on SK-N-SH cells
  12082. Neuroprotective Effects of Tempol and Its Acyl Esters in a Rat Partial Optic Nerve Crush Model
  12083. Neuroprotective effects of apigenin through inhibition of microglia cell activation
  12084. Novel Neuroprotective Neurotrophic NAP Analogs Targeting Iron Toxicity and Oxidative Stress in Neurodegenerative Diseases
  12085. The decrease of tissue oxygen correlates with the level of apoptosis in a focal ischemia in rat-the Neuroprotective role of systemic hypertension
  12086. Neuroprotective Effects of 3-bromo-pyruvic Acid in Organotypic Hippocampal Slice Culture
  12087. The Neuroprotective effects of anti-cd18 therapy after transient global ischemic brain injury in the mouse
  12088. Exogenous Modulation of Intrinsic Optic Nerve Neuroprotective Activity in Rodent Eyes Exposed to Elevated Intraocular Pressure
  12089. The Neuroprotective effect of mycophenolic acid via anti-apoptosis in perinatal hypoxic-ischemic brain injury
  12090. Histologically Neuroprotective Effect of MgSO4 after Moderate Diffuse Axonal Injury in Rats
  12091. The expression of the Neuroprotective factor seladin-1 is up-regulated by thyroid hormones in human neuronal precursor cells, but not in mature neurons
  12092. … : Prevention of down syndrome learning deficits mediated through Neuroprotective peptides, vasoactive intestinal peptide (VIP) and activity dependent Neuroprotective …
  12093. Neuroprotective effect of the different dosage of recombinant human erythropoietin on neonatal hypoxia ischemia encephalopathy
  12094. Neuroprotective Effect Of Heat Shock Protein Induced By Transpupillary Thermotherapy In The Optic Nerve Crush Injury Model In The Rat
  12095. Neuroprotective Effect of Small Interfering RNA on Rat Retinal Ganglion Cells Damage Induced by N–methyl–D–aspartate
  12096. Delayed Calpain Inhibition Is Neuroprotective After Transient Global brain Ischemia
  12097. An Investigation Into the Neuroprotective and Neurotoxic Properties of Levodopa, Dopamine and Selegiline
  12098. Long-term Neuroprotective effects of carbon dioxide on neonatal rat hypoxic-ischemic brain injury: An experimental study of skilled motor tasks
  12099. The Neuroprotective effects of progesterone on the injury of primary cultured hippocampal neurons induced by glutamate excitotoxicity
  12100. Neuroprotective effect of methanol extract of Smilacis chinae rhizome on NMDA-induced neurotoxicity and cerebral ischemia in rats
  12101. Neuroprotective Effect of Small Interfering RNA Targeted Against Caspase 3 on Rat Retinal Ganglion Cells Induced by Ischemia Reperfudion Injury in Rat
  12102. Neuroprotective effects of psalmotoxin‐1 in putamen after hypoxia‐ischemia in newborn piglet
  12103. Neuroprotective Sigma Ligands and Their Effects on Glutamate and KCL Induced Calcium Changes in Retinal Ganglion (RGC–5) Cells
  12104. Neuroprotective effect of melatonin against ischemia/reperfusion-induced neuronal apoptosis in mouse cerebellum
  12105. Neuroprotective effect by Z-ligustilide extracted from Radix Angelica sinensis for the treatment of cerebral ischemia
  12106. The Neuroprotective Qualities of Creatine on Rat Retinal Cultures Exposed to Glutamate-Induced Excitotoxic Injury
  12107. Neuroprotective Effects of Lithium in Deafferentation-Induced Cell Death of Chick Cochlear Nucleus Neurons
  12108. Neuroprotective potential of chronic rapeseed oil diet evaluated by audiogenic seizures test in magnesium-deficient mice.
  12109. Hsp72 is Neuroprotective in the the anoxia tolerant turtle, Trachemys scripta elegans
  12110. Synthesis and Evaluation of Neuroprotective α,β-Unsaturated Aldehyde Scavenger Histidyl-containing Analogs of Carnosine
  12111. Neuroprotective Effect of Dexmedetomidine on Morphine-Inducing Paraplegia after Spinal Ischemia
  12112. Neuroprotective Effect of Mitochondrial KATP Channel Opener upon Neuronal Cortical brain of Rat Population
  12113. Neuroprotective Effects of Cannabidiol Involve Inhibition of Glutamine Synthetase Nitration in Diabetic Retina
  12114. Minocycline Inhibits Caspase-Dependent Cell Death Pathway and is Neuroprotective against Hippocampal Damage after Kainic Acid-Induced Seizure in Mice
  12115. P25 IN VITRO Neuroprotective EFFECTS OF MTEP, A SELECTIVE MGLUR5 ANTAGONIST AGAINST KAINATE–INDUCED EXCITOTOXICITY.
  12116. Minocycline as a Neuroprotective Perioperative Antibiotic in Skull Base Tumors and Prevention of Delayed Facial Palsies (in Acoustic Neuromas), a Before and After …
  12117. Distribution and function of nicotinic acetylcholine receptors in glia cells and neurons with focus on the Neuroprotective mechanisms of cholesterol lowering …
  12118. Antegrade cerebral perfusion at higher temperatures is more Neuroprotective than deep hypothermic circulatory arrest (DHCA) during aortic arch operations in young …
  12119. Anti-apoptotic and Neuroprotective Effects of Acupuncture at on Focal brain Ischemic Injury Induced by Intraluminal Filament Insertion in Rats
  12120. Neuroprotective actions of melanocortins: a therapeutic opportunity
  12121. The Neuroprotective potential of flavonoids: a multiplicity of effects
  12122. Progress in Neuroprotective strategies for preventing epilepsy
  12123. Does progesterone have Neuroprotective properties?
  12124. Molecular mechanisms of apoptosis in cerebral ischemia: multiple Neuroprotective opportunities
  12125. T lymphocytes potentiate endogenous Neuroprotective inflammation in a mouse model of ALS
  12126. Antioxidant and Neuroprotective properties of N-arachidonoyldopamine
  12127. The experimental and clinical pharmacology of propofol, an anesthetic agent with Neuroprotective properties
  12128. Pro-inflammatory cytokine TNF-alpha as a Neuroprotective agent in the brain
  12129. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson’s disease in rats
  12130. Fasting is Neuroprotective following traumatic brain injury
  12131. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for Neuroprotective strategies
  12132. Progesterone exerts Neuroprotective effects after brain injury
  12133. Mechanisms of anti-inflammatory and Neuroprotective actions of PPAR-gamma agonists
  12134. Lipoic acid as an anti-inflammatory and Neuroprotective treatment for Alzheimer’s disease
  12135. Perioperative Neuroprotective strategies
  12136. In Vivo and In Vitro Characterization of a Novel Neuroprotective Strategy for Stroke: Ischemic Postconditioning
  12137. Neuroprotective effects of garlic a review
  12138. Neuroprotective strategies for the neonatal brain
  12139. Hypothesis-based RNAi screening identifies Neuroprotective genes in a Parkinson’s disease model
  12140. SOD activity of carboxyfullerenes predicts their Neuroprotective efficacy: a structure-activity study
  12141. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer’s disease
  12142. brain aging modulates the Neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review
  12143. Neuroprotective effects of the Alzheimer’s disease-related gene seladin-1
  12144. Androgen cell signaling pathways involved in Neuroprotective actions
  12145. Neuroprotective effect of prenyloxycoumarins from edible vegetables
  12146. Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a Neuroprotective phenotype
  12147. Neuroprotective effects of chronic hesperetin administration in mice
  12148. Neuroprotective effects of berberine on stroke models in vitro and in vivo
  12149. Targeted activation of astrocytes: a potential Neuroprotective strategy
  12150. Focal transplantation–based astrocyte replacement is Neuroprotective in a model of motor neuron disease
  12151. Leptin as a Neuroprotective agent
  12152. Curcumin improves learning and memory ability and its Neuroprotective mechanism in mice
  12153. Novel lipoxygenase inhibitors as Neuroprotective reagents
  12154. The Neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury.
  12155. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats
  12156. Implantation of human umbilical cord-derived mesenchymal stem cells as a Neuroprotective therapy for ischemic stroke in rats
  12157. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential Neuroprotective strategy for Alzheimer and Parkinson diseases
  12158. A broadly Neuroprotective derivative of curcumin
  12159. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia
  12160. Immunosuppression after traumatic or ischemic CNS damage: it is Neuroprotective and illuminates the role of microglial cells
  12161. Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
  12162. Adenosine A2A receptor antagonists exert motor and Neuroprotective effects by distinct cellular mechanisms
  12163. Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons
  12164. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture
  12165. Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury
  12166. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis
  12167. Effect of a Neuroprotective exercise protocol on oxidative state and BDNF levels in the rat hippocampus
  12168. Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential Neuroprotective mechanism of N-acetylcysteine
  12169. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging
  12170. Etazolate, a Neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing
  12171. Evidence of the Neuroprotective role of citicoline in glaucoma patients
  12172. A systematic review of existing data on long-term lithium therapy: Neuroprotective or neurotoxic?
  12173. Activation of Trk neurotrophin receptors by glucocorticoids provides a Neuroprotective effect
  12174. A Neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF)
  12175. Mechanistic investigations on the antioxidant action of a Neuroprotective estrogen derivative
  12176. Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia
  12177. Role of CB2 receptors in Neuroprotective effects of cannabinoids
  12178. Neuroprotective effect of Ro5-4864 following brain injury
  12179. Antiinflammatory and Neuroprotective actions of COX2 inhibitors in the injured brain
  12180. Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway
  12181. Neuroprotective Effects of the Citrus Flavanones against H2O2-Induced Cytotoxicity in PC12 Cells
  12182. Biochemical aspects of the Neuroprotective mechanism of PTEN‐induced kinase‐1 (PINK1)
  12183. PPARγ agonist rosiglitazone is Neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms
  12184. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson’s disease
  12185. Supportive care during Neuroprotective hypothermia in the term newborn: adverse effects and their prevention
  12186. Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy
  12187. A re-assessment of minocycline as a Neuroprotective agent in a rat spinal cord contusion model
  12188. Ginkgo Biloba Extract Neuroprotective Action Is Dependent on Heme Oxygenase 1 in Ischemic Reperfusion brain Injury
  12189. Proteomic analysis of the Neuroprotective mechanisms of acupuncture treatment in a Parkinson’s disease mouse model
  12190. Synergistic Neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition
  12191. Incensole Acetate: A Novel Neuroprotective Agent Isolated from Boswellia Carterii
  12192. Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY‐5Y cells
  12193. Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model
  12194. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile
  12195. Caffeine: Neuroprotective functions in cognition and Alzheimer’s disease
  12196. Neuroprotective effects of several korean medicinal plants traditionally used for stroke remedy
  12197. Block of purinergic P2X7 receptor is Neuroprotective in an animal model of Alzheimer’s disease
  12198. Neuroprotective effects of guanosine on stroke models in vitro and in vivo
  12199. Neuroprotective effect of hyperbaric oxygen therapy in brain injury is mediated by preservation of mitochondrial membrane properties
  12200. Amiloride is Neuroprotective in an MPTP model of Parkinson’s disease
  12201. Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, Neuroprotective properties, and free radical scavenger properties
  12202. Further pharmacological evidence of the Neuroprotective effect of catalpol from Rehmannia glutinosa
  12203. Neuroprotective actions of vitamin C related to decreased lipid peroxidation and increased catalase activity in adult rats after pilocarpine-induced seizures
  12204. Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia–reoxygenation
  12205. Uric acid: Neuroprotective or neurotoxic?
  12206. Triterpenoid saponins with Neuroprotective effects from the roots of Polygala tenuifolia
  12207. Targeting multiple Alzheimer’s disease etiologies with multimodal Neuroprotective and neurorestorative iron chelators
  12208. Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets
  12209. Dose dependence and therapeutic window for the Neuroprotective effects of curcumin in thromboembolic model of rat
  12210. Neuroprotective effects of salidroside in the PC12 cell model exposed to hypoglycemia and serum limitation
  12211. In vitro and in vivo Neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice)
  12212. Neuroprotective effect of Sanguisorbae radix against oxidative stress-induced brain damage: in vitro and in vivo
  12213. Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson’s disease
  12214. Potent anti-inflammatory and Neuroprotective effects of TGF-β1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in …
  12215. Changes at the focus of experimental ischemic stroke treated with Neuroprotective agents
  12216. AAV Vector–mediated RNAi of mutant Huntingtin expression is Neuroprotective in a novel genetic rat model of Huntington’s disease
  12217. Effects of aging on Neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases
  12218. Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase
  12219. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain : antioxidant and Neuroprotective effects of l‐carnitine
  12220. Rasagiline is Neuroprotective in a transgenic model of multiple system atrophy
  12221. Palmitoylation and membrane interactions of the Neuroprotective chaperone cysteine-string protein
  12222. Huperzine A exhibits anti‐inflammatory and Neuroprotective effects in a rat model of transient focal cerebral ischemia
  12223. Dose-response features of Neuroprotective agents : an integrative summary
  12224. Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their Neuroprotective activities
  12225. The Neuroprotective mechanism of action of the multimodal drug ladostigil
  12226. Are purines mediators of the anticonvulsant/Neuroprotective effects of ketogenic diets?
  12227. Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-κB: Neuroprotective implications
  12228. Essential role for Stat5 in the neurotrophic but not in the Neuroprotective effect of erythropoietin
  12229. Neuroprotective effects of chlorogenic acid against apoptosis of PC12 cells induced by methylmercury
  12230. Neuroprotective effects of tempol, a catalytic scavenger of peroxynitrite-derived free radicals, in a mouse traumatic brain injury model
  12231. Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the Neuroprotective Nrf2 activator 3H‐1, 2‐dithiole‐3‐thione
  12232. Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes
  12233. Possible role of opioids and KATP channels in Neuroprotective effect of postconditioning in mice
  12234. Neuroprotective and axon growth promoting effects of intraocular inflammation do not depend on oncomodulin or the presence of large numbers of activated …
  12235. Quercetin, kaempferol and biapigenin from Hypericum perforatum are Neuroprotective against excitotoxic insults
  12236. Excitatory amino acid transporter expression by astrocytes is Neuroprotective against microglial excitotoxicity
  12237. Donepezil: potential Neuroprotective and disease-modifying effects
  12238. Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the Neuroprotective activity of pigment epithelium-derived factor in a rat …
  12239. Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models
  12240. Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation
  12241. Neuroprotective Limonoids of Root Bark of Dictamnus dasycarpus
  12242. Human angiogenin is a Neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of …
  12243. Neuroprotective effect of progesterone on acute phase changes induced by partial global cerebral ischaemia in mice
  12244. Neuropharmacological mechanisms underlying the Neuroprotective effects of methylphenidate
  12245. Is deep brain stimulation Neuroprotective if applied early in the course of PD?
  12246. Dietary supplementation exerts Neuroprotective effects in ischemic stroke model
  12247. Neuroprotective effect of sonic hedgehog up‐regulated in Schwann cells following sciatic nerve injury
  12248. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation
  12249. Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice
  12250. Neuroprotective effects of vascular endothelial growth factor following hypoxic ischemic brain injury in neonatal rats
  12251. Neuroprotective actions of leptin on central and peripheral neurons in vitro
  12252. Neuroprotective effect of moderate epidural hypothermia after spinal cord injury in rats
  12253. Loss of Neuroprotective survival signal in mice lacking insulin receptor gene in rod photoreceptor cells
  12254. The contribution of the blood glutamate scavenging activity of pyruvate to its Neuroprotective properties in a rat model of closed head injury
  12255. Neuroprotective properties of gallic acid from Sanguisorbae Radix on amyloid β protein (25—35)-Induced toxicity in cultured rat cortical neurons
  12256. The Neuroprotective role of melatonin against amyloid β peptide injected mice
  12257. Neurotoxicity of cadmium on immature hippocampus and a Neuroprotective role for p38MAPK
  12258. Aryl azoles with Neuroprotective activity—Parallel synthesis and attempts at target identification
  12259. Tiagabine is Neuroprotective in the N171-82Q and R6/2 mouse models of Huntington’s disease
  12260. Broad Neuroprotective profile of nicotinamide in different mouse models of MPTP‐induced parkinsonism
  12261. Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous Neuroprotective mechanism
  12262. Neuroprotective effect of cobalt chloride on hypobaric hypoxia-induced oxidative stress
  12263. Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: glutamate receptor gene expression
  12264. Neuroprotective effects of (−)‐epigallocatechin‐3‐gallate (EGCG) on paraquat‐induced apoptosis in PC12 cells
  12265. Mechanism of the Neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism
  12266. DP-b99, a membrane-activated metal ion chelator, as Neuroprotective therapy in ischemic stroke
  12267. Three distinct Neuroprotective functions of myricetin against glutamate‐induced neuronal cell death: involvement of direct inhibition of caspase‐3
  12268. Differential Neuroprotective effects of carnosine, anserine, and N‐acetyl carnosine against permanent focal ischemia
  12269. Evidence for Neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro
  12270. Recombinant human erythropoietin: novel strategies for Neuroprotective /neuroregenerative treatment of multiple sclerosis
  12271. Synthesis and Neuroprotective properties of novel cinnamide derivatives
  12272. Anti-apoptotic and Neuroprotective effects of Tetramethylpyrazine following subarachnoid hemorrhage in rats
  12273. Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage
  12274. Neuroprotective effects of neuregulin-1 on B35 neuronal cells following ischemia
  12275. The Neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity
  12276. Neuroprotective effect of methanolic extracts of Allium cepa on ischemia and reperfusion-induced cerebral injury
  12277. Chrysogenamide A from an endophytic fungus associated with Cistanche deserticola and its Neuroprotective effect on SH-SY5Y cells
  12278. Identification of paracrine Neuroprotective candidate proteins by a functional assay-driven proteomics approach
  12279. Neuroprotective function of human neuroglobin is correlated with its guanine nucleotide dissociation inhibitor activity
  12280. Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia
  12281. Dysfunction of astrocytes in senescence‐accelerated mice SAMP8 reduces their Neuroprotective capacity
  12282. Exogenous agmatine has Neuroprotective effects against restraint‐induced structural changes in the rat brain
  12283. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium–binding proteins
  12284. Evaluation of antioxidant and Neuroprotective effect of ethanolic extract of Embelia ribes Burm in focal cerebral ischemia/reperfusion‐induced oxidative stress in rats
  12285. Neuroprotective effect of Smilacis chinae rhizome on NMDA-induced neurotoxicity in vitro and focal cerebral ischemia in vivo
  12286. Exploring the Neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy
  12287. Prophylactic Neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of …
  12288. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the Neuroprotective variant carbamyl-erythropoietin (CEPO)
  12289. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats
  12290. A re-assessment of erythropoietin as a Neuroprotective agent following rat spinal cord compression or contusion injury
  12291. Neuroprotective role of tripchlorolide on inflammatory neurotoxicity induced by lipopolysaccharide-activated microglia
  12292. Monomeric IgG is Neuroprotective via enhancing microglial recycling endocytosis and TNF-α
  12293. Neuroprotective effects of lactation against kainic acid treatment in the dorsal hippocampus of the rat
  12294. The Neuroprotective effects of isosteviol against focal cerebral ischemia injury induced by middle cerebral artery occlusion in rats
  12295. Neuroprotective effects of high-dose vs low-dose melatonin after blunt sciatic nerve injury
  12296. Recombinant erythropoietin is Neuroprotective in a novel mouse oxidative injury model
  12297. A Neuroprotective herbal mixture inhibits caspase-3-independent apoptosis in retinal ganglion cells
  12298. Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders
  12299. Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia
  12300. Comparison of Neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin‐induced nigrostriatal dopaminergic degeneration
  12301. A novel iron-chelating derivative of the Neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities
  12302. Efficient synthesis and Neuroprotective effect of substituted 1, 3-diphenyl-2-propen-1-ones
  12303. Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation
  12304. Carbamylated erythropoietin is Neuroprotective in an experimental model of traumatic brain injury
  12305. Developing Neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction
  12306. Neuroprotective role of minocycline in co-cultures of human fetal neurons and microglia
  12307. Neuroprotective effect of sodium ferulate and signal transduction mechanisms in the aged rat hippocampus1
  12308. Neuroprotective effects of PACAP27 in mice model of Parkinson’s disease involved in the modulation of KATP subunits and D2 receptors in the striatum
  12309. Neuroprotective properties of ciliary neurotrophic factor for cultured adult rat dorsal root ganglion neurons
  12310. Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor‐dependent inhibition of glycogen synthase kinase‐3β and a receptor …
  12311. Neuroprotective effects of the ketogenic diet
  12312. Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons
  12313. Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is Neuroprotective , decreases the number of activated microglia and …
  12314. The Neuroprotective effect of fish n-3 fatty acids in the hippocampus of diabetic rats
  12315. Ischemic tolerance as an active and intrinsic Neuroprotective mechanism
  12316. Neuroprotective effects of ginseng saponins against L-type Ca2+ channel-mediated cell death in rat cortical neurons
  12317. Neuroprotective effects of novel phosphatidylglycerol‐based phospholipids in the 6‐hydroxydopamine model of Parkinson’s disease
  12318. Decreased glutamate receptor binding and NMDA R1 gene expression in hippocampus of pilocarpine-induced epileptic rats: Neuroprotective role of Bacopa monnieri …
  12319. Increased expression of the oligopeptidase THOP1 is a Neuroprotective response to Aβ toxicity
  12320. … high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the Neuroprotective factor DHCR24 (Seladin-1)
  12321. … of brain -derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington’s disease: restoration by the Neuroprotective compound CEP-1347
  12322. Antioxidant and Neuroprotective properties of sour tea (Hibiscus sabdariffa, calyx) and green tea (Camellia sinensis) on some pro-oxidant-induced lipid peroxidation in …
  12323. The Amyloid-β Peptide of Alzheimer’s Disease Binds CuI in a Linear Bis-His Coordination Environment: Insight into a Possible Neuroprotective Mechanism for the …
  12324. S-adenosylmethionine mediates glutathione efficacy by increasing glutathione S-transferase activity: implications for S-adenosyl methionine as a Neuroprotective …
  12325. The development of new oximes and the evaluation of their reactivating, therapeutic and Neuroprotective efficacy against tabun
  12326. Anticonvulsant and Neuroprotective effect of (S)-3, 4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid
  12327. FGF19 exhibits Neuroprotective effects on adult mammalian photoreceptors in vitro
  12328. The Neuroprotective potential of phase II enzyme inducer on motor neuron survival in traumatic spinal cord injury in vitro
  12329. Rational design of a drug for Alzheimer’s disease with cholinesterase inhibitory and Neuroprotective activity
  12330. Neurotrophins induce Neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis nl of the anti-inflammatory and anti-apoptotic …
  12331. The multiple T-maze in vivo testing of the Neuroprotective effect of humanin analogues
  12332. Extracellular signal-regulated kinase involved in NGF/VEGF-induced Neuroprotective effect
  12333. In vitro and in vivo evidences that antioxidant action contributes to the Neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor …
  12334. Neuroprotective effects of prostaglandin A1 in rat models of permanent focal cerebral ischemia are associated with nuclear factor‐κB inhibition and peroxisome …
  12335. Neuroprotective effects of T-817MA against noise-induced hearing loss
  12336. Neuroprotective effects of erythropoietin on acute metabolic and pathological changes in experimentally induced neurotrauma
  12337. Antioxidative and Neuroprotective effects of enzymatic extracts from leaves of Perilla frutescens var. japonica
  12338. Neuroprotective features of phytoadaptogens
  12339. Flupirtine as Neuroprotective add-on therapy in autoimmune optic neuritis
  12340. Neuroprotective effects of aqueous date fruit extract on focal cerebral ischemia in rats
  12341. Molecular mechanisms of interaction between the Neuroprotective substance riluzole and GABAA-receptors
  12342. Mild systemic inflammation has a Neuroprotective effect after stroke in rats
  12343. Glutamate induces release of glutathione from cultured rat astrocytes–a possible Neuroprotective mechanism?
  12344. Neuroprotective and antiamnesic effect of donepezil, a nicotinic acetylcholine-receptor activator, on rats with concussive mild traumatic brain injury
  12345. Pramipexole has astrocyte-mediated Neuroprotective effects against lactacystin toxicity
  12346. Ethanol inhibits neuronal differentiation by disrupting activity-dependent Neuroprotective protein signaling
  12347. Small-molecule protein tyrosine phosphatase inhibition as a Neuroprotective treatment after spinal cord injury in adult rats
  12348. Frizzled‐1 is involved in the Neuroprotective effect of Wnt3a against Aβ oligomers
  12349. Neuroprotective effects of estrogens: cross-talk between estrogen and intracellular insulin signalling
  12350. … evaluation of cytoarchitectonic characteristics of prefrontal cortex pyramidal neurons, following global cerebral ischemia and Neuroprotective melatonin treatment, in …
  12351. Differential Neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury
  12352. Neuroprotective effects of memantine in a mouse model of retinal degeneration induced by rotenone
  12353. Delayed treatment of spinal cord injury with erythropoietin or darbepoetin—a lack of Neuroprotective efficacy in a contusion model of cord injury
  12354. Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is Neuroprotective in cultured hippocampal neurons
  12355. In vitro evidence for impaired Neuroprotective capacities of adult mesenchymal stem cells derived from a rat model of familial amyotrophic lateral sclerosis …
  12356. Epitope mapping and Neuroprotective properties of a human single chain FV antibody that binds an internal epitope of amyloid-beta 1-42
  12357. ANTI‐OXIDANT ACTIVITY MEDIATED Neuroprotective POTENTIAL OF TRIMETAZIDINE ON FOCAL CEREBRAL ISCHAEMIA–REPERFUSION INJURY IN …
  12358. Seladin-1 is a fundamental mediator of the Neuroprotective effects of estrogen in human neuroblast long-term cell cultures
  12359. Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain
  12360. Neuroprotective effects of serotonin 5-HT1A receptor activation against ischemic cell damage in gerbil hippocampus: Involvement of NMDA receptor NR1 subunit and …
  12361. Neuroprotective effects of breviscapine against apoptosis induced by transient focal cerebral ischaemia in rats
  12362. Therapeutic time window of flurbiprofen axetil’s Neuroprotective effect in a rat model of transient focal cerebral ischemia
  12363. 17α-Estradiol is Neuroprotective in male and female rats in a model of early brain injury
  12364. Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: Implication of ERK1/2 and PPARγ …
  12365. Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson’s disease
  12366. Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain …
  12367. Role of glycine receptors and glycine release for the Neuroprotective activity of bilobalide
  12368. Intrathecally injected granulocyte colony-stimulating factor produced Neuroprotective effects in spinal cord ischemia via the mitogen-activated protein kinase and Akt …
  12369. Neurodegeneration and Neuroprotective agents in multiple sclerosis
  12370. Dual neurotoxic and Neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation–possible role as a dependence receptor
  12371. Inducible nitric oxide synthase and estradiol exhibit complementary Neuroprotective roles after ischemic brain injury
  12372. … drugs: potential of dextromethorphan and novel Neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and Neuroprotective …
  12373. Evaluation of estrogen Neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or …
  12374. brain -regulated metabolic suppression during hibernation: a Neuroprotective mechanism for perinatal hypoxia–ischemia
  12375. A modelling approach to explore some hypotheses of the failure of Neuroprotective trials in ischemic stroke patients
  12376. Protein kinase M zeta regulation of Na/K ATPase: a persistent Neuroprotective mechanism of ischemic preconditioning in hippocampal slice cultures
  12377. Neuroprotective effect of aminoguanidine on iron-induced neurotoxicity
  12378. Pharmacological Neuroprotective therapy for acute spinal cord injury: state of the art.
  12379. Neuroprotective effect of C1-inhibitor following traumatic brain injury in mice
  12380. … mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain : Implications in the Neuroprotective therapy of Parkinson’s …
  12381. Hemostatic and Neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs
  12382. Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury
  12383. The Neuroprotective effect of antidepressant drug via inhibition of TIEG2-MAO B mediated cell death
  12384. Neuroprotective effects of the inhalational anesthetics isoflurane and xenon after cardiac arrest in pigs.
  12385. Neuroprotective effects of cactus polysaccharide on oxygen and glucose deprivation induced damage in rat brain slices
  12386. Neuroprotective effects of berberine in neurodegeneration model rats induced by ibotenic acid
  12387. Neuroprotective effects of riluzole in Huntington’s disease
  12388. Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase Neuroprotective signaling
  12389. The Neuroprotective effects of progesterone on experimental diabetic neuropathy in rats
  12390. Neurotoxic and Neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon‐α: Course and relationship with psychiatric …
  12391. VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is Neuroprotective against acute excitotoxic striatal insult
  12392. Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain
  12393. Na+/Ca2+ exchanger 2 is Neuroprotective by exporting Ca2+ during a transient focal cerebral ischemia in the mouse
  12394. Antibodies as promising novel Neuroprotective agents in the central nervous system injuries
  12395. Recombinant T-cell receptor ligands: Immunomodulatory, Neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis
  12396. Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington’s disease
  12397. Trans-activator of Transcription-mediated Delivery of NEP1-40 Protein into brain Has a Neuroprotective Effect against Focal Cerebral Ischemic Injury via Inhibition of …
  12398. Pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) co-localizes with activity-dependent Neuroprotective protein (ADNP) in the mouse …
  12399. A new Neuroprotective bakkenolide from the rhizome of Petasites tricholobus
  12400. Neuroprotective effects of apigenin on acute transient focal cerebral ischemia-reperfusion injury in rats
  12401. Expression of activity-dependent Neuroprotective protein in the brain of adult rats
  12402. Dopamine D3 receptor: A Neuroprotective treatment target in Parkinson’s disease
  12403. Translocation and Neuroprotective properties of transactivator‐of‐transcription protein‐transduction domain–neuroglobin fusion protein in primary cultured cortical …
  12404. Two new sesquiterpenoids and two new prenylated phenylpropanoids from Illicium fargesii, and Neuroprotective activity of macranthol
  12405. Neuroprotective actions of ovarian hormones without insult in the raphe region of rhesus macaques
  12406. On the pathogenesis and Neuroprotective treatment of Parkinson disease: what have we learned from the genetic forms of this disease?
  12407. Neuroprotective activities of catalpol on MPP+/MPTP-induced neurotoxicity
  12408. HYPOXIC-ISCHEMIC brain INJURY IN THE NEONATALPERIOD–CURRENT CONCEPTS, NOVEL DIAGNOSTICAPPROACHES AND Neuroprotective …
  12409. … spinal cord of moderate intensity leads to a higher time-dependent secondary neurodegeneration than severe one: An open-window for experimental Neuroprotective …
  12410. Neuroprotective effects of the novel glutamate transporter inhibitor (–)-3-hydroxy-4, 5, 6, 6a-tetrahydro-3aH-pyrrolo [3, 4-d]-isoxazole-4-carboxylic acid, which …
  12411. Regulation of activity-dependent Neuroprotective protein (ADNP) by the NO-cGMP pathway in the hippocampus during kainic acid-induced seizure
  12412. Neuroprotective effect of diazoxide on brain injury induced by cerebral ischemia/reperfusion during deep hypothermia
  12413. Neuroprotective lignans from Biota orientalis leaves
  12414. In vitro assessment of the neurotoxic and Neuroprotective effects of N-acetyl-L-cysteine (NAC) on the rat sciatic nerve fibers
  12415. Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exerts Neuroprotective effect via inhibition of neuronal apoptosis in vitro
  12416. Neuroprotective effect of erythropoietin after experimental cold injury–induced vasogenic brain edema in rats
  12417. Neuroprotective effects of ketorolac tromethamine after spinal cord injury in rats: an ultrastructural study
  12418. … OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to Neuroprotective interventions in schizophrenia
  12419. Prothymosin α plays a key role in cell death mode-switch, a new concept for Neuroprotective mechanisms in stroke
  12420. Natural host genetic resistance to lentiviral CNS disease: a Neuroprotective MHC class I allele in SIV-infected macaques
  12421. Peroxiredoxin 2 is involved in the Neuroprotective effects of PACAP in cultured cerebellar granule neurons
  12422. Estradiol attenuates Neuroprotective benefits of isoflurane preconditioning in ischemic mouse brain
  12423. Selenium compounds counteract the stimulation of ecto-nucleotidase activities in rat cultured cerebellar granule cells: putative correlation with Neuroprotective effects
  12424. A Neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine …
  12425. Neuroprotective antioxidant STAZN protects against myocardial ischemia/reperfusion injury
  12426. Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons
  12427. Neuroprotective Actions of Tannins from Myracrodruon urundeuva on 6-Hydroxydopamine-Induced Neuronal Cell Death
  12428. Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats
  12429. LAU-0901, a novel platelet-activating factor antagonist, is highly Neuroprotective in cerebral ischemia
  12430. Neuroprotective EFFECT AND REACTIVE OXYGEN SPECIES SCAVENGING CAPACITY OF MANGOSTEEN PERICARP EXTRACT IN CULTURED NEURONS.
  12431. Synergistic Neuroprotective effect via simian lentiviral vector‐mediated simultaneous gene transfer of human pigment epithelium‐derived factor and human fibroblast …
  12432. Neuroprotective effects of Ac. YVAD. cmk on experimental spinal cord injury in rats
  12433. Neuroprotective effects of resveratrol via anti-apoptosis on hypoxic-ischemic brain injury in neonatal rats
  12434. Neuroprotective activities of enzymatically hydrolyzed peptides from porcine hide gelatin
  12435. 2, 3-benzodiazepine-type AMPA receptor antagonists and their Neuroprotective effects
  12436. Ischemia‐induced ribosomal protein S3 expressional changes and the Neuroprotective effect against experimental cerebral ischemic damage
  12437. Neuroprotective effects of sinapine on PC12 cells apoptosis induced by sodium dithionite
  12438. The Neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside
  12439. Neuroprotective EFFECTS OF A SELECTIVE N‐METHYL‐d‐ASPARTATE NR2B RECEPTOR ANTAGONIST IN THE 6‐HYDROXYDOPAMINE RAT MODEL …
  12440. Neuroprotective effect of melatonin on glucocorticoid toxicity in the rat hippocampus
  12441. Profound hypothermia determines the anticonvulsant and Neuroprotective effects of swim stress
  12442. … noncompetitive AMPAR antagonists: Identification of the 1-(4-amino-3-methylphenyl)-3, 5-dihydro-7, 8-ethylenedioxy-4H-2, 3-benzodiazepin-4-one as Neuroprotective …
  12443. Recombinant human erythropoietin as a Neuroprotective therapy in brain ischemia
  12444. Neuroprotective effect of propofol: a study progress [J]
  12445. Late expression of Na+/H+ exchanger 1 (NHE1) and Neuroprotective effects of NHE inhibitor in the gerbil hippocampal CA1 region induced by transient ischemia
  12446. The nitrone free radical scavenger NXY-059 is Neuroprotective when administered after traumatic brain injury in the rat
  12447. Galanin in Alzheimer’s disease: neuroinhibitory or Neuroprotective ?
  12448. Hormonal mechanisms of Neuroprotective effects of the mild hypoxic preconditioning in rats
  12449. Neuroprotective use of mild hypothermia in patients with severe vasospasms after subarachnoid haemorrhage
  12450. A novel Neuroprotective role of a small peptide from flesh fly, 5-S-GAD in the rat retina in vivo
  12451. Investigating the potential Neuroprotective effects of statins on DNA damage in mouse striatum
  12452. The Neuroprotective effect of PACAP, VIP, and derivatives in brain ischemia
  12453. Stratification of patients is the way to go to develop Neuroprotective /disease-modifying drugs for Alzheimer’s disease
  12454. Inhibition of ATF‐3 expression by B‐Raf mediates the Neuroprotective action of GW5074
  12455. Neuroprotective effect of ultra-high dose of methylcobalamin in models of mononeuropathy in rats
  12456. Neuroprotective Effects of Amiloride
  12457. AL-108 and AL-208, formulations of the Neuroprotective NAP fragment of activity-dependent Neuroprotective protein, for cognitive disorders.
  12458. Synthesis and structure-activity relationship studies of 3-substituted indolin-2-ones as effective Neuroprotective agents
  12459. Neuroprotective effects of sodium orthovanadate after hypoxic-ischemic brain injury in neonatal rats
  12460. Neuroprotective gene profile in the brain of magnesium-deficient mice
  12461. Neuroprotective effects of combined application of JAK-STAT signal pathway inhibitor and free radical scavenger on focal cerebral ischemia/reperfusion injury in rats
  12462. Neuroprotective effects of topiramate and folic acid on young rats with kindling-induced epilepsy
  12463. Neuroprotective effects of water extracts of American Ginseng on SH-SY5Y cells apoptosis induced by Abeta25-35
  12464. Neuroprotective effect of epigallocatechin gallate on oxidative-stress-injured retinal cells
  12465. Neuroprotective therapy for ischemic stroke with free radical scavenger and gene-stem cell therapy
  12466. Antioxidant and Neuroprotective effects of Perilla frutescens var. japonica leaves
  12467. Mitochondria, oxidative stress and PARP-1 network: a new target for Neuroprotective effects of tetracyclines?
  12468. The many faces of erythropoietin: from erythropoiesis to a rational Neuroprotective strategy
  12469. Neuroprotective effect of afobazole on rats with bilateral local photothrombosis of vessels in the prefrontal cortex
  12470. Neuroprotective effects of lithium relevant to its therapeutic actions
  12471. Anti-apoptotic and Neuroprotective Effects of Gastrodiae Elata Pharmacupuncture at on Focal brain Ischemic Injury Induced by Intraluminal Filament Insertion in …
  12472. A potential Neuroprotective and synaptic plasticity mechanism induced by estradiol through PI3K/GSK3beta in cerebral ischaemia
  12473. Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice
  12474. Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia
  12475. Neuroprotective effects and physicochemical characteristics of milk fortified with fibroin BF-7
  12476. The hypoxic transcriptome of the retina: identification of factors with potential Neuroprotective activity
  12477. Neuroprotective effects of ferulic acid against glutamate-induced neurotoxicity in pc12 cells
  12478. Exercise as a Neuroprotective mechanism in parkinson’s disease: future treatment potential?
  12479. Neuroprotective effects of Sesame seed on in vitro and in vivo ischemia models
  12480. Neuroprotective effect of citicoline on dopaminergic neuron injury induced by MPP+ in mouse mesencephalic dissociated culture
  12481. A comparison of the Neuroprotective efficacy of newly developed oximes (K156, K203) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned …
  12482. Neuroprotective effect of Hwangryunhaedok-tang against glucose-deprivation induced cytotoxicity in PC-12 Cells
  12483. The selective oestrogen receptor modulator, LY362321, is not Neuroprotective in a rat model of transient focal ischaemia
  12484. Neuroprotective and metabolic effects of micro-and nanomolar concentrations of the GM1 Ganglioside on PC12 cells under oxidative stress conditions
  12485. Development of new stroke therapies: outlook for Neuroprotective drugs
  12486. Resuscitation with 21 or 100% oxygen in hypoxic nicotine-pretreated newborn piglets: possible Neuroprotective effects of nicotine
  12487. Neuroprotective effects of alpha7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer’s disease
  12488. The Neuroprotective Effect of Tanshinone ⅡA on Cerebral Ischemic Reperfusion Injury in Rats and its Mechanism [J]
  12489. Neuroprotective effect of the roots of Polygonum cuspidatum on transient focal cerebral ischemia in rats
  12490. Neuroprotective effects of oral lamotrigine administration on rabbit retinas after pars plana vitrectomy and silicone oil injection
  12491. Neuroprotective Efects of Gagam-ChongMeong-Tang on cognitive Function after Ischemic brain Injury in Rats
  12492. The Neuroprotective effect by single intracisternal injection of erythropoietin on a rabbit model of subarachnoid hemorrhage
  12493. Neuroprotective effect of the systemic delivery of (-) nicotine in hemiparkinsonian rats
  12494. The many faces of erythropoietin: from erythropoiesis to a rational Neuroprotective strategy–correspondence
  12495. Both mild hypothermia and dopamine D2 agonist are Neuroprotective against hyperthermia-induced injury in PC12 cells
  12496. Neuroprotective effects of geneticin (G418) via apoptosis in perinatal hypoxic-ischemic brain injury
  12497. Neuroprotective effects of Sopung-tang (Shufeng-tang) on cognition and motor function recovery after ischemic brain injury in rats
  12498. Is good old minocycline a new Neuroprotective drug?
  12499. Neuroprotective effect of polysaccharides from Erjingling prescription on hippocampal neuron apoptosis induced by glutamate
  12500. Neuroprotective effects of inflammation in the nervous system
  12501. Neuroprotective effects of TSG on Degeneration of Nigral Dopaminergic Neurons Induced by Paraquat and Maneb in Mice [J]
  12502. Neuroprotective effect of preconditioning with cannabinoid receptor agonist WIN 55, 212-2 on focal cerebral ischemia: experiment with rats
  12503. Neuroprotective Effects of Apigenin on Acute Transient Focal Cerebral Ischemia-reperfusion Injury in Rats [J]
  12504. Adenovirus-mediated VEGF165 gene transfer has Neuroprotective effects in neonatal rats following hypoxic-ischemic brain damage
  12505. Approaches to Neuroprotective and reperfusion injury therapy
  12506. Neuroprotective effect of topiramate in the experimental model of febrile seizures
  12507. THERAPITIC AND Neuroprotective EFFECT OF ELECTRIC ACUPUNCTURE ON ACUTE CEREBRAL ISCHEMIA IN RATS [J]
  12508. Evaluation of the Neuroprotective role of Garlic (Allium sativum) extract and Methionine on mercury induced toxicity-an in vitro study.
  12509. 26 Tocotrienols as Natural Neuroprotective Vitamins
  12510. Neuroprotective effects of the edaravone in rats with traumatic brain injury
  12511. Neuroprotective effect of deep hypothermic circulatory arrest with low priming volume: study in a rabbit model
  12512. Syntheses of DMVD and DMVD-fmk Derivatives and Evaluation of their Neuroprotective Effects as Caspase Inhibitors
  12513. CE study of Neuroprotective humanin peptide and its derivatives: Interactions with phosphate, sulphate, alkylsulphonates and sulphated‐β‐CD
  12514. Neuroprotective Effects of Acetylsalicylic Acid in Middle Cerebral Artery Occlusion–Induced brain Ischemia in Rats: Suppression of iNOS, HIF-1α, TNF-α, and Active …
  12515. Neuroprotective effects of water extracts of Red Ginseng on SH-SY5Y cells apoptosis induced by Aβ_ (25-35)[J]
  12516. Neuroprotection Against Neurodegenerative Diseases: Development of a Novel Hybrid Neuroprotective Peptide Colivelin
  12517. Neuroprotective Effect of Ischemic Preprocessing and Postprocessing [J]
  12518. Pharmacokinetics and brain uptake of AM‐36, a novel Neuroprotective agent, following intravenous administration to rats
  12519. The Neuroprotective effect of transforming growth factor-beta1 via anti-apoptosis on hypoxic-ischemic brain injury in neonatal rats
  12520. Anti-apoptotic and Neuroprotective effects of acupuncture techniques of tonification or sedation at HT9? LR1, HT3? KI10 on focal brain ischemic injury induced …
  12521. Elucidating the Neuroprotective role of teneurin C-terminal associated peptide (TCAP)-1
  12522. Neuroprotective effect of qingnao capsule on thrombus formation in rabbits
  12523. Prophylactic Neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of …
  12524. Neuroprotective and pro-apoptotic responses of ubiquitin proteasome system
  12525. Neuroprotective Effect of the Ketone Bodies Acetoacetate and β-hydroxybutyrate on Retinal Ganglion Cells in a Rat Model of NMDA Toxicity
  12526. Multimechanistic Neuroprotective effect of vitamin E
  12527. The Neuroprotective effects of MK-801 on Aβ42 transgenic drosophila model of Alzheimer’s disease
  12528. Neuroprotective effect of rhEPO on facial motoneurons after facial nerve injury in rats
  12529. Neuroprotective effect of phenytoin and hypothermia on a spinal cord ischemic injury model in rabbits
  12530. Neuroprotective effects of vitamin C
  12531. Advances in Neuroprotective Effects of Estrogen
  12532. Neuroprotective effect of cannabinoid receptor agonist WIN 55,212-2 on focal cerebral ischemia in rats [J]
  12533. Improving Blood brain Barrier Permeation of Small Molecules Exhibiting Chemotherapeutic and Neuroprotective Effects
  12534. Understanding the mechanism of retinal detachment-induced photoreceptor apoptosis: Neuroprotective treatments for photoreceptor apoptosis
  12535. Neuroprotective effect of genistein in 6-hydroxydopamine hemi-Parkinsonian rat model
  12536. Neuroprotective Features Of Hsp90 Inhibitors Exhibiting Anti-Inflammatory Actions: Implications For Multiple Sclerosis
  12537. Neuroprotective effects of plant extracts from Baekdu mountain on glutamate-induced cytotoxicity in HT22 cells
  12538. Neuroprotective Effects of Copper against Apoptosis Induced by Low Potassium in Cultured Rat Cerebellar Granule Neurons
  12539. The individual and combined Neuroprotective effects of propofol and ketamine on rat mixed cortical cultures exposed to oxygen-glucose deprivation-reperfusion injury.
  12540. Neuroprotective activity of mexidole and 3-hydroxypyridine acetylcysteinate against the background of cerebral ischemia in the complex of experimental diabetes …
  12541. Neuroprotective Effect of Green Tea Polyphenol, EGCG in Animal Model of Parkinson’s Disease
  12542. Neuroprotective Effect of Thioredoxin Overexpression on Retinal Ganglion Cells After Optic Nerve Transection
  12543. EXISTING IMMUNOMODULATORY THERAPY AND POTENTIAL Neuroprotective ROLES.
  12544. Why Neuroprotective Therapies That Work in Laboratories Fail in Clinical Trials
  12545. Neuroprotective effects of an extract from the inflamed skin of rabbits inoculated with vaccinia virus on glutamate-induced neurotoxicity in cultured neuronal cell line
  12546. Research Status of Neuroprotective therapy for Cerebral Ischemia
  12547. Erythropoietin: a new Neuroprotective agent
  12548. Neuroprotective effects of subthalamic nucleus high-frequency stimulation on substantia nigra neurons in a Parkinson’s disease rat model*☆◇
  12549. The Ocular Hypotensive and Neuroprotective Effects of Propentofylline
  12550. Neuroprotective therapies for CNS injuries
  12551. Preclinical quantitative microPET images in evaluation of Neuroprotective drug candidates
  12552. Neuroprotective Trials: No Longer a Cautious Optimism
  12553. Neuroprotective Signaling Pathways in Glaucoma
  12554. Neuroprotective effect and mechanism of estrogen on H_2O_2-induced oxidative stress
  12555. Neuroprotective signaling mechanisms in the mammalian brain
  12556. Newly Identified Genetic Allele Seems to Be Neuroprotective Against MS
  12557. Evaluation of Neuroprotective effect of Slimaluma in cerebral ischemia reperfusion injury in rats
  12558. Mechanism Study of Neuroprotective Effect of Ischemic Preconditioning
  12559. CHAPTER III: Neuroprotective EFFECT OF PKCδ INHIBITOR
  12560. Improvement of memory Impairment by Ltheanine through its Anti-oxidant and Neuroprotective Effect
  12561. Neuroprotective Effect of Benzylideneacetophenone Derivative on the MPTP Model of Neurodegeneratione in Mic
  12562. Uric acid: Neuroprotective or neurotoxic?[reply]
  12563. Neuroprotective Mechanism of Statins in Models of Ischemic Stroke [J]
  12564. Transfection of a neuronal cell line with the Wlds gene to further study its Neuroprotective phenotype
  12565. Therapy of Stroke with Novel Neuroprotective and Anti-inflammatory agents
  12566. Neuroprotective effects of K252a in Aβ_ (25-35)-induced learning and memory impairments in mice
  12567. Neuroprotective effects of propofol in a model of traumatic brain injury: 9AP6-7
  12568. The Neuroprotective Effect of CoEnzymeQ10 in Experimental Glaucoma is Mediated Through Mitochondrial Mechanisms
  12569. Activated Microglia are Neuroprotective Following ET-1 Mediated RGC Death
  12570. EMERGING TREATMENTS ON THE HORIZON: ANTI-INFLAMMATORY AND Neuroprotective THERAPIES FOR MS.
  12571. From bench to bedside: Neuroprotective effects of erythropoietin
  12572. TOPIC: progesterone exert Neuroprotective and myelinating effects on the nervous system
  12573. The kinetics of Neuroprotective tumor necrosis factor TNF-α molecular signaling
  12574. Neuroprotective Effects of SP-8203 in Ischemic brain Injury
  12575. Estrogen Replacement Therapy Found Neuroprotective for Dementia
  12576. Spinal Cord Injury: Advances Reported for Neuroprotective Strategies and Immune Approaches to Repair
  12577. In-vitro Neuroprotective activity of Cynomorium songaricum extracts
  12578. Analysis of Neuroprotective effects of valproic acid and the analogues in motor neurons
  12579. Identification of Mueller Glia-Derived Paracrine Neuroprotective Proteins
  12580. COIN TRIAL: THE GREEK EXPERIENCE. NCPAP VERSUS IPPV FOR PRETERM NEONATES: IS NCPAP Neuroprotective ?
  12581. Tumor Necrosis Factor Dependent Mechanisms and Neuroprotective Strategies in Models of Parkinson’s Disease
  12582. Neuroprotective Roles of Lutein in Endotoxin-Induced Uveitis
  12583. Neuroprotective effect of sodium ferulate and signal transduction mechanisms in the aged rat hippocampus1
  12584. The Neuroprotective effect of quercetin against alcohol toxicity
  12585. Valproic Acid Is Neuroprotective in Mouse Model of Alzheimer Disease
  12586. The Neuroprotective effects of genistein on dopaminergic neurons of rats in vitro
  12587. Amiloride is not Neuroprotective when given after perinatal hypoxic ischaemia
  12588. Neuroprotective Effects of Trophic Factors and Natural Products: Involvement of Multiple Intracellular Kinases
  12589. Neuroprotective effect of estrogen on hypoglycemic injury in hypothalamic cells
  12590. Are NSAIDs Neuroprotective for Dementia and Parkinson Disease? What the Latest Data Suggest
  12591. Neuroprotective effect of mesenchymal stem cells in neurodegenerative disease: focusing on Parkinsonian disease
  12592. Neuroprotective Effect of Baicalein on H_2O_2-induced PC12 Injury
  12593. Neuroprotective effects of hibernating woodchuck plasma and plasma fractions
  12594. Influence of applied times of Batroxobin on Neuroprotective effects in cerebral ischemic-reperfusion injury gerbils
  12595. Synthesis, Neuroprotective Effect and Modeling Study of Chalcone Derivatives
  12596. Neuroprotective Effects of Extracts of Guiling Pill on Ischemic-Reperfusion Induced brain Injury
  12597. Evaluation of Aged Garlic Extract Neuroprotective Effect in a Focal Model of Cerebral Ischemia
  12598. Defining the molecular tipping points between Neuroprotective and neurodestructive responses in microglia
  12599. Neuroprotective effects of acetaminophen in a rat model of cerebral ischemia/reperfusion
  12600. Neuroprotective effect of ciliary neurotrophic factor on rats with cerebral hemorrhage
  12601. Towards a representative in vitro model for testing putative Neuroprotective drugs in stroke: dissecting factors that govern the selectivity and time cource of OGD …
  12602. Endogenous Neuroprotective protein to protect cell death under ischemia
  12603. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain damage in neonatal rats
  12604. Neuroprotective Properties of Erythropoietin in the Rats with Epilepsy Compared with Topiramate
  12605. Neuroprotective Constituents of Dictamnus dasycarpus Root Bark
  12606. Expression, Purification and Characterization of [Gly14]-Humanin, a Novel Neuroprotective Peptide
  12607. Assessing viral vectors as gene therapy agents and the study of Neuroprotective effects of HSP70
  12608. Perinatal asphyxia and intervention: possible Neuroprotective effects of intravenous nicotine administration.
  12609. Neuroprotective Effect of Keamferia parviflora to Protect Against Alzheimer’s Disease Model in Rats
  12610. Antibody Production: Activity-Dependent Neuroprotective Protein (ADNP) as an Example
  12611. Pll Radical Scavenging and Neuroprotective Activities from Extracts of Centella asiatica
  12612. Neuroprotective benefit in a neurorestorative treatment of embolic stroke with EPO in rats detected by MRI
  12613. Neuroprotective effect of aspirin preconditioning on cerebral ischemia reperfusion injury in Sprague-Dawley rats [J]
  12614. Neuroprotective efficacy of estrogen in acute and chronic spinal cord injury in rats
  12615. A research on neuron protective effect of lentivirus Neuroprotective peptid to Alzheimer’s disease mice in the hippocampus
  12616. Neuroprotective Lignans from Biota orientalis Leaves
  12617. Inflammation and Neuroprotective strategies in the immature brain after hypoxic-ischemic brain injury
  12618. Flavonoids and Neuroprotection : biochemical and population-based analyses of potential Neuroprotective factors related to dementia.
  12619. Influence of NF-kBmRNA expressing and praxiology of Alzheimer’s disease mice in the hippocampus by lentivirus Neuroprotective peptid
  12620. Study on the Neuroprotective Effects of Ethyl pyurvate in MPTP-induced Mouse PD Models
  12621. Transcription Factor Max Is Neuroprotective for Retinal Ganglion Cells: On the Road to Gene Therapy for Glaucoma
  12622. Neuroprotective effect of epigallocatechin gallate against glutamate toxicity
  12623. Neuroprotective Effect of Grape Seed Extract in Rat Retinal Ganglion Cell line
  12624. In vivo imaging of microglia reveals a prominent Neuroprotective role in Alzheimer’s disease
  12625. Anti-diabetic and Neuroprotective activities of phytochemicals in traditionally used boreal plants
  12626. Neuroprotective Effects of GMHOIO in Primary Rat Mesencephalic Dopaminergic Neurons
  12627. Neuroprotective effect of estrogens and its mechanism in reproductively senescent female rats with cerebral Ischemia
  12628. Neuroprotective Effects of Edaravone on Rat Middle Cerebral Artery Occlusion and Reperfusion Model
  12629. Neuroprotective Effect of Naloxone in Inflammation-Mediated Dopaminergic Neurodegeneration
  12630. Neuroprotective Effects of Banryong-hwan in Primary Rat Mesencephalic Dopaminergic Neurons
  12631. Experiment Study of Neuroprotective Effect of Mannitol Combined with Nimodipine and Dexamethasone on Acute Cerebral Ischemia [J]
  12632. Neuroprotective Effect of Phase II Enzyme Inducer CPDT on the Selective Motor Neuron Injury and Possible Mechanisms
  12633. The Neuroprotective Role of Hyperbaric Oxygen Chamber Therapy in Ischemic Optic Neuropathy in a Murine Model
  12634. What is the pathway by which estrogen promotes the Neuroprotective effect on hypoglycemic injury in hypothalamic cell lines?
  12635. Antioxidative Activity and Neuroprotective Effect from Various Enzymatic Hydrolysates of Hericium Erinacium
  12636. LONG-TERM BEHAVIORAL OUTCOME AND Neuroprotective EFFECT OF CREATINE AFTER CEREBRAL HYPOXIA ISCHEMIA IN NEONATAL RATS
  12637. Neuroprotective properties of xenon and helium in an in vitro model of traumatic brain injury: One small step or one big jump?
  12638. The Neuroprotective Role of brain -derived Neurotrophic Factor for Embryonic Rat Cortical Neurons Against Hypoxia Via CREB Phosphorylation
  12639. Binding of novel rapamycin analogs to calcium channels and FKBP52 contributes to their Neuroprotective activities
  12640. Neuroprotective effect and expression changes nitric oxide synthase of estrogens in reproductively senescent female rats with cerebral Ischemia
  12641. Neuroprotective effect of BNP7787 on taxane/platinum-induced neurite toxicity in a PC12 cell model and the mode of action
  12642. Neuroprotective Effects of CBNU06 against Beta-Amyloid-Induced Toxicity through the Inhibition of NF-kB Signaling Pathway in PC 12 Cells
  12643. Neuroprotective Effects of Scrophulariae Radix on Cerebral Ischemia in Mongolian Gerbils
  12644. Intermittent high glucose concentrations reduce neuronal precursor proliferation by altering the IGF system: the involvement of the Neuroprotective factor seladin-1
  12645. Neuroprotective Effects of Small Interfering RNA Targeted Against Caspase3 or Caspase9 on Rat Retinal Damage Induced by Transient Ischemia Injury
  12646. Minocycline Is Neuroprotective in Glaucoma and Optic Nerve Transection by Affecting Inflammatory Genes and the Bcl-2 Family Expression
  12647. Neuroprotective Effects of Sulforaphane Against a-Amyloid-Induced Cell Death and memory Impairments
  12648. Neuroprotective effects of pyruvate and piroxicam in animals treated with 1‐methyl‐4‐phenyl‐1, 2, 3, 6 tetrahydropyridine (MPTP)
  12649. How can Neuroprotective drugs (FK506 and CSA) affect epileptogenesis and susceptibility to status epilepticus in the normal and pathological brain ?
  12650. Neuroprotective Effects of a Purinergic Receptor Antagonist in the rd1 Mouse Model of Retinal Degeneration
  12651. Neuroprotective effects of Neprilysin on neuronal apoptosis induced by Amyloid-beta peptide
  12652. Neuroprotective and Neurotoxic Properties of α-Synuclein in Cell Culture Models of Dopaminergic Degeneration
  12653. Cerebral MR Spectroscopy Evaluation of the Neuroprotective Effects of Lithium and Olanzapine in Bipolar Affective Disorder Patients
  12654. Neuroprotective effect of post ischemic treatment of acetylsalicylic acid on CA1 hippocampus neuron and spatial learning in transient MCA occlusion in rat
  12655. OXIDATION/GLUCURONIDATION OF A NOVEL Neuroprotective AGENT T-817MA IN HUMAN AND MONKEY LIVER MICROSOMES AND HEPATOCYTES
  12656. Neuroprotective Effects of Licochalcone E from Glycyrrhiza Inflata Involves Anti-inflammatory and Anti-Oxidative Activity
  12657. Intracerebroventricular administration of adenosine A1 receptor antisense oligodeoxynucleotide inhibites the Neuroprotective effect of the cerebral ischemic …
  12658. … amyloid toxicity induced by a single icv injection of Aβ (25–35) on cerebral inflammation, hippocampic cellular death and Neuroprotective molecule expression (BDNF …
  12659. Enhanced Insulin Receptor Activated Neuroprotective Survival Signal in Mice Lacking the Protein Tyrosine Phosphatase-1B Gene in Rod Photoreceptor Cells
  12660. Neuroprotective effects of recombinant human erythropoietin on facial motoneurons after facial nerve injury in rats★
  12661. A Novel Neuroprotective Effect of Naloxone in Light-Induced Photoreceptor Degeneration Through Inhibiting Activation of Retinal Microglia
  12662. The central histaminergic neurons in vitro, and their Neuroprotective role in excitotoxic cell death in the postnatal rat hippocampus.
  12663. Caveolin‐1 knockout mice are resistant to the Neuroprotective effect of ischemic preconditioning
  12664. Erythropoietin, a Neuroprotective & Pro-Angiogenic Cytokine, and Its Receptors Are Elevated in the Neuroglial Retina Prior to Neovascularization in the …
  12665. N-methyl-D-aspartate (NMDA) and sigma receptor antagonism as Neuroprotective strategy for polycyclic amines
  12666. A Decrease of Neuroprotective effect of ganglioside GM1 on PC12 cells under conditions of oxidative stress in the presence of inhibitor of tyrosine kinase of Trk …
  12667. Neuroprotective Effects of Methanol Extract of Sophorae Subprostratae Radix on Glutamate Excitotoxicity in PC12 Cells and Organotypic Hippocampal Slice Cultures
  12668. … in 6-hydroxydopamine model of Parkinson’s disease and its modulation by Peroxisome Proliferator Activated receptor gamma (PPAR-γ) agonist as a Neuroprotective …
  12669. Therapeutic Targeting of Phosphodiesterase 4 with Rolipram as an Acute Neuroprotective Strategy following Spinal Cord Injury
  12670. Combination of hyperbaric oxygenation and selective JNK-inhibition by D-JNK-I-1 as a potent Neuroprotective strategy in a focal ischaemia/reperfusion injury model in …
  12671. Neuroimmunology and the Pathogenesis of HIV‐1 Encephalitis in the HAART Era: Implications for Neuroprotective Treatment
  12672. … BARRIER OF TANSHINONE IIA: A NOVEL EXPLANATION FOR THE PARADOX OF ITS POOR brain DISTRIBUTION AND POWERFUL Neuroprotective …
  12673. Transient receptor potential vanilloid 1 exhibits Neuroprotective effects in LPS-induced dopaminergic neuronal death in the suabstantia nigra in vivo.
  12674. Frizzled‐1 is involved in the Neuroprotective effect of Wnt3a against Aβ oligomers
  12675. β-amyloid monomers are Neuroprotective
  12676. Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects
  12677. Coupling of the NMDA receptor to Neuroprotective and neurodestructive events
  12678. Neuroprotective role of lactate after cerebral ischemia
  12679. The Neuroprotective mechanism of brain ischemic preconditioning
  12680. Neuroprotective actions of brain aromatase
  12681. Neuroprotective actions of sex steroids in Parkinson’s disease
  12682. Neuroprotective effects of estrogens following ischemic stroke
  12683. Neuroprotective effects of brain -derived neurotrophic factor in rodent and primate models of Alzheimer’s disease
  12684. Ischemic tolerance: the mechanisms of Neuroprotective strategy
  12685. Neuroprotective effect of volatile anesthetic agents : molecular mechanisms
  12686. Neuroprotective and neurological properties of Melissa officinalis
  12687. Inhibition of NADPH oxidase is Neuroprotective after ischemia—reperfusion
  12688. Erythropoietin: a multimodal Neuroprotective agent
  12689. Pharmacomimetics of exercise: novel approaches for hippocampally-targeted Neuroprotective agents
  12690. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo
  12691. The Neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
  12692. The neurotrophic and Neuroprotective effects of psychotropic agents
  12693. Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads
  12694. Erythropoietin as a Neuroprotective agent in traumatic brain injury
  12695. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke
  12696. Insulin-like growth factor I: a potential Neuroprotective compound for the treatment of acute ischemic stroke?
  12697. Neuroprotective effects of hydrogen saline in neonatal hypoxia–ischemia rat model
  12698. Progesterone as a Neuroprotective factor in traumatic and ischemic brain injury
  12699. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti‐inflammatory action
  12700. Neuroprotective versus tumorigenic protein kinase C activators
  12701. Hyperbaric oxygen therapy and cerebral ischemia: Neuroprotective mechanisms
  12702. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation
  12703. Triggering endogenous Neuroprotective processes through exercise in models of dopamine deficiency
  12704. Neuroprotective actions of selective estrogen receptor modulators
  12705. Astrocytes produce the antiinflammatory and Neuroprotective agent hydrogen sulfide
  12706. An in vitro screening cascade to identify Neuroprotective antioxidants in ALS
  12707. Methodological quality of animal studies of Neuroprotective agents currently in phase II/III acute ischemic stroke trials
  12708. Antioxidant and Neuroprotective activities of Mogami-benibana (safflower, Carthamus tinctorius Linne)
  12709. Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties
  12710. Antiamnesic and Neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid β 25–35-induced toxicity in mice
  12711. Mechanism of Neuroprotective function of taurine
  12712. Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid
  12713. Adipose stromal cells-secreted Neuroprotective media against neuronal apoptosis
  12714. Experimental and clinical evidence for brimonidine as an optic nerve and retinal Neuroprotective agent: an evidence-based review
  12715. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer’s disease
  12716. The Neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage
  12717. Is oestrogen Neuroprotective ?
  12718. Resveratrol exerts its Neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia
  12719. Neuroprotective role of erythropoietin by antiapoptosis in the retina
  12720. Comparative Neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury
  12721. Neuroprotective role of haptoglobin after intracerebral hemorrhage
  12722. Modulation of brain -derived neurotrophic factor as a potential Neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model
  12723. Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain
  12724. Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson’s disease
  12725. Is progesterone a candidate Neuroprotective factor for treatment following ischemic stroke?
  12726. The Neuroprotective effect of dental pulp cells in models of Alzheimer’s and Parkinson’s disease
  12727. Neuroprotective and neurotoxic effects of nicotine
  12728. Neuroprotective effect of cocoa flavonids on in vitro oxidative stress
  12729. Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1
  12730. Multifunctional Neuroprotective derivatives of rasagiline as anti-Alzheimer’s disease drugs
  12731. Combination therapy with Coenzyme Q10 and creatine produces additive Neuroprotective effects in models of Parkinson’s and Huntington’s Diseases
  12732. Novel Neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial …
  12733. Baicalein exerts Neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro
  12734. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture
  12735. Secondary retinal ganglion cell death and the Neuroprotective effects of the calcium channel blocker lomerizine
  12736. Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats
  12737. Procognitive and Neuroprotective activity of a novel α7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders
  12738. Umbilical cord blood mesenchymal stromal cells are Neuroprotective and promote regeneration in a rat optic tract model
  12739. Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons
  12740. GOSPEL: a Neuroprotective protein that binds to GAPDH upon S-nitrosylation
  12741. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer’s disease
  12742. Neuroprotective actions of androgens on motoneurons
  12743. Neuroprotective effects of Withania somnifera dunal.: a possible mechanism
  12744. Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia
  12745. Modulation of cannabinoid receptor activation as a Neuroprotective strategy for EAE and stroke
  12746. Microglial CB2 cannabinoid receptors are Neuroprotective in Huntington’s disease excitotoxicity
  12747. Design and synthesis of novel Neuroprotective 1, 2-dithiolane/chroman hybrids
  12748. Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are Neuroprotective in experimental models of ischemic injury
  12749. Induction of Nrf2 and xCT are involved in the action of the Neuroprotective antibiotic ceftriaxone in vitro
  12750. Neuroprotective Effects of (−)-Epigallocatechin-3-gallate on Aging Mice Induced by D-Galactose
  12751. Neuroprotective effects of a ligand of translocator protein-18kDa (Ro5-4864) in experimental diabetic neuropathy
  12752. Soy phytoestrogens are Neuroprotective against stroke-like injury in vitro
  12753. Non-nuclear WldS determines its Neuroprotective efficacy for axons and synapses in vivo
  12754. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice
  12755. Nicotine is Neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys
  12756. Clovamide and rosmarinic acid induce Neuroprotective effects in in vitro models of neuronal death
  12757. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation
  12758. Bilberry and its main constituents have Neuroprotective effects against retinal neuronal damage in vitro and in vivo
  12759. Neuroprotective effects of donepezil through inhibition of GSK‐3 activity in amyloid‐β‐induced neuronal cell death
  12760. Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers
  12761. Neuroprotective effects of Centella asiatica against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress
  12762. Novel dehydroepiandrosterone derivatives with antiapoptotic, Neuroprotective activity
  12763. Minocycline: A Neuroprotective agent for hypoxic‐ischemic brain injury in the neonate?
  12764. Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke
  12765. Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity
  12766. Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor …
  12767. Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice
  12768. Progesterone exerts Neuroprotective effects by inhibiting inflammatory response after stroke
  12769. Neuroprotective roles and mechanisms of neuroglobin
  12770. Tacrine–melatonin hybrids as multifunctional agents for Alzheimer’s disease, with cholinergic, antioxidant, and Neuroprotective properties
  12771. ROS scavenging capacity and Neuroprotective effect of α-mangostin against 3-nitropropionic acid in cerebellar granule neurons
  12772. Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for Neuroprotective and neurotoxic effects
  12773. Docosahexaenoic acid (DHA) has Neuroprotective effects against oxidative stress in retinal ganglion cells
  12774. Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster
  12775. The α-secretase-derived N-terminal product of cellular prion, N1, displays Neuroprotective function in vitro and in vivo
  12776. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a Neuroprotective peptide
  12777. Neuroprotective effect of genistein in 6‐hydroxydopamine hemi‐parkinsonian rat model
  12778. The Neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic
  12779. Site-activated multifunctional chelator with acetylcholinesterase and Neuroprotective − neurorestorative moieties for Alzheimer’s therapy
  12780. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better Neuroprotective effects of allopregnanolone over progesterone
  12781. Neuroprotective and neuritogenic activities of novel multimodal iron‐chelating drugs in motor‐neuron‐like NSC‐34 cells and transgenic mouse model of amyotrophic …
  12782. Neuroprotective effects of a standardized flavonoid extract from Diospyros kaki leaves
  12783. Combined Neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia
  12784. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription
  12785. Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line
  12786. Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more Neuroprotective than green coffees
  12787. Magnesium chloride in a polyethylene glycol formulation as a Neuroprotective therapy for acute spinal cord injury: preclinical refinement and optimization
  12788. Asiatic acid, a pentacyclic triterpene from Centella asiatica, is Neuroprotective in a mouse model of focal cerebral ischemia
  12789. The Neuroprotective effects of the seeds of Cassia obtusifolia on transient cerebral global ischemia in mice
  12790. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats
  12791. Assessment of symptomatic and Neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson’s disease
  12792. Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-β (25–35)
  12793. Chemical constituents isolated from Paeonia lactiflora roots and their Neuroprotective activity against oxidative stress in vitro
  12794. Neuroprotective effects of inositol 1, 4, 5-trisphosphate receptor C-terminal fragment in a Huntington’s disease mouse model
  12795. Neuroprotective effect of transcorneal electrical stimulation on light-induced photoreceptor degeneration
  12796. Lenalidomide (Revlimid®) administration at symptom onset is Neuroprotective in a mouse model of amyotrophic lateral sclerosis
  12797. Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in Neuroprotective autophagy activation
  12798. Doxycycline is Neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3
  12799. Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4
  12800. Synergistic Neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage
  12801. Synthesis of novel trans-stilbene derivatives and evaluation of their potent antioxidant and Neuroprotective effects
  12802. Estradiol: a hormone with diverse and contradictory Neuroprotective actions
  12803. Histone deacetylase inhibitor ITF2357 is Neuroprotective , improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury
  12804. Dose-related Neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis
  12805. Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially Neuroprotective compound
  12806. Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells
  12807. Neuroprotective and antioxidative effect of cactus polysaccharides in vivo and in vitro
  12808. Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo
  12809. Neuroinflammation and Neuroprotective strategies in acute ischaemic stroke-from bench to bedside
  12810. Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease
  12811. Oxadiazolylindazole sodium channel modulators are Neuroprotective toward hippocampal neurones
  12812. Neuropeptide Y fragments derived from neprilysin processing are Neuroprotective in a transgenic model of Alzheimer’s disease
  12813. Neuroprotective evaluation of extract of ginger (Zingiber officinale) root in monosodium glutamate-induced toxicity in different brain areas male albino rats.
  12814. FOXO3a is broadly Neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases
  12815. The differences in Neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain -derived neurotrophic factor …
  12816. Neuroprotective effects of glycyrrhizic acid and 18β-glycyrrhetinic acid in PC12 cells via modulation of the PI3K/Akt pathway
  12817. A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor β-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo
  12818. Antioxidative and anti‐inflammatory Neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells
  12819. Neuroprotective role of curcumin in the cerebellum of streptozotocin-induced diabetic rats
  12820. Alloxan diabetes-induced oxidative stress and impairment of oxidative defense system in rat brain : Neuroprotective effects of cichorium intybus
  12821. Hyperoxia-induced neurodegeneration as a tool to identify Neuroprotective genes in Drosophila melanogaster
  12822. Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats
  12823. Neuroprotective action of genipin on tunicamycin-induced cytotoxicity in neuro2a cells
  12824. The Neuroprotective effect of bone marrow stem cells is not dependent on direct cell contact with hypoxic injured tissue
  12825. Neuroprotective effects of infliximab in experimental spinal cord injury
  12826. Possible Neuroprotective Effect of Withania somnifera Root Extract Against 3-Nitropropionic Acid-Induced Behavioral, Biochemical, and Mitochondrial Dysfunction in …
  12827. The Neuroprotective properties of palmitoylethanolamine against oxidative stress in a neuronal cell line
  12828. … with Rhodiola rosea extract reduces cognitive impairment induced by intracerebroventricular streptozotocin in rats: implication of anti-oxidative and Neuroprotective …
  12829. Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats
  12830. Neuroprotective role of δ-opioid receptors against mitochondrial respiratory chain injury
  12831. Neuroprotective effect of epigallocatechin-3-gallate against β-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity
  12832. Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats
  12833. Impaired expression of Neuroprotective molecules in the HIF-1α Pathway following traumatic brain injury in aged mice
  12834. Neuroprotective effects of onion extract and quercetin against ischemic neuronal damage in the gerbil hippocampus
  12835. Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is Neuroprotective in a culture model of Parkinson’s disease
  12836. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma
  12837. Neuroprotective effects of Brazilian green propolis and its main constituents against oxygen‐glucose deprivation stress, with a gene‐expression analysis
  12838. … exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired …
  12839. Neuroprotective effects of genistein and folic acid on apoptosis of rat cultured cortical neurons induced by β-amyloid 31-35
  12840. Erythrocyte-bound tissue plasminogen activator is Neuroprotective in experimental traumatic brain injury
  12841. Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated Neuroprotective genes promote survival through inhibition of mitochondrial …
  12842. Neuroprotective effects of N-stearoyltyrosine on transient global cerebral ischemia in gerbils
  12843. Neuroprotective effects of blockers for T-type calcium channels
  12844. The Neuroprotective impact of the leak potassium channel TASK1 on stroke development in mice
  12845. The Neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate
  12846. Neuroprotective interventions: is it too late?
  12847. Free iron, total F2‐isoprostanes and total F4‐neuroprostanes in a model of neonatal hypoxic–ischemic encephalopathy: Neuroprotective effect of melatonin
  12848. Comparative Neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site?
  12849. Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin
  12850. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats
  12851. Loss of Na+ channel β2 subunits is Neuroprotective in a mouse model of multiple sclerosis
  12852. The combined Neuroprotective effects of lidocaine and dexmedetomidine after transient forebrain ischemia in rats
  12853. Neuroprotective effect of memantine combined with topiramate in hypoxic–ischemic brain injury
  12854. Neuroprotective properties of melatonin in a model of birth asphyxia in the spiny mouse (Acomys cahirinus)
  12855. Novel pharmacological approaches to Schwann cells as Neuroprotective agents for peripheral nerve regeneration
  12856. Berberine exerts Neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell …
  12857. Neuroprotective effects of Dioscorea opposita on scopolamine-induced memory impairment in in vivo behavioral tests and in vitro assays
  12858. Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: Neuroprotective effects of Cerebrolysin
  12859. Role of protein phosphatases and mitochondria in the Neuroprotective effects of estrogens
  12860. Comparative Neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis
  12861. Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia
  12862. Neuroprotective effects of dibornol and mechanism of its action in rats with cerebral ischemia
  12863. … of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or Neuroprotective action
  12864. Neuroprotective and anti-inflammatory effects of phenolic compounds in Panax ginseng CA Meyer
  12865. Galanin fiber hyperinnervation preserves Neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer’s disease
  12866. Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia/reperfusion injury in rats
  12867. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice
  12868. The Erythropoietin Neuroprotective Effect: Assessment in CABG Surgery (TENPEAKS) A Randomized, Double-Blind, Placebo Controlled, Proof-of-Concept Clinical …
  12869. An evaluation of the Neuroprotective effects of melatonin in an in vitro experimental model of age‐induced neuronal apoptosis
  12870. Neuroprotective effects of an alkaloid-free ethyl acetate extract from the root of Sophora flavescens Ait. against focal cerebral ischemia in rats
  12871. Neuroprotective Effect of Long-term NDI1 Gene Expression in a Chronic Mouse Model of Parkinson Disorder
  12872. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a Neuroprotective strategy
  12873. Neuroprotective effects of chalcones from Myracrodruon urundeuva on 6-hydroxydopamine-induced cytotoxicity in rat mesencephalic cells
  12874. Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage
  12875. Bakkenolides from Petasites tricholobus and their Neuroprotective effects related to antioxidant activities
  12876. Neuroprotective effects of acetyl‐L‐carnitine on neuropathic pain and apoptosis: A role for the nicotinic receptor
  12877. Neuroprotective potential of combination of resveratrol and 4-amino 1, 8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and …
  12878. Pigment epithelium derived factor (PEDF) is Neuroprotective in two in vitro models of Parkinson’s disease
  12879. Neuroprotective effects of testosterone on the morphology and function of somatic motoneurons following the death of neighboring motoneurons
  12880. Neuroprotective Effects of Vinpocetine and its Major Metabolite Cis‐apovincaminic Acid on NMDA‐Induced Neurotoxicity in a Rat Entorhinal Cortex Lesion Model
  12881. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia
  12882. Continuous intraventricular infusion of erythropoietin exerts Neuroprotective /rescue effects upon Parkinson’s disease model of rats with enhanced neurogenesis
  12883. Highly efficient transfection of rat cortical neurons using carbosilane dendrimers unveils a Neuroprotective role for HIF-1α in early chemical hypoxia-mediated …
  12884. Estrogenic and Neuroprotective properties of scutellarin from Erigeron breviscapus: a drug against postmenopausal symptoms and Alzheimer’s disease
  12885. Synthesis, biological evaluation of prenylflavonoids as vasorelaxant and Neuroprotective agents
  12886. Estradiol after cardiac arrest and cardiopulmonary resuscitation is Neuroprotective and mediated through estrogen receptor-β
  12887. Binding epitopes and interaction structure of the Neuroprotective protease inhibitor cystatin C with β-amyloid revealed by proteolytic excision mass spectrometry and …
  12888. … major green tea polyphenol,(-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective Neuroprotective agent against oxidative …
  12889. Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide
  12890. Neuroprotective effect of l‐dopa on dopaminergic neurons is comparable to pramipexol in MPTP‐treated animal model of Parkinson’s disease: a direct comparison …
  12891. Neuroprotective effects of ugonin K on hydrogen peroxide-induced cell death in human neuroblastoma SH-SY5Y cells
  12892. Review of the effects of 17α‐estradiol in humans: a less feminizing estrogen with Neuroprotective potential
  12893. Simple ortho-and para-hydroquinones as compounds Neuroprotective against oxidative stress in a manner associated with specific transcriptional activation
  12894. Astrocyte-derived MCP-1 mediates Neuroprotective effects of noradrenaline
  12895. Neuroprotective effect of transretinal electrical stimulation on neurons in the inner nuclear layer of the degenerated retina
  12896. Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B
  12897. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARγ-dependent, Neuroprotective effects of rosiglitazone in experimental stroke
  12898. Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is Neuroprotective after retinal ganglion cell axotomy
  12899. Neuroprotective effects of diazoxide and its antagonism by glibenclamide in pyramidal neurons of rat hippocampus subjected to ischemia-reperfusion-induced injury
  12900. Metallo-complex activation of Neuroprotective signalling pathways as a therapeutic treatment for Alzheimer’s disease
  12901. Neuroprotective and toxic changes in microglia in neurodegenerative disease
  12902. New insights on the Neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm
  12903. The Neuroprotective effects of NGF combined with GM1 on injured spinal cord neurons in vitro
  12904. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and Neuroprotective role
  12905. Multimodal Neuroprotective therapy with induced hypothermia after ischemic stroke
  12906. Neuroprotective Activity of Viola mandshurica Extracts on Hydrogen Peroxide‐Induced DNA Damage and Cell Death in PC12 Cells
  12907. Nitric oxide utilizes NF-κB to signal its Neuroprotective effect against alcohol toxicity
  12908. Interleukin-4 mediates the Neuroprotective effects of rosiglitazone in the aged brain
  12909. 20 (S)‐ginsenoside Rg3, a Neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain
  12910. Neuroprotective effects of statins in an in vitro model of Alzheimer’s disease
  12911. Neuroprotective effect of melatonin on experimental peripheral nerve injury: an electron microscopic and biochemical study
  12912. Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause
  12913. Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine‐induced status epilepticus
  12914. Neuroprotective effects of 5-S-GAD against oxidative stress-induced apoptosis in RGC-5 cells
  12915. Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or Neuroprotective in acute mouse seizure models
  12916. BDNF mediates the Neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices
  12917. Clinical efficacy and Neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
  12918. Nephro-and Neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial
  12919. Neuroprotective effects of bone morphogenetic protein 7 (BMP7) treatment after spinal cord injury
  12920. Systematic gene expression profile of hypothalamus in calorie-restricted mice implicates the involvement of mTOR signaling in Neuroprotective activity
  12921. Context dependent Neuroprotective properties of prion protein (PrP)
  12922. Evaluation of long-lasting sensorimotor consequences following neonatal hypoxic-ischemic brain injury in rats: the Neuroprotective role of MgSO4
  12923. Possible Neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy
  12924. 2‐Arachidonoylglycerol elicits Neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal‐cannabidiol‐sensitive receptors on …
  12925. Biomarkers for evaluation of clinical efficacy of multipotential Neuroprotective drugs for Alzheimer’s and Parkinson’s diseases
  12926. In vitro dopaminergic Neuroprotective and in vivo antiparkinsonian-like effects of Δ 3, 2-hydroxybakuchiol isolated from Psoralea corylifolia (L.)
  12927. IFN‐γ and IL‐4 differentially shape metabolic responses and Neuroprotective phenotype of astrocytes
  12928. Phytochemical study and evaluation of antioxidant, Neuroprotective and acetylcholinesterase inhibitor activities of Galeopsis ladanum L. extracts
  12929. Neuroprotective effects and brain transport of ginsenoside Rg1
  12930. Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat
  12931. Neuroprotective potential of phase II enzyme inducer diallyl trisulfide
  12932. Neuroprotective protein and carboxypeptidase E
  12933. Reducing the risk of recurrent ischemic stroke after transient ischemic attack along with Neuroprotective and antiaggregant therapy
  12934. Compounds with Neuroprotective activity from the medicinal plant Machilus thunbergii
  12935. Cilnidipine mediates a Neuroprotective effect by scavenging free radicals and activating the phosphatidylinositol 3‐kinase pathway
  12936. Co-treatment with riluzole, a Neuroprotective drug, ameliorates the 3-acetylpyridine-induced neurotoxicity in cerebellar Purkinje neurones of rats: behavioural and …
  12937. Neuroprotective effects of (±)-catechin against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice
  12938. The Neuroprotective effects of ginsenosides on calcineurin activity and tau phosphorylation in SY5Y cells
  12939. Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models
  12940. Neuronal IκB kinase β protects mice from autoimmune encephalomyelitis by mediating Neuroprotective and immunosuppressive effects in the central nervous system
  12941. Drug screening of Neuroprotective agents on an organotypic-based model of spinal cord excitotoxic damage
  12942. Neuroprotective effects of erythropoietin posttreatment against kainate‐induced excitotoxicity in mixed spinal cultures
  12943. Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons
  12944. Traumatic brain injury: Neuroprotective anaesthetic techniques, an update
  12945. Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible Neuroprotective mechanism?
  12946. Neuroprotective effect of methanol extract of Phellodendri Cortex against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells
  12947. The Neuroprotective role of l-cysteine towards the effects of short-term exposure to lanthanum on the adult rat brain antioxidant status and the activities of …
  12948. Glucose-containing flavones—their synthesis and antioxidant and Neuroprotective activities
  12949. Antioxidant and Neuroprotective effects of synthesized sintenin derivatives
  12950. The Neuroprotective factor Wlds fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy
  12951. The Neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein …
  12952. Activity-dependent Neuroprotective protein–derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse
  12953. The Neuroprotective and anti-inflammatory effects of diltiazem in spinal cord ischaemia–reperfusion injury
  12954. Ischemia-related changes in naive and mutant forms of ubiquitin and Neuroprotective effects of ubiquitin in the hippocampus following experimental transient ischemic …
  12955. Arachidonyl trifluoromethyl ketone is Neuroprotective after spinal cord injury
  12956. NO‐flurbiprofen reduces amyloid‐β, is Neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade
  12957. Neuroprotective effects of edaravone, a free radical scavenger, on the rat hippocampus after pilocarpine-induced status epilepticus
  12958. Olesoxime (cholest-4-en-3-one, oxime): analgesic and Neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic …
  12959. Neuroprotective function in brain microglia
  12960. Neuroprotective effects of R, R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor …
  12961. Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and Neuroprotective strategy?
  12962. Neuroprotective effects of the new diterpene, CBNU06 against beta-amyloid-induced toxicity through the inhibition of NF-kappaB signaling pathway in PC12 cells
  12963. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: Neuroprotective effects of antiretroviral therapy
  12964. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats
  12965. Neuroprotective effect of adenoviral catalase gene transfer in cortical neuronal cultures
  12966. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is Neuroprotective in a rat model of familial ALS
  12967. Polycyclic cage structures as carrier molecules for Neuroprotective non-steroidal anti-inflammatory drugs
  12968. Neuroprotective effects of curcumin
  12969. Neuroprotective effect of transpupillary thermotherapy in the optic nerve crush model of the rat
  12970. NNZ-2566: A Gly–Pro–Glu analogue with Neuroprotective efficacy in a rat model of acute focal stroke
  12971. Natural coumarins as a novel class of Neuroprotective agents .
  12972. The localization of PGE2 receptor subtypes in rat retinal cultures and the Neuroprotective effect of the EP2 agonist butaprost
  12973. The Neuroprotective effects of traditional oriental herbal medicines against β-amyloid-induced toxicity
  12974. Increased connexin 43 expression as a potential mediator of the Neuroprotective activity of the corticotropin-releasing hormone
  12975. The AMPA receptor positive allosteric modulator, S18986, is Neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis
  12976. A comparison of Neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats
  12977. Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival
  12978. Neuroprotective effects of vitamin E on adult rat motor neurones following facial nerve avulsion
  12979. Neuroprotective effects of mebudipine and dibudipine on cerebral oxygen–glucose deprivation/reperfusion injury
  12980. Neuroprotective effects of the survival promoting peptide Y-P30
  12981. Neurotrophic and Neuroprotective actions of an enhancer of ganglioside biosynthesis
  12982. Haploinsufficiency of RanBP2 is Neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons
  12983. Neuroprotective effects of a nanocrystal formulation of sPLA2 inhibitor PX-18 in cerebral ischemia/reperfusion in gerbils
  12984. Reduction of nuclear peroxisome proliferator-activated receptor γ expression in methamphetamine-induced neurotoxicity and Neuroprotective effects of ibuprofen
  12985. Neuroprotective profile of dextromethorphan in an experimental model of penetrating ballistic-like brain injury
  12986. Potential Neuroprotective drugs in cerebral ischemia: new saturated and polyunsaturated lipids coupled to hydrophilic moieties: synthesis and biological activity
  12987. Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure
  12988. Neuroprotective effect of testosterone treatment on motoneuron recruitment following the death of nearby motoneurons
  12989. Neuroprotective effects of probenecid in a transgenic animal model of Huntington’s disease
  12990. Neuroprotective effects of testosterone on dendritic morphology following partial motoneuron depletion: efficacy in female rats
  12991. Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia
  12992. Cocaine challenge enhances release of Neuroprotective amino acid taurine in the striatum of chronic cocaine treated rats: a microdialysis study
  12993. Zocor Forte®(simvastatin) has a Neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not
  12994. Involvement of endocannabinoid signaling in the Neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia
  12995. Neuroprotective effects of enriched environment in MPTP-treated SAMP8 mice
  12996. Traditional Chinese herb Dihuang Yinzi (DY) plays Neuroprotective and anti-dementia role in rats of ischemic brain injury
  12997. Neuroprotective effect of nipradilol [3, 4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration
  12998. Neuroprotective effects of Kangen-karyu on spatial memory impairment in an 8-arm radial maze and neuronal death in the hippocampal CA1 region induced by …
  12999. Region-specific Neuroprotective effect of ZM 241385 towards glutamate uptake inhibition in cultured neurons
  13000. Neuroprotective role of heme-oxygenase 1 against iodoacetate-induced toxicity in rat cerebellar granule neurons: Role of bilirubin
  13001. Neuroprotective treatment strategies for poststroke mood disorders: A minireview on atypical neuroleptic drugs and selective serotonin re-uptake inhibitors
  13002. Antidepressant effects of piperine and its Neuroprotective mechanism in rats
  13003. Alpha-lipoic acid potently inhibits peroxynitrite-mediated DNA strand breakage and hydroxyl radical formation: implications for the Neuroprotective effects of alpha …
  13004. Analysis of Neuroprotective effects of valproic acid on primary motor neurons in monoculture or co-cultures with astrocytes or Schwann cells
  13005. Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster.
  13006. Valproate and Neuroprotective effects for bipolar disorder
  13007. Antiapoptotic and Neuroprotective effects of mycophenolate mofetil after acute spinal cord injury in young rats
  13008. Amyotrophic lateral sclerosis and the Neuroprotective potential of exercise
  13009. Neuroprotective effects of edaravone on early brain injury in rats after subarachnoid hemorrhage
  13010. Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their Neuroprotective effects
  13011. Complement inhibition as a proposed Neuroprotective strategy following cardiac arrest
  13012. Neuroprotective Effects of Ethyl Pyruvate on brain Energy Metabolism after Ischemia-Reperfusion Injury: A 31 P-Nuclear Magnetic Resonance Study
  13013. Anticonvulsant and Neuroprotective effects of the novel calcium antagonist NP04634 on kainic acid‐induced seizures in rats
  13014. Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells.
  13015. Inhibition of NMDA Receptors Underlies the Neuroprotective Effect of Ginsenoside Rb3
  13016. Neuroprotective effects of Bunsimgieum
  13017. Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson’s disease
  13018. β-Lactams as Neuroprotective agents
  13019. Immune maintenance in glaucoma: boosting the body’s own Neuroprotective potential
  13020. Erythropoietin does not attenuate cytokine production and inflammation in microglia—Implications for the Neuroprotective effect of erythropoietin in neurological …
  13021. Apolipoprotein D modulates F2-isoprostane and 7-ketocholesterol formation and has a Neuroprotective effect on organotypic hippocampal cultures after kainate …
  13022. Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats
  13023. Neuroprotective effects of (arylthio) cyclopentenone derivatives on manganese-induced apoptosis in PC12 cells
  13024. Neuroprotective effect of N-acetylcysteine in neurons exposed to arachidonic acid during simulated ischemia in vitro
  13025. Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma
  13026. Neuroprotective effect of SSRI among 781 cancer patients receiving chemotherapy: A URCC CCOP Study
  13027. Calpains are activated by light but their inhibition has no Neuroprotective effect against light-damage
  13028. Investigation of Neuroprotective action of drug “Semax” at ischemic insult by Raman spectroscopy method by estimation of damage of low density lipoprotein of rat …
  13029. Neuroprotective activities of some medicinal plants against glutamate-induced neurotoxicity in primary cultures of rat cortical cells
  13030. Neuroprotective effects of the anti-inflammatory compound triflusal on ischemia-like neurodegeneration in mouse hippocampal slice cultures occur independent of …
  13031. The Antioxidative and Neuroprotective Effect of Guibi-tang (Guipitang) and Guibi-tang gamibang (Guipitang jiaweijang) on PC12 cells.
  13032. EUK-207, a superoxide dismutase/catalase mimetic, is Neuroprotective against oxygen/glucose deprivation-induced neuronal death in cultured hippocampal slices
  13033. Assessing the Neuroprotective effect of antioxidative food factors by application of lipid-derived dopamine modification adducts
  13034. Lithium treatment in Alzheimer’s disease does not promote cognitive enhancement, but may exert long-term Neuroprotective effects
  13035. Adenosine A 1 receptor-mediated transactivation of the EGF receptor produces a Neuroprotective effect on cortical neurons in vitro
  13036. Neuroprotective effects of furopyrazole derivative of benzylindazole analogs on C2 ceramide-induced apoptosis in cultured cortical neurons
  13037. Neuroprotective effects of testosterone in two models of spinal motoneuron injury
  13038. Neuroprotective effect of Insamyangyung-tang
  13039. Slowly progressive dopamine cell loss—a model on which to test Neuroprotective strategies for Parkinson’s disease?
  13040. Nitric oxide regulates activity-dependent Neuroprotective protein (ADNP) in the dentate gyrus of the rodent model of kainic acid-induced seizure
  13041. Neuroprotective effect of Nigella sativa hydro alcoholic extract on serum/glucose deprivation induced PC12 cells death
  13042. The Neuroprotective effects of benzylideneacetophenone derivatives on excitotoxicity and inflammation via phosphorylated Janus tyrosine kinase 2/phosphorylated …
  13043. Taurine exerts Neuroprotective effects via anti-apoptosis in hypoxic-ischemic brain injury in neonatal rats
  13044. Ciliary neurotrophic factor fused to a protein transduction domain retains full Neuroprotective activity in the absence of cytokine‐like side effects
  13045. Neuroprotective studies of rubia cordifolia Linn. On β-amyloid induced cognitive dysfunction in mice
  13046. Neuroprotective Effect of Extracts from Root Bark of Morus alba on Glutamate-induced Cytotoxicity in Neuronal Cells.
  13047. Neuroprotective effects of afobazole in a hemorrhagic stroke model
  13048. Neuroprotective effects and mechanisms of Chuanxiong Chatiao pulvis against MPTP-induced dopaminergic neurotoxicity in mice model of parkinson’s disease
  13049. Neuroprotective and neurotrophic effects of isorosmanol
  13050. Deleterious versus Neuroprotective effect of metabolic inhibition after traumatic spinal cord injury
  13051. Neuroprotective effects of Equisetum telmateia in rat
  13052. Active form of Neuroprotective Humanin, HN, and inactive analog, S7AHN, are monomeric and disordered in aqueous phosphate solution at pH 6.0; No correlation of …
  13053. PINK1: one protein, multiple Neuroprotective functions
  13054. Neuroprotective effects of human telomerase reverse transcriptase on beta-amyloid fragment 25–35-treated human embryonic cortical neurons****☆
  13055. Omega-3 fatty acids: their Neuroprotective and regenerative potential in traumatic neurological injury
  13056. Neuroprotective effect of ouabain and Bcl-2 peptide expression during hyperactivation of NMDA receptors in rat brain cortical neurons in Vitro
  13057. Putative Neuroprotective role of centrally administered corticotropin-releasing factor in low-temperature-exposed neonatal chicks
  13058. The Neuroprotective potentials of sour (Hibiscus sabdariffa, Calyx) and green (Camellia sinensis) teas on some pro-oxidants induced oxidative stress in brain .
  13059. Use of ‘Click Chemistry’for the Synthesis of Tetrazole-Containing Analogues of the Neuroprotective Agent Glycyl-l-prolyl-l-glutamic Acid
  13060. Neuroprotective effect of Curcuma longa alcoholic extract on peripheral nerves degeneration after sciatic nerve compression in rats.
  13061. Mito K (ATP) and kappa-opioid receptor mediate the Neuroprotective effect of limb ischemic post-conditioning on rat brain ischemia/reperfusion injury
  13062. Expression of the Neuroprotective slow Wallerian degeneration (Wld S) gene in non-neuronal tissues
  13063. Neurochemical and Neuroprotective aspects of phenelzine and its active metabolite B-phenylethylidenehydrazine
  13064. Fibroblast growth factor 2 requires complex formation with ATP for Neuroprotective activity
  13065. Neuroprotective effect of quercetin in a model of Parkinson’s disease in rat: A histochemical analysis
  13066. GABA is not elevated during Neuroprotective neuronal depression in the hypoxic epaulette shark (Hemiscyllium ocellatum)
  13067. Antidepressant-like effects of piperine and its Neuroprotective mechanism
  13068. Neuroprotective effect of Salvia staminea alcoholic extract on peripheral nerve degeneration after sciatic nerve compression in rats
  13069. The extract of inflamed rabbit skin induced by inoculation of vaccinia virus possesses antioxidant and Neuroprotective effects in acute ischemic stroke
  13070. Adult neural stem/progenitor cells reduce NMDA‐induced excitotoxicity via the novel Neuroprotective peptide pentinin
  13071. A comparison of the Neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned rats
  13072. Neuroprotective compounds and innovative therapeutic strategies for Parkinson’s disease: experimental and clinical studies
  13073. FREE RADICAL SCAVENGING ACTIVITY BY ESR SPECTROSCOPY AND Neuroprotective EFFECT ON H2O2‐INDUCED DAMAGE IN PC‐12 CELLS OF …
  13074. Neuroprotective effect of Yukul-tang against the oxidative stress
  13075. Neuroprotective effects of laminin and its KDI domain
  13076. Are female sex steroids Neuroprotective in experimental stroke
  13077. Evaluation of the Neuroprotective efficacy of individual oxime (HI-6) and oxime mixtures (HI-6+ trimedoxime, HI-6+ K203) in tabun-poisoned rats
  13078. Neuroprotective effects of some plant extracts against oxygen-glucose deprivation (OGD)-induced oxidative cell death on neuronal cell
  13079. Neuroprotective effect of batroxobin on experimental intracerebral hemorrhage in rats
  13080. Neuroprotective effect of batroxobin on experimental intracerebral hemorrhage in rats.
  13081. Neuroprotective Effects of Pinelliae Rhizoma Water-Extract by Suppression of Reactive Oxygen Species and Mitochondrial Membrane Potential Loss in a Hypoxic …
  13082. Evaluation of the Neuroprotective Efficacy of Newly Developed Oximes (K206, K269) and Currently Available Oximes (Obidoxime, HI‐6) in Cyclosarin‐Poisoned Rats
  13083. Short Neuroprotective peptides, ADNF9 and NAP, are structurally disordered and monomeric in PBS
  13084. Mitochondrial dysfunction in neurodegenerative diseases and stroke: Neuroprotective strategies
  13085. The Neuroprotective effects of cyclin-dependent kinase-5 inhibition in mice with Niemann-Pick disease type C
  13086. Progress in the research on Neuroprotective effects of puerarin in the central nervous system [J]
  13087. Neuroprotective Effect of Methanol Extract of Phellodendri Cortex Against 1-methyl-4-Phenylpyridinium-induced Apoptosis in PC-12 Cells
  13088. The Neuroprotective effects of Nokyongdaebo-tang (Lurongdabutang) treatment in pathological Alzheimer’s disease model of neural tissues
  13089. Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different Neuroprotective effect
  13090. Neuroprotective Effect of Semen Persicae in Middle Cerebral Artery Occlusion Rats
  13091. The original nootropic and Neuroprotective drug noopept potentiates the anticonvulsant activity of valproate in mice
  13092. Fluorescein angiography findings strengthen the theoretical basis for trialling Neuroprotective agents in cerebral malaria
  13093. Neuroprotective effects of combined lead and cadmium, as well as N-acetylcysteine, on cerebral cortical neurons following lipid peroxidation injury**☆
  13094. Neuroprotective Herbs for Stroke
  13095. Neuroprotective effect of curcumin on focal cerebral ischemia-reperfution in rats [J]
  13096. Neuroprotective effects of tanshinone Ⅱ_A on vascular dementia in rats [J]
  13097. Neuroprotective mechanism of edaravone on rat brain damage following cerebral ischemia-reperfusion [J]
  13098. In vitro binding and in vivo biodistribution studies of the Neuroprotective peptide humanin using [125I] humanin derivatives
  13099. Role of residual flow on the Neuroprotective efficacy of human albumin in the rat with transient cerebral ischemia
  13100. In vitro evaluation of the Neuroprotective effects of Lepidium meyenii (maca) in crayfish neuronal and rat neuroblastoma cell lines
  13101. The Neuroprotective effect of CSF intraperitoneal injection on alpha motor degeneration after sciatic nerve compression in rat
  13102. Neuroprotective effects of MCI-186 on PC12 cells induced by Aβ_ (25-35)
  13103. Neuroprotective effects and mechanisms of ligustrazine against MPTP-induced dopaminergic neurotoxicity in a mouse model of Parkinson’s disease
  13104. Neuroprotective mechanisms of SIRT1
  13105. Neuroprotective effects of leptin and nitric oxide against cerebral ischemia
  13106. Neuroprotective effect and mechanism of ginsenosides and its application in neurodegenerative disorders.
  13107. Experimental study of edaravone on Neuroprotective effect in intracerebral hemorrhage of rats [J]
  13108. The Neuroprotective effect of acupuncture at GB34 in a MPTP-induced Parkinson’s disease mouse model
  13109. (3R,5S,7as)-(3,5-Bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol, a Novel Neuroprotective Agent
  13110. Excitotoxicity in rat’s brain induced by exposure of manganese and Neuroprotective effects of pinacidil and nimodipine
  13111. Neuroprotective effect of polysaccharide of Atractylodes macrocephala Koidz on focal cerebral ischemia reperfusion in rats
  13112. Neuroprotective mechanisms after hypoxic–ischemic injury
  13113. Neuroprotective effect of fucoidan against N-methyl-d-aspartate-induced excitotoxicity in rat hippocampus
  13114. Luminescence analysis of blood components in studies of the Neuroprotective properties of the drug “Semax” in cerebral ischemia
  13115. Vitamin E derivative alpha-tocotrienol failed to show Neuroprotective effects after embolic Stroke in rats
  13116. Environmental toxins and dopaminergic neurotoxicity: Novel Neuroprotective strategies
  13117. FLAVONOID CONTENTS, ANTIOXIDANT AND Neuroprotective ACTIVITY OF EXTRACTS OF RUSSIAN PLANTS
  13118. Neuroprotective effects of Lycium barbarum polysaccharides on retinal ischemic injury
  13119. The Neuroprotective effect of granulocyte colony-stimulating tactor (C-CSF) in acute middle cerebral artery occlusion
  13120. Neuroprotective effects of Naoshenkang capsule against anoxia-reoxygenation injury on cultured rat hippocampal neurons
  13121. Intracisternal administration of glibenclamide or 5-hydroxydecanoate does not reverse the Neuroprotective effect of ketogenic diet against ischemic brain injury …
  13122. Neuroprotective effect of heat shock protein 70*☆: Inhibition of Tau protein expression
  13123. Neuroprotective effect of bilobalide against neuronal damage by glutamate-induced excitotoxicity [J]
  13124. Neuroprotective effect of hemin and its molecular mechanism in the hippocampal organotypic tissue cultures after combined oxygen/glucose deprivation [J]
  13125. Identification of protein targets of novel Neuroprotective sulfhydryl reducing drugs
  13126. Neuroprotective Effects of Doxycycline on Thrombolysis Therapy at Different Time in Rats
  13127. MÜLLER CELL-DERIVED NEUROTROPHIC FACTORS. A ROAD TO Neuroprotective THERAPY IN THE RETINA
  13128. Analysis of the Neuroprotective function and the N-glycosylation progranulin (PGRN)
  13129. Neuroprotective effect of puerarin after hypoxic-ischemic in neonatal and its mechanism.
  13130. The Neuroprotective effect of combination therapy of polyethylene glycol and magnesium sulfate in acute spinal cord injury
  13131. The Neuroprotective effects of PACAP in several models of neurodegeneration in the rat retina
  13132. Study on the mechanism underlying Neuroprotective effect of Ginsenosides in rats after spinal cord injury
  13133. Neuroprotective effects of epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a histological study
  13134. Neuroprotective effects of Lycium barbarum polysaccharides on acute ischemic stroke injury
  13135. Neuroprotective Effects of Herba Erigeromtis against the Aβ Neurotoxicity
  13136. Symbol Neuroprotective effects of nerve growth factor in olfactory ensheathing cell conditioned medium
  13137. Neuroprotective effect of nimodipine and nooglutyl in rats with experimentally produced hemorrhagic stroke
  13138. Neuroprotective Effect of PD-1 Extract in MPTP-lesioned Mouse Model of Parkinson’s Disease
  13139. Nitric oxide and cGMP protect the retina from ischemia and mediate somatostatin’s Neuroprotective effects
  13140. Neuroprotective effects of some plant extracts against dopamine-induced oxidative stress on neuronal cell
  13141. Advance in damage mechanism on blood brain barrier after cerebral ischemia reperfusion and Neuroprotective drugs
  13142. Bioavailability of gallic acid and catechins from Neuroprotective grape seed extract is improved by repeated dosing in rats
  13143. Neuroprotective Effects of Ginkgo Biloba Extract on the Dopaminergic Neurons in Model Mice of Parkinson’s Disease [J]
  13144. Neuroprotective Effect of Yukmijihwamg-tang (Liuweidihuangtang) Gamibang on the Deficits of Learning and memory in Trimethyltin-Intoxicated Rats
  13145. Neuroprotective Role of Testosterone
  13146. Neuroprotective Strategies in Epilepsy
  13147. Neuroprotective strategies in excitotoxic brain injury: potential applications to the preterm brain
  13148. Neuroprotective effects of combined nimodipine with cyclophos phamide and superoxide dismutase on cerebral ischemia-reperfusion in rats [J]
  13149. Does serum osmolarity change as a result of the reflex Neuroprotective mechanism of cerebral osmo-regulation after minor head trauma?
  13150. Neuroprotective effect of a plants extracts complex ACG
  13151. Calbindin D28k Is Sole Calcium Binding Protein With Neuroprotective Function Against Pressure-Induced Retinal Ischemia-Reperfusion in Rats
  13152. Neuroprotective effect of fasudil, a Rho-kinase inhibitor, after transient forebrain ischemia in rats
  13153. PLGA microparticles loaded with Neuroprotective agents (GDNF and BDNF). A potential treatment for glaucoma
  13154. Vincristine-induced neuropathy in rats is mediated via NMDA excitotoxicity and impairment of CGRP: Possible Neuroprotective effect of erythropoietin
  13155. The Rdcvf Signaling Is Linking Oxidative Stress to Neuroprotective Response
  13156. Structural and functional characterization of bacterial response and Neuroprotective proteins
  13157. Nicotinic Acetylcholine Receptors and its Neuroprotective Effects
  13158. P74 NTR and its Role in Regeneration: Potential Neuroprotective Effects
  13159. Neuroprotective Effects of Pomegranate Juice in Mice
  13160. Research Progress in Neuroprotective Function of Resveratrol
  13161. Low pressure glaucoma: update and a Neuroprotective clinical trial
  13162. The Development of LCD EEG Display System for Neuroprotective Treatment Instrument
  13163. Neuroprotective Effect of Amphiphilic Cholesterol-Based PBN Derivatives
  13164. Research Progress on the Neuroprotective Effect of Ischemic Preconditioning
  13165. Antithrombotic and Neuroprotective Therapy in Acute Ischemic Stroke
  13166. Regeneration Associated Genes (RAGS) and Cell Survival and Neuroprotective Genes (CsNp)
  13167. Interleukin and CRP with Cerebral Ischemia and Current Situation of Neuroprotective Treatment
  13168. Potential therapies and Neuroprotective cascades in anoxia
  13169. Neuroprotective Role of Dickkopf2 (Dkk2) in the Endothelial Cells after the Cerebral Ischemia
  13170. Multi-tier analysis for screening Neuroprotective extracts from Chinese herbs.
  13171. Switching microglial activation from neurodestructive to Neuroprotective mode
  13172. Neuroprotective effects of neurosteroids in pilocarpine-treated rats
  13173. Neuroprotective effect of erythropoietin on intracerebral hemorrhage
  13174. Expression of Neuroglobin and Neuroprotective Mechanisms after MACO in Rat
  13175. Neuroprotective Effect of SP-8203 in Focal Cerebral Ischemia in Rats
  13176. Neuroprotective effect of fasudil on rat model of acute cerebral infarction
  13177. Glial Nurr1 Is Neuroprotective
  13178. Neuroprotective effects of cytokines in a pesticide model of Parkinson’s disease
  13179. Neuroprotective Effects of Leptin in a Model of Cerebral Ischemia in Rat
  13180. Neuroprotective Effects of Acacetin through the Inhibition of Micrioglial Activation
  13181. Neuroprotective effects of neurokinin receptor one agonist septide in models of Parkinson’s disease
  13182. Neuroprotective effects of 17β-estradiol in a rat model of neonatal X radiation
  13183. Neuroprotective and Neurorestorative Effects of Erythropoetin After brain Injury
  13184. Experimental Research of Neuroprotective Effect of Magnesium Sulfate Preconditioning on Global Ischemia in Rabbits
  13185. Neuroprotective activity of guanosine in an in vitro model of Alzheimer’s disease
  13186. Assessment of Neuroprotective Properties from Food Containing AntiInflammatory Compounds to Effectively Inhibit AD Presymptom in A Cell Cultured Model
  13187. The study on the Neuroprotective effects of celecoxib against degeneration of dopaminergic neurons
  13188. Synthesis of Glucose-containing Flavones and their Antioxidant and Neuroprotective Activity
  13189. Study on the Neuroprotective role and its mechanism of p-nerve growth factor in rats with focal cerebral ischemia
  13190. Neuroprotective effect and mechanism of moderate epidural hypothermia in rats with spinal cord injury
  13191. Expression of Hsp22 and VEGF after brain I/R injury in gerbils and its Neuroprotective effects
  13192. Changes of the brain stem neurocytes in newborn rats in the conditions of experimental model of hypoxia during Neuroprotective correction
  13193. Postcoditioning Induces Neuroprotective Effect in Ischemic brain by Activating eNOS.
  13194. Vasoactive and Neuroprotective Actions of a Non-Pyschotropic Atypical Cannabinoid in the Retina
  13195. Neuroprotective Effects of a Taurine Containing Intraocular Irrigation Solution (Acriprotect)
  13196. Systemic Brimonidine Is Neuroprotective in Abeta-Induced RGC Apoptosis in vivo Model of Neurodegeneration
  13197. Neuroprotective Effect of Diazoxide in Animal Model of Focal Cerebral Ischemia
  13198. S-Adenosylmethionine Is Neuroprotective Following Acute Ischemic Retinal Injury
  13199. Clinical and non clinical positron emission tomography (PET) studies on vinpocetine, a Neuroprotective drug
  13200. Neuroprotective Effect of Up-regulated Sonic Hedgehog in Retinal Ganglion Cells Following Chronic Ocular Hypertension
  13201. Neuroprotective effect of salidroside on diabetic encephalopathy rats
  13202. A study on Neuroprotective effect of memantine in hippocampus of rats with vascular dementia
  13203. The Neuroprotective Effects of Transplanted Embryo-Derived Retinal Cells Are Developmental Stage Specific
  13204. Hippocampal neurogenesis and dentritic enrichment are involved in Neuroprotective of physical exercise on stress
  13205. Lactate Infusion as a Neuroprotective Agent in a Rat Focal Cerebral Infarct Model
  13206. Neuroprotective Effect of an Antioxidant Lutein in Light-Induced Retinal Degeneration
  13207. Neuroprotective Effects of Triticum aestivum L. against β-Amyloid-induced Cell Death and memory Impairments.
  13208. Neuroprotective effects of Y2 and Y5 neuropeptide Y receptor agonists
  13209. Neuroprotective effect of rAAV-mediated rhBDNF gene transfection on rabbit retina against acute high intraocular pressure
  13210. Dysregulation of iron of amyotrophic lateral sclerosis mice and Neuroprotective effects of iron chelator
  13211. The Neuroprotective Effects of Exercise in an Immobilization Chronic Stress Model in the Mouse Hippocampus
  13212. Wnt Signaling Regulates Expression of Neuroprotective Growth Factors in Muller Glia
  13213. Neuroprotective Effect of Sodium Valproate on Photoreceptor Cell in rd Mice
  13214. In Vitro Characterization of Novel Neuroprotective Phosphine-Borane Complexes
  13215. Bone marrow stromal cells isolated from the infarcted region of the postischemic brain secrete Neuroprotective and angiogenic factors
  13216. Neuroprotective effects of edaravone on brain injuries caused by infrasound
  13217. Synthesis of Novel Borane-Protected Phosphines That are Neuroprotective Against Superoxide-Dependent Apoptosis in RGC-5 Cells
  13218. Olanzapine does not aggrevate ischemic neuronal injury by focal cerebral ischemia: a dose related restriction of the Neuroprotective effect?
  13219. Neuroprotective effects of low-concentration alpha-tocopherol*★: Confocal laser microscopy observations
  13220. Neuroprotective EFFECTS OF LYCIUM BABARUM ABSTRACT ON HEREDITARY RETINAL DYSTROPHY OF RCS RATS
  13221. Polycyclic cage structures as carrier molecules for Neuroprotective non-steroidal anti-inflammatory drugs
  13222. Neuroprotective Effects of Water Extract of Ginseng on SH-SY5Y Cell Apoptosis Induced by Amyloid β Peptide
  13223. Multimodal Neuroprotective –neurorestorative drugs acting on the mitochondria for treatment of Alzheimer’s disease
  13224. Measurement of free radical scavenging activity and Neuroprotective effect by oxidative damage from various enzymatic extracts of Inonotus obliquus
  13225. Neuroprotective effect of green tea extract against lead toxicity in rats.
  13226. Tocomin tocotrienol/tocopherol complex. A potent natural Neuroprotective vitamin.
  13227. Tacrolimus is not Neuroprotective Against Bilirubin Induced Auditory Impairment
  13228. Neuroprotective effects of methylprednisolone and hypothermia after experimental spinal cord injury: A histopathological and stereological Study
  13229. Neuroprotective Effects of Taurine Via Modulation of Nitric Oxide Synthase on Hypoxic-Ischemic brain Injury in Neonatal Rats
  13230. Gene Expression Analysis of GDNF-induced Mueller Glial Cell-derived Neuroprotective Factors: Possible Candidates for Photoreceptor Survival
  13231. The Neuroprotective effects of lesion and high frequency stimulation of the subthalamic nucleus on the substantia nigra neurons
  13232. Neuroprotective effects of rhG-CSF on brain given intranasal in cerebral infarct rats
  13233. Neuroprotective Effect of Quercetin against Damage Induced by Oxygen Deprivation in Cultured Rat Cortical Neurons
  13234. Neuroprotective EFFECTS OF CURCUMA LONGA EXTRACT ON NEURODEGENERATION AFTER SCIATIC NERVE INJURY IN RAT
  13235. Neuroprotective Effect of Flavonoid from the Leaves of Diospyros Kaki on Acute Forebrain Ischemia Reperfusion Injury in Rats [J]
  13236. THE Neuroprotective EFFECT OF WIN 55,212-2 AND NMDA INTERACTION IN NEUROTOXICITY INDUCED BY PARAOXON IN PC12 CELLS
  13237. Neuroprotective Effect of Thyrotropin-releasing Hormone (TRH) Against Glutamate Toxicity in Vitro
  13238. Neuroprotective effects of antifreeze protein against hypothermia induced cell death in rat hippocampal slices
  13239. Neuroprotective Effect of Ciliary Neurotrophic Factor (CNTF) in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy
  13240. 229: Neuroprotective peptides NAP and SAL may alter KIF17 levels in TS65DN mice treated postnatally
  13241. Intravitreal Injections of Neurotrophic Factors Secreting Mesenchymal Stem Cells Are Neuroprotective in Post Optic Nerve-Transected Rat Eyes
  13242. Synthesis and characterization of dopamine agonist prodrug for symptomatic and Neuroprotective treatment of Parkinson’s disease
  13243. 54: Prevention of the alcohol-induced changes in brain -derived neurotrophic factor expression using Neuroprotective peptides in a model of fetal alcohol syndrome
  13244. Multimodal NMR assessment of Erythropoietin as a Neuroprotective agent following Hypoxia-Ischemia on P3 pup rat brain
  13245. The Neuroprotective Effects of Cyclin-dependent Kinase-5 Inhibition in Mice with Niemann-Pick Disease Type C
  13246. Neuroprotective effect of asymmetrical dimethylarginine against 1-methyl-4-phenylpyridinium ion-induced damage in PC12 cells
  13247. Neuroprotective Effects of Small Interfering Rna Targeted Diablo on Rat Retinal Damage Induced by Transient Ischemic Injury
  13248. Neuroprotective effects of ginsenosides Rb1 on 6‐hydroxydopamine‐induced cytotoxicity in human dopaminergic cells
  13249. Neuroprotective evaluation of extract of ginger (Zingiber Officinale) root in monosodium glutamate–induced toxicity in defferent brain areas male albino rats.
  13250. Neuroprotective effects of creatine against rotenone induced neurotoxicity and mitochondrial dysfunctions in Drosophila melanogaster
  13251. The Neuroprotective effect of NBQX to oligodendrocyte precursor cells in the brain of adult rats after focal cerebral ischemia and reperfusion
  13252. Norrin Mediates Neuroprotective Effects on Retinal Ganglion Cells via Induction of Neurotrophic Factors in Müller Cells
  13253. Lack of Neuroprotective effect of astroglia-derived BDNF on hippocampal cell cultures exposed to trimethyltin
  13254. The Neuroprotective effects of urocortin in bilateral common carotid occlusion induced retinal degeneration
  13255. Neuroprotective role induced by destrogen receptor via up-regulation Akt phosphorylation against ischemic injury in hippocampal CA1 region of the rats
  13256. Neuroprotective Potential of the Root Extract of Decalepis Hamiltonii Against Ethanol Induced Oxidative Stress in the Cerebellum of Rat Brian
  13257. Neuroprotective effect of GLP-1 receptor agonist exendin-4 in rat models of Parkinson’s disease
  13258. Anticonvulsant and Neuroprotective effects of the novel calcium antagonist NP04634 on kainic acid-induced seizures in rats.
  13259. Neuroprotective effects of Celecoxib on the dopaminergic neurons in the substantia nigra in MPTP-induced C57BL6 mice
  13260. Brimonidine Is Neuroprotective Against Glutamate-Induced Neurotoxicity, Oxidative Stress and Hypoxia in Purified Rat Retinal Ganglion Cells
  13261. 703: Prenatal treatment with Neuroprotective peptides restores DYRK1A expression in a mouse model of Down syndrome
  13262. Dendrimer-Fluocinolone Acetonide Nanodevices Supress Retinal Neuroinflammation and Are Neuroprotective in RCS Rats
  13263. Elucidating the role of nucleolus in neuronal cell death pathways: Assessing the Neuroprotective role of Nucleophosmin protein (NPM)
  13264. Synapse Stabilization, De-stabilization, and Re-stabilization: Genetic analysis of Neuroprotective Fos signaling at the Drosophila neuromuscular junction
  13265. Potential therapies and Neuroprotective cascades in anoxia tolerant freshwater turtle Trachemys scripta elegans
  13266. Identification of Neuroprotective genes against alpha-synuclein toxicity using a Caenorhabditis elegans Parkinson disease model
  13267. Inhibition of Beta2 Integrin-mediated Leukocyte Adhesion Attenuates the Inflammatory Response and is Neuroprotective Following Global Cerebral Ischemia
  13268. Neuroprotective effect of isoflavones against homocysteine‐mediated neuronal degeneration in SH‐SY5Y cells
  13269. Neuroprotective EFFECT OF AQUEOUS EXTRACT OF CERASUS AVIUM L. ON THE DESTRUCTION OF SUBSTANCIA NIGRA BY 6-HYDROXYDOPAMINE IN …
  13270. The Neuroprotective effects of urocortin 2 in bilateral common carotid occlusion induced retinal degeneration
  13271. Tolerance and safety of ocular use of recombinant human erythropoietin (rhEPO). Neuroprotective effects in ocular hypertension/glaucoma
  13272. Neuroprotective effects of melatonin upon the offspring cerebellar cortex in the rat model of BCNU-induced cortical dysplasia
  13273. 15 Dietary Flavonoids as Neuroprotective agents
  13274. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats
  13275. Neuroprotective Flavonoids of Agrimonia eupatoria on Glutamate-Induced Oxidative Injury in HT 22 Hippocampal Cells
  13276. Neuroprotective effect of marine-derived compounds obtained from the soft coral on 6-hydroxydopamine-induced death in human neuroblastoma cells
  13277. COMPARISON OF Neuroprotective EFFECTS OF AQUA AND ETHANOL EXTRACTS OF ROOT AND LEAVES OF SALVIA STAMINEA ON CENTRAL …
  13278. Neuroprotective peptides in Alzheimer’s disease: structural characterization an affinity of ß-amyloid and human cystatin C peptides interactions
  13279. Intracellular Pathway and Neuroprotective Effect of Carpinus tschonoskii MAX on 6-Hydroxydopamine-Induced Death of PC12 Cells
  13280. Neuroprotective Effects of Sophora flavesce Extract Against Nitric Oxide-Induced Apoptosis in Neuronal Cells and Focal Cerebral Ischemia-Reperfusion …
  13281. Centrally administered nociceptin/orphanin FQ and the Neuroprotective effect of electroacupuncture against cerebral ischemia following middle cerebral artery …
  13282. 2 The Neuroprotective Role of Micronutrients in Parkinson’s Disease
  13283. Angiotensin Type-1 Receptor Inhibition Is Neuroprotective to Amacrine Cells in a Rat Model of Retinopathy of Prematurity
  13284. … and NMDA Receptors, IP3, cGMP and cAMP Functional Regulation in Pilocarpine Induced Temporal Lobe Epilepsy in Rats: Neuroprotective Role of Bacopa …
  13285. An okadaic acid induced Alzheimer’s model and the Neuroprotective effects of estrogen
  13286. Discovery of a proneurogenic, Neuroprotective chemical
  13287. Nutraceutical antioxidants as novel Neuroprotective agents
  13288. Neuroprotective properties of chitosan and its derivatives
  13289. Exercise exerts Neuroprotective effects on Parkinson’s disease model of rats
  13290. Rational design and simple chemistry yield a superior, Neuroprotective HDAC6 inhibitor, tubastatin A
  13291. Synergistic Neuroprotective therapies with hypothermia
  13292. Neuroprotective properties of resveratrol in different neurodegenerative disorders
  13293. Olesoxime (TRO19622): a novel mitochondrial-targeted Neuroprotective compound
  13294. Differential Neuroprotective effects of 14-3-3 proteins in models of Parkinson’s disease
  13295. Neuroprotective and neurochemical properties of mint extracts
  13296. Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models
  13297. Neuroprotective herbs and foods from different traditional medicines and diets
  13298. Role of astroglia in the neuroplastic and Neuroprotective actions of estradiol
  13299. Erythropoietin as Neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research
  13300. Neuroprotective activities of CEP-1347 in models of neuroAIDS
  13301. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma
  13302. RANTES upregulation in the Alzheimer’s disease brain : a possible Neuroprotective role
  13303. Extranuclear estrogen receptors mediate the Neuroprotective effects of estrogen in the rat hippocampus
  13304. Exploring new routes for Neuroprotective drug development in traumatic brain injury
  13305. Neuroprotective mechanisms of natural polyphenolic compounds
  13306. cognitive enhancement and Neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model
  13307. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer’s disease
  13308. Neuroprotective phenolics in medicinal plants
  13309. Exploring Neuroprotective drug therapies for intracerebral hemorrhage
  13310. Cardioprotective and Neuroprotective roles of oleuropein in olive
  13311. The Neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation
  13312. Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with Neuroprotective activity
  13313. Functional role of brain -derived neurotrophic factor in Neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis
  13314. Neuroprotective effects of Lepidium meyenii (Maca)
  13315. Neuroprotective effect of morroniside on focal cerebral ischemia in rats
  13316. An antiapoptotic Neuroprotective role for neuroglobin
  13317. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial
  13318. Functional identification of Neuroprotective molecules
  13319. Mitochondrial preconditioning: a potential Neuroprotective strategy
  13320. Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved
  13321. A possible Neuroprotective action of a vinylic telluride against Mn-induced neurotoxicity
  13322. Resveratrol protects against experimental stroke: putative Neuroprotective role of heme oxygenase 1
  13323. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective Neuroprotective therapy?
  13324. Annexin A1: a central player in the anti-inflammatory and Neuroprotective role of microglia
  13325. Wormwood (Artemisia absinthium L.)—A curious plant with both neurotoxic and Neuroprotective properties?
  13326. Neuroprotective strategies for intracerebral hemorrhage: trials and translation
  13327. Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons
  13328. Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with Neuroprotective autoimmunity
  13329. Humanins, the Neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties
  13330. Monoamine oxidase inhibitors as Neuroprotective agents in age-dependent neurodegenerative disorders
  13331. … mediates Neuroprotective effects on retinal ganglion cells via activation of the Wnt/β-catenin signaling pathway and the induction of Neuroprotective growth factors in …
  13332. Neuroprotective effects of zonisamide target astrocyte
  13333. Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats
  13334. Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia
  13335. The Neuroprotective mechanism of 1‐(R)‐aminoindan, the major metabolite of the anti‐parkinsonian drug rasagiline
  13336. Neuroprotective activity of Matricaria recutita Linn against global model of ischemia in rats
  13337. Mechanisms of Neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of α4 and α7 receptors in Neuroprotection
  13338. Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice
  13339. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor
  13340. Control of intracellular calcium signaling as a Neuroprotective strategy
  13341. Ischemic pre‐conditioning alters cerebral microRNAs that are upstream to Neuroprotective signaling pathways
  13342. Inhibition of cytokine-induced connexin43 hemichannel activity in astrocytes is Neuroprotective
  13343. Anti-inflammatory activity of salvianolic acid B in microglia contributes to its Neuroprotective effect
  13344. Activation of autophagy and Akt/CREB signaling play an equivalent role in the Neuroprotective effect of rapamycin in neonatal hypoxia-ischemia
  13345. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and Neuroprotective phenotype
  13346. Effects of estrogen in the brain : is it a Neuroprotective agent in Alzheimer’s disease?
  13347. Potential future Neuroprotective therapies for neurodegenerative disorders and stroke
  13348. Antioxidant Components as Potential Neuroprotective agents in Sesame (Sesamum indicum L.)
  13349. Neuroprotective effect of Artemisia absinthium L. on focal ischemia and reperfusion-induced cerebral injury
  13350. Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats
  13351. Antioxidant properties and Neuroprotective capacity of strawberry tree fruit (Arbutus unedo)
  13352. Glucosamine exerts a Neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury
  13353. Morin exerts Neuroprotective actions in Parkinson disease models in vitro and in vivo
  13354. Neuroprotective effects of hyperbaric oxygen treatment on traumatic brain injury in the rat
  13355. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is Neuroprotective after ischemic stroke in rats
  13356. Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity
  13357. The mechanism for the Neuroprotective effect of melatonin against methamphetamine‐induced autophagy
  13358. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells
  13359. The Neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons
  13360. Peroxisome proliferator-activated receptor gamma agonists as Neuroprotective agents .
  13361. Neuroprotective effect of Centella asiatica extract (CAE) on experimentally induced parkinsonism in aged Sprague-Dawley rats
  13362. Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25–35) oligomer-induced toxicity
  13363. Antioxidant, antiinflammatory and Neuroprotective actions of chondroitin sulfate and proteoglycans
  13364. Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury
  13365. Notch signaling influences Neuroprotective and proliferative properties of mature Müller glia
  13366. Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons
  13367. Phenolic content of grapevine leaves (Vitis labrusca var. Bordo) and its Neuroprotective effect against peroxide damage
  13368. Valproic acid is Neuroprotective in the rotenone rat model of Parkinson’s disease: involvement of α-synuclein
  13369. Stimulation of the rat subthalamic nucleus is Neuroprotective following significant nigral dopamine neuron loss
  13370. Synthesis, inhibitory activity of cholinesterases, and Neuroprotective profile of novel 1, 8-naphthyridine derivatives
  13371. Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats
  13372. Cassiae semen, a seed of Cassia obtusifolia, has Neuroprotective effects in Parkinson’s disease models
  13373. Novel tacrine− 8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with Neuroprotective , cholinergic, antioxidant, and copper …
  13374. Neuroprotective effects of naturally occurring polyphenols on quinolinic acid‐induced excitotoxicity in human neurons
  13375. Antihypertensive and Neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity
  13376. Magnetic resonance biomarkers of Neuroprotective effects in infants with hypoxic ischemic encephalopathy
  13377. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo
  13378. Phosphatidylserine-dependent Neuroprotective signaling promoted by docosahexaenoic acid
  13379. Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties
  13380. New-generation Skulachev ions exhibiting nephroprotective and Neuroprotective properties
  13381. Neuroprotective effects of the polyphenolic antioxidant agent, Curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat
  13382. Neuroprotective effect of astaxanthin on H2O2-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo
  13383. Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats
  13384. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on Neuroprotective effects of stromal …
  13385. Neuroprotective properties of picroside II in a rat model of focal cerebral ischemia
  13386. Neuroprotective effects of progesterone following stroke in aged rats
  13387. Neuroprotective effects of postconditioning on lipid peroxidation and apoptosis after focal cerebral ischemia/reperfusion injury in rats.
  13388. Synthesis of tropolone derivatives and evaluation of their in vitro Neuroprotective activity
  13389. Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are Neuroprotective in rat eyes following optic nerve transection
  13390. Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice
  13391. Impaired ganglioside metabolism in Huntington’s disease and Neuroprotective role of GM1
  13392. The Neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors
  13393. Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats
  13394. Neuroprotective effects of leonurine on ischemia/reperfusion-induced mitochondrial dysfunctions in rat cerebral cortex
  13395. Chronic in vitro ketosis is Neuroprotective but not anti‐convulsant
  13396. The Neuroprotective role of PEDF: implication for the therapy of neurological disorders
  13397. The anti-inflammatory and Neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats
  13398. Neuroprotective effect of 4-hydroxybenzyl alcohol against transient focal cerebral ischemia via anti-apoptosis in rats
  13399. Neuroprotective effect of Bacopa monniera on ischemia induced brain injury
  13400. Trials of Neuroprotective therapies for Parkinson’s disease: problems and limitations
  13401. A Neuroprotective sulfone of marine origin and the in vivo anti-inflammatory activity of an analogue
  13402. Targeting NMNAT1 to axons and synapses transforms its Neuroprotective potency in vivo
  13403. Iba1+/NG2+ Macrophage-Like Cells Expressing a Variety of Neuroprotective Factors Ameliorate Ischemic Damage of the brain
  13404. Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a Neuroprotective therapeutic modality
  13405. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc as a Neuroprotective drug target
  13406. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress
  13407. Genistein as a Neuroprotective antioxidant attenuates redox imbalance induced by β-amyloid peptides 25–35 in PC12 cells
  13408. Tetrabenazine is Neuroprotective in Huntington’s disease mice
  13409. Novel anti-inflammatory and Neuroprotective agents for Parkinson’s disease
  13410. Neuroprotective effects of bis (7)-tacrine against glutamate-induced retinal ganglion cells damage
  13411. Optic nerve and vitreal inflammation are both RGC Neuroprotective but only the latter is RGC axogenic
  13412. Up‐regulation of crystallins is involved in the Neuroprotective effect of wolfberry on survival of retinal ganglion cells in rat ocular hypertension model
  13413. Neuroprotective effects of astaxanthin in oxygen-glucose deprivation in SH-SY5Y cells and global cerebral ischemia in rat
  13414. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta‐amyloid‐induced toxicity in PC12 cells
  13415. Developmental regulation and Neuroprotective effects of striatal tonic GABAA currents
  13416. Clinically Relevant Progestins Regulate Neurogenic and Neuroprotective Responses in Vitro and in Vivo
  13417. Chronic and acute models of retinal neurodegeneration TrkA activity are Neuroprotective whereas p75NTR activity is neurotoxic through a paracrine …
  13418. Neuroprotective effects of emodin in rat cortical neurons against β-amyloid-induced neurotoxicity
  13419. Neuroprotective effect of Spirulina in cerebral ischemia–reperfusion injury in rats
  13420. Optimal parameters of transcorneal electrical stimulation (TES) to be Neuroprotective of axotomized RGCs in adult rats
  13421. Neuroprotective effect of 3, 5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate …
  13422. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible Neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion
  13423. Neuroprotective effects of alpha-lipoic acid in experimental spinal cord injury in rats
  13424. … promotion of neural regeneration in an extreme rat spinal cord injury model using a collagen scaffold containing a collagen binding Neuroprotective protein and an …
  13425. Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities
  13426. Neuroprotective effect of piperine on primarily cultured hippocampal neurons
  13427. Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats
  13428. Neuroprotective effect of atorvastatin in an experimental model of nerve crush injury
  13429. Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage
  13430. Curcumin produces Neuroprotective effects via activating brain -derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons
  13431. Neuroprotective effect of baicalein on hydrogen peroxide-mediated oxidative stress and mitochondrial dysfunction in PC12 cells
  13432. Neuroprotective role for galanin in Alzheimer’s disease
  13433. Neuroprotective potential of the NF-κB inhibitor peptide IKK-NBD in cerebral ischemia-reperfusion injury
  13434. Disease‐toxicant screen reveals a Neuroprotective interaction between Huntington’s disease and manganese exposure
  13435. Parkinson’s disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic Neuroprotective nutrition
  13436. Neuroprotective effect of osthole on MPP+-induced cytotoxicity in PC12 cells via inhibition of mitochondrial dysfunction and ROS production
  13437. Lack of Neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury
  13438. Vascular endothelial growth factor signaling implicated in Neuroprotective effects of placental growth factor in an in vitro ischemic model
  13439. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of Parkinson’s …
  13440. Neuroprotective effects of Dendrobium alkaloids on rat cortical neurons injured by oxygen-glucose deprivation and reperfusion
  13441. Baicalein is Neuroprotective in rat MCAO model: role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2
  13442. Neuroprotective effect of ginsenoside Rb1 on glutamate-induced neurotoxicity: with emphasis on autophagy
  13443. Morphine induces the release of CCL5 from astrocytes: potential Neuroprotective mechanism against the HIV protein gp120
  13444. Novel Neuroprotective strategies in ischemic retinal lesions
  13445. CSPα: the Neuroprotective J protein
  13446. Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo
  13447. Neuroprotective effect of quercetin encapsulated liposomes: a novel therapeutic strategy against Alzheimer’s disease.
  13448. Neuroprotective effect of baicalin on compression spinal cord injury in rats
  13449. Melatonin potentiates the Neuroprotective properties of resveratrol against beta-amyloid-induced neurodegeneration by modulating AMP-activated protein …
  13450. Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury
  13451. Erythropoietin is Neuroprotective in a preterm ovine model of endotoxin-induced brain injury
  13452. Inhibition of CCAAT/enhancer binding protein δ expression by chrysin in microglial cells results in anti‐inflammatory and Neuroprotective effects
  13453. Activated protein C is Neuroprotective and mediates new blood vessel formation and neurogenesis after controlled cortical impact
  13454. Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
  13455. The Neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke
  13456. Synergistic Neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH‐SY5Y neuroblastoma cells
  13457. Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington’s disease
  13458. Resveratrol is Neuroprotective because it is not a direct activator of Sirt1—A hypothesis
  13459. Curcumin exerts Neuroprotective effects against homocysteine intracerebroventricular injection-induced cognitive impairment and oxidative stress in rat brain
  13460. Expression of activity-dependent Neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis
  13461. Neuroprotective effect of Rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y
  13462. Hydrogen is Neuroprotective and preserves cerebrovascular reactivity in asphyxiated newborn pigs
  13463. Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice
  13464. Neuroprotective effect of L‐serine against temporary cerebral ischemia in rats
  13465. Neuroprotective Mechanism of Mitochondrial Ferritin on 6-Hydroxydopamine–Induced Dopaminergic Cell Damage: Implication for Neuroprotection in Parkinson’s …
  13466. Neuroprotective properties of mildronate, a mitochondria-targeted small molecule
  13467. Neuroprotective effect of luteolin on amyloid β protein (25–35)‐induced toxicity in cultured rat cortical neurons
  13468. Mitochondrial UCP5 is Neuroprotective by preserving mitochondrial membrane potential, ATP levels, and reducing oxidative stress in MPP+ and dopamine toxicity
  13469. Oxytocin is Neuroprotective against oxygen–glucose deprivation and reoxygenation in immature hippocampal cultures
  13470. Neuroprotective effects of leptin following kainic acid-induced status epilepticus
  13471. Dealing with misfolded proteins: examining the Neuroprotective role of molecular chaperones in neurodegeneration
  13472. Neuroprotective effects of icariin on memory impairment and neurochemical deficits in senescence-accelerated mouse prone 8 (SAMP8) mice
  13473. Neuroprotective effect of s-methylisothiourea in transient focal cerebral ischemia in rat
  13474. Neuroprotective effects of Triticum aestivum L. against β‐Amyloid‐induced cell death and memory impairments
  13475. Why do we need multifunctional Neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s diseases as disease modifying agents
  13476. Neuroprotective role of intermittent fasting in senescence-accelerated mice P8 (SAMP8)
  13477. A method for preparing primary retinal cell cultures for evaluating the Neuroprotective and neuritogenic effect of factors on axotomized mature CNS neurons
  13478. Effect of Neuroprotective Flavonoids of Agrimonia eupatoria on Glutamate-Induced Oxidative Injury to HT22 Hippocampal Cells
  13479. Neuroprotective effects of hydroxysafflor yellow A against excitotoxic neuronal death partially through down-regulation of NR2B-containing NMDA receptors
  13480. Evaluating a simple method of Neuroprotective hypothermia for newborn infants
  13481. … kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not Neuroprotective in the R6/2 …
  13482. Kinin receptor antagonists as potential Neuroprotective agents in central nervous system injury
  13483. The β2-adrenoceptor agonist clenbuterol elicits Neuroprotective , anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity
  13484. The acute administration of eicosapentaenoic acid is Neuroprotective after spinal cord compression injury in rats
  13485. Therapeutic efficacy of the Neuroprotective plant adaptogen in neurodegenerative disease (Parkinson’s disease as an example)
  13486. Neuroprotective effects of genistein in mongolian gerbils: Estrogen receptor–β involvement
  13487. Neuroprotective effect of flurbiprofen in focal cerebral ischemia: the possible role of ASIC1a
  13488. Comparison of Neuroprotective effects in ischemic rats with different hypothermia procedures
  13489. Multipotent drugs with cholinergic and Neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment …
  13490. The Neuroprotective effects of Tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF …
  13491. Future Neuroprotective strategies
  13492. Immunomodulatory, β-cell, and Neuroprotective actions of fenugreek oil from alloxan-induced diabetes
  13493. Comparison of uptake and Neuroprotective potential of seven zinc-salts
  13494. Symptomatic and Neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson’s disease
  13495. Potent Neuroprotective effects of novel structural derivatives of valproic acid: potential roles of HDAC inhibition and HSP70 induction
  13496. Neuroprotective effect of gypenosides against oxidative injury in the substantia nigra of a mouse model of Parkinson’s disease
  13497. Neuroprotective effects of constituents of the root bark of Dictamnus dasycarpus in mouse hippocampal cells
  13498. Red mold rice promotes Neuroprotective sAPPalpha secretion instead of Alzheimer’s risk factors and amyloid beta expression in hyperlipidemic Aβ40-infused rats
  13499. Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat
  13500. A versatile high throughput screening system for the simultaneous identification of anti-inflammatory and Neuroprotective compounds
  13501. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have Neuroprotective effects against focal cerebral ischemia
  13502. PPARγ agonist rosiglitazone is Neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats
  13503. Neuroprotective effects of tamoxifen on experimental spinal cord injury in rats
  13504. Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat
  13505. Potent Neuroprotective role of novel melatonin derivatives for management of central neuropathy induced by acrylamide in rats
  13506. Neuroprotective Effect of Lipoxin A 4 Methyl Ester in a Rat Model of Permanent Focal Cerebral Ischemia
  13507. Prolonged activation of ERK triggers glutamate‐induced apoptosis of astrocytes: Neuroprotective effect of FK506
  13508. Neuroprotective effect of seaweeds inhabiting South Indian coastal area (Hare Island, Gulf of Mannar Marine Biosphere Reserve): Cholinesterase inhibitory effect of …
  13509. β-Adrenoceptor activation depresses brain inflammation and is Neuroprotective in lipopolysaccharide-induced sensitization to oxygen-glucose deprivation in …
  13510. The COX-2 inhibitor parecoxib is Neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy
  13511. CalDAG-GEFI down-regulation in the striatum as a Neuroprotective change in Huntington’s disease
  13512. Neuroprotective effects of testosterone on regenerating spinal cord motoneurons in rats
  13513. Neuroprotective agents in glaucoma therapy: Recent developments and future directions
  13514. Estrogen receptor alpha and G-protein coupled receptor 30 mediate the Neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models
  13515. Antioxidant and Neuroprotective effects of standardized extracts of Mangifera indica leaf.
  13516. Cysteine-string protein’s Neuroprotective role
  13517. Ibuprofen and lipoic acid diamides as potential codrugs with Neuroprotective activity
  13518. Stem cell-based Neuroprotective and neurorestorative strategies
  13519. Anti-apoptotic and Neuroprotective effects of alpha-lipoic acid on spinal cord ischemia–reperfusion injury in rabbits
  13520. Ketogenic diet exhibits Neuroprotective effects in hippocampus but fails to prevent epileptogenesis in the lithium‐pilocarpine model of mesial temporal lobe epilepsy in …
  13521. A Neuroprotective Polysaccharide from Hyriopsis cumingii
  13522. Novel insights into lithium’s mechanism of action: neurotrophic and Neuroprotective effects
  13523. Brimonidine is Neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells
  13524. NGF‐Dependent activation of TrkA pathway: A mechanism for the Neuroprotective effect of troxerutin in D‐galactose‐treated mice
  13525. Study on the Neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET
  13526. Neuroprotective effects of infliximab in experimental spinal cord ischemic injury
  13527. Neuroprotective effect of repeated treatment with Hericium erinaceum in mice subjected to middle cerebral artery occlusion
  13528. Antiviral and Neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis
  13529. An investigation of the Neuroprotective effects of Curcumin in a model of Homocysteine-induced oxidative stress in the rat’s brain
  13530. Polyamine conjugation of curcumin analogues toward the discovery of mitochondria-directed Neuroprotective agents
  13531. The functional and Neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury
  13532. A pharmacological analysis of the Neuroprotective efficacy of the brain -and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact …
  13533. Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats
  13534. Involvement of mitochondria on Neuroprotective effect of sphingosine-1-phosphate in cell death in an in vitro model of brain ischemia
  13535. Neuroprotective effect of small heat shock protein, Hsp27, after acute and chronic alcohol administration
  13536. Neuroprotective effect of pioglitazone on acute phase changes induced by partial global cerebral ischemia in mice
  13537. Neuroprotective effects of (−)-epigallocatechin-3-gallate against quinolinic acid-induced excitotoxicity via PI3K pathway and NO inhibition
  13538. Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study
  13539. Erythropoietin and sonic hedgehog mediate the Neuroprotective effects of brain -derived neurotrophic factor against mitochondrial inhibition
  13540. The Neuroprotective effects of fibronectin mats and fibronectin peptides following spinal cord injury in the rat
  13541. Neuroprotective effects of NSTyr on cognitive function and neuronal plasticity in rats of chronic cerebral hypoperfusion
  13542. Amelioration of endothelial damage/dysfunction is a possible mechanism for the Neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage
  13543. Neuroprotective effect of visnagin on kainic acid-induced neuronal cell death in the mice hippocampus
  13544. Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington’s disease
  13545. … and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino (6-trifluoromethoxy) benzothiazole as Neuroprotective agents potentially useful in …
  13546. The orally combined Neuroprotective effects of sodium ferulate and borneol against transient global ischaemia in C57 BL/6J mice
  13547. Growth hormone expression and Neuroprotective activity in a quail neural retina cell line
  13548. The Neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats
  13549. Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study
  13550. Neuroprotective effect of Hibiscus rosa sinensis in an oxidative stress model of cerebral post-ischemic reperfusion injury in rats
  13551. Alterations in hippocampal serotonergic and INSR function in streptozotocin induced diabetic rats exposed to stress: Neuroprotective role of pyridoxine and …
  13552. Neuroprotective mechanisms of brain ‐derived neurotrophic factor against 3‐nitropropionic acid toxicity: therapeutic implications for Huntington’s disease
  13553. Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis
  13554. Amyloid-beta peptide, oxidative stress and inflammation in alzheimer’s disease: Potential Neuroprotective effects of omega-3 polyunsaturated fatty acids
  13555. Role of ERK signaling in the Neuroprotective efficacy of magnesium sulfate treatment during focal cerebral ischemia in the gerbil cortex
  13556. Neuroprotective effects of Xiao-Xu-Ming decoction against ischemic neuronal injury in vivo and in vitro
  13557. Neuroprotective efficacy and therapeutic window of Forsythoside B: in a rat model of cerebral ischemia and reperfusion injury
  13558. Gene expression profiling in brain of mice exposed to the marine neurotoxin ciguatoxin reveals an acute anti-inflammatory, Neuroprotective response
  13559. Neuroprotective effect of WIN 55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signal-regulated kinases in rats
  13560. Neuroprotective effects of salvianolic acid B against oxygenglucose deprivation/reperfusion damage in primary rat cortical neurons
  13561. Synthesis and biological evaluation of novel pyrazolyl-2, 4-thiazolidinediones as anti-inflammatory and Neuroprotective agents
  13562. Voltage-gated K+ channel modulators as Neuroprotective agents
  13563. Neuroprotective effect of upregulated sonic Hedgehog in retinal ganglion cells following chronic ocular hypertension
  13564. Breakdown of the blood-brain barrier in stress alters cognitive dysfunction and induces brain pathology: new perspectives for Neuroprotective strategies
  13565. Cell type-specific Neuroprotective activity of untranslocated prion protein
  13566. Neuroprotective effects of C-type natriuretic peptide on rat retinal ganglion cells
  13567. Neuroprotective effect of 5, 7, 3′, 4′, 5′-pentahydroxy dihdroflavanol-3-O-(2 ″-O-galloyl)-β-d-glucopyranoside, a polyphenolic compound in focal cerebral …
  13568. Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress
  13569. Synthesis and in vitro evaluation of novel 1, 2, 4-triazine derivatives as Neuroprotective agents
  13570. Neuroprotective effects of gabapentin in experimental spinal cord injury
  13571. Antioxidant and Neuroprotective effects of gamisoyo-san
  13572. Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment
  13573. Neuroprotective Xanthone Glycosides from Swertia punicea
  13574. Neuroprotective actions of aminoguanidine involve reduced the activation of calpain and caspase-3 in a rat model of stroke
  13575. Neuroprotective properties of prostaglandin I2 IP receptor in focal cerebral ischemia
  13576. The interaction of the Neuroprotective compounds riluzole and phenobarbital with AMPA-type glutamate receptors: a patch-clamp study
  13577. The new inhibitor of monoamine oxidase, M30, has a Neuroprotective effect against dexamethasone-induced brain cell apoptosis
  13578. Neuroprotective effect of overexpression of thioredoxin on photoreceptor degeneration in Tubby mice
  13579. Neuroprotective action of FK-506 (tacrolimus) after seizures induced with pilocarpine: quantitative and topographic elemental analysis of brain tissue
  13580. brain microvascular endothelial cells mediate Neuroprotective effects on ischemia/reperfusion neurons
  13581. … highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and Neuroprotective therapy for Parkinson’s …
  13582. Ethyl pyruvate has a Neuroprotective effect through activation of extracellular signal-regulated kinase in Parkinson’s disease model
  13583. Long-term Neuroprotective effect of postischemic hypothermia in a neonatal rat model of severe hypoxic ischemic encephalopathy: a comparative study on the …
  13584. Extension of the Neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion
  13585. Neuritogenic and Neuroprotective properties of peptide agonists of the fibroblast growth factor receptor
  13586. Neuroprotective effect of HT008‐1, a prescription of traditional Korean medicine, on transient focal cerebral ischemia model in rats
  13587. Cell permeable peptides: a promising tool to deliver Neuroprotective agents in the brain
  13588. Nanowired-drug delivery enhances Neuroprotective efficacy of compounds and reduces spinal cord edema formation and improves functional outcome following …
  13589. Activity-dependent Neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer’s disease
  13590. Neuroprotective effects of selective N-type VGCC blockade on stretch-injury-induced calcium dynamics in cortical neurons
  13591. Potential Neuroprotective effects of acupuncture stimulation on diabetes mellitus in a global ischemic rat model
  13592. Cyclic-AMP response element binding protein and tau are involved in the Neuroprotective mechanisms of nerve growth factor during focal cerebral ischemia …
  13593. Modulation of Neuroprotective effect of ischemic post-conditioning by dichlorobenzamil a Na+/Ca2+ exchanger inhibitor in mice
  13594. Morphological changes of the neural cells after blast injury of spinal cord and Neuroprotective effects of sodium β-aescinate in rabbits
  13595. The factors affecting the extraction condition for Neuroprotective activity of Centella asiatica evaluated by metal chelating activity assay.
  13596. Exogenous modulation of intrinsic optic nerve Neuroprotective activity
  13597. Enhanced retinal insulin receptor-activated Neuroprotective survival signal in mice lacking the protein-tyrosine phosphatase-1B gene
  13598. Neuroprotective strategies in drug abuse‐evoked encephalopathy
  13599. Neuroprotective effects of ischemic preconditioning on global brain ischemia through up-regulation of acid-sensing ion channel 2a
  13600. Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load
  13601. The Neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules
  13602. Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are Neuroprotective in a rat model of Huntington’s disease
  13603. Neuroprotective effect of Hericium erinaceum against oxidative stress on PC12 cells
  13604. Neuroprotective effects of estrogen treatment on ischemia-induced behavioural deficits in ovariectomized gerbils at different ages
  13605. Neuroprotective effects of testosterone in a naturally occurring model of neurodegeneration in the adult avian song control system
  13606. Neuroprotective effects of constituents of Eragrostis ferruginea against Aβ-induced toxicity in PC12 cells
  13607. Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson’s disease
  13608. Neuroprotective effects of pyruvate following NMDA-mediated excitotoxic insults in hippocampal slices
  13609. Neuroprotective Activity of Vitis thunbergii var. taiwaniana Extracts In Vitro and In Vivo
  13610. The Neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing …
  13611. Neuroprotective preconditioning of rat brain cultures with ethanol: potential transduction by PKC isoforms and focal adhesion kinase upstream of increases in effector …
  13612. Novel D3 dopamine receptor‐preferring agonist D‐264: Evidence of Neuroprotective property in Parkinson’s disease animal models induced by 1‐methyl‐4‐phenyl‐1 …
  13613. Neuroprotective effect of Spirulina in a mouse model of ALS
  13614. Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus
  13615. Electroconvulsive seizure-induced VEGF is correlated with Neuroprotective effects against cerebral infarction: Involvement of the phosphatidylinositol-3 kinase/Akt …
  13616. Genome-wide microarray analysis of the differential Neuroprotective effects of antioxidants in neuroblastoma cells overexpressing the familial Parkinson’s disease α …
  13617. Human angiogenin presents Neuroprotective and migration effects in neuroblastoma cells
  13618. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures
  13619. Flaviogeranin, a new Neuroprotective compound from Streptomyces sp.
  13620. Neuroprotective effect of vitamin C against the ethanol and nicotine modulation of GABAB receptor and PKA‐α expression in prenatal rat brain
  13621. Up‐regulation of the type 3 ryanodine receptor is Neuroprotective in the TgCRND8 mouse model of Alzheimer’s disease
  13622. New secoisolariciresinol derivatives from Lindera obtusiloba stems and their Neuroprotective activities
  13623. Phenelzine: An old drug that may hold clues to the development of new Neuroprotective agents
  13624. Neuroprotective effects of a novel peptide purified from venison protein
  13625. Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow’s Neuroprotective therapies against neurodegenerative diseases
  13626. Neuroprotective effects of stanniocalcin 2 following kainic acid-induced hippocampal degeneration in ICR mice
  13627. Neuroprotective effects of erythropoietin during deep hypothermic circulatory arrest
  13628. Heme oxygenase 1: another possible target to explain the Neuroprotective action of resveratrol, a multifaceted nutrient-based molecule
  13629. Neuroprotective effects of a sesquiterpene lactone and flavanones from Paulownia tomentosa Steud. against glutamate‐induced neurotoxicity in primary cultured rat …
  13630. Neuroprotective role of lipoic acid against acute toxicity of N-acetylaspartic acid
  13631. The c-Jun N-terminal kinase inhibitor SP600125 is Neuroprotective in amygdala kindled rats
  13632. Alterations in blood–brain barrier function and brain pathology by morphine in the rat. Neuroprotective effects of antioxidant H-290/51
  13633. Differing short-term Neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson’s disease
  13634. Ameliorative and Neuroprotective effect in MPTP model of Parkinson’s disease by Zhen-Wu-Tang (ZWT), a traditional Chinese medicine
  13635. Pharmacological preconditioning by milrinone: memory preserving and Neuroprotective effect in ischemia-reperfusion injury in mice
  13636. Androgens exert direct Neuroprotective effects on the brain : a review of pre-clinical evidences
  13637. Effect of dipyridamole during acute stroke: exploring antithrombosis and Neuroprotective benefits
  13638. Advanced achievements about Neuroprotective mechanisms of paeoniflorin
  13639. Neuroprotective actions of the synthetic estrogen 17α-Ethynylestradiol in the Hippocampus
  13640. Neuroprotective effects of calmodulin peptide 76‐121aa: disruption of calmodulin binding to mutant huntingtin
  13641. Neuroprotective effect of modified Wu-Zi-Yan-Zong granule, a traditional Chinese herbal medicine, on CoCl2-induced PC12 cells
  13642. Transplantation of cultured choroid plexus epithelial cells via cerebrospinal fluid shows prominent Neuroprotective effects against acute ischemic brain injury in the rat
  13643. Calcium antagonists: current and future applications based on new evidence. Neuroprotective effect of calcium antagonists
  13644. AP‐1 inhibitory peptides are Neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures
  13645. Pharmacology review: Neuroprotective treatments for hypoxic-ischemic injury
  13646. Ibuprofen and lipoic acid diamide as co-drug with Neuroprotective activity: Pharmacological properties and effects in β-amyloid (1–40) infused Alzheimer’s disease rat …
  13647. Expression profile of rat hippocampal neurons treated with the Neuroprotective compound 2, 4-dinitrophenol: up-regulation of cAMP signaling genes
  13648. A Neuroprotective exercise protocol reduces the adenine nucleotide hydrolysis in hippocampal synaptosomes and serum of rats
  13649. Neuroprotective effect of transient ischemic attack
  13650. Neuroprotective effect of mesna (2-mercaptoethane sulfonate) against spinal cord ischemia/reperfusion injury in rabbits
  13651. Bio-released gold ions modulate expression of Neuroprotective and hematopoietic factors after brain injury
  13652. Neuroprotective effect of aqueous extract of Berberis vulgaris L. in a model of Parkinson’s disease in rat.
  13653. Neuroprotective drugs in traumatic CNS injury
  13654. Prevention of the alcohol-induced changes in brain -derived neurotrophic factor expression using Neuroprotective peptides in a model of fetal alcohol syndrome
  13655. Neuroprotective and Anti-inflammatory Effects of Bee Venom Acupuncture on MPTP-induced Mouse
  13656. Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury
  13657. Neuroprotective effects of the drug GVT (monosodium luminol) are mediated by the stabilization of Nrf2 in astrocytes
  13658. Neuroprotective effect of dauricine after transient middle cerebral artery occlusion in rats: involvement of Bcl-2 family proteins
  13659. Approaches to Neuroprotective strategies in multiple sclerosis
  13660. Neuroprotective effect of hydroalcoholic extract of dried fruits of Trapa bispinosa Roxb on lipofuscinogenesis and fluorescence product in brain of D-galactose …
  13661. Neuroprotective effect of parthenocissin A, a natural antioxidant and free radical scavenger, in focal cerebral ischemia of rats
  13662. Neuroprotective effects of Asparagus racemosus Linn root extract: an experimental and clinical evidence
  13663. Dopamine D1 and D2 receptor functional down regulation in the cerebellum of hypoxic neonatal rats: Neuroprotective role of glucose and oxygen, epinephrine …
  13664. Neuroprotective effects of tanshinone II A on vascular dementia in rats
  13665. Neuroprotective effects of consuming bovine colostrum after focal brain ischemia/reperfusion injury in rat model
  13666. Key compound groups for the Neuroprotective effect of roots of Polygonum cuspidatum on transient middle cerebral artery occlusion in Sprague-Dawley rats
  13667. Electrophysiological effects of SKF83959 on hippocampal CA1 pyramidal neurons: potential mechanisms for the drug’s Neuroprotective effects
  13668. Additive effects of combination treatment with anti-inflammatory and Neuroprotective agents in experimental autoimmune encephalomyelitis
  13669. The Neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+-or 6-OHDA-treated SK-N-BE (2) C and SH-SY5Y human neuroblastoma cells
  13670. Studies on the Neuroprotective role of Piper longum in C6 glioma induced rats
  13671. Recent advances on the possible Neuroprotective activities of Epstein-Barr virus oncogene BARF1 protein in chronic inflammatory disorders of central nervous system
  13672. Endothelin-1 is elevated in Alzheimer’s disease brain microvessels and is Neuroprotective
  13673. Neuroprotective effect of modified Boyanghwano-Tang and the major medicinal plants, Astragali Radix and Salviae Miltiorrhizae Radix on ischemic stroke in rats
  13674. Mitochondrial optic neuropathy: in vivo model of neurodegeneration and Neuroprotective strategies
  13675. Angiotensin type‐1 receptor inhibition is Neuroprotective to amacrine cells in a rat model of retinopathy of prematurity
  13676. Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
  13677. More indirect evidence of potential Neuroprotective benefits of angiotensin receptor blockers
  13678. The Neuroprotective efficacy of vitamins
  13679. The biochemical basis of hydroxymethylglutaryl-CoA reductase inhibitors as Neuroprotective agents in aneurysmal subarachnoid hemorrhage
  13680. Neuroprotective effect of Fn14 deficiency is associated with induction of the granulocyte-colony stimulating factor (G-CSF) pathway in experimental stroke and …
  13681. Neuroprotective effects and mechanism of cognitive -enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis …
  13682. Acute treatment with herbal extracts provides Neuroprotective benefits in in vitro and in vivo stroke models, characterized by reduced ischemic cell death and …
  13683. … ±)-Methyl (1R,2S/1S,2R)-2-[(4-Hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-methylphenyl)cyclopropanecarboxylate [(±)-PPCC)]: New σ Receptor Ligands with Neuroprotective …
  13684. The only evidence based Neuroprotective therapy for acute ischemic stroke: Thrombolysis
  13685. The selective β1‐adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with Neuroprotective abilities
  13686. Neuroprotective effects of Korean kiwifruit against t-BHP-induced cell damage in PC12 cells
  13687. A phase I clinical trial of tiopronin, a putative Neuroprotective agent, in aneurysmal subarachnoid hemorrhage
  13688. 11 Biomarkers to Enable the Development of Neuroprotective Therapies for Huntington’s Disease
  13689. G-CSF administration is Neuroprotective following transient cerebral ischemia even in the absence of a functional NOS-2 gene
  13690. Neuroprotective Effects of Ginsenoside Rg3 against 24-OH-cholesterol-induced Cytotoxicity in Cortical Neurons
  13691. Neuroprotective effects of mexiletine on motor evoked potentials in demyelinated rat spinal cords
  13692. Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: Neuroprotective effects of acetyl-L-carnitine and resveratrol
  13693. Neuroprotective action of Piper longum against MPTP-induced changes in mouse brain
  13694. Systemic Hyperthermia Masks the Neuroprotective Effects of MK‐801, but not Rosiglitazone in brain Ischaemia
  13695. Why do we need multifunctional Neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s disorders?
  13696. Neuroprotective effects of neutral pharmacopuncture for blood stasis and Tangguisusangami-tang (dangguixusanjiawei-tang) in the experimental traumatic brain …
  13697. Neuroprotective effects of FK506 against excitotoxicity in organotypic hippocampal slice culture
  13698. Pharmacology of rasagiline, a new MAO-B inhibitor drug for the treatment of Parkinson’s disease with Neuroprotective potential
  13699. Synthesis and Neuroprotective action of optically pure Neoechinulin A and its analogs
  13700. Neuroprotective effect on retinal ganglion cells by transpupillary laser irradiation of the optic nerve head
  13701. Neuroprotective Effects of the extract of Zingiberis Rhizoma
  13702. Potential Neuroprotective effect of γ-glutamylcysteine ethyl ester on rat brain against kainic acid-induced excitotoxicity
  13703. Neuroprotective effect of KB-R7943 against glutamate excitotoxicity is related to mild mitochondrial depolarization
  13704. A purpose-oriented life: is it potentially Neuroprotective ?
  13705. New Neuroprotective dibenzylbutane lignans isolated from Machilus thunbergii
  13706. The σ1 receptor agonist 4-PPBP elicits ERK1/2 phosphorylation in primary neurons: a possible mechanism of Neuroprotective action
  13707. An in vitro study on Neuroprotective effects of serum containing Gengnianchun decoction and its main monomers against amyloid beta protein-induced cellular toxicity.
  13708. In vivo Neuroprotective effects of peripheral kynurenine on acute neurotoxicity induced by glutamate in rat cerebral cortex
  13709. Neuroprotective mechanism of tetrahydroxystilbene glucoside on rats after cerebral ischemia-reperfusion
  13710. Neuroprotective effect of taurine against oxidative stress-induced damages in neuronal cells
  13711. Enhanced expression of glycine N‐methyltransferase by adenovirus‐mediated gene transfer in CNS culture is Neuroprotective
  13712. The Neuroprotective effect of intranasally applied leptin against hypoxic neuronal injury
  13713. Is a Neuroprotective Therapy Suitable for Schizophrenia Patients?
  13714. Neuroprotective effect of extract of Ginkgo biloba against excitotoxicty compared with ginkgolide B in neuron cell of rat
  13715. Erythropoietin as a neonatal Neuroprotective agent
  13716. Neuroprotective and neurotoxic phenotypes of activated microglia in neonatal mice with respective MPTP-and ethanol-induced brain injury
  13717. Delayed Neuroprotective effect of sevoflurane on the expression of NF-kappaB following transient focal ischemia-reperfusion in rats
  13718. The Neuroprotective effect of talipexole from paraquat-induced cell death in dopaminergic neuronal cells
  13719. A Comparison of Neuroprotective Efficacy of the Oxime K203 and its Fluorinated Analogue (KR‐22836) with Obidoxime in Tabun‐Poisoned Rats
  13720. An approach for Neuroprotective therapies of secondary brain damage after excitotoxic retinal injury in mice
  13721. Neuroprotective Effects of N‐Alkyl‐1,2,4‐oxadiazolidine‐3,5‐diones and Their Corresponding Synthetic Intermediates N‐Alkylhydroxylamines and N‐1‐Alkyl‐3 …
  13722. Assessing the Neuroprotective effect of antioxidant food factors by application of lipid-derived dopamine modification adducts
  13723. Neuroprotective effects of erythropoietin in preterm infants
  13724. Antioxidant activity and Neuroprotective effect of concentrates from commercial sweet persimmon wine
  13725. Neuroprotective properties of afobazole in repeated hemorrhagic stroke modeling in aged rats
  13726. Research progress of bioactive constituents, absorption, metabolism, and Neuroprotective effects from blueberry
  13727. Neuroprotective effects of Carpinus tschonoskii MAX on 6-hydroxydopamine-induced death of PC12 cells
  13728. Cobalt chloride induced histotoxic cerebral hypoxia: A new experimental model to study Neuroprotective effect
  13729. Neuroprotective effect of asymmetric dimethylarginine against 1‐methyl‐4‐phenylpyridinium ion‐induced damage in PC12 cells
  13730. Semisynthesis of novel monacolin J derivatives: hypocholesterolemic and Neuroprotective activities
  13731. Design, synthesis and biological evaluation of new ionone derivatives as potential Neuroprotective agents in cerebral ischemia
  13732. Is there a future for Neuroprotective agents in cardiac surgery?
  13733. Neuroprotective Effects of Bee Venom, which Removes High Molecular Elements against -induced Human Neuroblastoma SH-SY5Y Cell Death
  13734. Neuroprotective effects of emodin on primary rat cortical neurons apoptosis induced by hydrogen peroxide
  13735. Review on the Neuroprotective effects of green tea polyphenols for the treatment of neurodegenerative diseases
  13736. Neuroprotective effects of preconditioning with resveratrol on focal cerebral ischemia-reperfusion injury in rats
  13737. Neuroprotective effects of cromakalim on cerebral ischemia-reperfusion injury in rats: Correlation with hippocampal metabotropic glutamate receptor 1 alpha and …
  13738. Modulation of synaptic transmission and analysis of Neuroprotective effects of valproic acid and derivates in rat embryonic motoneurons
  13739. Neuroprotective role of statins in Alzheimers disease: anti-apoptotic signaling
  13740. Effect of the novel nootropic and Neuroprotective dipeptide noopept on the streptozotocin-induced model of sporadic Alzheimer disease in rats
  13741. Neuroprotective effect of CPDT on THA-induced cortical motor neuron death in an organotypic culture model
  13742. Calcium signal-initiated early activation of NF-κB in neurons is a Neuroprotective event in response to kainic acid-induced excitotoxicity
  13743. Potential Neuroprotective strategies for traumatic brain injury
  13744. Neuroprotective effect of Dabuyin pill, Qianzheng powder and combined formula on Parkinson’s disease mice brain .
  13745. Edaravone and Nrf2-inducers as Neuroprotective agents in human astrocytes exposed to hypoxia/reoxygenation
  13746. Neuroprotective effect of Bacopa monnieri leaf extract targeted at adenosine receptor in diabetic neuropathic pain.
  13747. Neuroprotective actions of curcumin
  13748. The Neuroprotective Efficacy of Antioxidants Against In Vitro Models of Oxidative Stress and Their Theoretical Application Via Intravitreal Injection Encapsulated in …
  13749. Neuroprotective effect of dahk peptide in an occlusive model of permanent focal ischemia in rats
  13750. Evaluate Neuroprotective chemicals in Drosophila models of Parkinson s disease
  13751. Neuroprotective effects of the immunodepressant FTY720 on caspase-3 expression and neural apoptosis in a rat model of acute spinal cord injury☆
  13752. Advances in research and application prospects of Neuroprotective therapy.
  13753. Cyclocreatine, an anticancer and Neuroprotective agent. Spectroscopic, structural and theoretical study
  13754. The Neuroprotective Effects of InSamYangYoung-tang (Renshenyangrongtang) on Aβ-induced Damages in Mice
  13755. N, N-Bis-(8-hydroxyquinoline-5-yl methyl)-benzyl substituted amines (HQNBA): Peroxisome proliferator-activated receptor (PPAR-γ) agonists with Neuroprotective …
  13756. Examination of the Neuroprotective effects of Liposome Encapsulated Curcumin Against Methylmercury induced Neurotoxicity in SH‐SY5Y Cells
  13757. Potential Neuroprotective effect of herbal extracts (NHA56) on hydrogen peroxide-induced SH-SY5Y cell lines
  13758. Neuroprotective Effects of Agrimoniae Herba against Intrastriatal Hemorrhage in Rats
  13759. Neuroprotective Effects of Gastrodin on PQ and MB Induced Dopaminergic Neurons Damage in C_ (57) BL mice [J]
  13760. Neuroprotective effect of picroside II on cerebral ischemia-reperfusion injury in rats.
  13761. «Green» synthesis of the Neuroprotective drug “Memantine”®
  13762. … DNA-repair enzyme Ku70 mRNA in the rat cerebral cortex following global cerebral ischemia/reperfusion: Is this correlated with Neuroprotective effects of theanine?
  13763. Novel Neuroprotective therapies for alzheimer’s and Parkinsons’s disease
  13764. Microglia as a target for inflammatory processes and Neuroprotective strategies
  13765. Dietary restriction to accompany the aging process in mice: Can it be Neuroprotective ?*☆
  13766. 6-Mercaptopurine exerts an immunomodulatory and Neuroprotective effect on permanent focal cerebral occlusion in rats
  13767. Management of glaucoma with Neuroprotective drug
  13768. Neuroprotective Effect of Ketone Bodies and Ketogenic Diet in Nmda-Induced Rgc Damage in Rat. Possible Involvement of Kynurenic Acid?
  13769. Neuroprotective Treatment for Ischemic Injury
  13770. Neuroprotective Effect of Isoflurane and N-Methyl-d-Aspartate Receptors in Ischemic brain Injury
  13771. Investigation of Neuroprotective effect using herb medicine against dementia related brain damage in organotypic hippocampal slice culture
  13772. FURTHER ELUCIDATION OF Neuroprotective PROPERTIES OF ASTROCYTOMA (ASTROCYTES-LIKE) CELLS.
  13773. Mechanisms of Chronic Nicotine Treatment–Induced Enhancement of the Sensitivity of Cortical Neurons to the Neuroprotective Effect of Donepezil in Cortical Neurons
  13774. Neuroprotective effects and mechanisms of the activation of group III metabotropic glutamate receptor in rodent models of Parkinson’s Disease.
  13775. The Neuroprotective actions of quercetin
  13776. Neuroprotective agents in Mood Disorders: Pathophysiological and Therapeutic Implications
  13777. Indip—a novel Neuroprotective agent?
  13778. Neuroprotective effect of low-molecular peptide mimetic (GK-2) of nerve growth factor is related to activated synthesis of heat shock proteins (HSP32 and HSP70) and …
  13779. Neuroprotective effect of dizocilpine (MK-801) via anti-apoptosis on hypoxic-ischemic brain injury in neonatal rats
  13780. Research Progress on Neuroprotective Effect of Uric Acid on Parkinson’s Disease
  13781. Mechanism of Neuroprotective effect of sinomenine after focal cerebral ischemia reperfusion injury in rats [J]
  13782. Neuroprotective Effects and Possible Mechanisms of SZJN on Cycle and Apoptosis Rate of Aβ-induced Cell Model of Alzheimer’s Disease [J]
  13783. Anticonvulsant and Neuroprotective effects of the ketogenic diet
  13784. Neuroprotective effects of serum with Tongqiao Huoxue decoction (TQHXD) against glutamate-induced neurotoxicity in PC12 cells
  13785. Neuroprotective Effect of Aqueous Extract of Polygala tenuifolia Willdenow on Nitric Oxide-induced Apoptosis in SK-N-MC Cells
  13786. Neuroprotective role of edaravone and the effects of endoplasmic reticulum stress in an adult rat model of focal cerebral ischemia/reperfusion☆
  13787. Neuroprotective effects of NsTyr against OGD-induced apoptosis on cortical neurons [J]
  13788. Immunohistochemistry and Western blot methodologies to evaluate Neuroprotective agents in models of retinopathies
  13789. … cells reaction in trimethyltin‐injured hippocampus of rats treated with myelin basic protein‐reactive T cells: Possible contribution to the Neuroprotective effect of T cells
  13790. In vivo and in vitro Neuroprotective effects of the pentane soluble compounds from Lepidium meyenii (Maca)
  13791. The Neuroprotective Effects of Daidzein on Hippocampal Neurons Injury Induced by Glutamate in Vitro on Rats [J]
  13792. Neuroprotective and procognitive activity of a family of benzothiopene SERMs
  13793. Therapeutic potential of thyreoliberin (TRH) and its analogues as antiepileptic and Neuroprotective drugs
  13794. The mechanisms of Neuroprotective effect of pioglitazone on amyloid beta-protein fragment 25-35-induced neurotoxicity in the cultured cortical neurons [J]
  13795. n-3 fatty acids are Neuroprotective after cerebral hypoxia-ischemia in rodent models
  13796. A study on the Neuroprotective effect of estrogen on H_2O_2-induced oxidative stress in PC12 cells [J]
  13797. Health-related Quality of Life Impairment in Schizophrenia and Related Disorders as a Target for Neuroprotective Therapy
  13798. Comparison of the Neuroprotective Potential of Theanine and Minocycline
  13799. Striatal ablation of GABAergic neurons prevents the in vivo Neuroprotective effect of DCG-IV against the MPP+-induced neurotoxicity on dopaminergic nerve terminals
  13800. Neuroprotective Approaches for Alzheimer’s Disease
  13801. Neuroprotective effect of ceftriaxone sodium on focal cerebral ischemia in rats and the mechanism
  13802. Neuroprotective and neurorestorative effects of neuregulins in the injured and aged dopaminergic nigrostriatal system
  13803. Identification of Radical Scavenging Compound From the Leaves of Phyllostachys nigra by Online HPLC-ABTS+ and Its Neuroprotective Effects Against Oxidative …
  13804. Neuroprotective effect of andrographolide against ischemic stroke in rats through reducing iNOS and gp91phox/NOX2 expression
  13805. Neuroprotective effect of tea polyphenol on mouse brain slices subjected to oxygen-glucose deprivation and glutamate injury
  13806. Combination of taurine and diazepam has Neuroprotective effect on focal cerebral ischemia-reperfusion in rats
  13807. Neuroprotective effects of calmodulin inhibitor W-7 on PTZ-induced rats [J]
  13808. Neuroprotective effect of caffeine in an early model of Parkinson’s disease in rat: behavioral and histochemical evidence
  13809. The Neuroprotective effect of schizandrin on glutamate-induced neuronal excitotoxicity
  13810. The Neuroprotective Effect of Acupuncture Treatment at Shaofu (HT8) on Kainic Acid-induced Epilepsy Mouse Model.
  13811. Assessment of symptomatic and Neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson’s disease
  13812. Neuroprotective effects of lamotrigine on neonatal rats after perinatal hypoxia-induced seizures
  13813. Study on activation of NF-κB p65 in rat hippocampal formation after experimental seizure and Neuroprotective effects of W-7
  13814. Plants and their chemical compounds affecting betha-amyloid and secretase activity as potential sources of Neuroprotective herbal medicinal products. Part 1
  13815. Neuroprotective of Curcumin and Vit. B Against Apoptotic Cell Death in Diabetic Neuropathic Pain Rats
  13816. Glaucoma and options for Neuroprotective treatment.
  13817. Vasoregulatory and Neuroprotective effects of oral antioxidants against glaucomateus damage
  13818. Potential Neuroprotective Strategies for Ischemic Injury
  13819. Neuroprotective activity of phytochemical combination of Quercetin and Curcumin against paraquat induced oxidative stress markers in Drosophila …
  13820. Neuroprotective and neuroregenerative strategies after contusion spinal cord injury
  13821. 10. Neuroprotective effects of oxyresveratrol from fruit against neurodegeneration in Alzheimer’s disease
  13822. Neuroprotective effect of cerebrocurin in a model of acute cerebral stroke
  13823. Neuroprotective effect of T-cell on central nervous system
  13824. Potential Neuroprotective Strategies for Experimental Spinal Cord Injury
  13825. The Potential Neuroprotective Role of Chemokine Receptor GPR75
  13826. Neuroprotective strategies against neurodegeneration in cellular model systems
  13827. Cannabinoids are Neuroprotective in POMD11
  13828. Neuroprotective functions of DJ-1 and MsrA: Implications for Parkinson’s disease
  13829. Assessment of Neuroprotective efficacy of phytochemicals against oxidatiive stress mediated neurodegeneratiion in Drosophilla mellanogaster
  13830. Developments of Novel Neuroprotective agents (YJC or YJP Series) Against Alzheimer’s and Parkinsonian Conditions
  13831. Puri Protect®-A New Neuroprotective Irrigation Solution for Vitrectomy?
  13832. Potential Neuroprotective agents for Facial Nerve Injury
  13833. Neuroprotective effects of anandamide and its analogs
  13834. Hyperglycemia is Neuroprotective in a Rat Model of Experimental Glaucoma
  13835. Neuroprotective effect of picrosideⅡon cerebral ischemia-reperfusion injury in rats
  13836. Neuroprotective effects of some creatine derivative compounds
  13837. Cerebral ischemic postconditioning and its Neuroprotective mechanisms
  13838. Design of selective estrogen receptor modulators as Neuroprotective and procognitive agents
  13839. Tocotrienol: An Emerging Neuroprotective Bioactive
  13840. Antioxidants as Neuroprotective Buffer Against Stroke Damage
  13841. Neuroprotective effects of pomegranate juice in mice.
  13842. The Neuroprotective effects of UCF-101 on rat focal cerebral ischemia-reperfusion
  13843. Neuroprotective mechanisms of histone deacetylase inhibitors in ischemic stroke
  13844. Neuroprotective Actions of Morphine Against Glaucomatous Injury
  13845. Examination of the Neuroprotective Effects of URB597 in Young and Aged Rat Retina
  13846. Potential Neuroprotective effect of commercial Bacopa monniera extract
  13847. Antioxygen and Neuroprotective effect of edaravone on patients with acute cerebral infarction
  13848. The Neuroprotective effects of nomifensine on dopaminergic neurotoxicity in MA depending rat.
  13849. Neuroprotective Activities of CD4+ CD25+ Regulatory T Cells
  13850. Neuroprotective Effect of Morus alba Extracts in N18-RE-105 Cells
  13851. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson’s disease in rats
  13852. Axon Death Prevented: Wlds and Other Neuroprotective Molecules: A Dissertation
  13853. Autophagy: Neuroprotective Response to Stress in Mammalian Retina
  13854. A possible cannabinergic Neuroprotective mechanism of action of Lepidium meyenii (Maca)
  13855. Neuroprotective effect of erythropoietin in a rat model of cerebral ischemia-reperfusion models
  13856. Systemic Brimonidine is Neuroprotective in OHT-Induced RGC Apoptosis in vivo
  13857. Neuroprotective effects of postinjury lithium treatment: Determining the optimal dosing paradigm and assessing potential mechanisms of action
  13858. Study of the possible Neuroprotective effects of certain natural products in experimentally-induced dementia in rats
  13859. Neuroprotective Effect of Timolol in Experimental Rat Glaucoma Model
  13860. Neuroprotective EFFECT OF ROSMARINIC ACID ON 1-METHYL-4-PHENYLPYRIDINIUM INDUCED CYTOTOXICITY OF THE MES 23.5 CELLS
  13861. Neuroprotective strategies for the neonatal brain after hypoxia-ischemia: pharmacological interventions and hypothermia
  13862. Neuroprotective effect of propofol on intracerebral hemorrhage injury of rats [J]
  13863. Design and synthesis of heterocyclic compounds for Neuroprotective enzyme interactions
  13864. The Neuroprotective effect of Fructus Alpiniae oxyphyllae on PC12 cells and zebrafish
  13865. The Role of Glutathione Metabolism in the Neuroprotective Effect of Mood Stabilizers
  13866. Time Window of Xenon Administration for Neuroprotective Effects during Transient Middle Cerebral Artery Occlusion
  13867. Redox Modulation is Neuroprotective for Photoreceptor Death After Photic Injury
  13868. Antioxidative and Neuroprotective effects of metallothioneins on dopaminergic neurons
  13869. Can Retinal Explant Cultures Be Used to Screen Novel Neuroprotective Strategies for Retinal Ganglion Cells?
  13870. Neuroprotective effect of Progesterone on neurons after traumatic brain injury in rats
  13871. Neuroprotective Strategies After Repetitive Mild Traumatic brain Injury (mTBI)
  13872. Toxicity of levodopa to nerve cells and its relevant Neuroprotective factors
  13873. Uncovering the Neuroprotective role of adenosine in diabetic retinopathy: alterations in the adenosinergic system
  13874. Neuroprotective Effect on Retinal Ganglion Cells by Transpupillary Laser Irradiation of the Optic Nerve Head
  13875. Neuroprotective effect and its mechanism of progesterone on neurons after traumatic brain injury in rats
  13876. Neuroprotective effects of β blockers on acute experimental cerebral hemorrhage in rats
  13877. Characterization and bioavailability of Neuroprotective grape seed extract in an animal model
  13878. Neuroprotective effect of acetyl-L-carnitine in rodent models of stroke
  13879. Erythropoietin may modify tyrosine kinase activity for its Neuroprotective action in mice
  13880. Neuroprotective Effect of Persimmon Peel Extracts in Neuronal Cells
  13881. Neuroprotective role of ibuprofen in hypoxic ischemic encephalopathy in term infants
  13882. Advance in Apoptosis Mechanism on Nerve Cell after Cerebral Ischemia-reperfusion and Neuroprotective Drugs
  13883. Alpiniae oxyphyllae ethanolic extract exerts Neuroprotective effect on 6-OHDA-induced PC12 cells damage via inhibition of iNOS-NO
  13884. Neuroprotective Mechanism by Novel Autophagy Regulators, Oxi-α and Oxi-β, in Dopamine Neurons
  13885. Neuroprotective effect of ceftriaxone on nerve cells against glutamate
  13886. Human Placenta Stem Cells as Potential Neuroprotective Mediators for the Treatment of Degenerative Retinopathy
  13887. Neuroprotective Effect of Ischemic Preconditioning in Traumatic brain Injured Rats.
  13888. Eukaryotic expression and biological activity analysis of Neuroprotective peptide [Gly14]-Humanin
  13889. Towards an Effective Neuroprotective Strategy for Glaucoma: Identification of Protein Kinase Inhibitors That Promote RGC Survival and Neurite Outgrowth
  13890. Identification of New Neuroprotective Strategies for the Treatment of Glaucoma Through Screening Inhibitors of Axon Degeneration in vitro
  13891. Alpha-Crystallin Neuroprotective Function in the Retina and its Regulation During Diabetes
  13892. Molecular mechanism of Neuroprotective action by grafted neuroectodermal stem cells following injury to spinal motoneurones
  13893. Neuroprotective Effect of Astaxanthin Against Rat Retinal Ganglion Cells Damage Under the Various Stress
  13894. Search for Neuroprotective Substances Regulating Cytotoxicity Induced by Glutamate and Oxidative Stress
  13895. Neuroprotective effects of glycine receptor agonists on focal cerebral ischemia-reperfusion injury in rats
  13896. Neuroprotective effects of hypothermia after neonatal hypoxic-ischemic brain injury are gender dependent
  13897. The Neuroprotective Effect Of Decreased Luteinizing Hormone On Astrocytic Pathology In An Alzheimer’s Disease Model
  13898. Hypothermia: a Neuroprotective therapy for neonatal Hypoxic ischemic encephalopathy
  13899. VEGF Infusion and Rearing in Enriched Environments During the Visual Critical Period Have Neuroprotective Effects in Rats
  13900. The Possible Neuroprotective Effects of RoY Peptide Ligation to Membranal Grp78 in the Ischemic Retina
  13901. Neuroprotective Effect of an Anti-Oxidant, Lutein, on Light-Induced Retinal Degeneration
  13902. Neuroprotective Factors Secreted by U‐87 Astrocytoma (Astrocytes‐Like) Cells and Their Associated Metabolic Adaptation
  13903. Anti-apoptotic and Neuroprotective Effects of Edaravone on Neurological Tissue after Acute Spinal Cord Injury in Rats
  13904. Neuroprotective effects of nerve growth factor on injured basal ganglia neurons in vitro
  13905. The influence of epilepsy in synaptic plasticity in the hippocampus: Neuroprotective role of VIP and its receptors
  13906. Neuroprotective Effects of Ethyl Pyruvate Derivatives by Transition Metal Chelation
  13907. Iron and Manganese Corroles Are Neuroprotective for Serum-Deprived Retinal Neurons
  13908. Neuroprotective Effect of Ginkgolides on Cultured Dorsal Root Ganglion Neurons with Neurotoxicity Induced by Glutamate
  13909. Potential Targets for Ginkgo Biloba Neuroprotective Effects in a Rat Glaucoma Model; Cytochrome c, APP and Aβeta
  13910. PDZ-Binding Peptides as Neuroprotective agents against Excitoxic brain damage
  13911. Neuroprotective effect of 2-phenoxy-indan-1-one derivatives YKY-7, a novel acetylcholinesterase inhibitor, on β-amyloid peptide induced damage in vitro
  13912. Study on the Therapeutic time window of Qingkailing’s Neuroprotective effect in a mouse model of FCIR [J]
  13913. Adipose-derived mesenchymal stem cells: neuronal differentiation potential and Neuroprotective action
  13914. Neuroprotective effects of anthocyanins on neuronal death induced by inhibition of Bcl-2 and oxidative stress
  13915. Expression of Nogo receptor in brain and Neuroprotective effect of NEP1-40 on hypoxic ischemic brain damage in newborn rats
  13916. Novel Neuroprotective hydrogen sulfide-releasing L-DOPA derivatives for the treatment of Parkinson disease
  13917. Effects of hypoxic-ischemia on human fetal subventricular zone at mid-gestation and Neuroprotective effects
  13918. Molecular mechanisms of excitotoxicity: a mechanism for deafferentation-induced death and a mechanism underlying the Neuroprotective effects of progesterone.
  13919. Neuroprotective effects of sinomenine against degeneration of dopaminergic neurons in Parkinson’s disease rat model
  13920. Possible Neuroprotective Mechanisms of Quercetin 3-Methyl Ether Isolated from Opuntia ficus-indica var. saboten
  13921. Microglia Are Neurotoxic or Neuroprotective During the Development of Glaucoma Depending Upon the Expression of Membrane and Soluble FasL
  13922. Neuroprotective effects of exogenous melatonin on spontaneously hypertensive rats with focal cerebral ischemia
  13923. Neuroprotective effect of Glycyrrhizae Radix on neuronal injury induced by hydrogen peroxide in cultured rat cortical neurons
  13924. Neuroprotective effects of treadmill exercise on brain damage in spontaneously hypertensive rats with focal cerebral ischemia
  13925. Role of adenosine A2A receptors in the Neuroprotective effect of corticotrophin releasing hormone (CRH)
  13926. Neuroprotective Effects of Some Plant Extracts Against Oxygen-Glucose Deprivation-Induced Oxidative Cell Death on Neuronal Cell
  13927. Neuroprotective Drug Delivery to the Injured Spinal Cord with Hyaluronan and Methylcellulose
  13928. Neuroprotective Effects of Eucommia Ulmoides Oliver Bark on cognitive Deficit and Neuronal Cell Death
  13929. GSK-3b-Nrf2 Signaling Pathway as a Neuroprotective Mechanism in Alzheimer’s Disease
  13930. Association of the Neuroprotective J proteins: cysteine string protein and Hsp40 following heat shock
  13931. Neuroprotective effects of anthocyanins on neuronal death induced by inhibition of BCL-2 and mitochondrial oxidative stress
  13932. Investigation on anti-prion, Neuroprotective and anti-cholinesterase activities of acridine derivatives
  13933. Neuroprotective Effects of the Herbal Ethanol Extracts in 6-hydroxydopamine-lesioned Rat Model of Parkinson’s Disease
  13934. Neuroprotective effects of astragalosides against amyloid β-protein and DEX-induced neurotoxicity in rat hippocampal neurons.
  13935. Neuroprotective Effects of Agmatine on Ischemia-Reperfusion-Induced Retinal Ganglion Cell Damage by Transient Middle Cerebral Artery Occlusion
  13936. The article entitled ”The Functional and Neuroprotective Actions of Neu2000, in the Treatment of Acute Spinal Cord Injury,”in 2010; 27 (of authors. The correct order of …
  13937. Neuroprotective Effects of Propofol and Ketamine (alone or combined) Against Oxygen-Glucose Deprivation-Reperfusion Injury
  13938. Continuous hypothermic low-flow-perfusion during aortic arch operations is Neuroprotective and cardioprotective
  13939. Neuroprotective effect of MnTBAP on facial neurons after facial nerve injury in rats.
  13940. Neuroprotective effect of celecoxib against degeneration of dopaminergic neurons in rat model of Parkinson disease.
  13941. Neuroprotective Effects of Some Compounds of Morus alba L. against Oxygen-Glucose Deprivation (OGD) Induced Oxidative Cell Death on Neuronal Cells
  13942. Preconditioning With Whole Body Periodic Acceleration (pGz) is Neuroprotective in Model of Asphyxial Cardiac Arrest in Rats.
  13943. Neuroprotective effect of intravitreal cell‐based glucagon‐like peptide‐1 production in the optic nerve crush model
  13944. Cross-Talk Between the Neuroprotective Wnt Signaling Pathway and the Innate Immunity Toll-Like Receptor 4 (tlr4) in Glia
  13945. Neuroprotective effect of 5, 7, 3′, 4′, 5′-pentahydroxy dihdroflavanol-3-O-(2 ″-O-galloyl)-β-D-glucopyranoside, a polyphenolic compound in focal cerebral …
  13946. Neuroprotective properties and neural differentiation of the human adipose tissue-derived mesenchymal stem cells transplanted in ischemic rat brain injury
  13947. Hydrogen is Neuroprotective and preserves cerebrovascular reactivity in asphyxiated newborn pigs Running title: Neuroprotection by hydrogen
  13948. Disinfecting dystonia? Drug discovery using worms identifies an antibiotic as a Neuroprotective lead molecule for movement disorders
  13949. Neuroprotective effects of chelator agents toward aluminium and Aβ amyloid peptide interactions in hippocampal cells
  13950. Puromycin Sensitive Aminopeptidase (PSA/NPEPPS) has Neuroprotective effect in the mouse model of TAU induced neurodegeneration
  13951. Modulation of CD38 and Cx43 in astrocytes as new Neuroprotective strategy at perinatal hypoxic-ischemic brain damage
  13952. Symbol Neuroprotective effect of glial cell line-derived neurotrophic factor gene-modified bone marrow stromal cells transplantation on intracerebral hemorrhage in …
  13953. The Neuroprotective potentials of sour (Hibiscus sabdariffa, Calyx) and green (Camellia sinensis) teas on some pro-oxidants induced oxidative stress in brain .
  13954. Neuroprotective effects of lycium barbarum on the retina of monocular visual deprived amblyopia in rats.
  13955. Neuroprotective Effects of the n-Hexane Fraction from Laurus nobilis Leaves in Dopamine-Induced Cells and Animal Models of Parkinson’s Disease
  13956. Neuroprotective Effects of Active Compounds in Triticum aestivum L. against β-Amyloid-induced Oxidative Cell Death and Scopolamine-caused memory …
  13957. Neuroprotective Effect of Neurotrophic Factors, VEGF, and Citicoline on Retinal Neuronal Cell Death Induced by High Glucose Exposure
  13958. 109 Evaluation of Dextromethorphan as Neuroprotective Strategy in Neonatal Hyperoxic brain Injury
  13959. Neuroprotective effects of Complement C3 convertase inhibition after traumatic brain injury: a randomized placebo-controlled study in mice
  13960. … Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on Neuroprotective effects of stromal …
  13961. Neuroprotective Effects of the Butanol Extracts of Gynostemma pentaphyllum in 6-hydroxydopamine-lesioned Rats with Chronic L-DOPA
  13962. P03-353 Neuroprotective effect of haloperidol vs. aripiprazole at hippocampal and frontal cortex at rats
  13963. Neuroprotective Flavonoids of Rhus verniciflua Barks on Glutamate-Induced Oxidative Injury in HT22 Hippocampal Cells
  13964. Analysis in vitro of the Neuroprotective action of recombinant human TAT-parkin and parkin over-expression in the 6-hydroxydopamine model of Parkinson’s …
  13965. 9P. 9 Evaluation of Neuroprotective abilities of the novel mitochondria-targeted antioxidants
  13966. … of Nrf2 and HO-1 in spinal cord tissues of experimental autoimmune encephalomyelitis of rats and the mechanism underlying Neuroprotective effect of edaravone.
  13967. B1-Integrin Activating Antibody HUTS-21 Exhibits Retinal Ganglion Cell Neuroprotective Properties
  13968. L‐pGlu‐(1‐Benzyl)‐L‐His‐L‐ProNH2: a Newer Thyrotropin‐Releasing Hormone Analog with anticonvulsive and Neuroprotective properties
  13969. Inhibition of proteasome function in rat nigrostriatal dopaminergic neurons as an animal model of Parkinson’s disease for studying Neuroprotective compounds
  13970. SU‐GG‐J‐135: Exploring the Neuroprotective Effects of Bee Venom in a Mouse Parkinson Model with Immunohistochemistry, Magnetization Transfer Ratio Imaging …
  13971. … receptor by RNA interference and of stimulating its activity with an 7 agonist in SH-SY5Y cells indicate that this receptor plays a Neuroprotective role in connection with …
  13972. Upregulation of# alpha# 7 nicotinic receptor and Neuroprotective effect induced by Lovastatin in PC12 cells
  13973. 273. The HSV-2 Protein, ICP10PK, Potentiates the Neuroprotective Activity of Stem Cells
  13974. ARP2/3 complex has a Neuroprotective role and is required for mature dendritic spine head morphology
  13975. PP-33. Possible Neuroprotective effect of magnesium sulfate administered alone or in combination with melatonin in neonatal hypoxic–ischemic rat model
  13976. 6-Mercaptopurine exerts an immunomodulatory and Neuroprotective effect on permanent focal cerebral occlusion in rats.
  13977. New approaches to Neuroprotective drug development
  13978. Development of proneurogenic, Neuroprotective small molecules
  13979. Neuroprotective features of mesenchymal stem cells
  13980. Neuroprotective actions of estradiol revisited
  13981. Neuroprotective effects of marine algae
  13982. Does vigorous exercise have a Neuroprotective effect in Parkinson disease?
  13983. Neuroprotective actions of flavonoids
  13984. Neuroprotective effects of creatine
  13985. Neuroprotective strategies involving ROS in Alzheimer disease
  13986. Neuroprotective therapeutics for Alzheimer’s disease: progress and prospects
  13987. The promise of Neuroprotective agents in Parkinson’s disease
  13988. Neuroprotective properties of GLP-1: theoretical and practical applications
  13989. Neuroprotective properties of resveratrol and derivatives
  13990. Statins: multiple Neuroprotective mechanisms in neurodegenerative diseases
  13991. Advances in Neuroprotective strategies: potential therapies for intracerebral hemorrhage
  13992. Mechanism of Neuroprotective mitochondrial remodeling by PKA/AKAP1
  13993. A systematic review of non-invasive pharmacologic Neuroprotective treatments for acute spinal cord injury
  13994. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration
  13995. Neuroprotective features of carnosine in oxidative driven diseases
  13996. Fumaric acid esters exert Neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
  13997. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional Neuroprotective strategy for cognitive and neurodegenerative disorders
  13998. Resveratrol modulates astroglial functions: Neuroprotective hypothesis
  13999. Centella asiatica in food and beverage applications and its potential antioxidant and Neuroprotective effect
  14000. Perlecan domain V is Neuroprotective and proangiogenic following ischemic stroke in rodents
  14001. Neuroprotective actions of neurosteroids
  14002. Cyclosporine-A as a Neuroprotective agent against stroke: its translation from laboratory research to clinical application
  14003. The L-type channel antagonist isradipine is Neuroprotective in a mouse model of Parkinson’s disease
  14004. Neuroprotective effects of phytocannabinoid‐based medicines in experimental models of Huntington’s disease
  14005. Antiglycative and Neuroprotective activity of colon‐derived polyphenol catabolites
  14006. A critical appraisal of the premotor symptoms of Parkinson’s disease: potential usefulness in early diagnosis and design of Neuroprotective trials
  14007. Neuroprotective and anti-oxidative effects of the hemodialysate actovegin on primary rat neurons in vitro
  14008. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats
  14009. Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction
  14010. Long-term treadmill exercise induces Neuroprotective molecular changes in rat brain
  14011. Neuroprotective effect of silibinin in diabetic mice
  14012. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia
  14013. CX3CL1 is Neuroprotective in permanent focal cerebral ischemia in rodents
  14014. Therapeutic window analysis of the Neuroprotective effects of cyclosporine A after traumatic brain injury
  14015. Symptom‐relieving and Neuroprotective effects of the phytocannabinoid Δ9‐THCV in animal models of Parkinson’s disease
  14016. Long-term treatment with suberythropoietic Epo is vaso-and Neuroprotective in experimental diabetic retinopathy
  14017. Neuroprotective potential of phytochemicals
  14018. Neuroprotective effects of citrus flavonoids
  14019. Neuroprotective mechanisms of hypothermia in brain ischaemia
  14020. Neuroprotective effect of natural products against Alzheimer’s disease
  14021. Life or death: Neuroprotective and anticancer effects of quercetin
  14022. Neuroprotective actions of methylene blue and its derivatives
  14023. Transformation from a Neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS
  14024. Nicotine as a potential Neuroprotective agent for Parkinson’s disease
  14025. Pleiotropic Neuroprotective and metabolic effects of Actovegin’s mode of action
  14026. Curcumin: a potential Neuroprotective agent in Parkinson’s disease
  14027. Resveratrol, a Neuroprotective supplement for Alzheimer’s disease
  14028. The Neuroprotective functions of transforming growth factor beta proteins
  14029. Centella asiatica (L.) Urban: from traditional medicine to modern medicine with Neuroprotective potential
  14030. Neuroprotective agents : cannabinoids
  14031. The sirtuin 2 inhibitor AK-7 is Neuroprotective in Huntington’s disease mouse models
  14032. Neuroprotective effects of lutein in the retina
  14033. Chemotherapy-induced neurotoxicity: the value of Neuroprotective strategies
  14034. Dexmedetomidine is Neuroprotective in an in vitro model for traumatic brain injury
  14035. Which Neuroprotective agents are ready for bench to bedside translation in the newborn infant?
  14036. GPE and GPE analogues as promising Neuroprotective agents
  14037. Effect of the Neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
  14038. Neuroprotective function for ramified microglia in hippocampal excitotoxicity
  14039. Neuroprotective and anti-ageing role of leptin
  14040. Multi-faced Neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model
  14041. Modelling neuroinflammation in vitro: a tool to test the potential Neuroprotective effect of anti-inflammatory agents
  14042. Stimulation of autophagy is Neuroprotective in a mouse model of human tauopathy
  14043. Neuroprotective lifestyles and the aging brain : activity, atrophy, and white matter integrity
  14044. Alcohol consumption in mild cognitive impairment and dementia: harmful or Neuroprotective ?
  14045. The Neuroprotective effects of apocynin
  14046. Do tocotrienols have potential as Neuroprotective dietary factors?
  14047. Neuroprotective role of erythropoietin in neonates
  14048. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration
  14049. Neuronal autophagy in cerebral ischemia–a potential target for Neuroprotective strategies?
  14050. Neuroprotective role of Sirt1 in mammalian models of Huntington’s disease through activation of multiple Sirt1 targets
  14051. Melatonin plus physical exercise are highly Neuroprotective in the 3xTg-AD mouse
  14052. The potential of GPNMB as novel Neuroprotective factor in amyotrophic lateral sclerosis
  14053. Neuroprotective and neurotrophic actions of glucagon‐like peptide‐1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
  14054. Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson’s disease
  14055. Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells
  14056. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease
  14057. Anticonvulsant and Neuroprotective effects of Pimpinella anisum in rat brain
  14058. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis
  14059. Neuroprotective strategies for the treatment of inherited photoreceptor degeneration
  14060. Are volatile anesthetics Neuroprotective or neurotoxic?
  14061. The Neuroprotective effect of vitamin E on chronic sleep deprivation-induced memory impairment: the role of oxidative stress
  14062. Recent advances on the Neuroprotective potential of antioxidants in experimental models of Parkinson’s disease
  14063. Neuroprotective effects of valproic acid following transient global ischemia in rats
  14064. Suppression of local inflammation contributes to the Neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia
  14065. Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats
  14066. Neuroprotective effects of Bacopa monnieri in experimental model of dementia
  14067. Neuroprotective effect of acute ethanol administration in a rat with transient cerebral ischemia
  14068. Physical training exerts Neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinson’s disease
  14069. Neuroprotective and neuroregenerative properties of metallothioneins
  14070. Phytochemical composition, antioxidant activity, and Neuroprotective effect of Terminalia chebula Retzius extracts
  14071. Neuroprotective effects of sulforaphane after contusive spinal cord injury
  14072. Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion
  14073. Signaling pathways mediating the Neuroprotective effects of sex steroids and SERMs in Parkinson’s disease
  14074. Potential Neuroprotective effects of oxyresveratrol against traumatic injury
  14075. Oestrogen receptors and signalling pathways: implications for Neuroprotective effects of sex steroids in Parkinson’s disease
  14076. Inhibition of GTRAP3-18 may increase Neuroprotective glutathione (GSH) synthesis
  14077. Mitochondrial functions in astrocytes: Neuroprotective implications from oxidative damage by rotenone
  14078. Progesterone is Neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway
  14079. Neuroprotective activity of lavender oil on transient focal cerebral ischemia in mice
  14080. Selectivity, cocrystal structures, and Neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid …
  14081. Anti-inflammatory mechanism of compound K in activated microglia and its Neuroprotective effect on experimental stroke in mice
  14082. Estrogens: mechanisms of Neuroprotective effects
  14083. Chemical modification of the multitarget Neuroprotective compound fisetin
  14084. Neuroprotective effect of oleuropein following spinal cord injury in rats
  14085. Using lithium as a Neuroprotective agent in patients with cancer
  14086. Neuroprotective effect of 20 (R)-ginsenoside Rg3 against transient focal cerebral ischemia in rats
  14087. Neuroprotective properties of Melissa officinalis after hypoxic-ischemic injury both in vitro and in vivo
  14088. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy
  14089. Neuroprotective effects of pre-treament with l-carnitine and acetyl-l-carnitine on ischemic injury in vivo and in vitro
  14090. Ladostigil: a novel multimodal Neuroprotective drug with cholinesterase and brain -selective monoamine oxidase inhibitory activities for Alzheimer’s disease treatment
  14091. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and Neuroprotective …
  14092. Suppressing inflammation by inhibiting the NF‐κB pathway contributes to the Neuroprotective effect of angiotensin‐(1‐7) in rats with permanent cerebral ischaemia
  14093. Anti-inflammatory and Neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease
  14094. The conditioned medium of murine and human adipose-derived stem cells exerts Neuroprotective effects against experimental stroke model
  14095. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus
  14096. The anticonvulsant and Neuroprotective effects of baicalin on pilocarpine-induced epileptic model in rats
  14097. Membrane progesterone receptors: evidence for Neuroprotective , neurosteroid signaling and neuroendocrine functions in neuronal cells
  14098. Neuroprotective effects of testosterone on motoneuron and muscle morphology following spinal cord injury
  14099. Immediate hypothermia is not Neuroprotective after severe hypoxia-ischemia and is deleterious when delayed by 12 hours in neonatal rats
  14100. Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress
  14101. Oxaloacetate: a novel Neuroprotective for acute ischemic stroke
  14102. Norrin: molecular and functional properties of an angiogenic and Neuroprotective growth factor
  14103. Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats
  14104. Long-term Neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials
  14105. Multiple sclerosis: Neuroprotective alliance of estrogen–progesterone and gender
  14106. The hypoxia imaging agent CuII(atsm) is Neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease
  14107. Axon injury and stress trigger a microtubule-based Neuroprotective pathway
  14108. Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial
  14109. Postnatal administration of IL-1Ra exerts Neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries
  14110. Neuroprotective tri-and tetracyclic BChE inhibitors releasing reversible inhibitors upon carbamate transfer
  14111. Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats–time window and mechanism
  14112. Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats
  14113. A Neuroprotective role for the DNA damage checkpoint in tauopathy
  14114. Neuroprotective capabilities of Tanshinone IIA against cerebral ischemia/reperfusion injury via anti-apoptotic pathway in rats
  14115. Neuroprotective effect of α-mangostin and curcumin against iodoacetate-induced cell death
  14116. Molecular mechanisms of the Neuroprotective /neurorescue action of multi-target green tea polyphenols.
  14117. Potential Neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats
  14118. Neuroprotective effects of progranulin in ischemic mice
  14119. Neuroprotective , neurotherapeutic, and neurometabolic effects of carbon monoxide
  14120. Clinical utility of Neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer’s, Parkinson’s and Huntington’s diseases …
  14121. Nitrite therapy is Neuroprotective and safe in cardiac arrest survivors
  14122. Neuroprotective effects of Salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and H 2 O 2-induced neurotoxicity in vitro
  14123. The immunomodulatory and Neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple …
  14124. Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis
  14125. Neuroprotective roles of the P2Y2 receptor
  14126. Neuronal uptake and Neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line
  14127. Melatonin as a Neuroprotective agent in the rodent models of Parkinson’s disease: is it all set to irrefutable clinical translation?
  14128. Neuroprotective Effect of Fucoidan on H2O2-Induced Apoptosis in PC12 Cells Via Activation of PI3K/Akt Pathway
  14129. Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and Neuroprotective responses in HIV-1-infected humanized mice
  14130. Neuroprotective effects of vitexin, a flavonoid, on pentylenetetrazole‐induced seizure in rats
  14131. Tissue-type plasminogen activator has a Neuroprotective effect in the ischemic brain mediated by neuronal TNF-α
  14132. Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model
  14133. Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines
  14134. CD200‐CD200R1 interaction contributes to Neuroprotective effects of anandamide on experimentally induced inflammation
  14135. Estrone is Neuroprotective in rats after traumatic brain injury
  14136. Evidence that membrane‐bound G protein‐coupled melatonin receptors MT1 and MT2 are not involved in the Neuroprotective effects of melatonin in focal cerebral …
  14137. Treatment with a substance P receptor antagonist is Neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson’s disease
  14138. Palmitoylethanolamide exerts Neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated …
  14139. Δ9‐tetrahydrocannabinol (Δ9‐THC) exerts a direct Neuroprotective effect in a human cell culture model of Parkinson’s disease
  14140. Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington’s disease
  14141. Noninvasive limb remote ischemic preconditioning contributes Neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal …
  14142. Neuroprotective effects of extremely low-frequency electromagnetic fields on a Huntington’s disease rat model: effects on neurotrophic factors and neuronal density
  14143. The Neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson’s disease patients
  14144. Neuroprotective effect of sinapic acid in a mouse model of amyloid β1–42 protein-induced Alzheimer’s disease
  14145. The Neuroprotective effect of platelet‐rich plasma on erectile function in bilateral cavernous nerve injury rat model
  14146. Sativex-like combination of phytocannabinoids is Neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB1 and CB2 …
  14147. Experimental evidence of Ginkgo biloba extract EGB as a Neuroprotective agent in ischemia stroke rats
  14148. Valproic acid, a drug with multiple molecular targets related to its potential Neuroprotective action
  14149. Neuroprotective effects of tanshinone IIA and/or tetramethylpyrazine in cerebral ischemic injury in vivo and in vitro
  14150. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms
  14151. Mild uncoupling of respiration and phosphorylation as a mechanism providing nephro-and Neuroprotective effects of penetrating cations of the SkQ family
  14152. Neuroprotective effect of ginkgolide K on glutamate-induced cytotoxicity in PC 12 cells via inhibition of ROS generation and Ca2+ influx
  14153. Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates Neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons
  14154. The Neuroprotective potential of phenolic-enriched fractions from four Juniperus species found in Portugal
  14155. Neuroprotective actions of Glucagon‐like peptide‐1 in differentiated human neuroprogenitor cells
  14156. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with Neuroprotective effects
  14157. Nasal neuro EPO could be a reliable choice for Neuroprotective stroke treatment
  14158. Secondary Neuroprotective effects of hypotensive drugs and potential mechanisms of action
  14159. Citicoline in pre‐clinical animal models of stroke: a meta‐analysis shows the optimal Neuroprotective profile and the missing steps for jumping into a stroke clinical trial
  14160. The beta-lactam antibiotic, ceftriaxone, provides Neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury
  14161. Neuroprotective effects of statins: evidence from preclinical and clinical studies
  14162. Neuroprotective Effects of Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), in Ischemic Stroke of Rats
  14163. Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses
  14164. Use of PC12 cells and rat superior cervical ganglion sympathetic neurons as models for Neuroprotective assays relevant to Parkinson’s disease
  14165. Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration
  14166. Neuroprotective effects of osthole pretreatment against traumatic brain injury in rats
  14167. Pigment epithelium-derived factor released by Müller glial cells exerts Neuroprotective effects on retinal ganglion cells
  14168. Bone marrow–derived stromal cell therapy for traumatic brain injury is Neuroprotective via stimulation of non-neurologic organ systems
  14169. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is Neuroprotective , in a mouse model of …
  14170. Neuroprotective effects of reactive oxygen species mediated by BDNF-independent activation of TrkB
  14171. Flaxseed oil as a Neuroprotective agent on lead acetate-induced monoamineric alterations and neurotoxicity in rats
  14172. Anti-inflammatory and Neuroprotective effects of triptolide on traumatic brain injury in rats
  14173. Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats
  14174. Electroacupuncture at the Quchi and Zusanli acupoints exerts Neuroprotective role in cerebral ischemia-reperfusion injured rats via activation of the PI3K/Akt …
  14175. Panax notoginsenoside produces Neuroprotective effects in rat model of acute spinal cord ischemia–reperfusion injury
  14176. SUMO modification of the Neuroprotective protein TDP1 facilitates chromosomal single-strand break repair
  14177. Bioassay-guided isolation of Neuroprotective compounds from Uncaria rhynchophylla against beta-amyloid-induced neurotoxicity
  14178. The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and Neuroprotective activities
  14179. Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease
  14180. Assessment of Neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo
  14181. Therapeutic hypothermia as a Neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury
  14182. Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model
  14183. Flavonoid transport across blood-brain barrier: Implication for their direct Neuroprotective actions
  14184. … κB activation and oxidative stress by increasing Gli1, Ptch1, SOD1 expression and ameliorates blood–brain barrier permeability for its Neuroprotective effect in pMCAO …
  14185. Involvement of PPAR-γ in the Neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist …
  14186. Neurotoxic/Neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells
  14187. Neuroprotective and anticonvulsant effects of organic and conventional purple grape juices on seizures in Wistar rats induced by pentylenetetrazole
  14188. Design and synthesis of Neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy
  14189. Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study
  14190. Combination therapy with VELCADE and tissue plasminogen activator is Neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor …
  14191. Excitotoxicity downregulates TrkB. FL signaling and upregulates the Neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons
  14192. Estimation of in vitro Neuroprotective properties and quantification of rutin and fatty acids in buckwheat (Fagopyrum esculentum Moench) cultivated in Turkey
  14193. Neuroprotective effects of 17β-estradiol rely on estrogen receptor membrane initiated signals
  14194. Neuroprotective and neurorestorative effects of Thymosin beta 4 treatment following experimental traumatic brain injury
  14195. Neuroprotective and anti-inflammatory activities of atorvastatin in a rat chronic constriction injury model
  14196. The Neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice
  14197. Neuroprotective effects of ischemic preconditioning and postconditioning on global brain ischemia in rats through the same effect on inhibition of apoptosis
  14198. NP03, a novel low-dose lithium formulation, is Neuroprotective in the YAC128 mouse model of Huntington disease
  14199. Antiangiogenic effect of carnosic acid and carnosol, Neuroprotective compounds in rosemary leaves
  14200. A Neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson’s disease model
  14201. Possible GABAergic mechanism in the Neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity
  14202. Neuroprotective effects of carnosic acid on neuronal cells under ischemic and hypoxic stress
  14203. Rat hippocampal slice culture models for the evaluation of Neuroprotective agents
  14204. Resveratrol: a Neuroprotective polyphenol in the Mediterranean diet
  14205. Total synthesis of the initially reported and revised structures of the Neuroprotective agent palmyrolide A
  14206. The Neuroprotective effect of lactate is not due to improved glutamate uptake after controlled cortical impact in rats
  14207. Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer’s disease in rats
  14208. Coumestrol has Neuroprotective effects before and after global cerebral ischemia in female rats
  14209. Clinical Neuroprotective drugs for treatment and prevention of stroke
  14210. GluN2B-containing NMDA receptors as possible targets for the Neuroprotective and antidepressant effects of fluoxetine
  14211. Neuroprotective effect of quercetin against hydrogen peroxide-induced oxidative injury in P19 neurons
  14212. HIF-1α is Neuroprotective during the early phases of mild hypoxia in rat cortical neurons
  14213. Sleep deprivation has a Neuroprotective role in a traumatic brain injury of the rat
  14214. Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons
  14215. Ketamine as a Neuroprotective and anti-inflammatory agent in children undergoing surgery on cardiopulmonary bypass: a pilot randomized, double-blind, placebo …
  14216. A monoclonal antibody-GDNF fusion protein is not Neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys
  14217. Neuroprotective effects of human umbilical cord mesenchymal stromal cells in an immunocompetent animal model of Parkinson’s disease
  14218. The Neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy …
  14219. … -Aryl-N-alkyl Nitrones, as Potential agents for Stroke Treatment: Synthesis, Theoretical Calculations, Antioxidant, Anti-inflammatory, Neuroprotective , and brain –Blood …
  14220. Neuroprotective effects of black soybean anthocyanins via inactivation of ASK1–JNK/p38 pathways and mobilization of cellular sialic acids
  14221. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels
  14222. Neuroprotective effects of germinated brown rice against hydrogen peroxide induced cell death in human SH-SY5Y cells
  14223. A reassessment of P2X7 receptor inhibition as a Neuroprotective strategy in rat models of contusion injury
  14224. Neuroprotective effect of edible brown alga Eisenia bicyclis on amyloid beta peptide-induced toxicity in PC12 cells
  14225. Involvement of PI3K/Akt pathway in the Neuroprotective effect of Sonic hedgehog on cortical neurons under oxidative stress
  14226. Antidiabetic and Neuroprotective effects of Trigonella foenum-graecum seed powder in diabetic rat brain
  14227. The Neuroprotective Effect of Losartan through Inhibiting AT 1/ASK 1/MKK 4/JNK 3 Pathway Following Cerebral I/R in Rat Hippocampal CA 1 Region
  14228. The Neuroprotective effect of eupatilin against ischemia/reperfusion-induced delayed neuronal damage in mice
  14229. Neuroprotective effects of allicin on spinal cord ischemia–reperfusion injury via improvement of mitochondrial function in rabbits
  14230. Copaiba oil-resin treatment is Neuroprotective and reduces neutrophil recruitment and microglia activation after motor cortex excitotoxic injury
  14231. … improving regional cortical blood flow, attenuating mitochondrial dysfunction and sequential apoptosis galangin acts as a potential Neuroprotective agent after acute …
  14232. The Neuroprotective and lifespan-extension activities of Damnacanthus officinarum extracts in Caenorhabditis elegans
  14233. Prerequisites to launch Neuroprotective trials in Parkinson’s disease: an industry perspective
  14234. Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice
  14235. Neuroprotective effects of phlorotannins isolated from a brown alga, Ecklonia cava, against H2O2-induced oxidative stress in murine hippocampal HT22 cells
  14236. Systemically administered human bone marrow-derived mesenchymal stem home into peripheral organs but do not induce Neuroprotective effects in the MCAo …
  14237. Challenges in Neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma
  14238. Morphological and biochemical investigation into the possible Neuroprotective effects of kolaviron (Garcinia kola bioflavonoid) on the brain s of rats exposed to …
  14239. Neuroprotective effects of adipose-derived stem cells against ischemic neuronal damage in the rabbit spinal cord
  14240. Neuroprotective efficacy of Nardostachys jatamansi and crocetin in conjunction with selenium in cognitive impairment
  14241. The Neuroprotective effect of fisetin in the MPTP model of Parkinson’s disease
  14242. Alpha-linolenic acid is a potent Neuroprotective agent against soman-induced neuropathology
  14243. Antioxidative and Neuroprotective activities of the pre-germinated brown rice extract
  14244. Neuroprotective effect of phlorotannin isolated from Ishige okamurae against H 2 O 2-induced oxidative stress in murine hippocampal neuronal cells, HT22
  14245. Combinations of ketamine and atropine are Neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice
  14246. Four new sesquiterpenes from Commiphora myrrha and their Neuroprotective effects
  14247. Evaluation of the neurotoxic/Neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6 …
  14248. Immunosuppressant FK506: focusing on Neuroprotective effects following brain and spinal cord injury
  14249. Neuroprotective iridoid glycosides from Cornus officinalis fruits against glutamate-induced toxicity in HT22 hippocampal cells
  14250. Furoxans (1,2,5-Oxadiazole-N-Oxides) as Novel NO Mimetic Neuroprotective and Procognitive agents
  14251. Neuroprotective effects of exogenous activin A on oxygen-glucose deprivation in PC12 cells
  14252. Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro
  14253. Neuroprotective effects of anti-tumor necrosis factor-alpha antibody on apoptosis following subarachnoid hemorrhage in a rat model
  14254. Neuroprotective effect of ginkgolide K against acute ischemic stroke on middle cerebral ischemia occlusion in rats
  14255. Neuroprotective effects of TongLuoJiuNao in neurons exposed to oxygen and glucose deprivation
  14256. Intraspinal injection of human umbilical cord blood-derived cells is Neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis
  14257. Wnt-5a is a synaptogenic factor with Neuroprotective properties against Aβ toxicity
  14258. α7 Nicotinic acetylcholine receptors in Alzheimer’s disease: Neuroprotective , neurotrophic or both?
  14259. Tianeptine exerts Neuroprotective effects in the brain tissue of rats exposed to the chronic stress model
  14260. Neuroprotective effects of pretreatment with propofol in LPS-induced BV-2 microglia cells: role of TLR4 and GSK-3β
  14261. Inhibition of mitochondrial permeability transition pore opening contributes to the Neuroprotective effects of ischemic postconditioning in rats
  14262. Neuroprotective effects of Eleutherococcus senticosus bark on transient global cerebral ischemia in rats
  14263. Transcorneal electrical stimulation shows Neuroprotective effects in retinas of light-exposed rats
  14264. Silencing microRNA-134 produces Neuroprotective and prolonged seizure-suppressive effects
  14265. Neuroprotective effects of melatonin administered alone or in combination with topiramate in neonatal hypoxic-ischemic rat model
  14266. The Neuroprotective Effect of a Specific P2X7 Receptor Antagonist Derives from its Ability to Inhibit Assembly of the NLRP3 Inflammasome in Glial Cells
  14267. Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence
  14268. Bumetanide augments the Neuroprotective efficacy of phenobarbital plus hypothermia in a neonatal hypoxia–ischemia model
  14269. Neuroprotective effects of phenolic antioxidant tBHQ associate with inhibition of FoxO3a nuclear translocation and activity
  14270. Unraveling the Neuroprotective mechanisms of PrPC in excitotoxicity
  14271. The Neuroprotective effect of pyrroloquinoline quinone on traumatic brain injury
  14272. Behavioural studies with a newly developed Neuroprotective KYNA-amide
  14273. cognition -enhancing and Neuroprotective activities of the standardized extract of Betula platyphylla bark and its major diarylheptanoids
  14274. Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo
  14275. Neuroprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on spinal cord injury
  14276. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the Neuroprotective effect of huperzine A
  14277. Naringenin and quercetin reverse the effect of hypobaric hypoxia and elicit Neuroprotective response in the murine model
  14278. Selective gelatinase inhibitor Neuroprotective agents cross the blood-brain barrier
  14279. Novel evolutionary-conserved role for the activity-dependent Neuroprotective protein (ADNP) family that is important for erythropoiesis
  14280. Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole body hyperthermia-induced …
  14281. Genetic inactivation of the p66 isoform of ShcA is Neuroprotective in a murine model of multiple sclerosis
  14282. Comparison of Neuroprotective effects of five major lipophilic diterpenoids from Danshen extract against experimentally induced transient cerebral ischemic damage
  14283. Mutant erythropoietin without erythropoietic activity is Neuroprotective against ischemic brain injury
  14284. Neuroprotective effects of VEGF administration after focal cerebral ischemia/reperfusion: dose response and time window
  14285. Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats
  14286. Neuroprotective effects of high affinity sigma 1 receptor selective compounds
  14287. Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)
  14288. The Neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid β toxicity
  14289. Neuroprotective activity of galloylated cyanogenic glucosides and hydrolysable tannins isolated from leaves of Phyllagathis rotundifolia
  14290. Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats
  14291. In-vitro Neuroprotective properties of the Maydis stigma extracts from four corn varieties
  14292. The Neuroprotective effect of treatment of valproic Acid in acute spinal cord injury
  14293. Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain
  14294. Neuroprotective activity of Cymbopogon martinii against cerebral ischemia/reperfusion-induced oxidative stress in rats
  14295. Neuroprotective effects of nimodipine and nifedipine in the NGF-differentiated PC12 cells exposed to oxygen-glucose deprivation or trophic withdrawal
  14296. Multi-target, Neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer’s-like neuropathology and age-related alterations in …
  14297. MicroRNA-223 is Neuroprotective by targeting glutamate receptors
  14298. Neuroprotective effect of quercetin on the duodenum enteric nervous system of streptozotocin-induced diabetic rats
  14299. Similarity of cycloprolylglycine to piracetam in antihypoxic and Neuroprotective effects
  14300. Isolation and Neuroprotective Activities of Acylated Iridoids from Valeriana jatamansi
  14301. Elucidation of Neuroprotective role of endogenous GABA and energy metabolites in middle cerebral artery occluded model in rats
  14302. Neuroprotective effects of tert-butylhydroquinone on paraquat-induced dopaminergic cell degeneration in C57BL/6 mice and in PC12 cells
  14303. Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemic brain injury
  14304. Are the Neuroprotective effects of estradiol and physical exercise comparable during ageing in female rats?
  14305. Novel bismuth/multi-walled carbon nanotubes-based electrochemical sensor for the determination of Neuroprotective drug cilostazol
  14306. Bererine induces peripheral lymphocytes immune regulations to realize its Neuroprotective effects in the cerebral ischemia/reperfusion mice
  14307. Fluoxetine has Neuroprotective effects after cardiac arrest and cardiopulmonary resuscitation in mouse
  14308. Bioassay-guided isolation of Neuroprotective compounds from Loranthus parasiticus against H2O2-induced oxidative damage in NG108-15 cells
  14309. Neuroprotective effects of san-huang-xie-xin-tang in the MPP+/MPTP models of Parkinson’s disease in vitro and in vivo
  14310. Superior Neuroprotective effects of cerebrolysin in nanoparticle-induced exacerbation of hyperthermia-induced brain pathology
  14311. A reassessment of a classic Neuroprotective combination therapy for spinal cord injured rats: LPS/pregnenolone/indomethacin
  14312. Selective Neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system
  14313. UPLC–TOF-MS analysis of Galium spurium towards its Neuroprotective and anticonvulsant activities
  14314. Neuroprotective role of estrogens: relationship with insulin/IGF-1 signaling
  14315. Neuroprotective effect of neotrofin in a neonatal rat model of periventricular leukomalacia
  14316. Design, synthesis, and evaluation of resveratrol derivatives as Aß1–42 aggregation inhibitors, antioxidants, and Neuroprotective agents
  14317. Patterns of cell activity in the subthalamic region associated with the Neuroprotective action of near-infrared light treatment in MPTP-treated mice
  14318. Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is Neuroprotective after spinal cord injury
  14319. Different Neuroprotective responses of Ginkgolide B and bilobalide, the two Ginkgo components, in ischemic rats with hyperglycemia
  14320. Rationale for the use of multifunctional drugs as Neuroprotective agents for glaucoma
  14321. Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration
  14322. G-protein-coupled receptor 30 mediates rapid Neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors
  14323. Neuroprotective effects of dehydroglyasperin C through activation of heme oxygenase-1 in mouse hippocampal cells
  14324. Neuroprotective Activity of (+)-(S)-2-[(1 S, 5 R)-(3, 7-Dioxo-2, 4, 6, 8-Tetraazabicyclo [3.3. 0] oct-2-yl)]-4-methylthiobutanoic acid
  14325. Neuroprotective compounds isolated from Cynanchum paniculatum
  14326. Neuroprotective effects of INM-176 against lipopolysaccharide-induced neuronal injury
  14327. Neuroprotective properties of Loranthus parasiticus aqueous fraction against oxidative stress-induced damage in NG108-15 cells
  14328. The Neuroprotective role of TERT via an antiapoptotic mechanism in neonatal rats after hypoxia–ischemia brain injury
  14329. Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in …
  14330. Neuroprotective effect of phosphocreatine on focal cerebral ischemia-reperfusion injury
  14331. A novel Neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial complex I activity
  14332. Polychlorinated biphenyls-induced oxidative stress on rat hippocampus: a Neuroprotective role of quercetin
  14333. Neuroprotective effects of melatonin on the nigrostriatal dopamine system in the zitter rat
  14334. Is the zinc Neuroprotective effect caused by prevention of intracellular zinc accumulation
  14335. Neuroprotective effects of diallyl sulfide against transient focal cerebral ischemia via anti-apoptosis in rats
  14336. Neuroprotective effects of neuroglobin after mechanical injury
  14337. Neuroprotective effects of hypothermia after spinal cord injury in rats: comparative study between epidural hypothermia and systemic hypothermia
  14338. Neuroprotective effect of raspberry extract by inhibiting peroxynitrite-induced DNA damage and hydroxyl radical formation
  14339. … drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and Neuroprotective properties for Alzheimer’s disease
  14340. A pilot study for the Neuroprotective effect of Gongjin-dan on transient middle cerebral artery occlusion-induced ischemic rat brain
  14341. Topiramate treatment is Neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury
  14342. Neuroprotective effect of baicalein in patients with Parkinson’s disease
  14343. Immunocal® and preservation of glutathione as a novel Neuroprotective strategy for degenerative disorders of the nervous system
  14344. Daidzein has Neuroprotective effects through ligand-binding-independent PPARγ activation
  14345. The anticonvulsant and Neuroprotective effects of walnuts on the neurons of rat brain cortex
  14346. Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress
  14347. Progesterone produces antinociceptive and Neuroprotective effects in rats with microinjected lysophosphatidic acid in the trigeminal nerve root
  14348. Neuroprotective properties of phytochemicals against paraquat-induced oxidative stress and neurotoxicity in Drosophila melanogaster
  14349. Neuroprotective effects of LBP on brain ischemic reperfusion neurodegeneration
  14350. Triazolbenzo [d] thiazoles: Efficient synthesis and biological evaluation as Neuroprotective agents
  14351. Acute Neuroprotective effects of extremely low-frequency electromagnetic fields after traumatic brain injury in rats
  14352. Docosahexaenoic acid complexed to human albumin in experimental stroke: Neuroprotective efficacy with a wide therapeutic window
  14353. Neuroprotective action of bacterial melanin in rats after corticospinal tract lesions
  14354. Interaction structure of the complex between Neuroprotective factor humanin and Alzheimer’s β‐amyloid peptide revealed by affinity mass spectrometry and molecular …
  14355. Quantitative analysis of phenolic components and glycoalkaloids from 20 potato clones and in vitro evaluation of antioxidant, cholesterol uptake, and Neuroprotective …
  14356. Neuroprotective effects of caffeic acid phenethyl ester on experimental traumatic brain injury in rats
  14357. Monoamine oxidase inhibitors and Neuroprotective mechanisms
  14358. Activation of Elk‐1 participates as a Neuroprotective compensatory mechanism in models of Huntington’s disease
  14359. (R)‐α‐Lipoyl‐Glycyl‐L‐Prolyl‐L‐Glutamyl Dimethyl Ester Codrug as a Multifunctional Agent with Potential Neuroprotective Activities
  14360. Treatment with MOG-DNA vaccines induces CD4+ CD25+ FoxP3+ regulatory T cells and up-regulates genes with Neuroprotective functions in experimental …
  14361. Possible Neuroprotective property of nicotinic acetylcholine receptors in association with predominant upregulation of glial cell line‐derived neurotrophic factor in …
  14362. The Neuroprotective disease-modifying potential of psychotropics in Parkinson’s disease
  14363. Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line
  14364. A potential Neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension …
  14365. Neuroprotective effects of PEP-1-Cu, Zn-SOD against ischemic neuronal damage in the rabbit spinal cord
  14366. Activity-dependent Neuroprotective protein modulates its own gene expression
  14367. Neuroprotective effect of vitamin e supplementation in wistar rat treated with acrylamide
  14368. Neuroprotective effects of kolaviron, a biflavonoid complex of Garcinia kola, on rats hippocampus against methamphetamine-induced neurotoxicity
  14369. Saponins with Neuroprotective effects from the roots of Pulsatilla cernua
  14370. 2, 5-Diketopiperazines as Neuroprotective agents
  14371. Isolation, Structural Elucidation, and Neuroprotective Effects of Iridoids from Valeriana jatamansi
  14372. Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia
  14373. Synthesis and biological evaluation of 21-arylidenepregnenolone derivatives as Neuroprotective agents
  14374. Neuroprotective effects of lithium treatment following hypoxic–ischemic brain injury in neonatal rats
  14375. Cortical spreading depression differentially affects lysine methylation of H3 histone at Neuroprotective genes and retrotransposon sequences
  14376. IGF-I receptor signaling pathway is involved in the Neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells
  14377. Age-related decrease in cerebrovascular-derived Neuroprotective proteins: effect of acetaminophen
  14378. Neuroprotective effect of alpha-lipoic acid on hydrostatic pressure-induced damage of retinal ganglion cells in vitro
  14379. Neuroprotective treatment for perinatal asphyxia
  14380. Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl) amides as anticonvulsant and Neuroprotective
  14381. Neuroprotective and hepatoprotective effects of micronized purified flavonoid fraction (Daflon®) in lipopolysaccharide-treated rats
  14382. RGS10 exerts a Neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cells
  14383. The Neuroprotective effect of post ischemic brief mild hypothermic treatment correlates with apoptosis, but not with gliosis in endothelin-1 treated rats
  14384. Neuroprotective effect of early and short-time applying sophoridine in pMCAO rat brain : down-regulated TRAF6 and up-regulated p-ERK1/2 expression, ameliorated …
  14385. The Neuroprotective activity of tamoxifen and tibolone during glutathione depletion in vitro
  14386. Matrix metalloproteinase-7 regulates cleavage of pro-nerve growth factor and is Neuroprotective following kainic acid-induced seizures
  14387. Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson’s …
  14388. Neuroprotective effect of Manasamitra vatakam against aluminium induced cognitive impairment and oxidative damage in the cortex and hippocampus of rat brain
  14389. Dantrolene is Neuroprotective in vitro, but does not affect survival in SOD1G93A mice
  14390. Neuroprotective effect of undecylenic acid extracted from Ricinus communis L. through inhibition of μ-calpain
  14391. Neuroprotective effect of Rhizoma Atractylodis macrocephalae against excitotoxicity‐induced apoptosis in cultured cerebral cortical neurons
  14392. Argon in the fast lane: noble gases and their Neuroprotective effects
  14393. Neuroprotective effects of riluzole in early phase Parkinson’s disease on clinically relevant parameters in the marmoset MPTP model
  14394. Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson’s disease model
  14395. Neuroprotective effect of methyl lucidone against microglia-mediated neurotoxicity
  14396. Mild activation of poly (ADP‐ribose) polymerase (PARP) is Neuroprotective in rat hippocampal slice models of ischemic tolerance
  14397. Neuroprotective and memory enhancing properties of a dual agonist of the FGF receptor and NCAM
  14398. Neuroprotective properties of nicotine
  14399. Neuroprotective effects of ginseng pectin through the activation of ERK/MAPK and Akt survival signaling pathways
  14400. l-Proline-catalyzed diastereoselective synthesis of cis-isoquinolonic acids and evaluation of their Neuroprotective effects
  14401. Neuroprotective properties of ketone bodies
  14402. Neuroprotective effect of the aminoestrogen prolame against impairment of learning and memory skills in rats injected with amyloid-β-25–35 into the hippocampus
  14403. Neuroprotective effect of Cyclosporin A on the development of early brain injury in a subarachnoid hemorrhage model: a pilot study
  14404. Preoperative mucosal tolerance to brain antigens and a Neuroprotective immune response following surgical brain injury
  14405. An overview on potential Neuroprotective compounds for management of Alzheimer’s disease
  14406. The Neuroprotective effect of agmatine after focal cerebral ischemia in diabetic rats
  14407. Overexpression of the immunoreceptor CD300f has a Neuroprotective role in a model of acute brain injury
  14408. Neuroprotective effects of the immunomodulatory drug Setarud on cerebral ischemia in male rats
  14409. Neuroprotective effects of racemic ketamine and (S)-ketamine on spinal cord injury in rat
  14410. Activation of ATP-sensitive potassium channels as an element of the Neuroprotective effects of the Traditional Chinese Medicine MLC901 against oxygen glucose …
  14411. … proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible Neuroprotective …
  14412. Left-shifted Nav channels in injured bilayer: primary targets for Neuroprotective Nav antagonists?
  14413. GSK3β inhibition is involved in the Neuroprotective effects of cyclin-dependent kinase inhibitors in neurons
  14414. Melatonin: neuritogenesis and Neuroprotective effects in crustacean x-organ cells
  14415. Synthesis and Biological Evaluation of (−)‐Linarinic Acid Derivatives as Neuroprotective agents against OGD‐Induced Cell Damage
  14416. Melanocortins: anti-inflammatory and Neuroprotective peptides
  14417. Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are Neuroprotective on cultured and mast cell co-cultured rat myenteric neurons
  14418. Type A monoamine oxidase is associated with induction of Neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase
  14419. Neuroprotective effect of epigallocatechin‐3‐gallate against N‐methyl‐D‐aspartate‐induced excitotoxicity in the adult rat retina
  14420. Lipoxin A 4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a Neuroprotective effect in cerebral ischemia/reperfusion injury
  14421. Neuroprotective potential of Piroxicam in cerebral ischemia: an in silico evaluation of the hypothesis to explore its therapeutic efficacy by inhibition of aquaporin-4 and …
  14422. Potential Neuroprotective strategies against tauopathy
  14423. Cytotoxic and Neuroprotective biflavonoids from the fruit of Rhus parviflora
  14424. New synthesis and promising Neuroprotective role in experimental ischemic stroke of ONO-1714
  14425. Encapsulated cell-based biodelivery of meteorin is Neuroprotective in the quinolinic acid rat model of neurodegenerative disease
  14426. Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective …
  14427. Neuroprotective role of estradiol against neuronal death induced by glucose deprivation in cultured rat hippocampal neurons
  14428. Neuroprotective role of the TREK-1 channel in decompression sickness
  14429. Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, part 1: a phase I and IIa clinical …
  14430. Neuroprotective Effects of Flax Lignan Against NMDA‐Induced Neurotoxicity In Vitro
  14431. Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina
  14432. A series of novel Neuroprotective blood brain barrier penetrating flavonoid drugs to treat acute ischemic stroke
  14433. Neuroprotective therapy using granulocyte colony–stimulating factor for patients with worsening symptoms of thoracic myelopathy: a multicenter prospective controlled …
  14434. Superior Neuroprotective efficacy of LAU-0901, a novel platelet-activating factor antagonist, in experimental stroke
  14435. In search of the Neuroprotective mechanism of thiazolidinediones in Parkinson’s disease
  14436. The endocannabinoid N-arachidonoyldopamine (NADA) exerts Neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB1)
  14437. Statins as potentially Neuroprotective agents : a review
  14438. Neuroprotective effect of ischemic postconditioning and remote preconditioning. Prospective of clinical use
  14439. Neuroprotective Effect of Vitamin E Isoforms Against Chronic Alcohol‐induced Peripheral Neurotoxicity: Possible Involvement of Oxidative‐Nitrodative Stress
  14440. A cellular lipidomic study on the Aβ-induced neurotoxicity and Neuroprotective effects of EGCG by using UPLC/MS-based glycerolipids profiling and multivariate …
  14441. Neuroprotective cyclopentenone prostaglandins up-regulate neurotrophic factors in C6 glioma cells
  14442. Quantitative retinal protein analysis after optic nerve transection reveals a Neuroprotective role for hepatoma-derived growth factor on injured retinal ganglion …
  14443. Neuregulin-1 is Neuroprotective in a rat model of organophosphate-induced delayed neuronal injury
  14444. Dietary supplementations as Neuroprotective therapies: focus on NT-020 diet benefits in a rat model of stroke
  14445. Coumarin glycosides and iridoid glucosides with Neuroprotective effects from Hydrangea paniculata
  14446. Neuroprotective agents in brain injury: a partial failure?
  14447. A study of the potential Neuroprotective effect of riluzole on locomotor networks of the neonatal rat spinal cord in vitro damaged by excitotoxicity
  14448. Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially Neuroprotective in a mouse model of frontotemporal dementia
  14449. Neuroprotective effect of Uncaria rhynchophylla in Kainic acid-induced epileptic seizures by modulating hippocampal mossy fiber sprouting, neuron survival …
  14450. Neuroprotective effects of L-carnitine against oxygen-glucose deprivation in rat primary cortical neurons
  14451. Antidepressants are Neuroprotective against nutrient deprivation stress in rat hippocampal neurons
  14452. Study on Neuroprotective effects of astragalan in rats with ischemic brain injury and its mechanisms
  14453. Enhanced Neuroprotective effects of co-administration of G-CSF with simvastatin on intracerebral hemorrhage in rats.
  14454. Neuroprotective and neurogenesis agent for treating bipolar II disorder: add-on memantine to mood stabilizer works
  14455. The soy phytoestrogens genistein and daidzein as Neuroprotective agents against anoxia-glucopenia and reperfusion damage in rat urinary bladder
  14456. Two new compounds from the fruits of Buddleja lindleyana with Neuroprotective effect
  14457. Neuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brain
  14458. Intravitreal silicon-based quantum dots as Neuroprotective factors in a model of retinal photoreceptor degeneration
  14459. Carbamazepine prevents hippocampal neurodegeneration in mice lacking the Neuroprotective protein, carboxypetidase E
  14460. Neuroprotective effect according to reactive oxygen species scavenging activity from extracts of Cudrania tricuspidata leaves
  14461. Resuscitation with 100% oxygen increases injury and counteracts the Neuroprotective effect of therapeutic hypothermia in the neonatal rat
  14462. Transcriptional expression patterns triggered by chemically distinct Neuroprotective molecules
  14463. Neuroprotective effects of recombinant human erythropoietin in the developing brain of rat after lithium-pilocarpine induced status epilepticus
  14464. Neuroprotective Lignans from the Stems of Schisandra glaucescens
  14465. Clinical trials for Neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside
  14466. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a Neuroprotective effect in the …
  14467. Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model
  14468. Granulocyte colony stimulating factor Neuroprotective effects on spinal motoneurons after ventral root avulsion
  14469. Neuroprotective peptides influence cytokine and chemokine alterations in a model of fetal alcohol syndrome
  14470. Neuron‐specific non‐classical release of prothymosin alpha: a novel Neuroprotective damage‐associated molecular patterns
  14471. Three new myrsinol diterpenes from Euphorbia prolifera and their Neuroprotective activities
  14472. Oxygen–glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of Neuroprotective perlecan LG3 by neurons
  14473. … and brain -derived neurotrophic factor but not granulocyte colony-stimulating factor, nimodipine and dizocilpine, require ATP for Neuroprotective activity after oxygen …
  14474. Impaired recruitment of Neuroprotective microglia and T cells during acute neuronal injury coincides with increased neuronal vulnerability in an amyotrophic lateral …
  14475. Neuroprotective effect of vaccination with autoantigen-pulsed dendritic cells after spinal cord injury
  14476. Neuroprotective effects of selective beta-1 adrenoceptor antagonists, landiolol and esmolol, on transient forebrain ischemia in rats; a dose–response study
  14477. Neuroprotective treatment of cerebral infarction: an experimental study
  14478. Antioxidant and Neuroprotective activities of essential oil, isolated from Chinese herb pairs of Angelica sinensis and Sophora flavescens
  14479. Early cerebral perfusion pressure augmentation with phenylephrine after traumatic brain injury may be Neuroprotective in a pediatric swine model
  14480. Neuroprotective strategies for hypoxic ischemic encephalopathy
  14481. Neuroprotective effect of mesenchymal and neural stem and progenitor cells on sensorimotor recovery after brain injury
  14482. … effect of seeds of Adenanthera pavonina aqueous extract in neuropathic pain in streptozotocin-induced diabetic rats: an evidence of Neuroprotective effects
  14483. Neuroprotective effects of recombinant adeno-associated virus expressing vascular endothelial growth factor on rat traumatic spinal cord injury and its mechanism
  14484. The benefit of combination of oximes for the Neuroprotective efficacy of antidotal treatment of sarin-poisoned rats
  14485. Culture of rat cerebellar granule neurons and application to identify Neuroprotective agents
  14486. Long‐lasting Neuroprotective effect of sildenafil against 3, 4‐methylenedioxymethamphetamine‐induced 5‐hydroxytryptamine deficits in the rat brain
  14487. Prediction of Neuroprotective treatment efficiency using a HRMAS NMR-based statistical model of refractory status epilepticus on mouse: A metabolomic approach …
  14488. Studies on the enantiomers of ZJM-289: synthesis and biological evaluation of antiplatelet, antithrombotic and Neuroprotective activities
  14489. Whole transcriptome analysis of a reversible neurodegenerative process in Drosophila reveals potential Neuroprotective genes
  14490. A novel 7-O-modified genistein derivative with acetylcholinesterase inhibitory effect, estrogenic activity and Neuroprotective effect
  14491. … of Diabetic Retinopathy: A multicentric, prospective, phase II‐III, randomised controlled trial to assess the efficacy of Neuroprotective drugs administered topically to …
  14492. Neuroprotective effects of a dipeptide mimetic on the GK-2 nerve growth factor in model of permanent common carotid artery occlusion in rats
  14493. Bambusae Caulis in Taeniam modulates Neuroprotective and anti-neuroinflammatory effects in hippocampal and microglial cells via HO-1-and Nrf-2 …
  14494. The Neuroprotective effects of lidocaine and methylprednisolone in a rat model of retinal ischemia-reperfusion injury
  14495. Neuroprotective potential beyond immunoregulation of helminth infection as a therapeutic target in multiple sclerosis
  14496. Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice
  14497. Efficacy of reflexology in the combination with Neuroprotective treatment in hemiparetic form of children cerebral palsy
  14498. Neuroprotective effect of curcumin with a fixator of absorption against both aluminium neurotoxicity and alzheimer’s disease (experimental studies in mice)
  14499. Neuroprotective effect of granulocyte colony-stimulating factor in a focal cerebral ischemic rat model with hyperlipidemia
  14500. A Neuroprotective mechanism of YGY‐E in cerebral ischemic injury in rats
  14501. Neuroprotective Effects of Longan (Dimocarpus longan Lour.) Flower Water Extract on MPP+-Induced Neurotoxicity in Rat brain
  14502. Carcinine has 4-hydroxynonenal scavenging property and Neuroprotective effect in mouse retina
  14503. Long-acting NanoART elicits potent antiretroviral and Neuroprotective responses in HIV-1 infected humanized mice
  14504. Therapeutic Neuroprotective effects of XQ-1H in a rat model of permanent focal cerebral ischemia
  14505. Neuroprotective Effect of Convolvulus pluricaulis methanol extract on Hydrogen Peroxide induced oxidative stress in human IMR32 neuroblastoma cell line
  14506. Neuroprotective therapies for multiple sclerosis
  14507. Neuroprotective effects of quercetin 3-O-methyl ether, quercetin and (±)-dihydroquercetin in a rat model of transient focal cerebral ischemia
  14508. Erratum to: Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and Neuroprotective phenotype
  14509. Evaluation of the Neuroprotective effect of minocycline in a rabbit spinal cord ischemia model
  14510. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and Neuroprotective effects in in vitro and in vivo
  14511. Neuroprotective effects of total saponins from Rubus parvifolius L. on cerebral ischemia/reperfusion injury in rats
  14512. Novel Neuroprotective effect of cisternal and intra-cerebral magnesium sulfate solution infusion on delayed cerebral death in rat hippocampal neurons after transient …
  14513. Neuroprotective activity of S-allylcysteine on haloperidol induced Parkinson’s disease in albino mice
  14514. Flavonoids from the leaves of Deguelia utilis (Leguminosae): structural elucidation and Neuroprotective properties
  14515. Neuroprotective effects of combined pretreatment with edaravone and propofol on neonatal rat cerebral cortical neurons with ischemia/reperfusion injury in vitro
  14516. Neuroprotective effect of small interfering RNA targeted to caspase-3 on rat retinal ganglion cell loss induced by ischemia and reperfusion injury
  14517. Neuroprotective effects of a new skin care formulation following ultraviolet exposure
  14518. Neuroprotective effects of triterpene glycosides from glycine max against glutamate induced toxicity in primary cultured rat cortical cells
  14519. Antihypertensive and Neuroprotective activity of quercetin and its derivatives
  14520. Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke
  14521. Neuroprotective effect of curcumin involved in increasing the protein levels of UCP2 and inhibiting oxidative stress induced by chronic cerebral ischemia in vitro
  14522. Subcutaneous fat necrosis: a complication of Neuroprotective cooling
  14523. Transplantation of novel human GDF 5‐expressing CHO cells is Neuroprotective in models of P arkinson’s disease
  14524. Neuroprotective effects of a taurine-containing irrigation solution for vitrectomy
  14525. Inhibition of free radical and Neuroprotective effect of four varieties of Ficus deltoidea
  14526. Comparison of Neuroprotective effects of hypothermia induced by different methods in rats with early cerebral ischemia
  14527. Neuroprotective and cardioprotective effects of hypothermic preconditioning
  14528. Neuroprotective action and free radical scavenging activity of guttiferone-A, a naturally occurring prenylated benzophenone
  14529. Neuroprotective effects of Nannochloropsis oculata against AAPH-induced oxidative DNA damage in HT22 cells
  14530. Neuroprotective effects of imidazenil against chemical warfare nerve agent soman toxicity in guinea pigs
  14531. Status epilepticus and cardiopulmonary arrest in a patient with carbon monoxide poisoning with full recovery after using a Neuroprotective strategy: a case …
  14532. Relationship between the Neuroprotective effects of insulin‐like growth factor‐1 and 17β‐oestradiol in human neuroblasts
  14533. [The Neuroprotective action of enantiomers and racemate of 2-(3, 7-dioxo-2, 4, 6, 8-tetraazabicyclo [3.3. 0] oct-2-yl)-4-methylthiobutanoic acid].
  14534. IL‐2 may possess Neuroprotective properties in glaucomatous optic neuropathy
  14535. Neuroprotective effect of cow colostrum and tetramethylpyrazine against global cerebral ischemia reperfusion injury
  14536. 4-iodophenyl isothiocyanate: a Neuroprotective compound
  14537. Cyclooxygenase-independent Neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity
  14538. Neuroprotective effect of endacannabinoid N-arachidonoyldopamine in acute hypobaric hypoxia
  14539. Neuroprotective effect of four flavonoids in the root of Scutellaria baicalensis Georgi
  14540. Neuroprotective effects of Sohaphwangwon essential oil in a Parkinson’s disease mouse model
  14541. The two different effects of the potential Neuroprotective compound minocycline on AMPA-type glutamate receptors
  14542. Preparative isolation and purification of Neuroprotective compounds from Rhus verniciflua by high speed counter-current chromatography
  14543. Neuroprotective mitochondrial glutamate receptors
  14544. Molecular alterations associated with the NMDA preconditioning-induced Neuroprotective mechanism against glutamate cytotoxicity
  14545. Comparative study of Neuroprotective effect of tricyclics vs. trazodone on animal model of depressive disorder
  14546. Neuroprotective effects of 17β-estradiol associate with KATP in rat brain
  14547. Diabetes mellitus and retinal vein occlusion as risk factors for open angle glaucoma and Neuroprotective therapies for retinal ganglion cell neuropathy
  14548. Modeling emergence in Neuroprotective regulatory networks
  14549. Acute rosiglitazone treatment during reperfusion after hyperglycemic stroke is Neuroprotective not vascular protective
  14550. A novel pathway for enhanced metabolic capacities underlies the Neuroprotective actions of Teneurin C-Terminal Associated Peptide (TCAP)-1
  14551. Functional aspects of Neuroprotective effects of new salts and compositions of baclofen in the convulsive syndrome caused by electroshock
  14552. The mechanisms responsible for Neuroprotective capacity of arylpiperazine dopaminergic ligands against cell death induced by sodium nitroprusside
  14553. Neuroprotective effects of NKN on focal cerebral ischemia in rats
  14554. Neuroprotective effects of bovine colostrum on intracerebral hemorrhage-induced apoptotic neuronal cell death in rats
  14555. Role of the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways in the Neuroprotective effects of cilnidipine against hypoxia in a primary …
  14556. Neuroprotective effect of Scutellaria baicalensis against MCAO induced focal cerebral ischemia
  14557. Neuroprotective effect of recombinant human erythropoietin-loaded poly (lactic-co-glycolic) acid nanoparticles in rats with intracerebral posttraumatic hematoma
  14558. Neuroprotective dose response in RCS rats implanted with microphotodiode arrays
  14559. Progress on the Neuroprotective Effects of Estrogen
  14560. Neuroprotective Effects of New Protein Kinase C Activator TPPB Against Aβ 25–35 Induced Neurotoxicity in PC12 Cells
  14561. Neuroprotective effect of longistyline A against corticosterone-induced neurotoxicity in PC12 cells
  14562. Experimental study on Neuroprotective effect of EGb after spinal cord injury in rats [J]
  14563. Perinatal brain damage: mechanisms and Neuroprotective strategies
  14564. Current opinions about using of medication intervention as Neuroprotective therapy for degenerative ocular fundus diseases
  14565. Modulation of neurotransmission by a specified oregano extract alters brain electrical potentials indicative of antidepressant-like and Neuroprotective activities
  14566. Progress of Acute Hypoxic-ischemic Encephalopathy Neuroprotective Treatment [J]
  14567. Comparative studies of antihypoxic, Neuroprotective and analgesic action of succinate-containing drugs
  14568. Neuroprotective effect of Puerariae Radix extract on focal cerebral ischemia in mice
  14569. Neuroprotective effects of HM15211, a novel long-acting GLP-1/glucagon/GIP triple agonist in the MPTP Parkinson’s disease mouse model
  14570. Neuroprotective effects of sacral epidural neuromodulation following spinal cord injury: an experimental study in rats
  14571. Progesterone as a Neuroprotective treatment in brain ischemic injury in Ovariectomized rats: relation to brain derived neurotrophic factor, Synaptic Plasticity and …
  14572. Neuroprotective effects of raloxifene on Aβ25-35-induced damages in PC12 cells via mitogen-activated protein kinase signaling pathway
  14573. Neuro-EPO by Nasal Route as a Neuroprotective Therapy in brain Ischemia
  14574. Neuroprotective Strategies
  14575. 17α-Ethynyl-androst-5-ene-3β, 7β, 17β-triol (HE3286) Is Neuroprotective and reduces motor impairment and neuroinflammation in a murine MPTP Model of …
  14576. RESEARCH OF Neuroprotective ACTIVITY OF PHYTOREMEDY «PHYTOTON»
  14577. Field Neuroprotective therapy followed by intravenous thrombolysis in a phase 3 clinical trial
  14578. Neurodegenerative process in multiple sclerosis and a possible Neuroprotective effect of β-interferon 1a (avonex)
  14579. Neuroprotective Effects of BG-12 on Malonate-Induced Striatal Lesion Volume in Sprague-Dawley Rat brain (P02. 121)
  14580. Neuroprotective EFFECTS OF
  14581. Alzheimer’s disease: focus on the Neuroprotective role of melatonin
  14582. Antioxidant and Neuroprotective effect of PSE-1 against oxidative stress-induced cytotoxicity in N18-RE-105 cells
  14583. In vitro Neuroprotective activity of phenibut
  14584. Neuroprotective Effect of Resveratrol after Optic Nerve Transection
  14585. Novel Neuroprotective agents : a HIF activator and an Akt activator
  14586. Neuroprotective effect of butylphthalide preconditioning on cerebral ischemia/reperfusion injury in rats
  14587. Neuroprotective effects of Cambodian Plant extracts on glutamate-induced Cytotoxicity in HT22 cells
  14588. Neuroprotective effects of hypothermia 1646–51
  14589. Neuroprotective effects of cortexin, a drug derived from the brain cortex
  14590. Neuroprotective effect of spiradoline and naloxone in focal cerebral ischemia: Promising behavioral and biochemical changes in Wistar rats
  14591. Isolation of Neuroprotective compounds from Phlomis umbrosa
  14592. Anthocyanins: Janus Nutraceuticals Displaying Chemotherapeutic and Neuroprotective Properties
  14593. Neurodegeneration in multiple sclerosis and the Neuroprotective effect of glatiramer acetate: a literature review
  14594. Therapeutic approaches to Neuroprotective activity by complementary and alternative medicines
  14595. Interleukin‐10 overexpression does not synergize with the Neuroprotective action of RGD‐containing vectors after postnatal brain excitotoxicity but modulates the main …
  14596. Pharmacopore hypothesis generation of BACE-1 inhibitors and pharmacophore-driven identification of potent multi-target Neuroprotective agents
  14597. Neuroprotective effect of modify Bo-Yang-Hwan-O-Tang on global ischemia in rat
  14598. Neuroprotective effects of Catalpol on BV2 cells injured by MPP~
  14599. Neuroprotective Effects of Herbal Butanol Extracts from Gynostemma Pentaphyllum on the Exposure to Chronic Stress in a 6-Hydroxydopamine-Lesioned Rat …
  14600. Neuroprotective therapy of the visual pathway in glaucoma
  14601. Neuropeptide GPCRs in neuroendocrinology: the case of activity-dependent Neuroprotective protein (ADNP)
  14602. Neuroprotective effect of granulocyte colony-stimulating factor in a focal cerebral ischemic rat model with hyperlipidemia.
  14603. Research of polyphenols with Neuroprotective potential in a yeast model of degeneration
  14604. Neuroprotective effect of acute ethanol administration in cerebral ischemia through inhibiting adenosine phosphate-activated protein kinase (AMPK) pathway
  14605. The neurodegenerative process in multiple sclerosis and the possible Neuroprotective effect of treatment with Β-interferon 1a (avonex)
  14606. Intranasal delivery of transforming growth factor-beta1 is Neuroprotective against hippocampal damage after status epilepticus [J]
  14607. Neuroprotective activity of Sibjeondaebo-tang on Aβ peptide-induced damages
  14608. Ketogenic diet plays a Neuroprotective role in traumatic brain injury
  14609. Angiotensin receptor antagonists: A potential Neuroprotective strategy after brain trauma
  14610. The Neuroprotective effects of voluntary exercise in a restraint stress model
  14611. Perlecan domain V is Neuroprotective and proangiogenic following ischemic stroke in rodents
  14612. Neuroprotective Effects of Caffeine in Sleep Deprivation
  14613. Could the Neuroprotective drug NA-1 limit ischaemic brain damage after stroke?
  14614. Crocus sativus L. is not just a spice: Neuroprotective effect of saffron extract.
  14615. Generation of recombinant adenoviruses and lentiviruses expressing angiogenic and Neuroprotective factors using Gateway cloning technology.
  14616. Comparison of Neuroprotective effects of anticonvulsant drugs in brain injury therapy
  14617. Neuroprotective Efficacy Of Topical Unoprostone Isopropyl In Patients With Retinitis Pigmentosa
  14618. PdII‐Catalyzed Conjugate Addition of Boronic Acids to Ketoglutaconic Esters toward the Synthesis of Functionalized Pyridazin‐3(2H)‐ones with Neuroprotective …
  14619. Developmental origins of cerebrovascular disease II: considering gene-environment interactions when developing Neuroprotective strategies
  14620. Neuroprotective effect of Celecoxib on radiation-induced acute brain injury
  14621. Neuroprotective effect of the water extract of Angelicae Gigantis Radix Palva in ischemic stroke rats
  14622. Neuroprotective effect of MNG on ischemic stroke
  14623. The Neuroprotective Effects of Therapeutic Hypothermia in Post-Cardiac Arrest Patients: A Systematic Review of the Evidence
  14624. Neuroprotective effects of FGF20 on dopamine neurones
  14625. Neuroprotective and antitremor effect of the mixture of luteolin and rutin on 6-hydroxydopamine induced Parkinson’s disease in rat models
  14626. Neuroprotective effect of Cx43 blocking agent octanol on ischemia-reperfusion in mouse brain
  14627. Neuroprotective Effects of Papaya Epicarp Extract against Aluminum‐Induced Oxidative Stress in Human Neuronal (SHSY5Y) Cells
  14628. The Study on the Neuroprotective Effects of Resveratrol against Degeneration of Dopaminergic Neurons in Parkinson′ s Disease Rat Model [J]
  14629. Neuroprotective effects of Rhodiola rosea extracts against excitotoxicity and oxygen-glucose deprivation in hippocampal slice cultures
  14630. The comparison of Neuroprotective action of antibodies to glutamate and drug preparation semax in the focal ischemic damage of the brain prefrontal cortex of rats
  14631. Neuroprotective effect of Wushen-Xingnao Fang against neuronal injury and vascular dementia induced by transient forebrain ischemia in rats [J]
  14632. Neuroprotective effects of minocycline on double-stranded RNA-induced neurotoxicity in cultured cortical neurons
  14633. Erratum: Chlorogenic Acid Improves Neuroprotective Effect of PEP-1-Ribosomal Protein S3 Against Ischemic Insult
  14634. Neuroprotective Effect of 3, 6-disubstituted-pyrones from a marine Nocardiopsis sp. KMF-001
  14635. Neuroprotective Effect of Isorhamnetin IRN a Flavanol Aglycone on Intracerebroventricular Injection of Amyloid Beta 2535 Aand# 946; 25 35 Induced Alzheimer S …
  14636. Neuroprotective effect and mechanism of polygala hongkongensis hemsl extracts on the focal cerebral ischemia in rats [J]
  14637. Neuroprotective effects of Humanin by inhibiting expression of NR1 subunit and NR2B subunit phosphorylation [J]
  14638. Neuroprotective effects of caffeine
  14639. Novel Neuroprotective targets for stroke treatment
  14640. Neuroprotective Properties of NMDA R1 Antagonist (Ketamine) in Cyanide Treated Neurons in vitro
  14641. Neuroprotective effects of a novel apple peel extract AF4 in a mouse model of hypoxic-ischemic brain injury
  14642. Neuroprotective effect of Ginsenoside Rd on spinal cord motoneurons from glutamate-induced injury in vitro
  14643. Neuroprotective Effect of Hepatocyte Growth Factor
  14644. Neuroprotective effects of bee venom by suppression of neuroinflammatory responses in mouse model of Parkinson’s disease: role of CD4+ CD25+ Foxp3+ regulatory …
  14645. Combination therapy with VELCADE and tPA is Neuroprotective in aged rats after stroke and targets miRNA-146a and the toll-like receptor signaling pathway
  14646. Synthesis of Selenoflavone: Potential Antioxidant and Neuroprotective agents
  14647. Neuroprotective properties of thiacremonone in experimental alzheimer’s disease models
  14648. Why this Neuroprotective Stroke Primate Model May Be Different
  14649. Neuroprotective strategies in a rat model of retinal detachment
  14650. Progress in Studies of Neuroprotective agents Combination Treatment for Ischemic Cerebrovascular Disease [J]
  14651. Vascular endothelial growth factor and HDAC 6: a Neuroprotective signalling pathway against cancer therapy-induced neuropathy
  14652. Autophagic pathway is essential for the Neuroprotective effect of T10 in PD model
  14653. Reasearch on the Neuroprotective Effects of Anti-stroke Effective Compound Group of BaiMai Powder on Experimental MCAO/R Model
  14654. PCV27 Pharmacoeconomic Evaluation of Neuroprotective Therapy of Patients With Acute Ischemic Stroke in Ukraine
  14655. Neuroprotective properties of Phytoestrogens
  14656. Neuroprotective Activity of Sibjeondaebo-tang on A Peptide-Induced Damages
  14657. Conference Report (11th International Conference on Neuroprotective agents , Wendake, Quebec City, Quebec, Canada, Sept 30-Oct 3, 2012)
  14658. Centella asiatica (L.) Urban: From Traditional Medicine to Modern Medicine with Neuroprotective Potential
  14659. Neuroprotective Mechanisms of Intermittent Hypoxia: An In Vitro Study
  14660. The Multi-functional and Neuroprotective Peptide Derivative Carcinine Has Strong Potential for Therapeutic Applications In Retinopathies
  14661. Characterization of Novel Neuroprotective Lipid Analogues for the Treatment of Stroke
  14662. Guest Lecture: The impact of comorbidities and Neuroprotective treatments in brain recovery
  14663. Neuroprotective effect of compound isolated from Cynanchum paniculatum
  14664. Choroid plexus-with special reference to Neuroprotective function
  14665. Anti-inflammatory and Neuroprotective Properties of Ladostigil and Its Primary Metabolites in Vitro and in Vivo
  14666. Neuroprotective effect of GF1029 on primary cortical neuron apoptosis induced by Aβ1-42 in rats
  14667. Chemical analysis and potential Neuroprotective effects of Newfoundland berries
  14668. A Neuroprotective dietary guide for the prevention of initiation and progression of Alzheimer’s Disease
  14669. The Study on Neuroprotective Effects and Mechanism of Estradiol When Administered after Cerebral Ischemic in-sult
  14670. Evaluation of the Neuroprotective effect of minocycline in a rabbit spinal cord
  14671. Behavioral and electrophysiological study on the Neuroprotective effects of lixisenatide against Aβ25-35-induced neurotoxicity in rats
  14672. Fetuin A: a new Neuroprotective serum protein?
  14673. Progress in Research on Neuroprotective Effects of Radix Polygoni Multiflori
  14674. A main role for metabotropic glutamate receptor 1 in the Neuroprotective effect of estrogen
  14675. Neuroprotective Effects of the Acanthopanax sessiliflorus Extract
  14676. Neuroprotective effects of T10 in acute MPTP Parkinsonism model
  14677. Valproic Acid Neuroprotective in HIV-Related Dementia
  14678. 105. Central interleukin-4 infusion after a peripheral lipopolysaccharide injection promotes a Neuroprotective CNS environment with increased M2 microglia
  14679. Neuroprotective Effect of Coeloglossum Extract on Cholinergic Impaired Rats
  14680. Wnt-5a Is a Synaptogenic Factor with Neuroprotective Properties against A Toxicity
  14681. Molecular Mechanisms Underlying the Neuroprotective Effect of Hypothermia in Cerebral Ischemia
  14682. Evaluation of Neuroprotective effects of natural extracts obtained from portuguese agro-food residues
  14683. Neuroprotective factors against retinal injury in response to hypoxia: new perspectives
  14684. Functional characterization of Shadoo, a PrP-like protein with Neuroprotective activity
  14685. Neuroprotective Effects of Selective brain Hypothermia (SBH) on Permanent Focal
  14686. Neuroprotective effects of nerve growth factor on ischemia-referfusion injury in rats
  14687. Neuroprotective Small Molecules for the Treatment of Amyotrophic Lateral Sclerosis
  14688. The Neuroprotective effect of colloids in forebrain ischemia model
  14689. Neuroprotective compounds in Eragrostis ferruginea
  14690. Neuro-EPO by Nasal Route as a Neuroprotective Therapy in brain Ischemia
  14691. Age dependent regulation of the Neuroprotective factor activin in the mouse brain
  14692. The study of Neuroprotective effects of electroacupuncture on Parkinsonian models with concomitant depression and the related mechanisms
  14693. The Action of the Neuroprotective Compound Riluzole on Kv Channels
  14694. The Neuroprotective role of osteopontin in in-vitro and in-vivo models of Parkinson’s disease
  14695. Neurotoxicity and Neuroprotective effect of carbon nanotubes on neuroblastoma cells
  14696. Neuroprotective Effect Of Acute Ethanol Administration In Rat With Transient Cerebral Ischemia
  14697. Neuroprotective effect of MaFGF on hippocampal neurons damaged by cisplatin in vitro
  14698. Investigation of Neuroprotective effects of testosterone in primary cultured hippocampal neurons
  14699. HIF-1α is Neuroprotective during the early phases of mild hypoxia
  14700. Neuroprotective Effect of Neuroglobin after Cerebral Ischemia and Signal Transduction Mechanism
  14701. Neuroprotective effects of red ginseng extract and its action mechanism
  14702. Neuroprotective effects of succinate-containing antihypoxante reamberine in treatment of patients with toxicohypoxic brain injury
  14703. Neuroprotective effect of oxaloacetate in rats with lithium-pilocarpine-induced epilepsy
  14704. Q08 Potential Neuroprotective effects of pridopidine in Huntington’s disease
  14705. Neuroprotective effects of LBP on brain ischemic reperfusion neurodegeneration
  14706. Antioxidant, anti-inflammatory and Neuroprotective activities of plastoquinones from the seed fat of Pycnanthus Angolensis
  14707. Neuroprotective Effect of Rapamycin in Optic Nerve Transection Model
  14708. Evaluation of Neuroprotective Effect of Celastrol in Optic Nerve Crush Model
  14709. Neuroprotective Effects Of Erythropoietin In Mouse Models With Retinal Degeneration
  14710. Neuroprotective effects of Toll-like receptor 4 antagonism in spinal cord cultures and in
  14711. A novel Neuroprotective curcuminoid alleviates glucose intolerance and improves insulin signaling
  14712. 8 Prothymosin α—A Novel Endogenous Neuroprotective Polypeptide against Ischemic Damages
  14713. Preliminary research of Neuroprotective effects of recombinant human erythropoietin in pediatric open-heart surgery
  14714. Neuroprotective Effects of Tianshu Capsules on Focal Cerebral Ischemia Reperfusion Injury in Rats
  14715. The Neuroprotective Role of Shenfu Injection on Rat Model with Focal Ischemic Stroke
  14716. Neuroprotective effect of Celecoxib on radiation-induced acute brain injury
  14717. Expression of neuroglobin in brain tissue of rats with cerebral infarction and its Neuroprotective mechanisms
  14718. Development of a novel model of optic neuritis to assess Neuroprotective and repair strategies in multiple sclerosis
  14719. Neuroprotective effects of three compounds on neurons exposed to oxygen glucose deprivation in vitro
  14720. Proteomic analysis of a neurodegeneration cell model, treated with plant extracts with potential Neuroprotective activity
  14721. Neuroprotective Effect of Cactus Polysaccharides on Focal Cerebral Ischemia in Rats
  14722. Antidepressant properties of flavonoids from Glycyrrhiza uralensis and its Neuroprotective effects
  14723. Neuroprotective effect of L-carnitine on ischemic brain injury in rats
  14724. The Immunoregulatory and Neuroprotective roles of Dimethyl Fumarate in Multiples Sclerosis
  14725. Neuroprotective effect and mechanism of VEGF_ (165) gene-modified neural stem cells on rats following traumatic brain injury
  14726. The Neuroprotective properties of acacetin are regulated by neuroinflammation
  14727. The effect of dietary-relevant concentrations of flavonoids on Neuroprotective pathways in astrocytes
  14728. Neuroprotective effects of dehydroglyasperin C through increased expression of heme oxygenase-1 in mouse hippocampal cells
  14729. Neuroprotective Effect and Mechanism of Scutellarin Ethyl Ester on Cerebral Ischemia in Vitro [J]
  14730. Neuroprotective Effect of Terminalia chebula Retz. and Its Pharmacodynamic Material Basis [J]
  14731. The Neuroprotective effects of relaxin-2 and relaxin-3
  14732. ANTI-INFLAMMATORY AND Neuroprotective EFFECTS OF A NOVEL COMPOUND DIAPOCYNIN IN A MOUSE MODEL OF PARKINSON’S DISEASE
  14733. Neuroprotective effect of a new formulated traditional Chinese medicine in the MPTP model mice with Parkinson’s disease
  14734. Coprismycins A and B, Neuroprotective phenylpyridines from the dung beetle-associated bacterium, Streptomyces sp.
  14735. Neuroprotective effect of Scrophularia striata Boiss on the glutamate neurotoxicity rat cerebellar granule neurons: in vitro study
  14736. Experimental study of the Neuroprotective properties of alpha-lipoic acid and superoxide dismutase in cerebral ischemia in rats
  14737. Gene Therapy for Epilepsy-Dissecting the Role of Somatostatin as a Neuroprotective Agent
  14738. Neuroprotective Role of Endogenous Serum Magnesium on the Severity of Spontaneous Intraparenchymal Hemorrhage (P02. 225)
  14739. Neuroprotective mechanism of Loranthus parasiticus (L.) merr against oxidative stress-induced damage in NG108-15 cells/Daniel Wong Zin Hua
  14740. Neuroprotective Effect of Genistein: Studies in Rat Models of Parkinson’s and Alzheimer’s Disease
  14741. Physiological Neuroprotective Mechanisms in Natural Genetic Systems: Therapeutic Clues for Hypoxia-Induced brain Injuries
  14742. Neuroprotective roles for apelin, a novel neuropeptide, in HIV-associated excitotoxic injury
  14743. Neuroprotective and Neuroregenerative Properties of Haruan (channa Striatus) Traditional Formulation
  14744. Neuroprotective effect of Neanthes japonica (Izuka) fibrinolytic enzyme on rat models of focal cerebral ischemia
  14745. The Neuroprotective Effects of Docosahexaenoic Acid and Lithium Chloride; A Novel Pathway Implicated in Alzheimer’s Disease (P02. 274)
  14746. Neuroprotective Effects of Long-term Endurance Training on the Cortical Autonomic Network in the Aging brain
  14747. Neuroprotective effect of aloe polysaccharide against spinal cord ischemic injury in rabbits [J]
  14748. Neuroprotective Effect of Da-Huo-Luo Pill from Cerebral Ischemia-Reperfusion Injury in Rats in Early Convalescence
  14749. The Neuroprotective Effect of delta-opioid Receptor Stimulation with [D-Ala2, D-Leu5] Enkephalin Against Ischemic Neuronal Injury
  14750. Neuroprotective effect of porphyra polysaccharide on 6-OHDA-induced cytotoxicity in MES23. 5 dopaminergic cells
  14751. Neuroprotective alkaloids isolated from tubers of Corydalis ternata
  14752. GM-CSF is Neuroprotective in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION)
  14753. Neuroprotective effect of peroxisome proliferator-activated receptor γ coactivator-1α in cerebral ischemia
  14754. Neuroprotective effect of α-lipoic acid on cultured retinal ganglion cells under elevated pressure in vitro
  14755. Neuroprotective STUDIES ON THE MPTP AND SOD1 MOUSE MODELS OF NEURODEGENERATIVE DISEASES
  14756. Additional Neuroprotective Effects Of Proinsulin On Vision And Retinal Structure In The Rd10 Mouse Model Of Retinitis Pigmentosa
  14757. Quantum Dots As Neuroprotective Factor In A Model Of Retinal Photoreceptor Degeneration
  14758. Evaluation of Neuroprotective and antioxidant effects of α-and γ-Mangostin in the primary cultured rat cortical cells
  14759. Human umbilical cord mesenchymal stem cells have Neuroprotective effect on neonatal mouse periventricular leukomalacia
  14760. Bone Marrow Derived Mononuclear Cells Are Neuroprotective By Modulating Microglia In A Rodent Model Of Ischemic Stroke
  14761. Topiramate Treatment Is Neuroprotective and Reduces Oligodendrocyte Loss after Cervical Spinal
  14762. Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early
  14763. The Neuroprotective Effect of Platelet-rich Plasma on Erectile Function in Bilateral Cavernous Nerve Injury Rat Model
  14764. Histidine Neuroprotective Effect on CA1 Region of Rat Hippocampus Following Transient brain Ischemia
  14765. Neuroprotective effects of lycium barbarum polysaccharide on corticosterone-induced damage on retinal ganglion cells
  14766. Neuroprotective activities of Citrus sunki peel extract against neroinfalmmation and microglia-mediated neurotoxicity
  14767. The mimicking agent of postconditioning has Neuroprotective effect through activation of NF-κB on cerebral ischemia
  14768. The Neuroprotective effect of lycium barbarum polysaccharides on retinal neurons in a novel acute glaucoma attack animal model
  14769. Poly (ethylene glycol) Microspheres for the Delivery of Neuroprotective agents after Spinal Cord Injury
  14770. Neuroprotective effects of HB08 against dopamine-induced cell death by regulating nurr1 and asynuclein expression.
  14771. Investigation of Neuroprotective and cognition enhancing potential of Tualang Honey in chronic cerebral hypoperfusion-induced neurodegeneration in rats
  14772. Neuroprotective effects of total coumarins of Angelica pubescens (TCA) and mechanism against neuron damage induced by Aβ25-35 [J]
  14773. An investigation into pro-apoptotic targets in experimental glaucoma and the Neuroprotective effects of Ginkgo biloba in retinal ganglion cells
  14774. Neuroprotective effect and possible mechanisms of sulforaphane on focal cerebral ischemic-reperfusion injury in rats [J]
  14775. Neuroprotective effect of Tanshinone ⅡA on early cerebral ischemia and cerebral ischemia-reperfusion models [J]
  14776. Neuroprotective Effects of Cinnamon (Cinnamomum Verum) Via Modulation of Stress Response Signaling
  14777. Neuroprotective potential of solid lipid nanoparticles of sesamol: Possible brain targeting strategy
  14778. Neuroprotective effect of Mailuoning on injury after oxygen glucose deprivation/reoxygenation in primary cultures of rat hippocampal neurons
  14779. Neuroprotective effects of SMB-1 against DA-induced apoptosis and ROS production on neroblastoma SH-SY5Y cells
  14780. Neuroprotective effect of melatonin on preterm rat after hypoxia-ischemia brain damage
  14781. Neuroprotective Role of brain Pericytes through PDGFRβ-Akt Signaling in Ischemic Stroke
  14782. Neuroprotective Effects of Guanosine Against Glutamatergic Excitotoxicity in Experimental Models of brain Injury
  14783. Neuroprotective Effects Of Sirna, Targeted Caspase9, And Atelocollagen Complex On Rat Retinal Damage Induced By Transient Ischemic Injury
  14784. Sulforaphane as a multifunctional Neuroprotective molecule to prevent and slow down the progression of Alzheimer’s disease
  14785. Neuroprotective Appraisal of Methanolic Extract of Flowers of Nerium oleander in a Non Classical Rat Model of Alzheimer Disease
  14786. Effects of EMS Routing to Stroke Centers and Participation in a Prehospital Neuroprotective Trial on Door to Needle Times for IV tPA
  14787. … following Hypoxia-Ischemia in the immature rat brain : macro-, micro-structural and metabolic assessment of the Neuroprotective effect using multimodal MR
  14788. Effects of ibuprofen and celecoxib as Neuroprotective agents in chronic cerebral hypoperfusion-induced neurodegeneration in rats
  14789. Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses
  14790. Valproate Exerts Pleiotropic Neuroprotective Effects on Retinal Ganglion Cells in vivo Through Epigenetic Modulation in an Experimental Model of Glaucoma
  14791. The Neuroprotective effect of ischemic postconditioning and citicoline against cerebral ischemia-reperfusion injury in mongolian gerbils
  14792. Neuroprotective effects of peroxisome proliferators-acfivated receptor γ ligand thiazolidinediones in cerebral ischemia
  14793. Neuroprotective effects of Eucommia ulmoides Oliv. Bark. on cognitive deficit and neuronal cell death in in vivo and in vitro models
  14794. HYPOXIC-ISCHEMIC brain INJURY IN NEWBORN RAT: Neuroprotective EFFECTS OF ACETAMINOPHEN AND THE INVOLVEMENT OF ACID …
  14795. Translational Stroke Research: Identification Of A Novel Family Of Natural Product Derived Flavonoid-Based Polyphenols With Potent Pleiotropic Neuroprotective …
  14796. Neuroprotective Effect of Memantine and Hyperbaric Oxygen Therapy After Acute Ischemia-Reperfusion Injury: Immunohistochemical Analysis
  14797. The Neuroprotective effect of hyperbaric oxygenation on the mitochondria of dopaminergic neurons in a mouse model of Parkinson’s disease
  14798. M-Type K+ Channel Openers: In Vivo Neuroprotective Role During Cerebrovascular Stroke
  14799. Neuroprotective Effects of neolignan from Magnolia obovata Frtuis on Glutamate-induced Cytotoxicity in HT22 cells
  14800. New Flavonoid Glycosides from Pyrrosia petiolosa and their Neuroprotective Activities Against Glutamate-Induced Oxidative Stress in HT22 Hippocampal Cells
  14801. Neurotrophin Peptidomimetics Activate TrkA/B Signaling and Display Neuroprotective Effects in Neuroinflammation and Neurodegeneration (P07. 091)
  14802. Immediate Hypothermia Is Not Neuroprotective After Severe Hypoxia-Ischemia and Is Deleterious When Delayed by 12 Hours in Neonatal Rats
  14803. Neuroprotective Effects of Epigallocatechin-3-gallate against N-methyl-D-aspartate Induced Excitotoxicity in Rat Retina
  14804. Cost-Effectivenss of 3 Common Neuroprotective agents for Acute Ischemic Stroke
  14805. Dexmedetomidine, a sedative/anesthetic and Neuroprotective drug, acts via astrocytic α2-adrenergic receptors
  14806. Transportation of Neuroprotective flavonoids using the BBB, Caco-2 cell model and everted rat intestinal sacs based on cell toxicity
  14807. Tropisetron as a Neuroprotective Agent Against Glutamate-Induced Excitotoxicity: Potential Mechanisms of Neuroprotection
  14808. Neuroprotective efficacy of ANAVEX2-73, a novel tetrahydrofuran derivative targeting the sigma-1 chaperone protein, in a mouse model of Alzheimer’s disease …
  14809. Neuroprotective effect of a new synthetic aspirin-decursinol adduct in the hippocampal CA1 region after transient cerebral ischemia
  14810. Neuroprotective and regenerative effect of neurotrophin‐4 on neuronal degeneration induced by advanced glycation end‐products in adult rat retinas
  14811. Neuroprotective role of Alpha lipoic acid (ALA) in arsenic (As) induced developmental neurotoxicity in rat pups
  14812. Neuroprotective Effect of Neurotropin on Chronic Oxaliplatin-Induced Neurotoxicity in Stage I and Stage II Colorectal Cancer Patients: Results from a …
  14813. Neuroprotective effects of Nigella Sativa seeds and Murraya Koenigii Leaves extracts in a two vessel occlusion rat model of Alzheimers disease
  14814. Neuroprotective and behavioral antiepileptic effects of oleamide as a novel calpain inhibitor in the kainic acid-induced epileptic rat model
  14815. Inhibition of Soluble Epoxide Hydrolase Improves Neuronal Survival after Cardiac Arrest and Alters Microglial Activation towards a Neuroprotective Phenotype
  14816. Neuroprotective Effect of Ginsenoside Rg1 on Oxidative Damage Induced by Oxygen-glucose Deprivation and Reperfusion in Cultured Hippocampal Cells
  14817. Shh10, A Novel müLler Glia Cell-specific Aav Vector, Expressing Gdnf Is Neuroprotective In Murine Model Of Microbead-induced Glaucoma
  14818. Function-Blocking Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Antibody Injection is Neuroprotective after Focal Cerebral Ischemia
  14819. Role of frataxin in erythropoietin-and carbamoylated erythropoietin-mediated Neuroprotective effects in the mouse retina after acute retinal ischemia/reperfusion …
  14820. … Upregulated Early Post-stroke and Exogenous Activation of the Pathway Promotes Neurogenesis, Enhances Functional Recovery and has Potential Neuroprotective …
  14821. Neuroprotective Effects of Echogenic Liposomes-Mediated Xenon Delivery in a Rat Embolic Stroke Model Combined With Tissue Plasminogen Activator Thrombolysis
  14822. Comparison of the Neuroprotective effects of bis (7)-tacrine, memantine and tacrine on cognitive impairment and neurogenesis in chronic cerebral ischemic rats
  14823. Evaluation of Neuroprotective effect of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2 (3H)-ylidene) methyl) pyridinium derivatives on beta amyloid (Aβ) induced toxicity in …
  14824. P-1288-Neuroprotective and cognitive enhancement effects of bacopa monnieri on novel object recognition in schizophrenic rat model
  14825. Neuroprotective effect of minocycline against morphine-induced apoptosis in rat brain cortex and spinal cord: A possible mechanism involves in attenuating morphine …
  14826. Neuroprotective effects of caffeic acid, syringic acid and HBU-3 (a synthetic caffeic acid-syringic acid adduct) on the delayed neuronal death induced by transient …
  14827. Neuroprotective effect of mulberrofuran G (M. bombycis) against OGD/Reoxygenation-induced cell death: inhibition of NADPH oxidase, ROS production and ASK1 …
  14828. Screening Neuroprotective agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation …
  14829. … peptide that inhibits N-methyl-D-aspartic acid ligand-gated and L-type voltage-gated calcium channels, is a potential Neuroprotective treatment for excitotoxicity
  14830. Diacylglycerol, novel protein kinase C isozymes [eta] and [theta], and other diacylglycerol activated proteins promote Neuroprotective plasmalemmal sealing in B104 …
  14831. 108 Investigating the Neuroprotective properties of Δ9-THC in a cell culture model of Parkinson’s disease
  14832. 309 Tumor Necrosis Factor-Inducible Gene 6 Protein: A Novel Neuroprotective Factor Against Inflammatory Developmental brain Injury
  14833. 1115 The Neuroprotective Effects of Valproic Acid, an Histone Deacetylase Inhibitor in a Neonatal Hypoxic-Ischemic Rat Model
  14834. DJ-1 Based Peptide as a Novel Neuroprotective Strategy for Parkinson’s Disease (P02. 239)
  14835. Down-regulation of complement component 3 is Neuroprotective after oxygen-glucose deprivation in mouse primary cortical neurons
  14836. Novel dimeric antiacetylcholinesterase Bis (12)-hupyridone: Neuroprotective and neuronal differentiation-promoting activities and their underlying molecular …
  14837. Effect of Connexin 43 in Neuroprotective Function of Ginkgo Biloba Extract in Rats with Ischemic Injury
  14838. Effect of heparin on expressions of cerebral Bcl-2 and Bax and its Neuroprotective effect after cardiopulmonary resuscitation in rats
  14839. Involvement of Heme Oxygenase-1 Induction in the Neuroprotective Activitiy of Extract of Siegesbeckia Herba in Murine Hippocampal HT22 Cells
  14840. Bone Marrow Mesenchymal Stem Cell (2-C3H D3# 2) Showed Neuroprotective Effects by Complement Component 3 Down-regulation after Transient Focal …
  14841. 170 Maternal Allopurinol Administration During Term Labor is Neuroprotective in Case of Fetal Hypoxia; A Multicenter Randomized Placebo Controlled Trial
  14842. 17a-Ethynyl-androst-5-ene-3ß, 7ß, 17ß-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of …
  14843. 17-Ethynyl-androst-5-ene-3, 7, 17-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of …
  14844. Central IL-4 promotes a Neuroprotective and anti-inflammatory brain environment following peripheral LPS injection
  14845. Neuroprotective function of DJ-1 in Parkinson’s disease
  14846. Putative Neuroprotective agents in neuropsychiatric disorders
  14847. Sulfhydration mediates Neuroprotective actions of parkin
  14848. Neuroprotective function of 14-3-3 proteins in neurodegeneration
  14849. The Neuroprotective roles of BDNF in hypoxic ischemic brain injury
  14850. Taurine and its Neuroprotective role
  14851. Obstacles to the development of a Neuroprotective therapy for Parkinson’s disease
  14852. Neuroprotective effects of liraglutide for stroke model of rats
  14853. The Neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects
  14854. The Neuroprotective effects of cocoa flavanol and its influence on cognitive performance
  14855. Therapeutic Neuroprotective agents for amyotrophic lateral sclerosis
  14856. Neuroprotective properties of curcumin in Alzheimer’s disease-merits and limitations
  14857. Neuroprotective Properties and Mechanisms of Resveratrol in in Vitro and in Vivo Experimental Cerebral Stroke Models
  14858. Neuroprotective Sirtuin ratio reversed by ApoE4
  14859. Neuroprotective effects of digested polyphenols from wild blackberry species
  14860. Fingolimod phosphate promotes the Neuroprotective effects of microglia
  14861. Nitric oxide donors as Neuroprotective agents after an ischemic stroke-related inflammatory reaction
  14862. Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain
  14863. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats
  14864. Neuroprotective mechanisms of taurine against ischemic stroke
  14865. Neuroprotective effect of human placenta-derived cell treatment of stroke in rats
  14866. Glutathione peroxidase activity is Neuroprotective in models of Huntington’s disease
  14867. Trial designs used to study Neuroprotective therapy in Parkinson’s disease
  14868. Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia
  14869. VEGF-A165b is an endogenous Neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro
  14870. GPR37 and GPR37L1 are receptors for the Neuroprotective and glioprotective factors prosaptide and prosaposin
  14871. Neuroprotective role of taurine during aging
  14872. Neuroprotective effects of salvianolic acid B on an Aβ25–35 peptide-induced mouse model of Alzheimer’s disease
  14873. Maintenance of retinal ganglion cell mitochondrial functions as a Neuroprotective strategy in glaucoma
  14874. Neuroprotective , anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer’s disease mouse model
  14875. Neuroprotective properties of the excitatory amino acid carrier 1 (EAAC1)
  14876. Neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features
  14877. Safety and efficacy evaluation of carnosine, an endogenous Neuroprotective agent for ischemic stroke
  14878. The Neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders
  14879. Neuroprotective effects of microRNA-210 on hypoxic-ischemic encephalopathy
  14880. Neuroprotective effect of brain -derived neurotrophic factor mediated by autophagy through the PI3K/Akt/mTOR pathway
  14881. Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats
  14882. Bee venom and its component apamin as Neuroprotective agents in a Parkinson disease mouse model
  14883. The neonatal integrative developmental care model: Seven Neuroprotective core measures for family-centered developmental care
  14884. Investigation of the Neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment
  14885. Neuroprotective , neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury
  14886. Neuroprotective effect of naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke
  14887. Elucidation of molecular mechanism involved in Neuroprotective effect of C oenzyme Q 10 in alcohol‐induced neuropathic pain
  14888. Nontoxic and Neuroprotective β-naphthotacrines for Alzheimer’s disease
  14889. Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action
  14890. The Neuroprotective effects of purslane (Portulaca oleracea) on rotenone-induced biochemical changes and apoptosis in brain of rat
  14891. Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson’s disease
  14892. Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules
  14893. Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia
  14894. Anti-inflammatory and Neuroprotective effects of constituents isolated from Rhodiola rosea
  14895. Neuroprotective role of nerve growth factor in hypoxic-ischemic brain injury
  14896. Neurotrophic and Neuroprotective actions of (−)-and (+)-phenserine, candidate drugs for Alzheimer’s disease
  14897. Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential Neuroprotective mechanism against Alzheimer’s disease: in vitro and in vivo studies
  14898. cognitive -enhancing effects of Rhus verniciflua bark extract and its active flavonoids with Neuroprotective and anti-inflammatory activities
  14899. Neuroprotective efficacy of methylene blue in ischemic stroke: an MRI study
  14900. MAP kinase phosphatase 1 (MKP-1/DUSP1) is Neuroprotective in Huntington’s disease via additive effects of JNK and p38 inhibition
  14901. Neuroprotective effect of physical exercise in a mouse model of Alzheimer’s disease induced by β-amyloid 1–40 peptide
  14902. Neuroprotective therapies after perinatal hypoxic-ischemic brain injury
  14903. Ghrelin is Neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic Neuroprotection
  14904. Connexin43 mimetic peptide is Neuroprotective and improves function following spinal cord injury
  14905. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and Neuroprotective therapy—a consensus statement from …
  14906. Discovery of novel N-substituted carbazoles as Neuroprotective agents with potent anti-oxidative activity
  14907. Neuroprotective effects of madecassoside in early stage of Parkinson’s disease induced by MPTP in rats
  14908. Chroman-like cyclic prenylflavonoids promote neuronal differentiation and neurite outgrowth and are Neuroprotective
  14909. B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of Neuroprotective peptide
  14910. Time-and dose-dependent Neuroprotective effects of sex steroid hormones on inflammatory cytokines after a traumatic brain injury
  14911. Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by Neuroprotective nuclear calcium signals
  14912. GM-CSF induces Neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine intoxicated mice
  14913. Neuroprotective strategies in hippocampal neurodegeneration induced by the neurotoxicant trimethyltin
  14914. Na+‐K+‐ATPase, a potent Neuroprotective modulator against Alzheimer disease
  14915. Neuroprotective effects of bacopaside I in ischemic brain injury
  14916. A Neuroprotective phase precedes striatal degeneration upon nucleolar stress
  14917. Histone deacetylase inhibitors are Neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury
  14918. Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain -derived neurotrophic …
  14919. Neuroprotective effects of PPAR‐γ agonist rosiglitazone in N171‐82Q mouse model of Huntington’s disease
  14920. Neuroprotective effects of inhaled lavender oil on scopolamine-induced dementia via anti-oxidative activities in rats
  14921. Neuroprotective effects of lutein in a rat model of retinal detachment
  14922. Structure–activity relationship study of vitamin K derivatives yields highly potent Neuroprotective agents
  14923. Delayed post-injury administration of riluzole is Neuroprotective in a preclinical rodent model of cervical spinal cord injury
  14924. The Neuroprotective effect of overexpression of calbindin-D 28k in an animal model of Parkinson’s disease
  14925. … , a promising component of propolis with a plethora of biological activities: A review on its anti‐inflammatory, Neuroprotective , hepatoprotective, and cardioprotective …
  14926. Antioxidant properties and Neuroprotective effects of isocampneoside II on hydrogen peroxide-induced oxidative injury in PC12 cells
  14927. Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is Neuroprotective
  14928. Neuroprotective effects of psychotropic drugs in Huntington’s disease
  14929. iPSC-derived neural precursors exert a Neuroprotective role in immune-mediated demyelination via the secretion of LIF
  14930. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and Neuroprotective activities of palmitoylethanolamide after spinal cord …
  14931. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers Neuroprotective mechanisms
  14932. Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury
  14933. Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson’s disease
  14934. Advances in Neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson’s disease
  14935. Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson’s disease
  14936. RANTES has a potential to play a Neuroprotective role in an autocrine/paracrine manner after ischemic stroke
  14937. Neuroprotective effect of Pycnogenol® following traumatic brain injury
  14938. Inhibition of cathepsin S produces Neuroprotective effects after traumatic brain injury in mice
  14939. Multi target Neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline
  14940. Neuroprotective effect of Liuwei Dihuang decoction on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat
  14941. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have Neuroprotective …
  14942. Neuroprotective effects of D-Ala 2 GIP on Alzheimer’s disease biomarkers in an APP/PS1 mouse model
  14943. Isolation, characterization, and Neuroprotective activities of sesquiterpenes from Petasites japonicus
  14944. Intrabodies as Neuroprotective therapeutics
  14945. Oxidative stress defines the Neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells
  14946. Prospects of levetiracetam as a Neuroprotective drug against status epilepticus, traumatic brain injury, and stroke
  14947. JNK inhibitors as anti-inflammatory and Neuroprotective agents
  14948. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in …
  14949. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and Neuroprotective lipid mediator
  14950. Neuroprotective role of Withania somnifera root extract in Maneb–Paraquat induced mouse model of parkinsonism
  14951. Neuroprotective polyhydroxypregnane glycosides from Cynanchum otophyllum
  14952. The Neuroprotective activities of heteropolysaccharides extracted from Saccharina japonica
  14953. Neuroprotective efficacy of eugenol and isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical evidence
  14954. Design, synthesis and Neuroprotective evaluation of novel tacrine–benzothiazole hybrids as multi-targeted compounds against Alzheimer’s disease
  14955. Neuroprotective effect of minocycline in a rat model of branch retinal vein occlusion
  14956. The Neuroprotective role and mechanisms of TERT in neurons with oxygen–glucose deprivation
  14957. Anti-inflammatory and Neuroprotective effects of auraptene, a citrus coumarin, following cerebral global ischemia in mice
  14958. Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma
  14959. The comparison of Neuroprotective effects of intrathecal dexmedetomidine and metilprednisolone in spinal cord injury
  14960. Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson’s disease
  14961. Iron uptake in quiescent and inflammation-activated astrocytes: a potentially Neuroprotective control of iron burden
  14962. Neuroprotective effect of resveratrol on ischemia/reperfusion injury in rats through TRPC6/CREB pathways
  14963. Neuroprotective effect of kaempferol glycosides against brain injury and neuroinflammation by inhibiting the activation of NF-κB and STAT3 in transient focal …
  14964. Neuroprotective effect of melatonin against hypoxia‐induced retinal ganglion cell death in neonatal rats
  14965. Neuroprotective efficacy of a new brain -penetrating C-Abl inhibitor in a murine Parkinson’s disease model
  14966. Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice
  14967. Neuritogenic and Neuroprotective activities of fruit residues
  14968. Oral ‘hydrogen water’induces Neuroprotective ghrelin secretion in mice
  14969. Potential Neuroprotective effect of ibuprofen, insights from the mice model of Parkinson’s disease
  14970. Neuroprotective role of γ‐enolase in microglia in a mouse model of Alzheimer’s disease is regulated by cathepsin X
  14971. Neuroprotective compounds from the bulbs of Lycoris radiata
  14972. Neuroprotective effects of donepezil against cholinergic depletion
  14973. Cocoa powder triggers Neuroprotective and preventive effects in a human Alzheimer’s disease model by modulating BDNF signaling pathway
  14974. Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat
  14975. Neuroprotective actions of perinatal choline nutrition
  14976. Neuroprotective effects of ginsenoside Rb1 on high glucose-induced neurotoxicity in primary cultured rat hippocampal neurons
  14977. Inhibition of Rho kinase mediates the Neuroprotective effects of estrogen in the MPTP model of Parkinson’s disease
  14978. Phytochemical composition, antioxidant activity and Neuroprotective effect of Crataegus pinnatifida fruit
  14979. Phenylbutyrate is a multifaceted drug that exerts Neuroprotective effects and reverses the Alzheimer s disease-like phenotype of a commonly used mouse model
  14980. Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson’s …
  14981. Galantamine potentiates the Neuroprotective effect of memantine against NMDA‐induced excitotoxicity
  14982. … monitoring of dynamic change of hippocampal ascorbate: toward a platform for in vivo evaluation of antioxidant Neuroprotective efficiency against cerebral ischemia …
  14983. Antioxidant and Nrf2 inducing activities of luteolin, a flavonoid constituent in Ixeris sonchifolia Hance, provide Neuroprotective effects against ischemia-induced cellular …
  14984. Neuroprotective effect of estrogen: role of nonsynaptic NR2B-containing NMDA receptors
  14985. Parthenolide is Neuroprotective in rat experimental stroke model: downregulating NF-B, phospho-p38MAPK, and caspase-1 and ameliorating BBB …
  14986. TOPS-MODE model of multiplexing Neuroprotective effects of drugs and experimental-theoretic study of new 1, 3-rasagiline derivatives potentially useful in …
  14987. Neuroprotective effects of lactate in brain ischemia: dependence on anesthetic drugs
  14988. Identification through high‐throughput screening of 4’‐methoxyflavone and 3′, 4’‐dimethoxyflavone as novel Neuroprotective inhibitors of parthanatos
  14989. A positive allosteric modulator of α7 n AChR s augments Neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia
  14990. Connexin hemichannel blockade is Neuroprotective after, but not during, global cerebral ischemia in near-term fetal sheep
  14991. Ischemia preconditioning is Neuroprotective in a rat cerebral ischemic injury model through autophagy activation and apoptosis inhibition
  14992. The antioxidant activities and Neuroprotective effect of polysaccharides from the starfish Asterias rollestoni
  14993. Neuroprotective effects of hydroalcoholic extract of Ocimum sanctum against H 2 O 2 induced neuronal cell damage in SH-SY5Y cells via its antioxidative defence …
  14994. Neuroprotective effects of biochanin A against glutamate-induced cytotoxicity in PC12 cells via apoptosis inhibition
  14995. Emerging Neuroprotective drugs for the treatment of acute ischaemic stroke
  14996. Neuroprotective effect of preoperatively induced mild hypothermia as determined by biomarkers and histopathological estimation in a rat subdural hematoma …
  14997. Neuroprotective effect of calcitriol on ischemic/reperfusion injury through the NR3A/CREB pathways in the rat hippocampus
  14998. Neuroprotective effect of pseudoginsenoside-f11 on a rat model of Parkinson’s disease induced by 6-hydroxydopamine
  14999. Ghrelin as a Neuroprotective and palliative agent in Alzheimer’s and Parkinson’s disease
  15000. Revelation in the Neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms
  15001. Neuroprotective effects of carvacrol and pomegranate against methotrexate-induced toxicity in rats
  15002. Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell–mediated dendrite and synapse loss
  15003. Neuroprotective effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury
  15004. Neuritogenic and Neuroprotective effects of polar steroids from the far east starfishes Patiria pectinifera and Distolasterias nipon
  15005. Cellular and molecular mechanisms involved in the Neuroprotective effects of VEGF on motoneurons
  15006. Neuroprotective activities of ca talpol against CaMKII‐dependent apoptosis induced by LPS in PC12 cells
  15007. Neuroprotective effect of ginkgolide B on bupivacaine-induced apoptosis in SH-SY5Y cells
  15008. Neuroprotective effects of treadmill exercise on BDNF and PI3-K/Akt signaling pathway in the cortex of transgenic mice model of Alzheimer’s disease
  15009. Pigment epithelium-derived factor is retinal ganglion cell Neuroprotective and axogenic after optic nerve crush injury
  15010. Neuroprotective effects of liquiritigenin isolated from licorice roots on glutamate-induced apoptosis in hippocampal neuronal cells
  15011. Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons
  15012. Neuroprotective effects of mesenchymal stem cells on spinal motoneurons following ventral root axotomy: synapse stability and axonal regeneration
  15013. Comparison of Neuroprotective effects of Melissa officinalis total extract and its acidic and non-acidic fractions against a β-induced toxicity
  15014. An in vitro study of Neuroprotective properties of traditional Chinese herbal medicines thought to promote healthy ageing and longevity
  15015. Antioxidant and Neuroprotective Effects of Scrophularia striata Extract Against Oxidative Stress-Induced Neurotoxicity
  15016. Dietary and plant polyphenols exert Neuroprotective effects and improve cognitive function in cerebral ischemia
  15017. Erythropoietin: a Neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy
  15018. Neuroprotective effects of forsythiaside on learning and memory deficits in senescence-accelerated mouse prone (SAMP8) mice
  15019. Rhes deletion is Neuroprotective in the 3-nitropropionic acid model of Huntington’s disease
  15020. The Neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models
  15021. Ubiquitination regulates the Neuroprotective function of the deubiquitinase ataxin-3 in vivo
  15022. Neuroprotective effect of a cell-free extract derived from human adipose stem cells in experimental stroke models
  15023. Enhanced Neuroprotective effects of resveratrol delivered by nanoparticles on hydrogen peroxide-induced oxidative stress in rat cortical cell culture
  15024. Intraoperative Neuroprotective drugs without beneficial effects? Results of the German Registry for Acute Aortic Dissection Type A (GERAADA)
  15025. Neuroprotective effects of Cyperus rotundus on SIN-1 induced nitric oxide generation and protein nitration: ameliorative effect against apoptosis mediated neuronal …
  15026. Effects of nicorandil in Neuroprotective activation of PI3K/AKT pathways in a cellular model of Alzheimer’s disease
  15027. Neuroprotective effects of microRNA-210 against oxygen-glucose deprivation through inhibition of apoptosis in PC12 cells
  15028. Cytochrome c is tyrosine 97 phosphorylated by Neuroprotective insulin treatment
  15029. Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and Neuroprotective …
  15030. A glutathione derivative with chelating and in vitro Neuroprotective activities: synthesis, physicochemical properties, and biological evaluation
  15031. Potentially Neuroprotective gene modulation in an in vitro model of mild traumatic brain injury
  15032. Clinical evaluation of a Neuroprotective drug in patients with cervical spondylotic myelopathy undergoing surgical treatment: design and rationale for the CSM-Protect …
  15033. Neuroprotective activity of gossypin from Hibiscus vitifolius against global cerebral ischemia model in rats
  15034. Açaí (Euterpe oleraceae Mart.) berry extract exerts Neuroprotective effects against β-amyloid exposure in vitro
  15035. The potential Neuroprotective effect of human adipose stem cells conditioned medium against light-induced retinal damage
  15036. Neuroprotective effect of CNB-001, a novel pyrazole derivative of curcumin on biochemical and apoptotic markers against rotenone-induced SK-N-SH cellular model …
  15037. Neuroprotective effects of total saikosaponins of Bupleurum yinchowense on corticosterone-induced apoptosis in PC12 cells
  15038. Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson’s disease in rats
  15039. Nicotine-encapsulated poly (lactic-co-glycolic) acid nanoparticles improve Neuroprotective efficacy against MPTP-induced parkinsonism
  15040. Long-term Neuroprotective effects of NT-4–engineered mesenchymal stem cells injected intravitreally in a mouse model of acute retinal injury
  15041. Sleep deprivation before stroke is Neuroprotective : a pre-ischemic conditioning related to sleep rebound
  15042. Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells
  15043. Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications
  15044. Neuroprotective effect of bicyclol in rat ischemic stroke: Down-regulates TLR4, TLR9, TRAF6, NF-κB, MMP-9 and up-regulates claudin-5 expression
  15045. Neuroprotective effects of NGF, BDNF, NT-3 and GDNF on axotomized extraocular motoneurons in neonatal rats
  15046. Neuroprotective effect of (–)-epigallocatechin-3-gallate in rats when administered pre-or post-traumatic brain injury
  15047. Role of the inhibition of oxidative stress and inflammatory mediators in the Neuroprotective effects of hydroxytyrosol in rat brain slices subjected to hypoxia …
  15048. Perlecan domain V is Neuroprotective and affords functional improvement in a photothrombotic stroke model in young and aged mice
  15049. Neuroprotective and procognitive effects of sertraline: in vitro and in vivo studies
  15050. Neuroprotective effects of Lycium barbarum polysaccharides in lipopolysaccharide-induced BV2 microglial cells
  15051. Altered network communication following a Neuroprotective drug treatment
  15052. Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a Neuroprotective mechanism in retinal degeneration
  15053. Neuroprotective effects of erythropoietin in patients with carbon monoxide poisoning
  15054. Neuroprotective Peptide humanin inhibits inflammatory response in astrocytes induced by lipopolysaccharide
  15055. Neuroprotective effects of donepezil against A β42‐induced neuronal toxicity are mediated through not only enhancing PP 2 A activity but also regulating GSK‐3β and …
  15056. Enhanced Neuroprotective effect of fish oil in combination with quercetin against 3‐nitropropionic acid induced oxidative stress in rat brain
  15057. Neuroprotective effect of a new synthetic aspirin-decursinol adduct in experimental animal models of ischemic stroke
  15058. Neuroprotective effects of paeoniflorin, but not the isomer albiflorin, are associated with the suppression of intracellular calcium and calcium/calmodulin protein kinase …
  15059. Neuroprotective Effects of Nicotinamide N‐Methyltransferase and its Metabolite 1‐Methylnicotinamide
  15060. Xanthotoxol exerts Neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia
  15061. Neuroprotective effect of atorvastatin involves suppression of TNF-α and upregulation of IL-10 in a rat model of intracerebral hemorrhage
  15062. Intravenous thrombolysis with Neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age
  15063. Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: Neuroprotective or neurotoxic properties of sirtuins in ALS?
  15064. Synthesis and Neuroprotective action of xyloketal derivatives in Parkinson’s disease models
  15065. The Neuroprotective effects of intraperitoneal injection of hydrogen in rabbits with cardiac arrest
  15066. A pharmacological screening approach for discovery of Neuroprotective compounds in ischemic stroke
  15067. Human stem cell‐derived astrocytes and their application to studying N rf2‐mediated Neuroprotective pathways and therapeutics in neurodegeneration
  15068. Selective activation of protein kinase C∊ in mitochondria is Neuroprotective in vitro and reduces focal ischemic brain injury in mice
  15069. Neuroprotective effects of progesterone in traumatic brain injury: blunted in vivo neutrophil activation at the blood-brain barrier
  15070. The Neuroprotective actions of hypoxic preconditioning and postconditioning in a neonatal rat model of hypoxic–ischemic brain injury
  15071. Genetically modified neural stem cells for a local and sustained delivery of Neuroprotective factors to the dystrophic mouse retina
  15072. Regulating the ubiquitin/proteasome pathway via cAMP-signaling: Neuroprotective potential
  15073. Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury
  15074. Estrogen receptor‐β ligand treatment after disease onset is Neuroprotective in the multiple sclerosis model
  15075. Optimization of hydrolysis conditions, isolation, and identification of Neuroprotective peptides derived from seahorse Hippocampus trimaculatus
  15076. Modeling the Neuroprotective role of enhanced astrocyte mitochondrial metabolism during stroke
  15077. Neuroprotective Potential of Bacopa monnieri and Bacoside A Against Dopamine Receptor Dysfunction in the Cerebral Cortex of Neonatal Hypoglycaemic Rats
  15078. Anticonvulsant, Neuroprotective and behavioral effects of organic and conventional yerba mate (Ilex paraguariensis St. Hil.) on pentylenetetrazol-induced …
  15079. Activated microglia provide a Neuroprotective role by balancing glial cell-line derived neurotrophic factor and tumor necrosis factor-α secretion after subacute …
  15080. Neuroprotective effect of resveratrol against prenatal stress induced cognitive impairment and possible involvement of Na+, K+-ATPase activity
  15081. Neuroprotective effects of PrxI over‐expression in an in vitro human Alzheimer’s disease model
  15082. In vitro Neuroprotective potential of four medicinal plants against rotenone-induced toxicity in SH-SY5Y neuroblastoma cells
  15083. Enhanced Neuroprotective effect of fish oil in combination with quercetin against 3‐nitropropionic acid induced oxidative stress in rat brain
  15084. The Neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects
  15085. Progress in dodecafluoropentane emulsion as a Neuroprotective agent in a rabbit stroke model
  15086. Neuroprotective properties of standardized extracts of hypericum perforatum on rotenone model of Parkinson’s disease
  15087. Enzyme inhibitory and antioxidant activities of Viburnum tinus L. relevant to its Neuroprotective potential
  15088. Neuroprotective effects of chloroform and petroleum ether extracts of Nigella sativa seeds in stroke model of rat
  15089. Neuroprotective effects of tanshinone I from Danshen extract in a mouse model of hypoxia-ischemia
  15090. Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats
  15091. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat
  15092. Ginkgolides and Neuroprotective effects
  15093. Does the Neuroprotective role of anandamide display diurnal variations?
  15094. Neuroprotective effect of erythropoietin on nandrolone decanoate-induced brain injury in rats
  15095. Neuroprotective efficacy of subcutaneous insulin-like growth factor-I administration in normotensive and hypertensive rats with an ischemic stroke
  15096. Neuroprotective effects of ultra-low-molecular-weight heparin on cerebral ischemia/reperfusion injury in rats: involvement of apoptosis, inflammatory reaction and …
  15097. The Neuroprotective effect of resveratrol on retinal ganglion cells after optic nerve transection
  15098. Presenilin mediates Neuroprotective functions of ephrinB and brain -derived neurotrophic factor and regulates ligand-induced internalization and metabolism of EphB2 …
  15099. Involvement of BDNF and NGF in the mechanism of Neuroprotective effect of human recombinant erythropoietin nanoforms
  15100. Neuroprotective role of a brain -enriched tyrosine phosphatase, STEP, in focal cerebral ischemia
  15101. Normobaric hyperoxia-based Neuroprotective therapies in ischemic stroke
  15102. The Neuroprotective effects of Coccomyxa gloeobotrydiformis on the ischemic stroke in a rat model
  15103. Inhibition of endoplasmic reticulum stress is involved in the Neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson’s disease
  15104. Sonic hedgehog is Neuroprotective in the cavernous nerve with crush injury
  15105. Synergistic action of flavonoids, baicalein, and daidzein in estrogenic and Neuroprotective effects: a development of potential health products and therapeutic …
  15106. Neuroprotective effect through the cerebral sodium–glucose transporter on the development of ischemic damage in global ischemia
  15107. Neuroprotective effect of Decalepis hamiltonii in paraquat-induced neurotoxicity in Drosophila melanogaster: biochemical and behavioral evidences
  15108. Neuroprotective effects of Polygonum multiflorum extract against glutamate-induced oxidative toxicity in HT22 hippocampal cells
  15109. Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance …
  15110. Neuroprotective effects of medicinal plants
  15111. Neuroprotective properties of a novel non-thiazoledinedione partial PPAR-γ agonist against MPTP
  15112. Neuroprotective effect of olive oil in the hippocampus CA1 neurons following ischemia: Reperfusion in mice
  15113. Neuroprotective effect of resveratrol prophylaxis on experimental retinal ischemic injury
  15114. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a Neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats
  15115. Minocycline modulates Neuroprotective effect of hesperidin against quinolinic acid induced Huntington’s disease like symptoms in rats: behavioral, biochemical …
  15116. Neuroprotective role of naringenin on carbaryl induced neurotoxicity in mouse neuroblastoma cells
  15117. Neuroprotective effect of arctigenin via upregulation of P-CREB in mouse primary neurons and human SH-SY5Y neuroblastoma cells
  15118. Neuroprotective effects of prior exposure to enriched environment on cerebral ischemia/reperfusion injury in rats: the possible molecular mechanism
  15119. Oil palm phenolics confer Neuroprotective effects involving cognitive and motor functions in mice
  15120. Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction
  15121. Mild Mitochondrial Depolarization is Involved in a Neuroprotective Mechanism of Citrus sunki Peel Extract
  15122. In vivo modification of Abeta plaque toxicity as a novel Neuroprotective lithium-mediated therapy for Alzheimer’s disease pathology
  15123. MicroRNA-22 (miR-22) overexpression is Neuroprotective via general anti-apoptotic effects and may also target specific Huntington’s disease-related …
  15124. Neurite outgrowth and Neuroprotective effects of quercetin from Caesalpinia mimosoides Lamk. on cultured P19-derived neurons
  15125. Neuroprotective effects of AMP-activated protein kinase on scopolamine induced memory impairment
  15126. Cost-effectiveness analysis of the Neuroprotective agent edaravone for noncardioembolic cerebral infarction
  15127. A Systematic, Integrated Study on the Neuroprotective Effects of Hydroxysafflor Yellow A Revealed by NMR-Based Metabonomics and the NF-B Pathway
  15128. Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson’s disease
  15129. RETRACTED ARTICLE: Neuropathological and Neuroprotective features of vitamin B 12 on the dorsal spinal ganglion of rats after the experimental crush of …
  15130. Engineering the biosynthesis of the polyketide-nonribosomal peptide collismycin A for generation of analogs with Neuroprotective activity
  15131. The Neuroprotective effects of ipriflavone against H2O2 and amyloid beta induced toxicity in human neuroblastoma SH-SY5Y cells
  15132. Quantitative proteomic analysis reveals the Neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N 2a cells
  15133. Neuroprotective effects of uridine in a rat model of neonatal hypoxic–ischemic encephalopathy
  15134. Synthesis and Neuroprotective effect of E-3, 4-dihydroxy styryl aralkyl ketones derivatives against oxidative stress and inflammation
  15135. A screen for inducers of p21waf1/cip1 identifies HIF prolyl hydroxylase inhibitors as Neuroprotective agents with antitumor properties
  15136. The potential role of Portulaca oleracea as a Neuroprotective agent in rotenone-induced neurotoxicity and apoptosis in the brain of rats
  15137. Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model
  15138. Development of a scalable synthesis of P7C3-A20, a potent Neuroprotective agent
  15139. Extracts from Quercus sp. acorns exhibit in vitro Neuroprotective features through inhibition of cholinesterase and protection of the human dopaminergic cell line SH …
  15140. The Neuroprotective activities and antioxidant activities of the polysaccharides from Saccharina japonica
  15141. Alterations on Na+, K+-ATPase and acetylcholinesterase activities induced by amyloid-β peptide in rat brain and GM1 ganglioside Neuroprotective action
  15142. Paeoniflorin, a natural Neuroprotective agent, modulates multiple anti-apoptotic and pro-apoptotic pathways in differentiated PC12 cells
  15143. Neuroprotective effect of Rhodiola rosea Linn against MPTP induced cognitive impairment and oxidative stress
  15144. (M)- and (P)-Bicelaphanol A, Dimeric Trinorditerpenes with Promising Neuroprotective Activity from Celastrus orbiculatus
  15145. Neuroprotective effect of Danshensu derivatives as anti-ischaemia agents on SH-SY5Y cells and rat brain
  15146. Neuroprotective effect of gadolinium: a stretch-activated calcium channel blocker in mouse model of ischemia–reperfusion injury
  15147. The Neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson’s disease
  15148. Homeotic Gene teashirt (tsh) has a Neuroprotective function in amyloid-beta 42 mediated neurodegeneration
  15149. Discovery of potent in vitro Neuroprotective effect of the seed extracts from seven Paeonia L.(peony) taxa and their fatty acid composition
  15150. The Neuroprotective mechanism of puerarin treatment of acute spinal cord injury in rats
  15151. Potential Neuroprotective flavonoid-based inhibitors of CDK5/p25 from Rhus parviflora
  15152. Lipophilic adamantyl-or deferasirox-based conjugates of desferrioxamine B have enhanced Neuroprotective capacity: implications for Parkinson disease
  15153. Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats
  15154. Neuroprotective Effects of Formononetin Against NMDA‐Induced Apoptosis in Cortical Neurons
  15155. Neuroprotective effects of volume-regulated anion channel blocker DCPIB on neonatal hypoxic-ischemic injury
  15156. Neuroprotective activity of pongamia pinnata in monosodium glutamate-induced neurotoxicity in rats
  15157. Microglial SK3 and SK4 currents and activation state are modulated by the Neuroprotective drug, riluzole
  15158. The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the Neuroprotective action of daidzein
  15159. The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is Neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated …
  15160. Neuroprotective effects of oxymatrine against excitotoxicity partially through down-regulation of NR2B-containing NMDA receptors
  15161. Neuroprotective Effect of Lutein Against 3-Nitropropionic Acid–Induced Huntington’s Disease–Like Symptoms: Possible Behavioral, Biochemical, and Cellular …
  15162. Neuroprotective mechanisms of the standardized extract of Bacopa monniera in a paraquat/diquat-mediated acute toxicity
  15163. Acanthopanax senticosus exerts Neuroprotective effects through HO-1 signaling in hippocampal and microglial cells
  15164. Amelioration of Alzheimer’s disease by Neuroprotective effect of sulforaphane in animal model
  15165. Dehydroepiandrosterone and dehydroepiandrosterone sulfate: anabolic, Neuroprotective , and neuroexcitatory properties in military men
  15166. Anti-oxidative and Neuroprotective activities of pig skin gelatin hydrolysates
  15167. Indanostatin, a new Neuroprotective compound from Streptomyces sp.
  15168. Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells
  15169. Neuroprotective effect of tea polyphenols on oxyhemoglobin induced subarachnoid hemorrhage in mice
  15170. Novel Neuroprotective function of apical-basal polarity gene crumbs in amyloid beta 42 (aβ42) mediated neurodegeneration
  15171. Neuroprotective effect of cocaine-and amphetamine-regulated transcript peptide in spinal cord injury in mice
  15172. Glaucomatous optic neuropathy management: the role of Neuroprotective agents
  15173. N-3 fatty acid rich triglyceride emulsions are Neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice
  15174. Anticonvulsant and Neuroprotective Effects of Oligosaccharides from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes)
  15175. Neuroprotective effects of valproic acid against hemin toxicity: possible involvement of the down-regulation of heme oxygenase-1 by regulating ubiquitin–proteasomal …
  15176. Improvement in regional CBF by L-serine contributes to its Neuroprotective effect in rats after focal cerebral ischemia
  15177. Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain
  15178. Arundic acid a potential Neuroprotective agent: biological development and syntheses
  15179. Role of α7-and α4β2-nAChRs in the Neuroprotective effect of nicotine in stress-induced impairment of hippocampus-dependent memory
  15180. Docosahexaenoic acid and its derivative neuroprotectin D1 display Neuroprotective properties in the retina, brain and central nervous system
  15181. Hypoxic-ischemic neonatal encephalopathy: animal experiments for Neuroprotective therapies
  15182. Neuroprotective effects of flavonoids extracted from licorice on kainate-induced seizure in mice through their antioxidant properties
  15183. Two new Neuroprotective phenolic compounds from Gastrodia elata
  15184. Postischemic sevoflurane offers no additional Neuroprotective benefit to preischemic dexmedetomidine
  15185. Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus …
  15186. Gua Lou Gui Zhi decoction exerts Neuroprotective effects on post-stroke spasticity via the modulation of glutamate levels and AMPA receptor expression
  15187. Combined treatment with celecoxib and sevoflurane after global cerebral ischaemia has no additive Neuroprotective effects in rats
  15188. Improved Neuroprotective effect of methylene blue with hypothermia after porcine cardiac arrest
  15189. Improvement of the circulatory function partially accounts for the Neuroprotective action of the phytoestrogen genistein in experimental ischemic stroke
  15190. Neuroprotective and reparative effects of carotid body grafts in a chronic MPTP model of Parkinson’s disease
  15191. Neuroprotective role of a novel copper chelator against induced neurotoxicity
  15192. The Neuroprotective effect of acute moderate alcohol consumption on caspase-3 mediated neuroapoptosis in traumatic brain injury: the role of lysosomal cathepsin L …
  15193. Can intrabodies serve as Neuroprotective therapies for Parkinson’s disease? Beginning thoughts
  15194. Neuroprotective potential of epigallo catechin-3-gallate in PC-12 cells
  15195. Neuroprotective effect of curcumin on spinal cord in rabbit model with ischemia/reperfusion
  15196. Two cerebrosides isolated from the seeds of Sterculia lychnophora and their Neuroprotective effect
  15197. JAK2 inhibition is Neuroprotective and reduces astrogliosis after quinolinic acid striatal lesion in adult mice
  15198. Metabotropic glutamate receptor 5 positive allosteric modulators are Neuroprotective in a mouse model of H untington’s disease
  15199. Chemical, Pharmacological, and in vitro Metabolic Stability Studies on Enantiomerically Pure RC‐33 Compounds: Promising Neuroprotective agents Acting as …
  15200. Neuroprotective effect of melatonin in experimentally induced hypobaric hypoxia
  15201. Neuroprotective effect of suppression of astrocytic activation by arundic acid on brain injuries in rats with acute subdural hematomas
  15202. The Neuroprotective effect of praeruptorin C against NMDA-induced apoptosis through down-regulating of GluN2B-containing NMDA receptors
  15203. Histopathological investigation of Neuroprotective effects of Nigella sativa on motor neurons anterior horn spinal cord after sciatic nerve crush in rats
  15204. Imbalance of p75 NTR/TrkB protein expression in Huntington’s disease: implication for Neuroprotective therapies
  15205. The Neuroprotective effects of intramuscular insulin-like growth factor-I treatment in brain ischemic rats
  15206. Design, synthesis and biological evaluation of glucose-containing scutellarein derivatives as Neuroprotective agents based on metabolic mechanism of scutellarin in …
  15207. Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation
  15208. Dose- and Time-Dependent Neuroprotective Effects of Pycnogenol® following Traumatic brain Injury
  15209. Inhibition of soluble epoxide hydrolase after cardiac arrest/cardiopulmonary resuscitation induces a Neuroprotective phenotype in activated microglia and improves …
  15210. Novel Neuroprotective action of prothymosin alpha‐derived peptide against retinal and brain ischemic damages
  15211. Dose-dependent anti-inflammatory and Neuroprotective effects of an ανβ3 integrin-binding peptide
  15212. Neuroprotective effect of penehyclidine hydrochloride on focal cerebral ischemia-reperfusion injury
  15213. Efficacy of cyclin dependent kinase 4 inhibitors as potent Neuroprotective agents against insults relevant to Alzheimer’s disease
  15214. Neuroprotective and antioxidant potential of terpenoid fraction from Hygrophila auriculata against transient global cerebral ischemia in rats
  15215. Neuroprotective effects of adenosine receptor agonist coadministration with ascorbic acid on CA1 hippocampus in a mouse model of ischemia reperfusion injury
  15216. Effects of novel Neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism
  15217. Neuroprotective Effect of Aqueous Extract of Selaginella delicatula as Evidenced by Abrogation of Rotenone-Induced Motor Deficits, Oxidative Dysfunctions, and …
  15218. Neuroprotective Effects of Methyl-3-O-methyl gallate Against Sodium Fluoride-Induced Oxidative Stress in the brain of Rats
  15219. Neuroprotective Effects of Lycium chinense Miller Against Rotenone-Induced Neurotoxicity in PC12 Cells
  15220. Neuroprotective activity of thioctic acid in central nervous system lesions consequent to peripheral nerve injury
  15221. The GluN3A subunit exerts a Neuroprotective effect in brain ischemia and the hypoxia process
  15222. Ulinastatin as a Neuroprotective and anti‐inflammatory agent in infant piglets model undergoing surgery on hypothermic low‐flow cardiopulmonary bypass
  15223. Ibuprofen and lipoic acid conjugate Neuroprotective activity is mediated by Ngb/Akt intracellular signaling pathway in Alzheimer’s disease rat model
  15224. Neuroprotective effects of Vitis vinifera extract on prediabetic mice induced by a high-fat diet
  15225. Transplantation of CX3CL1-expressing mesenchymal stem cells provides Neuroprotective and immunomodulatory effects in a rat model of retinal degeneration
  15226. Screening of radical-scavenging natural Neuroprotective antioxidants from Swertia chirayita
  15227. Neuroprotective Effect of Hydrogen‐Rich Saline in Acute Carbon Monoxide Poisoning
  15228. Neuroprotective compounds from Salix pseudo-lasiogyne twigs and their anti-amnesic effects on scopolamine-induced memory deficit in mice
  15229. Neuroprotective consequences of postconditioning on embolic model of cerebral ischemia in rat
  15230. Nrf2-dependent Neuroprotective activity of diterpenoids isolated from Sideritis spp
  15231. The Neuroprotective effect of gugijihwang-tang on trimethyltin-induced memory dysfunction in the rat
  15232. O-GlcNAc cycling shows Neuroprotective potential in C. elegans models of neurodegenerative disease
  15233. Complement component 3 inhibition by an antioxidant is Neuroprotective after cerebral ischemia and reperfusion in mice
  15234. Tropisetron as a Neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action
  15235. Surfactin exhibits Neuroprotective effects by inhibiting amyloid β-mediated microglial activation
  15236. Antioxidant, anticonvulsive and Neuroprotective effects of dapsone and phenobarbital against kainic acid-induced damage in rats
  15237. Increase in retinal ganglion cells’ susceptibility to elevated intraocular pressure and impairment of their endogenous Neuroprotective mechanism by age
  15238. Intraperitoneal melatonin is not Neuroprotective in the G93ASOD1 transgenic mouse model of familial ALS and may exacerbate neurodegeneration
  15239. α-Iso-cubebene exerts Neuroprotective effects in amyloid beta stimulated microglia activation
  15240. Neuroprotective effects of Pouteria ramiflora (Mart.) Radlk (Sapotaceae) extract on the brain s of rats with streptozotocin-induced diabetes
  15241. Rosuvastatin may have Neuroprotective effect on spinal cord ischemia reperfusion injury
  15242. Neuroprotective agents in ischemic stroke: past failures and future opportunities
  15243. Neuroprotective role of fibronectin in neuron-glial extrasynaptic transmission
  15244. A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as Neuroprotective …
  15245. Neuroprotective effects of aqueous extracts of Uncaria tomentosa: insights from 6-OHDA induced cell damage and transgenic Caenorhabditis elegans model
  15246. Neuroprotective effect of total and sequential extract of Scrophularia striata Boiss. in rat cerebellar granule neurons following glutamate-induced neurotoxicity …
  15247. Memantine–Neuroprotective drug in aging brain
  15248. Neuroprotective Effect of Zinc Chelator DEDTC in a Zebrafish (Danio rerio) Model of Hypoxic brain Injury
  15249. Neuroprotective effects of focal brain cooling on photochemically-induced cerebral infarction in rats: analysis from a neurophysiological perspective
  15250. A potent (R)-alpha-bis-lipoyl derivative containing 8-hydroxyquinoline scaffold: synthesis and biological evaluation of its Neuroprotective capabilities in SH-SY5Y …
  15251. Status and perspectives of Neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper
  15252. Drug-like property profiling of novel Neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules
  15253. Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats
  15254. Tenidap is Neuroprotective in a pilocarpine rat model of temporal lobe epilepsy
  15255. Neuroprotective effects of erythropoietin in acute ischemic stroke
  15256. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is Neuroprotective in rat model of ischemic stroke
  15257. Study of the Neuroprotective effect of ginseng on superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) levels in experimental diffuse head trauma
  15258. Neuroprotective effect of magnesium sulfate and dexamethasone on intrauterine ischemia in the fetal rat brain : ultrastructural evaluation.
  15259. Neuroprotective effects of raloxifene on experimental spinal cord injury in rats
  15260. Neuroprotective effect of resveratrol against scopolamine-induced cognitive impairment and oxidative stress in rats
  15261. Zinc, a Neuroprotective agent against aluminum-induced oxidative DNA injury
  15262. Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants
  15263. brain derived neurotrophic factor and oxidative stress index in pups with developmental hypothyroidism: Neuroprotective effects of selenium
  15264. The dose-dependent Neuroprotective effect of alpha-lipoic acid in experimental spinal cord injury
  15265. Trefoil factor 3 as an endocrine Neuroprotective factor from the liver in experimental cerebral ischemia/reperfusion injury
  15266. Neuroprotective effects of peptides bioregulators in people of various age
  15267. Flutamide enhances Neuroprotective effects of testosterone during experimental cerebral ischemia in male rats
  15268. Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson’s disease induced by 6-OHDA
  15269. Neuroprotective effect of acute interferon-beta 1B treatment after spinal cord injury
  15270. Neuroprotective effects of anti-high-mobility group box 1 antibody in juvenile rat hippocampus after kainic acid-induced status epilepticus
  15271. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is Neuroprotective : differential effects on astrocytes
  15272. Docosahexaenoic acid and tetracyclines as promising Neuroprotective compounds with poly (ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic …
  15273. Neuroprotective changes of thalamic degeneration-related gene expression by acupuncture in an MPTP mouse model of parkinsonism: microarray analysis
  15274. Neuroprotective response of the hippocampus region of the brain to Withania somnifera and Asparagus racemosus root extract: An in vitro study
  15275. Neuroprotective effect of allopurinol and nimesulide against cerebral ischemic reperfusion injury in diabetic rats
  15276. Mitogen-activated protein kinase phosphatase (MKP)-1 as a Neuroprotective agent: promotion of the morphological development of midbrain dopaminergic neurons
  15277. Neuroprotective role of superoxide dismutase 1 in retinal ganglion cells and inner nuclear layer cells against N-methyl-d-aspartate-induced cytotoxicity
  15278. … of compounds from Penthorum chinense Pursh with antioxidant and antihepatocarcinoma properties: pinocembrin and its rapidly emerging Neuroprotective effects
  15279. Hypoxia-induced retinal ganglion cell damage through activation of AMPA receptors and the Neuroprotective effects of DNQX
  15280. Neuroprotective effects of curcumin and highly bioavailable curcumin on oxidative stress induced by sodium nitroprusside in rat striatal cell culture
  15281. Neuroprotective effect of Bacopa monniera on memory deficits and ATPase system in Alzheimer’s disease (AD) induced mice
  15282. Neuroprotective effects of the Chinese Yi-Qi-Bu-Shen recipe extract on injury of rat hippocampal neurons induced by hypoxia/reoxygenation
  15283. … , IL-8, IL-10, TNF-α levels, and IL-10 mRNA, TNF-α mRNA expression levels, cerebral TGF-β1 positive expression level and its Neuroprotective mechanisms in CIR …
  15284. Neuroprotective effects of non-classical estrogen-like signaling activators: from mechanism to potential implications
  15285. Studies on the enantiomers of RC-33 as Neuroprotective agents : Isolation, configurational assignment, and preliminary biological profile
  15286. Leptin as a Neuroprotective agent in glaucoma
  15287. Neuroprotective activity of 2-amino-1, 3, 4-thiadiazole derivative 4BrABT–an in vitro study
  15288. Metallothioneins I/II are involved in the Neuroprotective effect of sildenafil in focal brain injury
  15289. Metabolism of a potent Neuroprotective hydrazide
  15290. Neuroprotective effects of alpha-ketoglutarate and ethyl pyruvate against motor dysfunction and oxidative changes caused by repeated 1-methyl-4-phenyl-1, 2, 3, 6 …
  15291. Neuroprotective effects of paeoniflorin: an emerging concept in neurology
  15292. Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson’s disease
  15293. Gremlin is a novel VTA derived Neuroprotective factor for dopamine neurons
  15294. Autophagy as a Neuroprotective mechanism against 3-nitropropionic acid-induced murine astrocyte cell death
  15295. The Neuroprotective effects of rituximab in rat spinal cord injury model: an immunohistochemical study.
  15296. Neuroprotective potential of Ocimum sanctum (Linn) leaf extract in monosodium glutamate induced excitotoxicity
  15297. Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5
  15298. Advancing therapeutic options in multiple sclerosis with Neuroprotective properties
  15299. Assessment of novel iloperidone-and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and Neuroprotective potential
  15300. The Neuroprotective potential of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in response to hypoxia in isolated bovine retina
  15301. Neuroprotective activity of Stereospermum suaveolens against global cerebral ischemia rat model
  15302. Chronic mild stress eliminates the Neuroprotective effect of Copaxone after CNS injury
  15303. The Neuroprotective effect of long-term n-3 polyunsaturated fatty acids supplementation in the cerebral cortex and hippocampus of aging rats
  15304. Camellia sinensis as a safe Neuroprotective radiation counter measure agent
  15305. Neuroprotective effects of polyhydroxy pregnane glycoside isolated from Wattakaka volubilis (Lf) Stapf. after middle cerebral artery occlusion and reperfusion in rats
  15306. Neuroprotective effect of insulin-like growth factor-1: Effects on tyrosine kinase receptor (Trk) expression in dorsal root ganglion neurons with glutamate-induced …
  15307. An alternative medical approach for the Neuroprotective therapy to slow the progression of Parkinson’s disease.
  15308. Neuroprotective effect of protease-activated receptor-2 in the hypoxia-induced apoptosis of rat RGC-5 cells
  15309. Synthesis and biological evaluation of novel Neuroprotective agents for paraquat-induced apoptosis in human neuronal SH-SY5Y cells
  15310. The Neuroprotective effect of diazoxide is mediated by mitochondrial ATP-dependent potassium channels in a rat model of acute subdural hematoma
  15311. The Neuroprotective effects of Prosopis farcta pod aqueous and ethanol extracts on spinal cord α-motoneurons neuronal density after sciatic nerve injury in rats
  15312. Involvement of Nrf2 signaling pathway in the Neuroprotective activity of natural kaurane diterpenes
  15313. Neuroprotective effects of the antioxidant action of 2-cyclopropylimino-3-methyl-1, 3-thiazoline hydrochloride against ischemic neuronal damage in the brain
  15314. Neuroprotective effects of SNX-185 in an in vitro model of TBI with a second insult
  15315. Crucial roles of Glu60 in human neuroglobin as a guanine nucleotide dissociation inhibitor and Neuroprotective agent
  15316. Potential Neuroprotective effects of SIRT1 induced by glucose deprivation in PC12 cells
  15317. Neuroprotective therapy with citicoline (ceraxon) in patients with ischemic stroke
  15318. Marketing researches of market of medications of Neuroprotective action in Ukraine
  15319. Neuroprotective effect of Lycium barbarum on retina of Royal College of Surgeons (RCS) rats: a preliminary study
  15320. Neuroprotective effects of the SCR1–3 functional domain of CR1 on acute cerebral ischemia and reperfusion injury in rats
  15321. Synthesis and docking study of diaryl-isothiazole and 1, 2, 3-thiadiazole derivatives as potential Neuroprotective agents
  15322. Death receptor 6 (DR6) antagonist antibody is Neuroprotective in the mouse SOD1 G93A model of amyotrophic lateral sclerosis
  15323. Neuroprotective profile of pyruvate against ethanol-induced neurodegeneration in developing mice brain
  15324. Neuroprotective effect of melatonin in a rat model of streptozotocin-induced diabetic neuropathy: light and electron microscopic study
  15325. Neuroprotective action of synthetic steroids with oxygen bridge. Activity on GABAA receptor
  15326. Neuroprotective effects of N-acetylglucosamine against hydrogen peroxide-induced apoptosis in human neuronal SK-N-SH cells by inhibiting the activation of …
  15327. Homodimerization as a molecular switch between low and high efficiency PrPC cell surface delivery and Neuroprotective activity
  15328. GABAA receptor chloride channels are involved in the Neuroprotective role of GABA following oxygen and glucose deprivation in the rat cerebral cortex but not in the …
  15329. Valuing the endangered species Antirrhinum lopesianum: Neuroprotective activities and strategies for in vitro plant propagation
  15330. γ‐Aminobutyric acid type a receptor inhibition triggers a nicotinic Neuroprotective mechanism
  15331. Using the endocannabinoid system as a Neuroprotective strategy in perinatal hypoxic-ischemic brain injury
  15332. The Neuroprotective role of Nigella sativa extract on ciprofloxacin and pentylenetetrazole treated rats
  15333. Neuroprotective effect of metaplexis japonica against in vitro ischemia model
  15334. Neurotoxic or Neuroprotective ? current controversies in SCI-induced autoimmunity
  15335. The Neuroprotective ability of polyethylene glycol is affected by temperature in ex vivo spinal cord injury model
  15336. Neuroprotective effects of hypothermia and erythropoietin after perinatal asphyxia in newborn rats
  15337. Neuroprotective effects of Alpinia katsumadai against experimental ischemic damage via control of oxidative stress
  15338. … -diisothiocyanatostilbenedisulphonic acid) induces apoptotic cell death in a hippocampal neuronal cell line and is not Neuroprotective against ischemic stress
  15339. Evaluation of neurotoxic and Neuroprotective pathways affected by antiepileptic drugs in cultured hippocampal neurons
  15340. Antioxidant activity-mediated Neuroprotective effects of an antagonist of AT1 receptors, candesartan, against cerebral ischemia and edema in rats
  15341. Retracted: Cav2.3 (R‐type) calcium channels are critical for mediating anticonvulsive and Neuroprotective properties of lamotrigine in vivo
  15342. Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with Neuroprotective effects
  15343. Neuroprotective effects of a butanol fraction of rosa hybrida petals in a middle cerebral artery occlusion model
  15344. Monitoring Neuroprotective Effects Using Positron Emission Tomography With [11C]ITMM, a Radiotracer for Metabotropic Glutamate 1 Receptor
  15345. Discovery of alkenylboronic acids as Neuroprotective agents affecting multiple biological targets involved in Alzheimer’s disease
  15346. Machilusmarin, a new Neuroprotective isocoumarin dimer from the stems of Machilus ichangensis Rehd. et Wils.
  15347. Validated LC-ESI-MS/MS Method for the Quantitation of Neopanaxadiol: a Novel Neuroprotective Agent from Panax ginseng and Its Application to a Pharmacokinetic …
  15348. Neuroprotective evaluation of Tilia americana and Annona diversifolia in the neuronal damage induced by intestinal ischemia
  15349. Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol
  15350. Neuroprotective effects of α-tocotrienol on kainic acid-induced neurotoxicity in organotypic hippocampal slice cultures
  15351. Neuroprotective effect of AG490 in experimental traumatic brain injury of rats.
  15352. Neuroprotective properties of dry extracts of Fumaria schleicheri and Ocimum basilicum
  15353. Qualitative and quantitative analysis of four different polarity fractions from Huang-Lian-Jie-Du-Decoction by HPLC-DAD-ESI-MS/MS and their related Neuroprotective …
  15354. Similar Neuroprotective effects of ischemic and hypoxic preconditioning on hypoxia–ischemia in the neonatal rat: A proton MRS study
  15355. Neuroprotective actions of clinoptilolite and ethylenediaminetetraacetic acid against lead-induced toxicity in mice Mus musculus
  15356. An NO donor approach to Neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk
  15357. Design, synthesis and pharmacological evaluation of (E)-3, 4-dihydroxy styryl sulfonamides derivatives as multifunctional Neuroprotective agents against oxidative …
  15358. Anti-apoptotic and Neuroprotective effects of oxysophoridine on cerebral ischemia both in vivo and in vitro
  15359. Natural products inspired synthesis of Neuroprotective agents against H2O2-induced cell death
  15360. Neuroprotective effect of TAT PTD-Ngb fusion protein on primary cortical neurons against hypoxia-induced apoptosis
  15361. SUN11602, a novel aniline compound, mimics the Neuroprotective mechanisms of basic fibroblast growth factor
  15362. N-substituted 8-aminopentacyclo [5.4. 0.02, 6.03, 10.05, 9] undecanes as σ receptor ligands with potential Neuroprotective effects
  15363. Review of recently documented clinical Neuroprotective and cellular treatment for spinal cord injury: an analysis of outcomes
  15364. Neuroprotective effects of dipeptide analogue of brain -derived neurotrophic factor GSB-106 in in vitro experiments
  15365. Neuroprotective effect of a caffeic acid derivative from Abacopteris penangiana
  15366. Neuroprotective effects of tadalafil on gerbil dopaminergic neurons following cerebral ischemia
  15367. SH3-binding protein 5 mediates the Neuroprotective effect of the secreted bioactive peptide humanin by inhibiting c-Jun NH2-terminal kinase
  15368. Is longer sevoflurane preconditioning Neuroprotective in permanent focal cerebral ischemia?
  15369. Neuroprotective effect of human placental extract on hypoxic–ischemic brain injury in neonatal rats
  15370. Neuroprotective potential of akatinol-memantine in ischemic stroke
  15371. Neuroprotective strategy in an experimental newborn rat model of brain ischemia and hypoxia: Effects of Resveratrol and hypothermia
  15372. Neuroprotective approaches
  15373. Identification of 4, 6-diaryl-1, 4-dihydropyridines as a new class of Neuroprotective agents
  15374. Stem cells from wildtype and Friedreich’s ataxia mice present similar Neuroprotective properties in dorsal root ganglia cells
  15375. A potentially Neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial
  15376. Can we teach old dogs new tricks? Neuroprotective cell therapy in Alzheimer’s and Parkinson’s disease
  15377. Generation of hydrogen peroxide-resistant murine neuroblastoma cells: a target discovery platform for novel Neuroprotective genes
  15378. Neuroprotective effect of leukemia inhibitory factor on antimycin a-induced oxidative injury in differentiated PC12 cells
  15379. A structurally simplified analogue of geldanamycin exhibits Neuroprotective activity
  15380. Neuroprotective effects of ganoderic acid extract against epilepsy in primary hippocampal neurons.
  15381. Neuroprotective effects of the Asparagus racemosus root extract on ovariectomized rats
  15382. Neuroprotective effect of Chunghyuldan (Qing Xue Dan) on hypoxia-reoxygenation induced damage of neuroblastoma 2a cell lines
  15383. Neuroprotective effect of silymarin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy
  15384. Neuroprotective effects of citicoline in diffuse axonal injuries
  15385. Interleukin‐27 promotes inflammatory and Neuroprotective responses in microglia
  15386. Neuroprotective effects of progesterone in spinal cord ischemia in rabbits
  15387. Investigation of the Neuroprotective effects of bee-venom acupuncture in a mouse model of Parkinson’s disease by using immunohistochemistry and In-vivo 1 H …
  15388. Neuroprotective effects of electrical stimulation of the anterior nucleus of the thalamus for hippocampus neurons in intractable epilepsy
  15389. OP07 Neuroprotective effect of hydrogen sulfide: regulation of amyloidosis and inflammation in SH-SY5Y neuroblastoma and BV-2 microglia cells
  15390. Neuroprotective effects of mercaptoethylleonurine and mercaptoethylguanidine analogs on hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells
  15391. Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease
  15392. Fenobam promoted the Neuroprotective effect of PEP-1-FK506BP following oxidative stress by increasing its transduction efficiency
  15393. Neuroprotective effects of sulfated polysaccharides from seaweed
  15394. Cerebral microdialysis reflects the Neuroprotective effect of fractionated plasma separation and adsorption in acute liver failure better and earlier than …
  15395. Neuroprotective mode of action of resveratrol in central nervous system
  15396. Synthesis and Neuroprotective effects of the fluorine substituted salidroside analogues in the PC12 cell model exposed to hypoglycemia and serum limitation
  15397. Activation of type-2 cannabinoid receptor inhibits Neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two
  15398. Neuroprotective effects of quetiapine on neuronal apoptosis following experimental transient focal cerebral ischemia in rats
  15399. Screening of various sources of phytochemicals for Neuroprotective activity against oxygen-glucose deprivation in vitro
  15400. Neuroprotective effect of petroleum ether, methanolic and aqueous extracts of flower heads of Sphaeranthus indicus on lipofuscinogenesis and fluorescence product …
  15401. Neuroprotective effects of N-acetylcysteine: a review
  15402. Lithium’s Neuroprotective effects
  15403. Neuroprotective effect of 2-(4-methoxyphenyl) ethyl-2-acetamido-2-deoxy-β-D-pyranoside against sodium nitroprusside-induced neurotoxicity in HT22 cells
  15404. Neuroprotective approaches in the animal model
  15405. Antiamnesic and Neuroprotective effects of low dose of ramipril and losartan in scopolamine-induced amnesia model of dementia
  15406. 3-Mercaptopropionic acid-induced repetitive seizures increase GluN2A expression in rat hippocampus: a potential Neuroprotective role of cyclopentyladenosine
  15407. (2 S)-5, 2′, 5′-trihydroxy-7-methoxyflavanone, a natural product from Abacopteris penangiana, presents Neuroprotective effects in vitro and in vivo
  15408. Neuroprotective role of 17β estradiol with tachykinin neuropeptide NKB and Aβ (25-35) in aging female rat brain
  15409. A comparison of a Neuroprotective effects of hypoxic postconditioning and cerebrolysin in the experimental model
  15410. Inflammation, oxidative stress, and Neuroprotective factors in the pathophysiology of PTSD in an animal model
  15411. Design, synthesis and pharmacological evaluation of caffeic acid phenethyl ester acylation as multifunctional Neuroprotective agents against oxidative stress injury
  15412. Neuroprotective effect of ginseng against alteration of calcium binding proteins immunoreactivity in the mice hippocampus after radiofrequency exposure
  15413. Neuroprotective effects of Maca extract and macamides against amyloid β peptide induced neurotoxicity in B‐35 neuroblastoma cells
  15414. Challenges for parents and clinicians discussing Neuroprotective treatments
  15415. Vitamin K: a structural basis for the design of novel Neuroprotective agents ?
  15416. Neuroprotective mechanism of hydrogen sulfide after cerebral ischemia-reperfusion in rats
  15417. Potential Neuroprotective actions of dietary flavonoids
  15418. Prospects and Potential Applications of Seaweeds as Neuroprotective agents
  15419. In-silico identification of 6-hydroxy-L-nicotine as a novel Neuroprotective drug
  15420. Neuroprotective Effect of Ethyl Acetate Fraction of Portulaca oleracea L.
  15421. Erythropoietin and its emerging Neuroprotective effects
  15422. Dulbecco’s Modified Eagle Medium is Neuroprotective when compared to standard vitrectomy irrigation solution
  15423. Neuroprotective Activity of Berberis aristata against 6‐OHDA Induced Parkinson’s Disease Model
  15424. Neuroprotective Effects of Olanzapine in N-Methyl-d-Aspartate-Induced Retinal Injury
  15425. Enantioselective Neuroprotective Effects of Tacripyrine ITH122 Against Oxygen and Glucose Deprivation in Rat Hippocampal Slices
  15426. Regional pathology in glaucoma–An overlooked link to Neuroprotective strategies
  15427. Molecular dissection of cyclosporin a’s Neuroprotective effect reveals potential therapeutics for ischemic brain injury
  15428. Computational insights into the Neuroprotective action of riluzole on 3-acetylpyridine-induced ataxia in rats
  15429. Neuroprotective Strategies in Animal and in Vitro Models of Neuronal Damage: Ischemia and Stroke
  15430. Diabetes exacerbates Alzheimer’s disease induced brain pathology. Possible Neuroprotective effects of Cerebrolysin
  15431. Development of a rapid screening method for discovering Neuroprotective components from traditional Chinese medicine
  15432. Neuroprotective effect of Shengmai Injection on expression of tissue factor and related signal pathways in mice with cerebral ischemia-reperfusion injury
  15433. Quantitative evaluation of the Neuroprotective effects of a short-acting β-adrenoceptor antagonist at a clinical dose on forebrain ischemia in gerbils: effects of esmolol …
  15434. Neuroprotective effects of vagus nerve stimulation on hippocampal neurons in intractable epilepsy
  15435. Neuroprotective Benzyl Benzoate Glycosides from Disporum viridescens Roots in HT22 Hippocampal Neuronal Cells
  15436. 8-Hydroxycalamenene isolated from the rhizomes of Reynoutria elliptica exerts Neuroprotective effects both in vitro and in vivo
  15437. Specific Neuroprotective effects of manual stimulation of real acupoints versus non-acupoints in rats after middle cerebral artery occlusion
  15438. Neuroprotective effects of voluntary exercise and hydroalcoholic extraction of Eriobotrya Japonica on dopamine and tyrosine hydroxylase in the striatum of …
  15439. The results of the application of the pre-formed physical factors and Neuroprotective therapy for the rehabilitative treatment of the patients with diabetic retinopathy
  15440. Neuroprotective effect of thymoquinone on repeated immobilization stress-induced oxidative stress in rats
  15441. The Neuroprotective Effects of Hydroalcoholic Extract of Nigella Sativa on Alpha Motoneurons Degeneration After Sciatic Nerve Injury in Rats
  15442. Parallel pathways of glutamate and ATP-mediated excitotoxicity cause significant neural cell death during ischaemia: potential for novel Neuroprotective strategies
  15443. Lornoxicam alone and with selegiline improves the Neuroprotective effect and cognition in scopolamine induced neurodegeneration and cognitive impairment …
  15444. Morphological study of Neuroprotective properties of dipeptide mimetic of nerve growth factor (GK-2h) in focal ischemic damage of rat brain prefrontal cortex
  15445. Neuroprotective effect of aerobic training against Leadinduced oxidative stress in rat cerebellum.
  15446. Neuroprotective strategies in the prevention of chemotherapy-induced neuropathies
  15447. Neuroprotective Effects of Quercetin, Lycium Barbarum and Chitosan Against of the Oxidative Stress Induced by Exposure to Hypobaric Hypoxia.
  15448. Neuroprotective Strategies 2013
  15449. The Neuroprotective effects of long-term exercise training in older adults: A look at world-ranking elite Masters athletes
  15450. Neuroprotective role of protein tyrosine phosphatase-1B in rod photoreceptor neurons
  15451. Neuroprotective Strategies–What Do We Really Need to Know
  15452. Neuroprotective Effects of Heptapeptide Mystixin
  15453. Signaling mechanism of Neuroprotective effect of ischemic preconditioning of brain
  15454. Neuroprotective effect of volatile induction and maintenance of the anesthesia (VIMA) vs. total intravenous anesthesia (TIVA) during on-pump coronary artery bypass …
  15455. Neuroprotective agents for Management of Parkinson’s disease
  15456. Neuroprotective effects of bee venom phospholipase 2 by suppression of neuroinflammatory responses in mouse model of Parkinson’s disease: role of CD4+ CD25+ …
  15457. Neuroprotective Effect and Treatment Prospect of Catalpol in Rehmannia [J]
  15458. Neuroprotective activity of Ascophyllum Nodosum on experimentally induced global cerebral ischemia/reperfusion injury in mice
  15459. Gabapentin is Neuroprotective through glutamate receptor-independent mechanisms in staurosporine-induced apoptosis of cultured rat cerebellar neurons
  15460. Facilitating healthy ageing: Neuroprotective effects of mindfulness practice
  15461. Effect of Neuroprotective therapies (hypothermia and cyclosporine a) on dopamine-induced apoptosis in human neuronal SH-SY5Y cells
  15462. Neuroprotective Efficacy of Eugenol and Isoeugenol in Acrylamide-Induced Neuropathy in rats: Behavioral and Biochemical evidence.
  15463. The antidepressant/antipanic/Neuroprotective drug phenelzine: neuropharmacological and drug metabolism studies
  15464. Neuroprotective effect of peanut hairy root extract against oxidative stress in PC12 derived neurons
  15465. Antioxidant and Neuroprotective properties of trichilia catigua (catuaba) against ischemia-reperfusion and pro-oxidants agents in rat hippocampal slices
  15466. Cyclosporin and mitochondria: a Neuroprotective approach.
  15467. Neuroprotective effects of quercetin in chemical hypoxia: in silico evaluation of the hypothesis exploring PKC inhibition-mediated pharmacotherapy
  15468. Neuroprotective effects of some herbal medicine plant extract against ischemia· reperfusion-induced cell death in SK-N-SH neuronal cells
  15469. T-type Channel Blockers as Neuroprotective agents
  15470. Stimulation of CB1 Cannabinoid and NMDA Receptors Increases Neuroprotective Effect against Diazinon-Induced Neurotoxicity
  15471. of Neuroprotective agents
  15472. Neuroprotective Agent
  15473. as Neuroprotective agents
  15474. Bad news for Neuroprotective therapies in PD?
  15475. BG-12 (DIMETHYL fumarate) is Neuroprotective in the murine cuprizone/rapamycin model of demyelination and neurodegeneration (P05. 184)
  15476. Neuroprotective effect of sesamol and quercetin against QA induced neurotoxicity: An experimental paradigm of Huntington’s disease
  15477. Novel adamantane derivatives as multifunctional Neuroprotective agents
  15478. The ameliorating effects of 2, 3-dihydroxy-4-methoxyacetophenone on scopolamine-induced memory impairment in mice and its Neuroprotective activity
  15479. The neurodegenerative process in multiple sclerosis and the possible Neuroprotective effect of treatment with β-interferon 1a (Avonex)
  15480. Mechanisms of Neuroprotective action of imipramine against dexamethasone neurotoxicity
  15481. Novel Neuroprotective therapies
  15482. The Neuroprotective role of catalase overexpression in SH-SY5Y cells against beta-amyloid and H2O2 toxicity
  15483. … -induced Wernicke’s encephalopathy modifies crucial rat brain parameters: the importance of Na+, K+-ATPase and a potentially Neuroprotective role for antioxidant …
  15484. SYNTHESIS AND Neuroprotective PROPERTIES OF ISOSTERIC ANALOGS OF NICOTINE
  15485. Neuroprotective effects of estrogen rely on neuroglobin upregulation
  15486. The Neuroprotective Effect of Cerebrolysin Against Type 1 Diabetes‐Induced Dementia In Rats
  15487. Neuroprotective Treatment Strategies for Delayed Cerebral Ischemia after Subarachnoid Hemorrhage–Review of Literature and Future Prospects
  15488. Cholinergic and Antioxidant Effects of a Novel Neuroprotective Compound HAB16R26 Exposed in Sprague Dawley Rats
  15489. Neuroprotective role of VEGF induced in response to photodynamic therapy
  15490. Neuroprotective effects of EGCG on H2O2‐and MPTP‐stressed PC12 cells
  15491. Neuroprotective Effects of crocin against traumatic brain injury in mice
  15492. Neuroprotective effect of curcumin on rats under chronic unpredictable mild stress
  15493. Neuroprotective effects of 2-BFI on rat model of experimental autoimmune encephalomyelitis and its immunomodulatory mechanism
  15494. Novel Therapeutic Approaches to Multiple Sclerosis: Neuroprotective Drugs for Relapsing-Remitting Multiple Sclerosis
  15495. Neuroprotective effects of eugenol on cerebral ischemia/reperfusion injury in rats [J]
  15496. Neuroprotective effect and chemical composition of traditional Chinese medicines, zha-chong-shi-san-wei pill, against ischemic stroke on middle cerebral ischemia …
  15497. Therapeutic potential of longevity modulators as Neuroprotective targets in neurodegenerative disease
  15498. Neuroprotective effects of Cannabis sativa leaves extracts on α-motoneurons density after sciatic nerve injury in rats
  15499. Neuroprotective effect of estradiol in mice with selective cholinergic lesions in nucleus basalis magnocellularis: morphological and behavioural studies
  15500. Awaiting evidence of Neuroprotective effects of recombinant erythropoietin in very preterm infants
  15501. Inhibition of pro-inflammatory enzyme soluble epoxide hydrolase exerts a Neuroprotective effect after cardiac arrest and cardio-pulmonary resuscitation in mice: 7AP2 …
  15502. Molecularly-biochemical and neuropsychophysiological aspects of Neuroprotective activity of mexidol during chronic immobilizational stress
  15503. Synthesis and biological evaluation of Esaprazole analogues showing σ1 binding and Neuroprotective properties in vitro
  15504. Gene Therapy Based on Fragment C of Tetanus Toxin in ALS: A Promising Neuroprotective Strategy for the Bench to the Bedside Approach
  15505. Preliminary study of mechanism and Neuroprotective effects of hydrogen-rich saline intraperitoneal injection in rats with acute cauda equina symdrome
  15506. Estrogens need insulin-like growth factor I cooperation to exert their Neuroprotective effects in post-menopausal women
  15507. Study of acetylsalicylic acid role in the potentiation of antiamnesic and Neuroprotective properties of piracetam in rats with alloxan diabetes
  15508. Investigating Neuroprotective effect of leave of solanum Nigrum L Ethyl acetate fraction on motoneurons degeneration rate in rats
  15509. Neuroprotective effect of creatine against propionic acid toxicity in neuroblastoma SH-SY5Y cells in culture
  15510. Registry surveillance after Neuroprotective treatment
  15511. Activation of caspase-activated deoxyribonuclease and Neuroprotective effect of caspase-3 inhibitor after focal cerebral ischemia-reperfusion injury
  15512. Serum Cytokines, Neuroprotective Proteins, and Interferon Signaling in IFN Therapy Responders (R) and Non-Responders (NR) in MS (P05. 182)
  15513. Abstract TP111: Activation of the brain renin-angiotensin system by translational approaches following stroke onset is Neuroprotective in a rat model of ischemic stroke
  15514. The influence of flavonoids from polygala Hongkongensis on Neuroprotective and the contents of TGF-β and HSP70 in the rats of focal cerebral ischemia [J]
  15515. Neuroprotective mechanism of Butylphthalide injection pretreatment on protect cerebral ischemica reperfusion injury viathrough the PI3K/Akt pathway in rats [J]
  15516. Characterization of the Neuroprotective potential of Passion Fruit
  15517. Erratum: The promise of Neuroprotective agents in Parkinson’s disease
  15518. Neuroprotective Mechanisms of Methylene Blue
  15519. Neuroprotective efficacy of a combination of fish oil and ferulic acid against 3-nitropropionic acid-induced oxidative stress and neurotoxicity in rats: behavioural and …
  15520. Neuroprotective Effect of a Novel Herbmedicine, Hepad on SH-SY5Y Cells
  15521. Progress on Neuroprotective effects of erythropoietin
  15522. Novel Neuroprotective compounds for use in Parkinson’s disease
  15523. Use of Quantitative EEG Methods for Assessment of Efficiency of Neuroprotective Impact on Neuroglial Level
  15524. Nontoxic and Neuroprotective β‑Naphthotacrines for Alzheimer’s
  15525. Neuroprotective effects of antioxidants, Idebenone and Ferulic Acid, in MPTP/MPP+ intoxicated PC12 cells as a model of Parkinson’s Disease
  15526. Neuroprotective Effect of Ethyl Acetate Fraction of KMU-PO1301
  15527. Neuroprotective mechanisms of ischemic postconditioning
  15528. The application of Neuroprotective preparations for the rehabili-33 tative treatment of the patients presenting with diabetic retinopathy
  15529. Anticonvulsant and Neuroprotective effects of cyclopentyladenosine on the model of convulsive status in rats
  15530. Neuroprotective agents for Traumatic brain Injury: Theoretical Therapy or the Future of Treatment?
  15531. Fenobam promoted the Neuroprotective effect of PEP-1-FK506BP following oxidative stress by increasing its transduction efficiency
  15532. Interactive Neuroprotective Strategies Employing Phytochemicals and Omega-3 Fatty Acids.
  15533. General anesthetics: Neuroprotective or neurotoxic?
  15534. mGluR3 PAM: a novel Neuroprotective strategy for Parkinson’s disease
  15535. Comparative study on Neuroprotective effects of soybean and tempeh extracts
  15536. Designing Clinical Trials to Test Neuroprotective Therapies in Multiple Sclerosis
  15537. Effects of acupuncture on Neuroprotective mechanisms in hypoxia Rats
  15538. Role of innate immunity in the Neuroprotective effect of estrogens
  15539. Neuroprotective effects of modified Shengyu Decoction on rats with traumatic brain injury
  15540. Laquinimod is an oral drug with a marked Neuroprotective effect for pathogenetic treatment of multiple sclerosis (review)
  15541. Study on the Neuroprotective effect of caffeic acid derivatives and their mechanisms
  15542. Neuroprotective Effects of Propofol in Acute Cerebral Injury [J]
  15543. An Update on Neuroprotective Effects of Estrogen in Alzheimer’s Disease
  15544. Neuroprotective effect of olive oil in focal cerebral ischemic animal models
  15545. Stimulating Neuroprotective and regenerative mechanisms in Alzheimer disease
  15546. Neuroprotective effects of inhaled lavender oil in vivo
  15547. The investigation of Neuroprotective activity of 5-hydroxyadamantane-2-on in rats under the conditions of local permanent brain ischemia
  15548. A Review of the Neuroprotective Mechanisms of Plant Polyphenol Extracts in Alzheimer’s Disease
  15549. Nanoparticles mediated delivery of TIMP-1 across BBB and its Neuroprotective effects
  15550. Erratum to: Neuroprotective role of taurine during aging
  15551. The Neuroprotective effect of blood pressure regulation on cerebral ischemia-reperfusion rats
  15552. Effects of Current Medical Therapies on Reparative and Neuroprotective Functions in Multiple Sclerosis
  15553. Ocular Hypotensive and Neuroprotective Effects of Agmatine
  15554. Neuroprotective Effect of Electroacupuncture Combined with Annao Pills on Cerebral Infarction in Rat Models
  15555. Size-controllable striatal lesion model for evaluation of Neuroprotective agents in rats
  15556. Neuroprotective mechanisms of ischemic preconditioning: caspases and neuronal apoptosis
  15557. In-vitro Evaluation of the Neuroprotective Effects of Forskolin on Retinal Ganglion Cells
  15558. Neuroprotective effects of polyunsaturated fatty acids in an in vitro hypothalamic model
  15559. Abstract WP61: Pre-hospital Remote Ischemic Perconditioning-A Promising Neuroprotective Therapy.
  15560. Pharmacological mechanism underlying anti-inflammatory, anti-nociceptive and Neuroprotective activities of anomalin and capillarisin
  15561. Neuroprotective effects of cortexin, a drug derived from the brain cortex
  15562. Involvement in Neuroprotective Effect of Pabing II Formula on the Dopaminergic Neurons of Parkinson’s disease Rats [J]
  15563. Neuroprotective effect of topiramate on spinal cord injury in rats
  15564. STUDY ON THE Neuroprotective EFFECT OF EGCG ON HIPPOCAMPAL NEURONS UNDER STRESS IN VITRO AND ITS MECHANISM
  15565. Neuroprotective EFFECT OF N-ACETYLCYSTEINE ON INDUCED ALCOHOLIC NEUROPATHY IN RATS
  15566. Potential Neuroprotective effect of ibuprofen, insights from the mice model of Parkinson’s
  15567. Neuroprotective effect of histone deacetylases inhibitor MS-275 following traumatic brain injury in rats
  15568. Magnesium Sulfate: Fetal Neuroprotective Role in Reducing the Risk of Cerebral Palsy
  15569. Neuroprotective EFFECTS OF LITHIUM ON THE cognitive DISORDERS IN AN ANIMAL MODEL OF TRIMETHYLTININDUCED IN ALZHEIMER’S DISEASE
  15570. Design and in vitro characterization of therapeutic expression systems for ex vivo Neuroprotective gene therapy
  15571. Neuroprotective effect of VCP inhibitors on mice models of glaucoma
  15572. A cell culture model of cerebral ischemia as a convenient system to screen for Neuroprotective drugs J. Ekblom’, H. Garpenstrand’, O. Tottmar, JA Prince’, and L …
  15573. Study of the possible Neuroprotective effect of certain drugs in experimentally induced hepatic encephalopathy in Rats
  15574. Antioxidant and Neuroprotective Effects of Sprouted Garlic Extracts
  15575. The Neuroprotective effect of adiponectin on rats with cerebral ischemic-reperfusion injury
  15576. Neuroprotective role of statins in treating Alzheimer’s disease: a comparative study of biomedical and clinical trials
  15577. Neuroprotective Effect of Terminalia chebula Fruit in Cerebral Ischemia
  15578. Neuroprotective effect of NMDA receptor NR2A subunit in brain ischemic postconditioning
  15579. Neuroprotective effect of escitalopram on cerebral ischemia/reperfusion in rats by promoting angiogenesis
  15580. Neuroprotective EFFECTS OF SEX STEROID HORMONES FOLLOWING DIFFUSE TRAUMATIC brain INJURY
  15581. Design And Synthesis Of New Monoamine Oxidase Inhibitors As Potential Neuroprotective agents
  15582. Neuroprotective effect of genistein on pMCAO rats and ist influence on the proliferation of neural stem cells
  15583. Neuroprotective properties of antioxidants in stroke correlate with their effects on ischemic release of glutamate
  15584. The Neuroprotective Effects of Moderate Treadmill Exercise in a Rat Model of Alzheimer’s Disease
  15585. Neuroprotective Effect of Pre-Stroke Statin Therapy in a Cohort of Elderly Ischemic Stroke Patients (P03. 195)
  15586. Induction of a Neuroprotective phenotype of macrophages by the β-hydroxybutyrate receptor HCA2
  15587. Erratum: Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer’s disease (Eur. J. Pharmacol.(2013) 704: 1-3 (70-77
  15588. Neuroprotective effect of ginsenoside Rd during the subacute stage of the cerebral ischemia
  15589. Neuroprotective role of ibuprofen in hypoxic-ischemic brain damage in neonatal rats
  15590. Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol
  15591. Neuroprotective effect of borneol and its analogues on glutamic acid induced neuron injury
  15592. Neuroprotective and memory enhancing effect of crocetin after chronic cerebral hypoperfusion in rats
  15593. Metabolite profiling of the Neuroprotective phosphine-borane complex PB1
  15594. Study on the Neuroprotective effect of Hemin on hypoxic-ischemic brain damage in neonatal rats
  15595. The Neuroprotective Effects of Coenzyme Q10 on Retinal Ganglion Cells and Its Reversal of Apoptosis
  15596. of Presentation: Mechanisms and Neuroprotective strategies in neurodegeneration: Huntington disease can lead the way
  15597. Spinal cord changes consequent to peripheral nerve injury: Neuroprotective role of thioctic acid enantiomers
  15598. Neuroprotective effects of phosphatidylcholine and L-alpha-glycerylphosphorylcholine in experimental inflammation
  15599. Neuroprotective EFFECTS OF RESVERATROL ON OXIDATIVE STRESS INDUCED TOXICITY IN SK-N-MC CELLS
  15600. New Insights on the Neuroprotective Role of Albumin for Acute Stroke Based on a Study of the Transition Zone between the Penumbra and Core (P01. 251)
  15601. The Neuroprotective effects of SIRT1 on NMDA-induced excitotoxicity
  15602. Neuroprotective effect of HMGB1 suppression on post-ischemic inflammation in diabetic rats
  15603. Neuroprotective Effects of Allium hookeri Cultivated against Oxidative Stress-induced Neurotoxicity
  15604. Neuroprotective effect of inhibition of soluble epoxide hydrolase on focal cerebral ischemia/reperfusion in Rats
  15605. Neuroprotective role of dehydroepiandrosterone on age-associated alterations in male rat brain
  15606. An evaluation of the potentially Neuroprotective properties of cannabinoids in a cell culture model of Parkinson’s disease
  15607. Neuroprotective Effect of 17β Estradiol on Membrane Fluidity in Ageing Rat brain
  15608. The Neuroprotective effects of lithium chloride (LiCl) on anxiety behavior in animal models/INS; of Alzheimer’s disease
  15609. Retinal Astrocytes Mediate Neuroprotective Effects Through p38 MAPK Dependent Activation
  15610. Study into possible molecular targets of a Neuroprotective compound dimebon using a transgenic mouse line
  15611. Neuroprotective effect of lithium chloride on trimethyltin-induced learning and memory deficits in rats
  15612. Neuroprotective Effects of IGF-1 on Retinal Ganglion Cell Survival and Axonal Outgrowth
  15613. Loss of the E3 ubiquitin ligase Phr1 is Neuroprotective in Retinal Ganglion Cells
  15614. Interfering with the excitatory amino acids signalling in the brain for the design of novel Neuroprotective agents
  15615. Neuroprotective effect of n-butanol extract of Chinese toon seeds on mouse with injury of ischemia-reperfusion and its mechanism
  15616. Neuroprotective effects of rosiglitazone in chlorpyrifos-induced apoptosis in SH-SY5Y cells
  15617. Antioxidative and Neuroprotective activities of isocampneoside II on H2O2-induced oxidative injury in PC12 cells
  15618. Estradiol and Tamoxifen produces acute and chronic Neuroprotective effects after spinal cord injury
  15619. Neuroprotective effects of bone marrow stromal cells in cocultures of fetal dopaminergic neuronal cultures
  15620. Neuroprotective effects of pyrroloquinoline quinone in rotenone induced Parkinson’s disease model and the underlying mechanisms
  15621. Prehospital Study Enrollment Enables Initiation of Neuroprotective Agent for Acute Stroke in Hyperacute Time Windows
  15622. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response
  15623. Neuroprotective role of PKR in a model of neurodegeneration due to mild impairment of oxidative metabolism
  15624. The Neuroprotective Effect of Picroside II and Its Best Therapeutic Dose and Time Window in Cerebral Ischemic Injury in Rats
  15625. The Neuroprotective Effects of the Modulation of Glycogen Synthase Kinase-3 in Diabetic Encephalopathy Through Pharmacological and Genetic Means
  15626. Neuroprotective EFFECTS OF CROCIN ON THE TRANSIENT FOCAL CEREBRAL ISCHEMIA/REPERFUSION INJURIES IN RATS
  15627. Neuroprotective effect of tacrolimus on injured spinal cord of rats via attenuating lipid peroxidation
  15628. CURCUMIN HAS Neuroprotective EFFECT AGAINST HOMOCYSTEINE INDUCED PARKINSON LIKE BEHAVIOR IN RAT
  15629. Abstract WP274: Novel Platelet-Activating Factor Receptor Antagonists are Highly Neuroprotective in Focal Cerebral Ischemia
  15630. Neuroprotective mechanisms of standardized extracts of Bacopa monniera and their relevance in the treatment of Alzheimer’s and Parkinson’s diseases.
  15631. Design, Synthesis, Biological Evaluation And Molecular Modeling Studies Of Novel Multifunctional Neuroprotective Drugs For The Treatment Of Parkinson’s …
  15632. A STUDY ON ANTI-INFLANNATORY AND Neuroprotective EFFECTS OS COSTUNOLIDE ON LIPOPOLYSACCHARIDE ACTIVATED MURINE brain …
  15633. Study on the Neuroprotective effects of citalopram for SERT on hearing loss rat model using small animal PET
  15634. Norrin mediates Neuroprotective effects on retinal ganglion cells via the induction of leukemia inhibitory factor
  15635. Neuroprotective EFFICACY OF AMINOPROPYL CARBAZOLES IN A NEONATAL RAT MODEL OF NERVE INJURY
  15636. Neuroprotective Effects of SK95 against Dopamine-induced Cell Death by Up-regulating Proteasome Activity
  15637. Neuroprotective Effect of Voluntary Exercise on Dopamine and Tyrosine Hydroxylase in the Striatum of Parkinsonian Rats
  15638. Neuroprotective effects of edaravone on 6-OHDA-induced substantia nigra neurons in rat model with Parkinson′ s disease
  15639. Neuroprotective effects of recombinant human granulocyte colony-stimulationg factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION)
  15640. Neuroprotective mechanisms of cocaine-and amphetamine-regulated transcript peptides in brain ischemia
  15641. Neuroprotective effects of heme oxygenase 1 in striatial astrocytes in MPTP intoxicated mice
  15642. Necroptosis modulation by chitooligosaccharide presents a Neuroprotective issue in Ngf-differentiated PC12 cells
  15643. Neuroprotective Effect of Verapamil on Rabbit Spinal Cord Ischemia-Reperfusion Injury
  15644. Neuroprotective Effects of Ginkgo Biloba Extract (GbE) on Oxygen-Glucose Deprivation (OGD) in PC12 Cells
  15645. Neuropeptide Y Y1 receptor is Neuroprotective and modulates microglia reactivity in the rat retina
  15646. Fermentation Enhances the In Vitro Neuroprotective Effect of Clove (Eugenia caryophyllata) via Increasing in the Contents of Dehydrodieugenol and …
  15647. Nurr1 agonist acts as a Neuroprotective agent by reducing reactive oxygen level
  15648. The Neuroprotective Effects of Minocycline evaluated by Electroretinogram on High Intraocular Pressure Induced Retinal Ischemia in the Rat
  15649. Neuroprotective properties of mild therapeutic hypothermia in a co-culture model following a hypoxic ischemic event
  15650. Neuroprotective role of 17β estradiol with tachykinin neuropeptide NKB and Aβ (25 – 35) in aging female rat brain
  15651. Neuroprotective Effect of Loganin against β-Amyloid Peptide25-35-Induced Toxicity in PC12 Cells
  15652. Neuroprotective Effects of the Ethyl Acetate Fraction Prepared from the Fruit of Physalis alkekengi var. franchetii
  15653. The Neuroprotective effect of immune serum of adeno-associated virus vaccine containing Aβ1-15 gene on amyloid toxicity
  15654. Involvement of CRH Receptors in the Neuroprotective Action of R-Apomorphine in the Striatal 6-OHDA Rat Model
  15655. Synthetic PreImplantation Factor (sPIF)# Neuroprotective role in intracranial stem cell transplantation: Encephalopathy of prematurity rat model
  15656. Acute Neuroprotective effects of alpha-lipoic asit in experimental spinal cord injury in rats Ratlarda oluşturulan spinal kord hasari {dotless} nda alpha-lipoic asit’in akut …
  15657. Neuroprotective effect of 1′‐acetoxychavicol acetate against amyloid β induced toxicity is related with upregulation of proteasome activity
  15658. Neuroprotective effects of Fisetin and Diosmetin, alone and in combination, on lipopolysaccharide‐induced neuronal cells
  15659. TrkB Receptor Agonists as Neuroprotective Molecules in Glaucoma-Effect of 7, 8 Dihydroxyflavone
  15660. Neuroprotective Effect of Kaempferol Glycosides against brain Injury and Neuroinflammation by
  15661. Neuroprotective Effects of Hydrogen-rich Saline on brain Injury of Acute Carbon Monoxide Poisoned Rats
  15662. Neuroprotective effects of hypoxia and hypoxia-mimetics following hypoxic-ischemic brain injury
  15663. Neuroprotective efficacy of Punica granatum peels extract against rotenone induced oxidative stress in rat brain
  15664. M‐type K+ Channel Openers: In vivo Neuroprotective Role during Cerebrovascular Stroke
  15665. Exploring the Neuroprotective and alerting effects of modafinil in multiple sclerosis and experimental autoimmune encephalomyelitis
  15666. Neuroprotective EFFECT OF HYPOTHERMIA FOLLOWING SPINAL CORD INJURY IN RATS-COMPARATIVE STUDY BETWEEN EPIDURAL AND SYSTEMIC …
  15667. Exploring the Neuroprotective effects of resveratrol in a rat model of hearing loss using 4-[18F]-ADAM/small animal PET
  15668. Cocoa Powder Triggers Neuroprotective and Preventive Effects in a Human Alzheimer 0 s Disease Model by Modulating BDNF Signaling Pathway
  15669. Neuroprotective effect of a new synthetic aspirin-decursinol adduct in a rat model of ischemic stroke
  15670. Neuroprotective effect on the retinal ganglion cells by brimonidine loaded HSA nanoparticles in the acute optic nerve crush model
  15671. Neuroprotective effects of an active constituent derived from Indigofera tinctoria extract in experimental models of Parkinson’s disease.
  15672. Neuroprotective effects of norgestrel in retinitis pigmentosa: preservation of retinal cytoarchitecture and synaptic connectivity
  15673. Tri‐docosahexaenoic but not Tri‐eicosapentaenoic Acid‐Rich Emulsions are Neuroprotective after Cerebral Hypoxic‐Ischemic Injury in Mice
  15674. PI3K/Akt signaling pathway is involved in the Neuroprotective effects of icariin on dopaminergic neurons in the mice model of Parkinson’s disease
  15675. Neuroprotective effects of siRna, targeted caspase 3 on rat retinal damage induced by different time course of transient Ischemic Injury
  15676. Abstract WP110: TLR5 Is Related To Neuroprotective Mechanism Of Postconditioning Through NF-κB-Akt Survival Pathway In Cerebral Ischemia
  15677. The Neuroprotective effect of BDNF on oxidative DNA damage in rat cortical neurons: evaluation by comet assay
  15678. Neuroprotective EFFECTS OF SALVIA CHOLOROLEUCALEAVES ALCOHOLIC EXTRACT ON NEURONAL DENSITY OF α-MOTONEURONS AFTER SCIATIC …
  15679. Abstract WP433: Haemostatic and Neuroprotective Effects of Xe-loaded Echogenic Liposomes in a Subarachnoid Hemorrhagic Stroke Model
  15680. Neuroprotective Properties of Phytochemicals against Paraquat-Induced Oxidative Stress and Neurotoxicity in Drosophila melanogaster
  15681. LITHIUM AS A Neuroprotective AGENT IN PATIENTS UNDERGOING PROPHYLACTIC CRANIAL IRRADIATION (PCI) FOR SMALL CELL LUNG CANCER …
  15682. Research report 1: Alzheimer’s disease: The search of Neuroprotective compounds
  15683. Neuroprotective role of docosahexaenoic acid and gamma-linolenic acid in lead induced neurological deficit in Swiss albino mice
  15684. The Neuroprotective effects of HOEC against hydrogen peroxide-induced cytotoxicity and apoptosis via phosphorylation of p38 MAPK in SH-SY5Y cells
  15685. Neuroprotective effect of liver X receptor agonist TO901317 on ganglion cells in alcohol-induced retinal injury in neonatal mice [J]
  15686. The Neuroprotective effects of oxaloacetate and puruvate in a rat model of subarachnoid hemorrhage is mediated by its blood glutamate scavenging activity: ESAPC1 …
  15687. Antioxidant and Neuroprotective Effects of Kaempferol and Tannic Acid against 6-Hydroxydopamine-induced Oxidative Stress
  15688. Alpha7 nicotinic ACh receptor mediated Neuroprotective action by nicotine and GTS-21~ An approach by the hippocampal organotypic slice cultures~
  15689. The PEDF Neuroprotective domain plus DHA selectively induces corneal nerve regeneration after experimental surgery
  15690. Discovery of Neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
  15691. Neuroprotective Effect of DHEA-derivative BNN27 against N-Methyl-D-Aspartate-induced Retinal Excitotoxicity in Mice
  15692. The effectiveness of endonasal electrophoresis of Neuroprotective agents used in the rehabilitative treatment of the patients presenting with primary open angle …
  15693. … deficits in simple discrimination following frontal traumatic brain injury in rats: The relative contribution of motor deficits, motivation deficits and Neuroprotective …
  15694. Neuronal DNA Double Strand Break Damage and Repair Following Sublethal iGluR Activation, and the Neuroprotective Effects of Melatonin
  15695. Neuroprotective effect of extracts of roots and aerial parts of Astragalus membranaceus in cerebellar neurons culture of rats with glutamate excitotoxicity
  15696. Neuroprotective effects of icariin and astragaloside Ⅳ on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons
  15697. Neuroprotective Effect of Rapamycin (Autophagy Enhancer) in Transgenic SOD1-G93A Mice of Amyotrophic Lateral Sclerosis
  15698. Presenilin mediates Neuroprotective functions of efnB and BDNF and regulates ligand-induced internalization and metabolism of EphB2 and TrkB receptors
  15699. Synthesis of (1E)-phenyl-2-(3′, 4′-dihydroxyphenyl) ethenesulfonates as potent Neuroprotective agents and evaluation of their activities
  15700. Neuroprotective efficacy of the endogenous neuropeptide Urocortin in a oxygen-glucose deprivation model of transient cerebral ischaemia with reperfusion
  15701. … and Chemoinformatics Approach for Developing Asymmetric Bivalent AMPA Receptor Positive Allosteric Modulators as Neuroprotective agents (ChemMedChem 2 …
  15702. Abstract TP268: Huwe1 Is Neuroprotective Against Monkey Cerebral Ischemia-reperfusion Injury By Regulating P53-And Mcl1-Dependent Apoptotic Pathways
  15703. The regulation of endocannabinoids after neuronal damage and the Neuroprotective impact of GPR55 in organotypic hippocampal slice cultures
  15704. Neuroprotective Effect of Photoactive Quantum Dots in Progressive Retinal Photoreceptor Degeneration. J Nanomater Mol Nanotechnol 2: 4
  15705. Neuroprotective Effects of Quercetin, Lycium Barbarum and Chitosan Against of the Oxidative Stress Induced by Exposure to Hypobaric Hypoxia DUMITROVICI …
  15706. Neuroprotective Effects of Herbal Ethanol Extract from Gynostemma pentaphyllum on Dopamine Neurons in Rotenone-and MPTP-induced Animal Model of …
  15707. Quantitative evaluation of the Neuroprotective effects of a short-acting β-adrenoceptor antagonist at a clinical dose on forebrain ischemia in gerbils: effects of esmolol …
  15708. Quantitative evaluation of the Neuroprotective effects of a short-acting ß-adrenoceptor antagonist at a clinical dose on forebrain ischemia in gerbils: Effects of esmolol …
  15709. URMC-099, a Novel Kinase Inhibitor with Drug-like Properties, is Neuroprotective in Models of Human Immunodeficiency Virus Associated Neurocognitive Disorders
  15710. Abstract TP275: Glucagon-Like Peptide-1 Is Increased In Blood Plasma and May Play Neuroprotective Roles After Ischemic Stroke In Human
  15711. Examining the potential of PGE2 receptor EP4 as a Neuroprotective target following ischaemic injury
  15712. Robust self-association of arrestin-1 is a Neuroprotective mechanism
  15713. N-substituted 8-aminopentacyclo [5.4. 0.0 ², ⁶. 0³, ¹⁰. 0⁵, ⁹] undecanes as σ receptor ligands with potential Neuroprotective effects
  15714. AAV-Mediated Neurotrophin-4 Is Neuroprotective In Murine Model Of Microbead-Induced Glaucoma with Neurotrophin Expression in the Visual Pathway
  15715. Erratum to: Heme Oxygenase-2 Is Neuroprotective in Cerebral Ischemia
  15716. Exercise: is it a Neuroprotective and if so, how does it work?
  15717. Neuroprotective gases–fantasy or reality for clinical use?
  15718. Neuroprotective strategies for traumatic brain injury: improving clinical translation
  15719. Pharmacological Neuroprotective strategies in neonatal brain injury
  15720. Neuroprotective effects of physical activity on the brain : a closer look at trophic factor signaling
  15721. Neuroprotective effects of berry fruits on neurodegenerative diseases
  15722. Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury
  15723. Neuroprotective effects of lithium: implications for the treatment of Alzheimer’s disease and related neurodegenerative disorders
  15724. Neuroprotective properties of citicoline: facts, doubts and unresolved issues
  15725. Neuroprotective effects of resveratrol in Alzheimer disease pathology
  15726. Importance of preclinical research in the development of Neuroprotective strategies for ischemic stroke
  15727. Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice
  15728. The Neuroprotective effect of Klotho is mediated via regulation of members of the redox system
  15729. Neuroprotective effects of testosterone treatment in men with multiple sclerosis
  15730. Neuroprotective effects of perflurocarbon (oxycyte) after contusive spinal cord injury
  15731. Neuroprotective effects of intravenous anesthetics: a new critical perspective
  15732. Molecular mechanisms involved in the cardiovascular and Neuroprotective effects of anthocyanins
  15733. Suppression of microglial activation is Neuroprotective in a mouse model of human retinitis pigmentosa
  15734. Neuroprotective effects of leptin in the context of obesity and metabolic disorders
  15735. Loss of the Neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
  15736. Discovery of vinyl sulfones as a novel class of Neuroprotective agents toward Parkinson’s disease therapy
  15737. Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis
  15738. Methylene blue is Neuroprotective against mild traumatic brain injury
  15739. brain -derived estrogen exerts anti-inflammatory and Neuroprotective actions in the rat hippocampus
  15740. The β-hydroxybutyrate receptor HCA 2 activates a Neuroprotective subset of macrophages
  15741. Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model
  15742. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands
  15743. Neuroprotective effects of madecassoside against focal cerebral ischemia reperfusion injury in rats
  15744. Promises of novel multi-target Neuroprotective and neurorestorative drugs for Parkinson’s disease
  15745. The Neuroprotective role of acupuncture and activation of the BDNF signaling pathway
  15746. GDNF-transfected macrophages produce potent Neuroprotective effects in Parkinson’s disease mouse model
  15747. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases
  15748. Neuroprotective Effects of Bikaverin on H2O2-Induced Oxidative Stress Mediated Neuronal Damage in SH-SY5Y Cell Line
  15749. Neuroprotective effect of ginger in the brain of streptozotocin-induced diabetic rats
  15750. Rosmarinic acid mediated Neuroprotective effects against H2O2-induced neuronal cell damage in N2A cells
  15751. Hypothermia is not Neuroprotective after infection-sensitized neonatal hypoxic–ischemic brain injury
  15752. Berberine was Neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved
  15753. Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia
  15754. memory deficits and oxidative stress in cerebral ischemia–reperfusion: Neuroprotective role of physical exercise and green tea supplementation
  15755. P7C3 Neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury
  15756. Subcellular expression and Neuroprotective effects of SK channels in human dopaminergic neurons
  15757. Neuroprotective effects of swimming training in a mouse model of Parkinson’s disease induced by 6-hydroxydopamine
  15758. Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats
  15759. Novel treatment with Neuroprotective and antiviral properties against a neuroinvasive human respiratory virus
  15760. Caffeine Neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions
  15761. Neuroprotective effects of different modalities of acupuncture on traumatic spinal cord injury in rats
  15762. Granulocyte-macrophage colony-stimulating factor is Neuroprotective in experimental traumatic brain injury
  15763. Screening and identification of Neuroprotective compounds relevant to Alzheimer׳ s disease from medicinal plants of S. Tomé e Príncipe
  15764. Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson’s disease rat
  15765. Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice
  15766. Palmitoylethanolamide controls reactive gliosis and exerts Neuroprotective functions in a rat model of Alzheimer’s disease
  15767. Fingolimod exerts Neuroprotective effects in a mouse model of intracerebral hemorrhage
  15768. Discovery of a Neuroprotective Chemical, (S)-N-(3-(3,6-Dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(−)-P7C3-S243], with Improved …
  15769. Evaluation of the Neuroprotective effect of chrysin via modulation of endogenous biomarkers in a rat model of spinal cord injury
  15770. Magnesium is not consistently Neuroprotective for perinatal hypoxia-ischemia in term-equivalent models in preclinical studies: a systematic review
  15771. Neuroprotective effect of pAkt and HIF-1 α on ischemia rats
  15772. Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and …
  15773. Neuroprotective effect of melatonin against ischemia is partially mediated by alpha‐7 nicotinic receptor modulation and HO‐1 overexpression
  15774. Expansion of the clinical phenotype associated with mutations in activity-dependent Neuroprotective protein
  15775. Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats
  15776. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson’s disease mouse model
  15777. Association of duration of Neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes
  15778. Microglia activation in a model of retinal degeneration and TUDCA Neuroprotective effects
  15779. Evaluation of Neuroprotective effect of glucagon‐like peptide 1 analogs using neuroimaging
  15780. Riluzole for acute traumatic spinal cord injury: a promising Neuroprotective treatment strategy
  15781. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson’s disease model in rats
  15782. Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration
  15783. Neuroprotective effects of Asiaticoside
  15784. Neurotrophic and Neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease
  15785. Neuroprotective effect of apigenin in rats after contusive spinal cord injury
  15786. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson’s-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses
  15787. Connexin hemichannel blockade is Neuroprotective after asphyxia in preterm fetal sheep
  15788. Neuroprotective and symptomatic effects of targeting group III mG lu receptors in neurodegenerative disease
  15789. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson’s disease
  15790. Neuroprotective effect of chebulagic acid via autophagy induction in SH-SY5Y cells
  15791. Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1 …
  15792. Neuroprotective effect of nobiletin on cerebral ischemia–reperfusion injury in transient middle cerebral artery-occluded rats
  15793. Neuroprotective effects of Huang-Lian-Jie-Du-Decoction on ischemic stroke rats revealed by 1H NMR metabolomics approach
  15794. Neuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage
  15795. A preliminary study of the Neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy
  15796. Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration
  15797. Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism
  15798. Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model
  15799. Neuroprotective effects of orientin on hydrogen peroxide‑induced apoptosis in SH‑SY5Y cells
  15800. Ceftriaxone blocks the polymerization of α-synuclein and exerts Neuroprotective effects in vitro
  15801. Neuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oil
  15802. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation
  15803. The monoacylglycerol lipase inhibitor JZL184 is Neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
  15804. Neuroprotective Effects of Puerarin on 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine induced Parkinson’s Disease Model in Mice
  15805. Oxidative stress mediated by NMDA, AMPA/KA channels in acute hippocampal slices: Neuroprotective effect of resveratrol
  15806. Indirect application of near infrared light induces Neuroprotection in a mouse model of parkinsonism–an abscopal Neuroprotective effect
  15807. cognitive deficits and decreased locomotor activity induced by single-walled carbon nanotubes and Neuroprotective effects of ascorbic acid
  15808. Neuroprotective effect of cathodal transcranial direct current stimulation in a rat stroke model
  15809. Neuroprotective copper bis (thiosemicarbazonato) complexes promote neurite elongation
  15810. Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats
  15811. Prospects for Neuroprotective therapies in prodromal Huntington’s disease
  15812. Neuroprotective effects of rhynchophylline against ischemic brain injury via regulation of the Akt/mTOR and TLRs signaling pathways
  15813. Neuroprotective effect of punicalagin against cerebral ischemia reperfusion-induced oxidative brain injury in rats
  15814. FTY720 (fingolimod) is a Neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease
  15815. Neuroprotective Xanthones from the Root Bark of Cudrania tricuspidata
  15816. A Smoothened receptor agonist is Neuroprotective and promotes regeneration after ischemic brain injury
  15817. The Neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96‐110
  15818. MLC901, a traditional Chinese medicine induces Neuroprotective and neuroregenerative benefits after traumatic brain injury in rats
  15819. Nanoencapsulation of the sasanquasaponin from Camellia oleifera, its photo responsiveness and Neuroprotective effects
  15820. Neuroprotective effects of gallic acid against hypoxia/reoxygenation-induced mitochondrial dysfunctions in vitro and cerebral ischemia/reperfusion injury in vivo
  15821. Neuroprotective effects of sulforaphane on cholinergic neurons in mice with Alzheimer’s disease-like lesions
  15822. Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia in rats
  15823. The NAP motif of activity-dependent Neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins
  15824. Inhibition of the microglial response is essential for the Neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death
  15825. Non-feminizing estrogens: a novel Neuroprotective therapy
  15826. Nrf2 signaling contributes to the Neuroprotective effects of urate against 6-OHDA toxicity
  15827. The Neuroprotective effects of carnosine in early stage of focal ischemia rodent model
  15828. Antiepileptogenic and Neuroprotective effects of losartan in kainate model of temporal lobe epilepsy
  15829. Neuroprotective effects of histone deacetylase inhibitors in brain ischemia
  15830. Neuroprotective ferulic acid (FA)–glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord
  15831. Identification of a Neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine
  15832. Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat
  15833. Neuroprotective effects of corn silk maysin via inhibition of H2O2-induced apoptotic cell death in SK-N-MC cells
  15834. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum
  15835. Coptis chinensis Franch. exhibits Neuroprotective properties against oxidative stress in human neuroblastoma cells
  15836. Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia–reperfusion in rats
  15837. Neuroprotective effect of schizandrin A on oxygen and glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons
  15838. Resveratrol treatment has Neuroprotective effects and prevents cognitive impairment after chronic cerebral hypoperfusion
  15839. Evaluation of nicotine and cotinine analogs as potential Neuroprotective agents for Alzheimer’s disease
  15840. The Neuroprotective effects of cordycepin inhibit glutamate-induced oxidative and ER stress-associated apoptosis in hippocampal HT22 cells
  15841. Cinnamon treatment upregulates Neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson’s disease
  15842. Gelatin nanoparticles enhance the Neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model
  15843. Neuroprotective effect of allicin against traumatic brain injury via Akt/endothelial nitric oxide synthase pathway-mediated anti-inflammatory and anti-oxidative activities
  15844. Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible …
  15845. Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP (+)-induced cell death in human neuroblastoma SH-SY5Y cells: the …
  15846. Short-term preoperative dietary restriction is Neuroprotective in a rat focal stroke model
  15847. Neuroprotective effects of rosmarinic acid on ciguatoxin in primary human neurons
  15848. Extracellular visfatin has nicotinamide phosphoribosyltransferase enzymatic activity and is Neuroprotective against ischemic injury
  15849. New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative …
  15850. Neuroprotective effect of aquaporin-4 deficiency in a mouse model of severe global cerebral ischemia produced by transient 4-vessel occlusion
  15851. Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression
  15852. Comparison of the Neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD mice …
  15853. Cerebral oxidative stress induces spatial working memory dysfunction in uremic mice: Neuroprotective effect of tempol
  15854. Understanding the pathophysiology of traumatic brain injury and the mechanisms of action of Neuroprotective interventions
  15855. Neuroprotective effects of human spinal cord-derived neural precursor cells after transplantation to the injured spinal cord
  15856. Neuroprotective effects of vagus nerve stimulation on traumatic brain injury
  15857. AKT-related autophagy contributes to the Neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats
  15858. The Neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using …
  15859. Neuroprotective effect of pretreatment with Lavandula officinalis ethanolic extract on blood-brain barrier permeability in a rat stroke model
  15860. Neuroprotective Potential of Laurus nobilis Antioxidant Polyphenol-Enriched Leaf Extracts
  15861. Lack of Neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson’s …
  15862. Anti-allodynic and Neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy
  15863. New drug treatments show Neuroprotective effects in Alzheimer’s and Parkinson’s diseases
  15864. Neuroprotective effect of muscone on glutamate-induced apoptosis in PC12 cells via antioxidant and Ca2+ antagonism
  15865. The Neuroprotective properties of the superoxide dismutase mimetic tempol correlate with its ability to reduce pathological glutamate release in a rodent model of …
  15866. Iridal-Type Triterpenoids with Neuroprotective Activities from Iris tectorum
  15867. Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: relevance to neuropathy
  15868. Neuroprotective role of hydroalcoholic extract of Vitis vinifera against aluminium-induced oxidative stress in rat brain
  15869. Jujuboside A, a Neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Aβ1–42
  15870. Neuropeptides as Neuroprotective agents : Oxytocin a forefront developmental player in the mammalian brain
  15871. HSP60 is involved in the Neuroprotective effects of naloxone
  15872. Neuroprotective effects of autophagy induced by rapamycin in rat acute spinal cord injury model
  15873. Neuroprotective effect of a triterpenoid saponin isolated from Momordica cymbalaria Fenzl in diabetic peripheral neuropathy
  15874. Neuroprotective effect of curcumin against oxidative damage in BV-2 microglia and high intraocular pressure animal model
  15875. Polycyclic propargylamine and acetylene derivatives as multifunctional Neuroprotective agents
  15876. Monocytes are essential for the Neuroprotective effect of human cord blood cells following middle cerebral artery occlusion in rat
  15877. Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson’s disease induced by MPTP
  15878. Curcumin’s Neuroprotective Efficacy in Drosophila Model of Idiopathic Parkinson’s Disease Is Phase Specific: Implication of its Therapeutic Effectiveness
  15879. The Neuroprotective effect of electro-acupuncture against ischemic stroke in animal model: a review
  15880. Phenolic derivatives from the rhizomes of Dioscorea nipponica and their anti-neuroinflammatory and Neuroprotective activities
  15881. Neuroprotective effect of astaxanthin against rat retinal ganglion cell death under various stresses that induce apoptosis and necrosis
  15882. Neuroprotective effect of pretreatment with ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus
  15883. Comparative analysis of the Neuroprotective effects of ginsenosides Rg1 and Rb1 extracted from Panax notoginseng against cerebral ischemia
  15884. Neuroprotective effects of macranthoin G from Eucommia ulmoides against hydrogen peroxide-induced apoptosis in PC12 cells via inhibiting NF-κB activation
  15885. Neuroprotective effects of erythropoiesis stimulating agents in term and preterm neonates
  15886. Neuroprotective effects of edaravone after intraventricular hemorrhage in rats
  15887. Antioxidant and Neuroprotective Activities of Hyptis suaveolens (L.) Poit. Against Oxidative Stress-Induced Neurotoxicity
  15888. Lignans from the Fruit of Schisandra glaucescens with Antioxidant and Neuroprotective Properties
  15889. Neuroprotective effect of osmotin against ethanol-induced apoptotic neurodegeneration in the developing rat brain
  15890. Neurotrophic and Neuroprotective potential of human limbus-derived mesenchymal stromal cells
  15891. Sunitinib produces Neuroprotective effect via inhibiting nitric oxide overproduction
  15892. Combination of mild hypothermia with neuroprotectants has greater Neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated …
  15893. Neuroprotective effects of Nigella sativa extract on cell death in hippocampal neurons following experimental global cerebral ischemia-reperfusion injury in rats
  15894. A systematic review of Neuroprotective strategies after cardiac arrest: from bench to bedside (Part I–Protection via specific pathways)
  15895. Neuroprotective effect of steroidal alkaloids on glutamate-induced toxicity by preserving mitochondrial membrane potential and reducing oxidative stress
  15896. Neuroprotective effect of TAT-14-3-3ε fusion protein against cerebral ischemia/reperfusion injury in rats
  15897. Study of the Neuroprotective effects of memantine in patients with mild to moderate ischemic stroke
  15898. Neuroprotective effects of argatroban and C 5a receptor antagonist (PMX 53) following intracerebral haemorrhage
  15899. Neuroprotective role of hydralazine in rat spinal cord injury‐attenuation of acrolein‐mediated damage
  15900. A Novel Neuroprotective Strategy for Ischemic Stroke: Transient Mild Acidosis Treatment by CO2 Inhalation at Reperfusion
  15901. Ketogenic diet provides Neuroprotective effects against ischemic stroke neuronal damages
  15902. The proton permeability of self-assembled polymersomes and their Neuroprotection by enhancing a Neuroprotective peptide across the blood–brain barrier after …
  15903. Identification of licopyranocoumarin and glycyrurol from herbal medicines as Neuroprotective compounds for Parkinson’s disease
  15904. Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation
  15905. Synthesis, and the antioxidant, Neuroprotective and P-glycoprotein induction activity of 4-arylquinoline-2-carboxylates
  15906. Neuroprotective effect of chondroitinase ABC on primary and secondary brain injury after stroke in hypertensive rats
  15907. Korean red ginseng extract exhibits Neuroprotective effects through inhibition of apoptotic cell death
  15908. Neuroprotective effect of didymin on hydrogen peroxide-induced injury in the neuronal membrane system
  15909. A systematic review of Neuroprotective strategies after cardiac arrest: from bench to bedside (part II-comprehensive protection)
  15910. Neuroprotective effects of melittin on hydrogen peroxide-induced apoptotic cell death in neuroblastoma SH-SY5Y cells
  15911. PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce Neuroprotective pathways in human malaria
  15912. Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the Neuroprotective effect of berberine against cerebral ischemia
  15913. Neuroprotective properties of a standardized extract from Myracrodruon urundeuva Fr. All.(Aroeira-Do-Sertao), as evaluated by a Parkinson’s disease model …
  15914. Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent Neuroprotective protein (ADNP) in the face of Tau mutation
  15915. EPO mediates neurotrophic, Neuroprotective , anti-oxidant, and anti-apoptotic effects via downregulation of miR-451 and miR-885-5p in SH-SY5Y neuron-like …
  15916. A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a Neuroprotective drug, edaravone as compared with uric acid, glutathione, and trolox
  15917. Neuroprotective effects of 3, 6′-disinapoyl sucrose through increased BDNF levels and CREB phosphorylation via the CaMKII and ERK1/2 pathway
  15918. Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel Neuroprotective factor in cerebral ischemia–reperfusion injury
  15919. Neuroprotective and anti-apoptotic effects of valproic acid on adult rat cerebral cortex through ERK and Akt signaling pathway at acute phase of traumatic brain injury
  15920. The Neuroprotective effects of tocotrienol rich fraction and alpha tocopherol against glutamate injury in astrocytes
  15921. Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment
  15922. Neuroprotective effect of Ginkgolide K against H2O2-induced PC12 cell cytotoxicity by ameliorating mitochondrial dysfunction and oxidative stress
  15923. Neuroprotective effect of Panax notoginseng plysaccharides against focal cerebral ischemia reperfusion injury in rats
  15924. Neuroprotective effects of guanosine administration on behavioral, brain activity, neurochemical and redox parameters in a rat model of chronic hepatic …
  15925. Lixisenatide improves recognition memory and exerts Neuroprotective actions in high-fat fed mice
  15926. Estrogen receptors’ Neuroprotective effect against glutamate-induced neurotoxicity
  15927. Inhibition of Let7c microRNA is Neuroprotective in a rat intracerebral hemorrhage model
  15928. Sterols from Mytilidae show anti-aging and Neuroprotective effects via anti-oxidative activity
  15929. Synthesis of natural and non-natural curcuminoids and their Neuroprotective activity against glutamate-induced oxidative stress in HT-22 cells
  15930. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion
  15931. The Neuroprotective effect of treatment with curcumin in acute spinal cord injury
  15932. Neuroprotective effect of diphenyl diselenide in a experimental stroke model: maintenance of redox system in mitochondria of brain regions
  15933. Erythropoietin exerts a Neuroprotective function against glutamate neurotoxicity in experimental diabetic retina
  15934. The Neuroprotective effect of tropisetron on vincristine-induced neurotoxicity
  15935. ERK5/KLF4 signaling as a common mediator of the Neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning
  15936. Possible involvement of nitric oxide mechanism in the Neuroprotective effect of rutin against immobilization stress induced anxiety like behaviour, oxidative damage in …
  15937. Neuroprotective role of Indirubin-3′-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice
  15938. Mild hypothermia combined with neural stem cell transplantation for hypoxic-ischemic encephalopathy: Neuroprotective effects of combined therapy
  15939. Neuroprotective effects of propofol on ER stress-mediated apoptosis in neuroblastoma SH-SY5Y cells
  15940. In vivo antioxidative and Neuroprotective effect of 4-Allyl-2-methoxyphenol against chlorpyrifos-induced neurotoxicity in rat brain
  15941. Biodegradable gelatin microspheres enhance the Neuroprotective potency of osteopontin via quick and sustained release in the post-ischemic brain
  15942. HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is Neuroprotective in mice
  15943. Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by β‐amyloid through activation of SIRT1/Akt1 pathway
  15944. N-Methyl-d-Aspartate Receptor Blockade Is Neuroprotective in Experimental Autoimmune Optic Neuritis
  15945. Synthesis of glycosides of resveratrol, pterostilbene, and piceatannol, and their anti-oxidant, anti-allergic, and Neuroprotective activities
  15946. Neuroprotective effects of Gualou Guizhi decoction in vivo and in vitro
  15947. Neuroprotective effects of Arctium lappa L. roots against glutamate-induced oxidative stress by inhibiting phosphorylation of p38, JNK and ERK 1/2 MAPKs in PC12 …
  15948. Combination of therapeutic hypothermia and other Neuroprotective strategies after an ischemic cerebral insult
  15949. … (Sesamum indicum L.) seeds extracts by CO2 supercritical fluid extraction: Isotherms of global yield, kinetics data, total fatty acids, phytosterols and Neuroprotective …
  15950. Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells
  15951. Discovery of a natural product-like iNOS inhibitor by molecular docking with potential Neuroprotective effects in vivo
  15952. Spinal cord stimulation exerts Neuroprotective effects against experimental Parkinson’s disease
  15953. Minocycline but not tigecycline is Neuroprotective and reduces the neuroinflammatory response induced by the superimposition of sepsis upon traumatic brain injury
  15954. Neuroprotective effect of Feronia limonia on ischemia reperfusion induced brain injury in rats
  15955. Neuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress
  15956. Four new compounds from the bulbs of Lycoris aurea with Neuroprotective effects against CoCl 2 and H 2 O 2-induced SH-SY5Y cell injuries
  15957. Specific induction of Akt3 in spinal cord motor neurons is Neuroprotective in a mouse model of familial amyotrophic lateral sclerosis
  15958. The Neuroprotective effects of isoflurane preconditioning in a murine transient global cerebral ischemia–reperfusion model: The role of the notch signaling pathway
  15959. The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for Neuroprotective treatment in glaucoma
  15960. Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal …
  15961. Cucurbitacin E has Neuroprotective properties and autophagic modulating activities on dopaminergic neurons
  15962. Neuroprotective effects of Citrus reticulata in scopolamine-induced dementia oxidative stress in rats
  15963. Neuroprotective effects of the andrographolide analogue AL-1 in the MPP+/MPTP-induced Parkinson’s disease model in vitro and in mice
  15964. Neuroprotective effects of tibolone against oxidative stress induced by ozone exposure
  15965. Quercetin enhances exercise-mediated Neuroprotective effects in brain ischemic rats.
  15966. Investigation of the Neuroprotective impact of nimodipine on Neuro2a cells by means of a surgery-like stress model
  15967. Autophagy suppression by exercise pretreatment and p38 inhibition is Neuroprotective in cerebral ischemia
  15968. Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro
  15969. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION)
  15970. Umbilical cord blood mesenchymal stem cells co-modified by TERT and BDNF: a novel Neuroprotective therapy for neonatal hypoxic-ischemic brain damage
  15971. Neuroprotective effects of diarylpropionitrile against β-amyloid peptide-induced neurotoxicity in rat cultured cortical neurons
  15972. Neuroprotective effect of PEP-1-peroxiredoxin2 on CA1 regions in the hippocampus against ischemic insult
  15973. Neuroprotective study of Nigella sativa-loaded oral provesicular lipid formulation: in vitro and ex vivo study
  15974. A hypothesis: hydrogen sulfide might be Neuroprotective against subarachnoid hemorrhage induced brain injury
  15975. Neuroprotective effects of daphnetin against NMDA receptor-mediated excitotoxicity
  15976. Discovery of the Neuroprotective effects of alvespimycin by computational prioritization of potential anti‐Parkinson agents
  15977. Development of a novel Neuroprotective strategy: combined treatment with hypothermia and valproic acid improves survival in hypoxic hippocampal cells
  15978. Neuroprotective effects of β-myrcene following global cerebral ischemia/reperfusion-mediated oxidative and neuronal damage in a C57BL/J6 mouse
  15979. The Neuroprotective effect of cornus MAS on brain tissue of Wistar rats
  15980. A PPAR-β/δ agonist is Neuroprotective and decreases cognitive impairment in a rodent model of Parkinson’s disease
  15981. Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth
  15982. The Neuroprotective effect of modified “Shengyu” decoction is mediated through an anti-inflammatory mechanism in the rat after traumatic brain injury
  15983. cognitive enhancing and Neuroprotective effect of the embryo of the Nelumbo nucifera seed
  15984. Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in parkinsonian mice
  15985. Neuroprotective effects of vitexin by inhibition of NMDA receptors in primary cultures of mouse cerebral cortical neurons
  15986. Neuroprotective effects of carboxymethylated chitosan on hydrogen peroxide induced apoptosis in Schwann cells
  15987. Neurotropic and Neuroprotective activities of the earthworm peptide Lumbricusin
  15988. Neuroprotective potential of peroxisome proliferator activated receptor-α agonist in cognitive impairment in Parkinson’s disease: Behavioral, biochemical, and …
  15989. Neuroprotective effects of ginsenoside Rg1 against oxygen–glucose deprivation in cultured hippocampal neurons
  15990. Neuroprotective Potential of Adenosine A2A and Cannabinoid CB1 Receptor Antagonists in an Animal Model of Parkinson Disease
  15991. Lixisenatide, a drug developed to treat type 2 diabetes, shows Neuroprotective effects in a mouse model of Alzheimer’s disease
  15992. Hesperidin potentiates the Neuroprotective effects of diazepam and gabapentin against pentylenetetrazole-induced convulsions in mice: Possible behavioral …
  15993. Neuroprotective role of quercetin in locomotor activities and cholinergic neurotransmission in rats experimentally demyelinated with ethidium bromide
  15994. brain ‑derived neurotrophic factor exerts Neuroprotective actions against amyloid β‑induced apoptosis in neuroblastoma cells
  15995. Neuroprotective effect of resveratrol in diabetic cerebral ischemic-reperfused rats through regulation of inflammatory and apoptotic events
  15996. Neuroprotective effects of electro acupuncture on hypoxic-ischemic encephalopathy in newborn rats Ass.
  15997. Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is Neuroprotective and attenuates allodynia following traumatic spinal cord …
  15998. Neuroprotective effect of purple rice extract and its constituent against amyloid beta-induced neuronal cell death in SK-N-SH cells
  15999. Anticholinesterase, antioxidant, and Neuroprotective effects of Tripleurospermum disciforme and Dracocephalum multicaule
  16000. Triple-layered mixed co-culture model of RPE cells with neuroretina for evaluating the Neuroprotective effects of adipose-MSCs
  16001. A Neuroprotective brain -penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis
  16002. Neuroprotective effects of rosuvastatin against traumatic spinal cord injury in rats
  16003. … ethanol consumption increases corticosterone levels and neurodegneration whereas occupancy of type II glucocorticoid receptors with mifepristone is Neuroprotective
  16004. Prediction of multi-target networks of Neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1, 2-rasagiline …
  16005. Antihypertensive and Neuroprotective effects of catestatin in spontaneously hypertensive rats: interaction with GABAergic transmission in amygdala and brain stem
  16006. Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation
  16007. iPSC-Derived neural stem cells act via kinase inhibition to exert Neuroprotective effects in spinal muscular atrophy with respiratory distress type 1
  16008. Pretreatment by evodiamine is Neuroprotective in cerebral ischemia: up-regulated pAkt, pGSK3β, down-regulated NF-κB expression, and ameliorated BBB …
  16009. Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injury
  16010. Novel tubulin and tau Neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide)
  16011. Neuroprotective effects of PEP-1-carbonyl reductase 1 against oxidative-stress-induced ischemic neuronal cell damage
  16012. PreImplantation factor (PIF*) promotes embryotrophic and Neuroprotective decidual genes: effect negated by epidermal growth factor
  16013. Neuroprotective effects of the anti‐cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders
  16014. Neuroprotective effect of the 3α5β-pregnanolone glutamate treatment in the model of focal cerebral ischemia in immature rats
  16015. Neuroprotective effects of ginsenoside Rg1 on oxygen-glucose deprivation reperfusion in PC12 cells
  16016. Novel Neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication
  16017. Pharmacological evidence for connection of nitric oxide-mediated pathways in Neuroprotective mechanism of ischemic postconditioning in mice
  16018. Alkaloids from the hook-bearing branch of Uncariarhynchophylla and their Neuroprotective effects against glutamate-induced HT22 cell death
  16019. γ-Synuclein antibodies have Neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway
  16020. Neuroprotective effect of asiatic acid in rat model of focal embolic stroke
  16021. Phenoxybenzamine is Neuroprotective in a rat model of severe traumatic brain injury
  16022. Piperlonguminine is Neuroprotective in experimental rat stroke
  16023. Pharmacologic evidence for role of endothelial nitric oxide synthase in Neuroprotective mechanism of ischemic postconditioning in mice
  16024. Neuroprotective effect of exercise in rat hippocampal slices submitted to in vitro ischemia is promoted by decrease of glutamate release and pro‐apoptotic markers
  16025. Pifithrin-α provides Neuroprotective effects at the level of mitochondria independently of p53 inhibition
  16026. Blood glutamate scavenging as a novel Neuroprotective treatment for paraoxon intoxication
  16027. Resveratrol is Neuroprotective and improves cognition in pentylenetetrazole-kindling model of epilepsy in rats
  16028. Non-hypotensive dose of telmisartan and nimodipine produced synergistic Neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels
  16029. Neuroprotective effect of buyang huanwu decoction on rat ischemic/reperfusion brain damage by promoting migration of neural precursor cells
  16030. Inhibition of cPLA2 has Neuroprotective effects on motoneuron and muscle atrophy following spinal cord injury
  16031. The incretin hormones glucagonlike peptide 1 and glucose‐dependent insulinotropic polypeptide are Neuroprotective in mouse models of Alzheimer’s disease
  16032. Futsch/MAP1B mRNA is a translational target of TDP-43 and is Neuroprotective in a Drosophila model of amyotrophic lateral sclerosis
  16033. An in vitro study of the Neuroprotective effect of propofol on hypoxic hippocampal slice
  16034. Neuroprotective effect of glutamate-substituted analog of gramicidin A is mediated by the uncoupling of mitochondria
  16035. Isolation of the Sapogenin from Defatted Seeds of Camellia oleifera and Its Neuroprotective Effects on Dopaminergic Neurons
  16036. Group III mGlu receptor agonist, ACPT-I, exerts potential Neuroprotective effects in vitro and in vivo
  16037. Attenuated Neuroprotective effect of riboflavin under UV-B irradiation via miR-203/c-Jun signaling pathway in vivo and in vitro
  16038. ITH12410/SC058: A new Neuroprotective compound with potential in the treatment of Alzheimer’s disease
  16039. Neuroprotective and antioxidant effects of Thalassia testudinum extract BM-21, against acrylamide-induced neurotoxicity in mice
  16040. Poly (D, L-lactide-co-glycolide) nanoparticles loaded with cerebrolysin display Neuroprotective activity in a rat model of concussive head injury
  16041. Electroacupuncture-like stimulation at Baihui and Dazhui acupoints exerts Neuroprotective effects through activation of the brain -derived neurotrophic factor …
  16042. Neuroprotective effect of 4-methylcyclopentadecanone on focal cerebral ischemia/reperfusion injury in rats
  16043. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and Neuroprotective …
  16044. Rhythmic oscillations of the microRNA miR-96-5p play a Neuroprotective role by indirectly regulating glutathione levels
  16045. Neuroprotective effects of lipoxin A4 in central nervous system pathologies
  16046. Gastrodia elata Shows Neuroprotective Effects via Activation of PI3K Signaling against Oxidative Glutamate Toxicity in HT22 Cells
  16047. Neuroprotective effects of Psoralea corylifolia Linn seed extracts on mitochondrial dysfunction induced by 3-nitropropionic acid
  16048. The Neuroprotective effect exerted by oligodendroglial progenitors on ischemically impaired hippocampal cells
  16049. Differential Neuroprotective effects of 5′-deoxy-5′-methylthioadenosine
  16050. The Neuroprotective effect of picroside II via regulating the expression of myelin basic protein after cerebral ischemia injury in rats
  16051. Neuroprotective effects of ebselen in traumatic brain injury model: involvement of nitric oxide and p38 mitogen‐activated protein kinase signalling pathway
  16052. Selective androgen receptor modulator RAD140 is Neuroprotective in cultured neurons and kainate-lesioned male rats
  16053. New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective agents against Ischemic Injury
  16054. Role of P2X7 purinoceptors in Neuroprotective mechanism of ischemic postconditioning in mice
  16055. Role of P2X7 purinoceptors in Neuroprotective mechanism of ischemic postconditioning in mice
  16056. Syringaldehyde exerts Neuroprotective effect on cerebral ischemia injury in rats through anti-oxidative and anti-apoptotic properties
  16057. Regular and moderate exercise initiated in middle age prevents age-related amyloidogenesis and preserves synaptic and Neuroprotective signaling in mouse …
  16058. Combination fluconazole/paroxetine treatment is Neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease
  16059. The Neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson’s disease
  16060. Neuroprotective effects of methyl 3, 4-dihydroxybenzoate against H2O2-induced apoptosis in RGC-5 cells
  16061. Isolation and screened Neuroprotective active constituents from the roots and rhizomes of Valeriana amurensis
  16062. Novel analogues of chlormethiazole are Neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABAA receptor …
  16063. D-Arginine as a Neuroprotective amino acid: promising outcomes for neurological diseases
  16064. Assessing antioxidant capacity in brain tissue: methodologies and limitations in Neuroprotective strategies
  16065. Neuroprotective effects of cuscutae semen in a mouse model of Parkinson’s disease
  16066. Equol is Neuroprotective during focal cerebral ischemia and reperfusion that involves p-Src and gp91phox
  16067. Neuroprotective effects of therapeutic hypercapnia on spatial memory and sensorimotor impairment via anti-apoptotic mechanisms after focal cerebral ischemia …
  16068. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein
  16069. Guanosine exerts Neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson’s disease
  16070. Acetylation: a lysine modification with Neuroprotective effects in ischemic retinal degeneration
  16071. Enzyme-treated Asparagus officinalis Extract Shows Neuroprotective Effects and Attenuates cognitive Impairment in Senescence-accelerated Mice
  16072. Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6 …
  16073. Further evidence for the Neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats
  16074. Anti-necroptosis chemical necrostatin-1 can also suppress apoptotic and autophagic pathway to exert Neuroprotective effect in mice intracerebral hemorrhage model
  16075. Neuroprotective effects of dietary supplement Kang-fu-ling against high-power microwave through antioxidant action
  16076. Neuroprotective effects of a novel single compound 1-methoxyoctadecan-1-ol isolated from Uncaria sinensis in primary cortical neurons and a …
  16077. Neuroprotective effect of the fermented Gumiganghwal-tang
  16078. … dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for Neuroprotective drug screening and …
  16079. Curcumin I mediates Neuroprotective effect through attenuation of quinoprotein formation, p‐p38 MAPK expression, and caspase‐3 activation in 6‐hydroxydopamine …
  16080. Neuroprotective effect of curcumin to Aβ of double transgenic mice with Alzheimer’s disease
  16081. Antiepileptic and Neuroprotective effects of human umbilical cord blood mononuclear cells in a pilocarpine-induced epilepsy model
  16082. Urinary metabolites of isorhynchophylline in rats and their Neuroprotective activities in the HT22 cell assay
  16083. Design, Synthesis, and Biological Evaluation of (E)-3,4-Dihydroxystyryl Aralkyl Sulfones and Sulfoxides as Novel Multifunctional Neuroprotective agents
  16084. Transition metal complexes of s-triazine derivative: new class of anticonvulsant, anti-inflammatory, and Neuroprotective agents
  16085. Gypenosides might have Neuroprotective and immunomodulatory effects on optic neuritis
  16086. Neuroprotective effects of total steroid saponins on cerebral ischemia injuries in animal model of focal ischemia/reperfusion
  16087. Antidepressant and Neuroprotective effect of the Chinese herb kaixinsan against lentiviral shRNA knockdown brain -derived neurotrophic factor-induced injury in vitro …
  16088. NMDA receptor-mediated Neuroprotective effect of the Scutellaria baicalensis Georgi extract on the excitotoxic neuronal cell death in primary rat cortical cell …
  16089. Neuroprotective mechanism of ischemic postconditioning in mice: a possible relationship between protein kinase C and nitric oxide pathways
  16090. Neuroprotective peptide–macrocycle conjugates reveal complex structure–activity relationships in their interactions with amyloid β
  16091. Flavonoids isolated from Rumex aquaticus exhibit Neuroprotective and neurorestorative properties by enhancing neurite outgrowth and synaptophysin
  16092. Neuroprotective effect of N-acyl 5-hydroxytryptamines on glutamate-induced cytotoxicity in HT-22 cells
  16093. Critical Neuroprotective roles of heme oxygenase‐1 induction against axonal injury‐induced retinal ganglion cell death
  16094. Neuroprotective efficiency of tetanus toxin C fragment in model of global cerebral ischemia in Mongolian gerbils
  16095. Targeted thrombolysis strategies for Neuroprotective effect
  16096. Nicotine exerts Neuroprotective effects against β-amyloid-induced neurotoxicity in SH-SY5Y cells through the Erk1/2-p38-JNK-dependent signaling pathway
  16097. iTRAQ-based quantitative proteomics study on the Neuroprotective effects of extract of Acanthopanax senticosus harm on SH-SY5Y cells overexpressing A53T mutant …
  16098. Evidence of the innate antiviral and Neuroprotective properties of progranulin
  16099. Neuroprotective effects of oxysophocarpine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion
  16100. Andrographolide, a major component of Andrographis paniculata leaves, has the Neuroprotective effects on glutamate-induced HT22 cell death
  16101. Neuroprotective and anti-apoptotic propensity of Bacopa monniera extract against sodium nitroprusside induced activation of iNOS, heat shock proteins and apoptotic …
  16102. Nanomedicine-based Neuroprotective strategies in patient specific-iPSC and personalized medicine
  16103. Neuroprotective effects of bis (7)-tacrine in a rat model of pressure-induced retinal ischemia
  16104. Comparison of GDF5 and GDNF as Neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures
  16105. Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells
  16106. Synthesis and evaluation of selenoflavones that have potential Neuroprotective effects
  16107. Neuroprotective effect of a formula, moschus combined with borneolum synthcticum, from traditional chinese medicine on ischemia stroke in rats
  16108. Neuroprotective effects of sevoflurane against electromagnetic pulse-induced brain injury through inhibition of neuronal oxidative stress and apoptosis
  16109. Neuroprotective effect of yokukansan against cytotoxicity induced by corticosterone on mouse hippocampal neurons
  16110. Intermittent hypothermia is Neuroprotective in an in vitro model of ischemic stroke
  16111. Neuroprotective effects of bread containing Cirsium setidens or Aster scaber
  16112. An investigation into the ameliorating effect of black soybean extract on learning and memory impairment with assessment of Neuroprotective effects
  16113. Inhibition of the connexin 43 elevation may be involved in the Neuroprotective activity of leptin against brain ischemic injury
  16114. Antihypoxic and Neuroprotective properties of BDNF and GDNF in vitro and in vivo under hypoxic conditions
  16115. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis
  16116. Neuroprotective effect of lovastatin by inhibiting NMDA receptor1 in 6-hydroxydopamine treated PC12 cells
  16117. Neuroprotective effects of hypothermia on synaptic actin cytoskeletal changes induced by perinatal asphyxia
  16118. Involvement of IGF-II receptors in the antioxidant and Neuroprotective effects of IGF-II on adult cortical neuronal cultures
  16119. Histological studies of Neuroprotective effects of Curcuma longa Linn. on neuronal loss induced by dexamethasone treatment in the rat hippocampus
  16120. Hot spots and future directions of research on the Neuroprotective effects of nimodipine
  16121. Neuroprotective effect of Prunus avium on streptozotocin induced neurotoxicity in mice
  16122. Neuroprotective and anti-inflammatory roles of the phosphatase and tensin homolog deleted on chromosome ten (PTEN) inhibition in a mouse model of …
  16123. Neuroprotective glucosides of magnolol and honokiol from microbial-specific glycosylation
  16124. Anti-neutrophil antibody enhances the Neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model
  16125. Neuroprotective effects of amlodipine besylate and benidipine hydrochloride on oxidative stress-injured neural stem cells
  16126. A high content screening approach to identify molecules Neuroprotective for photoreceptor cells
  16127. Neuroprotective effect of ischemic preconditioning in focal cerebral infarction: relationship with upregulation of vascular endothelial growth factor
  16128. Neuroprotective and antioxidant role of Phoenix dactylifera in permanent bilateral common carotid occlusion in rats
  16129. Evaluation of the Neuroprotective activity of stansin 6, a resin glycoside from Ipomoea stans
  16130. Rosiglitazone synergizes the Neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways
  16131. Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist Neuroprotective treatment before ischemic stroke
  16132. Endoplasmic reticulum stress is involved in the Neuroprotective effect of propofol
  16133. Neuroprotective effect of tempol (4 hydroxy-tempo) on neuronal death induced by sciatic nerve transection in neonatal rats
  16134. Neuroprotective Effects of idebenone against pilocarpine-induced seizures: modulation of antioxidant status, DNA damage and Na+, K+-ATPase activity in rat …
  16135. Neurotrophic and Neuroprotective actions of Achyranthes bidentata polypeptides on cultured dorsal root ganglia of rats and on crushed common peroneal nerve of …
  16136. Improved Neuroprotective Effects by Combining Bacopa monnieri and Rosmarinus officinalis Supercritical CO2 Extracts
  16137. Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is Neuroprotective in a rodent model of …
  16138. Neuroprotective effect of heme oxygenase-2 knockout in the blood injection model of intracerebral hemorrhage
  16139. Neuroprotective effect of weak static magnetic fields in primary neuronal cultures
  16140. The voltage‐gated calcium channel blocker lomerizine is Neuroprotective in motor neurons expressing mutant SOD 1, but not TDP‐43
  16141. Membrane permeability-guided identification of Neuroprotective components from Polygonum cuspidatun
  16142. Neuroprotective effects of Fructus Chebulae extracts on experimental models of cerebral ischemia
  16143. The Neuroprotective Effect of Carnosine (β-Alanyl-l-Histidine) on Retinal Ganglion Cell Following Ischemia-Reperfusion Injury
  16144. Chronic Neuroprotective effects of low concentration lithium on SH-SY5Y cells: possible involvement of stress proteins and gene expression
  16145. Camellia sinensis Neuroprotective role in experimentally induced hydrocephalus in Wistar rats
  16146. The neurophysiological and Neuroprotective effects of leptin
  16147. Neuroprotective effect of melatonin against kainic acid-induced oxidative injury in hippocampal slice culture of rats
  16148. Food restriction enhances oxidative status in aging rats with Neuroprotective effects on myenteric neuron populations in the proximal colon
  16149. The Neuroprotective mechanism of erythropoietin-TAT fusion protein against neurodegeneration from ischemic brain injury
  16150. Neuroprotective effects of adipose-derived stem cells are maintained for 3 weeks against ischemic damage in the rabbit spinal cord
  16151. Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain …
  16152. Neuroprotective effect against axonal damage-induced retinal ganglion cell death in apolipoprotein E-deficient mice through the suppression of kainate receptor …
  16153. Comparison of Neuroprotective effects of extract and fractions from Agarum clathratum against experimentally induced transient cerebral ischemic damage
  16154. Neuroprotective effect of steamed and fermented Codonopsis lanceolata
  16155. Preparation of Neuroprotective condensed 1, 4-benzoxazepines by regio-and diastereoselective domino Knoevenagel–[1, 5]-hydride shift cyclization reaction
  16156. ALS-associated peripherin spliced transcripts form distinct protein inclusions that are Neuroprotective against oxidative stress
  16157. Neuroprotective effect of Atractylodes macrocephalaon polysaccharides in vitro on neuronal apoptosis induced by hypoxia
  16158. XAV939, a small molecular inhibitor, provides Neuroprotective effects on oligodentrocytes
  16159. Neuroprotective potentials of neurotrophin rich olfactory ensheathing cell’s conditioned media against 6OHDA-induced oxidative damage
  16160. Neuroprotective effect of panax notoginseng saponins and its main components
  16161. Potent Neuroprotective activity of monoterpene derived 4-[(3aR, 7aS)-1, 3, 3a, 4, 5, 7a-hexahydro-3, 3, 6-trimethylisobenzofuran-1-yl]-2-methoxyphenol in MPTP mice …
  16162. Neuroprotective role of the basic leucine zipper transcription factor NFIL3 in models of amyotrophic lateral sclerosis
  16163. Does progesterone show Neuroprotective effects on traumatic brain injury through increasing phosphorylation of Akt in the hippocampus?
  16164. (2 R, 3 S)-pinobanksin-3-cinnamate, a new flavonone from seeds of Alpinia galanga willd., presents in vitro Neuroprotective effects
  16165. An integrated stroke model with a consistent penumbra for the assessment of Neuroprotective interventions
  16166. Involvement of ERK1/2 pathway in Neuroprotective effects of pyrroloquinoline quinine against rotenone-induced SH-SY5Y cell injury
  16167. OCT evaluation of Neuroprotective effects of tafluprost on retinal injury after intravitreal injection of endothelin-1 in the rat eye
  16168. Pharmacological investigations on possible role of Src kinases in Neuroprotective mechanism of ischemic postconditioning in mice
  16169. Neuroprotective effects of agmatine in experimental peripheral nerve injury in rats: a prospective randomized and placebo-controlled trial
  16170. Neuronal differentiation of rat hair follicle stem cells: the involvement of the Neuroprotective factor Seladin-1 (DHCR24)
  16171. MiR-134 blockade prevents status epilepticus like-activity and is Neuroprotective in cultured hippocampal neurons
  16172. Ceramide metabolism analysis in a model of binge drinking reveals both Neuroprotective and toxic effects of ethanol
  16173. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo
  16174. Neuroprotective –neurotrophic effect of endogenous dehydroepiandrosterone sulfate during intense stress exposure
  16175. Neuroprotective effect of bone marrow stromal cell combination with atorvastatin in rat model of spinal cord injury
  16176. Neuroprotective effects of tramadol on cerebral injuries caused by hind limb ischaemia/reperfusion in rats
  16177. The Neuroprotective effects of grape seed proanthocyanidin on rat brain injury caused by chronic intermittent hypoxia.
  16178. The Neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats
  16179. Neuronal and nonneuronal COX‐2 expression confers neurotoxic and Neuroprotective phenotypes in response to excitotoxin challenge
  16180. Related expressional change of HIF-1α to the Neuroprotective activity of exendin-4 in transient global ischemia
  16181. Neuroprotective effects of Lepidium meyenii (Maca) and macamides against amyloid‐beta (25‐35) induced toxicity in B‐35 neuroblastoma cells (657.13)
  16182. Hepatic branch vagus nerve plays a critical role in the recovery of post-ischemic glucose intolerance and mediates a Neuroprotective effect by hypothalamic …
  16183. Neuroprotective effect of resveratrol on arsenic trioxide–induced oxidative stress in feline brain
  16184. Neuroprotective and nootropic activity of Clitorea ternatea Linn.(Fabaceae) leaves on diabetes induced cognitive decline in experimental animals
  16185. Neuroprotective effects of Jitai tablet, a traditional chinese medicine, on the MPTP-Induced acute model of Parkinson’s disease: involvement of the dopamine …
  16186. Extracranial Hypothermia During Cardiac Arrest and Cardiopulmonary Resuscitation Is Neuroprotective In Vivo
  16187. … by in vivo cerebral oxidative stress: evidence for beneficial effects of SRT1720, a sirtuin 1 activator, and sirtuin 1-mediated Neuroprotective effects of poly …
  16188. Neuroprotective and memory improvement effects of a standardized extract of Emilia coccinea (SIMS) G. on animal models of anxiety and depression
  16189. Tadalafil enhances the Neuroprotective effects of ischemic postconditioning in mice, probably in a nitric oxide associated manner
  16190. Cerebrovascular and Neuroprotective effects of adamantane derivative
  16191. Neuroprotective effects of geniposide in SH-SY5Y cells and primary hippocampal neurons exposed to Aβ42
  16192. Molecular and biochemical aspects of the Neuroprotective effect of the selective estrogen receptor modulator tamoxifen in a model of acute cerebral ischemia
  16193. Neuroprotective effects of GDNF-expressing human amniotic fluid cells
  16194. Comparative Neuroprotective effects of dexamethasone and minocycline during hepatic encephalopathy
  16195. Evolving possible link between PI3K and NO pathways in Neuroprotective mechanism of ischemic postconditioning in mice
  16196. The Neuroprotective effect of 17β-estradiol is independent of its antioxidative properties
  16197. Neuroprotective activity of phytosterols isolated from Artemisia apiacea
  16198. Neuroprotective effect of dimebon against ischemic neuronal damage
  16199. Evaluation of potential topical and systemic Neuroprotective agents for ocular hypertension‐induced retinal ischemia‐reperfusion injury
  16200. Is there a molecular logic that sustains neuronal functional integrity and survival? Lipid signaling is necessary for Neuroprotective neuronal transcriptional programs
  16201. Neuroprotective effect of ethanol extract of leaves of Malva parviflora against amyloid-β-(Aβ-) mediated Alzheimer’s disease
  16202. Depletion of canonical Wnt signaling components has a Neuroprotective effect on midbrain dopaminergic neurons in an MPTP‑induced mouse model of …
  16203. Neuroprotective effect of rotigotine against complex I inhibitors, MPP+ and rotenone, in primary mesencephalic cell culture
  16204. A model in which heat shock protein 90 targets protein-folding clefts: rationale for a new approach to Neuroprotective treatment of protein folding diseases
  16205. Extracellular signal–regulated kinase 1/2 is involved in a tamoxifen Neuroprotective effect in a lateral fluid percussion injury rat model
  16206. Mechanisms of neurotrophic and Neuroprotective effects of cerebrolysin in cerebral ischemia
  16207. N‐Acyl Derivatives of 4‐Phenoxyaniline as Neuroprotective agents
  16208. Neuroprotective properties of ciliary neurotrophic factor on retinoic acid (RA)-predifferentiated SH-SY5Y neuroblastoma cells
  16209. The Neuroprotective effects of α-iso-cubebene on dopaminergic cell death: Involvement of CREB/Nrf2 signaling
  16210. High-dose intravenous immunoglobulin exerts Neuroprotective effect in the rat model of neonatal asphyxia
  16211. Radio-Neuroprotective effect of L-alpha-glycerylphosphorylcholine (GPC) in an experimental rat model
  16212. Repeated febrile convulsions impair hippocampal neurons and cause synaptic damage in immature rats: Neuroprotective effect of fructose-1, 6-diphosphate
  16213. Neuroprotective and cognitive enhancing activity of the fermented Bozhougyiqi-Tang
  16214. Structural insights from GRP78–NF-κB binding interactions: a computational approach to understand a possible Neuroprotective pathway in brain injuries
  16215. Central inflammatory response to experimental stroke is inhibited by a Neuroprotective dose of dietary soy
  16216. Neuroprotective effect of Scutellaria baicalensis flavones against global ischemic model in rats
  16217. Synthesis of pterostilbene and resveratrol carbamate derivatives as potential dual cholinesterase inhibitors and Neuroprotective agents
  16218. Neuroprotective effects of Hu-Yi-Neng, a diet supplement, on SH-SY5Y human neuroblastoma cells
  16219. The Neuroprotective effect of Nepeta menthoides on axotomized dorsal root ganglion sensory neurons in neonate rats
  16220. Neuroprotective effect of rice bran extract supplemented with ferulic acid in the rat model of ischemic brain injury
  16221. Neuroprotective effects of caffeine on a maternally separated Parkinsonian rat model
  16222. Neuroprotective Activity of p DING in Response to HIV‐1 Tat
  16223. Neuroprotective effect of cerebrolysin on diabetic neuropathy: a study on male rats
  16224. The Neuroprotective effect of Sulindac after ischemia-reperfusion injury in rats
  16225. Neuroprotective effects of low level electrical stimulation therapy on retinal degeneration
  16226. The Neuroprotective effect of L-Theanine and its inhibition on nicotine dependence
  16227. Neuroprotective effect of potassium comenate against glutamate toxicity on the model of cultured rat cerebellar neurons.
  16228. Neuroprotective effect of Ascorbic acid and Ginkgo biloba against fluoride caused neurotoxicity
  16229. Liposome‐encapsulated superoxide dismutase mimetic: theranostic potential of an MR detectable and Neuroprotective agent
  16230. Radiation‑induced cytochrome c release and the Neuroprotective effects of the pan-caspase inhibitor z‑VAD‑fmk in the hypoglossal nucleus
  16231. In vitro radical scavenging effect and Neuroprotective activity from oxidative stress of Petasites japonicus
  16232. Neuroprotective effects of oral ellagic acid on locomotor activity and anxiety-induced by ischemia/hypoperfusion in rat
  16233. The Neuroprotective potential of retinal Müller glial cells
  16234. Inflammatory cytokine tumor necrosis factor α suppresses Neuroprotective endogenous erythropoietin from astrocytes mediated by hypoxia‐inducible factor‐2α
  16235. Synthesis and structural analysis of novel Neuroprotective pentacyclo [5.4. 1.0 2, 6. 0 3, 10. 0 5, 9] undecane-and adamantane-derived propargylamines
  16236. Neuroprotective effects of erythropoietin in focal brain ischemia in rats
  16237. Neuroprotective role of BNIP3 under oxidative stress through autophagy in neuroblastoma cells
  16238. Preliminary histological and histochemical studies on the Neuroprotective effect of aqueous fruit extract of phoenix dactylifera L.(Date Palm) on atesunate …
  16239. Neuroprotective effects of 4, 5-dimethoxypyrocatechol isolated from Cynanchum paniculatum on HT22 cells
  16240. Valproic acid in normal therapeutic concentration has no Neuroprotective or differentiation influencing effects on long term expanded murine neural stem cells
  16241. Dibenzo [1, 4, 5] thiadiazepine: a hardly-known heterocyclic system with Neuroprotective properties of potential usefulness in the treatment of neurodegenerative …
  16242. The comparison between hot-water extracts and microwave extracts of Scutellaria Radix for antioxidant and Neuroprotective effects
  16243. Stereoselective Reduction of 1‐O‐Isopropyloxygenipin Enhances Its Neuroprotective Activity in Neuronal Cells from Apoptosis Induced by Sodium Nitroprusside
  16244. Neuroprotective mechanism of BNG-1 against focal cerebral ischemia: a neuroimaging and neurotrophin study
  16245. Neuroprotective effect of epidural hypothermia after spinal cord lesion in rats
  16246. Autophagy occurs within an hour of adenosine triphosphate treatment after nerve cell damage: the Neuroprotective effects of adenosine triphosphate against …
  16247. Neuroprotective effect of guggulipid alone and in combination with aspirin on middle cerebral artery occlusion (MCAO) model of focal cerebral ischemia in rats
  16248. Neuroprotective effects of Gua Lou Gui Zhi decoction against glutamate-induced apoptosis in BV-2 cells
  16249. Neuroprotective effect of erythropoietin against pressure ulcer in a mouse model of small fiber neuropathy
  16250. Neuroprotective Effects of the MAO‐B Inhibitor, PF9601N, in an In Vivo Model of Excitotoxicity
  16251. Neuroprotective effect of the traditional Chinese herbal formula Tongxinluo: a PET imaging study in rats
  16252. Neuroprotective effect of 1-methoxyoctadecan-1-ol from Uncaria sinensis on glutamate-induced hippocampal neuronal cell death
  16253. Neuroprotective effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDAR1 immunodensity in the prefrontal cortex, striatum and hippocampus of …
  16254. Neuroprotective treatment with FK506 reduces hippocampal damage and prevents learning and memory deficits after transient global ischemia in rat
  16255. Neuroprotective effect of the proanthocyanidin‐rich fraction in experimental model of spinal cord injury
  16256. Neuroprotective effects of C3 exoenzyme in excitotoxic retinopathy
  16257. Chemical profile of the active fraction of Yi-Gan San by HPLC-DAD-Q-TOF-MS and its Neuroprotective effect against glutamate-induced cytotoxicity
  16258. Neuroprotective Effects of Hyangsayangwi-tang in MPTP-induced Mouse Model of Parkinson’s Disease
  16259. Progesterone as a potential Neuroprotective treatment in the retina
  16260. Synthesis of new lipoic acid conjugates and evaluation of their free radical scavenging and Neuroprotective activities
  16261. Relationship with spatial memory in diabetic rats and protein kinase Cγ, caveolin-1 in the hippocampus and Neuroprotective effect of catalpol
  16262. Free radical scavenging activity and Neuroprotective potentials of D138, one Cu (II)/Zn (II) Schiff-base complex derived from N, N′-bis (2-hydroxynaphthylmethylidene …
  16263. In contrast to its anti-inflammatory and anti-apoptotic peripheral effect, levosimendan failed to induce a long-term Neuroprotective effect in a rat model of mild septic …
  16264. Synergistic Neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke‐prone spontaneously hypertensive rats
  16265. New antioxidants as Neuroprotective agents for the treatment of ischemic brain injury and neurodegenerative diseases
  16266. Neuroprotective effect of ethanolic extract of mimosa pudica in D-galactose induced Alzheimer’s model.
  16267. Promising Neuroprotective effects of the angiotensin-(1-7)-angiotensin-converting enzyme 2-Mas axis in stroke.
  16268. The role of VEGF, HSP-70 and protein S-100B in the potentiation effect of the Neuroprotective effect of hypercapnic hypoxia
  16269. Neuroprotective efficacy of a combination of fish oil and ferulic acid against 3-nitropropionic acid-induced oxidative stress and neurotoxicity in rats: behavioural and …
  16270. Neurotoxicity and Neuroprotective effects of African medicinal plants
  16271. Xenon as a Neuroprotective treatment in neonatal encephalopathy
  16272. The Neuroprotective effect of total coumarine of Angelica pubescentis on APP/PS1 double transgenic AD model mouse
  16273. Studying the Neuroprotective effect of the novel glutamic acid derivative neiroglutam on focal cerebral ischemia in rats
  16274. Neuroprotective Action of Deer Bone Extract Against Glutamate or Aβ1–42-Induced Oxidative Stress in Mouse Hippocampal Cells
  16275. Neuroprotective Strategies–What Do We Really Need to Know?
  16276. Antioxidant and Neuroprotective effect of organic and conventional white grape juices on oxidative stress induced by sodium azide in cerebral cortex of rats
  16277. Effect of nonionic surfactants and HPMC F4M on the development of formulations of Neuro-EPO as a Neuroprotective agent
  16278. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl) piperazin-1-yl) butyl) benzo [d] oxazol-2 (3H)-one (SN79), a sigma receptor ligand, mitigates …
  16279. Promising Neuroprotective Effects of the Angiotensin 1-7/ACE2/Mas axis in Stroke
  16280. Neuroprotective role of liver growth factor “LGF” in an experimental model of cerebellar ataxia
  16281. Evaluation of the Neuroprotective effects of trabodenoson in a model of acute ocular hypertension
  16282. Neuroprotective effects of soybean oligopeptides (SOPs) against H2O2-induced oxidative stress in PC12 cells
  16283. Neuroprotective effects of the extracts from the aerial parts of Carthamus tinctorius L. on transient cerebral global ischemia in rats
  16284. Neuroprotective effects of ethanol extract of Ganoderma lucidum L. on murine hippocampal cells
  16285. Neuroprotective effects of neuregulin-1 ss on oligodendrocyte type 2 astrocyte progenitors following oxygen and glucose deprivation
  16286. Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are Neuroprotective during optic neuritis in a mouse model of multiple sclerosis
  16287. WITHDRAWN: Multimechanistic Neuroprotective effect of vitamin E against deltamethrin induced brain toxicity
  16288. Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: relevance to neuropathy
  16289. Neuroprotective effect of neuroglutam under conditions of activated free radical oxidation
  16290. Posterior quadrantic disconnection maintains the activity of isolated temporal-parietal-occipital nerve tissue: Neuroprotective measures in the surgical …
  16291. Neuroprotective potential of Withania somnifera in cerebral ischemia
  16292. An impact of Neuroprotective therapy on blood rheological and morphodensitometric parameters in patients with chronic cerebral ischemia
  16293. Comparison of the Neuroprotective effects of a novel bispyridinium oxime KR-22934 with the oxime K203 and obidoxime in tabun-poisoned male rats
  16294. The Neuroprotective effect and probable mechanism of dl-3-n-butylphthalide in brain diseases
  16295. Lignans from Saururus chinen sis with Antiplatelet Aggregation and Neuroprotective Activities
  16296. Neuroprotective effects of Eriobotrya japonica and Salvia miltiorrhiza Bunge in in vitro and in vivo models
  16297. Neuroprotective effect of Acorus Calamus on a rat model of parkinson’s disease induced by 6-hydroxydopamine
  16298. Novel Neuroprotective Formulations Based on St. John’s Wort Extract
  16299. Neuroprotective effect of coenzyme Q10 in chronic constriction injury-induced neuropathic pain in rat
  16300. Neuroprotective effect of RYGB in Zucker fatty diabetic rats
  16301. Neuroprotective evaluation of ethanolic leaf extract of Dalbergia sissoo in monosodium glutamate induced neurotoxicity in rats.
  16302. Neuroprotective Activity of Stachytrapheta indica on Rotenone induced Parkinson’s disease in Zebra fish‖
  16303. Neuroprotective and Free Radicals Scavenging Potentials of Some Common Leafy Vegetables Consumed in South-Eastern Nigeria
  16304. When should Neuroprotective drugs move from mice to men?
  16305. A new flavonone from seeds of Alpinia katsumadai and its Neuroprotective effect on PC12 cells.
  16306. Neuroprotective effect of Dracocephalum moldavica L. total flavonoids in transient cerebral ischemia in rats
  16307. Neuroprotective effects of exercise with hydroalcoholic extraction of Eriobotrya japonica on MANF in the brain stem of parkinson’s rats
  16308. Advance in studies on Neuroprotective mechanism of Uncariae Ramulus Cum Uncis
  16309. Simultaneous determination of four Neuroprotective compounds of Tilia amurensis by high performance liquid chromatography coupled with diode array …
  16310. An assessment of the in vitro Neuroprotective properties of selected Algerian and South African medicinal plant extracts
  16311. Neuroprotective effect of ginsenoside Rg1 against spinal cord ischemia and reperfusion injury in rats
  16312. Study on Neuroprotective capacity of key flavonoids of ampelopsis grossedentata
  16313. The active Neuroprotective therapy of acute carotid ischemic stroke of moderate severity
  16314. Neuroprotective mechanism of ethanolic extract of Irvingia gabonensis stem bark against cadmium-induced neurotoxicity in rats
  16315. Sodium-glucose transporter type 3-mediated Neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage
  16316. Investigating the Neuroprotective Effect of Alcholic Extracts of Achillea Biebersteinii Leave on α Motoneurons after Sciatic Nerve Compression in Rats
  16317. Combining Prehospital Neuroprotective Therapy With Post-Hospital Arrival Recanalization Therapies: The FAST-MAG Experience
  16318. Minocycline as a Neuroprotective agent in a rodent model of NAION
  16319. Sulindac for stroke treatment: Neuroprotective mechanism and therapy
  16320. A comparative study of Neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat
  16321. Peptides analogous to tethered ligands liberated by activated protein C exert Neuroprotective effects in glutamate-induced excitotoxicity
  16322. Neuroprotective activity of Crataeva nurvula Buch-Ham stem bark against Scopolamineinduced cognitive impairment via antioxidative activites in rats
  16323. Glaucoma: role of Neuroprotective agents
  16324. Prostacyclin mediates endothelial COX-2-dependent Neuroprotective effects during excitotoxic brain injury
  16325. Flavonoid-glycosides from Rumex aquaticus with Neuroprotective activity
  16326. … rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion: Effect of Neuroprotective …
  16327. In vitro Neuroprotective effect of Valeriana wallichii extract against neurotoxin and endoplasmic reticulum stress induced cell death in SH-SY5Y cells
  16328. Studying in vitro Neuroprotective properties of GK-2 (h)–a new original mimetic of human nerve growth factor
  16329. The Neuroprotective effect of caffeic acid phenethyl ester on global ischemia-reperfusion injury in rat brain s
  16330. A diet containing specific anti-inflammatory and Neuroprotective ingredients ameliorates behavioural and serotonergic deficits in a murine model of autism …
  16331. The results of Semax Neuroprotective efficacy investigation
  16332. Comparative Neuroprotective potentials of the extracts of Talinum triangulare against nitroprusside-induced damages in albino rats
  16333. The Neuroprotective effects of fluoxetine on rat hippocampus, after chronic and acute 5‐fluorouracil treatment (1143.6)
  16334. Neuroprotective EFFECT OF CASSIA OCCIDENTALIS AGAINST 3-NITROPROPIONIC ACID-INDUCED NEUROTOXICITY IN RATS
  16335. The option of Neuroprotective therapeutics for glaucoma
  16336. Neuroprotective effects of melatonin and calpeptin in a rat model
  16337. Peptide drugs that have been developed to treat type 2 diabetes show Neuroprotective effects
  16338. The Neuroprotective benefits of central adenosine receptor stimulation in a soman nerve agent rat model
  16339. Corrigendum to” Rapid eye movement sleep behavior disorder: Devising controlled active treatment studies for symptomatic and Neuroprotective therapy-a consensus …
  16340. Neuroprotective effect of ethyl pyruvate in vincristine and cisplatin induced neuropathic pain
  16341. Assessment of Neuroprotective effects of gamma-hydroxybutyrate and neurosteroids on cellular models of Alzheimer’s disease
  16342. Antioxidant and Neuroprotective potential of two halophytes from the Algarve coast
  16343. Neuroprotective treatment of chronic cerebrovascular insufficiency
  16344. Differential Neuroprotective Effects of 5
  16345. Neuroprotective Material Base of Yigan San
  16346. Neuroprotective effects of intravitreal triamcinolone acetonide and dexamethasone implant in rabbit retinas after pars plana vitrectomy and silicone oil injection
  16347. Neuroprotective effect of methanolic extract of Passiflora nepalensis against oxidative stress in middle cerebral artery occlusion model of stroke in rats
  16348. Neuroprotective effect of estradiol-loaded poly (lactic-co-glycolic acid) nanoparticles on glutamate-induced excitotoxic neuronal death
  16349. Neuroprotective effects of α-lipoic acid on the development of oxidative stress and astrogliosis in the brain of STZ-diabetic rats
  16350. Neuroprotective effects of anthocyanidins on astrocytes and apoptosis induced by oxidative damage
  16351. Antioxidant activity of dorzolamide/timolol fixed combination in Neuroprotective therapy in glaucoma
  16352. Potential Neuroprotective effects of Blueberry and Lingonberry fruits and Leaves
  16353. Trial to assess the efficacy of Neuroprotective drugs administered topically to prevent or arrest diabetic retinopathy (EUROCONDOR)
  16354. Neuroprotective effect of melatonin and omega-3 on the hippocampus of rat that prenatally exposed to 900 mhz electromagnetic fields
  16355. Neuroprotective role of glutathione against hydrogen peroxide induced toxicity to the neuronal cells in culture
  16356. Will statin therapy improve the outcome after ischaemic stroke through Neuroprotective effects?
  16357. Neuroprotective effects of mas-receptor ligands in an experimental rat glaucoma
  16358. Neuroprotective Effect of Prophylactic Intrathecal Methylprednisolone in Spinal Cord Injury in Rat Model
  16359. Study into molecular targets of a Neuroprotective compound dimebon using a transgenic mice line
  16360. Neuroprotective effects of hydrogen sulfide in rats with acute cauda equina syndrome
  16361. Exploration of Neuroprotective mechanism of opposing needling on the ischemia-reperfusion injured rats
  16362. Baicalein exerts Neuroprotective effects in 6‐hydroxydopamine induced experimental Parkisonism (LB625)
  16363. Comparative study on Neuroprotective effect of dry and fresh Panax ginseng against the damage in PC12 cells
  16364. Neuroprotective Effects of a Variety of Pomegranate Juice Extracts (PJE) Against the Excitotoxin Quinolinic Acid in Human Primary Neurons.
  16365. Neuroprotective effect of epigallocatechin gallate in an experimental model of Parkinson’s disease induced by 6-hydroxydopamine
  16366. ACRYLONITRILE-INDUCED MITOCHONDRIAL DYSFUNCTION: Neuroprotective ROLE OF ALA VIA ENHANCEMENT OF OXIDATIVE STRESS IN RATS.
  16367. T2-weighted Magnetic Resonance Imaging Accurately shows Treatment Response of Novel Neuroprotective Compound, Tat-N-dimer, in Ischemic Stroke
  16368. Analysis of Neuroprotective effects of polyprenols in a rat model of posttraumatic stress disorder
  16369. Neuroprotective effects and its mechanism of Qizhen on retinal ganglion cells in rat optic nerve crush model
  16370. The Neuroprotective protein Stanniocalcin-1 (STC-1) has ocular hypotensive properties in the human anterior segment organ culture model
  16371. Neuroprotective effects of resveratrol on 6-hydroxydopamine-induced damage of SH-SY5Y cell line
  16372. Neuroprotective effects of the effective components group of xiaoshuantongluo against oxygen-glucose deprivation in primary cultured rat cortical neurons
  16373. Neuroprotective Effect of an Α-7 Nicotinic Acetylcholine Receptor Agonist and a Positive Allosteric Modulator in an In Vitro Model of Glaucoma
  16374. Anti‐aging and Neuroprotective effects of Jambolan (Eugenia jambolana) L. via modulation of stress response signaling in C. elegans (829.26)
  16375. Current research of Neuroprotective effect of chitosan
  16376. Neuroprotective , Anti-Inflammatory and Immune Tolerizing Properties of Peptides Derived from Diffusion Survival Evasion Protein (DSEP)/Dermcidin.(P1. 175)
  16377. Genome Wide Association Study of Early Neurological Deterioration after Acute Ischemic Stroke Defines the Interferon-Stimulated Gene IFIT1 as a Neuroprotective …
  16378. Neuroprotective effects of Apigenin in Human Neuroblastoma SH-SY5Y cells Against Rotenone toxicity: a pilot study.
  16379. Neuroprotective Drug Gives a Nod to NAD
  16380. Neuroprotective effects of Asiaticoside
  16381. Neuroprotective Effects of Lycium Barbarum Polysaccharides
  16382. Nrf2/ARE/HO-1 signaling pathway is a new Neuroprotective target for Parkinson’s disease
  16383. Results of the search of substances with Neuroprotective action among the new derivatives of baclophen
  16384. 16 Melatonin’s Neuroprotective
  16385. Evaluating progesterone as a novel Neuroprotective drug after ocular injury
  16386. Synthesis and biological evaluation of XB-1 analogues as novel histamine H 3 receptor antagonists and Neuroprotective agents
  16387. Gene Therapy Using Neuroprotective Factors in Glaucoma
  16388. The current strategy was the use of Neuroprotective protein diet purposes
  16389. Effects of topically administered Neuroprotective drugs in early stages of diabetic
  16390. The Neuroprotective effect of electrical stimulation in chronic epilepsy
  16391. Neuroprotective mechanisms of resveratrol in cerebral ischemia
  16392. Antioxidant, Cytoprotective and Neuroprotective Properties of Wild Partridgeberry of Southern Labrador
  16393. New in Neuroprotective therapy for children with aseptic meningitis.
  16394. Neuroprotective effect of citicoline on ischemic stroke
  16395. Neuroprotective Effects of IGF-1 on Retinal Ganglion Cell Survival
  16396. P57: The Neuroprotective Effect of Periodic Fasting on the brain Damages
  16397. NDD-01. Animal models to Parkinson’s disease study and Neuroprotective strategies
  16398. Neuroprotective Strategies for Transient Focal Cerebral Ischemia-An Experimental Model
  16399. Mechanisms of Action of Pramipexole: Putative Neuroprotective Effects
  16400. Neuroprotective roles of the P2Y2 nucleotide receptor
  16401. Effect of some Neuroprotective drugs on certain biochemical parameters during experimental brain ischaemia.
  16402. Neuroprotective Effect of Vitamin E in a KainateInduced Rat Model of Temporal Lobe Epilepsy
  16403. Study of Possible Neuroprotective Effects of Certain Drugs on Experimentally Induced Parkinson’s Disease in Rats
  16404. Erratum to: Neuroprotective role of taurine during aging
  16405. Neuroprotective Effect of H88 in OGD Model in SH-SY5Y Cells and MCAO Model in Rats for Ischemic Stroke
  16406. Neuroprotective effect of flavonoid components extracted from Violet on oxidative stress-induced RGC death
  16407. The Neuroprotective role of Nrf2 in ischemia-reperfusion mouse model
  16408. Evaluation of antioxidant and Neuroprotective therapies in a mouse model of amyotrophic lateral sclerosis
  16409. Mechanism of cerebral ischemia tolerance and Neuroprotective effect of estrogen via the mechanism
  16410. Neuroprotective Effects of Natural Compounds against Dopamine Toxicity
  16411. Antioxidant Activity, Cellular Bioavailability, and Iron and Calcium Management of Neuroprotective and NonNeuroprotective Flavones
  16412. Investigations into the Neuroprotective Effects of Osteopontin in In Vitro and In Vivo
  16413. THE Neuroprotective ROLE OF ACUPUNCTURE AND brain -DERIVED NEUROTROPHIC FACTOR SIGNAL PATHWAY
  16414. Neuroprotective mechanism of erythropoietin on neonatal brain injury
  16415. The Neuroprotective and anti-amnestic effects of derivatives of erythropoietin in experimental ischemic injury of the cerebral cortex
  16416. AB35. Future potential of the Neuroprotective agent (local application) for the nerve injury in radical prostatectomy
  16417. Conference Report: 12th International Congress on Neuroprotective agents (ICNA), Charlottesville, VA, USA September 28, 2014-Ocobert 01, 2014
  16418. Neuroprotective Effects of 1-(4-hydroxy-3-methoxyphenyl)-4-decen-3-one by Regulating Proinflammatory Cytokines in vitro and in vivo
  16419. Neuroprotective properties of sigma-1 receptor in glaucoma
  16420. Neuronal differentiation and Neuroprotective properties of mesenchymal stem cells
  16421. Neuroprotective effect of green tea polyphenols in cerebral ischemia
  16422. Effects of vagus nerve stimulation on Neuroprotective mechanism of cerebral ischemia in rats
  16423. Investigating the Neuroprotective effects of histone deacetylase inhibitors in Parkinson’s Disease
  16424. Synthetic Investigations towards the Total Synthesis of Neuroprotective Natural Products
  16425. Hydroquinone shows Neuroprotective potential in rodent ischemic stroke model
  16426. Advances in research of filament middle cerebral artery occlusion model and Neuroprotective agents
  16427. Neuroprotective EFFECT OF MEDICINAL HERBS ON CEREBRAL ISCHEMIA IN MALE WISTAR RATS
  16428. Neuroprotective effects of Co-ultraPEALut on inflammatory process induced by traumatic brain injury
  16429. Granulocyte Colony-Stimulating Factor-Mediated Neuroprotective Therapy for Spinal Cord Injury
  16430. Neuroprotective effects of two creatine salts in brain hippocampal slices
  16431. Abstract T MP52: Treatment Times are Reduced by Prehospital Initiation of Neuroprotective Stroke Therapy
  16432. Neuroprotective Effect of Doenjang Supplemented with Various Garlic Products
  16433. Phr1 disruption is Neuroprotective for retinal ganglion cells in a mouse glaucoma model
  16434. COMP-Ang1 has retinal Neuroprotective properties after hypoxic and vascular insults
  16435. Correction: Inhibition of Let7c MicroRNA Is Neuroprotective in a Rat Intracerebral Hemorrhage Model
  16436. Preischemic Neuroprotective Effect of Minocycline and Sodium Ozagrel on Transient Cerebral Ischemic Rat Model
  16437. Neuroprotective Targets of Delta Opioid-Receptor in Glaucoma
  16438. Delivery of a Neuroprotective cell-penetrating Hsp70
  16439. Antenatal Magnesium Sulfate for Neuroprotective Effects In Preterm Infants
  16440. The Neuroprotective Effect of Treatment with Curcumin in Acute Spinal Cord Injury
  16441. Phosphorylation of α-crystallins: regulation of Neuroprotective properties and chaperone function
  16442. Neuroprotective effect of Coenzyme Q10 in hippocampal injury in Balb/c mouse
  16443. 0356. Effect of the Neuroprotective p53-inhibitor pifithrin-µ in a rodent cardiac arrest model
  16444. Evidence suggests that steric acid possesses a Neuroprotective role in a Caenorhabditis elegans Parkinson’s Model.
  16445. Neuroprotective and Antioxidant Effects of a PPAR-alpha Agonist in Diabetic Retinopathy
  16446. Neuroprotective Effects of Palm vitamin E Tocotrienols
  16447. Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson’s
  16448. Neuroprotective effect of escitalopram oxalate on cerebral ischemia reperfusion injury in rats
  16449. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer’s disease
  16450. Neuroprotective Bioactivity of NPD1 and Dendrimer-NPD1 in the S334-ter-5 model of Retinitis Pigmentosa
  16451. Putative Neuroprotective role of visfatin against cognitive dysfunction in obese patients
  16452. Fingolimod promotes Neuroprotective effects of astrocytes
  16453. The study of Neuroprotective and anti-inflammatory effects of magnesium sulfate in rats following cerebral ischemia reperfusion injury
  16454. Neuroprotective EFFECT OF SELECTED PLANTS AND THEIR FORMULATION AGAINST INDUCED NEURODEGENERATION
  16455. Abstract W MP48: Post-stroke Administration of Exogenous Inter-alpha Inhibitor Proteins is Neuroprotective .
  16456. The role of megalin in the Neuroprotective properties of Transthyretin
  16457. Neuroprotective Effect of Sevoflurane on Controlled Hypotension in Patients with Coronary Heart Disease Undergoing Craniocerebral Surgery
  16458. Lithium, as a Neuroprotective therapy for Alzheimer’s disease pathology, modifies abeta plaque toxicity
  16459. Neuroprotective effects of cheonggukjang prepared with B. amyloliquefaciens MJ1‐4 and Bacillus sp EMD17 (629.12)
  16460. Neuroprotective effects of human mesenchymal stem cell transplantation into the cistern magna of a parkinsonian animal model
  16461. Soluble Fas ligand is a Neuroprotective molecule critical in restricting glaucomatous damage to retinal ganglion cells
  16462. Neuroprotective role of 17B-estradiol administration on altered age related neuronal parameters in female rats
  16463. Suppression of microglial activation is Neuroprotective in a mouse model of human retinitis pigmentosa
  16464. Neuronal differentiation and Neuroprotective properties of mesenchymal stem cells: summary of doctoral thesis: biomedical sciences, biophysics (02B)
  16465. The Neuroprotective Effects of Paeoniflorin on Multi-infarct Dementia (MID) Model
  16466. Studies on the Chemical Modulation of Neuroprotective agents Related to CR-6 Addressed to Improve the Delivery through the Blood-brain Barrier
  16467. Neuroprotective effect of mesenchymal stromal cells in a 3D model of Parkinson’s disease
  16468. Neuroprotective effects of Hu-Yi-Neng, a diet supplement, on SH-SY5Y human neuroblastoma cells?
  16469. The Neuroprotective effect of Bax-inhibiting peptide on neonatal rats with hypoxic-ischemic brain damage
  16470. Recombinant human proteins: delivery of a Neuroprotective cell-penetrating Hsp70
  16471. Histone deacetylase inhibitors as novel Neuroprotective agents in in vitro and in vivo models of Parkinson’s disease
  16472. Systemic rAAV Delivery of Modified Erythropoietin is Neuroprotective in a Mouse Model of Induced Ocular Hypertension
  16473. A study on Neuroprotective effects of methyl lucidone on glutamate-induced neuronal cell death in HT-22 neurons
  16474. A role for the neuropeptide galanin in the Neuroprotective and neuromodulatory effects of physical activity
  16475. Neuroprotective Effects of the Standardized Extract of Betula platyphylla Barks
  16476. Neuroprotective Therapy Using Granulocyte Colony-Stimulating Factor for Acute Spinal Cord Injury: A Multicenter Prospective Controlled Clinical Trial
  16477. Neuroprotective Effect of Madecassoside Evaluated Using Amyloid β1-42-Mediated in Vitro and in Vivo Alzheimer’s Disease Models
  16478. Neuroprotective Effect of Steamed and Fermented Codonopsis lanceolata
  16479. Is High-Fat High-Carbohydrate Diet (HFCD) Neuroprotective ? A Magnetic Resonance Imaging Study in Wistar Rats.
  16480. Neuroprotective Effect of a Human Serum Albumin Nanoparticle on Retinal Ganglion Cells in the Glaucoma Animal Model
  16481. Abstract T P217: Neuroprotective Effects of Cilostazol through the Multi-mechanisms in Mice Permanent Focal Ischemia
  16482. Validation of Neuroprotective effect of blackberries digested metabolites in a model of neurodegeneration based on mice neurons primary culture
  16483. Neuroprotective Effects of Lyicium Barbarum (Wolfberry) on Retinas after Partial Optic Nerve Transection
  16484. Neuroprotective Effect of JGK-263 in Transgenic SOD1-G93A Mice Model of Amyotrophic Lateral Sclerosis
  16485. Neuroprotective and regenerative effect of taurine-conjugated urosodeoxycholic acid in rat retinas exposed to high glucose
  16486. Anti-murine CD52 therapy provides anti-inflammatory and Neuroprotective effects in an EAE mouse model (THER3P. 888)
  16487. Neuroprotective Effects of Morin on MPTP-Induced Parkinson’s Disease Model
  16488. P35: Neuroprotective Effect of Noscapine on Cerebral Oxygen-Glucose Deprivation Injury
  16489. Electrophysiological investigation of the mechanism of action of xenon on ion-channels and determination of the Neuroprotective potential of xenon in an in vivo model …
  16490. The Neuroprotective Effects of the Novel Thiol Antioxidant, N-acetylcysteineamide (NACA), on SH-SY5Y Neuroblastoma Cells
  16491. Neuroprotective effects of nitrite-derived NO in brain injury is via NOS-independent but GC-dependent pathway: 7AP1-5
  16492. Neuroprotective Effect of Mesenchymal Stem Cell by Modulation of Complement Activation in Cerebral Ischemia
  16493. Neuroprotective effect of estrogen on hypoglycemic injury in hypothalamic mouse cells (767.6)
  16494. A in vivo Study on the Neuroprotective Effects of Rapamycin Against Neurotoxic Aβ in Rats
  16495. P76: The Neuroprotective Roles of NMDA Receptors Antagonist Against with Lesion in Central Nucleus of Amygdala
  16496. Neuroprotective effect of a traditional Korean herbal formula via autophagy induction in models of Parkinson’s disease
  16497. The Role of Autophagy in Neuroprotective Effect of Baicalein on MPP+-induced Neurotoxicity
  16498. Preventive, personalized medicine at the level of key regulatory proteins: updates on activity-dependent Neuroprotective protein (ADNP) as a case study
  16499. MICAL—methionine sulfoxide reductase couple: a new target for the development of Neuroprotective strategies
  16500. Neuroprotective effects of hypothermia and levetiracetam after hypoxia-ischemia in the neonatal mouse brain
  16501. Testing direct Neuroprotective effects of current MS therapeutic compounds with intravital two photon laser scanning microscopy
  16502. THE Neuroprotective EFFECTS ON RETINAL STRUCTURE BY MINOCYCLINE IN A RAT MODEL OF HIGH IOP INDUCED RETINAL ISCHEMIA INJURY
  16503. Neuroprotective mechanisms of the Rheb/mTORC1 signaling pathway in the adult dopaminergic system in vivo
  16504. PO-0483d No Neuroprotective Effects Of Cannabidiol After Severe Hypoxia-ischemia In Newborn Piglets
  16505. Neuroprotective effects of siRNA, targeting Caspase9 on rat retinal damage induced by different time course of transient ischemic injury.
  16506. Changes in collateral blood flow and Neuroprotective efficacy of transient aortic occlusion during acute ischemic stroke
  16507. Neuroprotective Properties of Partridgeberry (Vaccinium vitis-idaea L. var. minus Lodd) Polyphenols
  16508. Neuroprotective effects of agmatine ın experimental peripheral nerve ınjury ın rats: a prospective randomized and placebo-controlled trial
  16509. Antiepileptic and Neuroprotective effects of human umbilical cord blood mononuclear cells in a pilocarpine-induced epilepsy model
  16510. Influence of the Neuroprotective drug memantine on organ-cultured diabetic or Alzheimer’s disease retina
  16511. Neuroprotective effects of minocycline on retinal ganglion cells in early stage of optic nerve crush injury
  16512. Role of lysophosphatidic acid in traumatic brain injury: anti‐LPA antibodies are Neuroprotective after experimental TBI (999.3)
  16513. Molecular characterization of Neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
  16514. Neuroprotective effects of rosmarinic acid in the MPTP mouse model of Parkinson’s disease
  16515. Neuroprotective Strategies in Amyotrophic Lateral Sclerosis: Modulation of Neurotransmittory and Neurotrophic Input to Motor Neurons
  16516. Exploring the astrocytic Neuroprotective functions in a chronic mild stredd model of depression
  16517. … -induced Wernicke s encephalopathy modifies crucial rat brain parameters: the importance of Na+, K+-ATPase and a potentially Neuroprotective role for antioxidant …
  16518. Investigating the Neuroprotective effect of citalopram in a MDMA-lesioned rat model using 4-[18F]-ADAM/micro-PET
  16519. P55: Neuroprotective and Neurogenesis Effects of Curcumin in the Adult Rat brain Following Transient Global Ischemia
  16520. The Neuroprotective effect of caffeic acid phenethyl ester on global ischemia-reperfusion injury in rat brain s [Rat beyinlerinde global iskemi-reperfüzyon hasarı üzerine …
  16521. The Neuroprotective effects of baicalin on ethanol-induced impairment via anti-oxidative and anti-apoptotic pathway
  16522. Neuroprotective role of vitamin E, green tea extract, and spirulina in rats treated with cadmium chloride
  16523. In vitro Neuroprotective Effect of Crude Extract of Agrimonia pilosa in Hypoxia-induced Mouse Neuronal Cells
  16524. Neuroprotective effect of peanut sprout extract and its solvent soluble fractions on glutathione‐depleted neuronal HT22 cells (629.11)
  16525. Microfluidic testing of the Neuroprotective effect of mesenchymal stromal cells using a 3D model of Parkinson’s disease
  16526. CCL5 activates a orphan G-protein coupled receptor 75 Neuroprotective effect of CCL5 via the G-protein coupled receptor 75 (GPR75) activation. 20th Meeting of …
  16527. Neuroprotective effect of minocycline on mouse retinal ganglion cells in the early stage after optic nerve crush
  16528. Neuroprotective Effect of SK95, a Proteasome Activator, against MPP+-Induced Cell Death
  16529. Prolonged NMDA Stimulation Induces Neuroprotective Pathways and Enhances Survivability of Primary Retinal Ganglion Cells
  16530. Neuroprotective effect of KUS121, a VCP modulator, on a rat model of ischemia and reperfusion-induced retinal degeneration.
  16531. Development of a Novel Neuroprotective Strategy: Synergistic Treatment With Hypothermia and Valproic Acid Improves Survival in Hypoxic Hippocampal Cells
  16532. Study the Neuroprotective effect of tyrosol in an experimental model of huntington’s disease as a subsidy for the development of new medicines
  16533. Mechanisms of Vitamin K Defense against Oxidative Glutamate Toxicity and the Design of Novel Neuroprotective agents
  16534. Exploring the Neuroprotective mechanism of poly-ICLC preconditioning against oxygen glucose deprivation in the in vitro blood-brain barrier model
  16535. Incorporation of Neuroprotective extracts from Hypericum perforatum in yoghurt: Interactions and stability throughout storage
  16536. Neuroprotective and Neurorestorative Effects of Thymosin Beta4 Treatment after Traumatic brain Injury (S21. 004)
  16537. In vitro ischemia-induced changes in the transcriptome of hippocampal neurons: Neuroprotective pathways in brain ischemia
  16538. Poly (D, L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display Neuroprotective activity in a rat model of closed head injury
  16539. Activation of Plasmin Proteolytic System in Glaucoma and the Neuroprotective Role of TrkB Receptor Agonists
  16540. Neuroprotective effects of cyclosporine A and GluR2 AMPA receptors against excitotoxicity in FVB/N and C57BL/6 mice
  16541. Evaluation of the Neuroprotective Potential of the 5HT2A Receptor Antagonist Sarpogrelate Hydrochloride in a Light Damage Model of Retinal Degeneration
  16542. The Neuroprotective Effects of Rattin Against Neurotoxic Aβ are Involved in JAK/STAT3 and Calcium Homeostasis
  16543. Neuroprotective effects of a xanthine oxidase inhibitor in progressive EAE by ameliorating mitochondrial dysfunction
  16544. Neuroprotective effects of carnosic acid on the hippocampus of 6-hydroxydopamine injured rats
  16545. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION)
  16546. The study of the Neuroprotective activity of the apolipoprotein E peptide mimetic Cog1410 in transgenic strains of Drosophila melanogaster
  16547. Neuroprotective Effect of Diosmin on Arsenic Trioxide Induced Neurotoxicity in Albino Wistar Rats.
  16548. An Investigation of the Neuroprotective Effects of Palm Vitamin E Tocotrienols Using White Matter Lesions as the Human Study Model
  16549. In Vitro Neuroprotective Activity of Sesquiterpenoids from the Flower Buds of Tussilago farfara
  16550. The Neuroprotective Effects of Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP) in Focal Cerebral Ischemia
  16551. Investigation of Neuroprotective activity of apolipoprotein E peptide mimetic Cog1410 in transgenic lines of Drosophila melanogaster
  16552. Neuroprotective activity of water soluble extract from Chorispora bungeana against focal cerebral ischemic/reperfusion injury in mice
  16553. Neuroprotective Effect of Extract of Cornus controversa in Hypoxia-induced HT22 Neuronal Cell in vitro
  16554. Neuroprotective effects of Retinal Ganglion cells by specific alpha 7 nicotine acetylcholine receptor agonists and an acetylcholineesterase inhibitor
  16555. P6: Neuroprotective Effect of Estrogen against brain Edema and Blood brain Barrier Disruption: Roles of Estrogen Receptors α and β
  16556. Neuroprotective effects of resveratrol against β‐amyloid induced oxidative damage and memory loss in rat hippocampal (H19‐7) cells (647.44)
  16557. PROLONGED NMDA STIMULATION INDUCES Neuroprotective PATHWAYS AND ENHANCES SURVIVABILITY OF PRIMARY RETINAL GANGLION CELLS
  16558. Parthenolide is Neuroprotective in rat experimental stroke model: downregulating NF-κB, phospho-p38MAPK and caspase-1, ameliorating BBB permeability
  16559. Erratum in “Antioxidant Activity-Mediated Neuroprotective Effects of an Antagonist of AT1 Receptors, Candesartan, Against Cerebral Ischemia and Edema in Rats,”
  16560. The assessment of the Neuroprotective effect of herbal medicinal products in patients with early stages (I-II) of primary open-angle glaucoma and stabilized intraocular …
  16561. Synthesis And Characterization Of brain Penetrant Prodrug Of Neuroprotective D264: Potential Disease Modifying Treatment Agent For Parkinson’s Disease
  16562. A diet containing specific anti-inflammatory and Neuroprotective ingredients prevents impaired behaviour, but not the allergic response, in food allergic mice
  16563. Abstract W P87: Focal Hypothermia Induced by Post-Ischemic Intra-arterial Infusion of Cold Saline Has a Neuroprotective Effect on Cerebral Ischemia Reperfusion …
  16564. STUDY OF THE Neuroprotective EFFECT OF ALPHA LIPOIC ACID ON ACRYLONITRILE INDUCED CELLULAR DYSFUNCTION BY ENHANCEMENT …
  16565. Neuroprotective effects of pre-and post-treatment with fasudil (a Rho-kinase inhibitor) in a rat transient spinal cord ischemia-reperfusion model: 7AP1-10
  16566. Neuroprotective Effects of Spinosin, a C-glucosylflavone from Zizyphus jujuba var. spinosa, on Aβ1-42 Oligomer-induced Mouse Model of Alzheimer’s …
  16567. The role of DJ-1 in neurodegeneration and aging in a Drosophila model of Parkinson’s Disease and its implications for novel Neuroprotective therapies
  16568. Neuroprotective role of Regulatory T cells in Parkinson’s disease: Effect of COP-1/alpha-synuclein vaccination on pathology progression
  16569. Neuroprotective EFFECTS OF ATORVASTATIN THROUGH ANTI-OXIDANT, ANTI-INFLAMMATORY AND ANTI-APOPTOTIC MECHANISMS AGAINST …
  16570. Luteolin Exerts Neuroprotective Effect by Up-regulation of HO-1 via JNK Pathway in Primary Cultured Rat Cortical Cells
  16571. Neuroprotective effects of gamma-glutamylcysteine ethyl ester on an in vivo moderate traumatic brain injury-mediated model and in vitro in cortical astrocytes and …
  16572. Neuroprotective effect of bicyclol in rat ischemic stroke: down-regulates TLR4, TLR9, TRAF6, NF-κB, MMP-9 and up-regulates claudin-5 expression
  16573. Estetrol attenuates Neonatal Hypoxic-Ischemic brain injury Running title: Estetrol and its Neuroprotective effect
  16574. Observation periods of 1 year for clinical trials of Neuroprotective agents in glaucoma are feasible
  16575. Neuroprotective EFFECTS OF AQUATIC EXTRACT OF ACHILLEA WILLHELMSII ON SPINAL CORD MOTONEURONS AFTER SCIATIC NERVE …
  16576. An Efficient Fmoc Solid-Phase Synthesis of an Amphiphile of the Neuroprotective Agent Glycyl-prolyl-glutamic Acid
  16577. Neuroprotective Effects of the Standardized Extract of Betula Platyphylla Bark against Amyloid Beta Induced Toxicity in Amnesic Mice
  16578. Abstract W P212: Combination Therapy With Amlodipine and Irbesartan Persists a Neuroprotective Effect Associated With Glial Deactivation on Paraventricular …
  16579. brain cell injury following cerebral ischemia and reperfusion: positive effects of ICAM-1/Neuroprotective role of Taurine
  16580. PS-042a Docosahexaenoic Acid (dha) Is Neuroprotective After Newborn Asphyxia Proton-magnetic-resonance-spectroscopy (h±-mrs) On Hypoxic brain Tissue In …
  16581. Chalcone Derivatives Represent Neuroprotective Effect against Oxidative Stress through Dual Inhibition of μ-Calpain and Cathepsin B
  16582. Neuroprotective effect of early and short-time applying sophoridine in pMCAO rat brain : down-regulated TRAF6 and up-regulated p-ERK1/2 expression, ameliorated …
  16583. Schwann Cell-Derived Desert Hedgehog Provides a Neuroprotective Effect Against the Mechanical Stimuli from Compressive Neuropathies (S6. 007)
  16584. Role of MT1/MT2 Melatonin Membrane Receptors in Mediating the Neuroprotective Effects of Melatonin in Alzheimer’s Disease
  16585. … rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion: Effect of Neuroprotective …
  16586. A novel low pHo‐induced Cl‐ conductance in nodose ganglion neurons is Neuroprotective during simulated ischemia: implication for vagal afferent activity in heart …
  16587. Quantitative Proteomics Profiling Unravels Synergetic Neuroprotective Effect of Novel Combination of Chrysin and Protocatechuic Acid on Experimental Model of …
  16588. Review of “Neuroprotective Effects of Mesenchymal Stem Cells on Spinal Motoneurons Following Ventral Root Axotomy: Synapse Stability and Axonal Regeneration” …
  16589. The Neuroprotective role of L-cysteine towards the effects of short-term exposure to lanthanum on the adult rat brain antioxidant status and the activities of …
  16590. … -detected emboli can be differentiated between solid and gaseous emboli during transcatheter aortic valve implantation and this has implications for Neuroprotective …
  16591. Insights of [18F] FDG and [18F]-DOPA to assess striatal fiber status through PET/MR in living rodents under Neuroprotective treatment
  16592. Neuroprotective EFFECT OF ALCOHOLIC EXTRACT OF SALVIA CHLOROLEUCA AGAINST NEURONAL DEGENERATION OF ALPHA MOTONEURONS OF …
  16593. Neuroprotective Effects of (-)-Epigallocatechin 3-O-gallate (EGCG) on l-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine (MPTP) and Hydrogen Peroxide (H2O2) Stressed …
  16594. Abstract W P219: Delivery of an Oral Formulation of Angiotensin-(1-7) After Stroke is Neuroprotective
  16595. 034—(LIB0083) Parawixin10: A new natural compound from Parawixia bistriata spider venom that presents Neuroprotective , memory -saving, and disease-modifying …
  16596. Erythropoietin exerts Neuroprotective function against glutamate neurotoxicity in experimental diabetic retina 2 Running title: EPO protects diabetic retina by …
  16597. 37 Neuroprotective Role of
  16598. MP47-03 OFF-TARGET EFFECT OF SILDENAFIL IS Neuroprotective VIA PHOSPHODIESTERASE TYPE-4
  16599. Melatonin in Alzheimer’s Disease: Focus on Neuroprotective Role
  16600. The Role of Interleukin-4 in the Neuroprotective Benefits from Social Interaction
  16601. 17 Neuroprotective Role of
  16602. 6 Neuroprotective Effect
  16603. 0353. Do the noble gases helium and argon exert Neuroprotective effects in a rodent cardiac arrest model?
  16604. MRZ-99030-a novel modulator of β-amyloid (Aβ) aggregation for the topical Neuroprotective treatment of glaucoma and age-related macular degeneration (AMD)
  16605. 785: Neuroprotective role of Wharton’s jelly-derived mesenchymal stem cells in encephalopathy of prematurity (rat model)
  16606. POSTER PRESENTATION 2: Critical Care/Experimental Medicine: PS2-29; Hydroquinone Shows Neuroprotective Potential in Rodent Ischemic Stroke Model
  16607. CAVEOLIN-1 MODULATES RETINAL Neuroprotective AND INFLAMMATORY CYTOKINE EXPRESSION
  16608. 244: THE Neuroprotective EFFECT OF VALPROATE COMBINED WITH HYPOTHERMIA ON ASPHYXIAL CARDIAC ARREST MODEL
  16609. Glial HO-1 Suppression as a Neuroprotective Strategy in Alzheimer’s Disease
  16610. 027—(GOD0081) Antiepileptic and Neuroprotective effect of Parawixin2, isolated Parawixia bistriata spider venom, in lithium–pilocarpine model of temporal lobe …
  16611. PO-0400 Neuroprotective Effect Of Pentoxifylline In Rat Pups With Hypoxic-ischaemic Encephalopathy
  16612. … Induced by In Vivo Cerebral Oxidative Stress: Evidence for Beneficial Effects of SRT1720, a Sirtuin 1 Activator, and Sirtuin 1-Mediated Neuroprotective Effects of Poly …
  16613. brain Dysfunction and Cell Death in Type 2 Diabetes: A Neuroprotective role for the peripheral treatment with Exendin-4
  16614. 2. Insulin pump therapy in type 1 diabetes: Potential to be Neuroprotective
  16615. … and moderate exercise initiated in middle age prevents 2 age-related amyloidogenesis and preserves synaptic and 3 Neuroprotective signaling in mouse brain …
  16616. Abstract W P196: Post-Stroke Activation of Angiotensin Converting Enzyme 2 is Neuroprotective
  16617. Korean Paper Presentation 1: Critical Care/Radiology/Pediatric Emergency: OK1-2; Neuroprotective Effect of Progesterone in Post-cardiac Arrest Care After Asphyxia …
  16618. P218 tPA in combination with MMP-10 a new effective strategy for thrombolysis in ischemic stroke with Neuroprotective effect
  16619. Melatonin’s Neuroprotective Actions on Hippocampal Neurons
  16620. microRNA 103‐1 exerts a Neuroprotective effect in stroke by enhancing ncx1 expression in the brain (654.1)
  16621. The Neuroprotective actions of oestradiol and oestrogen receptors
  16622. The Neuroprotective aspects of sleep
  16623. Neuroprotective action of resveratrol
  16624. The ongoing pursuit of Neuroprotective therapies in Parkinson disease
  16625. Luteolin as an anti-inflammatory and Neuroprotective agent: A brief review
  16626. Neuroprotective effects of chrysin: From chemistry to medicine
  16627. Impact of nutrition on brain development and its Neuroprotective implications following preterm birth
  16628. Neuroprotective effects of angiotensin receptor blockers
  16629. Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy
  16630. Plant-derived Neuroprotective agents in Parkinson’s disease
  16631. Microglial regulation of immunological and Neuroprotective functions of astroglia
  16632. Parkinson risk in idiopathic REM sleep behavior disorder: preparing for Neuroprotective trials
  16633. Astaxanthin as a potential Neuroprotective agent for neurological diseases
  16634. Neuroprotective effects of dietary restriction: evidence and mechanisms
  16635. Potential Neuroprotective properties of epigallocatechin-3-gallate (EGCG)
  16636. Neuroprotective properties of cannabigerol in Huntington’s disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice
  16637. Neuroprotective therapies for glaucoma
  16638. Ginseng: a promising Neuroprotective strategy in stroke
  16639. Neuroprotective properties of kavalactones
  16640. The sphingosine 1‐phosphate receptor agonist FTY 720 is Neuroprotective after cuprizone‐induced CNS demyelination
  16641. Update on the Neuroprotective effect of estrogen receptor alpha against Alzheimer’s disease
  16642. Potential Neuroprotective activity of Ginseng in Parkinson’s disease: a review
  16643. Propofol: an anesthetic possessing Neuroprotective effects
  16644. An overview on Neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases
  16645. Inflammasomes are Neuroprotective targets for sex steroids
  16646. Neuroprotective effects of yoga practice: age-, experience-, and frequency-dependent plasticity
  16647. Neuroprotective agents target molecular mechanisms of disease in ALS
  16648. Fractalkine in the nervous system: Neuroprotective or neurotoxic molecule
  16649. Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
  16650. The wee care Neuroprotective NICU program (Wee Care): The effect of a comprehensive developmental care training program on seven Neuroprotective core …
  16651. Synthesis, characterization, antioxidant activity and Neuroprotective effects of selenium polysaccharide from Radix hedysari
  16652. Neuroprotective agents for neonatal hypoxic–ischemic brain injury
  16653. Mechanisms underlying the Neuroprotective effect of brain reserve against late life depression
  16654. Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson’s disease
  16655. The Neuroprotective effects of bilingualism upon the inferior parietal lobule: a structural neuroimaging study in aging Chinese bilinguals
  16656. Riluzole as a Neuroprotective drug for spinal cord injury: from bench to bedside
  16657. Putative Neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major …
  16658. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties
  16659. C9orf72 promoter hypermethylation is Neuroprotective : neuroimaging and neuropathologic evidence
  16660. Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation
  16661. Small molecule-induced oxidation of protein disulfide isomerase is Neuroprotective
  16662. Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity
  16663. Neuroprotective effects of rutin in streptozotocin-induced diabetic rat retina
  16664. Phytochemicals Having Neuroprotective Properties from Dietary Sources and Medicinal Herbs.
  16665. The P7C3 class of Neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis
  16666. Neuroprotective mechanisms of the ACE2–Angiotensin-(1-7)–Mas axis in stroke
  16667. Gut-brain connection: The Neuroprotective effects of the anti-diabetic drug liraglutide
  16668. Neuroprotective effects of ginkgolide B against ischemic stroke: A review of current literature
  16669. Neuroprotective effects of bisperoxovanadium on cerebral ischemia by inflammation inhibition
  16670. Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders
  16671. Novel sites of Neuroprotective action of Dimebon (latrepirdine)
  16672. Examining the Neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease
  16673. Tract-based spatial statistics to assess the Neuroprotective effect of early erythropoietin on white matter development in preterm infants
  16674. Poly-arginine and arginine-rich peptides are Neuroprotective in stroke models
  16675. Neuroprotective effects of hydrogen sulfide and the underlying signaling pathways
  16676. Developing drug strategies for the Neuroprotective treatment of acute ischemic stroke
  16677. Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer’s disease in Wistar rats
  16678. Activation of the Neuroprotective angiotensin-converting enzyme 2 in rat ischemic stroke
  16679. Neuroprotective core measure 1: the healing NICU environment
  16680. Astrocyte-derived TGF-β1 accelerates disease progression in ALS mice by interfering with the Neuroprotective functions of microglia and T cells
  16681. PACAP as a Neuroprotective factor in ischemic neuronal injuries
  16682. Oxidative damage induced by retching; antiemetic and Neuroprotective role of Sambucus ebulus L.
  16683. Neuroprotective effect of microRNA-99a against focal cerebral ischemia–reperfusion injury in mice
  16684. Is lithium a Neuroprotective agent
  16685. The Neuroprotective effect of salubrinal in a mouse model of traumatic brain injury
  16686. Neuroprotective effects of geniposide on Alzheimer’s disease pathology
  16687. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
  16688. Delaying aging is Neuroprotective in Parkinson’s disease: a genetic analysis in C. elegans models
  16689. Pharmacological and Neuroprotective profile of an essential oil derived from leaves of Aloysia citrodora Palau
  16690. Evidence for a Neuroprotective microRNA pathway in amnestic mild cognitive impairment
  16691. Neuroprotective strategies against calpain-mediated neurodegeneration
  16692. On the antioxidant, Neuroprotective and anti-inflammatory properties of S-allyl cysteine: an update
  16693. Promising Neuroprotective plants from north-east India
  16694. Treatment of stroke with liposomal Neuroprotective agents under cerebral ischemia conditions
  16695. Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia
  16696. Neuroprotective effect of sulforaphane against methylglyoxal cytotoxicity
  16697. Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: A comparative study
  16698. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder
  16699. The Neuroprotective effect of erythropoietin on experimental Parkinson model in rats
  16700. The Neuroprotective effect of berberine in mercury-induced neurotoxicity in rats
  16701. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia‐reperfusion
  16702. Hypothermia augments Neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy
  16703. Neuroprotective effect of sodium butyrate against cerebral ischemia/reperfusion injury in mice
  16704. Neuroprotective effects of testosterone on ischemia/reperfusion injury of the rabbit spinal cord
  16705. Neuroprotective effects of Clostridium butyricum against vascular dementia in mice via metabolic butyrate
  16706. Nicotine inhibits microglial proliferation and is Neuroprotective in global ischemia rats
  16707. Fingolimod induces Neuroprotective factors in human astrocytes
  16708. Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson’s disease
  16709. A unique array of Neuroprotective effects of pyruvate in neuropathology
  16710. Multi-faced Neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model
  16711. Neuroprotective effect of simvastatin via inducing the autophagy on spinal cord injury in the rat model
  16712. Orexin receptors exert a Neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103
  16713. Drug repurposing: a systematic approach to evaluate candidate oral Neuroprotective interventions for secondary progressive multiple sclerosis
  16714. Neuroprotective effects of viral overexpression of microRNA‐22 in rat and cell models of cerebral ischemia‐reperfusion injury
  16715. Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia
  16716. The Neuroprotective effects of taurine against nickel by reducing oxidative stress and maintaining mitochondrial function in cortical neurons
  16717. Neuroprotective effects of daidzein on focal cerebral ischemia injury in rats
  16718. Activity-dependent Neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer’s pathologies
  16719. Neuroprotective effect of ginsenoside-Rg1 on cerebral ischemia/reperfusion injury in rats by downregulating protease-activated receptor-1 expression
  16720. Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia
  16721. Neuroprotective effect of lycopene against MPTP induced experimental Parkinson’s disease in mice
  16722. A Neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity
  16723. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow–derived mesenchymal stem cells in an experimental ocular hypertension model
  16724. Is genistein Neuroprotective in traumatic brain injury?
  16725. Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
  16726. Linalool as a Neuroprotective agent against acrylamide-induced neurotoxicity in Wistar rats
  16727. Neuroprotective effect of dexmedetomidine on hyperoxia-induced toxicity in the neonatal rat brain
  16728. A potent multi-functional Neuroprotective derivative of tetramethylpyrazine
  16729. Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis
  16730. Neuroprotective effect of bexarotene in the SOD1G93A mouse model of amyotrophic lateral sclerosis
  16731. Hippocampal cAMP/PKA/CREB is required for Neuroprotective effect of acupuncture
  16732. TrkB-mediated Neuroprotective and antihypoxic properties of brain -derived neurotrophic factor
  16733. Isoprenylated flavonoids from the root bark of Morus alba and their hepatoprotective and Neuroprotective activities
  16734. Neuroprotective effects of crocin against traumatic brain injury in mice: Involvement of notch signaling pathway
  16735. Neuroprotective effects of crocin against oxidative stress induced by ischemia/reperfusion injury in rat retina
  16736. Attachment and early brain development–Neuroprotective interventions in infant–caregiver therapy
  16737. Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
  16738. Neuroprotective effects of vildagliptin in rat rotenone Parkinson’s disease model: role of RAGE‐NF κB and Nrf2‐antioxidant signaling pathways
  16739. Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release
  16740. Neuroprotective effects of erythropoietin in patients with severe closed brain injury
  16741. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson’s disease mouse model
  16742. Neuroprotective effects of intravenous lidocaine on early postoperative cognitive dysfunction in elderly patients following spine surgery
  16743. Neuroprotective effects of Liriope platyphylla extract against hydrogen peroxide-induced cytotoxicity in human neuroblastoma SH-SY5Y cells
  16744. Neuroprotective activity and cytotoxic potential of two Parmeliaceae lichens: Identification of active compounds
  16745. Neuroprotective effects of DAHP and Triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation
  16746. Neuroprotective effects of voluntary exercise in an inherited retinal degeneration mouse model
  16747. Activation of the Nrf2 defense pathway contributes to Neuroprotective effects of phloretin on oxidative stress injury after cerebral ischemia/reperfusion in rats
  16748. Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models
  16749. Liraglutide is neurotrophic and Neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice
  16750. Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia
  16751. Neuroprotective effects of Kukoamine B against hydrogen peroxide-induced apoptosis and potential mechanisms in SH-SY5Y cells
  16752. Neuroprotective actions of progesterone in an in vivo model of retinitis pigmentosa
  16753. Neuroprotective therapies: preclinical reproducibility is only part of the problem
  16754. Context-dependent GluN2B-selective inhibitors of NMDA receptor function are Neuroprotective with minimal side effects
  16755. ROS-dependent Neuroprotective effects of NaHS in ischemia brain injury involves the PARP/AIF pathway
  16756. Neuroprotective effect of memantine on the retinal ganglion cells of APPswe/PS1ΔE9 mice and its immunomodulatory mechanisms
  16757. The role of the Neuroprotective factor Npas4 in cerebral ischemia
  16758. Suppression of mitochondrial fission in experimental cerebral ischemia: the potential Neuroprotective target of p38 MAPK inhibition
  16759. Neuroprotective effects of quercetin in a mouse model of brain ischemic/reperfusion injury via anti‑apoptotic mechanisms based on the Akt pathway
  16760. Neural and glial progenitor transplantation as a Neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS)
  16761. A Neuroprotective sericin hydrogel as an effective neuronal cell carrier for the repair of ischemic stroke
  16762. Resveratrol exerts anti-inflammatory and Neuroprotective effects to prevent memory deficits in rats exposed to chronic unpredictable mild stress
  16763. Neuroprotective Effects of cistanches herba therapy on patients with moderate Alzheimer’s Disease
  16764. Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts Neuroprotective effects in a transient ischemic stroke model in rats: analyses of …
  16765. Cloning, expression, and purification of cold inducible RNA-binding protein and its Neuroprotective mechanism of action
  16766. Adenosine A3 receptor activation is Neuroprotective against retinal neurodegeneration
  16767. PPAR gamma activation is Neuroprotective in a Drosophila model of ALS based on TDP-43
  16768. In vivo screening of traditional medicinal plants for Neuroprotective activity against Aβ42 cytotoxicity by using Drosophila models of Alzheimer’s disease
  16769. Current knowledge on the Neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke
  16770. Multifunctional scutellarin–rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and Neuroprotective properties for the treatment of Alzheimer’s disease
  16771. p75NTR ectodomain is a physiological Neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer’s disease
  16772. Combined treatment of an amyotrophic lateral sclerosis rat model with recombinant GOT1 and oxaloacetic acid: a novel Neuroprotective treatment
  16773. Purification, characterization and Neuroprotective effects of a polysaccharide from Gynostemma pentaphyllum
  16774. Pulsed transcranial ultrasound stimulation immediately after the ischemic brain injury is Neuroprotective
  16775. Isoflavones with Neuroprotective activities from fruits of Cudrania tricuspidata
  16776. Drugs that bind to α-synuclein: Neuroprotective or neurotoxic?
  16777. Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer’s disease with cholinergic, antioxidant, Neuroprotective and hepatoprotective properties
  16778. Pridopidine, a dopamine stabilizer, improves motor performance and shows Neuroprotective effects in Huntington disease R6/2 mouse model
  16779. Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts Neuroprotective effects in animal and cellular models of Parkinson’s disease
  16780. Induction of GDNF and BDNF by hRheb (S16H) transduction of SNpc neurons: Neuroprotective mechanisms of hRheb (S16H) in a model of Parkinson’s disease
  16781. Status epilepticus results in persistent overproduction of reactive oxygen species, inhibition of which is Neuroprotective
  16782. Meridianin derivatives as potent Dyrk1A inhibitors and Neuroprotective agents
  16783. Neuroprotective effect of astaxanthin against glutamate-induced cytotoxicity in HT22 cells: Involvement of the Akt/GSK-3β pathway
  16784. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and Neuroprotective properties as innovative drugs for …
  16785. Neuroprotective effects of (−)-epigallocatechin-3-gallate against focal cerebral ischemia/reperfusion injury in rats through attenuation of inflammation
  16786. Activation of the nuclear receptor PPARδ is Neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation
  16787. Lignans and neolignans from the stems of Vibrunum erosum and their Neuroprotective and anti-inflammatory activity
  16788. Carnosine exerts Neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat
  16789. Neuroprotective effect of rapamycin on spinal cord injury via activation of the Wnt/β-catenin signaling pathway
  16790. Promising Neuroprotective effects of oligostilbenes
  16791. Rapamycin plays a Neuroprotective effect after spinal cord injury via anti‐inflammatory effects
  16792. The Neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent
  16793. Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control
  16794. The neuritogenic and Neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells
  16795. Neuroprotective effects of mitochondria-targeted plastoquinone and thymoquinone in a rat model of brain ischemia/reperfusion injury
  16796. Antihypertensive and Neuroprotective actions of pyridoxine and its derivatives
  16797. Neuroprotective therapeutics from botanicals and phytochemicals against Huntington’s disease and related neurodegenerative disorders
  16798. Maternal allopurinol administration during suspected fetal hypoxia: a novel Neuroprotective intervention? A multicentre randomised placebo controlled trial
  16799. Neuroprotective effect of resveratrol against glutamate-induced excitotoxicity
  16800. Murine adipose-derived mesenchymal stromal cell vesicles: in vitro clues for Neuroprotective and neuroregenerative approaches
  16801. Mechanisms underlying the perifocal Neuroprotective effect of the nrf2–are signaling pathway after intracranial hemorrhage
  16802. Impact of time to return of spontaneous circulation on Neuroprotective effect of targeted temperature management at 33 or 36 degrees in comatose survivors of out-of …
  16803. Rosmarinic acid exerts a Neuroprotective effect in the kainate rat model of temporal lobe epilepsy: Underlying mechanisms
  16804. Spiroindole Alkaloids and Spiroditerpenoids from Aspergillus duricaulis and Their Potential Neuroprotective Effects
  16805. The Neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat
  16806. Improved Neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly (lactide) nanoparticles in MPTP-induced Parkinsonism
  16807. Neuroprotective effects of Argon are mediated via an ERK‐1/2 dependent regulation of heme‐oxygenase‐1 in retinal ganglion cells
  16808. Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
  16809. Pharmacologic rescue of motor and sensory function by the Neuroprotective compound P7C3 following neonatal nerve injury
  16810. Neuroprotective effects of ginkgetin against neuroinjury in Parkinson’s disease model induced by MPTP via chelating iron
  16811. Neuroprotective effects of the cultivated Chondrus crispus in a C. elegans model of Parkinson’s disease
  16812. Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and Neuroprotective responses?
  16813. Neuroprotective effect of transplanted neural precursors embedded on PLA/CS scaffold in an animal model of multiple sclerosis
  16814. Neuroprotective effects of Ganoderma lucidum polysaccharides against traumatic spinal cord injury in rats
  16815. Neuroprotective effects of oligodendrocyte progenitor cell transplantation in premature rat brain following hypoxic-ischemic injury
  16816. Neuroprotective and Antioxidant Constituents from Curcuma zedoaria Rhizomes.
  16817. Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
  16818. Neuroprotective activity of coptisine from Coptis chinensis (Franch)
  16819. SUMOylation: novel Neuroprotective approach for Alzheimer’s disease?
  16820. Acupuncture elicits Neuroprotective effect by inhibiting NAPDH oxidase-mediated reactive oxygen species production in cerebral ischaemia
  16821. The Neuroprotective role of ferrostatin-1 under rotenone-induced oxidative stress in dopaminergic neuroblastoma cells
  16822. Novel arylalkenylpropargylamines as Neuroprotective , potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson’s disease
  16823. Inhibition of the prostaglandin EP2 receptor is Neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus
  16824. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of …
  16825. cognitive deficits and anxiety induced by diisononyl phthalate in mice and the Neuroprotective effects of melatonin
  16826. Neuroprotective properties of the standardized extract from Camellia sinensis (green tea) and its main bioactive components, epicatechin and …
  16827. Neuroprotective effect of humic acid on focal cerebral ischemia injury: an experimental study in rats
  16828. Neuroprotective effect of Juniperus communis on chlorpromazine induced Parkinson disease in animal model
  16829. IGF-1R reduction triggers Neuroprotective signaling pathways in spinal muscular atrophy mice
  16830. Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence
  16831. Neuroprotective effects of (Val8) GLP-1-Glu-PAL in the MPTP Parkinson’s disease mouse model
  16832. Neuroprotective effects of N-acetylcysteine amide on experimental focal penetrating brain injury in rats
  16833. Nootropic, Neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice
  16834. Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson’s disease
  16835. Natural β-Dihydroagarofuran-Type Sesquiterpenoids as cognition -Enhancing and Neuroprotective agents from Medicinal Plants of the Genus Celastrus
  16836. Neuroprotective effects of Rosa damascena extract on learning and memory in a rat model of amyloid-β-induced Alzheimer’s disease
  16837. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson’s disease
  16838. Neuroprotective effects of hypothermia.
  16839. The emerging Neuroprotective role of mitochondrial uncoupling protein-2 in traumatic brain injury
  16840. Neuroprotective effect and underlying mechanism of sodium danshensu [3-(3, 4-dihydroxyphenyl) lactic acid from Radix and Rhizoma Salviae miltiorrhizae= Danshen …
  16841. The role of p38MAPK signal pathway in the Neuroprotective mechanism of limb postconditioning against rat cerebral ischemia/reperfusion injury
  16842. Hydroxysafflor yellow A exerts Neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway
  16843. Neuroprotective mechanism of Lycium barbarum polysaccharides against hippocampal-dependent spatial memory deficits in a rat model of obstructive sleep …
  16844. Neuroprotective effects of alpha-mangostin on MPP+-induced apoptotic cell death in neuroblastoma SH-SY5Y cells
  16845. Immune regulatory and Neuroprotective properties of preimplantation factor: From newborn to adult
  16846. Neuroprotective effects of alkaloids from Piper longum in a MPTP-induced mouse model of Parkinson’s disease
  16847. Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats
  16848. Combination of thrombolytic therapy and Neuroprotective therapy in acute ischemic stroke: is it important
  16849. The PEDF Neuroprotective domain plus DHA induces corneal nerve regeneration after experimental surgery
  16850. Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools
  16851. Natural products from marine organisms with Neuroprotective activity in the experimental models of Alzheimer’s disease, Parkinson’s disease and ischemic brain …
  16852. Neuroprotective effects of MK-801 against traumatic brain injury in immature rats
  16853. Schisandrin B shows Neuroprotective effect in 6-OHDA-induced Parkinson’s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway
  16854. Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice
  16855. Neuroprotective effect of resveratrol on acute brain ischemia reperfusion injury by measuring annexin V, p53, Bcl-2 levels in rats
  16856. Neuroprotective effects of safranal in a rat model of traumatic injury to the spinal cord by anti-apoptotic, anti-inflammatory and edema-attenuating
  16857. The Neuroprotective effect of syringic acid on spinal cord ischemia/reperfusion injury in rats
  16858. Ginkgolide B revamps Neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Aβ25–35‐induced …
  16859. Drosophila eye model to study Neuroprotective role of CREB binding protein (CBP) in Alzheimer’s disease
  16860. Neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson’s disease
  16861. Neuroprotective effects and dynamic expressions of MMP9 and TIMP1 associated with atorvastatin pretreatment in ischemia–reperfusion rats
  16862. Neuroprotective effect of masitinib in rats with postischemic stroke
  16863. Neuroprotective potential of Beta vulgaris L. in Parkinson’s disease
  16864. Neuroprotective effects of ginsenoside Rg1-induced neural stem cell transplantation on hypoxic-ischemic encephalopathy
  16865. Neuroprotective effects of Gymnema sylvestre on streptozotocin-induced diabetic neuropathy in rats
  16866. Neuroprotective effects of dried camu-camu (Myrciaria dubia HBK McVaugh) residue in C. elegans
  16867. Early Neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal …
  16868. Neuroprotective strategies and neuroprognostication after cardiac arrest
  16869. Rosiglitazone exerts Neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury
  16870. Anxiolytic-like, stimulant and Neuroprotective effects of Ilex paraguariensis extracts in mice
  16871. Nampt/PBEF/visfatin exerts Neuroprotective effects against ischemia/reperfusion injury via modulation of Bax/Bcl-2 ratio and prevention of caspase-3 activation
  16872. Neuroprotective effect of paeoniflorin on H2O2-induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response
  16873. Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and Neuroprotective and behavioral effects
  16874. Neuroprotective effect of ginseng against spinal cord injury induced oxidative stress and inflammatory responses
  16875. Enhancement of neurotrophic factors in astrocyte for Neuroprotective effects in brain disorders using low-intensity pulsed ultrasound stimulation
  16876. Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells
  16877. Anti-amnesic and Neuroprotective effects of Artemisia argyi H.(Seomae mugwort) extracts
  16878. Anticonvulsant and Neuroprotective effects of Rosa damascena hydro-alcoholic extract on rat hippocampus
  16879. Neuroprotective effects of trans-caryophyllene against kainic acid induced seizure activity and oxidative stress in mice
  16880. Multiple sclerosis at menopause: Potential Neuroprotective effects of estrogen
  16881. Seven core measures of Neuroprotective family-centered developmental care: Creating an infrastructure for implementation
  16882. Acidic FGF promotes neurite outgrowth of cortical neurons and improves Neuroprotective effect in a cerebral ischemic rat model
  16883. The solution structure and dynamics of full-length human cerebral dopamine neurotrophic factor and its Neuroprotective role against α-synuclein oligomers
  16884. Cortexin. Molecular mechanisms and targets of Neuroprotective activity
  16885. Neuroprotective effects of direct intrathecal administration of granulocyte colony‐stimulating factor in rats with spinal cord injury
  16886. Rosiglitazone activation of PPARγ-dependent signaling is Neuroprotective in mutant huntingtin expressing cells
  16887. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson’s disease in rats
  16888. The striatal long noncoding RNA Abhd11os is Neuroprotective against an N-terminal fragment of mutant huntingtin in vivo
  16889. The Neuroprotective effect of tetramethylpyrazine against contusive spinal cord injury by activating PGC-1α in rats
  16890. Neuroprotective effect of water extract of Panax ginseng on corticosterone-induced apoptosis in PC12 cells and its underlying molecule mechanisms
  16891. Neuroprotective metabolites from the endophytic fungus Penicillium citrinum of the mangrove Bruguiera gymnorrhiza
  16892. Neuroprotective effect of brassica oleracea sprouts crude juice in a cellular model of alzheimer’s disease
  16893. Neuroprotective effects of salidroside on focal cerebral ischemia/reperfusion injury involve the nuclear erythroid 2-related factor 2 pathway
  16894. Neuroprotective effect of ulinastatin on spinal cord ischemia-reperfusion injury in rabbits
  16895. Neuroprotective effects of exendin-4 in rat model of spinal cord injury via inhibiting mitochondrial apoptotic pathway
  16896. Exercise preconditioning exhibits Neuroprotective effects on hippocampal CA1 neuronal damage after cerebral ischemia
  16897. Neuroprotective effect of hemeoxygenase-1/glycogen synthase kinase-3β modulators in 3-nitropropionic acid-induced neurotoxicity in rats
  16898. Inhibition of β-amyloid aggregation by albiflorin, aloeemodin and neohesperidin and their Neuroprotective effect on primary hippocampal cells against β-amyloid …
  16899. BAG1 is Neuroprotective in in vivo and in vitro models of Parkinson’s disease
  16900. The Neuroprotective effect of glycyrrhizic acid on an experimental model of focal cerebral ischemia in rats
  16901. Does being female provide a Neuroprotective advantage following spinal cord injury?
  16902. Neuroprotective effect of N-acetyl cysteine against streptozotocin-induced memory dysfunction and oxidative damage in rats
  16903. Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
  16904. Neuroprotective Effect of Prenylated Arylbenzofuran and Flavonoids from Morus alba Fruits on Glutamate-Induced Oxidative Injury in HT22 Hippocampal Cells
  16905. Activated microglia/macrophage whey acidic protein (AMWAP) inhibits NFκB signaling and induces a Neuroprotective phenotype in microglia
  16906. … FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a Neuroprotective role in the …
  16907. Conformational switch of polyglutamine-expanded huntingtin into benign aggregates leads to Neuroprotective effect
  16908. Comparison of the Neuroprotective effects and recovery profiles of isoflurane, sevoflurane and desflurane as neurosurgical pre-conditioning on ischemia …
  16909. Neuroprotective effects of pioglitazone against transient cerebral ischemic reperfusion injury in diabetic rats: Modulation of antioxidant, anti-inflammatory, and anti …
  16910. Increased 14-3-3 phosphorylation observed in Parkinson’s disease reduces Neuroprotective potential of 14-3-3 proteins
  16911. Neuroprotective effects of hydrated fullerene C 60: Cortical and hippocampal eeg interplay in an amyloid-infused rat model of alzheimer’s disease
  16912. Role of the catechol group in the antioxidant and Neuroprotective effects of virgin olive oil components in rat brain
  16913. In vitro Neuroprotective effect of shikimic acid against hydrogen peroxide-induced oxidative stress
  16914. Neuroprotective effect of xueshuantong for injection (lyophilized) in transient and permanent rat cerebral ischemia model
  16915. Genistein exerts Neuroprotective effect on focal cerebral ischemia injury in rats
  16916. Advances in research of the Neuroprotective mechanisms of cerebral ischemic postconditioning
  16917. Neuroprotective role of novel triazine derivatives by activating Wnt/β catenin signaling pathway in rodent models of Alzheimer’s disease
  16918. Serum uric acid is Neuroprotective in Chinese patients with acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator
  16919. Neuroprotective effect of human mesenchymal stem cells in a compartmentalized neuronal membrane system
  16920. Exploring cinnamic acid scaffold: development of promising Neuroprotective lipophilic antioxidants
  16921. Antibacterial, anti-inflammatory and Neuroprotective layer-by-layer coatings for neural implants
  16922. Partial depletion of the proinflammatory monocyte population is Neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of …
  16923. Human adipose-derived mesenchymal stem cells improve motor functions and are Neuroprotective in the 6-hydroxydopamine-rat model for Parkinson’s disease when …
  16924. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
  16925. Combined exposure to hypercapnia and hypoxia provides its maximum Neuroprotective effect during focal ischemic injury in the brain
  16926. Neuroprotective effects of Nigella sativa extracts during germination on central nervous system
  16927. Neuroprotective effect of loganin against Aβ 25–35-induced injury via the NF-κB-dependent signaling pathway in PC12 cells
  16928. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling
  16929. GGF2 is Neuroprotective in a rat model of cavernous nerve injury-induced erectile dysfunction
  16930. Neuroprotective effects of a polyphenolic white grape juice extract in a mouse model of experimental autoimmune encephalomyelitis
  16931. Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows Neuroprotective properties
  16932. The Neuroprotective effect of a novel agent N2 on rat cerebral ischemia associated with the activation of PI3K/Akt signaling pathway
  16933. Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats
  16934. Copaíba (Copaifera sp.) leaf extracts obtained by CO2 supercritical fluid extraction: Isotherms of global yield, kinetics data, antioxidant activity and Neuroprotective …
  16935. In vitro Neuroprotective activity of sesquiterpenoids from the flower buds of Tussilago farfara
  16936. A novel natural product inspired scaffold with robust neurotrophic, neurogenic and Neuroprotective action
  16937. A Neuroprotective role of the NMDA receptor subunit GluN3A (NR3A) in ischemic stroke of the adult mouse
  16938. Potential Neuroprotective strategies for perinatal infection and inflammation
  16939. Neuroprotective activity of (1S, 2E, 4R, 6R,-7E, 11E)-2, 7, 11-cembratriene-4, 6-diol (4R) in vitro and in vivo in rodent models of brain ischemia
  16940. The Neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro
  16941. Network-based proteomic approaches reveal the neurodegenerative, Neuroprotective and pain-related mechanisms involved after retrograde axonal damage
  16942. Activity-dependent Neuroprotective protein (ADNP): a case study for highly conserved chordata-specific genes shaping the brain and mutated in cancer
  16943. Neuroprotective effects of electroacupuncture on early-and late-stage spinal cord injury
  16944. Neuroprotective effects of Aceglutamide on motor function in a rat model of cerebral ischemia and reperfusion
  16945. Neuroprotective effect of thalidomide on MPTP-induced toxicity
  16946. The Neuroprotective effect of liraglutide is mediated by glucagon-like peptide 1 receptor-mediated activation of cAMP/PKA/CREB pathway
  16947. ELR-CXC chemokine antagonism is Neuroprotective in a rat model of ischemic stroke
  16948. Alpha-linolenic acid: an omega-3 fatty acid with Neuroprotective properties—ready for use in the stroke clinic?
  16949. Identification of p58IPK as a novel Neuroprotective factor for retinal neurons
  16950. … differentially modulate heparan sulfate proteoglycan sulfation during postnatal cerebellum development: evidence for Neuroprotective and neurite outgrowth …
  16951. Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis
  16952. Neuroprotective and neuroregenerative effects of nimodipine in a model system of neuronal differentiation and neurite outgrowth
  16953. Development of a Neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity
  16954. Neuroprotective effect of tauroursodeoxycholic acid on N-methyl-D-aspartate-induced retinal ganglion cell degeneration
  16955. Proteomic identification of calcium-binding chaperone calreticulin as a potential mediator for the Neuroprotective and neuritogenic activities of fruit-derived glycoside …
  16956. Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion
  16957. Neuroprotective effect of ethyl acetate extract from gastrodia elata against transient focal cerebral ischemia in rats induced by middle cerebral artery occlusion
  16958. Neuroprotective effect of the hairy root extract of Angelica gigas NAKAI on transient focal cerebral ischemia in rats through the regulation of angiogenesis
  16959. Mercury-induced neurotoxicity and Neuroprotective effects of berberine
  16960. Evaluation of multi-Neuroprotective effects of erythropoietin using cisplatin induced peripheral neurotoxicity model
  16961. Neuroprotective effect of neuroserpin in oxygen-glucose deprivation-and reoxygenation-treated rat astrocytes in vitro
  16962. Low doses of camptothecin induced hormetic and Neuroprotective effects in PC12 cells
  16963. Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice
  16964. Differential Neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides
  16965. Neuroprotective core measures 1–7: Neuroprotection of skin-to-skin contact (SSC)
  16966. Immunomodulatory and Neuroprotective effects of ginsenoside Rg1 in the MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine)-induced mouse model of Parkinson’s …
  16967. Biology-oriented development of novel lipophilic antioxidants with Neuroprotective activity
  16968. Neuroprotective effect of gui zhi (ramulus cinnamomi) on ma huang-(herb ephedra-) induced toxicity in rats treated with a ma huang-gui zhi herb pair
  16969. In vitro Neuroprotective activities of compounds from Angelica shikokiana Makino
  16970. Neuroprotective effects of hydrogen sulfide in Parkinson’s disease animal models: methods and protocols
  16971. Substantial Neuroprotective and neurite outgrowth-promoting activities by bis (propyl)-cognitin via the activation of alpha7-nAChR, a promising anti-Alzheimer’s dimer
  16972. Neuroprotective effects of deep hypothermia in refractory status epilepticus
  16973. Pro-GLP-1, a Pro-drug of GLP-1, is Neuroprotective in cerebral ischemia
  16974. Estrogens are Neuroprotective factors for hypertensive encephalopathy
  16975. Differences in the Neuroprotective Effect of Orally Administered Virgin Olive Oil (Olea europaea) Polyphenols Tyrosol and Hydroxytyrosol in Rats
  16976. Early upregulation of NLRP3 in the brain of neonatal mice exposed to hypoxia-ischemia: no early Neuroprotective effects of NLRP3 deficiency
  16977. Synthesis and evaluation of Neuroprotective selenoflavanones
  16978. Neuroprotective agents and modulation of temporal lobe epilepsy
  16979. Synthetic phenylethanoid glycoside derivatives as potent Neuroprotective agents
  16980. Neuroprotective effect of biatractylenolide against memory impairment in D-galactose-induced aging mice
  16981. Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat
  16982. Neuroprotective naphthalene and flavan derivatives from Polygonum cuspidatum
  16983. Neuroprotective effects of atorvastatin against cerebral ischemia/reperfusion injury through the inhibition of endoplasmic reticulum stress
  16984. Neuroprotective effects of monosialotetrahexosylganglioside
  16985. Neuroprotective role of an N-acetyl serotonin derivative via activation of tropomyosin-related kinase receptor B after subarachnoid hemorrhage in a rat model
  16986. α7 nicotinic receptor promotes the Neuroprotective functions of astrocytes against oxaliplatin neurotoxicity
  16987. Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome system
  16988. Tract shape modeling detects changes associated with preterm birth and Neuroprotective treatment effects
  16989. Neuroprotective effect of allicin in a rat model of acute spinal cord injury
  16990. Neuroprotective effect of calpeptin on acrylamide-induced neuropathy in rats
  16991. Evaluation of cyclosporine a as a cardio-and Neuroprotective agent after cardiopulmonary resuscitation in a rat model
  16992. Neuroprotective effects of nitidine against traumatic CNS injury via inhibiting microglia activation
  16993. Astrocytes in ischemic stroke-a potential target for Neuroprotective strategies
  16994. Sustained high levels of Neuroprotective , high molecular weight, phosphorylated tau in the longest-lived rodent
  16995. Blood-brain barrier permeability of Gualou Guizhi granules and Neuroprotective effects in ischemia/reperfusion injury
  16996. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a Neuroprotective role in vitro and in vivo
  16997. Forsythoneosides A–D, Neuroprotective Phenethanoid and Flavone Glycoside Heterodimers from the Fruits of Forsythia suspensa
  16998. Neuroprotective effects of torularhodin against H2O2-induced oxidative injury and apoptosis in PC12 cells
  16999. In vivo longitudinal proton magnetic resonance spectroscopy on neonatal hypoxic‐ischemic rat brain injury: Neuroprotective effects of acetyl‐L‐carnitine
  17000. Pentoxifylline Neuroprotective effects are possibly related to its anti-inflammatory and TNF-alpha inhibitory properties, in the 6-OHDA model of Parkinson’s …
  17001. The Neuroprotective effect of maltol against oxidative stress on rat retinal neuronal cells
  17002. Fractalkine/CX3CL1 engages different Neuroprotective responses upon selective glutamate receptor overactivation
  17003. Estrogen receptor (ER)-α36 is involved in estrogen-and tamoxifen-induced Neuroprotective effects in ischemic stroke models
  17004. The Neuroprotective and antioxidant activities of protein hydrolysates from grass carp (Ctenopharyngodon idella) skin
  17005. Synthesis and biological evaluation of novel marine-derived indole-based 1, 2, 4-oxadiazoles derivatives as multifunctional Neuroprotective agents
  17006. Repeated systemic administration of the nutraceutical alpha-linolenic acid exerts Neuroprotective efficacy, an antidepressant effect and improves cognitive …
  17007. Flecainide in amyotrophic lateral sclerosis as a Neuroprotective strategy (FANS): a randomized placebo-controlled trial
  17008. Substance P and its tachykinin NK1 receptor: a novel Neuroprotective target for Parkinson’s disease
  17009. MicroRNA-214 participates in the Neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson’s disease mouse
  17010. Neuroprotective effects and impact on caspase-12 expression of tauroursodeoxycholic acid after acute spinal cord injury in rats
  17011. The cyclic AMP effects and Neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation
  17012. The effectiveness of different Neuroprotective agents in facial nerve injury: an experimental study
  17013. Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease
  17014. The role of Rho/Rho-kinase pathway and the Neuroprotective effects of fasudil in chronic cerebral ischemia
  17015. Evaluation of antioxidant and Neuroprotective effect of Hippophae rhamnoides (L.) on oxidative stress induced cytotoxicity in human neural cell line IMR32
  17016. Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia
  17017. The sirtuin-2 inhibitor AK7 is Neuroprotective in models of Parkinson’s disease but not amyotrophic lateral sclerosis and cerebral ischemia
  17018. FGF-21, a novel metabolic regulator, has a robust Neuroprotective role and is markedly elevated in neurons by mood stabilizers
  17019. Co-administration of subtherapeutic diazepam enhances Neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus
  17020. Characterization of the Neuroprotective potential of derivatives of the iron chelating drug deferiprone
  17021. Monoamine oxidase inhibitors extracted from tobacco smoke as Neuroprotective factors for potential treatment of Parkinson’s disease
  17022. Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential Neuroprotective agents
  17023. Neuroprotective effect of cellular prion protein (PrPC) is related with activation of alpha7 nicotinic acetylcholine receptor (α7nAchR)-mediated autophagy flux
  17024. … -Induced Blood-brain Barrier Breakdown and brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles. Neuroprotective Effects of a 5 …
  17025. The Neuroprotective Agent CNTF Decreases Neuronal Metabolites in the Rat Striatum: An in Vivo Multimodal Magnetic Resonance Imaging Study
  17026. Neuroprotective effects of human serum albumin nanoparticles loaded with brimonidine on retinal ganglion cells in optic nerve crush model
  17027. Neuroprotective effect of the active components of three Chinese herbs on brain iron load in a mouse model of Alzheimer’s disease
  17028. Neuroprotective effect of VEGF-mimetic peptide QK in experimental brain ischemia induced in rat by middle cerebral artery occlusion
  17029. A comparative study of Neuroprotective effect of angiotensin converting enzyme inhibitors against scopolamine-induced memory impairments in rats
  17030. Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro
  17031. Neuroprotective effect of ketamine on acute spinal cord injury in rats
  17032. Neuroprotective role of thymoquinone against 1-methyl-4-phenylpyridinium-induced dopaminergic cell death in primary mesencephalic cell culture
  17033. Intraventricular Sialidase administration enhances GM1 ganglioside expression and is partially Neuroprotective in a mouse model of Parkinson’s disease
  17034. Neuroprotective effects of α-iso-cubebene against glutamate-induced damage in the HT22 hippocampal neuronal cell line
  17035. Neuroprotective effects of transplanted mesenchymal stromal cells-derived human umbilical cord blood neural progenitor cells in EAE
  17036. (+)-Naltrexone is Neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitation
  17037. Neuroprotective effects of enriched environment housing after transient global cerebral ischaemia are associated with the upregulation of insulin‐like growth factor‐1 …
  17038. Pharmacological actions and potential Neuroprotective effects of Rhus coriaria L. And Echium amoenum L.: a brief review
  17039. Nanoparticles exacerbate both ubiquitin and heat shock protein expressions in spinal cord injury: Neuroprotective effects of the proteasome inhibitor carfilzomib and …
  17040. Endogenous Neuroprotective molecules and their mechanisms in the central nervous system
  17041. Pharmacologic investigations on the role of Sirt-1 in Neuroprotective mechanism of postconditioning in mice
  17042. Intranasal delivery of apelin-13 is Neuroprotective and promotes angiogenesis after ischemic stroke in mice
  17043. Survival, Differentiation, and Neuroprotective Mechanisms of Human Stem Cells Complexed With Neurotrophin‐3‐Releasing Pharmacologically Active Microcarriers …
  17044. Mechanisms of neurodegeration in type 2 diabetes and the Neuroprotective potential of dipeptidyl peptidase 4 inhibitors
  17045. Re-engineering a Neuroprotective , clinical drug as a procognitive agent with high in vivo potency and with GABA a potentiating activity for use in dementia
  17046. Preischemic Neuroprotective effect of minocycline and sodium ozagrel on transient cerebral ischemic rat model
  17047. Pharmacokinetic and pharmacodynamic synergism between neuropeptides and lithium in the neurotrophic and Neuroprotective action of cerebrolysin
  17048. Neuroprotective effect of Citrus unshiu immature peel and nobiletin inhibiting hydrogen peroxide-induced oxidative stress in HT22 murine hippocampal …
  17049. Human umbilical cord blood cells induce Neuroprotective change in gene expression profile in neurons after ischemia through activation of Akt pathway
  17050. 12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ: a possible Neuroprotective effect in ischemic brain
  17051. PARP-1 inhibition is Neuroprotective in the R6/2 mouse model of Huntington’s disease
  17052. Neuroprotective strategies can prevent permanent paraplegia in the majority of patients who develop spinal cord ischaemia after endovascular repair of …
  17053. Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats
  17054. In vivo and in vitro ketamine exposure exhibits a dose-dependent induction of activity-dependent Neuroprotective protein in rat neurons
  17055. Increasing levels of the endocannabinoid 2-AG is Neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson’s disease
  17056. Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice
  17057. Neuroprotective effects of ultrasound-guided nerve growth factor injections after sciatic nerve injury
  17058. Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and Neuroprotective signaling events in the mouse hippocampus and prefrontal cortex
  17059. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a Neuroprotective therapy in TDP-43-related disorders
  17060. Short-and long-term consequences of perinatal asphyxia: looking for Neuroprotective strategies
  17061. Development of multifunctional, heterodimeric isoindoline-1, 3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with Neuroprotective …
  17062. Neurotrophic and Neuroprotective properties of exendin-4 in adult rat dorsal root ganglion neurons: involvement of insulin and RhoA
  17063. Neuroprotective body hypothermia among newborns with hypoxic ischemic encephalopathy: three-year experience in a tertiary university hospital. A …
  17064. Sulforaphane exerts Neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia
  17065. Lignan and flavonoids from the stems of Zea mays and their anti-inflammatory and Neuroprotective activities
  17066. Differential Neuroprotective and anti-inflammatory effects of L-type voltage dependent calcium channel and ryanodine receptor antagonists in the substantia nigra and …
  17067. Alkaloids from the bulbs of Lycoris longituba and their Neuroprotective and acetylcholinesterase inhibitory activities
  17068. The Discovery of a Highly Selective 5,6,7,8‐Tetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one SIRT2 Inhibitor that is Neuroprotective in an in vitro Parkinson’s …
  17069. In vitro and in vivo Neuroprotective effect of caffeic acid phenethyl ester
  17070. Neuroprotective effects of a novel translocator protein (18 kD a) ligand, ZBD‐2, against focal cerebral ischemia and NMDA‐induced neurotoxicity
  17071. Synthesis of resveratrol glycosides by plant glucosyltransferase and cyclodextrin glucanotransferase and their Neuroprotective activity
  17072. Design of the interface of edible nanoemulsions to modulate the bioaccessibility of Neuroprotective antioxidants
  17073. Could EEG monitoring in critically ill children be a cost-effective Neuroprotective strategy?
  17074. Evaluation of the Neuroprotective effect of taurine and green tea extract against oxidative stress induced by pilocarpine during status epilepticus
  17075. Neuroprotective properties of vitamin C on equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in high fat diet fed neonatal mice
  17076. Neuroprotective core measures 1–7: a developmental care journey: transformations in NICU design and caregiving attitudes
  17077. Neuroinflammatory signals enhance the immunomodulatory and Neuroprotective properties of multipotent adult progenitor cells
  17078. Evaluation of angiogenic and Neuroprotective potential of different extracts from three Veronica species
  17079. Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson’s disease rat model
  17080. Pravastatin acute Neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia
  17081. The Neuroprotective effect of coumaric acid on spinal cord ischemia/reperfusion injury in rats
  17082. The natural therapeutic magnesium lithospermate B potently provides Neuroprotective effects on cerebral ischemia/reperfusion injury in rats
  17083. Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ (1–42)-induced toxicity
  17084. Neuroprotective effects of three different sizes nanochelating based nano complexes in MPP (+) induced neurotoxicity
  17085. Neuroprotective effects of nitric oxide donor NOC-18 against brain ischemia-induced mitochondrial damages: role of PKG and PKC
  17086. Neuroprotective effect of alpha-lipoic acid and methylprednisolone on the spinal cord ischemia/reperfusion injury in rabbits
  17087. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats
  17088. Combination treatment with ethyl pyruvate and IGF-I exerts Neuroprotective effects against brain injury in a rat model of neonatal hypoxic-ischemic …
  17089. Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective …
  17090. A combination therapy of 17β-estradiol and memantine is more Neuroprotective than monotherapies in an organotypic brain slice culture model of traumatic brain …
  17091. Neuroprotective effect of modified Chungsimyeolda-tang, a traditional Korean herbal formula, via autophagy induction in models of Parkinson׳ s disease
  17092. Neuroprotective effect of atorvastatin in spinal cord ischemia-reperfusion injury
  17093. Neuroprotective effects of aframomum melegueta extract after experimental traumatic brain injury
  17094. Oxidative stress in the brain of cigarette smoke-induced noxiousness: Neuroprotective role of Sesbania grandiflora
  17095. Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is Neuroprotective in an animal model of Alzheimer’s …
  17096. Deletion of aquaporin-4 is Neuroprotective during the acute stage of micro traumatic brain injury in mice
  17097. High throughput characterization of adult stem cells engineered for delivery of therapeutic factors for Neuroprotective strategies
  17098. Kinin B2 receptor can play a Neuroprotective role in Alzheimer’s disease
  17099. Integrating image-based high-content screening with mouse models identifies 5-hydroxydecanoate as a Neuroprotective drug for paclitaxel-induced neuropathy
  17100. Acyl-2-aminobenzimidazoles: A novel class of Neuroprotective agents targeting mGluR5
  17101. Ligustrazinyl amides: a novel class of ligustrazine-phenolic acid derivatives with Neuroprotective effects
  17102. Neuroprotective effects of mGluR II and III activators against staurosporine-and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism …
  17103. Regional and time‐dependent Neuroprotective effect of hypothermia following oxygen‐glucose deprivation
  17104. The Neuroprotective effect of kefir on spinal cord ischemia/reperfusion injury in rats
  17105. The Neuroprotective mechanism of puerarin in the treatment of acute spinal ischemia–reperfusion injury is linked to cyclin-dependent kinase 5
  17106. Anti-Aβ single-chain variable fragment antibodies exert synergistic Neuroprotective activities in Drosophila models of Alzheimer’s disease
  17107. Neuroprotective and antiapoptotic activity of lineage-negative bone marrow cells after intravitreal injection in a mouse model of acute retinal injury
  17108. Exacerbation of methamphetamine neurotoxicity in cold and hot environments: Neuroprotective effects of an antioxidant compound H-290/51
  17109. The Neuroprotective effect of lovastatin on MPP+-induced neurotoxicity is not mediated by PON2
  17110. A tripeptide isolated from Bothrops atrox venom has Neuroprotective and neurotrophic effects on a cellular model of Parkinson’s disease
  17111. Poloxamer-188 can attenuate blood–brain barrier damage to exert Neuroprotective effect in mice intracerebral hemorrhage model
  17112. Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity
  17113. Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
  17114. Neuroprotective core measure 5: minimizing stress and pain—neonatal pain management practices during heel lance and venipuncture in Ontario, Canada
  17115. Potential Neuroprotective role of transforming growth factor β1 (TGFβ1) in the brain
  17116. An involvement of PI3‐K/Akt Activation and inhibition of AIF translocation in Neuroprotective effects of undecylenic acid (UDA) against pro‐apoptotic factors‐induced …
  17117. Neuroprotective potential of mesenchymal stem cell-based therapy in acute stages of TNBS-induced colitis in guinea-pigs
  17118. The Neuroprotective effects of decursin isolated from angelica gigas nakai against amyloid β-protein-induced apoptosis in pc 12 cells via a mitochondria-related …
  17119. Polyelectrolyte-coated nanocapsules containing undecylenic acid: synthesis, biocompatibility and Neuroprotective properties
  17120. Neuroprotective effects of salidroside against focal celebral ischemia/reperfusion injury in rats
  17121. Isolation and identification of twelve metabolites of isocorynoxeine in rat urine and their Neuroprotective activities in HT22 cell assay
  17122. Antioxidant activity, cellular bioavailability, and iron and calcium management of Neuroprotective and nonNeuroprotective flavones
  17123. Identification of 5-methoxyflavone as a novel DNA polymerase-beta inhibitor and Neuroprotective agent against beta-amyloid toxicity
  17124. Tamoxifen and Src kinase inhibitors as Neuroprotective /neuroregenerative drugs after spinal cord injury
  17125. Rg1 exhibits Neuroprotective effects by inhibiting the endoplasmic reticulum stress‑mediated c‑Jun N‑terminal protein kinase apoptotic pathway in a rat model …
  17126. Mexicanolide limonoids with in vitro Neuroprotective activities from seeds of Khaya senegalensis
  17127. The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its Neuroprotective role in Drosophila melanogaster
  17128. Chemically bonding of amantadine with gardenamide a enhances the Neuroprotective effects against corticosterone-induced insults in PC12 cells
  17129. Combined Neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus
  17130. Insulin exerts Neuroprotective effects via Akt/Bcl-2 signaling pathways in differentiated SH-SY5Y cells
  17131. Novel antiepileptic drug lacosamide exerts Neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke
  17132. Application of online microdialysis coupled with liquid chromatography-tandem mass spectrometry method in assessing Neuroprotective effect of Rhizoma coptidis on …
  17133. Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and Neuroprotective agents for Alzheimer’s disease
  17134. The blockade of NF-κB activation by a specific inhibitory peptide has a strong Neuroprotective role in a Sprague-Dawley rat kernicterus model
  17135. The Neuroprotective effect of a triazine derivative in an Alzheimer’s rat model.
  17136. Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: Neuroprotective role in maintaining blood brain …
  17137. Neuroprotective changes in degeneration-related gene expression in the substantia nigra following acupuncture in an MPTP mouse model of Parkinsonism …
  17138. Early combined therapy with pharmacologically induced hypothermia and edaravone exerts Neuroprotective effects in a rat model of intracerebral hemorrhage
  17139. Spatio-temporal assessment of the Neuroprotective effects of neuregulin-1 on ischemic stroke lesions using MRI
  17140. Pressure-induced alterations in PEDF and PEDF-R expression: implications for Neuroprotective signaling in glaucoma
  17141. Modification of autophagy-lysosomal pathway as a Neuroprotective treatment for spinal cord injury
  17142. Neuroprotective effects of Bcl-2 overexpression on nerve cells of rats with acute cerebral infarction
  17143. Neuroprotective effects of pretreatment with macrolide antibiotics on cerebral ischemia reperfusion injury
  17144. Neuroprotective effect from stem bark extracts of Knema laurina against H2O2- and Aβ1–42-induced cell death in human SH-SY5Y cells
  17145. Neuroprotective effects of propolis and caffeic acid phenethyl ester (CAPE) on the radiation-injured brain tissue (Neuroprotective effects of propolis and CAPE)
  17146. Transplanted neural stem cells: playing a Neuroprotective role by ceruloplasmin in the substantia nigra of PD model rats?
  17147. Translational principles of Neuroprotective and neurorestorative therapy testing in animal models of traumatic brain injury
  17148. Fluoxetine is Neuroprotective in slow-channel congenital myasthenic syndrome
  17149. Neuroprotective effect of lentivirus mediated VEGF on rat model with cerebral ischemic injury
  17150. The incremental induction of Neuroprotective properties by multiple therapeutic strategies for primary and secondary neural injury
  17151. Comparing Neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model …
  17152. Antioxidative and Neuroprotective effects of volatile components in essential oils from Chrysanthemum indicum Linné flowers
  17153. Comparative metabolomic analysis of the Neuroprotective effects of scutellarin and scutellarein against ischemic insult
  17154. Remote limb ischemic preconditioning: a Neuroprotective technique in rodents
  17155. The intracellular domain of L1CAM binds to casein kinase 2α and is Neuroprotective via inhibition of the tumor suppressors PTEN and p53
  17156. Limonoids from the root bark of Dictamnus angustifolius: potent Neuroprotective agents with biometal chelation and halting copper redox cycling properties
  17157. Current neurogenic and Neuroprotective strategies to prevent and treat neurodegenerative and neuropsychiatric disorders
  17158. Neuroprotective effect of noscapine on cerebral oxygen–glucose deprivation injury
  17159. α-Linolenic acid, a nutraceutical with pleiotropic properties that targets endogenous Neuroprotective pathways to protect against organophosphate nerve agent …
  17160. Neuronal regulation of Neuroprotective microglial apolipoprotein e secretion in rat in vitro models of brain pathophysiology
  17161. Determining the Neuroprotective effects of dextromethorphan in lipopolysaccharide‑stimulated BV2 microglia
  17162. Paracrine Neuroprotective effects of neural stem cells on glutamate-induced cortical neuronal cell excitotoxicity
  17163. Neuroprotective effect of Brahmi, an ayurvedic drug against oxidative stress induced by methyl mercury toxicity in rat brain mitochondrial-enriched fractions
  17164. A Neuroprotective Function of NSF1 Sustains Autophagy and Lysosomal Trafficking in Drosophila
  17165. Neuroprotective effect of erythropoietin in postoperation cervical spinal cord injury: case report and review
  17166. Sulfiredoxin-1 exerts anti-apoptotic and Neuroprotective effects against oxidative stress-induced injury in rat cortical astrocytes following exposure to oxygen …
  17167. Wnt-related SynGAP1 is a Neuroprotective factor of glutamatergic synapses against Aβ oligomers
  17168. Neuroprotective effect of interleukin-6 regulation of voltage-gated Na+ channels of cortical neurons is time-and dose-dependent
  17169. Picroside II has a Neuroprotective effect by inhibiting ERK 1/2 activation after cerebral ischemic injury in rats
  17170. Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid
  17171. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation-and kainate-induced neuronal cell …
  17172. Stress-induced Neuroprotective effects of epiregulin and amphiregulin
  17173. Neuroprotective effect of nicorandil through inhibition of apoptosis by the PI3K/Akt1 pathway in a mouse model of deep hypothermic low flow
  17174. Pierisformoside B exhibits Neuroprotective and anti-inflammatory effects in murine hippocampal and microglial cellsviathe HO-1/Nrf2-mediated pathway
  17175. The Neuroprotective effects of ratanasampil on oxidative stress-mediated neuronal damage in human neuronal SH-SY5Y cells
  17176. Stromal cell-derived factor-1α plays a crucial role based on Neuroprotective role in neonatal brain injury in rats
  17177. Role of NF-E2-related factor 2 in Neuroprotective effect of l-carnitine against high glucose-induced oxidative stress in the retinal ganglion cells
  17178. brain ischemia downregulates the Neuroprotective GDNF-Ret signaling by a calpain-dependent mechanism in cultured hippocampal neurons
  17179. The Neuroprotective effect of magnesium sulfate in preterm fetal mice
  17180. NGF expression in reelin-deprived retinal cells: A potential Neuroprotective effect
  17181. Neuroprotective core measure 2: partnering with families-exploratory study on web-camera viewing of hospitalized infants and the effect on parental stress, anxiety …
  17182. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-l-carnitine
  17183. … dopamine agonist D-512 against oxidative stress produced by depletion of glutathione in PC12 cells: implication in Neuroprotective therapy for Parkinson’s disease
  17184. Palmitoyl serine: an endogenous Neuroprotective endocannabinoid-like entity after traumatic brain injury
  17185. Neuroprotective effects of collagen matrix in rats after traumatic brain injury
  17186. Neuroprotective , antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review
  17187. Neuroprotective core measure 7: optimizing nutrition—breastfeeding, human milk and attachment
  17188. MRZ-99030–A novel modulator of Aβ aggregation: I–mechanism of action (MoA) underlying the potential Neuroprotective treatment of Alzheimer’s disease, glaucoma …
  17189. Oleanolic acid: a promising Neuroprotective agent for cerebral ischemia
  17190. Neuroprotective effect of functionalized multi-walled carbon nanotubes on spinal cord injury in rats
  17191. Neuroprotective mechanisms of 9-hydroxy epinootkatol against glutamate-induced neuronal apoptosis in primary neuron culture
  17192. Synthesis and biological evaluation of 3-([1, 2, 4] triazolo [4, 3-a] pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and Neuroprotective …
  17193. Neuroprotective effects of α-iso-cubebenol on glutamate-induced neurotoxicity
  17194. Early applied electric field stimulation attenuates secondary apoptotic responses and exerts Neuroprotective effects in acute spinal cord injury of rats
  17195. Regiospecific synthesis of Neuroprotective 1, 4-benzoxazine derivatives through a tandem oxidation–Diels–Alder reaction
  17196. Modulation of the nitrergic pathway via activation of PPAR-γ contributes to the Neuroprotective effect of pioglitazone against streptozotocin-induced memory …
  17197. Neuroprotective effect of oral choline administration after global brain ischemia in rats
  17198. Determination of Neuroprotective oxysterols in Calculus bovis, human gallstones, and traditional Chinese medicine preparations by liquid chromatography with mass …
  17199. Neuroprotective effects of activated protein C on intrauterine inflammation-induced neonatal white matter injury are associated with the downregulation of …
  17200. Neuroprotective effect of compound anisodine in a mouse model with chronic ocular hypertension
  17201. Berberine chloride pretreatment exhibits Neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat
  17202. Hepatoprotective and Neuroprotective tocopherol analogues isolated from the peels of Citrus unshiu Marcovich
  17203. Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
  17204. Neuroprotective effects of an aqueous extract of Futokadsura stem in an Aβ-induced Alzheimer’s disease-like rat model
  17205. Coffee and its active compounds are Neuroprotective
  17206. Green tea catechins as Neuroprotective agents : system-atic review of the literature in animal pre-clinical trials
  17207. Neuroprotective and antioxidant effects of novel benzofuran-2-carboxamide derivatives
  17208. Neuroprotective effects of intravitreal triamcinolone acetonide and dexamethasone implant in rabbit retinas after pars plana vitrectomy and silicone oil injection
  17209. Neuroprotective role of sphingosine-1-phosphate in L-BMAA treated neuroblastoma cells (SH-SY5Y)
  17210. HspB8 is Neuroprotective during oxygen glucose deprivation and reperfusion
  17211. Flavonoids as novel Neuroprotective nutraceuticals
  17212. Chemical composition and in-vitro study for analysis of potential Neuroprotective and antidiabetic activity in Mimusops elengi L
  17213. Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its Neuroprotective and regenerative properties in vitro
  17214. Neuroprotective effect of methylprednisolone combined with placenta-derived mesenchymal stem cell in rabbit model of spinal cord injury
  17215. Neuroprotective activities of fermented Ganoderma lucidum extracts by lactic acid bacteria against H 2 O 2-stimulated oxidative stress in PC12 cells
  17216. Neuroprotective effects of sildenafil in experimental spinal cord injury in rabbits
  17217. Neuroprotective effects of piperine, an alkaloid from the Piper genus, on the Parkinson’s disease model in rats
  17218. Neuroprotective activity of creatylglycine ethyl ester fumarate
  17219. Neuroprotective compounds of Tilia amurensis
  17220. Potential Neuroprotective effect of Anakinra in spinal cord injury in an in vivo experimental animal model
  17221. Neuroprotective effect of phytoceramide against transient focal ischemia-induced brain damage in rats
  17222. Neuroprotective Effect of Sargassum thunbergii (Mertens ex Roth) Kuntze in Activated Murine Microglial Cells
  17223. Neuroprotective mechanisms of oxygen and ethanol: a potential combination therapy in stroke
  17224. Neuroprotective effect of Radix Trichosanthis Saponins on subarachnoid hemorrhage
  17225. The Neuroprotective role of vesicular monoamine transporter 2 in neurodegenerative diseases
  17226. Neuroprotective and anti‐inflammatory mechanisms are activated early in O ptic N euritis
  17227. Progesterone is Neuroprotective by inhibiting cerebral edema after ischemia
  17228. The Neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis
  17229. The Neuroprotective mechanism of low-frequency rTMS on nigral dopaminergic neurons of Parkinson’s disease model mice
  17230. Screening of Possible In Vitro Neuroprotective , Skin Care, Antihyperglycemic, and Antioxidative Effects of Anchusa undulata L. subsp. hybrida (Ten.) Coutinho from …
  17231. Maternal obesity and Neuroprotective magnesium sulfate
  17232. Erythropoiesis stimulating agents demonstrate safety and show promise as Neuroprotective agents in neonates
  17233. Neuroprotective core measure 4: Safeguarding sleep—Its value in Neuroprotection of the newborn
  17234. Neuroprotective effect of Tagara, an Ayurvedic drug against methyl mercury induced oxidative stress using rat brain mitochondrial fractions
  17235. Neuroprotective mechanisms activated in non-seizing rats exposed to sarin
  17236. Interferon beta (IFN-β) treatment exerts potential Neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor …
  17237. Effects of methylprednisolone on Neuroprotective effects of delay hypothermia on spinal cord injury in rat
  17238. Transplantation of human mesenchymal stem cells into the cisterna magna and its Neuroprotective effects in a parkinsonian animal model
  17239. Methodologies and limitations in the analysis of potential Neuroprotective compounds derived from natural products
  17240. Neuroprotective effect of pretreatment with Mentha longifolia L. extract on brain ischemia in the rat stroke model
  17241. Neuroprotective effects of cutamesine, a ligand of the sigma‐1 receptor chaperone, against noise‐induced hearing loss
  17242. The use of nanotechnology to improve the Neuroprotective effects of adenosine in stroke and spinal cord injury
  17243. cognitive training in neurodegenerative diseases: a way to boost Neuroprotective molecules?
  17244. The Neuroprotective effects of (S)-3, 5-dihydroxyphenylglycine preconditioning in middle cerebral artery occluded rats: a perspective as a contrivance for …
  17245. Dietary modifications in Parkinson’s disease: A Neuroprotective intervention?
  17246. In vitro antiradical and Neuroprotective activity of polyphenolic extract from marine algae Padina australis H
  17247. Adipose tissue-derived mesenchymal stem cells cultured at high cell density express brain -derived neurotrophic factor and exert Neuroprotective effects in a 6 …
  17248. Neuroprotective effects of cirsium setidens, pleurospermum kamtschaticumin, and allium victorials based on antioxidant and p38 phosphorylation inhibitory activities …
  17249. Does the intrathecal propofol have a Neuroprotective effect on spinal cord ischemia?
  17250. Anticonvulsive and Neuroprotective effects of synergetic combination of phenytoin and gastrodin on the convulsion induced by penicillin in mice
  17251. Evaluation of anticonvulsant and Neuroprotective effects of camel milk in strychnine-induced seizure model
  17252. Assessment of the Neuroprotective effects of the acetylcholinesterase inhibitor huperzine A in an experimental spinal cord trauma model.
  17253. Neuroprotective effects of soybean protein isolate hydrolysates against neuronal oxidative damage in PC12 neuronal cells
  17254. Neuroprotective effects of hemicraniectomy in malignant middle cerebral artery infarctions: experimental study.
  17255. An experimental study: does the Neuroprotective effect increase when hypothermia deepens after traumatic brain injury?
  17256. Shoot cultures of Hoppea fastigiata (Griseb.) CB Clarke as potential source of Neuroprotective xanthones
  17257. Neuroprotective effects of okadaic acid following oxidative injury in organotypic hippocampal slice culture
  17258. Enhanced Neuroprotective effects of coadministration of tetrandrine with Glutathione in preclinical model of parkinson’s disease
  17259. Involvement of the GABAergic system in the Neuroprotective and sedative effects of acacetin 7-O-glucoside in rodents
  17260. Neuroprotective effect of Mentha longifolia L. extract on ischemia/reperfusion-induced brain injury in male Wistar rats
  17261. Hyaluronan tetrasaccharide exerts Neuroprotective effect and promotes functional recovery after acute spinal cord injury in rats
  17262. The Neuroprotective effect of erythropoietin on spinal motor neurons after nerve root avulsion injury in rats
  17263. Neuroprotective effects of a glutathione depletor in rat post-ischemic reperfusion brain damage
  17264. The Neuroprotective effect of alcoholic and aqueous extracts of Achillea biebersteinii leaves on spinal motoneurons denegation after sciatic nerve compression in rats
  17265. Highly efficient synthesis of 1, 3-dihydroxy-2-carboxycarbazole and its Neuroprotective effects
  17266. Neuroprotective efficacy of decompressive craniectomy after controlled cortical impact injury in rats: an MRI study
  17267. Beyond the 5-HT3 receptors: a role for α7nACh receptors in Neuroprotective aspects of tropisetron
  17268. LC-MS/MS profiling and Neuroprotective effects of Mentat® against transient global ischemia and reperfusion–induced brain injury in rats
  17269. Neuroprotective role of lazaroids against aluminium chloride poisoning
  17270. Neuroprotective impact of a vitamin trace element composition—A randomized, double blind, placebo controlled clinical trial with healthy volunteers
  17271. Possibilities of the treatment of speech impairment in the acute stage of ischemic stroke using Neuroprotective therapy
  17272. Neuroprotective effects of IL-22 during CNS inflammation (CCR4P. 203)
  17273. Neuroprotective efficacy of newly developed oximes in comparison with currently available oximes in tabun-poisoned rats
  17274. Are high cumulative doses of erythropoietin Neuroprotective in preterm infants? A two year follow-up report
  17275. Neuroprotective effect of pet ether extract of Ficus religiosa (L.) leaves in 3-nitropropionic acid induced Huntington
  17276. Neuroprotective or neurotoxic effects of 4-aminopyridine mediated by KChIP1 regulation through adjustment of Kv 4.3 potassium channels expression and GABA …
  17277. Monocarboxylate transporter 4 plays a significant role in the Neuroprotective mechanism of ischemic preconditioning in transient cerebral ischemia
  17278. Neuroprotective Effects of Modified Yuldahanso-tang (MYH) in a Parkinson’s Disease Mouse Model
  17279. Neuroprotective mechanism of acupuncture at GB34 for dopaminergic neurons in the striatum of a Parkinson’s disease mouse model
  17280. Dual anticonvulsant and Neuroprotective effects of therapeutic hypothermia after status epilepticus
  17281. Possible role of pannexin 1/P2x7 purinoceptor in Neuroprotective mechanism of ischemic postconditioning in mice
  17282. The Neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
  17283. Neuroprotective effects of tetracyclines on blunt head trauma: An experimental study on rats
  17284. Tetrahydrohyperforin: a Neuroprotective modified natural compound against Alzheimer’s disease
  17285. An imprinted dopamine receptor for discovery of highly potent and selective D3 analogues with Neuroprotective effects
  17286. Calbindin‐D28K is increased in the ventral horn of spinal cord by Neuroprotective factors for motor neurons
  17287. Neuroprotective effects of ginkgo biloba extract on brain damage induced by γ-radiation and lead acetate
  17288. Neuroprotective EFFECT OF THYMOQUINONE AGAINST GLUTAMATE-INDUCED TOXICITY IN SH-SY5Y CELLS.
  17289. Neuroprotective effects of Indigofera tinctoria on noise stress affected Wistar albino rat brain
  17290. Research progress of Neuroprotective mechanisms of puerarin
  17291. Neuroprotective role of wheatgrass powder in experimental diabetic neuropathy via modulating oxidative stress markers in rat sciatic nerves
  17292. Neuroprotective activity of parawixin 10, a compound isolated from Parawixia bistriata spider venom (Araneidae: Araneae) in rats undergoing …
  17293. 3,2/-Dihydroxyflavone-Treated Pluripotent Stem Cells Show Enhanced Proliferation, Pluripotency Marker Expression, and Neuroprotective Properties
  17294. Secondary Degeneration After Partial Optic Nerve Injury and Possible Neuroprotective Effects of Lycium Barbarum (Wolfberry)
  17295. Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders
  17296. Neuroprotective and antioxidant effects of neuroglutam in cerebral ischemia
  17297. Neuroprotective core measure 2: partnering with families-effects of a weighted maternally-scented parental simulation device on premature infants in neonatal …
  17298. Neuroprotective effect of Annona squamosa & (-) Anonaine in decreased GABA receptor of epileptic rats
  17299. Differential effects of early postinjury treatment with Neuroprotective drugs in a mouse model using diffuse reflectance spectroscopy
  17300. Toll-like receptor 2 deficiency shifts PrP106-126-induced microglial activation from a neurotoxic to a Neuroprotective phenotype
  17301. Study of Neuroprotective , antihypoxic and antiamnesic effects of new mixture of tripeptides
  17302. The Neuroprotective effects of aspirin following crush injury to rat sciatic nerve
  17303. Neuroprotective drugs
  17304. Neuroprotective effects of Rhizoma Dioscoreae polysaccharides against neuronal apoptosis induced by in vitro hypoxia
  17305. Neuroprotective Effect of Aqueous Extract of Garcinia kola on Monosodium Glutamate-Induced Cerebellar Cortical Damage in Adult Wistar Rats
  17306. Neuroprotective effects of estrogen following neural injury
  17307. Pharmacokinetic and pharmacodynamic analysis of ferulic acid-puerarin-astragaloside in combination with Neuroprotective in cerebral ischemia/reperfusion injury in …
  17308. Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion.
  17309. Neuroprotective effects of xylopic acid on lipopolysaccharide-induced neuroinflammation
  17310. Synthesis of GK-2, a Dimeric Dipeptide Nerve Growth Factor Mimetic and Potential Neuroprotective Agent
  17311. Ultrastructural mitochondria changes in perihematomal brain and Neuroprotective effects of huperzine A after acute intracerebral hemorrhage
  17312. Neuroprotective effect of Reseda luteola L. extract in a mouse neuronal cell model
  17313. Enhancement of the Neuroprotective activity of Hericium erinaceus mycelium co-cultivated with Allium sativum extract
  17314. Neuroprotective effect of geniposide on Parkinson’s disease model mice
  17315. Dietary interventions as a Neuroprotective therapy for the delay of the onset of cognitive decline in older adults: an umbrella review protocol
  17316. Evaluating rehabilitation interventions in Parkinson’s disease with functional MRI: a promising Neuroprotective strategy
  17317. Synthesis of (2-amino) ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and Neuroprotective effects
  17318. Neuroprotective Core Measure 3: Positioning & Handling—A Look at Preventing Positional Plagiocephaly
  17319. Synergistic Neuroprotective effect of microglial‑conditioned media treated with geniposide and ginsenoside Rg1 on hypoxia injured neurons
  17320. A single fraction from Uncaria sinensis exerts Neuroprotective effects against glutamate-induced neurotoxicity in primary cultured cortical neurons
  17321. Long-term treatment of aged Long Evans rats with a dietary supplement containing Neuroprotective peptides (N-PEP-12) to prevent brain aging: effects of …
  17322. Neuroprotective effects of 3-O-demethylswertipunicoside against MPTP-induced Parkinson׳ s disease in vivo and its antioxidant properties in vitro
  17323. Neuroprotective Effects of pterois volitans venom against alcohol induced oxidative dysfunction in Rats
  17324. Neuroprotective properties of the PrP-like Shadoo glycoprotein assessed in the middle cerebral artery occlusion model of ischemia
  17325. Neuroprotective effect of lercanidipine-a novel calcium channel blocker in albino mice
  17326. Neuroprotective and antiamnesic effect of erythropoietin derivatives after experimental ischemic injury of cerebral cortex
  17327. The Neuroprotective effects of endurance training on the aging brain
  17328. Antioxidant and Neuroprotective Effects of Korean Fermented Food Doenjang
  17329. Endurance exercise confers Neuroprotective mitochondrial phenotypes in the brain of Alzheimer’s disease mice
  17330. Neuroprotective effects of rosuvastatin in spinal cord ischemia-reperfusion injury in rabbits
  17331. Neuroprotective effects of porphyran derivatives against 6-hydroxydopamine-induced cytotoxicity is independent on mitochondria restoration
  17332. Transcription factor Nrf2: a novel target to modulate inflammatory and Neuroprotective responses in Parkinson’s disease
  17333. Neuroprotective effects of YXETNZ injection on SH-SY5 Y cells against injury induced by oxygen-glucose deprivation
  17334. The Neuroprotective effect of lithium in cannabinoid dependence is mediated through modulation of cyclic AMP, ERK1/2 and GSK-3β phosphorylation in …
  17335. The Neuroprotective effect of pretreatment with Lavandula officinalis ethanolic extract on brain edema in rat stroke model
  17336. Neuroprotective effect of flavonoids, via up‐regulating Nrf2‐ARE pathway, in MPP+‐induced PC12 cells, as a model of Parkinson’s disease
  17337. Role of the Toll‑like receptor 3 signaling pathway in the Neuroprotective effect of sevoflurane pre‑conditioning during cardiopulmonary bypass in rats
  17338. Neuroprotective Effects of 17β-Estradiol against Thrombin-Induced Apoptosis in Primary Cultured Cortical Neurons
  17339. Neuroprotective activity of hydroponic Teucrium polium following bilateral ovariectomy
  17340. Marine Algae for Protecting Your brain : Neuroprotective Potentials of Marine Algae
  17341. Neuroprotective core measure 6: Protecting skin-Neuroprotective care in the newborn: does skin protect the immature brain from hyperbilirubinemia?
  17342. Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress
  17343. Neuroprotective effect of escitalopram oxalate in rats with chronic hypoperfusion
  17344. PHARMACOECONOMIC ANALYSIS OF Neuroprotective DRUGS IN THE TREATMENT OF ACUTE DISORDERS OF CEREBRAL CIRCULATION
  17345. No‐carrier‐added labeling of the Neuroprotective Ebselen with selenium‐73 and selenium‐75
  17346. The inositol metabolism pathway as a target for Neuroprotective strategies
  17347. Activity-dependent Neuroprotective protein (ADNP): From autism to Alzheimer’s disease
  17348. Design, synthesis and biological evaluation of tricyclic diterpene derivatives as novel Neuroprotective agents against ischemic brain injury
  17349. Neuroprotective effects of bee venom phospholipase A2 mediated by the suppression of neuroinflammatory responses in the 3xTg AD mouse model of Alzheimer’s …
  17350. Neuroprotective effect of barley plant (Hardeum Valgara) against the changes in MAO induced by lead and cadmium administration in different CNS regions of male …
  17351. Neuroprotective effects of cortexin and ischemic preconditioning
  17352. Is prolidase a Neuroprotective molecule in post-traumatic stress disorder?
  17353. Neuroprotective effect of bisabolangelone on hydrogen peroxide-induced neurotoxicity in SH-SY5Y cells
  17354. A role of Neuroprotective therapy in the rehabilitation of children with sensorineural hearing loss, IV degrees, after cochlear implanta-tion
  17355. Neuroprotective effect of Jobelyn in the hippocampus of alcoholic rat is mediated in part by alterations in GFAP and NF protein expressions
  17356. Caffeinol: a Neuroprotective action in ischemic brain damage
  17357. Neuroprotective effect of Melissa officinalis in animal model of spinal cord injurya
  17358. Neuroprotective effect of Chinese herbal monomers and extracts via activation of Nrf2 signal pathway
  17359. New labeled derivatives of the Neuroprotective peptide colivelin: Synthesis, characterization, and first in vitro and in vivo applications
  17360. The Neuroprotective effect of a traditional herbal (kyung‐ok‐ko) on transient middle cerebral artery occlusion‐Induced ischemic rat brain
  17361. Neuroprotective effects of paeonol in a cell model of Parkinson disease
  17362. Potential Neuroprotective Role of Verapamil in Experimentally-Induced Chronic Sciatic Nerve Constriction in Mice
  17363. Free radicals scavenging and Neuroprotective effects of ethanolic leaf extract of Combretum zenkeri leaf
  17364. Evaluation of Neuroprotective activity of Bauhinia variegata on reserpine induced catalepsy in rats
  17365. Neuroprotective effect of renin angiotensin system blockers on experimentally induced Alzheimer’s disease in rats
  17366. Neuroprotective strategies using vegetal compounds in the treatment of Alzheimer’s disease
  17367. Two-arm randomised futility trials: PD-stat-a futility trial of a potential Neuroprotective treatment in people with Parkinson’s disease
  17368. Role of microRNA-134 in the Neuroprotective effects of propofol against oxygen-glucose deprivation and related mechanisms
  17369. AND Neuroprotective EFFECTS
  17370. Breaking out from the Neuroprotective logjam: combined treatment with remote ischemic conditioning and minocycline in the prehospital setting
  17371. Neuroprotective Efficacy of lipoic acid in Acrylamide-Induced Neuropathy in Rats: Behavioral and Histopathological evidence
  17372. Neuroprotective potential of AAV-mediated NURR1 expression in a rat model of Parkinson’s disease
  17373. Knockdown of interleukin-1 receptor 1 is not Neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson’s disease
  17374. NEUROLOGICAL, cognitive , AND Neuroprotective EFFECTS OF TREATMENTS USED IN BIPOLAR DISORDER
  17375. Structure of Neuroprotective [G-14] humanin peptide by quantum chemistry, NMR and circular dichroism
  17376. Neuroprotective effects of Salvia aristata Aucher ex Benth. on hydrogen peroxide induced apoptosis in SH-SY5Y neuroblastoma cells
  17377. Potential antioxidant, genoprotective and Neuroprotective effect of spent coffee
  17378. Neuroprotective Effect of Demethylsuberosin, a Proteasome Activator, against MPP+-induced Cell Death in Human Neuroblastoma SH-SY5Y Cells
  17379. The Neuroprotective potential of endoplasmic reticulum chaperones
  17380. Neuroprotective Effect of Aqueous Extract of Achillea millifolium Against Retrograde Destruction of Neurons of Ventral Horn of the Spinal Cord After Sciatic Nerve …
  17381. Polycyclic propargylamine derivatives as multifunctional Neuroprotective agents
  17382. Neuroprotective effect of Cleistocalyx nervosum var. paniala extract in a rat model of ischemic stroke
  17383. Mechanisms of improving the Neuroprotective effects of multipotent stromal cells after Co-culturing with neurons
  17384. Neuroprotective Properties of Xenon in Traumatic brain Injury
  17385. Losartan is Neuroprotective in experimental mouse glaucoma
  17386. Acute optic neuritis: a clinical paradigm for evaluation of Neuroprotective and restorative strategies?
  17387. Neuroprotective effects of aqueous extract of achillea wilhelmsii on motor neuron destruction of spinal cord ventral horn after sciatic nerve compression in male adult …
  17388. Lycium Barbarum: Neuroprotective Effects in Ischemic Stroke
  17389. P8: NCX Family as a Neuroprotective
  17390. Overview of ethical issues for conducting Neuroprotective clinical trials in patients with spinal cord injury
  17391. Neuroprotective effect of acetyl L carnitine in compression-induced model of spinal cord injury in adult rats
  17392. Neuroprotective effert of carbon monoxide and Nrf2 in cerebral ischemia
  17393. Structural studies of humanin and its derivatives in the investigation of their Neuroprotective role against Alzheimer’s disease
  17394. Abstract W MP94: Neuroprotective Effect of Isosteviol Sodium on Focal Cerebral Ischemia in Rats
  17395. Neuroprotective effect of sulfated pachymaran on the MPTP-induced Parkinson mice
  17396. Synthesis of natural and non-natural diarylheptanoids and evaluation of their Neuroprotective activity
  17397. Granulocyte colony-stimulating factor-mediated Neuroprotective therapy for acute spinal cord injury: From bench to bedside
  17398. The Neuroprotective Role Of Vitamin D On Neurons In A Central Nervous System Autoimmune Disease
  17399. Bacterial melanin in rat models of Parkinson’s disease: a potential Neuroprotective strategy
  17400. Neuroprotective effect of progesterone on focal cerebral ischemia/reperfusion injury in rats and its mechanism
  17401. Neuroprotective effect of 3-morpholinosydnonimine against Zn2+-induced PC12 cell death
  17402. Comparison of Neuroprotective effects of derivatives of eritropoetine by different way of bringing in drugs with model of bilateral photochemically induced thrombosis of …
  17403. Neuroprotective effect of silymarin on acrylamide-induced neurotoxicity in both in-vitro and in-vivo assessments.
  17404. The Neuroprotective effect of astaxanthin on newborn rat models of hypoxic-ischemic brain damage
  17405. Nutraceuticals: Novel Neuroprotective agents
  17406. An experience with Neuroprotective therapy of primary open-angle glaucoma based on the use of different dosage forms of Mexidol
  17407. Neuroprotective evaluation of Lagenaria vulgaris extract hypoxic neurotoxicity induced rats
  17408. Depletion of microglia is Neuroprotective after cardiac arrest
  17409. Polyphenols Neuroprotective effect in a Parkinson’s disease yeast model: phosphoproteome alterations
  17410. Neuroprotective effects of ginsenoside Rg1-induced neural stem cell transplantation on hypoxic-ischemic encephalopathy
  17411. Neuroprotective effect of fluoxetine on the APP/PS1 transgenic mouse model of Alzheimer’s disease
  17412. Autophagy as a Neuroprotective Mechanism Against 3-Nitropropionic Acid-Induced Cell Death
  17413. Deciphering the Neuroprotective Potential of Interleukin-1β (IL-1β) using in vitro Murine Models of Oxidative Stress
  17414. Neuroprotective Activities of Granulocyte-Macrophage Colony Stimulating Factor Following Controlled Cortical Impact
  17415. Beta-amyloid-acetylcholine structural interaction: evidence for Neuroprotective effects of acetylcholine in neural cells
  17416. Neuroprotective effect of insulin-like growth factor-II on 1-Methyl-4-phenyl pyridinium-induced oxidative damage in cortical neuronal cells
  17417. Polyphenols and Bionanoparticle Combinations as Neuroprotective and Anticarcinogenic agents : A Potential Neuropharmacological Solution to Combat Cerebral …
  17418. Neuroprotective effects of α-mangostin against scopolamine-induced cognitive deficits
  17419. Potential Neuroprotective effects of herbal compounds.
  17420. Neuroprotective effects of hexane‐ and methylene chloride‐soluble fractions of Salicornia herbacea L. in mouse hippocampal HT22 cells
  17421. POTENTIAL Neuroprotective EFFECTS OF HERBAL COMPOUNDS
  17422. Isoflurane and Ketamine/Xylazine Anesthesia do not Influence the Neuroprotective Effects of Simvastatin in a Model of Permanent Cerebral Ischemic Injury in C57BL …
  17423. EHT™ coffee extract: A Neuroprotective agent and modulator of PP2A methylation with anti-inflammatory and antioxidant properties (S16. 006)
  17424. Wnt3a recapitulates the Neuroprotective effects of mesenchymal stem cells and promotes neurocognitive recovery in traumatic brain injury
  17425. In vivo Neuroprotective effects of cinnamon bioactive compounds in C. elegans and D. melanogaster
  17426. To investigate Neuroprotective mechanism in female brain
  17427. Study of the Mechanism of Estrogen on Neuroprotective Effect
  17428. Dietary supplementation with sodium nitrite can exert Neuroprotective effects on global cerebral ischemia/reperfusion in mice
  17429. Neuroprotective action of valproic acid accompanied of the modification on the expression of Bcl-2 and activated caspase-3 in the brain of rats submitted to ischemia …
  17430. Neuroprotective effect of Quince leaf hydroalcoholic extract on intracerebroventricular streptozotocin-induced oxidative stress in cortical tissue of rat brain
  17431. Studying Neuroprotective activity of GABA conjugate with arachidonic acid under conditions of local permanent brain ischemia in rats
  17432. Neuroprotective effects of albumin, pioglitazone and insulin against ischemic brain damage in mice
  17433. Enhancing hippocampal blood flow after cerebral ischemia and vasodilating basilar arteries: in vivo and in vitro Neuroprotective effect of antihypertensive …
  17434. Trimethyltin can induce cell death in the entorhinal cortex of rat brain : a histological architecture and neuronal density evaluation of the Neuroprotective role of lithium …
  17435. Graphene oxide has a Neuroprotective effect against glutamate-induced excitoxicity on B35 neuroblastoma cell line
  17436. Association of Neuroprotective Effect of Di-O-Demethylcurcumin on Ab25–35-Induced Neurotoxicity with Suppression of NF-jB and Activation of Nrf2
  17437. Matrix assisted laser desorption ionisation time of flight mass spectrometry of Neuroprotective peptides
  17438. The Neuroprotective effect of stachys lavandulifolia Vahl leaves aqueous extract on the density of alpha neurons in anterior horn of spinal cord after sciatic nerve …
  17439. Neuroprotective therapy for glaucoma
  17440. Neuroprotective EFFECTS OF WIN 55 212-2 ON MOTOR DISTURBANCES DUE TO HARMA LINE ADMINISTRATION IN RATS
  17441. Neuroprotective strategies for traumatic brain injury
  17442. The Neuroprotective potential of STN DBS and the role of BDNF
  17443. The physiological role of APP in the activation of Neuroprotective signaling mechanisms
  17444. Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (A review).
  17445. Neuroprotective Agent Given Soon After Stroke Shows No Benefit
  17446. Neuroprotective effect of rapamycin in the retina
  17447. Development of P7C3-Class of Neuroprotective Molecules
  17448. Morphological functional criteria of Neuroprotective therapy efficacy in glaucomatous optic neuropathy
  17449. Neuroprotective effect screening and the mechanism of 10 kinds of coumarin derivatives
  17450. Neuroprotective effect of uric acid in ischemic stroke
  17451. Progress in research of Neuroprotective agents based on the NMDA signaling pathway
  17452. Anti-stroke activity and underlying Neuroprotective mechanism of natural substances
  17453. Correlation study of the phytochemical composition and the Neuroprotective bioactivity of Gastrodia elata from different sources
  17454. Neuroprotective Mechanisms of Parkinsons’s Disease Related Protein DJ-1
  17455. Neuroprotective Effects of Ginseng Extract
  17456. Electrophysiology in the evaluation of Neuroprotective effect in early diabetic retinopathy-a pilot study
  17457. Neuroprotective effects of statins in subarachnoid hemorrhage
  17458. Neuroprotective and neuritogenic activities of Lignosus rhinocerotis (COOKE) ryvarden/Priscilla Ann a/p Moknasing@ John
  17459. Erythropoietin as a possible Neuroprotective agent in patients with schizophrenia
  17460. Scrophularia striata with antiinflammatory and Neuroprotective properties.
  17461. Neuroprotective mechanisms of curcumin in cerebral ischemia
  17462. AMA0428, a novel and potent ROCK inhibitor, as a Neuroprotective and regenerative therapy for glaucoma
  17463. Neuroprotective effects of 17 [beta]-oestradiol: a therapeutic potential drug for Alzheimer
  17464. Mechanisms Underlying the Neuroprotective Effects of Histone Deacetylase Inhibitors
  17465. The contribution of decanoic acid to the Neuroprotective effect of the ketogenic diet
  17466. Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
  17467. Neuroprotective effect of a new Insulin-Nanogel system
  17468. Neuroprotective effects of maltol on experimental glaucoma models
  17469. Neuroprotective effects of WSY against lipopolysaccharide-induced neuronal damage
  17470. P12: Progesterone Act as Neuroprotective in Traumatic brain Injury
  17471. Research on Neuroprotective effects of mesenchymal stem cells in retinal disease
  17472. Evaluation of Neuroprotective Properties of Ecchium Amoenum L. Ethanolic Extract
  17473. Neuroprotective and anti-neuroinflammatory effects of KHUR-EcPr against lipopolysaccharide-induced neuronal damage
  17474. Scrophularia striata as an Iranian medicinal palnt has anti-inflammatory and Neuroprotective properties
  17475. Neuroprotective effect of α-tocopherolhydroquinone against glutamate-induced cytotoxicity in N18-RE-105 cells
  17476. An Experimental Study: Does the Neuroprotective Effect Increase When Hypothermia Deepens After Traumatic brain Injury?
  17477. Neuroprotective spiroindole alkaloids and spiroditerpenoids isolated from Aspergillus duricaulis
  17478. Neuroprotective Effects of Laquinimod in Lewis Rat Experimental Autoimmune Neuritis (P4. 107)
  17479. Neuroprotective EFFECT OF EARLY AND SPECIFIC MICROGLIA ACTIVATION IN A RAT MODEL OF ALZHEIMER’S DISEASE
  17480. Neuroprotective EFFECTS OF RHIZOMA CURCUMAE ON FOCAL CEREBRAL ISCHEMIA IN RATS
  17481. Neuroprotective Effects of Clopidogrel in Experimental Spinal Cord Injury.
  17482. Neuroprotective Effects of Against Hypoxic Injury via Modulation MAPK Pathway and Apoptosis
  17483. Examining the Neuroprotective Properties of 3-Dimethoxybenzylidene-Anabasine (DMXB-A) in a Third Trimester Chronic Ethanol Exposure Model in Rats
  17484. Neuroprotective effects of intravenous erythropoietin in patients with spinal cord injury
  17485. Neuroprotective Effects of Hydrogen Sulfide in Parkinson’s
  17486. Identification of novel Neuroprotective genes against oxidative stress: a combined genetic and proteomic approach
  17487. Neuroprotective ACTIVITY OF PENTAPETES PHOENICEA ON HYPOXIC RATS
  17488. Preparation and analysis of nanocarriers for brain delivery of Neuroprotective andrographolide
  17489. Neuroprotective Effects of Brn3b in PC12 Cells and Retinal Ganglion Cells under Glaucomatous Conditions
  17490. Gender difference on Neuroprotective effect of rat BMSCs aganist the hypoxia-induced apoptosis of RGCs
  17491. Anti-inflammatory and Neuroprotective effects of GILZ analogs.(THER7P. 951)
  17492. Unraveling the Neuroprotective role of TUDCA in Parkinson´ s disease
  17493. Abstract W P255: Neuroprotective Effects Of Thyroid Hormone-T2 (3, 5-diiodo-I-thyronine) After Transient MCAO In Mice
  17494. Preventive Neuroprotective effect of commonly used antihypertensive drugs in ischemic cerebral injury in rats
  17495. ESTETROL AND ITS Neuroprotective EFFECT IN NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY
  17496. Investigating the Neuroprotective effect of plant (poly) phenols in models of Parkinson´ s disease
  17497. Neuroprotective effect of PTEN inhibitor BPV on cerebral ischemia-reperfusion injury in rats and its mechanism
  17498. The role of cannabinoid receptors (type 1 and type 2) in implementation of Neuroprotective and antihypoxic effects of N-arachidonoyldopamine in acute …
  17499. Study of the Neuroprotective and neurogenic actions of synthetic micromolecules in animal models of neurodegeneration
  17500. NEWS FROM THE INTERNATIONAL STROKE CONFERENCE: The Mediterranean Diet Proves Neuroprotective for Stroke
  17501. Neuroprotective Treatments for Acute Spinal Cord Injury Associated with Intervertebral Disc Herniation
  17502. Abstract W P259: Selective Intra-arterial Administration of Verapamil is Neuroprotective in Acute Ischemic Stroke
  17503. Neuroprotective and Antinociceptive Activity of Two New Derivatives of Deoxypeganine Alkaloid
  17504. Evaluation of Neuroprotective Interventions in Different Pde6a Mutant Animal Models for Retinitis Pigmentosa
  17505. Novel neurotrophic and Neuroprotective properties of the BBB-permeable polysaccharide, Midi-GAGR
  17506. Flavonoids from fruits of Cudrania tricuspidata and their Neuroprotective activities
  17507. Combine application of Neuroprotective agents in complex treatment of patients with ischemic stroke as a way to an acute cerebrovascular pathology therapy …
  17508. THE Neuroprotective EFFECT OF SINAPIC ACID IN AN EXPERIMENTAL MODEL OF PARKINSON’S DISEASE
  17509. Neuroprotective effect of Dengzhan Shengmai capsule on ischemia/reperfusion injury in rats
  17510. Neuroprotective EFFECTS OF RESVERATROL AGAINST AMYLOID BETA-INDUCED NEUROTOXICITY WITH A FOCUS ON ELECTROPHYSIOLOGICAL …
  17511. The antidepressant and Neuroprotective effect mediated by TREK-1 potassium channel
  17512. Neuroprotective effect of geniposide on Parkinson’s disease model mice
  17513. Neuroprotective effect of glucagon-like peptide-1 receptor activation in cerebral ischemia
  17514. Intracellular sorting pathways of the amyloid precursor protein provide novel Neuroprotective strategies
  17515. Neuroprotective effects of short-term and long-term administration of genistein on ET-1 induced ischemic stroke rats
  17516. Mycophenolate mofetil is Neuroprotective in a mouse model of retinitis pigmentosa (RP)
  17517. Neuroprotective and immunomodulatory roles of anti-inflammatory neuropeptides on central nervous system disorders
  17518. The Neuroprotective therapy of outpatient treatment of chronic cerebral ischemia
  17519. Neuroprotective Activity of Valeriana officinalisagainst Global Cerebral Ischemia/Reperfusion Induced Oxidative Stress in Rat
  17520. Synergistic Neuroprotective effects of Withania somnifera with specific dietary derived polyphenols
  17521. Neuroprotective effect of fucoxanthin on β-amyloid-induced cell death
  17522. Green Coffee Bean Extracts as Potential Neuroprotective and Chemoprotective Dietary Supplements: a Molecular Point of View
  17523. Neuroprotective synergy of chlorpromazine and mesenchymal stem cells in an animal model of multiple sclerosis
  17524. Neuroprotective activities of isorhynchophylline on Alzheimer′ s disease and other central nervous systems
  17525. Discovery of Neuroprotective marine natural products using Drosophila melanogaster
  17526. Neuroprotective abilities and cognitive enhancing effects of red jasmine rice extract in animal model of Alzheimer’s disease
  17527. Neuroprotective Effect of Rosiglitazone on Retinal Changes in a Rat Model of Parkinson’s Disease
  17528. PHENOLIC PROFILE, ANTIBACTERIAL, Neuroprotective AND CYTOTOXIC PROPERTIES OF THREE ALGERIAN MENTHA SPECIES
  17529. WITHDRAWN: Neuroprotective action of Gmelina arborea (bark) and Punica granatum (peel) extracts
  17530. Picroside Ⅱ plays Neuroprotective effect on cerebral ischemic injury in rats
  17531. Neuroprotective Effect of Bexarotene in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis (P6. 104)
  17532. Neuroprotective potentials of recombinant human erythropoietin in premature rats with white matter damage
  17533. Neuroprotective effects of Piperine on1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced Parkinson’s mice model
  17534. (Under review) Orexin receptors exert a Neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103
  17535. The Neuroprotective Effect of Uric Acid on Apoptosis Prevention of Dorsal Root Ganglion Neurons
  17536. Neuroprotective effect of Xuebijing following the brain injury in the rat after cardiopulmonary resuscitation
  17537. Characterization of the striatal kinase Dclk3 and its Neuroprotective effects against mutant huntingtin
  17538. Voluntary Exercise is Neuroprotective in an Inherited Retinal Degeneration Mouse Model
  17539. Neuroprotective constituents from the xylem of Toxicodendron vernicifluum
  17540. Neuroprotective modifications in retinal Müller cells due to oxidative stress and energy restriction
  17541. Minocycline exerts a Neuroprotective action against 6-OHDA-induced neurotoxicity: in vivo and in vitro studies
  17542. Neuroprotective and behavioral efficacy of intravenous transplanted adipose stem cells in experimental Parkinsonian rat models
  17543. Neuroprotective Effects of Amnion-derived Cellular Cytokine Solution (ACCS) in Experimental Optic Neuritis
  17544. POTENTIAL Neuroprotective EFFECT OF TETRAMETHYLPYRAZINE IN AN EXPERIMENTAL ANIMAL MODEL OF PARKINSON’S DISEASE
  17545. In Vitro Testing of the Neuroprotective Effect of Mesenchymal Stromal Cells in a 3D Model of Parkinson’s Disease
  17546. Multi-Target Prediction of Neuroprotective Drugs, Synthesis, Assay, and Theoretical Study of Rasagiline Carbamates
  17547. Neuroprotective Effects of Combination of Dexmedetomidine and Hypothermia after Asphyxial Cardiac Arrest in Rats
  17548. Neuroprotective effect of osthole on neuron synapses infected APP gene
  17549. Abstract T P228: Ischemic Stroke Results in Increased Activity of the Neuroprotective Angiotensin Converting Enzyme 2 in Rat brain and Serum
  17550. Identification of Neuroprotective and anti-parkinsonian strategies for the treatment of Parkinson’s disease modulating the endocannabinoid system in animal models
  17551. Minimization of adsorption in capillary zone electrophoresis of proteins and Neuroprotective peptides
  17552. Calcium/calmodulin-dependent Protein Kinase Kinase β (CaMKK β) is Neuroprotective in Stroke in Aged Mice
  17553. Correction for the article “Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders
  17554. Expression of the Neuroprotective cytokine, Leukemia Inhibitory Factor, is potentially regulated by elements in its 3’untranslated region
  17555. Investigating the Neuroprotective potential of short-term 5-HT7 receptor activation against neuronal excitotoxicity
  17556. Development of polymeric nanoparticles containing Neuroprotective compounds of Hypericum perforatum
  17557. Novel arylalkenylpropargylamines as Neuroprotective , potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson’s disease
  17558. Neuroprotective effects of Mannitol in a Drosophila model for Parkinson’s disease
  17559. Neuroprotective effects of growth hormone releasing hormone (GHRH) in traumatic optic neuropathy
  17560. Neuroprotective effect of cerebral ischemic preconditioning is associated with regulation of expressions of nuclear factor-κB and Hes1 in rats
  17561. Neuroprotective Effect of Clonidine on Primary Cultured Cortical Neurons in Rats Subjected to Oxygen-glucose Deprivation Injury
  17562. The Neuroprotective and behavioural effects of group III metabotropic glutamate receptor ligands in rodent models of Parkinson’s disease
  17563. Neuroprotective effects of salvianolic acid B against Schwann cell injury induced by lipopolysaccharide
  17564. Analyzing the Neuroprotective Potential of Nicotine in Parkinson’s Disease (PD) and its Effect on Dopamine Levels in Rodents and Primates
  17565. In vitro and in vivo studies of the Neuroprotective peptide humanin using 125I-radiolabeled humanin derivatives
  17566. Human Mesenchymal Stem Cells and Endothelial Progenitor Cells exert a Neuroprotective effect on rat cortical neurons injured by oxygen and glucose deprivation
  17567. Neuroprotective effects of Cannabidiol in the acute pilocarpine model of temporal lobe seizure in rats
  17568. Neuroprotective effect of neuroserpin in non-tPA-induced intracerebral hemorrhage mouse models
  17569. Abstract T P84: Neuroprotective Effect of Probenecid in a Rat Model of Transient Global Cerebral Ischemia-Reperfusion
  17570. Lucentis is Not Neuroprotective in a Primate Model of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
  17571. Neuroprotective effect of fingolimod and pramipexole in Parkinson’s disease animal model
  17572. Neuroprotective effects of PACAP, VIP and NAP against hyperglycaemic retinal damage
  17573. MITOCHONDRIAL AND Neuroprotective EFFECTS OF PHENELZINE RELATED TO SCAVENGING OF NEUROTOXIC LIPID PEROXIDATION PRODUCTS
  17574. CX3CR1 mediates the Neuroprotective effect of triptolide on 1-methyl-4-phenylpyridinium-induced hemiparkinson rats
  17575. THC exerts Neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells
  17576. Inhibiting JNK3 signals is important molecular mechanism in Neuroprotective effect of Hypothermia after ischemia-reperfusion.
  17577. Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion
  17578. The possible Neuroprotective effect of ischemic preconditioning, postconditioning and certain agents in global cerebral ischemia-reperfusion induced in rats.
  17579. Neuroprotective effect of quercetin nanocrystal on spatial memory in animal model of Parkinson’s diseases
  17580. Neuroprotective effects of thymoquinone against retinal damage in a rat model of Leber’s hereditary optic neuropathy.
  17581. Neuroprotective Interactions Between Delta-Opioid Receptors and Glutamatergic Signaling Mediate Hypoxia-Tolerance in brain
  17582. Neuroprotective Effect of Hydroalcoholic Extract of Boerhaavia Diffusa Linn against MPTP Induced Neurodegenartion in Rats
  17583. Neuroprotective EFFECT OF SILYMARIN AGAINST ACRYLAMIDE-INDUCED NEUROTOXICITY IN BOTH IN VITRO AND IN VIVO ASSESSMENTS
  17584. Fractalkine signaling in microglia is Neuroprotective in the diabetic retina following lipopolysaccharide-induced activation
  17585. Neuroprotective and antihypoxic effects of glial cell line-derived neurotrophic factor (GDNF) in hypoxia modeling
  17586. Neuroprotective effect of brain -derived neurotrophic factor on hippocampal neurons through the regulation of synaptic plasticity associated proteins
  17587. Neuroprotective effects against ischemia injury derived from Smad7-modulated ActA/Smads pathway activation
  17588. Neuroprotective EFFECTS OF SALVIA ARISTATA ON HYDROGEN PEROXIDE-INDUCED APOPTOSIS IN SH-SY5Y NEUROBLASTOMA CELLS
  17589. A histological and morphometric study of the sciatic nerve in experimentally induced male diabetic rabbits and the potential Neuroprotective role of coenzyme Q10
  17590. Neuroprotective effect of hypothermia in a model of neonatal encephalopathy resulting from E. coli-induced inflammation combined to hypoxia-ischemia
  17591. Induction of heat shock protein-72 by magnetic nanofluid hyperthermia in cultured retinal ganglion cells for Neuroprotective treatment in glaucoma
  17592. Neuroprotective Effect of Mulberry Extract on Glutamate-induced Oxidative Stress in Mouse Hippocampal HT-22 cells
  17593. Neuroprotective role of natural polyphenols
  17594. Neuroprotective and therapeutic strategies against Parkinson’s disease: recent perspectives
  17595. Concise review: bridging the gap: novel neuroregenerative and Neuroprotective strategies in spinal cord injury
  17596. Development of a Neuroprotective potential algorithm for medicinal plants
  17597. Manganese-induced neurotoxicity: a review of its behavioral consequences and Neuroprotective strategies
  17598. Ginsenoside Rb1 as a Neuroprotective agent: a review
  17599. Breastmilk from obese mothers has pro-inflammatory properties and decreased Neuroprotective factors
  17600. Neuroprotective role of steroidal sex hormones: an overview
  17601. Recent updates in Neuroprotective and neuroregenerative potential of Centella asiatica
  17602. Treatment temperature and insult severity influence the Neuroprotective effects of therapeutic hypothermia
  17603. Immunomodulation as a Neuroprotective and therapeutic strategy for Parkinson’s disease
  17604. Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for Neuroprotective interventions
  17605. A new look at an old drug: Neuroprotective effects and therapeutic potentials of lithium salts
  17606. Neuroprotective effects of quercetin: from chemistry to medicine
  17607. The Neuroprotective properties of the amyloid precursor protein following traumatic brain injury
  17608. A Neuroprotective role for microglia in prion diseases
  17609. Near‐infrared light is Neuroprotective in a monkey model of P arkinson disease
  17610. A review of recent advances in Neuroprotective potential of 3-N-butylphthalide and its derivatives
  17611. Discovery of Neuroprotective compounds by machine learning approaches
  17612. Neuroprotective activity of Hypericum perforatum and its major components
  17613. Cell therapy centered on IL-1Ra is Neuroprotective in experimental stroke
  17614. Neuroprotective effects of lithium in human brain ? Food for thought
  17615. Approaches in methodology for population-based longitudinal study on Neuroprotective model for healthy longevity (TUA) among Malaysian Older Adults
  17616. Klotho is a Neuroprotective and cognition -enhancing protein
  17617. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is Neuroprotective in Huntington’s disease
  17618. Exercise-induced Neuroprotective effects on neurodegenerative diseases: the key role of trophic factors
  17619. Neuroprotective and functional improvement effects of methylene blue in global cerebral ischemia
  17620. Bioactive compounds and their Neuroprotective effects in diabetic complications
  17621. Prokineticins are Neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro
  17622. Neuroprotective strategies during cardiac surgery with cardiopulmonary bypass
  17623. Ghrelin-AMPK signaling mediates the Neuroprotective effects of calorie restriction in Parkinson’s disease
  17624. Neuroprotective activities of natural products from marine macroalgae during 1999–2015
  17625. Neuroprotective therapies for multiple sclerosis and other demyelinating diseases
  17626. Quercetin, not caffeine, is a major Neuroprotective component in coffee
  17627. Neuroprotective effects of Co-ultraPEALut on secondary inflammatory process and autophagy involved in traumatic brain injury
  17628. Neuroprotective effects of polygalacic acid on scopolamine-induced memory deficits in mice
  17629. … neonatal integrative developmental care model: advanced clinical applications of the seven core measures for Neuroprotective family-centered developmental …
  17630. Neuroprotective effects of salidroside through PI3K/Akt pathway activation in Alzheimer’s disease models
  17631. Neuroprotective properties of mitochondria-targeted antioxidants of the SkQ-type
  17632. Neuroprotective effects of dexmedetomidine conditioning strategies: Evidences from an in vitro model of cerebral ischemia
  17633. Graphene quantum dots conjugated Neuroprotective peptide improve learning and memory capability
  17634. Neuroprotective mechanisms mediated by CDK5 inhibition
  17635. Neuroprotective effects of theaflavins against oxidative stress-induced apoptosis in PC12 cells
  17636. Streptomyces antioxidans sp. nov., a novel mangrove soil actinobacterium with antioxidative and Neuroprotective potentials
  17637. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson’s disease
  17638. In vitro Neuroprotective properties of some commonly consumed green leafy vegetables in Southern Nigeria
  17639. Neuroprotective and cytotoxic phthalides from Angelicae Sinensis Radix
  17640. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease
  17641. Neuroprotective effects of CD4+ CD25+ Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer’s disease model
  17642. Pridopidine activates Neuroprotective pathways impaired in Huntington Disease
  17643. Anti‐Inflammatory and Neuroprotective Effects of Triptolide via the NF‐κ B Signaling Pathway in a Rat MCAO Model
  17644. Neuroprotective and cognition -enhancing effects of compound K isolated from red ginseng
  17645. The Neuroprotective effect of puerarin in acute spinal cord injury rats
  17646. Antioxidant and Neuroprotective effects of Dictyophora indusiata polysaccharide in Caenorhabditis elegans
  17647. Neuroprotective effect of asiatic acid against spinal cord injury in rats
  17648. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone
  17649. Neuroprotective actions of taurine on hypoxic-ischemic brain damage in neonatal rats
  17650. Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects
  17651. The histone deacetylase inhibitor, sodium butyrate, exhibits Neuroprotective effects for ischemic stroke in middle-aged female rats
  17652. The dietary components carnosic acid and carnosol as Neuroprotective agents : a mechanistic view
  17653. Neuroprotective effects of metformin against Aβ-mediated inhibition of long-term potentiation in rats fed a high-fat diet
  17654. Preclinical Neuroprotective actions of xenon and possible implications for human therapeutics: a narrative review
  17655. The Neuroprotective effects of preconditioning exercise on brain damage and neurotrophic factors after focal brain ischemia in rats
  17656. Neuroprotective effects of ellagic acid in a rat model of Parkinson’s disease
  17657. Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage
  17658. Huperzine A as a Neuroprotective and antiepileptic drug: a review of preclinical research
  17659. Neuroprotective effects of pomegranate peel extract after chronic infusion with amyloid-β peptide in mice
  17660. Wnt3a, a protein secreted by mesenchymal stem cells is Neuroprotective and promotes neurocognitive recovery following traumatic brain injury
  17661. Neuroprotective effects of a GIP analogue in the MPTP Parkinson’s disease mouse model
  17662. Exosome derived from murine adipose-derived stromal cells: Neuroprotective effect on in vitro model of amyotrophic lateral sclerosis
  17663. The mitochondria-regulated immune pathway activated in the C. elegans intestine is Neuroprotective
  17664. Neuroprotective effects of syringic acid against OGD/R-induced injury in cultured hippocampal neuronal cells
  17665. Reduction of oxidative/nitrosative stress in brain and its involvement in the Neuroprotective effect of n-3 PUFA in Alzheimer’s disease
  17666. Sodium butyrate exerts Neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice
  17667. Neuroprotective effect of melatonin in experimental optic neuritis in rats
  17668. Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer’s disease
  17669. The Neuroprotective properties of Hericium erinaceus in glutamate-damaged differentiated PC12 cells and an Alzheimer’s disease mouse model
  17670. Neuroprotective effects of fisetin in Alzheimer’s and Parkinson’s Diseases: From chemistry to medicine
  17671. Neuroprotective hypothermia–Why keep your head cool during ischemia and reperfusion
  17672. Neuroprotective effects of a standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson’s disease
  17673. Intraoperative Neuroprotective interventions prevent spinal cord ischemia and injury in thoracic endovascular aortic repair
  17674. Pre-stroke metformin treatment is Neuroprotective involving AMPK reduction
  17675. Cortical spreading depression produces a Neuroprotective effect activating mitochondrial uncoupling protein-5
  17676. The Neuroprotective effect of erythropoietin on rotenone-induced neurotoxicity in SH-SY5Y cells through the induction of autophagy
  17677. Neuroprotective effects of quercetin on memory and anxiogenic-like behavior in diabetic rats: Role of ectonucleotidases and acetylcholinesterase activities
  17678. Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin
  17679. Post‐ischemic salubrinal treatment results in a Neuroprotective role in global cerebral ischemia
  17680. Neuroprotective effect of matrine in mouse model of vincristine-induced neuropathic pain
  17681. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
  17682. In vitro and in vivo Neuroprotective effects of cJun N-terminal kinase inhibitors on retinal ganglion cells
  17683. Neuroprotective effect of ischemic preconditioning via modulating the expression of cerebral miRNAs against transient cerebral ischemia in diabetic rats
  17684. Nrf2/antioxidant defense pathway is involved in the Neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning
  17685. Neuroprotective effects of a PSD-95 inhibitor in neonatal hypoxic-ischemic brain injury
  17686. Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities
  17687. Neuroprotective effect of natural products on peripheral nerve degeneration: a systematic review
  17688. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and Neuroprotective agents for Alzheimer’s disease
  17689. Evidence of Neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism
  17690. SIRT3 acts as a Neuroprotective agent in rotenone-induced Parkinson cell model
  17691. Acylated but not des‐acyl ghrelin is Neuroprotective in an MPTP mouse model of Parkinson’s disease
  17692. Neuroprotective effects of endurance exercise against high‐fat diet‐induced hippocampal neuroinflammation
  17693. Tamoxifen: an FDA approved drug with Neuroprotective effects for spinal cord injury recovery
  17694. Neuroprotective effect of salvianolic acids against cerebral ischemia/reperfusion injury
  17695. Neuroprotective effect of quercetin against oxidative damage and neuronal apoptosis caused by cadmium in hippocampus
  17696. MicroRNA-135b has a Neuroprotective role via targeting of β-site APP-cleaving enzyme 1
  17697. Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: in vitro and in vivo studies
  17698. Neuroprotective effects of oleuropein against cognitive dysfunction induced by colchicine in hippocampal CA1 area in rats
  17699. Neuroprotective effect of berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats
  17700. Bioactive polyphenol interactions with β amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and Neuroprotective capacity
  17701. PI3K/Akt pathway contributes to Neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats
  17702. Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity
  17703. Olfactory ensheathing cell transplantation after a complete spinal cord transection mediates Neuroprotective and immunomodulatory mechanisms to facilitate …
  17704. Identification of flavonoids from Flammulina velutipes and its Neuroprotective effect on pheochromocytoma-12 cells
  17705. Neuroprotective effect of β-asarone against Alzheimer’s disease: regulation of synaptic plasticity by increased expression of SYP and GluR1
  17706. Peptides from hydrolysate of lantern fish (Benthosema pterotum) proved Neuroprotective in vitro and in vivo
  17707. Neuroprotective effects of polydatin against mitochondrial-dependent apoptosis in the rat cerebral cortex following ischemia/reperfusion injury
  17708. Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis
  17709. Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice
  17710. … –I, Unexpected Minor Dimeric Flavonol Diglycosidic Truxinate and Truxillate Esters from Ginkgo biloba Leaves and Their Antineuroinflammatory and Neuroprotective …
  17711. Vagus nerve stimulation exerts the Neuroprotective effects in obese-insulin resistant rats, leading to the improvement of cognitive function
  17712. Novel Neuroprotective multicomponent therapy for amyotrophic lateral sclerosis designed by networked systems
  17713. Methylene blue exerts a Neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation
  17714. Hyaluronic acid scaffold has a Neuroprotective effect in hemisection spinal cord injury
  17715. Neuroprotective measures in children with traumatic brain injury
  17716. Quantitative proteomics study of the Neuroprotective effects of B12 on hydrogen peroxide-induced apoptosis in SH-SY5Y cells
  17717. Neuroprotective effect of progesterone in MPTP-treated male mice
  17718. Acute hydrogen sulfide–induced neuropathology and neurological sequelae: challenges for translational Neuroprotective research
  17719. … basic tail modifications of coumarin-based dual acetylcholinesterase-monoamine oxidase B inhibitors: identification of water-soluble, brain -permeant Neuroprotective …
  17720. Naringin treatment induces Neuroprotective effects in a mouse model of Parkinson’s disease in vivo, but not enough to restore the lesioned dopaminergic system
  17721. Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system
  17722. Neuroprotective effects of a standardized flavonoid extract from safflower against a rotenone-induced rat model of Parkinson’s disease
  17723. Neuroprotective and memory enhancing effects of auraptene in a rat model of vascular dementia: Experimental study and histopathological evaluation
  17724. Neuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway
  17725. In vitro Neuroprotective potential of the monoterpenes α-pinene and 1, 8-cineole against H2O2-induced oxidative stress in PC12 cells
  17726. Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b …
  17727. Neuroprotective effects of (−)-linalool against oxygen-glucose deprivation-induced neuronal injury
  17728. Butein provides Neuroprotective and anti‐neuroinflammatory effects through Nrf2/ARE‐dependent haem oxygenase 1 expression by activating the PI3K/Akt pathway
  17729. In vitro Neuroprotective potentials of aqueous and methanol extracts from Heinsia crinita leaves
  17730. Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D-galactose/AlCl3 inducing rats model of Alzheimer’s disease
  17731. Potent anticholinesterasic and Neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer’s …
  17732. Neuroprotective effects of tanshinone I against 6-OHDA-induced oxidative stress in cellular and mouse model of Parkinson’s disease through upregulating Nrf2
  17733. Thiamine as a Neuroprotective agent after cardiac arrest
  17734. Cdk5–Foxo3 axis: initially Neuroprotective , eventually neurodegenerative in Alzheimer’s disease models
  17735. The Neuroprotective effect of lithium against high dose methylphenidate: possible role of BDNF
  17736. Stroke Neuroprotection revisited: intra-arterial verapamil is profoundly Neuroprotective in experimental acute ischemic stroke
  17737. Polyprenylated Tetraoxygenated Xanthones from the Roots of Hypericum monogynum and Their Neuroprotective Activities
  17738. Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury
  17739. An integrative genome-wide transcriptome reveals that candesartan is Neuroprotective and a candidate therapeutic for Alzheimer’s disease
  17740. Evaluation of Neuroprotective effect of thymoquinone nanoformulation in the rodent cerebral ischemia-reperfusion model
  17741. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of …
  17742. The Neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats: Contribution of TRPM2 …
  17743. Meclizine-induced enhanced glycolysis is Neuroprotective in Parkinson disease cell models
  17744. Neuroprotective effects against POCD by photobiomodulation: evidence from assembly/disassembly of the cytoskeleton
  17745. Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity
  17746. Neuroprotective effects of icariin on brain metabolism, mitochondrial functions, and cognition in triple‐transgenic Alzheimer’s disease mice
  17747. The Neuroprotective effect of rapamycin as a modulator of the mTOR-NF-κB axis during retinal inflammation
  17748. Neuroprotective effects of Chrysophanol against inflammation in middle cerebral artery occlusion mice
  17749. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β‐amyloid in ageing and Alzheimer’s disease
  17750. Toward the identification of Neuroprotective agents : g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising Sigma1 receptor …
  17751. Neuroprotective effect of carnosine on primary culture of rat cerebellar cells under oxidative stress
  17752. Metformin activation of AMPK-dependent pathways is Neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction
  17753. Exploring Neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: an in silico study
  17754. Tetramethylpyrazine nitrone, a multifunctional Neuroprotective agent for ischemic stroke therapy
  17755. Neuroprotective efficacy of an aminopropyl carbazole derivative P7C3‐A20 in ischemic stroke
  17756. Neuroprotective effects of VCP modulators in mouse models of glaucoma
  17757. Neuroprotective role of gap junctions in a neuron astrocyte network model
  17758. Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats
  17759. Anti-neuroinflammatory and Neuroprotective effects of the Lindera neesiana fruit in vitro
  17760. Neuroprotective effects of penehyclidine hydrochloride against cerebral ischemia/reperfusion injury in mice
  17761. Neuroprotective activities of saffron and crocin
  17762. Blood-borne activity-dependent Neuroprotective protein (ADNP) is correlated with premorbid intelligence, clinical stage, and Alzheimer’s disease biomarkers
  17763. Neuroprotective , neurotrophic and anti-oxidative role of Bacopa monnieri on CUS induced model of depression in rat
  17764. Neuroprotective effects of phytosterols and flavonoids from Cirsium setidens and Aster scaber in human brain neuroblastoma SK-N-SH cells
  17765. Treatment with the neurotoxic Aβ (25–35) peptide modulates the expression of Neuroprotective factors Pin1, Sirtuin 1, and brain -derived neurotrophic factor in SH …
  17766. Neuroprotective effect of scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor
  17767. Neuroprotective effect of ginsenoside Rd in spinal cord injury rats
  17768. Estrogen-induced Neuroprotective and anti-inflammatory effects are dependent on the brain areas of middle-aged female rats
  17769. Neuroprotective effect of the marine macroalga Gelidiella acerosa: identification of active compounds through bioactivity-guided fractionation
  17770. Neuroprotective effect of fucoidan from Turbinaria decurrens in MPTP intoxicated Parkinsonic mice
  17771. Neuroprotective and anti‐inflammatory effects of morin in a murine model of Parkinson’s disease
  17772. Nanoemulsions loaded Carbopol® 934 based gel for intranasal delivery of Neuroprotective Centella asiatica extract: in–vitro and ex–vivo permeation study
  17773. Neuroprotective effects of ginsenosides on neural progenitor cells against oxidative injury
  17774. Neuroprotective effects of melatonin and omega-3 on hippocampal cells prenatally exposed to 900 MHz electromagnetic fields
  17775. The Neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury
  17776. Electro-acupuncture at LI11 and ST36 acupoints exerts Neuroprotective effects via reactive astrocyte proliferation after ischemia and reperfusion injury in rats
  17777. Neuroprotective effects of brain -derived neurotrophic factor and noggin-modified bone mesenchymal stem cells in focal cerebral ischemia in rats
  17778. Progesterone exerts Neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice
  17779. Rosiglitazone activation of PPARγ-dependent pathways is Neuroprotective in human neural stem cells against amyloid-beta–induced mitochondrial dysfunction and …
  17780. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson’s disease: Involvement of the dopamine system
  17781. Enhancement in the Neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle
  17782. Neuroprotective effect of hydrogen-rich saline in global cerebral ischemia/reperfusion rats: up-regulated Tregs and down-regulated miR-21, miR-210 and NF …
  17783. Neuroprotective effects of β-asarone against 6-hydroxy dopamine-induced parkinsonism via JNK/Bcl-2/Beclin-1 pathway
  17784. Neuroprotective role of intermittent hypobaric hypoxia in unpredictable chronic mild stress induced depression in rats
  17785. Neuroprotective effect of crude polysaccharide isolated from the fruiting bodies of Morchella importuna against H2O2-induced PC12 cell cytotoxicity by reducing …
  17786. Neuroprotective effect of lidocaine: is there clinical potential?
  17787. Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats
  17788. Neuroprotective effects of cyanidin against Aβ-induced oxidative and ER stress in SK-N-SH cells
  17789. ALCAR exerts Neuroprotective and pro-neurogenic effects by inhibition of glial activation and oxidative stress via activation of the Wnt/β-catenin signaling in …
  17790. Neuroprotective effects of docosahexaenoic acid on hippocampal cell death and learning and memory impairments in a valproic acid-induced rat autism model
  17791. Neuroprotective effect of the marine-derived compound 11-dehydrosinulariolide through DJ-1-related pathway in in vitro and in vivo models of Parkinson’s disease
  17792. The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), lysin motif (LysM), domain catalytic (TLDc) domain is Neuroprotective against oxidative stress
  17793. Neuroprotective effects of pregabalin on cerebral ischemia and reperfusion
  17794. Dihydropyridine derivatives modulate heat shock responses and have a Neuroprotective effect in a transgenic mouse model of Alzheimer’s disease
  17795. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent Neuroprotective activity and reduced in vivo cardiovascular …
  17796. Neuroprotective effects of 20 (S)-protopanaxadiol against glutamate-induced mitochondrial dysfunction in PC12 cells
  17797. Neuroprotective and antioxidant lanostanoid triterpenes from the fruiting bodies of Ganoderma atrum
  17798. Robust Neuroprotective effects of intranasally delivered iNOS siRNA encapsulated in gelatin nanoparticles in the postischemic brain
  17799. Neuroprotective and restorative effects of the brain -derived neurotrophic factor in retinal diseases
  17800. Secoiridoids and lignans from the leaves of Diospyros kaki Thunb. with antioxidant and Neuroprotective activities
  17801. Neuroprotective effects of paeoniflorin on 6-OHDA-lesioned rat model of Parkinson’s disease
  17802. Antioxidative and Neuroprotective effects of curcumin in an Alzheimer’s disease rat model co-treated with intracerebroventricular streptozotocin and subcutaneous D …
  17803. A beacon of hope in stroke therapy—Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential Neuroprotective strategies
  17804. Neuroprotective and anti-inflammatory effects of lidocaine in kainic acid-injected rats
  17805. Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets
  17806. Polycyclic Polyprenylated Derivatives from Hypericum uralum: Neuroprotective Effects and Antidepressant-like Activity of Uralodin A
  17807. Neuroprotective effects of Biochanin A against β-amyloid-induced neurotoxicity in PC12 cells via a mitochondrial-dependent apoptosis pathway
  17808. Neuroprotective effects of isosteviol sodium injection on acute focal cerebral ischemia in rats
  17809. Neuronal membrane bioreactor as a tool for testing crocin Neuroprotective effect in Alzheimer’s disease
  17810. Neuroprotective effects of the glucagon-like peptide-1 analog exenatide after out-of-hospital cardiac arrest: a randomized controlled trial
  17811. Neuroprotective effects of resveratrol against traumatic brain injury in rats: involvement of synaptic proteins and neuronal autophagy
  17812. The Neuroprotective and anti‐apoptotic effects of melatonin on hemolytic hyperbilirubinemia‐induced oxidative brain damage
  17813. A review of the Neuroprotective role of vitamin D in traumatic brain injury with implications for supplementation post-concussion
  17814. Neuroprotective effects of the anticancer drug NVP-BEZ235 (dactolisib) on amyloid-β 1–42 induced neurotoxicity and memory impairment
  17815. Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery
  17816. Neuroprotective effects of silymarin on ischemia-induced delayed neuronal cell death in rat hippocampus
  17817. Neuroprotective effect and mechanism of Mu-Xiang-You-Fang on cerebral ischemia-reperfusion injury in rats
  17818. Neuroprotective Effects of Castanea sativa Mill. Bark Extract in Human Neuroblastoma Cells Subjected to Oxidative Stress
  17819. Investigating the Neuroprotective effects of turmeric extract: structural interactions of β-amyloid peptide with single curcuminoids
  17820. Neuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury
  17821. Methamphetamine-induced dopaminergic toxicity prevented owing to the Neuroprotective effects of salicylic acid
  17822. Neuroprotective effect of osthole on neuron synapses in an Alzheimer’s disease cell model via upregulation of microRNA-9
  17823. Neuroprotective effects of lycopene pretreatment on transient global cerebral ischemia‑reperfusion in rats: The role of the Nrf2/HO‑1 signaling pathway
  17824. Quantitative analysis of Psoralea corylifolia Linne and its Neuroprotective and anti-neuroinflammatory effects in HT22 hippocampal cells and BV-2 microglia
  17825. Neuroprotective role of microRNA-22 in a 6-hydroxydopamine-induced cell model of Parkinson’s disease via regulation of its target gene TRPM7
  17826. Ajuga chamaecistus subsp. scoparia (Boiss.) Rech. f.: A new source of phytochemicals for antidiabetic, skin-care, and Neuroprotective uses
  17827. Dopaminergic neuron‐specific deletion of p53 gene is Neuroprotective in an experimental Parkinson’s disease model
  17828. Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix …
  17829. Glucocorticoid receptor is involved in the Neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia …
  17830. Xenon combined with therapeutic hypothermia is not Neuroprotective after severe hypoxia-ischemia in neonatal rats
  17831. Perspectives for gallotannins Neuroprotective potential-current experimental evidences
  17832. Neuroprotective effects of various doses of topiramate against methylphenidate-induced oxidative stress and inflammation in isolated rat amygdala: the possible role …
  17833. Neuroprotective effects of caffeine in MPTP model of Parkinson’s disease: a 13C NMR study
  17834. Neuroprotective effect of Celastrus paniculatus on chronic stress-induced cognitive impairment
  17835. Neuroprotective effect of peptides extracted from walnut (Juglans Sigilata Dode) proteins on Aβ25-35-induced memory impairment in mice
  17836. Neuroprotective effects of adenosine isolated from Cordyceps cicadae against oxidative and ER stress damages induced by glutamate in PC12 cells
  17837. Tau protein hyperphosphorylation and aggregation in Alzheimer’s disease and other tauopathies, and possible Neuroprotective strategies
  17838. Neuroprotective effect of Phyllanthus acidus L. on learning and memory impairment in scopolamine-induced animal model of dementia and oxidative stress …
  17839. Anticonvulsant and Neuroprotective effects of apelin-13 on pentylenetetrazole-induced seizures in male rats
  17840. The Neuroprotective effect of rosemary (Rosmarinus officinalis L.) hydro-alcoholic extract on cerebral ischemic tolerance in experimental stroke
  17841. Intermittent fasting is Neuroprotective in focal cerebral ischemia by minimizing autophagic flux disturbance and inhibiting apoptosis
  17842. Neuroprotective potential of molecular hydrogen against perinatal brain injury via suppression of activated microglia
  17843. Neuroprotective effects of salidroside in the MPTP mouse model of Parkinson’s disease: involvement of the PI3K/Akt/GSK3β pathway
  17844. Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for Neuroprotective therapeutics for stroke
  17845. Neuroprotective effects of etidronate and 2, 3, 3-trisphosphonate against glutamate-induced toxicity in PC12 cells
  17846. Neuroprotective effects of vitexin against isoflurane-induced neurotoxicity by targeting the TRPV1 and NR2B signaling pathways
  17847. Diverging novobiocin anti-cancer activity from Neuroprotective activity through modification of the amide tail
  17848. Neuroprotective effect of several phytochemicals and its potential application in the prevention of neurodegenerative diseases
  17849. Discovery, Synthesis, and Functional Characterization of a Novel Neuroprotective Natural Product from the Fruit of Alpinia oxyphylla for use in Parkinson’s Disease …
  17850. Electroacupuncture at the Baihui acupoint alleviates cognitive impairment and exerts Neuroprotective effects by modulating the expression and processing of …
  17851. The Neuroprotective effect of apelin-13 in a mouse model of intracerebral hemorrhage
  17852. Neuroprotective effect of ginsenoside Rg1 prevents cognitive impairment induced by isoflurane anesthesia in aged rats via antioxidant, anti-inflammatory and …
  17853. Neuroprotective potential of cerium oxide nanoparticles for focal cerebral ischemic stroke
  17854. Progesterone exerts Neuroprotective effects against Aβ-induced neuroinflammation by attenuating ER stress in astrocytes
  17855. Inhibitory RNA aptamers of tau oligomerization and their Neuroprotective roles against proteotoxic stress
  17856. Combining Neuroprotective agents : effect of riluzole and magnesium in a rat model of thoracic spinal cord injury
  17857. Neuroprotective effects of folic acid on experimental diabetic peripheral neuropathy
  17858. Organoselenium compounds as potential Neuroprotective therapeutic agents
  17859. ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and Neuroprotective potential
  17860. Neuroprotective effects of the securinine-analogues: identification of allomargaritarine as a lead compound
  17861. Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia–reperfusion
  17862. Potential Neuroprotective effect of lithium in bipolar patients evaluated by neuropsychological assessment: preliminary results
  17863. Neuroprotective Effects of the Glutamate Transporter Activator (R)-(−)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic brain Injury in the Adult Rat
  17864. Neuroprotective effect of ischemic preconditioning via modulating the expression of adropin and oxidative markers against transient cerebral ischemia in diabetic rats
  17865. Neuroprotective effects of hypothermia in inflammatory-sensitized hypoxic-ischemic encephalopathy
  17866. … cinnamic–N, N-dibenzyl (N-methyl) amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, Neuroprotective and neurogenic properties
  17867. Novel Neuroprotective and hepatoprotective effects of citric acid in acute malathion intoxication
  17868. Neuroprotective effects of açaí (Euterpe oleracea Mart.) against rotenone in vitro exposure
  17869. Glycoprotein nonmetastatic melanoma protein B extracellular fragment shows Neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via …
  17870. Neuroprotective effects of melatonin as evidenced by abrogation of oxaliplatin induced behavioral alterations, mitochondrial dysfunction and neurotoxicity in rat brain
  17871. A new secoiridoid glycoside and a new sesquiterpenoid glycoside from Valeriana jatamansi with Neuroprotective activity
  17872. Neuroprotective effect of the LRRK2 kinase inhibitor PF-06447475 in human nerve-like differentiated cells exposed to oxidative stress stimuli: implications for …
  17873. Anthocyanin-rich extract of Acai (Euterpe precatoria Mart.) mediates Neuroprotective activities in Caenorhabditis elegans
  17874. Neuroprotective Activity of ()-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity
  17875. Neuroprotective effects of estrogens: the role of cholesterol
  17876. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is Neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human …
  17877. Neuroprotective effects of valproic acid on blood-brain barrier disruption and apoptosis-related early brain injury in rats subjected to subarachnoid hemorrhage are …
  17878. Neuroprotective mechanism of coenzyme Q10 (CoQ10) against PTZ induced kindling and associated cognitive dysfunction: possible role of microglia inhibition
  17879. Loganin possesses Neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal …
  17880. Neuroprotective effects of kukoamine a against radiation-induced rat brain injury through inhibition of oxidative stress and neuronal apoptosis
  17881. Inhibition of endoplasmic reticulum stress is involved in the Neuroprotective effect of bFGF in the 6-OHDA-induced Parkinson’s disease model
  17882. Neuroprotective effects of methane-rich saline on experimental acute carbon monoxide toxicity
  17883. Neurodegeneration and glial response after acute striatal stroke: histological basis for Neuroprotective studies
  17884. Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a Neuroprotective role
  17885. Reduction of the Neuroprotective transcription factor Npas4 results in increased neuronal necrosis, inflammation and brain lesion size following ischaemia
  17886. Enhanced Neuroprotective effect of DHA and EPA-enriched phospholipids against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced oxidative stress in …
  17887. Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson’s disease
  17888. Neuroprotective effects of exogenous methane in a rat model of acute carbon monoxide poisoning
  17889. Neuroprotective effects of bone marrow mesenchymal stem cells on bilateral common carotid arteries occlusion model of cerebral ischemia in rat
  17890. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with Neuroprotective profile
  17891. Targeted activation of CREB in reactive astrocytes is Neuroprotective in focal acute cortical injury
  17892. Biological evaluation of synthetic α, β-unsaturated carbonyl based cyclohexanone derivatives as Neuroprotective novel inhibitors of acetylcholinesterase …
  17893. Synergistic Neuroprotective effects of two herbal ingredients via CREB-dependent pathway
  17894. Neuroprotective effects of caffeic acid phenethyl ester against sevoflurane‑induced neuronal degeneration in the hippocampus of neonatal rats involve MAPK …
  17895. Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
  17896. 17β-Estradiol augments antidepressant efficacy of escitalopram in ovariectomized rats: Neuroprotective and serotonin reuptake transporter modulatory effects
  17897. Phenolic Profiles, Antioxidant Activities, and Neuroprotective Properties of Mulberry (Morus atropurpurea Roxb.) Fruit Extracts from Different Ripening Stages
  17898. Neuroprotective effects of dexmedetomidine against hypoxia-induced nervous system injury are related to inhibition of NF-κB/COX-2 pathways
  17899. Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats
  17900. The Neuroprotective Role of Insulin Against MPP+‐Induced Parkinson’s Disease in Differentiated SH‐SY5Y Cells
  17901. Low-level stress induces production of Neuroprotective factors in wild-type but not BDNF+/-mice: interleukin-10 and kynurenic acid
  17902. Neuroprotective and neurorestorative potential of xenon
  17903. The Akt/mTOR/p70S6K pathway is involved in the Neuroprotective effect of erythropoietin on hypoxic/ischemic brain injury in a neonatal rat model
  17904. Neuroprotective activity of curcumin in combination with piperine against quinolinic acid induced neurodegeneration in rats
  17905. Thioflavones as novel Neuroprotective agents
  17906. Neuroprotective and anti-inflammatory effects of diphenylheptanes from the fruits of Amomum tsaoko, a Chinese spice
  17907. Neuroprotective effects of acetyl-L-carnitine against oxygen-glucose deprivation-induced neural stem cell death
  17908. Neuroprotective effects of cold-inducible RNA-binding protein during mild hypothermia on traumatic brain injury
  17909. Kai-Xin-San, a traditional Chinese medicine formulation, exerts antidepressive and Neuroprotective effects by promoting pCREB upstream pathways
  17910. Synthesis and biological evaluation of aryloxyacetamide derivatives as Neuroprotective agents
  17911. Neuroprotective effects of germinated brown rice in rotenone-induced Parkinson’s-like disease rats
  17912. Levetiracetam as an antiepileptic, Neuroprotective , and hyperalgesic drug
  17913. Novel fermented chickpea milk with enhanced level of γ-aminobutyric acid and Neuroprotective effect on PC12 cells
  17914. Possible Neuroprotective mechanisms of clove oil against icv-colchicine induced cognitive dysfunction
  17915. Neuroprotective potential of superparamagnetic iron oxide nanoparticles along with exposure to electromagnetic field in 6-OHDA rat model of parkinson’s disease
  17916. Neuroprotective effects of engineered polymeric nasal microspheres containing Hydroxypropyl-β-cyclodextrin on β-amyloid (1-42)–induced toxicity
  17917. Neuroprotective effect of sulfated polysaccharide isolated from sea cucumber Stichopus japonicus on 6-OHDA-induced death in SH-SY5Y through inhibition of MAPK …
  17918. Comparative study of the Neuroprotective and nootropic activities of the carboxylate and amide forms of the HLDF-6 peptide in animal models of Alzheimer’s disease
  17919. Clematichinenoside serves as a Neuroprotective agent against ischemic stroke: the synergistic action of ERK1/2 and cPKC pathways
  17920. Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is Neuroprotective in intrastriatal 6-Hydroxydopamine rat model of Parkinson’s disease
  17921. Evaluation of Neuroprotective , anticonvulsant, sedative and anxiolytic activity of citicoline in rats
  17922. Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB2 Receptors
  17923. Neuroprotective effect of lycopene against PTZ‐induced kindling seizures in mice: possible behavioural, biochemical and mitochondrial dysfunction
  17924. Neuroprotective effects of bone marrow stromal cell transplantation in combination with treadmill exercise following traumatic brain injury
  17925. Neuroprotective DAMPs member prothymosin alpha has additional beneficial actions against cerebral ischemia-induced vascular damages
  17926. Involvement of AMPA/kainate and GABAA receptors in topiramate Neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and …
  17927. Neuroprotective effects of liquiritin on cognitive deficits induced by soluble amyloid-β1–42 oligomers injected into the hippocampus
  17928. Methylprednisolone exerts Neuroprotective effects by regulating autophagy and apoptosis
  17929. Neuroprotective effects of thymoquinone on the hippocampus in a rat model of traumatic brain injury
  17930. Encapsulation of curcumin in polyelectrolyte nanocapsules and their Neuroprotective activity
  17931. Neuroprotective effect of puerarin on glutamate-induced cytotoxicity in differentiated Y-79 cells via inhibition of ROS generation and Ca2+ influx
  17932. Neuroprotective Effect of Coptis chinensis in MPP and MPTP-Induced Parkinson’s Disease Models
  17933. In vitro and in vivo Neuroprotective effects of walnut (Juglandis semen) in models of Parkinson’s disease
  17934. Phenytoin in acute optic neuritis: Neuroprotective or not?
  17935. Epicatechin plus treadmill exercise are Neuroprotective against moderate-stage amyloid precursor protein/presenilin 1 mice
  17936. Chrysin exerts Neuroprotective effects against 3-Nitropropionic acid induced behavioral despair—Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl …
  17937. Anxiolytic activity of the Neuroprotective peptide HLDF-6 and its effects on brain neurotransmitter systems in BALB/c and C57BL/6 mice
  17938. Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro …
  17939. Neuroprotective potential of Indigofera oblongifolia leaf methanolic extract against lead acetate-induced neurotoxicity
  17940. The Neuroprotective effects of the anti-diabetic drug linagliptin against Aβ-induced neurotoxicity
  17941. Induction of endothelial phenotype from Wharton’s Jelly-derived MSCs and comparison of their vasoprotective and Neuroprotective potential with primary WJ-MSCs in …
  17942. Pomegranate’s Neuroprotective effects against Alzheimer’s disease are mediated by urolithins, its ellagitannin-gut microbial derived metabolites
  17943. Neuroprotective effects of 7, 8-dihydroxyflavone on midbrain dopaminergic neurons in MPP+-treated monkeys
  17944. An in vitro model for synaptic loss in neurodegenerative diseases suggests a Neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling
  17945. Neuroprotective effects of rhGLP‐1 in diabetic rats with cerebral ischemia/reperfusion injury
  17946. Dose‐dependent short‐and long‐term effects of ionizing irradiation on neural stem cells in murine hippocampal tissue cultures: Neuroprotective potential of resveratrol
  17947. … prognosis and analysis of clinical trials in traumatic brain injury: prognostic models for traumatic brain injury on the study of the Neuroprotective activity of progesterone …
  17948. The Neuroprotective properties of a novel variety of passion fruit
  17949. Estrogen receptors and estetrol-dependent Neuroprotective actions: a pilot study
  17950. Carvacrol exerts Neuroprotective effects via suppression of the inflammatory response in middle cerebral artery occlusion rats
  17951. The Neuroprotective effect of the association of aquaporin-4/glutamate transporter-1 against Alzheimer’s disease
  17952. Intranasal delivery of granulocyte colony-stimulating factor enhances its Neuroprotective effects against ischemic brain injury in rats
  17953. Neuroprotective effects of acetyl-l-carnitine on neonatal hypoxia ischemia-induced brain injury in rats
  17954. Neuroprotective effect of lutein on NMDA-induced retinal ganglion cell injury in rat retina
  17955. Neuroprotective effects of sodium hydrosulfide against β-amyloid-induced neurotoxicity
  17956. The Neuroprotective effects of R-phenibut after focal cerebral ischemia
  17957. Preliminary research concerning the obtaining of herbal extracts with potential Neuroprotective activity note I. Obtaining and characterization of a selective …
  17958. Insights into the Neuroprotective mechanisms of 2-iminobiotin employing an in-vitro model of hypoxic-ischemic cell injury
  17959. Neuroprotective and antioxidant activities of 4-methylcoumarins: development of structure–activity relationships
  17960. Neuroprotective strategies in glaucoma
  17961. Daphnane Diterpenes from Daphne genkwa Activate Nurr1 and Have a Neuroprotective Effect in an Animal Model of Parkinson’s Disease
  17962. Neuroprotective and antiapoptotic potential of trigonelline in a striatal 6-hydroxydopamine rat model of Parkinson’s disease
  17963. Neuroprotective actions of pterostilbene on hypoxic-ischemic brain damage in neonatal rats through upregulation of heme oxygenase-1
  17964. Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue Neuroprotective effect
  17965. Preconditioning with VEGF enhances angiogenic and Neuroprotective effects of bone marrow mononuclear cell transplantation in a rat model of chronic cerebral …
  17966. Neuroprotective properties of a macrolide antibiotic in a mouse model of middle cerebral artery occlusion: characterization of the immunomodulatory effects and …
  17967. Recurrent sleep fragmentation induces insulin and Neuroprotective mechanisms in middle-aged flies
  17968. Novel and Neuroprotective tetranortriterpenoids from Chinese mangrove Xylocarpus granatum Koenig
  17969. Neuroprotective effect of non-viral gene therapy treatment based on tetanus toxin C-fragment in a severe mouse model of spinal muscular atrophy
  17970. Assessment of the Neuroprotective effects of lavandula angustifolia extract on the contusive model of spinal cord injury in wistar rats
  17971. Neuroprotective effect of paeonol mediates anti-inflammation via suppressing toll-like receptor 2 and toll-like receptor 4 signaling pathways in cerebral …
  17972. A novel dual GLP-1 and GIP receptor agonist is Neuroprotective in the MPTP mouse model of Parkinson′ s disease by increasing expression of BNDF
  17973. Evaluation of the Neuroprotective effect of silymarin on acrylamide-induced neurotoxicity
  17974. Antioxidant, DNA damage protective, Neuroprotective , and α-glucosidase inhibitory activities of a flavonoid glycoside from leaves of Garcinia gracilis
  17975. Antioxidant and Neuroprotective effects of green tea seed shell ethanol extracts
  17976. Neuroprotective transcription factors in animal models of Parkinson disease
  17977. Neuroprotective effects of electroacupuncture on an animal model of bilateral common carotid artery occlusion
  17978. 2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: thrombotic stroke: Neuroprotective therapy by recombinant-activated protein C
  17979. Mechanisms of Neuroprotective action of incretin mimetics
  17980. Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense
  17981. Neuroprotective effect of grape seed extract against cadmium toxicity in male albino rats
  17982. Neuroprotective effect of human adipose stem cell-derived extract in amyotrophic lateral sclerosis
  17983. Neuroprotective effects of Methyl 3, 4-dihydroxybenzoate against TBHP-induced oxidative damage in SH-SY5Y cells
  17984. The comparison of Neuroprotective effects of isoliquiritigenin and its Phase I metabolites against glutamate-induced HT22 cell death
  17985. The Neuroprotective effects and possible mechanism of action of a methanol extract from Asparagus cochinchinensis: In vitro and in vivo studies
  17986. Study of Neuroprotective function of Ginkgo biloba extract (EGb761) derived‐flavonoid monomers using a three‐dimensional stem cell‐derived neural model
  17987. Neuroprotective effects of honokiol against beta-amyloid-induced neurotoxicity via GSK-3β and β-catenin signaling pathway in PC12 cells
  17988. Neuroprotective effect of caffeic acid phenethyl ester in 3-nitropropionic acid-induced striatal neurotoxicity
  17989. Neuroprotective effects of poly (ADP-ribose) polymerase inhibitor olaparib in transient cerebral ischemia
  17990. Human adipose-derived stem cells delay retinal degeneration in Royal College of Surgeons rats through anti-apoptotic and VEGF-mediated Neuroprotective effects
  17991. … retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a Neuroprotective effect of rosiglitazone …
  17992. Neuroprotective effect of Myo/Nog cells in the stressed retina
  17993. Possible role of P-glycoprotein in the Neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction
  17994. Neuroprotective effects of Ilexonin A following transient focal cerebral ischemia in rats
  17995. Antioxidant and Neuroprotective effects of Doenjang prepared with Rhizopus, Pichia, and Bacillus
  17996. A novel dual GLP-1 and GIP incretin receptor agonist is Neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain
  17997. Neuroprotective effect of ethyl pyruvate against Zn2+ toxicity via NAD replenishment and direct Zn2+ chelation
  17998. Neuroprotective effects of herbal extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on rat model of sporadic Alzheimer’s disease
  17999. Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the Neuroprotective effects of telmisartan in the …
  18000. The Toll-like receptor 4-activated Neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling
  18001. Antioxidant and Neuroprotective potential of chitooligomers in Caenorhabditis elegans exposed to Monocrotophos
  18002. Neuroprotective effect of 4-(Phenylsulfanyl) butan-2-one on optic nerve crush model in rats
  18003. Neuroprotective effect of hydroxy safflor yellow A against cerebral ischemia-reperfusion injury in rats: putative role of mPTP
  18004. Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy
  18005. Phenotypic modulation and Neuroprotective effects of olfactory ensheathing cells: a promising tool for cell therapy
  18006. Neuroprotective effect of Portulaca oleraceae ethanolic extract ameliorates methylmercury induced cognitive dysfunction and oxidative stress in cerebellum and cortex …
  18007. Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
  18008. Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed Neuroprotective treatment drugs in freely …
  18009. Maternal magnesium sulfate fetal Neuroprotective effects to the fetus: inhibition of neuronal nitric oxide synthase and nuclear factor kappa-light-chain-enhancer of …
  18010. Improvement of erinacine A productivity in Hericium erinaceus mycelia and its Neuroprotective bioactivity against the glutamate-insulted apoptosis
  18011. Comparative evaluation of Neuroprotective effect of three varieties of Allium cepa in chronic constriction injury induced neuropathic pain
  18012. Neuroprotective effects of adenosine deaminase in the striatum
  18013. Neuroprotective effect of Arthrospira (Spirulina) platensis against kainic acid-neuronal death
  18014. Neuroprotective effect of S-allyl-l-cysteine derivatives against endoplasmic reticulum stress-induced cytotoxicity is independent of calpain inhibition
  18015. Neuroprotective mechanism of HIF-1α overexpression in the early stage of acute cerebral infarction in rats
  18016. Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats
  18017. Neuroprotective activities of marine natural products from marine sponges
  18018. Passiflora actinia hydroalcoholic extract and its major constituent, isovitexin, are Neuroprotective against glutamate‐induced cell damage in mice hippocampal slices
  18019. Ret is essential to mediate GDNF’s Neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
  18020. Oral administration of sitagliptin activates CREB and is Neuroprotective in murine model of brain trauma
  18021. HSP60 mediates the Neuroprotective effects of curcumin by suppressing microglial activation
  18022. BBB-permeable, Neuroprotective , and neurotrophic polysaccharide, midi-GAGR
  18023. AUTEN-67, an autophagy-enhancing drug candidate with potent antiaging and Neuroprotective effects
  18024. Neuroprotective effect of Decalepis hamiltonii on cyclophosphamide-induced oxidative stress in the mouse brain
  18025. Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice
  18026. Neuroprotective effect of angiotensin II type 2 receptor during cerebral ischemia/reperfusion
  18027. The Neuroprotective Effects of Justicidin A on Amyloid Beta25–35-Induced Neuronal Cell Death Through Inhibition of Tau Hyperphosphorylation and Induction of …
  18028. Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson’s disease
  18029. Compositions, formation mechanism, and Neuroprotective effect of compound precipitation from the traditional chinese prescription huang-lian-jie-du-tang
  18030. Crude Saponins of Panax notoginseng Have Neuroprotective Effects To Inhibit Palmitate-Triggered Endoplasmic Reticulum Stress-Associated Apoptosis and Loss of …
  18031. The synthetic progesterone N orgestrel is Neuroprotective in stressed photoreceptor‐like cells and retinal explants, mediating its effects via basic fibroblast growth …
  18032. Neuroprotective , antiapoptotic and antioxidant effects of l-carnitine against caffeine-induced neurotoxicity in SH-SY5Y neuroblastoma cell line
  18033. Synthesis and evaluation of novel 1, 2, 3-triazole-based acetylcholinesterase inhibitors with Neuroprotective activity
  18034. Neuroprotective effects of human umbilical cord–derived mesenchymal stromal cells combined with nimodipine against radiation-induced brain injury through …
  18035. Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against μ-calpain and cathepsin B through the downregulation of tau …
  18036. Neuroprotective effect of propofol against excitotoxic injury to locomotor networks of the rat spinal cord in vitro
  18037. Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injury
  18038. An orally active allosteric GLP-1 receptor agonist is Neuroprotective in cellular and rodent models of stroke
  18039. The Neuroprotective effect of dark chocolate in monosodium glutamate-induced nontransgenic Alzheimer disease model rats: biochemical, behavioral, and …
  18040. Design, synthesis, and biological evaluation of novel tetramethylpyrazine derivatives as potential Neuroprotective agents
  18041. Neuroprotective role of (Val8) GLP-1-Glu-PAL in an in vitro model of Parkinson’s disease
  18042. A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is Neuroprotective in transient focal cerebral ischemia in the …
  18043. Neuroprotective effects of tetrandrine against vascular dementia
  18044. Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson’s disease
  18045. Neuroprotective effects of fermented soybean products (Cheonggukjang) manufactured by mixed culture of Bacillus subtilis MC31 and Lactobacillus sakei 383 on …
  18046. Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised …
  18047. Studies on the purification of polysaccharides separated from Tremella fuciformis and their Neuroprotective effect
  18048. Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na+/Ca2+ exchanger
  18049. Effects of the Neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy
  18050. Discovery of KLS-13019, a cannabidiol-derived Neuroprotective agent, with improved potency, safety, and permeability
  18051. Neuroprotective effect of carnosine and cyclosporine-A against inflammation, apoptosis, and oxidative brain damage after closed head injury in immature rats
  18052. Calcium/calmodulin‐dependent protein kinase kinase β is Neuroprotective in stroke in aged mice
  18053. brain -derived neurotrophic factor and suicide in schizophrenia: critical role of Neuroprotective mechanisms as an emerging hypothesis
  18054. Synthesis and Neuroprotective activity of dictyoquinazol A and analogues
  18055. Neuroprotective effect of Portulaca oleracea extracts against 6-hydroxydopamine-induced lesion of dopaminergic neurons
  18056. Additive Neuroprotective effects of the multifunctional iron chelator M30 with enriched diet in a mouse model of amyotrophic lateral sclerosis
  18057. Neuroprotective effects of the Buyang Huanwu decoction on functional recovery in rats following spinal cord injury
  18058. Neuroprotective effects of memantine in the retina of glaucomatous rats: an electron microscopic study
  18059. Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
  18060. Chemical analysis of extracts from newfoundland berries and potential Neuroprotective effects
  18061. A review on the possible Neuroprotective effects of Moringa oleifera leaf extract
  18062. Neuroprotective activity of stiripentol with a possible involvement of voltage‐dependent calcium and sodium channels
  18063. Dose-dependent Neuroprotective effect of caffeine on a rotenone-induced rat model of parkinsonism: A histological study
  18064. Association of Neuroprotective Effect of Di-O-Demethylcurcumin on Aβ25–35-Induced Neurotoxicity with Suppression of NF-κB and Activation of Nrf2
  18065. Manipulation of the N‐terminal sequence of the Borna disease virus X protein improves its mitochondrial targeting and Neuroprotective potential
  18066. Neurocognitive , Neuroprotective , and cardiometabolic effects of raloxifene: potential for improving therapeutic outcomes in schizophrenia
  18067. Spontaneous recovery of reflex voiding following spinal cord injury mediated by anti-inflammatory and Neuroprotective factors
  18068. G-1 exerts Neuroprotective effects through G protein-coupled estrogen receptor 1 following spinal cord injury in mice
  18069. OFD1, as a ciliary protein, exhibits Neuroprotective function in photoreceptor degeneration models
  18070. Dopamine treatment during acute hypoxia is Neuroprotective in the developing sheep brain
  18071. 17β-Estradiol/N-acetylcysteine interaction enhances the Neuroprotective effect on dopaminergic neurons in the weaver model of dopamine deficiency
  18072. Melanocortin-1 receptor activation is Neuroprotective in mouse models of neuroinflammatory disease
  18073. Epobis is a nonerythropoietic and Neuroprotective agonist of the erythropoietin receptor with anti-inflammatory and memory enhancing effects
  18074. Neuroprotective coordination of cell mitophagy by the ATPase Inhibitory Factor 1
  18075. β-Secretase (BACE1) inhibitory and Neuroprotective effects of p-terphenyls from Polyozellus multiplex
  18076. New Thymoquinol Glycosides and Neuroprotective Dibenzocyclooctane Lignans from the Rattan Stems of Schisandra chinensis
  18077. Neuroprotective effectiveness of intravenous ubiquinone in rat model of irreversible cerebral ischemia
  18078. Neuroprotective effects of an erythropoietin-derived peptide in PC1 2 cells under oxidative stress
  18079. Neuroprotective effect is driven through the upregulation of CB1 receptor in experimental autoimmune encephalomyelitis
  18080. Neuroprotective effects of Danggui-Jakyak-San on rat stroke model through antioxidant/antiapoptotic pathway
  18081. Neuroprotective effects of the Phellinus linteus ethyl acetate extract against H2O2-induced apoptotic cell death of SK-N-MC cells
  18082. Neuroprotective effect of a DJ-1 based peptide in a toxin induced mouse model of multiple system atrophy
  18083. Neuroprotective Role of LNG-Nitroarginine Methyl Ester (L-NAME) against Chronic Hypobaric Hypoxia with Crowding Stress (CHC) Induced Depression-Like …
  18084. Possible Involvement of Nitric Oxide Modulatory Mechanisms in the Neuroprotective Effect of Centella asiatica Against Sleep Deprivation Induced Anxiety Like …
  18085. Potential Neuroprotective effects of an LSD1 inhibitor in retinal ganglion cells via p38 MAPK activity
  18086. Neuroprotective effects of pregabalin against spinal cord ischemia-reperfusion injury in rats
  18087. Neuroprotective role of nanoparticles against Alzheimer’s disease
  18088. Intranasal delivery of exendin-4 confers Neuroprotective effect against cerebral ischemia in mice
  18089. Gender difference in valproic acid-induced Neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer’s disease
  18090. Melatonin, Neuroprotective agents and antidepressant therapy
  18091. Anti‐diabetic and Neuroprotective effects of pancreatic islet transplantation into the central nervous system
  18092. Neuroprotective properties of compounds extracted from Dianthus superbus L. against glutamate-induced cell death in HT22 cells
  18093. The Neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage
  18094. The Neuroprotective action of naringenin on oseltamivir (Tamiflu) treated male rats
  18095. LBH589, a hydroxamic acid-derived HDAC inhibitor, is Neuroprotective in mouse models of Huntington’s disease
  18096. The Neuroprotective potential of arginine-rich peptides for the acute treatment of traumatic brain injury
  18097. 14, 15‐epoxyeicosatrienoic acid promotes production of brain derived neurotrophic factor from astrocytes and exerts Neuroprotective effects during ischaemic injury
  18098. Apigetrin from Scutellaria baicalensis Georgi Inhibits Neuroinflammation in BV-2 Microglia and Exerts Neuroprotective Effect in HT22 Hippocampal Cells
  18099. Glutamate Transporters/Na+, K+-ATPase Involving in the Neuroprotective Effect as a Potential Regulatory Target of Glutamate Uptake
  18100. Antiapoptotic and Neuroprotective role of Curcumin in Pentylenetetrazole (PTZ) induced kindling model in rat
  18101. The biochemical, histopathological and clinical comparison of the Neuroprotective effects of subcutaneous adalimumab and intravenous methylprednisolone in …
  18102. Red lentil extract: Neuroprotective effects on perphenazine induced catatonia in rats
  18103. Neuronal release of cytokine IL-3 triggered by mechanosensitive autostimulation of the P2X7 receptor is Neuroprotective
  18104. A study on Neuroprotective effects of curcumin on the diabetic rat brain
  18105. Neuroprotective effects of LMW and HMW FGF2 against amyloid beta toxicity in primary cultured hippocampal neurons
  18106. Doxycycline exerted Neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1
  18107. Neuroprotective effects of Caralluma tuberculata on ameliorating cognitive impairment in a d-galactose-induced mouse model
  18108. Neuroprotective effect of mesenchymal stem cell through complement component 3 downregulation after transient focal cerebral ischemia in mice
  18109. Involvement of IGF-1 receptor signaling pathway in the Neuroprotective effects of Icaritin against MPP+-induced toxicity in MES23. 5 cells
  18110. New 6-aminoquinoxaline derivatives with Neuroprotective effect on dopaminergic neurons in cellular and animal parkinson disease models
  18111. Neuroprotective effects of Kaempferide-7-O-(4 ″-O-acetylrhamnosyl)-3-O-rutinoside on cerebral ischemia-reperfusion injury in rats
  18112. … of trifluoromethylated proline and surrogates into peptides: application to the synthesis of fluorinated analogues of the Neuroprotective glycine-proline-glutamate (GPE …
  18113. Further structure–activity relationships study of substituted dithiolethiones as glutathione-inducing Neuroprotective agents
  18114. Neuroprotective effects of ellagic acid on neonatal hypoxic brain injury via inhibition of inflammatory mediators and down-regulation of JNK/p38 MAPK activation
  18115. Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson’s disease
  18116. Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats
  18117. The Neuroprotective effects of resveratrol preconditioning in transient global cerebral ischemia-reperfusion in mice
  18118. Neuroprotective effect of Amaranthus lividus and Amaranthus tricolor and their effects on gene expression of RAGE during oxidative stress in SH-SY5Y cells
  18119. Design, synthesis and biological evaluation of novel chiral oxazino-indoles as potential and selective Neuroprotective agents against Aβ25–35-induced neuronal …
  18120. A systematic RNAi screen of Neuroprotective genes identifies novel modulators of alpha-synuclein-associated effects in transgenic Caenorhabditis elegans
  18121. Neuroprotective effect of antioxidant compounds
  18122. Apigenin-7-O-β-D-(-6”-p-coumaroyl)-Glucopyranoside treatment elicits Neuroprotective effect against experimental ischemic stroke
  18123. Neuroprotective effects of placenta-derived mesenchymal stromal cells in a rat model of experimental autoimmune encephalomyelitis
  18124. Structure–activity studies of non-steroid analogues structurally-related to Neuroprotective estrogens
  18125. Neuroprotective effects of lotus seedpod procyanidins on extremely low frequency electromagnetic field-induced neurotoxicity in primary cultured hippocampal …
  18126. Neuroprotective effects of erythropoietin against oxidant injury following brain irradiation: An experimental study
  18127. Neuroprotective effect of docosahexaenoic acid nanoemulsion on erectile function in a rat model of bilateral cavernous nerve injury
  18128. Neuroprotective effect of Shenqi Fuzheng injection pretreatment in aged rats with cerebral ischemia/reperfusion injury
  18129. Downregulation of Homer1b/c in SOD1 G93A models of ALS: A novel mechanism of Neuroprotective effect of lithium and valproic acid
  18130. Pharmacophore elucidation of phosphoiodyn A–Potent and selective peroxisome proliferator-activated receptor β/δ agonists with Neuroprotective activity
  18131. Silymarin versus Silibinin: Differential Antioxidant and Neuroprotective Effects against H2O2-induced Oxidative Stress in PC12 Cells
  18132. Establishment of cell-based neuroglobin promoter reporter assay for Neuroprotective compounds screening
  18133. Neuroprotective effect of Picholine virgin olive oil and its hydroxycinnamic acids component against β-amyloid-induced toxicity in SH-SY5Y neurotypic cells
  18134. … on Zn–In2O3 nanorods coated glassy carbon microspheres paste electrode for square wave voltammetric determination of Neuroprotective hibifolin in biological fluids …
  18135. Neuroprotective effects of dimerumic acid and deferricoprogen from Monascus purpureus NTU 568-fermented rice against 6-hydroxydopamine-induced oxidative …
  18136. Novel group-based QSAR and combinatorial design of CK-1δ inhibitors as Neuroprotective agents
  18137. Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and Neuroprotective properties
  18138. Neuroprotective effects of HTR1A antagonist WAY-100635 on scopolamine-induced delirium in rats and underlying molecular mechanisms
  18139. α-lipoic acid exerts Neuroprotective effects on neuronal cells by upregulating the expression of PCNA via the P53 pathway in neurodegenerative conditions
  18140. Neuroprotective constituent from the seeds of Alpinia katsumadai Hayata
  18141. Alterations in activity-dependent Neuroprotective protein in sporadic and experimental Parkinson’s disease
  18142. Robust Neuroprotective effects of 2-((2-oxopropanoyl) oxy)-4-(trifluoromethyl) benzoic acid (OPTBA), a HTB/pyruvate ester, in the postischemic rat brain
  18143. Neuroprotective effects of bloodletting at Jing points combined with mild induced hypothermia in acute severe traumatic brain injury
  18144. Neuroprotective effect of the endogenous amine 1MeTIQ in an animal model of Parkinson’s disease
  18145. COA-Cl, a novel synthesized nucleoside analog, exerts Neuroprotective effects in the acute phase of intracerebral hemorrhage
  18146. brain atrophy as a measure of Neuroprotective drug effects in multiple sclerosis: influence of inflammation
  18147. Neuroprotective effects of sufentanil preconditioning on spinal cord injury in mouse models
  18148. Prophylactic Neuroprotective efficiency of co-administration of Ginkgo biloba and Trifolium pretense against sodium arsenite-induced neurotoxicity and dementia in …
  18149. Relative Neuroprotective effects hyperbaric oxygen treatment and TLR4 knockout in a mouse model of temporary middle cerebral artery occlusion
  18150. Neuroprotective effect of the novel compound ITH33/IQM9. 21 against oxidative stress and Na+ and Ca 2+ overload in motor neuron-like NSC-34 cells
  18151. Neuroprotective effects of Wnt/β-catenin signaling pathway against Aβ-induced tau protein over-phosphorylation in PC12 cells
  18152. Neuroprotective effects of curcumin against transient global ischemia are dose and area dependent
  18153. Retinal Neuroprotective effects of flibanserin, an FDA-approved dual serotonin receptor agonist-antagonist
  18154. Seladin-1/DHCR24 is Neuroprotective by associating EAAT2 glutamate transporter to lipid rafts in experimental stroke
  18155. Combined Magnesium/Polyethylene glycol facilitates the Neuroprotective effects of magnesium in traumatic brain injury at a reduced magnesium dose
  18156. Genistein improves sensorimotor gating: Mechanisms related to its Neuroprotective effects on the striatum
  18157. Autophagy inhibitor 3-MA weakens Neuroprotective effects of posttraumatic brain injury moderate hypothermia
  18158. Is there a role for neurotrophic factors and their receptors in augmenting the Neuroprotective effect of (−)-epigallocatechin-3-gallate treatment of sciatic nerve crush …
  18159. The Neuroprotective mechanism of ampicillin in a mouse model of transient forebrain ischemia
  18160. Neuroprotective effect of Korea Red Ginseng extract on 1-methyl-4-phenylpyridinium-induced apoptosis in PC12 Cells
  18161. Neuroprotective plants; what, how, and why? A narrative review
  18162. Neuroprotective effect of hydrogen sulfide on acute cauda equina injury in rats
  18163. Programmed death ligand 1 plays a Neuroprotective role in experimental autoimmune neuritis by controlling peripheral nervous system inflammation of rats
  18164. mTOR regulates Neuroprotective effect of immunized CD4+ Foxp3+ T cells in optic nerve ischemia
  18165. 1, 25-Dihydroxyvitamin D3 exerts Neuroprotective effects in an ex vivo model of mild hyperhomocysteinemia
  18166. Development of glycine-α-methyl-proline-containing tripeptides with Neuroprotective properties
  18167. Neuroprotective effect of ocular hypotensive drugs: latanoprost/timolol in combination are more effective than each as monotherapy in RGC-5
  18168. The MLN4924 inhibitor exerts a Neuroprotective effect against oxidative stress injury via Nrf2 protein accumulation
  18169. Neuroprotective effects of intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats on ischemic stroke
  18170. Comparison of Neuroprotective effect of bevacizumab and sildenafil following induction of stroke in a mouse model
  18171. THC (Δ9‐tetrahydrocannabinol) exerts Neuroprotective effect in glutamate‐affected murine primary mesencephalic cultures through restoring mitochondrial membrane …
  18172. New compounds with Neuroprotective activities from Gastrodia elata
  18173. Neuroprotective effects of herbal cocktail on cerebrovascular dysfunction in rats with induced hyperhomocysteinaemia
  18174. Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivatives in vitro models of Parkinson’s disease
  18175. Bcl-2, Bcl-xL, and p-AKT are involved in Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
  18176. Non-invasive evaluation of Neuroprotective drug candidates for cerebral infarction by PET imaging of mitochondrial complex-I activity
  18177. PML regulates Neuroprotective innate immunity and neuroblast commitment in a hypoxic–ischemic encephalopathy model
  18178. Anxiolytic and Neuroprotective effects of the Traditional Chinese Medicinal formulation Dan-zhi-xiao-yao-san in a rat model of chronic stress
  18179. Regulatory T cells exhibit Neuroprotective effect in a mouse model of traumatic brain injury Retraction in/10.3892/mmr. 2017.6299
  18180. Synthesis and characterization of brain penetrant prodrug of Neuroprotective D-264: Potential therapeutic application in the treatment of Parkinson’s disease
  18181. 4′-Chlorodiazepam is Neuroprotective against amyloid-beta through the modulation of survivin and bax protein expression in vitro
  18182. Assessment of antioxidant activity and Neuroprotective capacity on PC12 cell line of Frankenia thymifolia and related phenolic LC-MS/MS identification
  18183. Self-assembly of Neuroprotective carbazolium based small molecules at octane/water interface: A simulation investigation
  18184. Neuroprotective effects of electroacupuncture on hypoxic-ischemic encephalopathy in newborn rats are associated with increased expression of GDNF-RET and …
  18185. Retinal caveolin-1 modulates Neuroprotective signaling
  18186. Tumor necrosis factor-inducible gene 6 protein: A novel Neuroprotective factor against inflammation-induced developmental brain injury
  18187. The chemical molecule B355252 is Neuroprotective in an in vitro model of Parkinson’s disease
  18188. Neuroprotective effects of a chromatin modifier on ischemia/reperfusion neurons: Implication of its regulation of BCL2 transactivation by ERα signaling
  18189. Two for the price of one: a Neuroprotective chaperone kit within NAD synthase protein NMNAT2
  18190. 2-(3′, 5′-Dimethoxybenzylidene) cyclopentanone, a novel synthetic small-molecule compound, provides Neuroprotective effects against ischemic stroke
  18191. A meta-analysis of Neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma
  18192. Neuroprotective effects of erythromycin on ischemic injury following permanent focal cerebral ischemia in rats
  18193. Adaptogenic and Neuroprotective effects of lithium ascorbate
  18194. 6, 8-Di-C-methyl-flavonoids with Neuroprotective activities from Rhododendron fortunei
  18195. In vitro evaluation of antioxidant and Neuroprotective effects of curcumin loaded in Pluronic micelles
  18196. Gas1 knockdown increases the Neuroprotective effect of glial cell-derived neurotrophic factor against glutamate-induced cell injury in human SH-SY5Y neuroblastoma …
  18197. Experimental procedures for demonstration of microRNA mediated enhancement of functional Neuroprotective effects of estrogen receptor agonists
  18198. Comparable Neuroprotective effects of pergolide and pramipexole on ferrous sulfate-induced dopaminergic cell death in cell culture
  18199. Neuroprotective effects of Inhibiting Fyn S-nitrosylation on cerebral ischemia/reperfusion-induced damage to CA1 hippocampal neurons
  18200. Design and evaluation of mucoadhesive microemulsion for Neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model
  18201. Are the endocannabinoid-like compounds N-acyl aminoacids Neuroprotective after traumatic brain injury?
  18202. Neuroprotective effects of nitidine in Parkinson’s disease models through inhibiting microglia activation: role of the Jak2–Stat3 pathway
  18203. Neurotrophic and Neuroprotective effects of muscle contraction
  18204. Neuroprotective effects of the herbal formula b401 in both cell and mouse models of alzheimer’s disease
  18205. Increase of neurofilament-H protein in sensory neurons in antiretroviral neuropathy: Evidence for a Neuroprotective response mediated by the RNA-binding protein …
  18206. Neolignans from the Fruits of Magnolia obovata Inhibit NO Production and Have Neuroprotective Effects
  18207. Assessment of Neuroprotective Properties of Melissa officinalis in Combination With Human Umbilical Cord Blood Stem Cells After Spinal Cord Injury
  18208. A novel synthetic isothiocyanate ITC-57 displays antioxidant, anti-inflammatory, and Neuroprotective properties in a mouse Parkinson’s disease model
  18209. Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats
  18210. New lignans with Neuroprotective activity from Adelostemma gracillimum
  18211. Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation
  18212. Assessment of Neuroprotective effects of local administration of 17-beta-estradiol on peripheral nerve regeneration in ovariectomized female rats
  18213. Widespread brain transcriptome alterations underlie the Neuroprotective actions of dietary saffron
  18214. c-Fos protects neurons through a noncanonical mechanism involving HDAC3 interaction: identification of a 21-amino acid fragment with Neuroprotective activity
  18215. Molecular properties and insilico Neuroprotective activity of eugenol against glutamate metabotrophic receptors
  18216. Neuroprotective effect of Grewia carpinifolia extract against vanadium induced behavioural impairment
  18217. Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry
  18218. Neuroprotective effects of bone marrow-derived mesenchymal stem cells and conditioned medium in mechanically injured neuroblastoma cells
  18219. Galacto-N-biose is Neuroprotective against glutamate-induced excitotoxicity in vitro
  18220. Neuroprotective effect of Cerebralcare Granule after cerebral ischemia/reperfusion injury
  18221. Peripheral sensory stimulation is Neuroprotective in a rat photothrombotic ischemic stroke model
  18222. The herbal extract KCHO-1 exerts a Neuroprotective effect by ameliorating oxidative stress via heme oxygenase-1 upregulation
  18223. Antioxidant and antihypoxic properties of Neuroprotective drugs
  18224. Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and Neuroprotective effects of melatonin
  18225. Manual acupuncture at the SJ5 (Waiguan) acupoint shows Neuroprotective effects by regulating expression of the anti-apoptotic gene Bcl-2
  18226. A novel translocator protein 18 kDa ligand, ZBD‐2, exerts Neuroprotective effects against acute spinal cord injury
  18227. S100b induces expression of myoglobin in APβ treated neuronal cells In vitro: a possible Neuroprotective mechanism
  18228. Neuroprotective properties of extracellular vesicles derived from mesenchymal stem cells
  18229. Neuroprotective Activity of Garcinia pedunculata Roxb. ex Buch.-Ham. Fruit Extract Against Aluminium Chloride Induced Neurotoxicity in Mice
  18230. Neuroprotective effect of active components of Xiaoxuming decoction on focal cerebral ischemia/reperfusion injury in rats during early recovery period
  18231. Neuroprotective Fatty Acids from the Stem Bark of Sorbus commixta
  18232. Delayed bradykinin postconditioning modulates intrinsic Neuroprotective enzyme expression in the rat CA1 region after cerebral ischemia: a proteomic study
  18233. Activation of peroxisome proliferator-activated receptor–γ by a 12/15-lipoxygenase product of arachidonic acid: a possible Neuroprotective effect in the brain after …
  18234. Neuroprotective effect of acute melatonin treatment on hippocampal neurons against irradiation by inhibition of caspase‑3
  18235. Neuroprotective effect of activated 5′-adenosine monophosphate-activated protein kinase on cone system function during retinal inflammation
  18236. Ilex paraguariensis hydroalcoholic extract exerts antidepressant-like and Neuroprotective effects: involvement of the NMDA receptor and the L-arginine-NO pathway
  18237. Neuroprotective effect of perilla extracts on PC12 cells
  18238. Mass Spectrometric Evidence for Iron Binding to the Neuroprotective Peptide NAP and its Cys5 Mutant
  18239. Neuroprotective effects of adalimumab on rats with experimental peripheral nerve injury: An electron microscopic and biochemical study
  18240. Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis
  18241. Design, synthesis and biological evaluation of novel dicarbonylalkyl piperazine derivatives as Neuroprotective agents
  18242. High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its Neuroprotective effects
  18243. cognitive enhancement and Neuroprotective effects of ancient ayurvedic medicinal plant celastrus paniculatus: An overview
  18244. Neuroprotective effects associated with wine and its phenolic constituents
  18245. Omega-3 fatty acids: possible Neuroprotective mechanisms in the model of global ischemia in rats
  18246. Antioxidative and Neuroprotective effects of extract and fractions from Adenophora triphylla
  18247. Fermentation enhances the Neuroprotective effect of shogaol-enriched ginger extract via an increase in 6-paradol content
  18248. Neuroprotective effect of apocynin nitrone in oxygen glucose deprivation-treated SH-SY5Y cells and rats with ischemic stroke
  18249. Synthesis and evaluation of Neuroprotective 4-O-substituted chrysotoxine derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease
  18250. Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke
  18251. Recent evidence of the regulatory role of PPARs in neural stem cells and their underlying mechanisms for Neuroprotective effects
  18252. Neuroprotective and anti-nociceptive potential of ambroxol in oxaliplatin induced peripheral neuropathic pain in rats
  18253. Neuroprotective effects of low-dose statins in the retinal ultrastructure of hypercholesterolemic rabbits
  18254. Neuroprotective and antioxidant activities of bamboo salt soy sauce against H2O2-induced oxidative stress in rat cortical neurons
  18255. The Neuroprotective influence of employment on cognitive reserve: Implications for an aging HIV population
  18256. Neuroprotective role of galectin-1 in central nervous system pathophysiology
  18257. Neuroprotective effects of Paeonia Lactiflora extract against cell death of dopaminergic SH-SY5Y cells is mediated by epigenetic modulation
  18258. Neuroprotective role of Mucuna pruriens in Parkinson’s disease model system
  18259. Neuroprotective role of antidiabetic drug metformin against amyloid β peptide-induced neuronal loss in hippocampal CA1 pyramidal neurons in rats fed high fat diet
  18260. Neuroprotective effect of NecroX-5 against retinal degeneration in rodents
  18261. Involvement of bax and Bcl2 in Neuroprotective effect of curcumin in kainic acid-induced model of temporal lobe epilepsy in male rat
  18262. An integrated Neuroprotective intervention for brain ischemia validated by ECoG-fPAM
  18263. Alcohol and amyotrophic lateral sclerosis: a possible Neuroprotective effect
  18264. Hydrogen does not Exert Neuroprotective Effects or Improve Functional Outcomes in Rats After Intracerebral Hemorrhage.
  18265. 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic Neuroprotective effects of L-DOPA
  18266. Neuroprotective effects of peptides during ischemic preconditioning
  18267. Neuroprotective mechanisms of dietary phytochemicals: Implications for successful brain aging
  18268. Enhanced Neuroprotective effects of combination therapy with bone marrow-derived mesenchymal stem cells and ginkgo biloba extract (EGb761) in a rat model of …
  18269. Neuroprotective effect of Sapucaia nuts (Lecythis pisonis) on rats fed with high-fat diet
  18270. Neuroprotective effect of picroside II in brain injury in mice
  18271. The Neuroprotective effect of atorvastatin on apoptosis of hippocampus following transient global ischemia/reperfusion
  18272. Neuroprotective effect of antioxidants and moderate hypoxia as combined preconditioning in cerebral ischemia
  18273. Neuroprotective effect of Amorphophallus campanulatus in STZ induced Alzheimer rat model
  18274. Neuroprotective effect of electric conduction treatment on hippocampus cell apoptosis in KA induced acute temporal lobe epileptic rats
  18275. The Neuroprotective effect of mild therapeutic hypothermia after out-of-hospital cardiac arrest with successful reanimation-a case report
  18276. Screening and identification of Neuroprotective compounds produced by Lactobacillus paracasei subsp. paracasei NTU 101
  18277. Comparison of Neuroprotective and cognition -enhancing properties of hydrolysates from soybean, walnut, and peanut protein
  18278. Estrogen is Neuroprotective against hypoglycemic injury in murine N38 hypothalamic cells
  18279. Antioxidative activity of methyl amygdalinate from the seeds of Prunus persica and Neuroprotective effects on Aβ 1–42-induced neurodegeneration models
  18280. In vitro Neuroprotective and anti-inflammatory activities of natural and semi-synthetic spirosteroid analogues
  18281. Limonoids with Neuroprotective activity from the stems of Clausena emarginata
  18282. Neuroprotective effect of ibuprofen by intranasal application of mucoadhesive nanoemulsion in MPTP induced Parkinson model
  18283. Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
  18284. Neuroprotective effects of a novel antidiabetic drug (D-Ser2) Oxm on amyloid β protein-induced cytotoxicity
  18285. Neuroprotective strategies for Alzheimer’s disease prevention and therapy
  18286. Lycopene: an effective Neuroprotective option against neurodeterioration induced by formaldehyde inhalation
  18287. 10. Neuroprotective Effects of Glucosinolates
  18288. Comparative analysis of synthetic and nutraceutical antioxidants as possible Neuroprotective agents
  18289. Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer’s Disease Through Activation of Canonical Wnt/β-Catenin …
  18290. The role of ATP-dependent potassium channels and nitric oxide system in the Neuroprotective effect of preconditioning
  18291. In vivo Neuroprotective effect of histidine-tryptophan-ketoglutarate solution in an ischemia/reperfusion spinal cord injury animal model
  18292. The Neuroprotective role of repetitive transcranial magnetic stimulation (rTMS) for neurodegenerative diseases: A short review on experimental studies
  18293. Neuroprotective effect of whole-plant extract of Torilis leptophylla in isoflurane-treated rats
  18294. Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration
  18295. Neuroprotective subthalamotomy in Parkinson’s disease. The role of magnetic resonance-guided focused ultrasound in early surgery
  18296. Thioflavones as novel Neuroprotective compounds
  18297. Evaluation of Neuroprotective effect of propofol on pyramidal neurons in CA1 region of hippocampus among male lab rats following ischemia/transient overall …
  18298. Melatonin, a Neuroprotective agent: Relevance for stress-induced neuropsychiatric disorders
  18299. Neuroprotective effects of compound FLZ in an ischemic model mediated by improving cerebral blood flow and enhancing Hsp27 expression
  18300. Neuroprotective Effects of Ezetimibe versus Simvastatin in Alzheimer’s Induced Dementia: Perspectives from Female Rats.(P5. 205)
  18301. Neuroprotective effects of systemic cerebral endothelial cell transplantation in a rat model of cerebral ischemia
  18302. Antihyperglycemic and Neuroprotective effects of Wattakaka volubilis (Lf) Stapf root against streptozotocin induced diabetes
  18303. Correction: Neuroprotective effect of Scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor
  18304. Neuroprotective Effect of Garcinia Mangostana on Streptozotocin Induced Sporadic Type Alzheimer’s Disease in Mice
  18305. Synthesis and Neuroprotective evaluation of (E)-3, 4-dihydroxystyryl p-substituted-phenethyl ketone derivatives against inflammatory and oxidative injury
  18306. Neuroprotective role of basic fibroblast growth factor in ischemic brain lesion: a review
  18307. Blood-brain barrier permeability studies of Centella asiatica extract as potential Neuroprotective agent
  18308. Is levetiracetam Neuroprotective in neonatal rats with hypoxic ischemic brain injury?
  18309. Cholinergic anti-inflammatory pathway involves in the Neuroprotective effect of huperzine A on sepsis-associated encephalopathy
  18310. Gene expression-based screen for Parkinson’s disease identifies GW8510 as a Neuroprotective agent
  18311. Erythropoietin as potential Neuroprotective and antiepileptogenic agent in epilepsy and refractory epilepsy
  18312. Retraction Note: Neuropathological and Neuroprotective features of vitamin B 12 on the dorsal spinal ganglion of rats after the experimental crush of sciatic nerve: an …
  18313. Autologous bone marrow mononuclear cells as Neuroprotective treatment of amyotrophic lateral sclerosis
  18314. Neuroprotective effect of placental factors in model of glutamate induced toxicity in newborn rat brain cells
  18315. Neuroprotective effect of pterostilbene on ketamine induced schizophrenia in mice
  18316. The Neuroprotective and therapeutic effects of anthocyanins and their metabolites in vitro and in a mouse model of amyotrophic lateral sclerosis
  18317. Neuroprotective effect of nitrite-derived NO in brain injury mediated through the NOS-independent but not the GC/COX/xanthine oxidase/PGIS-dependent …
  18318. 4′-O-β-D-Glucosyl-5-O-Methylvisamminol, A Natural Histone H3 Phosphorylation Epigenetic Suppressor, Exerts a Neuroprotective Effect Through PI3K/Akt Signaling …
  18319. Investigating the regulation of ARNT2, a Neuroprotective protein, in models of multiple sclerosis
  18320. Soy products fermented with sprouted garlic have increased Neuroprotective activities and restore cognitive functions
  18321. THE THERAPEUTIC AND Neuroprotective EFFECTS OF GREEN TEA IN A RAT MODEL OF TERLIPRESSIN-INDUCED CHRONIC HYPONATREMIA
  18322. Thrombotic Stroke: Neuroprotective Therapy by Recombinant Activated Protein C
  18323. Bee venom exerts Neuroprotective effects on neuronal cells and astrocytes under hypoxic conditions through mapk signaling pathways
  18324. The Neuroprotective activity of a proanthocyanidin enriched Ginkgo biloba L. leaves extract in vitro and in vivo
  18325. A facile synthesis and Neuroprotective role of novel quinoxaline-2, 3-bis hydrazones in ethidium bromide-induced demyelinated rats
  18326. Research progress on Neuroprotective effects of vitexin and its mechanisms
  18327. Microglia: Neuroprotective and Neurodestructive Properties
  18328. Neuroprotective effect of Nevirapine on cerebral ischemic stroke by middle cerebral artery occlusion in wistar rats
  18329. Proliferative Activity and Neuroprotective Effect of Ligustrazene Derivative by Irritation of Vascular Endothelial Growth Factor Expression in Middle Cerebral Artery …
  18330. The investigation of Neuroprotective effects of pomegranate juice against low level lead induced oxidative stress in rats brain .
  18331. Neuroprotective effects of xanthone extract from Swertia punicea Hemsl against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced mouse model of …
  18332. Neuroprotective agents
  18333. Stem cell-based Neuroprotective strategies in stroke
  18334. Gender difference in the Neuroprotective effect of rat bone marrow mesenchymal cells against hypoxia-induced apoptosis of retinal ganglion cells
  18335. Neuroprotective EFFECTS OF EXERCISE
  18336. Neuroprotective PROPERTIES OF A NEW INHIBITOR OF NA+/H+ EXCHANGER (COMPOUND RU-1355) ON THE MODEL OF FOCAL ISCHEMIA IN RATS.
  18337. Prescription of “ineffective Neuroprotective ” drugs to stroke patients: a cross sectional study in North Indian population
  18338. Neuroprotective and antioxidant effects of Metasequoia glyptostroboides leaf extract
  18339. Neuroprotective INTERVENTIONS
  18340. 9 Alzheimer’s Disease, Oxidative Stress, and Neuroprotective Approaches
  18341. Neuroprotective activity in vivo and HPLC determination of 6-hydroxykynurenic acid (6-HKA), an active constituent of Ginkgo biloba L. leaves extract
  18342. Neuroprotective role of estrogen receptor-beta in Alzheimers disease pathology
  18343. Comparison of nootropic and Neuroprotective features of aryl-substituted analogs of gamma-aminobutyric acid
  18344. Neuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease
  18345. Antihypoxic and Neuroprotective effects of glial cell-derived neurotrophic factor (GDNF) in cultures of dissociated hippocampal cells under conditions of experimental …
  18346. Neuroprotective effect of tamoxifen in a model rat with aucte spinal cord injury
  18347. Neuroprotective properties of novel positive allosteric modulators of EAAT2
  18348. Neuroprotective effects of Tilia americana var. mexicana on damage induced by cerebral ischaemia in mice
  18349. Study on the Neuroprotective effects and action mechanisms of four Chinese herbal; monomer on cerebral ischemia reperfusion mice
  18350. Neuroprotective Effect of EGCG on Alzheimer Model Rats and Expression of PPARγ mRNA
  18351. Neuroprotective And memory -Enhancing Effects of The Water Extract From Pericarp of Mangosteen Fruit
  18352. Comparable Neuroprotective effect of rapamycin against low and high rotenone concentrations in primary dopaminergic cell culture
  18353. Neuroprotective Effects of Thymoquinone in Aβ1–42‐induced Toxicity in SK‐N‐SH Neuronal Cells
  18354. Neuroprotective , NON CBS-DEPENDANT ACTIVITIES OF PHYTOCANNABINOIDS
  18355. Neural Stem Cells Transplantation as a Neuroprotective Strategy for Amyotrophic Lateral Sclerosis (ALS)
  18356. Neuroprotective Activity of Ethanolic Extract of Tamarindus indica Seeds against Aluminium Induced Neurotoxicity
  18357. New four-herb formula ameliorates memory impairments via Neuroprotective effects on hippocampal cells
  18358. Neuroprotective properties of Madecassoside from Centella asiatica after hypoxic-ischemic injury.
  18359. Isolation and identification of chemical constituents from twigs of Cinnamomum cassia Presl (Lauraceae) and their Neuroprotective activities
  18360. Abstract PR161: Neuroprotective Effect of Hydrogen Gas on brain Injury in A Rat Transient Forebrain Ischemia Model
  18361. Os 32-03 angiotensin II type 2 receptor agonist exerts sustained Neuroprotective effects in aged rats
  18362. Morphometric evaluation of the Neuroprotective effect of the extract of astragalus membranaceus on the brain of rats subjected to immobilization stress
  18363. Neuroprotective actions of hydrogen sulfide (H2S) and sulfhydration in the brain
  18364. Structure-Based Design and Optimization of AIF/CypA peptide inhibitors with Neuroprotective activity
  18365. Neuroprotective EFFECT OF FLAVONOIDS AGAINST PARAQUAT INDUCED OXIDATIVE STRESS AND NEUROTOXICITY IN DROSOPHILA MELANOGASTER …
  18366. Antipsychotics as Psychosis Drugs and Neuroprotective Promoters Evaluated by Chemical QSAR-in silico and in vivo Studies
  18367. Neuroprotective effect of paeonol against isofluraneinduced neuroapoptosis and cognitive dysfunction
  18368. Neuroprotective effects of SYM 2081, targeting kainate receptors in the neonatal hypoxic-ischemic brain injury
  18369. Editorial (Thematic Issue: Neuroprotective Effects of Li-It is Elementary)
  18370. Genoprotective and Neuroprotective effects of Daphne gnidium leaf methanol extract, tested on male mice
  18371. Neuroprotective effect of curcumin on kainic acid model of epilepsy in male swiss albino mice
  18372. Neuroprotective properties of arginine: conclusiveness 2016
  18373. Neuroprotective ROLE OF ACORUS CALAMUS AND IT’S ACTIVE PRINCIPLE BETA ASARONE IN RETAINING THE memory OF RATS USING 8 ARM …
  18374. Neuroprotective effect of Aristotelia chilensis (Maqui Berry) extract and dapsone in a status epilepticus model.
  18375. Evaluation of Neuroprotective Effect of Ficus benghalensis against Alloxan Induced Diabetic Neuropathy in Rats
  18376. Bioactive dietary compounds regulate mitochondrial apoptosis signaling in ambivalent way to function as Neuroprotective or antitumor agents
  18377. Corrigendum to” Neuroprotective and Anti-Apoptotic Effects of Valproic Acid on Adult Rat Cerebral Cortex Through ERK and Akt Signaling Pathway at Acute Phase of …
  18378. A network analysis based proteomic and transcriptomic investigation into HIV-Tat induced neuronal dysfunction and the Neuroprotective effect of lithium
  18379. Neuroprotective ROLE OF 17B ESTRADIOL AGAINST AMYLOID BETA NEUROTOXICITY IN SYNAPTOSOMES OF AGING FEMALE RATS
  18380. Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds and Cannabinoids in the Bovine Isolated Neural Retina
  18381. Evaluation of Neuroprotective properties of two synthetic prenylated xanthone analogues against paraquat and 6-hydroxydopamine toxicity in human neuroblastoma …
  18382. … status: a multi-arm phase IIB randomised double blind placebo-controlled clinical trial comparing the efficacy of three repositioned Neuroprotective drugs in secondary …
  18383. Neuroprotective effect of hydroalcoholic extract of Boerhaavia diffusa linn against MPTP induced neurodegeneration in rats
  18384. Neuroprotective effect of lipoxin receptor agonist BML-111 on spinal cord ischemia-reperfusion injury in a rat model
  18385. CANNABINOIDS ARE Neuroprotective AGAINST HIV‐1 TAT AND OCCLUDE THE TAT‐INDUCED DECREASE IN GABAERGIC NEUROTRANSMISSION IN …
  18386. Neuroprotective role of Erythropoietin
  18387. Neuroprotective Properties of the Coffee Component EHT
  18388. Lessons learned: Neuroprotective trials in Parkinson’s disease
  18389. New insights in the mechanisms of Neuroprotective effects of ceftriaxone
  18390. How does Neuroprotective sAPPα initiate its signalling cascade?
  18391. Neuroprotective EFFECTS OF ERYTHROPOIETIN: OPPORTUNITIES, PROSPECTS AND REALITY
  18392. Neuroprotective effects of neuroglobin
  18393. Neuroprotective compounds from Euonymus alatus
  18394. Models and mechanisms in neurodegeneration: Towards Neuroprotective therapy in Huntington disease
  18395. Neuroprotective effect of ketone metabolism on brain during times of traumatic brain injury
  18396. Neuroprotective effect of Prunusaviumon on cerebral ischemic stroke in rats
  18397. Investigating the Neuroprotective properties of PAR2
  18398. Recent advances in Neuroprotective effect of histone deacetylase inhibitors
  18399. Neuroprotective action of a kyotorphin derivative in an animal model of Alzheimer’s disease
  18400. The Neuroprotective effect of Rhodiolae on dementia rat induced by ibotenic acid
  18401. Neuroprotective effects of herbal mixture HT070 on global cerebral ischemia in rats
  18402. THE Neuroprotective EFFECT OF HYDROALCOHOLIC EXTRACT OF SALVIAOFFICINALIS ON INFRACT VOLUME AND NEUROLOGIC DEFICITSIN RAT …
  18403. The Neuroprotective role of melatonin against amyloid β peptide injected mice
  18404. Neuroprotective effect of spirocyclic derivative Oxindol on acute cerebral ischemia model
  18405. Evidence for the Use of Rosmarinic Acid as a Neuroprotective Agent: A Review
  18406. The Validity of the Use of Neuroprotective Therapy in the Treatment of Hypertension in Patients with Aanamnesis to Radiation
  18407. Assessment of treatment with Neuroprotective agents in patients with encephalopathy
  18408. Neuroprotective effect of cerebrolysin in ophthalmology
  18409. Intravitreal NA3 is Neuroprotective in the RCS Rat
  18410. Curcumin Exerts Neuroprotective Effects Against Homocysteine Intracerebroventricular Injection-Induced…
  18411. Mechanism of Neuroprotective effects of fibroblast growth factor 2 in the mouse model of ALS
  18412. Understanding the mechanisms underlying the Neuroprotective role of calorie restriction in Parkinson’s Disease
  18413. Characterization of novel mitochondrial modulators for the development of Neuroprotective strategies
  18414. Delaying Aging Is Neuroprotective in Parkinson’s Disease (P6. 376)
  18415. Neuroprotective Role of Antenatal Magnesium Sulphate in Preterms
  18416. In vitro study of potential Neuroprotective and regenerative agents for diabetic retinopathy
  18417. Seafood Found Neuroprotective for Alzheimer’s in Those with the Risk Gene
  18418. Neuroprotective Effects of Betaxolol Mediated by Heme Oxygenase-1 Induction in RGC-5
  18419. Neuroprotective effects of miR-223 against inflammation-induced neurodegeneration
  18420. Chronic brain vascular failure: clinical and neuroval parameters, risk factors and Neuroprotective therapy
  18421. CHAPTER ONE Neuroprotective STRATEGIES AFTER NEONATAL HYPOXIC ISCHEMIC ENCEPHALOPATHY
  18422. Neuroprotective Effects of Phytocannabinoid-Based Medicines in Experimental Models of Huntington’s
  18423. The role of miRNA in regulating Progesterone’s Neuroprotective function in the ischemic brain
  18424. Neuroprotective and nephroprotective effects of remote postconditioning: Prospects for clinical use
  18425. The Neuroprotective Coordination of Mitophagy by IF1
  18426. Neuroprotective BENEFITS OF ATORVASTATIN IN DEMENTIA AND STROKE
  18427. Neuroprotective Mechanisms of Mefenamic Acid in an in vitro Model of Stroke
  18428. Spinal cord injury: potential Neuroprotective therapy based on neural-derived peptides
  18429. A Promising Dual-functional Neuroprotective Derivative of Memantine
  18430. Novel mechanisms of Neuroprotective effects of Quercetin on human striatal neuroblasts
  18431. Combined Magnesium/Polyethylene Glycol Facilitates the Neuroprotective Effects of Magnesium in Traumatic…
  18432. Cyclo-prolylalanine: the Neuroprotective and antioxidative properties on the model of acute cerebral disease in rats
  18433. Neuroprotective roles of early exercise training after stroke
  18434. The Role of Arrestins in the Neuroprotective Effects of Antidepressant Drugs
  18435. Development of the New Group of Indole-Derived Neuroprotective Drugs Affecting Oxidative Stress
  18436. Neuroprotective Effect of Cinamomum zeylanicum in streptozotocin induced diabetes in Mice
  18437. Neuroprotective Properties of Apo6856, a Novel Hydroxypyridinone Iron Chelator, in Alzheimer’s Disease (P5. 208)
  18438. Active Neuroprotective Therapy of Acute Carotid Ischemic Stroke of Moderate Severity
  18439. Evaluation of Neuroprotective effect of flupirtine in brain of albino rats
  18440. What are the mechanisms mediating the Neuroprotective effects of ozone in diabetic neuropathy?
  18441. Defining a Neuroprotective Pathway for the Treatment of Ataxias
  18442. Study of the Possible Neuroprotective Mechanisms of Antidepressants in Experimentally Induced Parkinson’s Disease in Rats
  18443. The retinal explant as a model to investigate neuronal pathology and Neuroprotective strategies
  18444. Neuroprotective activities of Nepalese and Native American traditional medicine in Parkinson’s disease models
  18445. Neuroprotective effects of carnitinoid antioxidants in rodent models of mitochondrial dysfunction
  18446. Screening for the Active Ingredients of Ziziphus jujuba with Neuroprotective Effects and Their Mechanisms of Action
  18447. Alterations of crystallins in experimental model of glaucoma and their Neuroprotective properties
  18448. Antioxidative and Neuroprotective Activities of Wild and Tissue Cultured Helicteres angustifolia L.
  18449. A Cell Based Assay To Identify Neuroprotective Molecules for the Treatment of Amyotrophic Lateral Sclerosis
  18450. Neuroprotective effects of epigallocatechin gallate in cell culture and animal models of Parkinson’s disease
  18451. Neuroprotective Effect of Cinamomum zeylanicum in streptozotocin induced diabetes in Mice
  18452. THE POSITIVE MNEMOTROPIC INFLUENCE OF THE NEW Neuroprotective OLIGOPEPTIDES, HOMOLOGOUS OF ACTH15-18 SEQUENCE, ON ALL …
  18453. Neuroprotective role of gap junctions in a neuron astrocyte network model
  18454. Selective Episcleral Drug Delivery of Neuroprotective Drugs. Toxicokinetics of a Neuroprotective Estradiol Analog and Implications for Treatment of Traumatic and …
  18455. Clinical and Biochemical Efficiency of Neuroprotective Therapy in Patients with Chronic Cerebral Ischemia
  18456. Antioxidative activity of methyl amygdalinate from the seeds of Prunus persica and Neuroprotective effects on Aβ₁–₄₂-induced neurodegeneration models
  18457. Neuroprotective Effects of Sulforaphane and the Involvement of Autophagy
  18458. Reactive Microglia are Neuroprotective in the Mammalian Retina
  18459. Expression and localization of endogenous Neuroprotective protein Iduna in neonatal rat brain
  18460. Neuroprotective effects of Resveratrol against oxidative stress and memory impairment in vivo and in vitro
  18461. Neuroprotective effects of Korean medicinal plants in animal model of Parkinson’s disease
  18462. Neuroprotective activity of Macamides on Manganese Chloride Induced Toxicity in U‐87 MG Glioblastoma Cells
  18463. Novel, peptide-mediated Neuroprotective strategies for Huntington’s Disease
  18464. THE POSITIVE MNEMOTROPIC INFLUENCE OF THE NEW Neuroprotective OLIGOPEPTIDES, HOMOLOGOUS OF ACTH15-18 SEQUENCE, ON ALL …
  18465. Neuroprotective Effects of AO-1 and AO-2 on Amyloid β-induced Cytotoxicity in SH-SY5Y Cells
  18466. Erratum to: Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
  18467. Neuroprotective ACTIONS OF L‐CYSTEINE AND METH‐ANADAMIDE IN THE BOVINE ISOLATED NEURAL RETINA
  18468. Study the efficacy of Neuroprotective drugs on brain physiological properties during focal head injury using optical spectroscopy data analysis
  18469. Neuropeptide Y induces Neuroprotective effects and neurite outgrowth in rat retinal cell cultures
  18470. Neuroprotective Molecules and Strategies in a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
  18471. Macrophage CD163 expression is Neuroprotective in subarachnoid hemorrhage patients
  18472. Perlecan LG3 is Neuroprotective When Administered Intra-arterially After Experimental Ischemic Stroke
  18473. The Neuroprotective role of TNF-alpha receptors 1 and 2 in mouse model of optic nerve crush
  18474. Abstract WP337: Publication Bias and Low Power Contribute to the Efficacy Decline of Neuroprotective Drugs From Experimental Stroke Studies to Phase Iii Clinical …
  18475. Neuroprotective Effects of Chrysin on Adult Male Albino Rats exposed to Acrylamide and Radiation
  18476. Leukemia Inhibitory Factor as a Neuroprotective Agent against Focal Cerebral Ischemia
  18477. Neuroprotective Activity of Ethanolic Extract of Polyherbal Formulation on Streptozotocin Induced Alzheimer’s Disease in Mice
  18478. Neuroprotective actions of taurine on hypoxic-ischemic
  18479. THE Neuroprotective EFFECT OF OXYTOCIN AGAINST APOPTOSIS AND OXIDATIVE STRESS
  18480. Neuroprotective action of Gmelina arborea (bark) and Punica granatum (peel) extracts
  18481. The Neuroprotective effects of PARP inhibition in different types of photoreceptor degeneration
  18482. Potential Neuroprotective Effect of Serelaxin During Hypoxia in a Sheep Model
  18483. Curcumin/Melatonin Hybrids as Neuroprotective agents for Alzheimer’s disease
  18484. IL6 Signaling in acute retinal detachment: Anti-inflammatory or Neuroprotective ?
  18485. PM524. VEGF may have a Neuroprotective role in the improvement of schizophrenia or in the treatment effects of antipsychotics
  18486. Neuroprotective role of GDNF and BDNF in diabetic retinopathy
  18487. PS139. Neuroprotective effect of multifunctional drug M30 against depressive-like behavior induced by hypercortisolemia in rats
  18488. Neuroprotective EFFECTS OF MANGIFERIN ON ACUTE SPINAL CORD INJURY IN RATS AND ITS MECHANISM
  18489. Factor XII inhibition is Neuroprotective after traumatic brain injury in mice
  18490. Melatonin and Other Neuroprotective agents Target Molecular Mechanisms of Disease in Amyotrophic Lateral Sclerosis
  18491. Abstract Reference: BNA0545 F: Nervous System Disorders Antioxidant, cytotoxicity and Neuroprotective activity of endemic Mascarene Aloes Devina Lobine (, M …
  18492. Neuroprotective effects of blonanserin on H2O2-induced injury in PC12 cells
  18493. Neuroprotective and immunomodulatory properties of the new PPARγ agonist MDG548: an in vitro and in vivo study in PD models
  18494. Modulation of the BK Channel During Acute Spinal Cord Injury is Neuroprotective
  18495. Rapid neuronal responses during spreading neurotoxic and Neuroprotective network activity
  18496. The Neuroprotective role of exogenous TERT gene in neonatal rats with hypoxic-ischemic brain damage
  18497. The Neuroprotective Effect of Erythropoietin on Spinal Motoneurons Following Axotomy in Neonate Rats
  18498. Neuroprotective effect of nicorandil in mice under deep hypothermic low flow
  18499. Neuroprotective and Neurorestorative Processes after Spinal Cord Injury: The Case of the Bulbospinal Respiratory Neurons
  18500. Neuroprotective effects of uric acid on axotomized spinal motoneurons in neonate rats.
  18501. Neuroprotective effects of PGC-1α activators in dopaminergic neurons
  18502. Radical Scavenging Effect and Neuroprotective Activity from Oxidative Stress of Engelhardtia chrysolepis Leaf
  18503. Neuroprotective ACTION OF PHENIBUT AND NEUROGLUTAM IN EXPERIMENTAL CEREBRAL ISCHEMIA ON THE BACKGROUND OF ALTERED …
  18504. Neuroprotective Effects of Amantadine on the Hypoxic-ischemic brain Inj ury of Neonatal Rats
  18505. CHOLINESTERASE INHIBITORY AND Neuroprotective POTENTIALS OF BROWN AND GREEN SEAWEEDS FROM MALAYSIA
  18506. Flavonoid bioactivity: transport across blood-brain -barrier and Neuroprotective effects. In vivo studies
  18507. Translating TNFR signalling into Neuroprotective strategies: Proof of concept in acute in vivo models of neurodegeneration using humanized TNFR mice
  18508. Antiiflammatory and Neuroprotective Role of Fingolimod in Experimental Autoimmune Neuritis in Lewis Rats (S28. 007)
  18509. EXPERIMENTAL MODEL OF TRAUMATIC SPINAL CORD INJURY AND Neuroprotective EFFECT OF KETAMINE IN ACUTE PHASE OF INJURY
  18510. Müller cell-derived YAP signaling as a new Neuroprotective pathway in the degenerating retina
  18511. Neuroprotective hypothermia–Why keep your head cool during ischemia and reperfusion General subjects
  18512. Neuroprotective and antiamnestic effects of mutant molecules of erythropoietin on model of photochemical thrombosis of rat brain prefrontal cortex.
  18513. ORIGINAL PERFORMANCE OF THE INTEGRATED CIRCUITS Neuroprotective LECHNIYA ANTERIOR ISCHEMIC OPTIC NEUROPATHY DEPENDING ON …
  18514. The Neuroprotective effects of Anemarrhena asphodeloides rhizome extract in the PC12 cell model.
  18515. Phenytoin Appears Neuroprotective of Retinal Nerve Fiber Layer Thickness in Optic Neuritis
  18516. Neuroprotective effect of acupuncture combined with Danhong injection on focal cerebral ischemia/reperfusion injury in rats
  18517. Neuroprotective effects of electroacupuncture on hypoxic-ischemic encephalopathy in newborn rats association with increased expression of mTOR
  18518. Neuroprotective EFFECT OF BETAXOLOL, DORZOLAMIDE, BRIMONIDINE AND GINKGO BILOBA IN PATIENTS WITH NORMAL TENSION GLAUCOMA
  18519. Neuroprotective effect of Nrf2/HO-1 signaling pathway in cerebral ischemia combined with diabetes mellitus
  18520. Targeted TMC-based non-viral vectors for BDNF Neuroprotective gene therapy in nerve injury
  18521. Neuroprotective effect of Nogo-66 receptor silencing in preterm rats with brain injury caused by intrauterine infection
  18522. Investigation of Neuroprotective effects of topiramate as an antiepileptic agent in experimental spinal cord injury model/Bir antiepileptik ajan olan topiramatin …
  18523. Alterations of metabolic parameters and antioxidant enzymes in diabetic aging female rat brain : Neuroprotective role of metformin
  18524. Retinal Neuroprotective Effect of a Liposomal Formulation of Rosiglitazone in a Rat Model of Parkinson’s Disease
  18525. Neuroprotective Effects of Pramipexole in Parkinson’s Disease Induced by Rotenone in Mice
  18526. INVESTIGATION OF THE POSSIBLE Neuroprotective EFFECT OF AN ESTROGEN RECEPTOR BETA AGONIST AGAINST ROTENONE-INDUCED …
  18527. Abstract P1-15-07: The Neuroprotective aminopropyl carbazole, P7C3-A20, prevents paclitaxel-induced pain
  18528. Reversal of Post-stroke Cerebral Microvascular Dysfunction by Neuroprotective and Hyperdynamic Therapy for Experimental Subarachnoid Hemorrhage
  18529. Corrigendum to ‘The MLN4924 inhibitor exerts a Neuroprotective effect against oxidative stress injury via Nrf2 protein accumulation'[Redox Biol. 8 (2016) 341–347]
  18530. Hypoxia Inducible Factor 1α Mediates Neuroprotective Role in Rat Model of Chronic Cerebral Hypoperfusion (P5. 209)
  18531. Neuroprotective Effects of Sulforaphane on Oxygen/Glucose Deprived Neurons and Astrocytes
  18532. Involvement of p38-p53 signal pathway in Neuroprotective effects of DGMI on SH-SY5 Y cells damaged by oxygen-glucose deprivation
  18533. Neuroprotective activity of compounds of Clematis mandshurica against glutamate-induced cell death in HT22 cells
  18534. Abstract WMP46: Histone Deacetylase Inhibitor, Sodium Butyrate, Exhibits Neuroprotective Effects in a Stroke Model of Middle-Aged Female Rats
  18535. The retinal macroglia in hypercholesterolemic rabbits: Neuroprotective effect of a non‐lipid‐lowering statin dose
  18536. Erythropoietin is Neuroprotective During Ongoing Compression and Speeds Recovery Following Surgical Decompression in a Murine Model of Chronic Compression …
  18537. Neuroprotective effect of H2 S by inhibiting autophagy after restoration of spontaneous circulation in rats with cardiac arrest
  18538. Neuroprotective effect of Raphanus sativus var. hortensis f. raphanistroides, in SH-SY5Y cells via regulation of microglial activation
  18539. Neuroprotective Effect of Demethylsuberosin against MPP+-induced Cell Death in Neuroblastoma SH-SY5Y Cells
  18540. Investigating the Role of In Utero Inflammation on Neurodevelopment in the Fetus and Offspring and the Neuroprotective Properties Afforded by Broccoli Sprouts
  18541. Ultrasound Microbubbles Enhance the Neuroprotective Effect of Mouse Nerve Growth Factor on Intraocular Hypertension-Induced Neuroretina Damage in …
  18542. The Neuroprotective effects of fluoxetine and other potentially protective reagents on adult hippocampal neurogenesis, after chronic and actue 5-fluorouracil treatment
  18543. Neuroprotective Effects of GuaL ou GuiZ hi Decoction on Oxygen-Glucose Deprived Organotypic Cortical brain Slices
  18544. Pharmacological analysis of Neuroprotective action of methylprednisolone with citicoline in conditions of experimental allergic encephalomyelitis
  18545. Neuroprotective Effects of Different Protein Hydrolysates against Oxidative Stress-induced Cytotoxicity in PC12 Cells
  18546. Regulatory mechanisms of the Neuroprotective function of αA-and αB-crystallins in retinal neurons and glia
  18547. Combining Neuroprotective agents : effect of riluzole and magnesium in a rat model of thoracic spinal cord injury
  18548. Influence of different Neuroprotective drugs on dopamine neurotoxicity induced by 3, 4-methylenedioxymethamphetamine and MPTP in mice
  18549. L27 Peripheral microencapsulated porcine sertoli cells for a xenograft Neuroprotective treatment in huntington’s disease
  18550. Synthesis, Crystal Structure and Neuroprotective Activity of (E)-1-(4-(4-Chlorobenzyl) piperazin-1-yl)-3-(benzo [d][1, 3] dioxol-5-yl) prop-2-en-1-one 简
  18551. Neuroprotective effect of ischemic preconditioning via modulating the expression of cerebral miRNAs against transient cerebral ischemia in diabetic rats
  18552. Neuroprotective Effects of Dexmedetomidine against Thapsigargin-induced ER-stress via Activity of α2-adrenoceptors and Imidazoline Receptors [J]. AIMS …
  18553. Neuroprotective EFFECTS OF HERBAL EXTRACT (R. CANINA, T. VULGARE AND U. DIOICA) ON RAT MODEL OF SPORADIC ALZHEIMER’S DISEASE
  18554. Neuroprotective effects of kaempferol against 2VO-induced chronic cerebral ischemia in rats
  18555. Neuroprotective effect of astrocyte protein phosphatase 2 A up-regulation on APP/PS1 double transgenic mice
  18556. Neuroprotective properties of nigella sativa (L.) seeds and murraya koenigii (L.) spreng leaves extracts in experimental animal models
  18557. The influence of glutamate signaling on Neuroprotective glial aromatase following traumatic brain injury
  18558. Application of fourier transform infrared spectroscopy in investigations of the Neuroprotective potential of selected bioactive substances: Search for plasma and tissue …
  18559. Neuroprotective Effects of Polysialic Acid and SIGLEC-11 in Activated Phagocytic Cells
  18560. Neuroprotective effect of ethanol extract of Capsicum annuum var. abbreviatum on H₂O₂-induced apoptosis in HT22 mouse hippocampal cells
  18561. A miniaturized in vitro 3D model to assess the Neuroprotective effect of mesenchymal stromal cell secretome on neuroblastoma cells exposed to oxidative stress
  18562. Combined Neuroprotective Effects of Propofol and Dexmedetomidine on Endoplasmic Reticulum Stress-mediated Apoptosis in SH-SY5Y Cells
  18563. Molecular genetic analysis of rosmarinic acid Neuroprotective potential against methamphetamine-induced neuronal damage in zebrafish
  18564. Neuroprotective Effect of Hydroalcoholic Seed Extract of Langenaria Siceraria (Mol) Standl. On Hypoxia Neurotoxicity Induced in Wistar Rats
  18565. Ceftriaxone and erythropoietin produce synergistic Neuroprotective effects in an MPTP-induced animal model of Parkinson’s disease
  18566. Neuropharmacological Activity of Apium graveolens L. and its Neuroprotective Effect on MPTP-Induced Parkinson-Like Symptoms
  18567. … Integrative Developmental Care Model: Advanced Clinical Applications of the Seven Core Measures for Neuroprotective Family-Centered Developmental Care
  18568. Neuroprotective effects of kolaviron against psycho-emotional stress induced oxidative brain injury in rats: The whisker removal model
  18569. Neuroprotective effect of Zhen Tian Wan on pial strip-induced cognitive impairments and anti-oxidant status in rats
  18570. Neuroprotective effect of Sigesbeckia pubescens extract onglutamate-induced oxidative stress in HT22 cells via downregulation of MAPKs and caspase …
  18571. THC (Î 9â Tetrahydrocannabinol) Exerts Neuroprotective Effect in Glutamateâ affected Murine Primary Mesencephalic Cultures Through Restoring Mitochondrial …
  18572. Neuroprotective effects of EPA and DHA fatty acids in the DBA/2J hereditary glaucoma mouse model
  18573. Discovery of a selective GluN2A-containing N-methyl-d-aspartate glutamate receptor positive modulator as a novel post-stroke Neuroprotective therapy
  18574. Neuroprotective strategies for retinal disease
  18575. Neuroprotective agents in the management of glaucoma
  18576. Neuroprotective role of phytochemicals
  18577. On the Neuroprotective role of astaxanthin: new perspectives?
  18578. The Neuroprotective role of melatonin in neurological disorders
  18579. Block of A1 astrocyte conversion by microglia is Neuroprotective in models of Parkinson’s disease
  18580. Neuroprotective mechanisms of resveratrol in Alzheimer’s disease: role of SIRT1
  18581. Apigenin as Neuroprotective agent: Of mice and men
  18582. Neuroprotective drug for nerve trauma revealed using artificial intelligence
  18583. Neuroprotective natural molecules, from food to brain
  18584. Neuroprotective strategies in neonatal brain injury
  18585. The Neuroprotective effects of thymoquinone: A review
  18586. Complex Neuroprotective and neurotoxic effects of histone deacetylases
  18587. Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress
  18588. The Neuroprotective effects of exercise: maintaining a healthy brain throughout aging
  18589. Ginsenosides: a potential Neuroprotective agent
  18590. Biochemical properties and Neuroprotective effects of compounds in various species of berries
  18591. Mechanisms of endogenous Neuroprotective effects of astrocytes in brain injury
  18592. Neuroprotective effects of plant polysaccharides: A review of the mechanisms
  18593. Neuroprotective effect of quercetin against the detrimental effects of LPS in the adult mouse brain
  18594. Neuroprotective effects of neuroEPO using an in vitro model of stroke
  18595. Edaravone (Radicava): a novel Neuroprotective agent for the treatment of amyotrophic lateral sclerosis
  18596. Neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases
  18597. Topical curcumin nanocarriers are Neuroprotective in eye disease
  18598. Black phosphorus nanosheets as a Neuroprotective nanomedicine for neurodegenerative disorder therapy
  18599. Neuroprotective effect of gold nanoparticles composites in Parkinson’s disease model
  18600. A systematic review on the Neuroprotective perspectives of beta‐caryophyllene
  18601. Targeting AMPK signaling as a Neuroprotective strategy in Parkinson’s disease
  18602. A brief review on the Neuroprotective mechanisms of vitexin
  18603. N-Docosahexaenoylethanolamine: A neurotrophic and Neuroprotective metabolite of docosahexaenoic acid
  18604. Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants
  18605. Exploring the potential of natural and synthetic Neuroprotective steroids against neurodegenerative disorders: A literature review
  18606. Neuroprotective and cognitive enhancement potentials of baicalin: a review
  18607. KEAP1 inhibition is Neuroprotective and suppresses the development of epilepsy
  18608. Flavonoids and its Neuroprotective effects on brain ischemia and neurodegenerative diseases
  18609. Neuroprotective effects of epoxyeicosatrienoic acids
  18610. The Neuroprotective effects of experience on cognitive functions: evidence from animal studies on the neurobiological bases of brain reserve
  18611. Connection between systemic inflammation and neuroinflammation underlies Neuroprotective mechanism of several phytochemicals in neurodegenerative …
  18612. Neuroprotective effect of tetrahedral DNA nanostructures in a cell model of Alzheimer’s disease
  18613. Neuroprotective effect of curcumin against cerebral ischemia-reperfusion via mediating autophagy and inflammation
  18614. Immune and Neuroprotective effects of physical activity on the brain in depression
  18615. Sex steroid hormones as Neuroprotective elements in ischemia models
  18616. Gut microbiota modulation accounts for the Neuroprotective properties of anthocyanins
  18617. Neuroprotective effects of AEOL10150 in a rat organophosphate model
  18618. A focused library of psychotropic analogues with Neuroprotective and neuroregenerative potential
  18619. Neuroprotective effect of artesunate in experimental model of traumatic brain injury
  18620. The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson’s Disease
  18621. Neuroprotective effects of heat shock protein70
  18622. Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury
  18623. Antioxidant activity, Neuroprotective properties and bioactive constituents analysis of varying polarity extracts from Eucalyptus globulus leaves
  18624. Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway
  18625. SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and Neuroprotective effects in an AD mouse model
  18626. NGF steers microglia toward a Neuroprotective phenotype
  18627. An overview of Neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis
  18628. Neuroprotective effect of vildagliptin against cerebral ischemia in rats
  18629. Neuroprotective potential of the fruit (acorn) from Quercus coccifera L.
  18630. Curcumin plays Neuroprotective roles against traumatic brain injury partly via Nrf2 signaling
  18631. Activity-dependent Neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome
  18632. Magnesium as a Neuroprotective agent: a review of its use in the fetus, term infant with neonatal encephalopathy, and the adult stroke patient
  18633. Neuroprotective effects of human mesenchymal stem cells and platelet‐derived growth factor on human retinal ganglion cells
  18634. A proteomic approach to uncover Neuroprotective mechanisms of oleocanthal against oxidative stress
  18635. Neuroprotective efficacy of a sigma 2 receptor/TMEM97 modulator (DKR-1677) after traumatic brain injury
  18636. Custom‐Made Ceria Nanoparticles Show a Neuroprotective Effect by Modulating Phenotypic Polarization of the Microglia
  18637. Activity-dependent Neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes
  18638. Neuroprotective effects of DTIO, a novel analog of Nec-1, in acute and chronic stages after ischemic stroke
  18639. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: gut microbiota, glial reaction and TLR4/TNF-α signaling …
  18640. Neurosteroidogenesis and progesterone anti‐inflammatory/Neuroprotective effects
  18641. Metabotropic glutamate receptors: targets for Neuroprotective therapies in Parkinson disease
  18642. Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson’s Disease
  18643. Alkaloids with Neuroprotective effects from the leaves of Isatis indigotica collected in the Anhui Province, China
  18644. The role of endogenous Neuroprotective mechanisms in the prevention of retinal ganglion cells degeneration
  18645. Phenolic Constituents Isolated from the Twigs of Cinnamomum cassia and Their Potential Neuroprotective Effects
  18646. Neuroprotective effects of Quercetin on radiation-induced brain injury in rats
  18647. Neuroprotective effects of TRPA1 channels in the cerebral endothelium following ischemic stroke
  18648. Antioxidant and Neuroprotective properties of Eugenia dysenterica leaves
  18649. Neuroprotective mechanisms of calycosin against focal cerebral ischemia and reperfusion injury in rats
  18650. Vlasoulamine A, a Neuroprotective [3.2.2]Cyclazine Sesquiterpene Lactone Dimer from the Roots of Vladimiria souliei
  18651. Enzymatic production of fully deacetylated chitooligosaccharides and their Neuroprotective and anti-inflammatory properties
  18652. Neuroprotective effects of soy isoflavones on scopolamine-induced amnesia in mice
  18653. The migraine attack as a homeostatic, Neuroprotective response to brain oxidative stress: preliminary evidence for a theory
  18654. Biological and Neuroprotective activity of Thai edible plant extracts
  18655. Search of Neuroprotective polyphenols using the “overlay” isolation method
  18656. Clostridium butyricum exerts a Neuroprotective effect in a mouse model of traumatic brain injury via the gut‐brain axis
  18657. Alpha-synuclein, proteotoxicity and Parkinson’s disease: search for Neuroprotective therapy
  18658. The possible Neuroprotective effect of ellagic acid on sodium arsenate-induced neurotoxicity in rats
  18659. Neuroprotective effect of caffeic acid phenethyl ester in a mouse model of Alzheimer’s disease involves Nrf2/HO-1 pathway
  18660. Neuroprotective potential of spermidine against rotenone induced Parkinson’s disease in rats
  18661. nitric Oxide Synthase inhibition as a Neuroprotective Strategy Following Hypoxic–ischemic encephalopathy: evidence From Animal Studies
  18662. Resveratrol provides Neuroprotective effects through modulation of mitochondrial dynamics and ERK1/2 regulated autophagy
  18663. Seven new sesquineolignans isolated from the seeds of hawthorn and their Neuroprotective activities
  18664. Neuroprotective effect of DAHP via antiapoptosis in cerebral ischemia
  18665. memory deficits and hippocampal inflammation in cerebral hypoperfusion and reperfusion in male rats: Neuroprotective role of vanillic acid
  18666. Neuroprotective efficacy of P7C3 compounds in primate hippocampus
  18667. Acyl-CoA synthetase 6 enriches the Neuroprotective omega-3 fatty acid DHA in the brain
  18668. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis
  18669. Antioxidant activity and Neuroprotective activity of stilbenoids in rat primary cortex neurons via the PI3K/Akt signalling pathway
  18670. Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: assessment of safety aspects and Neuroprotective potential via antioxidant …
  18671. Targeting the noradrenergic system for anti-inflammatory and Neuroprotective effects: implications for Parkinson’s disease
  18672. Chemical composition, antioxidant potential, macromolecule damage and Neuroprotective activity of Convolvulus pluricaulis
  18673. Neuroprotective effects of temsirolimus in animal models of Parkinson’s disease
  18674. Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer’s-like disease in rats
  18675. Granulocyte-macrophage colony-stimulating factor Neuroprotective activities in Alzheimer’s disease mice
  18676. Thymus pulegioides L. as a rich source of antioxidant, anti-proliferative and Neuroprotective phenolic compounds
  18677. Diosmin is Neuroprotective in a rat model of scopolamine-induced cognitive impairment
  18678. A meta-analysis of the effect of different Neuroprotective drugs in management of patients with traumatic brain injury
  18679. Harnessing the power of microbiome assessment tools as part of Neuroprotective nutrition and lifestyle medicine interventions
  18680. The role of the leukemia inhibitory factor receptor in Neuroprotective signaling
  18681. Multi-target-directed ligands for treating Alzheimer’s disease: Butyrylcholinesterase inhibitors displaying antioxidant and Neuroprotective activities
  18682. Neuroprotective effects of radix scrophulariae on cerebral ischemia and reperfusion injury via MAPK pathways
  18683. Neuroprotective role of agmatine in neurological diseases
  18684. Edaravone and cyclosporine A as Neuroprotective agents for acute ischemic stroke
  18685. The Neuroprotective role of the brain opioid system in stroke injury
  18686. Ellagic acid: Insights into its Neuroprotective and cognitive enhancement effects in sporadic Alzheimer’s disease
  18687. Neuroprotective effects of 20 (S)‐protopanaxatriol (PPT) on scopolamine‐induced cognitive deficits in mice
  18688. Neuroprotective and regenerative roles of intranasal Wnt-3a administration after focal ischemic stroke in mice
  18689. Astaxanthin is Neuroprotective in an aged mouse model of Parkinson’s disease
  18690. Neuroprotective effects of pifithrin-α against traumatic brain injury in the striatum through suppression of neuroinflammation, oxidative stress, autophagy, and …
  18691. The Neuroprotective role of MiR‐124‐3p in a 6‐hydroxydopamine‐induced cell model of Parkinson’s disease via the regulation of ANAX5
  18692. Multifunctional Neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction
  18693. Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice
  18694. Neuroprotective effects of pinocembrin on ischemia/reperfusion-induced brain injury by inhibiting autophagy
  18695. Neuroprotective activity of macamides on manganese-induced mitochondrial disruption in U-87 MG glioblastoma cells
  18696. The Neuroprotective effects and probable mechanisms of Ligustilide and its degradative products on intracerebral hemorrhage in mice
  18697. bFGF plays a Neuroprotective role by suppressing excessive autophagy and apoptosis after transient global cerebral ischemia in rats
  18698. Neuroprotective effect of p-coumaric acid in mice with cerebral ischemia reperfusion injuries
  18699. Neuroprotective role of Asiatic acid in aluminium chloride induced rat model of Alzheimer’s disease
  18700. Neuroprotective effects of ginsenoside-Rg1 against depression-like behaviors via suppressing glial activation, synaptic deficits, and neuronal apoptosis in rats
  18701. Neuroprotective effects of protein tyrosine phosphatase 1B inhibitor on cerebral ischemia/reperfusion in mice
  18702. Orexin-A exerts Neuroprotective effects via OX1R in Parkinson’s disease
  18703. Neuroprotective effects and mechanisms of curcumin–Cu (II) and–Zn (II) complexes systems and their pharmacological implications
  18704. ent-Kaurane Diterpenoids with Neuroprotective Properties from Corn Silk (Zea mays)
  18705. Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer’s disease
  18706. Neuroprotective effect of formononetin against TBI in rats via suppressing inflammatory reaction in cortical neurons
  18707. Neuroprotective effects of phenolic and carboxylic acids on oxidative stress-induced toxicity in human neuroblastoma SH-SY5Y cells
  18708. Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia
  18709. Pronounced synergistic Neuroprotective effect of GDNF and CNTF on axotomized retinal ganglion cells in the adult mouse
  18710. Neuroprotective efficiency of Mangifera indica leaves extract on cadmium-induced cortical damage in rats
  18711. The c-Abl inhibitor, Radotinib HCl, is Neuroprotective in a preclinical Parkinson’s disease mouse model
  18712. From stroke to neurodegenerative diseases: The multi-target Neuroprotective effects of 3-n-butylphthalide and its derivatives
  18713. Neuroprotective role of fucoxanthin against cerebral ischemic/reperfusion injury through activation of Nrf2/HO-1 signaling
  18714. Neuroprotective effects of oxytocin hormone after an experimental stroke model and the possible role of calpain-1
  18715. Seizure-suppressant and Neuroprotective effects of encapsulated BDNF-producing cells in a rat model of temporal lobe epilepsy
  18716. Neuroprotective effect of duloxetine in a mouse model of diabetic neuropathy: role of glia suppressing mechanisms
  18717. Neuroprotective effects of dexmedetomidine on traumatic brain injury: Involvement of neuronal apoptosis and HSP70 expression
  18718. The effects of tramadol administration on hippocampal cell apoptosis, learning and memory in adult rats and Neuroprotective effects of crocin
  18719. Neuroprotective effects of ginsenoside Rf on amyloid-β-induced neurotoxicity in vitro and in vivo
  18720. Neuroprotective mechanisms of glucagon‐like peptide‐1‐based therapies in ischaemic stroke: a systematic review based on pre‐clinical studies
  18721. Benfotiamine treatment activates the Nrf2/ARE pathway and is Neuroprotective in a transgenic mouse model of tauopathy
  18722. Neuroprotective effects of hydrogen inhalation in an experimental rat intracerebral hemorrhage model
  18723. Embryonic stem cell‐derived mesenchymal stem cells (MSCs) have a superior Neuroprotective capacity over fetal MSCs in the hypoxic‐ischemic mouse brain
  18724. Nootkatone, a Neuroprotective agent from Alpiniae Oxyphyllae Fructus, improves cognitive impairment in lipopolysaccharide-induced mouse model of Alzheimer’s …
  18725. Neuroprotective effects of seaweeds against 6-hydroxidopamine-induced cell death on an in vitro human neuroblastoma model
  18726. Neuroprotective potential of crocin against malathion-induced motor deficit and neurochemical alterations in rats
  18727. Neuroprotective Dihydroagarofuran Sesquiterpene Derivatives from the Leaves of Tripterygium wilfordii
  18728. Investigation of the Neuroprotective effects of Lycium barbarum water extract in apoptotic cells and Alzheimer’s disease mice
  18729. Chemical composition, antioxidant activity, Neuroprotective and anti-inflammatory effects of cipó-pucá (Cissus sicyoides L.) extracts obtained from supercritical …
  18730. Evaluation of the Neuroprotective and antidiabetic potential of phenol-rich extracts from virgin olive oils by in vitro assays
  18731. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson’s disease mouse model
  18732. Irisin exerts Neuroprotective effects on cultured neurons by regulating astrocytes
  18733. Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer’s …
  18734. Micromanaging freeze tolerance: the biogenesis and regulation of Neuroprotective microRNAs in frozen brain s
  18735. Monitoring cerebral oxygenation of the immature brain : a Neuroprotective strategy?
  18736. Neuroprotective and neurological/cognitive enhancement effects of curcumin after brain ischemia injury with Alzheimer’s disease phenotype
  18737. Neuroprotective effect of phosphocreatine on oxidative stress and mitochondrial dysfunction induced apoptosis in vitro and in vivo: involvement of dual PI3K/Akt and …
  18738. Neuroprotective effect of docosahexaenoic acid in rat traumatic brain injury model via regulation of TLR4/NF-Kappa B signaling pathway
  18739. Novel dual incretin agonist peptide with antidiabetic and Neuroprotective potential
  18740. Anticonvulsant and Neuroprotective effects of the thyroid hormone metabolite 3-iodothyroacetic acid
  18741. Connexin 30 deficiency attenuates chronic but not acute phases of experimental autoimmune encephalomyelitis through induction of Neuroprotective …
  18742. Neuroprotective effects of dl-3-n-butylphthalide against doxorubicin-induced neuroinflammation, oxidative stress, endoplasmic reticulum stress, and …
  18743. Neuroprotective effect of Caryocar brasiliense Camb. leaves is associated with anticholinesterase and antioxidant properties
  18744. Neuroprotective effects of INT-777 against Aβ1–42-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice
  18745. Protection before impact: the potential Neuroprotective role of nutritional supplementation in sports-related head trauma
  18746. Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells
  18747. Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a Neuroprotective effect on ALS murine model
  18748. Resveratrol activation of AMPK-dependent pathways is Neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress
  18749. LncRNA MALAT1 is Neuroprotective in a rat model of spinal cord ischemia-reperfusion injury through miR-204 regulation
  18750. Role of cerium oxide nanoparticles in a paraquat-induced model of oxidative stress: emergence of Neuroprotective results in the brain
  18751. Evaluation of the Neuroprotective effect of EGCG: a potential mechanism of mitochondrial dysfunction and mitochondrial dynamics after subarachnoid hemorrhage
  18752. Pinostrobin exerts Neuroprotective actions in neurotoxin-induced Parkinson’s disease models through Nrf2 induction
  18753. Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synuclein
  18754. Neuroprotective effect of formononetin in ameliorating learning and memory impairment in mouse model of Alzheimer’s disease
  18755. In vitro activities of kappa-carrageenan isolated from red marine alga Hypnea musciformis: Antimicrobial, anticancer and Neuroprotective potential
  18756. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson’s disease is mediated by a reduction of inducible nitric oxide …
  18757. Neuroprotective effects of four phenylethanoid glycosides on H2O2-induced apoptosis on PC12 cells via the Nrf2/ARE pathway
  18758. Neuroprotective activity of sitagliptin via reduction of neuroinflammation beyond the incretin effect: Focus on Alzheimer’s disease
  18759. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer’s disease agents with cholinergic, antioxidant, and Neuroprotective properties
  18760. Pharmacological aspects of the Neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease
  18761. Neuroprotective agents in the Intensive Care Unit:-Neuroprotective agents in ICU
  18762. Neuroprotective Potential and Chemical Profile of Alternatively Cultivated Ganoderma lucidum Basidiocarps
  18763. Potential Neuroprotective role of astroglial exosomes against smoking-induced oxidative stress and HIV-1 replication in the central nervous system
  18764. Inhibition of excessive autophagy and mitophagy mediates Neuroprotective effects of URB597 against chronic cerebral hypoperfusion
  18765. Neuroprotective effect of hydrogen sulfide in hyperhomocysteinemia is mediated through antioxidant action involving Nrf2
  18766. Neuroprotective mechanisms of rutin for spinal cord injury through anti-oxidation and anti-inflammation and inhibition of p38 mitogen activated protein kinase …
  18767. Neuroprotective care of extremely preterm infants in the first 72 hours after birth
  18768. The role of monoamines in the development of Alzheimer’s disease and Neuroprotective effect of a proline rich polypeptide
  18769. Neuroprotective effects of a biodegradable poly (lactic-co-glycolic acid)-ginsenoside rg3 nanoformulation: a potential nanotherapy for alzheimer’s disease?
  18770. Evaluation of antioxidant and Neuroprotective activities of Cassia fistula (L.) using the Caenorhabditis elegans model
  18771. Baicalin exerts Neuroprotective effects via inhibiting activation of GSK3β/NF-κB/NLRP3 signal pathway in a rat model of depression
  18772. Neuroprotective effect and mechanism of action of tetramethylpyrazine nitrone for ischemic stroke therapy
  18773. Blue light induces a Neuroprotective gene expression program in Drosophila photoreceptors
  18774. Neuroprotective effects of mitochondria-targeted plastoquinone in a rat model of neonatal hypoxic–ischemic brain injury
  18775. In vitro Neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation
  18776. Neuroprotective effect of epigallocatechin-3-gallate (EGCG) on radiation-induced damage and apoptosis in the rat hippocampus
  18777. Targeted Isolation of Neuroprotective Dicoumaroyl Neolignans and Lignans from Sageretia theezans Using in Silico Molecular Network Annotation Propagation …
  18778. Nrf2 signaling elicits a Neuroprotective role against PFOS-mediated oxidative damage and apoptosis
  18779. Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies
  18780. SIRT1 activation with neuroheal is Neuroprotective but SIRT2 inhibition with AK7 is detrimental for disconnected motoneurons
  18781. Virgin coconut oil (VCO) by normalizing NLRP3 inflammasome showed potential Neuroprotective effects in Amyloid-β induced toxicity and high-fat diet fed rat
  18782. The Neuroprotective effects of cinnamic aldehyde in an MPTP mouse model of Parkinson’s disease
  18783. Neuroprotective effects of luteolin against spinal cord ischemia–reperfusion injury by attenuation of oxidative stress, inflammation, and apoptosis
  18784. Proteomics reveals ablation of PlGF increases antioxidant and Neuroprotective proteins in the diabetic mouse retina
  18785. Neuroprotective effect of the carnosine–α-lipoic acid nanomicellar complex in a model of early-stage Parkinson’s disease
  18786. Endothelial progenitor cell-conditioned medium promotes angiogenesis and is Neuroprotective after spinal cord injury
  18787. Neuroprotective effects of galantamine on nerve agent-induced neuroglial and biochemical changes
  18788. Neuroprotective effects of creatine in the CMVMJD135 mouse model of spinocerebellar ataxia type 3
  18789. Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone Neuroprotective …
  18790. Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-γ, Bax/Bcl-2, and caspase-3
  18791. Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo
  18792. … -SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three Neuroprotective drugs in secondary …
  18793. Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates Neuroprotective pathways in the YAC128 HD …
  18794. A Neuroprotective role of kaempferol against chlorpyrifos-induced oxidative stress and memory deficits in rats via GSK3β-Nrf2 signaling pathway
  18795. Potential Neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables
  18796. … -modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and Neuroprotective …
  18797. … raspberry, and strawberry for free radical scavenging, reactive carbonyl species trapping, anti-glycation, anti-β-amyloid aggregation, and microglial Neuroprotective …
  18798. Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson’s disease
  18799. Optimized induction of beta common receptor enhances the Neuroprotective function of erythropoietin in spinal cord ischemic injury
  18800. Neuroprotective Effects of 1,2-Diarylpropane Type Phenylpropanoid Enantiomers from Red Raspberry against H2O2-Induced Oxidative Stress in Human …
  18801. Neuroprotective activity of some marine fungal metabolites in the 6-hydroxydopamin-and paraquat-induced parkinson’s disease models
  18802. Eckmaxol, a Phlorotannin Extracted from Ecklonia maxima, Produces Anti-β-amyloid Oligomer Neuroprotective Effects Possibly via Directly Acting on Glycogen …
  18803. Effects of therapeutic hypothermia combined with other Neuroprotective strategies on ischemic stroke: Review of evidence
  18804. Sinomenine exerts anticonvulsant profile and Neuroprotective activity in pentylenetetrazole kindled rats: involvement of inhibition of NLRP1 inflammasome
  18805. The Neuroprotective and antioxidant profiles of selenium-containing polysaccharides from the fruit of Rosa laevigata
  18806. Neuroprotective effects of dietary borax in the brain tissue of rainbow trout (Oncorhynchus mykiss) exposed to copper-induced toxicity
  18807. Neuroprotective effects of melatonin on experimental allergic encephalomyelitis mice via anti-oxidative stress activity
  18808. Exercise wards off Alzheimer disease by boosting neurogenesis and Neuroprotective factors
  18809. Neurogenic and Neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer’s disease
  18810. Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions
  18811. Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson’s Disease
  18812. Tolerogenic bone marrow-derived dendritic cells induce Neuroprotective regulatory T cells in a model of Parkinson’s disease
  18813. Neuroprotective effects of isosteviol sodium through increasing CYLD by the downregulation of miRNA-181b
  18814. Anti-inflammatory and Neuroprotective effects of fungal immunomodulatory protein involving microglial inhibition
  18815. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy
  18816. A novel selective MAO-B inhibitor with Neuroprotective and anti-Parkinsonian properties
  18817. Tanshinone IIA exerts Neuroprotective effects on hippocampus-dependent cognitive impairments in diabetic rats by attenuating ER stress-induced apoptosis
  18818. Neuroprotective effects of Tualang honey against oxidative stress and memory decline in young and aged rats exposed to noise stress
  18819. Upregulation of miR-216a exerts Neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory …
  18820. Neuroprotective effects of cordycepin inhibit Aβ-induced apoptosis in hippocampal neurons
  18821. In vivo and in vitro Neuroprotective effects of Panax ginseng glycoproteins
  18822. The effect of different substitute groups and molecular weights of fucoidan on Neuroprotective and anticomplement activity
  18823. Neuroprotective investigation of chitosan nanoparticles for dopamine delivery
  18824. … induced CREB activation ameliorates arsenic mediated alterations in NMDA receptors and associated signaling in rat hippocampus: Neuroprotective role of curcumin
  18825. Bojungikgi-tang, a traditional herbal formula, exerts Neuroprotective effects and ameliorates memory impairments in Alzheimer’s disease-like experimental models
  18826. Comparison of Neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the …
  18827. Neuroprotective effect of quercetin nanocrystal in a 6-hydroxydopamine model of parkinson disease: biochemical and behavioral evidence
  18828. Neuroprotective effects of Magnoliae Flos extract in mouse hippocampal neuronal cells
  18829. Sesquiterpenoids from Chloranthus anhuiensis with Neuroprotective Effects in PC12 Cells
  18830. Anchusa italica extract: phytochemical and Neuroprotective evaluation on global cerebral ischemia and reperfusion
  18831. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats
  18832. Neuroprotective effects of melatonin on amphetamine‐induced dopaminergic fiber degeneration in the hippocampus of postnatal rats
  18833. The Neuroprotective effect of lithium chloride on cognitive impairment through glycogen synthase kinase-3β inhibition in intracerebral hemorrhage rats
  18834. Neuroprotective potential of glibenclamide is mediated by antioxidant and anti-apoptotic pathways in intracerebral hemorrhage
  18835. Paeoniflorin exerts Neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular …
  18836. Neuroprotective effects of voluntary running on cognitive dysfunction in an α-synuclein rat model of Parkinson’s disease
  18837. Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS
  18838. Modulation of autophagy by a small molecule inverse agonist of ERRα is Neuroprotective
  18839. Resveratrol acts anti-inflammatory and Neuroprotective in an infant rat model of pneumococcal meningitis by modulating the hippocampal miRNome
  18840. Assessment of Neuroprotective effects of Gallic acid against glutamate-induced neurotoxicity in primary rat cortex neuronal culture
  18841. The Neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson’s disease in rat
  18842. Neuroprotective action of human Wharton’s jelly-derived mesenchymal stromal cell transplants in a rodent model of stroke
  18843. The cardio-and Neuroprotective effects of corvitin and 2-oxoglutarate in rats with pituitrin-isoproterenol-induced myocardial damage
  18844. Neuroprotective mechanisms of sildenafil and selenium in PTZ-kindling model: implications in epilepsy
  18845. Neuroprotective effect of anethole against neuropathic pain induced by chronic constriction injury of the sciatic nerve in mice
  18846. Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF …
  18847. Neuroprotective effects of the absence of JNK1 or JNK3 isoforms on kainic acid-induced temporal lobe epilepsy-like symptoms
  18848. Phospholipid and lipid derivatives as potential Neuroprotective compounds
  18849. Triterpenes and Meroterpenes with Neuroprotective Effects from Ganoderma leucocontextum
  18850. Remote tissue conditioning is Neuroprotective against MPTP insult in mice
  18851. Molecular mechanisms underlying the Neuroprotective role of atrial natriuretic peptide in experimental acute ischemic stroke
  18852. Biaryl scaffold-focused virtual screening for anti-aggregatory and Neuroprotective effects in Alzheimer’s disease
  18853. Neolignans from Red Raspberry (Rubus idaeus L.) Exhibit Enantioselective Neuroprotective Effects against H2O2-Induced Oxidative Injury in SH-SY5Y Cells
  18854. Exogenous ketone bodies as promising Neuroprotective agents for developmental brain injury
  18855. Alantolactone plays Neuroprotective roles in traumatic brain injury in rats via anti-inflammatory, anti-oxidative and anti-apoptosis pathways
  18856. Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen–glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular …
  18857. Does combined therapy of curcumin and epigallocatechin gallate have a synergistic Neuroprotective effect against spinal cord injury?
  18858. Histamine upregulates the expression of histamine receptors and increases the Neuroprotective effect of astrocytes
  18859. Design, synthesis, Neuroprotective , antibacterial activities and docking studies of novel thieno [2, 3-d] pyrimidine-alkyne Mannich base and oxadiazole hybrids
  18860. Synthetic α5β1 integrin ligand PHSRN is proangiogenic and Neuroprotective in cerebral ischemic stroke
  18861. Neuroprotective effects of MAGL (Monoacylglycerol Lipase) inhibitors in experimental ischemic stroke
  18862. Neuroprotective , antidiabetic and antioxidant effect of Hedera nepalensis and lupeol against STZ+ AlCl 3 induced rats model
  18863. Neuroprotective and anti-inflammatory effects of Rhus coriaria extract in a mouse model of ischemic optic neuropathy
  18864. Sitagliptin enhances the Neuroprotective effect of pregabalin against pentylenetetrazole-induced acute epileptogenesis in mice: implication of oxidative, inflammatory …
  18865. Simulated microgravity culture enhances the Neuroprotective effects of human cranial bone-derived mesenchymal stem cells in traumatic brain injury
  18866. Cerebral dopamine neurotrophic factor (CDNF) has Neuroprotective effects against cerebral ischemia that may occur through the endoplasmic reticulum stress …
  18867. Neuroprotective effect of zolpidem against glutamate-induced toxicity is mediated via the PI3K/Akt pathway and inhibited by PK11195
  18868. Neuroprotective effects of statins against amyloid β-induced neurotoxicity
  18869. Characterization of phospholipids from Pacific saury (Cololabis saira) viscera and their Neuroprotective activity
  18870. Neuroprotective effects of psalmotoxin-1, an acid-sensing ion channel (ASIC) inhibitor, in ischemia reperfusion in mouse eyes
  18871. Compressional-puffing pretreatment enhances Neuroprotective effects of fucoidans from the brown seaweed Sargassum hemiphyllum on 6-hydroxydopamine-induced …
  18872. Nano-pulsed laser therapy is Neuroprotective in a rat model of blast-induced neurotrauma
  18873. Hydrogen exerts Neuroprotective effects on OGD/R damaged neurons in rat hippocampal by protecting mitochondrial function via regulating mitophagy …
  18874. Neuroprotective effects of n-3 polyunsaturated fatty acid-enriched phosphatidylserine against oxidative damage in PC12 cells
  18875. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and Neuroprotective effect of three traditional medicinal …
  18876. Neuroprotective effects of baicalein on acrolein-induced neurotoxicity in the nigrostriatal dopaminergic system of rat brain
  18877. Neuroprotective effect of Citrus kawachiensis (Kawachi Bankan) peels, a rich source of naringin, against global cerebral ischemia/reperfusion injury in mice
  18878. Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats
  18879. Dammarane-type saponins from the leaves of Panax notoginseng and their Neuroprotective effects on damaged SH-SY5Y cells
  18880. … pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with Neuroprotective role for Alzheimer’s …
  18881. Improved Neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial …
  18882. Neuroprotective effect of Da Chuanxiong Formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury
  18883. Remediation of radiation-induced cognitive dysfunction through oral administration of the Neuroprotective compound NSI-189
  18884. Cilostazol mediated Nurr1 and autophagy enhancement: Neuroprotective activity in rat rotenone PD model
  18885. Neuroprotective effects of bioactive compounds and MAPK pathway modulation in “ischemia”—stressed PC12 pheochromocytoma cells
  18886. Beyond the therapeutic effect of rTMS in Alzheimer’s disease: a possible Neuroprotective role of hippocampal BDNF?: A minireview
  18887. Synthesis of protocatechuic acid grafted chitosan copolymer: Structure characterization and in vitro Neuroprotective potential
  18888. Acupuncture as a multifunctional Neuroprotective therapy ameliorates cognitive impairment in a rat model of vascular dementia: a quantitative iTRAQ proteomics study
  18889. Literature evidence and ARRIVE assessment on Neuroprotective effects of flavonols in neurodegenerative diseases’ Models
  18890. Levodopa-reduced Mucuna pruriens seed extract shows Neuroprotective effects against Parkinson’s disease in murine microglia and human neuroblastoma cells …
  18891. Delta opioids: Neuroprotective roles in preclinical studies
  18892. BHDPC is a novel neuroprotectant that provides anti-neuroinflammatory and Neuroprotective effects by inactivating NF-κB and activating PKA/CREB
  18893. Neuroprotective effects of Taraxacum officinale Wigg. extract on glutamate-induced oxidative stress in HT22 cells via HO-1/Nrf2 pathways
  18894. Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status …
  18895. CpG-ODN exerts a Neuroprotective effect via the TLR9/pAMPK signaling pathway by activation of autophagy in a neonatal HIE rat model
  18896. Neuroprotective effect of 1-Deoxynojirimycin on cognitive impairment, β-amyloid deposition, and neuroinflammation in the SAMP8 mice
  18897. Neuroprotective effects of nootkatone from Alpiniae oxyphyllae Fructus against amyloid-β-induced cognitive impairment
  18898. Treadmill exercise with bone marrow stromal cells transplantation facilitates Neuroprotective effect through BDNF-ERK1/2 pathway in spinal cord injury rats
  18899. Alternative routes of administration of the Neuroprotective pituitary adenylate cyclase activating polypeptide
  18900. Neuroprotective effect of He-Ying-Qing-Re formula on retinal ganglion cell in diabetic retinopathy
  18901. The Neuroprotective effect of conditioned medium from human adipose-derived mesenchymal stem cells is impaired by N-acetyl cysteine supplementation
  18902. Neuroprotective effect of bispectral index-guided fast-track anesthesia using sevoflurane combined with dexmedetomidine for intracranial aneurysm …
  18903. Fisetin exerts antioxidant and Neuroprotective effects in multiple mutant hSOD1 models of amyotrophic lateral sclerosis by activating ERK
  18904. Neuroprotective effects of salidroside administration in a mouse model of Alzheimer’s disease
  18905. Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats
  18906. Estrogen Receptors Are Involved in the Neuroprotective Effect of Silibinin in Aβ 1–42-Treated Rats
  18907. Neuroprotective effects of antidepressants via upregulation of neurotrophic factors in the MPTP model of Parkinson’s disease
  18908. Neuroprotective effect of Asparagus racemosus root extract via the enhancement of brain -derived neurotrophic factor and estrogen receptor in ovariectomized rats
  18909. Neuroprotective activities of heparin, heparinase III, and hyaluronic acid on the Aβ42-treated forebrain spheroids derived from human stem cells
  18910. Pure mechanistic analysis of additive Neuroprotective effects between baicalin and jasminoidin in ischemic stroke mice
  18911. Enhancement of the Neuroprotective effect of fermented Spirulina maxima associated with antioxidant activities by ultrasonic extraction
  18912. Neuroprotective effects of Coptis chinensis Franch polysaccharide on amyloid-beta (Aβ)-induced toxicity in a transgenic Caenorhabditis elegans model of Alzheimer’s …
  18913. Novel dual GLP-1/GIP receptor agonists show Neuroprotective effects in Alzheimer’s and Parkinson’s disease models
  18914. A mechanistic approach to explore the Neuroprotective potential of zonisamide in seizures
  18915. Thymoquinone increases the expression of Neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB …
  18916. Neuroprotective effect of alpha-linolenic acid against Aβ-mediated inflammatory responses in C6 glial cell
  18917. Neuroprotective effects of amylin analogues on Alzheimer’s disease pathogenesis and cognition
  18918. Neuroprotective effect of licochalcone A against oxygen‐glucose deprivation/reperfusion in rat primary cortical neurons by attenuating oxidative stress injury and …
  18919. The Neuroprotective effects of hypothermia on bilirubin-induced neurotoxicity in vitro
  18920. Evaluation of the antiparkinsonism and Neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson’s disease …
  18921. Perinatal hypoxic-ischemic encephalopathy and Neuroprotective peptide therapies: a case for cationic arginine-rich peptides (CARPs)
  18922. Atomic force microscopy reveals new biophysical markers for monitoring subcellular changes in oxidative injury: Neuroprotective effects of quercetin at the …
  18923. Methods for assessing serpins as Neuroprotective therapeutics
  18924. AAV-Syn-BDNF-EGFP virus construct exerts Neuroprotective action on the hippocampal neural network during hypoxia in vitro
  18925. Stem cell factor induces polarization of microglia to the Neuroprotective phenotype in vitro
  18926. TLQP Peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a Neuroprotective role
  18927. Neuroprotective drugs in infants with severe congenital heart disease: A systematic review
  18928. Blood-brain barrier permeability and Neuroprotective effects of three main alkaloids from the fruits of Euodia rutaecarpa with MDCK-pHaMDR cell monolayer …
  18929. Bioactive constituents from Medicago sativa L. with antioxidant, Neuroprotective and acetylcholinesterase inhibitory activities
  18930. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington’s disease-like symptoms in rats
  18931. Blood glutamate scavenger as a novel Neuroprotective treatment in spinal cord injury
  18932. Picroside II exerts a Neuroprotective effect by inhibiting mPTP permeability and EndoG release after cerebral ischemia/reperfusion injury in rats
  18933. The synergistic Neuroprotective effects of combined rosuvastatin and resveratrol pretreatment against cerebral ischemia/reperfusion injury
  18934. Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3β pathway in SH-SY5Y cells
  18935. Neuroprotective and tumoricidal activities of cardiac glycosides. Could oleandrin be a new weapon against stroke and glioblastoma?
  18936. Neuroprotective Effect of Oxysophocarpine by Modulation of MAPK Pathway in Rat Hippocampal Neurons Subject to Oxygen–Glucose Deprivation and Reperfusion
  18937. Neuroprotective effect of angiotensin II type 2 receptor stimulation in vincristine-induced mechanical allodynia
  18938. Phenolic Compounds Isolated and Identified from Amla (Phyllanthus emblica) Juice Powder and their Antioxidant and Neuroprotective Activities
  18939. Proanthocyanidins exert a Neuroprotective effect via ROS/JNK signaling in MPTP‑induced Parkinson’s disease models in vitro and in vivo
  18940. Ocular nerve growth factor (NGF) and NGF eye drop application as paradigms to investigate NGF Neuroprotective and reparative actions
  18941. Pharmacological activation of the Nrf2 pathway by 3H-1, 2-dithiole-3-thione is Neuroprotective in a mouse model of Alzheimer disease
  18942. Reduced Neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis
  18943. Evaluation of Neuroprotective effects of wedelolactone and gallic acid on aluminium-induced neurodegeneration: relevance to sporadic amyotrophic lateral sclerosis
  18944. Integrated Proteomics and Lipidomics Investigation of the Mechanism Underlying the Neuroprotective Effect of N-benzylhexadecanamide
  18945. Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with Neuroprotective and β-secretase inhibition activities
  18946. Neuroprotective effect of agmatine in mouse spinal cord injury model: Modulation by imidazoline receptors
  18947. Genesis of Neuroprotective Peptoid from Aβ30–34 Inhibits Aβ Aggregation and AChE Activity
  18948. Triphenylphosphonium moiety modulates proteolytic stability and potentiates Neuroprotective activity of antioxidant tetrapeptides in vitro
  18949. Antidepressant-Like and Neuroprotective Effects of Ethanol Extract from the Root Bark of Hibiscus syriacus L.
  18950. Neuroprotective effects of lithium: what are the implications in humans with neurodegenerative disorders?
  18951. Biocompatibility and Neuroprotective potential of encapsulated S-Allyl-L-Cysteine into PCL-based nanocarrier
  18952. Neuroprotective role of astroglia in Parkinson disease by reducing oxidative stress through dopamine-induced activation of pentose-phosphate pathway
  18953. Fluoxetine is Neuroprotective in early brain injury via its anti-inflammatory and anti-apoptotic effects in a rat experimental subarachnoid hemorrhage model
  18954. Comparison of the Neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
  18955. Neuroprotective effects of orientin on oxygen-glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons
  18956. Preliminary optimization of a Chinese herbal medicine formula based on the Neuroprotective effects in a rat model of rotenone-induced Parkinson’s disease
  18957. Enhancement of Neuroprotective activity of Sagunja-tang by fermentation with lactobacillus strains
  18958. Neuroprotective effect of morin on lead acetate-induced apoptosis by preventing cytochrome c translocation via regulation of Bax/Bcl-2 ratio
  18959. Synergistic Neuroprotective effects of Geniposide and ursodeoxycholic acid in hypoxia‑reoxygenation injury in SH‑SY5Y cells
  18960. Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as Neuroprotective agents
  18961. Neuroprotective effects of tocovid pretreatment in a mouse stroke model
  18962. Targeting voltage-dependent calcium channels with pregabalin exerts a direct Neuroprotective effect in an animal model of multiple sclerosis
  18963. Cinnamon polyphenol extract exerts Neuroprotective activity in traumatic brain injury in male mice
  18964. Neuroprotective properties of Cantharellus cibarius polysaccharide fractions in different in vitro models of neurodegeneration
  18965. Neuroprotective effects of kinetin against glutamate-induced oxidative cytotoxicity in HT22 cells: Involvement of Nrf2 and heme oxygenase-1
  18966. Agmatine potentiates Neuroprotective effects of subthreshold concentrations of ketamine via mTOR/S6 kinase signaling pathway
  18967. Expression of the Neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple …
  18968. Neuroprotective effects of Korean red pine (Pinus densiflora) bark extract and its phenolics
  18969. Neuroprotective effect of olfactory ensheathing cells co-transfected with Nurr1 and Ngn2 in both in vitro and in vivo models of Parkinson’s disease
  18970. Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson’s disease in experimental animals
  18971. Neuroprotective properties of asiatic acid against 5-fluorouracil chemotherapy in the hippocampus in an adult rat model
  18972. ATG5 overexpression is Neuroprotective and attenuates cytoskeletal and vesicle-trafficking alterations in axotomized motoneurons
  18973. … , characterization, antioxidant and hepatoprotective properties of poly (Ɛ-caprolactone) nanoparticles loaded with a Neuroprotective fraction of Hypericum perforatum
  18974. Cerebral ischemic postconditioning plays a Neuroprotective role through regulation of central and peripheral glutamate
  18975. Nanodelivery of cerebrolysin and rearing in enriched environment induce Neuroprotective effects in a preclinical rat model of Parkinson’s disease
  18976. Neuroprotective effect and molecular mechanism of [6]-gingerol against scopolamine-induced amnesia in C57BL/6 mice
  18977. Aspidosperma pyrifolium Mart: Neuroprotective , antioxidant and anti‐inflammatory effects in a Parkinson’s disease model in rats
  18978. The Neuroprotective effect of thalidomide against ischemia through the cereblon-mediated repression of AMPK activity
  18979. Angiotensin II induces oxidative stress and upregulates Neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells
  18980. Involvement of adenosine triphosphate-sensitive potassium channels in the Neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal …
  18981. Chromaffin cells as a model to evaluate mechanisms of cell death and Neuroprotective compounds
  18982. Neuroprotective effect of coumarin nasal formulation: kindling model assessment of epilepsy
  18983. A silver lining for 24-hydroxycholesterol in Alzheimer’s disease: the involvement of the Neuroprotective enzyme sirtuin 1
  18984. Neuroprotective effects of fucoxanthin and its derivative fucoxanthinol from the phaeophyte Undaria pinnatifida attenuate oxidative stress in hippocampal neurons
  18985. Nanoparticle-mediated delivery of Neuroprotective substances for the treatment of diabetic retinopathy
  18986. Synthesis of biocompatible titanate nanofibers for effective delivery of Neuroprotective agents
  18987. Neuroprotective effect of a physiological ratio of testosterone and estradiol on corticosterone-induced apoptosis in PC12 cells via Traf6/TAK1 pathway
  18988. Hypothermia reduces mortality, prevents the calcium plateau, and is Neuroprotective following status epilepticus in rats
  18989. β-Amyrin rich Bombax ceiba leaf extract with potential Neuroprotective activity against scopolamine-induced memory impairment in rats
  18990. Olive and its phenolic compound as the promising Neuroprotective agent
  18991. Neuroprotective nature of adipokine resistin in the early stages of focal cerebral ischemia in a stroke mouse model
  18992. The Nurr1 ligand, 1, 1-bis (3′-indolyl)-1-(p-chlorophenyl) methane, modulates glial reactivity and is Neuroprotective in MPTP-induced parkinsonism
  18993. Inhibition of transcription factor SP1 produces Neuroprotective effects through decreasing MAO B activity in MPTP/MPP+ Parkinson’s disease models
  18994. Chemical identification of isoflavonoids from a termite-associated Streptomyces sp. RB1 and their Neuroprotective effects in murine hippocampal HT22 cell line
  18995. Neuroprotective effect of acute ethanol intoxication in TBI is associated to the hierarchical modulation of early transcriptional responses
  18996. Neuroprotective effects of polydeoxyribonucleotide in a murine model of cadmium toxicity
  18997. Curcumin loading potentiates the Neuroprotective efficacy of Fe3O4 magnetic nanoparticles in cerebellum cells of schizophrenic rats
  18998. A natural benzofuran from the patagonic aleurodiscus vitellinus fungus has potent Neuroprotective properties on a cellular model of amyloid-β peptide toxicity
  18999. Fractionally delineate the Neuroprotective function of calbindin- in Parkinson’s disease
  19000. Neuroprotective effect of an Nrf2-ARE activator identified from a chemical library on dopaminergic neurons
  19001. Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide–induced toxicity in mice: Novel hypothesis for therapeutic approach …
  19002. Neuroprotective role of chrysin in attenuating loss of dopaminergic neurons and improving motor, learning and memory functions in rats
  19003. Triterpene saponins with Neuroprotective effects from a wild vegetable Aralia elata
  19004. Design, synthesis, and Neuroprotective effects of a series of Pyrazolines against 6-hydroxydopamine-induced oxidative stress
  19005. Neuroprotective effects of prenatal folic acid supplementation: why timing matters
  19006. The Neuroprotective and antioxidative effects of submicron and blended Lycium barbarum in experimental retinal degeneration in rats
  19007. MicroRNA-21 overexpression promotes the Neuroprotective efficacy of mesenchymal stem cells for treatment of intracerebral hemorrhage
  19008. Neuroprotective benefits of aerobic exercise and organoselenium dietary supplementation in hippocampus of old rats
  19009. Neuroprotective effect of protein phosphatase 2A/tristetraprolin following subarachnoid hemorrhage in rats
  19010. Neuroprotective effects of proanthocyanidins, natural flavonoids derived from plants, on rotenone-induced oxidative stress and apoptotic cell death in human …
  19011. The Neuroprotective and antidepressant‐like effects of Hcyb1, a novel selective PDE2 inhibitor
  19012. Neuroprotective effect of polysaccharides from Gastrodia elata blume against corticosterone‑induced apoptosis in PC12 cells via inhibition of the endoplasmic …
  19013. Phytochemical allylguaiacol exerts a Neuroprotective effect on hippocampal cells and ameliorates scopolamine-induced memory impairment in mice
  19014. Suramin-induced neurotoxicity: preclinical models and Neuroprotective strategies
  19015. GLP-1 receptor agonists show Neuroprotective effects in animal models of diabetes
  19016. Fingolimod anti-inflammatory and Neuroprotective effects modulation of RAGE axis in multiple sclerosis patients
  19017. Revalidation of the Neuroprotective effects of a United States patented polyherbal formulation on scopolamine induced learning and memory impairment in …
  19018. Flavonoids and saponins from two Bulgarian Astragalus species and their Neuroprotective activity
  19019. SK channel activation is Neuroprotective in conditions of enhanced ER–mitochondrial coupling
  19020. Neuroprotective effect of baicalin on focal cerebral ischemia in rats
  19021. Neuroprotective effect of Nrf2 activator dimethyl fumarate, on the hippocampal neurons in chemical kindling model in rat
  19022. Stereoisomers of schisandrin B are potent ATP competitive GSK-3β inhibitors with Neuroprotective effects against Alzheimer’s disease: Stereochemistry and biological …
  19023. Anti‑oxidative and anti‑apoptotic Neuroprotective effects of Azadirachta indica in Parkinson‑induced functional damage
  19024. Design, synthesis, and pharmacological characterization of carbazole based dopamine agonists as potential symptomatic and Neuroprotective therapeutic agents for …
  19025. Potential Neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells
  19026. Experience of Neuroprotective air injection during radiofrequency ablation (RFA) of spinal osteoid osteoma
  19027. Prostaglandin EP2 receptors mediate mesenchymal stromal cell-Neuroprotective effects on dopaminergic neurons
  19028. Neuroprotective effects of HM15211, a novel long-acting GLP-1/GIP/Glucagon triple agonist in the neurodegenerative disease models
  19029. Long-term Neuroprotective effect of erythropoietin on executive functions in very preterm children (EpoKids): protocol of a prospective follow-up study
  19030. Damage-associated molecular pattern recognition is required for induction of retinal Neuroprotective pathways in a sex-dependent manner
  19031. Two novel dual GLP-1/GIP receptor agonists are Neuroprotective in the MPTP mouse model of Parkinson’s disease
  19032. Neuroprotective Compound from an Endophytic Fungus, Colletotrichum sp. JS-0367
  19033. Evaluation of Diarylheptanoid–Terpene Adduct Enantiomers from Alpinia officinarum for Neuroprotective Activities
  19034. Comparison study of antioxidant activity and Neuroprotective effects of barley sprout leaf, root, and stem ethanol extracts
  19035. The novel Neuroprotective compound KMS99220 has an early anti-neuroinflammatory effect via AMPK and HO-1, independent of Nrf2
  19036. Neuroprotective effects of Tongxinluo on focal cerebral ischemia and reperfusion injury in rats associated with the activation of the MEK1/2/ERK1/2/p90RSK signaling …
  19037. Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson’s disease
  19038. Neuroprotective effects of Foeniculum vulgare seeds extract on lead-induced neurotoxicity in mice brain
  19039. Structure–property relationship study of the HPLC enantioselective retention of Neuroprotective 7‐[(1‐alkylpiperidin‐3‐yl) methoxy] coumarin derivatives on an …
  19040. Neuroprotective effects of SMTP‐44D in mice stroke model in relation to neurovascular unit and trophic coupling
  19041. Neuroprotective effect and antioxidant activity of Passiflora edulis fruit flavonoid fraction, aqueous extract, and juice in aluminum chloride-induced Alzheimer’s …
  19042. Neuroprotective effect of treadmill exercise against blunted brain insulin signaling, NADPH oxidase, and Tau hyperphosphorylation in rats fed a high-fat diet
  19043. Synthesis and evaluation of a ring-constrained Hsp90 C-terminal inhibitor that exhibits Neuroprotective activity
  19044. A new Iq-peptide of the Kunitz Type from the Heteractis magnifica sea anemone exhibits Neuroprotective activity in a model of Alzheimer’s disease
  19045. Modulatory role of Nurr1 activation and thrombin inhibition in the Neuroprotective effects of dabigatran etexilate in rotenone-induced Parkinson’s disease in rats
  19046. G protein‐coupled receptor 37‐like 1 modulates astrocyte glutamate transporters and neuronal NMDA receptors and is Neuroprotective in ischemia
  19047. Hypothermia Is Neuroprotective after severe hypoxic-ischaemic brain injury in neonatal rats pre-exposed to PAM3CSK4
  19048. SIRT1 and NRF2 gene transfer mediate distinct Neuroprotective effects upon retinal ganglion cell survival and function in experimental optic neuritis
  19049. Neuroprotective effects of Cassia tora against paraquat-induced neurodegeneration: relevance for Parkinson’s disease
  19050. The Neuroprotective effect of Ocimum sanctum Linn. ethanolic extract on human embryonic kidney-293 cells as in vitro model of neurodegenerative disease
  19051. Neuroprotective Effects of Butanol Fraction of Cordyceps cicadae on Glutamate‐Induced Damage in PC12 Cells Involving Oxidative Toxicity
  19052. In vitro antiglycating effect and in vivo Neuroprotective activity of Trigonelline in d-galactose induced cognitive impairment
  19053. The Neuroprotective effects of Chinese bayberry leaves proanthocyanidins
  19054. Modifying Rap1-signalling by targeting Pde6δ is Neuroprotective in models of Alzheimer’s disease
  19055. Neuroprotective effects of platonin, a therapeutic immunomodulating medicine, on traumatic brain injury in mice after controlled cortical impact
  19056. Neuroprotective effect of berberine agonist against impairment of learning and memory skills in severe traumatic brain injury via Sirt1/p38 MAPK expression
  19057. Neuroprotective effects of a traditional multi-herbal medicine Kyung-Ok-Ko in an animal model of Parkinson’s disease: Inhibition of MAPKs and NF-κB …
  19058. Synergistic Neuroprotective effect of rasagiline and idebenone against retinal ischemia-reperfusion injury via the Lin28-let-7-Dicer pathway
  19059. Synthesis and biological evaluations of NO-donating oxa-and aza-pentacycloundecane derivatives as potential Neuroprotective candidates
  19060. 17β-Estradiol as a Neuroprotective agent
  19061. Neuroprotective and neuroregenerative potential of pharmacologically-induced hypothermia with D-alanine D-leucine enkephalin in brain injury
  19062. Neuroprotective effect of the group III mGlu receptor agonist ACPT-I after ischemic stroke in rats with essential hypertension
  19063. New therapeutic property of Dimebon as a Neuroprotective agent
  19064. Neuroprotective effect of carnosine in the olfactory bulb after vanadium inhalation in a mouse model
  19065. Fingerprint analysis of Huolingshengji Formula and its Neuroprotective effects in SOD1 G93A mouse model of amyotrophic lateral sclerosis
  19066. Neuroprotective effect of tanshinone IIA weakens spastic cerebral palsy through inflammation, p38MAPK and VEGF in neonatal rats
  19067. Onjisaponin B (OB) is Neuroprotective during cognitive loss through immune-mediated and SIRT1 pathways
  19068. Neuroprotective effects of tenuigenin on neurobehavior, oxidative stress, and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in …
  19069. Multi-functional Neuroprotective activity of neohesperidin dihydrochalcone: a novel scaffold for Alzheimer’s disease therapeutics identified via drug repurposing …
  19070. Neuroprotective assessment of prolonged local hypothermia post contusive spinal cord injury in rodent model
  19071. Neuroprotective effects of cerebral ischemic preconditioning in a rat middle cerebral artery occlusion model: the role of the Notch signaling pathway
  19072. Neuroprotective effect of berberine against learning and memory deficits in diffuse axonal injury
  19073. Transcriptomic study reveals recovery of impaired astrocytes contribute to Neuroprotective effects of Danhong injection against cerebral ischemia/reperfusion …
  19074. Antioxidant and Neuroprotective effects of N-((3, 4-dihydro-2H-benzo [h] chromen-2-yl) methyl)-4-methoxyaniline in primary cultured rat cortical cells: involvement of …
  19075. Neuroprotective effect of hydroxytyrosol in experimental diabetic retinopathy: Relationship with cardiovascular biomarkers
  19076. … rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and Neuroprotective …
  19077. Development of noviomimetics that modulate molecular chaperones and manifest Neuroprotective effects
  19078. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington’s disease-like behavioral, biochemical, and cellular alterations …
  19079. Neuroprotective effect of monophosphoryl lipid A, a detoxified lipid A derivative, in photothrombotic model of unilateral selective hippocampal ischemia in rat
  19080. Neuroprotective effects of silibinin: an in silico and in vitro study
  19081. Neuroprotective effect of cannabinoid receptor 1 antagonist in the MNU-induced retinal degeneration model
  19082. Neuroprotective effects of C-terminal domain of tetanus toxin on rat brain against motorneuron damages after experimental spinal cord injury
  19083. Neuroprotective role of the RON receptor tyrosine kinase underlying central nervous system inflammation in health and disease
  19084. Atrial natriuretic peptide acts as a Neuroprotective agent in in vitro models of Parkinson’s disease via up-regulation of the Wnt/β-Catenin pathway
  19085. A deficiency of the GluN2C subunit of the N-methyl-D-aspartate receptor is Neuroprotective in a mouse model of ischemic stroke
  19086. Yacon leaf extract supplementation demonstrates Neuroprotective effect against memory deficit related to β-amyloid-induced neurotoxicity
  19087. Neuroprotective effect of nortriptyline in overt hepatic encephalopathy through attenuation of mitochondrial dysfunction
  19088. Neuregulin-1β Plays a Neuroprotective Role by Inhibiting the Cdk5 Signaling Pathway after Cerebral Ischemia-Reperfusion Injury in Rats
  19089. Echinacoside, an active constituent of Cistanche Herba, exerts a Neuroprotective effect in a kainic acid rat model by inhibiting inflammatory processes and activating …
  19090. Design and synthesis of novel senkyunolide analogues as Neuroprotective agents
  19091. A novel BACE inhibitor isolated from Eisenia bicyclis exhibits Neuroprotective activity against β-amyloid toxicity
  19092. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2, 3-dihydrothiazolo [4, 5-d] pyrimidin-6 (7H)-yl) urea) in 6-OHDA induced rodent model of hemiparkinson’s …
  19093. The Neuroprotective effect of melatonin on the hippocampus exposed to diclofenac sodium during the prenatal period
  19094. Neuroprotective effects of ferruginol, jatrophone, and junicedric acid against amyloid-β injury in hippocampal neurons
  19095. Neuroprotective effects of nicotine on hippocampal long-term potentiation in brain disorders
  19096. Pharmacokinetics and Toxicology of the Neuroprotective e, e, e-Methanofullerene (60)-63-tris Malonic Acid [C 3] in Mice and Primates
  19097. Neuroprotective effects of melatonin on erectile dysfunction in streptozotocin-induced diabetic rats
  19098. Neuroprotective and neurotrophic effects of Lanthionine Ketimine Ester
  19099. Anticonvulsant and Neuroprotective effects of cannabidiol during the juvenile period
  19100. Calpeptin is Neuroprotective against acrylamide-induced neuropathy in rats
  19101. Tryptophan-containing dual Neuroprotective peptides: prolyl endopeptidase inhibition and caenorhabditis elegans protection from β-amyloid peptide toxicity
  19102. 3-n-butylphthalide exerts Neuroprotective effects by enhancing anti-oxidation and attenuating mitochondrial dysfunction in an in vitro model of ischemic stroke
  19103. Estrogen receptor-α is involved in tamoxifen Neuroprotective effects in a traumatic brain injury male rat model
  19104. Immunomodulation as a Neuroprotective strategy after spinal cord injury
  19105. Neuroprotective alpha-cleavage of the human prion protein significantly impacts Cu (II) coordination at its His111 site
  19106. Neuroprotective effect of (-)-tetrahydropalmatine in Japanese encephalitis virus strain GP-78 infected mouse model
  19107. Secoiridoid glycosides from the twigs of Ligustrum obtusifolium possess anti-inflammatory and Neuroprotective effects
  19108. Neuroprotective strategies in repair and replacement of the aortic arch
  19109. The Neuroprotective effect of ethanol intoxication in traumatic brain injury is associated with the suppression of ErbB signaling in parvalbumin-positive interneurons
  19110. Sustained-release of FGF-2 from a hybrid hydrogel of heparin-poloxamer and decellular matrix promotes the Neuroprotective effects of proteins after spinal …
  19111. ERK 1/2 Activation Mediates the Neuroprotective Effect of BpV (pic) in Focal Cerebral Ischemia–Reperfusion Injury
  19112. Proteomic analysis of hippocampus in a mouse model of depression reveals Neuroprotective function of ubiquitin c-terminal hydrolase L1 (UCH-L1) via stress …
  19113. Neuroprotective Properties of Statins
  19114. Neuroprotective effect of dietary black seed flour on key enzymes linked with neuronal signaling molecules in rats exposed to mixture of environmental metals
  19115. Neuroprotective effect of ethanol in acute carbon monoxide intoxication: A retrospective study
  19116. Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model.
  19117. The atypical RhoGTPase RhoE/Rnd3 is a key molecule to acquire a Neuroprotective phenotype in microglia
  19118. Neuroprotective effect of S-allyl cysteine on an experimental model of multiple sclerosis: antioxidant effects
  19119. … and oxidative/nitrative status and causes protein/DNA damage, as well as ultrastructural changes in cerebral cortex: is acetylsalicylic acid Neuroprotective ?
  19120. Identification of proteins that bind to the Neuroprotective agent neoechinulin A
  19121. Triple herbal extract DA-9805 exerts a Neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson’s disease
  19122. A new target for Alzheimer’s disease: A small molecule SERCA activator is Neuroprotective in vitro and improves memory and cognition in APP/PS1 mice
  19123. Neuroprotective effect of Sirt2-specific inhibitor AK-7 against acute cerebral ischemia is P38 activation-dependent in mice
  19124. Phytochemical screening and evaluation of Neuroprotective , anti-mutagenic and anti-genotoxic effects of Turkish endemic Glaucium acutidentatum
  19125. The Neuroprotective effect of rat adipose tissue-derived mesenchymal stem cell-conditioned medium on cortical neurons using an in vitro model of SCI inflammation
  19126. Low cerebral exposure cannot hinder the Neuroprotective effects of panax notoginsenosides
  19127. Additive Neuroprotective effect of borneol with mesenchymal stem cells on ischemic stroke in mice
  19128. The structural features of the sulfated heteropolysaccharide (ST-1) from Sargassum thunbergii and its Neuroprotective activities
  19129. Growth of triple negative and progesterone positive breast cancer causes oxidative stress and down-regulates Neuroprotective transcription factor Npas4 and …
  19130. Neuroprotective and anti-inflammatory effects of a dodecamer peptide harboring Ninjurin 1 cell adhesion motif in the postischemic brain
  19131. Neuroprotective effect of Capsicum annuum var. abbreviatum against hydrogen peroxide-induced oxidative stress in HT22 hippocampus cells
  19132. Neuroprotective effects of inhibitors of acid-sensing ion channels (ASICs) in optic nerve crush model in rodents
  19133. Neuroprotective Effects of Purple Sweet Potato Balinese Cultivar in Wistar Rats With Ischemic Stroke
  19134. Small molecule SUMOylation activators are novel Neuroprotective agents
  19135. The Neuroprotective effects of 17β-estradiol pretreatment in a model of neonatal hippocampal injury induced by trimethyltin
  19136. Metallothioneins are Neuroprotective agents in lysosomal storage disorders
  19137. Neuroprotective effects of filgrastim in rotenone-induced Parkinson’s disease in rats: insights into its anti-inflammatory, neurotrophic, and antiapoptotic effects
  19138. 3-Iodothyronamine acting through an anti-apoptotic mechanism is Neuroprotective against spinal cord injury in rats
  19139. Neuroprotective effects of sigesbeckia pubescens extract on glutamate-induced oxidative stress in HT22 cells via downregulation of MAPK/caspase-3 pathways
  19140. A hydroxypyrone-based inhibitor of metalloproteinase-12 displays Neuroprotective properties in both status epilepticus and optic nerve crush animal models
  19141. Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats
  19142. Enhancing endogenous nitric oxide by whole body periodic acceleration elicits Neuroprotective effects in dystrophic neurons
  19143. Clinical perspectives of lithium’s Neuroprotective effect
  19144. Neuroprotective , neurogenic, and amyloid beta reducing effect of a novel alpha 2-Adrenoblocker, mesedin, on astroglia and neuronal progenitors upon hypoxia and …
  19145. Bradykinin B2 receptors play a Neuroprotective role in Hypoxia/reoxygenation injury related to pyroptosis pathway
  19146. Fluoxetine-mediated inhibition of endoplasmic reticulum stress is involved in the Neuroprotective effects of Parkinson’s disease
  19147. 7-Methoxyderivative of tacrine is a ‘foot-in-the-door’open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with Neuroprotective activity in vivo
  19148. Astroglial DJ-1 over-expression up-regulates proteins involved in redox regulation and is Neuroprotective in vivo
  19149. Neuroprotective effect of tanshinone IIA against neuropathic pain in diabetic rats through the Nrf2/ARE and NF-κB signaling pathways
  19150. Neuroprotective effect of arctigenin against neuroinflammation and oxidative stress induced by rotenone
  19151. Neuroprotective effect of duloxetine on chronic cerebral hypoperfusion-induced hippocampal neuronal damage
  19152. Xuebijing enhances Neuroprotective effects of ulinastatin on transient cerebral ischemia via Nrf2-are signal pathways in the hippocampus.
  19153. Neuroprotective effect of agaricus blazei extract against rotenone-induced motor and nonmotor symptoms in experimental model of parkinson’s disease
  19154. Furoxans (Oxadiazole-4N-oxides) with Attenuated Reactivity are Neuroprotective , Cross the Blood brain Barrier, and Improve Passive Avoidance memory
  19155. The Neuroprotective roles of sonic hedgehog signaling pathway in ischemic stroke
  19156. Neuroprotective effect of polysaccharide separated from Perilla frutescens Britton var. acuta Kudo against H2O2-induced oxidative stress in HT22 hippocampus …
  19157. Neuroprotective and anti-neuroinflammatory activities of anthraquinones isolated from Photorhabdus temperata culture broth
  19158. Neuroprotective effects of leonurine against oxygen–glucose deprivation by targeting Cx36/CaMKII in PC12 cells
  19159. Neuroprotective effect of (‑)‑epigallocatechin‑3‑gallate on autoimmune thyroiditis in a rat model by an anti‑inflammation effect, anti‑apoptosis and inhibition of …
  19160. Neuroprotective lithium salts protect pancreatic β-сells from damage
  19161. Salusin-β mediate Neuroprotective effects for Parkinson’s disease
  19162. Design, synthesis and biological evaluation of LX2343 derivatives as Neuroprotective agents for the treatment of Alzheimer’s disease
  19163. Antioxidant activity and Neuroprotective effect of root bark of Morus alba L. extract against hydrogen peroxide-induced cytotoxicity in PC12 Cells
  19164. The prohormone proinsulin as a Neuroprotective factor: past history and future prospects
  19165. Phenylethanoid glycoside from Forsythia koreana (Oleaceae) flowers shows a Neuroprotective effect
  19166. Neuroprotective effect of fermented papaya preparation by activation of Nrf2 pathway in astrocytes
  19167. Phosphodiesterase-4 inhibition confers a Neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by …
  19168. Neuroprotective effects of Flaveria bidentis and Lippia salsa extracts on SH-SY5Y cells
  19169. Potentiation of antiseizure and Neuroprotective efficacy of standard nerve agent treatment by addition of tariquidar
  19170. Chemical constituents from the rhizomes of Gastrodia elata f. glauca and their potential Neuroprotective effects
  19171. Neuroprotective effects of p53/microRNA‑22 regulate inflammation and apoptosis in subarachnoid hemorrhage
  19172. Neuroprotective effects of oleocanthal, a compound in virgin olive oil, in a rat model of traumatic brain injury
  19173. Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive Neuroprotective effects
  19174. DNA damage and oxidative stress induced by seizures are decreased by anticonvulsant and Neuroprotective effects of lobeline, a candidate to treat alcoholism
  19175. Neuroprotective Effects of Extracts from the Radix Curcuma aromatica on H2O2-induced Damage in PC12 Cells
  19176. Screening and identification of Neuroprotective compounds from Scrophularia buergeriana using cell extraction coupled with LC–MS
  19177. Ineffectiveness of saxagliptin as a Neuroprotective drug in 6‐OHDA‐lesioned rats
  19178. Neuroprotective effect of angiotensin-(1–7) against rotenone-induced oxidative damage in CATH. a neurons
  19179. Neuroprotective effects of silk fibroin hydrolysate against Aβ25–35 induced cytotoxicity in SH-SY5Y cells and primary hippocampal neurons by regulating ROS …
  19180. Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression
  19181. Non-invasive assessment of disease progression and Neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1G93A mouse model: A …
  19182. Neuroprotective effect of curcumin nanoparticles against rat model of status epilepticus induced by pilocarpine
  19183. Aripiprazole exerts a Neuroprotective effect in mouse focal cerebral ischemia
  19184. Comparing the antiseizure and Neuroprotective efficacy of LY293558, diazepam, caramiphen, and LY293558-caramiphen combination against soman in a rat model …
  19185. Neuroprotective ability of TMV coat protein on rat PC-12 cells and it’s in silico study with LRRK2 receptor
  19186. Bicuculline reverts the Neuroprotective effects of meloxicam in an oxygen and glucose deprivation (OGD) model of organotypic hippocampal slice cultures
  19187. Neuroprotective effect of total glycosides from paeonies against neurotoxicity induced by strychnos alkaloids related to recovering the levels of …
  19188. Neuroprotective effect of recombinant adeno‑associated virus human thioredoxin‑PR39 on acute cerebral infarction in rats
  19189. Combined rosiglitazone and Forskolin have Neuroprotective effects in SD rats after spinal cord injury
  19190. Molecular mechanisms of Neuroprotective effect of adjuvant therapy with phenytoin in pentylenetetrazole-induced seizures: impact on Sirt1/NRF2 signaling pathways
  19191. LyTONEPAL: long term outcome of neonatal hypoxic encephalopathy in the era of Neuroprotective treatment with hypothermia: a French population-based …
  19192. Jia-Jian-Di-Huang-Yin-Zi decoction exerts Neuroprotective effects on dopaminergic neurons and their microenvironment
  19193. Additive Neuroprotective effects of 24 (S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model
  19194. Treatment with acetyl-L-carnitine exerts a Neuroprotective effect in the sciatic nerve following loose ligation: a functional and microanatomical study
  19195. Activation of the Large-Conductance, Voltage, and Ca2+-Activated K+ (BK) Channel in Acute Spinal Cord Injury in the Wistar Rat Is Neuroprotective
  19196. Antioxidant and Neuroprotective activity of the aerial parts of seven Eragrostis species and bioactive compounds from E. japonica
  19197. Neuroprotective potential and paracrine activity of stromal vs. culture-expanded hMSC derived from Wharton jelly under co-cultured with hippocampal …
  19198. Triterpene saponins with Neuroprotective effects from the leaves of Diospyros kaki Thunb
  19199. Lig4-4 selectively inhibits TREK-1 and plays potent Neuroprotective roles in vitro and in rat MCAO model
  19200. Enhancement of Neuroprotective effects of spirulina platensis extract from a high-pressure homogenization process
  19201. Neuroprotective effect of IRL-1620, an endothelin B receptor agonist, on a pediatric rat model of middle cerebral artery occlusion
  19202. A novel Neuroprotective mechanism for lithium that prevents association of the p75NTR-sortilin receptor complex and attenuates proNGF-induced neuronal …
  19203. A study of antibacterial, antioxidant and Neuroprotective effect of stem of Syzygium cumini
  19204. Assessment of antioxidant and Neuroprotective activities of methanol extract of Moringa oleifera Lam. leaves in subchronic chlorpyrifos-intoxicated rats
  19205. Neuroprotective effects of N-acetyl cysteine on primary hippocampus neurons against hydrogen peroxide-induced injury are mediated via inhibition of …
  19206. n-Propanol extract of boiled and fermented koro benguk (Mucuna pruriens seed) shows a Neuroprotective effect in paraquat dichloride-induced Parkinson’s …
  19207. Exogenous progesterone is Neuroprotective following injury to the male zebra finch brain
  19208. Neuroprotective effects of garlic in model systems of neurodegenerative diseases
  19209. Neuroprotective effects of α-lipoic acid on long-term experimental autoimmune encephalomyelitis
  19210. Neuroprotective effects and UPLC-Q-TOF/MS-based active components identification of external applied a novel Wen-Luo-Tong microemulsion
  19211. Neuroprotective effects of Aegle marmelos (L.) Correa against cadmium toxicity by reducing oxidative stress and maintaining the histoarchitecture of neural tissue in …
  19212. Neuroprotective Effect of CeO 2@ PAA-LXW7 Against H 2 O 2-Induced Cytotoxicity in NGF-Differentiated PC12 Cells
  19213. Neuroprotective effects of vigabatrin on spinal cord ischemia-reperfusion injury
  19214. Design, synthesis and bioevaluation of 1, 2, 3, 9-tetrahydropyrrolo [2, 1-b] quinazoline-1-carboxylic acid derivatives as potent Neuroprotective agents
  19215. Neuroprotective effect of paroxetine on memory deficit induced by cerebral ischemia after transient bilateral occlusion of common carotid arteries in rat
  19216. Hi1a as a novel Neuroprotective agent for ischemic stroke by inhibition of acid-sensing ion channel 1a
  19217. Neuroprotective effects of fasudil, a Rho-kinase inhibitor, after spinal cord ischemia and reperfusion in rats
  19218. The adaptogenic and Neuroprotective properties of lithium ascorbate
  19219. Gene expression profiling confirms the dosage-dependent additive Neuroprotective effects of Jasminoidin in a mouse model of ischemia-reperfusion injury
  19220. Neuroprotective role of erythropoietin in spinal cord ischemic injury: Where have we been and where are we going?
  19221. Probing the striatal dopamine system for a putative Neuroprotective effect of DBS in PD
  19222. Design, synthesis and evaluation of the antioxidant and Neuroprotective properties of alkyl-and terpenylphenolchlorin conjugates
  19223. Antidiabetic and Neuroprotective Effect of the N-Butanol Extract of Fragaria nilgerrensis Schlecht. in STZ-Induced Diabetic Mice
  19224. Pyroxazone, a new Neuroprotective compound from Streptomyces sp. RAN54
  19225. Neuroprotective effect of Decalepis hamiltonii aqueous root extract and purified 2-hydroxy-4-methoxy benzaldehyde on 6-OHDA induced neurotoxicity in …
  19226. Possible Neuroprotective role of P2X2 in the retina of diabetic rats
  19227. Antioxidant mechanisms in Neuroprotective action of lipoic acid on learning and memory of rats with experimental dementia
  19228. Neuroprotective action of 4-hydroxyisophthalic acid against paraquat-induced motor impairment involves amelioration of mitochondrial damage and …
  19229. Neuroprotective capabilities of Vitex negundo in primary hippocampal neurons.
  19230. Comparison of Neuroprotective effect of Forsythia suspensa leaf extract and forsythiaside, one of its metabolites
  19231. Observational study shows that it is feasible to provide Neuroprotective treatment for neonatal encephalopathy in low‐income countries
  19232. Silencing VEGF-B diminishes the Neuroprotective effect of candesartan treatment after experimental focal cerebral ischemia
  19233. Review on the Neuroprotective effects of environmental enrichment in models of Parkinson’s disease
  19234. Inhibition of dynamin-related protein 1 has Neuroprotective effect comparable with therapeutic hypothermia in a rat model of cardiac arrest
  19235. Oleocanthalic acid, a chemical marker of olive oil aging and exposure to a high storage temperature with potential Neuroprotective activity
  19236. Non‐Covalent Interactions of a Neuroprotective Peptide Revealed by Photodissociative Cross‐Linking in the Gas Phase
  19237. Neuroprotective effect of lovastatin through down-regulation of pro-apoptotic Mst1 gene expression in rat model pilocarpine epilepsy
  19238. Neuroprotective effect of the ethanol extract of Artemisia capillaris on transient forebrain ischemia in mice via nicotinic cholinergic receptor
  19239. Neuroprotective effects of quercetin 4′-O-β-d-diglucoside on human striatal precursor cells in nutrient deprivation condition
  19240. Traumatic penumbra: opportunities for Neuroprotective and neurorestorative processes
  19241. Neuroprotective role of dexmedetomidine pretreatment in cerebral ischemia injury via ADRA2A‑mediated phosphorylation of ERK1/2 in adult rats
  19242. Carica Papaya leaf extract as a Neuroprotective agent against behavioral and neurotransmitter changes in brain of the rat treated with sodium fluoride in Pre-and Post …
  19243. Long‐term immunosuppression for CNS mouse xenotransplantation: Effects on nigrostriatal neurodegeneration and Neuroprotective carotid body cell therapy
  19244. Neuroprotective functions of Alpinia galanga in forebrain ischemia induced neuronal damage and oxidative insults in rat Hippocampus
  19245. Comparison of behavioral, Neuroprotective , and proinflammatory cytokine modulating effects exercised by (+)‐cis‐EC and (−)‐cis‐EC stereoisomers in a PTZ‐induced …
  19246. Neuroprotective effect of Annona glabra extract against ethanol-induced apoptotic neurodegeneration in neonatal rats
  19247. Copper-Catalyzed Synthesis, Bio-Evaluation, and in Silico Studies of 2-Aryl-N-alkylbenzimidazoles as Neuroprotective agents
  19248. Investigation into the intracellular fates, speciation and mode of action of selenium-containing Neuroprotective agents using XAS and XFM
  19249. Electroacupuncture exerts Neuroprotective effects on ischemia/reperfusion injury in JNK knockout mice: the underlying mechanism
  19250. Acid-base fractions separated from Streblus asper leaf ethanolic extract exhibited antibacterial, antioxidant, anti-acetylcholinesterase, and Neuroprotective …
  19251. Neuroprotective effect of local hypothermia in a computer‑controlled compression model in minipig: Correlation of tissue sparing along the rostro‑caudal axis …
  19252. Neuroprotective effect of the recombinant human leukemia inhibitory factor in mice with an experimental cuprizone model of multiple sclerosis: possible mechanisms
  19253. A Randomized, Double-Masked, Placebo-Controlled Trial of the Efficacy of a Novel Neuroprotective Combination for Reversing Mitochondrial Dysfunction in …
  19254. Apelin-12 exerts Neuroprotective effect against ischemia-reperfusion injury by inhibiting JNK and P38MAPK signaling pathway in mouse
  19255. Chitosan-coated C-phycocyanin liposome for extending the Neuroprotective time window against ischemic brain stroke
  19256. Methods for Defining the Neuroprotective Properties of Xenon
  19257. Neuroprotective effects of vitamin D on high fat diet-and palmitic acid-induced enteric neuronal loss in mice
  19258. Antiepileptogenic and Neuroprotective effects of Ziziphus jujuba leaves methanolic extract against pentylenetetrazole-induced kindling model in mice
  19259. Assessment of the antigenic and Neuroprotective activity of the subunit anti-Toxoplasma vaccine in T. gondii experimentally infected mice
  19260. Methylene blue exerts anticonvulsant and Neuroprotective effects on self-sustaining status epilepticus (SSSE) induced by prolonged basolateral amygdala …
  19261. The relaxin peptide family–potential future hope for Neuroprotective therapy? A short review
  19262. Neuroprotective role of N-acetylcysteine against Learning deficits and Altered brain neurotransmitters in rat pups subjected to prenatal stress
  19263. Neuroprotective dobutamine treatment upregulates superoxide dismutase 3, anti-oxidant and survival genes and attenuates genes mediating inflammation
  19264. Validation of ethnopharmacology of ayurvedic sarasvata ghrita and comparative evaluation of its Neuroprotective effect with modern alcoholic and lipid based extracts …
  19265. Determination of permeability, plasma protein binding, blood partitioning, pharmacokinetics and tissue distribution of Withanolide A in rats: A Neuroprotective steroidal …
  19266. Yolkin-A Polypeptide Complex Isolated From Chicken Egg Yolk with Potential Neuroprotective and Antioxidative Activity
  19267. Mechanisms of cell damage in neurological diseases and putative Neuroprotective strategies
  19268. Neuroprotective Effects of Forced Exercise and Bupropion on Chronic Methamphetamine-induced cognitive Impairment via Modulation of cAMP Response …
  19269. Oxidative damage mechanisms in traumatic brain injury and antioxidant Neuroprotective approaches
  19270. Neuroprotective effects of bread Containing Aster scaber Thunb. and Stachys sieboldii Miq. against ethanol-or H2O2-induced neuronal cell death
  19271. Anticonvulsant and Neuroprotective effects of methanolic extract of Cinnamomum camphora leaves in rat brain
  19272. Evaluation of nutrient content and antioxidant, neuritogenic, and Neuroprotective activities of upland rice bran oil
  19273. In vivo Neuroprotective activity of erythropoietin-alginate microspheres at different polymer concentrations
  19274. The antiepileptic and Neuroprotective effect of the Buxus hyrcana Pojark hydroethanolic extract against the pentylentetrazol induced model of the seizures in the male …
  19275. A dopamine-dependent activity in controlling the motor functions in cadmium induced neurotoxicity: Neuroprotective potential of quercetin
  19276. Neuroprotective effect of melatonin in mice with toxic cuprizone model of demyelination and possible pathways of its realization
  19277. NICU nurses and families partnering to provide Neuroprotective , family-centered, developmental care
  19278. Evaluating the Neuroprotective effect of 17β-estradiol in rodent models of oxidative retinopathies
  19279. Neuroprotective measures throughout the TAVI pathway.
  19280. Heptanoate is Neuroprotective in vitro but triheptanoin post-treatment did not protect against middle cerebral artery occlusion in rats
  19281. Synthesis and evaluation of coumarin/1, 2, 4-oxadiazole hybrids as selective BChE inhibitors with Neuroprotective activity
  19282. Neuroprotective Mechanisms of Orientin against Hydrogen Peroxide-induced Oxidative Damage in SH-SY5Y Cells
  19283. Synthesis, docking and ADME prediction of novel 1, 2, 3-triazole-tethered coumarin derivatives as potential Neuroprotective agents
  19284. … HAIYPRH (T7) peptide dual-ligand functionalized nanoformulation enhances the brain delivery of tanshinone IIA and exerts Neuroprotective effects against ischemic …
  19285. Neuroprotective effects of the multitarget agent AVCRI104P3 in brain of middle-aged mice
  19286. Neuroprotective effects of cryptotanshinone and 1, 2-dihydrotanshinone I against MPTP induced mouse model of Parkinson’s disease
  19287. Antioxidant and Neuroprotective Effects of KM-34, A Novel Synthetic Catechol, Against Oxidative Stress-Induced Neurotoxicity
  19288. Neuroprotective effects of Zingerone against carbon tetrachloride (CCl4) induced brain mitochondrial toxicity in Swiss albino mice
  19289. Neuroprotective effects of chloroform and aqueous fractions of noni juice against t-Butyl hydroperoxide-induced oxidative damage in SH-SY5Y cells
  19290. Design, synthesis, and Neuroprotective effects of dual‐brain targeting naproxen prodrug
  19291. Neuroprotective effects of erythropoietin on rat retinas subjected to oligemia
  19292. A Neuroprotective approach to optimizing treatment and correction activities in children with autism spectrum disorders
  19293. Neuroprotective effects of magnesium lithospermate B against subarachnoid hemorrhage in rats
  19294. Plant-derived alkaloids: a promising window for Neuroprotective drug discovery
  19295. Culture of Rat Mesencephalic Dopaminergic Neurons and Application to Neurotoxic and Neuroprotective agents
  19296. Thymosin β4 for the treatment of acute stroke: neurorestorative or Neuroprotective ?
  19297. Potential Neuroprotective effect of androst‐5‐ene‐3β, 17β‐diol (ADIOL) on the striatum, and substantia nigra in Parkinson’s disease rat model
  19298. An Angiopep-2 functionalized nanoformulation enhances brain accumulation of tanshinone IIA and exerts Neuroprotective effects against ischemic stroke
  19299. Geranylgeranylacetone exerts Neuroprotective roles through medicating the phosphatidylinositol-3 kinase/Akt signaling pathway in an intracerebral hemorrhage rat …
  19300. A Neuroprotective brain stimulation for vulnerable cerebellar Purkinje cell after ischemic stroke: a study with low-intensity focused ultrasound
  19301. Novel Neuroprotective lead compound ligustrazine derivative mass spectrometry fragmentation rule and metabolites in rats by LC/LTQ-Orbitrap MS
  19302. Neuroprotective and nootropic activity of Carica papaya seeds on Diabetes induced cognitive decline in rats
  19303. Central nervous system neuron-glia co-culture models and application to Neuroprotective agents
  19304. Acetophenone derivatives from the root bark of Cynanchum wilfordii as potential Neuroprotective agents
  19305. Neuroprotective effect of ischemic postconditioning on sciatic nerve transection
  19306. Adenosine A1 receptor: A Neuroprotective target in light induced retinal degeneration
  19307. Neuroprotective effect and relative mechanisms of lycii fructus polysaccharide
  19308. Study of the Neuroprotective effects of carnosine in an experimental model of focal cerebral ischemia/reperfusion
  19309. Neuroprotective effects of boric acid against fluoride toxicity on rat synaptosomes
  19310. Neuroprotective Effects of Guarana (Paullinia cupana Mart.) against Vincristine in Vitro Exposure
  19311. Neuroprotective Effects of Dibornol in Focal Cerebral Ischemia/Reperfusion in Rats
  19312. Antioxidant, anti-inflammatory and Neuroprotective activities of a plant extract derived from traditional Chinese medicine: SuHeXiang Wan (AT000)
  19313. In vitro Neuroprotective effect of charantin from Momordica charantia against neurotoxin and endoplasmic reticulum stress-induced cell death in SH-SY5Y cells
  19314. Analysis of gene expression profiles of CR80, a Neuroprotective 1, 8-Naphthyridine
  19315. Neuroprotective effect of treadmill exercise possibly via regulation of lysosomal degradation molecules in mice with pharmacologically induced Parkinson’s …
  19316. Repeated forced swim exacerbates methamphetamine-induced neurotoxicity: Neuroprotective effects of nanowired delivery of 5-HT3-receptor antagonist ondansetron
  19317. Neuronal adenosine A 2A receptor overexpression is Neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington’s disease
  19318. Neuroprotective effect of rapamycin against Parkinson’s disease in mice
  19319. Pediatric ECMO after drowning: Neuroprotective strategies
  19320. Time to reconsider urate: Neuroprotective potential may prevail on cardiovascular risk in animal models and clinical trials
  19321. Acupuncture at ST36 exerts Neuroprotective effects via inhibition of reactive astrogliosis in infantile rats with hydrocephalus
  19322. Environmentally enriched pigs have transcriptional profiles consistent with Neuroprotective effects and reduced microglial activity
  19323. Antioxidant and Neuroprotective effects of crude polysaccharide fractions from Cudrania tricuspidata fruits
  19324. Neuroprotective effect of acute prior inflammation with lipopolysaccharide for adult male rat facial motoneurones
  19325. Neuroprotective action and mechanistic evaluation of protodioscin against rat model of Parkinson’s disease
  19326. Natural Phytoestrogens: A Class of Promising Neuroprotective agents for Parkinson Disease
  19327. Acupuncture elicits Neuroprotective effect by ameliorating cognitive deficits
  19328. Anti-Zn 2+-toxicity of 4-hydroxybenzyl alcohol in astrocytes and neurons contribute to a robust Neuroprotective effects in the postischemic brain
  19329. Neuroprotective effect of selective antegrade cerebral perfusion during prolonged deep hypothermic circulatory arrest: Cerebral metabolism evidence in a pig …
  19330. Evaluating apolipoprotein E genotype status and Neuroprotective effects against white matter hyperintensity development in high-altitude careers
  19331. Evaluating Neuroprotective Effects of Ascorbic Acid Against 3-Nitropropionic Acid Induced Huntington’s Disease in Rats: Possible Involvement of GABAA Receptors
  19332. Neuroprotective effects of Schisandra chinensis and Ribes fasciculatum extract on hydrogen peroxide-mediated oxidative stress in neuroblastic SH-SY5Y cell line
  19333. 2-Methyl-5H-benzo [d] pyrazolo [5, 1-b][1, 3] oxazin-5-imine, an edaravone analog, exerts Neuroprotective effects against acute ischemic injury via inhibiting …
  19334. MiRNome of epileptic children suggests the involvement of antioxidant pathways in the Neuroprotective role of ketogenic diet
  19335. Discovery of Neuroprotective antioxidants for the management of ischemic brain stroke
  19336. Optimal doses and Neuroprotective effects of prolonged treatment with young coconut juice in orchidectomized rats. A preliminary study
  19337. An experimental evaluation of the therapeutic window of the Neuroprotective activity of a low-molecular nerve growth factor mimetic GK-2
  19338. Neuroprotective Effects of Gagam-Sipjeondaebo-Tang, a Novel Herbal Formula, against MPTP-Induced Parkinsonian Mice and MPP+-Induced Cell Death in …
  19339. Neuroprotective role of 6-Gingerol-rich fraction of Zingiber officinale (Ginger) against acrylonitrile-induced neurotoxicity in male Wistar rats
  19340. Phytochemical and Neuroprotective evaluation of Citrus aurantium essential oil on cerebral ischemia and reperfusion
  19341. Correction: Meng, X., et al. Neuroprotective Effects of Radix Scrophulariae on Cerebral Ischemia and Reperfusion Injury via MAPK Pathways. Molecules 2018, 23 …
  19342. Correction: Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice
  19343. Neuroprotective activity of Sesbania grandifolara seeds extract against celecoxib induced amnesia in mice
  19344. Neuroprotective Role of Alpha-tocopherol in H2O2 induced Oxidative stress in Neonatal Sheep’s brain Tissue Culture
  19345. Investigating the Neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy
  19346. Evaluation of Neuroprotective effect of medicinal plants in Drosophila melanogaster model
  19347. Neuroprotective Effect of ω-3 Polyunsaturated Fatty Acids on Bilirubin Encephalopathy In Vitro and In Vivo
  19348. Neuroprotective effect of Trichosanthes kirilowii cassia twig on cerebral ischemia-reperfusion injury in rats.
  19349. Discovery and Development of Neuroprotective agents from Natural Products: An Overview
  19350. Study on Dual Inhibitors of HIV‐1 IN/CCR5 Caffeoyl Derivatives as Neuroprotective agents
  19351. The Neuroprotective effect of sodium butyrate on short-term memory and serum level of b-cell lymphoma 2 in a rat model of cerebral hypoxic-ischemia
  19352. Coumarin-Based Molecules as Suitable Models for Developing New Neuroprotective agents Through Structural Modification
  19353. Neuroprotective effect of ginsenoside Rh1 on scopolamine-induced cognitive dysfunctions
  19354. The new perspective Neuroprotective effect of boric acid against ethanol-induced oxidative damage on synaptosome
  19355. Neuroprotective effect of icariin on spinal cord injury in rats
  19356. Abstract WP251: Neuroprotective Effect of a New Endovascular Hypothermia: Intrajugular Cooling Infusion in Experimental Ischemic Stroke
  19357. Corrigendum to” Combined NADPH and the NOX Inhibitor Apocynin Provides Greater Anti-Inflammatory and Neuroprotective Effects in a Mouse Model of Stroke”[Free …
  19358. Neuroprotective effects of selegiline on rat neural stem cells treated with hydrogen peroxide
  19359. Neuroprotective effects of selegiline on rat neural stem cells treated with hydrogen peroxide
  19360. Synthesis and Neuroprotective Activity of Neolamellarin A Analogues
  19361. Neuroprotective effects of phenolic compounds isolated from Spiraea prunifolia var. simpliciflora
  19362. Neurotoxic and Neuroprotective effects of homocysteine and hydrogen sulfide
  19363. Results of Neuroprotective therapy in primary open-angle glaucoma
  19364. Antioxidant and Neuroprotective effects of gossypitrin, a flavonoid from Talipariti elatum, against chemical hypoxia-induced PC12 cell death
  19365. Evaluation of Neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1. 3 channel blocker
  19366. Neuroprotective effect of ZnT3 knockout on subarachnoid hemorrhage
  19367. Dual Neuroprotective role of Hsp2 against α-Synuclein aggregates
  19368. The acetylation of histone H3 at Lys24 is accompanied by delayed expression of Neuroprotective proteins Bcl-2 and BDNF in the neocortex of rats exposed to severe …
  19369. Neuroprotective Efficacy of Clitoria Ternacea Root Extract on Hippocampal CA3 Neurons–A Quantitative Study in Mice
  19370. Evaluate Neuroprotective effect of silibinin using chronic unpredictable stress (cus) model
  19371. Does exercise have a Neuroprotective function in multiple sclerosis? A brief overview of the physical training potential effects on cytokines and brain -derived …
  19372. Enhancement of Neuroprotective Effects of Spirulina maxima by a Low-temperature Extraction Process with Ultrasonic Pretreatment
  19373. Corrigendum to “Neuroprotective Effects of Polydeoxyribonucleotide in a Murine Model of Cadmium Toxicity”
  19374. Potential therapeutics of Alzheimer’s diseases: New insights into the Neuroprotective role of trehalose‐conjugated beta sheet breaker peptides
  19375. Neuroprotective effects of electroacupuncture preventive treatment in senescence-accelerated mouse prone 8 mice
  19376. Antioxidant and Neuroprotective effects of Hyptis suaveolens, Hyptis pectinata and Hyptis marrubioides in Caenorhabditiselegans
  19377. Neuroprotective Strategies in the Pediatric
  19378. Neuroprotective effect of astaxanthin in a rat model of anterior ischemic optic neuropathy
  19379. Neuroprotective effect of lurasidone via antagonist activities on histamine in a rat model of cranial nerve involvement
  19380. Antiaging and Neuroprotective Properties of Mediterranean Diet Components in Humans
  19381. Neuroprotective role of Asiatic acid in aluminium chloride induced rat model of Alzheimer’s disease.
  19382. An Efficient Method for the Synthesis of Neuroprotective Drug Riluzole
  19383. Neuroprotective effects of Bergenia ciliata on NMDA induced injury in SH-SY5Y cells and attenuation of cognitive deficits in scopolamine induced amnesia in …
  19384. The Neuroprotective effects of 2-APB in rats with experimentally-induced severe acute pancreatitis
  19385. Nitric Oxide Synthase Inhibition as a Neuroprotective Strategy Following Hypoxic-Ischemic: Evidence From Animal Studies
  19386. New triterpenoids from Staphylea bumalda flower buds and their Neuroprotective activity against H 2 O 2-induced injury in vitro
  19387. Neuroprotective potential of Citrullus lanatus seed extract and Vitamin E against mercury chloride intoxication in male rat brain
  19388. Cannabidiol, a non‐psychoactive marijuana component, exhibits antioxidant and Neuroprotective effects in neuronal Alzheimer’s cell model SH‐5Y
  19389. Neuroprotective Effects of the Methanol Extract of Kimchi, a Korean Fermented Vegetable Food, Mediated Via Suppression of Endoplasmic Reticulum Stress and …
  19390. Synthesis and biological evaluation of N-alkyl-1, 4-dihydroquinoline prodrugs of scutellarin methyl ester as Neuroprotective agents
  19391. Oral administration of a novel lipophilic PPARδ agonist is not Neuroprotective after rodent cerebral ischemia
  19392. Ketogenic diets may provide Neuroprotective benefits after unilateral chronic sciatic nerve constriction injury
  19393. Preclinical study of ibuprofen loaded transnasal mucoadhesive microemulsion for Neuroprotective effect in MPTP mice model
  19394. Neuroprotective effects of oligodendrocyte precursor cells on white matter damage in preterm infants
  19395. Neuroprotective effects of high-dose human albumin against traumatic spinal cord injury in rats.
  19396. UHPLC-DAD-ESI-MS/MS Analysis of Gossypitrin Sample from Talipariti elatum (Sw.) with Antioxidant and Neuroprotective Effects
  19397. Design, synthesis and Neuroprotective activities of novel cinnamide derivatives containing benzylpiperazine moiety
  19398. Neuroprotective Sesquiterpenes from Capsella bursa-pastoris
  19399. Targeted temperature management at 33° C or 36° C produces equivalent Neuroprotective effects in the middle cerebral artery occlusion rat model of ischemic stroke
  19400. Comparison of Neuroprotective effects of oil-and water-soluble fractions of sea buckthorn juice against light-induced retinal degeneration in rats
  19401. Neuroprotective agents Target Molecular Mechanisms of Programmed Cell Death After Traumatic brain Injury
  19402. ApoE2-Mediated Neuroprotective Mechanism Through Up-regulation of Glycolysis
  19403. Neuroprotective effect of Qinggan Lishui formula on retinal ganglion cell apoptosis in a microbead-induced rat chronic glaucoma model
  19404. Neuroprotective properties of wine: Implications for the prevention of cognitive impairment
  19405. Neuroprotective effect of rutin on iron induced oxidative stress and cytotoxicity in PC12 neuronal cells via Bcl-2/Bax/caspase-3 signaling pathways
  19406. Laccase fermentation of clove extract increases content of dehydrodieugenol, which has Neuroprotective activity against glutamate toxicity in HT22 cells
  19407. Investigating the Neuroprotective role of OGA inhibition by Thiamet-G against Alzheimer’s disease
  19408. Neuroprotective NICU Care
  19409. Neuroprotective effect of PDGF-C in retina degeneration models
  19410. Neuroprotective Effects of Pramlintide Against Oxidative Stress and Alzheimer’s Disease
  19411. Neuroprotective effects of estradiol and its derivatives
  19412. Neuroprotective Effect of Intraocular BDNF and Optogenetic Stimulation of Visual Cortex on Retinal Ganglion Cell Survival and Function in the Rat following …
  19413. Neuroprotective Activity of D-HES in Transient Global Cerebral Ischemia in Rats
  19414. Neuroprotective effect of luteolin-7-O-β-D-glucuronide in a rat model offocal cerebral ischemia
  19415. The Neuroprotective Effect of the Thr–Ser–Lys–Tyr Peptide in a Goldfish Mauthner Cell Model in vivo
  19416. Neuroprotective effects of alcoholic extract of Artemisia herba-alba on degeneration of alpha motoneurons of spinal cord ventral horn after sciatic nerve compression …
  19417. Neuroprotective efficacy of swarna bhasma on sleep deprived induced cognitive impairment in rats
  19418. Neuroprotective effects of lithium carbonate in conditions of tumor growth
  19419. Xenon is Neuroprotective against blast traumatic brain injury in vitro
  19420. Anti-Oxidative and Neuroprotective Effects of Supplementary Flaxseed on Oxidative Damage in the Hippocampus Area of a Rat Model of Hypoxia
  19421. Correction: Monitoring cerebral oxygenation of the immature brain : a Neuroprotective strategy?
  19422. Anti-Radical and Neuroprotective Potential of Ficus infectoria in Scopolamine Induced memory Impairment in Mice
  19423. Analysis of the antioxidant enzyme‐mimetic activity and Neuroprotective effects of cerium oxide nanoparticles stabilized with varying ratios of citric acid and EDTA
  19424. A New and Promising Perspective on Neuroprotective agents in Stroke Management
  19425. Neuroprotective effect of Neurokinin 1 receptor antagonist on CA1 region of hippocampus in male Wistar rats following ischemic/reperfusion induction
  19426. Cerebral Fat Embolism: Neuroprotective Goals in an Unusual Cause of Altered Mental Status
  19427. Molecular Field Topology Analysis (MFTA) in the Design of Neuroprotective Compounds
  19428. Neuroprotective effect of wine against hydrogen peroxide-induced oxidative stress in human neuron-like cells
  19429. Neuroprotective effects of progesterone in acute brain trauma and its physiological mechanism
  19430. A Neuroprotective role of IGFBPL1 in glaucoma
  19431. Neuroprotective activity of orexin system in ischemic stroke
  19432. Neuroprotective Effects of Ocimum basilicum Extract against Hydrogen Peroxide-Induced Oxidative Stress in SK-N-SH Neuroblastoma Cells
  19433. Salivary Levels of Neurotoxic Versus Neuroprotective Indices Underpin the Aberrant Response to Psychological Stress in Schizophrenic Patients
  19434. Evaluation of Neuroprotective properties of dimethylfumarate by optical coherence tomography in non-inflammatory models of retinal neurodegeneration (P2. 163)
  19435. Neuroprotective Properties of Nigella sativa (L.) Seeds Extract in Sprague Dawley Rats models
  19436. Neuroprotective effects of food intake regulating peptides in vitro and in vivo
  19437. Nociceptin/Orphanin FQ (N/OFQ) is Neuroprotective in an ex vivo mouse model of cerebral ischaemia
  19438. Correction to: Ret is essential to mediate GDNF’s Neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
  19439. Neuroprotective Properties of Statins
  19440. In vitro and In vivo Neuroprotective study of solid lipid nanoparticles loaded with dimethyl fumarate
  19441. Neuroprotective effect mechanisms of hypoxia and hypercapnia combined impact
  19442. Neuroprotective Positioning and Positive Touch
  19443. Efficiency of Retinoprotective Dry AMD Therapy with Neuroprotective Therapy: a Randomized Clinical Trials Meta-analysis
  19444. Neuroprotective treatment strategies after rewarming from accidental hypothermia
  19445. Neuroprotective Effect of Durio zibithinus against Beta Amyloid
  19446. Neuroprotective Effect of Parkin on Mitochondria in Central Dopaminergic Neurons (P3. 062)
  19447. Neuroprotective Effect of 4T1 and Sertoli Cells Co-Transplantation in Animal Model of brain Ischemia
  19448. Neuroprotective and Neuroregenerative Effect of Secreted Factors from Human Adipose Stem Cells in a Rat Stroke Model
  19449. Neuroprotective Effect of Ethanol in Acute Carbon Monoxide Intoxication
  19450. Exploring Neuroprotective potential of astrocytes
  19451. Identification of a retinal Neuroprotective kinase inhibitor with preferential activity against DLK compared to LZK
  19452. Lamotrigine enhances the Neuroprotective effects of memantine on aluminum chloride-induced behavioral changes in rats
  19453. The Molecular Mechanism and Neuroprotective Effect of Dihydrocapsaicin-Induced Mild Hypothermia After Cardiopulmonary Resuscitation in Rats
  19454. Correction to Furoxans (Oxadiazole-N-oxides) with Attenuated Reactivity Are Neuroprotective , Cross the Blood brain Barrier, and Improve Passive Avoidance …
  19455. Structural Remodeling Of Alpha-Synuclein By Small Molecules: A Novel Path To Neuroprotective Therapeutics
  19456. 1metiq, an Endogenous Compound Present in the Mammalian brain Displays Neuroprotective , Antiaddictive and Antidepressant-Like Activity in Animal …
  19457. Therapy of Dredging the Bowels Enhanced the Neuroprotective Effect of Nourishing Kidney Herbs on Hippocampal Cholinergic System in Alzheimer’s …
  19458. Rho kinase inhibitors-A growing Neuroprotective therapeutic paradigm
  19459. Oligomeric α-synuclein-specific degradation by HtrA2/Omi to bestow a Neuroprotective function
  19460. INVESTIGATION OF Neuroprotective EFFECT OF EXTRACT ON TYPE1 DIABETE INDUCED NEUROPATHIC PAIN PERCEPTION IN RAT
  19461. Neuroprotective Effect of Ethanol Extract of Moringa oleifera Leaf on the Neurofibres of Cerebellum of Quinine-treated Adult Wistar Rats
  19462. Evaluation of Neuroprotective Potential of Some Newly Synthesized Benzopyran-2-One Derivatives in Swiss Albino Mice
  19463. Neuroprotective potential of Viburnum orientale Pallas through enzyme inhibition and antioxidant activity assays
  19464. The Neuroprotective Effects of Targeted Temperature Management on Post-Cardiac Arrest Patients
  19465. Maternal Immune Activation adversely affects the ontogeny of dopamine neurons. Is Vitamin D Neuroprotective ?
  19466. Attenuating the DNA damage response to double strand breaks is Neuroprotective
  19467. Polyester-based microdisc systems for sustained release of Neuroprotective phosphine-borane complexes
  19468. The Neuroprotective effect of Ocimum sanctum Linn. ethanolic extract on human embryonic kidney-293 cells as in vitro model of neurodegenerative disease …
  19469. HPLC-MS Determination and Pharmacokinetic Study of 7, 8-Dihydroxyflavone, a Naturally-Occurring Neuroprotective Agent after a Single Oral Administration in Rats
  19470. Motor Unit Integrity in Pathophysiological States and the Assessment of Potential Neuroprotective Therapeutics
  19471. Influence of Cadmium on Nerve Cells of the brain and the Neuroprotective Effect of Ca2+ Chelator and N-Acetyl-L-Cysteine
  19472. Corrigendum: The Neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats: Contribution of …
  19473. Examining estradiols Neuroprotective abilities and mechanisms of action in cerebrovascular accidents and neurodegenerative conditions
  19474. Simultaneous Occurrence of Bioactive Compounds (Melatonin, Protocatechuic Acid and Hydroxytyrosol) Increases Their Neuroprotective Effects Against Alpha …
  19475. Neuroprotective effect of ATM/ATR inhibitor CGK733 on acrylamide-induced inhibition of cytotoxic effects and neurite outgrowth in PC12 cells
  19476. Preservation of slow wave sleep as a Neuroprotective strategy in aging
  19477. Chemistry of Advanced Materials 3 (2)(2018) 36-59 Antioxidant, Anti-inflammatory and Neuroprotective Activities of a Plant Extract Derived from Traditional Chinese …
  19478. Neuroprotective mechanisms of CB2 cannabinoid receptors and PPAR-α in hypoxia/ischemia-induced brain damage
  19479. Zebrafish upregulate cortisol catabolism as a Neuroprotective coping mechanism in response to waterborne cortisol exposure
  19480. Using C. elegans to Investigate Neuroprotective and Risk-Associated Genes in Alzheimer’s Disease
  19481. STUDY OF Neuroprotective ACTIVITY OF SOME HERBAL DRUG EXTRACT
  19482. Histidine–Tryptophan-–Ketoglutarate Solution as a Neuroprotective Against Ischemia/Reperfusion Injury
  19483. … of chronic neuroinflammation on cognition and behaviour in the GFAP-IL6 transgenic mouse and investigation of the flavonoid apigenin as a Neuroprotective …
  19484. Neuroprotective effects of cultured and fermented wild ginseng extracts on oxidative stress induced by hydrogen peroxide in PC12 cells
  19485. Neuroprotective THERAPY IN A COMPREHENSIVE TREATMENT OF MILD CRANIOCEREBRAL INJURY
  19486. Logical Decision Rules to Assign Neuroprotective Hypothermia Treatment to Infants with Hypoxic Ischemic Encephalopathy
  19487. Mechanistic Insights and Neuroprotective Approaches to Enhance Recovery in Cervical Spondylotic Myelopathy
  19488. Neuroprotective mechanisms of resveratrol in a high-fat diet-fed Alzheimer’s disease mouse model
  19489. Radix Scrophulariae Aqueous Extract Seems to Exert Neuroprotective Effects on Cerebral Ischemia and Reperfusion Injury with Inhibiting Apoptosis via ERK1/2 and p …
  19490. Phytochemical Characterization and Neuroprotective Assessment of Standardized Extract of Pedalium Murex Linn. Leaves
  19491. Neuroprotective effects of carnosic acid
  19492. Neuroprotective effects of low-dose alcohol consumption following transient focal cerebral ischemia
  19493. INTERNATIONAL JOURNAL OF ENGINEERING SCIENCES & RESEARCH TECHNOLOGY STUDY OF Neuroprotective ACTIVITY OF METHANOLIC …
  19494. The Neuroprotective effects of modifying soft coral-derived compound
  19495. Neuroprotective Effects of Dietary Phytoestrogens in an Aging Rodent Model
  19496. Neuroprotective potential of the fruit (acorn) from Quercus coccifera L.
  19497. Comparative Neuroprotective effects of native curcumin and its galactomannoside formulation in carbofuran-induced neurotoxicity model
  19498. The Role of Human α7-Nicotinic Acetylcholine Receptors in Mediating Neuroprotective Action of Curcumin
  19499. Normelatonin is a Neuroprotective factor for postnatal spiral ganglion cells
  19500. Exploring the Neuroprotective function of extracellular vesicles containing small heat-shock proteins (HSPB1 and HSPB8) upon neuroinflammation
  19501. The Neuroprotective effects of music training in epilepsy
  19502. Transcriptional Profiling of the Neuroprotective Mechanisms of Inhaled Nitric Oxide in a Swine Model of Pediatric Cardiac Arrest
  19503. Neuroprotective Effects of Purple Sweet Potato Balinese Cultivar in Wistar Rats With Ischemic Stroke. Open Access Maced J Med Sci
  19504. IGF-II AS A Neuroprotective AND NEUROPLASTIC FACTOR IN AN OXIDATIVE DAMAGE MODEL INDUCED BY GLUCOCORTICOIDS
  19505. Neuroprotective effect of hesperidin on cerebral stroke using cerebral ischemic reperfusion model
  19506. Neuroprotective effect of uric acid in cerebral ischemia-reperfusion injury
  19507. Multiplexed CRISPR activation of Neuroprotective genes for Alzheimer’s Disease
  19508. A combined treatment approach emphasizing Neuroprotective effects in a rat model of anterior ischemic optic neuropathy (rAION)
  19509. Combined Neuroprotective Action of JWH-015 and AM251 in the CA1 Hippocampal Area of Rat Model of Transient Global Cerebral Ischemia
  19510. Some Aspects of Neuroprotective Action of a New Derivative of 3-Methylxanthine (Compound C-3) Under Conditions of Acute Disorder of Cerebral Circulation …
  19511. Neuroprotective roles of fractalkine in multiple sclerosis: Characterization of novel humanized animal model
  19512. Propionic Acid Shapes the Course of Multiple Sclerosis by a Distinct Immunomodulatory and Neuroprotective Mechanism
  19513. P143: The Neuroprotective Effect of Chloroquine in Animal Model of Traumatic brain Injury
  19514. Age‐Dependent Anti‐seizure and Neuroprotective Effect of Cannabidivarin in Neonatal Rats
  19515. Mesenchymal Stem Cells Conditioned Medium as a Source of Neuroprotective Factors
  19516. Topical Curcumin Nanocarriers are Neuroprotective in Rodent Retinal Injury Models
  19517. Neuroprotective EFFECT OF CITICOLINE AND GLUCOCORTICOSTEROID COMBINATION UNDER CONDITIONS OF EXPERIMENTAL …
  19518. Neuroprotective Role of Oxytocin Receptor Signaling in Vascular Dementia
  19519. Neuroprotective signaling mechanisms of telomerase in neuronal cells against oxidative stress
  19520. Effect of Pyridoxine on toxicity of Aminoguanidine and its Neuroprotective effect in Aluminum Chloride induced Dementia in rats
  19521. Microtubule dynamics in Drosophila models of neurodegeneration in search of a Neuroprotective response
  19522. Simplified immunosuppressive and Neuroprotective agents based on gracilin A
  19523. Insights into the molecular aspects of Neuroprotective bacoside A and bacopaside I
  19524. Mechanism of siponimod: anti-inflammatory and Neuroprotective mode of action
  19525. Neuroprotective strategies for neurological disorders by natural products: an update
  19526. Hesperidin as a Neuroprotective agent: a review of animal and clinical evidence
  19527. Neuroprotective effects of the second generation antipsychotics
  19528. Neuroprotective potency of some spice herbs, a literature review
  19529. Are the Neuroprotective effects of exercise training systemically mediated?
  19530. Novel quinolylnitrones combining Neuroprotective and antioxidant properties
  19531. Glycolysis upregulation is Neuroprotective as a compensatory mechanism in ALS
  19532. Molecular mechanisms and cellular events involved in the Neuroprotective actions of estradiol. Analysis of sex differences
  19533. Neuroprotective effect of SCM-198 through stabilizing endothelial cell function
  19534. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders
  19535. The Neuroprotective effects of astaxanthin: therapeutic targets and clinical perspective
  19536. The Neuroprotective mechanisms and effects of sulforaphane
  19537. A review for the Neuroprotective effects of andrographolide in the central nervous system
  19538. Neuropeptides exert Neuroprotective effects in Alzheimer’s disease
  19539. Current drugs and potential future Neuroprotective compounds for Parkinson’s disease
  19540. Potential Neuroprotective treatment of stroke: targeting excitotoxicity, oxidative stress, and inflammation
  19541. Neuroprotective effects of ginseng phytochemicals: recent perspectives
  19542. The Neuroprotective effect of doxycycline on neurodegenerative diseases
  19543. Microglia are an essential component of the Neuroprotective scar that forms after spinal cord injury
  19544. Recent advances in the development of Neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia
  19545. Neuroprotective effects of choline and other methyl donors
  19546. Antioxidant and Neuroprotective potential of the brown seaweed Bifurcaria bifurcata in an in vitro Parkinson’s disease model
  19547. Neuroprotective effects of PPARα in retinopathy of type 1 diabetes
  19548. Mechanism of Neuroprotective effect of mGluR4 agonists
  19549. Single-cell profiles of retinal ganglion cells differing in resilience to injury reveal Neuroprotective genes
  19550. Targeting mast cell as a Neuroprotective strategy
  19551. Recent advances in the Neuroprotective effects of medical gases
  19552. Putative Neuroprotective pharmacotherapies to target the staged progression of mental illness
  19553. Effects of topically administered Neuroprotective drugs in early stages of diabetic retinopathy: results of the EUROCONDOR clinical trial
  19554. Neuroprotective potential and phytochemical composition of acorn fruits
  19555. Erythropoietin as a Neuroprotective molecule: an overview of its therapeutic potential in neurodegenerative diseases
  19556. Neuroprotective offerings by agmatine
  19557. The Neuroprotective activities of natural products through the Nrf2 upregulation
  19558. Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
  19559. Mechanisms of Neuroprotective effects of peptides derived from natural materials and their production and assessment
  19560. The potential of l-type calcium channels as a drug target for Neuroprotective therapy in Parkinson’s disease
  19561. Neuroprotective peptides in retinal disease
  19562. Neuroprotective effects of methylene blue in vivo and in vitro
  19563. Carbazole Alkaloids with Potential Neuroprotective Activities from the Fruits of Clausena lansium
  19564. Neuroprotective effects of antioxidants in the management of neurodegenerative disorders: A literature review
  19565. Pistacia genus as a potential source of Neuroprotective natural products
  19566. On the Neuroprotective effects of naringenin: Pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective
  19567. Design, synthesis and evaluation of pentacycloundecane and hexacycloundecane propargylamine derivatives as multifunctional Neuroprotective agents
  19568. Medicinal plants in traumatic brain injury: Neuroprotective mechanisms revisited
  19569. Neuroprotective and Neurotherapeutic Effects of Tetrahedral Framework Nucleic Acids on Parkinson’s Disease in Vitro
  19570. Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS
  19571. Neuroprotective effects of BHDPC, a novel neuroprotectant, on experimental stroke by modulating microglia polarization
  19572. Neuroprotective effects of exercise in rodent models of memory deficit and Alzheimer’s
  19573. Simultaneous co-delivery of Neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
  19574. miR‑133b is a potential diagnostic biomarker for Alzheimer’s disease and has a Neuroprotective role
  19575. Neuroprotective effects of ginsenosides against cerebral ischemia
  19576. Comparative study on Neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida
  19577. Total Synthesis and Structure Revision of (−)-Illisimonin A, a Neuroprotective Sesquiterpenoid from the Fruits of Illicium simonsii
  19578. The Neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review
  19579. Exploring the multifaceted Neuroprotective actions of Emblica officinalis (Amla): a review
  19580. Astrocytes do not forfeit their Neuroprotective roles after surviving intense oxidative stress
  19581. Identification of a prosurvival Neuroprotective mitochondrial peptide in a mammalian hibernator
  19582. In vitro studies of the Neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ1-42) toxicity and aggregation
  19583. The Neuroprotective effects of micronized PEA (PEA‐m) formulation on diabetic peripheral neuropathy in mice
  19584. MiR-130a exerts Neuroprotective effects against ischemic stroke through PTEN/PI3K/AKT pathway
  19585. Loss of Orai2-Mediated Capacitative Ca2+ Entry Is Neuroprotective in Acute Ischemic Stroke
  19586. Neuroprotective potential of Ginkgo biloba in retinal diseases
  19587. Possible Neuroprotective mechanisms of action involved in the neurobehavioral property of naringin in mice
  19588. Neuroprotective effect of CuATSM on neurotoxin-induced motor neuron loss in an ALS mouse model
  19589. Saffron: A multitask Neuroprotective agent for retinal degenerative diseases
  19590. Envisioning the Neuroprotective effect of metformin in experimental epilepsy: a portrait of molecular crosstalk
  19591. Chaperone Sigma1R mediates the Neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease
  19592. Neuroprotective effect of swertiamain on cerebral ischemia/reperfusion injury by inducing the Nrf2 protective pathway
  19593. Rutin as Neuroprotective agent: from bench to bedside
  19594. Quassinoids from Picrasma quassioides and Their Neuroprotective Effects
  19595. Ceruloplasmin plays a Neuroprotective role in cerebral ischemia
  19596. The Neuroprotective effects of carvacrol on ischemia/reperfusion-induced hippocampal neuronal impairment by ferroptosis mitigation
  19597. Neuroprotective effect of chlorogenic acid in global cerebral ischemia-reperfusion rat model
  19598. Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3β/Nrf2 signaling
  19599. Liraglutide and its Neuroprotective properties—focus on possible biochemical mechanisms in Alzheimer’s disease and cerebral ischemic events
  19600. Synthesis, Neuroprotective and antioxidant capacity of PBN-related indanonitrones
  19601. Neuroprotective role of the Nrf2 pathway in subarachnoid haemorrhage and its therapeutic potential
  19602. Chemistry-oriented synthesis (ChOS) and target deconvolution on Neuroprotective effect of a novel scaffold, oxaza spiroquinone
  19603. Neuroprotective effects of bergenin in Alzheimer’s disease: Investigation through molecular docking, in vitro and in vivo studies
  19604. Neuroprotective effects of anthraquinones from rhubarb in central nervous system diseases
  19605. Computational systems pharmacology reveals an antiplatelet and Neuroprotective mechanism of Deng-Zhan-Xi-Xin injection in the treatment of ischemic stroke
  19606. Neurotoxic and Neuroprotective role of exosomes in Parkinson’s disease
  19607. Neuroprotective effects of oleic acid in rodent models of cerebral ischaemia
  19608. The Neuroprotective effects of melatonin: Possible role in the pathophysiology of neuropsychiatric disease
  19609. Investigation of the Neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer’s disease
  19610. Neuroprotective effects of cyclosporine in a porcine pre-clinical trial of focal traumatic brain injury
  19611. Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies
  19612. Promising Neuroprotective effects of β-caryophyllene against LPS-induced oligodendrocyte toxicity: A mechanistic study
  19613. Neuroprotective effects of Ellagic acid against acrylamide-induced neurotoxicity in rats
  19614. Bone marrow mesenchymal stem cells’ secretome exerts Neuroprotective effects in a Parkinson’s disease rat model
  19615. Cromolyn sodium delays disease onset and is Neuroprotective in the SOD1 G93A Mouse Model of amyotrophic lateral sclerosis
  19616. Activation of Nrf2 by costunolide provides Neuroprotective effect in PC12 cells
  19617. Uncovering the Neuroprotective mechanisms of curcumin on transthyretin amyloidosis
  19618. The Neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K/AKT and IKK/IκBα/NF-κB pathway
  19619. Semisynthesis of the Neuroprotective metabolite, serofendic acid
  19620. Neuroprotective role of vitamin D in primary neuronal cortical culture
  19621. Neuroprotective effects of anthocyanins and its major component cyanidin-3-O-glucoside (C3G) in the central nervous system: An outlined review
  19622. Neuroprotective effect of cardamom oil against aluminum induced neurotoxicity in rats
  19623. Neuroprotective mechanisms of 3‑n‑butylphthalide in neurodegenerative diseases
  19624. Neuroprotective actions of glucagon-like peptide-1 (GLP-1) analogues in Alzheimer’s and Parkinson’s diseases
  19625. Neuroprotective effects of irisin against cerebral ischemia/reperfusion injury via Notch signaling pathway
  19626. In vitro characterization of gut microbiota-derived bacterial strains with Neuroprotective properties
  19627. Lactobacillus acidophilus Exerts Neuroprotective Effects in Mice with Traumatic brain Injury
  19628. Aromatic constituents from Ganoderma lucidum and their Neuroprotective and anti-inflammatory activities
  19629. Angiopoietin: a novel Neuroprotective /neurotrophic agent
  19630. Intranasally administered exosomes from umbilical cord stem cells have preventive Neuroprotective effects and contribute to functional recovery after perinatal brain …
  19631. Chemical composition and in vitro Neuroprotective activity of fibre-type Cannabis sativa L.(hemp)
  19632. Baicalein exerts Neuroprotective effects in FeCl3-induced posttraumatic epileptic seizures via suppressing ferroptosis
  19633. Neuroprotective effects of rapamycin on spinal cord injury in rats by increasing autophagy and Akt signaling
  19634. Neuroprotective effects of brain -gut peptides: a potential therapy for Parkinson’s disease
  19635. The Neuroprotective role of coenzyme Q10 against lead acetate-induced neurotoxicity is mediated by antioxidant, anti-inflammatory and anti-apoptotic activities
  19636. Molecular insights into NR4A2 (Nurr1): an emerging target for Neuroprotective therapy against neuroinflammation and neuronal cell death
  19637. Curcumin- and Fish Oil-Loaded Spongosome and Cubosome Nanoparticles with Neuroprotective Potential against H2O2-Induced Oxidative Stress in Differentiated …
  19638. Blood–brain barrier transport and Neuroprotective potential of blackberry-digested polyphenols: an in vitro study
  19639. Immunomodulation as a Neuroprotective strategy for glaucoma treatment
  19640. Assessing Neuroprotective agents for aβ-induced neurotoxicity
  19641. Neuroprotective effects of memantine via enhancement of autophagy
  19642. Pleiotropic Neuroprotective effects of taxifolin in cerebral amyloid angiopathy
  19643. New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective (Z)-N-tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead …
  19644. Applications of liposomal drug delivery systems to develop Neuroprotective agents for the treatment of ischemic stroke
  19645. Neuroprotective effects of thymoquinone in acrylamide-induced peripheral nervous system toxicity through MAPKinase and apoptosis pathways in rat
  19646. Isorhamnetin exerts Neuroprotective effects in STZ-induced diabetic rats via attenuation of oxidative stress, inflammation and apoptosis
  19647. An active cognitive lifestyle as a potential Neuroprotective factor in Huntington’s disease
  19648. Neuroprotective effects of curcumin on IL-1β-induced neuronal apoptosis and depression-like behaviors caused by chronic stress in rats
  19649. A systematic review of Neuroprotective efficacy and safety of DL-3-N-Butylphthalide in ischemic stroke
  19650. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer’s disease induced by β-amyloid 1-42 peptide in aged female mice
  19651. Neuroprotective effects of a catalytic antioxidant in a rat nerve agent model
  19652. Neuroprotective effect of placenta‐derived mesenchymal stromal cells: role of exosomes
  19653. Neuroprotective and anti-inflammatory effects of a hydrophilic saffron extract in a model of glaucoma
  19654. Discovery of novel benzofuran-based compounds with Neuroprotective and immunomodulatory properties for Alzheimer’s disease treatment
  19655. Antineuroinflammatory and Neuroprotective effects of Gyejibokryeong-Hwan in lipopolysaccharide-stimulated BV2 microglia
  19656. Neuroprotective and antioxidant effect of naringenin-loaded nanoparticles for nose-to-brain delivery
  19657. … effects of traditional Chinese medicines on preclinical in vivo models of brain ischemia-reperfusion-injury: prospects for Neuroprotective drug discovery and …
  19658. Neuroprotective effects of serpina3k in traumatic brain injury
  19659. Neuroprotective effects of Brazilian green propolis on oxytosis/ferroptosis in mouse hippocampal HT22 cells
  19660. ERK activation by zeranol has Neuroprotective effect in cerebral ischemia reperfusion
  19661. Guaiane-Type Sesquiterpenoids from the Roots of Daphne genkwa and Evaluation of Their Neuroprotective Effects
  19662. Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and Neuroprotective agents
  19663. Novel positive allosteric modulators of glutamate transport have Neuroprotective properties in an in vitro excitotoxic model
  19664. Anticonvulsant and Neuroprotective effects of paeonol in epileptic rats
  19665. Hispidulin exhibits Neuroprotective activities against cerebral ischemia reperfusion injury through suppressing NLRP3-mediated pyroptosis
  19666. Post-injury Neuroprotective effects of the thalidomide analog 3, 6′-dithiothalidomide on traumatic brain injury
  19667. Sodium butyrate exerts Neuroprotective effects in spinal cord injury
  19668. Neuroprotective and antinociceptive effects of rosemary (Rosmarinus officinalis L.) extract in rats with painful diabetic neuropathy
  19669. Neuroprotective potential of curcumin-loaded nanostructured lipid carrier in an animal model of Alzheimer’s disease: behavioral and biochemical evidence
  19670. The Neuroprotective effects of curcumin are associated with the regulation of the reciprocal function between autophagy and HIF-1α in cerebral ischemia …
  19671. An overview of the Neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating …
  19672. Mechanism of the Neuroprotective effect of GLP-1 in a rat model of Parkinson’s with pre-existing diabetes
  19673. Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation
  19674. Egg yolk phosphatidylcholine: Extraction, purification and its potential Neuroprotective effect on PC12 cells
  19675. Evidence on Neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
  19676. The selective GSK3 inhibitor, SAR502250, displays Neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of …
  19677. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer’s disease
  19678. Synthesis and Neuroprotective Properties of N-Substituted C-Dialkoxyphosphorylated Nitrones
  19679. The bile acids urso-and tauroursodeoxycholic acid as Neuroprotective therapies in retinal disease
  19680. LncRNA SNHG12 as a potent autophagy inducer exerts Neuroprotective effects against cerebral ischemia/reperfusion injury
  19681. Neuroprotective Effect of Ginkgo Biloba Extract Against Hypoxic Retinal Ganglion Cell Degeneration In Vitro and In Vivo
  19682. Wnt‐induced activation of glucose metabolism mediates the in vivo Neuroprotective roles of Wnt signaling in Alzheimer disease
  19683. Liraglutide and a lipidized analog of prolactin-releasing peptide show Neuroprotective effects in a mouse model of β-amyloid pathology
  19684. Neuroprotective effects of andrographolide derivative CX-10 in transient focal ischemia in rat: Involvement of Nrf2/AE and TLR/NF-κB signaling
  19685. Neuroprotective effect of ethanol and Modafinil on focal cerebral ischemia in rats
  19686. Long-term, targeted delivery of GDNF from encapsulated cells is Neuroprotective and reduces seizures in the pilocarpine model of epilepsy
  19687. Neuroprotective benefits of antidepressants in multiple sclerosis: are we missing the mark?
  19688. Potential Neuroprotective effect of miR-451 against cerebral ischemia/reperfusion injury in stroke patients and a mouse model
  19689. Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric Neuroprotective PSD-95 inhibitor
  19690. Evaluation of the Neuroprotective effect of Sirt3 in experimental stroke
  19691. Combined anti-inflammatory and Neuroprotective treatments have the potential to impact disease phenotypes in Cln3−/− mice
  19692. Neuroprotective effect of Vanillin on hypoxic-ischemic brain damage in neonatal rats
  19693. New iridoid derivatives from the fruits of Cornus officinalis and their Neuroprotective activities
  19694. Network based statistics reveals trophic and Neuroprotective effect of early high dose erythropoetin on brain connectivity in very preterm infants
  19695. Mesenchymal stem cells provide paracrine Neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures
  19696. Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia
  19697. Antiaging, stress resistance, and Neuroprotective efficacies of Cleistocalyx nervosum var. paniala fruit extracts using Caenorhabditis elegans model
  19698. Multi-targeted ChEI-copper chelating molecules as Neuroprotective agents
  19699. Neuroprotective effect of nerve growth factor loaded in porous silicon nanostructures in an Alzheimer’s Disease model and potential delivery to the brain
  19700. Australeols A− F, Neuroprotective meroterpenoids from Ganoderma australe
  19701. Neuroprotective effects of HSF1 in retinal ischemia-reperfusion injury
  19702. Restriction of mitochondrial calcium overload by mcu inactivation renders a Neuroprotective effect in zebrafish models of Parkinson’s disease
  19703. Neuroprotective effects of Scrophularia buergeriana extract against glutamate-induced toxicity in SH-SY5Y cells
  19704. Neuroprotective effects of inter-alpha inhibitor proteins after hypoxic-ischemic brain injury in neonatal rats
  19705. Efficacy of Neuroprotective drugs in acute ischemic stroke: Is it helpful?
  19706. Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and Neuroprotective effects against stroke
  19707. Computational and in-vitro validation of natural molecules as potential acetylcholinesterase inhibitors and Neuroprotective agents
  19708. Functional and Neuroprotective Role of Striatal Adenosine A2A Receptor Heterotetramers
  19709. Lutein prevents corticosterone-induced depressive-like behavior in mice with the involvement of antioxidant and Neuroprotective activities
  19710. Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson’s disease therapeutics
  19711. Neuroprotective action of diazepam at very low and moderate doses in Alzheimer’s disease model rats
  19712. Semaglutide is Neuroprotective and reduces α-synuclein levels in the chronic MPTP mouse model of Parkinson’s disease
  19713. Neuroprotective effect of ginkgetin in experimental cerebral ischemia/reperfusion via apoptosis inhibition and PI3K/Akt/mTOR signaling pathway activation
  19714. Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach
  19715. The Neuroprotective effect of hemin and the related mechanism in sevoflurane exposed neonatal rats
  19716. Neuroprotective effects of different frequency preconditioning exercise on neuronal apoptosis after focal brain ischemia in rats
  19717. Retinal neurodegeneration as an early manifestation of diabetic eye disease and potential Neuroprotective therapies
  19718. A positive allosteric modulator of mGluR5 promotes Neuroprotective effects in mouse models of Alzheimer’s disease
  19719. Mitochondria and Neuroprotection in stroke: cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted Neuroprotective therapeutics
  19720. Neuroprotective effects of the new Na channel blocker rs100642 in global ischemic brain injury
  19721. Palmitic acid methyl ester is a novel Neuroprotective agent against cardiac arrest
  19722. Neuroprotective effects of the amylin analog, pramlintide, on Alzheimer’s disease are associated with oxidative stress regulation mechanisms
  19723. Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of cerium oxide nanoparticles stabilized with various ratios of citric acid and EDTA
  19724. Neuroprotective effects of targeting BET proteins for degradation with dBET1 in aged mice subjected to ischemic stroke
  19725. Glycyrrhizin, an HMGB1 inhibitor, exhibits Neuroprotective effects in rats after lithium‐pilocarpine‐induced status epilepticus
  19726. Neuroprotective Effects and Hepatorenal Toxicity of Angong Niuhuang Wan Against Ischemia–Reperfusion brain Injury in Rats
  19727. Old age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent Neuroprotective compound from Yerba santa
  19728. Neuroplasticity and Neuroprotective effect of treadmill training in the chronic mouse model of Parkinson’s disease
  19729. Neuroprotective effects of PACAP against paraquat-induced oxidative stress in the Drosophila central nervous system
  19730. Comprehensive evaluation of effective polyphenols in apple leaves and their combinatory antioxidant and Neuroprotective activities
  19731. HDAC1 silence promotes Neuroprotective effects of human umbilical cord-derived mesenchymal stem cells in a mouse model of traumatic brain injury via …
  19732. Neuroprotective effects of curcumin against rats with focal cerebral ischemia-reperfusion injury
  19733. The Neuroprotective role of the GM1 oligosaccharide, II 3 Neu5Ac-Gg 4, in Neuroblastoma cells
  19734. The Neuroprotective effect of Hericium erinaceus extracts in mouse hippocampus after pilocarpine-induced status epilepticus
  19735. Neuroprotective effect of l-serine against white matter demyelination by harnessing and modulating inflammation in mice
  19736. Neuroprotective effects and mechanisms of zhenlong xingnao capsule in in vivo and in vitro models of hypoxia
  19737. Evaluation of the Neuroprotective and antioxidant effects of Dorema aucheri extract on cerebral ischaemia-reperfusion injury in rats
  19738. Neuroprotective effects of baicalein in animal models of Parkinson’s disease: A systematic review of experimental studies
  19739. Neuroprotective effects of gabapentin against cerebral ischemia reperfusion-induced neuronal autophagic injury via regulation of the PI3K/Akt/mTOR signaling …
  19740. Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE/BuChE and oxidative stress
  19741. The Neuroprotective effect of astaxanthin on pilocarpine-induced status epilepticus in rats
  19742. Phomopsols A and B from the Mangrove Endophytic Fungus Phomopsis sp. xy21: Structures, Neuroprotective Effects, and Biogenetic Relationships
  19743. Catalpol exerts a Neuroprotective effect in the MPTP mouse model of Parkinson’s disease
  19744. Neuroprotective effects of human bone marrow mesenchymal stem cells against cerebral ischemia are mediated in part by an anti-apoptotic mechanism
  19745. Are glutamate transporters Neuroprotective or neurodegenerative during cerebral ischemia?
  19746. Potential Neuroprotective and anti-inflammatory effects provided by omega-3 (DHA) against Zika virus infection in human SH-SY5Y cells
  19747. Glycine exhibits Neuroprotective effects in ischemic stroke in rats through the inhibition of M1 microglial polarization via the NF-κB p65/Hif-1α signaling pathway
  19748. Neuroprotective effect of glycosides in Buyang Huanwu Decoction on pyroptosis following cerebral ischemia-reperfusion injury in rats
  19749. Astragaloside IV supplementation promotes a Neuroprotective effect in experimental models of neurological disorders: a systematic review
  19750. Triterpenes and aromatic meroterpenoids with antioxidant activity and Neuroprotective effects from Ganoderma lucidum
  19751. Nanoceria Neuroprotective effects in the light-damaged retina: A focus on retinal function and microglia activation
  19752. Fumaric acids directly influence gene expression of Neuroprotective factors in rodent microglia
  19753. Neuroprotective effects of minocycline and progesterone on white matter injury after focal cerebral ischemia
  19754. Neuroprotective effects of microglial P2Y1 receptors against ischemic neuronal injury
  19755. Antioxidant and Neuroprotective effects of lycopene and insulin in the hippocampus of streptozotocin‑induced diabetic rats
  19756. Neuroprotective effect of Neuro-EPO in neurodegenerative diseases:“Alea jacta est”
  19757. Comprehensive chemical profiling of Yindan Xinnaotong soft capsule and its Neuroprotective activity evaluation in vitro
  19758. Moxibustion exerts a Neuroprotective effect through antiferroptosis in Parkinson’s disease
  19759. Hypoxia conditioning enhances Neuroprotective effects of aged human bone marrow mesenchymal stem cell-derived conditioned medium against cerebral ischemia …
  19760. Annexin A1 as Neuroprotective determinant for blood-brain barrier integrity in neonatal hypoxic-ischemic encephalopathy
  19761. Neuroprotective role of selected antioxidant agents in preventing cisplatin-induced damage of human neurons in vitro
  19762. … polyprenylated acylphloroglucinol and phenolic metabolites from the aerial parts of Hypericum elatoides and their Neuroprotective and anti-neuroinflammatory …
  19763. Posttreatment intervention with lycium barbarum polysaccharides is Neuroprotective in a rat model of chronic ocular hypertension
  19764. A pharmacological appraisal of Neuroprotective and neurorestorative flavonoids against neurodegenerative diseases
  19765. New Neuroprotective perspectives in fighting oxidative stress and improving cellular energy metabolism by oleocanthal
  19766. Effect of α-glucosylation on the stability, antioxidant properties, toxicity, and Neuroprotective activity of (–)-epigallocatechin gallate
  19767. Pretreatment of grape seed proanthocyanidin extract exerts Neuroprotective effect in murine model of neonatal hypoxic-ischemic brain injury by its antiapoptotic …
  19768. Neuroprotective effect of echinacoside in subacute mouse model of Parkinson’s disease
  19769. The Neuroprotective role of Origanum syriacum L. and Lavandula dentata L. essential oils through their effects on AMPA receptors
  19770. Neuroprotective effects of ginsenoside Rg1 against hyperphosphorylated tau-induced diabetic retinal neurodegeneration via activation of IRS-1/akt/gsk3β signaling
  19771. Phenolic constituents with Neuroprotective activities from Hypericum wightianum
  19772. Nafamostat and sepimostat identified as novel Neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity …
  19773. Strength training and running elicit different Neuroprotective outcomes in a β-amyloid peptide-mediated Alzheimer’s disease model
  19774. Combination of schisandrin and nootkatone exerts Neuroprotective effect in Alzheimer’s disease mice model
  19775. Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: effect on glucose transporter-1 and GAP43 expression
  19776. Targeted delivery of intranasally administered nanoparticles-mediated Neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke
  19777. Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration
  19778. An update on the anxiolytic and Neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action
  19779. FoxO1-mediated autophagy plays an important role in the Neuroprotective effects of hydrogen in a rat model of vascular dementia
  19780. Antiseizure and Neuroprotective effects of delayed treatment with midazolam in a rodent model of organophosphate exposure
  19781. Neuroprotective effects of Withania somnifera in BPA induced-cognitive dysfunction and oxidative stress in mice
  19782. Seven new Neuroprotective sesquineolignans isolated from the seeds of Crataegus pinnatifida
  19783. Neuroprotective role of naringenin against methylmercury induced cognitive impairment and mitochondrial damage in a mouse model
  19784. Neuroprotective effect of Schisandra chinensis on methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonian syndrome in C57BL/6 Mice
  19785. Neuroprotective effect of naringenin against MPTP-induced oxidative stress
  19786. Macrophage migration inhibitory factor mediates Neuroprotective effects by regulating inflammation, apoptosis and autophagy in Parkinson’s disease
  19787. Neuroprotective effect of β-lapachone in MPTP-induced Parkinson’s disease mouse model: involvement of astroglial p-AMPK/Nrf2/HO-1 signaling pathways
  19788. Neuroprotective effects of an engineered commensal bacterium in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine Parkinson disease mouse model via producing …
  19789. The locus coeruleus Neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer’s disease
  19790. Neuroprotective autophagic flux induced by hyperbaric oxygen preconditioning is mediated by cystatin C
  19791. The Neuroprotective effect of vitamin E on waterpipe tobacco smoking-induced memory impairment: The antioxidative role
  19792. Abundant Neuroprotective chaperone Lipocalin-type prostaglandin D synthase (L-PGDS) disassembles the Amyloid-β fibrils
  19793. Adalimumab improves cognitive impairment, exerts Neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer’s …
  19794. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson’s disease
  19795. GM1 ganglioside modifies α-synuclein toxicity and is Neuroprotective in a rat α-synuclein model of parkinson’s disease
  19796. Amentoflavone affects epileptogenesis and exerts Neuroprotective effects by inhibiting NLRP3 inflammasome
  19797. Polyphenolic composition, antibacterial, modulator and Neuroprotective activity of Tarenaya spinosa (Jacq.) Raf.(Cleomaceae)
  19798. Cordycepin exerts Neuroprotective effects via an anti-apoptotic mechanism based on the mitochondrial pathway in a rotenone-induced parkinsonism rat model
  19799. Neuroprotective role of dexmedetomidine in epilepsy surgery: A preliminary study
  19800. Targeting Smox is Neuroprotective and ameliorates brain inflammation in cerebral ischemia/reperfusion rats
  19801. Neuroprotective effect of insulin-loaded chitosan nanoparticles/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats
  19802. Donepezil ameliorates oxaliplatin-induced peripheral neuropathy via a Neuroprotective effect
  19803. Neuroprotective effects of thymol, a dietary monoterpene against dopaminergic neurodegeneration in rotenone-induced rat model of Parkinson’s disease
  19804. Piperine as a Neuroprotective functional component in rats with cerebral ischemic injury
  19805. Bone marrow mesenchymal stem cell transplantation exerts Neuroprotective effects following cerebral ischemia/reperfusion injury by inhibiting autophagy via the PI3K …
  19806. Neuroprotective potential of GDF11 in experimental intracerebral hemorrhage in elderly rats
  19807. Ethanol extract of centipeda minima exerts antioxidant and Neuroprotective effects via activation of the Nrf2 signaling pathway
  19808. Opposite effects of Neuroprotective cannabinoids, palmitoylethanolamide, and 2-arachidonoylglycerol on function and morphology of microglia
  19809. The Neuroprotective Effects of Necrostatin-1 on Subarachnoid Hemorrhage in Rats Are Possibly Mediated by Preventing Blood–brain Barrier Disruption and RIP3 …
  19810. Region-specific Neuroprotective features of astrocytes against oxidative stress induced by 6-hydroxydopamine
  19811. The Neuroprotective effects of novel estrogen receptor GPER1 in mouse retinal ganglion cell degeneration
  19812. The dual Neuroprotective -neurotoxic effects of sevoflurane after hemorrhagic shock injury
  19813. Neuroprotective protein hydrolysates from hemp (Cannabis sativa L.) seeds
  19814. Dose-dependent Neuroprotective effect of standardized bee venom phospholipase A2 against MPTP-induced Parkinson’s disease in mice
  19815. Neuroprotective effect of natural alkaloid fangchinoline against oxidative glutamate toxicity: involvement of keap1-Nrf2 axis regulation
  19816. Neuroprotective effect of astaxanthin on newborn rats exposed to prenatal maternal seizures
  19817. Neuroprotective effects of Spinosin on recovery of learning and memory in a mouse model of Alzheimer’s disease
  19818. Neuroprotective role of icariin in experimental spinal cord injury via its antioxidant, anti‑neuroinflammatory and anti‑apoptotic properties
  19819. Neuroprotective effects of a Rhodiola crenulata extract on amyloid-β peptides (Aβ1-42)-induced cognitive deficits in rat models of Alzheimer’s disease
  19820. Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a Neuroprotective strategy
  19821. The Neuroprotective effect of agmatine against amyloid β-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt/GSK-3β, and TNF-α
  19822. Glutamate dehydrogenase as a Neuroprotective target against neurodegeneration
  19823. Metabolomic study of hibernating syrian hamster brain s: in search of Neuroprotective agents
  19824. The possible Neuroprotective role of grape seed extract on the histopathological changes of the cerebellar cortex of rats prenatally exposed to Valproic Acid: Animal …
  19825. The NLRP3 inflammasome is involved in the Neuroprotective mechanism of neural stem cells against microglia-mediated toxicity in SH-SY5Y cells via the attenuation …
  19826. Potential Neuroprotective peptide emerged from dual neurotherapeutic targets: a fusion approach for the development of anti-alzheimer’s lead
  19827. Neuroprotective effect of catechins derivatives isolated from Anhua dark tea on NMDA-induced excitotoxicity in SH-SY5Y cells
  19828. Rheumatoid arthritis induces enteric neurodegeneration and jejunal inflammation, and quercetin promotes Neuroprotective and anti-inflammatory actions
  19829. Neuroprotective effect of salidroside against central nervous system inflammation‐induced cognitive deficits: A pivotal role of sirtuin 1‐dependent N rf‐2/HO‐1/NF‐κ B …
  19830. Crocin acting as a Neuroprotective agent against methamphetamine-induced neurodegeneration via CREB-BDNF signaling pathway
  19831. Promising Neuroprotective function for M2 microglia in Kainic Acid-induced neurotoxicity via the down-regulation of NF-κB and caspase 3 signaling pathways
  19832. Gadd45b acts as Neuroprotective effector in global ischemia-induced neuronal death
  19833. The Neuroprotective role of melatonin in a gestational hypermethioninemia model
  19834. Isolation and purification of a Neuroprotective phlorotannin from the marine algae Ecklonia maxima by size exclusion and high-speed counter-current chromatography
  19835. … , and three-dimensional quantitative structure–activity relationship (3D-QSAR) of Sigma1 receptor ligands, analogs of the Neuroprotective agent RC-33
  19836. Structure and Neuroprotective Effect of Polysaccharide from Viscera Autolysates of Squid Ommastrephes bartrami
  19837. Neuroprotective effects of glucomoringin-isothiocyanate against H2O2-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells
  19838. Neuroprotective effects of isoliquiritigenin against cognitive impairment via suppression of synaptic dysfunction, neuronal injury, and neuroinflammation in rats with …
  19839. Assessing retinal ganglion cell death and Neuroprotective agents using real time imaging
  19840. Fine-tuning the Neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction
  19841. Novel cannabis flavonoid, cannflavin A displays both a hormetic and Neuroprotective profile against amyloid β-mediated neurotoxicity in PC12 cells: Comparison with …
  19842. Synthesis of Forsythenethoside A, a Neuroprotective Macrocyclic Phenylethanoid Glycoside, and NMR Analysis of Conformers
  19843. Neuroprotective effect of dichloromethane extraction from piper nigrum L. and piper longum L. on permanent focal cerebral ischemia injury in rats
  19844. Targeting the brain with a Neuroprotective omega-3 fatty acid to enhance neurogenesis in hypoxic condition in culture
  19845. In Vitro and in vivo Neuroprotective effects of stellettin B through anti-apoptosis and the Nrf2/HO-1 pathway
  19846. The possible Neuroprotective effects of melatonin in aluminum chloride-induced neurotoxicity via antioxidant pathway and Nrf2 signaling apart from metal chelation
  19847. Eplingiella fruticosa leaf essential oil complexed with β-cyclodextrin produces a superior Neuroprotective and behavioral profile in a mice model of Parkinson’s …
  19848. Neuroprotective effects of AG490 in neonatal hypoxic-ischemic brain injury
  19849. Dopamine neuron induction and the Neuroprotective effects of thyroid hormone derivatives
  19850. Neuroprotective effect of tanshinone IIA-incubated mesenchymal stem cells on Aβ25-35-induced neuroinflammation
  19851. Aminoalkyl-substituted flavonoids: synthesis, cholinesterase inhibition, β-amyloid aggregation, and Neuroprotective study
  19852. Antidepressant and Neuroprotective effects of naringenin via sonic hedgehog-GLI1 cell signaling pathway in a rat model of chronic unpredictable mild stress
  19853. Neuroprotective effects of berberine on recognition memory impairment, oxidative stress, and damage to the purinergic system in rats submitted to …
  19854. Nestorone exerts long-term Neuroprotective effects against transient focal cerebral ischemia in adult male rats
  19855. Synergistic effects of curcumin and piperine as potent acetylcholine and amyloidogenic inhibitors with significant Neuroprotective activity in SH-SY5Y cells via …
  19856. Discovery of arylbenzylamines as PDE4 inhibitors with potential Neuroprotective effect
  19857. Prophylactic Neuroprotective propensity of Crocin, a carotenoid against rotenone induced neurotoxicity in mice: behavioural and biochemical evidence
  19858. Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and …
  19859. Neuroprotective effect of Dictyopteris divaricata extract-capped gold nanoparticles against oxygen and glucose deprivation/reoxygenation
  19860. Neuroprotective Secondary Metabolite Produced by an Endophytic Fungus, Neosartorya fischeri JS0553, Isolated from Glehnia littoralis
  19861. Breviscapine provides a Neuroprotective effect after traumatic brain injury by modulating the Nrf2 signaling pathway
  19862. Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts Neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the …
  19863. A novel microtubule-tau association enhancer and Neuroprotective drug candidate: Ac-SKIP
  19864. Aronia melanocarpa (Michx.) Elliot fruit juice reveals Neuroprotective effect and improves cognitive and locomotor functions of aged rats
  19865. The sour side of vitamin C might mediate Neuroprotective , anticonvulsive and antidepressant-like effects
  19866. Neuroprotective effects of mildronate in a rat model of traumatic brain injury
  19867. In Silico Approach for Designing Potent Neuroprotective Hexapeptide
  19868. Synthesis of new proteomimetic quinazolinone alkaloids and evaluation of their Neuroprotective and antitumor effects
  19869. The Neuroprotective effect of amitriptyline on radiation-induced impairment of hippocampal neurogenesis
  19870. Synergistic properties of bioavailable phenolic compounds from olive oil: Electron transfer and Neuroprotective properties
  19871. Neuroprotective and anti-inflammatory effects of isoliquiritigenin in kainic acid-induced epileptic rats via the TLR4/MYD88 signaling pathway
  19872. Building your best day for healthy brain aging—The Neuroprotective effects of optimal time use
  19873. Genistein: Mechanisms of action for a pleiotropic Neuroprotective agent in stroke
  19874. Preclinical evaluation of long-term Neuroprotective effects of BDNF-engineered mesenchymal stromal cells as intravitreal therapy for chronic retinal degeneration in …
  19875. The Neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet …
  19876. In vitro Neuroprotective activities of two distinct probiotic consortia
  19877. Neuroprotective role of hyperforin on aluminum maltolate-induced oxidative damage and apoptosis in PC12 cells and SH-SY5Y cells
  19878. Neuroprotective effects of some seaweeds against Zn–induced neuronal damage in HT-22 cells via modulation of redox imbalance, inhibition of apoptosis and …
  19879. Oleanolic acid exerts a Neuroprotective effect against microglial cell activation by modulating cytokine release and antioxidant defense systems
  19880. Neuroprotective mechanisms of dieckol against glutamate toxicity through reactive oxygen species scavenging and nuclear factor-like 2/heme oxygenase-1 …
  19881. P2Y6 and P2X7 receptor antagonism exerts Neuroprotective /neuroregenerative effects in an animal model of Parkinson’s disease
  19882. G protein-coupled estrogen receptor is involved in the Neuroprotective effect of IGF-1 against MPTP/MPP+-induced dopaminergic neuronal injury
  19883. Neuroprotective mitochondrial remodeling by AKAP121/PKA protects HT22 cell from glutamate-induced oxidative stress
  19884. Neuroprotective effects of exercise on the morphology of somatic motoneurons following the death of neighboring motoneurons
  19885. Neuroprotective effects of EpoL against oxidative stress induced by soluble oligomers of Aβ peptide
  19886. Umbelliferone derivatives exert Neuroprotective effects by inhibiting monoamine oxidase A, self-amyloidβ aggregation, and lipid peroxidation
  19887. Synthesis, characterization, theoretical studies and biological (antioxidant, anticancer, toxicity and Neuroprotective ) determinations of a copper (II) complex …
  19888. MLN4924 exerts a Neuroprotective effect against oxidative stress via Sirt1 in spinal cord ischemia-reperfusion injury
  19889. Ivabradine possesses anticonvulsant and Neuroprotective action in mice
  19890. CXCR7: A key Neuroprotective molecule against alarmin HMGB1 mediated CNS pathophysiology and subsequent memory impairment
  19891. Evaluation of antidiabetic, dermatoprotective, Neuroprotective and antioxidant activities of Chrysanthemum fontanesii flowers and leaves extracts
  19892. Neuroprotective effects of increasing levels of HSP70 against neuroinflammation in Parkinson’s disease model by inhibition of NF-κB and STAT3
  19893. Neuroprotective effects of different molecular weight peptide fractions obtained from beef by hydrolysis with commercial enzymes in SH-SY5Y cells
  19894. Low molecular weight sulfated chitosan: Neuroprotective effect on rotenone-induced in vitro Parkinson’s disease
  19895. Targeting PSD95-nNOS interaction by Tat-N-dimer peptide during status epilepticus is Neuroprotective in MAM-pilocarpine rat model
  19896. Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson’s disease
  19897. Neuroprotective effect of FMS-like tyrosine kinase-3 silence on cerebral ischemia/reperfusion injury in a SH-SY5Y cell line
  19898. Chiral resolution and Neuroprotective activities of enantiomeric dihydrobenzofuran neolignans from the fruit of Crataegus pinnatifida
  19899. Chiral resolution and Neuroprotective activities of enantiomeric 8-O-4′ neolignans from the fruits of Crataegus pinnatifida Bge
  19900. Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson’s disease model of mice
  19901. Enduring Neuroprotective effect of subacute neural stem cell transplantation after penetrating TBI
  19902. EPO regulates Neuroprotective Transmembrane BAX Inhibitor-1 Motif-containing (TMBIM) family members GRINA and FAIM2 after cerebral ischemia-reperfusion …
  19903. Neuroprotective triterpene saponins from the leaves of Panax notoginseng
  19904. Neuroprotective potential of pituitary adenylate cyclase activating polypeptide in retinal degenerations of metabolic origin
  19905. The Neuroprotective effect of mesenchymal stem cells is mediated through inhibition of apoptosis in hypoxic ischemic injury
  19906. Neuroprotective effects of Astilbin on MPTP-induced Parkinson’s disease mice: Glial reaction, α-synuclein expression and oxidative stress
  19907. In vivo effects of single or combined topical Neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model
  19908. Neuroprotective influence of sitagliptin against cisplatin-induced neurotoxicity, biochemical and behavioral alterations in Wistar rats
  19909. Neuroprotective effect of miR-410-3p against sevoflurane anesthesia-induced cognitive dysfunction in rats through PI3K/Akt signaling pathway via targeting C–X–C …
  19910. … and Multidirectional Biological Investigation of Two Wild Anthemis Species (Anthemis tinctoria var. Pallida and A. cretica subsp. tenuiloba): Focus on Neuroprotective …
  19911. The heme oxygenase/biliverdin reductase system as effector of the Neuroprotective outcomes of herb-based nutritional supplements
  19912. The Neuroprotective action of 3, 3′-diindolylmethane against ischemia involves an inhibition of apoptosis and autophagy that depends on HDAC and AhR …
  19913. Linear Peptides Containing d-Leucine with Neuroprotective Activities from the Leech Whitmania pigra Whitman
  19914. Antioxidant, anti-inflammatory, and Neuroprotective effects of novel vinyl sulfonate compounds as Nrf2 activator
  19915. Hepatoprotective and Neuroprotective flavanes from the fruits of Ulmus pumila L.(Ulmaceae).
  19916. Neuroprotective agents in acute ischemic stroke-a reality check
  19917. Selective head cooling and whole body cooling as Neuroprotective agents in severe perinatal asphyxia
  19918. Neuroprotective effects of salidroside on cerebral ischemia/reperfusion-induced behavioral impairment involves the dopaminergic system
  19919. Neuroprotective effects of flavonoid compounds on neuronal death associated to alzheimer’s disease
  19920. Neuroprotective effect of citicoline eye drops on corneal sensitivity after lasik
  19921. Network pharmacology for antiepileptogenesis: tolerability and Neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status …
  19922. Neuroprotective and memory -Enhancing Effects of Antioxidant Peptide From Walnut (Juglans regia L.) Protein Hydrolysates
  19923. Cytotoxic and Neuroprotective activities of constituents from Alternaria alternate, a fungal endophyte of Psidium littorale
  19924. Selenepezil, a Selenium-Containing Compound, Exerts Neuroprotective Effect via Modulation of the Keap1–Nrf2–ARE Pathway and Attenuates Aβ-Induced cognitive …
  19925. Neuroprotective mechanism of hypoxic post-conditioning involves HIF1-associated regulation of the pentose phosphate pathway in rat brain
  19926. Neuroprotective efficacy of thymoquinone against amyloid beta-induced neurotoxicity in human induced pluripotent stem cell-derived cholinergic neurons
  19927. Investigation of the Neuroprotective effects of thymoquinone on rat spinal cord exposed to 900 MHz electromagnetic field
  19928. Neuroprotective effects of overexpressed microRNA-200a on activation of glaucoma-related retinal glial cells and apoptosis of ganglion cells via downregulating FGF7 …
  19929. Neuroprotective activity of isoquinoline alkaloids from of Chilean Amaryllidaceae plants against oxidative stress-induced cytotoxicity on human neuroblastoma SH …
  19930. Conditioned media from dental pulp stem cells improved diabetic polyneuropathy through anti‐inflammatory, Neuroprotective and angiogenic actions: cell‐free …
  19931. Methyl lucidone exhibits Neuroprotective effects on glutamate-induced oxidative stress in HT-22 cells via Nrf-2/HO-1 signaling
  19932. Relevance of collaterals for the success of Neuroprotective therapies in acute ischemic stroke: insights from the randomized URICO-ICTUS trial
  19933. Natural Neuroprotective alkaloids from Stephania japonica (Thunb.) Miers
  19934. The Neuroprotective effects of histamine H3 receptor antagonist E177 on pilocarpine-induced status epilepticus in rats
  19935. Viola cornuta and Viola x wittrockiana: Phenolic compounds, antioxidant and Neuroprotective activities on Caenorhabditis elegans
  19936. Methylene blue exerts rapid Neuroprotective effects on lipopolysaccharide-induced behavioral deficits in mice
  19937. Neuroprotective effect of quercetin in murine cortical brain tissue cultures
  19938. Duloxetine by modulating the Akt/GSK3 signaling pathways has Neuroprotective effects against methamphetamine-induced neurodegeneration and cognition …
  19939. Nicotine exerts Neuroprotective effects by attenuating local inflammatory cytokine production following crush injury to rat sciatic nerves
  19940. Neuroprotective activity of leukemia inhibitory factor is relayed through myeloid zinc finger-1 in a rat model of stroke
  19941. Neuroprotective effects of methanolic extract of avocado persea americana (var. Colinred) peel on paraquat-induced locomotor impairment, lipid peroxidation and …
  19942. Use of ebselen as a Neuroprotective agent in rat spinal cord subjected to traumatic injury
  19943. Neuroprotective effects of genistein in a SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis
  19944. hUC-MSCs exert a Neuroprotective effect via anti-apoptotic mechanisms in a neonatal HIE rat model
  19945. Anticonvulsive and Neuroprotective effects of aqueous and methanolic extracts of Anacyclus pyrethrum root in kainic acid-induced-status epilepticus in mice
  19946. Cross-talk between guanidinoacetate neurotoxicity, memory and possible Neuroprotective role of creatine
  19947. Xenon exerts anti-seizure and Neuroprotective effects in kainic acid-induced status epilepticus and neonatal hypoxia-induced seizure
  19948. Neuroprotective effect of nilotinib on pentylenetetrazol-induced epilepsy in adult rat hippocampus: involvement of oxidative stress, autophagy, inflammation, and …
  19949. … peptides from Protopalythoa variabilis virtually interact with voltage-gated sodium channel and display anti-epilepsy and Neuroprotective activities in zebrafish
  19950. Geranylated carbazole alkaloids with potential Neuroprotective activities from the stems and leaves of Clausena lansium
  19951. The NAC family transcription factor GmNAC42–1 regulates biosynthesis of the anticancer and Neuroprotective glyceollins in soybean
  19952. Screening of novel 3α5β-neurosteroids for Neuroprotective activity against glutamate-or NMDA-induced excitotoxicity
  19953. Neuroprotective effect of juçara (Euterpe edulis Martius) fruits extracts against glutamate-induced oxytosis in HT22 hippocampal cells
  19954. Neuroprotective effects of 6-shogaol and its metabolite, 6-paradol, in a mouse model of multiple sclerosis
  19955. The Neuroprotective effects of an ethanolic turmeric (Curcuma longa L.) extract against trimethyltin-induced oxidative stress in rats
  19956. Cellular signaling in Müller glia: Progenitor cells for regenerative and Neuroprotective responses in pharmacological models of retinal degeneration
  19957. A Triazolotriazine‐Based Dual GSK‐3β/CK‐1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition
  19958. Neuroprotective effect of biosynthesised gold nanoparticles synthesised from root extract of Paeonia moutan against Parkinson disease–In vitro & In vivo …
  19959. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and Neuroprotective effects via the PKA signaling pathway in neuroinflammation and …
  19960. Characterization of enantiomeric lignanamides from Solanum nigrum L. and their Neuroprotective effects against MPP+-induced SH-SY5Y cells injury
  19961. Neuroprotective effects of diets containing olive oil and DHA/EPA in a mouse model of cerebral ischemia
  19962. Neuroprotective effects of (−)-epigallocatechin-3-gallate (EGCG) against peripheral nerve transection-induced apoptosis
  19963. Isolation of enantiomeric furolactones and furofurans from Rubus idaeus L. with Neuroprotective activities
  19964. In vivo Neuroprotective , antinociceptive, anti-inflammatory potential in Swiss albino mice and in vitro antioxidant and clot lysis activities of fractionated Holigarna …
  19965. Neuroprotective effect of omega‐3 fatty acids on spinal cord injury induced rats
  19966. Neuroprotective effect of anodal transcranial direct current stimulation on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice through …
  19967. Neuroprotective Effect of Ilex Paraguariensis Intake on brain Myelin of Lung Adenocarcinoma-Bearing Male Balb/c Mice
  19968. Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
  19969. Neuroprotective influence of miR-301a inhibition in experimental cerebral ischemia/reperfusion rat models through targeting NDRG2
  19970. Neuroprotective effects of docosahexaenoic acid against sub-acute manganese intoxication induced dopaminergic and motor disorders in mice
  19971. In vitro evaluation of the Neuroprotective effect of oligo-porphyran from Porphyra yezoensis in PC12 cells
  19972. Neuroprotective effects of acetyl-L-carnitine (ALC) in a chronic MPTP-induced Parkinson’s disease mouse model: endothelial and microglial effects
  19973. Klotho is Neuroprotective in the superoxide dismutase (SOD1 G93A) mouse model of ALS
  19974. Preventive hypothermia as a Neuroprotective strategy for paclitaxel-induced peripheral neuropathy
  19975. Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as Neuroprotective agents
  19976. Pep‐lipid cubosomes and vesicles compartmentalized by Micelles from self‐assembly of multiple Neuroprotective building blocks including a large peptide hormone …
  19977. Neuroprotective Effects of Lacosamide in Experimental
  19978. Neuroprotective effects of musk of muskrat on transient focal cerebral ischemia in rats
  19979. Neuroprotective effects of Potentilla fulgens on spinal cord injury in rats: an immunohistochemical analysis
  19980. Neuroprotective effects of 1δ-1-acetoxyeugenol acetate on Aβ (25-35) induced cognitive dysfunction in mice
  19981. Neuroprotective effects of triterpenoid saponins from Medicago sativa L. against H2O2-induced oxidative stress in SH-SY5Y cells
  19982. The Neuroprotective effects of simvastatin on high cholesterol following traumatic brain injury in rats
  19983. Two Pairs of Isomerically New Phenylpropanoidated Epicatechin Gallates with Neuroprotective Effects on H2O2-Injured SH-SY5Y Cells from Zijuan Green Tea and …
  19984. Does Decompressive Duraplasty Have a Neuroprotective Effect on Spinal Trauma?: An Experimental Study
  19985. Pre-and post-treatment with novel antiepileptic drug oxcarbazepine exerts Neuroprotective effect in the hippocampus in a gerbil model of transient global cerebral …
  19986. Calcium-Binding Proteins in the Nervous System during Hibernation: Neuroprotective Strategies in Hypometabolic Conditions?
  19987. Neuroprotective factors and incident hearing impairment in the epidemiology of hearing loss study
  19988. Neuroprotective effects of combined treatment with minocycline and olfactory ensheathing cells transplantation against inflammation and oxidative stress after …
  19989. Naked mole rats activate Neuroprotective proteins during hypoxia
  19990. Activity-dependent Neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice
  19991. Tribolium castaneum as a whole‐animal screening system for the detection and characterization of Neuroprotective substances
  19992. Effects of exercise and ferulic acid on alpha synuclein and Neuroprotective heat shock protein 70 in an experimental model of Parkinsonism disease
  19993. Neuroprotective effects of Hibiscus Sabdariffa against hydrogen peroxide-induced toxicity
  19994. Maternal consumption of piceatannol: A nutritional Neuroprotective strategy against hypoxia-ischemia in rat neonates
  19995. Neuroprotective effect of Verbascoside on hypoxic-ischemic brain damage in neonatal rat
  19996. Neuroprotective effects of MHY908, a PPAR α/γ dual agonist, in a MPTP-induced Parkinson’s disease model
  19997. Epigenetic mechanisms of peptide-driven regulation and Neuroprotective protein FKBP1b
  19998. V232M substitution restricts a distinct O-glycosylation of PLD3 and its Neuroprotective function
  19999. Neuroprotective effect of dioscin on the aging brain
  20000. Neuroprotective effects of dexmedetomidine against isoflurane-induced neuronal injury via glutamate regulation in neonatal rats
  20001. Lichens of Parmelioid Clade as Promising Multitarget Neuroprotective agents
  20002. Simvastatin as a Neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study
  20003. Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as Neuroprotective agents
  20004. Neuroprotective effect of grape seed extract on brain ischemia: a proteomic approach
  20005. The Neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer’s disease
  20006. Neuroprotective effects of a novel carnosine-hydrazide derivative on hippocampal CA1 damage after transient cerebral ischemia
  20007. Neuroprotective effects of an Nrf2 agonist on high glucose-induced damage in HT22 cells
  20008. Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats
  20009. … –human cannabinoid receptor 2 ligands show pronounced Neuroprotection in vitro and overadditive and disease-modifying Neuroprotective effects in vivo
  20010. Comparative analysis of stilbene and benzofuran neolignan derivatives as acetylcholinesterase inhibitors with Neuroprotective and anti-inflammatory activities
  20011. Neuroprotective Effects of Tea Against Cadmium Toxicity
  20012. Neuroprotective and antihyperalgesic effects of orexin-A in rats with painful diabetic neuropathy
  20013. Antihypernociceptive and Neuroprotective effects of Combretin A and Combretin B on streptozotocin-induced diabetic neuropathy in mice
  20014. Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson’s Disease
  20015. Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through …
  20016. Magnolol exhibits anti-inflammatory and Neuroprotective effects in a rat model of intracerebral haemorrhage
  20017. The role of microglia in bacterial meningitis: inflammatory response, experimental models and new Neuroprotective therapeutic strategies
  20018. Insights into the discovery of novel Neuroprotective agents : A comparative study between sulfanylcinnamic acid derivatives and related phenolic analogues
  20019. Neuroprotective effects of an aqueous extract of Forsythia viridissima and its major constituents on oxaliplatin-induced peripheral neuropathy
  20020. Neuroprotective effects of a protein tyrosine phosphatase inhibitor against hippocampal excitotoxic injury
  20021. Enantiomeric Isoflavones with Neuroprotective activities from the Fruits of Maclura tricuspidata
  20022. Increases in miR-124-3p in microglial exosomes confer Neuroprotective effects by targeting fip200-mediated neuronal autophagy following traumatic brain injury
  20023. Neuroprotective effect of AM404 against NMDA-induced hippocampal excitotoxicity
  20024. Comparative efficacy and safety of Neuroprotective therapies for neonates with hypoxic ischemic encephalopathy: A network meta-analysis
  20025. Coadministration with tea polyphenols enhances the Neuroprotective effect of defatted walnut meal hydrolysate against scopolamine-induced learning and memory …
  20026. Intracellular Neuroprotective mechanisms in neuron-glial networks mediated by glial cell line-derived neurotrophic factor
  20027. Neuroprotective effects of dammarane-type saponins from Panax notoginseng on glutamate-induced cell damage in PC12 cells
  20028. Tongluojiunao, a traditional Chinese medication with Neuroprotective ability: A review of the cellular, molecular and physiological mediators of TLJN’s …
  20029. Neuroprotective Dihydro-β-agarofuran-Type Sesquiterpenes from the Seeds of Euonymus maackii
  20030. Neuroprotective effects of myristargenol A against glutamate-induced apoptotic HT22 cell death
  20031. Neuroprotective effects of dehydroepiandrosterone sulfate through inhibiting expression of matrix metalloproteinase-9 from bradykinin-challenged astroglia
  20032. … of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or Neuroprotective strategies on disease …
  20033. A complex Neuroprotective effect of alpha-2-adrenergic receptor agonists in a model of cerebral ischemia–reoxygenation in vitro
  20034. Rho-inhibition and Neuroprotective effect on rotenone-treated dopaminergic neurons in vitro
  20035. Novel Neuroprotective hydroquinones with a vinyl alkyne from the fungus, Pestalotiopsis microspora
  20036. Involvement of PI3K/Akt/GSK-3β signaling pathway in the antidepressant-like and Neuroprotective effects of Morus nigra and its major phenolic, syringic acid
  20037. GALECTIN-8 is a Neuroprotective factor in the brain that can be neutralized by human autoantibodies
  20038. Neuroprotective properties of linagliptin: focus on biochemical mechanisms in cerebral ischemia, vascular dysfunction and certain neurodegenerative diseases
  20039. Neuroprotective potential of secondary metabolites from melicope lunu-ankenda (rutaceae)
  20040. The Neuroprotective effect of bisperoxovandium (pyridin-2-squaramide) in intracerebral hemorrhage
  20041. New sesquiterpenoids from the stems of Dendrobium nobile and their Neuroprotective activities
  20042. Sleep deprivation exacerbates concussive head injury induced brain pathology: Neuroprotective effects of nanowired delivery of cerebrolysin with α-melanocyte …
  20043. Bee venom soluble phospholipase A2 exerts Neuroprotective effects in a lipopolysaccharide-induced mouse model of Alzheimer’s disease via inhibition of …
  20044. Nrg1 intracellular signaling is Neuroprotective upon stroke
  20045. … 1, 2, 3, 4, 5, 6-hexahydroazepino [4, 3-b] indole as scaffold of butyrylcholinesterase-selective inhibitors with additional Neuroprotective activities for Alzheimer’s …
  20046. The study of Neuroprotective effect of ferulic acid based on cell metabolomics
  20047. Neuroprotective effects of collagen-glycosaminoglycan matrix implantation following surgical brain injury
  20048. Fumaric Acids Do Not Directly Influence Gene Expression of Neuroprotective Factors in Highly Purified Rodent Astrocytes
  20049. A synthetic agonist to vasoactive intestinal peptide receptor-2 induces regulatory T cell Neuroprotective activities in models of Parkinson’s disease
  20050. Synergistic Neuroprotective effect of schisandra chinensis and Ribes fasciculatum on neuronal cell death and scopolamine-induced cognitive impairment in rats
  20051. A network-based method for mechanistic investigation and Neuroprotective effect on post-treatment of senkyunolid-H against cerebral ischemic stroke in …
  20052. In vitro screening of traditional medicinal herbs combined with donepezil for Neuroprotective effects in SH-SY5Y cells
  20053. The Neuroprotective mechanism of cinnamaldehyde against amyloid-β in neuronal SHSY5Y cell line: The role of N-methyl-D-aspartate, ryanodine, and …
  20054. Neuroprotective effect of clavulanic acid on trimethyltin (TMT)-induced cytotoxicity in PC12 cells
  20055. Buffering of cytosolic calcium plays a Neuroprotective role by preserving the autophagy-lysosome pathway during MPP+-induced neuronal death
  20056. Neuroprotective effects of kinin B2 receptor in organotypic hippocampal cultures of middle-aged mice
  20057. Neuroprotective effects of agmatine in antineoplastic drugs induced neurotoxicity: In vitro study
  20058. Synthesis of Novel Baicalein Amino Acid Derivatives and Biological Evaluation as Neuroprotective agents
  20059. Stereoselective semi-synthesis of the Neuroprotective natural product, serofendic acid
  20060. Neuroprotective effect of Zataria Multiflora essential oil on rats with Alzheimer disease: A mechanistic study
  20061. Synergistic effects of curcumin and piperine as potent acetylcholine and amyloidogenic inhibitors with significant Neuroprotective activity in SH-SY5Y cells via …
  20062. Neuroprotective effects of neurotropin in a mouse model of hypoxic–ischemic brain injury
  20063. Neuroprotective role of hypothermia in hypoxic-ischemic brain injury: Combined therapies using estrogen
  20064. Neuroprotective effect of pharmacological postconditioning on cerebral ischaemia–reperfusion‐induced injury in mice
  20065. Neuroprotective effect of rL osac on supplement‐deprived mouse cultured cortical neurons involves maintenance of monocarboxylate transporter MCT 2 protein levels
  20066. The Neuroprotective effect of L-Stepholidine on methamphetamine-induced memory deficits in mice
  20067. Effects of different starter cultures on the biogenic amine concentrations, mutagenicity, oxidative stress, and Neuroprotective activity of fermented sausages and their …
  20068. microRNA-128 enhances Neuroprotective effects of dexmedetomidine on neonatal mice with hypoxic-ischemic brain damage by targeting WNT1
  20069. Synphilin-1 has Neuroprotective effects on MPP+-induced Parkinson’s disease model cells by inhibiting ROS production and apoptosis
  20070. Therapeutic potential of cannabinoids as Neuroprotective agents for damaged cells conducing to movement disorders
  20071. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson’s disease
  20072. Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer’s Diseases
  20073. Evaluation of Neuroprotective activity of digoxin and semisynthetic derivatives against partial chemical ischemia
  20074. Interleukin 1 alpha administration is Neuroprotective and neuro-restorative following experimental ischemic stroke
  20075. Testing the Neuroprotective Properties of PCSO-524® Using a Neuronal Cell Cycle Suppression Assay
  20076. The selective oestrogen receptor modulator, bazedoxifene, mimics the Neuroprotective effect of 17β‐oestradiol in diabetic ischaemic stroke by modulating oestrogen …
  20077. Methodology approaches and challenges in population‐based longitudinal study of a Neuroprotective model for healthy longevity
  20078. Requirement for preclinical prioritization of Neuroprotective strategies in stroke: Incorporation of preconditioning
  20079. Studies on the structure-activity relationship of caffeate derivatives as Neuroprotective agents
  20080. … –chalcone hybrid compounds with anti-β-amyloid (A β) aggregation, monoamine oxidase B (MAO-B) inhibition and Neuroprotective properties against Alzheimer’s …
  20081. Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its Neuroprotective potential
  20082. Sirtuin 1 regulates mitochondrial biogenesis and provides an endogenous Neuroprotective mechanism against seizure-induced neuronal cell death in the …
  20083. Chemical constituents from the stems of Machilus philippinensis Merr. and the Neuroprotective activity of cinnamophilin
  20084. ABCA7 risk genotype diminishes the Neuroprotective value of aerobic fitness in healthy older African Americans
  20085. Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson’s Disease through the Inflammation Pathway
  20086. Evaluation and identification of the Neuroprotective compounds of Xiaoxuming decoction by machine learning: a novel mode to explore the combination rules …
  20087. Neuroprotective potential of methanolic extract of Saraca asoca bark against doxorubicin-induced neurotoxicity
  20088. GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term Neuroprotective effects at an early-stage of Parkinson’s disease …
  20089. Neuroprotective norsesquiterpenoids and triterpenoids from Populus euphratica resins
  20090. Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
  20091. GLP-1 receptor agonist liraglutide has a Neuroprotective effect on an aged rat model of Wolfram syndrome
  20092. Optimization of Degradation Conditions with PRG, a Polysaccharide from Phellinus ribis, by RSM and the Neuroprotective Activity in PC12 Cells Damaged by Aβ25 …
  20093. Alkaloid Enantiomers from Isatis tinctoria with Neuroprotective Effects against H2O2-Induced SH-SY5Y Cell Injury
  20094. Neuroprotective effects of Tat-ATOX1 protein against MPP+-induced SH-SY5Y cell deaths and in MPTP-induced mouse model of Parkinson’s disease
  20095. Music training is Neuroprotective for verbal cognition in focal epilepsy
  20096. Neuroprotective effects of blueberry anthocyanins against perfluorooctanoic sulfonate on planarian Dugesia japonica
  20097. 9-Methylfascaplysin Is a More Potent Aβ Aggregation Inhibitor than the Marine-Derived Alkaloid, Fascaplysin, and Produces Nanomolar Neuroprotective Effects in SH …
  20098. Beyond contraception and hormone replacement therapy: Advancing Nestorone to a Neuroprotective drug in the clinic
  20099. Neuroprotective effect of L-arginine in a neonatal rat model of hypoxic-ischemia
  20100. Neuroprotective effect of Astragalus polysacharin on streptozotocin (STZ)-Induced diabetic rats
  20101. … in spinocerebellar ataxia type-3 and other autosomal-dominant cerebellar ataxias: Potential role in pathogenesis and expected relevance as Neuroprotective …
  20102. The Neuroprotective peptide PACAP1-38 Contributes to horizontal cell development in postnatal rat retina
  20103. Neuroprotective aurones from Sophora japonica
  20104. Neuroprotective effects of midazolam on focal cerebral ischemia in rats through anti‑apoptotic mechanisms
  20105. MiR-410 exerts Neuroprotective effects in a cellular model of Parkinson’s disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling …
  20106. Neuroprotective effects of tocilizumab on experimentally-induced spinal cord ischemia-reperfusion injury
  20107. Neuroprotective agents
  20108. Eudesmane Glycosides from Ambrosia artemisiifolia (Common Ragweed) as Potential Neuroprotective agents
  20109. Targeting CB 1 and GPR55 endocannabinoid receptors as a potential Neuroprotective approach for Parkinson’s disease
  20110. Neuroprotective effects of MK-801 on auditory cortex in salicylate-induced tinnitus: Involvement of neural activity, glutamate and ascorbate
  20111. Neuroprotective effect of myxobacterial extracts on quinolinic acid-induced toxicity in primary human neurons
  20112. Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential Neuroprotective agents
  20113. Neuroprotective effects of a potent bradykinin B2 receptor antagonist HOE-140 on microvascular permeability, blood flow disturbances, edema formation, cell injury …
  20114. Involvement of mitochondrial apoptotic pathway and MAPKs/NF-κ B inflammatory pathway in the Neuroprotective effect of atractylenolide III in corticosterone-induced …
  20115. … inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced Neuroprotective effect in an Alzheimer’s disease …
  20116. Neuroprotective potential of Cucurbita maxima Duchesne ex Poir, Caeselpenia bunduc (L.) Roxb and Bombax ceiba Linn extracts
  20117. Neuroprotective effect of exogenous melatonin on the noradrenergic neurons of adult male rats’ locus coeruleus nucleus following REM sleep deprivation
  20118. Evaluation of the Neuroprotective , anticonvulsant, and cognition -improvement effects of apigenin in temporal lobe epilepsy: Involvement of the mitochondrial …
  20119. The mitochondrial targets of Neuroprotective drug vinpocetine on primary neuron cultures, brain capillary endothelial cells, synaptosomes, and brain …
  20120. Anti-inflammatory and Neuroprotective Effects of DIPOPA (N, N-Diisopropyl-2-oxopropanamide), an ethyl pyruvate bioisoster, in the postischemic brain
  20121. Neuroprotective effects of P7C3 against spinal cord injury in rats
  20122. Neuroprotective effect of Panax ginseng extract against cerebral ischemia–reperfusion-injury-induced oxidative stress in middle cerebral artery occlusion models
  20123. Design and biological assessment of membrane-tethering Neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor
  20124. Modulation of Apoptotic Cell Death and Neuroprotective Effects of Glutathione—L-Dopa Codrug Against H2O2-Induced Cellular Toxicity
  20125. Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2
  20126. miR‑223‑3p/TIAL1 interaction is involved in the mechanisms associated with the Neuroprotective effects of dexmedetomidine on hippocampal neuronal cells …
  20127. Neuroprotective effect of quercetin against radiation‐induced endoplasmic reticulum stress in neurons
  20128. Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1H-Pyrrolo[3,2-c]quinolines with Neuroprotective and Procognitive Activity
  20129. The novel GLP-1/GIP dual receptor agonist DA3-CH is Neuroprotective in the pilocarpine-induced epileptogenesis rat model
  20130. Neuroprotective effect of naturally occurring RXR agonists isolated from Sophora tonkinensis Gagnep. on amyloid-β-induced cytotoxicity in PC12 cells
  20131. Estrogenic regulation of Neuroprotective and neuroinflammatory mechanisms: implications for depression and cognition
  20132. The AAA+ ATPase Thorase is Neuroprotective against ischemic injury
  20133. 16, 17-N′-(alky/arylsulfonyl) pyrazoline substituted Neuroprotective heterosteroids: Synthesis, molecular docking and preclinical efficacy/toxicity studies in rodents
  20134. Neuroprotective effect of tempeh against lipopolysaccharide-induced damage in BV-2 microglial cells
  20135. Novel Neuroprotective loci modulating ischemic stroke volume in wild-derived inbred mouse strains
  20136. Neuroprotective effect of ghrelin in methamphetamine-treated male rats
  20137. Neuroprotective effects of phytochemicals on dopaminergic neuron cultures
  20138. Potential roles of miR-374a-5p in mediating Neuroprotective effects and related molecular mechanism
  20139. Discovery of cycloneolignan enantiomers from Isatis indigotica Fortune with Neuroprotective effects against MPP+-induced SH-SY5Y cell injury
  20140. Neuroprotective behaviour of Phyllanthus emblica (L) on human neural cell lineage (PC12) against glutamate-induced cytotoxicity
  20141. Neuroprotective activation of astrocytes by methylmercury exposure in the inferior colliculus
  20142. Protein kinase C is involved in the Neuroprotective effect of berberine against intrastriatal injection of quinolinic acid‐induced biochemical alteration in mice
  20143. The interactions of an Aβ protofibril with a cholesterol-enriched membrane and involvement of Neuroprotective carbazolium-based substances
  20144. The Neuroprotective mechanism of 2-arachidonoylglycerol 2-AG against non-caspase-dependent apoptosis in mice hippocampal neurons following MCAO
  20145. Human Embryonic Stem Cell-Derived Neural Lineages as In Vitro Models for Screening the Neuroprotective Properties of Lignosus rhinocerus (Cooke) …
  20146. Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer’s Disease
  20147. Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but not phenobarbital-induced neurotoxicity in immature rats
  20148. Neuroprotective effects of hesperidin on cerebral vasospasm after experimental subarachnoid hemorrhage in rats: biochemical, pathologic, and histomorphometric …
  20149. General anesthetics are Neuroprotective
  20150. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson’s disease.
  20151. … lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts Neuroprotective effects against ischemic …
  20152. Neuroprotective mechanism of low-dose sodium nitrite in oxygen-glucose deprivation model of cerebral ischemic stroke in PC12 cells
  20153. Treatment with MQA, a Derivative of Caffeoylquinic Acid, Provides Neuroprotective Effects against Cerebral Ischemia Through Suppression of the p38 Pathway and …
  20154. The use of human induced pluripotent stem cells for testing Neuroprotective activity of pharmacological compounds
  20155. Assessment of the Neuroprotective effects of (-)-epigallocatechin-3-gallate on spinal cord ischemia-reperfusion injury in rats
  20156. Neuroprotective and long term potentiation improving effects of vitamin E in juvenile hypothyroid rats
  20157. Hybrid compound SA-2 is Neuroprotective in animal models of retinal ganglion cell death
  20158. Schwann cell transplantation exerts Neuroprotective roles in rat model of spinal cord injury by combating inflammasome activation and improving motor recovery and …
  20159. Neuroprotective effect of Paeoniae Radix Rubra on hippocampal CA1 region of mice induced by transient focal cerebral ischemia via anti-gliosis and anti-oxidant …
  20160. Aldehyde adducts inhibit 3, 4-dihydroxyphenylacetaldehyde-induced α-synuclein aggregation and toxicity: implication for Parkinson Neuroprotective therapy
  20161. Neuroprotective effect of flavonoids: A systematic review
  20162. Neuroprotective effects of matrix metalloproteinases in cerebral ischemic rats by promoting activation and migration of astrocytes and microglia
  20163. Design, synthesis and biological evaluation of 1-benzyl-5-oxopyrrolidine-2-carboximidamide derivatives as novel Neuroprotective agents
  20164. Neuroprotective effect of cyperi rhizome against corticosterone-induced PC12 cell injury via suppression of Ca2+ overloading
  20165. Crocin acts as a Neuroprotective mediator against methylphenidateinduced neurobehavioral and neurochemical sequelae: Possible role of the CREB-BDNF …
  20166. The Neuroprotective effect of BSA-based nanocurcumin against 6-OHDA-induced cell death in SH-SY5Y cells
  20167. Physical & mental activities enhance the Neuroprotective effect of vinpocetine & coenzyme Q10 combination against Alzheimer & bone remodeling in rats
  20168. Neuroprotective potential of dimethyl fumarate-loaded polymeric Nanoparticles against multiple sclerosis
  20169. Neuroprotective and reparative effects of endoplasmic reticulum luminal proteins–mesencephalic astrocytederived neurotrophic factor and cerebral dopamine …
  20170. In vivo forward genetic screen to identify novel Neuroprotective genes in Drosophila melanogaster
  20171. Creatine is Neuroprotective to retinal neurons in vitro but not in vivo
  20172. microRNA‐129‐5p involved in the Neuroprotective effect of dexmedetomidine on hypoxic‐ischemic brain injury by targeting COL3A1 through the Wnt/β‐catenin …
  20173. Comparison of the Neuroprotective effects of aspirin, atorvastatin, captopril and metformin in diabetes mellitus
  20174. brain -Derived Neurotrophic Factor Is Required for the Neuroprotective Effect of Mifepristone on Immature Purkinje Cells in Cerebellar Slice Culture
  20175. Insulin-like growth factor-1 is Neuroprotective in aged rats with ischemic stroke
  20176. Neuroprotective potential of new chromones isolated from the soil actinomycete Microbispora sp. TBRC6027
  20177. Aromatic monoterpenoid glycosides from rattan stems of Schisandra chinensis and their Neuroprotective activities
  20178. Insulin-like growth factor-1 enhances Neuroprotective effects of neural stem cell exosomes after spinal cord injury via an miR-219a-2-3p/YY1 mechanism
  20179. … evaluation of a novel peptide based on anemonia sulcata BDS-I toxin as a new KV3. 4 inhibitor exerting a Neuroprotective effect against amyloid-β peptide
  20180. The mechanism of Neuroprotective effect of Viola odorata against serum/glucose deprivation-induced PC12 cell death
  20181. Anticonvulsant and Neuroprotective effects of dexmedetomidine on pilocarpine-induced status epilepticus in rats using a metabolomics approach
  20182. Neuroprotective effects of kaempferol, quercetin, and its glycosides by regulation of apoptosis
  20183. Araucaria angustifolia (Bertol.) Kuntze has Neuroprotective action through mitochondrial modulation in dopaminergic SH-SY5Y cells
  20184. Investigating the Neuroprotective effect of Copolymer‐1 in acute primary angle closure–Interim report of a randomized placebo‐controlled double‐masked clinical trial
  20185. Neuroprotective Potential of GDF11: Myth or Reality?
  20186. Enantiomeric 8, 4′-type oxyneolignans from the root barks of Ailanthus altissima (Mill.) Swingle and their Neuroprotective effects against H2O2-induced SH-SY5Y …
  20187. … , Tyrosol, and p-Coumaric Acid Individually and in an Equimolar Combination. Differences in LC-ESI-MS2 Profiles of Oxidation Products and Their Neuroprotective …
  20188. Sesquiterpenoids and γ-pyranone derivatives from the whole plant of Erigeron breviscapus and their Neuroprotective effects
  20189. Annexin A1-derived peptide Ac 2-26 in a pilocarpine-induced status epilepticus model: anti-inflammatory and Neuroprotective effects
  20190. Preliminary investigation of the Neuroprotective potentials of Crossyne guttata in MPP+-induced toxicity in SH-SY5Y
  20191. (Pyrrolo-pyridin-5-yl) benzamides: BBB permeable monoamine oxidase B inhibitors with Neuroprotective effect on cortical neurons
  20192. Disubstituted Dithiolethione ACDT Exerts Neuroprotective Effects Against 6-Hydroxydopamine-Induced Oxidative Stress in SH-SY5Y Cells
  20193. Purification, structural elucidation, antioxidant capacity and Neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam …
  20194. The amidated PACAP1–23 fragment is a potent reduced-size Neuroprotective agent
  20195. Neuroprotective Effects of Trolox, Human Chorionic Gonadotropin, and Carnosic Acid on Hippocampal Neurodegeneration After Ischemia-reperfusion Injury
  20196. Neuroprotective effect of low mean arterial pressure on postoperative cognitive deficit attenuated by prolonged coronary artery bypass time: a meta-analysis
  20197. Synthesis and biological evaluation of 3-carbamate smilagenin derivatives as potential Neuroprotective agents
  20198. Nateglinide exerts Neuroprotective effects via downregulation of HIF-1α/TIM-3 inflammatory pathway and promotion of caveolin-1 expression in the rat’s hippocampus …
  20199. HIF inhibitor topotecan has a Neuroprotective effect in a murine retinal ischemia-reperfusion model
  20200. Neuroprotective action of Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) acids on Paraquat intoxication in Drosophila melanogaster
  20201. Neuroprotective Effects of Red Ginseng Saponins in Scopolamine-Treated Rats and Activity Screening Based on Pharmacokinetics
  20202. Novel Neuroprotective tetramethylpyrazine analog T-006 promotes neurogenesis and neurological restoration in a rat model of stroke
  20203. Tetramethylpyrazine analogue T-006 exerts Neuroprotective effects against 6-hydroxydopamine-induced Parkinson’s disease in vitro and in vivo
  20204. Systematic review and technological prospection: ethyl ferulate, a phenylpropanoid with antioxidant and Neuroprotective actions
  20205. Neuroprotective effects on the morphology of somatic motoneurons following the death of neighboring motoneurons: A role for microglia?
  20206. Synthesis of potent Neuroprotective butenolides based on plant smoke derived 3, 4, 5-Trimethylfuran-2 (5H)-one and 3-methyl-2H-furo [2, 3-c] pyrone-2-one
  20207. Neuroprotective potential of Spirulina platensis on lesioned spinal cord corticospinal tract under experimental conditions in rat models
  20208. 2-(4-methoxyphenyl) ethyl-2-acetamido-2-deoxy-β-d-pyranoside exerts a Neuroprotective effect through regulation of energy homeostasis and O-GlcNAcylation
  20209. Pharmacoeconomic analysis of the Neuroprotective medicines in the treatment of ischemic stroke
  20210. Synthesis of sevoflurane loaded reduced graphene oxide nanoparticles system for Neuroprotective effects for preconditioning against focal cerebral ischaemia
  20211. A Systematic Review of Neuroprotective Strategies in the Management of Hypoglycemia
  20212. NAP Neuroprotective Peptide and its Analogs: Simultaneously Copper and Iron Binding and Reduction
  20213. The orphan cytokine receptor CRLF3 emerged with the origin of the nervous system and is a Neuroprotective erythropoietin receptor in locusts
  20214. Neuroprotective Function of Non-Proteolytic Amyloid-β Chaperones in Alzheimer’s Disease
  20215. Neuroprotective effects of ozone therapy after sciatic nerve cut injury
  20216. Neuroprotective effect of mogrol against Aβ1–42‐induced memory impairment neuroinflammation and apoptosis in mice
  20217. Hepato-, Neuroprotective effects and QSAR studies on flavoalkaloids and flavonoids from Astragalus monspessulanus
  20218. Potential impact of DARC technology in Neuroprotective therapies
  20219. Role of toll‐like receptors 2 and 4 in the Neuroprotective effects of bone marrow–derived mesenchymal stem cells in an experimental model of ischemic stroke
  20220. Neuroprotective effects of lovastatin in the pilocarpine rat model of epilepsy according to the expression of neurotrophic factors
  20221. Neuroprotective effects of clavulanic acid following permanent bilateral common carotid artery occlusion in rats
  20222. Knockdown of microRNA-17-5p enhances the Neuroprotective effect of Act A/Smads signal loop after ischemic injury
  20223. Synthesis of biocompatible zinc oxide (ZnO) nanoparticles and their Neuroprotective effect of 6-OHDA induced neural damage in SH-SY 5Y cells
  20224. Endogenous Neuroprotective potential due to preconditioning exercise in stroke
  20225. TREK-2 mediates the Neuroprotective effect of isoflurane preconditioning against acute cerebral ischemia in the rat
  20226. Neuroprotective Activity of Evolvulus alsinoides & Centella asiatica Ethanolic Extracts in Scopolamine-Induced Amnesia in Swiss Albino Mice
  20227. Neuroprotective action of 4-hydroxyisophthalic acid against ethanol-induced oxidative stress in the rat brain
  20228. … -Dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1-propanone (RGM079): A positive allosteric modulator of α7 nicotinic receptors with analgesic and Neuroprotective …
  20229. A novel Neuroprotective role of phosphatase of regenerating liver-1 against CO2 stimulation in Drosophila
  20230. Neuroprotective effect of Notch pathway inhibitor DAPT against focal cerebral ischemia/reperfusion 3 hours before model establishment
  20231. Neuro-pharmacological evaluation of anticonvulsant and Neuroprotective activity of Cocculus laurifolius leaves in wistar rats
  20232. Neuroprotective effect of green tea extractives against oxidative stress by enhancing the survival and proliferation of PC12 cells
  20233. Structure-activity relationship studies of (E)-3, 4-dihydroxystyryl alkyl sulfones as novel Neuroprotective agents based on improved antioxidant, anti-inflammatory …
  20234. Neuroprotective action of PHD inhibitors is predominantly HIF‐1‐independent: An Editorial for ‘Sex differences in neonatal mouse brain injury after hypoxia‐ischemia …
  20235. Target proteins in the dorsal hippocampal formation sustain the memory -enhancing and Neuroprotective effects of Ginkgo biloba
  20236. Neuroprotective Potential of Small Molecule Phytochemicals in Stroke Therapy
  20237. Remyelination: a good Neuroprotective strategy for preventing axonal degeneration?
  20238. Neuroprotective and therapeutic effect of Cordyceps militaris on ischemia-induced neuronal death and cognitive impairments
  20239. Neuroprotective effects of low dose anandamide in pentylenetetrazole-induced kindling in rats
  20240. Neuroprotective and anti-amyloid β effect and main chemical profiles of white tea: comparison against green, oolong and black tea
  20241. Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) Contributes to the Neuroprotective Effects of Histone Deacetylase Inhibitors In Retinal Ischemia–Reperfusion Injury
  20242. Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson’s disease via regulation of α‑synuclein methylation
  20243. Neuroprotective Glycosylated Cyclic Lipodepsipeptides, Colletotrichamides A–E, from a Halophyte-Associated Fungus, Colletotrichum gloeosporioides JS419
  20244. A hypothetic role of minocycline as a Neuroprotective agent against methylphenidate-induced neuronal mitochondrial dysfunction and tau protein hyper …
  20245. Neuroprotective effects of a Smoothened receptor agonist against postoperative cognitive dysfunction by promoting autophagy in the dentate gyrus of aged rats
  20246. Housefly Pupae-Derived Antioxidant Peptides Exerting Neuroprotective Effects on Hydrogen Peroxide-Induced Oxidative Damage in PC12 Cells
  20247. Famotidine has a Neuroprotective effect on MK-801 induced toxicity via the Akt/GSK-3β/β-catenin signaling pathway in the SH-SY5Y cell line
  20248. Neuroprotective effects of zafirlukast, piracetam and their combination on L‐Methionine‐induced vascular dementia in rats
  20249. Neuroprotective Peptides Regulate Protein-Synthesis Kinetics in Hepatocytes of Different Age Rats
  20250. Neuroprotective IMMUNITY: Leukaemia Inhibitory Factor (LIF) as guardian of brain health
  20251. Neuroprotective effects of nasopharyngeal perfluorochemical cooling in a rat model of subarachnoid hemorrhage
  20252. The Neuroprotective effect of hyperoxygenate hydrogen-rich saline on CO-induced brain injury in rats
  20253. Cornel iridoid glycoside exerts a Neuroprotective effect on neuroinflammation in rats with brain injury by inhibiting NF-κB and STAT3
  20254. Neuroprotective effect of CR-777, a glutathione derivative of Withaferin A, obtained through the bioconversion of Withania somnifera (L.) Dunal extract by the fungus …
  20255. Design, synthesis of novel purin-6-one derivatives as phosphodiesterase 2 (PDE2) inhibitors: The Neuroprotective and anxiolytic-like effects
  20256. Trends in Neuroprotective Strategies after Spinal Cord Injury: State of the Art
  20257. Neuroprotective effect of against aluminium-induced Gracilaria corticata neurotoxicity in the hippocampus and cerebral cortex of rat brain : Biochemical and …
  20258. Enhanced Neuroprotective effects of panax ginseng G115® and ginkgo biloba GK501® combinations in vitro models of excitotoxicity
  20259. General anesthetic agents are not Neuroprotective and may be neurotoxic
  20260. Characterizing the Neuroprotective effects of S/B remedy (Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd) in spinal cord injury
  20261. Expression of miR-210 mediated by adeno-associated virus performed Neuroprotective effects on a rat model of acute spinal cord injury
  20262. Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
  20263. The effect of a Neuroprotective dose of isatin or deprenyl to mice on the profile of brain isatin-binding proteins
  20264. Neuroprotective effect of a dietary supplement against glutamate-induced excitotoxicity in retina
  20265. Engineering the protein targeting two pathways of cerebral ischemia reperfusion injury provides better Neuroprotective effect than targeting one pathway
  20266. developing successful Neuroprotective treatments for TBI: translational approaches, novel directions, opportunities and challenges
  20267. Neuroprotective effects of the Anthocleista schweinfurthii Gilg.(loganiaceae) stem bark extract in postmenopause-like model of ovariectomized wistar rats
  20268. Mimengosides J and K: two new Neuroprotective triterpenoids from the fruits of Buddleja lindleyana
  20269. Adjuvant ursodeoxycholic acid for retinal detachment: a potential Neuroprotective therapy.
  20270. Neuroprotective effect of Sanqi Tongshuan Tablets on sequelae post-stroke in rats
  20271. Rational design, synthesis, and in vitro Neuroprotective evaluation of novel glitazones for PGC-1α activation via PPAR-γ: a new therapeutic strategy for …
  20272. Neuroprotective and anti-inflammatory activities of Aegiceras corniculatum (L.) Blanco
  20273. Trehalose Neuroprotective Effects on the Substantia Nigra Dopaminergic Cells by Activating Autophagy and Non-canonical Nrf2 Pathways
  20274. Combination of cell metabolomics and pharmacology: A novel strategy to investigate the Neuroprotective effect of Zhi-zi-chi decoction
  20275. Lentivirus vector-mediated knockdown of Sox9 shows Neuroprotective effects on light damage in rat retinas
  20276. Design, Synthesis, Neuroprotective and Antibacterial Activities of 1, 2, 4‐Triazolo [3, 4‐b] 1, 3, 4‐thiadiazole Linked Thieno [2, 3‐d] pyrimidine Derivatives and In Silico …
  20277. Effect of energy drinks on rat hippocampus and the possible Neuroprotective role of sesame oil: histological, immunohistochemical and molecular study
  20278. Systems Neuroprotective Mechanisms in Ischemic Stroke
  20279. Comparative Neuroprotective Effect of Celosia argentea Linn. and Vitamin E on Mercury-induced Oxidative and Histological Parameters of Rat brain
  20280. Cancer preventive and Neuroprotective potentials of red hulls, kernels and oleo-gum resins from Pistachio
  20281. Neuroprotective carbazole alkaloids from the stems and leaves of Clausena lenis
  20282. Rapamycin blocks the Neuroprotective effects of sex steroids in the adult birdsong system
  20283. New indole glycosides from Aesculus chinensis var. chekiangensis and their Neuroprotective activities
  20284. DPP-4 Inhibitor Linagliptin is Neuroprotective in Hyperglycemic Mice with Stroke via the AKT/mTOR Pathway and Anti-apoptotic Effects
  20285. Current Neurologic Assessment and Neuroprotective Strategies in Cardiac Anesthesia: A Survey to the Membership of the Society of Cardiovascular …
  20286. The Neuroprotective role of citicoline treatment in glaucoma–6 months results of a prospective therapeutic trial
  20287. New Insights in Neuroprotective Acute Stroke Treatment
  20288. Neuropeptide VGF-derived peptide LQEQ-19 has Neuroprotective effects in an in vitro model of amyotrophic lateral sclerosis
  20289. Dose-dependent Neuroprotective effect of oriental phyto-derived glycyrrhizin on experimental neuroterminal norepinephrine depletion in a rat brain model
  20290. Neuroprotective effects of lidocaine on early postoperative cognitive dysfunction and the possible mechanism
  20291. Neuroprotective and Antiamnestic Effects of a New Drug Emopag in Rats
  20292. The synthesis and biological evaluation of novel gardenamide A derivatives as multifunctional Neuroprotective agents
  20293. Attenuation of brain mitochondria oxidative damage by Albizia julibrissin Durazz: Neuroprotective and antiemetic effects
  20294. Hydrogen, the next Neuroprotective agent?
  20295. Design and Synthesis of CNb-targeted Flavones and Analogues with Neuroprotective Potential Against H2O2-and Aβ1-42-Induced Toxicity in SH-SY5Y Human …
  20296. The Neuroprotective Effect of Steroid Receptor Coactivator-Interacting Protein (SIP) in Astrocyte Model of 1-Methyl-4-Phenylpyridinium (MPP+)-Induced …
  20297. Quassinoids with Insecticidal Activity against Diaphorina citri Kuwayama and Neuroprotective Activities from Picrasma quassioides
  20298. Tumor necrosis factor‐related apoptosis‐inducing ligand reduces the expression of the Neuroprotective Na+/Ca2+ exchanger isoform NCX3 in human …
  20299. Effect of Different Processing Methods on Phytochemical Contents and Neuroprotective Activity of Camellia euphlebia Leaves Extract
  20300. Proteomic analysis reveals the potential Neuroprotective effects of tetramethylpyrazine dimer in neuro2a/APPswe cells
  20301. The anticonvulsant and Neuroprotective effects of the Tanacetum Polycephalum hydroalcoholic extract against the experimental pentylenetetrazol‐induced model of …
  20302. Neuroprotective Methodologies of Co-Enzyme Q10 Mediated brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
  20303. Preliminary in vitro evaluation of Neuroprotective and monoamine oxidase type B inhibitory effects of newly synthesized 8-aminocaffeines
  20304. Neuroprotective effect of Carica papaya leaf extract against aluminium toxicity: An experimental study on cognitive dysfunction and biochemical alterations in …
  20305. Neuroprotective effects of allopurinol on spinal cord injury in rats: a biochemical and immunohistochemical study
  20306. Management of HD: insight into molecular mechanisms and potential Neuroprotective drug strategies
  20307. Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective agents in the PC12 Cell-Line Model of Alzheimer’s Disease
  20308. Artificial Hibernation by Phenothiazines: A Potential Neuroprotective Therapy Against Cerebral Inflammation in Stroke
  20309. Neuroprotective and Antiapoptotic Effects of N-acetylcystein and Crocus sativus Aqueous Extract on Arsenic-induced Neurotoxicity in SH-SY5Y Human …
  20310. Evaluation of the Neuroprotective effects of electromagnetic fields and coenzyme Q10 on hippocampal injury in mouse
  20311. The Neuroprotective effect of forskolin and its influence of mitochondrial dysfunction in neurons in primary rat cerebellum cultures
  20312. Remote photobiomodulation as a Neuroprotective intervention—harnessing the indirect effects of photobiomodulation
  20313. Neuroprotective efficacy of withaferin a on aging mediated oxidative stress in striatum and Substantia nigra of wistar albino rat.
  20314. Neuroprotective effect of neuregulin-1β on spinal cord ischemia reperfusion injury
  20315. Neuroprotective effect of Triptolide in colony-stimulating factor 1 receptor inhibitor treated mice model of cerebral ischemia
  20316. Neuroprotective action of amidic neurolipins in models of neurotoxicity on the culture of human neural-like cells SH-SY5Y
  20317. Neuroprotective and Anti-Obesity Effects of Tocotrienols
  20318. Pre-exposure Prophylaxis Therapy and the Blood-brain Barrier: Is PrEP Neuroprotective ?
  20319. Neuroprotective effects of crocin I and II in an ischemia-reperfusion injury model
  20320. Nootropics: Phytochemicals with Neuroprotective and Neurocognitive Enhancing Properties
  20321. Neuroprotective effects of the glutathione precursor N-acetylcysteine against rotenone-induced neurodegeneration
  20322. Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against H2O2-and Aβ1-42-Induced Toxicity in SH-SY5Y Human …
  20323. Neuroprotective Effects of Curcumin on the Proliferation and Viability of Neural Stem Cells against H2O2
  20324. Neuroprotective properties of RT10, a fraction isolated from Parawixia bistriata spider venom, against excitotoxicity injury in neuron-glia cultures
  20325. Pharmacological evaluation of combined Neuroprotective effect of Melatonin and Simvastatin against LPS and STZ induced memory impairment in rodents
  20326. Neuroprotective Effect of (–)-Deprenyl
  20327. Extracellular signal-regulated kinase 1/2 pathway is insufficiently involved in the Neuroprotective effect by hydrogen sulfide supplement in experimental …
  20328. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its Neuroprotective activity and increased expression of tyrosine hydroxylase …
  20329. Neuroprotective effect of midazolam low dose against glutamate toxicity induced to olfactory, cortex and cerebellum neurons culture: In vitro study
  20330. Impact of Collateral Status on Neuroprotective Effect of Cyclosporine A in Acute Ischemic Stroke
  20331. Phytochemistry and Neuroprotective effects of Eclipta alba (L.) Hassk
  20332. Identification of a novel variant of Golli myelin basic protein BG21 in the uniquely Neuroprotective white-footed mouse
  20333. Study of Yerba Mate (Ilex Paraguariensis) as a Neuroprotective Agent of Dopaminergic Neurons in an Animal Model of Parkinson’s Disease (P5. 8-008)
  20334. 2-Deoxyglycosylation towards more effective and bioavailable Neuroprotective molecules inspired by nature
  20335. The Neuroprotective Effect of miR-181a After Oxygen–Glucose Deprivation/Reperfusion and the Associated Mechanism
  20336. Neuroprotective Effect of β-secretase Inhibitory Peptide from Pacific Hake (Merluccius productus) Fish Protein Hydrolysate
  20337. Neuroprotective effect and mechanism of human umbilical cord blood mesenchymal stem cells on hypoxic-ischemic brain injury in neonatal rats
  20338. Neuroprotective Propensity of Curcumin: Evidence in Animal Models, Mechanisms, and Its Potential Therapeutic Value
  20339. Cn and Cn‐1B Fullerenes as Potential Nanovehicles for Piribedil Neuroprotective Drug (n=20, 36 and 60)
  20340. Neuroprotective effects of stachys lavandulifolia hydroalcoholic extract on size of cerebral ischemia, blood-brain barrier permeability and edema volume in rat stroke …
  20341. The anticonvulsant and Neuroprotective effects of kir2. 3 activation in PTZ-induced seizures and the kainic acid model of TLE
  20342. Neuroprotective role of dexmedetomidine in epilepsy surgery
  20343. Inhibition of Autophagy Potentiated Hippocampal Cell Death Induced by Endoplasmic Reticulum Stress and its Activation by Trehalose Failed to be Neuroprotective
  20344. Selective brain Hypothermia Augmenting Neuroprotective Effects of Decompressive Craniectomy for Permanent Middle Cerebral Artery Infarction in a Rat Model
  20345. Neuroprotective effect of thiamine triethylorthoformate conjugate against Parkinson disease in a mouse model.
  20346. Neuritogenic and Neuroprotective Activities of the Essential Oil From Rhizomes of Curcuma alismatifolia
  20347. A new monoterpene-lactone with Neuroprotective activity from corn silk
  20348. (Z)-7, 4′-Dimethoxy-6-hydroxy-aurone-4-O-β-glucopyranoside exerts Neuroprotective effects in vitro and anxiolytic activity in vivo
  20349. Evaluation of the Neuroprotective effects of anti-inflammatory drugs in experimental spinal cord damage.
  20350. Neuroprotective Efficacy of Maytenus emarginata (Wild.) Ding Hou Against Paraquat Induced Oxidative Stress and Neurotoxicity in Drosophila Model System
  20351. Drug with Neuroprotective Properties Noopept Does Not Stimulate Cell Proliferation
  20352. Neuroprotective efficacy of polyphenols of marine brown macroalga Ecklonia cava in diabetic peripheral neuropathy
  20353. Chemical fingerprint of Bacopa monnieri L. and Rosmarinus officinalis L. and their Neuroprotective activity against Alzheimers disease in rat models putative …
  20354. Improving Neuroprotective effects of resveratrol by brain targeting through chitosan glutamate nanoparticles in MPTP induced parkinsonism
  20355. Immunomodulatory and Neuroprotective mechanisms of Huangqi glycoprotein treatment in experimental autoimmune encephalomyelitis.
  20356. Neuroprotective effect of Mayan medicinal plant extracts against glutamate-induced toxicity
  20357. Neuroprotective effects of Danshensu in Parkinson’s disease mouse model induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
  20358. Neuroprotective potential of Myrciaria plinioides D. Legrand extract in an in vitro human neuroblastoma model
  20359. Synthesis and Neuroprotective Biological Evaluation of Quinazolinone Derivatives via Scaffold Hopping
  20360. Neuroprotective modulation of the unfolded protein response in Marinesco-Sjögren syndrome: PERK signaling inhibition and beyond
  20361. Single-cell profiles of retinal neurons differing in resilience to injury reveal Neuroprotective genes
  20362. Neuroprotective Effects of Mitochondria-Targeted Quercetin Against Rotenone-Induced Oxidative Damage in Cerebellum of Mice
  20363. In Vitro Assessment of the Neuroprotective and Antioxidant Properties of New Benzimidazole Derivatives as Potential Drug Candidates for the Treatment of …
  20364. Neuroprotective therapy both for als and acute ischemic stroke
  20365. Molecular docking study for evaluation of Neuroprotective potential of sericin against cerebral stroke and exploring its biomaterial properties
  20366. Mnemonic and histopathological assessment of the Neuroprotective effects of Murraya koenigii leaves extract in rats with partial global cerebral Ischaemia
  20367. Novel 5-N, N-disubstituted-5-amino-3-(2-oxopropyl)-1, 2, 4-thiadiazoles: synthesis and study of Neuroprotective and antiproliferative properties
  20368. Synthesis and Structure Activity Relationships of Novel Dehydroepiandrosterone Derivatives as Potent Neuroprotective agents and Nitric Oxide Production Inhibitors
  20369. Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson’s disease
  20370. … of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson’s …
  20371. Neuroprotective potential of phytochemicals via in silico molecular docking techniques
  20372. Use of Neuroprotective agents for Traumatic brain Injury
  20373. Thymoquinone (TQ) demonstrates its Neuroprotective effect via an anti-inflammatory action on the Aβ(1–42)-infused rat model of Alzheimer’s disease
  20374. Neuroprotective effects and mechanism of ethanol extract of cistanche tubulosa against oxygen-glucose deprivation/reperfusion
  20375. Gelidiella acerosa Exhibits Neuroprotective Effect Against Amyloid Beta 25–35 Peptide–Induced Toxicity in PC12 Cells
  20376. Quantification of a Neuroprotective Agent Edaravone by Stability Indicating TLC Method and UV–Visible Spectroscopic Method in Bulk and Pharmaceutical Dosage …
  20377. Neuroprotective effect of Salvia splendens extract and its constituents against AlCl 3-induced Alzheimer’s disease in rats
  20378. Sex differences in the Neuroprotective effect of insulin against chemically-induced convulsions in mice
  20379. Neuroprotective EFFECT OF APOE2: EVIDENCE AND IMPLICATION FOR cognitive AGING
  20380. Comparative Study of Bang-poong (root of Saposhnikovia divaricata Schischkin) and Related Species on Neuroprotective and Acetylcholinesterase Inhibitory Effects
  20381. Synthesis of Fluoroflavones as Potential Neuroprotective agents
  20382. Reprint of: Beyond contraception and hormone replacement therapy: Advancing Nestorone to a Neuroprotective drug in the clinic
  20383. CX3CL1 Disruption Differentially Influences the Neuroprotective Effects of Mesenchymal Stromal Cells on ALS (P4. 4-021)
  20384. Neuroprotective Effects of Antisense Oligodeoxynucleotides on the GluN1 Subunit of the N-Methyl-D-Aspartate Receptor
  20385. Cosmetic and Neuroprotective Placement of Custom-Made Ultra-High-Molecular-Weight Polyethylene Cranial Plate (SKULPIO) in Single-Step Surgery: Technical …
  20386. Correction to: Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer’s Disease
  20387. Neuronal ICAM-5 plays a Neuroprotective role in progressive neurodegeneration
  20388. Outcomes of Perilla Seed Oil as an Additional Neuroprotective Therapy in Patients with Mild to Moderate Dementia: A Randomized Control Trial
  20389. Neuroprotective effects of d-penicillamine in the neonatal period
  20390. Neuroprotective Therapies in Infants
  20391. Assessment of Neuroprotective Strategies Using MEAs
  20392. Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes
  20393. Neuroprotective Effect of Huperzine A on d-Galactose-Induced Hearing Dysfunction
  20394. Exploring potential Neuroprotective properties of aqueous centella asiatica extract in chronic stress-induced rats
  20395. Anticancer and Neuroprotective Activity of Chrysin: Recent Advancement
  20396. Possible Neuroprotective effects of Caveolin 1 inhibitor, curcumin with association of folic acid and Vitamin B12 on ICV STZ induced Alzheimer Disease in rats
  20397. Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
  20398. Neuroprotective effects of electro-acupuncture in spinal cord injury rats via up-regulation of DUSP14.
  20399. Nicotine is Neuroprotective to neonatal neurons of sympathetic ganglion in rat
  20400. Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of Neuroprotective EETs and sulfonylurea metabolism in …
  20401. Procognitive and Neuroprotective effect of 5-HT7 agonist in an animal model by ICV amyloid-b injection (P1. 1-005)
  20402. In vitro evidence for post-insult Neuroprotective activity of an evolutionarily conserved motif against excitotoxic neuronal cell death
  20403. Neuroprotective Effects of Four Phenylethanoid
  20404. 141. Autophagy induction contributes to the Neuroprotective effect of intermittent fasting in experimental spinal cord injury
  20405. Morris water maze test on Neuroprotective effects of ethanolic extract of oyster mushroom (Pleurotus ostreatus) against neurotoxicity of mercury chloride in albino rats …
  20406. Sustained Neuroprotective effect of novel Aβ aggregation modulator GAL-101 shown in dry AMD and glaucoma models with transient peak concentrations using eye …
  20407. Neuroprotective Potential of Tetrahydrobiopterin Using a Rat Model
  20408. Homology modeling identified for purported drug targets to the Neuroprotective effects of levodopa and asiaticoside-D in degenerated cerebral ganglions of …
  20409. Neuroprotective Effect of Different Doses of Vitamine D3 in Diabetic-Induced Alzheimer Rat Model
  20410. Synthesis of novel vanillin derivatives: study of their antioxidant and potential Neuroprotective properties.
  20411. Evaluation of Betaine Neuroprotective Effects on 6-Hydroxydopamine-Induced hemi-Parkinsonism in Male Wistar Rats
  20412. Contribution at the Study of Neuroprotective Properties of Neuroglobin during Severe Chronic Glaucoma
  20413. Synthesis of Redox Active Neuroprotective Therapeutic agents
  20414. Guidelines for the Institutional Implementation of Developmental Neuroprotective Care in the NICU: A Joint Position Statement From CANN, CAPWHN, NANN and …
  20415. In Vitro Neuroprotective Properties of Positive Allosteric Modulators and Expression Enhancers of EAAT2
  20416. Neuroprotective effects of myricitrin on cognitive deficits in hippacampal demyelinated rats
  20417. Neuroprotective effects of ganoderma curtisii polysaccharides after kainic acid-seizure induced
  20418. Neuroprotective effect of sacha inchi oil (Plukenetia volubilis L.) in an experimental model of epilepsy
  20419. Neuroprotective Strategies for the Treatment of Blast-Induced Optic Neuropathy
  20420. Neuroprotective effects of 5-HT3 receptor antagonist ondansetron on morphine withdrawal induced brain edema formation, blood-brain barrier dysfunction, neuronal …
  20421. Neuroprotective effect of Salvia splendens extract and its constituents against AlCl3-induced Alzheimer’s disease in rats
  20422. Neuroprotective Effect of Taraxacum platycarpum Extract Against Glutamate-induced Oxidative Stress in HT22 Cells
  20423. Perinatal asphyxia: investigating novel Neuroprotective agents and optimising current pharmacotherapy
  20424. The Neuroprotective Effect of a Synthetic Chalcone Analog Through the Activation of Akt/Erk/Nrf2 Signaling
  20425. Acute Response of Neuroprotective Associated Biomarkers to Various Compound Resistance Exercises in Well-trained Men
  20426. Neuroprotective effect of cannabidiol on NTF-3 and IGF-1 genes expression
  20427. Neuroprotective effects of the novel ethylthiadiazole derivatives (LHT 4-15) in male rats
  20428. Neuroprotective Effect of Glial Cell-Derived Exosomes on Neurons
  20429. Neuroprotective effects of lipopolysaccharide and naltrexone co‑preconditioning in the photothrombotic model of unilateral selective hippocampal ischemia in …
  20430. Neuroprotective role of nicotinamide adenine dinucleotide precursor in modulation of mitochondrial fragmentation and brain energy metabolism
  20431. Study on the Neuroprotective Effect and Mechanism of RasGRP1 After Oxygen Deprivation and Reperfusion Based on Mutual Information and Artificial Neural …
  20432. Neuroprotective effects of Abelmoschus moschatus seed extract on fluoride-induced myelin degeneration in developing brain of rats
  20433. Commentary on Neuroprotective Role of Dexmedetomidine in Epilepsy Surgery
  20434. Neuroprotective and Restorative Potential of Remote Ischemic Conditioning Following Stroke
  20435. Neuroprotective PROPERTIES OF CENTELLA ASIATICA (L.) URBAN ON COMBINED D-GALACTOSE AND ALUMINIUM CHLORIDE-INDUCED …
  20436. Neuroprotective and antioxidant activities of saponins’ mixture from Astragalus glycyphylloides in a model of 6-hydroxydopamine-induced oxidative stress on …
  20437. Medhya rasayana restores memory function against doxorubicin-induced cognitive decline: possibly by its Neuroprotective effect
  20438. The ApoE-dependent Neuroprotective Effects of Sesamol on Diet-induced Obese Mice: The Role of Gut Microbiota and SCFAs (P06-049-19)
  20439. Adenosine triphosphate maintenance by branched chain amino acids as a novel Neuroprotective strategy for retinal neurodegenerative diseases
  20440. Neuroprotective effects of cannabidiol following concussion: A case study
  20441. INVESTIGATION OF Neuroprotective TARGETS FOR PARKINSON’S DISEASE AND THEIR ROLE IN PATHOPHYSIOLOGY WITH A SECONDARY LOOK AT A …
  20442. The Neuroprotective effects of xenon on neonatal rats with white matter damage by regulating expression of microRNA-210 and HIF-1α
  20443. Neuroprotective Effect of Quercetin in 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine-Induced Model of Parkinson’s Disease
  20444. Co‐delivery of Neuroprotective agents from biodegradable microspheres
  20445. Neuroprotective EFFECTS OF ESTROGENS
  20446. Using organotypic hippocampal slice cultures to gain insight into mechanisms responsible for the Neuroprotective effects of meloxicam: a role for gamma …
  20447. Comparative Neuroprotective effects of Progesterone and vitamin E in induced traumatic brain injury in Wistar rat
  20448. Neuroprotective effects of carnitinoid compounds in rodent cellular and in vivo models of mitochondrial complex I dysfunction
  20449. Neuroprotective STRATEGIES FOR OPTIC NEURITIS
  20450. Correction: Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
  20451. Medicinal plants in traumatic brain injury: Neuroprotective mechanism (s)
  20452. Therapeutic Assessment and Neuroprotective Effects of a Novel G Protein‐Coupled Estrogen Receptor (GPR30/GPER) Agonist
  20453. Neuroprotective Effects Of Genistein In Experimental Global Cerebral Ischemia And Reperfusion In Streptozotocin-Induced Diabetic Mice
  20454. Identification of novel Neuroprotective loci modulating ischemic stroke volume in a cross between wild-derived inbred mouse strains
  20455. Neuroprotective Potential of a Lanosteryl Triterpene from Protorhus longifolia Stem Bark (Benrh.) Engl in high fat diet fed and STZ-induced diabetic neuropathy in rats
  20456. Neuroprotective Effects of Metformin Versus Selegiline on Parkinson’s Disease Model By Reserpine through the Interrelation of α Synuclein and Antioxidants …
  20457. Erratum: Lee, JG, et al. The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease. brain Sciences 2019, 9 (10), 285
  20458. Neuroprotective Effects of Omega-3 Polyunsaturated Fatty Acids on Depression and Anxiety
  20459. Neuroprotective effects of Buchholzia coriacea seed extract on sodium azide-induced neurotoxicity of the prefrontal cortex of Wistar rats
  20460. Potential Neuroprotective Drug Evp4593 Reduces Excessive Expression of Huntingtin in iPSC-Based Juvenile Model of Huntington’s Disease
  20461. A55 CELL-MEDIATED DELIVERY OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) IS Neuroprotective FOR MYENTERIC NEURONS
  20462. Evaluation of Neuroprotective Activity of Melissa officinalis in MPTP Model of Parkinson’s Disease in Mice
  20463. Author Correction: ATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is Neuroprotective
  20464. Appraising the Neuroprotective competence of nitrogen-enriched Arthrospira platensis in comparison to commercial resource in depressed mice models
  20465. Correction to: The atypical RhoGTPase RhoE/Rnd3 is a key molecule to acquire a Neuroprotective phenotype in microglia
  20466. CHARACTERIZATION, QUANTIFICATON AND BIOACTIVITIES OF POTENTIAL Neuroprotective PHYTOCHEMICALS OF Centella asiatica (GOTU KOLA)
  20467. Neuroprotective effect of cranberry extract on chronic noise stress-induced changes in rat hippocampus.
  20468. Is dexmedetomidine a potential Neuroprotective agent for term neonates with hypoxic-ischemic encephalopathy?
  20469. Revisiting Pyrazolones As Proteasome Activators With Neuroprotective Activity
  20470. Dynamics changes of post operational cognitive functional to the results of the test on a scout Shylte on the background of Neuroprotective therapy
  20471. Neuroprotective effect of Centella asiatica (L.) Urb. against toxicity induced by different neurotoxic agents in neuroblastoma SH-SY5Y cells/Heymmela Kasi
  20472. Neuroprotective Effects of Lacosamide in Experimental
  20473. Neuroprotective effect of selected herbs on H2O2-induced neuroblastoma cell damage in SH-SY5Y/Farah Azirah Mohd Yusuf
  20474. Porous Materials: Neuroprotective Effect of Nerve Growth Factor Loaded in Porous Silicon Nanostructures in an Alzheimer’s Disease Model and Potential Delivery to …
  20475. The Neuroprotective Effects of Sumo Conjugase, Ubc9, in Dopaminergic Cells and Neurons
  20476. Antioxidant and Neuroprotective effects of caffeoylquinic acids from Geigeria alata
  20477. Multi-target Neuroprotective effect of Xixian Tongshuan Preparation against cerebral ischemia injury
  20478. The experimental Neuroprotective drug Na1 does not interfere with the fibrinolytic activities of alteplase or tenecteplase
  20479. Intraventricular CXCL12 is Neuroprotective and increases neurogenesis in a murine model of stroke
  20480. STUDY OF ZINC BINDING TO Neuroprotective PEPTIDES
  20481. MOLECULAR MECHANISMS UNDERLYING THE Neuroprotective EFFECTS OF AAA ATPase THORASE
  20482. Investigating the Dysregulation and Therapeutic Potential of Neuroprotective Stress Response Proteins in Huntington’s Disease
  20483. Neuroprotective effects of taurine and 3-hydroxypyridine derivatives in the intracerebral hemorrhage model in rats
  20484. The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
  20485. Neuroprotective effects of fasudil, a Rho-kinase inhibitor, in a rat transient forebrain ischemia-reperfusion model
  20486. Do you give Neuroprotective /alternative drugs to manage normal tension glaucoma?
  20487. Examining the Neuroprotective efficacy of arginine-rich peptides in a traumatic brain injury model
  20488. Neuroprotective effect of emodin on acute brain injury in sepsis mice
  20489. Anti-Inflammatory and Neuroprotective Effects of Isoquercitrin Isolated from Aster scaber
  20490. Neuroprotective EFFECT OF FENCHONE ON CHRONIC UNPREDICTABLE MILD STRESS (CUMS) INDUCED NEUROINFLAMMATION
  20491. Extremely low frequency magnetic fields as Neuroprotective treatment in acute ischemic stroke
  20492. Dynamics of changes in the condition of cognitive function according to the results of the Fab scale test on the background of Neuroprotective therapy
  20493. Neuroprotective Activity of Santalum Album Seeds in Sepsis Encephalopathy
  20494. Glycogen synthase kinase-3β may contribute to Neuroprotective effects of Sargassum oligocystum against amyloid-beta in neuronal SH-SY5Y cells
  20495. Effects of combined Neuroprotective and regenerative agents on damaged retinal ganglion cells in vivo
  20496. cognitive Outcome and Neuroprotective Effect of Lithium on Subchronic Alcohol-induced brain Damage in Mice
  20497. Features of the application of Neuroprotective therapy for traumatic optic neuropathy in the clinical setting
  20498. Neuroprotective Effects of Cyperus rotundus Rhizome Extract on Ischemic brain Injury: Expression profile of Bax, Bcl2, Bad and Bclxl Genes
  20499. Corrigendum: HDAC1 Silence Promotes Neuroprotective Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Mouse Model of Traumatic brain …
  20500. A systematic review of minor phytocannabinoids with promising Neuroprotective potential
  20501. Nanotechnology: a promising approach for delivery of Neuroprotective drugs
  20502. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and Neuroprotective treatment for COVID-19
  20503. Neuroprotective effects of quercetin in Alzheimer’s disease
  20504. Neuroprotective role of lactate in rat neonatal hypoxia-ischemia
  20505. Neuroprotective potentials of marine algae and their bioactive metabolites: Pharmacological insights and therapeutic advances
  20506. The antioxidant activity and Neuroprotective mechanism of isoliquiritigenin
  20507. Natural products and their bioactive compounds: Neuroprotective potentials against neurodegenerative diseases
  20508. Emerging Neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
  20509. Harnessing regulatory T cell Neuroprotective activities for treatment of neurodegenerative disorders
  20510. Current status and future prospects of pathophysiology-based Neuroprotective drugs for the treatment of vascular dementia
  20511. Possible Neuroprotective mechanisms of physical exercise in neurodegeneration
  20512. Neuroprotective potential of chrysin in Parkinson’s disease: Molecular mechanisms and clinical implications
  20513. Neuroprotective effects of curcumin through autophagy modulation
  20514. Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration
  20515. Neuroprotective effects of doxycycline in the R6/2 mouse model of Huntington’s disease
  20516. Exploring the multifunctional Neuroprotective promise of rasagiline derivatives for multi-dysfunctional Alzheimer’s disease
  20517. Can selective serotonin reuptake inhibitors have a Neuroprotective effect during COVID-19?
  20518. Synthesis of dithiolethiones and identification of potential Neuroprotective agents via activation of Nrf2-driven antioxidant enzymes
  20519. Exploring the multifaceted Neuroprotective actions of gallic acid: A review
  20520. Neuroprotective Effect of Antioxidants in the brain
  20521. Efficacy of three Neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo …
  20522. Novel Neuroprotective therapy with NeuroHeal by autophagy induction for damaged neonatal motoneurons
  20523. The Neuroprotective role of reactive astrocytes after central nervous system injury
  20524. Neuroprotective and Anti-Inflammatory Effects of Low–Moderate Dose Ionizing Radiation in Models of Alzheimer’s Disease
  20525. In vitro and in vivo evaluation of the Neuroprotective activity of Uncaria hirsuta Haviland
  20526. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and Neuroprotective mechanisms in epilepsy and Alzheimer’s disease
  20527. Potential Neuroprotective effect of the HMGB1 inhibitor Glycyrrhizin in neurological disorders
  20528. Neuroprotective effects of selective inhibition of histone deacetylase 3 in experimental stroke
  20529. Antioxidative and antiapoptosis: Neuroprotective effects of dauricine in Alzheimer’s disease models
  20530. L-linalool exerts a Neuroprotective action on hemiparkinsonian rats
  20531. ROCK inhibitors upregulate the Neuroprotective Parkin-mediated mitophagy pathway
  20532. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
  20533. Pharmacological mechanisms underlying the Neuroprotective effects of alpinia oxyphylla miq. On alzheimer’s disease
  20534. Deciphering the Neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPPα)
  20535. A lncRNA survey finds increases in Neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra
  20536. Neuroprotective polyphenols: A modulatory action on neurotransmitter pathways
  20537. Neuroprotective and neurotoxic outcomes of androgens and estrogens in an oxidative stress environment
  20538. Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
  20539. Neuroprotective effects of minocycline on focal cerebral ischemia injury: a systematic review
  20540. Renoprotective and Neuroprotective effects of enteric hydrogen generation from Si-based agent
  20541. Neuroprotective effects of diabetes drugs for the treatment of neonatal hypoxia-ischemia encephalopathy
  20542. Cationic arginine-rich peptides (CARPs): A novel class of Neuroprotective agents with a multimodal mechanism of action
  20543. Neuroprotective effect of Wogonin on Rat’s brain exposed to gamma irradiation
  20544. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson’s disease
  20545. Neuroprotective role of luteolin against lead acetate-induced cortical damage in rats
  20546. The Effect of (Poly) phenol-Rich Interventions on cognitive Functions and Neuroprotective Measures in Healthy Aging Adults: A Systematic Review and Meta-Analysis
  20547. New endovascular approach for hypothermia with intrajugular cooling and Neuroprotective effect in ischemic stroke
  20548. The metabolite urolithin-A ameliorates oxidative stress in Neuro-2a cells, becoming a potential Neuroprotective agent
  20549. Neuroprotective effect of melatonin on radiation‐induced oxidative stress and apoptosis in the brain stem of rats
  20550. Intranasal delivery of mesenchymal stem cell‐derived extracellular vesicles exerts immunomodulatory and Neuroprotective effects in a 3xTg model of Alzheimer’s …
  20551. Neuroprotective effect of subdural infusion of Serp-1 in spinal cord trauma
  20552. Neuroprotective Function of a Novel Hexapeptide QMDDQ from Shrimp via Activation of the PKA/CREB/BNDF Signaling Pathway and Its Structure–Activity …
  20553. Neuroprotective effect of rutin against colistin-induced oxidative stress, inflammation and apoptosis in rat brain associated with the CREB/BDNF expressions
  20554. The Neuroprotective effect of quetiapine in critically ill traumatic brain injury patients
  20555. Polyherbal drug loaded starch nanoparticles as promising drug delivery system: Antimicrobial, antibiofilm and Neuroprotective studies
  20556. Neuroprotective effects of ZL006 in Aβ1–42-treated neuronal cells
  20557. Neuroprotective effects of pomegranate juice against Parkinson’s disease and presence of ellagitannins-derived metabolite—Urolithin a—In the brain
  20558. VEGF is an autocrine/paracrine Neuroprotective factor for injured retinal ganglion neurons
  20559. Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective agents
  20560. Palhinosides A–H: Flavone Glucosidic Truxinate Esters with Neuroprotective Activities from Palhinhaea cernua
  20561. Neuroprotective and neuromodulatory effects induced by cannabidiol and cannabigerol in rat hypo-E22 cells and isolated hypothalamus
  20562. Neuroprotective effect of lithium in cold-induced traumatic brain injury in mice
  20563. Neuroprotective effect of astrocyte-derived IL-33 in neonatal hypoxic-ischemic brain injury
  20564. Development of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood–brain Barrier
  20565. Neuroprotective role of glutathione peroxidase 4 in experimental subarachnoid hemorrhage models
  20566. Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling
  20567. A fructan from Anemarrhena asphodeloides Bunge showing Neuroprotective and immunoregulatory effects
  20568. Altered secretory and Neuroprotective function of the choroid plexus in progressive multiple sclerosis
  20569. TET3 regulates DNA hydroxymethylation of Neuroprotective genes following focal ischemia
  20570. Neuroprotective and neurorestorative effects of Epo and VEGF: Perspectives for new therapeutic approaches to neurological diseases
  20571. Evaluating the Neuroprotective impact of senolytic drugs on human vision
  20572. Behavioral and electrophysiological evidence for a Neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model
  20573. The Neuroprotective properties of carnosine in a mouse model of manganism is mediated via mitochondria regulating and antioxidative mechanisms
  20574. Neuroimmunomodulatory and Neuroprotective effects of the flavonoid apigenin in in vitro models of neuroinflammation associated with Alzheimer’s disease
  20575. Neuroprotective effect of chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of DA neurons in a Parkinsonian mouse model
  20576. Probiotic properties and Neuroprotective effects of Lactobacillus buchneri KU200793 isolated from Korean fermented foods
  20577. Hibiscus sabdariffa L.: A potent natural Neuroprotective agent for the prevention of streptozotocin-induced Alzheimer’s disease in mice
  20578. Isolation of triterpenoid saponins from Medicago sativa L. with Neuroprotective activities
  20579. Edible seaweed-derived constituents: an undisclosed source of Neuroprotective compounds
  20580. Natural compounds as inhibitors of transthyretin amyloidosis and Neuroprotective agents : Analysis of structural data for future drug design
  20581. Neuroprotective role of taurine on MK-801-induced memory impairment and hyperlocomotion in zebrafish
  20582. GIP has Neuroprotective effects in Alzheimer and Parkinson’s disease models
  20583. Neuroprotective effect of resveratrol via activation of Sirt1 signaling in a rat model of combined diabetes and Alzheimer’s disease
  20584. Apoptotic inducement of neuronal cells by aluminium chloride and the Neuroprotective effect of eugenol in wistar rats
  20585. Structural characterization, Neuroprotective and hepatoprotective activities of flavonoids from the bulbs of Heleocharis dulcis
  20586. Ginseng polysaccharides: A potential Neuroprotective agent
  20587. Neuroprotective effect of ropinirole lipid nanoparticles enriched hydrogel for parkinson’s disease: In vitro, ex vivo, pharmacokinetic and pharmacodynamic evaluation
  20588. Of mice and monkeys: Neuroprotective efficacy of the p38 inhibitor BIRB 796 depends on model duration in experimental glaucoma
  20589. Characterization and Neuroprotective properties of alkaloid extract of Vernonia amygdalina Delile in experimental models of Alzheimer’s disease
  20590. Circular RNA circDLGAP4 exerts Neuroprotective effects via modulating miR-134-5p/CREB pathway in Parkinson’s disease
  20591. Neuroprotective terpenoids from the leaves of Viburnum odoratissimum
  20592. Comparison of Neuroprotective effects of monomethylfumarate to the sigma 1 receptor ligand (+)-pentazocine in a murine model of retinitis pigmentosa
  20593. … expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and Neuroprotective effects in the …
  20594. Patient semi-specific computational modeling of electromagnetic stimulation applied to Neuroprotective treatments in acute ischemic stroke
  20595. Restoration of CTSD (cathepsin D) and lysosomal function in stroke is Neuroprotective
  20596. Neuroprotective effect of CPCGI on Alzheimer’s disease and its mechanism
  20597. Neuroprotective effects of natural compounds on LPS-induced inflammatory responses in microglia
  20598. Neuroprotective and MAOB inhibitory effects of a series of caffeine-8-thioglycolic acid amides
  20599. Synergistic Neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway
  20600. Improved Neuroprotective effects of gallic acid-loaded chitosan nanoparticles against ischemic stroke
  20601. Potential therapeutic application of zinc oxide nanoflowers in the cerebral ischemia rat model through neuritogenic and Neuroprotective properties
  20602. Evaluation of the Neuroprotective effect of taurine in Alzheimer’s disease using functional molecular imaging
  20603. Arginine is Neuroprotective through suppressing HIF-1α/LDHA-mediated inflammatory response after cerebral ischemia/reperfusion injury
  20604. Recent advances in neurogenic and Neuroprotective effects of curcumin through the induction of neural stem cells
  20605. Neuroprotective and anti-inflammatory effect of tangeretin against cerebral ischemia-reperfusion injury in rats
  20606. Longshengzhi capsules improve ischemic stroke outcomes and reperfusion injury via the promotion of anti-inflammatory and Neuroprotective effects in MCAO …
  20607. … of Nitriles with Cyclic Diaryl Iodonium Salts: Direct Access to Structurally Diversified Diarylmethane Amides with Potential Neuroprotective and Anticancer Activities
  20608. Long-term continuous cervical spinal cord stimulation exerts Neuroprotective effects in experimental Parkinson’s disease
  20609. Antioxidant drug therapy as a Neuroprotective countermeasure of nerve agent toxicity
  20610. Synthesis, in vitro and structural aspects of benzothiazole analogs as anti-oxidants and potential Neuroprotective agents
  20611. Neuroprotective potential of allium sativum against monosodium glutamate-induced excitotoxicity: impact on short-term memory , gliosis, and oxidative stress
  20612. HPTLC based approach for bioassay-guided evaluation of antidiabetic and Neuroprotective effects of eight essential oils of the Lamiaceae family plants
  20613. Neuroprotective effects of miR-532-5p against ischemic stroke
  20614. Structural characteristics of Medicago Sativa L. Polysaccharides and Se-modified polysaccharides as well as their antioxidant and Neuroprotective activities
  20615. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and Neuroprotective glia in Alzheimer’s disease
  20616. Antioxidant activity and Neuroprotective effects of ethanol extracts from the core of Diospyros kaki
  20617. Neuroprotective effects of limonene (+) against Aβ42-induced neurotoxicity in a Drosophila model of Alzheimer’s disease
  20618. Ischemic postconditioning exerts Neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124
  20619. Neuroprotective modulation of microglia effector functions following priming with interleukin 4 and 13: Current limitations in understanding their mode-of-action
  20620. Neuroprotective effect of 25-Methoxyhispidol A against CCl4-induced behavioral alterations by targeting VEGF/BDNF and caspase-3 in mice
  20621. Evaluation of the Neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson’s disease
  20622. Neuroprotective effect of phthalide derivative CD21 against ischemic brain injury: involvement of MSR1 mediated DAMP peroxiredoxin1 clearance and TLR4 …
  20623. Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
  20624. Neuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia
  20625. Safety and Neuroprotective efficacy of palm oil and tocotrienol-rich fraction from palm oil: A systematic review
  20626. Rosmarinic acid exerts a Neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κB …
  20627. Neuroprotective effect of salvianolic acid a against diabetic peripheral neuropathy through modulation of nrf2
  20628. Impact of Ecklonia radiata extracts on the Neuroprotective activities against amyloid beta (Aβ1-42) toxicity and aggregation
  20629. The Neuroprotective and biomarker potential of PACAP in human traumatic brain injury
  20630. Neuroprotective Effects of Trilobatin, a Novel Naturally Occurring Sirt3 Agonist from Lithocarpus polystachyus Rehd., Mitigate Cerebral Ischemia/Reperfusion Injury …
  20631. Neuroprotective and Anti—Neuroinflammatory Effects of a Poisonous Plant Croton tiglium Linn. Extract
  20632. Neuroprotective and anti-neuroinflammatory properties of ebselen derivatives and their potential to inhibit neurodegeneration
  20633. Neuroprotective activity of ursodeoxycholic acid in CHMP2BIntron5 models of frontotemporal dementia
  20634. Comparing the Neuroprotective effects of caffeic acid in rat cortical slices and Caenorhabditis elegans: Involvement of Nrf2 and SKN-1 signaling pathways
  20635. Neuroprotective effect of crocin against rotenone-induced Parkinson’s disease in rats: Interplay between PI3K/Akt/mTOR signaling pathway and enhanced expression …
  20636. Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone-and Iron Supplement–Induced Parkinson’s Disease in Experimental Rats
  20637. Serial Systemic Injections of Endotoxin (LPS) Elicit Neuroprotective Spinal Cord Microglia through IL-1-Dependent Cross Talk with Endothelial Cells
  20638. Modified Eremophilanes from Parasenecio hastatus and Their Neuroprotective Activities
  20639. Neuroprotective mechanisms of three natural antioxidants on a rat model of Parkinson’s disease: A Comparative Study
  20640. Discovery of guaiane-type sesquiterpenoids from the roots of Daphne genkwa with Neuroprotective effects
  20641. Identification and optimization of piperine analogues as Neuroprotective agents for the treatment of Parkinson’s disease via the activation of Nrf2/keap1 pathway
  20642. Neuroprotective effect of chrysin on isoniazid-induced neurotoxicity via suppression of oxidative stress, inflammation and apoptosis in rats
  20643. Neuroprotective effects of olanzapine against rotenone-induced toxicity in PC12 cells
  20644. Neuroprotective Effects of Dried Tubers of Aconitum napellus
  20645. A new tetracyclic saponin from Astragalus glycyphyllos L. and its Neuroprotective and hMAO-B inhibiting activity
  20646. Neuroprotective Effects of Necrostatin-1 Against Oxidative Stress–Induced Cell Damage: an Involvement of Cathepsin D Inhibition
  20647. Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer’s disease
  20648. Neuroprotective action of teriflunomide in a mouse model of transient middle cerebral artery occlusion
  20649. Evaluation of Neuroprotective and anti-amnesic effects of Elaeagnus umbellata Thunb. On scopolamine-induced memory impairment in mice
  20650. Antioxidant properties and Neuroprotective effects of Esc-1GN through the regulation of MAPK and AKT signaling
  20651. TGFβ3 is Neuroprotective and alleviates the neurotoxic response induced by aligned poly-l-lactic acid fibers on naïve and activated primary astrocytes
  20652. Neuroprotective effects of carnosine-loaded elastic liposomes in cerebral ischemia rat model
  20653. Extracellular Matrix (ECM)-Mimicking Neuroprotective Injectable Sulfo-Functionalized Peptide Hydrogel for Repairing brain Injury
  20654. Pyridoxine-resveratrol hybrids as novel inhibitors of Mao-B with antioxidant and Neuroprotective activities for the treatment of parkinson’s disease
  20655. An early Neuroprotective effect of atorvastatin against subarachnoid hemorrhage
  20656. Glyproline Pro-Ampakine with Neuroprotective Activity
  20657. Quantitative proteomics reveals docosahexaenoic acid-mediated Neuroprotective effects in lipopolysaccharide-stimulated microglial cells
  20658. Neuroprotective activity of Mentha species on hydrogen peroxide-induced apoptosis in SH-SY5Y cells
  20659. Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke
  20660. Neuroprotective effect of the inhibitor salubrinal after cardiac arrest in a rodent model
  20661. … most acute stroke studies are positive in animals but not in patients: a systematic comparison of preclinical, early phase, and phase 3 clinical trials of Neuroprotective …
  20662. Neuroprotective and anti-inflammatory effects of pterostilbene metabolites in human neuroblastoma SH-SY5Y and RAW 264.7 macrophage cells
  20663. Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and Neuroprotective strategies
  20664. Neuroprotective Effect of Brazilin on Amyloid β (25–35)-Induced Pathology in a Human Neuroblastoma Model
  20665. Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson’s disease
  20666. The Neuroprotective effects of exercise on cognitive decline: a preventive approach to Alzheimer disease
  20667. Neuroprotective effect of menaquinone-4 (MK-4) on transient global cerebral ischemia/reperfusion injury in rat
  20668. Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model
  20669. Neuroprotective effect of deferoxamine on erastin-induced ferroptosis in primary cortical neurons
  20670. Antioxidant mechanisms in the Neuroprotective action of cemtirestat: studies in chemical models, liposomes and rat brain cortical slices
  20671. Isolation, structure elucidation and Neuroprotective effects of caffeoylquinic acid derivatives from the roots of Arctium lappa L.
  20672. Dopaminergic Neuroprotective effects of rotigotine via 5-HT1A receptors: possibly involvement of metallothionein expression in astrocytes
  20673. Chemical composition, antioxidant activity, anti-inflammatory and Neuroprotective effect of Croton matourensis Aubl. Leaves extracts obtained by supercritical CO2
  20674. Neuroprotective effects of Syringic acid against aluminium chloride induced oxidative stress mediated neuroinflammation in rat model of Alzheimer’s disease
  20675. Sterubin: enantioresolution and configurational stability, enantiomeric purity in nature, and Neuroprotective activity in vitro and in vivo
  20676. Neuroprotective effect of microglia against impairments of auditory steady-state response induced by anti-P IgG from SLE patients in naive mice
  20677. Neuroprotective and neurodegenerative aspects of coffee and its active ingredients in view of scientific literature
  20678. Identification of potential natural Neuroprotective molecules for Parkinson’s disease by using chemoinformatics and molecular docking
  20679. Risk-adjusted/Neuroprotective care services in the NICU: the elemental role of the neonatal therapist (OT, PT, SLP)
  20680. Neuroprotective effect of bergamot juice in 6-OHDA-induced SH-SY5Y cell death, an in vitro model of Parkinson’s disease
  20681. Human mesenchymal stem cell secretome exhibits a Neuroprotective effect over in vitro retinal photoreceptor degeneration
  20682. The Delayed Neuroprotective Effect of Methylene Blue in Experimental Rat brain Trauma
  20683. Cold exposure after exercise impedes the Neuroprotective effects of exercise on thermoregulation and UCP4 expression in an MPTP-induced Parkinsonian …
  20684. Neuroprotective Properties and Therapeutic Potential of Bone Marrow–Derived Microglia in Alzheimer’s Disease
  20685. Identification of Molecular Network Associated with Neuroprotective Effects of Yashtimadhu (Glycyrrhiza glabra L.) by Quantitative Proteomics of Rotenone-Induced …
  20686. Neuroprotective effects and treatment potential of incretin mimetics in a murine model of mild traumatic brain injury
  20687. Tibolone as Hormonal Therapy and Neuroprotective Agent
  20688. In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models
  20689. Neuroprotective effect of chitosan nanoparticle gene delivery system grafted with acteoside (ACT) in Parkinson’s disease models
  20690. Neuroprotective mechanisms of selenium against arsenic-induced behavioral impairments in rats
  20691. Enhanced oral bioavailability and Neuroprotective effect of fisetin through its SNEDDS against rotenone-induced Parkinson’s disease rat model
  20692. Thai trauma nurses’ knowledge of Neuroprotective nursing care of traumatic brain injury patients: A survey study
  20693. Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
  20694. Evaluation of the Neuroprotective effects of ozone in an experimental spine injury model
  20695. Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice
  20696. The Neuroprotective effect of the HDAC2/3 inhibitor MI192 on the Penumbra after photothrombotic stroke in the mouse brain
  20697. Neuroprotective effects of hesperidin against methotrexate-induced changes in neurogenesis and oxidative stress in the adult rat
  20698. Haematococcus pluvialis-derived astaxanthin is a potential Neuroprotective agent against optic nerve ischemia
  20699. Evaluation of Neuroprotective effects of quercetin against aflatoxin b1-intoxicated mice
  20700. Elucidation of the Structure and Synthesis of Neuroprotective Low Molecular Mass Components of the Parawixia bistriata Spider Venom
  20701. Synthesis and biological evaluation of isoliquiritigenin derivatives as a Neuroprotective agent against glutamate mediated neurotoxicity in HT22 cells
  20702. Neuroprotective effects of a ketogenic diet in combination with exogenous ketone salts following acute spinal cord injury
  20703. Neuroprotective effects of oolong tea extracts against glutamate-induced toxicity in cultured neuronal cells and β-amyloid-induced toxicity in Caenorhabditis elegans
  20704. Neuroprotective effects of saffron on the late cerebral ischemia injury through inhibiting astrogliosis and glial scar formation in rats
  20705. Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial
  20706. Neuroprotective effects of salidroside in a mouse model of Alzheimer’s disease
  20707. Neuroprotective activities of bacopa, lycopene, astaxanthin, and vitamin B12 combination on oxidative stress‐dependent neuronal death
  20708. Neuroprotective effect of dimethyl fumarate on cognitive impairment induced by ischemic stroke
  20709. Neuroprotective potential of azilsartan against cerebral ischemic injury: Possible involvement of mitochondrial mechanisms
  20710. Neuroprotective effects of astaxanthin against oxygen and glucose deprivation damage via the PI3K/Akt/GSK3β/Nrf2 signalling pathway in vitro
  20711. Sulfur-containing secondary metabolites as Neuroprotective agents
  20712. Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer’s disease
  20713. Neuroprotective Effects of Deuterium-Depleted Water (DDW) Against H 2 O 2-Induced Oxidative Stress in Differentiated PC12 Cells Through the PI3K/Akt Signaling …
  20714. A cannabinoid receptor-mediated mechanism participates in the Neuroprotective effects of oleamide against excitotoxic damage in rat brain synaptosomes and cortical …
  20715. Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors
  20716. Intra-arterial Neuroprotective therapy as an adjunct to endovascular intervention in acute ischemic stroke: A review of the literature and future directions
  20717. Neuroprotective effects of resveratrol against oxygen glucose deprivation induced mitochondrial dysfunction by activation of AMPK in SH-SY5Y cells with 3D gelatin …
  20718. Thymus algeriensis and Thymus fontanesii exert Neuroprotective effect against chronic constriction injury-induced neuropathic pain in rats
  20719. Pharmacological targeting of β2‐adrenoceptors is Neuroprotective in the LPS inflammatory rat model of Parkinson’s disease
  20720. Fruit Quality Characterization of New Sweet Cherry Cultivars as a Good Source of Bioactive Phenolic Compounds with Antioxidant and Neuroprotective Potential
  20721. Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson’s disease: significance of SIRT3-mediated FOXO3 deacetylation
  20722. Molecular, histological and behavioral evidences for Neuroprotective effects of minocycline against nicotine-induced neurodegeneration and cognition impairment …
  20723. Scorpion venom heat-resistant peptide is Neuroprotective against cerebral ischemia-reperfusion injury in association with the nmda-mapk pathway
  20724. Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson’s disease
  20725. Neuroprotective effect of Convolvulus pluricaulis Choisy in oxidative stress model of cerebral ischemia reperfusion injury and assessment of MAP2 in rats
  20726. Neuroprotective effects of vomifoliol, isolated from Tarenna obtusifolia Merr.(Rubiaceae), against amyloid-beta 1-42-treated neuroblastoma SH-SY5Y cells
  20727. Apilarnil: A Novel Neuroprotective Candidate
  20728. Capsaicin exerts anti-convulsant and Neuroprotective effects in pentylenetetrazole-induced seizures
  20729. Neuroprotective effects of endogenous secretory receptor for advanced glycation end-products in brain ischemia
  20730. Using acute optic neuritis trials to assess Neuroprotective and remyelinating therapies in multiple sclerosis
  20731. Plant polyphenols as Neuroprotective agents in Parkinson’s disease Targeting Oxidative Stress
  20732. Topical recombinant human Nerve growth factor (rh-NGF) is Neuroprotective to retinal ganglion cells by targeting secondary degeneration
  20733. UPLC-Orbitrap HRMS metabolic profiling of Cymbopogon citratus cultivated in Egypt; Neuroprotective effect against AlCl3-induced neurotoxicity in rats
  20734. Glibenclamide as a Neuroprotective antidementia drug
  20735. Levetiracetam, an antiepileptic drug has Neuroprotective effects on intracranial hemorrhage injury
  20736. Hormesis and ginseng: ginseng mixtures and individual constituents commonly display hormesis dose responses, especially for Neuroprotective effects
  20737. Neuroprotective effect of melatonin loaded in ethylcellulose nanoparticles applied topically in a retinal degeneration model in rabbits
  20738. Neuroprotective effects of ethyl Pyruvate against aluminum chloride-induced Alzheimer’s disease in rats via inhibiting toll-like receptor 4
  20739. Lycopene-A pleiotropic Neuroprotective nutraceutical: Deciphering its therapeutic potentials in broad spectrum neurological disorders
  20740. Neuroprotective biomarkers and cognitive function in a long-term prospective population-based study of aging US adults
  20741. A new multigene HCIQ subfamily from the sea anemone Heteractis crispa encodes Kunitz-peptides exhibiting Neuroprotective activity against 6 …
  20742. Neuroprotective effects of tetrahydrocurcumin against glutamate-induced oxidative stress in hippocampal HT22 cells
  20743. Intravitreal stem cell paracrine properties as a potential Neuroprotective therapy for retinal photoreceptor neurodegenerative diseases
  20744. Aerobic Exercise and Healthy Nutrition as Neuroprotective agents for brain Health in Patients with Parkinson’s Disease: A Critical Review of the Literature
  20745. When is a potential new Neuroprotective treatment ready for translation?
  20746. Isolation of macrocarpene-type sesquiterpenes from stigma maydis with Neuroprotective activities
  20747. Solid Lipid Nanoparticles Enhanced the Neuroprotective Role of Curcumin against Epilepsy through Activation of Bcl-2 Family and P38 MAPK Pathways
  20748. HspB5 Activates a Neuroprotective Glial Cell Response in Experimental Tauopathy
  20749. S-EQUOL: a Neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV
  20750. Neuroprotective actions of leptin facilitated through balancing mitochondrial morphology and improving mitochondrial function
  20751. Antidepressant, anxiolytic and Neuroprotective activities of two zinc compounds in diabetic rats
  20752. Neuroprotective Effect of New Nanochelating-Based Nano Complex, ALZc3, Against Aβ (1–42)-Induced Toxicity in Rat: a Comparison with Memantine
  20753. Gender biased Neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
  20754. Antioxidant and Neuroprotective effects induced by cannabidiol and cannabigerol in rat CTX-TNA2 astrocytes and isolated cortexes
  20755. The Neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction
  20756. The Neuroprotective effect of curcumin against Cd-induced neurotoxicity and hippocampal neurogenesis promotion through CREB-BDNF signaling pathway
  20757. Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
  20758. Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy
  20759. Neuroprotective effects of novel nitrones: In vitro and in silico studies
  20760. Neuroprotective effects of casein-derived peptide Met-Lys-Pro (MKP) in a hypertensive model
  20761. Paeoniflorin exerts Neuroprotective effects in a transgenic mouse model of Alzheimer’s disease via activation of adenosine A1 receptor
  20762. Potency of Selected Berries, Grapes, and Citrus Fruit as Neuroprotective agents
  20763. Increases in retinal nerve fiber layer thickness may represent the Neuroprotective effect of cannabis: an optical coherence tomography study
  20764. Antioxidant, antimicrobial and Neuroprotective effects of Octaviania asterosperma in vitro
  20765. Neuroprotective immunity by essential nutrient “Choline” for the prevention of SARS CoV2 infections: An in silico study by molecular dynamics approach
  20766. TNFα-mediated priming of mesenchymal stem cells enhances their Neuroprotective effect on retinal ganglion cells
  20767. Antinociceptive and Neuroprotective effects of bromelain in chronic constriction injury-induced neuropathic pain in Wistar rats
  20768. Rapid remote conditioning mediates modulation of blood cell paracrine activity and leads to the production of a secretome with Neuroprotective features
  20769. Neuroprotective Effect of Danhong Injection on Cerebral Ischemia-Reperfusion Injury in Rats by Activation of the PI3K-Akt Pathway
  20770. Neuroprotective Cationic Arginine-Rich Peptides (CARPs): An Assessment of Their Clinical Safety
  20771. Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine …
  20772. Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
  20773. Neuroprotective potential of choline alfoscerate against β‐amyloid injury: Involvement of neurotrophic signals
  20774. Adding value to polyvinylpolypyrrolidone winery residue: A resource of polyphenols with Neuroprotective effects and ability to modulate type 2 diabetes-relevant …
  20775. Structurally Diverse Flavonolignans with Immunosuppressive and Neuroprotective Activities from the Fruits of Hippophae rhamnoides L.
  20776. A More Comprehensive Approach to the Neuroprotective Potential of Long-Chain Polyunsaturated Fatty Acids in Preterm Infants Is Needed—Should We …
  20777. Evaluation of the Neuroprotective effect of microglial depletion by CSF-1R inhibition in a Parkinson’s animal model
  20778. Astrocyte-derived estrogen regulates reactive astrogliosis and is Neuroprotective following ischemic brain injury
  20779. Neuroprotective effects of mitochondria‐targeted curcumin against rotenone‐induced oxidative damage in cerebellum of mice
  20780. The circadian nuclear receptor RORα negatively regulates cerebral ischemia–reperfusion injury and mediates the Neuroprotective effects of melatonin
  20781. Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and Neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
  20782. Coumarin‐Rasagiline Hybrids as Potent and Selective hMAO‐B Inhibitors, Antioxidants, and Neuroprotective agents
  20783. The possible Neuroprotective effect of silymarin against aluminum chloride-prompted Alzheimer’s-like disease in Rats
  20784. Phenolic profiles of hardy kiwifruits and their Neuroprotective effects on PC-12 and SH-SY5Y cells against oxidative stress
  20785. Neuroprotective mechanism of L-cysteine after subarachnoid hemorrhage
  20786. Neuroprotective properties of green tea (Camellia sinensis) in Parkinson’s disease: a review
  20787. Iranian brown propolis possesses Neuroprotective effect against ischemic neuronal damage in mice
  20788. Neuroprotective effects of human neural stem cells over-expressing choline acetyltransferase in a middle cerebral artery occlusion model
  20789. Tavarua Deoxyriboside A and Jasplakinolide as Potential Neuroprotective agents : Effects on Cellular Models of Oxidative Stress and Neuroinflammation
  20790. An Insight of Vitamin E as Neuroprotective agents
  20791. Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in alzheimer’s disease
  20792. Injectable, photoresponsive hydrogels for delivering Neuroprotective proteins enabled by metal-directed protein assembly
  20793. Astrocyte-derived exosome-transported microrna-34c is Neuroprotective against cerebral ischemia/reperfusion injury via tlr7 and the nf-κb/mapk pathways
  20794. Open and rearranged norbornane derived polycyclic cage molecules as potential Neuroprotective agents through attenuation of MPP+-and calcium overload-induced …
  20795. Neuroprotective effects of vitamin D and 17ß-estradiol against ovariectomy-induced neuroinflammation and depressive-like state: Role of the AMPK/NF-κB pathway
  20796. Prohibitin S-nitrosylation is required for the Neuroprotective effect of nitric oxide in neuronal cultures
  20797. Up-regulation of HIF-1α is associated with Neuroprotective effects of agmatine against rotenone-induced toxicity in differentiated SH-SY5Y cells
  20798. Neuroprotective associations of apolipoproteins AI and A-II with neurofilament levels in early multiple sclerosis
  20799. Microglial-specific depletion of TAK1 is Neuroprotective in the acute phase after ischemic stroke
  20800. The Synergistic and Neuroprotective Effects of Alcohol–Antioxidant Treatment on Blood–brain Barrier Endothelial Cells
  20801. Neuroprotective effect of Brazilian green propolis on retinal ganglion cells in ischemic mouse retina
  20802. From synaptic dysfunction to Neuroprotective strategies in genetic Parkinson’s disease: lessons from LRRK2
  20803. Neuroprotective effects of mirtazapine and imipramine and their effect in pro-and anti-apoptotic gene expression in human neuroblastoma cells
  20804. Melatonin exerts Neuroprotective effects by inhibiting neuronal pyroptosis and autophagy in STZ‐induced diabetic mice
  20805. Neuroprotective role of quercetin on rotenone-induced toxicity in SH-SY5Y cell line through modulation of apoptotic and autophagic pathways
  20806. Neuroprotective effects of leptin on cerebral ischemia through JAK2/STAT3/PGC-1-mediated mitochondrial function modulation
  20807. Neuroprotective role of alendronate against APP processing and neuroinflammation in mice fed a high fat diet
  20808. Small-Molecule Ligands that Bind the RET Receptor Activate Neuroprotective Signals Independent of but Modulated by Coreceptor GFRα1
  20809. Salidroside as a potential Neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety
  20810. The potential Neuroprotective role of mesenchymal stem cell-derived exosomes in cerebellar cortex lipopolysaccharide-induced neuroinflammation in rats: A …
  20811. Structural characterization and Neuroprotective effect of a polysaccharide from Corydalis yanhusuo
  20812. Both N-Terminal and C-Terminal Histidine Residues of the Prion Protein Are Essential for Copper Coordination and Neuroprotective Self-Regulation
  20813. Neuroprotective effect of apigenin against cerebral ischemia/reperfusion injury
  20814. Alpha-pinene exerts Neuroprotective effects via anti-inflammatory and anti-apoptotic mechanisms in a rat model of focal cerebral ischemia-reperfusion
  20815. Neuroprotective effect of low-intensity transcranial ultrasound stimulation in moderate traumatic brain injury rats
  20816. The Neuroprotective effect of NeuroAid on morphine-induced amnesia with respect to the expression of TFAM, PGC-1α, ΔfosB and CART genes in the hippocampus of …
  20817. Neuroprotective mechanism involved in spinal cord stimulation postconditioning
  20818. Neuroprotective effect of novel celecoxib derivatives against spinal cord injury via attenuation of COX-2, oxidative stress, apoptosis and inflammation
  20819. Neuroprotective γ-Pyrones from Fusarium Solani JS-0169: Cell-Based Identification of Active Compounds and an Informatics Approach to Predict the Mechanism of …
  20820. Neuroprotective effects of adenosine A1 receptor signaling on cognitive impairment induced by chronic intermittent hypoxia in mice
  20821. 17β-Estradiol augments the Neuroprotective effect of agomelatine in depressive-and anxiety-like behaviors in ovariectomized rats
  20822. Profiles and Neuroprotective effects of Lycium ruthenicum polyphenols against oxidative stress‐induced cytotoxicity in PC12 cells
  20823. Neuroprotective effects of cerium oxide nanoparticles on experimental stress-induced depression in male rats
  20824. Repurposing of secukinumab as Neuroprotective in cuprizone-induced multiple sclerosis experimental model via inhibition of oxidative, inflammatory, and …
  20825. GPR68 Is a Neuroprotective Proton Receptor in brain Ischemia
  20826. Dihydro-β-agarofuran sesquiterpenoid derivatives with Neuroprotective activity from the leaves of Tripterygium wilfordii
  20827. The leading edge: Emerging Neuroprotective and neuroregenerative cell‐based therapies for spinal cord injury
  20828. Neuroprotective effect of red quinoa seeds extract on scopolamine-induced declarative memory deficits in mice: The role of acetylcholinesterase and oxidative …
  20829. Novel dammarane-type saponins from Gynostemma pentaphyllum and their Neuroprotective effect
  20830. Neuroprotective effects of fluoxetine against chronic stress-induced neural inflammation and apoptosis: involvement of the p38 activity
  20831. Lipidomics-based study on the Neuroprotective effect of geissoschizine methyl ether against oxidative stress-induced cytotoxicity
  20832. Dendritic arbor complexity and spine density changes after repetitive mild traumatic brain injury and Neuroprotective treatments
  20833. Clay-based hybrids for controlled release of 7-azaindole derivatives as Neuroprotective drugs in the treatment of Alzheimer’s disease
  20834. Neuroprotective effect of salvianolate on cerebral ischaemia-reperfusion injury in rats by inhibiting the Caspase-3 signal pathway
  20835. Neuroprotective and vision‐protective effect of preserving ATP levels by AMPK activator
  20836. The Neuroprotective and neurorestorative effects of growth differentiation factor 11 in cerebral ischemic injury
  20837. Neuroprotective Effects of D-(-)-Quinic Acid on Aluminum Chloride-Induced Dementia in Rats
  20838. Neuroprotective effects of boron nitride nanoparticles in the experimental Parkinson’s disease model against MPP+ induced apoptosis
  20839. The antioxidant and Neuroprotective effects of Zolpidem on acrylamide-induced neurotoxicity using Wistar rat primary neuronal cortical culture
  20840. Synaptotagmin 13 is Neuroprotective across motor neuron diseases
  20841. Neuroprotective effects of euonymus alatus extract on scopolamine-induced memory deficits in mice
  20842. Dimeric Diarylheptanoids with Neuroprotective Activities from Rhizomes of Alpinia officinarum
  20843. Anti-inflammatory and Neuroprotective agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
  20844. Neuroprotective effect of gastrodin in methamphetamine-induced apoptosis through regulating cAMP/PKA/CREB pathway in cortical neuron
  20845. Design and molecular dynamic investigations of 7, 8-dihydroxyflavone derivatives as potential Neuroprotective agents against alpha-synuclein
  20846. Neuroprotective effects of FK866 against traumatic brain injury: Involvement of p38/ERK pathway
  20847. The Nootropic Drug Α-Glyceryl-Phosphoryl-Ethanolamine Exerts Neuroprotective Effects in Human Hippocampal Cells
  20848. Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the …
  20849. Neuroprotective effects of two selenium-containing peptides, TSeMMM and SeMDPGQQ, derived from selenium-enriched rice protein hydrolysates on Pb2+-induced …
  20850. Herbal medicine as Neuroprotective potential agent in human and animal models: a historical overview
  20851. Neuroprotective effects of Levisticum officinale on LPS-induced spatial learning and memory impairments through neurotrophic, anti-inflammatory, and antioxidant …
  20852. Identification and Neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay
  20853. Allium cepa exerts Neuroprotective effect on retinal ganglion cells of pterygopalatine artery (PPA) ligated mice
  20854. Antioxidant and Neuroprotective effects of mGlu3 receptor activation on astrocytes aged in vitro
  20855. The detrimental action of adenosine on glutamate-induced cytotoxicity in PC12 cells can be shifted towards a Neuroprotective role through A1AR positive allosteric …
  20856. Neuroprotective effects and improvement of learning and memory elicited by erythravine and 11α-hydroxy-erythravine against the pilocarpine model of epilepsy
  20857. Potential Neuroprotective biomolecules in ophthalmology
  20858. Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: targeting Nav1. 7 channels and PPAR-γ
  20859. Neuroprotective efficacy of luteolin on a 900-MHz electromagnetic field-induced cerebellar alteration in adult male rat
  20860. Neuroprotective effects of emodin against ischemia/reperfusion injury through activating erk-1/2 signaling pathway
  20861. Baicalein exerts Neuroprotective effect against ischaemic/reperfusion injury via alteration of NF-kB and LOX and AMPK/Nrf2 pathway
  20862. Neuroprotective effects of Riluzole and Curcumin in human astrocytes and spinal cord white matter hypoxia
  20863. Neuroprotective efficacy of nano‐CoQ against propionic acid toxicity in rats: Role of BDNF and CREB protein expressions
  20864. Development and Application of a Chemical Probe Based on a Neuroprotective Flavonoid Hybrid for Target Identification Using Activity-Based Protein Profiling
  20865. Neuroprotective Effect of Rhodiola crenulata in D-Galactose-Induced Aging Model
  20866. The Neuroprotective Effect of Irisin in Ischemic Stroke
  20867. Role of senescence and Neuroprotective effects of telomerase in neurodegenerative diseases
  20868. Anti-hypernociceptive and anti-inflammatory effects of JM-20: A novel hybrid Neuroprotective compound
  20869. Limonoids from the Fresh Young Leaves and Buds of Toona sinensis and Their Potential Neuroprotective Effects
  20870. Procyanidins exhibits Neuroprotective activities against cerebral ischemia reperfusion injury by inhibiting TLR4-NLRP3 inflammasome signal pathway
  20871. Neuroprotective Mechanisms at the Blood-CSF Barrier of the Developing and Adult brain
  20872. Amburana cearensis: pharmacological and Neuroprotective effects of its compounds
  20873. Neuroprotective effect of enriched chicken bone broth as a dietary supplement in a model of migraine mediated by early life stress
  20874. Neuroprotective mechanism of TMP269, a selective class IIA histone deacetylase inhibitor, after cerebral ischemia/reperfusion injury
  20875. The Neuroprotective effects of activated α7 nicotinic acetylcholine receptor against mutant copper–zinc superoxide dismutase 1-mediated toxicity
  20876. Neuroprotective mechanisms of S-allyl-L-cysteine in neurological disease
  20877. Repurposing of cefpodoxime proxetil as potent Neuroprotective agent through computational prediction and in vitro validation
  20878. Neuroprotective effects of topical coenzyme Q10+ vitamin E in mechanic optic nerve injury model
  20879. Neuroprotective effect of Annona muricata-derived polysaccharides in neuronal HT22 cell damage induced by hydrogen peroxide
  20880. Design, synthesis, molecular modeling and Neuroprotective effects of a new framework of cholinesterase inhibitors for Alzheimer’s disease
  20881. Flavan derivative enantiomers and drimane sesquiterpene lactones from the Inonotus obliquus with Neuroprotective effects
  20882. Neuroprotective Effect of Catalpol via Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Mechanisms
  20883. The PERK pathway plays a Neuroprotective role during the early phase of secondary brain injury induced by experimental intracerebral hemorrhage
  20884. Neuroprotective effect of resveratrol against radiation after surgically induced brain injury by reducing oxidative stress, inflammation, and apoptosis through NRf2/HO …
  20885. Neuroprotective effects of Cornus officinalis on stress-induced hippocampal deficits in rats and H2O2-induced neurotoxicity in SH-SY5Y neuroblastoma cells
  20886. Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson’s Disease
  20887. Breviscapine exerts Neuroprotective effects through multiple mechanisms in APP/PS1 transgenic mice
  20888. Medicinal plants and natural products as Neuroprotective agents in age-related macular degeneration
  20889. Epigenomic analysis of Parkinson’s disease neurons identifies Tet2 loss as Neuroprotective
  20890. Neuroprotective Effects of Lindleyin on Hydrogen Peroxide-Induced Cell Injury and MPTP-Induced Parkinson’s Disease in C57BL/6 Mice
  20891. Neuroprotective effects of notoginsenoside R1 by upregulating Trx-1 on acrylamide-induced neurotoxicity in PC12
  20892. Iron nutrition, erythrocytes, and erythropoietin in the NICU: Erythropoietic and Neuroprotective effects
  20893. Neuroprotective Effect of Carotenoid-Rich Enteromorpha prolifera Extract via TrkB/Akt Pathway against Oxidative Stress in Hippocampal Neuronal Cells
  20894. Cytidine 5′-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
  20895. Novel insight to Neuroprotective potential of curcumin: a mechanistic review of possible involvement of mitochondrial biogenesis and PI3/Akt/GSK3 or PI3/Akt …
  20896. Compressed CO2 Technologies for the Recovery of Carotenoid-Enriched Extracts from Dunaliella salina with Potential Neuroprotective Activity
  20897. Neuroprotective effects of magnesium L-threonate in a hypoxic zebrafish model
  20898. Neuroprotective effect of Umbelliferone against Cerebral ischemia/Reperfusion induced neurological deficits: in-vivo and in-silico studies
  20899. Biopeptides with Neuroprotective Effect in the Treatment of Neuroinflammation Induced by Adiposity-based Chronic Disease
  20900. Seaweeds’ Neuroprotective potential set in vitro on a human cellular stress model
  20901. Neuroprotective brain -derived neurotrophic factor signaling in the TAU-P301L tauopathy zebrafish model
  20902. A Neuroprotective Dose of Isatin Causes Multilevel Changes Involving the brain Proteome: Prospects for Further Research
  20903. Neuroprotective and Anti-inflammatory Ditetrahydrofuran-Containing Diarylheptanoids from Tacca chantrieri
  20904. Neuroprotective Effects of 7-Geranyloxycinnamic Acid from Melicope lunu ankenda Leaves
  20905. Neuroprotective Compounds from Plant Sources and their Modes of Action: An Update
  20906. Antioxidant, anti-inflammatory and Neuroprotective effect of kaempferol on rotenone-induced Parkinson’s disease model of rats and SH-S5Y5 cells by …
  20907. Novel Neuroprotective Potential of Crocin in Neurodegenerative Disorders: An Illustrated Mechanistic Review
  20908. LSM12-EPAC1 defines a Neuroprotective pathway that sustains the nucleocytoplasmic RAN gradient
  20909. Isoquinolines from national herb Corydalis tomentella and Neuroprotective effect against lipopolysaccharide-induced BV2 microglia cells
  20910. Dose-dependent Neuroprotective effect of the JNK inhibitor Brimapitide in 5xFAD transgenic mice
  20911. Celecoxib promotes survival and upregulates the expression of Neuroprotective marker genes in two different in vitro models of Parkinson’s disease
  20912. Expression of Long Non-coding RNA RGD1566344 in the brain Cortex of Male Mice After Focal Cerebral Ischemia–Reperfusion and the Neuroprotective Effect of a …
  20913. In vitro Neuroprotective effects of farnesene sesquiterpene on alzheimer’s disease model of differentiated neuroblastoma cell line
  20914. Neuroprotective Effects of Lacosamide and Memantine on Hyperoxic brain Injury in Rats
  20915. Neuroprotective effect of ent-Kaur-15-en-17-al-18-oic acid on amyloid beta peptide-induced oxidative apoptosis in Alzheimer’s disease
  20916. New prenylated flavonoid and Neuroprotective compounds from Tephrosia purpurea subsp. dunensis
  20917. Neuroprotective effects of brain ‐derived neurotrophic factor against amyloid beta 1‐40‐induced retinal and optic nerve damage
  20918. A possible Neuroprotective property of ethanol and/or NeuroAiD on the modulation of cognitive function
  20919. Neuroprotective effects of melatonin during demyelination and remyelination stages in a mouse model of multiple sclerosis
  20920. Neuroprotective Effects of Qingnao Dripping Pills against cerebral ischemia via inhibiting NLRP3 inflammasome signaling pathway: in Vivo and in Vitro
  20921. Emerging Neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies
  20922. … Decelerates Bicarbonate-Driven Acid-Elimination of Human Neocortical Neurons: Strategic Significance for its Antiepileptic, Antimigraine and Neuroprotective …
  20923. Oleanane- and Ursane-Type Triterpene Saponins from Centella asiatica Exhibit Neuroprotective Effects
  20924. Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer’s Disease
  20925. Companion diagnosis for retinal Neuroprotective treatment by real-time imaging of calpain activation using a novel fluorescent probe
  20926. Biomimetic microenvironmental preconditioning enhance Neuroprotective properties of human mesenchymal stem cells derived from Wharton’s Jelly (WJ …
  20927. Neuroprotective Effect of Syringic Acid by Modulation of Oxidative Stress and Mitochondrial Mass in Diabetic Rats
  20928. Suppression of cGMP-Dependent Photoreceptor Cytotoxicity With Mycophenolate Is Neuroprotective in Murine Models of Retinitis Pigmentosa
  20929. … TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: The new molecular mechanism of ibudilast and its implication for Neuroprotective …
  20930. Dihydroagarofuran sesquiterpenoid derivatives from the leaves of Tripterygium wilfordii with potential Neuroprotective effects against H 2 O 2-induced SH-SY5Y cell …
  20931. Nix plays a Neuroprotective role in early brain injury after experimental subarachnoid hemorrhage in rats
  20932. Systemic administration of the di-apocarotenoid norbixin (BIO201) is Neuroprotective , preserves photoreceptor function and inhibits A2E and lipofuscin …
  20933. Neuroprotective Effects of Anti-proBDNF in a Rat Photothrombotic Ischemic Model
  20934. Recent antiepileptic and Neuroprotective applications of brain cooling
  20935. Dexmedetomidine had Neuroprotective effects on hippocampal neuronal cells via targeting lncRNA SHNG16 mediated microRNA-10b-5p/BDNF axis
  20936. Blood Exosomes Have Neuroprotective Effects in a Mouse Model of Parkinson’s Disease
  20937. Neuroprotective effects of Bacopa monnieri in Parkinson’s disease model
  20938. Neuroprotective effect of indomethacin in normal perfusion pressure breakthrough phenomenon
  20939. Neuroprotective and anticonvulsant effects of sinomenine in kainate rat model of temporal lobe epilepsy: Involvement of oxidative stress, inflammation and pyroptosis
  20940. Mitochondrial Dysfunction as a Novel Target for Neuroprotective Nutraceuticals in Ocular Diseases
  20941. Neuroprotective effects of the aerial parts of Polygala tenuifolia Willd extract on scopolamine‑induced learning and memory impairments in mice
  20942. Neuroprotective agents as an adjuvant treatment in patients with acute spinal cord injuries: a qualitative systematic review of randomized trials
  20943. Neuroprotective effects of curcumin-loaded emulsomes in a laser axotomy-induced CNS injury model
  20944. Synergistic Neuroprotective effect of endogenously-produced hydroxytyrosol and synaptic vesicle proteins on pheochromocytoma cell line against salsolinol
  20945. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson’s disease model
  20946. Isolation and Sequencing of Cu-, Fe-, and Zn-Binding Whey Peptides for Potential Neuroprotective Applications as Multitargeted Compounds
  20947. Neuroprotective effects of verbascoside against Alzheimer’s disease via the relief of endoplasmic reticulum stress in Aβ-exposed U251 cells and APP/PS1 …
  20948. Neuroprotective studies on Polygonum hydropiper L. essential oils using transgenic animal models
  20949. Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease
  20950. … -MS/MS profiling of secondary metabolites from Opuntia ficus-indica cladode, peel and fruit pulp extracts and their antioxidant, Neuroprotective effect in rats …
  20951. Inverse agonism of cannabinoid receptor Type 2 confers anti-inflammatory and Neuroprotective effects following status epileptics
  20952. Neuroprotective effect of Costus afer on low dose heavy metal mixture (lead, cadmium and mercury) induced neurotoxicity via antioxidant, anti-inflammatory …
  20953. Equol, a Blood–brain Barrier Permeable Gut Microbial Metabolite of Dietary Isoflavone Daidzein, Exhibits Neuroprotective Effects against Neurotoxins Induced …
  20954. An acidic heteropolysaccharide from Lycii fructus: Purification, characterization, neurotrophic and Neuroprotective activities in vitro
  20955. Ginsenoside Rg1 exerts Neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington’s disease via suppressing MAPKs and NF-κB pathways …
  20956. Apelin-36 mediates Neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson’s disease model mice
  20957. Hamartin: An Endogenous Neuroprotective Molecule Induced by Hypoxic Preconditioning
  20958. Overexpression of HDAC6, but not HDAC3 and HDAC4 in the penumbra after photothrombotic stroke in the rat cerebral cortex and the Neuroprotective effects of α …
  20959. Melatonin exerts Neuroprotective effects by attenuating astro-and microgliosis and suppressing inflammatory response following spinal cord injury
  20960. Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia
  20961. Plant natural products as Neuroprotective nutraceuticals: preclinical and clinical studies and future implications
  20962. Neuroprotective effects of andrographolide on chronic cerebral hypoperfusion-induced hippocampal neuronal damage in rats possibly via PTEN/AKT signaling …
  20963. Heat shock protein 27 as a Neuroprotective biomarker and a suitable target for stem cell therapy and pharmacotherapy in ischemic stroke
  20964. Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke
  20965. Evaluation of antioxidant and Neuroprotective activities of Lyngbya majuscula on human neural tissues
  20966. Modulation of the Neuroprotective and Anti-inflammatory Activities of the Flavonol Fisetin by the Transition Metals Iron and Copper
  20967. Defining a Target Population to Effectively Test a Neuroprotective Drug
  20968. Neuroprotective Effects of Early brain Injury after Subarachnoid Hemorrhage in Rats by Calcium Channel Mediating Hydrogen Sulfide
  20969. Acetylcholinesterase inhibitory activity, anti-inflammatory, and Neuroprotective potential of Hippeastrum psittacinum (Ker Gawl.) herb (Amaryllidaceae)
  20970. Neuroprotective effect of PPAR alpha and gamma agonists in a mouse model of amyloidogenesis through modulation of the Wnt/beta catenin pathway via targeting …
  20971. Characterization of lactic acid bacteria derived exopolysaccharides for use as a defined Neuroprotective agent against amyloid beta 1–42-induced apoptosis …
  20972. PPARδ and its ligand erucic acid may act anti-tumoral, Neuroprotective , and myelin protective in neuroblastoma, glioblastoma, and Parkinson’s disease
  20973. Neuroprotective function of Omi to α-synuclein-induced neurotoxicity
  20974. Neuroprotective Effects of Ellagic Acid in Alzheimer’s Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential
  20975. Neuroprotective efficacy of different levels of high-frequency repetitive transcranial magnetic stimulation in mice with CUMS-induced depression: Involvement …
  20976. Neuroprotective effects of chrysin on diclofenac-induced apoptosis in SH-SY5Y cells
  20977. Rho-kinase (ROCK) inhibitors-a Neuroprotective therapeutic paradigm with a focus on ocular utility
  20978. Neuroprotective Effect of Activated Protein C on Blood–brain Barrier Injury During Focal Cerebral Ischemia/Reperfusion
  20979. Modulation of the Astrocyte-Neuron Lactate Shuttle System contributes to Neuroprotective action of Fibroblast Growth Factor 21
  20980. Neuroprotective Effect of Oridonin on Traumatic brain Injury via Inhibiting NLRP3 Inflammasome in Experimental Mice
  20981. Neurobiology and Neuroprotective Benefits of Sleep
  20982. Antioxidant, Anti-inflammatory and Neuroprotective Profiles of Novel 1, 4-Dihydropyridine Derivatives for the Treatment of Alzheimer’s Disease
  20983. Neuroprotective Metabolites from Vietnamese Marine Derived Fungi of Aspergillus and Penicillium Genera
  20984. Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an Aβ1-42-Induced Rat Model of …
  20985. Neuroprotective effect of maternal resveratrol supplementation in a rat model of neonatal hypoxia-ischemia
  20986. Neuroprotective and anti-inflammatory effects of Kuwanon C from Cudrania tricuspidata are mediated by heme oxygenase-1 in HT22 hippocampal cells, RAW264. 7 …
  20987. Neuroprotective effects of lithium in neuropsychiatric disorders
  20988. The Antioxidant, Anti-Inflammatory, and Neuroprotective Properties of the Synthetic Chalcone Derivative AN07
  20989. Synthesis and Neuroprotective effects of novel chalcone-triazole hybrids
  20990. Neuroprotective properties of Dimethyl fumarate measured by optical coherence tomography in non-inflammatory animal models
  20991. Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels
  20992. A microscopy-based small molecule screen in primary neurons reveals Neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir
  20993. The Neuroprotective Action of Amidated-Kyotorphin on Amyloid β Peptide-Induced Alzheimer’s Disease Pathophysiology
  20994. L-Asparaginase Exerts Neuroprotective Effects in an SH-SY5Y-A53T Model of Parkinson’s Disease by Regulating Glutamine Metabolism
  20995. Special bioactive compounds and functional foods may exhibit Neuroprotective effects in patients with dementia
  20996. Neuroprotective Role of Oral Vitamin D Supplementation on Consciousness and Inflammatory Biomarkers in Determining Severity Outcome in Acute Traumatic brain …
  20997. Pioglitazone activates paraoxonase-2 in the brain : a novel Neuroprotective mechanism
  20998. Hypoxic naked mole–rat brain s use microRNA to coordinate hypometabolic fuels and Neuroprotective defenses
  20999. The Neuroprotective Effect of Mesna on Cisplatin-Induced Neurotoxicity: Behavioral, Electrophysiological, and Molecular Studies
  21000. Design, Synthesis and Biological Evaluation of Novel (E)‐Hydroxystyryl Aralkyl Sulfones as Neuroprotective agents
  21001. Neuroprotective Effects of Umbilical Cord-Derived Mesenchymal Stem Cells on Radiation-Induced brain Injury in Mice
  21002. Effect of Neuroprotective citicoline eye drops on macular microcirculation
  21003. Neuroprotective effects of prenylated flavanones isolated from Dalea species, in vitro and in silico studies
  21004. Elucidating the Neuroprotective Role of Formulated Camel α-Lactalbumin–Oleic Acid Complex by Curating the SIRT1 Pathway in Parkinson’s Disease Model
  21005. Neuroprotective effects of Sophora secundiflora, Sophora tomentosa leaves and formononetin on scopolamine-induced dementia
  21006. The Potential Neuroprotective Role of Citicoline in Hepatic Encephalopathy
  21007. BACE1 Inhibitor, Neuroprotective , and Neuritogenic Activities of Melatonin Derivatives
  21008. Neuroprotective effect of regular swimming exercise on calretinin-positive striatal neurons of Parkinsonian rats
  21009. Trained Innate Immunity by Repeated Low-Dose Lipopolysaccharide Injections Displays Long-Term Neuroprotective Effects
  21010. Neuroprotective Effect of N-Cyclohexylethyl-[A/G]-[D/E]-XV Peptides on Ischemic Stroke by Blocking nNOS–CAPON Interaction
  21011. New norlignan enantiomers from the fruit of Crataegus pinnatifida with Neuroprotective activities
  21012. An allosteric modulator of RNA binding targeting the N-terminal domain of TDP-43 yields Neuroprotective properties
  21013. Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment
  21014. Tissue Acidosis Associated with Ischemic Stroke to Guide Neuroprotective Drug Delivery
  21015. Synthetic structural modifications of neurosteroid pregnanolone sulfate: Assessment of Neuroprotective effects in vivo
  21016. Troxerutin flavonoid has Neuroprotective properties and increases neurite outgrowth and migration of neural stem cells from the subventricular zone
  21017. Mechanisms of ammonium-induced neurotoxicity. Neuroprotective effect of alpha-2 adrenergic agonists
  21018. Neuroprotective Effects of Molecular Hydrogen: A Critical Review
  21019. Early transcranial direct current stimulation treatment exerts Neuroprotective effects on 6-OHDA-induced Parkinsonism in rats
  21020. Neuroprotective properties of common lady’s mantle infusion
  21021. Topical Delivery of Four Neuroprotective Ingredients by Ethosome-Gel: Synergistic Combination for Treatment of Oxaliplatin-Induced Peripheral Neuropathy
  21022. The immunoregulatory and Neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune …
  21023. Neuroprotective effects of melatonin against neurotoxicity induced by intranasal sodium dimethyldithiocarbamate administration in mice
  21024. Evans Blue Might Produce Pathologically Activated Neuroprotective Effects via the Inhibition of the P2X4R/p38 Signaling Pathway
  21025. Gadolinium causes M1 and M2 microglial apoptosis after intracerebral haemorrhage and exerts acute Neuroprotective effects
  21026. Amarogentin from Gentiana rigescens Franch Exhibits Antiaging and Neuroprotective Effects through Antioxidative Stress
  21027. Neuroprotective effects of resveratrol in Alzheimer’s disease.
  21028. Neuroprotective effects of isoquercitrin in diabetic neuropathy via Wnt/β‐catenin signaling pathway inhibition
  21029. … CeO2@ SiO2-PEG nanoparticle carrier for delivery of food derived proanthocyanidin and curcumin as effective antioxidant, Neuroprotective and anticancer agent
  21030. Neuroprotective Effect of 2-Aminoethoxydiphenyl Borate (2-APB) in Amyloid β-Induced memory Dysfunction: A Mechanistic Study
  21031. Neuroprotective effects of soy isoflavones on chronic ethanol-induced dementia in male ICR mice
  21032. Nrf2/HO-1 mediates the Neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats
  21033. Neuroprotective Properties of Xenon
  21034. Hydrogen and therapeutic gases for neonatal hypoxic–ischemic encephalopathy: potential Neuroprotective adjuncts in translational research
  21035. Propolis as a potential disease-modifying strategy in Parkinson’s disease: cardioprotective and Neuroprotective effects in the 6-OHDA rat model
  21036. Neuroprotective racemic germacranolides from the roots of Chloranthus henryi
  21037. Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke
  21038. Neuroprotective Effects of Triterpenoids from Camellia japonica against Amyloid β-Induced Neuronal Damage
  21039. Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the Nrf2/HO-1 pathway
  21040. The Neuroprotective effect of betanin in trimethyltin-induced neurodegeneration in mice
  21041. Neuroprotective potential of Argan oil in neuropsychiatric disorders in rats: A review
  21042. Neuroprotective effects of Apium graveolens against focal cerebral ischemia occur partly via antioxidant, anti‐inflammatory, and anti‐apoptotic pathways
  21043. Circumdatin D Exerts Neuroprotective Effects by Attenuating LPS-Induced Pro-Inflammatory Responses and Downregulating Acetylcholinesterase Activity In …
  21044. Peptidomic analysis of hippocampal tissue for explore leptin Neuroprotective effect on the preterm ischemia-hypoxia brain damage model rats
  21045. Neuroprotective effects of Dendropanax morbifera leaves on glutamate-induced oxidative cell death in HT22 mouse hippocampal neuronal cells
  21046. Neuroprotective effects of p62 (SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study
  21047. Greek Sage Exhibits Neuroprotective Activity against Amyloid Beta-Induced Toxicity
  21048. Neuroprotective effects of phlorotannin-rich extract from brown seaweed Ecklonia cava on neuronal PC-12 and SH-SY5Y Cells with Oxidative Stress
  21049. Control of the Neuroprotective Lipocalin Apolipoprotein D expression by alternative promoter regions and differentially expressed mRNA 5’UTR variants
  21050. Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
  21051. Collagen–curcumin nanocomposites showing an enhanced Neuroprotective effect against short term focal cerebral ischemia
  21052. Selegiline acts as Neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of …
  21053. Neuroprotective Effects of Methyl Caffeate against Hydrogen Peroxide-Induced Cell Damage: Involvement of Caspase 3 and Cathepsin D Inhibition
  21054. Neuroprotective Effects of Dexmedetomidine Preconditioning on Oxygen-glucose Deprivation-reoxygenation Injury in PC12 Cells via Regulation of Ca 2+-STIM1 …
  21055. Stress-Induced Neurodegeneration: The Potential for Coping as Neuroprotective Therapy
  21056. Hypothesis: A Novel Neuroprotective Role for Glucose-6-phosphatase (G6PC3) in brain —To Maintain Energy-Dependent Functions Including cognitive Processes
  21057. Neuroprotective effect of CuATSM in mice stroke model by ameliorating oxidative stress
  21058. Neuroprotective effect of ACTH on collagenase-induced peri-intraventricular hemorrhage in newborn male rats
  21059. In Vitro Evaluation of the Neuroprotective Effect of Panax notoginseng Saponins by Activating the EGFR/PI3K/AKT Pathway
  21060. Safe and Neuroprotective vectors for long-term traumatic brain injury gene therapy
  21061. Tannic Acid Provides Neuroprotective Effects Against Traumatic brain Injury Through the PGC-1α/Nrf2/HO-1 Pathway
  21062. Neuroprotective effects of quercetin on cerebral vasospasm following experimental subarachnoid haemorrhage in rats
  21063. Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other brain Disorders: From Bench to Bedside
  21064. The emerging role of curcumin in the modulation of TLR-4 signaling pathway: focus on Neuroprotective and anti-rheumatic properties
  21065. Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis
  21066. Estrogen Exerts Neuroprotective Effects in Vascular Dementia Rats by Suppressing Autophagy and Activating the Wnt/β-Catenin Signaling Pathway
  21067. Cannabinoid 1 receptor antagonists play a Neuroprotective role in chronic alcoholic hippocampal injury related to pyroptosis pathway
  21068. Neuroprotective actions of cerebellar and pineal allopregnanolone on Purkinje cells
  21069. Understanding the Neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial
  21070. MicroRNA-579-3p exerts Neuroprotective effects against ischemic stroke via anti-inflammation and anti-apoptosis
  21071. Pyrola incarnata demonstrates Neuroprotective effects against β-amyloid-induced memory impairment in mice
  21072. The Neuroprotective effect of fullerenols on a model of Parkinson’s disease in Drosophila melanogaster
  21073. Identification of active chemical constituents of Asplenium ruprechtii Sa. Kurata based on in vitro Neuroprotective activity evaluation
  21074. The Neuroprotective effect of Riparin IV on oxidative stress and neuroinflammation related to chronic stress-induced cognitive impairment
  21075. The Neuroprotective Effect of Zingiber cassumunar Roxb. Extract on LPS-Induced Neuronal Cell Loss and Astroglial Activation within the Hippocampus
  21076. Scopolamine-Induced memory Impairment in Mice: Neuroprotective Effects of Carissa edulis (Forssk.) Valh (Apocynaceae) Aqueous Extract
  21077. Tauroursodeoxycholic acid (TUDCA) is Neuroprotective in a chronic mouse model of Parkinson’s disease
  21078. Design, synthesis and biological evaluation of novel osthole-based derivatives as potential Neuroprotective agents
  21079. Neuroprotective effects of baicalein, wogonin, and oroxylin A on amyloid beta-induced toxicity via NF-κB/MAPK pathway modulation
  21080. Neuroprotective effect of Hongjing I granules on erectile dysfunction in a rat model of bilateral cavernous nerve injury
  21081. Neuroprotective and Preventative Effects of Molecular Hydrogen
  21082. Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage
  21083. Neuroprotective Activity of Polyphenol-Rich Ribes diacanthum Pall against Oxidative Stress in Glutamate-Stimulated HT-22 Cells and a Scopolamine-Induced …
  21084. Neuroprotective Effect of Isobenzofuranones on Hydrogen Peroxide-Mediated Redox Imbalance in Primary Cultures of Hippocampal Neurons
  21085. Neuroprotective effect of 3, 3′-Diindolylmethane against perinatal asphyxia involves inhibition of the AhR and NMDA signaling and hypermethylation of …
  21086. Purified anacardic acids exert multiple Neuroprotective effects in pesticide model of Parkinson’s disease: in vivo and in silico analysis
  21087. Neuroprotective constituents from the aerial parts of Cannabis sativa L. subsp. sativa
  21088. Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity
  21089. … with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased Neuroprotective non-endocannabinoid lipid …
  21090. Sesquineolignans derivatives with Neuroprotective activity from the fruits of Crataegus pinnatifida
  21091. The Neuroprotective effect of osthole against chronic sleep deprivation (CSD)-induced memory impairment in rats
  21092. Attenuation of the mutual elevation of iron accumulation and oxidative stress may contribute to the Neuroprotective and anti-seizure effects of xenon in neonatal …
  21093. Neuroprotective effect of cajaninstilbene acid against cerebral ischemia and reperfusion damages by activating AMPK/Nrf2 pathway
  21094. Neuroprotective role of dietary supplementation with omega-3 fatty acids in the presence of basal forebrain cholinergic neurons degeneration in aged mice
  21095. Neuroprotective effects of vildagliptin on drug induced Alzheimer’s disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways
  21096. Neuroprotective effects of oleuropein on retina photoreceptors cells primary culture and olive leaf extract and oleuropein inhibitory effects on aldose reductase in a …
  21097. Virgin coconut oil enhances Neuroprotective and anti‐inflammatory factors in the thymus and mesenteric lymph nodes of rats
  21098. Integrin α5β1 inhibition by ATN-161 reduces neuroinflammation and is Neuroprotective in ischemic stroke
  21099. Adeno‐associated virus (AAV)‐mediated Neuroprotective effects on the degenerative retina: the therapeutic potential of erythropoietin
  21100. Neuroprotective effects of Fomes officinalis Ames polysaccharides on Aβ25–35-induced cytotoxicity in PC12 cells through suppression of mitochondria-mediated …
  21101. Neuroprotective Effect of Spice Oleoresins on memory and cognitive Impairment Associated with Scopolamine-Induced Alzheimer’s Disease in Rats
  21102. Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild cognitive Impairment: A …
  21103. miR-137 boosts the Neuroprotective effect of endothelial progenitor cell-derived exosomes in oxyhemoglobin-treated SH-SY5Y cells partially via COX2/PGE2 …
  21104. All-Trans Retinoic Acid Exerts Neuroprotective Effects in Amyotrophic Lateral Sclerosis-Like Tg (SOD1* G93A) 1Gur Mice
  21105. Significant combination of Aβ aggregation inhibitory and Neuroprotective properties in silico, in vitro and in vivo by bis (propyl)-cognitin, a multifunctional anti …
  21106. BRUP‐1, an intracellular bilirubin modulator, exerts Neuroprotective activity in a cellular Parkinson’s disease model
  21107. Restoration of PP2A levels in inflamed microglial cells: Important for Neuroprotective M2 microglial viability
  21108. Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis
  21109. PKM2: a crucial Neuroprotective target against oxidative stress
  21110. Synthetic analogues of memantine as Neuroprotective and influenza viral inhibitors: in vitro and physicochemical studies
  21111. Neuroprotective effects of isosteviol sodium in murine brain capillary cerebellar endothelial cells (cerebEND) after hypoxia
  21112. Xenon exerts Neuroprotective effects on kainic acid-induced acute generalized seizures in rats via increased autophagy
  21113. Coprinus comatus filtrate extract, a novel Neuroprotective agent of natural origin
  21114. Santalum album extract exhibits Neuroprotective effect against the TLR3‐mediated neuroinflammatory response in human SH‐SY5Y neuroblastoma cells
  21115. A Metabolic Insight Into the Neuroprotective Effect of Jin-Mai-Tong (JMT) Decoction on Diabetic Rats With Peripheral Neuropathy Using Untargeted …
  21116. Impact of the chemical structure on the distribution of Neuroprotective N-alkyl-9 H-carbazoles at octanol/water interfaces
  21117. Possible Neuroprotective effects of rasagiline in Alzheimer’s disease: a SPECT study
  21118. Neuroprotective Potential of Verbascoside Isolated from Acanthus mollis L. Leaves through Its Enzymatic Inhibition and Free Radical Scavenging Ability
  21119. Neuroprotective Effect Of Peptide Fractions from Chia (Salvia hispanica) on H 2 O 2-Induced Oxidative Stress-Mediated Neuronal Damage on N1E-115 Cell Line
  21120. Design, microwave synthesis, and molecular docking studies of catalpol crotonates as potential Neuroprotective agent of diabetic encephalopathy
  21121. Neuroprotective and Antioxidant Activity of Arachidonoyl Choline, Its Bis-Quaternized Analogues and Other Acylcholines
  21122. Anticholinergic Drugs Interact With Neuroprotective Chaperone L-PGDS and Modulate Cytotoxicity of Aβ Amyloids
  21123. Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
  21124. Apolipoprotein E4 disrupts the Neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signaling
  21125. Blood glutamate scavengers and exercises as an effective Neuroprotective treatment in mice with spinal cord injury
  21126. Hypoxia-inducible Factor 2α Exerts Neuroprotective Effects by Promoting Angiogenesis via the VEGF/Notch Pathway after Intracerebral Hemorrhage Injury in Rats
  21127. Neuroprotective effects of Fraxinus angustifolia Vahl. bark extract against Alzheimer’s disease
  21128. Glechoma curviflora Volatile Oil from Palestine: Chemical Composition and Neuroprotective , Antimicrobial, and Cyclooxygenase Inhibitory Activities
  21129. Neuroprotective Effects of Peptides in the brain : Transcriptome Approach
  21130. Structural studies and cyclization of the Neuroprotective octapeptide NAPVSIPQ to improve cell permeability
  21131. Inhibition of protein disulfide isomerase has Neuroprotective effects in a mouse model of experimental autoimmune encephalomyelitis
  21132. Astrocytic palmitoylethanolamide pre-exposure exerts Neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer’s …
  21133. Molecular mechanism of long-term Neuroprotective effects of gradual flow restoration on cerebral ischemia reperfusion injury in MCAO rats
  21134. Epigallocatechin 3-Gallate has a Neuroprotective effect in retinas of rabbits with ischemia/reperfusion through the activation of Nrf2/HO-1
  21135. Celecoxib exerts Neuroprotective effects in β-amyloid-treated SH-SY5Y cells through the regulation of heme oxygenase-1: novel insights for an old drug
  21136. MicroRNA-22 exerts its Neuroprotective and angiogenic functions via regulating PI3K/Akt signaling pathway in cerebral ischemia–reperfusion rats
  21137. Lignans and neolignans with isovaleroyloxy moiety from Solanum lyratum Thunb.: Chiral resolution, configurational assignment and Neuroprotective effects
  21138. Para-Substituted α-Phenyl-N-tert-butyl Nitrones: Spin-Trapping, Redox and Neuroprotective Properties
  21139. Induction of glial cell line-derived neurotrophic factor by the squamosamide derivative FLZ in astroglia has Neuroprotective effects on dopaminergic neurons
  21140. Neuroprotective Effects of the Sonic Hedgehog Signaling Pathway in Ischemic Injury through Promotion of Synaptic and Neuronal Health
  21141. Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway
  21142. Neuroprotective Effect of Optogenetics Varies With Distance From Channelrhodopsin-2 Expression in an Amyloid-β-Injected Mouse Model of Alzheimer’s …
  21143. Neuroprotective schinortriterpenoids with diverse scaffolds from Schisandra henryi
  21144. Structural and functional computational analysis of nicotine analogs as potential Neuroprotective compounds in Parkinson disease
  21145. MiR-1202 Exerts Neuroprotective Effects on OGD/R Induced Inflammation in HM Cell by Negatively Regulating Rab1a Involved in TLR4/NF-κB Signaling Pathway
  21146. The study of Neuroprotective effects and underlying mechanism of Naoshuantong capsule on ischemia stroke mice
  21147. The Small Molecule P7C3-A20 Exerts Neuroprotective Effects in a Hypoxic–ischemic Encephalopathy Model via Activation of PI3K/AKT/GSK3β Signaling
  21148. Antioxidative and Neuroprotective Effects of the Cytochalasans From Endophytes
  21149. … benefit of combined Neuroprotection : Cholesterol depletion restores membrane microviscosity but not lipid order and enhances Neuroprotective action of hypothermia …
  21150. Neuroprotective Effect of Nypa fruticans Wurmb by Suppressing TRPV1 Following Sciatic Nerve Crush Injury in a Rat
  21151. Chemical characterization and Neuroprotective properties of copper nanoparticles green-synthesized by nigella sativa L. seed aqueous extract against methadone …
  21152. Application of tandem biotransformation for biosynthesis of new pentacyclic triterpenoid derivatives with Neuroprotective effect
  21153. Neuroprotective Effect of Mesenchymal Stromal Cell-Derived Extracellular Vesicles Against Cerebral Ischemia-Reperfusion-Induced Neural Functional Injury …
  21154. Neuroprotective Effect of Lithospermum officinale Callus Extract on Inflamed Primary Microglial Cells
  21155. Increased Neuroprotective Microglia and Photoreceptor Survival in the Retina from a Peptide Inhibitor of Myeloid Differentiation Factor 88 (MyD88)
  21156. Regulation of cannabinoid CB1 and CB2 receptors, Neuroprotective mTOR and pro-apoptotic JNK1/2 kinases in postmortem prefrontal cortex of subjects with major …
  21157. Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson’s disease
  21158. Does alcohol play the role of confounder or Neuroprotective agent in acute carbon monoxide poisoning?
  21159. Rationale and Design of the PAIRED Trial: Partnered Dance Aerobic Exercise as a Neuroprotective , Motor, and cognitive Intervention in Parkinson’s Disease
  21160. Neuroprotective effects of 1‐O‐hexyl‐2, 3, 5‐trimethylhydroquinone on ischaemia/reperfusion‐induced neuronal injury by activating the Nrf2/HO‐1 pathway
  21161. Isolation and characterization of components responsible for Neuroprotective effects of Allium cepa outer scale extract against ischemia reperfusion induced cerebral …
  21162. Neuroprotective effects of natural cordycepin on LPS-induced Parkinson’s disease through suppressing TLR4/NF-κB/NLRP3-mediated pyroptosis
  21163. Tat-indoleamine 2, 3-dioxygenase 1 elicits Neuroprotective effects on ischemic injury
  21164. Previous adaptation triggers distinct molecular pathways and modulates early and long-term Neuroprotective effects of pregnancy swimming preventing neonatal …
  21165. Ibuprofen Exerts Antiepileptic and Neuroprotective Effects in the Rat Model of Pentylenetetrazol-Induced Epilepsy via the COX-2/NLRP3/IL-18 Pathway
  21166. Neuroprotective Effect of Tricyclic Pyridine Alkaloids from Fusarium lateritium SSF2, against Glutamate-Induced Oxidative Stress and Apoptosis in the HT22 …
  21167. Neuroprotective Effects of Celastrol on Transient Global Cerebral Ischemia Rats via Regulating HMGB1/NF-κB Signaling Pathway
  21168. Neuroprotective action of agmatine in rotenone-induced model of Parkinson’s disease: Role of BDNF/cREB and ERK pathway
  21169. Synthesis of natural product-like polyprenylated phenols and quinones: Evaluation of their Neuroprotective activities
  21170. Synthesis and biological evaluation of chalcone derivatives as Neuroprotective agents against glutamate-induced HT22 mouse hippocampal neuronal cell death
  21171. Neuroprotective effect of standardized extracts of three Lactuca sativa Linn. varieties against 3-NP induced Huntington’s disease like symptoms in rats
  21172. Lycopene Exerts Neuroprotective Effects After Hypoxic–Ischemic brain Injury in Neonatal Rats via the Nuclear Factor Erythroid-2 Related Factor 2/Nuclear …
  21173. Neuroprotective Effect of Virgin Coconut Oil Against Hydrocarbon Induced Neurotoxicity
  21174. Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and …
  21175. Neuroprotective effect of different physical exercises on cognition and behavior function by dopamine and 5-HT level in rats of vascular dementia
  21176. Guanosine Neuroprotective Action in Hippocampal Slices Subjected to Oxygen and Glucose Deprivation Restores ATP Levels, Lactate Release and Glutamate …
  21177. Neuroprotective effects of exogenous erythropoietin in Wistar rats by downregulating apoptotic factors to attenuate N-methyl-D-aspartate-mediated retinal …
  21178. Neuroprotective effect of Angelica gigas root in a mouse model of ischemic brain injury through MAPK signaling pathway regulation
  21179. No Added Neuroprotective Effect of Remote Ischemic Postconditioning and Therapeutic Hypothermia After Mild Hypoxia-Ischemia in a Piglet Model
  21180. Neuroprotective effect of Reinwardtia indica against scopolamine induced memory -impairment in rat by attenuating oxidative stress
  21181. Neuroprotective Effect of Piracetam against Cocaine-Induced Neuro Epigenetic Modification of DNA Methylation in Astrocytes
  21182. Pharmacological Evidences for Curcumin Neuroprotective Effects against Lead-Induced Neurodegeneration: Possible Role of Akt/GSK3 Signaling Pathway
  21183. Neuroprotective effect of low-intensity transcranial ultrasound stimulation in endothelin-1-induced middle cerebral artery occlusion in rats
  21184. Constituents of Gastrodia elata and Their Neuroprotective Effects in HT22 Hippocampal Neuronal, R28 Retinal Cells, and BV2 Microglial Cells
  21185. Saffron as a Neuroprotective agent
  21186. Neuroprotective effects of combination therapy of regional cold perfusion and hemoglobin-based oxygen carrier administration on rat transient cerebral ischemia
  21187. Drosophila Skp1 Homologue SkpA Plays a Neuroprotective Role in Adult brain
  21188. Neuroprotective Effects of OMO within the Hippocampus and Cortex in a D-Galactose and Aβ25–35-Induced Rat Model of Alzheimer’s Disease
  21189. Neuroprotective role of GLP-1 analog for retinal ganglion cells via PINK1/Parkin-mediated mitophagy in diabetic retinopathy
  21190. Neuroprotective and Neurorestorative Effects of Holothuria scabra Extract in the MPTP/MPP+-Induced Mouse and Cellular Models of Parkinson’s Disease
  21191. Chiral-phase resolution of sesquilignans from raspberries (Rubus idaeus L.) and their Neuroprotective effects
  21192. Comparing the Neuroprotective Effects of Aqueous and Methanolic Extracts of Vernonia Amygdalina on the Cerebellum of Adult Male Wistar Rats
  21193. Neuroprotective activity of Ulmus pumila L. in Alzheimer’s disease in rats; role of neurotrophic factors
  21194. Neuroprotective effect of paricalcitol in a rat model of transient global cerebral ischemia
  21195. Mangiferin exerts Neuroprotective activity against lead-induced toxicity and oxidative stress via Nrf2 pathway
  21196. Scopoletin: Antiamyloidogenic, Anticholinesterase, and Neuroprotective Potential of a Natural Compound Present in Argyreia speciosa Roots by In Vitro and In Silico …
  21197. Neuroprotective effects of Acer palmatum thumb. leaf extract (KIOM-2015E) against ischemia/reperfusion-induced injury in the rat retina
  21198. Structurally diverse terpenoids with Neuroprotective activities from the resins of Populus euphratica
  21199. Neuroprotective potential of the oxindole alkaloids isomitraphylline and mitraphylline in human neuroblastoma SH-SY5Y cells
  21200. TRPV1 Contributes to the Neuroprotective Effect of Dexmedetomidine in Pilocarpine-Induced Status Epilepticus Juvenile Rats
  21201. Parecoxib exhibits anti-inflammatory and Neuroprotective effects in a rat model of transient global cerebral ischemia
  21202. Neuroprotective Effects of Grape Seed Procyanidins on Ethanol-Induced Injury and Oxidative Stress in Rat Hippocampal Neurons
  21203. Neuroprotective effects of miR-142-5p downregulation against isoflurane-induced neurological impairment
  21204. Neuroprotective effect of tormentic acid against memory impairment and neuro‑inflammation in an Alzheimer’s disease mouse model
  21205. Neuroprotective effects of lacosamide in experimental peripheral nerve injury in rats: a prospective randomized and placebo-controlled trial
  21206. The Neuroprotective Effects of Danggui-Shaoyao San on Vascular cognitive Impairment: Involvement of the Role of the Low-Density Lipoprotein Receptor-Related …
  21207. Neuroprotective effects of urolithin A on H2O2-induced oxidative stress-mediated apoptosis in SK-N-MC cells
  21208. Neuroprotective potential of imatinib in global ischemia-reperfusion-induced cerebral injury: possible role of Janus-activated kinase 2/signal transducer and …
  21209. Multiple Neuroprotective features of Scutellaria pinnatifida–derived small molecule
  21210. The Neuroprotective action of lenalidomide on rotenone model of Parkinson’s Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta
  21211. Neuroprotective effects of Camellia nitidissima Chi leaf extract in hydrogen peroxide‐treated human neuroblastoma cells and its molecule mechanisms
  21212. Oral treatment with royal jelly improves memory and presents Neuroprotective effects on icv-STZ rat model of sporadic Alzheimer’s disease
  21213. TAT-tagging of VIP exerts positive allosteric modulation of the PAC1 receptor and enhances VIP Neuroprotective effect in the MPTP mouse model of Parkinson’s …
  21214. Comparative Neuroprotective effects of native curcumin and its galactomannoside formulation in carbofuran-induced neurotoxicity model
  21215. Synthesis of Novel Aryloxyethylamine Derivatives and Evaluation of Their in Vitro and in Vivo Neuroprotective Activities
  21216. Neuroprotective effects of food restriction in a rat model of traumatic brain injury–the role of glucocorticoid signaling
  21217. … lipopeptides derived from Mycoplasma hyorhinis upregulate calpastatin in SH-SY5Y neuroblastoma cells and induce a Neuroprotective effect against amyloid-β …
  21218. New diterpenoid quinones derived from Salvia miltiorrhiza and their cytotoxic and Neuroprotective activities
  21219. Ginsenoside Rb1 exerts Neuroprotective effects through regulation of Lactobacillus helveticus abundance and GABAA receptor expression
  21220. Salidroside shows anticonvulsant and Neuroprotective effects by activating the Nrf2-ARE pathway in a pentylenetetrazol-kindling epileptic model
  21221. Influence of cooking on the Neuroprotective properties of pepper (bird pepper and cayenne pepper) varieties in scopolamine‐induced neurotoxicity in rats
  21222. The Neuroprotective Effect of N-Docosahexaenoyldopamine on Degenerating Dopaminergic Neurons of the Mesencephalon
  21223. Neuroprotective Effect of Intravitreal Single-Dose Lithium Chloride after Optic Nerve Injury in Rats
  21224. β‐Methylphenylalanine exerts Neuroprotective effects in a Parkinson’s disease model by protecting against tyrosine hydroxylase depletion
  21225. Neuroprotective Effects of Apple‐Derived Drinks in a Mice Model of Inflammation
  21226. Investigation of Neuroprotective Effects of Erythropoietin on Chronic Neuropathic Pain in a Chronic Constriction Injury Rat Model
  21227. Neuroprotective expression of turmeric and curcumin
  21228. Neuroprotective effects of pulicaria undulata essential oil in rotenone model of parkinson’s disease in rats: Insights into its anti-inflammatory and anti-oxidant effects
  21229. Bacopa monnieri: The Neuroprotective Elixir from the East—Phytochemistry, Pharmacology, and Biotechnological Improvement
  21230. Combination of Omega 3 and Coenzyme Q10 Exerts Neuroprotective Potential Against Hypercholesterolemia-Induced Alzheimer’s-Like Disease in Rats
  21231. Neuroprotective and neuro-survival properties of safinamide against methamphetamine-induced neurodegeneration: Hypothetic possible role of BDNF/TrkB/PGC-1α …
  21232. Neuroprotective effect from Salvia hispanica peptide fractions on pro‐inflammatory modulation of HMC3 microglial cells
  21233. Anti-inflammatory and Neuroprotective effects of kissoone B and extracts of Valeriana amurensis
  21234. Neuroprotective effects of Tiliacora triandra leaf extract in a mice model of cerebral ischemia reperfusion
  21235. Neuroprotective Effects of Activated Protein C Involve the PARP/AIF Pathway against Oxygen-Glucose Deprivation in SH-SY5Y Cells
  21236. The Neuroprotective effects of SIRT1 in mice carrying the APP/PS1 double-transgenic mutation and in SH-SY5Y cells over-expressing human APP670/671 …
  21237. Cytisine is Neuroprotective in female but not male 6‐hydroxydopamine lesioned parkinsonian mice and acts in combination with 17‐β‐estradiol to inhibit apoptotic …
  21238. Does irisin has Neuroprotective effect against diabetes induced neuropathy in male rats?
  21239. Salen‑manganese complexes for controlling ROS damage: Neuroprotective effects, antioxidant activity and kinetic studies
  21240. Dexmedetomidine exerts Neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b
  21241. Proton Magnetic Resonance Spectroscopy Lactate/N-Acetylaspartate Within 48 h Predicts Cell Death Following Varied Neuroprotective Interventions in a …
  21242. Withanolide-A treatment exerts a Neuroprotective effect via inhibiting neuroinflammation in the hippocampus after pilocarpine-induced status epilepticus
  21243. microRNA-182 Negatively Influences the Neuroprotective Effect of Apelin Against Neuronal Injury in Epilepsy
  21244. Neuroprotective roles of total flavones of Camellia on early brain injury andcognitive dysfunction following subarachnoid hemorrhage in rats
  21245. Neuroprotective effects of miR-30c on rats with cerebral ischemia/reperfusion injury by targeting SOX9
  21246. Proteomics-Guided Study on Buyang Huanwu Decoction for Its Neuroprotective and Neurogenic Mechanisms for Transient Ischemic Stroke: Involvements of EGFR …
  21247. The Study of Neuroprotective Mechanisms of the Ubiquinol Action in Experimental Focal Ischemia
  21248. A validated quantitative method for the assessment of Neuroprotective barrier impairment in neurodegenerative disease models
  21249. Neuroprotective Potential of Peptides HFRWPGP (ACTH6–9PGP), KKRRPGP, and PyrRP in Cultured Cortical Neurons at Glutamate Excitotoxicity
  21250. Presenilin1 familial Alzheimer disease mutants inactivate EFNB1- and BDNF-dependent Neuroprotection against excitotoxicity by affecting Neuroprotective complexes of N …
  21251. Neuroprotective effect of alpinia galanga against middle cerebral artery occlusion-induced ischemia in rat
  21252. Neuroprotective Effect of Chronic Intracranial Toxoplasma gondii Infection in a Mouse Cerebral Ischemia Model
  21253. Neuroprotective role of resveratrol mediated by purinergic signalling in cerebral cortex of mice infected by Toxoplasma gondii
  21254. 4-aminopyridine is not just a symptomatic therapy, it has a Neuroprotective effect–Yes
  21255. Modified lanostane-type triterpenoids with Neuroprotective effects from the fungus Inonotus obliquus
  21256. Nonsteroidal Anti-Inflammatory Drugs and Their Neuroprotective Role After an Acute Spinal Cord Injury: A Systematic Review of Animal Models
  21257. Isolation and Neuroprotective Activity of Phenolic Derivatives from the Marine-Derived Fungus Penicillium janthinellum
  21258. Comparative Neuroprotective , Anti-Inflammatory and Neurite Outgrowth Activities of Extracts of King Oyster Mushroom, Pleurotus eryngii (Agaricomycetes)
  21259. Neuroprotective Compounds from Marine Microorganisms
  21260. Auroglaucin-related Neuroprotective compounds from Vietnamese marine sediment-derived fungus Aspergillus niveoglaucus
  21261. Neuroprotective effect of Crocus sativus against cerebral ischemia in rats
  21262. Prevention of systemic inflammation and Neuroprotective effects of Qingda granules against angiotensin II-mediated hypertension.
  21263. Neuroprotective and hepatoprotective effect of whole red rice forms against oxidative stress in streptozotocin induced diabetic rats.
  21264. Salsolinol—neurotoxic or Neuroprotective ?
  21265. Four pairs of alkaloid enantiomers from Isatis indigotica Fortune Ex Land with Neuroprotective effects against H2O2-induced SH-SY5Y cell injury
  21266. Neuroprotective Effects of Quercetin in Pediatric Neurological Diseases
  21267. Neuroprotective effects of 5-aminolevulinic acid against neurodegeneration in rat models of Parkinson’s disease and stroke
  21268. Neuroprotective role of Nrf2 on hypoxic‐ischemic brain injury in neonatal mice
  21269. Fucoidan serves a Neuroprotective effect in an Alzheimer’s disease model.
  21270. Neuroprotective mechanisms of DNA methyltransferase in a mouse hippocampal neuronal cell line after hypoxic preconditioning
  21271. Fetal Neuroprotective mechanism of maternal magnesium sulfate for late gestation inflammation: in a rodent model
  21272. Anxiolytic, antioxidant, and Neuroprotective effects of goji berry polysaccharides in ovariectomized rats: experimental evidence from behavioral, biochemical …
  21273. RAM-589.555 favors Neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice
  21274. Neuroprotective Effect of Oxyresveratrol in Rotenone-Induced Parkinsonism Rats
  21275. Neuroprotective effects of aromatic turmerone on activity deprivation-induced apoptosis in cerebellar granule neurons
  21276. Neuroprotective effects of Hericium erinaceus (Bull.: Fr.) Pers. against high-dose corticosterone-induced oxidative stress in PC-12 cells
  21277. Design, synthesis, and biological evaluation of novel stachydrine derivatives as potent Neuroprotective agents for cerebral ischemic stroke
  21278. The Neuroprotective effect of simvastatin on the cerebellum of experimentally-induced diabetic rats through klotho upregulation: An immunohistochemical study
  21279. Neuroprotective roles of neurotrophic growth factors in mood disorders
  21280. Natural Approaches for Neurological Disorders—The Neuroprotective Potential of Codium tomentosum
  21281. The Effect of Antenatal Neuroprotective Magnesium Sulfate Treatment on Cerebral Oxygenation in Preterm Infants
  21282. Neuroprotective effect of CTRP3 overexpression against sevoflurane anesthesia-induced cognitive dysfunction in aged rats through activating AMPK/SIRT1 and …
  21283. Neuroprotective Nanoscavenger Induces Coaggregation of β-Amyloid and Facilitates Its Clearance in Alzheimer’s Disease brain
  21284. Synthesis of α‐Ketoamide‐Based Stereoselective Calpain‐1 Inhibitors as Neuroprotective agents
  21285. The Akt/glycogen synthase kinase-3β pathway participates in the Neuroprotective effect of interleukin-4 against cerebral ischemia/reperfusion injury
  21286. Cenobamate: Neuroprotective Potential of a New Antiepileptic Drug
  21287. Neuroprotective effect of Allium hookeri against H 2 O 2-induced PC12 cell cytotoxicity by reducing oxidative stress
  21288. Neuroprotective Effects of Honey: A Mechanistic View
  21289. Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological …
  21290. Potential Neuroprotective effects of heat-killed Lactococcus lactis KC24 using SH-SY5Y cells against oxidative stress induced by hydrogen peroxide
  21291. Saffron: Chemical Composition and Neuroprotective Activity
  21292. β-Funaltrexamine Displayed Anti-Inflammatory and Neuroprotective Effects in Cells and Rat Model of Stroke
  21293. Neuroprotective effect of ketone metabolism on inhibiting inflammatory response by regulating macrophage polarization after acute cervical spinal cord injury …
  21294. Neuroprotective Effects of Higenamine Against the Alzheimer’s Disease Via Amelioration of cognitive Impairment, A β Burden, Apoptosis and Regulation of Akt …
  21295. Pycnogenol achieves Neuroprotective effects in rats with spinal cord injury by stabilizing the mitochondrial membrane potential
  21296. Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats
  21297. Neuroprotective effect of intermittent hypobaric hypoxia preconditioning on cerebral ischemia/reperfusion in rats
  21298. Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
  21299. Impact of dosing schedule on uptake of Neuroprotective magnesium sulfate
  21300. First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in …
  21301. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson’s Disease Mainly by Neuroprotective , Anti-Oxidative and Anti-Inflammatory Factors
  21302. Neuroprotective effects of mitoquinone and oleandrin on Parkinson’s disease model in zebrafish
  21303. Neuroprotective , anti-α-glucosidase and prolipase active flavonoids from Good King Henry (Chenopodium bonus-henricus L.)
  21304. … A and B, two pairs of novel quaternary protoberberine alkaloid cycloadduct enantiomers with anti-neuroinflammatory and Neuroprotective activities from the rhizomes …
  21305. The Neuroprotective Effects of Astragaloside IV against H2O2-Induced Damage in SH-SY5Y Cells are Associated with Synaptic Plasticity
  21306. Neuroprotective activities of Boophone haemanthoides (amaryllidaceae) extract and its chemical constituents
  21307. Vitamin B12 is Neuroprotective in experimental pneumococcal meningitis through modulation of hippocampal DNA methylation
  21308. Neuroprotective properties of photobiomodulation in retinal regeneration in rats: Perspectives from interaction levels
  21309. The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer’s Disease
  21310. Cannabis Phytochemicals: A Review of Phytocannabinoid Chemistry and Bioactivity as Neuroprotective agents
  21311. Eugenia uniflora fruit extract exerts Neuroprotective effect on chronic unpredictable stress‐induced behavioral and neurochemical changes
  21312. MiR‐302b‐5p enhances the Neuroprotective effect of IGF‐1 in methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐induced Parkinson’s disease by regulating inducible …
  21313. Expression Patterns of Hypoxia-Inducible Factors, Proinflammatory, and Neuroprotective Cytokines in Neuroepithelial Tissues of Lumbar Spinal Lipomas–A Pilot …
  21314. Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
  21315. Head Mild Hypothermia Exerts a Neuroprotective Role in Ischemia–Reperfusion Injury by Maintaining Glial Glutamate Transporter 1
  21316. Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer’s Disease Model
  21317. Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease
  21318. Monascin exhibits Neuroprotective effects in rotenone model of Parkinson’s disease via antioxidation and anti-neuroinflammation
  21319. Assessment of the Neuroprotective Potential of Glucose-Regulated Heat Shock Protein in a Model of Parkinson’s Disease in Rats
  21320. Neuroprotective and memory -enhancing effects of methanolic leaf extract of Peristrophe bicalyculata in rat model of type 2 diabetes mellitus.
  21321. Phenolic compounds profile, Neuroprotective effect and antioxidant potential of a commercial Turkish coffee
  21322. Neuroprotective effect of melatonin on nickel-induced affective and cognitive disorders and oxidative damage in rats
  21323. A new method in robotic-assisted laparoscopic radical prostatectomy: personalised Neuroprotective surgery with neuromonitoring system—randomised controlled …
  21324. Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
  21325. Neuroprotective compounds from the embryo of Nelumbo nucifera seeds
  21326. Analgesic and Neuroprotective Effects of Electroacupuncture in a Dental Pulp Injury Model—A Basic Research
  21327. Chemical Constituents of the Fruits of Lycium barbarum and their Neuroprotective Activity
  21328. Cerium oxide nanoparticles as a new Neuroprotective agent to promote functional recovery in a rat model of sciatic nerve crush injury
  21329. High Content Screening and Proteomic Analysis Identify the Kinase Inhibitor BX795 as a Potent Neuroprotective Compound in a Patient-Derived Model of Parkinson’s …
  21330. The Potential Mechanisms of the Neuroprotective Actions of Oil Palm Phenolics: Implications for Neurodegenerative Diseases
  21331. Synthesis of 4-oxatricyclo [5.2. 1.02, 6] dec-8-ene-3, 5-dione derivatives as lead scaffolds for Neuroprotective agents
  21332. Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer’s Disease
  21333. Neuroprotective Flavonoids from the Aerial Parts of Gynura cusimbua
  21334. Age-dependent Neuroprotective effect of an SK3 channel agonist on excitotoxity to dopaminergic neurons in organotypic culture
  21335. Apigenin-7-O-β-D-(-6”-p-coumaroyl)-glucopyranoside treatment elicits a Neuroprotective effect through GSK-3β phosphorylation-mediated Nrf2 activation
  21336. Corrigendum to “A Hypothesis: Hydrogen Sulfide Might Be Neuroprotective against Subarachnoid Hemorrhage Induced brain Injury”
  21337. Neuroprotective effect of the essential oil of Lavandula officinalis against hydrogen peroxide-induced toxicity in mice
  21338. Adjunctive Neuroprotective Therapies for Treatment of Hypoxic-Ischemic Encephalopathy (HIE)
  21339. Neurotrophic and Neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury
  21340. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson’s Disease Is Mediated by α7-Nicotinic …
  21341. Neuroprotective magnesium sulfate administration increases maternal Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Systemic Immune …
  21342. Treatment with CCR2 antagonist is Neuroprotective but does not alter epileptogenesis in the pilocarpine rat model of epilepsy
  21343. Activity-dependent Neuroprotective protein (ADNP)/NAP (CP201): Autism, schizophrenia, and Alzheimer’s disease
  21344. New 30-norlupane derivatives through chemical-microbial semi-synthesis of betulinic acid and their Neuroprotective effect
  21345. M211. Neuroprotective EFFECT OF SHI-ZHEN-AN-SHEN-TANG, A CHINESE HERB FORMULA ON MICE EXPOSED TO CUPRIZONE
  21346. Novel Neuroprotective agents to Treat Neonatal Hypoxic-Ischemic Encephalopathy: Inter-Alpha Inhibitor Proteins
  21347. Neuroprotective and Antiapoptotic Effects of Allopregnanolone and Curcumin on Arsenic-Induced Toxicity in SH-SY5Y Dopaminergic Human Neuroblastoma Cells
  21348. Neuroprotective Effect of L-carnitine. Focus on Changing Mitochondrial Function
  21349. Neuroprotective effect of organic and inorganically grown tea on oxidative damage in rat model of Alzheimer’s disease
  21350. Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats
  21351. Efficacy of different treatment times of mild cerebral hypothermia on oxidative factors and Neuroprotective effects in neonatal patients with moderate/severe hypoxic …
  21352. Identification of Kinome Representatives with Neuroprotective Activity
  21353. Propofol exerts Neuroprotective functions by down‐regulating microRNA‐19a in glutamic acid‐induced PC12 cells
  21354. Neuroprotective effects of peroxisome proliferator-activated receptor γ agonist through activation of Akt and signal transducers and activators of transcription 3 in …
  21355. Neuroprotective strategies in COVID-19
  21356. Neuroprotective role of phosphoserine in primary open-angle glaucoma patients
  21357. … Study of the Neuropharmacological Profile of Methanol Leaf Extract of Aloe vera and Identification of Associated Neuroprotective Compounds through Gas …
  21358. Optimal Design of Neuroprotective Focal brain Cooling Device Using Surrogate Model Approach
  21359. Design, Synthesis and Evaluation of 8-Thiosubstituted 1, 3, 7-Trimethylxanthine Hydrazones with In-vitro Neuroprotective and MAO-B Inhibitory Activities
  21360. Isolation and Neuroprotective prospective of novel bioactive compound “3-(3, 4-dimethoxyphenyl)-1-(4-methoxyphenyl) prop-2-en-1-one” against ketamine-induced …
  21361. Neuroprotective effect of DUSP14 overexpression against isoflurane-induced inflammatory response, pyroptosis and cognitive impairment in aged rats through …
  21362. Antioxidant, Hypoglycemic and Neuroprotective Activities of Extracts from Fruits Native to the Amazon Region: A Review
  21363. Ferroptosis-suppressor-protein 1: a potential Neuroprotective target for combating ferroptosis
  21364. Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective agents by Targeting the Sigma-1 Receptor (S1R)
  21365. Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
  21366. Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a …
  21367. Mechanism of the Neuroprotective effect of injecting brain cells on ST36 in an animal model of Parkinson’s disease
  21368. Neuroprotective mechanism of Vernonia amygdalina in a rat model of neurodegenerative diseases
  21369. The Neuroprotective effect of submicron and blended Lycium barbarum for experiment retinal ischemia and reperfusion injury in rats
  21370. Evaluation of Neuroprotective effects of alpha-tocopherol in cuprizone-induced demyelination model of multiple sclerosis
  21371. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
  21372. Neuroprotective Effect of Bean Phosphatidylserine on TMT-Induced memory Deficits in a Rat Model
  21373. Antioxidant and Neuroprotective Activities of the Mesocarp of Raphia hookeri Fruit against Aluminum Chloride-Induced Neurotoxicity in Rats
  21374. Withania somnifera showed Neuroprotective effect and increase longevity in Drosophila Alzheimer’s disease model
  21375. A New Diarylheptanoid from the Twigs of Quercus Acutissima and their Neuroprotective Activity
  21376. Neuroprotective Effects of Guanosine Supplementation in Experimental Models: A Systematic Review.
  21377. Neuroprotective mechanisms of erythropoietin in a rat stroke model
  21378. Neuroprotective and antioxidant activities of fraction isolated from methanolic extract of Sapindus laurifolia on scopolamine induced dementia
  21379. Role of Metallothionein-1 and Metallothionein-2 in the Neuroprotective Mechanism of Sevoflurane Preconditioning in Mice
  21380. Altered Cerebral Blood Flow and Potential Neuroprotective Effect of Human Relaxin-2 (Serelaxin) During Hypoxia or Severe Hypovolemia in a Sheep Model
  21381. Neuroprotective Effects of Co-administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats
  21382. Neuroprotective Activity of Methanolic Extract of Lysimachia christinae against Glutamate Toxicity in HT22 Cell and Its Protective Mechanisms
  21383. Neuroprotective effects of thromboxane receptor antagonist SQ 29,548 after pilocarpine-induced status epilepticus in mice
  21384. Preventive Effects of Neuroprotective agents in a Neonatal Rat of Photothrombotic Stroke Model
  21385. Author Correction: Design and Molecular dynamic Investigations of 7, 8-Dihydroxyflavone Derivatives as Potential Neuroprotective agents Against Alpha-synuclein
  21386. Neuroprotective Effect of Cudrania tricuspidataFruit Extracts on Scopolamine-Induced Learning and memory Impairment
  21387. Neuroprotective effect of Longshengzhi capsule following permanent middle cerebral artery occlusion in rats
  21388. Activation of silent information regulator 1 exerts a Neuroprotective effect after intracerebral hemorrhage by deacetylating NF‐κB/p65
  21389. Confirmation of potential Neuroprotective effects of natural bioactive compounds from traditional medicinal herbs in cerebral ischemia treatment
  21390. Abstract WP315: Neuroprotective Effects of Endogenous Adropin in Experimental Ischemic Stroke
  21391. The influence of B55γ on the Neuroprotective effect of W026B in t-MCAO mice
  21392. Study of the Neuroprotective Properties of Fullerenol C 60 (OH) 30 with a Model of Alzheimer’s Disease
  21393. Structural elucidation and Neuroprotective activities of lignans from the flower buds of Magnolia biondii Pamp.
  21394. Waggle needling wields preferable Neuroprotective and anti-spastic effects on post-stroke spasticity rats by attenuating γ-aminobutyric acid transaminase and …
  21395. Minocycline and Magnesium As Neuroprotective agents for Ischemic Stroke: A Systematic Review
  21396. In vitro evaluation of acetylcholinesterase inhibitory and Neuroprotective activity in commiphora species: A comparative study
  21397. Choice of Neuroprotective therapy regimens in patients with chronic cerebral ischemia, taking into account the synergy of drug interactions
  21398. Contribution of Lysosome and Sigma Receptors to Neuroprotective Effects of Memantine Against Beta-Amyloid in the SH-SY5Y Cells
  21399. Neuroprotective effects of Medicinal plants in cerebral hypoxia and anoxia: A systematic review
  21400. AGARICOMYCETES MEDICINAL MUSHROOMS WITH POTENTIAL Neuroprotective ACTIVITY GROWING IN ARMENIA
  21401. Neuroprotective effects of direct activation and transactivation of PDGFβ receptors
  21402. The Neuroprotective effects of stimulation of NMDA receptors against POX-induced neurotoxicity in hippocampal cultured neurons; a morphometric study
  21403. Machine Learning Neuroprotective Strategy Reveals a Unique Set of Parkinson Therapeutic Nicotine Analogs
  21404. Neuroprotective natural products
  21405. 5‐[2‐(N‐(Substituted phenyl) acetamide)] amino‐1, 3, 4‐thiadiazole‐2‐sulfonamides as Selective Carbonic Anhydrase II Inhibitors with Neuroprotective Effects
  21406. Mechanisms of Neuroprotective Action of Hesperetin and Carnosine in Focal Ischemia of the brain in Rats
  21407. Exploring beta amyloid cleavage enzyme‐1 inhibition and Neuroprotective role of benzimidazole analogues as anti‐alzheimer agents
  21408. Design and Synthesis of New Benzo [d] oxazole-Based Derivatives and Their Neuroprotective Effects on β-Amyloid-Induced PC12 Cells
  21409. Tau-based therapies for Alzheimer’s disease: Promising novel Neuroprotective approaches
  21410. Neuroprotective Strategies During Aortic Surgery
  21411. TAK‑242 exerts a Neuroprotective effect via suppression of the TLR4/MyD88/TRIF/NF‑κB signaling pathway in a neonatal hypoxic‑ischemic encephalopathy rat model
  21412. Discovery of bioactive drug candidates from some Turkish medicinal plants-Neuroprotective potential of Iris pseudacorus L.
  21413. Moderate intensity intermittent exercise upregulates neurotrophic and Neuroprotective genes expression and inhibits Purkinje cell loss in the cerebellum of …
  21414. Inhaled H2 or CO2 Do Not Augment the Neuroprotective Effect of Therapeutic Hypothermia in a Severe Neonatal Hypoxic-Ischemic Encephalopathy Piglet Model
  21415. Effects of Long-Term Endurance Exercise and Lithium Treatment on Neuroprotective Factors in Hippocampus of Obese Rats
  21416. In-vitro Neuroprotective effect and mechanism of 2β-hydroxy-δ-cadinol against amyloid β-induced neuronal apoptosis
  21417. Neuroprotective Effects of Safflower Flavonoid Extract in 6-Hydroxydopamine-Induced Model of Parkinson’s Disease May Be Related to its Anti-Inflammatory Action
  21418. Investigation on beneficial role of l-carnosine in Neuroprotective mechanism of ischemic postconditioning in mice: possible role of histidine histamine pathway
  21419. Fractalkine/CX3CR1 pathway is Neuroprotective in intracerebral hemorrhage through facilitating the expression of TGF-β1
  21420. Effect of M. chamomilla L. tea on chlorpromazine induced catalepsy: A Neuroprotective study.
  21421. Sandalwood oil Neuroprotective effects on middle cerebral artery occlusion model of ischemic brain stroke
  21422. Preclinical Perspectives of Mechanisms Underlying the Neuroprotective Effects of Selected Phyto-Constituents in Alzheimer’s Disease
  21423. Pharmacotranscriptomics of peptide drugs with Neuroprotective properties
  21424. Anti-amnesic and Neuroprotective effects of fluoroethylnormemantine in a pharmacological mouse model of Alzheimer’s disease
  21425. Neuroprotective effects of human amniotic fluid stem cells‐derived secretome in an ischemia/reperfusion model
  21426. In vivo Neuroprotective effect of a self-assembled peptide hydrogel
  21427. Neuroprotective Effects of the FGF21 Analogue LY2405319
  21428. Neuroprotective function of microglia in the developing brain
  21429. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT 1A …
  21430. Neuroprotective benefits of grape seed and skin extract in a mouse model of Parkinson’s disease
  21431. Exploring the Neuroprotective Potential of Rosiglitazone Embedded Nanocarrier System on Streptozotocin Induced Mice Model of Alzheimer’s Disease
  21432. Neuroprotective Effects of Motherhood on brain Function in Late Life: A Resting-State fMRI Study
  21433. Neuroprotective pentapeptide, CN-105, improves outcomes in translational models of intracerebral hemorrhage
  21434. Neuroprotective properties of vitamin C: A Scoping Review of pre-clinical and clinical studies
  21435. Neuroprotective Treatment of Postanoxic Encephalopathy: A Review of Clinical Evidence
  21436. Hydrogen sulfide is Neuroprotective in Alzheimer’s disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation
  21437. Neuroprotective Effect of α-Mangostin in the Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats
  21438. Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease
  21439. Neuroprotective effects of metalosalen complexes against oxidative stress
  21440. Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review
  21441. Neuroprotective Potential of Ellagic Acid: A Critical Review
  21442. Neuroprotective Role of Akt in Hypoxia Adaptation in Andeans
  21443. The Neuroprotective effect of oxytocin on vincristine-induced neurotoxicity in mice
  21444. In vitro Neuroprotective potential of Clivia miniata and Nerine humilis (Amaryllidaceae) in MPP+-induced neuronal toxicity in SH-SY5Y neuroblastoma cells
  21445. Exifone is a potent HDAC1 activator with Neuroprotective activity in human neuronal models of neurodegeneration
  21446. Neuroprotective effect of NXP031 in the MPTP-induced Parkinson’s disease model
  21447. Neuroprotective potential of Malva neglecta is mediated via down-regulation of cholinesterase and modulation of oxidative stress markers
  21448. Neuroprotective Effect of Cannabidiol Against Hydrogen Peroxide in Hippocampal Neuron Culture
  21449. Long-lasting analgesic and Neuroprotective action of the non-benzodiazepine anxiolytic etifoxine in a mouse model of neuropathic pain
  21450. Autophagy induction contributes to the Neuroprotective impact of intermittent fasting on the acutely injured spinal cord
  21451. Synthesis and identification of a novel derivative of salidroside as a selective, competitive inhibitor of monoamine oxidase B with enhanced Neuroprotective properties
  21452. Lithium-induced Neuroprotective activity in neuronal and microglial cells: A purinergic perspective
  21453. Phenotypic Discovery of Neuroprotective agents by Regulation of Tau Proteostasis via Stress‐Responsive Activation of PERK Signaling
  21454. Neuroprotective Effect of Apolipoprotein D in Cuprizone-Induced Cell Line Models: A Potential Therapeutic Approach for Multiple Sclerosis and Demyelinating …
  21455. Loliolide, a New Therapeutic Option for Neurological Diseases? In Vitro Neuroprotective and Anti-Inflammatory Activities of a Monoterpenoid Lactone Isolated from …
  21456. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson’s disease: motor and non‐motor outcomes
  21457. Granulocyte-Macrophage Colony-Stimulating Factor mRNA and Neuroprotective Immunity in Parkinson’s Disease
  21458. In vitro Neuroprotective potential of terpenes from industrial orange juice by-products
  21459. Composition, antioxidant activity, and Neuroprotective effects of anthocyanin-rich extract from purple highland barley bran and its promotion on autophagy
  21460. Discovery of Neuroprotective agents that inhibit human prolyl hydroxylase PHD2
  21461. A comparison of the location in membranes of curcumin and curcumin-derived bivalent compounds with potential Neuroprotective capacity for Alzheimer’s disease
  21462. Alkaloids extracted from Uncaria rhynchophylla demonstrate Neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the PI3K/Akt/mTOR …
  21463. E2-BSA and G1 exert Neuroprotective effects and improve behavioral abnormalities following traumatic brain injury: The role of classic and non-classic estrogen …
  21464. Distribution in the brain and possible Neuroprotective effects of intranasally delivered multi-walled carbon nanotubes
  21465. Glucagon-like peptide-1 receptor agonists as Neuroprotective agents for ischemic stroke: a systematic scoping review
  21466. The effectiveness of Bacopa monnieri (Linn.) Wettst. as a nootropic, Neuroprotective , or antidepressant supplement: analysis of the available clinical data
  21467. Chemical compounds with a Neuroprotective effect from the seeds of Celosia argentea L.
  21468. Transplantation of 3D MSC/HUVEC spheroids with Neuroprotective and proangiogenic potentials ameliorates ischemic stroke brain injury
  21469. Exercise and Fitness Neuroprotective Effects: Molecular, brain Volume and Psychological Correlates and Their Mediating Role in Healthy Late-Middle-Aged …
  21470. Detection and monitoring of the Neuroprotective behavior of curcumin micelles based on an AIEgen probe
  21471. Neuroprotective effects of microRNA-140-5p on ischemic stroke in mice via regulation of the TLR4/NF-κB axis
  21472. Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and …
  21473. The DJ1-Nrf2-STING axis mediates the Neuroprotective effects of Withaferin A in Parkinson’s disease
  21474. The role of G-CSF Neuroprotective effects in neonatal hypoxic-ischemic encephalopathy (HIE): current status
  21475. Priming mesenchymal stem cells with uric acid enhances Neuroprotective properties in parkinsonian models
  21476. Investigational Neuroprotective Compounds in Clinical Trials for Retinal Disease
  21477. Whether short peptides are good candidates for future Neuroprotective therapeutics?
  21478. Chromone–lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities
  21479. Total Synthesis, Structure Revision, and Neuroprotective Effect of Hericenones C–H and Their Derivatives
  21480. Mitochondrial PKA Is Neuroprotective in a Cell Culture Model of Alzheimer’s Disease
  21481. Neuroprotective effect of magnesium supplementation on cerebral ischemic diseases
  21482. Neuroprotective effects of troxerutin and cerebroprotein hydrolysate injection on the neurovascular unit in a rat model of Middle cerebral artery occlusion
  21483. Neuroprotective effects of Sonic hedgehog agonist SAG in a rat model of neonatal stroke
  21484. Neuroprotective effects of SOX5 against ischemic stroke by regulating VEGF/PI3K/AKT pathway
  21485. Extracts from Chinese herbs with anti-amyloid and Neuroprotective activities
  21486. Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease
  21487. Neuroprotective Properties of 4-Aminopyridine
  21488. Synthesis and Biological Evaluation of Benzimidazole Derivatives as Potential Neuroprotective agents in an Ethanol-Induced Rodent Model
  21489. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy
  21490. Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
  21491. Characterization, antioxidant, and Neuroprotective effects of anthocyanins from Nitraria tangutorum Bobr. fruit
  21492. Neuroprotective Effects of Coffee Bioactive Compounds: A Review
  21493. Neuroprotective Effects of Testosterone in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis
  21494. The Neuroprotective Effect of Short Chain Fatty Acids Against Sepsis-Associated Encephalopathy in Mice
  21495. Stem Cell-Engineered Nanovesicles Exert Proangiogenic and Neuroprotective Effects
  21496. Neuroprotective effects of maize tetrapeptide-anchored gold nanoparticles in Alzheimer’s disease
  21497. Gut microbiota-derived propionate mediates the Neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease
  21498. Exploring the possible Neuroprotective and antioxidant potency of lycopene against acrylamide-induced neurotoxicity in rats’ brain
  21499. Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a …
  21500. The pleiotropic Neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: from antioxidant to epigenetic therapy
  21501. The orphan nuclear receptor Nurr1 agonist amodiaquine mediates Neuroprotective effects in 6-OHDA Parkinson’s disease animal model by enhancing the …
  21502. Development of a novel in vitro assay to screen for Neuroprotective drugs against iatrogenic neurite shortening
  21503. Neuroprotective effects of Hemocoagulase Agkistrodon on experimental traumatic brain injury
  21504. Neuroprotective Effects of Exercise Postconditioning After Stroke via SIRT1-Mediated Suppression of Endoplasmic Reticulum (ER) Stress
  21505. A network-based method for mechanistic investigation and Neuroprotective effect on treatment of tanshinone Ⅰ against ischemic stroke in mouse
  21506. Neuroprotective compounds from the resinous heartwood of Aquilaria sinensis
  21507. Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
  21508. Neuroprotective effects of Myricetin on Epoxiconazole-induced toxicity in F98 cells
  21509. Xylarinaps A–E, five pairs of naphthalenone derivatives with Neuroprotective activities from Xylaria nigripes
  21510. Neuroprotective effect of paeonol in streptozotocin-induced diabetes in rats
  21511. Neuroprotective Effects of Carnitine and Its Potential Application to Ameliorate Neurotoxicity
  21512. Neuroprotective mechanisms of mangiferin in neurodegenerative diseases
  21513. Increasing O-GlcNAcylation is Neuroprotective in young and aged brain s after ischemic stroke
  21514. Enlightening the Neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities
  21515. Phytosterol-rich compressed fluids extracts from Phormidium autumnale cyanobacteria with Neuroprotective potential
  21516. Diaportheone A Analogues Instigate a Neuroprotective Effect by Protecting Neuroblastoma SH-SY5Y Cells from Oxidative Stress
  21517. Neuronal Metabolism and Neuroprotection : Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage
  21518. eNOS-dependent S-nitrosylation of the NF-κB subunit p65 has Neuroprotective effects
  21519. Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts
  21520. Shared and oppositely regulated transcriptomic signatures in Huntington´ s disease and brain ischemia confirm known and unveil novel potential Neuroprotective …
  21521. Antioxidant and Neuroprotective Activity of Extra Virgin Olive Oil Extracts Obtained from Quercetano Cultivar Trees Grown in Different Areas of the Tuscany Region …
  21522. Midkine is Neuroprotective and influences glial reactivity and the formation of Müller glia‐derived progenitor cells in chick and mouse retinas
  21523. Multi-target inhibition ability of neohesperidin dictates its Neuroprotective activity: Implication in Alzheimer’s disease therapeutics
  21524. Disclosing the potential of eleganolone for Parkinson’s disease therapeutics: Neuroprotective and anti-inflammatory activities
  21525. Neuroprotective effect of heparin Trisulfated disaccharide on ischemic stroke
  21526. In Silico Prediction of the Toxic Potential of Neuroprotective Bifunctional Molecules Based on Chiral N-Propargyl-1,2-amino Alcohol Derivatives
  21527. Guaiane-type sesquiterpenoids from the roots of Stellera chamaejasme L. and their Neuroprotective activities
  21528. Donepezil provides Neuroprotective effects against brain injury and Alzheimer’s pathology under conditions of cardiac ischemia/reperfusion injury
  21529. Neuroprotective Effect of Kinase Inhibition in Ischemic Factor Modeling In Vitro
  21530. Neuroprotective Effects of a GLP-2 Analogue in the MPTP Parkinson’s Disease Mouse Model
  21531. Neuroprotective effects of protocatechuic acid on sodium arsenate induced toxicity in mice: Role of oxidative stress, inflammation, and apoptosis
  21532. Multiple genetic pathways regulating lifespan extension are Neuroprotective in a G2019S LRRK2 nematode model of Parkinson’s disease
  21533. Neuroprotective roles of HAX-1 in ischemic neuronal injury
  21534. Neuroprotective effect of agomelatine in rat model of psychosis: Behavioural and histological evidence
  21535. The Neuroprotective Effect of Carvedilol on Diabetic Neuropathy: An In Vitro Study
  21536. Assessment of the Neuroprotective and Stemness Properties of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells under Variable (5% vs. 21%) Aerobic …
  21537. Acute Dose-Dependent Neuroprotective Effects of Poly (pro-17β-estradiol) in a Mouse Model of Spinal Contusion Injury
  21538. Nutraceuticals in the Prevention of Neonatal Hypoxia–Ischemia: A Comprehensive Review of their Neuroprotective Properties, Mechanisms of Action and Future …
  21539. Cytokinin Plant Hormones Have Neuroprotective Activity in In Vitro Models of Parkinson’s Disease
  21540. Neuroprotective Effects of Testosterone in the Hypothalamus of an Animal Model of Metabolic Syndrome
  21541. Synergistic Neuroprotective effects of Fingolimod and Mesenchymal Stem Cells (MSC) in Experimental Autoimmune Encephalomyelitis
  21542. Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
  21543. Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis
  21544. Characterization and Exploration of Potential Neuroprotective Peptides in Walnut (Juglans regia) Protein Hydrolysate against Cholinergic System Damage and …
  21545. Chemical similarity assisted search for acetylcholinesterase inhibitors: Molecular modeling and evaluation of their Neuroprotective properties
  21546. Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects
  21547. Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic …
  21548. Pharmacologic modulation of brain metabolism by valproic acid can induce a Neuroprotective environment
  21549. Neuroprotective and Neurorescue Mode of Action of Bacopa monnieri (L.) Wettst in 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Parkinson’s …
  21550. Neuroprotective Effect of Astragaloside IV on Cerebral Ischemia/Reperfusion Injury Rats Through Sirt1/Mapt Pathway
  21551. MANF is Neuroprotective against ethanol-induced neurodegeneration through ameliorating ER stress
  21552. Dietary administration of cumin-derived cuminaldehyde induce Neuroprotective and learning and memory enhancement effects to aging mice
  21553. Syringin exerts Neuroprotective effects in a rat model of cerebral ischemia through the FOXO3a/NF-κB pathway
  21554. Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson’s Disease Model
  21555. Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
  21556. Lack of Autophagy Induction by Lithium Decreases Neuroprotective Effects in the Striatum of Aged Rats
  21557. Recombinant human growth hormone activates Neuroprotective growth factors in hypoxic brain injury in neonatal mice
  21558. Camptothecin Regulates Microglia Polarization and Exerts Neuroprotective Effects via Activating AKT/Nrf2/HO-1 and Inhibiting NF-κB Pathways In Vivo and In …
  21559. Neuroprotective and anti-neuroinflammatory effects of ethanolic extract from leaves and stems of Aster glehni
  21560. The potential Neuroprotective role of Amphora coffeaeformis algae against monosodium glutamate-induced neurotoxicity in adult albino rats
  21561. Nobiletin Exhibits Neuroprotective Effects against Mitochondrial Complex I Inhibition via Regulating Apoptotic Signaling
  21562. Hydroazulene Diterpenes from a Dictyota Brown Alga and Their Antioxidant and Neuroprotective Effects Against Cerebral Ischemia-Reperfusion Injury
  21563. Neuroprotective effects of ProBeptigen/CMI-168 on aging-induced cognitive decline and neuroinflammation in mice: a comparison with essence of chicken
  21564. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease
  21565. Acute symptomatic neonatal seizures, brain injury, and long-term outcome: The role of Neuroprotective strategies
  21566. Neuroprotective role of chrysin‐loaded poly (lactic‐co‐glycolic acid) nanoparticle against kindling‐induced epilepsy through Nrf2/ARE/HO‐1 pathway
  21567. Danshen (Salvia miltiorrhiza) water extract shows potential Neuroprotective effects in Caenorhabditis elegans
  21568. Additional alkaloids from Zoanthus vietnamensis with Neuroprotective and anti-angiogenic effects
  21569. Neuroprotective effect of minocycline against acute brain injury in clinical practice: A systematic review
  21570. A review on the Neuroprotective effects of hyperbaric oxygen therapy
  21571. Neuroprotective effect of Val variant of BDNF Val66Met polymorphism on hippocampus is modulated by the severity of menstrual pain
  21572. Neuroprotective gain of Apelin/APJ system
  21573. Neuroprotective effects of mango cv.’Ataulfo’peel and pulp against oxidative stress in streptozotocin‐induced diabetic rats
  21574. Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
  21575. Isolation, Structure Elucidation, Semi-Synthesis, and Structural Modification of C19-Diterpenoid Alkaloids from Aconitum apetalum and Their Neuroprotective …
  21576. Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System
  21577. Novel pentacyclic triterpenes exhibiting strong Neuroprotective activity in SH-SY5Y cells in salsolinol-and glutamate-induced neurodegeneration models
  21578. Neuroprotective effects of carbenoxolone against amyloid-beta 1–42 oligomer-induced neuroinflammation and cognitive decline in rats
  21579. Neuroprotective mechanisms of chronic physical exercise via reduction of β-amyloid protein in experimental models of Alzheimer’s disease: A systematic review
  21580. Neuroprotective potential of cinnamon and its metabolites in Parkinson’s disease: Mechanistic insights, limitations, and novel therapeutic opportunities
  21581. Smurf2 exerts Neuroprotective effects on cerebral ischemic injury
  21582. Neuroprotective effects of quercetin 3-O-sophoroside from Hibiscus rosa-sinensis Linn. on scopolamine-induced amnesia in mice
  21583. Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors
  21584. The Neuroprotective effects of phosphocreatine on Amyloid Beta 25–35-induced differentiated neuronal cell death through inhibition of AKT/GSK-3β/Tau/APP/CDK5 …
  21585. One-bead-one-compound screening approach to the identification of cyclic peptoid inhibitors of cyclophilin D as Neuroprotective agents from mitochondrial …
  21586. High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects
  21587. Neuroprotective Effect of Aurantio-Obtusin, a Putative Vasopressin V1A Receptor Antagonist, on Transient Forebrain Ischemia Mice Model
  21588. Potential Neuroprotective Mechanisms of Methamphetamine Treatment in Traumatic brain Injury Defined by Large-Scale IonStar-Based Quantitative Proteomics
  21589. eNOS-dependent S-nitrosylation of the NF-κB subunit p65 has Neuroprotective effects
  21590. Neuroprotective effect of hypoxic preconditioning and neuronal activation in a in vitro human model of the ischemic penumbra
  21591. Neuroprotective Effect of Turmeric Extract in Combination with Its Essential Oil and Enhanced brain Bioavailability in an Animal Model
  21592. Electrophysiological and inflammatory changes of CA1 area in male rats exposed to acute kidney injury: Neuroprotective effects of erythropoietin
  21593. Study on the Neuroprotective effects of Genistein on Alzheimer’s disease
  21594. Conserved nicotine-activated Neuroprotective pathways involve mitochondrial stress
  21595. Isolation and characterization of neolignan derivatives with hepatoprotective and Neuroprotective activities from the fruits of Citrus medica L. var. Sarcodactylis Swingle
  21596. Plasma-derived and recombinant C1 esterase inhibitor: Binding profiles and Neuroprotective properties in brain ischemia/reperfusion injury
  21597. The Neuroprotective Effect of Byu d Mar 25 in LPS-Induced Alzheimer’s Disease Mice Model
  21598. Neuroprotective Effects of Extracts from Tiger Milk Mushroom Lignosus rhinocerus Against Glutamate-Induced Toxicity in HT22 Hippocampal Neuronal Cells and …
  21599. Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation
  21600. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson’s disease
  21601. Kellerin from Ferula sinkiangensis exerts Neuroprotective effects after focal cerebral ischemia in rats by inhibiting microglia-mediated inflammatory responses
  21602. Evaluation of the Neuroprotective effect of donepezil in type 2 diabetic rats
  21603. Neuroprotective effect of apigenin against hypoxic-ischemic brain injury in neonatal rats via activation of the PI3K/Akt/Nrf2 signaling pathway
  21604. Sea Anemone Kunitz-Type Peptides Demonstrate Neuroprotective Activity in the 6-Hydroxydopamine Induced Neurotoxicity Model
  21605. l-Borneol Exerted the Neuroprotective Effect by Promoting Angiogenesis Coupled With Neurogenesis via Ang1-VEGF-BDNF Pathway
  21606. Assessment of Neuroprotective Effects of Low-Intensity Transcranial Ultrasound Stimulation in a Parkinson’s Disease Rat Model by Fractional Anisotropy and …
  21607. Neuroprotective Effects of Early Hypothermia Induced by Phenothiazines and DHC in Ischemic Stroke
  21608. … in the serotoninergic and vasopressin systems causing anxiogenic-like behavior in Meriones shawi: Assessment of BDMC as a Neuroprotective compound for Pb …
  21609. Upregulation of Sec22b plays a Neuroprotective role in a rat model of traumatic brain injury via inducing protective autophagy
  21610. Neuroprotective Effects of Thymoquinone by the Modulation of ER Stress and Apoptotic Pathway in In Vitro Model of Excitotoxicity
  21611. … , blood partitioning, permeability, CYP phenotyping and CYP inhibition studies of Withanone using validated UPLC method: An active constituent of Neuroprotective …
  21612. Neuroprotective potential of hydroethanolic hull extract of Juglans regia L. on isoprenaline induced oxidative damage in brain of Wistar rats
  21613. 7-phenoxytacrine is a dually acting drug with Neuroprotective efficacy in vivo
  21614. Neuroprotective Effects of Telmisartan and Nifedipine Against Cuprizone-Induced Demyelination and Behavioral Dysfunction in Mice: Roles of NF-κB and Nrf2
  21615. Isolation and structural characterization of four diastereomeric lignan glycosides from Abies holophylla and their Neuroprotective activity
  21616. Role of inflammatory, oxidative, and ER stress signaling in the Neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats
  21617. Glycoside Compounds From Glycyrrhiza uralensis and Their Neuroprotective Activities
  21618. Neuroprotective effects of Actinidia eriantha cv. Bidan kiwifruit on amyloid beta-induced neuronal damages in PC-12 cells and ICR mice
  21619. Anti-inflammatory and Neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission
  21620. Neuroprotective Effect of Protaetia brevitarsis seulensis’ Water Extract on Trimethyltin-Induced Seizures and Hippocampal Neurodegeneration
  21621. Decoding the Neuroprotective Potential of Methyl Gallate-Loaded Starch Nanoparticles against Beta Amyloid-Induced Oxidative Stress-Mediated Apoptosis: An In …
  21622. Vlasoulides A and B, a pair of Neuroprotective C 32 dimeric sesquiterpenes with a hexacyclic 5/7/5/5/(5)/7 carbon skeleton from the roots of Vladimiria souliei
  21623. Neuroprotective effects of hydro-alcoholic extract of Eclipta alba against 1-methyl-4-phenylpyridinium-induced in vitro and in vivo models of Parkinson’s disease
  21624. Determining the Optimal Administration Conditions under Which MIF Exerts Neuroprotective Effects by Inducing BDNF Expression and Inhibiting Apoptosis in an In …
  21625. Neuroprotective Effect of 3-[(4-Chlorophenyl) selanyl]-1-methyl-1 H-indole on Hydrogen Peroxide-Induced Oxidative Stress in SH-SY5Y Cells
  21626. A Mechanistic Overview of Spinal Cord Injury, Oxidative DNA Damage Repair and Neuroprotective Therapies
  21627. … Chemical Profiling, Biological and In Silico Docking Studies to Unravel the Therapeutic Potential of Heliotropium crispum Desf. as a Novel Source of Neuroprotective …
  21628. Prolactin Neuroprotective action against excitotoxic insult in the hippocampus of male mice
  21629. Neuroprotective role of gallic acid in aflatoxin B1‐induced behavioral abnormalities in rats
  21630. Neuroprotective effect of ketamine against TNF‐α‐induced necroptosis in hippocampal neurons
  21631. Peptide OM-LV20 exerts Neuroprotective effects against cerebral ischemia/reperfusion injury in rats
  21632. Neuroprotective Effect of Gallocatechin Gallate on Glutamate-Induced Oxidative Stress in Hippocampal HT22 Cells
  21633. Thermo-Responsive PLGA-PEG-PLGA Hydrogels as Novel Injectable Platforms for Neuroprotective Combined Therapies in the Treatment of Retinal Degenerative …
  21634. Evaluation of adenosine A1 receptor agonists as Neuroprotective countermeasures against Soman intoxication in rats
  21635. Neuroprotective effect of emodin against Alzheimer’s disease via Nrf2 signaling in U251 cells and APP/PS1 mice
  21636. Methylphenidate exerts Neuroprotective effects through the AMPK signaling pathway
  21637. Neurotropin exerts Neuroprotective effects after spinal cord injury by inhibiting apoptosis and modulating cytokines
  21638. An Efficient Regioselective Synthesis of 8-Formylhomoisoflavonoids with Neuroprotective Activity by Enhancing Autophagy
  21639. Neuroprotective Effects of ZiBuPiYin Recipe on db/db Mice via PI3K-Akt Signaling Pathway by Activating Grb2
  21640. Neuroprotective Effects of Heat-Killed Lactobacillus plantarum 200655 Isolated from Kimchi Against Oxidative Stress
  21641. Neuroprotective function of microglia in the developing brain
  21642. Neuroprotective Effects of Growth Hormone (GH) and Insulin-Like Growth Factor Type 1 (IGF-1) after Hypoxic-Ischemic Injury in Chicken Cerebellar Cell Cultures
  21643. γ-and δ-lactones as fumarate esters analogues and their Neuroprotective effects
  21644. The Neuroprotective Effect of Thiopental on the Postoperative Neurological Complications in Patients Undergoing Surgical Clipping of Unruptured Intracranial …
  21645. Neuroprotective Effect of Fractalkine on Radiation-induced brain Injury Through Promoting the M2 Polarization of Microglia
  21646. Structural characterization of a polysaccharide from Lycium barbarum and its Neuroprotective effect against β-amyloid peptide neurotoxicity
  21647. Neuroprotective Benefits of Exercise and MitoQ on memory Function, Mitochondrial Dynamics, Oxidative Stress, and Neuroinflammation in D-Galactose-Induced …
  21648. Metabolomic Profiling and Neuroprotective Effects of Purslane Seeds Extract Against Acrylamide Toxicity in Rat’s brain
  21649. The Neuroprotective effect of MicroRNA-149-5p and coenzymeQ10 by reducing levels of inflammatory cytokines and metalloproteinases following focal brain ischemia …
  21650. Isolation of Neuroprotective Anthocyanins from Black Chokeberry (Aronia melanocarpa) against Amyloid-β-Induced cognitive Impairment
  21651. Remote Ischemic Postconditioning Inhibited Mitophagy to Achieve Neuroprotective Effects in the Rat Model of Cardiac Arrest
  21652. Exercise is Neuroprotective on the morphology of somatic motoneurons following the death of neighboring motoneurons via androgen action at the target muscle
  21653. Suntamide A, a Neuroprotective cyclic peptide from Cicadidae Periostracum
  21654. Antihypernociceptive and Neuroprotective Effects of the Aqueous and Methanol Stem-Bark Extracts of Nauclea pobeguinii (Rubiaceae) on STZ-Induced …
  21655. Neuroprotective and neurotoxic effects of endocannabinoid-like compounds, N-arachidonoyl dopamine and N-docosahexaenoyl dopamine in differentiated cultures of …
  21656. Neuroprotective effects of ethanolic extract from dry Rhodiola rosea L. rhizomes
  21657. Isolation and Characterization of Neuroprotective Components from Citrus Peel and Their Application as Functional Food
  21658. An antarctic krill oil-based diet elicits Neuroprotective effects by inhibiting oxidative stress and rebalancing the M1/M2 microglia phenotype in a cuprizone …
  21659. The Neuroprotective role of Wnt signaling in the retina
  21660. Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington’s disease through inhibition of NF-κB mediated neuroinflammatory …
  21661. Neuroprotective schinortriterpenoids from Schisandra neglecta collected in Medog County, Tibet, China
  21662. RNA‐Seq analysis of knocking out the Neuroprotective proton‐sensitive GPR68 on basal and acute ischemia‐induced transcriptome changes and signaling in mouse …
  21663. Neuroprotective Effects of Withania somnifera on 4-Hydroxynonenal Induced Cell Death in Human Neuroblastoma SH-SY5Y Cells Through ROS Inhibition and …
  21664. Quantification of BNN27, a novel Neuroprotective 17‐spiroepoxy dehydroepiandrosterone derivative in the blood and retina of rodents, after single intraperitoneal …
  21665. Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis
  21666. Neuroprotective Effects of 2-Substituted 1, 3-Selenazole Amide Derivatives on Amyloid-Beta-Induced Toxicity in a Transgenic Caenorhabditis Elegans Model of …
  21667. Melatonin exerts a Neuroprotective effect against γ-radiation-induced brain injury in the rat through the modulation of neurotransmitters, inflammatory cytokines …
  21668. Neuroprotective Effects Against Cerebral Ischemic Injury Exerted by Dexmedetomidine via the HDAC5/NPAS4/MDM2/PSD-95 Axis
  21669. Neuroprotective Effect of Near-Infrared Light in an Animal Model of CI Surgery
  21670. Neuroprotective effect of nerolidol in traumatic brain injury associated behavioural comorbidities in rats
  21671. Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells
  21672. Evaluation of hepato-and Neuroprotective effect of chemical constituents in Saussurea costus extract against the toxicity induced by chloropyrofos ethyl in rats
  21673. MiRNA-190 exerts Neuroprotective effects against ischemic stroke through Rho/Rho-kinase pathway
  21674. Neuroprotective effects of vitamin C and garlic on glycoconjugates changes of cerebellar cortex in lead-exposed rat offspring
  21675. The possible role of CREB‐BDNF signaling pathway in Neuroprotective effects of minocycline against alcohol‐induced neurodegeneration: molecular and behavioral …
  21676. Electrospun nanofibers for dual and local delivery of Neuroprotective drugs
  21677. Evaluation of the Neuroprotective effects of Vitamin E on the rat substantia nigra neural cells exposed to electromagnetic field: An ultrastructural study
  21678. The Pathogenesis of Neurotrauma Indicates Targets for Neuroprotective Therapies.
  21679. Inula viscosa (L.) Greuter, phytochemical composition, antioxidant, total phenolic content, total flavonoids content and Neuroprotective effects
  21680. Improved spatial memory , neurobehavioral outcomes, and Neuroprotective effect after progesterone administration in ovariectomized rats with traumatic brain injury …
  21681. Clinical-Neurological and Neurocognitive Indicators Against the Background of Neuroprotective Therapy in Vertebro-Basilar Insufficiency in Patients with Symptoms of …
  21682. Naringin ameliorates memory deficits and exerts Neuroprotective effects in a mouse model of Alzheimer’s disease by regulating multiple metabolic pathways
  21683. Neuroprotective phosphatidylserine liposomes alleviate depressive-like behavior related to stroke through neuroinflammation attenuation in the mouse hippocampus
  21684. Neuroprotective Effects of Milrinone on Experimental Acute Spinal Cord Injury: Rat Model
  21685. Oleanolic acid exerts Neuroprotective effects in subarachnoid hemorrhage rats through SIRT1-mediated HMGB1 deacetylation
  21686. Qingda granule exerts Neuroprotective effects against ischemia/reperfusion-induced cerebral injury via lncRNA GAS5/miR-137 signaling pathway
  21687. Low-dose lipopolysaccharide as an immune regulator for homeostasis maintenance in the central nervous system through transformation to Neuroprotective …
  21688. The Neuroprotective effect of ethanolic extract Ocimum sanctum Linn. in the regulation of neuronal density in hippocampus areas as a central autobiography memory …
  21689. Ac-FLTD-CMK inhibits pyroptosis and exerts Neuroprotective effect in a mice model of traumatic brain injury
  21690. Neuroprotective effect of Mulmina™ against chemotherapy‑induced cognitive decline in normal rats
  21691. N-acetylserotonin Derivative Exerts a Neuroprotective Effect by Inhibiting the NLRP3 Inflammasome and Activating the PI3K/Akt/Nrf2 Pathway in the Model of Hypoxic …
  21692. Neuroprotective effect of Betalain against AlCl3-induced Alzheimer’s disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear …
  21693. Polycyclic polyprenylated acylphloroglucinol derivatives with Neuroprotective effects from Hypericum monogynum
  21694. Caffeine improves bladder function in diabetic rats via a Neuroprotective effect
  21695. Regulation of Tau protein phosphorylation by glucosamine-induced O-GlcNAcylation as a Neuroprotective mechanism in a brain ischemia-reperfusion model
  21696. Neuroprotective effect of Na+/H+ exchangers isoform‐1 inactivation against 6‐hydroxydopamine‐induced mitochondrial dysfunction and neuronal apoptosis in …
  21697. Neuroprotective Effect of Fisetin Against the Cerebral Ischemia-Reperfusion Damage via Suppression of Oxidative Stress and Inflammatory Parameters
  21698. Sesquiterpenoids with Neuroprotective activities from the Chloranthaceae plant Chloranthus henryi
  21699. Neuroprotective effect of rhaponticin against Parkinson disease: Insights from in vitro BV‐2 model and in vivo MPTP‐induced mice model
  21700. Bioanalytical Method Development and Validation Study of Neuroprotective Extract of Kashmiri Saffron Using Ultra-Fast Liquid Chromatography-Tandem Mass …
  21701. Potential Neuroprotective activity of Mentha longifolia L. in aluminum chloride‐induced rat model of Alzheimer’s disease
  21702. Neuroprotective Effect of Membrane-Free Stem Cell Extract against Amyloid Beta 25–35-Induced Neurotoxicity in SH-SY5Y Cells
  21703. Nrf2 mediates the Neuroprotective effect of isoflurane preconditioning in cortical neuron injury induced by oxygen-glucose deprivation
  21704. Presumed Neuroprotective therapies prescribed by veterinary ophthalmologists for canine degenerative retinal and optic nerve diseases
  21705. Harpagide exerts a Neuroprotective effect by inhibiting endoplasmic reticulum stress via SERCA following oxygen-glucose deprivation/reoxygenation injury
  21706. Neuroprotective validation of pectin in T2DM-induced allodynia and hyperalgesia in diabetic peripheral neuropathic pain
  21707. Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, brain GLP-1 Response and Its brain /Plasma …
  21708. Four new resorcinol derivatives with Neuroprotective activities from Xylaria nigripes
  21709. Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson’s model through apoptosis and iron accumulation inhibition
  21710. ESCAPE-NA1 Trial Brings Hope of Neuroprotective Drugs for Acute Ischemic Stroke: Highlights of the Phase 3 Clinical Trial on Nerinetide
  21711. Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and memory Enhancer—Its Comparative Expression, Processing and Signaling in Mammalian CNS
  21712. The Neuroprotective role of SIRT1/PGC-1α signaling in limb postconditioning in cerebral ischemia/reperfusion injury
  21713. Hirsutanol A exhibits Neuroprotective activities against sevoflurane‐induced neurotoxicity in aged rats
  21714. The Neuroprotective effects of pregabalin after cerebral ischemia by occlusion of the middle cerebral artery in rats
  21715. Sulphonamide‐Containing Oxazoline Hybrids as New Class of Neuroprotective agents and Lead Molecule as Autophagy Inducer
  21716. Pyrimido [1, 2-b] indazole derivatives: Selective inhibitors of human monoamine oxidase B with Neuroprotective activity
  21717. The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display Neuroprotective and anti-inflammatory actions in the in vivo retinal …
  21718. Neuroprotective effect of roflumilast under cerebral ischemia/reperfusion injury in juvenile rats through NLRP‐mediated inflammatory response inhibition
  21719. Phosphine modification of proline-glycine-proline tripeptide and study of its Neuroprotective properties
  21720. … against Glutamate-Induced Oxidative Cell Death in HT22 Cells via Activating Nrf2 and HO-1 Signaling Pathway: Neuroprotective Principles and Mechanisms of …
  21721. Neuroprotective effect of immunomodulatory peptides in rats with traumatic spinal cord injury
  21722. Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget Neuroprotective activity
  21723. Overexpression of FKH-2/FOXG1 is Neuroprotective in a C. elegans model of Machado-Joseph disease
  21724. Prevention of MEK-ERK-1/2 hyper-activation underlines the Neuroprotective effect of Glycyrrhiza glabra L.(Yashtimadhu) against rotenone-induced cellular and …
  21725. Novel arylidene malonate derivative, KM-34, showed Neuroprotective effects on in vitro and in vivo models of ischemia/reperfusion
  21726. The Neurotrophic and Neuroprotective Potential of Macrofungi
  21727. Neuroprotective potential of fisetin in an experimental model of spinal cord injury: via modulation of NF-κB/IκBα pathway
  21728. Combined treatment with valproic acid and estrogen has Neuroprotective effects in ovariectomized mice with Alzheimer’s disease
  21729. The potential Neuroprotective roles of olive leaf extract in an epilepsy rat model induced by kainic acid
  21730. Neuroprotective effects of icariin in neonatal hypoxia-ischemic brain damage via its anti-apoptotic property
  21731. Neuroprotective and neurotrophic effects of ginkgetin and bilobalide on MPTP-induced mice with Parkinson’disease
  21732. Brassica Vegetables: Rich Sources of Neuroprotective Compounds
  21733. Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson’s disease
  21734. Neuroprotective and Mitoprotective Effects of Lemon IntegroPectin on SH-SY5Y Cells
  21735. Comparative effects of berberine and piperine on the Neuroprotective potential of neostigmine
  21736. A novel brain targeted plasma exosomes enhance the Neuroprotective efficacy of edaravone in ischemic stroke
  21737. Neuroprotective potential of Naringenin-loaded solid-lipid nanoparticles against rotenone-induced Parkinson’s disease model
  21738. Phytochemical analysis, Neuroprotective , anticholinesterase, cytotoxic and catalase potentials of Opuntia microdasys var. rufida and Opuntia leptocaulis
  21739. Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats
  21740. Continued development of azithromycin as a Neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
  21741. Neuroprotective effects of oleocanthal in neurological disorders
  21742. Caenorhabditis elegans: an elegant model organism for evaluating the Neuroprotective and neurotherapeutic potential of nutraceuticals
  21743. Balancing the Neuroprotective Versus Neurotoxic Effects of Cannabis
  21744. A novel palmitic acid hydroxy stearic acid (5‐PAHSA) plays a Neuroprotective role by inhibiting phosphorylation of the m‐TOR‐ULK1 pathway and regulating …
  21745. miR-221 Exerts Neuroprotective Effects in Ischemic Stroke by Inhibiting the Proinflammatory Response
  21746. Role of pERK1/2-NFκB signaling in the Neuroprotective effect of thalidomide against cerebral ischemia reperfusion injury in rats
  21747. Neuroprotective Effect of Ashwagandha Extract against the Neurochemical Changes Induced in Rat Model of Hypothyroidism
  21748. Effects of Early Crush on Aging Wild Type and Connexin 32 Knockout Mice: Evidence for a Neuroprotective State in CMT1X Mouse Nerve
  21749. Neuroprotective potential of selected lichen compounds on mouse neuroblastoma (N2a) cells
  21750. Structure–Activity Relationship of Phytoestrogen Analogs as ERα/β Agonists with Neuroprotective Activities
  21751. The Neuroprotective Mechanism of Spinal Cord Stimulation in Spinal Cord Ischemia/Reperfusion Injury
  21752. Oxytocin and Neuroprotective Effects
  21753. Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
  21754. Potential Neuroprotective of trans-resveratrol a promising agent tempeh and soybean seed coats-derived against beta-amyloid neurotoxicity on primary …
  21755. Evaluating the Neuroprotective Effect of Melatonin on Patients with Hemorrhagic Stroke Using Serum S100B Protein as a Prognostic Marker
  21756. Neuroprotective effects of curcumin loaded solid lipid nanoparticles on homocysteine induced oxidative stress in vascular dementia
  21757. Vasculoprotective and Neuroprotective Effects of Various Parts of Pomegranate: In Vitro, In Vivo, and Preclinical Studies
  21758. Neuroprotective Effects of Portulaca oleracea and Portulaca quadrifida Linn
  21759. Disordered structure and flexible roles: using the prion protein N1 fragment for Neuroprotective and regenerative therapy
  21760. Verification of Neuroprotective effects of alpha-lipoic acid on chronic neuropathic pain in a chronic constriction injury rat model
  21761. Discovery of β‐Dihydroagarofuran‐Type Sesquiterpenoids from the Leaves of Tripterygium wilfordii with Neuroprotective Activities
  21762. Neuroglobin as a Neuroprotective in Neonates with Hypoxic Ischemic Encephalopathy
  21763. Neuroprotective Effect of p38 MAPKs Inhibitor (SB239063) and Vitamin B12 against Lipopolysaccharide Induced Neuroinflammation
  21764. Neuroprotective and antioxidant effect of Curcuma longa (Rhizome) methanolic extract on SH-SY5Y cells and Javanese medaka.
  21765. Up-regulation of miRNA-151-3p enhanced the Neuroprotective effect of dexmedetomidine against β-amyloid by targeting DAPK-1 and TP53
  21766. Effects of 2600 MHz Radiofrequency Radiation in brain Tissue of Male Wistar Rats and Neuroprotective Effects of Melatonin
  21767. Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson’s disease models
  21768. Neuroprotective Xanthones and Their Biosynthesis in Shoot Cultures of Hoppea fastigiata (Griseb.) CB Clarke
  21769. CORM-3 exerts a Neuroprotective effect in a rodent model of traumatic brain injury via the bidirectional gut–brain interactions
  21770. Human primed endothelial colony forming cells exert Neuroprotective effects in the growth restricted newborn piglet
  21771. Claulansine F–Donepezil Hybrids as Anti-Alzheimer’s Disease agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities
  21772. Neuroprotective Effect of Fructus broussonetiae on APP/PS1 Mice via Upregulation of AKT/β-Catenin Signaling
  21773. In Vitro Analysis of Neuroprotective and Antioxidant Property of Sponge Extract
  21774. The Neuroprotective effects of Sonic hedgehog pathway agonist SAG in a rat model of neonatal stroke
  21775. Neuroprotective Effect of Alkylresorcinols from Wheat Bran in HT22 Cells: Correlation with in vitro Antioxidant Activity
  21776. Neuroprotective Effect of Empagliflozinon Cerebral Ischemia/Reperfusion Injury in Rat Model
  21777. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase-Design, synthesis and biological evaluation
  21778. Neurologic and Histologic Tests Used to Measure Neuroprotective Effectiveness of Virus-Derived Immune-Modulating Proteins
  21779. Search for Neuroprotective Compounds-From 4-Methycatechol to Citrus Compounds
  21780. Neuroprotective effects of farnesol on motor and cognitive impairment against 3-nitropropionic acid-induced Huntington’s disease.
  21781. Neuroprotective effects of Ginkgolide B in focal cerebral ischemia through selective activation of prostaglandin E2 receptor EP4 and the downstream transactivation of …
  21782. Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts. Nanomaterials 2021, 11, 563
  21783. Inhibition of histone deacetylase promotes a Neuroprotective mechanism in an experimental model of Parkinson’s disease
  21784. Arctigenin Exerts Neuroprotective Effect By Ameliorating Cortical Activities in Experimental Autoimmune Encephalomyelitis in Vivo
  21785. Inhaled gases as novel Neuroprotective therapies in the postcardiac arrest period.
  21786. Neuroprotective Effects of Extracts from Tiger Milk Mushroom Lignosus rhinocerus Against Glutamate-Induced Toxicity in HT22 Hippocampal Neuronal Cells and …
  21787. Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative …
  21788. Anti-Amnesic and Neuroprotective Effects of Ziziphus Jujuba Aqueous Extract on Scopolamine-Induced cognitive Impairments in Rats
  21789. Neuroprotective Effect of Filgrastim in Animal Models of 3-Nitropropionic Acid & Haloperidol Induced Neurotoxicity in Rats
  21790. Diffusion Basis Spectrum Imaging Measures Anti-Inflammatory and Neuroprotective Effects of Fingolimod on Murine Optic Neuritis
  21791. The Neuroprotective Effects of Insulin-Like Growth Factor 1 via the Hippo/YAP Signaling Pathway is Mediated by the PI3K/AKT Pathway Following Cerebral …
  21792. Neuroprotective Role of Diosgenin, A NGF Stimulator, Against Aβ (1–42) Induced Neurotoxicity in Animal Model of Alzheimer’s Disease
  21793. Neuroprotective Effects of Sildenafil on Traumatic brain Injury in an Experimental Rat Model
  21794. Exploring Neuroprotective Properties of Centella Asiatica Extract on Metabolic Change in Chronic Stress-Induced Rats
  21795. Neuroprotective effects of farnesol on motor and cognitive impairment against 3-nitropropionic acid-induced Huntington’s disease
  21796. Neuroprotective Effects Of The Inert Gas Argon Onexperimental Traumatic brain Injury In Vivo With The Controlled Cortical Impact Model In Mice
  21797. Neuroprotective effect of Exercise on Alzheimer’s disease in rats: Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF2).
  21798. Neuroprotective Effect of Telmisartan in brain Ischemic Reperfusion Injury in Male Rats
  21799. The Neuroprotective properties, Functions and Roles of Cannabis sativa in selected diseases related to the Nervous System.
  21800. Participation of glutamatergic ionotropic receptors in excitotoxicity: the Neuroprotective role of prolactin
  21801. The psychopharmacology of saffron, a plant with putative antidepressant and Neuroprotective properties
  21802. cognitive enhancement and Neuroprotective effects of a traditional Chinese herbal compound medicine on Aβ1–42 induced Alzheimer’s disease in rats
  21803. Trehalose-based Neuroprotective autophagy inducers
  21804. Vitamin D confers Neuroprotective effects in traumatic brain injury by activating Nrf2 signaling through an autophagy-mediated mechanism
  21805. Determining the Optimal Administration Conditions under Which MIF Exerts Neuroprotective Effects by Inducing BDNF Expression and Inhibiting Apoptosis in an In …
  21806. Neuroprotective Effects of Berberine Hydrochloride on cognitive Dysfunction-Induced by Methamphetamine: Immunohistochemical and Behavioral Studies in Rats
  21807. Design and Synthesis of Dipeptide Nerve Growth Factor Loop 1 Mimetics and In Vitro Studies of their Neuroprotective and Differentiation-Inducing Activities
  21808. Neuroprotective Effect of Xylopia Aethiopica Seed on Lead-Induced Injury on the Cerebral Cortex of Male Wistar Rat
  21809. The Results of the Usage of Electro Stimulation in Neuroprotective Therapy of the Glaucomatous Optic Neuropathy
  21810. BETA-GLUCOCEREBROSIDASE MEDIATES MICROGLIAL Neuroprotective FUNCTIONS: A POSSIBLE LINK BETWEEN PARKINSON’S AND GAUCHER’S …
  21811. Lycopus lucidus Turcz exerts Neuroprotective effect against H2O2‑induced neuroinflammation by inhibiting NLRP3 inflammasome activation in cortical neurons
  21812. Commentary: Diffuse optical spectroscopies: Shedding light on Neuroprotective strategies during cardiac surgery
  21813. Stratification Strategies for Patients to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson’s Disease.
  21814. Resveratrol nanoparticles are Neuroprotective in a model of multiple sclerosis
  21815. Novel Insights into Neuroprotective Strategies Employing NQO1 and DCLK1 in Parkinson’s Disease
  21816. Herbal Extracts as Neuroprotective agents in an In-vitro Model of Aluminum Neurotoxicity
  21817. The Neuroprotective role of EAAC1 in hippocampal injury following ischemia-reperfusion
  21818. A novel dammarane-type saponin from Gynostemma pentaphyllum and its Neuroprotective effect
  21819. Neuroprotective effect of anthocyanin oligomers demonstrated by ischemic insults and lipid peroxidation
  21820. Cleistocalyx nervosum var. paniala seed extracts exhibit sigma-1 antagonist sensitive Neuroprotective effects in PC12 cells and protect C. elegans from stress …
  21821. Abstract P349: Neuroprotective Effects of L-Carnitine on Vascular Dementia in Hemodialysis Patients
  21822. Neuroprotective Roles of the Adenosine A3 Receptor Agonist AST-004 in Mouse Model of Traumatic brain Injury
  21823. SRF regulates the generation of Neuroprotective astrocytes in the brain
  21824. Neuroprotective Effect of Cinnamic Acid on cognitive Impairment and the Level of Oxidative Stress Indicators in Rat’s Offspring in an Uteroplacental Insufficiency …
  21825. Neuroprotective validation of pectin in T2DM-induced allodynia and hyperalgesia in diabetic peripheral neuropathic pain
  21826. Evaluation of the Effectiveness of Neuroprotective Therapy on Retinal Morphometric Parameters in Primary Open-Angle Glaucoma
  21827. Abstract P772: Complement C3a Receptor Deletion is Neuroprotective in a Murine Model of Vascular cognitive Impairment
  21828. Idle Chit-Chat: Neuroprotective and Immunomodulatory Effects on Coronavirus
  21829. Neuroprotective Activity of Beetroot (Beta vulgaris) Extract on H2O2-Induced Damage in IMR32 and SHSY5Y Cell Lines
  21830. Abstract P755: Perlecan Lg3 is Neuroprotective and Functionally Restorative in Experimental Ischemic Stroke
  21831. A Neuroprotective strategy to reduce acute and chronic disability, and slowly progressive central nervous system atrophy in a new model of multiple sclerosis
  21832. Variations of neuronal nitric oxide synthase after hypophysectomy suggest a Neuroprotective effect of nitric oxide in response to damage of the neurons of the …
  21833. … : ReLiSyR-MND (Repurposing Living Systematic Review–Motor Neuron Disease): A systematic approach to identify Neuroprotective interventions for motor …
  21834. Biotransformation of 1α, 11α-dihydroxyisopimara-8 (14), 15-diene by Cunninghamella echinulata NRRL 1386 and their Neuroprotective activity
  21835. Endovascular Delivery of Low Dose Compound 21 is Neuroprotective Independent of Reperfusion in Ischemic Stroke
  21836. Neuroprotective effect of hydrogen sulfide against glutamate-induced oxidative stress is mediated via the p53/glutaminase 2 pathway after traumatic brain injury.
  21837. Glucagon-like peptide-1 receptor agonists as Neuroprotective agents for ischemic stroke: a systematic scoping review
  21838. MicroRNA-579-3p Exerts Neuroprotective Effects Against Ischemic Stroke via Anti-Inflammation and Anti-Apoptosis [Retraction]
  21839. 7: HNSC Therapy Is More Neuroprotective Than Glibenclamide After Cardiac Arrest via Immunomodulation

 

 

Related Posts

Shopping Cart
Scroll to Top